Citrus Sinensis ID: 016471
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 389 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FIM9 | 594 | CDPK-related kinase 4 OS= | yes | no | 0.966 | 0.632 | 0.723 | 1e-162 | |
| Q9SG12 | 594 | CDPK-related kinase 6 OS= | no | no | 0.966 | 0.632 | 0.707 | 1e-157 | |
| Q9ZUZ2 | 595 | CDPK-related kinase 3 OS= | no | no | 0.966 | 0.631 | 0.708 | 1e-154 | |
| Q9SCS2 | 601 | CDPK-related kinase 5 OS= | no | no | 0.976 | 0.632 | 0.638 | 1e-147 | |
| P53681 | 602 | CDPK-related protein kina | N/A | no | 0.933 | 0.602 | 0.667 | 1e-145 | |
| O80673 | 576 | CDPK-related kinase 1 OS= | no | no | 0.933 | 0.630 | 0.640 | 1e-142 | |
| Q9LET1 | 577 | CDPK-related kinase 7 OS= | no | no | 0.933 | 0.629 | 0.626 | 1e-139 | |
| Q9LJL9 | 599 | CDPK-related kinase 2 OS= | no | no | 0.982 | 0.637 | 0.602 | 1e-135 | |
| Q10KY3 | 600 | Calcium/calmodulin-depend | no | no | 0.933 | 0.605 | 0.623 | 1e-133 | |
| Q9FX86 | 606 | CDPK-related kinase 8 OS= | no | no | 0.938 | 0.602 | 0.6 | 1e-133 |
| >sp|Q9FIM9|CAMK4_ARATH CDPK-related kinase 4 OS=Arabidopsis thaliana GN=CRK4 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 573 bits (1476), Expect = e-162, Method: Compositional matrix adjust.
Identities = 272/376 (72%), Positives = 322/376 (85%)
Query: 12 SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPEN 71
+++ CEGGELLDRIL+RGGRY E DAK I+ +IL+ AF HLQGVVHRDLKPEN
Sbjct: 217 ADNVFVVMELCEGGELLDRILARGGRYPEVDAKRILVQILSATAFFHLQGVVHRDLKPEN 276
Query: 72 FLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVI 131
FLFT+R EDA LKVIDFGLSDF+R DQRLND+VGSAYYVAPEVLHRSY+ E DMWSIGVI
Sbjct: 277 FLFTSRNEDAILKVIDFGLSDFIRYDQRLNDVVGSAYYVAPEVLHRSYSTEADMWSIGVI 336
Query: 132 TYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTA 191
+YILLCGSRPF+ RTES IFR VLRA+PNF D PWPS+SP AKDFV+RLLNKDHRKRMTA
Sbjct: 337 SYILLCGSRPFYGRTESAIFRCVLRANPNFEDMPWPSISPTAKDFVKRLLNKDHRKRMTA 396
Query: 192 AQALTHPWLHDENRPVPLDILIYKLVKSYLRATPLKRAALKALSKALTEEELVYLRAQFM 251
AQAL HPWL DEN + LD +YKLVKSY+RA+P +R+ALKALSKA+ +EELV+L+AQFM
Sbjct: 397 AQALAHPWLRDENPGLLLDFSVYKLVKSYIRASPFRRSALKALSKAIPDEELVFLKAQFM 456
Query: 252 LLEPKDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQ 311
LL+PKDG +SLN F +AL R ATDAM +SR+ +ILN M+PL+ +KL +EEFCAAA SVYQ
Sbjct: 457 LLDPKDGGLSLNCFTMALTRYATDAMMESRLPDILNTMQPLAQKKLDFEEFCAAAVSVYQ 516
Query: 312 LEALERWDQIAITAFDYFEQEGNRVISVEELALELNLAPAAYSLLNDCIRNSDGKLSFLG 371
LEALE W+QIA +AF++FE EGNR+ISV+ELA E+++ P+AY LL D IR+SDGKLSFLG
Sbjct: 517 LEALEEWEQIATSAFEHFEHEGNRIISVQELAGEMSVGPSAYPLLKDWIRSSDGKLSFLG 576
Query: 372 YKRFLHGVTVRSSNTR 387
Y +FLHGVTVRSS++R
Sbjct: 577 YAKFLHGVTVRSSSSR 592
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9SG12|CAMK6_ARATH CDPK-related kinase 6 OS=Arabidopsis thaliana GN=CRK6 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 554 bits (1428), Expect = e-157, Method: Compositional matrix adjust.
Identities = 266/376 (70%), Positives = 316/376 (84%)
Query: 12 SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPEN 71
S++ CEGGELLD IL+RGGRY E +AK I+ +IL+ AF HLQGVVHRDLKPEN
Sbjct: 216 SDNVFVVMELCEGGELLDSILARGGRYPEAEAKRILVQILSATAFFHLQGVVHRDLKPEN 275
Query: 72 FLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVI 131
FLFT++ EDA LKVIDFGLSD+ R DQRLND+VGSAYYVAPEVLHRSY+ E D+WSIGVI
Sbjct: 276 FLFTSKNEDAVLKVIDFGLSDYARFDQRLNDVVGSAYYVAPEVLHRSYSTEADIWSIGVI 335
Query: 132 TYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTA 191
+YILLCGSRPF+ RTES IFR VLRA+PNF D PWPS+SP AKDFV+RLLNKDHRKRMTA
Sbjct: 336 SYILLCGSRPFYGRTESAIFRCVLRANPNFDDLPWPSISPIAKDFVKRLLNKDHRKRMTA 395
Query: 192 AQALTHPWLHDENRPVPLDILIYKLVKSYLRATPLKRAALKALSKALTEEELVYLRAQFM 251
AQAL HPWL DEN + LD IYKLVKSY+RA+P +RAALK+LSKA+ EEELV+L+AQFM
Sbjct: 396 AQALAHPWLRDENPGLLLDFSIYKLVKSYIRASPFRRAALKSLSKAIPEEELVFLKAQFM 455
Query: 252 LLEPKDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQ 311
LLEP+DG + L+NF AL R ATDAM +SR+ +ILN+M+PL+ +KL +EEFCAA+ SVYQ
Sbjct: 456 LLEPEDGGLHLHNFTTALTRYATDAMIESRLPDILNMMQPLAHKKLDFEEFCAASVSVYQ 515
Query: 312 LEALERWDQIAITAFDYFEQEGNRVISVEELALELNLAPAAYSLLNDCIRNSDGKLSFLG 371
LEALE W+QIA AF++FE EG+R ISV+ELA E++L P AY LL D IR+ DGKL+FLG
Sbjct: 516 LEALEEWEQIATVAFEHFESEGSRAISVQELAEEMSLGPNAYPLLKDWIRSLDGKLNFLG 575
Query: 372 YKRFLHGVTVRSSNTR 387
Y +FLHGVTVRSS++R
Sbjct: 576 YAKFLHGVTVRSSSSR 591
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUZ2|CAMK3_ARATH CDPK-related kinase 3 OS=Arabidopsis thaliana GN=CRK3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 546 bits (1407), Expect = e-154, Method: Compositional matrix adjust.
Identities = 267/377 (70%), Positives = 323/377 (85%), Gaps = 1/377 (0%)
Query: 12 SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPEN 71
+N+ C+GGELLDRIL+RGG+Y E+DAK IV +IL +V+FCHLQGVVHRDLKPEN
Sbjct: 217 ANNVYIVMELCDGGELLDRILARGGKYPEDDAKAIVVQILTVVSFCHLQGVVHRDLKPEN 276
Query: 72 FLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVI 131
FLFT+ ED+ LK+IDFGLSDF+RPD+RLNDIVGSAYYVAPEVLHRSY++E D+WSIGVI
Sbjct: 277 FLFTSSREDSDLKLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVI 336
Query: 132 TYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTA 191
TYILLCGSRPFWARTESGIFR+VLR +PN+ D PWPS S E KDFV+RLLNKD+RKRM+A
Sbjct: 337 TYILLCGSRPFWARTESGIFRTVLRTEPNYDDVPWPSCSSEGKDFVKRLLNKDYRKRMSA 396
Query: 192 AQALTHPWLHDENRPVPLDILIYKLVKSYLRATPLKRAALKALSKALTEEELVYLRAQFM 251
QALTHPWL D++R +PLDILIYKLVK+YL ATPL+RAALKAL+KALTE ELVYLRAQFM
Sbjct: 397 VQALTHPWLRDDSRVIPLDILIYKLVKAYLHATPLRRAALKALAKALTENELVYLRAQFM 456
Query: 252 LLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVY 310
LL P KDG VSL NFK ALM+ ATDAM +SRV EIL+ ME L+ +K+ +EEFCAAA S++
Sbjct: 457 LLGPNKDGSVSLENFKTALMQNATDAMRESRVPEILHTMESLAYRKMYFEEFCAAAISIH 516
Query: 311 QLEALERWDQIAITAFDYFEQEGNRVISVEELALELNLAPAAYSLLNDCIRNSDGKLSFL 370
QLEA++ W++IA F +FE EGNRVI++EELA ELN+ +AY L D +R+SDGKLS+L
Sbjct: 517 QLEAVDAWEEIATAGFQHFETEGNRVITIEELARELNVGASAYGHLRDWVRSSDGKLSYL 576
Query: 371 GYKRFLHGVTVRSSNTR 387
G+ +FLHGVT+R+++ R
Sbjct: 577 GFTKFLHGVTLRAAHAR 593
|
May play a role in signal transduction pathways that involve calcium as a second messenger (By similarity). Serine/threonine kinase that phosphorylates histone H3 an GLN1-1. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SCS2|CAMK5_ARATH CDPK-related kinase 5 OS=Arabidopsis thaliana GN=CRK5 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 520 bits (1338), Expect = e-147, Method: Compositional matrix adjust.
Identities = 249/390 (63%), Positives = 317/390 (81%), Gaps = 10/390 (2%)
Query: 3 HQKLQHLF-----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFC 57
H L H + + N ++ CEGGELLDRILSRGG+Y EEDAKT++ +ILN+VAFC
Sbjct: 209 HNNLPHFYDAYEDHDNVYIVM-ELCEGGELLDRILSRGGKYTEEDAKTVMIQILNVVAFC 267
Query: 58 HLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR 117
HLQGVVHRDLKPENFLFT++E+ + LK IDFGLSD+VRPD+RLNDIVGSAYYVAPEVLHR
Sbjct: 268 HLQGVVHRDLKPENFLFTSKEDTSQLKAIDFGLSDYVRPDERLNDIVGSAYYVAPEVLHR 327
Query: 118 SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFV 177
SY+ E D+WS+GVI YILLCGSRPFWARTESGIFR+VL+ADP+F D PWP +S EA+DFV
Sbjct: 328 SYSTEADIWSVGVIVYILLCGSRPFWARTESGIFRAVLKADPSFDDPPWPLLSSEARDFV 387
Query: 178 RRLLNKDHRKRMTAAQALTHPWLHDEN-RPVPLDILIYKLVKSYLRATPLKRAALKALSK 236
+RLLNKD RKR+TAAQAL+HPW+ D N VP+DIL++KL+++YLR++ L++AAL+ALSK
Sbjct: 388 KRLLNKDPRKRLTAAQALSHPWIKDSNDAKVPMDILVFKLMRAYLRSSSLRKAALRALSK 447
Query: 237 ALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQ 295
LT +EL YLR QF LLEP K+G +SL N K ALM+ ATDAM DSR+ E L + L +
Sbjct: 448 TLTVDELFYLREQFALLEPSKNGTISLENIKSALMKMATDAMKDSRIPEFLGQLSALQYR 507
Query: 296 KLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALELNLAPA--AY 353
++ +EEFCAAA SV+QLEAL+RW+Q A A++ FE+EGNR I ++ELA EL L P+ +
Sbjct: 508 RMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKEGNRPIMIDELASELGLGPSVPVH 567
Query: 354 SLLNDCIRNSDGKLSFLGYKRFLHGVTVRS 383
++L+D +R++DGKLSFLG+ + LHGV+ R+
Sbjct: 568 AVLHDWLRHTDGKLSFLGFVKLLHGVSSRT 597
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P53681|CRK_DAUCA CDPK-related protein kinase OS=Daucus carota GN=CRK PE=2 SV=1 | Back alignment and function description |
|---|
Score = 514 bits (1324), Expect = e-145, Method: Compositional matrix adjust.
Identities = 245/367 (66%), Positives = 308/367 (83%), Gaps = 4/367 (1%)
Query: 21 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREED 80
CEGGELLDRILSRGG+Y E+DAK ++ +ILN+VAFCHLQGVVHRDLKPENFLF +++ED
Sbjct: 231 LCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFKSKDED 290
Query: 81 APLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSR 140
+ LK IDFGLSD+V+PD+RLNDIVGSAYYVAPEVLHRSY+ E D+WSIGVI+YILLCGSR
Sbjct: 291 SQLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVISYILLCGSR 350
Query: 141 PFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200
PFWARTESGIFR+VL+A+ +F + PWPSVS EAKDFV+RLLNKD RKRMTAAQAL H W+
Sbjct: 351 PFWARTESGIFRAVLKANLSFDEPPWPSVSSEAKDFVKRLLNKDPRKRMTAAQALCHSWI 410
Query: 201 HDENR-PVPLDILIYKLVKSYLRATPLKRAALKALSKALTEEELVYLRAQFMLLEP-KDG 258
+ N PLDIL++KL+K Y+R++PL++AAL+ALSK LT +EL YL+ QF+LLEP K+G
Sbjct: 411 KNSNDIKFPLDILVFKLMKVYMRSSPLRKAALRALSKTLTVDELFYLKEQFVLLEPTKNG 470
Query: 259 CVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERW 318
+SL N K ALMR +TDAM DSRV ++L + L +++ +EEFCAAA SV+QLEAL+RW
Sbjct: 471 TISLENIKQALMRNSTDAMKDSRVLDLLVSLNALQYRRMDFEEFCAAALSVHQLEALDRW 530
Query: 319 DQIAITAFDYFEQEGNRVISVEELALELNLAPA--AYSLLNDCIRNSDGKLSFLGYKRFL 376
+Q A A+D FE++GNR I +EELA EL L P+ +++L+D IR++DGKLSFLGY + L
Sbjct: 531 EQHARCAYDLFEKDGNRAIMIEELASELGLGPSIPVHAVLHDWIRHTDGKLSFLGYVKLL 590
Query: 377 HGVTVRS 383
HGV+ R+
Sbjct: 591 HGVSTRA 597
|
Daucus carota (taxid: 4039) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O80673|CAMK1_ARATH CDPK-related kinase 1 OS=Arabidopsis thaliana GN=CRK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 504 bits (1297), Expect = e-142, Method: Compositional matrix adjust.
Identities = 235/367 (64%), Positives = 303/367 (82%), Gaps = 4/367 (1%)
Query: 21 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREED 80
C+GGELLD+IL RGG+Y E+DAK ++ +IL++VA+CHLQGVVHRDLKPENFLF+T++E
Sbjct: 206 LCKGGELLDKILQRGGKYSEDDAKKVMVQILSVVAYCHLQGVVHRDLKPENFLFSTKDET 265
Query: 81 APLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSR 140
+PLK IDFGLSD+V+PD+RLNDIVGSAYYVAPEVLHR+Y E DMWSIGVI YILLCGSR
Sbjct: 266 SPLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRTYGTEADMWSIGVIAYILLCGSR 325
Query: 141 PFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200
PFWARTESGIFR+VL+A+PNF ++PWPS+SPEA DFV+RLLNKD+RKR+TAAQAL HPWL
Sbjct: 326 PFWARTESGIFRAVLKAEPNFEEAPWPSLSPEAVDFVKRLLNKDYRKRLTAAQALCHPWL 385
Query: 201 HDENR-PVPLDILIYKLVKSYLRATPLKRAALKALSKALTEEELVYLRAQFMLLEP-KDG 258
+ +P D++IYKLVK Y+ +T L+++AL AL+K LT +L YLR QF LL P K+G
Sbjct: 386 VGSHELKIPSDMIIYKLVKVYIMSTSLRKSALAALAKTLTVPQLAYLREQFTLLGPSKNG 445
Query: 259 CVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERW 318
+S+ N+K A+++ +TDAM DSRVF+ ++++ L +KL +EEFCA+A SVYQLEA+E W
Sbjct: 446 YISMQNYKTAILKSSTDAMKDSRVFDFVHMISCLQYKKLDFEEFCASALSVYQLEAMETW 505
Query: 319 DQIAITAFDYFEQEGNRVISVEELALELNLAPA--AYSLLNDCIRNSDGKLSFLGYKRFL 376
+Q A A++ FE++GNR I +EELA EL L P+ + +L D IR+SDGKLSFLG+ R L
Sbjct: 506 EQHARRAYELFEKDGNRPIMIEELASELGLGPSVPVHVVLQDWIRHSDGKLSFLGFVRLL 565
Query: 377 HGVTVRS 383
HGV+ R+
Sbjct: 566 HGVSSRT 572
|
May play a role in signal transduction pathways that involve calcium as a second messenger (By similarity). Serine/threonine kinase that phosphorylates histone H3. Confers thermotolerance; involved in the heat-shock-mediated calmodulin-dependent signal transduction leading to the activation of heat-shock transcription factors (HSFs); phosphorylates HSFA1A. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LET1|CAMK7_ARATH CDPK-related kinase 7 OS=Arabidopsis thaliana GN=CRK7 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 494 bits (1272), Expect = e-139, Method: Compositional matrix adjust.
Identities = 230/367 (62%), Positives = 301/367 (82%), Gaps = 4/367 (1%)
Query: 21 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREED 80
C+GGELLD+IL RGG+Y E DAK ++ +IL++VA+CHLQGVVHRDLKPENFLFTT++E
Sbjct: 207 LCQGGELLDKILQRGGKYSEVDAKKVMIQILSVVAYCHLQGVVHRDLKPENFLFTTKDES 266
Query: 81 APLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSR 140
+PLK IDFGLSD+VRPD+RLNDIVGSAYYVAPEVLHR+Y E DMWSIGVI YILLCGSR
Sbjct: 267 SPLKAIDFGLSDYVRPDERLNDIVGSAYYVAPEVLHRTYGTEADMWSIGVIAYILLCGSR 326
Query: 141 PFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200
PFWAR+ESGIFR+VL+A+PNF ++PWPS+SP+A DFV+RLLNKD+RKR+TAAQAL HPWL
Sbjct: 327 PFWARSESGIFRAVLKAEPNFEEAPWPSLSPDAVDFVKRLLNKDYRKRLTAAQALCHPWL 386
Query: 201 HDENR-PVPLDILIYKLVKSYLRATPLKRAALKALSKALTEEELVYLRAQFMLLEP-KDG 258
+ +P D++IYKLVK Y+ ++ L+++AL AL+K LT +L YL+ QF LL P K+G
Sbjct: 387 VGSHELKIPSDMIIYKLVKVYIMSSSLRKSALAALAKTLTVPQLTYLQEQFNLLGPSKNG 446
Query: 259 CVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERW 318
+S+ N+K A+++ +T+A DSRV + ++++ L +KL +EEFCA+A SVYQLEA+E W
Sbjct: 447 YISMQNYKTAILKSSTEATKDSRVLDFVHMISCLQYKKLDFEEFCASALSVYQLEAMETW 506
Query: 319 DQIAITAFDYFEQEGNRVISVEELALELNLAPA--AYSLLNDCIRNSDGKLSFLGYKRFL 376
+Q A A++ +E++GNRVI +EELA EL L P+ + +L D IR+SDGKLSFLG+ R L
Sbjct: 507 EQHARRAYELYEKDGNRVIMIEELATELGLGPSVPVHVVLQDWIRHSDGKLSFLGFVRLL 566
Query: 377 HGVTVRS 383
HGV+ R+
Sbjct: 567 HGVSSRT 573
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LJL9|CAMK2_ARATH CDPK-related kinase 2 OS=Arabidopsis thaliana GN=CRK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 482 bits (1240), Expect = e-135, Method: Compositional matrix adjust.
Identities = 235/390 (60%), Positives = 306/390 (78%), Gaps = 8/390 (2%)
Query: 3 HQKLQHL---FYSNSFLFFT-RFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCH 58
HQ L F N+ ++ C GGELLDRIL+RGG+Y E+DAK ++ +ILN+VAFCH
Sbjct: 205 HQNLVQFYDAFEDNANVYIVMELCGGGELLDRILARGGKYSEDDAKAVLIQILNVVAFCH 264
Query: 59 LQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRS 118
LQGVVHRDLKPENFL+T++EE++ LKVIDFGLSDFVRPD+RLNDIVGSAYYVAPEVLHRS
Sbjct: 265 LQGVVHRDLKPENFLYTSKEENSMLKVIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRS 324
Query: 119 YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVR 178
Y E D+WSIGVI YILLCGSRPFWARTESGIFR+VL+ADP+F + PWPS+S EAKDFV+
Sbjct: 325 YTTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEPPWPSLSFEAKDFVK 384
Query: 179 RLLNKDHRKRMTAAQALTHPWLHDENR-PVPLDILIYKLVKSYLRATPLKRAALKALSKA 237
RLL KD RKRMTA+QAL HPW+ + +P DILI+K +K+YLR++ L++AAL ALSK
Sbjct: 385 RLLYKDPRKRMTASQALMHPWIAGYKKIDIPFDILIFKQIKAYLRSSSLRKAALMALSKT 444
Query: 238 LTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQK 296
LT +EL+YL+AQF L P K+G ++L++ ++AL AT+AM +SR+ + L ++ L +
Sbjct: 445 LTTDELLYLKAQFAHLAPNKNGLITLDSIRLALATNATEAMKESRIPDFLALLNGLQYKG 504
Query: 297 LAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALELNLAPA--AYS 354
+ +EEFCAA+ SV+Q E+L+ W+Q A++ FE GNRVI +EELA EL + + ++
Sbjct: 505 MDFEEFCAASISVHQHESLDCWEQSIRHAYELFEMNGNRVIVIEELASELGVGSSIPVHT 564
Query: 355 LLNDCIRNSDGKLSFLGYKRFLHGVTVRSS 384
+LND IR++DGKLSFLG+ + LHGV+ R S
Sbjct: 565 ILNDWIRHTDGKLSFLGFVKLLHGVSTRQS 594
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q10KY3|CAMK1_ORYSJ Calcium/calmodulin-dependent serine/threonine-protein kinase 1 OS=Oryza sativa subsp. japonica GN=CAMK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 476 bits (1225), Expect = e-133, Method: Compositional matrix adjust.
Identities = 229/367 (62%), Positives = 301/367 (82%), Gaps = 4/367 (1%)
Query: 21 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREED 80
C+GGELLDRIL+RGG+Y EEDAK ++ +IL++ +FCHLQGVVHRDLKPENFLF++++E+
Sbjct: 230 LCKGGELLDRILARGGKYSEEDAKVVMRQILSVASFCHLQGVVHRDLKPENFLFSSKDEN 289
Query: 81 APLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSR 140
+ +KVIDFGLSDFV+PD+RLNDIVGSAYYVAPEVLHRSY E DMWSIGVI YILLCGSR
Sbjct: 290 SAMKVIDFGLSDFVKPDERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIVYILLCGSR 349
Query: 141 PFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200
PFWARTESGIFR+VL+ADP+F ++PWP++S EAKDFVRRLLNKD+RKRMTAAQAL HPW+
Sbjct: 350 PFWARTESGIFRAVLKADPSFEEAPWPTLSAEAKDFVRRLLNKDYRKRMTAAQALCHPWI 409
Query: 201 HD-ENRPVPLDILIYKLVKSYLRATPLKRAALKALSKALTEEELVYLRAQFMLLEP-KDG 258
E +PLD++IY+L+++Y+ ++ L+RAAL+AL+K LT +++ YLR QF L+ P K
Sbjct: 410 RGTEEVKLPLDMIIYRLMRAYISSSSLRRAALRALAKTLTTDQIYYLREQFELIGPNKSD 469
Query: 259 CVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERW 318
++L N K ALM+ +T+AM DSRV + +N + + +KL +EEF AAA SVYQ+E LE W
Sbjct: 470 LITLQNLKTALMKNSTNAMKDSRVVDFVNTISNIQYRKLDFEEFSAAAISVYQMEGLETW 529
Query: 319 DQIAITAFDYFEQEGNRVISVEELALELNLAPAA--YSLLNDCIRNSDGKLSFLGYKRFL 376
+Q A A+++F++EGNR I ++ELA EL L P+ + +L D IR+ DGKLSFLG+ + L
Sbjct: 530 EQHARQAYEFFDKEGNRPIVIDELASELGLGPSVPLHVVLQDWIRHPDGKLSFLGFMKLL 589
Query: 377 HGVTVRS 383
HGV+ R+
Sbjct: 590 HGVSSRT 596
|
Possesses kinase activity in vitro. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 7 |
| >sp|Q9FX86|CAMK8_ARATH CDPK-related kinase 8 OS=Arabidopsis thaliana GN=CRK8 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 476 bits (1225), Expect = e-133, Method: Compositional matrix adjust.
Identities = 222/370 (60%), Positives = 299/370 (80%), Gaps = 5/370 (1%)
Query: 21 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREED 80
CEGGELLDRIL+RGG+Y E DAK ++ +ILN+VAFCH QGVVHRDLKPENFL+T++EE+
Sbjct: 233 LCEGGELLDRILARGGKYSENDAKPVIIQILNVVAFCHFQGVVHRDLKPENFLYTSKEEN 292
Query: 81 APLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSR 140
+ LK IDFGLSDFVRPD+RLNDIVGSAYYVAPEVLHRSY E D+WSIGVI YILLCGSR
Sbjct: 293 SQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYTTEADVWSIGVIAYILLCGSR 352
Query: 141 PFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200
PFWARTESGIFR+VL+ADP+F + PWP +S +AKDFV+RLL KD R+RM+A+QAL HPW+
Sbjct: 353 PFWARTESGIFRAVLKADPSFDEPPWPFLSSDAKDFVKRLLFKDPRRRMSASQALMHPWI 412
Query: 201 --HDENRPVPLDILIYKLVKSYLRATPLKRAALKALSKALTEEELVYLRAQFMLLEP-KD 257
++ + +P DILI++ +K+YLR++ L++AAL+ALSK L ++E++YL+ QF LL P KD
Sbjct: 413 RAYNTDMNIPFDILIFRQMKAYLRSSSLRKAALRALSKTLIKDEILYLKTQFSLLAPNKD 472
Query: 258 GCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALER 317
G ++++ ++AL AT+AM +SR+ E L ++ L + + +EEFCAAA +V+Q E+L+
Sbjct: 473 GLITMDTIRMALASNATEAMKESRIPEFLALLNGLQYRGMDFEEFCAAAINVHQHESLDC 532
Query: 318 WDQIAITAFDYFEQEGNRVISVEELALELNLAPA--AYSLLNDCIRNSDGKLSFLGYKRF 375
W+Q A++ F++ GNR I +EELA EL + P+ +S+L+D IR++DGKLSF G+ +
Sbjct: 533 WEQSIRHAYELFDKNGNRAIVIEELASELGVGPSIPVHSVLHDWIRHTDGKLSFFGFVKL 592
Query: 376 LHGVTVRSSN 385
LHGV+VR+S
Sbjct: 593 LHGVSVRASG 602
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 389 | ||||||
| 255549160 | 589 | calcium-dependent protein kinase, putati | 0.966 | 0.638 | 0.805 | 0.0 | |
| 16904222 | 599 | calcium/calmodulin-dependent protein kin | 0.969 | 0.629 | 0.798 | 1e-180 | |
| 224118412 | 535 | CPK related kinase 4 [Populus trichocarp | 0.966 | 0.702 | 0.776 | 1e-176 | |
| 356516120 | 599 | PREDICTED: CDPK-related protein kinase-l | 0.966 | 0.627 | 0.776 | 1e-176 | |
| 350534546 | 598 | serine/threonine protein kinase pk23 [So | 0.969 | 0.630 | 0.774 | 1e-176 | |
| 357464093 | 588 | Calcium dependent protein kinase-like pr | 0.964 | 0.637 | 0.768 | 1e-173 | |
| 302143963 | 494 | unnamed protein product [Vitis vinifera] | 0.951 | 0.748 | 0.787 | 1e-172 | |
| 357512599 | 596 | Calcium dependent protein kinase-like pr | 0.966 | 0.630 | 0.769 | 1e-172 | |
| 224130636 | 608 | predicted protein [Populus trichocarpa] | 0.966 | 0.618 | 0.763 | 1e-172 | |
| 255578190 | 602 | calcium-dependent protein kinase, putati | 0.969 | 0.626 | 0.767 | 1e-172 |
| >gi|255549160|ref|XP_002515635.1| calcium-dependent protein kinase, putative [Ricinus communis] gi|223545273|gb|EEF46780.1| calcium-dependent protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 647 bits (1669), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 303/376 (80%), Positives = 337/376 (89%)
Query: 12 SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPEN 71
+N+ CEGGELLDRILSRGGRY EEDAKTI+ +IL++VAFCHLQGVVHRDLKPEN
Sbjct: 212 ANNVYIVMELCEGGELLDRILSRGGRYPEEDAKTIIVQILSVVAFCHLQGVVHRDLKPEN 271
Query: 72 FLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVI 131
FLFTTR+EDAPLK+IDFGLSDF+RPDQRLNDIVGSAYYVAPEVLHRSY VE DMWSIGVI
Sbjct: 272 FLFTTRDEDAPLKIIDFGLSDFIRPDQRLNDIVGSAYYVAPEVLHRSYTVEADMWSIGVI 331
Query: 132 TYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTA 191
TYILLCGSRPFWARTESGIFRSVLRADPNF DSPWP+VSPEAKDFV+RLLNKDHRKRMTA
Sbjct: 332 TYILLCGSRPFWARTESGIFRSVLRADPNFADSPWPAVSPEAKDFVKRLLNKDHRKRMTA 391
Query: 192 AQALTHPWLHDENRPVPLDILIYKLVKSYLRATPLKRAALKALSKALTEEELVYLRAQFM 251
AQALTHPWL DE RPVPLDILIYKLVK Y+RATP KRAALKALSKA+ E++L YL+AQF
Sbjct: 392 AQALTHPWLRDEKRPVPLDILIYKLVKLYVRATPFKRAALKALSKAIPEDQLFYLKAQFK 451
Query: 252 LLEPKDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQ 311
LLEPKDG VSLNNFK A+MR TDAM +SRV +I NVMEPLS +K+ +EEFCAAA S YQ
Sbjct: 452 LLEPKDGFVSLNNFKAAIMRNVTDAMKESRVLDIFNVMEPLSYRKMGFEEFCAAAVSTYQ 511
Query: 312 LEALERWDQIAITAFDYFEQEGNRVISVEELALELNLAPAAYSLLNDCIRNSDGKLSFLG 371
LE LE W+ IA TAF+YFEQEGNR+IS +ELA+E+NL P A+S++ND IR+SDGKLSFLG
Sbjct: 512 LEPLEEWEDIARTAFEYFEQEGNRIISAQELAMEMNLGPTAHSIVNDWIRSSDGKLSFLG 571
Query: 372 YKRFLHGVTVRSSNTR 387
Y +FLHGVT+RSSNTR
Sbjct: 572 YTKFLHGVTIRSSNTR 587
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|16904222|gb|AAL30818.1|AF435450_1 calcium/calmodulin-dependent protein kinase CaMK1 [Nicotiana tabacum] | Back alignment and taxonomy information |
|---|
Score = 636 bits (1641), Expect = e-180, Method: Compositional matrix adjust.
Identities = 301/377 (79%), Positives = 335/377 (88%)
Query: 12 SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPEN 71
+N+ CEGG LLDRILSRGGRY EEDAK+I+ +ILN+VAFCHLQGVVHRDLKPEN
Sbjct: 221 ANNVYIVMELCEGGVLLDRILSRGGRYTEEDAKSILVQILNVVAFCHLQGVVHRDLKPEN 280
Query: 72 FLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVI 131
FLFT +EEDAP+KVIDFGLSDF+RPDQRLNDIVGSAYYVAPEVLHRSY++E DMWSIGVI
Sbjct: 281 FLFTKKEEDAPMKVIDFGLSDFIRPDQRLNDIVGSAYYVAPEVLHRSYSIEADMWSIGVI 340
Query: 132 TYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTA 191
TYILLCGSRPFWARTESGIFRSVLRADPNF DSPWPSVS EA+DFV+RLLNKDHRKRMTA
Sbjct: 341 TYILLCGSRPFWARTESGIFRSVLRADPNFEDSPWPSVSAEARDFVKRLLNKDHRKRMTA 400
Query: 192 AQALTHPWLHDENRPVPLDILIYKLVKSYLRATPLKRAALKALSKALTEEELVYLRAQFM 251
+QAL HPWL EN +PLDILI+KLVKSY RA+PLKRAALKALSKALTEEEL+YLRAQF
Sbjct: 401 SQALAHPWLRTENPVLPLDILIFKLVKSYTRASPLKRAALKALSKALTEEELIYLRAQFN 460
Query: 252 LLEPKDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQ 311
LLEPKDG VSLNNFK+AL +Q TDAM +SRVF+ILN+MEPLS + L +EEFCAAA S YQ
Sbjct: 461 LLEPKDGRVSLNNFKMALTKQMTDAMRESRVFDILNLMEPLSYKPLDFEEFCAAAISTYQ 520
Query: 312 LEALERWDQIAITAFDYFEQEGNRVISVEELALELNLAPAAYSLLNDCIRNSDGKLSFLG 371
LEALE W+QIA AF++FEQEGNRVISVEELA E+NL P AY+ L DCIR SD KLSFLG
Sbjct: 521 LEALENWEQIASAAFEHFEQEGNRVISVEELAQEMNLGPTAYAFLKDCIRPSDRKLSFLG 580
Query: 372 YKRFLHGVTVRSSNTRH 388
Y ++LHGVT+R S+TRH
Sbjct: 581 YTKYLHGVTIRGSSTRH 597
|
Source: Nicotiana tabacum Species: Nicotiana tabacum Genus: Nicotiana Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224118412|ref|XP_002317812.1| CPK related kinase 4 [Populus trichocarpa] gi|222858485|gb|EEE96032.1| CPK related kinase 4 [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 625 bits (1612), Expect = e-176, Method: Compositional matrix adjust.
Identities = 292/376 (77%), Positives = 331/376 (88%)
Query: 13 NSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENF 72
N+ CEGGELLDRILSRGGRY E+DAKTIV +IL++VA+CHLQGV HRDLKPENF
Sbjct: 159 NNVYIAMELCEGGELLDRILSRGGRYTEQDAKTIVVQILSVVAYCHLQGVSHRDLKPENF 218
Query: 73 LFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVIT 132
LFT+R+EDAP+++IDFGLSDFVRPD RLND+VGSAYYVAPEVLHRSYN+E DMWS GVIT
Sbjct: 219 LFTSRDEDAPMRIIDFGLSDFVRPDDRLNDVVGSAYYVAPEVLHRSYNLEADMWSTGVIT 278
Query: 133 YILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAA 192
YILLCGSRPFWARTESGIFRSVLRADPNF DSPWPSVSPEAKDFV+RLLNKDHRKRMTAA
Sbjct: 279 YILLCGSRPFWARTESGIFRSVLRADPNFDDSPWPSVSPEAKDFVKRLLNKDHRKRMTAA 338
Query: 193 QALTHPWLHDENRPVPLDILIYKLVKSYLRATPLKRAALKALSKALTEEELVYLRAQFML 252
QALTHPWL D N VPLDILI+KLVKSY+RATP KRAALKALSKA+ E+ELVYL+ QF L
Sbjct: 339 QALTHPWLRDLNPAVPLDILIFKLVKSYVRATPFKRAALKALSKAIPEDELVYLKTQFSL 398
Query: 253 LEPKDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQL 312
LEPK+G VSLNNF+VAL R TDAM +SRV +ILNVMEPL+ +++ +EEFCAAA S +QL
Sbjct: 399 LEPKNGSVSLNNFRVALTRHVTDAMKESRVLDILNVMEPLAHKRMGFEEFCAAAISTHQL 458
Query: 313 EALERWDQIAITAFDYFEQEGNRVISVEELALELNLAPAAYSLLNDCIRNSDGKLSFLGY 372
EALE W+ IA AF +FEQEGN+VISVEELA E+NL P AYS + D IR+SDGKLSF+GY
Sbjct: 459 EALEGWENIATEAFGFFEQEGNQVISVEELAQEMNLGPTAYSAVKDWIRSSDGKLSFIGY 518
Query: 373 KRFLHGVTVRSSNTRH 388
+FLHGVT+R+SN RH
Sbjct: 519 TKFLHGVTMRTSNARH 534
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356516120|ref|XP_003526744.1| PREDICTED: CDPK-related protein kinase-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 624 bits (1610), Expect = e-176, Method: Compositional matrix adjust.
Identities = 292/376 (77%), Positives = 334/376 (88%)
Query: 13 NSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENF 72
N+ CEGGELLDRIL RGGRY E+DAK I+ +IL++VAFCHLQGVVHRDLKPENF
Sbjct: 220 NNVYIVMELCEGGELLDRILDRGGRYPEDDAKAILVQILDVVAFCHLQGVVHRDLKPENF 279
Query: 73 LFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVIT 132
LF ++EEDA +KVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSY+VEGD+WSIGVI+
Sbjct: 280 LFVSKEEDAVMKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYSVEGDLWSIGVIS 339
Query: 133 YILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAA 192
YILLCGSRPFWARTESGIFRSVLRA+PNF DSPWPS+SPEAKDFV+RLLNKDHRKRMTAA
Sbjct: 340 YILLCGSRPFWARTESGIFRSVLRANPNFDDSPWPSISPEAKDFVKRLLNKDHRKRMTAA 399
Query: 193 QALTHPWLHDENRPVPLDILIYKLVKSYLRATPLKRAALKALSKALTEEELVYLRAQFML 252
QAL HPWL +E +PLDILIYKLVKSY+RA+PL+RAALK+L+KAL E+EL+YLRAQF L
Sbjct: 400 QALAHPWLRNEKNAIPLDILIYKLVKSYVRASPLRRAALKSLAKALNEDELIYLRAQFNL 459
Query: 253 LEPKDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQL 312
LEPKDGC+SL NF+VALM+ TDAM +SRV EILN+MEPLS +KL ++EFCAAA SVYQL
Sbjct: 460 LEPKDGCISLENFRVALMKNTTDAMKESRVPEILNLMEPLSYKKLDFKEFCAAAISVYQL 519
Query: 313 EALERWDQIAITAFDYFEQEGNRVISVEELALELNLAPAAYSLLNDCIRNSDGKLSFLGY 372
E + WD+IA TAF+YFE+ GNRVISVEELA E+NL P+AYS + D IR SDGKLS +GY
Sbjct: 520 EVHQEWDRIATTAFEYFEETGNRVISVEELAQEMNLGPSAYSSMGDWIRKSDGKLSLVGY 579
Query: 373 KRFLHGVTVRSSNTRH 388
+FLHGVT+RSSNTRH
Sbjct: 580 TKFLHGVTMRSSNTRH 595
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|350534546|ref|NP_001234146.1| serine/threonine protein kinase pk23 [Solanum lycopersicum] gi|19547871|gb|AAL87457.1| serine/threonine protein kinase pk23 [Solanum lycopersicum] | Back alignment and taxonomy information |
|---|
Score = 623 bits (1607), Expect = e-176, Method: Compositional matrix adjust.
Identities = 292/377 (77%), Positives = 335/377 (88%)
Query: 12 SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPEN 71
+N+ CEGGELLDRILSRGGRY EEDAK+IV +ILN+VAFCHLQGVVHRDLKPEN
Sbjct: 220 ANNVYIVMELCEGGELLDRILSRGGRYTEEDAKSIVVQILNVVAFCHLQGVVHRDLKPEN 279
Query: 72 FLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVI 131
FLF ++ED+P+KVIDFGLSDF++PDQRLNDIVGSAYYVAPEVLHRSY++E DMWSIGVI
Sbjct: 280 FLFAKKDEDSPMKVIDFGLSDFIKPDQRLNDIVGSAYYVAPEVLHRSYSIEADMWSIGVI 339
Query: 132 TYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTA 191
TYILLCGSRPFWARTESGIFRSVLRADPNF DSPWP+VS EA+DFV+RLLNKDHRKRMTA
Sbjct: 340 TYILLCGSRPFWARTESGIFRSVLRADPNFEDSPWPAVSAEARDFVKRLLNKDHRKRMTA 399
Query: 192 AQALTHPWLHDENRPVPLDILIYKLVKSYLRATPLKRAALKALSKALTEEELVYLRAQFM 251
+QALTHPWL EN VPLDILI+KLVKSY+R +PLKRAALKALSKALTEEEL+YL+AQF
Sbjct: 400 SQALTHPWLRTENPFVPLDILIFKLVKSYIRTSPLKRAALKALSKALTEEELIYLKAQFN 459
Query: 252 LLEPKDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQ 311
LLEPK G VSL+NF++ALM+Q TDAM ++RV +I+N++EPLS +++ +EEFCAAA S YQ
Sbjct: 460 LLEPKAGFVSLDNFRMALMKQTTDAMREARVLDIINLLEPLSYKQMDFEEFCAAAISTYQ 519
Query: 312 LEALERWDQIAITAFDYFEQEGNRVISVEELALELNLAPAAYSLLNDCIRNSDGKLSFLG 371
LEALE W+ IA AF+YFEQEGNRVISVEELA E+NL P AY+ L D IR SD KLSFLG
Sbjct: 520 LEALENWEHIASAAFNYFEQEGNRVISVEELAQEMNLGPTAYAFLKDWIRPSDRKLSFLG 579
Query: 372 YKRFLHGVTVRSSNTRH 388
Y +FLHGVT+RSS+TRH
Sbjct: 580 YTKFLHGVTMRSSSTRH 596
|
Source: Solanum lycopersicum Species: Solanum lycopersicum Genus: Solanum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357464093|ref|XP_003602328.1| Calcium dependent protein kinase-like protein [Medicago truncatula] gi|355491376|gb|AES72579.1| Calcium dependent protein kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 613 bits (1582), Expect = e-173, Method: Compositional matrix adjust.
Identities = 289/376 (76%), Positives = 332/376 (88%), Gaps = 1/376 (0%)
Query: 13 NSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENF 72
N+ CEGGELLDRIL RGGRY EEDAK I+ +ILN+VAFCHLQGVVHRDLKPENF
Sbjct: 213 NNVYIVMELCEGGELLDRILDRGGRYTEEDAKVILLQILNVVAFCHLQGVVHRDLKPENF 272
Query: 73 LFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVIT 132
LF +++EDA LKVIDFGLSDFVRP+QRLNDIVGSAYYVAPEVLHRSY+VE D+WS+GVI+
Sbjct: 273 LFVSKDEDAVLKVIDFGLSDFVRPEQRLNDIVGSAYYVAPEVLHRSYSVEADLWSVGVIS 332
Query: 133 YILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAA 192
YILLCGSRPFWARTESGIFRSVLRA+PNF DSPWPS+SPEAKDFV+RLLNKDHRKRMTAA
Sbjct: 333 YILLCGSRPFWARTESGIFRSVLRANPNFDDSPWPSISPEAKDFVKRLLNKDHRKRMTAA 392
Query: 193 QALTHPWLHDENRPVPLDILIYKLVKSYLRATPLKRAALKALSKALTEEELVYLRAQFML 252
QAL+HPWL DE VPLDILIYKLVKSY+RA+PLKRAALKALSKAL +E+ YLRAQF L
Sbjct: 393 QALSHPWLRDEKNVVPLDILIYKLVKSYVRASPLKRAALKALSKALPVDEVTYLRAQFSL 452
Query: 253 LEPKDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQL 312
LEPKDGC+SL NF+VALM+ ATDAM ++RV +ILN+M+PLS ++L +EEFCAAA SVYQL
Sbjct: 453 LEPKDGCISLENFRVALMKNATDAMKEARVPDILNLMDPLSYKRLDFEEFCAAAISVYQL 512
Query: 313 EALERWDQIAITAFDYFEQEGNRVISVEELALELNLAPAAYSLLNDCIRNSDGKLSFLGY 372
E W++IA TA+DYF++ GNRVISVEELA E+NL P+AYSL+ D IR SDGKLS +GY
Sbjct: 513 EVHPEWERIATTAYDYFDEAGNRVISVEELAQEMNLGPSAYSLMGDWIRKSDGKLSLVGY 572
Query: 373 KRFLHGVTVRSSNTRH 388
++LHGVT+R SNTRH
Sbjct: 573 TKYLHGVTIR-SNTRH 587
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302143963|emb|CBI23068.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 611 bits (1575), Expect = e-172, Method: Compositional matrix adjust.
Identities = 292/371 (78%), Positives = 327/371 (88%), Gaps = 1/371 (0%)
Query: 12 SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPEN 71
SN ++ CEGGELLDRILSRGGRY EEDAK IV +ILN+VAFCHLQGVVHRDLKPEN
Sbjct: 116 SNVYIIM-ELCEGGELLDRILSRGGRYREEDAKAIVVQILNVVAFCHLQGVVHRDLKPEN 174
Query: 72 FLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVI 131
FLFTTR+EDAP+KVIDFGLSDF+R DQRLNDIVGSAYYVAPEVLHRSYN+E D+WSIGVI
Sbjct: 175 FLFTTRDEDAPMKVIDFGLSDFIRTDQRLNDIVGSAYYVAPEVLHRSYNLEADVWSIGVI 234
Query: 132 TYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTA 191
TYILLCGSRPFWARTESGIFRSVLRADPNF D PWP+VSPEAKDFV+RLLNKD+RKRMTA
Sbjct: 235 TYILLCGSRPFWARTESGIFRSVLRADPNFDDLPWPAVSPEAKDFVKRLLNKDYRKRMTA 294
Query: 192 AQALTHPWLHDENRPVPLDILIYKLVKSYLRATPLKRAALKALSKALTEEELVYLRAQFM 251
AQALTHPWL DEN VPLDIL+YKLVKSY+R +P KRAALKALSKALTE+ELVYLRAQF
Sbjct: 295 AQALTHPWLRDENHAVPLDILVYKLVKSYVRVSPFKRAALKALSKALTEDELVYLRAQFR 354
Query: 252 LLEPKDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQ 311
LLEPK+G VSL NFK+ALMR ATDAM +SRV +ILN+ME LS +K+ +EEFCAAA S Q
Sbjct: 355 LLEPKNGRVSLENFKMALMRNATDAMKESRVADILNMMESLSFKKMDFEEFCAAAISPLQ 414
Query: 312 LEALERWDQIAITAFDYFEQEGNRVISVEELALELNLAPAAYSLLNDCIRNSDGKLSFLG 371
LEAL+ W++IA T F++FEQEGNRV +VEELA E+N+ PAAYS N IR+SDGKLSFLG
Sbjct: 415 LEALQGWEKIATTGFEFFEQEGNRVTTVEELAREMNVGPAAYSAFNGWIRSSDGKLSFLG 474
Query: 372 YKRFLHGVTVR 382
+ +FLHG R
Sbjct: 475 FTKFLHGSVSR 485
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357512599|ref|XP_003626588.1| Calcium dependent protein kinase-like protein [Medicago truncatula] gi|355501603|gb|AES82806.1| Calcium dependent protein kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 610 bits (1573), Expect = e-172, Method: Compositional matrix adjust.
Identities = 290/377 (76%), Positives = 333/377 (88%), Gaps = 1/377 (0%)
Query: 12 SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPEN 71
+N+ CEGGELLDRILSRGGRY EEDAK IV +IL++ AFCHLQGVVHRDLKPEN
Sbjct: 218 ANNVYIVMELCEGGELLDRILSRGGRYTEEDAKAIVLQILSVAAFCHLQGVVHRDLKPEN 277
Query: 72 FLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVI 131
FLFT+R EDA +K+IDFGLSDF+RP++RLNDIVGSAYYVAPEVLHRSY+VE D+WSIGVI
Sbjct: 278 FLFTSRSEDADMKLIDFGLSDFIRPEERLNDIVGSAYYVAPEVLHRSYSVEADIWSIGVI 337
Query: 132 TYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTA 191
TYILLCGSRPFWARTESGIFR+VLRADPNF D PWPSVSPE KDFV+RLLNKD+RKRMTA
Sbjct: 338 TYILLCGSRPFWARTESGIFRTVLRADPNFDDLPWPSVSPEGKDFVKRLLNKDYRKRMTA 397
Query: 192 AQALTHPWLHDENRPVPLDILIYKLVKSYLRATPLKRAALKALSKALTEEELVYLRAQFM 251
AQALTHPWL DE+RP+PLDILIYKLVKSYL ATP KRAA+KALSKALT+++LVYLRAQF
Sbjct: 398 AQALTHPWLRDESRPIPLDILIYKLVKSYLHATPFKRAAVKALSKALTDDQLVYLRAQFR 457
Query: 252 LLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVY 310
LLEP +DG VSL+NFK+AL R ATDAM +SRV +I++ MEPL+ +K+ +EEFCAAATS Y
Sbjct: 458 LLEPNRDGHVSLDNFKMALARHATDAMRESRVLDIIHTMEPLAYRKMDFEEFCAAATSTY 517
Query: 311 QLEALERWDQIAITAFDYFEQEGNRVISVEELALELNLAPAAYSLLNDCIRNSDGKLSFL 370
QLEAL+ W+ IA AF++FE EGNRVIS+EELA ELNL P+AYS+L D IRN+DGKLS L
Sbjct: 518 QLEALDGWEDIACAAFEHFESEGNRVISIEELARELNLGPSAYSVLRDWIRNTDGKLSLL 577
Query: 371 GYKRFLHGVTVRSSNTR 387
GY +FLHGVT+RSS R
Sbjct: 578 GYTKFLHGVTLRSSLPR 594
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224130636|ref|XP_002320890.1| predicted protein [Populus trichocarpa] gi|222861663|gb|EEE99205.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 610 bits (1572), Expect = e-172, Method: Compositional matrix adjust.
Identities = 288/377 (76%), Positives = 332/377 (88%), Gaps = 1/377 (0%)
Query: 12 SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPEN 71
+N+ CEGGELLDRIL+RGGRY EEDAK I+ +IL +VAFCHLQGVVHRDLKPEN
Sbjct: 230 ANNVYIVMELCEGGELLDRILARGGRYTEEDAKAIIVQILCVVAFCHLQGVVHRDLKPEN 289
Query: 72 FLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVI 131
FLFT+ EDA +K+IDFGLSDF+RPD+RLNDIVGSAYYVAPEVLHRSY++E D+WSIGVI
Sbjct: 290 FLFTSGSEDADMKLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVI 349
Query: 132 TYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTA 191
TYIL+CGSRPFWARTESGIFR+VLR+DPNF D PWPSV+PEAKDFV+RLLNKD+RKRMTA
Sbjct: 350 TYILICGSRPFWARTESGIFRAVLRSDPNFEDLPWPSVTPEAKDFVKRLLNKDYRKRMTA 409
Query: 192 AQALTHPWLHDENRPVPLDILIYKLVKSYLRATPLKRAALKALSKALTEEELVYLRAQFM 251
QALTHPWL D++RP+ LDILIYKLVK+YL ATP KRAALKALSKALTE+ELVYLRAQF
Sbjct: 410 VQALTHPWLRDDSRPINLDILIYKLVKAYLHATPFKRAALKALSKALTEDELVYLRAQFS 469
Query: 252 LLEPK-DGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVY 310
LLEP DG VSL+NF++AL+R ATDAM +SR EILN ME L+ +K+ +EEFCAAA S Y
Sbjct: 470 LLEPNGDGSVSLDNFRMALVRNATDAMRESRAPEILNAMESLAYRKMYFEEFCAAAISTY 529
Query: 311 QLEALERWDQIAITAFDYFEQEGNRVISVEELALELNLAPAAYSLLNDCIRNSDGKLSFL 370
QLEALE W+QIA TAF++FEQEGNRVISVEELA ELN+ P+AY+ + D IRNSDGKLS +
Sbjct: 530 QLEALEGWEQIAFTAFEHFEQEGNRVISVEELARELNVGPSAYTFIKDWIRNSDGKLSLI 589
Query: 371 GYKRFLHGVTVRSSNTR 387
GY +FLHGVT+RSSNTR
Sbjct: 590 GYTKFLHGVTLRSSNTR 606
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255578190|ref|XP_002529963.1| calcium-dependent protein kinase, putative [Ricinus communis] gi|223530525|gb|EEF32406.1| calcium-dependent protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 609 bits (1571), Expect = e-172, Method: Compositional matrix adjust.
Identities = 290/378 (76%), Positives = 334/378 (88%), Gaps = 1/378 (0%)
Query: 12 SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPEN 71
+N+ CEGGELLDRIL+RGGRY EEDAK IV +IL++V+FCHLQGVVHRDLKPEN
Sbjct: 224 ANNVYIVMELCEGGELLDRILARGGRYTEEDAKAIVVQILSVVSFCHLQGVVHRDLKPEN 283
Query: 72 FLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVI 131
FLFT+ EDA +++IDFGLSDF+RPD+RLNDIVGSAYYVAPEVLHRSY++E D+WSIGVI
Sbjct: 284 FLFTSGGEDADMRLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVI 343
Query: 132 TYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTA 191
+YILLCGSRPFWARTESGIFRSVLR+DPNF D PWPSV+PE KDFV+RLLNKD+RKRMTA
Sbjct: 344 SYILLCGSRPFWARTESGIFRSVLRSDPNFDDLPWPSVTPEGKDFVKRLLNKDYRKRMTA 403
Query: 192 AQALTHPWLHDENRPVPLDILIYKLVKSYLRATPLKRAALKALSKALTEEELVYLRAQFM 251
QALTHPWL D++R +PLD+LIYKLVK YL ATP KRAALKALSKALTE+ELVYLRAQF
Sbjct: 404 VQALTHPWLRDDSRSIPLDVLIYKLVKIYLHATPFKRAALKALSKALTEDELVYLRAQFR 463
Query: 252 LLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVY 310
LLEP +DG VSL+NFK+AL+R ATDAM +SRV EILN ME L+ +K+ +EEFCAAA S Y
Sbjct: 464 LLEPNRDGSVSLDNFKMALVRHATDAMRESRVPEILNAMEALAYRKMYFEEFCAAAISTY 523
Query: 311 QLEALERWDQIAITAFDYFEQEGNRVISVEELALELNLAPAAYSLLNDCIRNSDGKLSFL 370
QLEALE W+QIA TAF++FE+EGNRVISVEELA ELN+ P+AYS + D IRNSDGKLS L
Sbjct: 524 QLEALEGWEQIASTAFEHFEREGNRVISVEELARELNVGPSAYSFIKDWIRNSDGKLSLL 583
Query: 371 GYKRFLHGVTVRSSNTRH 388
GY +FLHGVT+RSSNTRH
Sbjct: 584 GYTKFLHGVTLRSSNTRH 601
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 389 | ||||||
| TAIR|locus:2152876 | 594 | AT5G24430 [Arabidopsis thalian | 0.961 | 0.629 | 0.682 | 5.4e-134 | |
| TAIR|locus:2062764 | 595 | CRK3 "AT2G46700" [Arabidopsis | 0.966 | 0.631 | 0.647 | 2.1e-132 | |
| TAIR|locus:2082931 | 594 | AT3G49370 [Arabidopsis thalian | 0.984 | 0.644 | 0.645 | 6.6e-129 | |
| TAIR|locus:2063197 | 576 | CRK1 "AT2G41140" [Arabidopsis | 0.930 | 0.628 | 0.595 | 1.1e-117 | |
| TAIR|locus:2103655 | 577 | AT3G56760 [Arabidopsis thalian | 0.930 | 0.627 | 0.581 | 5e-115 | |
| TAIR|locus:2094053 | 599 | AT3G19100 [Arabidopsis thalian | 0.982 | 0.637 | 0.556 | 2.9e-112 | |
| TAIR|locus:2012232 | 606 | AT1G49580 [Arabidopsis thalian | 0.964 | 0.618 | 0.545 | 1e-109 | |
| TAIR|locus:2827826 | 571 | CPK16 "AT2G17890" [Arabidopsis | 0.964 | 0.656 | 0.433 | 1.8e-80 | |
| TAIR|locus:2156947 | 523 | CPK28 "calcium-dependent prote | 0.974 | 0.724 | 0.419 | 9e-77 | |
| TAIR|locus:2177023 | 528 | CPK17 "calcium-dependent prote | 0.802 | 0.590 | 0.392 | 1.3e-61 |
| TAIR|locus:2152876 AT5G24430 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1313 (467.3 bits), Expect = 5.4e-134, P = 5.4e-134
Identities = 256/375 (68%), Positives = 295/375 (78%)
Query: 13 NSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENF 72
N F+ CEGGELLDRIL+RGGRY E DAK I+ +IL+ AF HLQGVVHRDLKPENF
Sbjct: 219 NVFVVM-ELCEGGELLDRILARGGRYPEVDAKRILVQILSATAFFHLQGVVHRDLKPENF 277
Query: 73 LFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVIT 132
LFT+R EDA LKVIDFGLSDF+R DQRLND+VGSAYYVAPEVLHRSY+ E DMWSIGVI+
Sbjct: 278 LFTSRNEDAILKVIDFGLSDFIRYDQRLNDVVGSAYYVAPEVLHRSYSTEADMWSIGVIS 337
Query: 133 YILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAA 192
YILLCGSRPF+ RTES IFR VLRA+PNF D PWPS+SP AKDFV+RLLNKDHRKRMTAA
Sbjct: 338 YILLCGSRPFYGRTESAIFRCVLRANPNFEDMPWPSISPTAKDFVKRLLNKDHRKRMTAA 397
Query: 193 QALTHPWLHDENRPVPLDILIYKLVKSYLRATPXXXXXXXXXXXXXXXXXXVYLRAQFML 252
QAL HPWL DEN + LD +YKLVKSY+RA+P V+L+AQFML
Sbjct: 398 QALAHPWLRDENPGLLLDFSVYKLVKSYIRASPFRRSALKALSKAIPDEELVFLKAQFML 457
Query: 253 LEPKDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQL 312
L+PKDG +SLN F +AL R ATDAM +SR+ +ILN M+PL+ +KL +EEFCAAA SVYQL
Sbjct: 458 LDPKDGGLSLNCFTMALTRYATDAMMESRLPDILNTMQPLAQKKLDFEEFCAAAVSVYQL 517
Query: 313 EALERWDQIAITAFDYFEQEGNRVISVXXXXXXXXXXXXXYSLLNDCIRNSDGKLSFLGY 372
EALE W+QIA +AF++FE EGNR+ISV Y LL D IR+SDGKLSFLGY
Sbjct: 518 EALEEWEQIATSAFEHFEHEGNRIISVQELAGEMSVGPSAYPLLKDWIRSSDGKLSFLGY 577
Query: 373 KRFLHGVTVRSSNTR 387
+FLHGVTVRSS++R
Sbjct: 578 AKFLHGVTVRSSSSR 592
|
|
| TAIR|locus:2062764 CRK3 "AT2G46700" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1298 (462.0 bits), Expect = 2.1e-132, P = 2.1e-132
Identities = 244/377 (64%), Positives = 296/377 (78%)
Query: 12 SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPEN 71
+N+ C+GGELLDRIL+RGG+Y E+DAK IV +IL +V+FCHLQGVVHRDLKPEN
Sbjct: 217 ANNVYIVMELCDGGELLDRILARGGKYPEDDAKAIVVQILTVVSFCHLQGVVHRDLKPEN 276
Query: 72 FLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVI 131
FLFT+ ED+ LK+IDFGLSDF+RPD+RLNDIVGSAYYVAPEVLHRSY++E D+WSIGVI
Sbjct: 277 FLFTSSREDSDLKLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVI 336
Query: 132 TYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTA 191
TYILLCGSRPFWARTESGIFR+VLR +PN+ D PWPS S E KDFV+RLLNKD+RKRM+A
Sbjct: 337 TYILLCGSRPFWARTESGIFRTVLRTEPNYDDVPWPSCSSEGKDFVKRLLNKDYRKRMSA 396
Query: 192 AQALTHPWLHDENRPVPLDILIYKLVKSYLRATPXXXXXXXXXXXXXXXXXXVYLRAQFM 251
QALTHPWL D++R +PLDILIYKLVK+YL ATP VYLRAQFM
Sbjct: 397 VQALTHPWLRDDSRVIPLDILIYKLVKAYLHATPLRRAALKALAKALTENELVYLRAQFM 456
Query: 252 LLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVY 310
LL P KDG VSL NFK ALM+ ATDAM +SRV EIL+ ME L+ +K+ +EEFCAAA S++
Sbjct: 457 LLGPNKDGSVSLENFKTALMQNATDAMRESRVPEILHTMESLAYRKMYFEEFCAAAISIH 516
Query: 311 QLEALERWDQIAITAFDYFEQEGNRVISVXXXXXXXXXXXXXYSLLNDCIRNSDGKLSFL 370
QLEA++ W++IA F +FE EGNRVI++ Y L D +R+SDGKLS+L
Sbjct: 517 QLEAVDAWEEIATAGFQHFETEGNRVITIEELARELNVGASAYGHLRDWVRSSDGKLSYL 576
Query: 371 GYKRFLHGVTVRSSNTR 387
G+ +FLHGVT+R+++ R
Sbjct: 577 GFTKFLHGVTLRAAHAR 593
|
|
| TAIR|locus:2082931 AT3G49370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1265 (450.4 bits), Expect = 6.6e-129, P = 6.6e-129
Identities = 248/384 (64%), Positives = 293/384 (76%)
Query: 5 KLQHLFYSNSFLFFT-RFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVV 63
K +F + +F CEGGELLD IL+RGGRY E +AK I+ +IL+ AF HLQGVV
Sbjct: 208 KFYDVFEDSDNVFVVMELCEGGELLDSILARGGRYPEAEAKRILVQILSATAFFHLQGVV 267
Query: 64 HRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEG 123
HRDLKPENFLFT++ EDA LKVIDFGLSD+ R DQRLND+VGSAYYVAPEVLHRSY+ E
Sbjct: 268 HRDLKPENFLFTSKNEDAVLKVIDFGLSDYARFDQRLNDVVGSAYYVAPEVLHRSYSTEA 327
Query: 124 DMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNK 183
D+WSIGVI+YILLCGSRPF+ RTES IFR VLRA+PNF D PWPS+SP AKDFV+RLLNK
Sbjct: 328 DIWSIGVISYILLCGSRPFYGRTESAIFRCVLRANPNFDDLPWPSISPIAKDFVKRLLNK 387
Query: 184 DHRKRMTAAQALTHPWLHDENRPVPLDILIYKLVKSYLRATPXXXXXXXXXXXXXXXXXX 243
DHRKRMTAAQAL HPWL DEN + LD IYKLVKSY+RA+P
Sbjct: 388 DHRKRMTAAQALAHPWLRDENPGLLLDFSIYKLVKSYIRASPFRRAALKSLSKAIPEEEL 447
Query: 244 VYLRAQFMLLEPKDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFC 303
V+L+AQFMLLEP+DG + L+NF AL R ATDAM +SR+ +ILN+M+PL+ +KL +EEFC
Sbjct: 448 VFLKAQFMLLEPEDGGLHLHNFTTALTRYATDAMIESRLPDILNMMQPLAHKKLDFEEFC 507
Query: 304 AAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVXXXXXXXXXXXXXYSLLNDCIRNS 363
AA+ SVYQLEALE W+QIA AF++FE EG+R ISV Y LL D IR+
Sbjct: 508 AASVSVYQLEALEEWEQIATVAFEHFESEGSRAISVQELAEEMSLGPNAYPLLKDWIRSL 567
Query: 364 DGKLSFLGYKRFLHGVTVRSSNTR 387
DGKL+FLGY +FLHGVTVRSS++R
Sbjct: 568 DGKLNFLGYAKFLHGVTVRSSSSR 591
|
|
| TAIR|locus:2063197 CRK1 "AT2G41140" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1159 (413.0 bits), Expect = 1.1e-117, P = 1.1e-117
Identities = 218/366 (59%), Positives = 280/366 (76%)
Query: 22 CEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDA 81
C+GGELLD+IL RGG+Y E+DAK ++ +IL++VA+CHLQGVVHRDLKPENFLF+T++E +
Sbjct: 207 CKGGELLDKILQRGGKYSEDDAKKVMVQILSVVAYCHLQGVVHRDLKPENFLFSTKDETS 266
Query: 82 PLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRP 141
PLK IDFGLSD+V+PD+RLNDIVGSAYYVAPEVLHR+Y E DMWSIGVI YILLCGSRP
Sbjct: 267 PLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRTYGTEADMWSIGVIAYILLCGSRP 326
Query: 142 FWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLH 201
FWARTESGIFR+VL+A+PNF ++PWPS+SPEA DFV+RLLNKD+RKR+TAAQAL HPWL
Sbjct: 327 FWARTESGIFRAVLKAEPNFEEAPWPSLSPEAVDFVKRLLNKDYRKRLTAAQALCHPWLV 386
Query: 202 DENR-PVPLDILIYKLVKSYLRATPXXXXXXXXXXXXXXXXXXVYLRAQFMLLEP-KDGC 259
+ +P D++IYKLVK Y+ +T YLR QF LL P K+G
Sbjct: 387 GSHELKIPSDMIIYKLVKVYIMSTSLRKSALAALAKTLTVPQLAYLREQFTLLGPSKNGY 446
Query: 260 VSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWD 319
+S+ N+K A+++ +TDAM DSRVF+ ++++ L +KL +EEFCA+A SVYQLEA+E W+
Sbjct: 447 ISMQNYKTAILKSSTDAMKDSRVFDFVHMISCLQYKKLDFEEFCASALSVYQLEAMETWE 506
Query: 320 QIAITAFDYFEQEGNRVISVXXXXXXXXXXXXX--YSLLNDCIRNSDGKLSFLGYKRFLH 377
Q A A++ FE++GNR I + + +L D IR+SDGKLSFLG+ R LH
Sbjct: 507 QHARRAYELFEKDGNRPIMIEELASELGLGPSVPVHVVLQDWIRHSDGKLSFLGFVRLLH 566
Query: 378 GVTVRS 383
GV+ R+
Sbjct: 567 GVSSRT 572
|
|
| TAIR|locus:2103655 AT3G56760 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1134 (404.2 bits), Expect = 5.0e-115, P = 5.0e-115
Identities = 213/366 (58%), Positives = 278/366 (75%)
Query: 22 CEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDA 81
C+GGELLD+IL RGG+Y E DAK ++ +IL++VA+CHLQGVVHRDLKPENFLFTT++E +
Sbjct: 208 CQGGELLDKILQRGGKYSEVDAKKVMIQILSVVAYCHLQGVVHRDLKPENFLFTTKDESS 267
Query: 82 PLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRP 141
PLK IDFGLSD+VRPD+RLNDIVGSAYYVAPEVLHR+Y E DMWSIGVI YILLCGSRP
Sbjct: 268 PLKAIDFGLSDYVRPDERLNDIVGSAYYVAPEVLHRTYGTEADMWSIGVIAYILLCGSRP 327
Query: 142 FWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLH 201
FWAR+ESGIFR+VL+A+PNF ++PWPS+SP+A DFV+RLLNKD+RKR+TAAQAL HPWL
Sbjct: 328 FWARSESGIFRAVLKAEPNFEEAPWPSLSPDAVDFVKRLLNKDYRKRLTAAQALCHPWLV 387
Query: 202 DENR-PVPLDILIYKLVKSYLRATPXXXXXXXXXXXXXXXXXXVYLRAQFMLLEP-KDGC 259
+ +P D++IYKLVK Y+ ++ YL+ QF LL P K+G
Sbjct: 388 GSHELKIPSDMIIYKLVKVYIMSSSLRKSALAALAKTLTVPQLTYLQEQFNLLGPSKNGY 447
Query: 260 VSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWD 319
+S+ N+K A+++ +T+A DSRV + ++++ L +KL +EEFCA+A SVYQLEA+E W+
Sbjct: 448 ISMQNYKTAILKSSTEATKDSRVLDFVHMISCLQYKKLDFEEFCASALSVYQLEAMETWE 507
Query: 320 QIAITAFDYFEQEGNRVISVXXXXXXXXXXXXX--YSLLNDCIRNSDGKLSFLGYKRFLH 377
Q A A++ +E++GNRVI + + +L D IR+SDGKLSFLG+ R LH
Sbjct: 508 QHARRAYELYEKDGNRVIMIEELATELGLGPSVPVHVVLQDWIRHSDGKLSFLGFVRLLH 567
Query: 378 GVTVRS 383
GV+ R+
Sbjct: 568 GVSSRT 573
|
|
| TAIR|locus:2094053 AT3G19100 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1108 (395.1 bits), Expect = 2.9e-112, P = 2.9e-112
Identities = 217/390 (55%), Positives = 283/390 (72%)
Query: 3 HQKLQHL---FYSNSFLFFT-RFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCH 58
HQ L F N+ ++ C GGELLDRIL+RGG+Y E+DAK ++ +ILN+VAFCH
Sbjct: 205 HQNLVQFYDAFEDNANVYIVMELCGGGELLDRILARGGKYSEDDAKAVLIQILNVVAFCH 264
Query: 59 LQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRS 118
LQGVVHRDLKPENFL+T++EE++ LKVIDFGLSDFVRPD+RLNDIVGSAYYVAPEVLHRS
Sbjct: 265 LQGVVHRDLKPENFLYTSKEENSMLKVIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRS 324
Query: 119 YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVR 178
Y E D+WSIGVI YILLCGSRPFWARTESGIFR+VL+ADP+F + PWPS+S EAKDFV+
Sbjct: 325 YTTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEPPWPSLSFEAKDFVK 384
Query: 179 RLLNKDHRKRMTAAQALTHPWLHDENR-PVPLDILIYKLVKSYLRATPXXXXXXXXXXXX 237
RLL KD RKRMTA+QAL HPW+ + +P DILI+K +K+YLR++
Sbjct: 385 RLLYKDPRKRMTASQALMHPWIAGYKKIDIPFDILIFKQIKAYLRSSSLRKAALMALSKT 444
Query: 238 XXXXXXVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQK 296
+YL+AQF L P K+G ++L++ ++AL AT+AM +SR+ + L ++ L +
Sbjct: 445 LTTDELLYLKAQFAHLAPNKNGLITLDSIRLALATNATEAMKESRIPDFLALLNGLQYKG 504
Query: 297 LAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVXXXXXXXXXXXXX--YS 354
+ +EEFCAA+ SV+Q E+L+ W+Q A++ FE GNRVI + ++
Sbjct: 505 MDFEEFCAASISVHQHESLDCWEQSIRHAYELFEMNGNRVIVIEELASELGVGSSIPVHT 564
Query: 355 LLNDCIRNSDGKLSFLGYKRFLHGVTVRSS 384
+LND IR++DGKLSFLG+ + LHGV+ R S
Sbjct: 565 ILNDWIRHTDGKLSFLGFVKLLHGVSTRQS 594
|
|
| TAIR|locus:2012232 AT1G49580 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1084 (386.6 bits), Expect = 1.0e-109, P = 1.0e-109
Identities = 208/381 (54%), Positives = 277/381 (72%)
Query: 10 FYSNSFLFFT-RFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLK 68
F N+ ++ CEGGELLDRIL+RGG+Y E DAK ++ +ILN+VAFCH QGVVHRDLK
Sbjct: 221 FEDNANVYIAMELCEGGELLDRILARGGKYSENDAKPVIIQILNVVAFCHFQGVVHRDLK 280
Query: 69 PENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSI 128
PENFL+T++EE++ LK IDFGLSDFVRPD+RLNDIVGSAYYVAPEVLHRSY E D+WSI
Sbjct: 281 PENFLYTSKEENSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYTTEADVWSI 340
Query: 129 GVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKR 188
GVI YILLCGSRPFWARTESGIFR+VL+ADP+F + PWP +S +AKDFV+RLL KD R+R
Sbjct: 341 GVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEPPWPFLSSDAKDFVKRLLFKDPRRR 400
Query: 189 MTAAQALTHPWLHDENRP--VPLDILIYKLVKSYLRATPXXXXXXXXXXXXXXXXXXVYL 246
M+A+QAL HPW+ N +P DILI++ +K+YLR++ +YL
Sbjct: 401 MSASQALMHPWIRAYNTDMNIPFDILIFRQMKAYLRSSSLRKAALRALSKTLIKDEILYL 460
Query: 247 RAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAA 305
+ QF LL P KDG ++++ ++AL AT+AM +SR+ E L ++ L + + +EEFCAA
Sbjct: 461 KTQFSLLAPNKDGLITMDTIRMALASNATEAMKESRIPEFLALLNGLQYRGMDFEEFCAA 520
Query: 306 ATSVYQLEALERWDQIAITAFDYFEQEGNRVISVXXXXXXXXXXXXX--YSLLNDCIRNS 363
A +V+Q E+L+ W+Q A++ F++ GNR I + +S+L+D IR++
Sbjct: 521 AINVHQHESLDCWEQSIRHAYELFDKNGNRAIVIEELASELGVGPSIPVHSVLHDWIRHT 580
Query: 364 DGKLSFLGYKRFLHGVTVRSS 384
DGKLSF G+ + LHGV+VR+S
Sbjct: 581 DGKLSFFGFVKLLHGVSVRAS 601
|
|
| TAIR|locus:2827826 CPK16 "AT2G17890" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 808 (289.5 bits), Expect = 1.8e-80, P = 1.8e-80
Identities = 165/381 (43%), Positives = 233/381 (61%)
Query: 13 NSFLFFTRFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPEN 71
NS CEGGELLDRIL+R RY E DA +V ++L + A CHL+G+VHRD+KPEN
Sbjct: 180 NSVYIVMELCEGGELLDRILARKDSRYSERDAAVVVRQMLKVAAECHLRGLVHRDMKPEN 239
Query: 72 FLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVI 131
FLF + EED+PLK DFGLSDF++P ++ +DIVGSAYYVAPEVL R E D+WSIGVI
Sbjct: 240 FLFKSTEEDSPLKATDFGLSDFIKPGKKFHDIVGSAYYVAPEVLKRRSGPESDVWSIGVI 299
Query: 132 TYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTA 191
+YILLCG RPFW +TE GIF+ VL+ P+F PWP++S AKDFV++LL KD R R+TA
Sbjct: 300 SYILLCGRRPFWDKTEDGIFKEVLKNKPDFRRKPWPTISNSAKDFVKKLLVKDPRARLTA 359
Query: 192 AQALTHPWLHD--ENRPVPLDILIYKLVKSYLRATPXXXXXXXXXXXXXXXXXXVYLRAQ 249
AQAL+HPW+ + + +P+DI + ++ +++ + LR Q
Sbjct: 360 AQALSHPWVREGGDASEIPIDISVLNNMRQFVKFSRLKQFALRALATTLDEEELADLRDQ 419
Query: 250 FMLLE-PKDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATS 308
F ++ K+G +SL + AL + + D+RV EIL ++ +D + + EF AAA
Sbjct: 420 FDAIDVDKNGVISLEEMRQALAKDHPWKLKDARVAEILQAIDSNTDGFVDFGEFVAAALH 479
Query: 309 VYQLEA--LERWDQIAITAFDYFEQEGNRVISVXXXXXXXXXXXXXYSLLNDCIRNSDGK 366
V QLE E+W Q + AF+ F+ +G+ I+ LL + ++DGK
Sbjct: 480 VNQLEEHDSEKWQQRSRAAFEKFDIDGDGFITAEELRMHTGLKGSIEPLLEEADIDNDGK 539
Query: 367 LSFLGYKRFLHGVTVRSSNTR 387
+S ++R L +++S N R
Sbjct: 540 ISLQEFRRLLRTASIKSRNVR 560
|
|
| TAIR|locus:2156947 CPK28 "calcium-dependent protein kinase 28" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 773 (277.2 bits), Expect = 9.0e-77, P = 9.0e-77
Identities = 162/386 (41%), Positives = 230/386 (59%)
Query: 5 KLQHLFYSNSFLFFT-RFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQGV 62
+ + F + +++ CEGGELLDRILS+ G RY E+DA +V ++L + CHL G+
Sbjct: 125 QFHNAFEDDDYVYIVMELCEGGELLDRILSKKGNRYSEKDAAVVVRQMLKVAGECHLHGL 184
Query: 63 VHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVE 122
VHRD+KPENFLF + + D+PLK DFGLSDF++P +R +DIVGSAYYVAPEVL R E
Sbjct: 185 VHRDMKPENFLFKSAQLDSPLKATDFGLSDFIKPGKRFHDIVGSAYYVAPEVLKRRSGPE 244
Query: 123 GDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLN 182
D+WSIGVITYILLCG RPFW RTE GIF+ VLR P+F PW ++S AKDFV++LL
Sbjct: 245 SDVWSIGVITYILLCGRRPFWDRTEDGIFKEVLRNKPDFSRKPWATISDSAKDFVKKLLV 304
Query: 183 KDHRKRMTAAQALTHPWLHDENRP--VPLDILIYKLVKSYLRATPXXXXXXXXXXXXXXX 240
KD R R+TAAQAL+H W+ + +P+DI + ++ ++R +
Sbjct: 305 KDPRARLTAAQALSHAWVREGGNATDIPVDISVLNNLRQFVRYSRLKQFALRALASTLDE 364
Query: 241 XXXVYLRAQFMLLE-PKDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAY 299
LR QF ++ K+G +SL + AL + + DSRV EIL ++ +D + +
Sbjct: 365 AEISDLRDQFDAIDVDKNGVISLEEMRQALAKDLPWKLKDSRVAEILEAIDSNTDGLVDF 424
Query: 300 EEFCAAATSVYQLEA--LERWDQIAITAFDYFEQEGNRVISVXXXXXXXXXXXXXYSLLN 357
EF AAA V+QLE E+W + AF+ F+ + + I+ LL+
Sbjct: 425 TEFVAAALHVHQLEEHDSEKWQLRSRAAFEKFDLDKDGYITPEELRMHTGLRGSIDPLLD 484
Query: 358 DCIRNSDGKLSFLGYKRFLHGVTVRS 383
+ + DGK+S ++R L ++ S
Sbjct: 485 EADIDRDGKISLHEFRRLLRTASISS 510
|
|
| TAIR|locus:2177023 CPK17 "calcium-dependent protein kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 630 (226.8 bits), Expect = 1.3e-61, P = 1.3e-61
Identities = 126/321 (39%), Positives = 190/321 (59%)
Query: 22 CEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDA 81
C GGEL DRI+++G Y E A +++ I+ IV CH GV+HRDLKPENFL ++E++
Sbjct: 154 CAGGELFDRIIAKG-HYSERAAASLLRTIVQIVHTCHSMGVIHRDLKPENFLLLNKDENS 212
Query: 82 PLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRP 141
PLK DFGLS F +P + DIVGSAYY+APEVL R Y E D+WSIGV+ YILLCG P
Sbjct: 213 PLKATDFGLSVFYKPGEVFKDIVGSAYYIAPEVLKRKYGPEADIWSIGVMLYILLCGVPP 272
Query: 142 FWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLH 201
FWA +E+GIF ++LR +F PWPS+SP+AKD V+++LN D ++R+TAAQ L HPW+
Sbjct: 273 FWAESENGIFNAILRGHVDFSSDPWPSISPQAKDLVKKMLNSDPKQRLTAAQVLNHPWIK 332
Query: 202 DENR-P-VPLDILIYKLVKSYLRATPXXXXXXXXXXXXXXXXXXVYLRAQFMLLEP-KDG 258
++ P VPLD + +K + + L+ F ++ G
Sbjct: 333 EDGEAPDVPLDNAVMSRLKQFKAMNNFKKVALRVIAGCLSEEEIMGLKEMFKGMDTDSSG 392
Query: 259 CVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERW 318
++L + L +Q T +++ V +++ + + + Y EF AA + +L+ E
Sbjct: 393 TITLEELRQGLAKQGT-RLSEYEVQQLMEAADADGNGTIDYGEFIAATMHINRLDREEH- 450
Query: 319 DQIAITAFDYFEQEGNRVISV 339
+AF +F+++ + I++
Sbjct: 451 ---LYSAFQHFDKDNSGYITM 468
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9FIM9 | CAMK4_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7234 | 0.9665 | 0.6329 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 389 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-66 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-58 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-44 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 7e-36 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-35 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-33 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-33 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-32 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-31 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-31 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 8e-31 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-30 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-29 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-28 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-28 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-28 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-27 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-27 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-26 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-26 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-25 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-25 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 7e-25 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 9e-25 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-24 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-24 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-23 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-23 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 6e-23 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-23 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 7e-23 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 9e-23 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-22 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-22 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-22 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-22 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-22 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-22 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-22 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-22 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-22 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-22 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 7e-22 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-21 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-21 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-21 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-21 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-21 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-21 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-21 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-21 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-21 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-21 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-20 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-20 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-20 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-20 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-20 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-20 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 8e-20 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 8e-20 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 9e-20 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-19 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-19 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-19 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-19 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-19 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-19 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-19 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 8e-19 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 8e-19 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 8e-19 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-18 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-18 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-18 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-18 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-18 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 7e-18 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 9e-18 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 9e-18 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-17 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-17 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-17 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-17 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-17 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-17 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-17 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-17 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-17 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-17 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-17 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 8e-17 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-16 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-16 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-16 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-16 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-16 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-16 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-16 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-16 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-16 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-16 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-16 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-16 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-16 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 6e-16 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-16 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-16 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 7e-16 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 9e-16 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 9e-16 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-15 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-15 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-15 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-15 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-15 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-15 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 4e-15 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-15 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 8e-15 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-14 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-14 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-14 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-14 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-14 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-14 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-14 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-14 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-14 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-14 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-14 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-14 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-14 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-14 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-14 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-14 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-14 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-14 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 6e-14 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-14 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 7e-14 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 8e-14 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 8e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-13 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-13 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-13 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-13 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-13 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-13 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-13 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-13 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-13 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-13 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-13 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 6e-13 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-13 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 7e-13 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 8e-13 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-12 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-12 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-12 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-12 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 7e-12 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 9e-12 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-11 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-11 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-11 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-11 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-11 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 6e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 7e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 9e-11 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-10 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-10 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-10 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-10 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-10 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 9e-10 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-09 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-09 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-09 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-09 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 6e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-08 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-08 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-08 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-08 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 7e-08 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-07 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-07 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-07 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-07 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-07 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 7e-07 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 9e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-06 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-06 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-06 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-06 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-06 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-06 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-06 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-06 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-06 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-06 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 8e-06 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 9e-06 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-05 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-05 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-05 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-05 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-05 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 6e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 7e-05 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 9e-05 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 9e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-04 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-04 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-04 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 2e-04 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-04 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-04 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-04 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-04 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-04 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-04 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-04 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-04 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 6e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 6e-04 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-04 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-04 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 8e-04 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 0.001 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 0.001 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 0.001 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.001 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 0.002 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 0.002 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 0.002 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 0.003 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 0.003 | |
| pfam06293 | 206 | pfam06293, Kdo, Lipopolysaccharide kinase (Kdo/Waa | 0.003 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 210 bits (536), Expect = 5e-66
Identities = 82/209 (39%), Positives = 121/209 (57%), Gaps = 16/209 (7%)
Query: 3 HQKLQH-----LFYS----NSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNI 53
+KL+H L+ + +CEGG+L D + RG R E++A+ + +IL+
Sbjct: 51 LKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRG-RLSEDEARFYLRQILSA 109
Query: 54 VAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPE 113
+ + H +G+VHRDLKPEN L ED +K+ DFGL+ + P ++L VG+ Y+APE
Sbjct: 110 LEYLHSKGIVHRDLKPENILLD---EDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPE 166
Query: 114 VL-HRSYNVEGDMWSIGVITYILLCGSRPFWARTE-SGIFRSVLRADPNFHDSPWPSVSP 171
VL + Y D+WS+GVI Y LL G PF + +F+ + + P F P +SP
Sbjct: 167 VLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPF-PPPEWDISP 225
Query: 172 EAKDFVRRLLNKDHRKRMTAAQALTHPWL 200
EAKD +R+LL KD KR+TA +AL HP+
Sbjct: 226 EAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 190 bits (484), Expect = 3e-58
Identities = 81/214 (37%), Positives = 111/214 (51%), Gaps = 19/214 (8%)
Query: 2 YHQKLQH--------LFYSNSFLFF-TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILN 52
++L H F L+ +CEGG+L D LSRGG E++AK I +IL
Sbjct: 51 ILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFD-YLSRGGPLSEDEAKKIALQILR 109
Query: 53 IVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVA 111
+ + H G++HRDLKPEN L +K+ DFGL+ ++ L VG+ +Y+A
Sbjct: 110 GLEYLHSNGIIHRDLKPENILLDENGV---VKIADFGLAKKLLKSSSSLTTFVGTPWYMA 166
Query: 112 PEVL--HRSYNVEGDMWSIGVITYILLCGSRPFWARTESG---IFRSVLRADPNFHDSPW 166
PEVL Y + D+WS+GVI Y LL G PF + R +L F + W
Sbjct: 167 PEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKW 226
Query: 167 PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200
S S EAKD +++ LNKD KR TA + L HPW
Sbjct: 227 SSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 153 bits (390), Expect = 2e-44
Identities = 70/200 (35%), Positives = 102/200 (51%), Gaps = 17/200 (8%)
Query: 9 LFYS---NSFLFF-TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVH 64
L Y+ L+ + GGEL LS+ GR+ EE A+ +I+ + + H G+++
Sbjct: 58 LHYAFQTEEKLYLVLEYAPGGELFSH-LSKEGRFSEERARFYAAEIVLALEYLHSLGIIY 116
Query: 65 RDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVLHRS-YNVE 122
RDLKPEN L D +K+ DFGL+ + R N G+ Y+APEVL Y
Sbjct: 117 RDLKPENILLD---ADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKA 173
Query: 123 GDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLN 182
D WS+GV+ Y +L G PF+A I+ +L+ F P +SPEA+D + LL
Sbjct: 174 VDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRF---P-EFLSPEARDLISGLLQ 229
Query: 183 KDHRKRMTAAQALT---HPW 199
KD KR+ + A HP+
Sbjct: 230 KDPTKRLGSGGAEEIKAHPF 249
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 7e-36
Identities = 66/215 (30%), Positives = 101/215 (46%), Gaps = 25/215 (11%)
Query: 8 HLFYS----NSFLFFTRFCEGGELLDRILSRGGRYLEED-AKTIVEKILNIVAFCHLQGV 62
L+YS + + GG+L +L G L+ED A+ + +I+ + + H G+
Sbjct: 57 KLYYSFQGKKNLYLVMEYLPGGDLA-SLLENVG-SLDEDVARIYIAEIVLALEYLHSNGI 114
Query: 63 VHRDLKPENFLFTTREEDAPLKVIDFGLSDF---------VRPDQRLNDIVGSAYYVAPE 113
+HRDLKP+N L + LK+ DFGLS ++ IVG+ Y+APE
Sbjct: 115 IHRDLKPDNILID---SNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE 171
Query: 114 V-LHRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPE 172
V L + ++ D WS+G I Y L G PF T IF+++L + + VS E
Sbjct: 172 VILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPED--VEVSDE 229
Query: 173 AKDFVRRLLNKDHRKRMTAAQA---LTHPWLHDEN 204
A D + +LL D KR+ A HP+ +
Sbjct: 230 AIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGID 264
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 5e-35
Identities = 65/198 (32%), Positives = 94/198 (47%), Gaps = 41/198 (20%)
Query: 5 KLQHLFYSNSFLFF-TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVV 63
KL +F + L+ +CEGG L D + G+ E++ I+ +IL + + H G++
Sbjct: 55 KLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGII 114
Query: 64 HRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPD-QRLNDIVGSAYYVAPEVLH--RSYN 120
HRDLKPEN L + +K+ DFGLS + D L IVG+ Y+APEVL Y+
Sbjct: 115 HRDLKPENILLDSDNGK--VKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 121 VEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRL 180
+ D+WS+GVI Y L PE KD +R++
Sbjct: 173 EKSDIWSLGVILYEL-----------------------------------PELKDLIRKM 197
Query: 181 LNKDHRKRMTAAQALTHP 198
L KD KR +A + L H
Sbjct: 198 LQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 127 bits (318), Expect = 4e-33
Identities = 64/262 (24%), Positives = 105/262 (40%), Gaps = 24/262 (9%)
Query: 6 LQHLFYSNSFLFFTRFCEGGELLDRI--LSRGGRYLEEDAKTIVEKILNIVAFCHLQGVV 63
S + +GG L D + + R G E +A I+ +IL+ + + H +G++
Sbjct: 64 YDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGII 123
Query: 64 HRDLKPENFLFTTREEDAPLKVIDFGLSDFVR-------PDQRLNDIVGSAYYVAPEVLH 116
HRD+KPEN L + +K+IDFGL+ + + VG+ Y+APEVL
Sbjct: 124 HRDIKPENILL--DRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181
Query: 117 ----RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLR---------ADPNFHD 163
+ D+WS+G+ Y LL G PF S L+
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSP 241
Query: 164 SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDILIYKLVKSYLRA 223
S +S A D +++LL KD + R++++ L+H L + K S
Sbjct: 242 SNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDSAPLR 301
Query: 224 TPLKRAALKALSKALTEEELVY 245
L + +S +
Sbjct: 302 LSLPPSLEALISSLNSLAISGS 323
|
Length = 384 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 5e-33
Identities = 65/222 (29%), Positives = 103/222 (46%), Gaps = 35/222 (15%)
Query: 5 KLQHLFYSNSFLFFT-RFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVV 63
KL + F L+F + GELL I G E+ + +IL + + H +G++
Sbjct: 66 KLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLD-EKCTRFYAAEILLALEYLHSKGII 124
Query: 64 HRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ---------------------RLND 102
HRDLKPEN L +D +K+ DFG + + P+ R
Sbjct: 125 HRDLKPENILLD---KDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFAS 181
Query: 103 IVGSAYYVAPEVL-HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNF 161
VG+A YV+PE+L + D+W++G I Y +L G PF E F+ +L+ + +F
Sbjct: 182 FVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSF 241
Query: 162 HDSPWPSVSPEAKDFVRRLLNKDHRKRMTA----AQALTHPW 199
P P+ P+AKD + +LL D + R+ + HP+
Sbjct: 242 ---P-PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 4e-32
Identities = 67/198 (33%), Positives = 102/198 (51%), Gaps = 23/198 (11%)
Query: 12 SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPEN 71
S+S + E G L +I+ + G + E V ++L +A+ H QGV+HRD+K N
Sbjct: 71 SDSLYIILEYAENGSLR-QIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAAN 129
Query: 72 FLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEG-----DM 125
L T +D +K+ DFG++ + +VG+ Y++APEV+ + G D+
Sbjct: 130 ILTT---KDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVI----EMSGASTASDI 182
Query: 126 WSIGVITYI-LLCGSRPFWARTE-SGIFRSVLRADPNFHDSPWPS-VSPEAKDFVRRLLN 182
WS+G T I LL G+ P++ + +FR V P P P +SPE KDF+ +
Sbjct: 183 WSLG-CTVIELLTGNPPYYDLNPMAALFRIVQDDHP-----PLPEGISPELKDFLMQCFQ 236
Query: 183 KDHRKRMTAAQALTHPWL 200
KD R TA Q L HPW+
Sbjct: 237 KDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 2e-31
Identities = 55/191 (28%), Positives = 94/191 (49%), Gaps = 27/191 (14%)
Query: 21 FCEGGELLDRILSRG--GRYLEEDAKTIVEKILNI-------VAFCHLQGVVHRDLKPEN 71
+ +GG+L +I + G+ E+ +IL+ + + H + ++HRD+KP+N
Sbjct: 80 YADGGDLSQKIKKQKKEGKPFPEE------QILDWFVQLCLALKYLHSRKILHRDIKPQN 133
Query: 72 -FLFTTREEDAPLKVIDFGLSDFVRPDQRL-NDIVGSAYYVAPEVL-HRSYNVEGDMWSI 128
FL + +K+ DFG+S + L +VG+ YY++PE+ ++ YN + D+WS+
Sbjct: 134 IFLTSNGL----VKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSL 189
Query: 129 GVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPS-VSPEAKDFVRRLLNKDHRK 187
G + Y L PF + +L+ P PS S E ++ V LL KD +
Sbjct: 190 GCVLYELCTLKHPFEGENLLELALKILKGQY----PPIPSQYSSELRNLVSSLLQKDPEE 245
Query: 188 RMTAAQALTHP 198
R + AQ L P
Sbjct: 246 RPSIAQILQSP 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 7e-31
Identities = 68/210 (32%), Positives = 108/210 (51%), Gaps = 20/210 (9%)
Query: 3 HQKLQH---LFYSNSFLFFTR------FCEGGELLDRILSRGGRYLEEDAKTIVEKILNI 53
+K +H + Y S+L FC GG L D + S E + +++L
Sbjct: 51 LKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKG 110
Query: 54 VAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPE 113
+ + H G++HRD+K N L T+ D +K+IDFGLS + + N +VG+ Y++APE
Sbjct: 111 LEYLHSNGIIHRDIKAANILLTS---DGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPE 167
Query: 114 VLHR-SYNVEGDMWSIGVITYI-LLCGSRPFWARTESGIFRSVLR-ADPNFHDSPWPS-V 169
V++ Y+ + D+WS+G IT I L G P+ +E +++ + A P
Sbjct: 168 VINGKPYDYKADIWSLG-ITAIELAEGKPPY---SELPPMKALFKIATNGPPGLRNPEKW 223
Query: 170 SPEAKDFVRRLLNKDHRKRMTAAQALTHPW 199
S E KDF+++ L K+ KR TA Q L HP+
Sbjct: 224 SDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 8e-31
Identities = 68/209 (32%), Positives = 105/209 (50%), Gaps = 14/209 (6%)
Query: 2 YHQKLQHLFYSNSFLFFT-RFCEGGELLDRILSRGGRYLEED-AKTIVEKILNIVAFCHL 59
Y KL + F S +L+ + GG+ I + GG L ED AK + +++ V H
Sbjct: 58 YVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGG--LPEDWAKQYIAEVVLGVEDLHQ 115
Query: 60 QGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RS 118
+G++HRD+KPEN L ++ LK+ DFGLS +++ VG+ Y+APE +
Sbjct: 116 RGIIHRDIKPENLLI---DQTGHLKLTDFGLSRNGLENKK---FVGTPDYLAPETILGVG 169
Query: 119 YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVR 178
+ D WS+G + + L G PF A T +F ++L N+ + SPEA D +
Sbjct: 170 DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLIN 229
Query: 179 RLLNKDHRKRMTA---AQALTHPWLHDEN 204
RLL D KR+ A + +HP+ N
Sbjct: 230 RLLCMDPAKRLGANGYQEIKSHPFFKSIN 258
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 2e-30
Identities = 65/216 (30%), Positives = 104/216 (48%), Gaps = 31/216 (14%)
Query: 4 QKLQHLFYSNSFLFFTRFCE------------GGELLDRI-LSRGGRYLEEDAKTIVEKI 50
Q+L H F N L+++ F + GG+L R LS+ ++ EE K + +I
Sbjct: 55 QELNHPFLVN--LWYS-FQDEENMYLVVDLLLGGDL--RYHLSQKVKFSEEQVKFWICEI 109
Query: 51 LNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV 110
+ + + H +G++HRD+KP+N L +E + + DF ++ V PD G+ Y+
Sbjct: 110 VLALEYLHSKGIIHRDIKPDNILL---DEQGHVHITDFNIATKVTPDTLTTSTSGTPGYM 166
Query: 111 APEVL-HRSYNVEGDMWSIGVITYILLCGSRPFWART---ESGIFRSVLRADPNFHDSPW 166
APEVL + Y+V D WS+GV Y L G RP+ + I AD +
Sbjct: 167 APEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLY----P 222
Query: 167 PSVSPEAKDFVRRLLNKDHRKRM--TAAQALTHPWL 200
+ S EA D + +LL +D +KR+ HP+
Sbjct: 223 ATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-29
Identities = 58/207 (28%), Positives = 103/207 (49%), Gaps = 15/207 (7%)
Query: 5 KLQHLFYSNSFLFF-TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVV 63
KL F +++ +C GGEL IL G + E A+ + ++ + H +G++
Sbjct: 57 KLYRTFKDKKYIYMLMEYCLGGELWT-ILRDRGLFDEYTARFYIACVVLAFEYLHNRGII 115
Query: 64 HRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEV-LHRSYNVE 122
+RDLKPEN L + +K++DFG + ++ Q+ G+ YVAPE+ L++ Y+
Sbjct: 116 YRDLKPENLLLDSN---GYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFS 172
Query: 123 GDMWSIGVITYILLCGSRPFWARTES--GIFRSVLRADPNFHDSPWPSVSPEAKDFVRRL 180
D WS+G++ Y LL G PF E I+ +L+ + + P + AKD +++L
Sbjct: 173 VDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGN-GKLEFP-NYIDKAAKDLIKQL 230
Query: 181 LNKDHRKRMTAAQA-----LTHPWLHD 202
L ++ +R+ + H W +
Sbjct: 231 LRRNPEERLGNLKGGIKDIKKHKWFNG 257
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 2e-28
Identities = 68/229 (29%), Positives = 102/229 (44%), Gaps = 43/229 (18%)
Query: 8 HLFYS---NSFLFF-TRFCEGGELLDRILSRGGRYLEEDAK-TIVEKILNIVAFCHLQGV 62
L+YS L+ + GG+L+ +L R + EE A+ I E +L + + H G
Sbjct: 65 KLYYSFQDEEHLYLVMEYMPGGDLM-NLLIRKDVFPEETARFYIAELVLALDSV-HKLGF 122
Query: 63 VHRDLKPENFLFTTREEDAPLKVIDFGLS--------DFVRPDQRLND------------ 102
+HRD+KP+N L D +K+ DFGL + N
Sbjct: 123 IHRDIKPDNILID---ADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRD 179
Query: 103 ----------IVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIF 151
VG+ Y+APEVL Y +E D WS+GVI Y +L G PF++ T +
Sbjct: 180 HKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETY 239
Query: 152 RSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAA-QALTHPW 199
++ + P P VSPEA D + RLL D R+ + + +HP+
Sbjct: 240 NKIINWKESLRFPPDPPVSPEAIDLICRLL-CDPEDRLGSFEEIKSHPF 287
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-28
Identities = 59/194 (30%), Positives = 96/194 (49%), Gaps = 13/194 (6%)
Query: 13 NSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENF 72
N+ F + GG L +L + G+ E + +IL +A+ H G+VHRD+K N
Sbjct: 74 NTLNIFLEYVSGGSLSS-LLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANI 132
Query: 73 LFTTREEDAPLKVIDFGLS---DFVRPDQRLNDIVGSAYYVAPEVLHRS-YNVEGDMWSI 128
L D +K+ DFG + + + + G+ Y++APEV+ Y D+WS+
Sbjct: 133 LVD---SDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSL 189
Query: 129 GVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPW-PS-VSPEAKDFVRRLLNKDHR 186
G + G P W+ + + + L + + P P +S EAKDF+R+ L +D +
Sbjct: 190 GCTVIEMATGKPP-WSELGNPM--AALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPK 246
Query: 187 KRMTAAQALTHPWL 200
KR TA + L HP+L
Sbjct: 247 KRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 7e-28
Identities = 61/200 (30%), Positives = 95/200 (47%), Gaps = 17/200 (8%)
Query: 10 FYSNSFLFFT-RFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLK 68
F +S L+ + GGEL L + GR+ E A+ +++ + + H +V+RDLK
Sbjct: 70 FQDDSNLYLVMEYVPGGELFSH-LRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLK 128
Query: 69 PENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEV-LHRSYNVEGDMWS 127
PEN L + D +K+ DFG + V+ R + G+ Y+APE+ L + Y D W+
Sbjct: 129 PENLLLDS---DGYIKITDFGFAKRVKG--RTYTLCGTPEYLAPEIILSKGYGKAVDWWA 183
Query: 128 IGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRK 187
+G++ Y +L G PF+ I+ +L F SP+AKD +R LL D K
Sbjct: 184 LGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFP----SFFSPDAKDLIRNLLQVDLTK 239
Query: 188 RM-----TAAQALTHPWLHD 202
R+ HPW
Sbjct: 240 RLGNLKNGVNDIKNHPWFAG 259
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 3e-27
Identities = 72/235 (30%), Positives = 108/235 (45%), Gaps = 48/235 (20%)
Query: 5 KLQHLFYSNSFLFF-TRFCEGGELLDRILSRGGRYL-EEDAKTIVEKILNIVAFCHLQGV 62
L F + ++L +C GGEL + + G+ L EE A+ ++L + + HL G+
Sbjct: 65 TLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGI 124
Query: 63 VHRDLKPENFLFTTREEDAPLKVIDFGLS----------------------------DFV 94
V+RDLKPEN L E + + DF LS +
Sbjct: 125 VYRDLKPENILLH---ESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETF 181
Query: 95 R--PDQRLNDIVGSAYYVAPEVL----HRSYNVEGDMWSIGVITYILLCGSRPFWARTES 148
P R N VG+ Y+APEV+ H S V D W++G++ Y +L G+ PF
Sbjct: 182 SEEPSFRSNSFVGTEEYIAPEVISGDGHGS-AV--DWWTLGILLYEMLYGTTPFKGSNRD 238
Query: 149 GIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRM----TAAQALTHPW 199
F ++L+ + F S P VS A+D +R+LL KD KR+ AA+ HP+
Sbjct: 239 ETFSNILKKEVTFPGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPF 291
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 7e-27
Identities = 74/232 (31%), Positives = 107/232 (46%), Gaps = 46/232 (19%)
Query: 5 KLQHLFYSNSFLFFTRFCEGGELLDRILSRGGRYL-EEDAKTIVEKILNIVAFCHLQGVV 63
KL+ +F N L+F G L + R G+ E ++I+ +IL +A H G
Sbjct: 62 KLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFF 121
Query: 64 HRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL--HRSYNV 121
HRDLKPEN L + E +K+ DFGL+ +R D V + +Y APE+L SY+
Sbjct: 122 HRDLKPENLLVSGPEV---VKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSS 178
Query: 122 EGDMWSIGVIT---YILLCGSRP-FWARTESG-IFR--SVLRADPNFHDSPW-------- 166
D+W++G I Y L RP F +E +++ SVL P W
Sbjct: 179 PVDIWALGCIMAELYTL----RPLFPGSSEIDQLYKICSVL-GTPT--KQDWPEGYKLAS 231
Query: 167 ------------------PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200
P+ SPEA D ++ +L D +KR TA+QAL HP+
Sbjct: 232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-26
Identities = 54/186 (29%), Positives = 88/186 (47%), Gaps = 33/186 (17%)
Query: 44 KTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLND 102
K+I+ ++L +A+CH ++HRDLKP+N L LK+ DFGL+ F P +
Sbjct: 101 KSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGV---LKLADFGLARAFGIPLRTYTH 157
Query: 103 IVGSAYYVAPEVL--HRSYNVEGDMWSIGVITYILLCGSRPFWARTESG----IFRSVL- 155
V + +Y APE+L + Y+ D+WS+G I ++ G F +E IF+ +L
Sbjct: 158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQ-ILG 216
Query: 156 ----RADPNFHDSPW-----------------PSVSPEAKDFVRRLLNKDHRKRMTAAQA 194
+ P P P + PE D + ++L + KR++A +A
Sbjct: 217 TPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEA 276
Query: 195 LTHPWL 200
L HP+
Sbjct: 277 LKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 5e-26
Identities = 67/200 (33%), Positives = 110/200 (55%), Gaps = 23/200 (11%)
Query: 21 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREED 80
F +GG L D I+S+ R EE T+ E +L + + H QGV+HRD+K ++ L T D
Sbjct: 99 FLQGGALTD-IVSQT-RLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTL---D 153
Query: 81 APLKVIDFGLSDFVRPD-QRLNDIVGSAYYVAPEVLHRS-YNVEGDMWSIGVITYILLCG 138
+K+ DFG + D + +VG+ Y++APEV+ R+ Y E D+WS+G++ ++ G
Sbjct: 154 GRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDG 213
Query: 139 SRPFWARTESGIFRSVLRADPNFHDSPWPS------VSPEAKDFVRRLLNKDHRKRMTAA 192
P+++ + ++A DSP P +SP +DF+ R+L ++ ++R TA
Sbjct: 214 EPPYFSDSP-------VQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQ 266
Query: 193 QALTHPWLHDENRP---VPL 209
+ L HP+L P VPL
Sbjct: 267 ELLDHPFLLQTGLPECLVPL 286
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 65/188 (34%), Positives = 101/188 (53%), Gaps = 20/188 (10%)
Query: 21 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREED 80
F EGG L D I++ R EE T+ +L ++F H QGV+HRD+K ++ L T+ D
Sbjct: 97 FLEGGALTD-IVTHT-RMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTS---D 151
Query: 81 APLKVIDFGLSDFVRPD-QRLNDIVGSAYYVAPEVLHRS-YNVEGDMWSIGVITYILLCG 138
+K+ DFG V + R +VG+ Y++APEV+ R Y E D+WS+G++ ++ G
Sbjct: 152 GRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDG 211
Query: 139 SRPFWARTESGIFRSVLRADPNFHDSPWP------SVSPEAKDFVRRLLNKDHRKRMTAA 192
P++ L+A D+ P VSP + F+ R+L +D +R TAA
Sbjct: 212 EPPYFN-------EPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAA 264
Query: 193 QALTHPWL 200
+ L HP+L
Sbjct: 265 ELLNHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-25
Identities = 56/188 (29%), Positives = 95/188 (50%), Gaps = 14/188 (7%)
Query: 18 FTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77
F GG L ++L + G + E + +IL + + H + VHRD+K N L
Sbjct: 80 FLELVPGGSLA-KLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILV--- 135
Query: 78 EEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYIL 135
+ + +K+ DFG++ V GS Y++APEV+ + Y + D+WS+G T +
Sbjct: 136 DTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGC-TVLE 194
Query: 136 LCGSRPFWARTE--SGIFRSVLRAD-PNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAA 192
+ +P W++ E + +F+ + P D +S EAKDF+ + L +D R TAA
Sbjct: 195 MATGKPPWSQLEGVAAVFKIGRSKELPPIPDH----LSDEAKDFILKCLQRDPSLRPTAA 250
Query: 193 QALTHPWL 200
+ L HP++
Sbjct: 251 ELLEHPFV 258
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 7e-25
Identities = 59/202 (29%), Positives = 100/202 (49%), Gaps = 11/202 (5%)
Query: 5 KLQHLFYSNSFLFFT-RFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQ-GV 62
K FY + + +GG L +L + G+ E I +IL + + H + +
Sbjct: 63 KCYGAFYKEGEISIVLEYMDGGSL-ADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHI 121
Query: 63 VHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP-DQRLNDIVGSAYYVAPEVLH-RSYN 120
+HRD+KP N L ++ E +K+ DFG+S + + N VG+ Y++PE + SY+
Sbjct: 122 IHRDIKPSNLLINSKGE---VKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYS 178
Query: 121 VEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPS--VSPEAKDFVR 178
D+WS+G+ G PF + F +++A + P+ SPE +DF+
Sbjct: 179 YAADIWSLGLTLLECALGKFPFLPPGQPSFF-ELMQAICDGPPPSLPAEEFSPEFRDFIS 237
Query: 179 RLLNKDHRKRMTAAQALTHPWL 200
L KD +KR +AA+ L HP++
Sbjct: 238 ACLQKDPKKRPSAAELLQHPFI 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 9e-25
Identities = 60/199 (30%), Positives = 96/199 (48%), Gaps = 23/199 (11%)
Query: 16 LFFTRFCEGGELLDRILSRGGRYLEEDA-KTIVEKILNIVAFCHLQGVVHRDLKPENFLF 74
F +C GG L + L GR L+E + ++L +A+ H G+VHRD+KP N
Sbjct: 75 YIFMEYCSGGTLEE--LLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFL 132
Query: 75 TTREEDAPLKVIDFGLSDFV-----RPDQRLNDIVGSAYYVAPEVLHRSYNVEG-----D 124
+K+ DFG + + + + + G+ Y+APEV+ +G D
Sbjct: 133 DHN---GVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG-KGKGHGRAAD 188
Query: 125 MWSIGVITYILLCGSRPFWARTESG---IFRSVLRADPNFHDSPWPSVSPEAKDFVRRLL 181
+WS+G + + G RP W+ ++ +F P DS +SPE KDF+ R L
Sbjct: 189 IWSLGCVVLEMATGKRP-WSELDNEFQIMFHVGAGHKPPIPDSL--QLSPEGKDFLDRCL 245
Query: 182 NKDHRKRMTAAQALTHPWL 200
D +KR TA++ L HP++
Sbjct: 246 ESDPKKRPTASELLQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 59/201 (29%), Positives = 100/201 (49%), Gaps = 21/201 (10%)
Query: 21 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREED 80
+C GG LD L + G+ E I+ ++L + + H +G +HRD+K N L + E+
Sbjct: 80 YCGGGSCLD--LLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLS---EE 134
Query: 81 APLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLHRS-YNVEGDMWSIGVITYILLCG 138
+K+ DFG+S + + N VG+ +++APEV+ +S Y+ + D+WS+G+ L G
Sbjct: 135 GDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKG 194
Query: 139 SRPFWARTESGI------FRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAA 192
P S + F P+ + + S KDFV LNKD ++R +A
Sbjct: 195 EPPL-----SDLHPMRVLFLIPKNNPPSLEGNKF---SKPFKDFVSLCLNKDPKERPSAK 246
Query: 193 QALTHPWLHDENRPVPLDILI 213
+ L H ++ + L +LI
Sbjct: 247 ELLKHKFIKKAKKTSYLTLLI 267
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 5e-24
Identities = 64/191 (33%), Positives = 90/191 (47%), Gaps = 34/191 (17%)
Query: 40 EEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR 99
E K+ + ++L +AFCH G++HRDLKPEN L T + LK+ DFGL+ R
Sbjct: 97 ESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINT---EGVLKLADFGLARSFGSPVR 153
Query: 100 -LNDIVGSAYYVAPEVLHRS--YNVEGDMWSIGVITYILLCGSRPFWARTE-----SGIF 151
V + +Y APE+L Y+ D+WS+G I LL RP + IF
Sbjct: 154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSR-RPLFPGKSEIDQLFKIF 212
Query: 152 R--------------SVLRAD----PNFHDSPW----PSVSPEAKDFVRRLLNKDHRKRM 189
R S+ R P P P+ SP+A D + ++L+ D KR+
Sbjct: 213 RTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRI 272
Query: 190 TAAQALTHPWL 200
TA QAL HP+
Sbjct: 273 TAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 2e-23
Identities = 62/207 (29%), Positives = 108/207 (52%), Gaps = 19/207 (9%)
Query: 6 LQHLFYSNSFLFFTRFCE---GGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGV 62
+Q+L + + + + F E GG + L GR+ E+ + E++L +A+ H +G+
Sbjct: 71 VQYLGFETTEEYLSIFLEYVPGGSI-GSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGI 129
Query: 63 VHRDLKPENFLFTTREEDAPLKVIDFGLS----DFVRPDQRLNDIVGSAYYVAPEVLH-- 116
+HRDLK +N L + D K+ DFG+S D DQ ++ + GS +++APEV+H
Sbjct: 130 LHRDLKADNLLV---DADGICKISDFGISKKSDDIYDNDQNMS-MQGSVFWMAPEVIHSY 185
Query: 117 -RSYNVEGDMWSIGVITYILLCGSRPFWARTES--GIFR-SVLRADPNFHDSPWPSVSPE 172
+ Y+ + D+WS+G + + G RP W+ E+ +F+ R+ P ++SP
Sbjct: 186 SQGYSAKVDIWSLGCVVLEMFAGRRP-WSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPV 244
Query: 173 AKDFVRRLLNKDHRKRMTAAQALTHPW 199
A DF+ + R TA + L HP+
Sbjct: 245 ALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 2e-23
Identities = 60/185 (32%), Positives = 101/185 (54%), Gaps = 21/185 (11%)
Query: 21 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQ--GVVHRDLKPENFLFTTRE 78
+ GGEL + R + E + + + +I ++A HL G+++RD+K EN L +
Sbjct: 86 YVNGGELFTHLYQRE-HFTESEVRVYIAEI--VLALDHLHQLGIIYRDIKLENILL---D 139
Query: 79 EDAPLKVIDFGLSDFVRPDQ--RLNDIVGSAYYVAPEVLHR---SYNVEGDMWSIGVITY 133
+ + + DFGLS ++ R G+ Y+APEV+ ++ D WS+GV+T+
Sbjct: 140 SEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTF 199
Query: 134 ILLCGSRPFWA----RTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRM 189
LL G+ PF ++S I R +L++ P F P ++S EA+DF+++LL KD +KR+
Sbjct: 200 ELLTGASPFTVDGEQNSQSEISRRILKSKPPF---P-KTMSAEARDFIQKLLEKDPKKRL 255
Query: 190 TAAQA 194
A A
Sbjct: 256 GANGA 260
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 6e-23
Identities = 58/200 (29%), Positives = 102/200 (51%), Gaps = 13/200 (6%)
Query: 6 LQHLFYSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIV---EKILNIVAFCHLQGV 62
H N+ L + GG L D+I+ + G+ EE + ++ +I++ V++ H G+
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEE--EMVLWYLFQIVSAVSYIHKAGI 122
Query: 63 VHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLND-IVGSAYYVAPEVLH-RSYN 120
+HRD+K N +F T+ +K+ DFG+S + + + + +VG+ YY++PE+ YN
Sbjct: 123 LHRDIKTLN-IFLTK--AGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYN 179
Query: 121 VEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRL 180
+ D+W++G + Y LL R F A + +++ + S + S E V L
Sbjct: 180 FKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVY---SSELISLVHSL 236
Query: 181 LNKDHRKRMTAAQALTHPWL 200
L +D KR TA + L P L
Sbjct: 237 LQQDPEKRPTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 7e-23
Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 24/204 (11%)
Query: 8 HLFYSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDL 67
F + +C G + D + EE+ I+ + L + + H +HRD+
Sbjct: 66 SYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDI 125
Query: 68 KPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLND-------IVGSAYYVAPEVLHRS-Y 119
K N L E+ K+ DFG+S +L D ++G+ +++APEV+ Y
Sbjct: 126 KAGNILLN---EEGQAKLADFGVS------GQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 176
Query: 120 NVEGDMWSIGVITYILLCGSRP--FWARTESGIFRSVLRADPNFHD-SPWPSVSPEAKDF 176
N + D+WS+G IT I + +P IF + P D W SPE DF
Sbjct: 177 NNKADIWSLG-ITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKW---SPEFNDF 232
Query: 177 VRRLLNKDHRKRMTAAQALTHPWL 200
V++ L KD +R +A Q L HP++
Sbjct: 233 VKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 7e-23
Identities = 58/193 (30%), Positives = 90/193 (46%), Gaps = 20/193 (10%)
Query: 20 RFCEGGELLD---RILSRGGRYLEED-AKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 75
+ GG LLD RGG L+E T+++++L + + H G +HRD+K N L
Sbjct: 79 PYLSGGSLLDIMKSSYPRGG--LDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILL- 135
Query: 76 TREEDAPLKVIDFGLSDFV-----RPDQRLNDIVGSAYYVAPEVLH--RSYNVEGDMWSI 128
ED +K+ DFG+S + R + VG+ ++APEV+ Y+ + D+WS
Sbjct: 136 --GEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSF 193
Query: 129 GVITYI-LLCGSRPFWARTESGIFRSVLRADPNF--HDSPWPSVSPEAKDFVRRLLNKDH 185
G IT I L G+ P+ + L+ DP + + S + + L KD
Sbjct: 194 G-ITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDP 252
Query: 186 RKRMTAAQALTHP 198
KR TA + L H
Sbjct: 253 SKRPTAEELLKHK 265
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 9e-23
Identities = 56/187 (29%), Positives = 88/187 (47%), Gaps = 31/187 (16%)
Query: 40 EEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR 99
E K ++ ++L V F H +VHRDLKP+N L T+ + +K+ DFGL+ +
Sbjct: 106 PETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQ---VKIADFGLARIYSFEMA 162
Query: 100 LNDIVGSAYYVAPEVLHRS-YNVEGDMWSIGVITYILLCGSRPFWARTESG----IFR-- 152
L +V + +Y APEVL +S Y DMWS+G I L F +E+ IF
Sbjct: 163 LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVI 222
Query: 153 ------------SVLRADPNFHDSP-------WPSVSPEAKDFVRRLLNKDHRKRMTAAQ 193
S+ R+ +F P + E D ++++L + KR++A +
Sbjct: 223 GLPSEEEWPRNVSLPRS--SFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFE 280
Query: 194 ALTHPWL 200
AL HP+
Sbjct: 281 ALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 1e-22
Identities = 58/201 (28%), Positives = 94/201 (46%), Gaps = 36/201 (17%)
Query: 21 FCEGG---ELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77
C GG +L+ + +G R EE I+ + L +A+ H V+HRD+K +N L T
Sbjct: 90 LCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLT-- 147
Query: 78 EEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVLH------RSYNVEGDMWSIGV 130
++A +K++DFG+S R N +G+ Y++APEV+ SY+ D+WS+G
Sbjct: 148 -KNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLG- 205
Query: 131 ITYILLCGSRPFWA-----RTESGIFRSVLRADPNFHDSPWPSVSPEAK------DFVRR 179
IT I L +P R I R +P P++ DF+
Sbjct: 206 ITAIELADGKPPLCDMHPMRALFKIPR-----------NPPPTLKSPENWSKKFNDFISE 254
Query: 180 LLNKDHRKRMTAAQALTHPWL 200
L K++ +R + L HP++
Sbjct: 255 CLIKNYEQRPFMEELLEHPFI 275
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 1e-22
Identities = 64/193 (33%), Positives = 94/193 (48%), Gaps = 37/193 (19%)
Query: 40 EEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD-FVRPDQ 98
E K+ + +L VA+ H G++HRDLKP N L + D LK+ DFGL+ F +
Sbjct: 98 EAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLIS---ADGVLKIADFGLARLFSEEEP 154
Query: 99 RL-NDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILLCGSRPFWARTE----SGIF 151
RL + V + +Y APE+L+ R Y+ D+W++G I LL GS F + + +F
Sbjct: 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVF 214
Query: 152 RSVLRADPNFHD--------------------SPW----PSVSPEAKDFVRRLLNKDHRK 187
R++ PN P P SPEA D ++ LL D K
Sbjct: 215 RTL--GTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSK 272
Query: 188 RMTAAQALTHPWL 200
R++AA+AL HP+
Sbjct: 273 RLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 2e-22
Identities = 60/198 (30%), Positives = 102/198 (51%), Gaps = 18/198 (9%)
Query: 10 FYSNSFLFFT-RFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLK 68
F + LFF + GG+L+ I R GR+ E A+ +I+ + F H +G+++RDLK
Sbjct: 65 FQTKDRLFFVMEYVNGGDLMFHIQ-RSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLK 123
Query: 69 PENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVL-HRSYNVEGDMW 126
+N L + + +K+ DFG+ + + + G+ Y+APE+L ++ Y D W
Sbjct: 124 LDNVLLDS---EGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWW 180
Query: 127 SIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWP-SVSPEAKDFVRRLLNKDH 185
++GV+ Y +L G PF E +F+S+L + + P +S EAK ++ L K+
Sbjct: 181 ALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRY-----PRWLSKEAKSILKSFLTKNP 235
Query: 186 RKRM----TAAQALT-HP 198
KR+ T Q + HP
Sbjct: 236 EKRLGCLPTGEQDIKGHP 253
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 2e-22
Identities = 68/215 (31%), Positives = 104/215 (48%), Gaps = 19/215 (8%)
Query: 10 FYSNSFLFFTRFCEGGELLDRILSRGGRYLEEDA-KTIVEKILNIVAFCHLQGVVHRDLK 68
FY N FC+GG L D I+ R L E + + ++L + F H V+HRDLK
Sbjct: 72 FYENKLWILIEFCDGGAL-DSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLK 130
Query: 69 PENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVL------HRSYNV 121
N L T D +K+ DFG+S Q+ + +G+ Y++APEV+ Y+
Sbjct: 131 AGNILLTL---DGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDY 187
Query: 122 EGDMWSIGVITYILLCGSRPFWARTES-GIFRSVLRADPNFHDSP--WPSVSPEAKDFVR 178
+ D+WS+G IT I L P + +L+++P D P W S DF++
Sbjct: 188 KADIWSLG-ITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKW---SSSFNDFLK 243
Query: 179 RLLNKDHRKRMTAAQALTHPWLHDENRPVPLDILI 213
L KD R TAA+ L HP++ D++ + L+
Sbjct: 244 SCLVKDPDDRPTAAELLKHPFVSDQSDNKAIKDLL 278
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 2e-22
Identities = 66/198 (33%), Positives = 99/198 (50%), Gaps = 19/198 (9%)
Query: 21 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREED 80
F EGG L D + R EE + +L ++ H QGV+HRD+K ++ L T D
Sbjct: 98 FLEGGALTDIVTHT--RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLT---HD 152
Query: 81 APLKVIDFGLSDFVRPD-QRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCG 138
+K+ DFG V + R +VG+ Y++APE++ R Y E D+WS+G++ ++ G
Sbjct: 153 GRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 212
Query: 139 SRPFWARTESGIFRSVLRADP----NFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQA 194
P++ + + P N H VSP K F+ RLL +D +R TAA+
Sbjct: 213 EPPYFNEPPLKAMKMIRDNLPPKLKNLH-----KVSPSLKGFLDRLLVRDPAQRATAAEL 267
Query: 195 LTHPWLHDENRP---VPL 209
L HP+L P VPL
Sbjct: 268 LKHPFLAKAGPPSCIVPL 285
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 2e-22
Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 16/212 (7%)
Query: 6 LQHLFYSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHR 65
L +Y N+ FC GG + +L E + + ++ L + + H ++HR
Sbjct: 68 LDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHR 127
Query: 66 DLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVL------HRS 118
DLK N LFT D +K+ DFG+S R QR + +G+ Y++APEV+ R
Sbjct: 128 DLKAGNILFTL---DGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 184
Query: 119 YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSP--WPSVSPEAKDF 176
Y+ + D+WS+G+ + P + + +++P P W S E KDF
Sbjct: 185 YDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW---SSEFKDF 241
Query: 177 VRRLLNKDHRKRMTAAQALTHPWLH-DENRPV 207
+++ L K+ R T Q L HP++ + N+P+
Sbjct: 242 LKKCLEKNVDARWTTTQLLQHPFVTVNSNKPI 273
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 2e-22
Identities = 62/209 (29%), Positives = 96/209 (45%), Gaps = 42/209 (20%)
Query: 26 ELLDRILSRGGRYLEEDA-KTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLK 84
ELL+ S GG L DA ++ + ++L +A+CH ++HRD+KPEN L + E LK
Sbjct: 88 ELLEA--SPGG--LPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVS---ESGVLK 140
Query: 85 VIDFGLSDFV--RPDQRLNDIVGSAYYVAPEVL--HRSYNVEGDMWSIGVITYILLCGSR 140
+ DFG + + RP L D V + +Y APE+L +Y D+W+IG I LL G
Sbjct: 141 LCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDG-E 199
Query: 141 PFWARTES-----GIFR----------SVLRADPNFHDSPWPSVSPE------------- 172
P + I + + ++P F +P S
Sbjct: 200 PLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSS 259
Query: 173 -AKDFVRRLLNKDHRKRMTAAQALTHPWL 200
A DF++ L D ++R+T + L HP+
Sbjct: 260 PALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 3e-22
Identities = 67/220 (30%), Positives = 112/220 (50%), Gaps = 19/220 (8%)
Query: 6 LQHLFYSNSFLFF-TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVH 64
L+ F ++S L+ T + GGEL L + GR+ E+ AK + +++ + H +V+
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWH-LQKEGRFSEDRAKFYIAELVLALEHLHKYDIVY 119
Query: 65 RDLKPENFLFTTREEDAPLKVIDFGLSDF-VRPDQRLNDIVGSAYYVAPEVL--HRSYNV 121
RDLKPEN L + + + DFGLS + ++ N G+ Y+APEVL + Y
Sbjct: 120 RDLKPENILL---DATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTK 176
Query: 122 EGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLL 181
D WS+GV+ + + CG PF+A ++R++ F P +S E + FV+ LL
Sbjct: 177 HVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRF---PKNVLSDEGRQFVKGLL 233
Query: 182 NKDHRKRMTAAQALT----HPWLHDENRPVPLDILIYKLV 217
N++ + R+ A + HP+ D + D+L K +
Sbjct: 234 NRNPQHRLGAHRDAVELKEHPFFADID----WDLLSKKQI 269
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 4e-22
Identities = 59/188 (31%), Positives = 92/188 (48%), Gaps = 16/188 (8%)
Query: 31 ILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGL 90
+L+ G E+ A+ + ++ V H G +HRDLKPENFL + +K+ DFGL
Sbjct: 91 LLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLI---DASGHIKLTDFGL 147
Query: 91 SDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESG 149
S + N +VGS Y+APEVL + Y+ D WS+G + Y LCG PF T +
Sbjct: 148 SKGIV--TYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE 205
Query: 150 IFRSVLR-----ADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204
+ ++ P + D P ++S EA D + +L+N R+ + HP+
Sbjct: 206 TWENLKYWKETLQRPVY-DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFF---- 260
Query: 205 RPVPLDIL 212
+ V + L
Sbjct: 261 KEVDWNEL 268
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 94.9 bits (237), Expect = 4e-22
Identities = 63/200 (31%), Positives = 93/200 (46%), Gaps = 34/200 (17%)
Query: 37 RYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVR 95
D K+ + L + + H ++HRDLKP N L D LK+ DFGL+ F
Sbjct: 98 VLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIA---SDGVLKLADFGLARSFGS 154
Query: 96 PDQRLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILLCGSRPFWARTE-----S 148
P++++ V + +Y APE+L R Y V DMWS+G I LL PF
Sbjct: 155 PNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLR-VPFLPGDSDIDQLG 213
Query: 149 GIFRS----------VLRADPNFHD------SPW----PSVSPEAKDFVRRLLNKDHRKR 188
IF + + + P++ + +P P+ S +A D ++RLL + KR
Sbjct: 214 KIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKR 273
Query: 189 MTAAQALTHPWLHDENRPVP 208
+TA QAL HP+ N P P
Sbjct: 274 ITARQALEHPYFS--NDPAP 291
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 7e-22
Identities = 71/221 (32%), Positives = 109/221 (49%), Gaps = 25/221 (11%)
Query: 3 HQKLQHL---FYSNSFLFFT-RFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCH 58
H L HL F + LFF + GG+L+ I S G R+ E A+ +I+ + F H
Sbjct: 55 HPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSG-RFDEARARFYAAEIICGLQFLH 113
Query: 59 LQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF-VRPDQRLNDIVGSAYYVAPEVLH- 116
+G+++RDLK +N L ++D +K+ DFG+ + + + + G+ Y+APE+L
Sbjct: 114 KKGIIYRDLKLDNVLL---DKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKG 170
Query: 117 RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPW--PSVSPEAK 174
+ YN D WS GV+ Y +L G PF E +F S+L +D P +S EAK
Sbjct: 171 QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSIL------NDRPHFPRWISKEAK 224
Query: 175 DFVRRLLNKDHRKRM-TAAQALTHP------WLHDENRPVP 208
D + +L +D KR+ HP W E R +P
Sbjct: 225 DCLSKLFERDPTKRLGVDGDIRQHPFFRGIDWERLEKREIP 265
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 1e-21
Identities = 61/205 (29%), Positives = 104/205 (50%), Gaps = 21/205 (10%)
Query: 21 FCEGGEL---LDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77
+CEGG L ++ RGGR E+ I E +L +++ H + ++HRD+KP N L T +
Sbjct: 82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRK 141
Query: 78 EEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPE-VLHRSYNVEGDMWSIGVITYIL 135
+ +K+ DFG+S + V + G+++Y+APE + + Y++ D+WS+G +T +
Sbjct: 142 GQ---VKLCDFGVSGELV--NSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLG-LTLLE 195
Query: 136 LCGSR-PFWARTESG-----IFRSVLRAD-PNFHDSPWPSV--SPEAKDFVRRLLNKDHR 186
+ +R PF E + ++ P D P + S E KDF+++ L KD
Sbjct: 196 VAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPT 255
Query: 187 KRMTAAQALTHPW-LHDENRPVPLD 210
+R T L HPW + V +
Sbjct: 256 RRPTPWDMLEHPWIKAQMKKKVNMA 280
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 1e-21
Identities = 68/212 (32%), Positives = 105/212 (49%), Gaps = 40/212 (18%)
Query: 10 FYSNSFLFF-TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQG------- 61
FY+N + + +GG L D+IL I E+IL +A L+G
Sbjct: 68 FYNNGDISICMEYMDGGSL-DKILKEV-------QGRIPERILGKIAVAVLKGLTYLHEK 119
Query: 62 --VVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDI----VGSAYYVAPEVL 115
++HRD+KP N L +R + +K+ DFG+S Q +N + VG++ Y+APE +
Sbjct: 120 HKIIHRDVKPSNILVNSRGQ---IKLCDFGVSG-----QLVNSLAKTFVGTSSYMAPERI 171
Query: 116 H-RSYNVEGDMWSIGVITYILLCGSR---PFWARTESGIFRSVLRADPNFHDSP-WPS-- 168
Y+V+ D+WS+G ++ I L R P GIF +L+ N P PS
Sbjct: 172 QGNDYSVKSDIWSLG-LSLIELATGRFPYPPENDPPDGIF-ELLQYIVN-EPPPRLPSGK 228
Query: 169 VSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200
SP+ +DFV L KD R+R + + L HP++
Sbjct: 229 FSPDFQDFVNLCLIKDPRERPSYKELLEHPFI 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 93.7 bits (234), Expect = 2e-21
Identities = 62/214 (28%), Positives = 97/214 (45%), Gaps = 41/214 (19%)
Query: 28 LDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVID 87
L +++ ++ + + +IL + + H V+HRDLKP N + D LK+ D
Sbjct: 90 LHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSN-ILVNSNCD--LKICD 146
Query: 88 FGLSDFVRPDQR----LNDIVGSAYYVAPEVL--HRSYNVEGDMWSIGVITYILLCGSRP 141
FGL+ V PD+ L + V + +Y APE+L Y D+WS+G I LL +P
Sbjct: 147 FGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELL-TRKP 205
Query: 142 FWA-----------------RTESGI-------FRSVLRADPNFHDSPW----PSVSPEA 173
+ +E + R+ L++ P P P SPEA
Sbjct: 206 LFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEA 265
Query: 174 KDFVRRLLNKDHRKRMTAAQALTHPWL---HDEN 204
D + ++L D +KR+TA +AL HP+L HD
Sbjct: 266 IDLLEKMLVFDPKKRITADEALAHPYLAQLHDPE 299
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 2e-21
Identities = 57/185 (30%), Positives = 83/185 (44%), Gaps = 31/185 (16%)
Query: 43 AKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLN 101
K+ ++L +AFCH V+HRDLKP+N L R E LK+ DFGL+ F P +
Sbjct: 102 VKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGE---LKLADFGLARAFGIPVNTFS 158
Query: 102 DIVGSAYYVAPEVL--HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADP 159
+ V + +Y AP+VL R+Y+ D+WS+G I ++ G F + R
Sbjct: 159 NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMG 218
Query: 160 NFHDSPWPSVS-------------------------PEAKDFVRRLLNKDHRKRMTAAQA 194
+S WP +S P D + RLL + R++A A
Sbjct: 219 TPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDA 278
Query: 195 LTHPW 199
L HPW
Sbjct: 279 LQHPW 283
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 2e-21
Identities = 59/183 (32%), Positives = 96/183 (52%), Gaps = 15/183 (8%)
Query: 24 GGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPL 83
GGEL L R G ++E+ A + +I + H QG+++RDLKPEN L + +
Sbjct: 84 GGELFMH-LEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQ---GHV 139
Query: 84 KVIDFGL-SDFVRPDQRLNDIVGSAYYVAPEVLHRS-YNVEGDMWSIGVITYILLCGSRP 141
K+ DFGL + + + G+ Y+APE+L RS + D WS+G + Y +L G+ P
Sbjct: 140 KLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199
Query: 142 FWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRM-----TAAQALT 196
F A +L+ N P P ++PEA+D +++LL ++ R+ AA+ +
Sbjct: 200 FTAENRKKTIDKILKGKLNL---P-PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255
Query: 197 HPW 199
HP+
Sbjct: 256 HPF 258
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 2e-21
Identities = 54/200 (27%), Positives = 94/200 (47%), Gaps = 17/200 (8%)
Query: 11 YSNSFL------FFTRFCEGGELLDRILSRGGRYLEEDA--KTIVEKILNIVAFCHLQGV 62
Y SFL + E G+L + + GR L ED + ++ +L + A H + +
Sbjct: 64 YYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGL-AHLHSKKI 122
Query: 63 VHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRL-NDIVGSAYYVAPEVLH-RSYN 120
+HRD+K N + +K+ D G++ + + N IVG+ YY++PE+ + YN
Sbjct: 123 LHRDIKSLNLFL---DAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYN 179
Query: 121 VEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRL 180
+ D+W++GV+ Y G PF A + + ++R F S + + +
Sbjct: 180 EKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRG--VFPPVSQM-YSQQLAQLIDQC 236
Query: 181 LNKDHRKRMTAAQALTHPWL 200
L KD+R+R Q L +P L
Sbjct: 237 LTKDYRQRPDTFQLLRNPSL 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 92.7 bits (231), Expect = 3e-21
Identities = 58/191 (30%), Positives = 94/191 (49%), Gaps = 24/191 (12%)
Query: 21 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREED 80
+ +GG L D I R E + ++L + + H Q V+HRD+K +N L + +D
Sbjct: 96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLS---KD 152
Query: 81 APLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVLHRS-YNVEGDMWSIGVITYILLCG 138
+K+ DFG + + + N +VG+ Y++APEV+ R Y + D+WS+G++ + G
Sbjct: 153 GSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212
Query: 139 SRPF---------WARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRM 189
P+ + T GI P + SPE KDF+ + L KD KR
Sbjct: 213 EPPYLREPPLRALFLITTKGI--------PPLKNP--EKWSPEFKDFLNKCLVKDPEKRP 262
Query: 190 TAAQALTHPWL 200
+A + L HP+L
Sbjct: 263 SAEELLQHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 3e-21
Identities = 53/199 (26%), Positives = 105/199 (52%), Gaps = 19/199 (9%)
Query: 21 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREED 80
+ EGG + R L + G E+ I+ ++L + + H GV+HRD+K N L T
Sbjct: 83 YAEGGSV--RTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTN---T 137
Query: 81 APLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILLC 137
+K+ DFG++ + + + VG+ Y++APEV+ + Y+ + D+WS+G+ Y +
Sbjct: 138 GNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMAT 197
Query: 138 GSRPFWARTESGIFRSVL----RADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQ 193
G+ P+ ++ FR+++ P D+ + S ++FV L+++ ++R++A +
Sbjct: 198 GNPPY---SDVDAFRAMMLIPKSKPPRLEDNGY---SKLLREFVAACLDEEPKERLSAEE 251
Query: 194 ALTHPWLHDENRPVPLDIL 212
L W+ ++ P+ IL
Sbjct: 252 LLKSKWIKAHSK-TPVSIL 269
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 4e-21
Identities = 67/221 (30%), Positives = 105/221 (47%), Gaps = 23/221 (10%)
Query: 6 LQHLFYSNSFLFFTRFCEGGELLDRILSRGGRYLEE-DAKTIVEKILNIVAFCHLQGVVH 64
L ++ FC GG + D I+ R L E + I ++L + + H ++H
Sbjct: 75 LGAFYWDGKLWIMIEFCPGGAV-DAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIH 133
Query: 65 RDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVL------HR 117
RDLK N L T D +K+ DFG+S V+ QR + +G+ Y++APEV+
Sbjct: 134 RDLKAGNVLLT---LDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDT 190
Query: 118 SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLR---ADPNFHDSP--WPSVSPE 172
Y+ + D+WS+G IT I + P E R +L+ ++P P W S E
Sbjct: 191 PYDYKADIWSLG-ITLIEMAQIEP--PHHELNPMRVLLKIAKSEPPTLSQPSKW---SME 244
Query: 173 AKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDILI 213
+DF++ L+K R +AAQ L HP++ PL L+
Sbjct: 245 FRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNRPLRELV 285
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 6e-21
Identities = 61/203 (30%), Positives = 100/203 (49%), Gaps = 27/203 (13%)
Query: 12 SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPEN 71
++ F + GG + +L+ G + E + V +IL + + H +G++HRD+K N
Sbjct: 78 ADHLNIFLEYVPGGSV-AALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGAN 136
Query: 72 FLFTTREEDAPLKVIDFGLSDFV------------RPDQRLNDIVGSAYYVAPEVLHR-S 118
L + +K+ DFG+S + RP + GS +++APEV+ + S
Sbjct: 137 ILVDNK---GGIKISDFGISKKLEANSLSTKTNGARPS-----LQGSVFWMAPEVVKQTS 188
Query: 119 YNVEGDMWSIGVITYILLCGSRPFWARTE-SGIFRSVLRADPNFHDSPWPSVSPEAKDFV 177
Y + D+WS+G + +L G PF T+ IF+ A P + +S EA DF+
Sbjct: 189 YTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSN----ISSEAIDFL 244
Query: 178 RRLLNKDHRKRMTAAQALTHPWL 200
+ DH KR TAA+ L HP+L
Sbjct: 245 EKTFEIDHNKRPTAAELLKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 1e-20
Identities = 60/188 (31%), Positives = 99/188 (52%), Gaps = 13/188 (6%)
Query: 6 LQHLFYSNSFL-FFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVH 64
L++ F ++ L F + GGEL LSR + E+ A+ +I++ + + H VV+
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGELFFH-LSRERVFSEDRARFYGAEIVSALGYLHSCDVVY 118
Query: 65 RDLKPENFLFTTREEDAPLKVIDFGL-SDFVRPDQRLNDIVGSAYYVAPEVLHRS-YNVE 122
RDLK EN + ++D +K+ DFGL + + + G+ Y+APEVL + Y
Sbjct: 119 RDLKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRA 175
Query: 123 GDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPS-VSPEAKDFVRRLL 181
D W +GV+ Y ++CG PF+ + +F +L + F P +SPEAK + LL
Sbjct: 176 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF-----PRTLSPEAKSLLAGLL 230
Query: 182 NKDHRKRM 189
KD ++R+
Sbjct: 231 KKDPKQRL 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.3 bits (225), Expect = 2e-20
Identities = 59/208 (28%), Positives = 82/208 (39%), Gaps = 43/208 (20%)
Query: 28 LDRILSRGGRYLEED-AKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVI 86
L +L E K ++++L + + H G++HRD+K N L LK+
Sbjct: 86 LTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGV---LKLA 142
Query: 87 DFGLSDFV--RPDQRLNDIVGSAYYVAPEVL--HRSYNVEGDMWSIGVITYILLCGSRPF 142
DFGL+ R + V + +Y PE+L Y E DMWS+G I L G F
Sbjct: 143 DFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIF 202
Query: 143 WARTESG----IFRSVLRADPNFHDSPWPSV---------------------------SP 171
TE IF L P D WP V P
Sbjct: 203 QGSTELEQLEKIFE--LCGSPT--DENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDP 258
Query: 172 EAKDFVRRLLNKDHRKRMTAAQALTHPW 199
A D + +LL D +KR++A QAL H +
Sbjct: 259 SALDLLDKLLTLDPKKRISADQALQHEY 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 2e-20
Identities = 58/199 (29%), Positives = 92/199 (46%), Gaps = 41/199 (20%)
Query: 40 EEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP-DQ 98
++ + +V +IL + + H G++HRDLKP N ED LK++DFGL+ R D
Sbjct: 117 DDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN---EDCELKILDFGLA---RHTDD 170
Query: 99 RLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILLCG------------------ 138
+ V + +Y APE++ YN D+WS+G I LL G
Sbjct: 171 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMN 230
Query: 139 -----SRPFWARTESGIFRSVLRADP-----NFHDSPWPSVSPEAKDFVRRLLNKDHRKR 188
+ S R+ +++ P +F + + +P A D + ++L D KR
Sbjct: 231 LVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEV-FSGANPLAIDLLEKMLVLDPDKR 289
Query: 189 MTAAQALTHPWL---HDEN 204
+TAA+AL HP+L HD
Sbjct: 290 ITAAEALAHPYLAEYHDPE 308
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 2e-20
Identities = 59/199 (29%), Positives = 104/199 (52%), Gaps = 24/199 (12%)
Query: 21 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREED 80
+ GGEL + R R+ E++ + +I+ + H G+++RD+K EN L + +
Sbjct: 86 YINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILL---DSN 141
Query: 81 APLKVIDFGLS-DFVRPD-QRLNDIVGSAYYVAPEVLH---RSYNVEGDMWSIGVITYIL 135
+ + DFGLS +F + +R G+ Y+AP+++ ++ D WS+GV+ Y L
Sbjct: 142 GHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYEL 201
Query: 136 LCGSRPFWA----RTESGIFRSVLRADPNFHDSPWPS-VSPEAKDFVRRLLNKDHRKRM- 189
L G+ PF +++ I R +L+++P P+P +S AKD ++RLL KD +KR+
Sbjct: 202 LTGASPFTVDGEKNSQAEISRRILKSEP-----PYPQEMSALAKDIIQRLLMKDPKKRLG 256
Query: 190 ----TAAQALTHPWLHDEN 204
A + HP+ N
Sbjct: 257 CGPSDADEIKKHPFFQKIN 275
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 4e-20
Identities = 59/187 (31%), Positives = 89/187 (47%), Gaps = 39/187 (20%)
Query: 49 KILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP-DQRLNDIVGSA 107
+IL + + H GVVHRDLKP N L E+ LK+ DFGL+ R D ++ V +
Sbjct: 116 QILRGLKYVHSAGVVHRDLKPSNILI---NENCDLKICDFGLA---RIQDPQMTGYVSTR 169
Query: 108 YYVAPEVL--HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIF-------------- 151
YY APE++ + Y+VE D+WS G I +L G F + F
Sbjct: 170 YYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDV 229
Query: 152 -------------RSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHP 198
+S+ + +P + + P A D + ++L D +KR++AA+AL HP
Sbjct: 230 INTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHP 289
Query: 199 WL---HD 202
+L HD
Sbjct: 290 YLAPYHD 296
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 5e-20
Identities = 61/200 (30%), Positives = 102/200 (51%), Gaps = 27/200 (13%)
Query: 21 FCEGGELLDRILSRGGRYLEEDA-KTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREE 79
+ GGE+ + R ED + +I+ + H G+V+RD+K EN L +
Sbjct: 86 YVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILL---DS 140
Query: 80 DAPLKVIDFGLS-DFVRPD-QRLNDIVGSAYYVAPEVLHRSYNVEG---DMWSIGVITYI 134
+ + + DFGLS +F+ + +R G+ Y+APE++ R G D WS+G++ +
Sbjct: 141 EGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEII-RGKGGHGKAVDWWSLGILIFE 199
Query: 135 LLCGSRPFWAR----TESGIFRSVLRADPNFHDSPWPS-VSPEAKDFVRRLLNKDHRKRM 189
LL G+ PF T+S + R +L+ DP P+PS + PEA+D + +LL KD +KR+
Sbjct: 200 LLTGASPFTLEGERNTQSEVSRRILKCDP-----PFPSFIGPEAQDLLHKLLRKDPKKRL 254
Query: 190 TAA-----QALTHPWLHDEN 204
A + HP+ +
Sbjct: 255 GAGPQGASEIKEHPFFKGLD 274
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 8e-20
Identities = 65/223 (29%), Positives = 112/223 (50%), Gaps = 19/223 (8%)
Query: 6 LQHLFYSNSFL-FFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVH 64
L++ F ++ L F + GGEL LSR + EE A+ +I++ + + H + VV+
Sbjct: 60 LKYAFQTHDRLCFVMEYANGGELFFH-LSRERVFTEERARFYGAEIVSALEYLHSRDVVY 118
Query: 65 RDLKPENFLFTTREEDAPLKVIDFGL-SDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVE 122
RD+K EN + ++D +K+ DFGL + + + G+ Y+APEVL Y
Sbjct: 119 RDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRA 175
Query: 123 GDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLN 182
D W +GV+ Y ++CG PF+ + +F +L + F ++SPEAK + LL
Sbjct: 176 VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLLK 231
Query: 183 KDHRKRM-----TAAQALTHPWLHDENRPVPLDILIYKLVKSY 220
KD ++R+ A + + H + N D++ KL+ +
Sbjct: 232 KDPKQRLGGGPSDAKEVMEHRFFLSINWQ---DVVQKKLLPPF 271
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 8e-20
Identities = 61/194 (31%), Positives = 100/194 (51%), Gaps = 17/194 (8%)
Query: 5 KLQHLFYSNSFLFFT-RFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVV 63
KL + F + L+ F GG+L R LS+ + EED K + ++ + H G++
Sbjct: 62 KLHYAFQTEGKLYLILDFLRGGDLFTR-LSKEVMFTEEDVKFYLAELALALDHLHSLGII 120
Query: 64 HRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVLHR-SYNV 121
+RDLKPEN L +E+ +K+ DFGLS + + +++ G+ Y+APEV++R +
Sbjct: 121 YRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQ 177
Query: 122 EGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRAD---PNFHDSPWPSVSPEAKDFVR 178
D WS GV+ + +L GS PF + +L+A P F +SPEA+ +R
Sbjct: 178 SADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQF-------LSPEAQSLLR 230
Query: 179 RLLNKDHRKRMTAA 192
L ++ R+ A
Sbjct: 231 ALFKRNPANRLGAG 244
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 9e-20
Identities = 63/198 (31%), Positives = 97/198 (48%), Gaps = 36/198 (18%)
Query: 21 FCEGGEL--LDRILSRGGRYLEEDAK-TIVEKILNIVAFCHLQG-----VVHRDLKPEN- 71
+CEGG+L L + + +Y+EE+ I+ ++L + CH + V+HRDLKP N
Sbjct: 82 YCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANI 141
Query: 72 FLFTTREEDAPLKVIDFGLSDFVRPDQRL-NDIVGSAYYVAPEVL-HRSYNVEGDMWSIG 129
FL + + +K+ DFGL+ + D VG+ YY++PE L H SY+ + D+WS+G
Sbjct: 142 FL----DANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLG 197
Query: 130 VITYILLCGSRPFWART--------ESGIFRSVLRADPNFHDSPWPSV-SPEAKDFVRRL 180
+ Y L S PF AR + G FR P S E + ++ +
Sbjct: 198 CLIYELCALSPPFTARNQLQLASKIKEGKFR------------RIPYRYSSELNEVIKSM 245
Query: 181 LNKDHRKRMTAAQALTHP 198
LN D KR + + L P
Sbjct: 246 LNVDPDKRPSTEELLQLP 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 1e-19
Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 22/209 (10%)
Query: 4 QKLQH---LFYSNSFL------FFTRFCEGGELLDRILSRGGRYLEEDAKTIVE---KIL 51
+ L H + Y +FL + GG L + I R L+ED TI+ +IL
Sbjct: 54 KLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDED--TILHFFVQIL 111
Query: 52 NIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVA 111
+ H + ++HRDLK +N L + +K+ DFG+S + + +VG+ Y++
Sbjct: 112 LALHHVHTKLILHRDLKTQNILLDKHK--MVVKIGDFGISKILSSKSKAYTVVGTPCYIS 169
Query: 112 PEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPN-FHDSPWPSV 169
PE+ + YN + D+W++G + Y L R F A + ++ D
Sbjct: 170 PELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISD----RY 225
Query: 170 SPEAKDFVRRLLNKDHRKRMTAAQALTHP 198
SP+ + + +LN D KR +Q + P
Sbjct: 226 SPDLRQLILSMLNLDPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 1e-19
Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 11/213 (5%)
Query: 6 LQHLFYSNSFLFFT-RFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVH 64
L F + L+F + GGEL L R +LE A+ +I + + + H +V+
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYH-LQRERCFLEPRARFYAAEIASALGYLHSLNIVY 119
Query: 65 RDLKPENFLFTTREEDAPLKVIDFGL-SDFVRPDQRLNDIVGSAYYVAPEVLHRS-YNVE 122
RDLKPEN L ++ + + DFGL + + + + G+ Y+APEVLH+ Y+
Sbjct: 120 RDLKPENILLDSQ---GHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRT 176
Query: 123 GDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLN 182
D W +G + Y +L G PF++R + ++ ++L P+++ A+ + LL
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSARHLLEGLLQ 232
Query: 183 KDHRKRMTAAQALTHPWLHDENRPVPLDILIYK 215
KD KR+ A H P+ D LI K
Sbjct: 233 KDRTKRLGAKDDFMEIKNHIFFSPINWDDLINK 265
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 87.6 bits (218), Expect = 3e-19
Identities = 58/199 (29%), Positives = 92/199 (46%), Gaps = 41/199 (20%)
Query: 39 LEEDAKT-IVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP- 96
LE+ K I+ ++L + + H V+HRDLKP N L + D +K+ DFGL+ +
Sbjct: 104 LEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNS---DCRVKLADFGLARSLSEL 160
Query: 97 -----DQRLNDIVGSAYYVAPEVL--HRSYNVEGDMWSIGVITYILLCGSRPFWART--- 146
+ L D V + +Y APE+L Y DMWS+G I +L G +P + T
Sbjct: 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG-KPLFPGTSTL 219
Query: 147 ---------------------ESGIFRSVLRADPNFHDSP----WPSVSPEAKDFVRRLL 181
+S ++L + P+ P P S +A D +++LL
Sbjct: 220 NQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLL 279
Query: 182 NKDHRKRMTAAQALTHPWL 200
+ KR+TA +AL HP++
Sbjct: 280 VFNPNKRLTAEEALEHPYV 298
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 4e-19
Identities = 61/194 (31%), Positives = 99/194 (51%), Gaps = 15/194 (7%)
Query: 3 HQKLQHLFYS----NSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCH 58
H L L YS + F + GGEL LSR + E+ A+ +I++ + + H
Sbjct: 54 HPFLTALKYSFQTHDRLCFVMEYANGGELFFH-LSRERVFSEDRARFYGAEIVSALDYLH 112
Query: 59 LQ-GVVHRDLKPENFLFTTREEDAPLKVIDFGL-SDFVRPDQRLNDIVGSAYYVAPEVLH 116
+ VV+RDLK EN + ++D +K+ DFGL + ++ + G+ Y+APEVL
Sbjct: 113 SEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLE 169
Query: 117 -RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKD 175
Y D W +GV+ Y ++CG PF+ + +F +L + F ++SPEAK
Sbjct: 170 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLSPEAKS 225
Query: 176 FVRRLLNKDHRKRM 189
+ LL KD ++R+
Sbjct: 226 LLSGLLKKDPKQRL 239
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 5e-19
Identities = 64/244 (26%), Positives = 103/244 (42%), Gaps = 55/244 (22%)
Query: 9 LFYS----NSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVH 64
L+YS ++ F + GG+++ +L R G + E+ A+ + ++ + H G +H
Sbjct: 66 LYYSFQDKDNLYFVMDYIPGGDMMS-LLIRLGIFEEDLARFYIAELTCAIESVHKMGFIH 124
Query: 65 RDLKPENFLFTTREEDAPLKVIDFGL--------------------SDFVRPDQRLNDI- 103
RD+KP+N L + D +K+ DFGL D + P + ++I
Sbjct: 125 RDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEID 181
Query: 104 -----------------------VGSAYYVAPEVLHRS-YNVEGDMWSIGVITYILLCGS 139
VG+ Y+APEVL R+ Y D WS+GVI Y +L G
Sbjct: 182 RCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 241
Query: 140 RPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLL-NKDHR-KRMTAAQALTH 197
PF A T + V+ + H +S EA D + RL + R + A + H
Sbjct: 242 PPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLCCGAEDRLGKNGADEIKAH 301
Query: 198 PWLH 201
P+
Sbjct: 302 PFFK 305
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 6e-19
Identities = 60/199 (30%), Positives = 91/199 (45%), Gaps = 42/199 (21%)
Query: 36 GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFV 94
+L+ + K ++ ++L+ VA H ++HRDLK N L R LK+ DFGL+ ++
Sbjct: 101 QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGI---LKICDFGLAREYG 157
Query: 95 RPDQRLNDIVGSAYYVAPEVL--HRSYNVEGDMWSIGVITYILLCGSRPFWARTE----S 148
P + +V + +Y APE+L + Y+ DMWS+G I LL F ++E +
Sbjct: 158 SPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLN 217
Query: 149 GIFRSVLRADPNFHDSPWPSVS--PEAK--------------------------DFVRRL 180
IF+ L P + WP S P AK D + RL
Sbjct: 218 KIFK--LLGTPT--EKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRL 273
Query: 181 LNKDHRKRMTAAQALTHPW 199
L D KR++A AL HP+
Sbjct: 274 LTYDPAKRISAEDALKHPY 292
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 7e-19
Identities = 62/195 (31%), Positives = 99/195 (50%), Gaps = 13/195 (6%)
Query: 21 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREED 80
F EGG L D + R EE T+ +L +++ H QGV+HRD+K ++ L T+ D
Sbjct: 100 FLEGGALTDIVTHT--RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTS---D 154
Query: 81 APLKVIDFGLSDFVRPD-QRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCG 138
+K+ DFG V + + +VG+ Y++APEV+ R Y E D+WS+G++ ++ G
Sbjct: 155 GRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDG 214
Query: 139 SRPFWARTESGIFRSVLRA-DPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 197
P++ R + P DS VS + F+ +L ++ +R TA + L H
Sbjct: 215 EPPYFNEPPLQAMRRIRDNLPPRVKDS--HKVSSVLRGFLDLMLVREPSQRATAQELLQH 272
Query: 198 PWLHDENRP---VPL 209
P+L P VPL
Sbjct: 273 PFLKLAGPPSCIVPL 287
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 8e-19
Identities = 66/216 (30%), Positives = 99/216 (45%), Gaps = 25/216 (11%)
Query: 4 QKLQHLFYSN---SFL------FFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIV 54
+L H F N SF F F GGEL L + GR+ + AK +++
Sbjct: 73 MELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTH-LRKAGRFPNDVAKFYHAELVLAF 131
Query: 55 AFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEV 114
+ H + +++RDLKPEN L + +KV DFG + V R + G+ Y+APEV
Sbjct: 132 EYLHSKDIIYRDLKPENLLL---DNKGHVKVTDFGFAKKVP--DRTFTLCGTPEYLAPEV 186
Query: 115 LH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEA 173
+ + + D W++GV+ Y + G PF+ T I+ +L F + W A
Sbjct: 187 IQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPN--W--FDGRA 242
Query: 174 KDFVRRLLNKDHRKRMTA-----AQALTHPWLHDEN 204
+D V+ LL DH KR+ A HP+ H N
Sbjct: 243 RDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGAN 278
|
Length = 329 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 8e-19
Identities = 59/191 (30%), Positives = 88/191 (46%), Gaps = 23/191 (12%)
Query: 21 FCEGGELLDRILSRGGRYLEEDAKTIV-EKILNIVAFCHLQGVVHRDLKPENFLFTTREE 79
+C GG L D I L E V + L +A+ H G +HRD+K N L T E
Sbjct: 81 YCGGGSLQD-IYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLT---E 136
Query: 80 DAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVL----HRSYNVEGDMWSIGVITYI 134
D +K+ DFG+S + +G+ Y++APEV Y+ + D+W++G IT I
Sbjct: 137 DGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALG-ITAI 195
Query: 135 LLCGSRPFWARTESGIFRSVLRADPNFHDSP-------WPSVSPEAKDFVRRLLNKDHRK 187
L +P + R++ + P W SP DF+++ L KD +K
Sbjct: 196 ELAELQP--PMFDLHPMRALFLISKSNFPPPKLKDKEKW---SPVFHDFIKKCLTKDPKK 250
Query: 188 RMTAAQALTHP 198
R TA + L HP
Sbjct: 251 RPTATKLLQHP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 8e-19
Identities = 61/190 (32%), Positives = 96/190 (50%), Gaps = 14/190 (7%)
Query: 6 LQHL---FYSNSFLFFT-RFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQG 61
L HL F + LFF F GG+L+ I +G R+ A +I+ + F H +G
Sbjct: 58 LTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLHSKG 116
Query: 62 VVHRDLKPENFLFTTREEDAPLKVIDFGL-SDFVRPDQRLNDIVGSAYYVAPEVLH-RSY 119
+++RDLK +N + + D +K+ DFG+ + V D R + G+ Y+APE+L Y
Sbjct: 117 IIYRDLKLDNVML---DRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKY 173
Query: 120 NVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRR 179
D WS GV+ Y +L G PF E +F S+ P H W ++ E+KD + +
Sbjct: 174 TFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTP--HYPRW--ITKESKDILEK 229
Query: 180 LLNKDHRKRM 189
L +D +R+
Sbjct: 230 LFERDPTRRL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 2e-18
Identities = 56/189 (29%), Positives = 93/189 (49%), Gaps = 15/189 (7%)
Query: 21 FCEGGELLDRILSRGGRYLEED-AKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREE 79
FC G + D I + G L+E+ I +IL ++ H V+HRD+K +N L T E
Sbjct: 90 FCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT---E 146
Query: 80 DAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVL------HRSYNVEGDMWSIGVIT 132
+A +K++DFG+S R R N +G+ Y++APEV+ +Y+ + D+WS+G+
Sbjct: 147 NAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITA 206
Query: 133 YILLCGSRPFW-ARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTA 191
+ G+ P +F P W S + + F+ L K+H +R T
Sbjct: 207 IEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKW---SKKFQSFIESCLVKNHSQRPTT 263
Query: 192 AQALTHPWL 200
Q + HP++
Sbjct: 264 EQLMKHPFI 272
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 3e-18
Identities = 52/191 (27%), Positives = 91/191 (47%), Gaps = 18/191 (9%)
Query: 21 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREED 80
+ GGEL + + G R+ +I+ + + H + +V+RDLKPEN L +++
Sbjct: 82 YVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILL---DKE 137
Query: 81 APLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRS-YNVEGDMWSIGVITYILLCGS 139
+K+ DFG + +R R + G+ Y+APEV+ +N D W++G++ Y +L G
Sbjct: 138 GHIKLTDFGFAKKLR--DRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGY 195
Query: 140 RPFWARTESGIFRSVLRADPNFHDSPWP-SVSPEAKDFVRRLLNKDHRKRM-----TAAQ 193
PF+ GI+ +L +P + AKD +++LL D +R+ A
Sbjct: 196 PPFFDDNPFGIYEKILA-----GKLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADD 250
Query: 194 ALTHPWLHDEN 204
H W +
Sbjct: 251 VKNHRWFKSVD 261
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 4e-18
Identities = 53/193 (27%), Positives = 95/193 (49%), Gaps = 14/193 (7%)
Query: 3 HQKLQHLFY----SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCH 58
H L L+ + F F GG+L+ I + R+ E A+ +I + + F H
Sbjct: 55 HPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHI-QKSRRFDEARARFYAAEITSALMFLH 113
Query: 59 LQGVVHRDLKPENFLFTTREEDAPLKVIDFGL-SDFVRPDQRLNDIVGSAYYVAPEVLHR 117
+G+++RDLK +N L + + K+ DFG+ + + + + G+ Y+APE+L
Sbjct: 114 DKGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQE 170
Query: 118 S-YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDF 176
Y D W++GV+ Y +LCG PF A E +F ++L + + W +S +A D
Sbjct: 171 MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVY--PTW--LSQDAVDI 226
Query: 177 VRRLLNKDHRKRM 189
++ + K+ R+
Sbjct: 227 LKAFMTKNPTMRL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 4e-18
Identities = 63/200 (31%), Positives = 98/200 (49%), Gaps = 28/200 (14%)
Query: 3 HQKLQHL---FYSNSFLFFT-RFCEGGELLDRI-------LSRGGRYLEEDAKTIVEKIL 51
H L HL F + LFF + GG+L+ I L R Y E I+
Sbjct: 55 HPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAE--------II 106
Query: 52 NIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGL-SDFVRPDQRLNDIVGSAYYV 110
+ F H +G+V+RDLK +N L T D +K+ DFG+ + + D + G+ Y+
Sbjct: 107 CGLQFLHSKGIVYRDLKLDNILLDT---DGHIKIADFGMCKENMLGDAKTCTFCGTPDYI 163
Query: 111 APEVL-HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSV 169
APE+L + YN D WS GV+ Y +L G PF E +F+S+ +P + W +
Sbjct: 164 APEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCY--PRW--L 219
Query: 170 SPEAKDFVRRLLNKDHRKRM 189
+ EAKD + +L ++ +R+
Sbjct: 220 TREAKDILVKLFVREPERRL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 4e-18
Identities = 59/186 (31%), Positives = 88/186 (47%), Gaps = 33/186 (17%)
Query: 43 AKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLN 101
K+ + ++L VA CH GV+HRDLKP+N L ++ LK+ D GL F P +
Sbjct: 112 IKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVD--KQKGLLKIADLGLGRAFSIPVKSYT 169
Query: 102 DIVGSAYYVAPEVL--HRSYNVEGDMWSIGVITYILLCGSRPFWARTES----GIFRSVL 155
+ + +Y APEVL Y+ D+WS+G I + F +E IF+ L
Sbjct: 170 HEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFK--L 227
Query: 156 RADPN------------FHDSP-W---------PSVSPEAKDFVRRLLNKDHRKRMTAAQ 193
P +H+ P W P +SPE D ++++L D KR++A
Sbjct: 228 LGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKA 287
Query: 194 ALTHPW 199
ALTHP+
Sbjct: 288 ALTHPY 293
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 5e-18
Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 14/205 (6%)
Query: 6 LQHLFYSNSFLFFT-RFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVH 64
L+ F S L+ F GGEL L R GR+ A+ ++L + H V++
Sbjct: 58 LKFSFQSPEKLYLVLAFINGGELFHH-LQREGRFDLSRARFYTAELLCALENLHKFNVIY 116
Query: 65 RDLKPENFLFTTREEDAPLKVIDFGLSDF-VRPDQRLNDIVGSAYYVAPEVLH-RSYNVE 122
RDLKPEN L + + + DFGL ++ D + N G+ Y+APE+L Y
Sbjct: 117 RDLKPENILL---DYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKA 173
Query: 123 GDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLN 182
D W++GV+ Y +L G PF+ + ++R +L+ F D +AKD + LL+
Sbjct: 174 VDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPD----GFDRDAKDLLIGLLS 229
Query: 183 KDHRKRM---TAAQALTHPWLHDEN 204
+D +R+ A + HP+ +
Sbjct: 230 RDPTRRLGYNGAQEIKNHPFFSQLS 254
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 7e-18
Identities = 62/204 (30%), Positives = 92/204 (45%), Gaps = 29/204 (14%)
Query: 13 NSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENF 72
N+ F F GG + IL+R G E ++IL+ VA+ H VVHRD+K N
Sbjct: 75 NTISIFMEFVPGGSI-SSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNV 133
Query: 73 LFTTREEDAPLKVIDFG-------LSDFVRPDQRLNDIVGSAYYVAPEVLHRS-YNVEGD 124
+ + +K+IDFG + L + G+ Y++APEV++ S Y + D
Sbjct: 134 MLMP---NGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSD 190
Query: 125 MWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNF----HDSPWPSV----SPEAKDF 176
+WSIG + + G +P A S+ R F H P + S A DF
Sbjct: 191 IWSIGCTVFEMATG-KPPLA--------SMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDF 241
Query: 177 VRRLLNKDHRKRMTAAQALTHPWL 200
V L +D +R +A Q L H +L
Sbjct: 242 VTSCLTRDQHERPSALQLLRHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 9e-18
Identities = 61/212 (28%), Positives = 94/212 (44%), Gaps = 40/212 (18%)
Query: 34 RGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 93
G E+ + +V ++L + + H G++HRDLKP N ED LK++DFGL+
Sbjct: 110 MGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVN---EDCELKILDFGLAR- 165
Query: 94 VRPDQRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVI-------------------- 131
D + V + +Y APEV+ YN D+WS+G I
Sbjct: 166 -HADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQL 224
Query: 132 TYILLCGSRP---FWARTESGIFRSVLRADPNFHDSP----WPSVSPEAKDFVRRLLNKD 184
T IL P F + E +S +++ P + +P SP+A D + ++L D
Sbjct: 225 TQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELD 284
Query: 185 HRKRMTAAQALTHPWL------HDENRPVPLD 210
KR+TA +AL HP+ +E P D
Sbjct: 285 VDKRLTATEALEHPYFDSFRDADEETEQQPYD 316
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 9e-18
Identities = 49/156 (31%), Positives = 77/156 (49%), Gaps = 19/156 (12%)
Query: 62 VVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVLHR--- 117
++HRD+KP N L + +K+ DFG+S + V + N +G Y+APE +
Sbjct: 124 IIHRDVKPTNVLVNGNGQ---VKLCDFGVSGNLVASLAKTN--IGCQSYMAPERIKSGGP 178
Query: 118 ----SYNVEGDMWSIGVITYILLCGSRPFWARTESGIF---RSVLRADPNFHDSPWPSVS 170
+Y V+ D+WS+G+ + G P+ T + IF +++ DP + S
Sbjct: 179 NQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP---PTLPSGYS 235
Query: 171 PEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRP 206
+A+DFV + LNK +R T AQ L HPWL
Sbjct: 236 DDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA 271
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 1e-17
Identities = 57/193 (29%), Positives = 93/193 (48%), Gaps = 22/193 (11%)
Query: 46 IVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR-LNDIV 104
+ + L + F H V+HRD+K +N L D +K+ DFG + P+Q + +V
Sbjct: 120 VCRECLQALEFLHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMV 176
Query: 105 GSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHD 163
G+ Y++APEV+ R +Y + D+WS+G++ ++ G P+ E+ + L A +
Sbjct: 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL--NENPLRALYLIATNGTPE 234
Query: 164 SPWP-SVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDILIYKLVKSYLR 222
P +S +DF+ R L D KR +A + L HP+L K+ K
Sbjct: 235 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFL--------------KIAKPLSS 280
Query: 223 ATPLKRAALKALS 235
TPL AA +A
Sbjct: 281 LTPLIAAAKEATK 293
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 62/194 (31%), Positives = 99/194 (51%), Gaps = 27/194 (13%)
Query: 5 KLQHLFYSNSFLFFT-RFCEGGELLDRILSRGGRYLEED-AKTIVEKILNIVAFCHLQGV 62
+LQ+ F L+ + GG+LL +L+R +ED A+ + +++ + H G
Sbjct: 65 QLQYAFQDKDNLYLVMEYQPGGDLLS-LLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGY 123
Query: 63 VHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDI--VGSAYYVAPEVLHR--- 117
VHRD+KPEN L + +K+ DFG + + ++ +N VG+ Y+APEVL
Sbjct: 124 VHRDIKPENVLI---DRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNG 180
Query: 118 ----SYNVEGDMWSIGVITYILLCGSRPFW----ARTESGI--FRSVLRADPNFHDSPWP 167
+Y VE D WS+GVI Y ++ G PF A+T + I F+ L+ F + P
Sbjct: 181 DGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLK----FPED--P 234
Query: 168 SVSPEAKDFVRRLL 181
VS + D ++ LL
Sbjct: 235 KVSSDFLDLIQSLL 248
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 1e-17
Identities = 54/196 (27%), Positives = 101/196 (51%), Gaps = 18/196 (9%)
Query: 13 NSFLFFTRFCEGGELLDRI--LSRGGRYLEEDAKTIVE---KILNIVAFCHLQGVVHRDL 67
++F T +CEG +L ++ L G+ L E+ + E ++L V + H + ++HRDL
Sbjct: 75 DAFCIITEYCEGRDLDCKLEELKHTGKTLSEN--QVCEWFIQLLLGVHYMHQRRILHRDL 132
Query: 68 KPENFLFTTREEDAPLKVIDFGLSDFVRPDQRL-NDIVGSAYYVAPEVL-HRSYNVEGDM 125
K +N ++ LK+ DFG+S + L G+ YY++PE L H+ Y+ + D+
Sbjct: 133 KAKNIFL----KNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDI 188
Query: 126 WSIGVITYILLCGSRPFWARTESGIFRSVLRAD-PNFHDSPWPSVSPEAKDFVRRLLNKD 184
WS+G I Y + C + F + + ++ P+ + + S + ++ +LNKD
Sbjct: 189 WSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPE----TYSRQLNSIMQSMLNKD 244
Query: 185 HRKRMTAAQALTHPWL 200
R +AA+ L +P++
Sbjct: 245 PSLRPSAAEILRNPFI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 82.1 bits (202), Expect = 2e-17
Identities = 57/198 (28%), Positives = 94/198 (47%), Gaps = 22/198 (11%)
Query: 40 EEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ- 98
E + + L + F H V+HRD+K +N L D +K+ DFG + P+Q
Sbjct: 114 EAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGM---DGSVKLTDFGFCAQITPEQS 170
Query: 99 RLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTE-SGIFRSVLR 156
+ + +VG+ Y++APEV+ R +Y + D+WS+G++ ++ G P+ ++
Sbjct: 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN 230
Query: 157 ADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDILIYKL 216
P + +SP +DF+ R L D KR +A + L HP+L KL
Sbjct: 231 GTPELQNPE--KLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFL--------------KL 274
Query: 217 VKSYLRATPLKRAALKAL 234
K TPL AA +A+
Sbjct: 275 AKPLSSLTPLILAAKEAM 292
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 2e-17
Identities = 56/189 (29%), Positives = 96/189 (50%), Gaps = 11/189 (5%)
Query: 6 LQHLFYSNSFLFFT-RFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVH 64
L + F + L+F + GGEL L R +LE A+ ++ + + + H +++
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFH-LQRERCFLEPRARFYAAEVASAIGYLHSLNIIY 119
Query: 65 RDLKPENFLFTTREEDAPLKVIDFGL-SDFVRPDQRLNDIVGSAYYVAPEVLHRS-YNVE 122
RDLKPEN L ++ + + DFGL + V P++ + G+ Y+APEVL + Y+
Sbjct: 120 RDLKPENILLDSQ---GHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRT 176
Query: 123 GDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLN 182
D W +G + Y +L G PF++R S ++ ++L + A D + LL+
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP----GGKTVAACDLLVGLLH 232
Query: 183 KDHRKRMTA 191
KD R+R+ A
Sbjct: 233 KDQRRRLGA 241
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 2e-17
Identities = 59/193 (30%), Positives = 94/193 (48%), Gaps = 14/193 (7%)
Query: 3 HQKLQHLFYS----NSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCH 58
H L L YS + F + GGEL LSR + E+ + +I++ + + H
Sbjct: 54 HPFLTSLKYSFQTKDRLCFVMEYVNGGELFFH-LSRERVFSEDRTRFYGAEIVSALDYLH 112
Query: 59 LQGVVHRDLKPENFLFTTREEDAPLKVIDFGL-SDFVRPDQRLNDIVGSAYYVAPEVLH- 116
+V+RDLK EN + ++D +K+ DFGL + + + G+ Y+APEVL
Sbjct: 113 SGKIVYRDLKLENLML---DKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLED 169
Query: 117 RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDF 176
Y D W +GV+ Y ++CG PF+ + +F +L D F ++S +AK
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPR----TLSADAKSL 225
Query: 177 VRRLLNKDHRKRM 189
+ LL KD KR+
Sbjct: 226 LSGLLIKDPNKRL 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 2e-17
Identities = 65/249 (26%), Positives = 106/249 (42%), Gaps = 22/249 (8%)
Query: 3 HQKLQHLFYS----NSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCH 58
H L L YS + F + GGEL L R + E A+ +I + + + H
Sbjct: 55 HPFLVGLHYSFQTADKLYFVLDYVNGGELFFH-LQRERSFPEPRARFYAAEIASALGYLH 113
Query: 59 LQGVVHRDLKPENFLFTTREEDAPLKVIDFGL-SDFVRPDQRLNDIVGSAYYVAPEVLHR 117
+++RDLKPEN L + + + DFGL + + + + G+ Y+APEVL +
Sbjct: 114 SLNIIYRDLKPENILL---DSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRK 170
Query: 118 S-YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDF 176
Y+ D W +G + Y +L G PF++R + ++ ++L P++S A+
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK----PNISVSARHL 226
Query: 177 VRRLLNKDHRKRMTAAQAL----THPWLHDENRPVPLDILIYKLVKSYLRATPLKRAALK 232
+ LL KD KR+ A H + + D L+ K + LK
Sbjct: 227 LEGLLQKDRTKRLGAKDDFLEIKNHVFF----SSINWDDLVNKKITPPFNPNVSGPMDLK 282
Query: 233 ALSKALTEE 241
TEE
Sbjct: 283 HFDPEFTEE 291
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 3e-17
Identities = 47/147 (31%), Positives = 73/147 (49%), Gaps = 10/147 (6%)
Query: 60 QGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL---- 115
GV+HRD+KP N L + +K+ DFG+S + + G A Y+APE +
Sbjct: 134 HGVIHRDVKPSNILL---DASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPD 190
Query: 116 -HRSYNVEGDMWSIGVITYILLCGSRPF-WARTESGIFRSVLRADPNFHDSPWPSVSPEA 173
+ Y++ D+WS+G+ L G P+ +TE + +L+ +P P SP+
Sbjct: 191 PNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLP-PNEGFSPDF 249
Query: 174 KDFVRRLLNKDHRKRMTAAQALTHPWL 200
FV L KDHRKR + L HP++
Sbjct: 250 CSFVDLCLTKDHRKRPKYRELLQHPFI 276
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 3e-17
Identities = 62/219 (28%), Positives = 102/219 (46%), Gaps = 43/219 (19%)
Query: 28 LDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVID 87
L +I+ G + ++ + +IL + + H V+HRDLKP N L D LK+ D
Sbjct: 92 LHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNA---DCELKICD 148
Query: 88 FGLS-----DFVRPDQRLNDIVGSAYYVAPEVL--HRSYNVEGDMWSIGVITYILLCGSR 140
FGL+ + + + V + +Y APE++ +SY D+WS+G I LL G +
Sbjct: 149 FGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRK 207
Query: 141 PFW------------------------ARTESGIFRSVLRADPNFHDSPWPSV----SPE 172
P + +R S ++ +R+ PN P+ S+ +P
Sbjct: 208 PVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPL 267
Query: 173 AKDFVRRLLNKDHRKRMTAAQALTHPWL---HD-ENRPV 207
A D + +LL D KR++ +AL HP+L HD ++ PV
Sbjct: 268 ALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDEPV 306
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 5e-17
Identities = 57/189 (30%), Positives = 91/189 (48%), Gaps = 15/189 (7%)
Query: 21 FCEGGELLDRILSRGGRYLEED-AKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREE 79
FC G + D + + G L+ED I +IL +A H V+HRD+K +N L T E
Sbjct: 100 FCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLT---E 156
Query: 80 DAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVL------HRSYNVEGDMWSIGVIT 132
+A +K++DFG+S R R N +G+ Y++APEV+ +Y+ D+WS+G+
Sbjct: 157 NAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITA 216
Query: 133 YILLCGSRPFW-ARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTA 191
+ G+ P +F P W S + DF+ L K++ R +
Sbjct: 217 IEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKW---SKKFIDFIEGCLVKNYLSRPST 273
Query: 192 AQALTHPWL 200
Q L HP++
Sbjct: 274 EQLLKHPFI 282
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 5e-17
Identities = 56/196 (28%), Positives = 90/196 (45%), Gaps = 30/196 (15%)
Query: 21 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREED 80
+ EGG+ + + G ++ E +L + + H G+VHRDLKP+N L T+
Sbjct: 82 YVEGGDCATLLKNIGALPVDMARMYFAETVLAL-EYLHNYGIVHRDLKPDNLLITSM--- 137
Query: 81 APLKVIDFGLSD-------------FVRPDQRL---NDIVGSAYYVAPEV-LHRSYNVEG 123
+K+ DFGLS + D R + G+ Y+APEV L + Y
Sbjct: 138 GHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPV 197
Query: 124 DMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWP----SVSPEAKDFVRR 179
D W++G+I Y L G PF+ T +F V+ D WP ++ +A+D + R
Sbjct: 198 DWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD-----DIEWPEGDEALPADAQDLISR 252
Query: 180 LLNKDHRKRMTAAQAL 195
LL ++ +R+ A
Sbjct: 253 LLRQNPLERLGTGGAF 268
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 8e-17
Identities = 55/191 (28%), Positives = 85/191 (44%), Gaps = 35/191 (18%)
Query: 40 EEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV-RPDQ 98
E K I+ + L V FCH +HRD+KPEN L T + + +K+ DFG + + P
Sbjct: 99 EHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQ---IKLCDFGFARILTGPGD 155
Query: 99 RLNDIVGSAYYVAPEVL--HRSYNVEGDMWSIGVITYILLCGSRPFWA-----------R 145
D V + +Y APE+L Y D+W+IG + LL G +P W R
Sbjct: 156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTG-QPLWPGKSDVDQLYLIR 214
Query: 146 TESG--IFR--SVLRADPNFH-------------DSPWPSVSPEAKDFVRRLLNKDHRKR 188
G I R + + F +S +P++S A F++ L D +R
Sbjct: 215 KTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTER 274
Query: 189 MTAAQALTHPW 199
++ + L HP+
Sbjct: 275 LSCEELLEHPY 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 1e-16
Identities = 59/188 (31%), Positives = 91/188 (48%), Gaps = 32/188 (17%)
Query: 44 KTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD-FVRPDQRLND 102
KT + +IL +A+CH V+HRDLKP+N L R LK+ DFGL+ F P +
Sbjct: 105 KTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN--ALKLADFGLARAFGIPVRTFTH 162
Query: 103 IVGSAYYVAPEVL--HRSYNVEGDMWSIGVITYILLCGSRP-FWARTE----SGIFRSV- 154
V + +Y APE+L R Y+ D+WS+G I + + +P F +E IFR +
Sbjct: 163 EVVTLWYRAPEILLGSRHYSTPVDIWSVGCI-FAEMVNQKPLFPGDSEIDELFKIFRILG 221
Query: 155 ---------LRADPNFHDS--PW---------PSVSPEAKDFVRRLLNKDHRKRMTAAQA 194
+ + P++ + W P++ P D + ++L D KR+TA A
Sbjct: 222 TPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAA 281
Query: 195 LTHPWLHD 202
L H + D
Sbjct: 282 LEHEYFKD 289
|
Length = 294 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 1e-16
Identities = 56/217 (25%), Positives = 90/217 (41%), Gaps = 56/217 (25%)
Query: 28 LDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQG---------VVHRDLKPENFLFTTRE 78
LD++L + GR I E IL ++ L+G ++HRD+KP N L +R
Sbjct: 86 LDQVLKKAGR--------IPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRG 137
Query: 79 EDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRS-YNVEGDMWSIGVITYILLC 137
E +K+ DFG+S + D N VG+ Y++PE L + Y V+ D+WS+G+ +
Sbjct: 138 E---IKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAI 193
Query: 138 GSRPFWARTESGI-------------FRSVLRADPNFHDSPWP----------------- 167
G P + S + DSP P
Sbjct: 194 GRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPK 253
Query: 168 ----SVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200
+ S E +DFV + L K+ ++R + HP++
Sbjct: 254 LPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFI 290
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 1e-16
Identities = 56/188 (29%), Positives = 89/188 (47%), Gaps = 10/188 (5%)
Query: 24 GGELLDRILSRGGRYLEED-AKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAP 82
GG+L I + G EE+ A +IL + H + V+RDLKPEN L ++
Sbjct: 84 GGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILL---DDYGH 140
Query: 83 LKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL-HRSYNVEGDMWSIGVITYILLCGSRP 141
+++ D GL+ + + + VG+ Y+APEVL ++ Y + D W +G + Y ++ G P
Sbjct: 141 IRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
Query: 142 FWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRM-----TAAQALT 196
F R E V R + S EAK + LL KD ++R+ A +
Sbjct: 201 FRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260
Query: 197 HPWLHDEN 204
HP+ + N
Sbjct: 261 HPFFRNMN 268
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 50/168 (29%), Positives = 79/168 (47%), Gaps = 28/168 (16%)
Query: 49 KILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRL---NDIVG 105
+IL+ +A+ H + +VHRD+KP N L + + +K+ DFG+S + Q + N VG
Sbjct: 176 QILSGIAYLHRRHIVHRDIKPSNLLINSAKN---VKIADFGVSRIL--AQTMDPCNSSVG 230
Query: 106 SAYYVAPEVLHRSYN------VEGDMWSIGVITYILLCGSRPF-------WARTESGIFR 152
+ Y++PE ++ N GD+WS+GV G PF WA I
Sbjct: 231 TIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICM 290
Query: 153 SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200
S P + S E + F+ L ++ KR +A Q L HP++
Sbjct: 291 S----QP---PEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFI 331
|
Length = 353 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 63/225 (28%), Positives = 99/225 (44%), Gaps = 39/225 (17%)
Query: 18 FTRFCEGGELLDRILSR---GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLF 74
E ++ L+ G EE A+ + ++L + + H V+HRDLKP N
Sbjct: 88 LNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFI 147
Query: 75 TTREEDAPLKVIDFGLSDFVRPDQR----LNDIVGSAYYVAPEVL--HRSYNVEGDMWSI 128
T ED LK+ DFGL+ V P L++ + + +Y +P +L +Y DMW+
Sbjct: 148 NT--EDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAA 205
Query: 129 GVITYILLCGSRPFWARTESG-----IFRSV-----------LRADPNF-HDSPW----- 166
G I +L G +P +A I SV L P+F +
Sbjct: 206 GCIFAEMLTG-KPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRP 264
Query: 167 -----PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRP 206
P V+PEA DF+ ++L + R+TA +AL HP++ + P
Sbjct: 265 LRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCP 309
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 2e-16
Identities = 58/195 (29%), Positives = 95/195 (48%), Gaps = 29/195 (14%)
Query: 18 FTRFCEGGELLDRILSRGGRYLEED-AKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76
F + GG + D++ + G L E + +IL V + H +VHRD+K N L
Sbjct: 82 FMEYMPGGSVKDQLKAYGA--LTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANIL--- 136
Query: 77 REEDAPLKVIDFGLSDFVRPDQRLNDI----------VGSAYYVAPEVLH-RSYNVEGDM 125
R+ +K+ DFG S +RL I G+ Y+++PEV+ Y + D+
Sbjct: 137 RDSAGNVKLGDFGAS------KRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADV 190
Query: 126 WSIGVITYILLCGSRPFWARTE--SGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNK 183
WS+G T + + +P WA E + IF+ + P P VSP+A++F+RR +
Sbjct: 191 WSVGC-TVVEMLTEKPPWAEFEAMAAIFK--IATQPTNPQLP-SHVSPDARNFLRRTFVE 246
Query: 184 DHRKRMTAAQALTHP 198
+ +KR +A + L H
Sbjct: 247 NAKKRPSAEELLRHF 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 59/201 (29%), Positives = 92/201 (45%), Gaps = 23/201 (11%)
Query: 10 FYSNSFLFFT-RFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLK 68
F S+L+ F GGE L R R+ + +I+ I + +V+RDLK
Sbjct: 100 FKDESYLYLVLEFVIGGEFFT-FLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLK 158
Query: 69 PENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL-HRSYNVEGDMWS 127
PEN L ++D +K+ DFG + V D R + G+ Y+APE+L + + D W+
Sbjct: 159 PENLLL---DKDGFIKMTDFGFAKVV--DTRTYTLCGTPEYIAPEILLNVGHGKAADWWT 213
Query: 128 IGVITYILLCGSRPFWARTESGIFRSVLRAD---PNFHDSPWPSVSPEAKDFVRRLLNKD 184
+G+ Y +L G PF+A I++ +L P F D+ K +++LL+ D
Sbjct: 214 LGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDN-------NCKHLMKKLLSHD 266
Query: 185 HRKRM-----TAAQALTHPWL 200
KR A HPW
Sbjct: 267 LTKRYGNLKKGAQNVKEHPWF 287
|
Length = 340 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 69/247 (27%), Positives = 106/247 (42%), Gaps = 59/247 (23%)
Query: 9 LFYS----NSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVH 64
L+YS ++ F + GG+++ +L R G + E+ A+ + ++ V H G +H
Sbjct: 66 LYYSFQDKDNLYFVMDYIPGGDMMS-LLIRMGIFPEDLARFYIAELTCAVESVHKMGFIH 124
Query: 65 RDLKPENFLFTTREEDAPLKVIDFGL---------------SDFVRPD------------ 97
RD+KP+N L + D +K+ DFGL D VR D
Sbjct: 125 RDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPA 181
Query: 98 -------------------QRL--NDIVGSAYYVAPEVLHRS-YNVEGDMWSIGVITYIL 135
QR + +VG+ Y+APEVL R+ Y D WS+GVI Y +
Sbjct: 182 NCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 241
Query: 136 LCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLN--KDHRKRMTAAQ 193
L G PF A+T V+ + H P +SPEA D + +L +D + A +
Sbjct: 242 LVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADE 301
Query: 194 ALTHPWL 200
HP+
Sbjct: 302 IKAHPFF 308
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.6 bits (198), Expect = 3e-16
Identities = 62/214 (28%), Positives = 98/214 (45%), Gaps = 30/214 (14%)
Query: 21 FCEGGEL---LDRILSRGGRYLEEDAKTIVEKILNIVAFCHL-------QGVVHRDLKPE 70
FC+ G+L + + G+ E I ++L+ +A+CH + V+HRDLKP+
Sbjct: 95 FCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQ 154
Query: 71 NFLFTT-------------REEDAPL-KVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL- 115
N +T P+ K+ DFGLS + + + VG+ YY +PE+L
Sbjct: 155 NIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLL 214
Query: 116 --HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEA 173
+SY+ + DMW++G I Y L G PF S L+ P D P S E
Sbjct: 215 HETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGP---DLPIKGKSKEL 271
Query: 174 KDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPV 207
++ LLN ++R +A Q L + + + PV
Sbjct: 272 NILIKNLLNLSAKERPSALQCLGYQIIKNVGPPV 305
|
Length = 1021 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 3e-16
Identities = 57/194 (29%), Positives = 89/194 (45%), Gaps = 18/194 (9%)
Query: 24 GGELLDRILSRGGRYLEE-DAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAP 82
GG+L I + G E A +I+ + H + +V+RDLKPEN L ++
Sbjct: 77 GGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLL---DDHGN 133
Query: 83 LKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRS-YNVEGDMWSIGVITYILLCGSRP 141
+++ D GL+ ++ +++ G+ Y+APEVL Y+ D +++G Y ++ G P
Sbjct: 134 VRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193
Query: 142 FWARTES----GIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRM-----TAA 192
F R E + R L + D SPEAKD LL KD KR+ +A
Sbjct: 194 FRQRKEKVEKEELKRRTLEMAVEYPD----KFSPEAKDLCEALLQKDPEKRLGCRGGSAD 249
Query: 193 QALTHPWLHDENRP 206
+ HP D N
Sbjct: 250 EVREHPLFKDLNWR 263
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 4e-16
Identities = 57/189 (30%), Positives = 89/189 (47%), Gaps = 39/189 (20%)
Query: 44 KTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD-FVRPDQRLND 102
K+ + ++L +A+CH V+HRDLKP+N L + LK+ DFGL+ F P +
Sbjct: 102 KSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDR---EGALKLADFGLARAFGVPVRTYTH 158
Query: 103 IVGSAYYVAPEVL--HRSYNVEGDMWSIGVITYILLCGSRP-FWARTE-SGIFRSVLRA- 157
V + +Y APE+L R Y+ D+WSIG I + + RP F +E +FR + R
Sbjct: 159 EVVTLWYRAPEILLGSRQYSTPVDIWSIGCI-FAEMVNRRPLFPGDSEIDQLFR-IFRTL 216
Query: 158 -DPNFHDSPWPSVS-------------------------PEAKDFVRRLLNKDHRKRMTA 191
P+ + WP V+ + D + ++L D KR++A
Sbjct: 217 GTPD--EDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISA 274
Query: 192 AQALTHPWL 200
AL HP+
Sbjct: 275 KAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 4e-16
Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 42/207 (20%)
Query: 40 EEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR 99
++ + ++ +IL + + H ++HRDLKP N ED LK++DFGL+ D
Sbjct: 119 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHT--DDE 173
Query: 100 LNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPF--------------- 142
+ V + +Y APE++ YN D+WS+G I LL G F
Sbjct: 174 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 233
Query: 143 --------WARTESGIFRSVLRADP-----NFHDSPWPSVSPEAKDFVRRLLNKDHRKRM 189
+ S R+ +++ NF + + +P A D + ++L D KR+
Sbjct: 234 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRI 292
Query: 190 TAAQALTHPWL---HD-ENRPV--PLD 210
TAAQAL H + HD ++ PV P D
Sbjct: 293 TAAQALAHAYFAQYHDPDDEPVADPYD 319
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 4e-16
Identities = 54/184 (29%), Positives = 90/184 (48%), Gaps = 31/184 (16%)
Query: 44 KTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD-FVRPDQRLND 102
K+ + ++L +AFCH V+HRDLKP+N L + +K+ DFGL+ F P +
Sbjct: 103 KSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTH 159
Query: 103 IVGSAYYVAPEVL--HRSYNVEGDMWSIGVITYILLCGSRPFWARTESG----IFRSVLR 156
V + +Y APE+L + Y+ D+WS+G I ++ F +E IFR++
Sbjct: 160 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT 219
Query: 157 AD----------PNFHDS--PW---------PSVSPEAKDFVRRLLNKDHRKRMTAAQAL 195
D P++ S W P + + +D + ++L+ D KR++A AL
Sbjct: 220 PDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAAL 279
Query: 196 THPW 199
HP+
Sbjct: 280 AHPF 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 77.5 bits (190), Expect = 5e-16
Identities = 55/201 (27%), Positives = 94/201 (46%), Gaps = 22/201 (10%)
Query: 40 EEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ- 98
E + + L + F H V+HRD+K +N L D +K+ DFG + P+Q
Sbjct: 114 EGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQS 170
Query: 99 RLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTE-SGIFRSVLR 156
+ + +VG+ Y++APEV+ R +Y + D+WS+G++ ++ G P+ ++
Sbjct: 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN 230
Query: 157 ADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDILIYKL 216
P + +S +DF+ R L D +R +A + L HP+L KL
Sbjct: 231 GTPELQNPE--RLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFL--------------KL 274
Query: 217 VKSYLRATPLKRAALKALSKA 237
K TPL AA +A+ +
Sbjct: 275 AKPLSSLTPLIIAAKEAIKNS 295
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 6e-16
Identities = 62/193 (32%), Positives = 91/193 (47%), Gaps = 20/193 (10%)
Query: 21 FCEGGELLDRI---LSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77
C GG + D + L RG R E I+ + L + H+ +HRD+K N L TT
Sbjct: 101 LCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTT- 159
Query: 78 EEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEV------LHRSYNVEGDMWSIGV 130
+ +K++DFG+S R N VG+ +++APEV L +Y+ D+WS+G
Sbjct: 160 --EGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLG- 216
Query: 131 ITYILLCGSRPFWARTE--SGIFRSVLRADPNFHDSP-WPSVSPEAKDFVRRLLNKDHRK 187
IT I L P A +F+ P H W S E DF+R+ L KD+ K
Sbjct: 217 ITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPELW---SNEFNDFIRKCLTKDYEK 273
Query: 188 RMTAAQALTHPWL 200
R T + L H ++
Sbjct: 274 RPTVSDLLQHVFI 286
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 6e-16
Identities = 50/176 (28%), Positives = 89/176 (50%), Gaps = 12/176 (6%)
Query: 17 FFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76
F + GG+L+ I + G++ E A +I + F H +G+++RDLK +N +
Sbjct: 78 FVMEYVNGGDLMYHI-QQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML-- 134
Query: 77 REEDAPLKVIDFGL-SDFVRPDQRLNDIVGSAYYVAPE-VLHRSYNVEGDMWSIGVITYI 134
+ + +K+ DFG+ + + + G+ Y+APE + ++ Y D W+ GV+ Y
Sbjct: 135 -DAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYE 193
Query: 135 LLCGSRPFWARTESGIFRSVLRADPNFHDSPWP-SVSPEAKDFVRRLLNKDHRKRM 189
+L G PF E +F+S++ H+ +P S+S EA + LL K KR+
Sbjct: 194 MLAGQPPFDGEDEDELFQSIME-----HNVSYPKSLSKEAVSICKGLLTKHPAKRL 244
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 7e-16
Identities = 55/196 (28%), Positives = 91/196 (46%), Gaps = 18/196 (9%)
Query: 17 FFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76
F + GG+L+ I + + E A ++ + + H +V+RDLK +N L T
Sbjct: 79 FVMEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDT 136
Query: 77 REEDAPLKVIDFGL-SDFVRPDQRLNDIVGSAYYVAPEVL-HRSYNVEGDMWSIGVITYI 134
+ +K+ DFGL + + R + G+ ++APEVL SY D W +GV+ Y
Sbjct: 137 ---EGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYE 193
Query: 135 LLCGSRPFWARTESGIFRSVLRADPNFHDSPWP-SVSPEAKDFVRRLLNKDHRKRM---- 189
+L G PF E +F S++ + +P +S EA +RRLL ++ +R+
Sbjct: 194 MLVGESPFPGDDEEEVFDSIVNDEV-----RYPRFLSREAISIMRRLLRRNPERRLGSGE 248
Query: 190 -TAAQALTHPWLHDEN 204
A P+ D N
Sbjct: 249 KDAEDVKKQPFFRDIN 264
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 7e-16
Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 17/210 (8%)
Query: 6 LQHLFYSNSFLFFT-RFCEGGELLDRILSRGGRYLEED-AKTIVEKILNIVAFCHLQGVV 63
L + F + L+ + GG+LL +LS+ L ED A+ + +++ + H G V
Sbjct: 66 LHYAFQDENNLYLVMDYYVGGDLLT-LLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYV 124
Query: 64 HRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ--RLNDIVGSAYYVAPEVLHR---- 117
HRD+KP+N L +++ DFG + D + N VG+ Y++PE+L
Sbjct: 125 HRDIKPDNVLLDKN---GHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDG 181
Query: 118 --SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPW-PSVSPEAK 174
Y E D WS+GV Y +L G PF+A + + ++ +F P VS EAK
Sbjct: 182 KGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAK 241
Query: 175 DFVRRLL-NKDHRKRMTAAQAL-THPWLHD 202
D +RRL+ + + R Q HP+
Sbjct: 242 DLIRRLICSPETRLGRNGLQDFKDHPFFEG 271
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 76.7 bits (188), Expect = 9e-16
Identities = 54/197 (27%), Positives = 92/197 (46%), Gaps = 22/197 (11%)
Query: 40 EEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ- 98
E + + L + F H V+HRD+K +N L D +K+ DFG + P+Q
Sbjct: 115 EGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQS 171
Query: 99 RLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTE-SGIFRSVLR 156
+ + +VG+ Y++APEV+ R +Y + D+WS+G++ ++ G P+ ++
Sbjct: 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN 231
Query: 157 ADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDILIYKL 216
P + +S +DF+ R L+ D KR +A + L H +L K+
Sbjct: 232 GTPELQNP--EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL--------------KI 275
Query: 217 VKSYLRATPLKRAALKA 233
K TPL AA +A
Sbjct: 276 AKPLSSLTPLIAAAKEA 292
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 9e-16
Identities = 55/192 (28%), Positives = 86/192 (44%), Gaps = 41/192 (21%)
Query: 50 ILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPD----QRLNDIVG 105
IL + + H V+HRDLKP N L T + LK+ DFGL+ P+ L + V
Sbjct: 115 ILRGLKYIHSANVLHRDLKPSNLLLNT---NCDLKICDFGLARIADPEHDHTGFLTEYVA 171
Query: 106 SAYYVAPEVL--HRSYNVEGDMWSIGVITYILLCGSRPFW-------------------- 143
+ +Y APE++ + Y D+WS+G I +L RP +
Sbjct: 172 TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN-RPLFPGKDYLHQLNLILGVLGTPS 230
Query: 144 ----ARTESGIFRSVLRADPNFHDSPW----PSVSPEAKDFVRRLLNKDHRKRMTAAQAL 195
S R+ +++ P PW P+ P+A D + ++L + KR+T +AL
Sbjct: 231 QEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEAL 290
Query: 196 THPWL---HDEN 204
HP+L HD +
Sbjct: 291 AHPYLEQYHDPS 302
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 54/189 (28%), Positives = 89/189 (47%), Gaps = 11/189 (5%)
Query: 6 LQHLFYSNSFLFFT-RFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVH 64
L + F + L+F F GGEL L R + E A+ +I + + + H +V+
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFH-LQRERSFPEPRARFYAAEIASALGYLHSINIVY 119
Query: 65 RDLKPENFLFTTREEDAPLKVIDFGL-SDFVRPDQRLNDIVGSAYYVAPEVLHRS-YNVE 122
RDLKPEN L ++ + + DFGL + + G+ Y+APEV+ + Y+
Sbjct: 120 RDLKPENILLDSQ---GHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNT 176
Query: 123 GDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLN 182
D W +G + Y +L G PF+ R + ++ ++L P S A + LL
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR----PGASLTAWSILEELLE 232
Query: 183 KDHRKRMTA 191
KD ++R+ A
Sbjct: 233 KDRQRRLGA 241
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 52/183 (28%), Positives = 90/183 (49%), Gaps = 11/183 (6%)
Query: 10 FYSNSFLFFT-RFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLK 68
F + LFF + GG+L+ +I R ++ E ++ ++ + F H GV++RDLK
Sbjct: 65 FQTKDRLFFVMEYVNGGDLMFQI-QRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLK 123
Query: 69 PENFLFTTREEDAPLKVIDFGL-SDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMW 126
+N L + + K+ DFG+ + + G+ Y+APE+L Y D W
Sbjct: 124 LDNILL---DAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWW 180
Query: 127 SIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHR 186
++GV+ Y ++ G PF A E +F S+L D + W +S EA ++ + K+
Sbjct: 181 ALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLY--PVW--LSKEAVSILKAFMTKNPN 236
Query: 187 KRM 189
KR+
Sbjct: 237 KRL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 2e-15
Identities = 56/179 (31%), Positives = 90/179 (50%), Gaps = 10/179 (5%)
Query: 24 GGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPL 83
GG LD L + G E TI+ +IL + + H + +HRD+K N L + E +
Sbjct: 86 GGSALD--LLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLS---EQGDV 140
Query: 84 KVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLHRS-YNVEGDMWSIGVITYILLCGSRP 141
K+ DFG++ + Q + N VG+ +++APEV+ +S Y+ + D+WS+G+ L G P
Sbjct: 141 KLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPP 200
Query: 142 FWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200
++ R + N + S K+FV LNKD R R TA + L H ++
Sbjct: 201 N---SDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 3e-15
Identities = 53/187 (28%), Positives = 97/187 (51%), Gaps = 17/187 (9%)
Query: 21 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNI---VAFCHLQGVVHRDLKPENFLFTTR 77
FCEGG+L ++ + G+ L E +VE + I + + H + ++HRDLK +N +F TR
Sbjct: 81 FCEGGDLYHKLKEQKGKLLPE--NQVVEWFVQIAMALQYLHEKHILHRDLKTQN-VFLTR 137
Query: 78 EEDAPLKVIDFGLSDFVRPDQRL-NDIVGSAYYVAPEVL-HRSYNVEGDMWSIGVITYIL 135
+KV D G++ + + + ++G+ YY++PE+ ++ YN + D+W++G Y +
Sbjct: 138 TN--IIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEM 195
Query: 136 LCGSRPFWAR-TESGIFRSVLRADPNFHDSPWPS-VSPEAKDFVRRLLNKDHRKRMTAAQ 193
F A+ S ++R + P P P SPE + + +L+K KR +
Sbjct: 196 ATLKHAFNAKDMNSLVYRIIEGKLP-----PMPKDYSPELGELIATMLSKRPEKRPSVKS 250
Query: 194 ALTHPWL 200
L P++
Sbjct: 251 ILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-15
Identities = 57/197 (28%), Positives = 94/197 (47%), Gaps = 41/197 (20%)
Query: 40 EEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR 99
E+ + +V ++L + + H G++HRDLKP N ED LK++DFGL+ + D
Sbjct: 117 EDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVN---EDCELKILDFGLAR--QTDSE 171
Query: 100 LNDIVGSAYYVAPEV----LHRSYNVEGDMWSIGVITYILLCG----------------- 138
+ V + +Y APEV +H + V D+WS+G I +L G
Sbjct: 172 MTGYVVTRWYRAPEVILNWMHYTQTV--DIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIM 229
Query: 139 ------SRPFWARTESGIFRSVLRADPNFHD----SPWPSVSPEAKDFVRRLLNKDHRKR 188
S+ F + +S ++ ++ P F S P+ +P A + + ++L D R
Sbjct: 230 KVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESR 289
Query: 189 MTAAQALTHPW---LHD 202
+TAA+AL HP+ HD
Sbjct: 290 ITAAEALAHPYFEEFHD 306
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-15
Identities = 70/255 (27%), Positives = 107/255 (41%), Gaps = 57/255 (22%)
Query: 9 LFYS----NSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVH 64
+FYS + F GG+++ ++ + E I E +L I A H G +H
Sbjct: 66 MFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAI-HQLGFIH 124
Query: 65 RDLKPENFLFTTREEDAPLKVIDFGL---------SDFVR------PD----QRLND--- 102
RD+KP+N L + +K+ DFGL ++F R P Q +N
Sbjct: 125 RDIKPDNLLLDAK---GHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRK 181
Query: 103 --------------IVGSAYYVAPEVLHRS-YNVEGDMWSIGVITYILLCGSRPFWARTE 147
VG+ Y+APEV ++ YN D WS+GVI Y +L G PF + T
Sbjct: 182 AETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETP 241
Query: 148 SGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAA---QALTHP------ 198
+R V+ P +S +AKD + R D R+ + + +HP
Sbjct: 242 QETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGVD 300
Query: 199 WLHDENRP--VPLDI 211
W H RP +P++I
Sbjct: 301 WGHIRERPAAIPIEI 315
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 4e-15
Identities = 52/194 (26%), Positives = 95/194 (48%), Gaps = 18/194 (9%)
Query: 14 SFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFL 73
+ F + GG + D++ + G E + +IL +++ H +VHRD+K N L
Sbjct: 80 TLTIFMEYMPGGSVKDQLKAYGA-LTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANIL 138
Query: 74 FTTREEDAPLKVIDFGLSDFVR----PDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSI 128
R+ +K+ DFG S ++ + + G+ Y+++PEV+ Y + D+WS+
Sbjct: 139 ---RDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSL 195
Query: 129 GVITYILLCGSRPFWARTE--SGIFRSVLRADPNFHDSPWPS-VSPEAKDFVRRLLNKDH 185
G T + + +P WA E + IF+ + P + PS +S A+DF+ + +
Sbjct: 196 GC-TVVEMLTEKPPWAEYEAMAAIFK--IATQPT--NPQLPSHISEHARDFLGCIF-VEA 249
Query: 186 RKRMTAAQALTHPW 199
R R +A + L HP+
Sbjct: 250 RHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 4e-15
Identities = 64/249 (25%), Positives = 102/249 (40%), Gaps = 59/249 (23%)
Query: 9 LFYS----NSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVH 64
L+YS ++ F + GG+++ +L R + E A+ + ++ + H G +H
Sbjct: 66 LYYSFQDKDNLYFVMDYIPGGDMMS-LLIRMEVFPEVLARFYIAELTLAIESVHKMGFIH 124
Query: 65 RDLKPENFLFTTREEDAPLKVIDFGL--------------------SDFVRPDQRLNDI- 103
RD+KP+N L + D +K+ DFGL D + P +D+
Sbjct: 125 RDIKPDNILI---DLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVS 181
Query: 104 ---------------------------VGSAYYVAPEVLHRS-YNVEGDMWSIGVITYIL 135
VG+ Y+APEVL R Y D WS+GVI + +
Sbjct: 182 NCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEM 241
Query: 136 LCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRL-LNKDHR-KRMTAAQ 193
L G PF A T + V+ + H P +SPEA D + +L + + R R A
Sbjct: 242 LVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADD 301
Query: 194 ALTHPWLHD 202
HP+ +
Sbjct: 302 IKAHPFFSE 310
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 5e-15
Identities = 54/186 (29%), Positives = 87/186 (46%), Gaps = 32/186 (17%)
Query: 43 AKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLN 101
K+ + ++L +AFCH V+HRDLKP+N L E LK+ DFGL+ F P + +
Sbjct: 101 VKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGE---LKLADFGLARAFGIPVRCYS 157
Query: 102 DIVGSAYYVAPEVL--HRSYNVEGDMWSIGVITYILLCGSRPFWARTE-----SGIFRSV 154
V + +Y P+VL + Y+ DMWS G I L RP + + IFR +
Sbjct: 158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL 217
Query: 155 ----------LRADPNFHDSP-------W----PSVSPEAKDFVRRLLNKDHRKRMTAAQ 193
+ P++ P P ++ +D ++ LL + +R++A +
Sbjct: 218 GTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEE 277
Query: 194 ALTHPW 199
AL HP+
Sbjct: 278 ALQHPY 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 8e-15
Identities = 52/180 (28%), Positives = 82/180 (45%), Gaps = 19/180 (10%)
Query: 40 EEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR 99
E + I L +A+ H +HRD+K N L T E +K+ DFG + V P
Sbjct: 114 EVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLT---EPGTVKLADFGSASLVSP--- 167
Query: 100 LNDIVGSAYYVAPEVL----HRSYNVEGDMWSIGVITYILLCGSRP--FWARTESGIFRS 153
N VG+ Y++APEV+ Y+ + D+WS+G IT I L +P F S ++
Sbjct: 168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG-ITCIELAERKPPLFNMNAMSALYHI 226
Query: 154 VLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDILI 213
P + W S ++FV L K + R ++ + L H ++ R P ++I
Sbjct: 227 AQNDSPTLSSNDW---SDYFRNFVDSCLQKIPQDRPSSEELLKHRFV---LRERPPTVII 280
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-14
Identities = 53/182 (29%), Positives = 91/182 (50%), Gaps = 15/182 (8%)
Query: 21 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNI---VAFCHLQGVVHRDLKPENFLFTTR 77
+C+GG+L+ +I + G+ ED TI++ + + V H + V+HRD+K +N T
Sbjct: 79 YCDGGDLMQKIKLQRGKLFPED--TILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLT-- 134
Query: 78 EEDAPLKVIDFGLSDFV-RPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYIL 135
++ +K+ DFG + + P VG+ YYV PE+ YN + D+WS+G I Y L
Sbjct: 135 -QNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYEL 193
Query: 136 LCGSRPFWARTESGIFRSVLRADPNFHDSPWPS-VSPEAKDFVRRLLNKDHRKRMTAAQA 194
PF A + + V + P PS S E + ++++ ++ R R +A
Sbjct: 194 CTLKHPFQANSWKNLILKVCQGSYK----PLPSHYSYELRSLIKQMFKRNPRSRPSATTI 249
Query: 195 LT 196
L+
Sbjct: 250 LS 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-14
Identities = 44/153 (28%), Positives = 70/153 (45%), Gaps = 9/153 (5%)
Query: 58 HLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL-H 116
H + +V+RDLKPEN L ++ +++ D GL+ + + + VG+ Y+APEV+ +
Sbjct: 119 HRERIVYRDLKPENILL---DDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKN 175
Query: 117 RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDF 176
Y D W +G + Y ++ G PF R E V R + S A+
Sbjct: 176 ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSI 235
Query: 177 VRRLLNKDHRKRM-----TAAQALTHPWLHDEN 204
R+LL KD R+ A + HP+ N
Sbjct: 236 CRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTAN 268
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 1e-14
Identities = 45/153 (29%), Positives = 70/153 (45%), Gaps = 9/153 (5%)
Query: 58 HLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL-H 116
+ +V+RDLKPEN L R +++ D GL+ + + + VG+ Y+APEV+ +
Sbjct: 119 QRERIVYRDLKPENILLDDR---GHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINN 175
Query: 117 RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDF 176
Y D W +G + Y ++ G PF R E V R + S +AK
Sbjct: 176 EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSI 235
Query: 177 VRRLLNKDHRKRM-----TAAQALTHPWLHDEN 204
R LL K+ ++R+ AA HP + N
Sbjct: 236 CRMLLTKNPKERLGCRGNGAAGVKQHPIFKNIN 268
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 1e-14
Identities = 57/183 (31%), Positives = 95/183 (51%), Gaps = 18/183 (9%)
Query: 24 GGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPL 83
GG LD L R G + E T++++IL + + H + +HRD+K N L + E +
Sbjct: 86 GGSALD--LLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLS---EQGDV 140
Query: 84 KVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLHRS-YNVEGDMWSIGVITYILLCGSRP 141
K+ DFG++ + Q + N VG+ +++APEV+ +S Y+ + D+WS+G+ L G P
Sbjct: 141 KLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPP 200
Query: 142 FWARTESGIFRSVLRADPNFHDSPWPSVSPE----AKDFVRRLLNKDHRKRMTAAQALTH 197
++ R VL P P+++ E K+F+ LNKD R TA + L H
Sbjct: 201 ---NSDMHPMR-VLFLIPKN---NPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253
Query: 198 PWL 200
++
Sbjct: 254 KFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 71/253 (28%), Positives = 110/253 (43%), Gaps = 58/253 (22%)
Query: 9 LFYS---NSFLFFT-RFCEGGELLDRILSRGGRYLEEDAK-TIVEKILNIVAFCHLQGVV 63
L+YS ++L+ + GG+++ +L + + EE+ + I E IL I + H G +
Sbjct: 66 LYYSFQDENYLYLIMEYLPGGDMMT-LLMKKDTFTEEETRFYIAETILAIDSI-HKLGYI 123
Query: 64 HRDLKPENFLFTTREEDAPLKVIDFGL---------SDFVR------PDQRLNDI----- 103
HRD+KP+N L + +K+ DFGL ++F R P L+ I
Sbjct: 124 HRDIKPDNLLL---DAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMS 180
Query: 104 -------------------VGSAYYVAPEVLHRS-YNVEGDMWSIGVITYILLCGSRPFW 143
VG+ Y+APEV ++ YN E D WS+GVI Y +L G PF
Sbjct: 181 SKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFC 240
Query: 144 ARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLL-NKDHR-KRMTAAQALTHP--- 198
+ +R ++ +SPEAKD ++RL + R + +HP
Sbjct: 241 SDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKSHPFFK 300
Query: 199 ---WLHDENRPVP 208
W H RP P
Sbjct: 301 GVDWEHIRERPAP 313
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 53/184 (28%), Positives = 78/184 (42%), Gaps = 27/184 (14%)
Query: 41 EDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRL 100
E K ++ + L + F H +VHRDLKPEN L T+ + +K+ DFGL+ L
Sbjct: 108 ETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQ---VKLADFGLARIYSCQMAL 164
Query: 101 NDIVGSAYYVAPEVLHRS-YNVEGDMWSIGVI------TYILLCG--------------- 138
+V + +Y APEVL +S Y DMWS+G I L CG
Sbjct: 165 TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG 224
Query: 139 --SRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196
W R + + P S P + + +L + KR++A +AL
Sbjct: 225 LPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284
Query: 197 HPWL 200
HP+
Sbjct: 285 HPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 2e-14
Identities = 63/229 (27%), Positives = 98/229 (42%), Gaps = 44/229 (19%)
Query: 15 FLFFTRFCEG--GELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENF 72
FL +CE LLD + + + E K ++ ++L + + H ++HRDLK N
Sbjct: 84 FLVM-EYCEQDLASLLDNMPTP---FSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNL 139
Query: 73 LFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVL--HRSYNVEGDMWSIG 129
L T + LK+ DFGL+ + P + + V + +Y APE+L +Y DMW++G
Sbjct: 140 LLTDKGC---LKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVG 196
Query: 130 VITYILLCGSRPFWARTESGIFRSV--LRADPNFHDSPWPSVS--PEAKDFV-------- 177
I LL ++E + L PN +S WP S P F
Sbjct: 197 CILAELLAHKPLLPGKSEIEQLDLIIQLLGTPN--ESIWPGFSDLPLVGKFTLPKQPYNN 254
Query: 178 ------------RRLLNK----DHRKRMTAAQALTHPWLHDENRPVPLD 210
RLLN D +KR TA +AL + + +P+P +
Sbjct: 255 LKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKE--KPLPCE 301
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 54/197 (27%), Positives = 95/197 (48%), Gaps = 24/197 (12%)
Query: 6 LQHLFYSNSFLFFT-RFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVH 64
L F + S LF + GG+L+ + R + EE A+ +I + F H +G+++
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFH-MQRQRKLPEEHARFYAAEICIALNFLHERGIIY 119
Query: 65 RDLKPENFLFTTREEDAPLKVIDFGL-SDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVE 122
RDLK +N L + D +K+ D+G+ + + P + G+ Y+APE+L Y
Sbjct: 120 RDLKLDNVLL---DADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFS 176
Query: 123 GDMWSIGVITYILLCGSRPF-------WARTESGIFRSVLRAD---PNFHDSPWPSVSPE 172
D W++GV+ + ++ G PF TE +F+ +L P F +S +
Sbjct: 177 VDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRF-------LSVK 229
Query: 173 AKDFVRRLLNKDHRKRM 189
A ++ LNKD ++R+
Sbjct: 230 ASHVLKGFLNKDPKERL 246
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 2e-14
Identities = 69/255 (27%), Positives = 106/255 (41%), Gaps = 55/255 (21%)
Query: 9 LFYS-----NSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVV 63
+FYS N +L F GG+++ ++ + EE I E +L I + H G +
Sbjct: 66 MFYSFQDKLNLYLIM-EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSI-HQLGFI 123
Query: 64 HRDLKPENFLFTTREEDAPLKVIDFGL---------SDFVR------PD----QRLND-- 102
HRD+KP+N L ++ +K+ DFGL ++F R P Q +N
Sbjct: 124 HRDIKPDNLLLDSK---GHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKR 180
Query: 103 ---------------IVGSAYYVAPEV-LHRSYNVEGDMWSIGVITYILLCGSRPFWART 146
VG+ Y+APEV + YN D WS+GVI Y +L G PF + T
Sbjct: 181 KAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240
Query: 147 ESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNK-DHRKRMTAAQALTH-------P 198
++ V+ P +S +AKD + R + +HR + +
Sbjct: 241 PQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEGVD 300
Query: 199 WLHDENRPVPLDILI 213
W H RP + I I
Sbjct: 301 WEHIRERPAAIPIEI 315
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 3e-14
Identities = 63/204 (30%), Positives = 99/204 (48%), Gaps = 38/204 (18%)
Query: 28 LDRILSRGGRYLE-EDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVI 86
LD + G+Y++ E K+ + +IL + FCH + V+HRDLKP+N L + +K+
Sbjct: 89 LDSL--PKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLI---DNKGVIKLA 143
Query: 87 DFGLS-DFVRPDQRLNDIVGSAYYVAPEVLHRS--YNVEGDMWSIGVITYILLCGSRP-F 142
DFGL+ F P + V + +Y APEVL S Y+ D+WSIG I + + +P F
Sbjct: 144 DFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTI-FAEMATKKPLF 202
Query: 143 WARTE-SGIFRSVLRADPNFHDSPWPSVS--PEAK-----------------------DF 176
+E +FR + R + WP V+ P+ K D
Sbjct: 203 HGDSEIDQLFR-IFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDL 261
Query: 177 VRRLLNKDHRKRMTAAQALTHPWL 200
+ ++L D KR++A +AL HP+
Sbjct: 262 LEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 3e-14
Identities = 63/213 (29%), Positives = 92/213 (43%), Gaps = 42/213 (19%)
Query: 28 LDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVID 87
L +I+ + K + +IL + + H G++HRD+KP N L + + LK+ D
Sbjct: 90 LHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNS---NCVLKICD 146
Query: 88 FGLSDFVRPDQRLNDI--VGSAYYVAPEVL--HRSYNVEGDMWSIGVITYILLCGSRPFW 143
FGL+ PD+ + V + YY APE+L R Y D+WS+G I LL F
Sbjct: 147 FGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQ 206
Query: 144 ARTE-----------------------SGIFRSVLRADPNFHDSPWPSV--------SPE 172
A++ G +LR H P V + E
Sbjct: 207 AQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGP---HKPPSLPVLYTLSSQATHE 263
Query: 173 AKDFVRRLLNKDHRKRMTAAQALTHPWLHDENR 205
A + R+L D KR++AA AL HP+L DE R
Sbjct: 264 AVHLLCRMLVFDPDKRISAADALAHPYL-DEGR 295
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 3e-14
Identities = 44/147 (29%), Positives = 72/147 (48%), Gaps = 9/147 (6%)
Query: 58 HLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL-H 116
H + +V+RDLKPEN L ++ +++ D GL+ V Q + VG+ Y+APEV+ +
Sbjct: 119 HQERIVYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN 175
Query: 117 RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDF 176
Y D W++G + Y ++ G PF R + V R + SP+A+
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSL 235
Query: 177 VRRLLNKDHRKRM-----TAAQALTHP 198
+ LL KD ++R+ A + HP
Sbjct: 236 CKMLLCKDPKERLGCQGGGAREVKEHP 262
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 3e-14
Identities = 56/202 (27%), Positives = 89/202 (44%), Gaps = 29/202 (14%)
Query: 28 LDRILSRGGRYLEEDAKTIVEKILNIVAFCH-LQGVVHRDLKPENFLFTTREEDAPLKVI 86
LDRI +GG E I ++ + + + + ++HRD+KP N L +R + +K+
Sbjct: 90 LDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQ---IKLC 146
Query: 87 DFGLSDFVRPDQRLNDI----VGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRP 141
DFG+S + +N I VG++ Y++PE + Y V+ D+WS+G+ L G P
Sbjct: 147 DFGVS-----GELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFP 201
Query: 142 FWARTES--------GIF----RSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRM 189
F GI + V P S +P + +DFV L KD +R
Sbjct: 202 FAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFP---EDLRDFVDACLLKDPTERP 258
Query: 190 TAAQALTHPWLHDENRPVPLDI 211
T Q P R +D+
Sbjct: 259 TPQQLCAMPPFIQALRASNVDL 280
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 3e-14
Identities = 57/196 (29%), Positives = 97/196 (49%), Gaps = 21/196 (10%)
Query: 6 LQHLFYSNSFLFFTR-FCEGGELLDRILSRGGRYLEED-AKTIVEKILNIVAFCHLQGVV 63
L + F ++L+ + GG+LL +LS+ L ED A+ + +++ + H V
Sbjct: 66 LHYAFQDENYLYLVMDYYVGGDLLT-LLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYV 124
Query: 64 HRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLND--IVGSAYYVAPEVLHR---- 117
HRD+KP+N L + + +++ DFG + D + VG+ Y++PE+L
Sbjct: 125 HRDIKPDNVLL---DMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDG 181
Query: 118 --SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPS----VSP 171
Y E D WS+GV Y +L G PF+A + + ++ + F +PS VS
Sbjct: 182 MGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQ---FPSHITDVSE 238
Query: 172 EAKDFVRRLLNKDHRK 187
EAKD ++RL+ R+
Sbjct: 239 EAKDLIQRLICSRERR 254
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 63/192 (32%), Positives = 92/192 (47%), Gaps = 17/192 (8%)
Query: 13 NSFLFFTRFCEGGELLDRILSRGGRYL---EEDAKTIVEKILNIVAFCHLQGVVHRDLKP 69
+ L + GG+L +I R +L E + + +I+ + H + ++HRDLK
Sbjct: 138 DKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKS 197
Query: 70 EN-FLFTTREEDAPLKVIDFGLS----DFVRPDQRLNDIVGSAYYVAPEVLHRS-YNVEG 123
N FL T +K+ DFG S D V D + G+ YY+APE+ R Y+ +
Sbjct: 198 ANIFLMPT----GIIKLGDFGFSKQYSDSVSLDVA-SSFCGTPYYLAPELWERKRYSKKA 252
Query: 124 DMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNK 183
DMWS+GVI Y LL RPF ++ I + VL + P P VS K + LL+K
Sbjct: 253 DMWSLGVILYELLTLHRPFKGPSQREIMQQVLYG--KYDPFPCP-VSSGMKALLDPLLSK 309
Query: 184 DHRKRMTAAQAL 195
+ R T Q L
Sbjct: 310 NPALRPTTQQLL 321
|
Length = 478 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 3e-14
Identities = 53/196 (27%), Positives = 96/196 (48%), Gaps = 20/196 (10%)
Query: 6 LQHLFYSNSFLFFT-RFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVH 64
L F + S LFF + GG+L+ + R + EE A+ +I + + H +G+++
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFH-MQRQRKLPEEHARFYSAEISLALNYLHERGIIY 119
Query: 65 RDLKPENFLFTTREEDAPLKVIDFGL-SDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVE 122
RDLK +N L + + +K+ D+G+ + +RP + G+ Y+APE+L Y
Sbjct: 120 RDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFS 176
Query: 123 GDMWSIGVITYILLCGSRPF---------WARTESGIFRSVLRADPNFHDSPWPSVSPEA 173
D W++GV+ + ++ G PF TE +F+ +L S+S +A
Sbjct: 177 VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SLSVKA 232
Query: 174 KDFVRRLLNKDHRKRM 189
++ LNKD ++R+
Sbjct: 233 ASVLKSFLNKDPKERL 248
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 4e-14
Identities = 46/151 (30%), Positives = 74/151 (49%), Gaps = 16/151 (10%)
Query: 46 IVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ----RLN 101
E +L + A H G +HRD+KP+N L ++ LK+ DFG ++ D R +
Sbjct: 148 TAEVVLALDAI-HSMGFIHRDVKPDNMLL---DKSGHLKLADFGTC--MKMDANGMVRCD 201
Query: 102 DIVGSAYYVAPEVL-----HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLR 156
VG+ Y++PEVL Y E D WS+GV Y +L G PF+A + G + ++
Sbjct: 202 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMD 261
Query: 157 ADPNFHDSPWPSVSPEAKDFVRRLL-NKDHR 186
+ +S +AKD + L +++ R
Sbjct: 262 HKNSLTFPDDIEISKQAKDLICAFLTDREVR 292
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 4e-14
Identities = 53/189 (28%), Positives = 96/189 (50%), Gaps = 13/189 (6%)
Query: 5 KLQHLFYSNSFLFFT-RFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVV 63
+L F + L+F + GG+L+ +I + GR+ E A +I + F H +G++
Sbjct: 65 QLHSCFQTMDRLYFVMEYVNGGDLMYQI-QQVGRFKEPHAVFYAAEIAIGLFFLHSKGII 123
Query: 64 HRDLKPENFLFTTREEDAPLKVIDFGL-SDFVRPDQRLNDIVGSAYYVAPEVL-HRSYNV 121
+RDLK +N + + + +K+ DFG+ + + G+ Y+APE++ ++ Y
Sbjct: 124 YRDLKLDNVML---DSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGK 180
Query: 122 EGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWP-SVSPEAKDFVRRL 180
D W+ GV+ Y +L G PF E +F+S++ H+ +P S+S EA + L
Sbjct: 181 SVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME-----HNVAYPKSMSKEAVAICKGL 235
Query: 181 LNKDHRKRM 189
+ K KR+
Sbjct: 236 MTKHPGKRL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 4e-14
Identities = 52/189 (27%), Positives = 89/189 (47%), Gaps = 32/189 (16%)
Query: 42 DAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR-PDQRL 100
+ K + ++L + +CH + V+HRDLKP+N L R E LK+ DFGL+ P +
Sbjct: 105 NVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGE---LKLADFGLARAKSIPTKTY 161
Query: 101 NDIVGSAYYVAPEVLHRS--YNVEGDMWSIGVITYILLCGSRPFWARTESG----IFRSV 154
++ V + +Y P++L S Y+ + DMW +G I Y + G F T IFR +
Sbjct: 162 SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRIL 221
Query: 155 ----------LRADPNFHDSPWPSVSPEA------------KDFVRRLLNKDHRKRMTAA 192
+ ++ F +P + + + +LL + RKR++A
Sbjct: 222 GTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAE 281
Query: 193 QALTHPWLH 201
+A+ HP+ H
Sbjct: 282 EAMKHPYFH 290
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 5e-14
Identities = 60/187 (32%), Positives = 93/187 (49%), Gaps = 17/187 (9%)
Query: 21 FCEGGELLDRILSRG--GR-YLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77
+ G+L I SR R + E +A + ++L V H + ++HRD+K N L +
Sbjct: 120 YANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCS- 178
Query: 78 EEDAPLKVIDFGLSDFVR---PDQRLNDIVGSAYYVAPEVLHRS-YNVEGDMWSIGVITY 133
+ +K+ DFG S D G+ YYVAPE+ R Y+ + DM+S+GV+ Y
Sbjct: 179 --NGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLY 236
Query: 134 ILLCGSRPFWARTESGIFRSVL--RADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTA 191
LL RPF + L R DP P PS+SPE ++ V LL+ D ++R ++
Sbjct: 237 ELLTLKRPFDGENMEEVMHKTLAGRYDP----LP-PSISPEMQEIVTALLSSDPKRRPSS 291
Query: 192 AQALTHP 198
++ L P
Sbjct: 292 SKLLNMP 298
|
Length = 496 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 6e-14
Identities = 52/193 (26%), Positives = 95/193 (49%), Gaps = 13/193 (6%)
Query: 5 KLQHLFYSNSFLFFT-RFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVV 63
+L F + L+F + GG+L+ I + G++ E A +I + F H +G++
Sbjct: 65 QLHSCFQTVDRLYFVMEYVNGGDLMYHI-QQVGKFKEPQAVFYAAEISVGLFFLHRRGII 123
Query: 64 HRDLKPENFLFTTREEDAPLKVIDFGL-SDFVRPDQRLNDIVGSAYYVAPEVL-HRSYNV 121
+RDLK +N + + + +K+ DFG+ + + G+ Y+APE++ ++ Y
Sbjct: 124 YRDLKLDNVML---DSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGK 180
Query: 122 EGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWP-SVSPEAKDFVRRL 180
D W+ GV+ Y +L G PF E +F+S++ H+ +P S+S EA + L
Sbjct: 181 SVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME-----HNVSYPKSLSKEAVSICKGL 235
Query: 181 LNKDHRKRMTAAQ 193
+ K KR+
Sbjct: 236 MTKHPSKRLGCGP 248
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 7e-14
Identities = 59/208 (28%), Positives = 88/208 (42%), Gaps = 39/208 (18%)
Query: 28 LDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVID 87
L I+ EE + + ++L + + H V+HRDLKP N L ED L++ D
Sbjct: 94 LHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVN---EDCELRIGD 150
Query: 88 FGLSDFV--RPDQR---LNDIVGSAYYVAPE---VLHRSYNVEGDMWSIG---------- 129
FG++ + P + + + V + +Y APE L Y DMWS+G
Sbjct: 151 FGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPE-YTTAIDMWSVGCIFAEMLGRR 209
Query: 130 -------------VITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPW----PSVSPE 172
+I +L S R S R ++ P PW P SPE
Sbjct: 210 QLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPE 269
Query: 173 AKDFVRRLLNKDHRKRMTAAQALTHPWL 200
A D + ++L D +R+T QAL HP+L
Sbjct: 270 ALDLLSQMLQFDPEERITVEQALQHPFL 297
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 7e-14
Identities = 54/191 (28%), Positives = 94/191 (49%), Gaps = 16/191 (8%)
Query: 18 FTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77
F GG + D++ S G E + +IL V++ H +VHRD+K N L R
Sbjct: 84 FMEHMPGGSIKDQLKSYGA-LTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANIL---R 139
Query: 78 EEDAPLKVIDFGLSDFVR----PDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVIT 132
+ +K+ DFG S ++ + + G+ Y+++PEV+ Y + D+WS+G T
Sbjct: 140 DSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGC-T 198
Query: 133 YILLCGSRPFWARTE--SGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMT 190
+ + +P WA E + IF+ + P P P VS +DF++R+ + + R +
Sbjct: 199 VVEMLTEKPPWAEFEAMAAIFK--IATQPTNPVLP-PHVSDHCRDFLKRIF-VEAKLRPS 254
Query: 191 AAQALTHPWLH 201
A + L H ++H
Sbjct: 255 ADELLRHTFVH 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 8e-14
Identities = 59/229 (25%), Positives = 94/229 (41%), Gaps = 54/229 (23%)
Query: 28 LDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVID 87
L +++ R R E K I+ +ILN + H +HRDL P N ++ K+ D
Sbjct: 106 LKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGI---CKIAD 162
Query: 88 FGLS---------------DFVRPDQRLNDIVGSAYYVAPEVLHRS--YNVEGDMWSIGV 130
FGL+ + ++ + + V + +Y APE+L + Y+ DMWS+G
Sbjct: 163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGC 222
Query: 131 ITYILLCGSRPFWARTE----SGIFRSVLRADPNFHDSPWPSV----------------- 169
I LL G F E IF L PN + WP
Sbjct: 223 IFAELLTGKPLFPGENEIDQLGRIFE--LLGTPN--EDNWPQAKKLPLYTEFTPRKPKDL 278
Query: 170 -------SPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDI 211
S +A D ++ LL + +R++A +AL H + ++ P+P D
Sbjct: 279 KTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYF--KSDPLPCDP 325
|
Length = 335 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 8e-14
Identities = 55/187 (29%), Positives = 91/187 (48%), Gaps = 41/187 (21%)
Query: 49 KILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR----PDQRLNDIV 104
++L +A+CH + V+HRDLKP+N L + R E LK+ DFGL+ R P + ++ V
Sbjct: 111 QLLRGLAYCHQRRVLHRDLKPQNLLISERGE---LKLADFGLA---RAKSVPSKTYSNEV 164
Query: 105 GSAYYVAPEVLHRS--YNVEGDMWSIGVITYILLCGSRPFWARTESG-----IFRSV--- 154
+ +Y P+VL S Y+ DMW +G I Y + G F T+ IFR +
Sbjct: 165 VTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTP 224
Query: 155 -------LRADP-----NFHDSP-------WPSVS--PEAKDFVRRLLNKDHRKRMTAAQ 193
+ ++P +F P P + P ++ + L + +KR++AA+
Sbjct: 225 TEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAE 284
Query: 194 ALTHPWL 200
A+ HP+
Sbjct: 285 AMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 1e-13
Identities = 53/179 (29%), Positives = 89/179 (49%), Gaps = 10/179 (5%)
Query: 24 GGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPL 83
GG LD L G E TI+ +IL + + H + +HRD+K N L + E +
Sbjct: 86 GGSALD--LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS---EHGEV 140
Query: 84 KVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLHRS-YNVEGDMWSIGVITYILLCGSRP 141
K+ DFG++ + Q + N VG+ +++APEV+ +S Y+ + D+WS+G+ L G P
Sbjct: 141 KLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP 200
Query: 142 FWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200
+ + + +P + + S K+FV LNK+ R TA + L H ++
Sbjct: 201 HSELHPMKVLFLIPKNNPPTLEGNY---SKPLKEFVEACLNKEPSFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 54/200 (27%), Positives = 92/200 (46%), Gaps = 38/200 (19%)
Query: 40 EEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR 99
+E + ++ ++L + + H G++HRDLKP N ED L+++DFGL+ + D
Sbjct: 117 DEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVN---EDCELRILDFGLAR--QADDE 171
Query: 100 LNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCG------------------- 138
+ V + +Y APE++ YN D+WS+G I LL G
Sbjct: 172 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEV 231
Query: 139 ----SRPFWARTESGIFRSVLRADPNFHDSPWPSV----SPEAKDFVRRLLNKDHRKRMT 190
S + S R +++ P+ + +P A D + ++L D KR++
Sbjct: 232 VGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRIS 291
Query: 191 AAQALTHPWL---HD-ENRP 206
A++AL HP+ HD E+ P
Sbjct: 292 ASEALAHPYFSQYHDPEDEP 311
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 57/205 (27%), Positives = 81/205 (39%), Gaps = 49/205 (23%)
Query: 44 KTIVEKILNIVAFCHLQGVVHRDLKPENFLFT-TREEDAPLKVIDFGLSDFVRPDQR--- 99
K+++ +ILN V + H V+HRDLKP N L E +K+ D GL+ +
Sbjct: 111 KSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLA 170
Query: 100 -LNDIVGSAYYVAPEVL--HRSYNVEGDMWSIGVITYILLCGSRPFWARTES-------- 148
L+ +V + +Y APE+L R Y D+W+IG I LL F R
Sbjct: 171 DLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQ 230
Query: 149 -----GIFR-------------------SVLRADPNFHDSPWPSV----------SPEAK 174
IF L D P S+ +
Sbjct: 231 RDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGF 290
Query: 175 DFVRRLLNKDHRKRMTAAQALTHPW 199
D +R+LL D KR+TA +AL HP+
Sbjct: 291 DLLRKLLEYDPTKRITAEEALEHPY 315
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 2e-13
Identities = 56/195 (28%), Positives = 90/195 (46%), Gaps = 34/195 (17%)
Query: 26 ELLDRILSRGGRYLEEDAKTIVEKILNIVAFC------HLQ---GVVHRDLKPENFLFTT 76
E++D L + + + + TI E IL +A +L V+HRD+KP N L
Sbjct: 80 EVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLI-- 137
Query: 77 REEDAPLKVIDFGLSDFVRPDQRLNDIV-----GSAYYVAPEVL-----HRSYNVEGDMW 126
+ +K+ DFG+S ++ + G Y+APE + + Y+V+ D+W
Sbjct: 138 -NRNGQVKLCDFGISG-----YLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVW 191
Query: 127 SIGVITYI-LLCGSRPF--WARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNK 183
S+G IT I L G P+ W + + V P P SPE +DFV + L K
Sbjct: 192 SLG-ITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQL---PAEKFSPEFQDFVNKCLKK 247
Query: 184 DHRKRMTAAQALTHP 198
++++R + L HP
Sbjct: 248 NYKERPNYPELLQHP 262
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-13
Identities = 52/189 (27%), Positives = 91/189 (48%), Gaps = 18/189 (9%)
Query: 18 FTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77
F + GG + D++ + G E + +IL V++ H +VHRD+K N L R
Sbjct: 84 FVEYMPGGSIKDQLKAYGA-LTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANIL---R 139
Query: 78 EEDAPLKVIDFGLSDFVR----PDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVIT 132
+ +K+ DFG S ++ + + G+ Y+++PEV+ Y + D+WS+ T
Sbjct: 140 DSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVAC-T 198
Query: 133 YILLCGSRPFWARTE--SGIFRSVLR-ADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRM 189
+ + +P WA E + IF+ + P D VS +DF++++ ++ R R
Sbjct: 199 VVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPD----GVSDACRDFLKQIFVEEKR-RP 253
Query: 190 TAAQALTHP 198
TA L HP
Sbjct: 254 TAEFLLRHP 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 2e-13
Identities = 65/232 (28%), Positives = 92/232 (39%), Gaps = 55/232 (23%)
Query: 11 YSNSFLFFTRFCEGGELLDRILSRGG-RYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKP 69
Y SF FCE L +LS ++ + K +++ +LN + + H ++HRD+K
Sbjct: 90 YKGSFYLVFEFCEHD--LAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKA 147
Query: 70 ENFLFTTREEDAPLKVIDFGLS-DFVRPD----QRLNDIVGSAYYVAPEVL--HRSYNVE 122
N L T +D LK+ DFGL+ F R + V + +Y PE+L R Y
Sbjct: 148 ANILIT---KDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPP 204
Query: 123 GDMWSIGVI--------------------TYIL-LCGS-----------RPFWARTE--S 148
DMW G I T I LCGS + + E
Sbjct: 205 IDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQ 264
Query: 149 GIFRSVLRADPNFHDSPWPSVS-PEAKDFVRRLLNKDHRKRMTAAQALTHPW 199
G R V + P V P A D + +LL D KR+ A AL H +
Sbjct: 265 GQKRKV-------KERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDF 309
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 3e-13
Identities = 53/194 (27%), Positives = 79/194 (40%), Gaps = 48/194 (24%)
Query: 58 HLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP----DQRLNDIVGSAYYVAPE 113
H V+HRDLKP N L + LK+ DFGL+ R + + V + +Y APE
Sbjct: 125 HSANVLHRDLKPSNLLLN---ANCDLKICDFGLA---RTTSEKGDFMTEYVVTRWYRAPE 178
Query: 114 VLHRS--YNVEGDMWSIGVITYILLCGSRPFWARTE--------SGIFRSVLRADPNFHD 163
+L Y D+WS+G I LL G +P + + + + S D F
Sbjct: 179 LLLNCSEYTTAIDVWSVGCIFAELL-GRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIR 237
Query: 164 SP--------------------WPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPW---L 200
+ +P +P A D + ++L D KR+T +AL HP+ L
Sbjct: 238 NEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297
Query: 201 HDENR----PVPLD 210
HD + P
Sbjct: 298 HDPSDEPVCQTPFS 311
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 3e-13
Identities = 51/184 (27%), Positives = 89/184 (48%), Gaps = 13/184 (7%)
Query: 13 NSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENF 72
N+ + GG+LL + R E+ A+ + +++ + H VHRD+KP+N
Sbjct: 74 NNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNI 133
Query: 73 LFTTREEDAPLKVIDFGLSDFVRPDQRLND--IVGSAYYVAPEVLHR------SYNVEGD 124
L + + +++ DFG + D + VG+ Y++PE+L Y E D
Sbjct: 134 LM---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECD 190
Query: 125 MWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFH-DSPWPSVSPEAKDFVRRLL-N 182
WS+GV Y +L G PF+A + + ++ F + VS +AKD +RRL+ +
Sbjct: 191 WWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICS 250
Query: 183 KDHR 186
++HR
Sbjct: 251 REHR 254
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 4e-13
Identities = 52/184 (28%), Positives = 79/184 (42%), Gaps = 43/184 (23%)
Query: 58 HLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEV-LH 116
H G++HRDLKP N + + D LK++DFGL+ + V + YY APEV L
Sbjct: 135 HSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG 191
Query: 117 RSYNVEGDMWSIGVITYILLCGSRPF--------WAR------TESGIF--------RSV 154
Y D+WS+G I ++ G+ F W + T S F R+
Sbjct: 192 MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNY 251
Query: 155 LRADPN---------FHDSPWPSVSPE--------AKDFVRRLLNKDHRKRMTAAQALTH 197
+ P F D +P S A+D + ++L D KR++ AL H
Sbjct: 252 VENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311
Query: 198 PWLH 201
P+++
Sbjct: 312 PYIN 315
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 4e-13
Identities = 52/200 (26%), Positives = 89/200 (44%), Gaps = 21/200 (10%)
Query: 11 YSNSFLFFTRFC------EGGELLDRILSRG--GRYLEEDA--KTIVEKILNIVAFCHLQ 60
Y +FL + C G+L I R + + E + ++ + + A H Q
Sbjct: 64 YKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL-HEQ 122
Query: 61 GVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSY 119
++HRDLK N L + +K+ D G+S V +G+ +Y+APEV R Y
Sbjct: 123 KILHRDLKSANILLVANDL---VKIGDLGISK-VLKKNMAKTQIGTPHYMAPEVWKGRPY 178
Query: 120 NVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSV-SPEAKDFVR 178
+ + D+WS+G + Y + + PF AR+ + V R P P + S + ++F+R
Sbjct: 179 SYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRG----KYPPIPPIYSQDLQNFIR 234
Query: 179 RLLNKDHRKRMTAAQALTHP 198
+L + R + L P
Sbjct: 235 SMLQVKPKLRPNCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 4e-13
Identities = 54/192 (28%), Positives = 82/192 (42%), Gaps = 18/192 (9%)
Query: 21 FCEGG---ELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77
C GG EL+ +L G R E I+ L + H ++HRD+K N L TT
Sbjct: 105 LCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTT- 163
Query: 78 EEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVL------HRSYNVEGDMWSIGV 130
+ +K++DFG+S R N VG+ +++APEV+ SY+ D+WS+G+
Sbjct: 164 --EGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGI 221
Query: 131 ITYILLCGSRPFWARTESGIFRSVLRADPN--FHDSPWPSVSPEAKDFVRRLLNKDHRKR 188
L G P + + R P H W F+ + L KD R
Sbjct: 222 TAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPEKW---CRSFNHFISQCLIKDFEAR 278
Query: 189 MTAAQALTHPWL 200
+ L HP++
Sbjct: 279 PSVTHLLEHPFI 290
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 4e-13
Identities = 50/188 (26%), Positives = 84/188 (44%), Gaps = 32/188 (17%)
Query: 42 DAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR-PDQRL 100
+ K + +IL +A+CH + V+HRDLKP+N L R E LK+ DFGL+ P +
Sbjct: 105 NVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGE---LKLADFGLARAKSVPTKTY 161
Query: 101 NDIVGSAYYVAPEVLHRS--YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRAD 158
++ V + +Y P+VL S Y+ + DMW +G I + + G F T + R
Sbjct: 162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLL 221
Query: 159 PNFHDSPWPSVSP--------------------------EAKDFVRRLLNKDHRKRMTAA 192
+ WP +S E + + + L + +KR++A
Sbjct: 222 GTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAE 281
Query: 193 QALTHPWL 200
+A+ H +
Sbjct: 282 EAMKHAYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 5e-13
Identities = 50/164 (30%), Positives = 84/164 (51%), Gaps = 15/164 (9%)
Query: 32 LSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS 91
LS+ G + E + + +I+ + H + VV+RDLKP N L +E +++ D GL+
Sbjct: 88 LSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLA 144
Query: 92 -DFVRPDQRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPF---WAR 145
DF + ++ + VG+ Y+APEVL + +Y+ D +S+G + + LL G PF +
Sbjct: 145 CDFSK--KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 202
Query: 146 TESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRM 189
+ I R L D S SPE + + LL +D +R+
Sbjct: 203 DKHEIDRMTLTMAVELPD----SFSPELRSLLEGLLQRDVNRRL 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 5e-13
Identities = 56/200 (28%), Positives = 89/200 (44%), Gaps = 42/200 (21%)
Query: 41 EDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRL 100
E ++ ++L + H G++HRDLKP N + + D LK++DFGL+ + +
Sbjct: 123 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTACTNFMM 179
Query: 101 NDIVGSAYYVAPEV-LHRSYNVEGDMWSIGVITYILLCGSRPF--------WAR------ 145
V + YY APEV L Y D+WS+G I L+ GS F W +
Sbjct: 180 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLG 239
Query: 146 TESGIF--------RSVLRADPNFH---------DSPWPSVS-------PEAKDFVRRLL 181
T S F R+ + P + D +PS S +A+D + ++L
Sbjct: 240 TPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKML 299
Query: 182 NKDHRKRMTAAQALTHPWLH 201
D KR++ +AL HP++
Sbjct: 300 VIDPDKRISVDEALRHPYIT 319
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 6e-13
Identities = 53/204 (25%), Positives = 93/204 (45%), Gaps = 28/204 (13%)
Query: 6 LQHLFYSNSFLFFTRFCEGGELLDRI-------LSRGGRYLEEDAKTIVEK--------I 50
L+ L + N + F E EL + LSR ++ ++ + I E+ +
Sbjct: 56 LKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQL 115
Query: 51 LNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYY 109
+ + H + ++HRD+KP N T +K+ D GL F + +VG+ YY
Sbjct: 116 CSALEHMHSKRIMHRDIKPANVFITA---TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYY 172
Query: 110 VAPEVLHRS-YNVEGDMWSIGVITYILLCGSRPFWARTES--GIFRSVLRADPNFHDSPW 166
++PE +H + YN + D+WS+G + Y + PF+ + + + + + D P
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDY----PPL 228
Query: 167 PS--VSPEAKDFVRRLLNKDHRKR 188
P+ S E +D V R +N D KR
Sbjct: 229 PADHYSEELRDLVSRCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 6e-13
Identities = 67/223 (30%), Positives = 104/223 (46%), Gaps = 38/223 (17%)
Query: 3 HQKLQH---LFYSNSFL---FFTRFCE---GGELLDRILSRGGRYLEEDAKTIV---EKI 50
H L+H + Y S FF F E GG L + S+ G L+++ +TI+ ++I
Sbjct: 59 HSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGP-LKDNEQTIIFYTKQI 117
Query: 51 LNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDI------- 103
L + + H +VHRD+K +N L T +K+ DFG S +RL I
Sbjct: 118 LEGLKYLHDNQIVHRDIKGDNVLVNTYS--GVVKISDFGTS------KRLAGINPCTETF 169
Query: 104 VGSAYYVAPEVLH---RSYNVEGDMWSIGVITYILLCGSRPFW--ARTESGIFR-SVLRA 157
G+ Y+APEV+ R Y D+WS+G + G PF ++ +F+ + +
Sbjct: 170 TGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKI 229
Query: 158 DPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200
P + S+S EAK+F+ R D KR +A L P+L
Sbjct: 230 HPEIPE----SLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 7e-13
Identities = 45/191 (23%), Positives = 80/191 (41%), Gaps = 10/191 (5%)
Query: 15 FLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLF 74
F F + GG + +LS+ G + E E++L +++ H ++HRD+K N L
Sbjct: 78 FNLFVEWMAGGSV-SHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLI 136
Query: 75 TTREEDAPLKVIDFGL-----SDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSI 128
+ + L++ DFG + + ++G+ ++APEVL Y D+WS+
Sbjct: 137 DSTGQR--LRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSV 194
Query: 129 GVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPS-VSPEAKDFVRRLLNKDHRK 187
G + + P+ A S + + P +SP +D R L
Sbjct: 195 GCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPED 254
Query: 188 RMTAAQALTHP 198
R + + L HP
Sbjct: 255 RPPSRELLKHP 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 8e-13
Identities = 50/193 (25%), Positives = 94/193 (48%), Gaps = 29/193 (15%)
Query: 21 FCEGGELLDRILSRGGRYLEEDAKTIVEKILN-IVAFC------HLQGVVHRDLKPENFL 73
+CEGG+L +I ++ G ED +IL+ V C H + ++HRD+K +N +
Sbjct: 80 YCEGGDLYKKINAQRGVLFPED------QILDWFVQICLALKHVHDRKILHRDIKSQN-I 132
Query: 74 FTTREEDAPLKVIDFGLSDFVRPDQRL-NDIVGSAYYVAPEVL-HRSYNVEGDMWSIGVI 131
F T+ D +K+ DFG++ + L +G+ YY++PE+ +R YN + D+W++G +
Sbjct: 133 FLTK--DGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCV 190
Query: 132 TYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSV----SPEAKDFVRRLLNKDHRK 187
Y + F A + ++R +P V S + ++ V +L ++ R
Sbjct: 191 LYEMCTLKHAFEAGNMKNLVLKIIRGS-------YPPVSSHYSYDLRNLVSQLFKRNPRD 243
Query: 188 RMTAAQALTHPWL 200
R + L ++
Sbjct: 244 RPSVNSILEKNFI 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-12
Identities = 56/199 (28%), Positives = 97/199 (48%), Gaps = 26/199 (13%)
Query: 6 LQHLFYSNSFLFFT-RFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVH 64
L F + S LFF F GG+L+ + R + EE A+ +I + F H +G+++
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFH-MQRQRKLPEEHARFYSAEISLALNFLHERGIIY 119
Query: 65 RDLKPENFLFTTREEDAPLKVIDFGL-SDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVE 122
RDLK +N L + + +K+ D+G+ + +RP + G+ Y+APE+L Y
Sbjct: 120 RDLKLDNVLL---DAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFS 176
Query: 123 GDMWSIGVITYILLCGSRPF---------WARTESGIFRSVLRAD---PNFHDSPWPSVS 170
D W++GV+ + ++ G PF TE +F+ +L P S+S
Sbjct: 177 VDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPR-------SLS 229
Query: 171 PEAKDFVRRLLNKDHRKRM 189
+A ++ LNKD ++R+
Sbjct: 230 VKASSVLKGFLNKDPKERL 248
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 56/183 (30%), Positives = 92/183 (50%), Gaps = 16/183 (8%)
Query: 13 NSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENF 72
+ F GG+L LS+ G + E++ + +I+ + H + VV+RDLKP N
Sbjct: 70 DKLCFILDLMNGGDL-HYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANI 128
Query: 73 LFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIG 129
L +E +++ D GL+ DF + ++ + VG+ Y+APEVL + +Y+ D +S+G
Sbjct: 129 LL---DEHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLG 183
Query: 130 VITYILLCGSRPFW---ARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHR 186
+ + LL G PF + + I R L + D S SPE K + LL +D
Sbjct: 184 CMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPD----SFSPELKSLLEGLLQRDVS 239
Query: 187 KRM 189
KR+
Sbjct: 240 KRL 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 2e-12
Identities = 45/190 (23%), Positives = 81/190 (42%), Gaps = 33/190 (17%)
Query: 40 EEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR-PDQ 98
E + + +IL + FCH ++HRD+KPEN L + + +K+ DFG + + P +
Sbjct: 99 ESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVS---QSGVVKLCDFGFARTLAAPGE 155
Query: 99 RLNDIVGSAYYVAPEVL--HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLR 156
D V + +Y APE+L Y D+W++G + +L G F ++ +++
Sbjct: 156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIK 215
Query: 157 ADPN--------FHDSP-------------------WPSVSPEAKDFVRRLLNKDHRKRM 189
N F +P +P +S D ++ L D R
Sbjct: 216 CLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRP 275
Query: 190 TAAQALTHPW 199
+++Q L H +
Sbjct: 276 SSSQLLHHEF 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 47/188 (25%), Positives = 81/188 (43%), Gaps = 32/188 (17%)
Query: 42 DAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR-PDQRL 100
+ K + ++L +++CH + ++HRDLKP+N L + E LK+ DFGL+ P +
Sbjct: 104 NVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGE---LKLADFGLARAKSVPTKTY 160
Query: 101 NDIVGSAYYVAPEVLHRS--YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRAD 158
++ V + +Y P+VL S Y+ DMW +G I Y + G F T + R
Sbjct: 161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLL 220
Query: 159 PNFHDSPWPSVSP--------------------------EAKDFVRRLLNKDHRKRMTAA 192
+ WP ++ + D + LL + + R++A
Sbjct: 221 GTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAE 280
Query: 193 QALTHPWL 200
AL H +
Sbjct: 281 AALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 3e-12
Identities = 52/180 (28%), Positives = 81/180 (45%), Gaps = 11/180 (6%)
Query: 25 GELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLK 84
G L +L+ G + ++ ++L+ +A H QG+VHRDLKP+N + + K
Sbjct: 63 GRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAK 122
Query: 85 VIDFG----LSDFVRPDQ----RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYIL 135
V+DFG L D R +++G+ Y APE L D+++ G+I
Sbjct: 123 VLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLEC 182
Query: 136 LCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQAL 195
L G R + + I L PW + P +R+ LNKD R+R +A AL
Sbjct: 183 LTGQRVVQGASVAEILYQQLSPVD-VSLPPWIAGHPLG-QVLRKALNKDPRQRAASAPAL 240
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 3e-12
Identities = 33/122 (27%), Positives = 64/122 (52%), Gaps = 5/122 (4%)
Query: 25 GELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQG-VVHRDLKPENFLFTTREEDAPL 83
GE + + + R+ EE I +++ + + H + +VHRDL P N + ++ +
Sbjct: 97 GEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDK---V 153
Query: 84 KVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL-HRSYNVEGDMWSIGVITYILLCGSRPF 142
+ DFGL+ +P+ +L +VG+ Y PE++ + Y + D+W+ G I Y + PF
Sbjct: 154 TITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPF 213
Query: 143 WA 144
++
Sbjct: 214 YS 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 4e-12
Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 27/204 (13%)
Query: 10 FYSNSFLFFT-RFCEGGELLDRILSRGGRYLEEDAKTIVEKILNI---VAFCHLQGVVHR 65
F N LF +C+GG+L+ RI + G ED I+ + I + H + ++HR
Sbjct: 68 FQENGRLFIVMEYCDGGDLMKRINRQRGVLFSED--QILSWFVQISLGLKHIHDRKILHR 125
Query: 66 DLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLND-------IVGSAYYVAPEVL-HR 117
D+K +N + A K+ DFG++ ++LND VG+ YY++PE+ +R
Sbjct: 126 DIKSQNIFLSKNGMVA--KLGDFGIA------RQLNDSMELAYTCVGTPYYLSPEICQNR 177
Query: 118 SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPW-PSVSPEAKDF 176
YN + D+WS+G + Y L PF E ++ + +P P+ S + +
Sbjct: 178 PYNNKTDIWSLGCVLYELCTLKHPF----EGNNLHQLVLKICQGYFAPISPNFSRDLRSL 233
Query: 177 VRRLLNKDHRKRMTAAQALTHPWL 200
+ +L R R + L P+L
Sbjct: 234 ISQLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 4e-12
Identities = 52/180 (28%), Positives = 82/180 (45%), Gaps = 19/180 (10%)
Query: 40 EEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR 99
E + I L +A+ H ++HRD+K N L T E +K+ DFG + P
Sbjct: 120 EVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLT---EPGQVKLADFGSASKSSP--- 173
Query: 100 LNDIVGSAYYVAPEVL----HRSYNVEGDMWSIGVITYILLCGSRP--FWARTESGIFRS 153
N VG+ Y++APEV+ Y+ + D+WS+G IT I L +P F S ++
Sbjct: 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG-ITCIELAERKPPLFNMNAMSALYHI 232
Query: 154 VLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDILI 213
P + W + + FV L K ++R +A+ L H ++ R P +LI
Sbjct: 233 AQNDSPTLQSNEW---TDSFRGFVDYCLQKIPQERPASAELLRHDFVR---RDRPARVLI 286
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 7e-12
Identities = 55/189 (29%), Positives = 87/189 (46%), Gaps = 17/189 (8%)
Query: 40 EEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR 99
E + I L +A+ H ++HRD+K N L T E +K+ DFG + P
Sbjct: 124 EVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLT---EPGQVKLADFGSASIASP--- 177
Query: 100 LNDIVGSAYYVAPEVL----HRSYNVEGDMWSIGVITYILLCGSRP--FWARTESGIFRS 153
N VG+ Y++APEV+ Y+ + D+WS+G IT I L +P F S ++
Sbjct: 178 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG-ITCIELAERKPPLFNMNAMSALYHI 236
Query: 154 VLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDILI 213
P + W S ++FV L K + R T+ + L H ++ E RP + I +
Sbjct: 237 AQNESPTLQSNEW---SDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE-RPETVLIDL 292
Query: 214 YKLVKSYLR 222
+ K +R
Sbjct: 293 IQRTKDAVR 301
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 9e-12
Identities = 40/127 (31%), Positives = 63/127 (49%), Gaps = 10/127 (7%)
Query: 58 HLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ--RLNDIVGSAYYVAPEVL 115
H G +HRD+KP+N L ++ LK+ DFG + + R + VG+ Y++PEVL
Sbjct: 159 HSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVL 215
Query: 116 HRS-----YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVS 170
Y E D WS+GV Y +L G PF+A + G + ++ + +S
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS 275
Query: 171 PEAKDFV 177
EAK+ +
Sbjct: 276 KEAKNLI 282
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 46/180 (25%), Positives = 79/180 (43%), Gaps = 29/180 (16%)
Query: 54 VAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPE 113
+A+ H + + HRDLKP+N L LK+ DFG + + QR + S +Y APE
Sbjct: 183 LAYIHSKFICHRDLKPQNLLIDPNTHT--LKLCDFGSAKNLLAGQRSVSYICSRFYRAPE 240
Query: 114 VL--HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRA------------DP 159
++ +Y D+WS+G I ++ G F ++ +++ +P
Sbjct: 241 LMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNP 300
Query: 160 NFHDSPWPSVSP-------------EAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRP 206
N+ D +P V P +A +F+ + L + KR+ +AL P+ D P
Sbjct: 301 NYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDP 360
|
Length = 440 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-11
Identities = 60/196 (30%), Positives = 90/196 (45%), Gaps = 32/196 (16%)
Query: 21 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREED 80
FC GG L D I G E + + L + + H +G +HRD+K N L T ++
Sbjct: 87 FCGGGSLQD-IYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLT---DN 142
Query: 81 APLKVIDFGLSDFVRPD-QRLNDIVGSAYYVAPEV--LHRS--YNVEGDMWSIGVITYIL 135
+K+ DFG+S + + +G+ Y++APEV + R YN D+W++G IT I
Sbjct: 143 GHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVG-ITAIE 201
Query: 136 LCGSRP--FWARTESGIFRSVLRADPNFHDSPWPSVSPEAKD----------FVRRLLNK 183
L +P F +F L NF P+ KD FV+ L K
Sbjct: 202 LAELQPPMFDLHPMRALF---LMTKSNFQ-------PPKLKDKMKWSNSFHHFVKMALTK 251
Query: 184 DHRKRMTAAQALTHPW 199
+ +KR TA + L HP+
Sbjct: 252 NPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 49/169 (28%), Positives = 81/169 (47%), Gaps = 25/169 (14%)
Query: 10 FYSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQG-------- 61
FYS+ + G LD++L + GR I E+IL V+ ++G
Sbjct: 72 FYSDGEISICMEHMDGGSLDQVLKKAGR--------IPEQILGKVSIAVIKGLTYLREKH 123
Query: 62 -VVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRS-Y 119
++HRD+KP N L +R E +K+ DFG+S + D N VG+ Y++PE L + Y
Sbjct: 124 KIMHRDVKPSNILVNSRGE---IKLCDFGVSGQL-IDSMANSFVGTRSYMSPERLQGTHY 179
Query: 120 NVEGDMWSIGVITYILLCGSRPFW---ARTESGIFRSVLRADPNFHDSP 165
+V+ D+WS+G+ + G P A+ +F + DP ++
Sbjct: 180 SVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETS 228
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 49/204 (24%), Positives = 82/204 (40%), Gaps = 51/204 (25%)
Query: 40 EEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP--- 96
E K + ++L + + H ++HRD+K N L + LK+ DFGL+ RP
Sbjct: 114 ESQIKCYMLQLLEGINYLHENHILHRDIKAANILI---DNQGILKIADFGLA---RPYDG 167
Query: 97 ------------DQRLNDIVGSAYYVAPEVL--HRSYNVEGDMWSIGVITYILLCGSRP- 141
++ ++V + +Y PE+L R Y D+W IG + + RP
Sbjct: 168 PPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR-RPI 226
Query: 142 FWARTE----SGIFR----------SVLRADPNFHDSPWP------------SVSPEAKD 175
+++ IF+ R+ P + PE D
Sbjct: 227 LQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLD 286
Query: 176 FVRRLLNKDHRKRMTAAQALTHPW 199
+ +LL+ D KR+TA+ AL HP+
Sbjct: 287 LLSKLLSLDPYKRLTASDALEHPY 310
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 3e-11
Identities = 52/189 (27%), Positives = 86/189 (45%), Gaps = 17/189 (8%)
Query: 40 EEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR 99
E + + L +A+ H ++HRD+K N L + E +K+ DFG + + P
Sbjct: 114 EVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASIMAP--- 167
Query: 100 LNDIVGSAYYVAPEVL----HRSYNVEGDMWSIGVITYILLCGSRP--FWARTESGIFRS 153
N VG+ Y++APEV+ Y+ + D+WS+G IT I L +P F S ++
Sbjct: 168 ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG-ITCIELAERKPPLFNMNAMSALYHI 226
Query: 154 VLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDILI 213
P W S ++FV L K + R T+ L H ++ E RP + + +
Sbjct: 227 AQNESPALQSGHW---SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE-RPPTVIMDL 282
Query: 214 YKLVKSYLR 222
+ K +R
Sbjct: 283 IQRTKDAVR 291
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-11
Identities = 57/190 (30%), Positives = 90/190 (47%), Gaps = 24/190 (12%)
Query: 21 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREED 80
+C GG L D I G E + + L +A+ H +G +HRD+K N L T ++
Sbjct: 87 YCGGGSLQD-IYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLT---DN 142
Query: 81 APLKVIDFGLSDFVRPD-QRLNDIVGSAYYVAPEVL----HRSYNVEGDMWSIGVITYIL 135
+K+ DFG++ + + +G+ Y++APEV + YN D+W++G IT I
Sbjct: 143 GDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVG-ITAIE 201
Query: 136 LCGSRP--FWARTESGIFRSVLRADPNFH------DSPWPSVSPEAKDFVRRLLNKDHRK 187
L +P F +F L + NF + W S +FV+ L K+ +K
Sbjct: 202 LAELQPPMFDLHPMRALF---LMSKSNFQPPKLKDKTKW---SSTFHNFVKISLTKNPKK 255
Query: 188 RMTAAQALTH 197
R TA + LTH
Sbjct: 256 RPTAERLLTH 265
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 4e-11
Identities = 48/178 (26%), Positives = 87/178 (48%), Gaps = 17/178 (9%)
Query: 10 FYSNSFLFFT-RFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLK 68
F + +L+ + GG+L++ L E+ AK +++ + H G++HRD+K
Sbjct: 112 FQDDKYLYMVMEYMPGGDLVN--LMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVK 169
Query: 69 PENFLFTTREEDAPLKVIDFGLSDFVRPDQ----RLNDIVGSAYYVAPEVLHRS-----Y 119
P+N L ++ LK+ DFG ++ D+ R + VG+ Y++PEVL Y
Sbjct: 170 PDNMLL---DKHGHLKLADFGTC--MKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYY 224
Query: 120 NVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFV 177
E D WS+GV + +L G PF+A + G + ++ + + +S AK+ +
Sbjct: 225 GRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLI 282
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 4e-11
Identities = 48/191 (25%), Positives = 77/191 (40%), Gaps = 33/191 (17%)
Query: 40 EEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR 99
E+ K+ ++++L + +CH + +HRD+K N L + + +K+ DFGL+ ++
Sbjct: 115 EDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ---IKLADFGLARLYNSEES 171
Query: 100 --LNDIVGSAYYVAPEVL--HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVL 155
+ V + +Y PE+L Y D+WS G I L F A E +
Sbjct: 172 RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELIS 231
Query: 156 RADPNFHDSPWPSV--------------------------SPEAKDFVRRLLNKDHRKRM 189
R + + WP V A D + +L D KR
Sbjct: 232 RLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRC 291
Query: 190 TAAQALTHPWL 200
TA +AL PWL
Sbjct: 292 TAEEALNSPWL 302
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 4e-11
Identities = 56/202 (27%), Positives = 90/202 (44%), Gaps = 24/202 (11%)
Query: 6 LQHLFYSNSFLFFTRFCEGGELLDRI-------LSRGGRYLEEDAKTIVEKIL--NIVAF 56
L+ L + N ++ F E EL + LSR ++ ++ + I EK + V
Sbjct: 56 LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQL 115
Query: 57 C------HLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRL-NDIVGSAYY 109
C H + V+HRD+KP N T +K+ D GL F + +VG+ YY
Sbjct: 116 CSALEHMHSRRVMHRDIKPANVFITA---TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYY 172
Query: 110 VAPEVLHRS-YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPS 168
++PE +H + YN + D+WS+G + Y + PF+ + S+ + P PS
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIEQCDYPPLPS 230
Query: 169 --VSPEAKDFVRRLLNKDHRKR 188
S E + V +N D KR
Sbjct: 231 DHYSEELRQLVNMCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 5e-11
Identities = 53/185 (28%), Positives = 75/185 (40%), Gaps = 37/185 (20%)
Query: 49 KILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR----LNDIV 104
++L + + H V HRDLKP+N L D LK+ DFGL+ D D V
Sbjct: 111 QLLRALKYIHTANVFHRDLKPKNILANA---DCKLKICDFGLARVAFNDTPTAIFWTDYV 167
Query: 105 GSAYYVAPEV---LHRSYNVEGDMWSIGVITYILLCGSRPFWAR---------------- 145
+ +Y APE+ Y D+WSIG I +L G F +
Sbjct: 168 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTP 227
Query: 146 ---TESGI-------FRSVLR-ADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQA 194
T S + + S +R P +P+ P A + RLL D + R TA +A
Sbjct: 228 SPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEA 287
Query: 195 LTHPW 199
L P+
Sbjct: 288 LADPY 292
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 6e-11
Identities = 59/200 (29%), Positives = 94/200 (47%), Gaps = 33/200 (16%)
Query: 26 ELLDRILSRGGRYLEEDAKT-IVEKILNIVAFC------HLQ---GVVHRDLKPENFLFT 75
EL+D L + +Y+ E K+ I E+IL +A +L+ ++HRD+KP N L
Sbjct: 83 ELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLD 142
Query: 76 TREEDAPLKVIDFGLSDFVRPDQRLNDI-----VGSAYYVAPEVLHRS----YNVEGDMW 126
+K+ DFG+S Q ++ I G Y+APE + S Y+V D+W
Sbjct: 143 RN---GNIKLCDFGISG-----QLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVW 194
Query: 127 SIGVITYILLCGSRPFWARTESGIF---RSVLRAD-PNFHDSPWPSVSPEAKDFVRRLLN 182
S+G+ Y + G P+ + +F V++ D P +S SP +F+ L
Sbjct: 195 SLGITLYEVATGKFPY--PKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLI 252
Query: 183 KDHRKRMTAAQALTHPWLHD 202
KD KR + L HP++ D
Sbjct: 253 KDESKRPKYKELLEHPFIKD 272
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 7e-11
Identities = 47/142 (33%), Positives = 73/142 (51%), Gaps = 22/142 (15%)
Query: 10 FYSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQG-------- 61
FYS+ + G LD++L ++AK I E+IL V+ L+G
Sbjct: 72 FYSDGEISICMEHMDGGSLDQVL--------KEAKRIPEEILGKVSIAVLRGLAYLREKH 123
Query: 62 -VVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRS-Y 119
++HRD+KP N L +R E +K+ DFG+S + D N VG+ Y++PE L + Y
Sbjct: 124 QIMHRDVKPSNILVNSRGE---IKLCDFGVSGQL-IDSMANSFVGTRSYMSPERLQGTHY 179
Query: 120 NVEGDMWSIGVITYILLCGSRP 141
+V+ D+WS+G+ L G P
Sbjct: 180 SVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 9e-11
Identities = 45/154 (29%), Positives = 73/154 (47%), Gaps = 10/154 (6%)
Query: 58 HLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLH 116
H + +++RDLKPEN L + D +++ D GL+ ++ Q + G+ ++APE+L
Sbjct: 114 HQRRIIYRDLKPENVLL---DNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQ 170
Query: 117 -RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKD 175
Y+ D +++GV Y ++ PF AR E + + + N + SP +K
Sbjct: 171 GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKS 230
Query: 176 FVRRLLNKDHRKRM-----TAAQALTHPWLHDEN 204
F LL KD KR+ THP D N
Sbjct: 231 FCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLN 264
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 47/191 (24%), Positives = 84/191 (43%), Gaps = 34/191 (17%)
Query: 39 LEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP-- 96
E ++ + +++ + +CH +VHRD+KPEN L + + LK+ DFG + +
Sbjct: 98 PPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISH---NDVLKLCDFGFARNLSEGS 154
Query: 97 DQRLNDIVGSAYYVAPEVLHRS-YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVL 155
+ + V + +Y +PE+L + Y DMWS+G I L G F +E ++
Sbjct: 155 NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQ 214
Query: 156 R--------------ADPNFHDSPWPSVS-PEA-------------KDFVRRLLNKDHRK 187
+ ++P FH +P+V+ P++ D ++ LL +
Sbjct: 215 KVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTD 274
Query: 188 RMTAAQALTHP 198
R Q L HP
Sbjct: 275 RYLTEQCLNHP 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 49/183 (26%), Positives = 79/183 (43%), Gaps = 42/183 (22%)
Query: 58 HLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEV-LH 116
H G++HRDLKP N + + D LK++DFGL+ + V + YY APEV L
Sbjct: 143 HSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG 199
Query: 117 RSYNVEGDMWSIGVITYILLCGSRPF--------WARTESGI--------------FRSV 154
Y D+WS+G I ++ G F W + + R+
Sbjct: 200 MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTY 259
Query: 155 LRADPN---------FHDSPWPSVS-------PEAKDFVRRLLNKDHRKRMTAAQALTHP 198
+ P F D +P+ S +A+D + ++L D KR++ +AL HP
Sbjct: 260 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319
Query: 199 WLH 201
+++
Sbjct: 320 YIN 322
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 59/203 (29%), Positives = 93/203 (45%), Gaps = 26/203 (12%)
Query: 44 KTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR-EEDAPLKVIDFGLSDF----VRPDQ 98
K+++ +IL+ + + H V+HRDLKP N L E +K+ D G + ++P
Sbjct: 111 KSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLA 170
Query: 99 RLNDIVGSAYYVAPEVL--HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLR 156
L+ +V + +Y APE+L R Y D+W+IG I LL F R E +
Sbjct: 171 DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE-----DIKT 225
Query: 157 ADPNFHDSPWPSVS----PEAKDF--VRRL-----LNKDHRKRMTAAQALTHPWLHDENR 205
++P HD S P KD+ +R++ L KD R+ A +L + E
Sbjct: 226 SNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIK---YMEKH 282
Query: 206 PVPLDILIYKLVKSYLRATPLKR 228
V D ++ L++ L P KR
Sbjct: 283 KVKPDSKVFLLLQKLLTMDPTKR 305
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 51/188 (27%), Positives = 82/188 (43%), Gaps = 43/188 (22%)
Query: 49 KILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR-PDQRLNDIVGSA 107
++L +A+ H Q ++HRDLKP+N L + E LK+ DFGL+ P Q + V +
Sbjct: 111 QLLRGLAYIHGQHILHRDLKPQNLLISYLGE---LKLADFGLARAKSIPSQTYSSEVVTL 167
Query: 108 YYVAPEVLHRS--YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLR-----ADPN 160
+Y P+VL + Y+ D+W G I +L G P + S +F + + P
Sbjct: 168 WYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ-PAFPGV-SDVFEQLEKIWTVLGVPT 225
Query: 161 FHDSPWPSVS----------------------------PEAKDFVRRLLNKDHRKRMTAA 192
+ WP VS P+A+D ++L + R++A
Sbjct: 226 --EDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQ 283
Query: 193 QALTHPWL 200
AL HP+
Sbjct: 284 DALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 36/92 (39%), Positives = 52/92 (56%), Gaps = 4/92 (4%)
Query: 41 EDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRL 100
E K ++ ++L + F H VVHRDLKP+N L T+ + +K+ DFGL+ L
Sbjct: 110 ETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ---IKLADFGLARIYSFQMAL 166
Query: 101 NDIVGSAYYVAPEV-LHRSYNVEGDMWSIGVI 131
+V + +Y APEV L SY D+WS+G I
Sbjct: 167 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCI 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 4e-10
Identities = 48/183 (26%), Positives = 77/183 (42%), Gaps = 42/183 (22%)
Query: 58 HLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEV-LH 116
H G++HRDLKP N + + D LK++DFGL+ + V + YY APEV L
Sbjct: 136 HSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG 192
Query: 117 RSYNVEGDMWSIGVIT------YILLCGSR----------------PFWARTESGIFRSV 154
Y D+WS+G I IL G P + + R+
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 252
Query: 155 LRADPNFHDSPWPSVSP----------------EAKDFVRRLLNKDHRKRMTAAQALTHP 198
+ P + +P + P +A+D + ++L D KR++ +AL HP
Sbjct: 253 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHP 312
Query: 199 WLH 201
+++
Sbjct: 313 YIN 315
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (144), Expect = 5e-10
Identities = 56/211 (26%), Positives = 95/211 (45%), Gaps = 33/211 (15%)
Query: 5 KLQHLFYS-NSFLFFTRFCEGGELLDRILSRGGRYLEEDA-KTIVEKILNIVAFCHLQGV 62
KL + + + + + G+L D L + L E K I+ +++ + H +
Sbjct: 73 KLYYSVTTLKGHVLIMDYIKDGDLFD--LLKKEGKLSEAEVKKIIRQLVEALNDLHKHNI 130
Query: 63 VHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVG--SAY-----YVAPE-V 114
+H D+K EN L+ R +D + + D+GL I+G S Y Y +PE +
Sbjct: 131 IHNDIKLENVLYD-RAKDR-IYLCDYGLCK----------IIGTPSCYDGTLDYFSPEKI 178
Query: 115 LHRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVL----RADPNFHDSPWPSVS 170
+Y+V D W++GV+TY LL G PF + + L + F +VS
Sbjct: 179 KGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFI----KNVS 234
Query: 171 PEAKDFVRRLLNKDHRKRMTA-AQALTHPWL 200
A DFV+ +L + R+T + + HP+L
Sbjct: 235 KNANDFVQSMLKYNINYRLTNYNEIIKHPFL 265
|
Length = 267 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 9e-10
Identities = 44/156 (28%), Positives = 73/156 (46%), Gaps = 20/156 (12%)
Query: 6 LQHLFYSNSFLFFTRFCEGGELLDRI-------LSRGGRYLEEDAKTIVEKIL--NIVAF 56
L+ L + N + F E EL + LS+ +Y ++ + I E+ + V
Sbjct: 56 LKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQL 115
Query: 57 C------HLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRL-NDIVGSAYY 109
C H + V+HRD+KP N T +K+ D GL F + +VG+ YY
Sbjct: 116 CSAVEHMHSRRVMHRDIKPANVFITATGV---VKLGDLGLGRFFSSKTTAAHSLVGTPYY 172
Query: 110 VAPEVLHRS-YNVEGDMWSIGVITYILLCGSRPFWA 144
++PE +H + YN + D+WS+G + Y + PF+
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 1e-09
Identities = 52/212 (24%), Positives = 90/212 (42%), Gaps = 43/212 (20%)
Query: 9 LFYSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQG------- 61
F N T F +GG L + + I E +L +A ++G
Sbjct: 68 FFVENRISICTEFMDGGSL-------------DVYRKIPEHVLGRIAVAVVKGLTYLWSL 114
Query: 62 -VVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDI----VGSAYYVAPE-VL 115
++HRD+KP N L TR + +K+ DFG+S Q +N I VG+ Y+APE +
Sbjct: 115 KILHRDVKPSNMLVNTRGQ---VKLCDFGVS-----TQLVNSIAKTYVGTNAYMAPERIS 166
Query: 116 HRSYNVEGDMWSIGVITYILLCGSRPFWARTES-------GIFRSVLRADPNFHDSPWPS 168
Y + D+WS+G+ L G P+ ++ + + ++ DP P
Sbjct: 167 GEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPV--LPVGQ 224
Query: 169 VSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200
S + F+ + + K ++R + HP++
Sbjct: 225 FSEKFVHFITQCMRKQPKERPAPENLMDHPFI 256
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.2 bits (139), Expect = 3e-09
Identities = 64/243 (26%), Positives = 89/243 (36%), Gaps = 81/243 (33%)
Query: 21 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFC--------HL--QGVVHRDLKPE 70
+ EGG+LLD + + + T+ K L ++F +L + VHRDL
Sbjct: 77 YMEGGDLLDYLRKSRPVFPSPEKSTLSLKDL--LSFAIQIAKGMEYLASKKFVHRDLAAR 134
Query: 71 NFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV------------APEVL-HR 117
N L ED +K+ DFGLS V D YY APE L
Sbjct: 135 NCLVG---EDLVVKISDFGLSRDVYDDD---------YYRKKTGGKLPIRWMAPESLKDG 182
Query: 118 SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFV 177
+ + D+WS GV LL W E IF +P+P +S E V
Sbjct: 183 IFTSKSDVWSFGV----LL------W---E--IF--------TLGATPYPGLSNEE---V 216
Query: 178 RRLLNKDHRKRMTAAQALTHP-WLHDENRPVPLDILIYKLVKSYLRATPLKRAALKALSK 236
L K +R L P + DE +Y+L+ S + P R L +
Sbjct: 217 LEYLRKGYR--------LPKPEYCPDE---------LYELMLSCWQLDPEDRPTFSELVE 259
Query: 237 ALT 239
L
Sbjct: 260 RLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 4e-09
Identities = 32/99 (32%), Positives = 52/99 (52%), Gaps = 3/99 (3%)
Query: 104 VGSAYYVAPEV-LHRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFH 162
VG+ Y+APE+ L + Y E D WS+G I + L G PF + +R ++ +
Sbjct: 209 VGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLY 268
Query: 163 DSPWPSVSPEAKDFVRRLL-NKDHR-KRMTAAQALTHPW 199
+S EA+D +RRL+ N ++R R A + +HP+
Sbjct: 269 FPDDIHLSVEAEDLIRRLITNAENRLGRGGAHEIKSHPF 307
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 5e-09
Identities = 50/190 (26%), Positives = 86/190 (45%), Gaps = 22/190 (11%)
Query: 24 GGELLDRILSRGGRYLEED-----AKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE 78
GG+L I + G R LE + + I IL++ H +V+RD+KPEN L +
Sbjct: 77 GGDLKYHIYNVGERGLEMERVIHYSAQITCGILHL----HSMDIVYRDMKPENVLL---D 129
Query: 79 EDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL-HRSYNVEGDMWSIGVITYILLC 137
+ ++ D GL+ ++ + + G+ Y+APE+L Y+ D +++G Y ++
Sbjct: 130 DQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVA 189
Query: 138 GSRPFWARTE----SGIFRSVLRADPNF-HDSPWPSVSPEAKDFVRRLLNKDHRKRMTAA 192
G PF E + R L + F H + + E+KD R L K R+ +
Sbjct: 190 GRTPFKDHKEKVAKEELKRRTLEDEVKFEHQ----NFTEESKDICRLFLAKKPEDRLGSR 245
Query: 193 QALTHPWLHD 202
+ P H+
Sbjct: 246 EKNDDPRKHE 255
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 6e-09
Identities = 56/203 (27%), Positives = 92/203 (45%), Gaps = 26/203 (12%)
Query: 44 KTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR-EEDAPLKVIDFGLSDF----VRPDQ 98
K+++ +IL+ + + H V+HRDLKP N L E +K+ D G + ++P
Sbjct: 111 KSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLA 170
Query: 99 RLNDIVGSAYYVAPEVL--HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLR 156
L+ +V + +Y APE+L R Y D+W+IG I LL F R E +
Sbjct: 171 DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE-----DIKT 225
Query: 157 ADPNFHDSPWPSVS----PEAKDF--VRRL-----LNKDHRKRMTAAQALTHPWLHDENR 205
++P HD + P KD+ ++++ L KD R+ +L + E
Sbjct: 226 SNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIK---YMEKH 282
Query: 206 PVPLDILIYKLVKSYLRATPLKR 228
V D + L++ L P+KR
Sbjct: 283 KVKPDSKAFHLLQKLLTMDPIKR 305
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 53/191 (27%), Positives = 85/191 (44%), Gaps = 32/191 (16%)
Query: 37 RYL-EEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 95
R L E+ K+ + ++L + H G+ HRD+KPEN L +D LK+ DFG +
Sbjct: 95 RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILI----KDDILKLADFGSCRGIY 150
Query: 96 PDQRLNDIVGSAYYVAPEVLHRS--YNVEGDMWSIGVITYILLCGSRPFWARTE----SG 149
+ + + +Y APE L Y + D+W++G + + +L F E +
Sbjct: 151 SKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAK 210
Query: 150 I--------------FRSVLRADPNF---HDS--PW--PSVSPEAKDFVRRLLNKDHRKR 188
I FR + NF + P+ S E D +++LL D +R
Sbjct: 211 IHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDER 270
Query: 189 MTAAQALTHPW 199
+TA QAL HP+
Sbjct: 271 ITAKQALRHPY 281
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 2e-08
Identities = 53/198 (26%), Positives = 87/198 (43%), Gaps = 43/198 (21%)
Query: 41 EDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR-PDQR 99
E+ K + ++L +++ H + ++HRDLKP+N L + E LK+ DFGL+ P
Sbjct: 103 ENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGE---LKLADFGLARAKSVPSHT 159
Query: 100 LNDIVGSAYYVAPEVLHRS--YNVEGDMWSIGVITYILLCGSRPFWARTE-----SGIFR 152
++ V + +Y P+VL S Y+ DMW +G I ++ G F + IF
Sbjct: 160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIF- 218
Query: 153 SVLRADPNFHDSPWPSV------SPE----------------------AKDFVRRLLNKD 184
++ PN + WP V PE A+D +LL
Sbjct: 219 -LVLGTPN--EDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCF 275
Query: 185 HRKRMTAAQALTHPWLHD 202
+ R++A AL+H + D
Sbjct: 276 PKNRLSAQAALSHEYFSD 293
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 49/165 (29%), Positives = 82/165 (49%), Gaps = 21/165 (12%)
Query: 3 HQKLQHLF---YSNS--FLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNI---V 54
H KL L+ S L F F E G L D + ++ G++ +T++ L++ +
Sbjct: 58 HPKLVQLYGVCTERSPICLVF-EFMEHGCLSDYLRAQRGKF---SQETLLGMCLDVCEGM 113
Query: 55 AFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV---A 111
A+ V+HRDL N L E+ +KV DFG++ FV DQ + G+ + V +
Sbjct: 114 AYLESSNVIHRDLAARNCLVG---ENQVVKVSDFGMTRFVLDDQYTSS-TGTKFPVKWSS 169
Query: 112 PEVLHRS-YNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSV 154
PEV S Y+ + D+WS GV+ + + G P+ R+ S + ++
Sbjct: 170 PEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETI 214
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 3e-08
Identities = 41/143 (28%), Positives = 66/143 (46%), Gaps = 9/143 (6%)
Query: 19 TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE 78
T + G LL+ + R G+ E + + + + G +HRDL N L
Sbjct: 78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVG--- 134
Query: 79 EDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV---APEVLHRS-YNVEGDMWSIGVITY- 133
ED +KV DFGL+ +V DQ + G+ + V PEV S ++ + D+WS GV+ +
Sbjct: 135 EDNVVKVSDFGLARYVLDDQYTSS-QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWE 193
Query: 134 ILLCGSRPFWARTESGIFRSVLR 156
+ G P+ + S + SV
Sbjct: 194 VFSEGKMPYERFSNSEVVESVSA 216
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 53.3 bits (129), Expect = 4e-08
Identities = 35/139 (25%), Positives = 54/139 (38%), Gaps = 30/139 (21%)
Query: 21 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNI---VAFCHLQGVVHRDLKPENFLFTTR 77
+ GG+LLD + + L ++ L I + + + +HRDL N L
Sbjct: 82 YMPGGDLLDYLRKNRPKEL--SLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGEN 139
Query: 78 EEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV-----------APEVL-HRSYNVEGDM 125
+K+ DFGLS + D YY APE L + + D+
Sbjct: 140 LV---VKISDFGLSRDLYDDD---------YYKVKGGKLPIRWMAPESLKEGKFTSKSDV 187
Query: 126 WSIGVITY-ILLCGSRPFW 143
WS GV+ + I G P+
Sbjct: 188 WSFGVLLWEIFTLGEEPYP 206
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 6e-08
Identities = 30/104 (28%), Positives = 50/104 (48%), Gaps = 4/104 (3%)
Query: 34 RGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 93
R + A I ++IL + + H Q ++HRD+K EN + + + D G + F
Sbjct: 150 RSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFI---NDVDQVCIGDLGAAQF 206
Query: 94 VRPDQRLNDIVGSAYYVAPEVLHRS-YNVEGDMWSIGVITYILL 136
+ G+ APEVL R YN + D+WS G++ + +L
Sbjct: 207 PVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 7e-08
Identities = 37/145 (25%), Positives = 69/145 (47%), Gaps = 9/145 (6%)
Query: 19 TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE 78
T F E G LL+ + R G+ ++ ++ + + + + +HRDL N L +
Sbjct: 78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVS--- 134
Query: 79 EDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV---APEVLHRS-YNVEGDMWSIGVITY- 133
+KV DFG++ +V D+ + G+ + V PEV + S Y+ + D+WS GV+ +
Sbjct: 135 STGVVKVSDFGMTRYVLDDEYTSS-SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWE 193
Query: 134 ILLCGSRPFWARTESGIFRSVLRAD 158
+ G PF ++ + + R
Sbjct: 194 VFTEGKMPFEKKSNYEVVEMISRGF 218
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 52.5 bits (127), Expect = 1e-07
Identities = 34/136 (25%), Positives = 54/136 (39%), Gaps = 25/136 (18%)
Query: 21 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREED 80
+ EGG+LL + + D + +I + + + +HRDL N L
Sbjct: 82 YMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLV- 140
Query: 81 APLKVIDFGLSDFVRPDQRLNDIVGSAYYV-----------APEVL-HRSYNVEGDMWSI 128
+K+ DFGLS + D YY APE L + + D+WS
Sbjct: 141 --VKISDFGLSRDLYDDD---------YYRKRGGKLPIRWMAPESLKEGKFTSKSDVWSF 189
Query: 129 GVITY-ILLCGSRPFW 143
GV+ + I G +P+
Sbjct: 190 GVLLWEIFTLGEQPYP 205
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-07
Identities = 43/167 (25%), Positives = 75/167 (44%), Gaps = 14/167 (8%)
Query: 1 MYHQKLQHLFY----SNSFLFFTRFCEGGELLDRILS-RGGRYLEEDAKTIVEKILNIVA 55
+ H KL L+ T + G LLD + S GG+ L +I +A
Sbjct: 58 LQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMA 117
Query: 56 FCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAY---YVAP 112
+ + +HRDL+ N L + E K+ DFGL+ + D G+ + + AP
Sbjct: 118 YIERKNYIHRDLRAANVLVS---ESLMCKIADFGLARVIE-DNEYTAREGAKFPIKWTAP 173
Query: 113 EVLHR-SYNVEGDMWSIGVITY-ILLCGSRPFWARTESGIFRSVLRA 157
E ++ S+ ++ D+WS G++ Y I+ G P+ + S + ++ R
Sbjct: 174 EAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG 220
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 50/200 (25%), Positives = 87/200 (43%), Gaps = 18/200 (9%)
Query: 1 MYHQKLQHLFYSNS---FLFFTRFCEGGELLDRILSRGGRYLE-EDAKTIVEKILNIVAF 56
+ H KL L+ S T F G LLD + G+YL+ + +I + +A+
Sbjct: 58 LRHDKLVPLYAVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAY 117
Query: 57 CHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAY---YVAPE 113
+HRDL+ N L ++ K+ DFGL+ + D G+ + + APE
Sbjct: 118 IERMNYIHRDLRAANILVG---DNLVCKIADFGLARLIE-DNEYTARQGAKFPIKWTAPE 173
Query: 114 -VLHRSYNVEGDMWSIGVI-TYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSP 171
L+ + ++ D+WS G++ T ++ G P+ + V R + P P P
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERG----YRMPCPQGCP 229
Query: 172 EA-KDFVRRLLNKDHRKRMT 190
E+ + ++ KD +R T
Sbjct: 230 ESLHELMKLCWKKDPDERPT 249
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 2e-07
Identities = 32/126 (25%), Positives = 51/126 (40%), Gaps = 11/126 (8%)
Query: 10 FYSNSFLFFTRFCEGGELLDRILSRGGRYLE-EDAKTIVEKILNIVAFCHLQGVVHRDLK 68
N T + G L+D + SRG + + + + + VHRDL
Sbjct: 70 LQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLA 129
Query: 69 PENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGS--AYYVAPEVL-HRSYNVEGDM 125
N L + ED KV DFGL+ + G + APE L + ++ + D+
Sbjct: 130 ARNVLVS---EDLVAKVSDFGLAK----EASQGQDSGKLPVKWTAPEALREKKFSTKSDV 182
Query: 126 WSIGVI 131
WS G++
Sbjct: 183 WSFGIL 188
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 4e-07
Identities = 45/168 (26%), Positives = 71/168 (42%), Gaps = 23/168 (13%)
Query: 3 HQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNI---VA 55
H+ L LF T E G LL + S G+ L V ++++ VA
Sbjct: 61 HKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLP------VASLIDMACQVA 114
Query: 56 --FCHL--QGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAY-YV 110
+L Q +HRDL N L ED KV DFGL+ ++ D L+ Y +
Sbjct: 115 EGMAYLEEQNSIHRDLAARNILV---GEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWT 171
Query: 111 APEVL-HRSYNVEGDMWSIGVITY-ILLCGSRPFWARTESGIFRSVLR 156
APE H +++ + D+WS G++ Y + G P+ ++ +
Sbjct: 172 APEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITA 219
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 7e-07
Identities = 41/151 (27%), Positives = 71/151 (47%), Gaps = 13/151 (8%)
Query: 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAF 56
+ H+KL L+ T + G LL+ + G R+ + + + +A+
Sbjct: 56 LSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAY 115
Query: 57 CHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV---APE 113
+ +HRDL N L ++ +KV DFGLS +V D+ + VGS + V PE
Sbjct: 116 LESKQFIHRDLAARNCLV---DDQGCVKVSDFGLSRYVLDDEYTSS-VGSKFPVRWSPPE 171
Query: 114 VLHRS-YNVEGDMWSIGVITY-ILLCGSRPF 142
VL S ++ + D+W+ GV+ + + G P+
Sbjct: 172 VLLYSKFSSKSDVWAFGVLMWEVYSLGKMPY 202
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 9e-07
Identities = 28/100 (28%), Positives = 45/100 (45%), Gaps = 8/100 (8%)
Query: 48 EKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ---RLNDIV 104
+I + + Q +HRDL N L E + +K+ DFGL+ + D+ + +
Sbjct: 116 SQICKGMDYLGSQRYIHRDLAARNILV---ESEDLVKISDFGLAKVLPEDKDYYYVKEPG 172
Query: 105 GS-AYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPF 142
S ++ APE L ++ D+WS GV Y L P
Sbjct: 173 ESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPS 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 34/117 (29%), Positives = 55/117 (47%), Gaps = 16/117 (13%)
Query: 103 IVGSAYYVAPEVL-HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNF 161
I+G+ Y+APE+L + + D W++GV + L G PF T +F+++L
Sbjct: 540 ILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILN----- 594
Query: 162 HDSPWP----SVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD------ENRPVP 208
D PWP +S A++ + LL D KR + HP H +N+ +P
Sbjct: 595 RDIPWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPLFHGVDWENLQNQTMP 651
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 40/161 (24%), Positives = 68/161 (42%), Gaps = 34/161 (21%)
Query: 12 SNSFLFFTRFCEGGELLDRILSRGGRYLEE-DAKTIVEKILNIVAFCHLQGV-------- 62
S + T + E G L ++L E D K V +++ + L+G+
Sbjct: 77 SRPVMIITEYMENGSL--------DKFLRENDGKFTVGQLVGM-----LRGIASGMKYLS 123
Query: 63 ----VHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVG---SAYYVAPEVL 115
VHRDL N L + KV DFGLS + + G + APE +
Sbjct: 124 EMNYVHRDLAARNILVN---SNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAI 180
Query: 116 -HRSYNVEGDMWSIGVITY-ILLCGSRPFWARTESGIFRSV 154
+R + D+WS G++ + ++ G RP+W + + ++V
Sbjct: 181 AYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAV 221
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 41/135 (30%), Positives = 68/135 (50%), Gaps = 13/135 (9%)
Query: 16 LFFTRFCEGGELLDRILSRGGRYLE-EDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLF 74
L T +C G+LL+ + + +L ED + ++ +AF + +HRDL N L
Sbjct: 115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLL 174
Query: 75 TTREEDAPLKVIDFGLSDFVRPDQRLNDIV-GSAY----YVAPE-VLHRSYNVEGDMWSI 128
T +K+ DFGL+ + D N +V G+A ++APE + + Y E D+WS
Sbjct: 175 T---HGKIVKICDFGLARDIMNDS--NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSY 229
Query: 129 GVITY-ILLCGSRPF 142
G++ + I GS P+
Sbjct: 230 GILLWEIFSLGSNPY 244
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 48/182 (26%), Positives = 77/182 (42%), Gaps = 17/182 (9%)
Query: 1 MYHQKLQHLFYSNS---FLFFTRFCEGGELLDRILSRGGRYLE-EDAKTIVEKILNIVAF 56
+ H+KL L+ S T + G LLD + G+YL + +I + +A+
Sbjct: 58 LRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY 117
Query: 57 CHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAY---YVAPE 113
VHRDL+ N L E+ KV DFGL+ + D G+ + + APE
Sbjct: 118 VERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPE 173
Query: 114 -VLHRSYNVEGDMWSIGVITYILLCGSR-PFWARTESGIFRSVLRADPNFHDSPWPSVSP 171
L+ + ++ D+WS G++ L R P+ + V R + P P P
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG----YRMPCPPECP 229
Query: 172 EA 173
E+
Sbjct: 230 ES 231
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (115), Expect = 3e-06
Identities = 39/140 (27%), Positives = 60/140 (42%), Gaps = 32/140 (22%)
Query: 21 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNI---VAFCHLQGVVHRDLKPENFLFTTR 77
+ GG+LLD + G + K +++ L I + + + VHRDL N L T
Sbjct: 82 YMPGGDLLDFLRKHGEKL---TLKDLLQMALQIAKGMEYLESKNFVHRDLAARNCLVT-- 136
Query: 78 EEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV------------APEVL-HRSYNVEGD 124
E+ +K+ DFGLS + D YY APE L + + D
Sbjct: 137 -ENLVVKISDFGLSRDIYED---------DYYRKRGGGKLPIKWMAPESLKDGKFTSKSD 186
Query: 125 MWSIGVITY-ILLCGSRPFW 143
+WS GV+ + I G +P+
Sbjct: 187 VWSFGVLLWEIFTLGEQPYP 206
|
Length = 258 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 3e-06
Identities = 30/106 (28%), Positives = 50/106 (47%), Gaps = 21/106 (19%)
Query: 61 GVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAY----------YV 110
G VHRDL N L + + KV DFGLS + D +AY +
Sbjct: 126 GYVHRDLAARNILVNS---NLVCKVSDFGLSRVLEDDPE------AAYTTRGGKIPIRWT 176
Query: 111 APEVL-HRSYNVEGDMWSIGVITY-ILLCGSRPFWARTESGIFRSV 154
APE + +R + D+WS G++ + ++ G RP+W + + +++
Sbjct: 177 APEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAI 222
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 51/175 (29%), Positives = 76/175 (43%), Gaps = 34/175 (19%)
Query: 46 IVEKILNIVAFCHLQGVVHRDLKPENFL----------------FTTREEDAPLKVIDFG 89
I KI + + H +GV+HRDLKP+N L F EE+ L ID
Sbjct: 118 IFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLD-IDVD 176
Query: 90 L-----SDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEG-DMWSIGVITYILLCGSRPFW 143
S P + IVG+ Y+APE L E D++++GVI Y +L S P+
Sbjct: 177 ERNICYSSMTIPGK----IVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY- 231
Query: 144 ARTESG---IFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQAL 195
R + G +R V+ P +P+ + P + L D +R ++ Q L
Sbjct: 232 -RRKKGRKISYRDVI-LSPI-EVAPYREIPPFLSQIAMKALAVDPAERYSSVQEL 283
|
Length = 932 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 5e-06
Identities = 42/179 (23%), Positives = 71/179 (39%), Gaps = 37/179 (20%)
Query: 1 MYHQKLQHLF---YSNSFLFFTRFCEGGELLDRI-LSRGGRYLEEDAKTIVEKILNIVAF 56
+ H+ L L+ ++ + T G LLDR+ G +L +I N + +
Sbjct: 53 LDHENLIRLYGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRY 112
Query: 57 CHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV------ 110
+ +HRDL N L + ++ +K+ DFGL + L +YV
Sbjct: 113 LESKRFIHRDLAARNILLASDDK---VKIGDFGLM------RALPQ--NEDHYVMEEHLK 161
Query: 111 ------APEVL-HRSYNVEGDMWSIGV-----ITYILLCGSRPFWARTESGIFRSVLRA 157
APE L R+++ D+W GV TY G P+ + S I + + +
Sbjct: 162 VPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTY----GEEPWAGLSGSQILKKIDKE 216
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 5e-06
Identities = 44/148 (29%), Positives = 67/148 (45%), Gaps = 35/148 (23%)
Query: 23 EGGELLD-----RILSRGGRYLEEDAKTIVEKILNIVAFCH-LQGV--VHRDLKPENFLF 74
EGG+LL R+ G L K +++ L++ C L+ + +HRDL N L
Sbjct: 82 EGGDLLSYLRDARVERFGPPLLT--LKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLV 139
Query: 75 TTREEDAP--LKVIDFGLSDFVRPDQRLNDIVGSAYY------------VAPEVLHRS-Y 119
+ + DA +K+ DFGL+ DI S YY +APE L +
Sbjct: 140 SEKGYDADRVVKIGDFGLA---------RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKF 190
Query: 120 NVEGDMWSIGVITY-ILLCGSRPFWART 146
+ D+WS GV+ + IL G +P+ A
Sbjct: 191 TTQSDVWSFGVLMWEILTLGQQPYPALN 218
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 6e-06
Identities = 30/86 (34%), Positives = 47/86 (54%), Gaps = 8/86 (9%)
Query: 62 VVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAY---YVAPE-VLHR 117
+VHRDL N L T + +K+ DFGL+ + D++ G ++A E +LHR
Sbjct: 130 LVHRDLAARNVLVKTPQH---VKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHR 186
Query: 118 SYNVEGDMWSIGVITYILLC-GSRPF 142
Y + D+WS GV + L+ GS+P+
Sbjct: 187 IYTHQSDVWSYGVTVWELMTFGSKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 8e-06
Identities = 38/151 (25%), Positives = 69/151 (45%), Gaps = 22/151 (14%)
Query: 19 TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNI-------VAFCHLQGVVHRDLKPEN 71
T F G LLD + S +E +K + K+++ +AF + +HRDL+ N
Sbjct: 79 TEFMAKGSLLDFLKS------DEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAAN 132
Query: 72 FLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAY---YVAPEVL-HRSYNVEGDMWS 127
L + K+ DFGL+ + D G+ + + APE + S+ ++ D+WS
Sbjct: 133 ILVSAS---LVCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWS 188
Query: 128 IGV-ITYILLCGSRPFWARTESGIFRSVLRA 157
G+ + I+ G P+ + + R++ R
Sbjct: 189 FGILLMEIVTYGRIPYPGMSNPEVIRALERG 219
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 9e-06
Identities = 29/87 (33%), Positives = 47/87 (54%), Gaps = 8/87 (9%)
Query: 61 GVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAY---YVAPE-VLH 116
+VHRDL N L T + +K+ DFGL+ + D++ G ++A E +LH
Sbjct: 129 RLVHRDLAARNVLVKTPQH---VKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILH 185
Query: 117 RSYNVEGDMWSIGVITYILLC-GSRPF 142
R Y + D+WS GV + L+ G++P+
Sbjct: 186 RIYTHKSDVWSYGVTVWELMTFGAKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 1e-05
Identities = 43/186 (23%), Positives = 83/186 (44%), Gaps = 29/186 (15%)
Query: 3 HQKLQHLF---YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNI------ 53
H +L L+ T + E G L+D + + E K + K++++
Sbjct: 60 HPRLVRLYAVVTQEPIYIITEYMENGSLVDFLKT------PEGIKLTINKLIDMAAQIAE 113
Query: 54 -VAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAY---Y 109
+AF + +HRDL+ N L + E K+ DFGL+ + ++ G+ + +
Sbjct: 114 GMAFIERKNYIHRDLRAANILVS---ETLCCKIADFGLARLIEDNEYTAR-EGAKFPIKW 169
Query: 110 VAPEVL-HRSYNVEGDMWSIGV-ITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWP 167
APE + + ++ ++ D+WS G+ +T I+ G P+ T + +++ R + P P
Sbjct: 170 TAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERG----YRMPRP 225
Query: 168 SVSPEA 173
PE
Sbjct: 226 DNCPEE 231
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 1e-05
Identities = 36/125 (28%), Positives = 61/125 (48%), Gaps = 12/125 (9%)
Query: 41 EDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFG----LSDFVRP 96
E A TI ++L +A+ H +G++HRD+K EN +F E+A L DFG L
Sbjct: 185 EQAITIQRRLLEALAYLHGRGIIHRDVKTEN-IFLDEPENAVLG--DFGAACKLDAHPDT 241
Query: 97 DQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWAR---TESGIFR 152
Q G+ +PE+L Y + D+WS G++ + + + + + + S R
Sbjct: 242 PQCYG-WSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLR 300
Query: 153 SVLRA 157
S++R
Sbjct: 301 SIIRC 305
|
Length = 392 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 1e-05
Identities = 28/98 (28%), Positives = 46/98 (46%), Gaps = 9/98 (9%)
Query: 63 VHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSA----YYVAPEVL-HR 117
VHRDL N L + E KV DFGLS + D + APE + +R
Sbjct: 129 VHRDLAARNILVNSNLE---CKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYR 185
Query: 118 SYNVEGDMWSIGVITY-ILLCGSRPFWARTESGIFRSV 154
+ D+WS G++ + ++ G RP+W + + +++
Sbjct: 186 KFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI 223
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 27/79 (34%), Positives = 40/79 (50%), Gaps = 8/79 (10%)
Query: 63 VHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRL----NDIVGSAYYVAPEVL-HR 117
VHRDL N L E + +K+ DFGL+ + D+ +D+ ++ APE L
Sbjct: 131 VHRDLAARNVLV---ESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQS 187
Query: 118 SYNVEGDMWSIGVITYILL 136
+ + D+WS GV Y LL
Sbjct: 188 KFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 23/88 (26%), Positives = 46/88 (52%), Gaps = 8/88 (9%)
Query: 60 QGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH 116
+VHR+L N L + D+ +++ DFG++D + PD + ++ ++A E +
Sbjct: 128 HRMVHRNLAARNILLKS---DSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESIL 184
Query: 117 -RSYNVEGDMWSIGVITYILLC-GSRPF 142
Y + D+WS GV + ++ G+ P+
Sbjct: 185 FGRYTHQSDVWSYGVTVWEMMSYGAEPY 212
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 2e-05
Identities = 29/89 (32%), Positives = 43/89 (48%), Gaps = 11/89 (12%)
Query: 63 VHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGS------AYYVAPE-VL 115
VHRDL N L + + KV DFGLS F+ D S + APE +
Sbjct: 128 VHRDLAARNILVNS---NLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIA 184
Query: 116 HRSYNVEGDMWSIGVITY-ILLCGSRPFW 143
+R + D+WS G++ + ++ G RP+W
Sbjct: 185 YRKFTSASDVWSYGIVMWEVMSYGERPYW 213
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 3e-05
Identities = 31/110 (28%), Positives = 54/110 (49%), Gaps = 9/110 (8%)
Query: 8 HLFYS----NSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVV 63
HL+YS N+ + GG++ +L G + EE A + ++ + + H G++
Sbjct: 68 HLYYSLQSANNVYLVMEYLIGGDV-KSLLHIYGYFDEEMAVKYISEVALALDYLHRHGII 126
Query: 64 HRDLKPENFLFTTREEDAPLKVIDFGLSDF-VRPDQRLNDIVGSAYYVAP 112
HRDLKP+N L + +K+ DFGLS + + + DI+ + P
Sbjct: 127 HRDLKPDNMLISNE---GHIKLTDFGLSKVTLNRELNMMDILTTPSMAKP 173
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 3e-05
Identities = 31/90 (34%), Positives = 48/90 (53%), Gaps = 18/90 (20%)
Query: 63 VHRDLKPENFLFTTREEDAPLKVIDFGLS-------DFVRP-DQRLNDIVGSAYYVAPE- 113
+HRDL N L + E+ +K+ DFGL+ D+VR D RL ++APE
Sbjct: 201 IHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVRKGDARL-----PLKWMAPET 252
Query: 114 VLHRSYNVEGDMWSIGVITY-ILLCGSRPF 142
+ R Y ++ D+WS GV+ + I G+ P+
Sbjct: 253 IFDRVYTIQSDVWSFGVLLWEIFSLGASPY 282
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 4e-05
Identities = 28/92 (30%), Positives = 47/92 (51%), Gaps = 7/92 (7%)
Query: 46 IVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLN---D 102
+ ++L+ + + H +G++HRD+K EN L E+ + + DFG + F R
Sbjct: 265 VARQLLSAIDYIHGEGIIHRDIKTENVLVNGPED---ICLGDFGAACFARGSWSTPFHYG 321
Query: 103 IVGSAYYVAPEVLH-RSYNVEGDMWSIGVITY 133
I G+ APEVL Y D+WS G++ +
Sbjct: 322 IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIF 353
|
Length = 461 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 5e-05
Identities = 39/137 (28%), Positives = 64/137 (46%), Gaps = 29/137 (21%)
Query: 30 RILSRGGRYLEEDAKTIV----------EKILNI-------VAFCHLQGVVHRDLKPENF 72
R R G Y+++D + + E +L+ ++F + +HRDL N
Sbjct: 186 RRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNI 245
Query: 73 LFTTREEDAPLKVIDFGLSDFVRPDQRLNDIV-GSAY----YVAPE-VLHRSYNVEGDMW 126
L T K+ DFGL+ +R D N +V G+A ++APE + + Y E D+W
Sbjct: 246 LLT---HGRITKICDFGLARDIRNDS--NYVVKGNARLPVKWMAPESIFNCVYTFESDVW 300
Query: 127 SIGVITY-ILLCGSRPF 142
S G++ + I GS P+
Sbjct: 301 SYGILLWEIFSLGSSPY 317
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 5e-05
Identities = 35/137 (25%), Positives = 58/137 (42%), Gaps = 15/137 (10%)
Query: 63 VHRDLKPENFLFTTREEDAPLKVIDFGLS------DFVRPDQRLNDIVGSAYYVAPEVLH 116
VHRDL N L E+ +K+ DFGLS D+ + + ND + + + +
Sbjct: 152 VHRDLATRNCLVG---ENMVVKIADFGLSRNIYSADYYKASE--NDAIPIRWMPPESIFY 206
Query: 117 RSYNVEGDMWSIGVITY-ILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKD 175
Y E D+W+ GV+ + I G +P++ + V D N P + E +
Sbjct: 207 NRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYV--RDGNVLSCP-DNCPLELYN 263
Query: 176 FVRRLLNKDHRKRMTAA 192
+R +K R + A
Sbjct: 264 LMRLCWSKLPSDRPSFA 280
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 6e-05
Identities = 53/200 (26%), Positives = 76/200 (38%), Gaps = 26/200 (13%)
Query: 2 YHQKLQHLFYSNSFLFFT-RFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQ 60
L S +F + EGG+L I EE K +++ + H +
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFL-NIPEECVKRWAAEMVVALDALHRE 104
Query: 61 GVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYN 120
G+V RDL P N L R +++ F V + V Y APEV S
Sbjct: 105 GIVCRDLNPNNILLDDR---GHIQLTYFSRWSEVED-SCDGEAV-ENMYCAPEVGGISEE 159
Query: 121 VEG-DMWSIGVITYILLCG-----SRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAK 174
E D WS+G I + LL G P SGI P + VS EA+
Sbjct: 160 TEACDWWSLGAILFELLTGKTLVECHP------SGINTHTTLNIPEW-------VSEEAR 206
Query: 175 DFVRRLLNKDHRKRMTAAQA 194
+++LL + +R+ A A
Sbjct: 207 SLLQQLLQFNPTERLGAGVA 226
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 7e-05
Identities = 19/46 (41%), Positives = 29/46 (63%), Gaps = 2/46 (4%)
Query: 44 KTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFG 89
+TI+ +IL + H G+VHRD+KP+N +F+ E K+ID G
Sbjct: 258 QTIMRQILFALDGLHSTGIVHRDVKPQNIIFS--EGSGSFKIIDLG 301
|
Length = 566 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 9e-05
Identities = 31/120 (25%), Positives = 55/120 (45%), Gaps = 9/120 (7%)
Query: 19 TRFCEGGELLDRILSRGGRYL-EEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77
T + G LLD + S G+ L + +I +A+ + +HRDL N L
Sbjct: 80 TEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVG-- 137
Query: 78 EEDAPLKVIDFGLSDFVRPDQRLNDIVGSAY---YVAPE-VLHRSYNVEGDMWSIGVITY 133
E+ K+ DFGL+ + D+ G+ + + APE + + ++ D+WS G++
Sbjct: 138 -ENLVCKIADFGLARLIEDDE-YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLT 195
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 9e-05
Identities = 47/198 (23%), Positives = 83/198 (41%), Gaps = 18/198 (9%)
Query: 3 HQKLQHLFYSNS---FLFFTRFCEGGELLDRILSRGGRYLE-EDAKTIVEKILNIVAFCH 58
H KL L+ S T + G LLD + GR L+ + + ++ +A+
Sbjct: 60 HDKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE 119
Query: 59 LQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAY---YVAPEV- 114
+HRDL+ N L + K+ DFGL+ + D G+ + + APE
Sbjct: 120 RMNYIHRDLRSANILVG---DGLVCKIADFGLARLIE-DNEYTARQGAKFPIKWTAPEAA 175
Query: 115 LHRSYNVEGDMWSIGV-ITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEA 173
L+ + ++ D+WS G+ +T ++ G P+ + V R + P P P +
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG----YRMPCPQDCPIS 231
Query: 174 -KDFVRRLLNKDHRKRMT 190
+ + + KD +R T
Sbjct: 232 LHELMLQCWKKDPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 30/90 (33%), Positives = 47/90 (52%), Gaps = 18/90 (20%)
Query: 63 VHRDLKPENFLFTTREEDAPLKVIDFGLS-------DFVRP-DQRLNDIVGSAYYVAPE- 113
+HRDL N L + E+ +K+ DFGL+ D+VR D RL ++APE
Sbjct: 195 IHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVRKGDARL-----PLKWMAPES 246
Query: 114 VLHRSYNVEGDMWSIGVITY-ILLCGSRPF 142
+ + Y + D+WS GV+ + I G+ P+
Sbjct: 247 IFDKVYTTQSDVWSFGVLLWEIFSLGASPY 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 35/146 (23%), Positives = 64/146 (43%), Gaps = 8/146 (5%)
Query: 2 YHQKLQHLFYSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQG 61
Y +L + +++ T+ G LLD + R +D +I +++
Sbjct: 70 YVCRLLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR 129
Query: 62 VVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSA----YYVAPEVLHR 117
+VHRDL N L + +K+ DFGL+ + D+ G + +LHR
Sbjct: 130 LVHRDLAARNVLVKSPNH---VKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHR 186
Query: 118 SYNVEGDMWSIGVITYILLC-GSRPF 142
+ + D+WS GV + L+ G++P+
Sbjct: 187 RFTHQSDVWSYGVTVWELMTFGAKPY 212
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 32/90 (35%), Positives = 45/90 (50%), Gaps = 18/90 (20%)
Query: 63 VHRDLKPENFLFTTREEDAPLKVIDFGLS------DFVRP--DQRLNDIVGSAYYVAPEV 114
+HRDL N L T ED +K+ DFGL+ D+ R + RL ++APE
Sbjct: 154 IHRDLAARNVLVT---EDHVMKIADFGLARDIHHIDYYRKTTNGRL-----PVKWMAPEA 205
Query: 115 L-HRSYNVEGDMWSIGVITY-ILLCGSRPF 142
L R Y + D+WS GV+ + I G P+
Sbjct: 206 LFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 20/46 (43%), Positives = 29/46 (63%), Gaps = 3/46 (6%)
Query: 44 KTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFG 89
K ++ ++L + H G+VHRD+KPEN L T D +K+IDFG
Sbjct: 312 KGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTV---DGQVKIIDFG 354
|
Length = 507 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 2e-04
Identities = 31/123 (25%), Positives = 57/123 (46%), Gaps = 26/123 (21%)
Query: 46 IVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVG 105
I ++I + + Q VHRDL N L E+ +K+ DFG+S D+
Sbjct: 125 IAQQIAAGMVYLASQHFVHRDLATRNCLVG---ENLLVKIGDFGMS---------RDVYS 172
Query: 106 SAYY------------VAPE-VLHRSYNVEGDMWSIGVITY-ILLCGSRPFWARTESGIF 151
+ YY + PE +++R + E D+WS+GV+ + I G +P++ + + +
Sbjct: 173 TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI 232
Query: 152 RSV 154
+
Sbjct: 233 ECI 235
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 32/122 (26%), Positives = 52/122 (42%), Gaps = 26/122 (21%)
Query: 36 GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 95
G I +I + + + Q VHRDL N L D +K+ DFG+S
Sbjct: 117 GELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGY---DLVVKIGDFGMS---- 169
Query: 96 PDQRLNDIVGSAYY------------VAPE-VLHRSYNVEGDMWSIGVITY-ILLCGSRP 141
D+ + YY + PE +++R + E D+WS GV+ + I G +P
Sbjct: 170 -----RDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
Query: 142 FW 143
++
Sbjct: 225 WY 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 35/124 (28%), Positives = 62/124 (50%), Gaps = 10/124 (8%)
Query: 25 GELLDRILSRGGRYLE-EDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPL 83
G LL+ + GR L+ + ++ + +A+ Q +HRDL N L E+
Sbjct: 86 GSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVG---ENNIC 142
Query: 84 KVIDFGLSDFVRPDQRLNDIVGSAY---YVAPE-VLHRSYNVEGDMWSIGV-ITYILLCG 138
KV DFGL+ ++ D G+ + + APE L+ ++++ D+WS G+ +T I+ G
Sbjct: 143 KVADFGLARVIKEDI-YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYG 201
Query: 139 SRPF 142
P+
Sbjct: 202 RMPY 205
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 32/88 (36%), Positives = 43/88 (48%), Gaps = 8/88 (9%)
Query: 60 QGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGS--AYYVAPEVL- 115
Q +HRDL N L T ED +K+ DFGL+ D D G ++APE L
Sbjct: 153 QKCIHRDLAARNVLVT---EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALF 209
Query: 116 HRSYNVEGDMWSIGVITY-ILLCGSRPF 142
R Y + D+WS GV+ + I G P+
Sbjct: 210 DRVYTHQSDVWSFGVLLWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 31/85 (36%), Positives = 42/85 (49%), Gaps = 8/85 (9%)
Query: 63 VHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGS--AYYVAPEVL-HRS 118
+HRDL N L T ED +K+ DFGL+ D D G ++APE L R
Sbjct: 162 IHRDLAARNVLVT---EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI 218
Query: 119 YNVEGDMWSIGVITY-ILLCGSRPF 142
Y + D+WS GV+ + I G P+
Sbjct: 219 YTHQSDVWSFGVLLWEIFTLGGSPY 243
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 3e-04
Identities = 29/95 (30%), Positives = 44/95 (46%), Gaps = 26/95 (27%)
Query: 63 VHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYY------------V 110
VHRDL N L + +K+ DFG+S DI + YY +
Sbjct: 144 VHRDLATRNCLVG---QGLVVKIGDFGMS---------RDIYSTDYYRVGGRTMLPIRWM 191
Query: 111 APE-VLHRSYNVEGDMWSIGVITY-ILLCGSRPFW 143
PE +L+R + E D+WS GV+ + I G +P++
Sbjct: 192 PPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWY 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 4e-04
Identities = 32/128 (25%), Positives = 49/128 (38%), Gaps = 39/128 (30%)
Query: 23 EGGELLDRILSRGGRYLEEDAKTIVEKILNIV-------AFCHLQGVVHRDLKPENFLFT 75
G LL YL++ + V + + A+ + VHRDL N L
Sbjct: 78 PLGPLLK--------YLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLV 129
Query: 76 TREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYY------------VAPEVLH-RSYNVE 122
R + K+ DFG+S + GS YY APE ++ ++ +
Sbjct: 130 NRHQ---AKISDFGMSRALGA--------GSDYYRATTAGRWPLKWYAPECINYGKFSSK 178
Query: 123 GDMWSIGV 130
D+WS GV
Sbjct: 179 SDVWSYGV 186
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 5e-04
Identities = 30/93 (32%), Positives = 47/93 (50%), Gaps = 24/93 (25%)
Query: 63 VHRDLKPENFLFTTREEDAPLKVIDFGLS-------DFVRPDQRLNDIVGSAY----YVA 111
+HRDL N L + E+ +K+ DFGL+ D+VR GSA ++A
Sbjct: 196 IHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVRK--------GSARLPLKWMA 244
Query: 112 PE-VLHRSYNVEGDMWSIGVITY-ILLCGSRPF 142
PE + + Y + D+WS GV+ + I G+ P+
Sbjct: 245 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY 277
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 5e-04
Identities = 54/209 (25%), Positives = 79/209 (37%), Gaps = 67/209 (32%)
Query: 63 VHRDLKPENFLFTTREEDAPLKVIDFGLS------DFVR--PDQRLNDIVGSAYYVAPEV 114
+HRDL N L T ED +K+ DFGL+ D+ + + RL ++APE
Sbjct: 156 IHRDLAARNVLVT---EDNVMKIADFGLARGVHDIDYYKKTSNGRL-----PVKWMAPEA 207
Query: 115 L-HRSYNVEGDMWSIGVITY-ILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPE 172
L R Y + D+WS G++ + I G SP+P + E
Sbjct: 208 LFDRVYTHQSDVWSFGILMWEIFTLGG------------------------SPYPGIPVE 243
Query: 173 AKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDILIYKLVKSYLRATPLKRAALK 232
+ +LL + HR M TH +Y L++ A P +R K
Sbjct: 244 E---LFKLLREGHR--MDKPSNCTHE--------------LYMLMRECWHAVPTQRPTFK 284
Query: 233 ALSKAL------TEEELVYLRAQFMLLEP 255
L +AL EE + L F P
Sbjct: 285 QLVEALDKVLAAVSEEYLDLSMPFEQYSP 313
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 6e-04
Identities = 31/88 (35%), Positives = 43/88 (48%), Gaps = 8/88 (9%)
Query: 60 QGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGS--AYYVAPEVL- 115
Q +HRDL N L T E+ +K+ DFGL+ D D G ++APE L
Sbjct: 156 QKCIHRDLAARNVLVT---ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALF 212
Query: 116 HRSYNVEGDMWSIGVITY-ILLCGSRPF 142
R Y + D+WS GV+ + I G P+
Sbjct: 213 DRVYTHQSDVWSFGVLMWEIFTLGGSPY 240
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 6e-04
Identities = 62/225 (27%), Positives = 88/225 (39%), Gaps = 71/225 (31%)
Query: 62 VVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ---RLND-------------IVG 105
++H DLKPEN L T + V+D + + PD R+ D IV
Sbjct: 253 LMHTDLKPENILMETSD-----TVVDPVTNRALPPDPCRVRICDLGGCCDERHSRTAIVS 307
Query: 106 SAYYVAPEV-LHRSYNVEGDMWSIGVITYILLCGSRPF---------------------- 142
+ +Y +PEV L + DMWS+G I Y L G +
Sbjct: 308 TRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSE 367
Query: 143 WAR---TESG--IFRSV--LR--ADPNFHDSPWPSVSPEAKDFVRR---------LLNKD 184
WA TE ++ S LR DP H + P ++ +R LL+ D
Sbjct: 368 WAGRCGTEEARLLYNSAGQLRPCTDPK-HLARIARARP-VREVIRDDLLCDLIYGLLHYD 425
Query: 185 HRKRMTAAQALTHPWLHD---ENRPVPLDILIYKLVKSYLRATPL 226
+KR+ A Q THP++ E R P Y +S LR TP+
Sbjct: 426 RQKRLNARQMTTHPYVLKYYPECRQHP----NYPDNRSMLRPTPI 466
|
Length = 467 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 6e-04
Identities = 38/149 (25%), Positives = 66/149 (44%), Gaps = 13/149 (8%)
Query: 1 MYHQKLQHLF---YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFC 57
++H+ L L N G L++ + +RG R L + + +
Sbjct: 56 LHHKNLVRLLGVILHNGLYIVMELMSKGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGME 114
Query: 58 HLQG--VVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL 115
+L+ +VHRDL N L + ED KV DFGL+ +++ + APE L
Sbjct: 115 YLESKKLVHRDLAARNILVS---EDGVAKVSDFGLARVGS--MGVDNSKLPVKWTAPEAL 169
Query: 116 -HRSYNVEGDMWSIGVITY-ILLCGSRPF 142
H+ ++ + D+WS GV+ + + G P+
Sbjct: 170 KHKKFSSKSDVWSYGVLLWEVFSYGRAPY 198
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 6e-04
Identities = 27/78 (34%), Positives = 40/78 (51%), Gaps = 8/78 (10%)
Query: 63 VHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIV----GSAYYVAPEVLHRS 118
VHRDL N L E + +K+ DFGL+ + D+ + ++ APE L S
Sbjct: 130 VHRDLATRNILV---ESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTES 186
Query: 119 -YNVEGDMWSIGVITYIL 135
++V D+WS GV+ Y L
Sbjct: 187 KFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 8e-04
Identities = 31/123 (25%), Positives = 55/123 (44%), Gaps = 26/123 (21%)
Query: 46 IVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVG 105
I +I + + + Q VHRDL N L + +K+ DFG+S D+
Sbjct: 128 IASQIASGMVYLASQHFVHRDLATRNCLVGA---NLLVKIGDFGMS---------RDVYS 175
Query: 106 SAYY------------VAPE-VLHRSYNVEGDMWSIGVITY-ILLCGSRPFWARTESGIF 151
+ YY + PE +++R + E D+WS GVI + I G +P++ + + +
Sbjct: 176 TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI 235
Query: 152 RSV 154
+
Sbjct: 236 ECI 238
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 8e-04
Identities = 39/200 (19%), Positives = 73/200 (36%), Gaps = 52/200 (26%)
Query: 46 IVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS---DFVRPDQRLND 102
I++ +LN + + H +G +HR +K + L + KV+ GL ++ +R
Sbjct: 106 ILKDVLNALDYIHSKGFIHRSVKASHILLS-----GDGKVVLSGLRYSVSMIKHGKRQRV 160
Query: 103 IVGSA-------YYVAPEVLHRS---YNVEGDMWSIGVITYILLCGSRPFW--------- 143
+ +++PEVL ++ YN + D++S+G+ L G PF
Sbjct: 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLL 220
Query: 144 -----------------------ARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRL 180
+++ S R + + S FV
Sbjct: 221 EKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRD--SVDHPYTRTFSEHFHQFVELC 278
Query: 181 LNKDHRKRMTAAQALTHPWL 200
L +D R +A+Q L H +
Sbjct: 279 LQRDPESRPSASQLLNHSFF 298
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (94), Expect = 0.001
Identities = 19/69 (27%), Positives = 34/69 (49%), Gaps = 8/69 (11%)
Query: 25 GELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLK 84
GE L +++ G E ++ I +V H G++H DL N + + + +
Sbjct: 83 GEPLKDLINSNGMEELELSREIGR----LVGKLHSAGIIHGDLTTSNMILSGGK----IY 134
Query: 85 VIDFGLSDF 93
+IDFGL++F
Sbjct: 135 LIDFGLAEF 143
|
Length = 211 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 30/95 (31%), Positives = 45/95 (47%), Gaps = 10/95 (10%)
Query: 48 EKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRL-----ND 102
++I +A+ H Q +HRDL N L + D +K+ DFGL+ V P+ D
Sbjct: 114 QQICEGMAYLHSQHYIHRDLAARNVLL---DNDRLVKIGDFGLAKAV-PEGHEYYRVRED 169
Query: 103 IVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILL 136
++ A E L ++ D+WS GV Y LL
Sbjct: 170 GDSPVFWYAVECLKENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 35/131 (26%), Positives = 60/131 (45%), Gaps = 20/131 (15%)
Query: 23 EGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAP 82
+GG+ L + + G R ++ +VE + + + +HRDL N L T E
Sbjct: 76 QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVT---EKNV 132
Query: 83 LKVIDFGLSDFVRPDQRLNDIVGSAY---------YVAPEVL-HRSYNVEGDMWSIGVIT 132
LK+ DFG+S + D V ++ + APE L + Y+ E D+WS G++
Sbjct: 133 LKISDFGMS------REEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILL 186
Query: 133 Y-ILLCGSRPF 142
+ G+ P+
Sbjct: 187 WEAFSLGAVPY 197
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 30/101 (29%), Positives = 50/101 (49%), Gaps = 12/101 (11%)
Query: 49 KILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSA 107
++ N + F + VHRDL N L E +K+ DFGL+ D +R ++ GS
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLIC---EGKLVKICDFGLARDIMRDSNYISK--GST 301
Query: 108 Y----YVAPE-VLHRSYNVEGDMWSIGVITY-ILLCGSRPF 142
+ ++APE + + Y D+WS G++ + I G P+
Sbjct: 302 FLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPY 342
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.002
Identities = 41/148 (27%), Positives = 64/148 (43%), Gaps = 27/148 (18%)
Query: 15 FLFFTRFCEGGELLDRILS-RGGRYLEEDAKTIVEKILNI---VAFCHLQGVVHRDLKPE 70
+L FC G+L + S R + D T+ I + H +H DL
Sbjct: 70 YLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALR 129
Query: 71 NFLFTTREEDAPLKVIDFGLSD-------FVRPDQRLNDIVGSAYYVAPEVL---HRSYN 120
N L T D +K+ D+GLS +V PDQ + ++APE++ H +
Sbjct: 130 NCLLTA---DLTVKIGDYGLSHNKYKEDYYVTPDQLWVPL----RWIAPELVDEVHGNLL 182
Query: 121 V-----EGDMWSIGVITYILL-CGSRPF 142
V E ++WS+GV + L GS+P+
Sbjct: 183 VVDQTKESNVWSLGVTIWELFELGSQPY 210
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.002
Identities = 39/142 (27%), Positives = 62/142 (43%), Gaps = 26/142 (18%)
Query: 15 FLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVE---------KILNIVAFCHLQGVVHR 65
F T F G LLD YL E + V +I + + + + +HR
Sbjct: 77 FYIITEFMTYGNLLD--------YLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 128
Query: 66 DLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAY---YVAPEVL-HRSYNV 121
DL N L E+ +KV DFGLS + D G+ + + APE L + +++
Sbjct: 129 DLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAH-AGAKFPIKWTAPESLAYNKFSI 184
Query: 122 EGDMWSIGVITY-ILLCGSRPF 142
+ D+W+ GV+ + I G P+
Sbjct: 185 KSDVWAFGVLLWEIATYGMSPY 206
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 27/85 (31%), Positives = 42/85 (49%), Gaps = 10/85 (11%)
Query: 54 VAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS----DFVRPDQRLNDIVGSAYY 109
+A+ + +HRDL N L E+ LK+ DFG+S D + L I +
Sbjct: 106 MAYLESKNCIHRDLAARNCLVG---ENNVLKISDFGMSRQEDDGIYSSSGLKQI--PIKW 160
Query: 110 VAPEVL-HRSYNVEGDMWSIGVITY 133
APE L + Y+ E D+WS G++ +
Sbjct: 161 TAPEALNYGRYSSESDVWSYGILLW 185
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 0.003
Identities = 40/153 (26%), Positives = 62/153 (40%), Gaps = 36/153 (23%)
Query: 63 VHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAY------YVAPEVLH 116
+HRDL N L E+ LK+ DFG+S R ++ V + APE L+
Sbjct: 115 IHRDLAARNCLVG---ENNVLKISDFGMS---REEEGGIYTVSDGLKQIPIKWTAPEALN 168
Query: 117 RS-YNVEGDMWSIGVITY-ILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAK 174
Y E D+WS G++ + G P+ + ++ R + + P P + PE
Sbjct: 169 YGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ---QTRERIESGYR-MPAPQLCPEE- 223
Query: 175 DFVRRLLNKDHRKRMTAAQALTHPWLHD-ENRP 206
+ RL+ W +D ENRP
Sbjct: 224 --IYRLML--------------QCWAYDPENRP 240
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.003
Identities = 49/209 (23%), Positives = 81/209 (38%), Gaps = 36/209 (17%)
Query: 42 DAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLN 101
D I +L + + H ++HRD+K EN +F D L DFG + F
Sbjct: 183 DILAIERSVLRAIQYLHENRIIHRDIKAEN-IFINHPGDVCLG--DFGAACFPV------ 233
Query: 102 DIVGSAYY--------VAPEVLHRS-YNVEGDMWSIGVITYILLCGSRPFWAR------- 145
DI + YY APE+L R Y D+WS G++ + + + +
Sbjct: 234 DINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDC 293
Query: 146 -TESGIFRSVLRADPNFHDSPWPSVSPEA--KDFVRRLLNKDHRKRMTAAQALTHPWLHD 202
++ I + R+ H + +P + +A + L K RK + W +
Sbjct: 294 DSDRQIKLIIRRS--GTHPNEFP-IDAQANLDEIYIGLAKKSSRKPGSRPL-----WTNL 345
Query: 203 ENRPVPLDILIYKLVKSYLRATPLKRAAL 231
P+ L+ LI K++ P A L
Sbjct: 346 YELPIDLEYLICKMLAFDAHHRPSAEALL 374
|
Length = 391 |
| >gnl|CDD|218977 pfam06293, Kdo, Lipopolysaccharide kinase (Kdo/WaaP) family | Back alignment and domain information |
|---|
Score = 38.1 bits (89), Expect = 0.003
Identities = 21/70 (30%), Positives = 31/70 (44%)
Query: 19 TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE 78
T EG + L L++ EE + + + ++A H GV H DL N L T E
Sbjct: 96 TERLEGAQDLVTWLAQWADPAEELRRALWRAVGRLIARMHRAGVNHTDLNAHNILLDTGE 155
Query: 79 EDAPLKVIDF 88
+ +IDF
Sbjct: 156 GGFKVWLIDF 165
|
These lipopolysaccharide kinases are related to protein kinases pfam00069. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of S. enterica. Length = 206 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.004
Identities = 31/113 (27%), Positives = 48/113 (42%), Gaps = 27/113 (23%)
Query: 26 ELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKV 85
EL+ ++ S G +YLEE VHRDL N L T+ K+
Sbjct: 99 ELVHQV-SMGMKYLEE------------------TNFVHRDLAARNVLLVTQHY---AKI 136
Query: 86 IDFGLSDFVRPDQRLNDIVGSA----YYVAPEVL-HRSYNVEGDMWSIGVITY 133
DFGLS + D+ + APE + + ++ + D+WS GV+ +
Sbjct: 137 SDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMW 189
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 389 | |||
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.98 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.98 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.98 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.98 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.98 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.98 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.98 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.98 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.98 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.97 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.96 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.95 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.95 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.95 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.93 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.93 | |
| COG5126 | 160 | FRQ1 Ca2+-binding protein (EF-Hand superfamily) [S | 99.92 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.92 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.9 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.9 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.89 | |
| KOG0027 | 151 | consensus Calmodulin and related proteins (EF-Hand | 99.89 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.88 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.86 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.86 | |
| KOG0028 | 172 | consensus Ca2+-binding protein (centrin/caltractin | 99.83 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.83 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.81 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.8 | |
| PTZ00183 | 158 | centrin; Provisional | 99.78 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.78 | |
| KOG0044 | 193 | consensus Ca2+ sensor (EF-Hand superfamily) [Signa | 99.78 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.77 | |
| PTZ00184 | 149 | calmodulin; Provisional | 99.77 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.76 | |
| KOG0034 | 187 | consensus Ca2+/calmodulin-dependent protein phosph | 99.75 | |
| KOG0031 | 171 | consensus Myosin regulatory light chain, EF-Hand p | 99.74 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.74 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.73 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.71 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.7 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.68 | |
| KOG0037 | 221 | consensus Ca2+-binding protein, EF-Hand protein su | 99.68 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.64 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.61 | |
| KOG0030 | 152 | consensus Myosin essential light chain, EF-Hand pr | 99.61 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.6 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.59 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.58 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.55 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.54 | |
| KOG0036 | 463 | consensus Predicted mitochondrial carrier protein | 99.53 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.41 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.4 | |
| KOG0038 | 189 | consensus Ca2+-binding kinase interacting protein | 99.39 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.36 | |
| KOG4223 | 325 | consensus Reticulocalbin, calumenin, DNA supercoil | 99.33 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.31 | |
| KOG4223 | 325 | consensus Reticulocalbin, calumenin, DNA supercoil | 99.31 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.3 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.29 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.28 | |
| cd05022 | 89 | S-100A13 S-100A13: S-100A13 domain found in protei | 99.25 | |
| PF13499 | 66 | EF-hand_7: EF-hand domain pair; PDB: 1TCF_A 2TN4_A | 99.25 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.23 | |
| PLN02964 | 644 | phosphatidylserine decarboxylase | 99.19 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.15 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.13 | |
| cd05026 | 93 | S-100Z S-100Z: S-100Z domain found in proteins sim | 99.09 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.07 | |
| cd05027 | 88 | S-100B S-100B: S-100B domain found in proteins sim | 99.05 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.02 | |
| cd05025 | 92 | S-100A1 S-100A1: S-100A1 domain found in proteins | 99.01 | |
| cd05023 | 89 | S-100A11 S-100A11: S-100A11 domain found in protei | 98.96 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.96 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.96 | |
| smart00027 | 96 | EH Eps15 homology domain. Pair of EF hand motifs t | 98.96 | |
| cd05031 | 94 | S-100A10_like S-100A10_like: S-100A10 domain found | 98.95 | |
| cd00252 | 116 | SPARC_EC SPARC_EC; extracellular Ca2+ binding doma | 98.93 | |
| cd00052 | 67 | EH Eps15 homology domain; found in proteins implic | 98.93 | |
| KOG0037 | 221 | consensus Ca2+-binding protein, EF-Hand protein su | 98.93 | |
| cd05029 | 88 | S-100A6 S-100A6: S-100A6 domain found in proteins | 98.93 | |
| PF13499 | 66 | EF-hand_7: EF-hand domain pair; PDB: 1TCF_A 2TN4_A | 98.91 | |
| PTZ00183 | 158 | centrin; Provisional | 98.89 | |
| KOG0027 | 151 | consensus Calmodulin and related proteins (EF-Hand | 98.89 | |
| cd05022 | 89 | S-100A13 S-100A13: S-100A13 domain found in protei | 98.88 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.84 | |
| cd00213 | 88 | S-100 S-100: S-100 domain, which represents the la | 98.83 | |
| smart00027 | 96 | EH Eps15 homology domain. Pair of EF hand motifs t | 98.81 | |
| cd05027 | 88 | S-100B S-100B: S-100B domain found in proteins sim | 98.8 | |
| COG5126 | 160 | FRQ1 Ca2+-binding protein (EF-Hand superfamily) [S | 98.78 | |
| KOG0044 | 193 | consensus Ca2+ sensor (EF-Hand superfamily) [Signa | 98.78 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.77 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.77 | |
| PF13833 | 54 | EF-hand_8: EF-hand domain pair; PDB: 3KF9_A 1TTX_A | 98.74 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.74 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.73 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.71 | |
| cd05026 | 93 | S-100Z S-100Z: S-100Z domain found in proteins sim | 98.7 | |
| KOG0028 | 172 | consensus Ca2+-binding protein (centrin/caltractin | 98.7 | |
| PTZ00184 | 149 | calmodulin; Provisional | 98.69 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.67 | |
| KOG0041 | 244 | consensus Predicted Ca2+-binding protein, EF-Hand | 98.64 | |
| cd05029 | 88 | S-100A6 S-100A6: S-100A6 domain found in proteins | 98.62 | |
| KOG0377 | 631 | consensus Protein serine/threonine phosphatase RDG | 98.59 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.59 | |
| PF13833 | 54 | EF-hand_8: EF-hand domain pair; PDB: 3KF9_A 1TTX_A | 98.57 | |
| cd00052 | 67 | EH Eps15 homology domain; found in proteins implic | 98.57 | |
| cd05025 | 92 | S-100A1 S-100A1: S-100A1 domain found in proteins | 98.57 | |
| PF14658 | 66 | EF-hand_9: EF-hand domain | 98.57 | |
| cd05023 | 89 | S-100A11 S-100A11: S-100A11 domain found in protei | 98.57 | |
| PLN02964 | 644 | phosphatidylserine decarboxylase | 98.56 | |
| KOG0040 | 2399 | consensus Ca2+-binding actin-bundling protein (spe | 98.55 | |
| cd00213 | 88 | S-100 S-100: S-100 domain, which represents the la | 98.54 |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-53 Score=383.68 Aligned_cols=203 Identities=32% Similarity=0.614 Sum_probs=187.5
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|+|||||+++ ..+.+|+||||++||+|++++..+ +.+.+..-+.+++|++.|+.|||++||+||||||+|||+++
T Consensus 233 L~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~n-k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~ 311 (475)
T KOG0615|consen 233 LSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVAN-KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSN 311 (475)
T ss_pred cCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHHhc-cccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEecc
Confidence 6899999998 357789999999999999999887 78999999999999999999999999999999999999987
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc----cCCCchhHHHHHHHHHHHHhCCCCCCCCChhH-HH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR----SYNVEGDMWSIGVITYILLCGSRPFWARTESG-IF 151 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~ 151 (389)
+.++-.+||+|||+|+.......+.+.||||.|.|||++.. .+..++|+||+|||+|-+|+|.+||.+..... ..
T Consensus 312 ~~e~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~ 391 (475)
T KOG0615|consen 312 DAEDCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLK 391 (475)
T ss_pred CCcceEEEecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHH
Confidence 66778899999999999988888999999999999999842 24568999999999999999999998876665 88
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 152 RSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 152 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
..|.++...+.++.|.++|.++++||.+||..||++|||++|+|+||||+...
T Consensus 392 eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 392 EQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred HHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 89999999999999999999999999999999999999999999999998654
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-51 Score=343.58 Aligned_cols=234 Identities=34% Similarity=0.657 Sum_probs=210.8
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|+||||+.+. .....|+|+|++.||+|..-|.++ ..++|..+..+++||++||.|||.+||||||+||.|+++.+
T Consensus 67 LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLAS 145 (355)
T KOG0033|consen 67 LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLAS 145 (355)
T ss_pred cCCCcEeehhhhhcccceeEEEEecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeee
Confidence 7899999999 356789999999999999888877 67999999999999999999999999999999999999998
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVL 155 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 155 (389)
.+....+||+|||+|.....+.....++|||.|||||++.+ +|+..+|||+.|||||-||.|.+||++.+...+++.|.
T Consensus 146 K~~~A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~ 225 (355)
T KOG0033|consen 146 KAKGAAVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIK 225 (355)
T ss_pred ccCCCceeecccceEEEeCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHh
Confidence 88888999999999998886667778999999999999964 79999999999999999999999999999999999999
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCCCCCC--ccHHHHHHHHHHhhcChhHHHHHHH
Q 016471 156 RADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVP--LDILIYKLVKSYLRATPLKRAALKA 233 (389)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~~~l~~ 233 (389)
++...++.+.|+.+++++++|+++||..||.+|+|+.|+|+|||+++...... -.......++++-...+++-+.+..
T Consensus 226 ~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~~~As~~H~~dtvd~lrkfNarRKLKgavLta 305 (355)
T KOG0033|consen 226 AGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNRERVASAIHRQDTVDCLKKFNARRKLKGAILTT 305 (355)
T ss_pred ccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcchHHHHHHhhhHHHHHHHHHhhHHHHHHHHHHHH
Confidence 99999999999999999999999999999999999999999999987643211 1223456677887778888888777
Q ss_pred HH
Q 016471 234 LS 235 (389)
Q Consensus 234 i~ 235 (389)
+.
T Consensus 306 v~ 307 (355)
T KOG0033|consen 306 VI 307 (355)
T ss_pred HH
Confidence 64
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-49 Score=369.35 Aligned_cols=197 Identities=29% Similarity=0.571 Sum_probs=182.5
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|+|||||++| +.+++|||.|+|+.|+|..+++ +.+.++|.+|+.+++||+.||.|||+++|+|||||..|+|+
T Consensus 75 L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL-- 151 (592)
T KOG0575|consen 75 LKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFL-- 151 (592)
T ss_pred cCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheee--
Confidence 7899999998 5789999999999999998776 55899999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCC-CCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPD-QRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
+++.+|||+|||+|+..... .+..+.||||.|+|||++.+ .++..+||||+|||+|.||+|++||...+..+++..|
T Consensus 152 -~~~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~I 230 (592)
T KOG0575|consen 152 -NENMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKI 230 (592)
T ss_pred -cCcCcEEecccceeeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHH
Confidence 67899999999999998754 67889999999999999965 6999999999999999999999999999999999999
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENR 205 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~~ 205 (389)
.......|. .+|.++++||.+||..+|.+|||++++|.|+||+....
T Consensus 231 k~~~Y~~P~----~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~ 277 (592)
T KOG0575|consen 231 KLNEYSMPS----HLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGFT 277 (592)
T ss_pred HhcCccccc----ccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCCc
Confidence 998887765 58999999999999999999999999999999965533
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-47 Score=336.61 Aligned_cols=197 Identities=30% Similarity=0.624 Sum_probs=176.7
Q ss_pred CCCccccceee----cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLFY----SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~~----~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
++||+|+.+++ .+.+|+|+||+.||+|+-++.+. ++++|..++.++.+|+.||.|||++|||||||||+|||+
T Consensus 82 v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~e-g~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILL-- 158 (357)
T KOG0598|consen 82 IKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQRE-GRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILL-- 158 (357)
T ss_pred CCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHHhc-CCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeee--
Confidence 58999999994 58899999999999999888655 899999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCcccc-CCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFV-RPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~-~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
+..|.++|+|||+|+.. ..+....++|||+.|||||++. ..|+..+|+||||+++|+|++|.+||.+.+....+.+|
T Consensus 159 -d~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I 237 (357)
T KOG0598|consen 159 -DEQGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKI 237 (357)
T ss_pred -cCCCcEEEeccccchhcccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHH
Confidence 68999999999999844 4445667789999999999985 57999999999999999999999999999999999999
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCC----CHHHHhCCCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRM----TAAQALTHPWLHDEN 204 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~----s~~e~l~h~~~~~~~ 204 (389)
.+.....++ .-++.+++++++++|..+|.+|. .+.++.+||||...+
T Consensus 238 ~~~k~~~~p---~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~in 288 (357)
T KOG0598|consen 238 LKGKLPLPP---GYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGIN 288 (357)
T ss_pred hcCcCCCCC---ccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCC
Confidence 988733322 23799999999999999999996 688999999997754
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-46 Score=348.40 Aligned_cols=250 Identities=47% Similarity=0.861 Sum_probs=219.1
Q ss_pred Ccccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeecC
Q 016471 3 HQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE 78 (389)
Q Consensus 3 Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~~ 78 (389)
||||+.++ +...+|+|||+|.||+|++++.+. .++|..+..++.||+.|++|||+.||+||||||+|+|+...+
T Consensus 95 hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~ 172 (382)
T KOG0032|consen 95 HPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKD 172 (382)
T ss_pred CCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeecccc
Confidence 99999999 467899999999999999999877 399999999999999999999999999999999999998654
Q ss_pred C-CCCEEEeecCCccccCCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 016471 79 E-DAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLR 156 (389)
Q Consensus 79 ~-~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 156 (389)
+ ++.+|++|||+|.....+....+.+||+.|+|||++. ..|+..+|+||+||++|.|++|.+||++.+.......|..
T Consensus 173 ~~~~~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~ 252 (382)
T KOG0032|consen 173 EGSGRIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILR 252 (382)
T ss_pred CCCCcEEEeeCCCceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHc
Confidence 4 4589999999999988777788899999999999997 6899999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCCC--CCCccHHHHHHHHHHhhcChhHHHHHHHH
Q 016471 157 ADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENR--PVPLDILIYKLVKSYLRATPLKRAALKAL 234 (389)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~~~l~~i 234 (389)
+...+..++|+.+|..++++|++||..||.+|+|+.++|+|||++.... ..+....+....+++...+.+++.++...
T Consensus 253 ~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (382)
T KOG0032|consen 253 GDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGEATNIPLDISVLSRSKQFLSMSKLKKLALRVL 332 (382)
T ss_pred CCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCcccccccccchhhhhHHHHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999999999999999999998632 23444444555556666666666666665
Q ss_pred HHhcCHHHHHHHHHHhhhcCC-CC
Q 016471 235 SKALTEEELVYLRAQFMLLEP-KD 257 (389)
Q Consensus 235 ~~~l~~ee~~~l~~~F~~~D~-~~ 257 (389)
....+ +..++..|..+|. ++
T Consensus 333 ~~~~~---~~~~~~~~~~~~~~~~ 353 (382)
T KOG0032|consen 333 AESLS---ISGLKEMFKLMDTDNN 353 (382)
T ss_pred hhhhh---HHHHHHHHHhhccccc
Confidence 55554 7777888888887 44
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=324.64 Aligned_cols=194 Identities=30% Similarity=0.622 Sum_probs=179.1
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||+++.++ +..++|+||||.+||.|+.++.+. +++++..++.++.||+.||+|||+++|++|||||+|||+
T Consensus 101 v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~-~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLl-- 177 (355)
T KOG0616|consen 101 VSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKS-GRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLL-- 177 (355)
T ss_pred ccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHhc-CCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeee--
Confidence 4799999999 568899999999999999988766 799999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVL 155 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 155 (389)
|.+|.+||+|||+|+.... ...+.||||.|+|||++. +.|+.++|+|||||++|||+.|.+||.+.+...++++|+
T Consensus 178 -D~~G~iKitDFGFAK~v~~--rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~ 254 (355)
T KOG0616|consen 178 -DQNGHIKITDFGFAKRVSG--RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKIL 254 (355)
T ss_pred -ccCCcEEEEeccceEEecC--cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHH
Confidence 6899999999999998754 367899999999999985 689999999999999999999999999999999999999
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCC-----CHHHHhCCCCCCCCC
Q 016471 156 RADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRM-----TAAQALTHPWLHDEN 204 (389)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----s~~e~l~h~~~~~~~ 204 (389)
.+...+|. .+++++++||+++|+.|-.+|. ...++..||||++..
T Consensus 255 ~~~v~fP~----~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~ 304 (355)
T KOG0616|consen 255 EGKVKFPS----YFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVD 304 (355)
T ss_pred hCcccCCc----ccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCccccccc
Confidence 99988874 4899999999999999999994 578999999998653
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=335.79 Aligned_cols=196 Identities=27% Similarity=0.470 Sum_probs=172.0
Q ss_pred CCcccccee----ecC-eEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCEecCCCCCcEEEe
Q 016471 2 YHQKLQHLF----YSN-SFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHL-QGVVHRDLKPENFLFT 75 (389)
Q Consensus 2 ~Hpni~~~~----~~~-~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~-~~i~Hrdlkp~Nill~ 75 (389)
+||+||.+| ... .++|+||||.||+|.+.+... |+++|.....++.+|++||.|||. ++|+||||||+|||+
T Consensus 135 ~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLv- 212 (364)
T KOG0581|consen 135 QSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLV- 212 (364)
T ss_pred CCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeee-
Confidence 699999999 345 599999999999998876555 889999999999999999999995 999999999999999
Q ss_pred ecCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCC-----ChhH
Q 016471 76 TREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWAR-----TESG 149 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~-----~~~~ 149 (389)
+..|.|||||||.+...... ...+++||..|||||.+.+ .|+.++||||||+.++|+.+|+.||... ...+
T Consensus 213 --NskGeVKicDFGVS~~lvnS-~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~ 289 (364)
T KOG0581|consen 213 --NSKGEVKICDFGVSGILVNS-IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFE 289 (364)
T ss_pred --ccCCCEEeccccccHHhhhh-hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHH
Confidence 57899999999999887655 5578899999999999875 7999999999999999999999999775 5567
Q ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 150 IFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 150 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
++..|+.+.+...+. ..+|+++++||..||++||.+|+|++++++|||++...
T Consensus 290 Ll~~Iv~~ppP~lP~--~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 290 LLCAIVDEPPPRLPE--GEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred HHHHHhcCCCCCCCc--ccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 788888754332221 25899999999999999999999999999999998764
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-46 Score=351.12 Aligned_cols=195 Identities=33% Similarity=0.619 Sum_probs=181.4
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|.|||++++| ...++|+|.||++||.|++++..+ |++++.+++.+++||+.|+.|||..+|+||||||+|+|+
T Consensus 69 i~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~k-G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLL-- 145 (786)
T KOG0588|consen 69 IEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVRK-GPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLL-- 145 (786)
T ss_pred hcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhh--
Confidence 5799999999 357899999999999999999988 789999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc-cC-CCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SY-NVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
+..+++||+|||+|....++..+.+.||+|+|.|||++.+ .| +.++||||+|||||.||+|+.||.+.+-..++.++
T Consensus 146 -d~~~nIKIADFGMAsLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV 224 (786)
T KOG0588|consen 146 -DVKNNIKIADFGMASLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKV 224 (786)
T ss_pred -hcccCEeeeccceeecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 5667799999999999888888999999999999999965 44 68899999999999999999999999999999999
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~ 203 (389)
.++....| ..+|+++++||++||.+||.+|+|.+++++|||+...
T Consensus 225 ~~G~f~MP----s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~ 269 (786)
T KOG0588|consen 225 QRGVFEMP----SNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGY 269 (786)
T ss_pred HcCcccCC----CcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcC
Confidence 99887766 4699999999999999999999999999999999764
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-47 Score=324.49 Aligned_cols=196 Identities=33% Similarity=0.652 Sum_probs=184.8
Q ss_pred CCccccceee----cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 2 YHQKLQHLFY----SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 2 ~Hpni~~~~~----~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
-||+|+.+.+ +.-+++|+|.|+.|.|+|++... -.++|...+.|++|++.|++|||.++||||||||+|||+
T Consensus 81 GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts~-VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILl--- 156 (411)
T KOG0599|consen 81 GHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSK-VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILL--- 156 (411)
T ss_pred CCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhhh-eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheee---
Confidence 5999999872 45578999999999999999776 579999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCCccccCCCCCcccccccCCcccccccc-------ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHH
Q 016471 78 EEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-------RSYNVEGDMWSIGVITYILLCGSRPFWARTESGI 150 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 150 (389)
+++.++||+|||+|+...++.+....||||+|+|||.+. ..|+..+|+|++|||+|.++.|.+||+....--+
T Consensus 157 ddn~~i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlM 236 (411)
T KOG0599|consen 157 DDNMNIKISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLM 236 (411)
T ss_pred ccccceEEeccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHH
Confidence 688999999999999999999999999999999999873 2488999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCC
Q 016471 151 FRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLH 201 (389)
Q Consensus 151 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~ 201 (389)
+..|..+...+..+.|.++|...++||.+||+.||.+|+|++|+|.||||.
T Consensus 237 LR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~ 287 (411)
T KOG0599|consen 237 LRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFI 287 (411)
T ss_pred HHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHH
Confidence 999999999999999999999999999999999999999999999999994
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-46 Score=349.66 Aligned_cols=192 Identities=37% Similarity=0.759 Sum_probs=176.6
Q ss_pred Ccccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeecC
Q 016471 3 HQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE 78 (389)
Q Consensus 3 Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~~ 78 (389)
||||++++ ....+|+|||||.||+|++++.+ .++++|.+++.+++|++.|++|||++||+||||||+|||+ +
T Consensus 79 HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENill---d 154 (370)
T KOG0583|consen 79 HPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILL---D 154 (370)
T ss_pred CCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEe---c
Confidence 99999999 45779999999999999999998 5899999999999999999999999999999999999999 4
Q ss_pred CC-CCEEEeecCCcccc-CCCCCcccccccCCccccccccc-c-C-CCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016471 79 ED-APLKVIDFGLSDFV-RPDQRLNDIVGSAYYVAPEVLHR-S-Y-NVEGDMWSIGVITYILLCGSRPFWARTESGIFRS 153 (389)
Q Consensus 79 ~~-~~~kl~Dfg~a~~~-~~~~~~~~~~gt~~y~aPE~~~~-~-~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 153 (389)
.+ +++||+|||++... .......+.+||+.|+|||++.+ . | +.++||||+||+||.|++|+.||...+...++..
T Consensus 155 ~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~k 234 (370)
T KOG0583|consen 155 GNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRK 234 (370)
T ss_pred CCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHH
Confidence 55 89999999999988 46677889999999999999964 4 6 4789999999999999999999999988899999
Q ss_pred HHhcCCCCCCCCCCCC-CHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCC
Q 016471 154 VLRADPNFHDSPWPSV-SPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 202 (389)
Q Consensus 154 i~~~~~~~~~~~~~~~-~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~ 202 (389)
|.++...++.. + |+++++|+.+||..+|.+|+|+.+++.||||+.
T Consensus 235 i~~~~~~~p~~----~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 235 IRKGEFKIPSY----LLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred HhcCCccCCCC----cCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 88887766643 4 999999999999999999999999999999987
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-46 Score=335.44 Aligned_cols=202 Identities=30% Similarity=0.614 Sum_probs=181.8
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|+|||||.++ ..+.+|+|||||+||+|.+|+.++ ++++|..++.++.||+.||++||+++||||||||+|||++.
T Consensus 66 l~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~-~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~ 144 (429)
T KOG0595|consen 66 LKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRRR-GRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLST 144 (429)
T ss_pred cCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEecc
Confidence 6899999999 368899999999999999999877 78999999999999999999999999999999999999986
Q ss_pred cCCC---CCEEEeecCCccccCCCCCcccccccCCccccccc-cccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 016471 77 REED---APLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL-HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFR 152 (389)
Q Consensus 77 ~~~~---~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 152 (389)
...+ ..+||+|||+|+...++....+.||+|.|||||++ ...|+.|+|+||+|+|+|+|++|++||...+..+.+.
T Consensus 145 ~~~~~~~~~LKIADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~ 224 (429)
T KOG0595|consen 145 TARNDTSPVLKIADFGFARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLL 224 (429)
T ss_pred CCCCCCCceEEecccchhhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHH
Confidence 5333 67999999999999988888899999999999998 5789999999999999999999999999999999998
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 153 SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 153 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
.+.++....+..+ ..+++...+++...|..+|..|.+..+-+.|+++....
T Consensus 225 ~~~k~~~~~~~~~-~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 225 YIKKGNEIVPVLP-AELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred HHhccccccCchh-hhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 8877665544432 35677888999999999999999999999999987653
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-46 Score=344.00 Aligned_cols=196 Identities=33% Similarity=0.645 Sum_probs=179.0
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
.||-|+++| ++..+|+|+||+++|+|.++|.+. |.|++..++.++.||+.||+|||++|||||||||+|||+
T Consensus 132 ~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILL--- 207 (604)
T KOG0592|consen 132 GHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILL--- 207 (604)
T ss_pred CCCCeEEEEEEeecccceEEEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeE---
Confidence 699999999 568899999999999999998776 899999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCCccccCCCCC--------------cccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCC
Q 016471 78 EEDAPLKVIDFGLSDFVRPDQR--------------LNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPF 142 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~~~~--------------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf 142 (389)
++++.+||+|||.|+.+.+... ..+++||..|.+||++.. ..++.+|+|+||||+|+|+.|.+||
T Consensus 208 d~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPF 287 (604)
T KOG0592|consen 208 DKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPF 287 (604)
T ss_pred cCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCC
Confidence 7899999999999987643211 145899999999999964 6889999999999999999999999
Q ss_pred CCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCCC
Q 016471 143 WARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENR 205 (389)
Q Consensus 143 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~~ 205 (389)
.+.++-.++++|+.....+++ .+++.+++||+++|..||.+|+|++++.+||||.+.++
T Consensus 288 ra~NeyliFqkI~~l~y~fp~----~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw 346 (604)
T KOG0592|consen 288 RAANEYLIFQKIQALDYEFPE----GFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDW 346 (604)
T ss_pred ccccHHHHHHHHHHhcccCCC----CCCHHHHHHHHHHHccCccccccHHHHhhCcccccCCh
Confidence 999999999999998887774 57899999999999999999999999999999987643
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-46 Score=320.72 Aligned_cols=203 Identities=38% Similarity=0.705 Sum_probs=185.5
Q ss_pred CCcccccee--------ecCeEEEEEEccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcE
Q 016471 2 YHQKLQHLF--------YSNSFLFFTRFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENF 72 (389)
Q Consensus 2 ~Hpni~~~~--------~~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Ni 72 (389)
-|||||... ....+.+|||.++||+|+.++..++ +.++|.++..|++||..|+.|||+.+|.||||||+|+
T Consensus 113 ~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENL 192 (400)
T KOG0604|consen 113 GHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENL 192 (400)
T ss_pred CCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhhe
Confidence 489999877 2367899999999999999998763 4599999999999999999999999999999999999
Q ss_pred EEeecCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCh----
Q 016471 73 LFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTE---- 147 (389)
Q Consensus 73 ll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---- 147 (389)
|.+....+..+||+|||+|+.......+.+.|.||+|.|||++. ..|+..+|+||+|||+|-|++|.+||+....
T Consensus 193 Lyt~t~~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ais 272 (400)
T KOG0604|consen 193 LYTTTSPNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS 272 (400)
T ss_pred eeecCCCCcceEecccccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCC
Confidence 99988888999999999999887777788899999999999996 4699999999999999999999999987543
Q ss_pred hHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 148 SGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 148 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
..+..+|..+...++.+.|..+|..++++|+++|..+|.+|.|+++++.|||+....
T Consensus 273 pgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~ 329 (400)
T KOG0604|consen 273 PGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE 329 (400)
T ss_pred hhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence 456778999999999999999999999999999999999999999999999998764
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=342.04 Aligned_cols=198 Identities=28% Similarity=0.544 Sum_probs=174.2
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
++|||||.|+ ..+.+|+||||++||+|.|.+... .++|.+++.|+++++.||+|||.+||+|||||.+|||+
T Consensus 327 ~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~~--~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL-- 402 (550)
T KOG0578|consen 327 LHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTKT--RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILL-- 402 (550)
T ss_pred ccchHHHHHHHHhcccceeEEEEeecCCCchhhhhhcc--cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEe--
Confidence 4799999998 468899999999999999977554 69999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC-CcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
..++.+||+|||+|..+.... +..+.+|||+|||||++.+ .|++++||||||+++.||+-|++||...++-..+..|
T Consensus 403 -~~~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLI 481 (550)
T KOG0578|consen 403 -TMDGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI 481 (550)
T ss_pred -ccCCcEEEeeeeeeeccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHH
Confidence 467889999999998876654 6678899999999999964 7999999999999999999999999988887777766
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
.... .+.......+|+.+++||.+||+.|+.+|++|.|+|+||||+...
T Consensus 482 a~ng-~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a~ 530 (550)
T KOG0578|consen 482 ATNG-TPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMAK 530 (550)
T ss_pred hhcC-CCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhcC
Confidence 5533 223333467999999999999999999999999999999995443
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-44 Score=325.63 Aligned_cols=199 Identities=32% Similarity=0.498 Sum_probs=178.5
Q ss_pred CC-Ccccccee----ecC-eEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEE
Q 016471 1 MY-HQKLQHLF----YSN-SFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLF 74 (389)
Q Consensus 1 l~-Hpni~~~~----~~~-~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill 74 (389)
|+ ||||++++ +.+ ++|+|||||.. +|++.++.++..|+++.++.|+.||++||+|+|++|+.||||||+|||+
T Consensus 65 ln~hpniikL~Evi~d~~~~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi 143 (538)
T KOG0661|consen 65 LNPHPNIIKLKEVIRDNDRILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILI 143 (538)
T ss_pred cCCCCcchhhHHHhhccCceEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEe
Confidence 45 99999998 334 89999999987 9999999888899999999999999999999999999999999999999
Q ss_pred eecCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 016471 75 TTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFR 152 (389)
Q Consensus 75 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 152 (389)
+ .+..|||+|||+|+........+..+.|++|+|||++- +.|+.+.|+|++|||++|+.+-++.|.|.++.+.+.
T Consensus 144 ~---~~~~iKiaDFGLARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~ 220 (538)
T KOG0661|consen 144 S---GNDVIKIADFGLAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIY 220 (538)
T ss_pred c---ccceeEecccccccccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHH
Confidence 5 46789999999999998888888999999999999984 469999999999999999999999999999998888
Q ss_pred HHHhcCCCCCCCCC--------------------------CCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCC
Q 016471 153 SVLRADPNFHDSPW--------------------------PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 153 ~i~~~~~~~~~~~~--------------------------~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~ 203 (389)
+|+...+.+....| +..++++.++|.+|+..||.+||||+++|+||||+..
T Consensus 221 KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~ 297 (538)
T KOG0661|consen 221 KICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG 297 (538)
T ss_pred HHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence 88765544433322 3468999999999999999999999999999999764
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=328.09 Aligned_cols=199 Identities=29% Similarity=0.530 Sum_probs=174.5
Q ss_pred CCccccceee----cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 2 YHQKLQHLFY----SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 2 ~Hpni~~~~~----~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
..|.||++|+ ..++||||||++||++...|.+. +.|++..++.++.+++.|++-||+.|++||||||+|+||
T Consensus 199 ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~~-~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLi--- 274 (550)
T KOG0605|consen 199 DSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMRK-DTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLI--- 274 (550)
T ss_pred CCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHhc-CcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheee---
Confidence 4689999994 58899999999999999987765 799999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCCccccCC----------------------C--C-----C-------------------cccccccCCc
Q 016471 78 EEDAPLKVIDFGLSDFVRP----------------------D--Q-----R-------------------LNDIVGSAYY 109 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~----------------------~--~-----~-------------------~~~~~gt~~y 109 (389)
|..|++||+|||+|..... . . . ....+|||-|
T Consensus 275 D~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDY 354 (550)
T KOG0605|consen 275 DAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDY 354 (550)
T ss_pred cCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccc
Confidence 7899999999999842210 0 0 0 0235799999
Q ss_pred ccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCC
Q 016471 110 VAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKR 188 (389)
Q Consensus 110 ~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 188 (389)
+|||++. ..|+..||+||||||+||||.|.+||.+.++.+++.+|.+....+..+.-..+++++++||.+||. ||.+|
T Consensus 355 iAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~R 433 (550)
T KOG0605|consen 355 IAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENR 433 (550)
T ss_pred cchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHh
Confidence 9999985 479999999999999999999999999999999999999987666555556789999999999999 99999
Q ss_pred CC---HHHHhCCCCCCCCCC
Q 016471 189 MT---AAQALTHPWLHDENR 205 (389)
Q Consensus 189 ~s---~~e~l~h~~~~~~~~ 205 (389)
.. ++||..||||++.++
T Consensus 434 LG~~G~~EIK~HPfF~~v~W 453 (550)
T KOG0605|consen 434 LGSKGAEEIKKHPFFKGVDW 453 (550)
T ss_pred cCcccHHHHhcCCccccCCc
Confidence 84 899999999987653
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=321.79 Aligned_cols=199 Identities=31% Similarity=0.542 Sum_probs=164.8
Q ss_pred CCCccccceeec----C--eEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEE
Q 016471 1 MYHQKLQHLFYS----N--SFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLF 74 (389)
Q Consensus 1 l~Hpni~~~~~~----~--~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill 74 (389)
|+|||||+++.. . .++++||||+||+|.+++.+.++.+++..++.+.+||++||.|||++||+||||||+|||+
T Consensus 71 l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl 150 (313)
T KOG0198|consen 71 LNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILL 150 (313)
T ss_pred CCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEE
Confidence 579999999931 2 6999999999999999998775589999999999999999999999999999999999999
Q ss_pred eecCC-CCCEEEeecCCccccCC----CCCcccccccCCccccccccccC--CCchhHHHHHHHHHHHHhCCCCCCC-CC
Q 016471 75 TTREE-DAPLKVIDFGLSDFVRP----DQRLNDIVGSAYYVAPEVLHRSY--NVEGDMWSIGVITYILLCGSRPFWA-RT 146 (389)
Q Consensus 75 ~~~~~-~~~~kl~Dfg~a~~~~~----~~~~~~~~gt~~y~aPE~~~~~~--~~~~DiwslG~il~~ll~g~~pf~~-~~ 146 (389)
. . ++.+||+|||.+..... ........||+.|||||++.... .+++||||+||++.||+||.+||.. ..
T Consensus 151 ~---~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~ 227 (313)
T KOG0198|consen 151 D---PSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFE 227 (313)
T ss_pred e---CCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcc
Confidence 4 5 68999999999887663 12234578999999999987432 3499999999999999999999977 33
Q ss_pred hhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 147 ESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 147 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
.....-.+..... .| .....+|+++++||.+||..+|.+||||+++|.|||.....
T Consensus 228 ~~~~~~~ig~~~~-~P-~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 228 EAEALLLIGREDS-LP-EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred hHHHHHHHhccCC-CC-CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 3333334433331 12 22245899999999999999999999999999999997654
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=303.24 Aligned_cols=186 Identities=23% Similarity=0.489 Sum_probs=163.3
Q ss_pred CCCccccceee-----c-CeEEEEEEccCCCChHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHH--CC--CEecCC
Q 016471 1 MYHQKLQHLFY-----S-NSFLFFTRFCEGGELLDRIL---SRGGRYLEEDAKTIVEKILNIVAFCHL--QG--VVHRDL 67 (389)
Q Consensus 1 l~Hpni~~~~~-----~-~~~~lv~E~~~gg~L~~~l~---~~~~~l~~~~~~~i~~qi~~~L~~lH~--~~--i~Hrdl 67 (389)
|+||||++||. + .-++||||||.+|+|.+.++ +.++.++|..++.++.|++.||..||+ .. |+||||
T Consensus 75 L~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDI 154 (375)
T KOG0591|consen 75 LNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDI 154 (375)
T ss_pred cCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccC
Confidence 79999999993 3 44899999999999988775 445789999999999999999999999 45 999999
Q ss_pred CCCcEEEeecCCCCCEEEeecCCccccCCCCC-cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 016471 68 KPENFLFTTREEDAPLKVIDFGLSDFVRPDQR-LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWAR 145 (389)
Q Consensus 68 kp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~ 145 (389)
||.||++ +.+|.|||+|||+++.+..... ..+.+|||+||+||.+. .+|+.++||||+||++|||..-++||.|.
T Consensus 155 KPaNIFl---~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~ 231 (375)
T KOG0591|consen 155 KPANIFL---TANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD 231 (375)
T ss_pred cchheEE---cCCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc
Confidence 9999999 5789999999999998876543 45679999999999985 57999999999999999999999999999
Q ss_pred ChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCH
Q 016471 146 TESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTA 191 (389)
Q Consensus 146 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~ 191 (389)
+-.++-.+|.++.. ++.+..-+|.++..+|..|+.+||.+||+.
T Consensus 232 n~~~L~~KI~qgd~--~~~p~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 232 NLLSLCKKIEQGDY--PPLPDEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred cHHHHHHHHHcCCC--CCCcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence 98899999988843 333223579999999999999999999986
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=314.68 Aligned_cols=201 Identities=32% Similarity=0.636 Sum_probs=186.7
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
++|||||++| ....+|||+|+=.||+|++||.++...+.|+.++.++.||+.|+.|||+..+|||||||+|+.+.
T Consensus 74 VQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFF- 152 (864)
T KOG4717|consen 74 VQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFF- 152 (864)
T ss_pred hcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEe-
Confidence 4899999999 35789999999999999999999988999999999999999999999999999999999999887
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc-cCC-CchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYN-VEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
..-|.|||+|||++..+.++.+..+.||+..|-|||++.+ .|+ +++||||||||||.|++|++||+..++.+.+..|
T Consensus 153 -EKlGlVKLTDFGFSNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmI 231 (864)
T KOG4717|consen 153 -EKLGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMI 231 (864)
T ss_pred -eecCceEeeeccccccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhh
Confidence 5688999999999999999999999999999999999854 565 7799999999999999999999999999999999
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPV 207 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~~~~ 207 (389)
+.+.+..|. .+|.++++||.+||+.||++|.|.+++..++|++..+.+.
T Consensus 232 mDCKYtvPs----hvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~ 280 (864)
T KOG4717|consen 232 MDCKYTVPS----HVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGL 280 (864)
T ss_pred hcccccCch----hhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCc
Confidence 998877664 4899999999999999999999999999999999876543
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=330.66 Aligned_cols=194 Identities=30% Similarity=0.550 Sum_probs=176.2
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
+||.|+++| ..+++|+||||+.||++.. + .+.+++++..++.|+..|+.||+|||++||||||||.+||||
T Consensus 427 ~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~-~-~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLL--- 501 (694)
T KOG0694|consen 427 RHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMH-H-IHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLL--- 501 (694)
T ss_pred cCCeEeecccccccCCeEEEEEEecCCCcEEE-E-EecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEE---
Confidence 599999999 4689999999999999543 3 234789999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCCccccC-CCCCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 016471 78 EEDAPLKVIDFGLSDFVR-PDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVL 155 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 155 (389)
|..|.+||+|||+++..- .+....++||||.|+|||++.+ .|+..+|+|||||++||||.|+.||.|.+.+++...|+
T Consensus 502 D~eGh~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~ 581 (694)
T KOG0694|consen 502 DTEGHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIV 581 (694)
T ss_pred cccCcEEecccccccccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh
Confidence 688999999999998654 5667788999999999999964 79999999999999999999999999999999999999
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCC-----HHHHhCCCCCCCCC
Q 016471 156 RADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMT-----AAQALTHPWLHDEN 204 (389)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s-----~~e~l~h~~~~~~~ 204 (389)
...+.+|. .+|.++.++++++|.++|.+|.. +.++..||||+..+
T Consensus 582 ~d~~~yP~----~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~ 631 (694)
T KOG0694|consen 582 NDEVRYPR----FLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSID 631 (694)
T ss_pred cCCCCCCC----cccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCC
Confidence 98887775 38999999999999999999985 57999999998764
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=307.62 Aligned_cols=200 Identities=33% Similarity=0.570 Sum_probs=176.4
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEe
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 75 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~ 75 (389)
+.||.|..+| .++.+|+|||||+||+|.....++ ++.++++.|+.++.+|+.||+|||-.|||+|||||+|||+
T Consensus 134 lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILv- 212 (459)
T KOG0610|consen 134 LDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILV- 212 (459)
T ss_pred cCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEE-
Confidence 5799999999 468899999999999999877655 3679999999999999999999999999999999999999
Q ss_pred ecCCCCCEEEeecCCccccCC---------------------------------C------------------------C
Q 016471 76 TREEDAPLKVIDFGLSDFVRP---------------------------------D------------------------Q 98 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~---------------------------------~------------------------~ 98 (389)
-++|.|.|+||.++..... . .
T Consensus 213 --redGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~ 290 (459)
T KOG0610|consen 213 --REDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGA 290 (459)
T ss_pred --ecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCc
Confidence 5789999999998632210 0 0
Q ss_pred CcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHH
Q 016471 99 RLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFV 177 (389)
Q Consensus 99 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 177 (389)
+...++||-.|+|||++.+ ..+.++|+|+|||.+|||+.|..||.|.+..+.+.+|+.....++.. +.++..+++||
T Consensus 291 RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~--~~vs~~akDLI 368 (459)
T KOG0610|consen 291 RSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEE--PEVSSAAKDLI 368 (459)
T ss_pred cccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCC--CcchhHHHHHH
Confidence 1234579999999999975 68999999999999999999999999999999999999988888766 47899999999
Q ss_pred HhhhccCcCCCCC----HHHHhCCCCCCCCCC
Q 016471 178 RRLLNKDHRKRMT----AAQALTHPWLHDENR 205 (389)
Q Consensus 178 ~~~l~~~p~~R~s----~~e~l~h~~~~~~~~ 205 (389)
+++|.+||.+|.. |+||.+||||.+.++
T Consensus 369 r~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnW 400 (459)
T KOG0610|consen 369 RKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNW 400 (459)
T ss_pred HHHhccChhhhhccccchHHhhcCccccCCCh
Confidence 9999999999998 999999999988754
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=301.23 Aligned_cols=198 Identities=26% Similarity=0.510 Sum_probs=171.5
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|+|||||.+. -...+++|+|||.. ++.+-+......++++.+..++.|++.|+.|||+++++||||||+|||++
T Consensus 58 LkH~NLVnLiEVFrrkrklhLVFE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit- 135 (396)
T KOG0593|consen 58 LKHENLVNLIEVFRRKRKLHLVFEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILIT- 135 (396)
T ss_pred cccchHHHHHHHHHhcceeEEEeeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEe-
Confidence 6899999988 46889999999998 55565666656799999999999999999999999999999999999996
Q ss_pred cCCCCCEEEeecCCccccC-CCCCcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVR-PDQRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRS 153 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 153 (389)
.++.+||||||+|+... ++...+..+.|.+|+|||.+-+ +|+..+||||+||++.||++|.+.|.|.++.+.+..
T Consensus 136 --~~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~ 213 (396)
T KOG0593|consen 136 --QNGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYL 213 (396)
T ss_pred --cCCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHH
Confidence 67899999999999887 6677788999999999998754 799999999999999999999999999998877766
Q ss_pred HHhcCCCCCC---------------------------CCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCC
Q 016471 154 VLRADPNFHD---------------------------SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 202 (389)
Q Consensus 154 i~~~~~~~~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~ 202 (389)
|.+....+.+ ..+|.++.-+.+|+++||..||.+|++.++++.||||.+
T Consensus 214 I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 214 IRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG 289 (396)
T ss_pred HHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence 6543222111 124567889999999999999999999999999999943
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=311.23 Aligned_cols=202 Identities=28% Similarity=0.470 Sum_probs=172.0
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEe
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 75 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~ 75 (389)
++||||+.+| .++.+|+||.||++|++++.+.... ..++|..++.|+++++.||.|||.+|.+|||||+.|||+
T Consensus 81 ~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi- 159 (516)
T KOG0582|consen 81 IDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILI- 159 (516)
T ss_pred cCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEE-
Confidence 5899999999 4789999999999999999887542 349999999999999999999999999999999999999
Q ss_pred ecCCCCCEEEeecCCccccCCC-C----CcccccccCCcccccccc---ccCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 016471 76 TREEDAPLKVIDFGLSDFVRPD-Q----RLNDIVGSAYYVAPEVLH---RSYNVEGDMWSIGVITYILLCGSRPFWARTE 147 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~~-~----~~~~~~gt~~y~aPE~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 147 (389)
+.+|.|||+|||.+..+... . +..+.+||++|||||++. ..|+.|+||||||++..||.+|..||..-.+
T Consensus 160 --~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP 237 (516)
T KOG0582|consen 160 --DSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP 237 (516)
T ss_pred --cCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh
Confidence 68999999999987654322 2 225679999999999963 3699999999999999999999999998888
Q ss_pred hHHHHHHHhcCCCCCC------CCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCCC
Q 016471 148 SGIFRSVLRADPNFHD------SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENR 205 (389)
Q Consensus 148 ~~~~~~i~~~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~~ 205 (389)
-+++-.-+++.+..+. .....++..++.+|..||++||.+|||++++|+|+||+....
T Consensus 238 mkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~ 301 (516)
T KOG0582|consen 238 MKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS 301 (516)
T ss_pred HHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence 7776666665553222 223457889999999999999999999999999999987643
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=290.90 Aligned_cols=202 Identities=30% Similarity=0.495 Sum_probs=180.6
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|+||||+.+. +.+.+.||+||++. +|...++.+...++..++..++.+++.||+|||++.|+||||||.|+|+
T Consensus 58 l~h~nIi~LiD~F~~~~~l~lVfEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLi-- 134 (318)
T KOG0659|consen 58 LKHPNIIELIDVFPHKSNLSLVFEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLI-- 134 (318)
T ss_pred ccCcchhhhhhhccCCCceEEEEEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEE--
Confidence 6899999988 56889999999997 9999888888889999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC-CcccccccCCcccccccc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRS 153 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 153 (389)
+.++.+||+|||+|+.+.... .....+-|.+|+|||.+- +.|+..+|+||.|||+.||+.|.+-|.|.++-+.+..
T Consensus 135 -s~~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~ 213 (318)
T KOG0659|consen 135 -SSDGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSK 213 (318)
T ss_pred -cCCCcEEeecccchhccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHH
Confidence 578999999999999886544 334458899999999885 4699999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCCCC------------------------CCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCCCC
Q 016471 154 VLRADPNFHDSPWPS------------------------VSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRP 206 (389)
Q Consensus 154 i~~~~~~~~~~~~~~------------------------~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~~~ 206 (389)
|++....+.+..||+ .+.++.+|+.+||.+||.+|+|+.|+++|+||++...+
T Consensus 214 If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~p 290 (318)
T KOG0659|consen 214 IFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLP 290 (318)
T ss_pred HHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCC
Confidence 998777766666654 35788999999999999999999999999999875443
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=313.57 Aligned_cols=199 Identities=30% Similarity=0.520 Sum_probs=177.3
Q ss_pred CCCcccccee------ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEE
Q 016471 1 MYHQKLQHLF------YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLF 74 (389)
Q Consensus 1 l~Hpni~~~~------~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill 74 (389)
|.||||+++. ....+|+|+|||+. +|...+....-+|++.++..+++||+.||+|||++||+|||||.+|||+
T Consensus 173 l~HpNIikL~eivt~~~~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLi 251 (560)
T KOG0600|consen 173 LDHPNIIKLEEIVTSKLSGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILI 251 (560)
T ss_pred cCCCcccceeeEEEecCCceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEE
Confidence 6899999998 24689999999998 8988776656689999999999999999999999999999999999999
Q ss_pred eecCCCCCEEEeecCCccccCCCC--CcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHH
Q 016471 75 TTREEDAPLKVIDFGLSDFVRPDQ--RLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGI 150 (389)
Q Consensus 75 ~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 150 (389)
|++|++||+|||+|+.+.... ..+..+-|.+|+|||.+.+ .|+..+|+||+|||+.||++|++.|+|.++.+.
T Consensus 252 ---dn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQ 328 (560)
T KOG0600|consen 252 ---DNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQ 328 (560)
T ss_pred ---cCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHH
Confidence 789999999999999776544 4677899999999998854 699999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCC-------------------------CCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCC
Q 016471 151 FRSVLRADPNFHDSPWP-------------------------SVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 151 ~~~i~~~~~~~~~~~~~-------------------------~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~ 203 (389)
+..|++....+....|+ .+++.+.+|+..||..||.+|.||.++|+|+||...
T Consensus 329 l~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~ 406 (560)
T KOG0600|consen 329 LHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTE 406 (560)
T ss_pred HHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccC
Confidence 99998866655554454 247889999999999999999999999999999544
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=319.74 Aligned_cols=194 Identities=29% Similarity=0.593 Sum_probs=175.5
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|+||||++++ ...++|+|+|||.| +|+.++. .++.++|+.++.++.|++.||.|||+++|+|||+||+|||+
T Consensus 58 lkHpniv~m~esfEt~~~~~vVte~a~g-~L~~il~-~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl-- 133 (808)
T KOG0597|consen 58 LKHPNIVEMLESFETSAHLWVVTEYAVG-DLFTILE-QDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILL-- 133 (808)
T ss_pred cCCcchhhHHHhhcccceEEEEehhhhh-hHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeee--
Confidence 6899999988 46899999999998 9998665 45899999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCC-cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQR-LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
+.++.+|+||||+|+.+..+.. .+...|||.|||||.+. +.|+..+|.||+|||+||+.+|++||...+-.+..+.|
T Consensus 134 -~~~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I 212 (808)
T KOG0597|consen 134 -EKGGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSI 212 (808)
T ss_pred -cCCCceeechhhhhhhcccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHH
Confidence 6899999999999998876543 45568999999999986 47999999999999999999999999999999999999
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~ 203 (389)
......++ +.+|..++.|+..+|.+||.+|+|+.+++.|||.+..
T Consensus 213 ~~d~v~~p----~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 213 LKDPVKPP----STASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred hcCCCCCc----ccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence 87765544 3689999999999999999999999999999998653
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=297.89 Aligned_cols=204 Identities=25% Similarity=0.442 Sum_probs=178.4
Q ss_pred CCCcccccee------ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEE
Q 016471 1 MYHQKLQHLF------YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLF 74 (389)
Q Consensus 1 l~Hpni~~~~------~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill 74 (389)
.+|||||.+- .-+.+|+|||||+. +|...+..-..+++..+++.++.|++.||+|||.+.|+||||||+|+|+
T Consensus 132 ~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm 210 (419)
T KOG0663|consen 132 ARHPNIVEVKEVVVGSNMDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLL 210 (419)
T ss_pred cCCCCeeeeEEEEeccccceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheee
Confidence 3799999988 23679999999998 8988877666789999999999999999999999999999999999999
Q ss_pred eecCCCCCEEEeecCCccccCCC-CCcccccccCCcccccccc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHH
Q 016471 75 TTREEDAPLKVIDFGLSDFVRPD-QRLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIF 151 (389)
Q Consensus 75 ~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 151 (389)
+ +.|.+||+|||+|+.+... ...+..+-|.+|+|||.+- ..|+.++|+||+|||+.|++++++.|.|.+..+.+
T Consensus 211 ~---~~G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl 287 (419)
T KOG0663|consen 211 S---HKGILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQL 287 (419)
T ss_pred c---cCCcEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHH
Confidence 4 7899999999999987654 4566778999999999875 46999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCCC----------------------------CCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCC
Q 016471 152 RSVLRADPNFHDSPWPS----------------------------VSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 152 ~~i~~~~~~~~~~~~~~----------------------------~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~ 203 (389)
.+|++....+....||. ++....+|+..+|.+||.+|.||.++|+|.||.+.
T Consensus 288 ~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~ 367 (419)
T KOG0663|consen 288 DKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET 367 (419)
T ss_pred HHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence 99987665555554442 34788899999999999999999999999999986
Q ss_pred CCCCC
Q 016471 204 NRPVP 208 (389)
Q Consensus 204 ~~~~~ 208 (389)
+.+.+
T Consensus 368 P~p~~ 372 (419)
T KOG0663|consen 368 PLPID 372 (419)
T ss_pred CCCCC
Confidence 55443
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=310.76 Aligned_cols=196 Identities=29% Similarity=0.591 Sum_probs=171.6
Q ss_pred CCCcccccee------ecCeEEEEEEccCCCChHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEE
Q 016471 1 MYHQKLQHLF------YSNSFLFFTRFCEGGELLDRILSRGGR-YLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFL 73 (389)
Q Consensus 1 l~Hpni~~~~------~~~~~~lv~E~~~gg~L~~~l~~~~~~-l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nil 73 (389)
|.|||||+++ ..+.+|||+|||+.|.+.. ....+. +++.+++.|++.++.||+|||.+||+||||||+|+|
T Consensus 165 l~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w--~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLL 242 (576)
T KOG0585|consen 165 LHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKW--CPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLL 242 (576)
T ss_pred cCCcCeeEEEEeecCcccCceEEEEEeccCCcccc--CCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheE
Confidence 6899999999 3688999999999999865 223344 999999999999999999999999999999999999
Q ss_pred EeecCCCCCEEEeecCCccccCCC------CCcccccccCCccccccccc-----cCCCchhHHHHHHHHHHHHhCCCCC
Q 016471 74 FTTREEDAPLKVIDFGLSDFVRPD------QRLNDIVGSAYYVAPEVLHR-----SYNVEGDMWSIGVITYILLCGSRPF 142 (389)
Q Consensus 74 l~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~DiwslG~il~~ll~g~~pf 142 (389)
+ +.+++|||+|||.+.....+ ..+...+|||.|+|||.+.. ..+.+.||||+||+||-|+.|+.||
T Consensus 243 l---~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF 319 (576)
T KOG0585|consen 243 L---SSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPF 319 (576)
T ss_pred E---cCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCc
Confidence 9 46799999999998766322 23345789999999998743 1467899999999999999999999
Q ss_pred CCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCC
Q 016471 143 WARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 143 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~ 203 (389)
.+....+++.+|.+....++.. +.+...+++||.+||.+||.+|+++.++..|||....
T Consensus 320 ~~~~~~~l~~KIvn~pL~fP~~--pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 320 FDDFELELFDKIVNDPLEFPEN--PEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred ccchHHHHHHHHhcCcccCCCc--ccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 9999999999999887776654 5789999999999999999999999999999999765
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=302.33 Aligned_cols=192 Identities=31% Similarity=0.617 Sum_probs=176.9
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|+||||+.+| ..+.+.|||||.+||+|+||+-.+ +.|+|.+++.+++||+.|+.|||.++++|||||.+|||+
T Consensus 110 LNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSer-~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILL-- 186 (668)
T KOG0611|consen 110 LNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISER-GSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILL-- 186 (668)
T ss_pred cCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHHh-ccccHHHHHHHHHHHHHHHHHHhhccceecccchhheee--
Confidence 7999999998 467899999999999999999777 789999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc-cC-CCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SY-NVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
|.++++||+|||++..+....-..++||+|.|.+||++++ .| ++.+|.|||||+||.|+.|..||.|.+...+..+|
T Consensus 187 -D~N~NiKIADFGLSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQI 265 (668)
T KOG0611|consen 187 -DQNNNIKIADFGLSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQI 265 (668)
T ss_pred -cCCCCeeeeccchhhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHh
Confidence 6889999999999999888888889999999999999976 44 68899999999999999999999999999999999
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLH 201 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~ 201 (389)
.++.+.-+. -+.++.-||+.||.+||.+|.|+.++..|=|+.
T Consensus 266 s~GaYrEP~-----~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 266 SRGAYREPE-----TPSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred hcccccCCC-----CCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 888765443 466899999999999999999999999998874
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=300.59 Aligned_cols=198 Identities=30% Similarity=0.534 Sum_probs=166.9
Q ss_pred CCCccccceee---------cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCc
Q 016471 1 MYHQKLQHLFY---------SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPEN 71 (389)
Q Consensus 1 l~Hpni~~~~~---------~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~N 71 (389)
|+|+||+.+++ -+.+|+|+|+|+. +|...+ +.+..+++..++.++.|++.||+|+|+.||+||||||.|
T Consensus 78 ~~HeNIi~l~di~~p~~~~~f~DvYiV~elMet-DL~~ii-k~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsN 155 (359)
T KOG0660|consen 78 LRHENIIGLLDIFRPPSRDKFNDVYLVFELMET-DLHQII-KSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSN 155 (359)
T ss_pred hcCCCcceEEeecccccccccceeEEehhHHhh-HHHHHH-HcCccccHHHHHHHHHHHHHhcchhhcccccccccchhh
Confidence 57999999983 2569999999954 787755 444569999999999999999999999999999999999
Q ss_pred EEEeecCCCCCEEEeecCCccccCC---CCCcccccccCCcccccccc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 016471 72 FLFTTREEDAPLKVIDFGLSDFVRP---DQRLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILLCGSRPFWART 146 (389)
Q Consensus 72 ill~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 146 (389)
+|+ +.+-.+||+|||+|+.... ...++..+.|.+|.|||++. ..|+...||||+|||+.||++|++.|.|.+
T Consensus 156 ll~---n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d 232 (359)
T KOG0660|consen 156 LLL---NADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKD 232 (359)
T ss_pred eee---ccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCc
Confidence 999 5677899999999998754 44567789999999999874 479999999999999999999999998887
Q ss_pred hhHHHHHHHh-----------------------cCCCCCCCC----CCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCC
Q 016471 147 ESGIFRSVLR-----------------------ADPNFHDSP----WPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPW 199 (389)
Q Consensus 147 ~~~~~~~i~~-----------------------~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~ 199 (389)
....+..|.. ..+..+..+ +|..++.+.+|+.+||..||.+|+|++|+|+|||
T Consensus 233 ~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPY 312 (359)
T KOG0660|consen 233 YVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPY 312 (359)
T ss_pred hHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChh
Confidence 6555544433 222333322 3678999999999999999999999999999999
Q ss_pred CCCC
Q 016471 200 LHDE 203 (389)
Q Consensus 200 ~~~~ 203 (389)
+...
T Consensus 313 l~~~ 316 (359)
T KOG0660|consen 313 LAPY 316 (359)
T ss_pred hhhh
Confidence 9765
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=310.39 Aligned_cols=195 Identities=30% Similarity=0.561 Sum_probs=170.1
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
++||||+.++ ..+.+|+|||||+||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+||++
T Consensus 52 l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll-- 128 (323)
T cd05571 52 TRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLML-- 128 (323)
T ss_pred CCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE--
Confidence 5799999987 457899999999999999988655 689999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccC-CCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVR-PDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
+.++.+||+|||++.... ........+||+.|+|||++. ..++.++||||+||++|+|++|..||.+.+.......+
T Consensus 129 -~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~ 207 (323)
T cd05571 129 -DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 207 (323)
T ss_pred -CCCCCEEEeeCCCCcccccCCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHH
Confidence 567889999999987532 223344567999999999985 46899999999999999999999999988888777777
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCC-----CHHHHhCCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRM-----TAAQALTHPWLHDE 203 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----s~~e~l~h~~~~~~ 203 (389)
......++ ..+++.+.++|.+||..||.+|| ++.++++||||...
T Consensus 208 ~~~~~~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 208 LMEEIRFP----RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred HcCCCCCC----CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 76654443 35899999999999999999999 89999999999775
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=279.47 Aligned_cols=194 Identities=30% Similarity=0.610 Sum_probs=177.5
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEe
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILS-RGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 75 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~-~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~ 75 (389)
|+||||.++| ++..+|+++||..+|+|+..+.. ..+++++..+..++.|++.||.|||.++++||||||+|+|+
T Consensus 79 L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLl- 157 (281)
T KOG0580|consen 79 LRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLL- 157 (281)
T ss_pred cCCccHHhhhhheeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhcc-
Confidence 7899999988 67899999999999999998873 34679999999999999999999999999999999999999
Q ss_pred ecCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 76 TREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
+..+.+|++|||-+.... ..+..+.|||.-|.|||+..+ .++..+|+|++|++.||++.|.+||...+..+.++.|
T Consensus 158 --g~~~~lkiAdfGwsV~~p-~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI 234 (281)
T KOG0580|consen 158 --GSAGELKIADFGWSVHAP-SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRI 234 (281)
T ss_pred --CCCCCeeccCCCceeecC-CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHH
Confidence 467889999999987755 555678999999999999865 6999999999999999999999999999999999999
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 202 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~ 202 (389)
.+....+| +.++..++++|.+||.++|.+|++..+++.|||+..
T Consensus 235 ~k~~~~~p----~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 235 RKVDLKFP----STISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred HHccccCC----cccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 99887776 468999999999999999999999999999999854
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=302.56 Aligned_cols=193 Identities=28% Similarity=0.569 Sum_probs=169.8
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ ....+|+|||||+||+|.+++..+ +.+++..+..++.||+.||+|||++||+||||||+||++
T Consensus 58 l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli-- 134 (291)
T cd05612 58 VSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNS-GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILL-- 134 (291)
T ss_pred CCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE--
Confidence 5799999988 457899999999999999988665 679999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVL 155 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 155 (389)
+.++.+||+|||++...... ....+||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+.+.......+.
T Consensus 135 -~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~ 211 (291)
T cd05612 135 -DKEGHIKLTDFGFAKKLRDR--TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKIL 211 (291)
T ss_pred -CCCCCEEEEecCcchhccCC--cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 56788999999998765432 234579999999998854 58899999999999999999999999988888888887
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCC-----HHHHhCCCCCCCC
Q 016471 156 RADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMT-----AAQALTHPWLHDE 203 (389)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s-----~~e~l~h~~~~~~ 203 (389)
.....++ ..+++.++++|++||+.||.+|++ +++++.||||...
T Consensus 212 ~~~~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 260 (291)
T cd05612 212 AGKLEFP----RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSV 260 (291)
T ss_pred hCCcCCC----ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCC
Confidence 7655443 246899999999999999999995 9999999999754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=304.05 Aligned_cols=191 Identities=24% Similarity=0.392 Sum_probs=164.7
Q ss_pred CCCcccccee--e-cC--eEEEEEEccCCCChHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC-CEecCCCCCcEE
Q 016471 1 MYHQKLQHLF--Y-SN--SFLFFTRFCEGGELLDRILS-RGGRYLEEDAKTIVEKILNIVAFCHLQG-VVHRDLKPENFL 73 (389)
Q Consensus 1 l~Hpni~~~~--~-~~--~~~lv~E~~~gg~L~~~l~~-~~~~l~~~~~~~i~~qi~~~L~~lH~~~-i~Hrdlkp~Nil 73 (389)
|+||||+.++ + +. .+++||||+++|+|.+++.+ .++.++...+..++.||++|++|||+++ ||||||||+|||
T Consensus 96 l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiL 175 (362)
T KOG0192|consen 96 LRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNIL 175 (362)
T ss_pred CCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEE
Confidence 6899999999 2 22 58999999999999999877 3688999999999999999999999999 999999999999
Q ss_pred EeecCCCC-CEEEeecCCccccCCC-CCcccccccCCccccccccc---cCCCchhHHHHHHHHHHHHhCCCCCCCCChh
Q 016471 74 FTTREEDA-PLKVIDFGLSDFVRPD-QRLNDIVGSAYYVAPEVLHR---SYNVEGDMWSIGVITYILLCGSRPFWARTES 148 (389)
Q Consensus 74 l~~~~~~~-~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 148 (389)
+ +.+. .+||+|||+++..... ...+...||+.|||||++.+ .|+.++|||||||++|||+||+.||.+....
T Consensus 176 v---~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~ 252 (362)
T KOG0192|consen 176 V---DLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV 252 (362)
T ss_pred E---cCCCCEEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH
Confidence 9 4665 9999999999876654 34445789999999999974 4999999999999999999999999998887
Q ss_pred HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 149 GIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 149 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
+....+.......+.+ ...++.+..++.+||..||.+||+..+++.
T Consensus 253 ~~~~~v~~~~~Rp~~p--~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 253 QVASAVVVGGLRPPIP--KECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HHHHHHHhcCCCCCCC--ccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 7776666544433322 238999999999999999999999988874
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=305.03 Aligned_cols=195 Identities=28% Similarity=0.524 Sum_probs=169.8
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||+.++ ..+.+|+|||||+||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+||++
T Consensus 50 l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili-- 126 (312)
T cd05585 50 VNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQRE-GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILL-- 126 (312)
T ss_pred CCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEE--
Confidence 5799999987 457899999999999999988665 679999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCC-CCCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRP-DQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
+.++.+||+|||++..... .......+||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+.+..+....+
T Consensus 127 -~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~ 205 (312)
T cd05585 127 -DYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKI 205 (312)
T ss_pred -CCCCcEEEEECcccccCccCCCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHH
Confidence 5778999999999875432 223345679999999998854 6899999999999999999999999998888888887
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCC---CHHHHhCCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRM---TAAQALTHPWLHDE 203 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~---s~~e~l~h~~~~~~ 203 (389)
......++ ..+++.++++|.+||..||.+|| ++.+++.||||...
T Consensus 206 ~~~~~~~~----~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 206 LQEPLRFP----DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred HcCCCCCC----CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence 76654433 35889999999999999999997 57999999999764
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=307.99 Aligned_cols=193 Identities=27% Similarity=0.527 Sum_probs=170.3
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ ....+|+|||||+||+|.+++.+. +.+++..+..++.|++.||.|||++||+||||||+|||+
T Consensus 88 l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl-- 164 (340)
T PTZ00426 88 INHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRN-KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLL-- 164 (340)
T ss_pred CCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE--
Confidence 5799999988 457899999999999999988665 679999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVL 155 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 155 (389)
+.++.+||+|||++..... .....+||+.|+|||++.+ .++.++|+||+||++|+|++|.+||.+.+.......+.
T Consensus 165 -~~~~~ikL~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~ 241 (340)
T PTZ00426 165 -DKDGFIKMTDFGFAKVVDT--RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKIL 241 (340)
T ss_pred -CCCCCEEEecCCCCeecCC--CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHh
Confidence 5778999999999976543 2345679999999999854 58899999999999999999999999988888888887
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCC-----CHHHHhCCCCCCCC
Q 016471 156 RADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRM-----TAAQALTHPWLHDE 203 (389)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----s~~e~l~h~~~~~~ 203 (389)
.....++ +.+++.++++|++||+.+|.+|+ |++++++||||.+.
T Consensus 242 ~~~~~~p----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~ 290 (340)
T PTZ00426 242 EGIIYFP----KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI 290 (340)
T ss_pred cCCCCCC----CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 7654443 34789999999999999999995 89999999999764
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=289.70 Aligned_cols=203 Identities=29% Similarity=0.463 Sum_probs=175.9
Q ss_pred CCCcc-ccceee----cC------eEEEEEEccCCCChHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCCCEecC
Q 016471 1 MYHQK-LQHLFY----SN------SFLFFTRFCEGGELLDRILSRG---GRYLEEDAKTIVEKILNIVAFCHLQGVVHRD 66 (389)
Q Consensus 1 l~Hpn-i~~~~~----~~------~~~lv~E~~~gg~L~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrd 66 (389)
|.|+| |+.+++ .+ .+++|+||+.. +|..++.... ..++...++.++.||+.||+|||++||+|||
T Consensus 67 L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRD 145 (323)
T KOG0594|consen 67 LSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRD 145 (323)
T ss_pred hCCCcceEEEEeeeeecccccccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccc
Confidence 57999 999882 33 78999999987 9999997765 3588889999999999999999999999999
Q ss_pred CCCCcEEEeecCCCCCEEEeecCCccccCC-CCCcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCC
Q 016471 67 LKPENFLFTTREEDAPLKVIDFGLSDFVRP-DQRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFW 143 (389)
Q Consensus 67 lkp~Nill~~~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~ 143 (389)
|||+|||+ ++++.+||+|||+|+.... .......++|.+|+|||++.+ .|+...||||+|||++||+++++.|.
T Consensus 146 LKPQNlLi---~~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFp 222 (323)
T KOG0594|consen 146 LKPQNLLI---SSSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFP 222 (323)
T ss_pred CCcceEEE---CCCCcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCC
Confidence 99999999 4689999999999997763 344667789999999999854 59999999999999999999999999
Q ss_pred CCChhHHHHHHHhcCCCCCCCCCCC--------------------------CCHHHHHHHHhhhccCcCCCCCHHHHhCC
Q 016471 144 ARTESGIFRSVLRADPNFHDSPWPS--------------------------VSPEAKDFVRRLLNKDHRKRMTAAQALTH 197 (389)
Q Consensus 144 ~~~~~~~~~~i~~~~~~~~~~~~~~--------------------------~~~~~~~li~~~l~~~p~~R~s~~e~l~h 197 (389)
|.++.+.+..|.+....+....||. .+++..+++.+||+++|.+|+|++.++.|
T Consensus 223 G~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 223 GDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 9999999999988766665555543 23689999999999999999999999999
Q ss_pred CCCCCCCCCC
Q 016471 198 PWLHDENRPV 207 (389)
Q Consensus 198 ~~~~~~~~~~ 207 (389)
|||.....+.
T Consensus 303 ~yf~~~~~~~ 312 (323)
T KOG0594|consen 303 PYFSELPEKS 312 (323)
T ss_pred hhhcccccch
Confidence 9998775433
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=306.84 Aligned_cols=193 Identities=30% Similarity=0.577 Sum_probs=169.7
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ ..+.+|+|||||.||+|.+++.+. +.+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 75 l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll-- 151 (329)
T PTZ00263 75 LSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKA-GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLL-- 151 (329)
T ss_pred CCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEE--
Confidence 5799999998 467899999999999999988765 689999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVL 155 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 155 (389)
+.++.+||+|||++...... .....||+.|+|||++. ..++.++||||+||++|+|++|..||.+.+..+.+..+.
T Consensus 152 -~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~ 228 (329)
T PTZ00263 152 -DNKGHVKVTDFGFAKKVPDR--TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKIL 228 (329)
T ss_pred -CCCCCEEEeeccCceEcCCC--cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHh
Confidence 57789999999999866432 23467999999999885 458899999999999999999999999988888888887
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCC-----HHHHhCCCCCCCC
Q 016471 156 RADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMT-----AAQALTHPWLHDE 203 (389)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s-----~~e~l~h~~~~~~ 203 (389)
.....++ ..++..+++||.+||..||.+|++ +++++.||||.+.
T Consensus 229 ~~~~~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~ 277 (329)
T PTZ00263 229 AGRLKFP----NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGA 277 (329)
T ss_pred cCCcCCC----CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence 7654433 237899999999999999999997 7999999999764
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=307.95 Aligned_cols=199 Identities=25% Similarity=0.465 Sum_probs=166.6
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||+.++ ....+|+|||||+||+|.+++.++ +.+++..++.++.|++.||+|||++||+||||||+|||+
T Consensus 58 ~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi-- 134 (363)
T cd05628 58 ADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLL-- 134 (363)
T ss_pred CCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE--
Confidence 4799999988 357899999999999999988765 689999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC------------------------------------CcccccccCCcccccccc-ccC
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ------------------------------------RLNDIVGSAYYVAPEVLH-RSY 119 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~-~~~ 119 (389)
+.++.+||+|||++....... .....+||+.|+|||++. ..+
T Consensus 135 -~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~ 213 (363)
T cd05628 135 -DSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGY 213 (363)
T ss_pred -CCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCC
Confidence 567899999999987542210 012457999999999985 468
Q ss_pred CCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcC---CCCCHHHHhC
Q 016471 120 NVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHR---KRMTAAQALT 196 (389)
Q Consensus 120 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~---~R~s~~e~l~ 196 (389)
+.++||||+||++|+|++|+.||.+.+..+.+..+.........+....++++++++|.+|+. +|. .||+++++++
T Consensus 214 ~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~ 292 (363)
T cd05628 214 NKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKT 292 (363)
T ss_pred CCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhC
Confidence 999999999999999999999999988888888887654333333334589999999999775 444 4689999999
Q ss_pred CCCCCCCC
Q 016471 197 HPWLHDEN 204 (389)
Q Consensus 197 h~~~~~~~ 204 (389)
||||.+.+
T Consensus 293 hp~f~~~~ 300 (363)
T cd05628 293 NPFFEGVD 300 (363)
T ss_pred CCCCCCCC
Confidence 99998753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=304.16 Aligned_cols=194 Identities=28% Similarity=0.565 Sum_probs=169.5
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
.||||++++ ..+.+|+|||||+||+|.+++.+. +.+++..+..++.|++.||.|||++||+||||||+|||+
T Consensus 54 ~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli--- 129 (320)
T cd05590 54 NHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLL--- 129 (320)
T ss_pred CCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE---
Confidence 699999988 457899999999999999877655 679999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCCccccCC-CCCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 016471 78 EEDAPLKVIDFGLSDFVRP-DQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVL 155 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 155 (389)
+.++.+||+|||++..... ........||+.|+|||++.+ .++.++|+||+||++|+|++|+.||.+.+.......+.
T Consensus 130 ~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~ 209 (320)
T cd05590 130 DHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL 209 (320)
T ss_pred CCCCcEEEeeCCCCeecCcCCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHh
Confidence 5678999999999875432 223345679999999999864 68999999999999999999999999998888888887
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCH------HHHhCCCCCCCC
Q 016471 156 RADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTA------AQALTHPWLHDE 203 (389)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~------~e~l~h~~~~~~ 203 (389)
......+ ..++++++++|++||..||.+||++ ++++.||||...
T Consensus 210 ~~~~~~~----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~ 259 (320)
T cd05590 210 NDEVVYP----TWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKEL 259 (320)
T ss_pred cCCCCCC----CCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCC
Confidence 7654433 3478999999999999999999998 999999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=298.31 Aligned_cols=201 Identities=25% Similarity=0.396 Sum_probs=165.3
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEe
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 75 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~ 75 (389)
+.||||+.++ ..+.+|+|||||+||+|.+++... ...+++..+..++.|++.||.|||++||+||||||+|||+
T Consensus 57 l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill- 135 (285)
T cd05631 57 VNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILL- 135 (285)
T ss_pred cCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE-
Confidence 5799999988 457899999999999998877643 2468999999999999999999999999999999999999
Q ss_pred ecCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 76 TREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
+.++.+||+|||++.............||+.|+|||++. ..++.++||||+||++|+|++|+.||.+.........+
T Consensus 136 --~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~ 213 (285)
T cd05631 136 --DDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEV 213 (285)
T ss_pred --CCCCCEEEeeCCCcEEcCCCCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHH
Confidence 567889999999998765444445668999999999985 46899999999999999999999999876553332222
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCC-----HHHHhCCCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMT-----AAQALTHPWLHDEN 204 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s-----~~e~l~h~~~~~~~ 204 (389)
..............+++.+.+|+++||..+|.+||+ ++++++||||.+.+
T Consensus 214 ~~~~~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~ 268 (285)
T cd05631 214 DRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNIN 268 (285)
T ss_pred HHHhhcccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence 221111122222468999999999999999999997 89999999997753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=298.57 Aligned_cols=196 Identities=24% Similarity=0.443 Sum_probs=162.8
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|.||||++++ ....+|+|||||.| +|.+++......+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 60 l~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~-- 136 (288)
T cd07871 60 LKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLI-- 136 (288)
T ss_pred CCCCCEeeEEEEEcCCCeEEEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE--
Confidence 5799999988 35679999999986 8999887766678999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCC-CCcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPD-QRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRS 153 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 153 (389)
+.++.+||+|||++...... .......||+.|+|||++.+ .++.++||||+||++|+|++|++||.+.+..+....
T Consensus 137 -~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~ 215 (288)
T cd07871 137 -NEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHL 215 (288)
T ss_pred -CCCCCEEECcCcceeeccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 56788999999998765332 22344578999999998743 589999999999999999999999988877666655
Q ss_pred HHhcCCCCCCC--------------------------CCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCC
Q 016471 154 VLRADPNFHDS--------------------------PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 154 i~~~~~~~~~~--------------------------~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~ 200 (389)
+.+.....+.. ..+.+++++++||++||.+||.+|||++++++||||
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 216 IFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred HHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 54322211111 113468899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=304.13 Aligned_cols=195 Identities=29% Similarity=0.545 Sum_probs=168.6
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||+.++ ..+.+|+|||||+||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 52 l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll-- 128 (328)
T cd05593 52 TRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRE-RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLML-- 128 (328)
T ss_pred CCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEE--
Confidence 5799999887 457899999999999998877654 679999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCC-CCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRP-DQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
+.++.+||+|||++..... .......+||+.|+|||++. ..++.++||||+||++|+|++|+.||.+.+.......+
T Consensus 129 -~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~ 207 (328)
T cd05593 129 -DKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 207 (328)
T ss_pred -CCCCcEEEecCcCCccCCCcccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHh
Confidence 5678999999999875422 22334567999999999985 46899999999999999999999999988877777777
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCC-----CHHHHhCCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRM-----TAAQALTHPWLHDE 203 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----s~~e~l~h~~~~~~ 203 (389)
......++ ..+++++.++|.+||..+|.+|+ ++.++++||||...
T Consensus 208 ~~~~~~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 257 (328)
T cd05593 208 LMEDIKFP----RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGV 257 (328)
T ss_pred ccCCccCC----CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 65544433 35899999999999999999997 89999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=302.16 Aligned_cols=195 Identities=30% Similarity=0.569 Sum_probs=169.0
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||+.++ ..+.+|+|||||+||+|..++... +.+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 52 l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll-- 128 (323)
T cd05595 52 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML-- 128 (323)
T ss_pred CCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE--
Confidence 5799999987 457899999999999998877654 679999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCC-CCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRP-DQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
+.++.+||+|||++..... ........||+.|+|||++. +.++.++|+||+||++|+|++|+.||.+.+.......+
T Consensus 129 -~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~ 207 (323)
T cd05595 129 -DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 207 (323)
T ss_pred -cCCCCEEecccHHhccccCCCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 5678999999999875322 22334567999999999985 46899999999999999999999999988888777777
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCC-----CHHHHhCCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRM-----TAAQALTHPWLHDE 203 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----s~~e~l~h~~~~~~ 203 (389)
......++ ..+++.++++|.+||..+|.+|+ ++.++++||||...
T Consensus 208 ~~~~~~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~ 257 (323)
T cd05595 208 LMEEIRFP----RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 257 (323)
T ss_pred hcCCCCCC----CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCC
Confidence 66554433 35799999999999999999998 89999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=297.18 Aligned_cols=200 Identities=26% Similarity=0.462 Sum_probs=171.5
Q ss_pred CCCccccceee------cC---eEEEEEEccCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCC
Q 016471 1 MYHQKLQHLFY------SN---SFLFFTRFCEGGELLDRILS---RGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLK 68 (389)
Q Consensus 1 l~Hpni~~~~~------~~---~~~lv~E~~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlk 68 (389)
|.|||||++.+ +. +..+||||++. +|.+.+.. .+.+++.-.++-++.||++||.|||+.||+|||||
T Consensus 74 l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIK 152 (364)
T KOG0658|consen 74 LDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIK 152 (364)
T ss_pred cCCcCeeeEEEEEEecCCCchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCC
Confidence 57999999761 22 46799999997 99888763 35789999999999999999999999999999999
Q ss_pred CCcEEEeecCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 016471 69 PENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWART 146 (389)
Q Consensus 69 p~Nill~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~ 146 (389)
|+|+|++ ...+.+||||||.|+....+....+..+|++|+|||.+.+ .|+.+.||||.|||+.||+-|++.|.|.+
T Consensus 153 PqNlLvD--~~tg~LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s 230 (364)
T KOG0658|consen 153 PQNLLVD--PDTGVLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDS 230 (364)
T ss_pred hheEEEc--CCCCeEEeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCC
Confidence 9999996 4569999999999999988887788899999999998854 69999999999999999999999999998
Q ss_pred hhHHHHHHHhcCCCCC--------------------CCCC-----CCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCC
Q 016471 147 ESGIFRSVLRADPNFH--------------------DSPW-----PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLH 201 (389)
Q Consensus 147 ~~~~~~~i~~~~~~~~--------------------~~~~-----~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~ 201 (389)
....+..|.+..+.+. ...| ...++++.+|+.++|.++|.+|.++.+++.||||.
T Consensus 231 ~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFd 310 (364)
T KOG0658|consen 231 SVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFD 310 (364)
T ss_pred HHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhH
Confidence 8887777664322211 1111 35689999999999999999999999999999996
Q ss_pred CC
Q 016471 202 DE 203 (389)
Q Consensus 202 ~~ 203 (389)
..
T Consensus 311 el 312 (364)
T KOG0658|consen 311 EL 312 (364)
T ss_pred Hh
Confidence 54
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=307.82 Aligned_cols=198 Identities=25% Similarity=0.479 Sum_probs=170.4
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
++||||+.++ ..+.+|+|||||+||+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 100 ~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl-- 175 (370)
T cd05596 100 ANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL-- 175 (370)
T ss_pred CCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE--
Confidence 5799999988 35779999999999999987754 468999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC--CcccccccCCccccccccc-----cCCCchhHHHHHHHHHHHHhCCCCCCCCChhH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ--RLNDIVGSAYYVAPEVLHR-----SYNVEGDMWSIGVITYILLCGSRPFWARTESG 149 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 149 (389)
+.++.+||+|||++....... .....+||+.|+|||++.+ .++.++|+||+||++|+|++|.+||.+.+...
T Consensus 176 -~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~ 254 (370)
T cd05596 176 -DKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG 254 (370)
T ss_pred -cCCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH
Confidence 578899999999987654322 2245679999999998742 37889999999999999999999999988888
Q ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCC--CCCHHHHhCCCCCCCC
Q 016471 150 IFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRK--RMTAAQALTHPWLHDE 203 (389)
Q Consensus 150 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~--R~s~~e~l~h~~~~~~ 203 (389)
.+..+.........+....+|..++++|++||..+|.+ |+|++++++||||+..
T Consensus 255 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 255 TYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND 310 (370)
T ss_pred HHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence 88888765544443444568999999999999999988 9999999999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=300.18 Aligned_cols=194 Identities=29% Similarity=0.574 Sum_probs=167.8
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
.||||++++ ..+++|+|||||+||+|..++..+ +.+++..+..++.||+.||+|||++||+||||||+||++
T Consensus 54 ~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~--- 129 (316)
T cd05620 54 ENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVML--- 129 (316)
T ss_pred CCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---
Confidence 699999988 457899999999999999988665 679999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCCccccCC-CCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 016471 78 EEDAPLKVIDFGLSDFVRP-DQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVL 155 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 155 (389)
+.++.+||+|||++..... .......+||+.|+|||++. ..++.++||||+||++|+|++|..||.+.+.......+.
T Consensus 130 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~ 209 (316)
T cd05620 130 DRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIR 209 (316)
T ss_pred CCCCCEEeCccCCCeecccCCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 5678999999999875322 22334567999999999986 468999999999999999999999999888887777776
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCH-HHHhCCCCCCCC
Q 016471 156 RADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTA-AQALTHPWLHDE 203 (389)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~-~e~l~h~~~~~~ 203 (389)
...+.++ ..++++++++|.+||..||.+||++ +++++||||...
T Consensus 210 ~~~~~~~----~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 210 VDTPHYP----RWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTI 254 (316)
T ss_pred hCCCCCC----CCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCC
Confidence 5544433 2478999999999999999999997 588899999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=303.05 Aligned_cols=195 Identities=29% Similarity=0.477 Sum_probs=175.9
Q ss_pred CCCcccccee----ecCe-EEEEEEccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEE
Q 016471 1 MYHQKLQHLF----YSNS-FLFFTRFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLF 74 (389)
Q Consensus 1 l~Hpni~~~~----~~~~-~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill 74 (389)
|+|||||.|. .++. ++|||+||+||++.+.+.+++ ..++|+.+..++.|++.||+|||+++|+|||||+.||++
T Consensus 60 ~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifl 139 (426)
T KOG0589|consen 60 LLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFL 139 (426)
T ss_pred ccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhc
Confidence 6899999999 2455 999999999999999998665 679999999999999999999999999999999999999
Q ss_pred eecCCCCCEEEeecCCccccCCCC-CcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 016471 75 TTREEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFR 152 (389)
Q Consensus 75 ~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 152 (389)
+ .++.|||+|||+|+...+.. ...+.+|||.|++||++.+ +|+.++|||||||++|||.+-+++|.+.+...+..
T Consensus 140 t---k~~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ 216 (426)
T KOG0589|consen 140 T---KDKKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELIL 216 (426)
T ss_pred c---ccCceeecchhhhhhcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHH
Confidence 6 56778999999999987765 5677899999999999975 79999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCC
Q 016471 153 SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLH 201 (389)
Q Consensus 153 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~ 201 (389)
+|.+....+.+ ..++.+++.+|+.||..+|..||++.++|.+|.+.
T Consensus 217 ki~~~~~~Plp---~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~ 262 (426)
T KOG0589|consen 217 KINRGLYSPLP---SMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLL 262 (426)
T ss_pred HHhhccCCCCC---ccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhh
Confidence 99987743332 35799999999999999999999999999998764
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=306.84 Aligned_cols=199 Identities=27% Similarity=0.546 Sum_probs=169.6
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
++||||+.++ ....+|+|||||+||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 58 l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~-- 134 (364)
T cd05599 58 ADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKK-DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLL-- 134 (364)
T ss_pred CCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE--
Confidence 5799999998 467899999999999999988665 679999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC---------------------------------------CcccccccCCcccccccc-
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ---------------------------------------RLNDIVGSAYYVAPEVLH- 116 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~---------------------------------------~~~~~~gt~~y~aPE~~~- 116 (389)
+.++.+||+|||++....... .....+||+.|+|||++.
T Consensus 135 -~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 213 (364)
T cd05599 135 -DAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ 213 (364)
T ss_pred -CCCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC
Confidence 578899999999986542111 011346999999999885
Q ss_pred ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCC---HHH
Q 016471 117 RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMT---AAQ 193 (389)
Q Consensus 117 ~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s---~~e 193 (389)
..++.++||||+||++|+|++|..||.+.+..+....+.........+....+++.++++|.+||. +|.+|++ +.+
T Consensus 214 ~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ 292 (364)
T cd05599 214 TGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNE 292 (364)
T ss_pred CCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHH
Confidence 468999999999999999999999999988888877777655444433334689999999999996 9999998 999
Q ss_pred HhCCCCCCCCC
Q 016471 194 ALTHPWLHDEN 204 (389)
Q Consensus 194 ~l~h~~~~~~~ 204 (389)
++.||||+...
T Consensus 293 ll~h~~~~~~~ 303 (364)
T cd05599 293 IKSHPFFKGVD 303 (364)
T ss_pred HhcCCCcCCCC
Confidence 99999998753
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=302.54 Aligned_cols=197 Identities=29% Similarity=0.515 Sum_probs=169.4
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ ..+.+|+|||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||++
T Consensus 58 ~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~-- 134 (333)
T cd05600 58 TKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNL-GVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLI-- 134 (333)
T ss_pred CCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE--
Confidence 4699999988 457899999999999999988654 679999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVL 155 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 155 (389)
+.++.+||+|||++..... ......||+.|+|||++. ..++.++||||+||++|+|++|..||.+.+..+.+..+.
T Consensus 135 -~~~~~~kL~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~ 211 (333)
T cd05600 135 -DASGHIKLTDFGLSKGIVT--YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLK 211 (333)
T ss_pred -CCCCCEEEEeCcCCccccc--ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHH
Confidence 5678999999999876543 334567999999999885 468999999999999999999999999988887777766
Q ss_pred hcCCCCCCCCC----CCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCC
Q 016471 156 RADPNFHDSPW----PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 156 ~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~ 203 (389)
........+.+ ..+++++.++|.+||..+|.+||++.++++||||...
T Consensus 212 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 212 YWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred hccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 54332222222 2579999999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=300.43 Aligned_cols=194 Identities=27% Similarity=0.510 Sum_probs=169.6
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
.||||+.++ ..+.+|+|||||+||+|..++.+. +.+++..+..++.||+.||.|||++||+||||||+||++
T Consensus 54 ~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill--- 129 (321)
T cd05591 54 KHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILL--- 129 (321)
T ss_pred CCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---
Confidence 699999988 357899999999999999887655 679999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCCccccCC-CCCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 016471 78 EEDAPLKVIDFGLSDFVRP-DQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVL 155 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 155 (389)
+.++.+||+|||++..... ........||+.|+|||++.+ .++.++|+||+||++|+|++|+.||.+.+.......+.
T Consensus 130 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~ 209 (321)
T cd05591 130 DAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESIL 209 (321)
T ss_pred CCCCCEEEeecccceecccCCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 5778999999999875432 223345679999999998854 68999999999999999999999999998888888887
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCC-------CHHHHhCCCCCCCC
Q 016471 156 RADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRM-------TAAQALTHPWLHDE 203 (389)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-------s~~e~l~h~~~~~~ 203 (389)
.....++ ..+++++.++|.+||..+|.+|+ +++++++||||...
T Consensus 210 ~~~~~~p----~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~ 260 (321)
T cd05591 210 HDDVLYP----VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEI 260 (321)
T ss_pred cCCCCCC----CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCC
Confidence 7654433 24789999999999999999999 89999999999664
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=299.79 Aligned_cols=195 Identities=29% Similarity=0.554 Sum_probs=169.3
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ .++.+|+|||||+||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 57 l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~-- 133 (323)
T cd05584 57 VKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLERE-GIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILL-- 133 (323)
T ss_pred CCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE--
Confidence 5799999987 457899999999999999988655 678999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCC-CCCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRP-DQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
+.++.+||+|||++..... ........||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+.+.......+
T Consensus 134 -~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~ 212 (323)
T cd05584 134 -DAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKI 212 (323)
T ss_pred -CCCCCEEEeeCcCCeecccCCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 5678999999999875432 223344679999999999854 5889999999999999999999999998888878877
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCC-----CHHHHhCCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRM-----TAAQALTHPWLHDE 203 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----s~~e~l~h~~~~~~ 203 (389)
.......+ +.+++.+.++|.+||..+|.+|| ++++++.||||...
T Consensus 213 ~~~~~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 213 LKGKLNLP----PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred HcCCCCCC----CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 76654433 45799999999999999999999 89999999999764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=300.84 Aligned_cols=195 Identities=27% Similarity=0.525 Sum_probs=169.0
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ ..+.+|+|||||+||+|..++... +.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 53 l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll-- 129 (323)
T cd05575 53 VKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILL-- 129 (323)
T ss_pred CCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE--
Confidence 5799999987 357899999999999999887654 689999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCC-CCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRP-DQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
+.++.+||+|||++..... .......+||+.|+|||++. ..++.++||||+||++|+|++|..||.+.+..+....+
T Consensus 130 -~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i 208 (323)
T cd05575 130 -DSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNI 208 (323)
T ss_pred -CCCCcEEEeccCCCcccccCCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHH
Confidence 5678999999999875422 22334567999999999885 46899999999999999999999999998888888887
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCH----HHHhCCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTA----AQALTHPWLHDE 203 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~----~e~l~h~~~~~~ 203 (389)
.......+ +.+++.+.++|.+||+.+|.+||++ .+++.||||...
T Consensus 209 ~~~~~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~ 257 (323)
T cd05575 209 LNKPLRLK----PNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSI 257 (323)
T ss_pred HcCCCCCC----CCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCC
Confidence 76544332 4579999999999999999999987 699999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=294.25 Aligned_cols=195 Identities=26% Similarity=0.393 Sum_probs=163.6
Q ss_pred CCccccceee---------cCeEEEEEEccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCc
Q 016471 2 YHQKLQHLFY---------SNSFLFFTRFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPEN 71 (389)
Q Consensus 2 ~Hpni~~~~~---------~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~N 71 (389)
.||||+++++ ...+++||||+. |+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|
T Consensus 62 ~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~N 140 (290)
T cd07862 62 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQN 140 (290)
T ss_pred CCCCcceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHH
Confidence 6999999983 245899999997 5898888653 2458999999999999999999999999999999999
Q ss_pred EEEeecCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHH
Q 016471 72 FLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGI 150 (389)
Q Consensus 72 ill~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 150 (389)
||+ +.++.+||+|||++.............||+.|+|||++. ..++.++||||+||++|+|++|.+||.+.+..+.
T Consensus 141 il~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~ 217 (290)
T cd07862 141 ILV---TSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ 217 (290)
T ss_pred EEE---cCCCCEEEccccceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH
Confidence 999 467899999999998765544445667999999999885 4689999999999999999999999999888777
Q ss_pred HHHHHhcCCCCCCC-----------------------CCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCC
Q 016471 151 FRSVLRADPNFHDS-----------------------PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 151 ~~~i~~~~~~~~~~-----------------------~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~ 200 (389)
+..+.......... ..+.+++.+++++.+||+.+|++|||+.++++||||
T Consensus 218 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 218 LGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred HHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 77665432211111 113578889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=302.70 Aligned_cols=195 Identities=30% Similarity=0.566 Sum_probs=168.5
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCEecCCCCCcEEEe
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHL-QGVVHRDLKPENFLFT 75 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~-~~i~Hrdlkp~Nill~ 75 (389)
+.||||+.++ ....+|+|||||+||+|..++... +.+++..+..++.||+.||.|||+ +||+||||||+|||+
T Consensus 52 ~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll- 129 (325)
T cd05594 52 SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML- 129 (325)
T ss_pred CCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEE-
Confidence 5799999887 457899999999999998877654 679999999999999999999997 799999999999999
Q ss_pred ecCCCCCEEEeecCCccccCC-CCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016471 76 TREEDAPLKVIDFGLSDFVRP-DQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRS 153 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 153 (389)
+.++.+||+|||++..... ........||+.|+|||++. ..++.++||||+||++|+|++|..||.+.+.......
T Consensus 130 --~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~ 207 (325)
T cd05594 130 --DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 207 (325)
T ss_pred --CCCCCEEEecCCCCeecCCCCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHH
Confidence 5778999999999875432 22334567999999999885 4689999999999999999999999998888777777
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCC-----CHHHHhCCCCCCCC
Q 016471 154 VLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRM-----TAAQALTHPWLHDE 203 (389)
Q Consensus 154 i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----s~~e~l~h~~~~~~ 203 (389)
+......++ ..+++++.++|.+||..||.+|+ ++.++++||||.+.
T Consensus 208 i~~~~~~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 258 (325)
T cd05594 208 ILMEEIRFP----RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGI 258 (325)
T ss_pred HhcCCCCCC----CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCC
Confidence 766554443 35799999999999999999997 89999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=298.13 Aligned_cols=194 Identities=34% Similarity=0.620 Sum_probs=167.9
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
.||||++++ ....+|+|||||+||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+||++
T Consensus 54 ~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill--- 129 (316)
T cd05592 54 EHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSS-GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLL--- 129 (316)
T ss_pred CCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEE---
Confidence 699999998 357899999999999999887655 689999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCCccccCCC-CCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 016471 78 EEDAPLKVIDFGLSDFVRPD-QRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVL 155 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 155 (389)
+.++.+||+|||++...... ......+||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+..+....+.
T Consensus 130 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~ 209 (316)
T cd05592 130 DKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSIL 209 (316)
T ss_pred CCCCCEEEccCcCCeECCCCCCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 56789999999998764322 23345679999999998854 68999999999999999999999999988888887776
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCH-HHHhCCCCCCCC
Q 016471 156 RADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTA-AQALTHPWLHDE 203 (389)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~-~e~l~h~~~~~~ 203 (389)
...+.++ ..+++++.++|.+||..+|.+||++ .+++.||||...
T Consensus 210 ~~~~~~~----~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05592 210 NDRPHFP----RWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGI 254 (316)
T ss_pred cCCCCCC----CCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCC
Confidence 6544333 3478999999999999999999986 588899999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=282.30 Aligned_cols=201 Identities=36% Similarity=0.674 Sum_probs=176.6
Q ss_pred Ccccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeecC
Q 016471 3 HQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE 78 (389)
Q Consensus 3 Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~~ 78 (389)
|+||+.+. ++..+|||||-+.||.|..+|.++ +.++|.++..++++|+.||.|||.+||.||||||+|||-..-+
T Consensus 135 h~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~~-~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn 213 (463)
T KOG0607|consen 135 HKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKR-KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPN 213 (463)
T ss_pred CccHHHHHHHhcccceEEEEEecccCchHHHHHHHh-hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCC
Confidence 89998876 678999999999999999999887 6899999999999999999999999999999999999997655
Q ss_pred CCCCEEEeecCCccccCC--------CCCcccccccCCcccccccc---c---cCCCchhHHHHHHHHHHHHhCCCCCCC
Q 016471 79 EDAPLKVIDFGLSDFVRP--------DQRLNDIVGSAYYVAPEVLH---R---SYNVEGDMWSIGVITYILLCGSRPFWA 144 (389)
Q Consensus 79 ~~~~~kl~Dfg~a~~~~~--------~~~~~~~~gt~~y~aPE~~~---~---~~~~~~DiwslG~il~~ll~g~~pf~~ 144 (389)
.-..|||+||.+...... .+...+.+|+..|||||++. + -|+.++|.||||||+|-||+|++||.|
T Consensus 214 ~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG 293 (463)
T KOG0607|consen 214 KVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVG 293 (463)
T ss_pred CcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccC
Confidence 556799999988654321 22345678999999999862 2 389999999999999999999999976
Q ss_pred CC---------------hhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 145 RT---------------ESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 145 ~~---------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
.. ...++..|..+...+|...|..+|.+++++++.+|..++.+|.++.++++|||++...
T Consensus 294 ~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~ 368 (463)
T KOG0607|consen 294 HCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCA 368 (463)
T ss_pred ccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccc
Confidence 43 2456788889999999999999999999999999999999999999999999998653
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=295.39 Aligned_cols=200 Identities=24% Similarity=0.409 Sum_probs=159.4
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|.||||+.++ ....+|+|||||. |+|.+++..+.+.+++..++.++.||+.||+|||++||+||||||+||++
T Consensus 60 l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill-- 136 (303)
T cd07869 60 LKHANIVLLHDIIHTKETLTLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLI-- 136 (303)
T ss_pred CCCCCcCeEEEEEecCCeEEEEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE--
Confidence 5799999988 3678999999996 58888887776789999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCC-CCcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChh-HHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPD-QRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTES-GIFR 152 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~ 152 (389)
+.++.+||+|||++...... .......||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.... ....
T Consensus 137 -~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~ 215 (303)
T cd07869 137 -SDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLE 215 (303)
T ss_pred -CCCCCEEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHH
Confidence 56788999999998754322 22344678999999998743 4788999999999999999999999875432 2233
Q ss_pred HHHhcCCCCCCCC--------------------------C--CCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 153 SVLRADPNFHDSP--------------------------W--PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 153 ~i~~~~~~~~~~~--------------------------~--~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
.+........... + ...++.+++|+.+||+.||.+|||+.++++||||++..
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~ 295 (303)
T cd07869 216 RIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP 295 (303)
T ss_pred HHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence 3222111000000 0 12457899999999999999999999999999997753
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=305.53 Aligned_cols=198 Identities=25% Similarity=0.475 Sum_probs=168.0
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ .+..+|+|||||+||+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 100 ~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl-- 175 (370)
T cd05621 100 ANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLL-- 175 (370)
T ss_pred CCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE--
Confidence 4799999998 45789999999999999998754 368999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC--CcccccccCCccccccccc-----cCCCchhHHHHHHHHHHHHhCCCCCCCCChhH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ--RLNDIVGSAYYVAPEVLHR-----SYNVEGDMWSIGVITYILLCGSRPFWARTESG 149 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 149 (389)
+.++.+||+|||+|....... ...+.+||+.|+|||++.+ .++.++|+||+||++|+|++|..||.+.+...
T Consensus 176 -~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~ 254 (370)
T cd05621 176 -DKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG 254 (370)
T ss_pred -CCCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH
Confidence 577899999999998764322 2345679999999998843 27889999999999999999999999988888
Q ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCC--CCCHHHHhCCCCCCCC
Q 016471 150 IFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRK--RMTAAQALTHPWLHDE 203 (389)
Q Consensus 150 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~--R~s~~e~l~h~~~~~~ 203 (389)
.+..+.........+....+++.+++++.+||..++.+ |+|+.++++||||+..
T Consensus 255 ~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 255 TYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred HHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 88888765444333333467999999999999866554 8999999999999764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=302.32 Aligned_cols=204 Identities=26% Similarity=0.505 Sum_probs=176.6
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
.||+|+.++ +++.+||+.|||.||-....+..-+..|++.++..+++|++.||+|||+++|+|||||..|||++
T Consensus 87 dHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~T-- 164 (1187)
T KOG0579|consen 87 DHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLT-- 164 (1187)
T ss_pred CChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEE--
Confidence 499999976 68999999999999999888888878899999999999999999999999999999999999997
Q ss_pred CCCCCEEEeecCCccccCC-CCCcccccccCCccccccc------cccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHH
Q 016471 78 EEDAPLKVIDFGLSDFVRP-DQRLNDIVGSAYYVAPEVL------HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGI 150 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 150 (389)
-+|.|+|+|||.+..... ..+..+++|||+|||||+. ..+|++++||||||++|.+|..+.+|-..-++..+
T Consensus 165 -ldGdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRV 243 (1187)
T KOG0579|consen 165 -LDGDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV 243 (1187)
T ss_pred -ecCcEeeecccccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHH
Confidence 468899999999765432 3345678999999999986 24699999999999999999999999988888888
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCCCCCCc
Q 016471 151 FRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPL 209 (389)
Q Consensus 151 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~~~~~~ 209 (389)
+-+|.+..+..-.. ...++..+.+|+++||.+||..||+++++++|||+.+.....++
T Consensus 244 llKiaKSePPTLlq-PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~SnK~i 301 (1187)
T KOG0579|consen 244 LLKIAKSEPPTLLQ-PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPSNKMI 301 (1187)
T ss_pred HHHHhhcCCCcccC-cchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCcchHH
Confidence 88877655432222 24678999999999999999999999999999999877655443
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=296.54 Aligned_cols=196 Identities=30% Similarity=0.559 Sum_probs=168.4
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ ..+.+|+|||||+||+|.+++... +.+++..+..++.|++.||.|||++||+||||||+||++
T Consensus 53 ~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~-- 129 (316)
T cd05619 53 WEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILL-- 129 (316)
T ss_pred cCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE--
Confidence 3799999988 457899999999999999988654 679999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCC-CCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRP-DQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
+.++.+||+|||++..... ........||+.|+|||++. ..++.++|+||+||++|+|++|..||.+.+..+....+
T Consensus 130 -~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i 208 (316)
T cd05619 130 -DTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI 208 (316)
T ss_pred -CCCCCEEEccCCcceECCCCCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 5678899999999875422 22334567999999999885 46899999999999999999999999988888777777
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHH-HHhCCCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAA-QALTHPWLHDEN 204 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~-e~l~h~~~~~~~ 204 (389)
....+.++ ..++..++++|.+||..+|.+||++. ++++||||....
T Consensus 209 ~~~~~~~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05619 209 RMDNPCYP----RWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREID 255 (316)
T ss_pred HhCCCCCC----ccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCC
Confidence 65544333 24789999999999999999999996 899999997743
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=302.32 Aligned_cols=199 Identities=27% Similarity=0.473 Sum_probs=170.4
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
++||||+.++ ..+.+|+|||||+||+|.+++.+..+.+++..++.++.||+.||+|||++||+||||||+||++
T Consensus 58 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll-- 135 (330)
T cd05601 58 SNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLI-- 135 (330)
T ss_pred CCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEE--
Confidence 4799999987 3578999999999999999887766789999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCC--cccccccCCcccccccc-------ccCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQR--LNDIVGSAYYVAPEVLH-------RSYNVEGDMWSIGVITYILLCGSRPFWARTE 147 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~-------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 147 (389)
+.++.+||+|||++........ .....||+.|+|||++. ..++.++||||+||++|+|++|..||...+.
T Consensus 136 -~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~ 214 (330)
T cd05601 136 -DRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS 214 (330)
T ss_pred -CCCCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH
Confidence 5778999999999987644322 22347999999999874 2477899999999999999999999998888
Q ss_pred hHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCC
Q 016471 148 SGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 148 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~ 203 (389)
...+..+.........+..+.+++.+.+||.+||. +|.+|||+++++.||||...
T Consensus 215 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~ 269 (330)
T cd05601 215 AKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI 269 (330)
T ss_pred HHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence 87777777654333333335689999999999998 99999999999999999764
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=305.99 Aligned_cols=198 Identities=30% Similarity=0.543 Sum_probs=167.5
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||+.++ ..+.+|+|||||+||+|.+++.+. +.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 58 ~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl-- 134 (382)
T cd05625 58 ADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILI-- 134 (382)
T ss_pred CCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE--
Confidence 4799999998 457899999999999999988655 679999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCC------------------------------------------------CCcccccccCC
Q 016471 77 REEDAPLKVIDFGLSDFVRPD------------------------------------------------QRLNDIVGSAY 108 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~------------------------------------------------~~~~~~~gt~~ 108 (389)
+.++.+||+|||++...... ......+||+.
T Consensus 135 -~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 213 (382)
T cd05625 135 -DRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPN 213 (382)
T ss_pred -CCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcc
Confidence 57889999999997532100 00123479999
Q ss_pred cccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCC
Q 016471 109 YVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRK 187 (389)
Q Consensus 109 y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 187 (389)
|+|||++. ..++.++||||+||++|+|++|++||.+.+..+....+.........+....+++++.++|.+|+ .+|.+
T Consensus 214 Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~ 292 (382)
T cd05625 214 YIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPED 292 (382)
T ss_pred cCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhH
Confidence 99999885 46899999999999999999999999998887777777765544444445678999999999986 59999
Q ss_pred CCC---HHHHhCCCCCCCC
Q 016471 188 RMT---AAQALTHPWLHDE 203 (389)
Q Consensus 188 R~s---~~e~l~h~~~~~~ 203 (389)
|++ ++++++||||+..
T Consensus 293 R~~~~~~~ei~~hp~f~~~ 311 (382)
T cd05625 293 RLGKNGADEIKAHPFFKTI 311 (382)
T ss_pred cCCCCCHHHHhcCCCcCCc
Confidence 997 9999999999764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=297.62 Aligned_cols=194 Identities=29% Similarity=0.510 Sum_probs=168.4
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ ..+.+|+|||||+||+|..++.. +.+++..++.++.||+.||+|||++||+||||||+||++
T Consensus 59 l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill-- 134 (324)
T cd05589 59 ERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLL-- 134 (324)
T ss_pred cCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE--
Confidence 4699999988 45789999999999999887643 579999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCC-CCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRP-DQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
+.++.+||+|||++..... .......+||+.|+|||++. ..++.++|+||+||++|+|++|+.||.+.+..+....+
T Consensus 135 -~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i 213 (324)
T cd05589 135 -DTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSI 213 (324)
T ss_pred -CCCCcEEeCcccCCccCCCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 5678999999999875322 23344567999999999885 46889999999999999999999999998888888887
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCC-----CHHHHhCCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRM-----TAAQALTHPWLHDE 203 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----s~~e~l~h~~~~~~ 203 (389)
.......+ ..+++.+.++|.+||..||.+|| ++.++++||||.+.
T Consensus 214 ~~~~~~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 214 VNDEVRYP----RFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred HhCCCCCC----CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 77655433 35799999999999999999999 69999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=296.50 Aligned_cols=194 Identities=29% Similarity=0.554 Sum_probs=168.8
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
.||||+.++ ..+.+|+|||||+||+|.+++.+. +.+++..+..++.||+.||.|||++||+||||||+||++
T Consensus 54 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill--- 129 (318)
T cd05570 54 KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLL--- 129 (318)
T ss_pred CCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEE---
Confidence 699999998 357899999999999999887655 689999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCCccccCC-CCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 016471 78 EEDAPLKVIDFGLSDFVRP-DQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVL 155 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 155 (389)
+.++.+||+|||++..... .......+||+.|+|||++. ..++.++|+||+||++|+|++|+.||.+.+.......+.
T Consensus 130 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~ 209 (318)
T cd05570 130 DSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSIL 209 (318)
T ss_pred CCCCcEEecccCCCeecCcCCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHH
Confidence 5678999999999865322 22334457999999999985 468999999999999999999999999888888877777
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCH-----HHHhCCCCCCCC
Q 016471 156 RADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTA-----AQALTHPWLHDE 203 (389)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~-----~e~l~h~~~~~~ 203 (389)
.....++ ..++..+.++|++||..||.+|||+ .+++.||||...
T Consensus 210 ~~~~~~~----~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 210 EDEVRYP----RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred cCCCCCC----CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 6554433 3578999999999999999999999 999999999774
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=300.80 Aligned_cols=197 Identities=24% Similarity=0.471 Sum_probs=167.7
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.+|||..|| ++..+|++||||.||++.+.+... +.+.|.++..++++++.||.|||+++.+|||||+.|||++
T Consensus 68 ~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~~-~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s- 145 (467)
T KOG0201|consen 68 CDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKSG-NILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLS- 145 (467)
T ss_pred cCcchHHhhhhheeecccHHHHHHHhcCcchhhhhccC-CCCccceeeeehHHHHHHhhhhhhcceecccccccceeEe-
Confidence 3678998888 678899999999999999977544 5569999999999999999999999999999999999996
Q ss_pred cCCCCCEEEeecCCccccCCCC-CcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
..+.+||+|||++....... +..+++|||.|||||++.. .|+.++||||||++.+||++|.+|+....+...+..|
T Consensus 146 --~~g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI 223 (467)
T KOG0201|consen 146 --ESGDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI 223 (467)
T ss_pred --ccCcEEEEecceeeeeechhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec
Confidence 55899999999998776543 3478999999999999975 7999999999999999999999999887775444434
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
-+..+ +..-..+|+.+++||..||++||+.||||.++|+|+|++...
T Consensus 224 pk~~P---P~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~ 270 (467)
T KOG0201|consen 224 PKSAP---PRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRAK 270 (467)
T ss_pred cCCCC---CccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhcC
Confidence 33222 111126899999999999999999999999999999998843
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=302.57 Aligned_cols=198 Identities=31% Similarity=0.593 Sum_probs=170.9
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ ..+.+|+|||||+||+|.+++.+. +.+++..++.++.||+.||+|||++||+||||||+||++
T Consensus 58 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll-- 134 (350)
T cd05573 58 ADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILI-- 134 (350)
T ss_pred cCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE--
Confidence 4799999987 467899999999999999988766 789999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC------------------------------CcccccccCCcccccccc-ccCCCchhH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ------------------------------RLNDIVGSAYYVAPEVLH-RSYNVEGDM 125 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~~Di 125 (389)
+.++.+||+|||++....... ......||+.|+|||++. ..++.++||
T Consensus 135 -~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 213 (350)
T cd05573 135 -DADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDW 213 (350)
T ss_pred -CCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceee
Confidence 577899999999987654332 223457999999999885 468999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCC-HHHHhCCCCCCCC
Q 016471 126 WSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMT-AAQALTHPWLHDE 203 (389)
Q Consensus 126 wslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s-~~e~l~h~~~~~~ 203 (389)
||+||++|+|++|+.||.+.........+.........+..+.+++.+.++|.+||. +|.+|++ ++++++||||...
T Consensus 214 wSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~ 291 (350)
T cd05573 214 WSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI 291 (350)
T ss_pred EecchhhhhhccCCCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence 999999999999999999988877777777643333333344589999999999997 9999999 9999999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=303.67 Aligned_cols=199 Identities=28% Similarity=0.508 Sum_probs=164.7
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||+.++ ....+|+|||||+||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 58 l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili-- 134 (381)
T cd05626 58 ADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM-EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILI-- 134 (381)
T ss_pred cCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEE--
Confidence 5799999998 357899999999999999988655 679999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC------------------------------------------------CcccccccCC
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ------------------------------------------------RLNDIVGSAY 108 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~------------------------------------------------~~~~~~gt~~ 108 (389)
+.++.+||+|||++....... .....+||+.
T Consensus 135 -~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 213 (381)
T cd05626 135 -DLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPN 213 (381)
T ss_pred -CCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCcc
Confidence 567899999999875321000 0123579999
Q ss_pred cccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhc--cCc
Q 016471 109 YVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLN--KDH 185 (389)
Q Consensus 109 y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~--~~p 185 (389)
|+|||++. ..++.++||||+||++|+|++|..||.+.+.......+.........+....+++++++||.+|+. .+|
T Consensus 214 Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~ 293 (381)
T cd05626 214 YIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEER 293 (381)
T ss_pred ccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccc
Confidence 99999885 468999999999999999999999999888777666666544333334445689999999999654 455
Q ss_pred CCCCCHHHHhCCCCCCCC
Q 016471 186 RKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 186 ~~R~s~~e~l~h~~~~~~ 203 (389)
..|+++++++.||||...
T Consensus 294 ~~R~~~~~~l~hp~f~~~ 311 (381)
T cd05626 294 LGRNGADDIKAHPFFSEV 311 (381)
T ss_pred cCCCCHHHHhcCcccCCC
Confidence 569999999999999764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=304.57 Aligned_cols=198 Identities=25% Similarity=0.468 Sum_probs=164.9
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ ....+|+|||||+||+|.+++... +.+++..++.++.|++.||+|||++||+||||||+|||+
T Consensus 58 l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll-- 134 (377)
T cd05629 58 SDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILI-- 134 (377)
T ss_pred CCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE--
Confidence 5799999998 357899999999999999988655 679999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC------------------------------------------------CcccccccCC
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ------------------------------------------------RLNDIVGSAY 108 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~------------------------------------------------~~~~~~gt~~ 108 (389)
+.++.+||+|||+++...... .....+||+.
T Consensus 135 -~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 213 (377)
T cd05629 135 -DRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPD 213 (377)
T ss_pred -CCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCcc
Confidence 567899999999986321100 0012469999
Q ss_pred cccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCC
Q 016471 109 YVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRK 187 (389)
Q Consensus 109 y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 187 (389)
|+|||++. ..++.++||||+||++|+|++|.+||.+.+....+..+.........+....+++++++||.+||. +|.+
T Consensus 214 y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~ 292 (377)
T cd05629 214 YIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAEN 292 (377)
T ss_pred ccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhh
Confidence 99999885 468999999999999999999999999888877777777544333333334689999999999998 6766
Q ss_pred C---CCHHHHhCCCCCCCC
Q 016471 188 R---MTAAQALTHPWLHDE 203 (389)
Q Consensus 188 R---~s~~e~l~h~~~~~~ 203 (389)
| +|+.+++.||||.+.
T Consensus 293 r~~r~~~~~~l~hp~~~~~ 311 (377)
T cd05629 293 RLGRGGAHEIKSHPFFRGV 311 (377)
T ss_pred cCCCCCHHHHhcCCCcCCC
Confidence 5 599999999999764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=297.69 Aligned_cols=194 Identities=27% Similarity=0.529 Sum_probs=161.6
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
.||||+.++ ..+.+|+|||||+||+|.+++.+. +++++..++.++.||+.||.|||++||+||||||+||++
T Consensus 54 ~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili--- 129 (329)
T cd05588 54 NHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLL--- 129 (329)
T ss_pred CCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---
Confidence 699999988 357899999999999999877655 689999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCCcccc-CCCCCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCC---------
Q 016471 78 EEDAPLKVIDFGLSDFV-RPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWART--------- 146 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~-~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~--------- 146 (389)
+.++.+||+|||++... .........+||+.|+|||++.+ .++.++|+||+||++|+|++|+.||....
T Consensus 130 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~ 209 (329)
T cd05588 130 DAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNT 209 (329)
T ss_pred CCCCCEEECcCccccccccCCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccc
Confidence 56789999999998753 22333445689999999999864 68999999999999999999999995321
Q ss_pred hhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCC------HHHHhCCCCCCCC
Q 016471 147 ESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMT------AAQALTHPWLHDE 203 (389)
Q Consensus 147 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s------~~e~l~h~~~~~~ 203 (389)
.......+.......+ ..+++.+.++|.+||+.+|.+|+| ++++++||||...
T Consensus 210 ~~~~~~~~~~~~~~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~ 268 (329)
T cd05588 210 EDYLFQVILEKQIRIP----RSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNI 268 (329)
T ss_pred hHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 1223444444433332 357899999999999999999997 7899999999653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=305.28 Aligned_cols=198 Identities=29% Similarity=0.522 Sum_probs=167.3
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|.||||++++ ..+.+|+|||||+||+|.+++.+. +.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 58 l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill-- 134 (376)
T cd05598 58 ADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI-- 134 (376)
T ss_pred CCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEE--
Confidence 5799999988 367899999999999999988665 679999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCC--------------------------------------------CCcccccccCCcccc
Q 016471 77 REEDAPLKVIDFGLSDFVRPD--------------------------------------------QRLNDIVGSAYYVAP 112 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~--------------------------------------------~~~~~~~gt~~y~aP 112 (389)
+.++.+||+|||+|..+... ......+||+.|+||
T Consensus 135 -~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 213 (376)
T cd05598 135 -DRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAP 213 (376)
T ss_pred -CCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCH
Confidence 56789999999997532100 001234799999999
Q ss_pred ccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCC--
Q 016471 113 EVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRM-- 189 (389)
Q Consensus 113 E~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-- 189 (389)
|++.+ .++.++||||+||++|+|++|+.||.+....+....+.........+....+++.+.++|.+|+ .+|.+|+
T Consensus 214 E~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~ 292 (376)
T cd05598 214 EVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGK 292 (376)
T ss_pred HHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCC
Confidence 99854 6899999999999999999999999988877777766655444444444578999999999976 5999999
Q ss_pred -CHHHHhCCCCCCCC
Q 016471 190 -TAAQALTHPWLHDE 203 (389)
Q Consensus 190 -s~~e~l~h~~~~~~ 203 (389)
|+.++++||||...
T Consensus 293 ~t~~ell~h~~~~~~ 307 (376)
T cd05598 293 NGADEIKAHPFFKGI 307 (376)
T ss_pred CCHHHHhCCCCcCCC
Confidence 99999999999764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=301.29 Aligned_cols=198 Identities=25% Similarity=0.469 Sum_probs=167.9
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
++||||++++ ....+|+|||||+||+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 100 ~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll-- 175 (371)
T cd05622 100 ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL-- 175 (371)
T ss_pred CCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEE--
Confidence 4799999998 35789999999999999998754 368999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC--CcccccccCCccccccccc-----cCCCchhHHHHHHHHHHHHhCCCCCCCCChhH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ--RLNDIVGSAYYVAPEVLHR-----SYNVEGDMWSIGVITYILLCGSRPFWARTESG 149 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 149 (389)
+.++.+||+|||++....... .....+||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+...
T Consensus 176 -~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~ 254 (371)
T cd05622 176 -DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG 254 (371)
T ss_pred -CCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH
Confidence 567899999999997664322 2335679999999998843 27889999999999999999999999988888
Q ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCC--CCCHHHHhCCCCCCCC
Q 016471 150 IFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRK--RMTAAQALTHPWLHDE 203 (389)
Q Consensus 150 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~--R~s~~e~l~h~~~~~~ 203 (389)
.+..+.........+..+.+++.++++|.+||..++.+ |++++++++||||++.
T Consensus 255 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 255 TYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred HHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 88888765544443444578999999999999854443 7899999999999764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=298.20 Aligned_cols=195 Identities=28% Similarity=0.519 Sum_probs=168.4
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ ..+.+|+|||||+||+|..++.+. +.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 53 ~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll-- 129 (325)
T cd05604 53 VKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILL-- 129 (325)
T ss_pred CCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE--
Confidence 5799999998 357899999999999999877654 689999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCC-CCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRP-DQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
+.++.+||+|||++..... .......+||+.|+|||++. ..++.++||||+||++|+|++|..||.+.+..+....+
T Consensus 130 -~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~ 208 (325)
T cd05604 130 -DSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNI 208 (325)
T ss_pred -CCCCCEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHH
Confidence 5778999999999875322 22334567999999999985 46899999999999999999999999998888888877
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCH----HHHhCCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTA----AQALTHPWLHDE 203 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~----~e~l~h~~~~~~ 203 (389)
........ +..+..+.++|++||..+|.+||++ .+++.||||...
T Consensus 209 ~~~~~~~~----~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~ 257 (325)
T cd05604 209 LHKPLVLR----PGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESL 257 (325)
T ss_pred HcCCccCC----CCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCC
Confidence 76543332 4588999999999999999999976 599999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=289.08 Aligned_cols=200 Identities=26% Similarity=0.403 Sum_probs=161.5
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEE
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILS---RGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFL 73 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nil 73 (389)
++||||+.++ ....+|+|||||+||+|.+++.. ..+.+++..+..++.||+.||.|||++||+||||||+||+
T Consensus 50 l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil 129 (280)
T cd05608 50 VHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVL 129 (280)
T ss_pred CCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEE
Confidence 5899999987 35779999999999999887643 3356999999999999999999999999999999999999
Q ss_pred EeecCCCCCEEEeecCCccccCCCC-CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHH
Q 016471 74 FTTREEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIF 151 (389)
Q Consensus 74 l~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 151 (389)
+ +.++.+||+|||++....... ......||+.|+|||++. ..++.++|+||+||++|+|++|+.||.........
T Consensus 130 i---~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~ 206 (280)
T cd05608 130 L---DNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN 206 (280)
T ss_pred E---CCCCCEEEeeCccceecCCCCccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH
Confidence 9 567889999999987654432 233457999999999885 46889999999999999999999999765432222
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCC-----CHHHHhCCCCCCCC
Q 016471 152 RSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRM-----TAAQALTHPWLHDE 203 (389)
Q Consensus 152 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----s~~e~l~h~~~~~~ 203 (389)
..+.......+....+.+++.+.+++.+||+.+|.+|| +++++++||||+..
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~ 263 (280)
T cd05608 207 KELKQRILNDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDL 263 (280)
T ss_pred HHHHHhhcccCCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcC
Confidence 22221111111112245899999999999999999999 88999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=302.73 Aligned_cols=198 Identities=27% Similarity=0.504 Sum_probs=166.5
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ ..+.+|+|||||+||+|.+++.+. +.+++..++.++.|++.||+|||++||+||||||+|||+
T Consensus 58 l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli-- 134 (360)
T cd05627 58 ADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLL-- 134 (360)
T ss_pred CCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE--
Confidence 4799999988 357899999999999999988655 679999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC------------------------------------CcccccccCCcccccccc-ccC
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ------------------------------------RLNDIVGSAYYVAPEVLH-RSY 119 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~-~~~ 119 (389)
+.++.+||+|||++....... .....+||+.|+|||++. ..+
T Consensus 135 -~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~ 213 (360)
T cd05627 135 -DAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGY 213 (360)
T ss_pred -CCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCC
Confidence 567899999999986442110 012357999999999985 468
Q ss_pred CCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCC---CHHHHhC
Q 016471 120 NVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRM---TAAQALT 196 (389)
Q Consensus 120 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~---s~~e~l~ 196 (389)
+.++|+||+||++|+|++|++||.+.+.......+.........+....+++.++++|.+|+ .+|.+|+ +++++++
T Consensus 214 ~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 214 NKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKS 292 (360)
T ss_pred CCcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence 99999999999999999999999998888888877764433332222357999999999987 4999998 4899999
Q ss_pred CCCCCCC
Q 016471 197 HPWLHDE 203 (389)
Q Consensus 197 h~~~~~~ 203 (389)
||||.+.
T Consensus 293 hp~f~~~ 299 (360)
T cd05627 293 HPFFEGV 299 (360)
T ss_pred CCCCCCC
Confidence 9999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=300.61 Aligned_cols=195 Identities=30% Similarity=0.565 Sum_probs=168.6
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
.||||+.++ ....+|+|||||+||+|.+++.+. +.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 54 ~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili--- 129 (330)
T cd05586 54 ESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKE-GRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILL--- 129 (330)
T ss_pred CCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---
Confidence 599999987 357899999999999999887654 789999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCCccccCC-CCCcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 78 EEDAPLKVIDFGLSDFVRP-DQRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
+.++.+||+|||++..... .......+||+.|+|||++.+ .++.++||||+||++|+|++|..||.+....+.+..+
T Consensus 130 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i 209 (330)
T cd05586 130 DATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNI 209 (330)
T ss_pred CCCCCEEEecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHH
Confidence 5678899999999875432 223345679999999998853 4789999999999999999999999998888888877
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCC----CHHHHhCCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRM----TAAQALTHPWLHDE 203 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~----s~~e~l~h~~~~~~ 203 (389)
......++. ..+++.++++|++||..+|.+|| ++.++++||||...
T Consensus 210 ~~~~~~~~~---~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 210 AFGKVRFPK---NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADI 259 (330)
T ss_pred HcCCCCCCC---ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCC
Confidence 766544432 34789999999999999999998 78999999999764
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=298.69 Aligned_cols=194 Identities=29% Similarity=0.556 Sum_probs=162.0
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
+||||+.++ ..+.+|+|||||+||+|.+++..+ +.+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 63 ~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili--- 138 (332)
T cd05614 63 QSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQR-DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILL--- 138 (332)
T ss_pred CCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEE---
Confidence 589999987 357799999999999999988765 679999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCCccccCCCC--CcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCC----hhH
Q 016471 78 EEDAPLKVIDFGLSDFVRPDQ--RLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWART----ESG 149 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~ 149 (389)
+.++.+||+|||++....... .....+||+.|+|||++.+ .++.++||||+||++|+|++|..||.... ...
T Consensus 139 ~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~ 218 (332)
T cd05614 139 DSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSE 218 (332)
T ss_pred CCCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHH
Confidence 567899999999987653322 2334679999999999854 47889999999999999999999996532 233
Q ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCC-----CHHHHhCCCCCCCC
Q 016471 150 IFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRM-----TAAQALTHPWLHDE 203 (389)
Q Consensus 150 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----s~~e~l~h~~~~~~ 203 (389)
....+....+.++ +.+++.+++++.+||..||.+|| +++++++||||...
T Consensus 219 ~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 219 VSRRILKCDPPFP----SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred HHHHHhcCCCCCC----CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 3444444333222 45899999999999999999999 88899999999764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=296.80 Aligned_cols=195 Identities=28% Similarity=0.540 Sum_probs=168.1
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ ..+.+|+|||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 53 ~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili-- 129 (325)
T cd05602 53 VKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL-- 129 (325)
T ss_pred CCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE--
Confidence 4799999987 457899999999999999987654 679999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCC-CCCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRP-DQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
+.++.+||+|||++..... .......+||+.|+|||++.+ .++.++||||+||++|+|++|.+||.+.+..+.+..+
T Consensus 130 -~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i 208 (325)
T cd05602 130 -DSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI 208 (325)
T ss_pred -CCCCCEEEccCCCCcccccCCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 5678999999999875422 223345679999999998854 6889999999999999999999999998888888777
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHH----HHhCCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAA----QALTHPWLHDE 203 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~----e~l~h~~~~~~ 203 (389)
....... .+.+++.+.++|.+||+.+|.+|+++. ++++|+||...
T Consensus 209 ~~~~~~~----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~ 257 (325)
T cd05602 209 LNKPLQL----KPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPI 257 (325)
T ss_pred HhCCcCC----CCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCC
Confidence 6654332 246899999999999999999999876 89999999654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=289.61 Aligned_cols=196 Identities=23% Similarity=0.384 Sum_probs=158.5
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ .++.+|+|||||++|.+. .+....+.+++..++.++.||+.||.|||++||+||||||+||++
T Consensus 57 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~-~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill-- 133 (287)
T cd07848 57 LKQENIVELKEAFRRRGKLYLVFEYVEKNMLE-LLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLI-- 133 (287)
T ss_pred CCCccccchhhhEecCCEEEEEEecCCCCHHH-HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE--
Confidence 5799999988 457899999999997665 444444679999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC--CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ--RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRS 153 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 153 (389)
+.++.+||+|||++....... ......||+.|+|||++. ..++.++|+||+||++|+|++|++||.+.+.......
T Consensus 134 -~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~ 212 (287)
T cd07848 134 -SHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFT 212 (287)
T ss_pred -cCCCcEEEeeccCcccccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 567899999999998764322 223457899999999885 4689999999999999999999999988765544333
Q ss_pred HHhcCCCC-------------------CCC---------CCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCC
Q 016471 154 VLRADPNF-------------------HDS---------PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 154 i~~~~~~~-------------------~~~---------~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~ 200 (389)
+....... +.. ....+|..+.+||++||++||.+|||++++++||||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 213 IQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred HHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 32211100 000 012368889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=294.28 Aligned_cols=193 Identities=26% Similarity=0.493 Sum_probs=165.3
Q ss_pred Ccccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeecC
Q 016471 3 HQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE 78 (389)
Q Consensus 3 Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~~ 78 (389)
|++|+.++ ..+.+|+|||||+||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||+ +
T Consensus 60 ~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill---~ 135 (324)
T cd05587 60 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---D 135 (324)
T ss_pred CCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---c
Confidence 45576665 357899999999999999888655 679999999999999999999999999999999999999 5
Q ss_pred CCCCEEEeecCCccccCC-CCCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 016471 79 EDAPLKVIDFGLSDFVRP-DQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLR 156 (389)
Q Consensus 79 ~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 156 (389)
.++.+||+|||++..... .......+||+.|+|||++.+ .++.++|+||+||++|+|++|+.||.+.+..+....+..
T Consensus 136 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~ 215 (324)
T cd05587 136 AEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIME 215 (324)
T ss_pred CCCCEEEeecCcceecCCCCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence 678999999999875322 223345679999999998864 689999999999999999999999999888888888876
Q ss_pred cCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCH-----HHHhCCCCCCCC
Q 016471 157 ADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTA-----AQALTHPWLHDE 203 (389)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~-----~e~l~h~~~~~~ 203 (389)
....++ ..+++.+.+++.+||..+|.+|++. +++++||||...
T Consensus 216 ~~~~~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~ 263 (324)
T cd05587 216 HNVSYP----KSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRI 263 (324)
T ss_pred CCCCCC----CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 654443 3579999999999999999999986 899999999764
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=295.52 Aligned_cols=194 Identities=27% Similarity=0.524 Sum_probs=161.5
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
.||||+.++ ..+.+|+|||||+||+|..++... +.+++..++.++.||+.||.|||++||+||||||+||++
T Consensus 54 ~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili--- 129 (329)
T cd05618 54 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL--- 129 (329)
T ss_pred CCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---
Confidence 699999988 457899999999999998877654 689999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCCccccC-CCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCC---------C
Q 016471 78 EEDAPLKVIDFGLSDFVR-PDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWAR---------T 146 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~---------~ 146 (389)
+.++.+||+|||++.... .........||+.|+|||++. ..++.++|+||+||++|+|++|+.||... .
T Consensus 130 ~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~ 209 (329)
T cd05618 130 DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT 209 (329)
T ss_pred CCCCCEEEeeCCccccccCCCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCccccc
Confidence 577899999999987532 223334567999999999885 46889999999999999999999999521 1
Q ss_pred hhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCC------HHHHhCCCCCCCC
Q 016471 147 ESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMT------AAQALTHPWLHDE 203 (389)
Q Consensus 147 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s------~~e~l~h~~~~~~ 203 (389)
.......+......++ ..++..+.++|++||+.||.+||| +.++++||||+..
T Consensus 210 ~~~~~~~i~~~~~~~p----~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 210 EDYLFQVILEKQIRIP----RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred HHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 1223444444443333 357899999999999999999998 5799999999764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=298.22 Aligned_cols=195 Identities=29% Similarity=0.534 Sum_probs=169.7
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|.||||++++ ....+|+|||||+||+|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+||++
T Consensus 55 l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~-- 131 (318)
T cd05582 55 VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL-- 131 (318)
T ss_pred CCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEE--
Confidence 5799999998 357899999999999999988654 679999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCC-CCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPD-QRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
+.++.+||+|||++...... .......||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+.+.......+
T Consensus 132 -~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i 210 (318)
T cd05582 132 -DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI 210 (318)
T ss_pred -CCCCcEEEeeccCCcccCCCCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHH
Confidence 56788999999998765433 23345679999999999854 6889999999999999999999999988888888777
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCC-----HHHHhCCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMT-----AAQALTHPWLHDE 203 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s-----~~e~l~h~~~~~~ 203 (389)
.+.....+ ..+++.+.++|++||+.||.+||| +.+++.||||...
T Consensus 211 ~~~~~~~p----~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 211 LKAKLGMP----QFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred HcCCCCCC----CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence 76554433 357899999999999999999999 7789999999764
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=303.52 Aligned_cols=195 Identities=32% Similarity=0.584 Sum_probs=179.8
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|.||||+++| ....+|+||||+.||++++|+.++ ++..+..++.++.|++.|++|||+++|||||||++||||
T Consensus 112 l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~~-gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL-- 188 (596)
T KOG0586|consen 112 LNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVKH-GRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILL-- 188 (596)
T ss_pred cCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHhc-ccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccc--
Confidence 6899999999 468899999999999999999887 788999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
+.+.++||+|||++..+..+....+.||++.|.|||+..+ .-++.+|+||+|+++|-|+.|..||.+.+........
T Consensus 189 -~~~mnikIaDfgfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rv 267 (596)
T KOG0586|consen 189 -DENMNIKIADFGFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRV 267 (596)
T ss_pred -ccccceeeeccccceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchh
Confidence 6788899999999999998888899999999999999865 3578999999999999999999999999988888888
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~ 203 (389)
+.+...++. .++.+++++|+++|.++|.+|++.++++.|.|....
T Consensus 268 l~gk~rIp~----~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~ 312 (596)
T KOG0586|consen 268 LRGKYRIPF----YMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDL 312 (596)
T ss_pred eeeeecccc----eeechhHHHHHHhhccCccccCCHHHhhhhcccchh
Confidence 877766654 379999999999999999999999999999998654
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=294.03 Aligned_cols=194 Identities=26% Similarity=0.484 Sum_probs=168.1
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
+||+|+.++ ..+.+|+|||||+||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 59 ~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill--- 134 (323)
T cd05616 59 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML--- 134 (323)
T ss_pred CCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEE---
Confidence 588888776 357899999999999999887655 679999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCCccccCC-CCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 016471 78 EEDAPLKVIDFGLSDFVRP-DQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVL 155 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 155 (389)
+.++.+||+|||++..... .......+||+.|+|||++. ..++.++|+||+||++|+|++|+.||.+.+.......+.
T Consensus 135 ~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~ 214 (323)
T cd05616 135 DSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 214 (323)
T ss_pred CCCCcEEEccCCCceecCCCCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 5778999999999875432 22334567999999999885 468999999999999999999999999988888888887
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCH-----HHHhCCCCCCCC
Q 016471 156 RADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTA-----AQALTHPWLHDE 203 (389)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~-----~e~l~h~~~~~~ 203 (389)
.....++ ..+++++.+++.+||..+|.+|++. .++++||||+..
T Consensus 215 ~~~~~~p----~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~ 263 (323)
T cd05616 215 EHNVAYP----KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 263 (323)
T ss_pred hCCCCCC----CcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCC
Confidence 7655443 3589999999999999999999984 899999999764
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=296.22 Aligned_cols=199 Identities=27% Similarity=0.424 Sum_probs=159.1
Q ss_pred CCCccccceee---------cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCc
Q 016471 1 MYHQKLQHLFY---------SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPEN 71 (389)
Q Consensus 1 l~Hpni~~~~~---------~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~N 71 (389)
|+||||+.++. ...+|+|||||. ++|.+.+... +.+++..+..++.||+.||.|||++||+||||||+|
T Consensus 56 l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~N 133 (338)
T cd07859 56 LRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKAN-DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKN 133 (338)
T ss_pred CCCCCEeeecceEeccCCCCCceEEEEEecCC-CCHHHHHHhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHH
Confidence 57999999872 135899999996 5898877654 679999999999999999999999999999999999
Q ss_pred EEEeecCCCCCEEEeecCCccccCCCC----CcccccccCCcccccccc---ccCCCchhHHHHHHHHHHHHhCCCCCCC
Q 016471 72 FLFTTREEDAPLKVIDFGLSDFVRPDQ----RLNDIVGSAYYVAPEVLH---RSYNVEGDMWSIGVITYILLCGSRPFWA 144 (389)
Q Consensus 72 ill~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~ 144 (389)
||+ +.++.+||+|||++....... ......||+.|+|||++. ..++.++||||+||++|+|++|++||.+
T Consensus 134 Ill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~ 210 (338)
T cd07859 134 ILA---NADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 210 (338)
T ss_pred eEE---CCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCC
Confidence 999 578899999999987543221 123457999999999874 3688999999999999999999999987
Q ss_pred CChhHHHHHHHh---------------------------cCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCC
Q 016471 145 RTESGIFRSVLR---------------------------ADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 197 (389)
Q Consensus 145 ~~~~~~~~~i~~---------------------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h 197 (389)
.+.......+.. ..+......++.+++.+.++|.+||..+|.+|||++++++|
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 211 KNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred CChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 654333221111 11111112235678899999999999999999999999999
Q ss_pred CCCCCCC
Q 016471 198 PWLHDEN 204 (389)
Q Consensus 198 ~~~~~~~ 204 (389)
|||+...
T Consensus 291 p~f~~~~ 297 (338)
T cd07859 291 PYFKGLA 297 (338)
T ss_pred chhhhcC
Confidence 9997654
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=294.34 Aligned_cols=195 Identities=28% Similarity=0.522 Sum_probs=167.1
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
++||||++++ ..+.+|+|||||+||+|...+... +.+++..++.++.||+.||.|||++||+||||||+||++
T Consensus 53 ~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll-- 129 (321)
T cd05603 53 LKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRE-RCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILL-- 129 (321)
T ss_pred CCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE--
Confidence 5799999987 357899999999999998877654 679999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccC-CCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVR-PDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
+.++.+||+|||++.... ........+||+.|+|||++. ..++.++||||+||++|+|++|..||.+.+.......+
T Consensus 130 -~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i 208 (321)
T cd05603 130 -DSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNI 208 (321)
T ss_pred -CCCCCEEEccCCCCccCCCCCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHH
Confidence 567899999999987532 222334567999999999885 46899999999999999999999999998887777777
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCH----HHHhCCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTA----AQALTHPWLHDE 203 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~----~e~l~h~~~~~~ 203 (389)
.......+ +..+..+.++|.+||+.+|.+|+++ .++++|+||...
T Consensus 209 ~~~~~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~ 257 (321)
T cd05603 209 LHKPLQLP----GGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPI 257 (321)
T ss_pred hcCCCCCC----CCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCC
Confidence 76543333 3578899999999999999999975 599999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=280.71 Aligned_cols=195 Identities=30% Similarity=0.587 Sum_probs=176.7
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
+||.+..+- ..+.+|+||||..||+|+-++... ..++|..++.+...|+.||.|||+++||+||||.+|.|+
T Consensus 226 ~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsre-r~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlL--- 301 (516)
T KOG0690|consen 226 RHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSRE-RVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLL--- 301 (516)
T ss_pred cCcHHHHhhhhhccCceEEEEEEEccCceEeeehhhh-hcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhhee---
Confidence 588888776 357899999999999999877554 689999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCCcccc-CCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 016471 78 EEDAPLKVIDFGLSDFV-RPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVL 155 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~-~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 155 (389)
|.+|.+||+|||+++.. ..+....++||||.|+|||++. ..|+..+|+|.+||++|||++|+.||...+...++..|+
T Consensus 302 DkDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl 381 (516)
T KOG0690|consen 302 DKDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL 381 (516)
T ss_pred ccCCceEeeecccchhcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH
Confidence 78999999999999753 4456778899999999999996 469999999999999999999999999999999999999
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCC-----CHHHHhCCCCCCCCC
Q 016471 156 RADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRM-----TAAQALTHPWLHDEN 204 (389)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----s~~e~l~h~~~~~~~ 204 (389)
.+...+|. .++++++.|+..+|.+||.+|. .+.|+..|+||...+
T Consensus 382 ~ed~kFPr----~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~ 431 (516)
T KOG0690|consen 382 MEDLKFPR----TLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVD 431 (516)
T ss_pred hhhccCCc----cCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCC
Confidence 88877764 5899999999999999999997 478999999998764
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=306.97 Aligned_cols=200 Identities=22% Similarity=0.339 Sum_probs=160.7
Q ss_pred CCCccccceee------------cCeEEEEEEccCCCChHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEec
Q 016471 1 MYHQKLQHLFY------------SNSFLFFTRFCEGGELLDRIL---SRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHR 65 (389)
Q Consensus 1 l~Hpni~~~~~------------~~~~~lv~E~~~gg~L~~~l~---~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hr 65 (389)
|.||||++++. ...+++|||||++ +|.+.+. ...+.+++..++.++.||+.||+|||++||+||
T Consensus 116 l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHr 194 (440)
T PTZ00036 116 LNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHR 194 (440)
T ss_pred cCCCCCcceeeeEeecccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecC
Confidence 57999998741 1247799999986 6766654 234679999999999999999999999999999
Q ss_pred CCCCCcEEEeecCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCC
Q 016471 66 DLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFW 143 (389)
Q Consensus 66 dlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~ 143 (389)
||||+|||++ ..++.+||+|||+|.............||+.|+|||++.+ .|+.++||||+||++|+|++|.+||.
T Consensus 195 DLKp~NILl~--~~~~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~ 272 (440)
T PTZ00036 195 DLKPQNLLID--PNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFS 272 (440)
T ss_pred CcCHHHEEEc--CCCCceeeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 9999999994 2345799999999987765555556788999999998743 58999999999999999999999999
Q ss_pred CCChhHHHHHHHhcCCCC-----------------CCCC-------C-CCCCHHHHHHHHhhhccCcCCCCCHHHHhCCC
Q 016471 144 ARTESGIFRSVLRADPNF-----------------HDSP-------W-PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHP 198 (389)
Q Consensus 144 ~~~~~~~~~~i~~~~~~~-----------------~~~~-------~-~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~ 198 (389)
+.+..+.+..+.+..... +... + ...++++++||.+||.++|.+|||+.++++||
T Consensus 273 ~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp 352 (440)
T PTZ00036 273 GQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADP 352 (440)
T ss_pred CCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCCh
Confidence 887766655554321110 1000 0 13578999999999999999999999999999
Q ss_pred CCCCC
Q 016471 199 WLHDE 203 (389)
Q Consensus 199 ~~~~~ 203 (389)
||...
T Consensus 353 ~f~~~ 357 (440)
T PTZ00036 353 FFDDL 357 (440)
T ss_pred hHHhh
Confidence 99654
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=285.98 Aligned_cols=200 Identities=26% Similarity=0.403 Sum_probs=165.2
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEe
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 75 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~ 75 (389)
|.||||+.++ ..+.+|+|||||.||+|.+++... ...+++..+..++.|++.||.|||++||+||||||+||++
T Consensus 57 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~- 135 (285)
T cd05605 57 VNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILL- 135 (285)
T ss_pred cCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEE-
Confidence 5799999988 357899999999999999877653 3469999999999999999999999999999999999999
Q ss_pred ecCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 76 TREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
++++.++|+|||++.............|++.|+|||++. ..++.++|+||+||++|+|++|+.||.+.........+
T Consensus 136 --~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~ 213 (285)
T cd05605 136 --DDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEV 213 (285)
T ss_pred --CCCCCEEEeeCCCceecCCCCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHH
Confidence 567889999999988765444444567999999999885 46889999999999999999999999886654433333
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCC-----CHHHHhCCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRM-----TAAQALTHPWLHDE 203 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----s~~e~l~h~~~~~~ 203 (389)
............+.++..+.+++.+||..||.+|| +++++++||||...
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05605 214 ERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA 267 (285)
T ss_pred HHHhhhcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence 22111111122245899999999999999999999 89999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=291.80 Aligned_cols=195 Identities=25% Similarity=0.491 Sum_probs=161.4
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
.||||+.++ ..+.+|+|||||+||+|..++... +.+++..++.++.||+.||+|||++||+||||||+||++
T Consensus 54 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili--- 129 (327)
T cd05617 54 SNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLL--- 129 (327)
T ss_pred CCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---
Confidence 699999988 357899999999999999877655 679999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCCccccC-CCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC-------hh
Q 016471 78 EEDAPLKVIDFGLSDFVR-PDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWART-------ES 148 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~-------~~ 148 (389)
+.++.+||+|||++.... ........+||+.|+|||++. ..++.++|+||+||++|+|++|..||.... ..
T Consensus 130 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~ 209 (327)
T cd05617 130 DADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTED 209 (327)
T ss_pred eCCCCEEEeccccceeccCCCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHH
Confidence 467889999999987532 233344568999999999885 468999999999999999999999996422 12
Q ss_pred HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCC------HHHHhCCCCCCCCC
Q 016471 149 GIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMT------AAQALTHPWLHDEN 204 (389)
Q Consensus 149 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s------~~e~l~h~~~~~~~ 204 (389)
.....+.......+ ..++..+.++|.+||..||.+|++ +++++.||||....
T Consensus 210 ~~~~~~~~~~~~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~ 267 (327)
T cd05617 210 YLFQVILEKPIRIP----RFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSID 267 (327)
T ss_pred HHHHHHHhCCCCCC----CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence 33444443332222 347899999999999999999998 46999999997653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=304.43 Aligned_cols=196 Identities=28% Similarity=0.425 Sum_probs=168.2
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEE
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILS---RGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFL 73 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nil 73 (389)
+.||||++++ ..+.+|+|||||+||+|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 122 l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIl 201 (478)
T PTZ00267 122 CDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIF 201 (478)
T ss_pred CCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEE
Confidence 5799999998 46889999999999999987753 2356899999999999999999999999999999999999
Q ss_pred EeecCCCCCEEEeecCCccccCCCC---CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhH
Q 016471 74 FTTREEDAPLKVIDFGLSDFVRPDQ---RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESG 149 (389)
Q Consensus 74 l~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 149 (389)
+ +.++.+||+|||++....... .....+||+.|+|||++. ..++.++||||+||++|+|++|+.||.+.+..+
T Consensus 202 l---~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~ 278 (478)
T PTZ00267 202 L---MPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE 278 (478)
T ss_pred E---CCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9 567899999999998764332 234467999999999885 468999999999999999999999999888888
Q ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCC
Q 016471 150 IFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 202 (389)
Q Consensus 150 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~ 202 (389)
....+..+..... ...+++.++++|.+||..+|.+|||+.+++.|+|++.
T Consensus 279 ~~~~~~~~~~~~~---~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 279 IMQQVLYGKYDPF---PCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred HHHHHHhCCCCCC---CccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 8777766543321 1357899999999999999999999999999999843
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=284.62 Aligned_cols=195 Identities=26% Similarity=0.400 Sum_probs=160.8
Q ss_pred CCccccceee---------cCeEEEEEEccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCc
Q 016471 2 YHQKLQHLFY---------SNSFLFFTRFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPEN 71 (389)
Q Consensus 2 ~Hpni~~~~~---------~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~N 71 (389)
.||||++++. ...+++||||+.+ +|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|
T Consensus 60 ~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~N 138 (288)
T cd07863 60 DHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPEN 138 (288)
T ss_pred CCCCeeeeeeeeccccCCCCceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 6999999883 2458999999985 8888776542 358999999999999999999999999999999999
Q ss_pred EEEeecCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHH
Q 016471 72 FLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGI 150 (389)
Q Consensus 72 ill~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 150 (389)
|++ +.++.+||+|||++.............||+.|+|||++. ..++.++||||+||++|+|++|.+||.+......
T Consensus 139 ili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~ 215 (288)
T cd07863 139 ILV---TSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ 215 (288)
T ss_pred EEE---CCCCCEEECccCccccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH
Confidence 999 567889999999998765444444567899999999885 4689999999999999999999999988777666
Q ss_pred HHHHHhcCCCCC-----------------------CCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCC
Q 016471 151 FRSVLRADPNFH-----------------------DSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 151 ~~~i~~~~~~~~-----------------------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~ 200 (389)
...+........ ....+.++..+.++|.+||.+||.+|||+.+++.||||
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 216 LGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred HHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 555543211000 00124578889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=290.00 Aligned_cols=200 Identities=28% Similarity=0.492 Sum_probs=166.3
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||+.++ ..+++|+|||||+||+|.+++.+..+.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 58 ~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill-- 135 (331)
T cd05597 58 GDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLL-- 135 (331)
T ss_pred CCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEE--
Confidence 4799999987 4578999999999999999887656789999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCC--cccccccCCcccccccc------ccCCCchhHHHHHHHHHHHHhCCCCCCCCChh
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQR--LNDIVGSAYYVAPEVLH------RSYNVEGDMWSIGVITYILLCGSRPFWARTES 148 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 148 (389)
+.++.+||+|||++........ .....||+.|+|||++. +.++.++||||+||++|+|++|+.||.+.+..
T Consensus 136 -~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~ 214 (331)
T cd05597 136 -DKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 214 (331)
T ss_pred -CCCCCEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH
Confidence 5678999999999876543322 22346999999999884 24788999999999999999999999988877
Q ss_pred HHHHHHHhcCCCCCC-CCCCCCCHHHHHHHHhhhccCcCC--CCCHHHHhCCCCCCCC
Q 016471 149 GIFRSVLRADPNFHD-SPWPSVSPEAKDFVRRLLNKDHRK--RMTAAQALTHPWLHDE 203 (389)
Q Consensus 149 ~~~~~i~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~--R~s~~e~l~h~~~~~~ 203 (389)
+.+..+......... ...+.++..++++|++||..++.+ |+++.++++||||...
T Consensus 215 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 215 ETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred HHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence 777777654332221 223458999999999998765544 7899999999999764
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=296.30 Aligned_cols=194 Identities=23% Similarity=0.355 Sum_probs=164.9
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|+||||+.|- ..-.||||||||..|.|...++.. ..++......+..+|+.|++|||.+.|||||||.-|||++
T Consensus 169 LkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~-~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs- 246 (904)
T KOG4721|consen 169 LKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAG-RPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILIS- 246 (904)
T ss_pred ccCcceeeEeeeecCCceeEEeeeccccccHHHHHhcc-CccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEee-
Confidence 6899999998 246799999999999999977665 6789999999999999999999999999999999999996
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVL 155 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 155 (389)
.+..|||+|||.++..........++||..|||||++.+ +++.++|||||||||||||||..||..-+...++.-+-
T Consensus 247 --~~d~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVG 324 (904)
T KOG4721|consen 247 --YDDVVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVG 324 (904)
T ss_pred --ccceEEeccccchHhhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEecc
Confidence 456799999999988776666678899999999999964 79999999999999999999999997766554443332
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCC
Q 016471 156 RADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~ 200 (389)
.....++ ....++..++-||+.||.-.|..|||+.+++.|-=+
T Consensus 325 sNsL~Lp--vPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 325 SNSLHLP--VPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred CCccccc--CcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 2222222 224688999999999999999999999999998533
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=289.29 Aligned_cols=199 Identities=23% Similarity=0.362 Sum_probs=161.4
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CCEecCCCCCcEEEe
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQ-GVVHRDLKPENFLFT 75 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~-~i~Hrdlkp~Nill~ 75 (389)
+.||||++++ .++.+++|||||+||+|.+++... +.+++..+..++.|++.||.|||++ +|+||||||+||++
T Consensus 60 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~- 137 (331)
T cd06649 60 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEA-KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILV- 137 (331)
T ss_pred CCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEE-
Confidence 5799999998 457899999999999999987655 5799999999999999999999986 69999999999999
Q ss_pred ecCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 76 TREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
+.++.+||+|||++...... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||......+....+
T Consensus 138 --~~~~~~kl~Dfg~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~ 214 (331)
T cd06649 138 --NSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIF 214 (331)
T ss_pred --cCCCcEEEccCccccccccc-ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Confidence 46788999999998765432 2345679999999999864 6899999999999999999999999766554332221
Q ss_pred HhcC--------------------------------------------CCCCCCCCCCCCHHHHHHHHhhhccCcCCCCC
Q 016471 155 LRAD--------------------------------------------PNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMT 190 (389)
Q Consensus 155 ~~~~--------------------------------------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s 190 (389)
.... ...+..+...+++++++||.+||..||++|||
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt 294 (331)
T cd06649 215 GRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERAD 294 (331)
T ss_pred cccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCC
Confidence 1000 00011111247889999999999999999999
Q ss_pred HHHHhCCCCCCCCC
Q 016471 191 AAQALTHPWLHDEN 204 (389)
Q Consensus 191 ~~e~l~h~~~~~~~ 204 (389)
+.++++||||+...
T Consensus 295 ~~ell~h~~~~~~~ 308 (331)
T cd06649 295 LKMLMNHTFIKRSE 308 (331)
T ss_pred HHHHhcChHHhhcc
Confidence 99999999997654
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=288.43 Aligned_cols=194 Identities=26% Similarity=0.496 Sum_probs=166.3
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
+||+|+.++ ..+.+|+|||||+||+|.+++... +.+++.++..++.||+.||.|||++||+||||||+|||+
T Consensus 59 ~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill--- 134 (323)
T cd05615 59 KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVML--- 134 (323)
T ss_pred CCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---
Confidence 467777766 357799999999999999887655 679999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCCccccCCC-CCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 016471 78 EEDAPLKVIDFGLSDFVRPD-QRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVL 155 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 155 (389)
+.++.+||+|||++...... .......||+.|+|||++. ..++.++|+||+||++|+|++|..||.+.........+.
T Consensus 135 ~~~~~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~ 214 (323)
T cd05615 135 DSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM 214 (323)
T ss_pred CCCCCEEEeccccccccCCCCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 56788999999998754322 2234457999999999885 468999999999999999999999999988888888887
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCC-----HHHHhCCCCCCCC
Q 016471 156 RADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMT-----AAQALTHPWLHDE 203 (389)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s-----~~e~l~h~~~~~~ 203 (389)
.....++ ..+++.+.+++.+||..+|.+|++ .+++++||||...
T Consensus 215 ~~~~~~p----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 215 EHNVSYP----KSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred hCCCCCC----ccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence 7654433 357899999999999999999997 4799999999764
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=311.33 Aligned_cols=188 Identities=30% Similarity=0.500 Sum_probs=165.9
Q ss_pred ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeecCCCCCEEEeecCC
Q 016471 11 YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGL 90 (389)
Q Consensus 11 ~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~~~~~~~kl~Dfg~ 90 (389)
++.++|+||||++||+|...+-+. +++|+..|++|+..|+.||.-||+.|+|||||||+|||+ |..|++||+|||.
T Consensus 146 D~~~LYlVMdY~pGGDlltLlSk~-~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLl---d~~GHikLADFGs 221 (1317)
T KOG0612|consen 146 DERYLYLVMDYMPGGDLLTLLSKF-DRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLL---DKSGHIKLADFGS 221 (1317)
T ss_pred CccceEEEEecccCchHHHHHhhc-CCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEe---cccCcEeeccchh
Confidence 578999999999999999977665 489999999999999999999999999999999999999 7899999999999
Q ss_pred ccccCCCC--CcccccccCCcccccccc------ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCC
Q 016471 91 SDFVRPDQ--RLNDIVGSAYYVAPEVLH------RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFH 162 (389)
Q Consensus 91 a~~~~~~~--~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 162 (389)
|-.+..+. .....+|||-|++||++. +.|++.||+||+||++|||+.|..||+..+..+.+.+|+.-...+.
T Consensus 222 Clkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~ 301 (1317)
T KOG0612|consen 222 CLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLS 301 (1317)
T ss_pred HHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcC
Confidence 88776443 345679999999999982 3599999999999999999999999999999999999997644433
Q ss_pred CCCCCCCCHHHHHHHHhhhccCcCCCCC---HHHHhCCCCCCCC
Q 016471 163 DSPWPSVSPEAKDFVRRLLNKDHRKRMT---AAQALTHPWLHDE 203 (389)
Q Consensus 163 ~~~~~~~~~~~~~li~~~l~~~p~~R~s---~~e~l~h~~~~~~ 203 (389)
-+.-..+|+++++||++++. +|..|.. ++++..||||.+.
T Consensus 302 FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~ 344 (1317)
T KOG0612|consen 302 FPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGI 344 (1317)
T ss_pred CCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCC
Confidence 33335699999999999875 5888888 9999999999765
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=287.46 Aligned_cols=200 Identities=25% Similarity=0.447 Sum_probs=164.4
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ .++..|+||||+.+ +|.+++...+..+++..++.++.||+.||.|||++||+||||||+||++
T Consensus 61 l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill-- 137 (309)
T cd07872 61 LKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLI-- 137 (309)
T ss_pred CCCCCcceEEEEEeeCCeEEEEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE--
Confidence 5799999998 45789999999986 8888887766678999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC-CcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRS 153 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 153 (389)
+.++.+||+|||++....... ......+|+.|+|||++.+ .++.++||||+||++|+|++|++||.+.+..+....
T Consensus 138 -~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~ 216 (309)
T cd07872 138 -NERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHL 216 (309)
T ss_pred -CCCCCEEECccccceecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 567889999999987643322 2334568999999998743 578999999999999999999999988776655554
Q ss_pred HHhcCCCCC-------------------C-------CCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 154 VLRADPNFH-------------------D-------SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 154 i~~~~~~~~-------------------~-------~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
+.+...... . ...+.++++++++|.+||..||.+|||+.+++.||||+...
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 217 IFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred HHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 433211100 0 01235788999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=290.57 Aligned_cols=200 Identities=27% Similarity=0.469 Sum_probs=167.6
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||+|+.++ ....+|+|||||+||+|.+++.+..+.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 58 ~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili-- 135 (332)
T cd05623 58 GDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM-- 135 (332)
T ss_pred CCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE--
Confidence 4799999987 3578999999999999999987756789999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC--CcccccccCCcccccccc------ccCCCchhHHHHHHHHHHHHhCCCCCCCCChh
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ--RLNDIVGSAYYVAPEVLH------RSYNVEGDMWSIGVITYILLCGSRPFWARTES 148 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 148 (389)
+.++.+||+|||++....... .....+||+.|+|||++. +.++.++||||+||++|+|++|+.||.+.+..
T Consensus 136 -~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~ 214 (332)
T cd05623 136 -DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 214 (332)
T ss_pred -CCCCCEEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH
Confidence 567899999999987653322 223357999999999874 24788999999999999999999999998888
Q ss_pred HHHHHHHhcCCCCCC-CCCCCCCHHHHHHHHhhhccCcCC--CCCHHHHhCCCCCCCC
Q 016471 149 GIFRSVLRADPNFHD-SPWPSVSPEAKDFVRRLLNKDHRK--RMTAAQALTHPWLHDE 203 (389)
Q Consensus 149 ~~~~~i~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~--R~s~~e~l~h~~~~~~ 203 (389)
+.+..+.......+. .....+++++++||++||..++.+ |++++++++||||.+.
T Consensus 215 ~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~ 272 (332)
T cd05623 215 ETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI 272 (332)
T ss_pred HHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence 888877765433322 122468999999999999765554 6899999999999764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=287.19 Aligned_cols=199 Identities=26% Similarity=0.387 Sum_probs=152.5
Q ss_pred CCCccccceee------cCeEEEEEEccCCCChHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCCEecC
Q 016471 1 MYHQKLQHLFY------SNSFLFFTRFCEGGELLDRILSR--------GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRD 66 (389)
Q Consensus 1 l~Hpni~~~~~------~~~~~lv~E~~~gg~L~~~l~~~--------~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrd 66 (389)
|.||||++++. +..+|+||||+.+ +|.+++... ...+++..++.++.||+.||+|||++||+|||
T Consensus 55 l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrD 133 (317)
T cd07868 55 LKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRD 133 (317)
T ss_pred cCCCCCcceeeeEecCCCcEEEEEEeccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCC
Confidence 57999999872 4568999999975 888776532 12589999999999999999999999999999
Q ss_pred CCCCcEEEeec-CCCCCEEEeecCCccccCCCC----CcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCC
Q 016471 67 LKPENFLFTTR-EEDAPLKVIDFGLSDFVRPDQ----RLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGS 139 (389)
Q Consensus 67 lkp~Nill~~~-~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~ 139 (389)
|||+|||+... +.++.+||+|||++....... ......||+.|+|||++.+ .++.++|+||+||++|+|++|+
T Consensus 134 lkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~ 213 (317)
T cd07868 134 LKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213 (317)
T ss_pred CCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCC
Confidence 99999999643 345789999999997654321 2345678999999998753 4889999999999999999999
Q ss_pred CCCCCCChh---------HHHHHHHhcCCCCCC----------------------------------CCCCCCCHHHHHH
Q 016471 140 RPFWARTES---------GIFRSVLRADPNFHD----------------------------------SPWPSVSPEAKDF 176 (389)
Q Consensus 140 ~pf~~~~~~---------~~~~~i~~~~~~~~~----------------------------------~~~~~~~~~~~~l 176 (389)
+||.+.... ..+..+......... ......+..+.+|
T Consensus 214 ~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl 293 (317)
T cd07868 214 PIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHL 293 (317)
T ss_pred CCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHH
Confidence 999654321 122222211110000 0001235678999
Q ss_pred HHhhhccCcCCCCCHHHHhCCCCC
Q 016471 177 VRRLLNKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 177 i~~~l~~~p~~R~s~~e~l~h~~~ 200 (389)
|++||..||.+|||++|+|+||||
T Consensus 294 i~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 294 LQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred HHHHhccCcccCCCHHHHhcCCCC
Confidence 999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=293.42 Aligned_cols=201 Identities=18% Similarity=0.316 Sum_probs=157.6
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|.||||++++ .....++|||++. |+|..++... +.+++..++.++.||+.||.|||++||+||||||+||++
T Consensus 140 l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll-- 215 (391)
T PHA03212 140 INHPSIIQLKGTFTYNKFTCLILPRYK-TDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFI-- 215 (391)
T ss_pred CCCCCCCCEeEEEEECCeeEEEEecCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEE--
Confidence 6899999998 3678999999996 6898887655 679999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCC--CCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCh------
Q 016471 77 REEDAPLKVIDFGLSDFVRPD--QRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTE------ 147 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------ 147 (389)
+.++.+||+|||+|...... ......+||+.|+|||++. ..++.++||||+||++|+|++|..||.....
T Consensus 216 -~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~ 294 (391)
T PHA03212 216 -NHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCD 294 (391)
T ss_pred -cCCCCEEEEeCCcccccccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCc
Confidence 56788999999998653221 2233567999999999885 4689999999999999999999988754321
Q ss_pred -hHHHHHHHhcCCC--------------------------CC--CCCC---CCCCHHHHHHHHhhhccCcCCCCCHHHHh
Q 016471 148 -SGIFRSVLRADPN--------------------------FH--DSPW---PSVSPEAKDFVRRLLNKDHRKRMTAAQAL 195 (389)
Q Consensus 148 -~~~~~~i~~~~~~--------------------------~~--~~~~---~~~~~~~~~li~~~l~~~p~~R~s~~e~l 195 (389)
...+..+...... .+ .+.| ..++.++.+||.+||..||.+|||++|+|
T Consensus 295 ~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL 374 (391)
T PHA03212 295 SDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALL 374 (391)
T ss_pred hhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHh
Confidence 1112222111100 00 0011 13567899999999999999999999999
Q ss_pred CCCCCCCCCCC
Q 016471 196 THPWLHDENRP 206 (389)
Q Consensus 196 ~h~~~~~~~~~ 206 (389)
+||||+....+
T Consensus 375 ~hp~f~~~~~~ 385 (391)
T PHA03212 375 DFAAFQDIPDP 385 (391)
T ss_pred cChhhccCCCC
Confidence 99999875433
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=280.87 Aligned_cols=197 Identities=23% Similarity=0.393 Sum_probs=161.9
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEe
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 75 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~ 75 (389)
+.||||++++ ...++|+||||++||+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+||++
T Consensus 50 l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili- 128 (277)
T cd05607 50 VNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLL- 128 (277)
T ss_pred cCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEE-
Confidence 5799999987 3578999999999999988876442 358899999999999999999999999999999999999
Q ss_pred ecCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCh----hHH
Q 016471 76 TREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTE----SGI 150 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~ 150 (389)
+.++.++|+|||++.............|++.|+|||++. ..++.++|+||+||++|+|++|+.||.+... ...
T Consensus 129 --~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~ 206 (277)
T cd05607 129 --DDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEEL 206 (277)
T ss_pred --cCCCCEEEeeceeeeecCCCceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHH
Confidence 567889999999988765444444567899999999875 4689999999999999999999999976433 223
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCH----HHHhCCCCCCCC
Q 016471 151 FRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTA----AQALTHPWLHDE 203 (389)
Q Consensus 151 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~----~e~l~h~~~~~~ 203 (389)
........... ....+++++++++.+||+++|.+||++ ++++.||||+..
T Consensus 207 ~~~~~~~~~~~---~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~ 260 (277)
T cd05607 207 KRRTLEDEVKF---EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTI 260 (277)
T ss_pred HHHhhcccccc---ccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCC
Confidence 33333222211 124589999999999999999999999 678899999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=293.37 Aligned_cols=187 Identities=32% Similarity=0.514 Sum_probs=161.3
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
.||||+.+. +..++|+|||.+.||.+.+++... +.+. .++..|+.+|+.|+.|||++|+|||||||+|||+.
T Consensus 374 ~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~-~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~-- 449 (612)
T KOG0603|consen 374 DHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSK-PEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD-- 449 (612)
T ss_pred CCCcceeecceecCCceeeeeehhccccHHHHHHHhc-chhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec--
Confidence 599999998 468899999999999999999776 3333 88889999999999999999999999999999995
Q ss_pred CCCCCEEEeecCCccccCCCCCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChh-HHHHHHH
Q 016471 78 EEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTES-GIFRSVL 155 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~ 155 (389)
+..++++|+|||.+...... ..+.+-|..|.|||++.. .|+.+|||||||++||+||+|+.||...... ++...+.
T Consensus 450 ~~~g~lrltyFG~a~~~~~~--~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~ 527 (612)
T KOG0603|consen 450 GSAGHLRLTYFGFWSELERS--CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQ 527 (612)
T ss_pred CCCCcEEEEEechhhhCchh--hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhc
Confidence 46788999999998876544 445577889999999864 6999999999999999999999999876665 5555554
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCC
Q 016471 156 RADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~ 200 (389)
.+... ..+|..+++||++||++||.+|+++.+++.||||
T Consensus 528 ~~~~s------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 528 MPKFS------ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred CCccc------cccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 32221 4589999999999999999999999999999999
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=286.88 Aligned_cols=189 Identities=23% Similarity=0.400 Sum_probs=162.4
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEe
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILS-RGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 75 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~-~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~ 75 (389)
|+|+|||++| .++.+||||||++.|+|.+++.. .++.+...+.+.++.|||+|++||+++++|||||...|||+
T Consensus 258 L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV- 336 (468)
T KOG0197|consen 258 LRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILV- 336 (468)
T ss_pred CcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheee-
Confidence 7899999999 23569999999999999999986 55789999999999999999999999999999999999999
Q ss_pred ecCCCCCEEEeecCCccccCCCCCccc--ccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 016471 76 TREEDAPLKVIDFGLSDFVRPDQRLND--IVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIF 151 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~--~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~ 151 (389)
+++..+||+|||+|+....+..... ..-...|.|||.+. +.++.++|||||||+|||++| |+.||.+.+..+++
T Consensus 337 --~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~ 414 (468)
T KOG0197|consen 337 --DEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVL 414 (468)
T ss_pred --ccCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHH
Confidence 5788999999999995543332111 11234699999985 679999999999999999999 99999999999999
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHh
Q 016471 152 RSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQAL 195 (389)
Q Consensus 152 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l 195 (389)
..+.++.. .+.+ +.+|+.+.+++..||..+|++|||.+.+.
T Consensus 415 ~~le~GyR-lp~P--~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 415 ELLERGYR-LPRP--EGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred HHHhccCc-CCCC--CCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 98877643 3333 46999999999999999999999997554
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=288.95 Aligned_cols=198 Identities=25% Similarity=0.507 Sum_probs=181.1
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
+.|.|+++| +++.+|++||-|-||+|...+.++ |.+.+..++.++.-+++|++|||++|||+|||||+|.++
T Consensus 478 ~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrdR-g~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllL--- 553 (732)
T KOG0614|consen 478 RSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRDR-GSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLL--- 553 (732)
T ss_pred CchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhhc-CCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheee---
Confidence 457888888 678999999999999999977655 899999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCCccccCCCCCcccccccCCccccccc-cccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 016471 78 EEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL-HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLR 156 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 156 (389)
+.+|.+||.|||+|+....+.+.+++||||.|.|||++ .+..+.++|.||||+++|||++|.+||.+.++..++..|++
T Consensus 554 d~~Gy~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILk 633 (732)
T KOG0614|consen 554 DNRGYLKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILK 633 (732)
T ss_pred ccCCceEEeehhhHHHhccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHh
Confidence 78999999999999999999999999999999999976 56799999999999999999999999999999999999998
Q ss_pred cCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCC-----HHHHhCCCCCCCCCC
Q 016471 157 ADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMT-----AAQALTHPWLHDENR 205 (389)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s-----~~e~l~h~~~~~~~~ 205 (389)
+...+.-+ ..++..+.+||+++...+|.+|.. +.++..|.||.+.++
T Consensus 634 Gid~i~~P--r~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdw 685 (732)
T KOG0614|consen 634 GIDKIEFP--RRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDW 685 (732)
T ss_pred hhhhhhcc--cccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCCh
Confidence 76544433 468999999999999999999985 889999999987653
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=287.20 Aligned_cols=200 Identities=27% Similarity=0.456 Sum_probs=167.3
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||+.++ ..+.+|+|||||+||+|.+++.+..+.+++..++.++.|++.||+|||++||+||||||+||++
T Consensus 58 ~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill-- 135 (331)
T cd05624 58 GDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLL-- 135 (331)
T ss_pred CCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEE--
Confidence 4799999987 4678999999999999999987755789999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCC--cccccccCCcccccccc------ccCCCchhHHHHHHHHHHHHhCCCCCCCCChh
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQR--LNDIVGSAYYVAPEVLH------RSYNVEGDMWSIGVITYILLCGSRPFWARTES 148 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 148 (389)
+.++.+||+|||++........ ....+||+.|+|||++. +.++.++|+||+||++|+|++|+.||.+.+..
T Consensus 136 -~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~ 214 (331)
T cd05624 136 -DMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 214 (331)
T ss_pred -cCCCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH
Confidence 5678899999999876543322 22357999999999875 34788999999999999999999999988887
Q ss_pred HHHHHHHhcCCCCCC-CCCCCCCHHHHHHHHhhhccCcCC--CCCHHHHhCCCCCCCC
Q 016471 149 GIFRSVLRADPNFHD-SPWPSVSPEAKDFVRRLLNKDHRK--RMTAAQALTHPWLHDE 203 (389)
Q Consensus 149 ~~~~~i~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~--R~s~~e~l~h~~~~~~ 203 (389)
+.+..+......++. ..+..++..++++|.+||...+++ |++++++++||||...
T Consensus 215 ~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~ 272 (331)
T cd05624 215 ETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGI 272 (331)
T ss_pred HHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCC
Confidence 777777664433321 223457999999999999876654 5689999999999764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=281.11 Aligned_cols=200 Identities=26% Similarity=0.461 Sum_probs=164.0
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|.||||+.++ ..+.+|+||||+. |+|.+++.+....+++..+..++.||+.||.|||++||+||||||+||++
T Consensus 61 l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~-- 137 (301)
T cd07873 61 LKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLI-- 137 (301)
T ss_pred cCCCCcceEEEEEecCCeEEEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEE--
Confidence 5799999998 3578999999998 48998887766779999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC-CcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRS 153 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 153 (389)
+.++.+||+|||++....... ......+++.|+|||++.+ .++.++||||+||++|+|++|++||.+.+..+....
T Consensus 138 -~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~ 216 (301)
T cd07873 138 -NERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHF 216 (301)
T ss_pred -CCCCcEEECcCcchhccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 567889999999987643222 2234567899999998743 478899999999999999999999988776655554
Q ss_pred HHhcCCCCCC--------------------------CCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 154 VLRADPNFHD--------------------------SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 154 i~~~~~~~~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
+......... ...+.+++.+++||.+||..||.+|||++++++||||....
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 217 IFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred HHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 4332111110 01135788999999999999999999999999999997664
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=288.78 Aligned_cols=196 Identities=25% Similarity=0.396 Sum_probs=155.5
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ ..+.+|+|||||.||+|.+. ...++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 129 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll-- 201 (353)
T PLN00034 129 VNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGT-----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLI-- 201 (353)
T ss_pred CCCCCcceeeeEeccCCeEEEEEecCCCCccccc-----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE--
Confidence 5799999988 45789999999999998652 346788889999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC-CcccccccCCccccccccc------cCCCchhHHHHHHHHHHHHhCCCCCCCCChhH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLHR------SYNVEGDMWSIGVITYILLCGSRPFWARTESG 149 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~------~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 149 (389)
+.++.+||+|||++....... ......||..|+|||++.. ..+.++|||||||++|+|++|+.||.......
T Consensus 202 -~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~ 280 (353)
T PLN00034 202 -NSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD 280 (353)
T ss_pred -cCCCCEEEcccccceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc
Confidence 567899999999987664332 2345679999999998732 23568999999999999999999997433322
Q ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 150 IFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 150 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
....+..............++.++++||.+||..+|.+|||+.++++||||....
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 281 WASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred HHHHHHHHhccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 2211111111111222246889999999999999999999999999999998763
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=279.85 Aligned_cols=197 Identities=26% Similarity=0.458 Sum_probs=162.0
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEe
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 75 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~ 75 (389)
+.||+|+.++ ..+.+|+||||++||+|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||++
T Consensus 57 l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~- 135 (285)
T cd05630 57 VNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILL- 135 (285)
T ss_pred CCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE-
Confidence 5799999887 3578999999999999998875432 358999999999999999999999999999999999999
Q ss_pred ecCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChh---HHH
Q 016471 76 TREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTES---GIF 151 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~ 151 (389)
+.++.++|+|||++.............|++.|+|||++. ..++.++|+||+||++|+|++|+.||...... ...
T Consensus 136 --~~~~~~~l~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~ 213 (285)
T cd05630 136 --DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV 213 (285)
T ss_pred --CCCCCEEEeeccceeecCCCccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHH
Confidence 567889999999987665444444567999999999985 46899999999999999999999999875432 122
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCC-----HHHHhCCCCCCCC
Q 016471 152 RSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMT-----AAQALTHPWLHDE 203 (389)
Q Consensus 152 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s-----~~e~l~h~~~~~~ 203 (389)
..+.... .......+++++++|+.+||+.+|.+||| ++++++||||...
T Consensus 214 ~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 214 ERLVKEV---QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred Hhhhhhh---hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence 2222211 11122457899999999999999999999 8999999999664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=288.06 Aligned_cols=198 Identities=20% Similarity=0.306 Sum_probs=155.3
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ .....|+||||+. |+|.+++....+.+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 114 l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill-- 190 (357)
T PHA03209 114 VNHPSVIRMKDTLVSGAITCMVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFI-- 190 (357)
T ss_pred CCCCCCcChhheEEeCCeeEEEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE--
Confidence 5899999988 4577899999996 58999888777789999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCC-CCCChh------
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPF-WARTES------ 148 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf-~~~~~~------ 148 (389)
+.++.+||+|||++.............||+.|+|||++. ..++.++||||+||++|+|+++..|+ ......
T Consensus 191 -~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~ 269 (357)
T PHA03209 191 -NDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVK 269 (357)
T ss_pred -CCCCCEEEecCccccccccCcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHH
Confidence 567889999999987644434444567999999999985 46899999999999999999855544 332111
Q ss_pred ---HHHHHHHhcCC----CCC---------------------C-----CCCCCCCHHHHHHHHhhhccCcCCCCCHHHHh
Q 016471 149 ---GIFRSVLRADP----NFH---------------------D-----SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQAL 195 (389)
Q Consensus 149 ---~~~~~i~~~~~----~~~---------------------~-----~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l 195 (389)
..+..+..... .++ . .....++.++.+||.+||..||.+|||+.|++
T Consensus 270 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l 349 (357)
T PHA03209 270 SCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEIL 349 (357)
T ss_pred HHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHh
Confidence 11111111100 000 0 00124577888999999999999999999999
Q ss_pred CCCCCCC
Q 016471 196 THPWLHD 202 (389)
Q Consensus 196 ~h~~~~~ 202 (389)
+||||++
T Consensus 350 ~hp~f~~ 356 (357)
T PHA03209 350 NYPMFAQ 356 (357)
T ss_pred cCchhcc
Confidence 9999975
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=289.74 Aligned_cols=197 Identities=21% Similarity=0.415 Sum_probs=172.4
Q ss_pred CCCccccceee------cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--CCEecCCCCCcE
Q 016471 1 MYHQKLQHLFY------SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQ--GVVHRDLKPENF 72 (389)
Q Consensus 1 l~Hpni~~~~~------~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~--~i~Hrdlkp~Ni 72 (389)
|+||||+++|+ ...+-+|+|.+..|+|..|.++. ++.+...++.|++||+.||.|||++ .|+|||||.+||
T Consensus 98 L~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~-~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNI 176 (632)
T KOG0584|consen 98 LKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKH-RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNI 176 (632)
T ss_pred CCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHHh-ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceE
Confidence 78999999993 36699999999999999998877 7899999999999999999999998 599999999999
Q ss_pred EEeecCCCCCEEEeecCCccccCCCCCcccccccCCccccccccccCCCchhHHHHHHHHHHHHhCCCCCCC-CChhHHH
Q 016471 73 LFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWA-RTESGIF 151 (389)
Q Consensus 73 ll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~ 151 (389)
+++ ++.|.|||+|+|+|+...... ....+|||.|||||++...|+..+||||||+.+.||+|+..||.- .++.+++
T Consensus 177 Fin--G~~G~VKIGDLGLAtl~r~s~-aksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIY 253 (632)
T KOG0584|consen 177 FVN--GNLGEVKIGDLGLATLLRKSH-AKSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIY 253 (632)
T ss_pred EEc--CCcCceeecchhHHHHhhccc-cceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHH
Confidence 997 778999999999998775433 344789999999999999999999999999999999999999965 5677888
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 152 RSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 152 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
+++..+...-.- ..--.+++++||.+||.. ...|+|+.|+|.||||....
T Consensus 254 KKV~SGiKP~sl--~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d~ 303 (632)
T KOG0584|consen 254 KKVTSGIKPAAL--SKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDEDG 303 (632)
T ss_pred HHHHcCCCHHHh--hccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhcccc
Confidence 888876533111 112378999999999999 99999999999999998763
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=274.63 Aligned_cols=193 Identities=25% Similarity=0.492 Sum_probs=158.9
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
.||||++++ ..+.+|+||||++||+|.+++..+ +.+++..+..++.|++.||.|||+.|++||||||+||++.
T Consensus 67 ~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~-- 143 (267)
T PHA03390 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYD-- 143 (267)
T ss_pred cCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEe--
Confidence 599999988 357899999999999999988665 5899999999999999999999999999999999999995
Q ss_pred CCCC-CEEEeecCCccccCCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHH-HHH
Q 016471 78 EEDA-PLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIF-RSV 154 (389)
Q Consensus 78 ~~~~-~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~i 154 (389)
.++ .++|+|||++...... ....|+..|+|||++. ..++.++|+||+||++|+|++|..||......... ...
T Consensus 144 -~~~~~~~l~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~ 219 (267)
T PHA03390 144 -RAKDRIYLCDYGLCKIIGTP---SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESL 219 (267)
T ss_pred -CCCCeEEEecCccceecCCC---ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHH
Confidence 445 8999999998765432 2346889999999985 46889999999999999999999999865443321 112
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCC-HHHHhCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMT-AAQALTHPWLHD 202 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s-~~e~l~h~~~~~ 202 (389)
.... .......+.+++.+.++|.+||+.+|.+||+ ++++++||||.+
T Consensus 220 ~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 220 LKRQ-QKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred HHhh-cccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 1111 2222233468999999999999999999996 699999999963
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=286.36 Aligned_cols=195 Identities=25% Similarity=0.408 Sum_probs=158.0
Q ss_pred CCCccccceee----------cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCC
Q 016471 1 MYHQKLQHLFY----------SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPE 70 (389)
Q Consensus 1 l~Hpni~~~~~----------~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~ 70 (389)
+.||||++++. ...+|+||||+.+ +|.+.+. ..+++..+..++.|++.||.|||++||+||||||+
T Consensus 80 l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~ 155 (364)
T cd07875 80 VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPS 155 (364)
T ss_pred cCCCCccccceeecccccccccCeEEEEEeCCCC-CHHHHHH---hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHH
Confidence 57999999872 1357999999976 6767663 34889999999999999999999999999999999
Q ss_pred cEEEeecCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhH
Q 016471 71 NFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESG 149 (389)
Q Consensus 71 Nill~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 149 (389)
||++ +.++.+||+|||++.............||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+.+...
T Consensus 156 NIll---~~~~~~kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~ 232 (364)
T cd07875 156 NIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID 232 (364)
T ss_pred HEEE---CCCCcEEEEeCCCccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999 5678999999999987654444455689999999998854 68999999999999999999999998877766
Q ss_pred HHHHHHhcCCCC----------------------CC----------------CCCCCCCHHHHHHHHhhhccCcCCCCCH
Q 016471 150 IFRSVLRADPNF----------------------HD----------------SPWPSVSPEAKDFVRRLLNKDHRKRMTA 191 (389)
Q Consensus 150 ~~~~i~~~~~~~----------------------~~----------------~~~~~~~~~~~~li~~~l~~~p~~R~s~ 191 (389)
.+..+....... .. ......+..+++||.+||..||.+|||+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~ 312 (364)
T cd07875 233 QWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 312 (364)
T ss_pred HHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCH
Confidence 655554321110 00 0001135678999999999999999999
Q ss_pred HHHhCCCCCCC
Q 016471 192 AQALTHPWLHD 202 (389)
Q Consensus 192 ~e~l~h~~~~~ 202 (389)
.++|+||||..
T Consensus 313 ~e~L~hp~~~~ 323 (364)
T cd07875 313 DEALQHPYINV 323 (364)
T ss_pred HHHhcCccccc
Confidence 99999999965
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=288.62 Aligned_cols=195 Identities=26% Similarity=0.453 Sum_probs=155.8
Q ss_pred CCCccccceeec----------CeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCC
Q 016471 1 MYHQKLQHLFYS----------NSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPE 70 (389)
Q Consensus 1 l~Hpni~~~~~~----------~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~ 70 (389)
+.||||++++.. ..+|+|||||.+ +|.+.+. ..+++..+..++.||+.||.|||++||+||||||+
T Consensus 77 l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~ 152 (359)
T cd07876 77 VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPS 152 (359)
T ss_pred CCCCCEeeeeeeeccCCCccccceeEEEEeCCCc-CHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHH
Confidence 579999998831 357999999986 5666553 35899999999999999999999999999999999
Q ss_pred cEEEeecCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhH
Q 016471 71 NFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESG 149 (389)
Q Consensus 71 Nill~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 149 (389)
||++ +.++.+||+|||++.............||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+.+...
T Consensus 153 NIl~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~ 229 (359)
T cd07876 153 NIVV---KSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHID 229 (359)
T ss_pred HEEE---CCCCCEEEecCCCccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999 5678999999999976544444455688999999998854 68999999999999999999999998776544
Q ss_pred HHHHHHhc----------------------CCCCCCCC----------------CCCCCHHHHHHHHhhhccCcCCCCCH
Q 016471 150 IFRSVLRA----------------------DPNFHDSP----------------WPSVSPEAKDFVRRLLNKDHRKRMTA 191 (389)
Q Consensus 150 ~~~~i~~~----------------------~~~~~~~~----------------~~~~~~~~~~li~~~l~~~p~~R~s~ 191 (389)
.+..+... .+..+... ....++.+++||.+||..||.+|||+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~ 309 (359)
T cd07876 230 QWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISV 309 (359)
T ss_pred HHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCH
Confidence 33322211 11111000 01236789999999999999999999
Q ss_pred HHHhCCCCCCC
Q 016471 192 AQALTHPWLHD 202 (389)
Q Consensus 192 ~e~l~h~~~~~ 202 (389)
.|+++||||..
T Consensus 310 ~e~l~hp~~~~ 320 (359)
T cd07876 310 DEALRHPYITV 320 (359)
T ss_pred HHHhcCchhhh
Confidence 99999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=271.58 Aligned_cols=196 Identities=30% Similarity=0.502 Sum_probs=168.2
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
.||||++++ ..+.+|+|||||+||+|.+++... +.+++..+..++.||+.||.|||+.|++||||+|+||++
T Consensus 55 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~--- 130 (260)
T cd05611 55 ESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLI--- 130 (260)
T ss_pred CCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---
Confidence 699999988 357899999999999999977654 679999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCCccccCCCCCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 016471 78 EEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLR 156 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 156 (389)
+.++.+||+|||++..... .....|++.|+|||.+.+ .++.++|+||+|+++|+|++|..||...+....+..+..
T Consensus 131 ~~~~~~~l~dfg~~~~~~~---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 207 (260)
T cd05611 131 DQTGHLKLTDFGLSRNGLE---NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILS 207 (260)
T ss_pred CCCCcEEEeecccceeccc---cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh
Confidence 4678899999998876432 234568899999998754 478999999999999999999999988888777777766
Q ss_pred cCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCC---HHHHhCCCCCCCCC
Q 016471 157 ADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMT---AAQALTHPWLHDEN 204 (389)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s---~~e~l~h~~~~~~~ 204 (389)
.....+......+++.+.+++.+||..+|++||+ +++++.||||.+.+
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~ 258 (260)
T cd05611 208 RRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSIN 258 (260)
T ss_pred cccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCC
Confidence 5555444444568999999999999999999995 57999999997654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=273.47 Aligned_cols=200 Identities=28% Similarity=0.515 Sum_probs=166.8
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ ..+..|+||||+++|+|..++.+..+.+++..+..++.|++.||.|||+.|++||||||+||++
T Consensus 59 l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili-- 136 (282)
T cd06643 59 CDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILF-- 136 (282)
T ss_pred CCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE--
Confidence 5799999988 4578999999999999988776655679999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCC-CCcccccccCCcccccccc------ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhH
Q 016471 77 REEDAPLKVIDFGLSDFVRPD-QRLNDIVGSAYYVAPEVLH------RSYNVEGDMWSIGVITYILLCGSRPFWARTESG 149 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 149 (389)
+.++.+||+|||++...... .......+++.|+|||++. ..++.++|+||+||++|+|++|++||...+..+
T Consensus 137 -~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~ 215 (282)
T cd06643 137 -TLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR 215 (282)
T ss_pred -ccCCCEEEccccccccccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH
Confidence 46788999999998765322 2234457899999999873 236789999999999999999999998877766
Q ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 150 IFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 150 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
....+......... ....++..++++|.+||..+|.+|||+.++++||||....
T Consensus 216 ~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 269 (282)
T cd06643 216 VLLKIAKSEPPTLA-QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNS 269 (282)
T ss_pred HHHHHhhcCCCCCC-CccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEeccC
Confidence 66666554332111 1235789999999999999999999999999999997653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=270.68 Aligned_cols=194 Identities=25% Similarity=0.468 Sum_probs=162.2
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ ....+|+|+||++||+|.+.+... +.+++..+..++.|++.||.|||+.|++||||+|+||++
T Consensus 61 l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv-- 137 (263)
T cd06625 61 LQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILR-- 137 (263)
T ss_pred CCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE--
Confidence 5799999998 457899999999999999988655 679999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCC----cccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQR----LNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIF 151 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 151 (389)
+.++.++|+|||++........ .....|+..|+|||++.+ .++.++|+||+|+++|++++|+.||.........
T Consensus 138 -~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~ 216 (263)
T cd06625 138 -DSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI 216 (263)
T ss_pred -cCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH
Confidence 4678899999999876543211 123568889999999854 5889999999999999999999999876665555
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCC
Q 016471 152 RSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 152 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~ 200 (389)
..+........ ....++..+.++|.+||..+|.+|||+.++++||||
T Consensus 217 ~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 217 FKIATQPTNPQ--LPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHhccCCCCC--CCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 44443322211 123578999999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=282.00 Aligned_cols=199 Identities=22% Similarity=0.360 Sum_probs=159.3
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CCEecCCCCCcEEEe
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQ-GVVHRDLKPENFLFT 75 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~-~i~Hrdlkp~Nill~ 75 (389)
|.||||+.++ ..+.+|+|||||+||+|.+++... +.+++..+..++.|++.||.|||++ +|+||||||+||++
T Consensus 60 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili- 137 (333)
T cd06650 60 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV- 137 (333)
T ss_pred CCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEE-
Confidence 5799999988 467899999999999999988654 6799999999999999999999985 79999999999999
Q ss_pred ecCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 76 TREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
+.++.+||+|||++...... ......||+.|+|||++.+ .++.++|+||+||++|+|++|+.||...........+
T Consensus 138 --~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~ 214 (333)
T cd06650 138 --NSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMF 214 (333)
T ss_pred --cCCCCEEEeeCCcchhhhhh-ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHh
Confidence 46788999999998755322 2234578999999999864 5889999999999999999999999765543332111
Q ss_pred H----------------------------------------h--cCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHH
Q 016471 155 L----------------------------------------R--ADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAA 192 (389)
Q Consensus 155 ~----------------------------------------~--~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~ 192 (389)
. . .....+......++.++++||.+||++||.+|||+.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ 294 (333)
T cd06650 215 GCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLK 294 (333)
T ss_pred cCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHH
Confidence 0 0 000000111123678999999999999999999999
Q ss_pred HHhCCCCCCCCC
Q 016471 193 QALTHPWLHDEN 204 (389)
Q Consensus 193 e~l~h~~~~~~~ 204 (389)
+++.||||+...
T Consensus 295 ell~h~~~~~~~ 306 (333)
T cd06650 295 QLMVHAFIKRSE 306 (333)
T ss_pred HHhhCHHHhcCc
Confidence 999999997653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=273.90 Aligned_cols=204 Identities=26% Similarity=0.479 Sum_probs=167.4
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ .+..+|+||||++||+|..++.+....+++..+..++.|++.||.|||++|++||||||+||++
T Consensus 66 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili-- 143 (292)
T cd06644 66 CNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLL-- 143 (292)
T ss_pred CCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEE--
Confidence 5799999988 4678999999999999988877666779999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCC-CCcccccccCCcccccccc------ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhH
Q 016471 77 REEDAPLKVIDFGLSDFVRPD-QRLNDIVGSAYYVAPEVLH------RSYNVEGDMWSIGVITYILLCGSRPFWARTESG 149 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 149 (389)
+.++.+||+|||++...... .......+++.|+|||++. ..++.++|+||+||++|+|++|..||...+...
T Consensus 144 -~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~ 222 (292)
T cd06644 144 -TLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR 222 (292)
T ss_pred -cCCCCEEEccCccceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH
Confidence 46788999999988754322 2233456889999999873 236788999999999999999999998776665
Q ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCCCCCC
Q 016471 150 IFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVP 208 (389)
Q Consensus 150 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~~~~~ 208 (389)
....+.+.... .......++.++.++|.+||..+|.+||++.++++||||.......+
T Consensus 223 ~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~ 280 (292)
T cd06644 223 VLLKIAKSEPP-TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNRP 280 (292)
T ss_pred HHHHHhcCCCc-cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccchh
Confidence 55555443221 11112457889999999999999999999999999999977654444
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=275.76 Aligned_cols=188 Identities=17% Similarity=0.239 Sum_probs=160.3
Q ss_pred CCCccccceee--------cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CCEecCCCCCc
Q 016471 1 MYHQKLQHLFY--------SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQ-GVVHRDLKPEN 71 (389)
Q Consensus 1 l~Hpni~~~~~--------~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~-~i~Hrdlkp~N 71 (389)
+.||||++++. ...+++|||||+||+|.+++.+. +.+++..+..++.|++.||.|||+. +++||||||+|
T Consensus 75 l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~n 153 (283)
T PHA02988 75 IDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVS 153 (283)
T ss_pred cCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhh
Confidence 58999999982 24689999999999999988655 6799999999999999999999984 99999999999
Q ss_pred EEEeecCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc---ccCCCchhHHHHHHHHHHHHhCCCCCCCCChh
Q 016471 72 FLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH---RSYNVEGDMWSIGVITYILLCGSRPFWARTES 148 (389)
Q Consensus 72 ill~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 148 (389)
|++ +.++.+||+|||++...... .....||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.+..
T Consensus 154 ill---~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~ 228 (283)
T PHA02988 154 FLV---TENYKLKIICHGLEKILSSP--PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK 228 (283)
T ss_pred EEE---CCCCcEEEcccchHhhhccc--cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH
Confidence 999 56789999999998765332 23456889999999985 36899999999999999999999999988887
Q ss_pred HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 149 GIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 149 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
+....+......++.+ ...++.+++++.+||+.||.+|||+++++.
T Consensus 229 ~~~~~i~~~~~~~~~~--~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 229 EIYDLIINKNNSLKLP--LDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred HHHHHHHhcCCCCCCC--CcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 7777776554433322 257899999999999999999999999985
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=279.36 Aligned_cols=194 Identities=27% Similarity=0.488 Sum_probs=153.2
Q ss_pred Ccccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeecC
Q 016471 3 HQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE 78 (389)
Q Consensus 3 Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~~ 78 (389)
|-+|+.+| .++.+|+||||=+- +|-..+.++.+.++.-.++.++.|++.|++++|.+||||.||||.|+|+.
T Consensus 419 ~~~IIqL~DYEv~d~~lYmvmE~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV--- 494 (677)
T KOG0596|consen 419 HDKIIQLYDYEVTDGYLYMVMECGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV--- 494 (677)
T ss_pred CceEEEEeeeeccCceEEEEeecccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE---
Confidence 67888988 36889999998554 88776666655555568999999999999999999999999999999995
Q ss_pred CCCCEEEeecCCccccCCCCC---cccccccCCccccccccc------------cCCCchhHHHHHHHHHHHHhCCCCCC
Q 016471 79 EDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLHR------------SYNVEGDMWSIGVITYILLCGSRPFW 143 (389)
Q Consensus 79 ~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~------------~~~~~~DiwslG~il~~ll~g~~pf~ 143 (389)
.|.+||+|||+|..+..+.. ..+.+||+.||+||.+.. ..++++||||||||||+|+.|++||.
T Consensus 495 -kG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~ 573 (677)
T KOG0596|consen 495 -KGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFG 573 (677)
T ss_pred -eeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchH
Confidence 78999999999988765542 346799999999998721 15688999999999999999999995
Q ss_pred CCC-hhHHHHHHHhcCCCCCCCCCCCCC--HHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 144 ART-ESGIFRSVLRADPNFHDSPWPSVS--PEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 144 ~~~-~~~~~~~i~~~~~~~~~~~~~~~~--~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
.-. ....+..|...... ..+|.++ .++.++++.||..||.+|||+.++|+|||+....
T Consensus 574 ~~~n~~aKl~aI~~P~~~---Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~ 634 (677)
T KOG0596|consen 574 QIINQIAKLHAITDPNHE---IEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQP 634 (677)
T ss_pred HHHHHHHHHHhhcCCCcc---ccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccccc
Confidence 422 22333333332221 2233332 2399999999999999999999999999997654
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=274.36 Aligned_cols=200 Identities=29% Similarity=0.537 Sum_probs=167.1
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|.||||++++ ....+|+||||++||+|.+++.+..+.+++..++.++.|++.||.|||++||+||||+|+||++
T Consensus 59 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili-- 136 (280)
T cd06611 59 CKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILL-- 136 (280)
T ss_pred CCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE--
Confidence 5799999998 4578999999999999999887766679999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCC-CCcccccccCCcccccccc------ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhH
Q 016471 77 REEDAPLKVIDFGLSDFVRPD-QRLNDIVGSAYYVAPEVLH------RSYNVEGDMWSIGVITYILLCGSRPFWARTESG 149 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 149 (389)
+.++.++|+|||++...... .......|++.|+|||.+. ..++.++|+||+||++|+|++|+.||.+.....
T Consensus 137 -~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~ 215 (280)
T cd06611 137 -TLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR 215 (280)
T ss_pred -CCCCCEEEccCccchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH
Confidence 56789999999988655332 2233456899999999873 236778999999999999999999998877666
Q ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 150 IFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 150 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
....+........ .....++..+.++|.+||..+|.+|||+.++++||||....
T Consensus 216 ~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (280)
T cd06611 216 VLLKILKSEPPTL-DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQS 269 (280)
T ss_pred HHHHHhcCCCCCc-CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcccc
Confidence 6666654432211 11235789999999999999999999999999999997763
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=273.55 Aligned_cols=193 Identities=26% Similarity=0.506 Sum_probs=170.6
Q ss_pred cccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeecCC
Q 016471 4 QKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREE 79 (389)
Q Consensus 4 pni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~~~ 79 (389)
|.++.+. .-+.+|+|||||+||+|.-.+..- |++.|..|..++.+|+.||-|||++||++||||.+||++ +.
T Consensus 410 pFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~-GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmL---d~ 485 (683)
T KOG0696|consen 410 PFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV-GKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DS 485 (683)
T ss_pred chHHHHHHHhhhhhheeeEEEEecCchhhhHHHHh-cccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEe---cc
Confidence 5555555 347899999999999998877554 899999999999999999999999999999999999999 68
Q ss_pred CCCEEEeecCCcccc-CCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc
Q 016471 80 DAPLKVIDFGLSDFV-RPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRA 157 (389)
Q Consensus 80 ~~~~kl~Dfg~a~~~-~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 157 (389)
.+.+||+|||+++.- -.+....++||||.|+|||++. .+|+.++|+||+||+||||+.|++||.|.+..++++.|...
T Consensus 486 eGHiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh 565 (683)
T KOG0696|consen 486 EGHIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH 565 (683)
T ss_pred CCceEeeecccccccccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc
Confidence 899999999998753 2344567889999999999874 78999999999999999999999999999999999999987
Q ss_pred CCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCH-----HHHhCCCCCCCCC
Q 016471 158 DPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTA-----AQALTHPWLHDEN 204 (389)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~-----~e~l~h~~~~~~~ 204 (389)
+..+|. ++|.++.++.+.+|.+.|.+|... .++-.||||+..+
T Consensus 566 nvsyPK----slSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iD 613 (683)
T KOG0696|consen 566 NVSYPK----SLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRID 613 (683)
T ss_pred cCcCcc----cccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhcc
Confidence 777663 589999999999999999999853 6899999997654
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=286.94 Aligned_cols=198 Identities=28% Similarity=0.445 Sum_probs=160.7
Q ss_pred CCCccccceee----cC-----eEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCc
Q 016471 1 MYHQKLQHLFY----SN-----SFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPEN 71 (389)
Q Consensus 1 l~Hpni~~~~~----~~-----~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~N 71 (389)
++||||++++. .. .+|+||||+. ++|.+.+... +.+++..++.++.||+.||.|||++||+||||||+|
T Consensus 56 l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~N 133 (372)
T cd07853 56 FKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGN 133 (372)
T ss_pred CCCCCcCCHhheecCCCccccceEEEEeeccc-cCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHH
Confidence 58999999882 22 7899999997 4788877554 679999999999999999999999999999999999
Q ss_pred EEEeecCCCCCEEEeecCCccccCCCC--CcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 016471 72 FLFTTREEDAPLKVIDFGLSDFVRPDQ--RLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTE 147 (389)
Q Consensus 72 ill~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 147 (389)
||+ +.++.+||+|||++....... ......+|+.|+|||++.+ .++.++||||+||++|+|++|+.||.+.+.
T Consensus 134 ili---~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 210 (372)
T cd07853 134 LLV---NSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSP 210 (372)
T ss_pred EEE---CCCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCH
Confidence 999 567899999999987654322 2334568999999998854 478999999999999999999999988776
Q ss_pred hHHHHHHHhcCC-----------------------CCCC-----CCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCC
Q 016471 148 SGIFRSVLRADP-----------------------NFHD-----SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPW 199 (389)
Q Consensus 148 ~~~~~~i~~~~~-----------------------~~~~-----~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~ 199 (389)
...+..+..... ..+. ...+..++.+.+||.+||..||.+|||+.++++|||
T Consensus 211 ~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 290 (372)
T cd07853 211 IQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPY 290 (372)
T ss_pred HHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHh
Confidence 655554432111 1110 011346889999999999999999999999999999
Q ss_pred CCCC
Q 016471 200 LHDE 203 (389)
Q Consensus 200 ~~~~ 203 (389)
|...
T Consensus 291 ~~~~ 294 (372)
T cd07853 291 LDEG 294 (372)
T ss_pred hCCC
Confidence 9775
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=292.71 Aligned_cols=197 Identities=27% Similarity=0.480 Sum_probs=167.0
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCC--CHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEE
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRY--LEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLF 74 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l--~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill 74 (389)
|+|.|||+|. .++.+-|+||-++||+|.+.+..+=|++ .|..+..+.+||++||+|||.+.|||||||-+|+|+
T Consensus 629 LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLv 708 (1226)
T KOG4279|consen 629 LRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLV 708 (1226)
T ss_pred HhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEE
Confidence 6899999999 3567889999999999999998877888 789999999999999999999999999999999999
Q ss_pred eecCCCCCEEEeecCCccccCC-CCCcccccccCCcccccccc---ccCCCchhHHHHHHHHHHHHhCCCCCCCC-Chh-
Q 016471 75 TTREEDAPLKVIDFGLSDFVRP-DQRLNDIVGSAYYVAPEVLH---RSYNVEGDMWSIGVITYILLCGSRPFWAR-TES- 148 (389)
Q Consensus 75 ~~~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~- 148 (389)
. --.|.+||+|||.+++... ++...++.||..|||||++. +.|+.++|||||||++.||.||++||..- ++.
T Consensus 709 N--TySGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA 786 (1226)
T KOG4279|consen 709 N--TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA 786 (1226)
T ss_pred e--eccceEEecccccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH
Confidence 6 3578999999999987753 45667789999999999995 36999999999999999999999999642 222
Q ss_pred HHHHH-HHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCC
Q 016471 149 GIFRS-VLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 149 ~~~~~-i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~ 203 (389)
.+++- +.+..+.+| .++|.+++.||.+|+.++|..||++.++|..||++..
T Consensus 787 AMFkVGmyKvHP~iP----eelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 787 AMFKVGMYKVHPPIP----EELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred hhhhhcceecCCCCc----HHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 22221 122222222 3689999999999999999999999999999999866
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=285.47 Aligned_cols=196 Identities=25% Similarity=0.423 Sum_probs=156.7
Q ss_pred CCCccccceeec----------CeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCC
Q 016471 1 MYHQKLQHLFYS----------NSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPE 70 (389)
Q Consensus 1 l~Hpni~~~~~~----------~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~ 70 (389)
+.||||++++.. ..+|+|||||.+ +|.+.+. ..+++..+..++.|++.||.|||++||+||||||+
T Consensus 73 l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~ 148 (355)
T cd07874 73 VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPS 148 (355)
T ss_pred hCCCchhceeeeeeccccccccceeEEEhhhhcc-cHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChH
Confidence 579999998831 357999999986 6666553 35899999999999999999999999999999999
Q ss_pred cEEEeecCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhH
Q 016471 71 NFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESG 149 (389)
Q Consensus 71 Nill~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 149 (389)
||++ +.++.+||+|||++.............||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+.....
T Consensus 149 Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 225 (355)
T cd07874 149 NIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 225 (355)
T ss_pred HEEE---CCCCCEEEeeCcccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999 5678999999999987655444455689999999998854 68999999999999999999999998876544
Q ss_pred HHHHHHhcC----------------------CCCCC----------------CCCCCCCHHHHHHHHhhhccCcCCCCCH
Q 016471 150 IFRSVLRAD----------------------PNFHD----------------SPWPSVSPEAKDFVRRLLNKDHRKRMTA 191 (389)
Q Consensus 150 ~~~~i~~~~----------------------~~~~~----------------~~~~~~~~~~~~li~~~l~~~p~~R~s~ 191 (389)
.+..+.... +.... ......+..+++||.+||..||.+|||+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~ 305 (355)
T cd07874 226 QWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305 (355)
T ss_pred HHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCH
Confidence 433322211 11000 0011245688999999999999999999
Q ss_pred HHHhCCCCCCCC
Q 016471 192 AQALTHPWLHDE 203 (389)
Q Consensus 192 ~e~l~h~~~~~~ 203 (389)
.++++||||...
T Consensus 306 ~ell~hp~~~~~ 317 (355)
T cd07874 306 DEALQHPYINVW 317 (355)
T ss_pred HHHhcCcchhcc
Confidence 999999999644
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=275.92 Aligned_cols=196 Identities=28% Similarity=0.503 Sum_probs=157.3
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
++||||++++ ....+|+|+|||.+ +|.+++....+.+++..++.++.||+.||.|||++||+||||||+||++
T Consensus 56 l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~-- 132 (284)
T cd07839 56 LKHKNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLI-- 132 (284)
T ss_pred cCCCCeeeHHHHhccCCceEEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE--
Confidence 5799999988 46789999999975 8888887666789999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC-CcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCC-CCChhHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFW-ARTESGIFR 152 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~-~~~~~~~~~ 152 (389)
+.++.+||+|||++....... ......+++.|+|||++.+ .++.++||||+||++|+|++|..||. +.+..+.+.
T Consensus 133 -~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~ 211 (284)
T cd07839 133 -NKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK 211 (284)
T ss_pred -cCCCcEEECccchhhccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHH
Confidence 467889999999987654332 2234567899999998753 47899999999999999999888854 444444443
Q ss_pred HHHhcCCC--------------C---CC--------CCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCC
Q 016471 153 SVLRADPN--------------F---HD--------SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 153 ~i~~~~~~--------------~---~~--------~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~ 200 (389)
.+.+.... . +. ...+.+++.++++|.+||..||.+|||+++++.||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 212 RIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred HHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 33221110 0 00 0123578999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=274.54 Aligned_cols=201 Identities=28% Similarity=0.439 Sum_probs=166.0
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEe
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 75 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~ 75 (389)
|.||||+.++ ..+.+|+||||+.+|+|.+++... ...+++..+..++.|++.||.|||++||+||||||+||++
T Consensus 57 l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili- 135 (285)
T cd05632 57 VNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILL- 135 (285)
T ss_pred cCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE-
Confidence 5799999887 457899999999999998877643 2469999999999999999999999999999999999999
Q ss_pred ecCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 76 TREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
+.++.+||+|||++.............|++.|+|||++. ..++.++|+||+||++|+|++|..||.+.........+
T Consensus 136 --~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~ 213 (285)
T cd05632 136 --DDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEV 213 (285)
T ss_pred --CCCCCEEEecCCcceecCCCCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 467889999999987654444444567999999999885 46899999999999999999999999877655443333
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCC-----HHHHhCCCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMT-----AAQALTHPWLHDEN 204 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s-----~~e~l~h~~~~~~~ 204 (389)
............+.+++.+.+|+.+||..+|.+||+ +.+++.|+||+...
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~ 268 (285)
T cd05632 214 DRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMN 268 (285)
T ss_pred HHhhhccccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCC
Confidence 332222222223568899999999999999999999 88999999997753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=278.18 Aligned_cols=196 Identities=29% Similarity=0.491 Sum_probs=168.3
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.|.||.+- ..+.+|+||..|+||+|.-+|.+.+ +.++++.++.++.+|+.||++||+.+||+|||||+|||+
T Consensus 243 ~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILL-- 320 (591)
T KOG0986|consen 243 SSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILL-- 320 (591)
T ss_pred ccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheee--
Confidence 345666654 3578999999999999988776553 479999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhH----HH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESG----IF 151 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~ 151 (389)
|+.|+|+|+|+|+|..+..+......+||.+|||||++.+ .|+...|+||+||++|+|+.|+.||....... +-
T Consensus 321 -Dd~GhvRISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvd 399 (591)
T KOG0986|consen 321 -DDHGHVRISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVD 399 (591)
T ss_pred -ccCCCeEeeccceEEecCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHH
Confidence 7899999999999999998888888899999999999964 69999999999999999999999997765443 33
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCC-----CHHHHhCCCCCCCCC
Q 016471 152 RSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRM-----TAAQALTHPWLHDEN 204 (389)
Q Consensus 152 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----s~~e~l~h~~~~~~~ 204 (389)
+.+......++ .++|++++++.+.+|.+||.+|. +++++.+||||++.+
T Consensus 400 rr~~~~~~ey~----~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~ln 453 (591)
T KOG0986|consen 400 RRTLEDPEEYS----DKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLN 453 (591)
T ss_pred HHHhcchhhcc----cccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCC
Confidence 34444333333 46899999999999999999997 578999999998854
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=271.71 Aligned_cols=195 Identities=25% Similarity=0.426 Sum_probs=159.7
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||+.++ ..+.+|+|||||++|+|.+++... +.+++..+..++.|++.||.|||++|++||||||+||++
T Consensus 63 l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili-- 139 (267)
T cd06645 63 CKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVT-GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILL-- 139 (267)
T ss_pred CCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE--
Confidence 5799999999 357899999999999999987655 689999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC-CcccccccCCcccccccc----ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLH----RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIF 151 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 151 (389)
+.++.++|+|||++....... ......|++.|+|||++. ..++.++|+||+||++|+|++|..||.........
T Consensus 140 -~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~ 218 (267)
T cd06645 140 -TDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL 218 (267)
T ss_pred -CCCCCEEECcceeeeEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH
Confidence 467889999999987654322 223457899999999873 34788999999999999999999999765554443
Q ss_pred HHHHhcCCCCCCC-CCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCC
Q 016471 152 RSVLRADPNFHDS-PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPW 199 (389)
Q Consensus 152 ~~i~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~ 199 (389)
..........+.. ....++..+.+++.+||..+|.+|||++++++|||
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 219 FLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 3333322221111 11247889999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=296.28 Aligned_cols=188 Identities=24% Similarity=0.350 Sum_probs=148.2
Q ss_pred cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCEecCCCCCcEEEeecCC-----------
Q 016471 12 SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHL-QGVVHRDLKPENFLFTTREE----------- 79 (389)
Q Consensus 12 ~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~-~~i~Hrdlkp~Nill~~~~~----------- 79 (389)
..++|+|||++ |++|.+++.++ +.+++..++.++.||+.||.|||+ .||+||||||+|||+...+.
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~ 281 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALP 281 (467)
T ss_pred CceEEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccC
Confidence 36799999998 67899888765 689999999999999999999998 59999999999999963211
Q ss_pred --CCCEEEeecCCccccCCCCCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 016471 80 --DAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLR 156 (389)
Q Consensus 80 --~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 156 (389)
...+||+|||.+.... ......+||+.|+|||++.+ .|+.++||||+||++|||++|++||.+.+..+.+..+..
T Consensus 282 ~~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~ 359 (467)
T PTZ00284 282 PDPCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEK 359 (467)
T ss_pred CCCceEEECCCCccccCc--cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 1259999999876432 22345689999999999854 699999999999999999999999988776555444433
Q ss_pred cCCCCCCC-----------------------C-------------CC--CCCHHHHHHHHhhhccCcCCCCCHHHHhCCC
Q 016471 157 ADPNFHDS-----------------------P-------------WP--SVSPEAKDFVRRLLNKDHRKRMTAAQALTHP 198 (389)
Q Consensus 157 ~~~~~~~~-----------------------~-------------~~--~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~ 198 (389)
....++.. . +. ..++.+.+||.+||++||.+|||++|+|+||
T Consensus 360 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp 439 (467)
T PTZ00284 360 TLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHP 439 (467)
T ss_pred HcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCc
Confidence 22111100 0 00 0145678999999999999999999999999
Q ss_pred CCCCC
Q 016471 199 WLHDE 203 (389)
Q Consensus 199 ~~~~~ 203 (389)
||...
T Consensus 440 ~~~~~ 444 (467)
T PTZ00284 440 YVLKY 444 (467)
T ss_pred ccccc
Confidence 99864
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=285.90 Aligned_cols=195 Identities=24% Similarity=0.397 Sum_probs=169.0
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|+|||++.|- -+...|+|||||-| +-.|.+.-+++.+.+.+++.|+.+.+.||.|||+++.||||||..|||++
T Consensus 83 l~HPntieYkgCyLre~TaWLVMEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLs- 160 (948)
T KOG0577|consen 83 LRHPNTIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLS- 160 (948)
T ss_pred ccCCCcccccceeeccchHHHHHHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEec-
Confidence 6899999987 35778999999986 77777766667899999999999999999999999999999999999995
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCccccccc----cccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL----HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFR 152 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 152 (389)
+.+.|||+|||.|....+ .++++|||+|||||++ .+.|+-++|||||||+..||...++|+...+....+.
T Consensus 161 --e~g~VKLaDFGSAsi~~P---AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALY 235 (948)
T KOG0577|consen 161 --EPGLVKLADFGSASIMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY 235 (948)
T ss_pred --CCCeeeeccccchhhcCc---hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHH
Confidence 789999999998876543 4678999999999987 3679999999999999999999999998887777776
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 153 SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 153 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
-|.++.+. ....+.+|..++.||..||.+-|..|||.+++|.|+|.....
T Consensus 236 HIAQNesP--tLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~R 285 (948)
T KOG0577|consen 236 HIAQNESP--TLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRER 285 (948)
T ss_pred HHHhcCCC--CCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCC
Confidence 67665432 222356799999999999999999999999999999996553
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=304.31 Aligned_cols=201 Identities=30% Similarity=0.539 Sum_probs=163.8
Q ss_pred CCCccccceee------cCeEEEEEEccCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-------CCEe
Q 016471 1 MYHQKLQHLFY------SNSFLFFTRFCEGGELLDRILSR---GGRYLEEDAKTIVEKILNIVAFCHLQ-------GVVH 64 (389)
Q Consensus 1 l~Hpni~~~~~------~~~~~lv~E~~~gg~L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~-------~i~H 64 (389)
|.||||+.++. ...+|||||||.+|+|.+++... .+.+++..++.|+.||+.||.|||+. +|+|
T Consensus 69 L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVH 148 (1021)
T PTZ00266 69 LKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLH 148 (1021)
T ss_pred cCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCcee
Confidence 67999999883 25689999999999999988642 35799999999999999999999994 4999
Q ss_pred cCCCCCcEEEeec--------------CCCCCEEEeecCCccccCCCCCcccccccCCcccccccc---ccCCCchhHHH
Q 016471 65 RDLKPENFLFTTR--------------EEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH---RSYNVEGDMWS 127 (389)
Q Consensus 65 rdlkp~Nill~~~--------------~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~Diws 127 (389)
|||||+|||++.. +....+||+|||++............+||+.|+|||++. ..++.++||||
T Consensus 149 RDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWS 228 (1021)
T PTZ00266 149 RDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWA 228 (1021)
T ss_pred ccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHH
Confidence 9999999999531 123459999999998765444445567999999999874 34889999999
Q ss_pred HHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 128 IGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 128 lG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
||||+|+|++|..||........+...+...+.. +.+..++++.+||.+||..+|.+||++.++|.|||+....
T Consensus 229 LG~ILYELLTGk~PF~~~~~~~qli~~lk~~p~l---pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~ 302 (1021)
T PTZ00266 229 LGCIIYELCSGKTPFHKANNFSQLISELKRGPDL---PIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG 302 (1021)
T ss_pred HHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCCCC---CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence 9999999999999998765544443333333322 2345789999999999999999999999999999997543
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=255.48 Aligned_cols=202 Identities=28% Similarity=0.491 Sum_probs=175.9
Q ss_pred CCCcccccee------------ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCC
Q 016471 1 MYHQKLQHLF------------YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLK 68 (389)
Q Consensus 1 l~Hpni~~~~------------~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlk 68 (389)
|+|+|++.+. +...+|+|+.+|+. +|...+-....+++..++..++++++.||.|+|+..|+|||+|
T Consensus 73 lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmK 151 (376)
T KOG0669|consen 73 LKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMK 151 (376)
T ss_pred hcchhHHHHHHHHhhccCCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhccc
Confidence 6899999987 23459999999998 8988776666789999999999999999999999999999999
Q ss_pred CCcEEEeecCCCCCEEEeecCCccccCCC-----CCcccccccCCcccccccc--ccCCCchhHHHHHHHHHHHHhCCCC
Q 016471 69 PENFLFTTREEDAPLKVIDFGLSDFVRPD-----QRLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILLCGSRP 141 (389)
Q Consensus 69 p~Nill~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~p 141 (389)
|.|+|+ +.++.+||+|||+++.+... ...+.++-|.+|++||.+. +.|+++.|+|+.|||+.+|++|.+.
T Consensus 152 aaNvLI---t~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspi 228 (376)
T KOG0669|consen 152 AANVLI---TKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPI 228 (376)
T ss_pred HhhEEE---cCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCcc
Confidence 999999 57899999999999766432 2345567799999999874 5799999999999999999999999
Q ss_pred CCCCChhHHHHHHHhcCCCCCCCCCCCC-------------------------------CHHHHHHHHhhhccCcCCCCC
Q 016471 142 FWARTESGIFRSVLRADPNFHDSPWPSV-------------------------------SPEAKDFVRRLLNKDHRKRMT 190 (389)
Q Consensus 142 f~~~~~~~~~~~i~~~~~~~~~~~~~~~-------------------------------~~~~~~li~~~l~~~p~~R~s 190 (389)
+++.+..+.+..|.....+.....||++ .+++.+|+.++|..||.+|+.
T Consensus 229 mqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ 308 (376)
T KOG0669|consen 229 MQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRID 308 (376)
T ss_pred ccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcc
Confidence 9999999998888877777777777653 257889999999999999999
Q ss_pred HHHHhCCCCCCCCCCC
Q 016471 191 AAQALTHPWLHDENRP 206 (389)
Q Consensus 191 ~~e~l~h~~~~~~~~~ 206 (389)
++++++|.||.....+
T Consensus 309 ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 309 ADQALNHDFFWKDPMP 324 (376)
T ss_pred hHhhhchhhhhcCCcc
Confidence 9999999999887655
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=293.95 Aligned_cols=196 Identities=27% Similarity=0.439 Sum_probs=165.7
Q ss_pred CCCccccceeec------------CeEEEEEEccCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCCEec
Q 016471 1 MYHQKLQHLFYS------------NSFLFFTRFCEGGELLDRILSR---GGRYLEEDAKTIVEKILNIVAFCHLQGVVHR 65 (389)
Q Consensus 1 l~Hpni~~~~~~------------~~~~lv~E~~~gg~L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hr 65 (389)
+.|+||+.++.. ..+++||||+++|+|.+++..+ ...+++..+..++.|++.||.|||++||+||
T Consensus 88 ~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHr 167 (496)
T PTZ00283 88 CDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHR 167 (496)
T ss_pred CCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecC
Confidence 469999987621 1378999999999999988643 3468999999999999999999999999999
Q ss_pred CCCCCcEEEeecCCCCCEEEeecCCccccCCC---CCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCC
Q 016471 66 DLKPENFLFTTREEDAPLKVIDFGLSDFVRPD---QRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRP 141 (389)
Q Consensus 66 dlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~p 141 (389)
||||+|||+ +.++.+||+|||+++..... ......+||+.|+|||++. ..++.++||||+||++|+|++|+.|
T Consensus 168 DLKP~NILl---~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~P 244 (496)
T PTZ00283 168 DIKSANILL---CSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRP 244 (496)
T ss_pred CCCHHHEEE---eCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 999999999 46788999999998765432 2234567999999999986 4689999999999999999999999
Q ss_pred CCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCC
Q 016471 142 FWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 202 (389)
Q Consensus 142 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~ 202 (389)
|.+.+....+..+....... ..+.+++.+.+++.+||..+|.+||++.++++|||++.
T Consensus 245 f~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 245 FDGENMEEVMHKTLAGRYDP---LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred CCCCCHHHHHHHHhcCCCCC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 99888877777776554322 12468999999999999999999999999999999864
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=278.15 Aligned_cols=199 Identities=25% Similarity=0.377 Sum_probs=151.0
Q ss_pred CCCccccceee------cCeEEEEEEccCCCChHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCCEecC
Q 016471 1 MYHQKLQHLFY------SNSFLFFTRFCEGGELLDRILSR--------GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRD 66 (389)
Q Consensus 1 l~Hpni~~~~~------~~~~~lv~E~~~gg~L~~~l~~~--------~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrd 66 (389)
|.||||++++. ...+|+||||+.+ +|.+++... ...+++..+..++.||+.||.|||++||+|||
T Consensus 55 l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~D 133 (317)
T cd07867 55 LKHPNVIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRD 133 (317)
T ss_pred CCCCCeeeEEEEEeccCCCeEEEEEeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCC
Confidence 57999999872 4678999999976 787776422 13588999999999999999999999999999
Q ss_pred CCCCcEEEeec-CCCCCEEEeecCCccccCCCC----CcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCC
Q 016471 67 LKPENFLFTTR-EEDAPLKVIDFGLSDFVRPDQ----RLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGS 139 (389)
Q Consensus 67 lkp~Nill~~~-~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~ 139 (389)
|||+||++... +.++.+||+|||++....... ......||+.|+|||++.+ .++.++||||+||++|+|++|+
T Consensus 134 lkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~ 213 (317)
T cd07867 134 LKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213 (317)
T ss_pred CCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCC
Confidence 99999999532 246789999999997654322 2334578999999998853 4789999999999999999999
Q ss_pred CCCCCCChh---------HHHHHHHhcCCCCC----------------------------------CCCCCCCCHHHHHH
Q 016471 140 RPFWARTES---------GIFRSVLRADPNFH----------------------------------DSPWPSVSPEAKDF 176 (389)
Q Consensus 140 ~pf~~~~~~---------~~~~~i~~~~~~~~----------------------------------~~~~~~~~~~~~~l 176 (389)
+||...... .....+........ .......+..+.+|
T Consensus 214 ~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 293 (317)
T cd07867 214 PIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLL 293 (317)
T ss_pred CCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHH
Confidence 999654321 11111111000000 00011245678899
Q ss_pred HHhhhccCcCCCCCHHHHhCCCCC
Q 016471 177 VRRLLNKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 177 i~~~l~~~p~~R~s~~e~l~h~~~ 200 (389)
|.+||+.||.+|||++|+|+||||
T Consensus 294 l~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 294 LQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred HHHHhccCcccccCHHHHhcCCCC
Confidence 999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=286.46 Aligned_cols=199 Identities=22% Similarity=0.381 Sum_probs=158.3
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|.||||++++ ....+|+|||++. ++|.+++. ..+.+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 143 l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~-~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill-- 218 (392)
T PHA03207 143 ISHRAIINLIHAYRWKSTVCMVMPKYK-CDLFTYVD-RSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFL-- 218 (392)
T ss_pred cCCCCccceeeeEeeCCEEEEEehhcC-CCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE--
Confidence 6899999988 3578999999997 58888884 44789999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC---CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChh---H
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ---RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTES---G 149 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~ 149 (389)
+.++.+||+|||++....... ......||+.|+|||++. ..++.++||||+||++|+|++|+.||.+.... .
T Consensus 219 -~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~ 297 (392)
T PHA03207 219 -DEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSS 297 (392)
T ss_pred -cCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHH
Confidence 567899999999987654322 123457999999999986 46899999999999999999999999775431 2
Q ss_pred HHHHHHhcCCC----CCC--------------------CCC------CCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCC
Q 016471 150 IFRSVLRADPN----FHD--------------------SPW------PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPW 199 (389)
Q Consensus 150 ~~~~i~~~~~~----~~~--------------------~~~------~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~ 199 (389)
.+..+.+.... ++. ... ..++.++.++|.+||..+|.+|||+.+++.|||
T Consensus 298 ~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~ 377 (392)
T PHA03207 298 QLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPL 377 (392)
T ss_pred HHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCch
Confidence 22222211100 000 000 135678999999999999999999999999999
Q ss_pred CCCCC
Q 016471 200 LHDEN 204 (389)
Q Consensus 200 ~~~~~ 204 (389)
|...+
T Consensus 378 f~~~~ 382 (392)
T PHA03207 378 FTKEP 382 (392)
T ss_pred hhccc
Confidence 97643
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=270.08 Aligned_cols=194 Identities=27% Similarity=0.496 Sum_probs=159.8
Q ss_pred CCccccceee----------cCeEEEEEEccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCC
Q 016471 2 YHQKLQHLFY----------SNSFLFFTRFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPE 70 (389)
Q Consensus 2 ~Hpni~~~~~----------~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~ 70 (389)
.||||++++. ...+|+|||||.+|+|.+++... ...+++..+..++.|++.||.|||++||+||||||+
T Consensus 61 ~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~ 140 (272)
T cd06637 61 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQ 140 (272)
T ss_pred CCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHH
Confidence 6999999882 24689999999999999988753 346899999999999999999999999999999999
Q ss_pred cEEEeecCCCCCEEEeecCCccccCCC-CCcccccccCCcccccccc------ccCCCchhHHHHHHHHHHHHhCCCCCC
Q 016471 71 NFLFTTREEDAPLKVIDFGLSDFVRPD-QRLNDIVGSAYYVAPEVLH------RSYNVEGDMWSIGVITYILLCGSRPFW 143 (389)
Q Consensus 71 Nill~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~pf~ 143 (389)
||++ +.++.++|+|||++...... .......|++.|+|||++. ..++.++|+||+||++|+|++|+.||.
T Consensus 141 nili---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~ 217 (272)
T cd06637 141 NVLL---TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC 217 (272)
T ss_pred HEEE---CCCCCEEEccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999 56788999999998765432 2234467899999999873 247889999999999999999999997
Q ss_pred CCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCC
Q 016471 144 ARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 144 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~ 200 (389)
..........+.... ........++..+.+|+.+||..+|.+|||+.+++.||||
T Consensus 218 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 218 DMHPMRALFLIPRNP--APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred ccCHHHHHHHHhcCC--CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 665554444333322 1222224578999999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=287.61 Aligned_cols=198 Identities=22% Similarity=0.377 Sum_probs=156.7
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|.||||++++ ..+..|+|||++. |+|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 217 L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl-- 293 (461)
T PHA03211 217 LSHPAVLALLDVRVVGGLTCLVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLV-- 293 (461)
T ss_pred CCCCCCCcEEEEEEECCEEEEEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEE--
Confidence 6899999998 3578999999996 68999887766679999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC---CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC------
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ---RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWART------ 146 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~------ 146 (389)
+.++.+||+|||++....... ......||+.|+|||++. ..++.++|||||||++|||++|..|+....
T Consensus 294 -~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~ 372 (461)
T PHA03211 294 -NGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERR 372 (461)
T ss_pred -CCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccC
Confidence 467889999999987654322 122457999999999885 468999999999999999999877654321
Q ss_pred --hhHHHHHHHhcCCC---------------------------CCCCCCC---CCCHHHHHHHHhhhccCcCCCCCHHHH
Q 016471 147 --ESGIFRSVLRADPN---------------------------FHDSPWP---SVSPEAKDFVRRLLNKDHRKRMTAAQA 194 (389)
Q Consensus 147 --~~~~~~~i~~~~~~---------------------------~~~~~~~---~~~~~~~~li~~~l~~~p~~R~s~~e~ 194 (389)
..++...+...... .....|. .++.++.+||.+||..||.+|||+.|+
T Consensus 373 ~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~el 452 (461)
T PHA03211 373 PYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAEL 452 (461)
T ss_pred CcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHH
Confidence 12222222221110 0111122 456789999999999999999999999
Q ss_pred hCCCCCCC
Q 016471 195 LTHPWLHD 202 (389)
Q Consensus 195 l~h~~~~~ 202 (389)
|+||||++
T Consensus 453 L~hp~f~~ 460 (461)
T PHA03211 453 LRLPLFQS 460 (461)
T ss_pred hhCcccCC
Confidence 99999964
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=279.75 Aligned_cols=190 Identities=22% Similarity=0.373 Sum_probs=152.3
Q ss_pred CCccccceee-----cCeEEEEEEccCCCChHHHHHhcC-----------------------------------------
Q 016471 2 YHQKLQHLFY-----SNSFLFFTRFCEGGELLDRILSRG----------------------------------------- 35 (389)
Q Consensus 2 ~Hpni~~~~~-----~~~~~lv~E~~~gg~L~~~l~~~~----------------------------------------- 35 (389)
+||||+.++. ...+|+|||||+||+|.+++....
T Consensus 69 ~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (338)
T cd05102 69 NHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSR 148 (338)
T ss_pred cCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccc
Confidence 7999999983 346899999999999999886531
Q ss_pred --------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeecCCCCCEEEeecCCccccC
Q 016471 36 --------------------GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR 95 (389)
Q Consensus 36 --------------------~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~~~~~~~kl~Dfg~a~~~~ 95 (389)
..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~---~~~~~~kl~DfG~a~~~~ 225 (338)
T cd05102 149 FQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIY 225 (338)
T ss_pred cccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEE---cCCCcEEEeecccccccc
Confidence 247788899999999999999999999999999999999 467889999999997653
Q ss_pred CCC---CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 016471 96 PDQ---RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSVS 170 (389)
Q Consensus 96 ~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 170 (389)
... ......+++.|+|||++. ..++.++||||+||++|+|++ |..||.+................... ...++
T Consensus 226 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~ 303 (338)
T cd05102 226 KDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRA--PENAT 303 (338)
T ss_pred cCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCC--CCCCC
Confidence 222 112334667899999875 468999999999999999997 99999876544433333332222211 24578
Q ss_pred HHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 171 PEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 171 ~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
+.+.+++.+||..+|.+|||+.++++
T Consensus 304 ~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 304 PEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHH
Confidence 99999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=281.95 Aligned_cols=196 Identities=27% Similarity=0.502 Sum_probs=158.3
Q ss_pred CCCccccceee----------cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCC
Q 016471 1 MYHQKLQHLFY----------SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPE 70 (389)
Q Consensus 1 l~Hpni~~~~~----------~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~ 70 (389)
+.||||++++. ...+|++||++ |++|.+.+. . +.+++..+..++.||+.||.|||++||+||||||+
T Consensus 71 l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~-~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~ 147 (343)
T cd07878 71 MKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVK-C-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPS 147 (343)
T ss_pred cCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHh-c-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChh
Confidence 57999999872 14579999998 678877653 3 57999999999999999999999999999999999
Q ss_pred cEEEeecCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChh
Q 016471 71 NFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTES 148 (389)
Q Consensus 71 Nill~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 148 (389)
||++ +.++.+||+|||++..... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+....
T Consensus 148 Nil~---~~~~~~kl~Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 222 (343)
T cd07878 148 NVAV---NEDCELRILDFGLARQADD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI 222 (343)
T ss_pred hEEE---CCCCCEEEcCCccceecCC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH
Confidence 9999 5678899999999886543 2345679999999998854 5889999999999999999999999877655
Q ss_pred HHHHHHHhcCCC-----------------------CCCC----CCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCC
Q 016471 149 GIFRSVLRADPN-----------------------FHDS----PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLH 201 (389)
Q Consensus 149 ~~~~~i~~~~~~-----------------------~~~~----~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~ 201 (389)
+.+..+...... .+.. .+...++.+.+||.+||..||.+|||+.++++||||.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~ 302 (343)
T cd07878 223 DQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFS 302 (343)
T ss_pred HHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchh
Confidence 544444321111 0100 0124567889999999999999999999999999997
Q ss_pred CCC
Q 016471 202 DEN 204 (389)
Q Consensus 202 ~~~ 204 (389)
...
T Consensus 303 ~~~ 305 (343)
T cd07878 303 QYH 305 (343)
T ss_pred ccC
Confidence 653
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=278.56 Aligned_cols=200 Identities=21% Similarity=0.300 Sum_probs=156.0
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEe
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 75 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~ 75 (389)
+.||||++++ .++..|+|||||++|+|.+++..+ .+.+++..++.++.|++.||.|||++||+||||||+||++
T Consensus 56 l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~- 134 (327)
T cd08227 56 FNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI- 134 (327)
T ss_pred cCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEE-
Confidence 5799999988 467899999999999999988654 2458999999999999999999999999999999999999
Q ss_pred ecCCCCCEEEeecCCccccCC-CC-------CcccccccCCccccccccc---cCCCchhHHHHHHHHHHHHhCCCCCCC
Q 016471 76 TREEDAPLKVIDFGLSDFVRP-DQ-------RLNDIVGSAYYVAPEVLHR---SYNVEGDMWSIGVITYILLCGSRPFWA 144 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~-~~-------~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~ 144 (389)
+.++.++++||+.+..... +. ......++..|+|||++.+ .++.++||||+||++|+|++|+.||..
T Consensus 135 --~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 135 --SVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred --ecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 4677899999986543211 11 0122356778999999853 488999999999999999999999976
Q ss_pred CChhHHHHHHHhcCCC-C----------------------------------C-------CCCCCCCCHHHHHHHHhhhc
Q 016471 145 RTESGIFRSVLRADPN-F----------------------------------H-------DSPWPSVSPEAKDFVRRLLN 182 (389)
Q Consensus 145 ~~~~~~~~~i~~~~~~-~----------------------------------~-------~~~~~~~~~~~~~li~~~l~ 182 (389)
................ . + .+....+++.+.+||.+||+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 292 (327)
T cd08227 213 MPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQ 292 (327)
T ss_pred cchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHh
Confidence 5544333222211100 0 0 00012357889999999999
Q ss_pred cCcCCCCCHHHHhCCCCCCCC
Q 016471 183 KDHRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 183 ~~p~~R~s~~e~l~h~~~~~~ 203 (389)
.||.+|||++++++||||+..
T Consensus 293 ~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 293 RNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred hCchhcCCHHHHhcChhhhhc
Confidence 999999999999999999653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=272.36 Aligned_cols=197 Identities=26% Similarity=0.406 Sum_probs=158.8
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
.||||+.++ ..+.+|+||||++||+|.+++..+ +.+++..+..++.|++.||.|||++||+||||||+||++
T Consensus 55 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~--- 130 (279)
T cd05633 55 DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQH-GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILL--- 130 (279)
T ss_pred CCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEE---
Confidence 689999877 357899999999999999887655 679999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCCccccCCCCCcccccccCCcccccccc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 016471 78 EEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVL 155 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 155 (389)
+.++.++|+|||++....... .....||+.|+|||.+. ..++.++|+||+||++|+|++|..||......... .+.
T Consensus 131 ~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~ 208 (279)
T cd05633 131 DEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EID 208 (279)
T ss_pred CCCCCEEEccCCcceeccccC-ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHH
Confidence 567899999999987553322 23356899999999874 34789999999999999999999999754322111 111
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCC-----CHHHHhCCCCCCCCC
Q 016471 156 RADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRM-----TAAQALTHPWLHDEN 204 (389)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----s~~e~l~h~~~~~~~ 204 (389)
......+....+.+++.++++|.+||..||.+|+ |++++++||||+...
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~ 262 (279)
T cd05633 209 RMTLTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGID 262 (279)
T ss_pred HHhhcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCC
Confidence 1111112222245889999999999999999999 699999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=272.36 Aligned_cols=196 Identities=28% Similarity=0.406 Sum_probs=157.4
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEE
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG--GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLF 74 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill 74 (389)
+.||||++++ .+..+|+|||||+ |+|.+++.... +.+++..++.++.||+.||.|||++|++||||+|+||++
T Consensus 56 l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~ 134 (285)
T cd07861 56 LQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLI 134 (285)
T ss_pred cCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE
Confidence 4799999998 4678999999998 58888775432 568999999999999999999999999999999999999
Q ss_pred eecCCCCCEEEeecCCccccCCCC-CcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHH
Q 016471 75 TTREEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIF 151 (389)
Q Consensus 75 ~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 151 (389)
+.++.+||+|||++....... ......+++.|+|||++.+ .++.++|+||+||++|+|++|++||.+.......
T Consensus 135 ---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~ 211 (285)
T cd07861 135 ---DNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQL 211 (285)
T ss_pred ---cCCCcEEECcccceeecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 567899999999987654322 2233467899999998753 4788999999999999999999999876654433
Q ss_pred HHHHhcCCCCC-------------------------CCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCC
Q 016471 152 RSVLRADPNFH-------------------------DSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 152 ~~i~~~~~~~~-------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~ 200 (389)
..+........ ......++++++++|.+||..||.+|||+.+++.||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 212 FRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred HHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 33222111000 01123578999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=284.79 Aligned_cols=200 Identities=35% Similarity=0.628 Sum_probs=180.3
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEe
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRIL-SRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 75 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~-~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~ 75 (389)
++||-||++. ..+.+++|||-+.| +..+.|. ...|++++.....++.||+.||+|||-+||+|+||||+|||+.
T Consensus 620 l~HPGiV~le~M~ET~ervFVVMEKl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLa 698 (888)
T KOG4236|consen 620 LHHPGIVNLECMFETPERVFVVMEKLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLA 698 (888)
T ss_pred cCCCCeeEEEEeecCCceEEEEehhhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeec
Confidence 6899999988 45889999999976 6667666 4458999999999999999999999999999999999999998
Q ss_pred ecCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 76 TREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
+.+.-.++||||||+|+.+.+..-..+.+|||.|+|||++. +.|+..-|+||+|||+|.-|+|..||.. ++++-.+|
T Consensus 699 s~~~FPQvKlCDFGfARiIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE--dEdIndQI 776 (888)
T KOG4236|consen 699 SASPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE--DEDINDQI 776 (888)
T ss_pred cCCCCCceeeccccceeecchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC--ccchhHHh
Confidence 87777899999999999998777667889999999999996 5799999999999999999999999943 45566677
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~ 203 (389)
.+....+|+.+|..+++.+.+||..+|++.-.+|.|.+..+.|||+++.
T Consensus 777 QNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 777 QNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred hccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 7777889999999999999999999999999999999999999999765
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=271.63 Aligned_cols=193 Identities=30% Similarity=0.616 Sum_probs=167.3
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||+.++ ....+|+|||||+||+|.+++.+. +.+++..+..++.|++.||.|||++|++||||+|+||++
T Consensus 58 l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili-- 134 (290)
T cd05580 58 IRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLL-- 134 (290)
T ss_pred CCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE--
Confidence 4799999988 457899999999999999988665 689999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVL 155 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 155 (389)
+.++.+||+|||++...... .....|++.|+|||.+. ..++.++|+||+|+++|+|++|..||...........+.
T Consensus 135 -~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 211 (290)
T cd05580 135 -DSDGYIKITDFGFAKRVKGR--TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL 211 (290)
T ss_pred -CCCCCEEEeeCCCccccCCC--CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Confidence 56788999999998876443 33457899999999875 457889999999999999999999998877777777776
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCC-----CHHHHhCCCCCCCC
Q 016471 156 RADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRM-----TAAQALTHPWLHDE 203 (389)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----s~~e~l~h~~~~~~ 203 (389)
......+ ..+++.++++|.+||..+|.+|+ +++++++||||...
T Consensus 212 ~~~~~~~----~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 260 (290)
T cd05580 212 EGKVRFP----SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGI 260 (290)
T ss_pred cCCccCC----ccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccC
Confidence 5544333 34689999999999999999999 99999999999664
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=287.26 Aligned_cols=195 Identities=28% Similarity=0.434 Sum_probs=161.2
Q ss_pred ccccee----ecCeEEEEEEccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeecCC
Q 016471 5 KLQHLF----YSNSFLFFTRFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREE 79 (389)
Q Consensus 5 ni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~~~ 79 (389)
|+|+++ ..+|+|||+|.++. +|+++++.++ ..++...++.++.||+.||.+||+.||||+||||+||||.+.+
T Consensus 249 n~Vrm~d~F~fr~HlciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~- 326 (586)
T KOG0667|consen 249 NIVRMLDYFYFRNHLCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPK- 326 (586)
T ss_pred eEEEeeeccccccceeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCC-
Confidence 677766 57999999999986 9999998653 4589999999999999999999999999999999999997643
Q ss_pred CCCEEEeecCCccccCCCCCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcC
Q 016471 80 DAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRAD 158 (389)
Q Consensus 80 ~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 158 (389)
...|||+|||.|+..... ..+.+-++.|+|||++.+ +|+.+.||||||||++||++|.+.|.|.+..+.+..|....
T Consensus 327 r~~vKVIDFGSSc~~~q~--vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~l 404 (586)
T KOG0667|consen 327 RSRIKVIDFGSSCFESQR--VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVL 404 (586)
T ss_pred cCceeEEecccccccCCc--ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHh
Confidence 458999999999876543 337788999999998865 79999999999999999999999999998887777765322
Q ss_pred CCCCCC-----------------------------------------------CCC------------CCCHHHHHHHHh
Q 016471 159 PNFHDS-----------------------------------------------PWP------------SVSPEAKDFVRR 179 (389)
Q Consensus 159 ~~~~~~-----------------------------------------------~~~------------~~~~~~~~li~~ 179 (389)
..++.. ..| .-...+.+||++
T Consensus 405 G~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~ 484 (586)
T KOG0667|consen 405 GLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKR 484 (586)
T ss_pred CCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHH
Confidence 211100 001 012567899999
Q ss_pred hhccCcCCCCCHHHHhCCCCCCCC
Q 016471 180 LLNKDHRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 180 ~l~~~p~~R~s~~e~l~h~~~~~~ 203 (389)
||..||.+|+|+.++|+|||+...
T Consensus 485 ~L~~dP~~R~tp~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 485 CLEWDPAERITPAQALNHPFLTGT 508 (586)
T ss_pred HhccCchhcCCHHHHhcCcccccc
Confidence 999999999999999999999854
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=272.95 Aligned_cols=196 Identities=34% Similarity=0.642 Sum_probs=160.7
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ ....+++|||||.+|+|.+++... +.+++..+..++.|++.||.+||++|++||||||+||++
T Consensus 55 l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~-- 131 (260)
T PF00069_consen 55 LRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQKN-KPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILL-- 131 (260)
T ss_dssp HTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHHHH-SSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEE--
T ss_pred cccccccccccccccccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccc--
Confidence 4799999988 467899999999999999988744 689999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCcccc-CCCCCcccccccCCcccccccc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCCh---hHH
Q 016471 77 REEDAPLKVIDFGLSDFV-RPDQRLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILLCGSRPFWARTE---SGI 150 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~-~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~ 150 (389)
+.++.++|+|||.+... ..........+++.|+|||++. ..++.++|+||+|+++|+|++|..||..... ...
T Consensus 132 -~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~ 210 (260)
T PF00069_consen 132 -DENGEVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEI 210 (260)
T ss_dssp -STTSEEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHH
T ss_pred -ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhh
Confidence 57888999999998763 2333445677899999999986 4689999999999999999999999988732 233
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCC
Q 016471 151 FRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 151 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~ 200 (389)
...................++.+.++|.+||..+|++|||+.++++||||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 211 IEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred hhhcccccccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 33332211111111111234899999999999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=266.32 Aligned_cols=196 Identities=26% Similarity=0.471 Sum_probs=162.7
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ ....+|+++||+++++|.+++......+++..+..++.|++.||.|||+.|++||||+|+||++
T Consensus 55 l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~-- 132 (256)
T cd06612 55 CDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILL-- 132 (256)
T ss_pred CCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE--
Confidence 4799999988 4578999999999999999887666789999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC-CcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
+.++.++|+|||++....... ......|+..|+|||++.+ .++.++|+||+||++|+|++|+.||...........+
T Consensus 133 -~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~ 211 (256)
T cd06612 133 -NEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI 211 (256)
T ss_pred -CCCCcEEEcccccchhcccCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh
Confidence 467889999999988765433 2334568899999998854 6889999999999999999999999876655444333
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~ 200 (389)
...... .......++..+.+++.+||..+|.+|||+.+++.||||
T Consensus 212 ~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 212 PNKPPP-TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred ccCCCC-CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 222111 111113577899999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=265.19 Aligned_cols=194 Identities=22% Similarity=0.460 Sum_probs=162.6
Q ss_pred CCCccccceee-----cCeEEEEEEccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEE
Q 016471 1 MYHQKLQHLFY-----SNSFLFFTRFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLF 74 (389)
Q Consensus 1 l~Hpni~~~~~-----~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill 74 (389)
+.|||++.++. +..+|+|||||++|+|.+++... ...+++.++..++.|++.||.|||++|++||||||+||++
T Consensus 56 l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~ 135 (257)
T cd08223 56 LKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFL 135 (257)
T ss_pred CCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEE
Confidence 57999999872 23589999999999999988764 3468999999999999999999999999999999999999
Q ss_pred eecCCCCCEEEeecCCccccCCCC-CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 016471 75 TTREEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFR 152 (389)
Q Consensus 75 ~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 152 (389)
+.++.++|+|||++....... ......+++.|+|||++. ..++.++|+||+|+++|++++|+.||.+.+......
T Consensus 136 ---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~ 212 (257)
T cd08223 136 ---TRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVY 212 (257)
T ss_pred ---ecCCcEEEecccceEEecccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 467889999999987654322 233456899999999875 458899999999999999999999998877666655
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCC
Q 016471 153 SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 153 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~ 200 (389)
.+...... . ....+++.+.+++.+||..+|.+|||+.+++.||||
T Consensus 213 ~~~~~~~~--~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 213 RIIEGKLP--P-MPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHHhcCCC--C-CccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 55544321 1 124588999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=265.24 Aligned_cols=194 Identities=24% Similarity=0.427 Sum_probs=164.8
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEe
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 75 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~ 75 (389)
+.||||++++ ..+..|+||||++|++|.+++... ...+++..+..++.|++.||.|||++|++||||+|+||+++
T Consensus 56 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~ 135 (256)
T cd08529 56 LDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLD 135 (256)
T ss_pred cCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEe
Confidence 5799999988 357799999999999999988764 46789999999999999999999999999999999999994
Q ss_pred ecCCCCCEEEeecCCccccCCCC-CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016471 76 TREEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRS 153 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 153 (389)
.++.++|+|||++....... ......|++.|+|||++. ..++.++|+||+||++|+|++|+.||...+.......
T Consensus 136 ---~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~ 212 (256)
T cd08529 136 ---AYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILK 212 (256)
T ss_pred ---CCCCEEEcccccceeccCccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 67889999999987664432 223456889999999875 4688999999999999999999999988877766666
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCC
Q 016471 154 VLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 154 i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~ 200 (389)
+......... ..++..+.+++.+||..+|++||++.+++.|||+
T Consensus 213 ~~~~~~~~~~---~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 213 IIRGVFPPVS---QMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHcCCCCCCc---cccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 6554322111 2578999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=273.46 Aligned_cols=202 Identities=28% Similarity=0.538 Sum_probs=166.7
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||+.++ ..+..|+||||++||+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||++
T Consensus 76 l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill-- 151 (292)
T cd06658 76 YHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILL-- 151 (292)
T ss_pred CCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE--
Confidence 4799999987 46789999999999999887643 468999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC-CcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
+.++.++|+|||++....... ......|++.|+|||.+.+ .++.++|+||+|+++|+|++|+.||.+.........+
T Consensus 152 -~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~ 230 (292)
T cd06658 152 -TSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI 230 (292)
T ss_pred -cCCCCEEEccCcchhhcccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 467889999999987543222 2234578999999998754 6889999999999999999999999887776665555
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVP 208 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~~~~~ 208 (389)
....... ......++..+.+++.+||..+|.+|||++++++||||.....+..
T Consensus 231 ~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~~ 283 (292)
T cd06658 231 RDNLPPR-VKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPPSC 283 (292)
T ss_pred HhcCCCc-cccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCccc
Confidence 4332211 1112357889999999999999999999999999999987765554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=312.21 Aligned_cols=195 Identities=29% Similarity=0.533 Sum_probs=164.3
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|+|||||.|| +.+.++|.||||+||+|.+.+ .+++-.+|...+.+..|++.|+.|||++|||||||||.||++
T Consensus 1291 lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll-~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~L-- 1367 (1509)
T KOG4645|consen 1291 LNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLL-EHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILL-- 1367 (1509)
T ss_pred ccCccccccCceeecHHHHHHHHHHhccCcHHHHH-HhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceee--
Confidence 7999999999 578899999999999998854 554667788888899999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC-----CcccccccCCccccccccc----cCCCchhHHHHHHHHHHHHhCCCCCCC-CC
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ-----RLNDIVGSAYYVAPEVLHR----SYNVEGDMWSIGVITYILLCGSRPFWA-RT 146 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~~ll~g~~pf~~-~~ 146 (389)
+.+|.+|++|||.|.....+. ......||+.|||||++.+ +...+.||||+|||+.||.||+.||.. .+
T Consensus 1368 -d~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn 1446 (1509)
T KOG4645|consen 1368 -DFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN 1446 (1509)
T ss_pred -ecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc
Confidence 567899999999998775442 3456789999999999854 356789999999999999999999965 44
Q ss_pred hhHHHHHHHhcC-CCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCC
Q 016471 147 ESGIFRSVLRAD-PNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 147 ~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~ 203 (389)
..++...+-.+. |++| .++|++.++||..||..||.+|.++.|+++|.|-+..
T Consensus 1447 e~aIMy~V~~gh~Pq~P----~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1447 EWAIMYHVAAGHKPQIP----ERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred hhHHHhHHhccCCCCCc----hhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence 455655555443 2222 2489999999999999999999999999999987544
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=240.94 Aligned_cols=200 Identities=28% Similarity=0.501 Sum_probs=176.0
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|+|.||++++ .++.+-+|+|||.. +|..++-.-+|.+..+.++.++.|+++||.|||++++.||||||+|.|+
T Consensus 58 lkhknivrl~dvlhsdkkltlvfe~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnlli-- 134 (292)
T KOG0662|consen 58 LKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLI-- 134 (292)
T ss_pred hhhcceeehhhhhccCceeEEeHHHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEe--
Confidence 6899999999 57889999999987 8999998888999999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC-CcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFR 152 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 152 (389)
+.++.+|++|||+++.+.... .....+-|.+|.+|.++-+ -|+...|+||.|||+.|+.. |++.|.|.+..+.+.
T Consensus 135 -n~ngelkladfglarafgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlk 213 (292)
T KOG0662|consen 135 -NRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK 213 (292)
T ss_pred -ccCCcEEecccchhhhcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHH
Confidence 688999999999998876543 3455678999999999854 59999999999999999998 888899999999999
Q ss_pred HHHhcCCCCCCCCCCC-------------------------CCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 153 SVLRADPNFHDSPWPS-------------------------VSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 153 ~i~~~~~~~~~~~~~~-------------------------~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
.|+.....+....||+ ++..-+++++++|.-+|.+|++++.+++||||.+..
T Consensus 214 rif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s 290 (292)
T KOG0662|consen 214 RIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFS 290 (292)
T ss_pred HHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccccC
Confidence 9887666555555543 345678999999999999999999999999997653
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=267.39 Aligned_cols=199 Identities=26% Similarity=0.485 Sum_probs=166.4
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||+.++ .+..+|+|+||+++|+|.+++... .+++..+..++.|++.||.|||++|++||||+|+||++
T Consensus 56 l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i-- 131 (274)
T cd06609 56 CRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILL-- 131 (274)
T ss_pred cCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE--
Confidence 5799999988 467899999999999999988654 79999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCC-CCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPD-QRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
+.++.++|+|||++...... .......+++.|+|||.+. ..++.++|+||+||++|+|++|..||...........+
T Consensus 132 -~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~ 210 (274)
T cd06609 132 -SEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLI 210 (274)
T ss_pred -CCCCCEEEcccccceeecccccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHh
Confidence 56788999999999876543 2334557889999999885 35899999999999999999999999876655555444
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRP 206 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~~~ 206 (389)
...... ......+++.+.+++.+||..+|.+|||++++++||||......
T Consensus 211 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 260 (274)
T cd06609 211 PKNNPP--SLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKKT 260 (274)
T ss_pred hhcCCC--CCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCCcc
Confidence 433221 11112378999999999999999999999999999999876543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=266.89 Aligned_cols=198 Identities=27% Similarity=0.570 Sum_probs=166.6
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ ....+|+||||++||+|.+++.+. ..+++..+..++.||+.||+|||++|++|+||+|+||++
T Consensus 50 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv-- 126 (262)
T cd05572 50 CNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDR-GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLL-- 126 (262)
T ss_pred CCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE--
Confidence 5799999987 457899999999999999988665 568999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC--hhHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWART--ESGIFRS 153 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~~ 153 (389)
+.++.++|+|||++.............|++.|+|||.+. ..++.++|+||+|+++|++++|..||.... .......
T Consensus 127 -~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 205 (262)
T cd05572 127 -DSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYND 205 (262)
T ss_pred -cCCCCEEEeeCCcccccCcccccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHH
Confidence 467889999999988765443334457899999999875 468899999999999999999999998776 5556666
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCC-----HHHHhCCCCCCCCC
Q 016471 154 VLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMT-----AAQALTHPWLHDEN 204 (389)
Q Consensus 154 i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s-----~~e~l~h~~~~~~~ 204 (389)
+.........+ ...++.++++|.+||..+|.+||+ +.|+++||||++..
T Consensus 206 ~~~~~~~~~~~--~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 259 (262)
T cd05572 206 ILKGNGKLEFP--NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFD 259 (262)
T ss_pred HhccCCCCCCC--cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCC
Confidence 65322222221 235899999999999999999999 99999999998653
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=270.79 Aligned_cols=197 Identities=31% Similarity=0.526 Sum_probs=162.7
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||+.++ ....+|+||||+ |++|.+++....+.+++..++.++.||+.||+|||++|++|+||||+||++
T Consensus 56 ~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~-- 132 (286)
T cd07832 56 CQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLI-- 132 (286)
T ss_pred CCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEE--
Confidence 4799999988 367899999999 999999887666779999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC--CcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ--RLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFR 152 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 152 (389)
+.++.++|+|||.+....... ......|+..|+|||.+.+ .++.++||||+||++|+|++|.+||.+.+....+.
T Consensus 133 -~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~ 211 (286)
T cd07832 133 -SADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLA 211 (286)
T ss_pred -cCCCcEEEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHH
Confidence 467889999999987664432 2334578999999998743 46899999999999999999999998777665555
Q ss_pred HHHhcCCCCCC--------------------------CCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCC
Q 016471 153 SVLRADPNFHD--------------------------SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLH 201 (389)
Q Consensus 153 ~i~~~~~~~~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~ 201 (389)
.+......... ...+..+..+.++|.+||..+|.+|||+++++.||||.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 212 IVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred HHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 54432111100 01235678999999999999999999999999999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=270.19 Aligned_cols=201 Identities=28% Similarity=0.446 Sum_probs=163.3
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEe
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 75 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~ 75 (389)
++||||++++ ..+.+|+||||++||+|.+++.+.. ..+++..+..++.|++.||.|||++|++||||+|+||++
T Consensus 50 l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~- 128 (277)
T cd05577 50 VSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLL- 128 (277)
T ss_pred CCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE-
Confidence 5799999987 3578999999999999999887653 369999999999999999999999999999999999999
Q ss_pred ecCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 76 TREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
++++.++|+|||.+.............++..|+|||++. +.++.++|+||+||++|+|++|+.||...........+
T Consensus 129 --~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 206 (277)
T cd05577 129 --DDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEEL 206 (277)
T ss_pred --CCCCCEEEccCcchhhhccCCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHH
Confidence 567899999999987665443344556888999999875 45889999999999999999999999775542222222
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCC-----CHHHHhCCCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRM-----TAAQALTHPWLHDEN 204 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----s~~e~l~h~~~~~~~ 204 (389)
.......+....+.+++.+.++|.+||..+|.+|| ++.+++.||||...+
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~ 261 (277)
T cd05577 207 KRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLN 261 (277)
T ss_pred HhccccccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCC
Confidence 22211122222245799999999999999999999 888999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=268.70 Aligned_cols=194 Identities=27% Similarity=0.434 Sum_probs=160.2
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
.||+|+.++ ..+.+|+|||||+||+|.+++... +.+++..++.++.|++.||.|||+++|+||||||+||++
T Consensus 55 ~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili--- 130 (278)
T cd05606 55 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH-GVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILL--- 130 (278)
T ss_pred CCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEE---
Confidence 589999876 357899999999999998877654 689999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCCccccCCCCCcccccccCCcccccccc-c-cCCCchhHHHHHHHHHHHHhCCCCCCCCCh---hHHHH
Q 016471 78 EEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-R-SYNVEGDMWSIGVITYILLCGSRPFWARTE---SGIFR 152 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~ 152 (389)
+.++.+||+|||++...... ......|+..|+|||++. + .++.++|+||+||++|+|++|+.||.+... .....
T Consensus 131 ~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~ 209 (278)
T cd05606 131 DEHGHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR 209 (278)
T ss_pred CCCCCEEEccCcCccccCcc-CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHH
Confidence 56788999999998765332 223457999999999985 3 488999999999999999999999977632 22222
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCC-----CHHHHhCCCCCCCCC
Q 016471 153 SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRM-----TAAQALTHPWLHDEN 204 (389)
Q Consensus 153 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----s~~e~l~h~~~~~~~ 204 (389)
.+...... ....+++.+.+++.+||..+|.+|| ++.++++||||+...
T Consensus 210 ~~~~~~~~----~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~ 262 (278)
T cd05606 210 MTLTMAVE----LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLD 262 (278)
T ss_pred HhhccCCC----CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCC
Confidence 22222221 1235789999999999999999999 999999999997754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=265.53 Aligned_cols=196 Identities=27% Similarity=0.467 Sum_probs=163.2
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
++||||++++ ....+|++|||++|++|.+++......+++..+..++.|++.||.|||++|++||||+|+||++
T Consensus 57 ~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i-- 134 (262)
T cd06613 57 CRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILL-- 134 (262)
T ss_pred CCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEE--
Confidence 5799999988 4678999999999999999887665789999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC-CcccccccCCcccccccc-c---cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLH-R---SYNVEGDMWSIGVITYILLCGSRPFWARTESGIF 151 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~-~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 151 (389)
+.++.+||+|||++....... ......++..|+|||.+. . .++.++|+||+||++|+|++|.+||.+.+.....
T Consensus 135 -~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~ 213 (262)
T cd06613 135 -TEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL 213 (262)
T ss_pred -CCCCCEEECccccchhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 567889999999987654322 334457889999999874 3 5788999999999999999999999887765555
Q ss_pred HHHHhcCCCCCC-CCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCC
Q 016471 152 RSVLRADPNFHD-SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPW 199 (389)
Q Consensus 152 ~~i~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~ 199 (389)
..+.......+. ...+.++.++.+++.+||..+|.+|||+.+++.|+|
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 214 FLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 444443211111 112346788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=265.90 Aligned_cols=199 Identities=22% Similarity=0.412 Sum_probs=167.5
Q ss_pred Cccccceee----cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeecC
Q 016471 3 HQKLQHLFY----SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE 78 (389)
Q Consensus 3 Hpni~~~~~----~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~~ 78 (389)
.|++|+||. ...+|||||||..|++.+.+..+++.++|.++..+++..+.||+|||...-+|||||..|||+ +
T Consensus 87 S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILL---N 163 (502)
T KOG0574|consen 87 SKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILL---N 163 (502)
T ss_pred CchhhhhhhhhccCCceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEE---c
Confidence 578888882 467999999999999999999888999999999999999999999999999999999999999 5
Q ss_pred CCCCEEEeecCCccccCCCC-CcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 016471 79 EDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLR 156 (389)
Q Consensus 79 ~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 156 (389)
..|..||+|||.|....... +.++..|||.|||||++.. .|+.++||||||++..||..|++||..-.+- +.|+-
T Consensus 164 T~G~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM---RAIFM 240 (502)
T KOG0574|consen 164 TDGIAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM---RAIFM 240 (502)
T ss_pred ccchhhhhhccccchhhhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc---ceeEe
Confidence 78999999999997665433 4567889999999999975 7999999999999999999999999765543 23332
Q ss_pred cCCCCCCCC--CCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCCCCC
Q 016471 157 ADPNFHDSP--WPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPV 207 (389)
Q Consensus 157 ~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~~~~ 207 (389)
....+++.. ...+|.++-+|+++||.++|.+|.|+.++++|||+++.....
T Consensus 241 IPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g~~ 293 (502)
T KOG0574|consen 241 IPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAPGCD 293 (502)
T ss_pred ccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCccc
Confidence 222222111 124689999999999999999999999999999998875444
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=268.50 Aligned_cols=194 Identities=26% Similarity=0.437 Sum_probs=159.0
Q ss_pred CCcccccee----ec--CeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEe
Q 016471 2 YHQKLQHLF----YS--NSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 75 (389)
Q Consensus 2 ~Hpni~~~~----~~--~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~ 75 (389)
.||||+.++ .. +.+++||||+.| +|.+.+..+.+.+++..+..++.|++.||+|||++|++||||+|+||+++
T Consensus 56 ~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~ 134 (282)
T cd07831 56 PHPNILRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIK 134 (282)
T ss_pred CCCCccceEEEEecCCCCcEEEEEecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEc
Confidence 499999988 23 779999999975 88888877656799999999999999999999999999999999999994
Q ss_pred ecCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016471 76 TREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRS 153 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 153 (389)
. +.+||+|||++.............+++.|+|||.+. +.++.++|+||+||++|+|++|.+||.+.+..+....
T Consensus 135 ---~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~ 210 (282)
T cd07831 135 ---D-DILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAK 210 (282)
T ss_pred ---C-CCeEEEecccccccccCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHH
Confidence 4 899999999998765444444556889999999763 3478899999999999999999999988776555444
Q ss_pred HHhcCCC------------------CCCC-------CCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCC
Q 016471 154 VLRADPN------------------FHDS-------PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 154 i~~~~~~------------------~~~~-------~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~ 200 (389)
+...... ++.. ..+.++..+.++|.+||.++|.+|||+.++++||||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 211 IHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred HHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 4321111 0000 013568999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=273.18 Aligned_cols=199 Identities=34% Similarity=0.610 Sum_probs=167.0
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEe
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 75 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~ 75 (389)
+.||||+.++ .....|+|||||.||+|.+++... ...+++..+..++.|++.||.|||+.|++||||||+||++
T Consensus 58 l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili- 136 (316)
T cd05574 58 LDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILL- 136 (316)
T ss_pred CCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEE-
Confidence 4699999998 457799999999999999987653 3579999999999999999999999999999999999999
Q ss_pred ecCCCCCEEEeecCCccccCCCC------------------------------CcccccccCCccccccccc-cCCCchh
Q 016471 76 TREEDAPLKVIDFGLSDFVRPDQ------------------------------RLNDIVGSAYYVAPEVLHR-SYNVEGD 124 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~~~------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~D 124 (389)
+.++.++|+|||++....... ......||..|+|||++.+ .++.++|
T Consensus 137 --~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~D 214 (316)
T cd05574 137 --HESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVD 214 (316)
T ss_pred --cCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHH
Confidence 467889999999876542211 1123468889999998854 5889999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCC----HHHHhCCCCC
Q 016471 125 MWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMT----AAQALTHPWL 200 (389)
Q Consensus 125 iwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s----~~e~l~h~~~ 200 (389)
|||+|+++|+|++|..||.+.+....+..+......++.. ..++..++++|.+||..+|.+||| +++++.||||
T Consensus 215 i~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~ 292 (316)
T cd05574 215 WWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFF 292 (316)
T ss_pred HHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCCccCCCc--cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchh
Confidence 9999999999999999998888777777766544433322 337899999999999999999999 9999999999
Q ss_pred CCCC
Q 016471 201 HDEN 204 (389)
Q Consensus 201 ~~~~ 204 (389)
++..
T Consensus 293 ~~~~ 296 (316)
T cd05574 293 RGVN 296 (316)
T ss_pred hcCC
Confidence 8753
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=271.95 Aligned_cols=202 Identities=25% Similarity=0.403 Sum_probs=164.8
Q ss_pred CCCccccceee----c--CeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEE
Q 016471 1 MYHQKLQHLFY----S--NSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLF 74 (389)
Q Consensus 1 l~Hpni~~~~~----~--~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill 74 (389)
+.||||++++. . +.+|+||||+.+ +|.+.+......+++..+..++.||+.||.|||++|++||||||+||++
T Consensus 63 l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~ 141 (309)
T cd07845 63 LRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLL 141 (309)
T ss_pred CCCCCCcceEEEEecCCCCeEEEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 57999999872 1 468999999975 8888877655779999999999999999999999999999999999999
Q ss_pred eecCCCCCEEEeecCCccccCCCC-CcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHH
Q 016471 75 TTREEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIF 151 (389)
Q Consensus 75 ~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 151 (389)
+.++.+||+|||++....... ......+++.|+|||++.+ .++.++|+||+||++|+|++|++||.+.+..+.+
T Consensus 142 ---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~ 218 (309)
T cd07845 142 ---TDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQL 218 (309)
T ss_pred ---CCCCCEEECccceeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 567899999999988764332 2233456788999998743 5789999999999999999999999988887777
Q ss_pred HHHHhcCCCCCCCC--------------------------CCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCCC
Q 016471 152 RSVLRADPNFHDSP--------------------------WPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENR 205 (389)
Q Consensus 152 ~~i~~~~~~~~~~~--------------------------~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~~ 205 (389)
..+........... .+..++.+.++|.+||..||.+|||+.+++.||||.....
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~ 298 (309)
T cd07845 219 DLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPL 298 (309)
T ss_pred HHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCC
Confidence 66654322111110 1235889999999999999999999999999999987654
Q ss_pred C
Q 016471 206 P 206 (389)
Q Consensus 206 ~ 206 (389)
+
T Consensus 299 ~ 299 (309)
T cd07845 299 P 299 (309)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=268.89 Aligned_cols=197 Identities=25% Similarity=0.465 Sum_probs=162.6
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ .....|+||||++||+|.+++.. +.+++.++..++.|++.||.|||++||+||||||+||++
T Consensus 74 ~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill-- 149 (296)
T cd06654 74 NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL-- 149 (296)
T ss_pred CCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE--
Confidence 4799999988 35789999999999999998753 468999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC-CcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
+.++.+||+|||++....... ......|++.|+|||.+.+ .++.++|+||+||++|+|++|+.||...........+
T Consensus 150 -~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~ 228 (296)
T cd06654 150 -GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI 228 (296)
T ss_pred -cCCCCEEECccccchhccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHH
Confidence 467889999999987654332 2234578999999998854 5789999999999999999999999877664444333
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~ 203 (389)
.... ..+....+.+++.+.+++.+||..+|.+|||+.+++.||||...
T Consensus 229 ~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 229 ATNG-TPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred hcCC-CCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 3221 11111224688999999999999999999999999999999765
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=271.16 Aligned_cols=204 Identities=29% Similarity=0.462 Sum_probs=165.5
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ .....|+||||+ +|+|.+++......+++..+..++.||+.||.|||++|++||||+|+||++
T Consensus 59 ~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill-- 135 (298)
T cd07841 59 LKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLI-- 135 (298)
T ss_pred cCCCCChhhhheeecCCEEEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEE--
Confidence 5799999988 457899999999 889999886653479999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCC-CCcccccccCCcccccccc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPD-QRLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRS 153 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 153 (389)
+.++.++|+|||++...... .......+++.|+|||.+. ..++.++|+||+||++|+|++|.+||.+......+..
T Consensus 136 -~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~ 214 (298)
T cd07841 136 -ASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGK 214 (298)
T ss_pred -cCCCCEEEccceeeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHH
Confidence 46788999999998766443 2233345788899999874 3578999999999999999999888887776655555
Q ss_pred HHhcCCCCCCC------------------------CCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCCCCCC
Q 016471 154 VLRADPNFHDS------------------------PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVP 208 (389)
Q Consensus 154 i~~~~~~~~~~------------------------~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~~~~~ 208 (389)
+.......... .+...+..+.++|.+||..+|.+|||+.+++.||||.+...+.+
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~ 293 (298)
T cd07841 215 IFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTP 293 (298)
T ss_pred HHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCC
Confidence 54321111000 11345788999999999999999999999999999998765554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=270.12 Aligned_cols=198 Identities=25% Similarity=0.493 Sum_probs=165.0
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||+.++ ..+.+|+|+||++||+|..++.. ..+++.++..++.|++.||.|||++|++||||||+||++
T Consensus 73 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili-- 148 (296)
T cd06655 73 LKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLL-- 148 (296)
T ss_pred cCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE--
Confidence 5799999988 35789999999999999987754 368999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCC-cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQR-LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
+.++.+||+|||++........ .....|++.|+|||.+. +.++.++|+||+||++|++++|+.||.+.+.......+
T Consensus 149 -~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~ 227 (296)
T cd06655 149 -GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI 227 (296)
T ss_pred -CCCCCEEEccCccchhcccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 4678899999999876544322 23456889999999885 45889999999999999999999999887766555544
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
..... ........+++.+.++|.+||..+|.+|||+.+++.||||+...
T Consensus 228 ~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 228 ATNGT-PELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred HhcCC-cccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence 43221 11122346889999999999999999999999999999997643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=269.64 Aligned_cols=199 Identities=26% Similarity=0.486 Sum_probs=166.0
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ ....+|+||||++||+|.+++... +.+++..+..++.|++.||.|||++|++||||||+||++
T Consensus 58 ~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll-- 134 (305)
T cd05609 58 AENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLI-- 134 (305)
T ss_pred CCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEE--
Confidence 4799999998 356789999999999999988655 679999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC----------------CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCC
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ----------------RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGS 139 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~----------------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~ 139 (389)
+.++.+||+|||++....... ......|+..|+|||.+. ..++.++|+||+||++|++++|.
T Consensus 135 -~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~ 213 (305)
T cd05609 135 -TSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGC 213 (305)
T ss_pred -CCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCC
Confidence 467889999999876321100 111245788999999874 46899999999999999999999
Q ss_pred CCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCC---HHHHhCCCCCCCCC
Q 016471 140 RPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMT---AAQALTHPWLHDEN 204 (389)
Q Consensus 140 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s---~~e~l~h~~~~~~~ 204 (389)
.||.+....+....+.......+... +.++.++.++|.+||..+|.+||+ +.++++||||....
T Consensus 214 ~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~ 280 (305)
T cd05609 214 VPFFGDTPEELFGQVISDDIEWPEGD-EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLD 280 (305)
T ss_pred CCCCCCCHHHHHHHHHhcccCCCCcc-ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCC
Confidence 99998888777777766544433332 257899999999999999999997 78999999996643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=264.98 Aligned_cols=195 Identities=28% Similarity=0.428 Sum_probs=160.9
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
++||||++++ ....+|+||||++||+|.+++.+. +.+++..+..++.|++.||+|||+.||+|+||+|+||++
T Consensus 59 l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~-- 135 (265)
T cd06631 59 LKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVML-- 135 (265)
T ss_pred cCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEE--
Confidence 5799999988 357899999999999999988655 578999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCC-------CCCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChh
Q 016471 77 REEDAPLKVIDFGLSDFVRP-------DQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTES 148 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~-------~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 148 (389)
+.++.++|+|||++..... ........|+..|+|||++.+ .++.++|+||+||++|+|++|..||...+..
T Consensus 136 -~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~ 214 (265)
T cd06631 136 -MPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL 214 (265)
T ss_pred -CCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH
Confidence 5678899999998875421 111233568899999999854 5889999999999999999999999776554
Q ss_pred HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCC
Q 016471 149 GIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 149 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~ 200 (389)
.....+.......+. ....++..+.++|.+||..+|.+||++.+++.||||
T Consensus 215 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 215 AAMFYIGAHRGLMPR-LPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHhhhccCCCCC-CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 444333332222222 224588999999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=263.16 Aligned_cols=195 Identities=24% Similarity=0.435 Sum_probs=165.0
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEe
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 75 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~ 75 (389)
++||||+.++ ....+++||||++||+|.+++.+.. ..+++..+..++.|++.||+|||++|++||||+|+||+++
T Consensus 56 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~ 135 (256)
T cd08220 56 LSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLD 135 (256)
T ss_pred CCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc
Confidence 5799999988 3678999999999999999987643 3589999999999999999999999999999999999995
Q ss_pred ecCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 76 TREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
+++..+||+|||++.............|++.|+|||.+.+ .++.++|+||+|+++|+|++|+.||.+.+.......+
T Consensus 136 --~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~ 213 (256)
T cd08220 136 --KHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKI 213 (256)
T ss_pred --CCCCEEEEccCCCceecCCCccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHH
Confidence 3455689999999987655444445678999999999864 5788999999999999999999999887776666665
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~ 200 (389)
....... ....+++.+++++.+||..+|.+|||+.++++||||
T Consensus 214 ~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 214 MSGTFAP---ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HhcCCCC---CCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 5433221 113578999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=271.10 Aligned_cols=198 Identities=24% Similarity=0.387 Sum_probs=160.1
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCEecCCCCCcEEEe
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHL-QGVVHRDLKPENFLFT 75 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~-~~i~Hrdlkp~Nill~ 75 (389)
+.||||+.++ .++.+|+||||++||+|.+++.+. +.+++..+..++.|++.||.|||+ .+++||||||+||++
T Consensus 56 l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~- 133 (308)
T cd06615 56 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILV- 133 (308)
T ss_pred CCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEE-
Confidence 5799999998 468899999999999999988665 679999999999999999999997 599999999999999
Q ss_pred ecCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 76 TREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
+.++.+||+|||++...... ......|++.|+|||.+.+ .++.++|+||+||++|+|++|+.||...+.......+
T Consensus 134 --~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~ 210 (308)
T cd06615 134 --NSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMF 210 (308)
T ss_pred --ecCCcEEEccCCCccccccc-ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhh
Confidence 46788999999998754322 2345678999999998854 5889999999999999999999999765543332222
Q ss_pred HhcCCC----------------------------------CCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCC
Q 016471 155 LRADPN----------------------------------FHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 155 ~~~~~~----------------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~ 200 (389)
...... .+..+...++.++++++.+||..+|++|||+.++++||||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~ 290 (308)
T cd06615 211 GRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFI 290 (308)
T ss_pred cCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence 111000 0111112367889999999999999999999999999999
Q ss_pred CCC
Q 016471 201 HDE 203 (389)
Q Consensus 201 ~~~ 203 (389)
...
T Consensus 291 ~~~ 293 (308)
T cd06615 291 KRA 293 (308)
T ss_pred hhc
Confidence 764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=265.59 Aligned_cols=197 Identities=27% Similarity=0.496 Sum_probs=164.7
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEE
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG--GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLF 74 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill 74 (389)
+.||||+.++ ..+..|+|||||+|++|.+++.... +.+++..+..++.|++.||.|||++|++||||+|+||++
T Consensus 56 l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~ 135 (267)
T cd06610 56 CNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILL 135 (267)
T ss_pred cCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE
Confidence 5799999988 4678999999999999999887542 468999999999999999999999999999999999999
Q ss_pred eecCCCCCEEEeecCCccccCCCCC-----cccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 016471 75 TTREEDAPLKVIDFGLSDFVRPDQR-----LNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTE 147 (389)
Q Consensus 75 ~~~~~~~~~kl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 147 (389)
++++.++|+|||++........ .....|+..|+|||++.. .++.++|+||+||++|+|++|+.||...+.
T Consensus 136 ---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~ 212 (267)
T cd06610 136 ---GEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP 212 (267)
T ss_pred ---cCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccCh
Confidence 4678899999999876543321 133468899999998753 588999999999999999999999988776
Q ss_pred hHHHHHHHhcCCCCCCC--CCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCC
Q 016471 148 SGIFRSVLRADPNFHDS--PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 148 ~~~~~~i~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~ 200 (389)
...+..+.+..+..... .+..+++.+.+++.+||..+|.+|||+.+++.||||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 213 MKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred hhhHHHHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 66666655543322111 124688999999999999999999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=267.86 Aligned_cols=194 Identities=27% Similarity=0.470 Sum_probs=158.5
Q ss_pred CCccccceee----------cCeEEEEEEccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCC
Q 016471 2 YHQKLQHLFY----------SNSFLFFTRFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPE 70 (389)
Q Consensus 2 ~Hpni~~~~~----------~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~ 70 (389)
.||||++++. ...+|+|||||.+|+|.+++... ...+++..+..++.||+.||.|||++||+||||+|+
T Consensus 71 ~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~ 150 (282)
T cd06636 71 HHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQ 150 (282)
T ss_pred CCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHH
Confidence 6999999872 35789999999999999988653 345889999999999999999999999999999999
Q ss_pred cEEEeecCCCCCEEEeecCCccccCCC-CCcccccccCCcccccccc------ccCCCchhHHHHHHHHHHHHhCCCCCC
Q 016471 71 NFLFTTREEDAPLKVIDFGLSDFVRPD-QRLNDIVGSAYYVAPEVLH------RSYNVEGDMWSIGVITYILLCGSRPFW 143 (389)
Q Consensus 71 Nill~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~pf~ 143 (389)
||++ +.++.++|+|||++...... .......|++.|+|||.+. ..++.++|+||+||++|+|++|..||.
T Consensus 151 nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~ 227 (282)
T cd06636 151 NVLL---TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLC 227 (282)
T ss_pred HEEE---CCCCCEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCcc
Confidence 9999 56788999999998765322 2234467899999999873 247889999999999999999999997
Q ss_pred CCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCC
Q 016471 144 ARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 144 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~ 200 (389)
..........+.... .+......++.++.++|.+||..+|.+|||+.+++.||||
T Consensus 228 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 228 DMHPMRALFLIPRNP--PPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred ccCHHhhhhhHhhCC--CCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 766544444333221 1111223578999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=267.95 Aligned_cols=196 Identities=26% Similarity=0.483 Sum_probs=158.4
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||+.++ ....+++||||++++.|..++. ....+++..++.++.||+.||.|||++|++||||||+||++
T Consensus 57 ~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~-- 133 (286)
T cd07847 57 LKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEK-NPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILI-- 133 (286)
T ss_pred CCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEE--
Confidence 5799999988 3578999999999987766543 44679999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC-CcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRS 153 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 153 (389)
+.++.+||+|||++....... ......++..|+|||.+.+ .++.++|+||+||++|+|++|++||.+.+..+....
T Consensus 134 -~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~ 212 (286)
T cd07847 134 -TKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYL 212 (286)
T ss_pred -cCCCcEEECccccceecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 467889999999998765433 2334567889999998743 478899999999999999999999988766544433
Q ss_pred HHhcCCC-------------------CCC--------CCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCC
Q 016471 154 VLRADPN-------------------FHD--------SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 154 i~~~~~~-------------------~~~--------~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~ 200 (389)
+.+.... .+. ..++.++..+.+|+.+||..+|.+|||+.+++.||||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 213 IRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred HHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 3221000 000 0124578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=267.71 Aligned_cols=201 Identities=25% Similarity=0.405 Sum_probs=161.7
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCCEecCCCCCcEE
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSR--GGRYLEEDAKTIVEKILNIVAFCHL-QGVVHRDLKPENFL 73 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~-~~i~Hrdlkp~Nil 73 (389)
+.||||++++ ..+.+|+|||||+||+|..++... .+.+++..+..++.|++.||.|||+ .||+||||||+||+
T Consensus 56 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil 135 (286)
T cd06622 56 AVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVL 135 (286)
T ss_pred cCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEE
Confidence 5799999988 467899999999999998877543 2479999999999999999999997 59999999999999
Q ss_pred EeecCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc-------cCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 016471 74 FTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-------SYNVEGDMWSIGVITYILLCGSRPFWART 146 (389)
Q Consensus 74 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~DiwslG~il~~ll~g~~pf~~~~ 146 (389)
++ .++.+||+|||++...... ......+++.|+|||.+.+ .++.++|+||+||++|+|++|+.||....
T Consensus 136 ~~---~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 211 (286)
T cd06622 136 VN---GNGQVKLCDFGVSGNLVAS-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET 211 (286)
T ss_pred EC---CCCCEEEeecCCcccccCC-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcc
Confidence 94 5788999999998765322 2234568889999998742 25789999999999999999999997765
Q ss_pred hhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCCC
Q 016471 147 ESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENR 205 (389)
Q Consensus 147 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~~ 205 (389)
.......+.......+....+.+++++.++|.+||..+|.+||++.++++||||.....
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~ 270 (286)
T cd06622 212 YANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKN 270 (286)
T ss_pred hhhHHHHHHHHhhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccC
Confidence 54444333222111122223458999999999999999999999999999999976643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=264.18 Aligned_cols=193 Identities=28% Similarity=0.534 Sum_probs=161.0
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|.||||+.++ .....++||||++|++|.+++... +.+++..+..++.|++.||.|||++|++||||+|+||++
T Consensus 63 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~-- 139 (267)
T cd06628 63 LQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILV-- 139 (267)
T ss_pred cCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEE--
Confidence 5799999998 457899999999999999988655 678999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC-------CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChh
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ-------RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTES 148 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~-------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 148 (389)
+.++.++|+|||.+....... ......|++.|+|||.+. ..++.++|+||+||++|+|++|+.||.+....
T Consensus 140 -~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 218 (267)
T cd06628 140 -DNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL 218 (267)
T ss_pred -cCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH
Confidence 567889999999987664211 122346889999999885 45888999999999999999999999876655
Q ss_pred HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCC
Q 016471 149 GIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 149 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~ 200 (389)
.....+.... .......++..+.++|.+||+.+|.+||++.++++||||
T Consensus 219 ~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 219 QAIFKIGENA---SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHHHHHhccC---CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 5444443321 111124578999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=261.50 Aligned_cols=194 Identities=29% Similarity=0.522 Sum_probs=166.5
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEe
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 75 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~ 75 (389)
++||||+.++ ..+.+++|||||+||+|.+++... ...+++..+..++.|++.||.|||+.|++||||+|+||+++
T Consensus 56 ~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~ 135 (256)
T cd08221 56 LQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLT 135 (256)
T ss_pred CCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEe
Confidence 5799999998 457899999999999999988764 45689999999999999999999999999999999999994
Q ss_pred ecCCCCCEEEeecCCccccCCCC-CcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016471 76 TREEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRS 153 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 153 (389)
.++.+||+|||++....... ......|++.|+|||.+.+ .++.++|+||+|+++|+|++|..||......+....
T Consensus 136 ---~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~ 212 (256)
T cd08221 136 ---KAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVK 212 (256)
T ss_pred ---CCCCEEECcCcceEEcccccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 67889999999987664333 2344578999999998754 578899999999999999999999988887777777
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCC
Q 016471 154 VLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 154 i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~ 200 (389)
+........ .+.++..+.+++.+||..+|.+|||+.++++|||+
T Consensus 213 ~~~~~~~~~---~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 213 IVQGNYTPV---VSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHcCCCCCC---ccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 765443322 14678999999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=265.39 Aligned_cols=195 Identities=25% Similarity=0.411 Sum_probs=157.9
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ ....+|+||||+++|+|.+++... +.+++..+..++.|++.||.|||++||+||||+|+||++
T Consensus 63 ~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill-- 139 (267)
T cd06646 63 CKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILL-- 139 (267)
T ss_pred cCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE--
Confidence 4799999988 457899999999999999987654 679999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC-CcccccccCCcccccccc----ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLH----RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIF 151 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 151 (389)
+.++.+||+|||++....... ......|++.|+|||.+. ..++.++|+||+||++|+|++|+.||.........
T Consensus 140 -~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~ 218 (267)
T cd06646 140 -TDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL 218 (267)
T ss_pred -CCCCCEEECcCccceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh
Confidence 567889999999988664322 233457889999999873 24778999999999999999999999765544333
Q ss_pred HHHHhcCCCCCCC-CCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCC
Q 016471 152 RSVLRADPNFHDS-PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPW 199 (389)
Q Consensus 152 ~~i~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~ 199 (389)
..+.......+.. ....++..+.+++++||..+|.+|||++++++|+|
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 219 FLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred eeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 2222222111111 11347899999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=268.35 Aligned_cols=202 Identities=29% Similarity=0.586 Sum_probs=167.4
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ .++.+|+||||+++|+|.+++.. ..+++..+..++.|++.||.|||++|++||||+|+||++
T Consensus 75 l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill-- 150 (297)
T cd06659 75 YQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILL-- 150 (297)
T ss_pred CCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEE--
Confidence 5799999988 46889999999999999886643 468999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC-CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
+.++.+||+|||++....... ......|++.|+|||++. ..++.++|+||+||++|+|++|+.||...........+
T Consensus 151 -~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~ 229 (297)
T cd06659 151 -TLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL 229 (297)
T ss_pred -ccCCcEEEeechhHhhcccccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 567899999999987554322 233457899999999885 46889999999999999999999999887766665555
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVP 208 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~~~~~ 208 (389)
...... .......++..+.++|.+||..+|.+||++.++++||||.....+..
T Consensus 230 ~~~~~~-~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~~~~ 282 (297)
T cd06659 230 RDSPPP-KLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLPEC 282 (297)
T ss_pred hccCCC-CccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCCccc
Confidence 433222 22223567899999999999999999999999999999987754433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=256.92 Aligned_cols=205 Identities=31% Similarity=0.488 Sum_probs=167.7
Q ss_pred CCCcccccee-----ecCeEEEEEEccCCCChHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCc
Q 016471 1 MYHQKLQHLF-----YSNSFLFFTRFCEGGELLDRILSR----GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPEN 71 (389)
Q Consensus 1 l~Hpni~~~~-----~~~~~~lv~E~~~gg~L~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~N 71 (389)
|+||||+.+- .+..+|+++||.+. +|...|.-+ .+.++...++.|+.||+.|+.|||++-|+||||||.|
T Consensus 84 l~h~nvi~Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaN 162 (438)
T KOG0666|consen 84 LKHPNVISLVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPAN 162 (438)
T ss_pred hcCCcchhHHHHHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcce
Confidence 6899999876 48899999999998 898877532 2468899999999999999999999999999999999
Q ss_pred EEEeec-CCCCCEEEeecCCccccCCCC----CcccccccCCcccccccc--ccCCCchhHHHHHHHHHHHHhCCCCCCC
Q 016471 72 FLFTTR-EEDAPLKVIDFGLSDFVRPDQ----RLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILLCGSRPFWA 144 (389)
Q Consensus 72 ill~~~-~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~ 144 (389)
||+... .+.|.|||+|+|+++.+...- .....+-|.+|.|||.+. +.|+++.|+|++|||+.||++-++.|.+
T Consensus 163 IlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 163 ILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred EEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 999743 135899999999998875432 234467899999999885 4699999999999999999999999976
Q ss_pred CCh---------hHHHHHHHhcCCCCCCCCCCCC---------------------------------CHHHHHHHHhhhc
Q 016471 145 RTE---------SGIFRSVLRADPNFHDSPWPSV---------------------------------SPEAKDFVRRLLN 182 (389)
Q Consensus 145 ~~~---------~~~~~~i~~~~~~~~~~~~~~~---------------------------------~~~~~~li~~~l~ 182 (389)
... ...+..|+.....+....||.+ ++...+|+.+||.
T Consensus 243 ~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~ 322 (438)
T KOG0666|consen 243 REEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLT 322 (438)
T ss_pred hhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhc
Confidence 432 2455666665555555445421 4668899999999
Q ss_pred cCcCCCCCHHHHhCCCCCCCCCCC
Q 016471 183 KDHRKRMTAAQALTHPWLHDENRP 206 (389)
Q Consensus 183 ~~p~~R~s~~e~l~h~~~~~~~~~ 206 (389)
+||.+|+|++++|+|+||.....+
T Consensus 323 yDP~kRIta~qAleh~yF~~d~lp 346 (438)
T KOG0666|consen 323 YDPIKRITAEQALEHPYFTEDPLP 346 (438)
T ss_pred cCchhhccHHHHhcccccccCCCC
Confidence 999999999999999999887544
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=265.31 Aligned_cols=207 Identities=24% Similarity=0.417 Sum_probs=167.7
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ ....+|+||||++||+|.+++.. +.+++..+..++.|++.||.|||++|++|+||+|+||++
T Consensus 59 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~-- 134 (277)
T cd06640 59 CDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLL-- 134 (277)
T ss_pred CCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEE--
Confidence 5799999998 45789999999999999998753 468999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC-CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
+.++.++|+|||++....... ......++..|+|||++. ..++.++|+||+||++|+|++|..||...........+
T Consensus 135 -~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~ 213 (277)
T cd06640 135 -SEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI 213 (277)
T ss_pred -cCCCCEEEcccccceeccCCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh
Confidence 467889999999987654332 223346888999999875 45889999999999999999999999877665555444
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCCCCCCccHHHHH
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDILIYK 215 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~~~~~~~~~~~~ 215 (389)
.... ++.....++..+.+++.+||..+|.+||++.+++.|+||............+.+
T Consensus 214 ~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~~~~~~~~ 271 (277)
T cd06640 214 PKNN---PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAKKTSYLTELID 271 (277)
T ss_pred hcCC---CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcchhhhHHHHHHH
Confidence 3222 112223578899999999999999999999999999999776654443333333
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=268.60 Aligned_cols=196 Identities=28% Similarity=0.448 Sum_probs=160.1
Q ss_pred CCCcccccee----ec--CeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEE
Q 016471 1 MYHQKLQHLF----YS--NSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLF 74 (389)
Q Consensus 1 l~Hpni~~~~----~~--~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill 74 (389)
+.||||++++ .. ...|+||||+.+ +|.+.+......+++..++.++.||+.||+|||++|++||||||+||++
T Consensus 61 l~h~ni~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili 139 (293)
T cd07843 61 LQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLL 139 (293)
T ss_pred cCCCCEEEEEEEEEecCCCcEEEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE
Confidence 5799999986 23 789999999985 9988887665679999999999999999999999999999999999999
Q ss_pred eecCCCCCEEEeecCCccccCCC-CCcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHH
Q 016471 75 TTREEDAPLKVIDFGLSDFVRPD-QRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIF 151 (389)
Q Consensus 75 ~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 151 (389)
+.++.+||+|||++...... .......+++.|+|||.+.+ .++.++|+||+|+++|+|++|.+||.+.+.....
T Consensus 140 ---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~ 216 (293)
T cd07843 140 ---NNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQL 216 (293)
T ss_pred ---CCCCcEEEeecCceeeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 56789999999998876543 22334567889999998753 3688999999999999999999999887766555
Q ss_pred HHHHhcCCCCC--------------------------CCCCCC--CCHHHHHHHHhhhccCcCCCCCHHHHhCCCCC
Q 016471 152 RSVLRADPNFH--------------------------DSPWPS--VSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 152 ~~i~~~~~~~~--------------------------~~~~~~--~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~ 200 (389)
..+........ ...++. +++.+.++|++||..+|++|||+.|++.||||
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 217 NKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred HHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 54433211000 011122 48899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=266.01 Aligned_cols=196 Identities=24% Similarity=0.433 Sum_probs=159.5
Q ss_pred CCccccceee---------cCeEEEEEEccCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCC
Q 016471 2 YHQKLQHLFY---------SNSFLFFTRFCEGGELLDRILS---RGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKP 69 (389)
Q Consensus 2 ~Hpni~~~~~---------~~~~~lv~E~~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp 69 (389)
.||||++++. ...+|+||||++||+|.+++.. ....+++..++.++.|++.||+|||++|++||||||
T Consensus 77 ~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp 156 (291)
T cd06639 77 NHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKG 156 (291)
T ss_pred CCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCH
Confidence 6999999872 1468999999999999987753 346789999999999999999999999999999999
Q ss_pred CcEEEeecCCCCCEEEeecCCccccCCCC-CcccccccCCccccccccc------cCCCchhHHHHHHHHHHHHhCCCCC
Q 016471 70 ENFLFTTREEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLHR------SYNVEGDMWSIGVITYILLCGSRPF 142 (389)
Q Consensus 70 ~Nill~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~------~~~~~~DiwslG~il~~ll~g~~pf 142 (389)
+||++ +.++.+||+|||++....... ......|+..|+|||++.. .++.++|+||+||++|+|++|++||
T Consensus 157 ~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~ 233 (291)
T cd06639 157 NNILL---TTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233 (291)
T ss_pred HHEEE---cCCCCEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCC
Confidence 99999 467789999999987654322 2234568899999998742 2678999999999999999999999
Q ss_pred CCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCC
Q 016471 143 WARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLH 201 (389)
Q Consensus 143 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~ 201 (389)
...........+.+.... .......++..+.++|.+||..+|.+||++.++++||||+
T Consensus 234 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 234 FDMHPVKTLFKIPRNPPP-TLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred CCCcHHHHHHHHhcCCCC-CCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 877665555554433221 1111134678899999999999999999999999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=267.30 Aligned_cols=198 Identities=25% Similarity=0.466 Sum_probs=162.4
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||+.++ ..+..|+||||++||+|.+++.+ ..+++.++..++.|++.||.|||+.|++||||||+||++
T Consensus 73 ~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili-- 148 (297)
T cd06656 73 NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILL-- 148 (297)
T ss_pred CCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE--
Confidence 4799999988 35789999999999999998754 468999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCC-cccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQR-LNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
+.++.++|+|||++........ .....+++.|+|||.+.+ .++.++|+||+||++|++++|..||.+.+.......+
T Consensus 149 -~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~ 227 (297)
T cd06656 149 -GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI 227 (297)
T ss_pred -CCCCCEEECcCccceEccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee
Confidence 5678999999999876544322 234578899999998854 5889999999999999999999999876654433322
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
.... ..+......++..+++++.+||..+|.+||++.+++.||||....
T Consensus 228 ~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 276 (297)
T cd06656 228 ATNG-TPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAK 276 (297)
T ss_pred ccCC-CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccc
Confidence 2211 111112245788999999999999999999999999999997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=254.47 Aligned_cols=196 Identities=26% Similarity=0.466 Sum_probs=165.3
Q ss_pred cccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCEecCCCCCcEEEeecC
Q 016471 4 QKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHL-QGVVHRDLKPENFLFTTRE 78 (389)
Q Consensus 4 pni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~-~~i~Hrdlkp~Nill~~~~ 78 (389)
|.||++| .+..+++.||.|.. -+...+..-.+.++|.-+-.+...++.||.||.+ +||+|||+||+|||+ |
T Consensus 151 pyIV~c~GyFi~n~dV~IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILl---D 226 (391)
T KOG0983|consen 151 PYIVQCFGYFITNTDVFICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---D 226 (391)
T ss_pred CeeeeeeeEEeeCchHHHHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEE---c
Confidence 7888888 46778889998865 4444444445789999999999999999999986 589999999999999 7
Q ss_pred CCCCEEEeecCCccccCCCCCcccccccCCcccccccc----ccCCCchhHHHHHHHHHHHHhCCCCCCC-CChhHHHHH
Q 016471 79 EDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH----RSYNVEGDMWSIGVITYILLCGSRPFWA-RTESGIFRS 153 (389)
Q Consensus 79 ~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~ 153 (389)
+.|++||||||++.+.......+...|.+.|||||.+. ..|+.++||||||+.++||.||+.||.+ ..+.+++.+
T Consensus 227 e~GniKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltk 306 (391)
T KOG0983|consen 227 ERGNIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTK 306 (391)
T ss_pred cCCCEEeecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHH
Confidence 89999999999999887766666678999999999884 2599999999999999999999999988 456788888
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 154 VLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 154 i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
+++..+..-+.. ..+|+++++|+..||.+|+.+||...++|+|||+....
T Consensus 307 vln~ePP~L~~~-~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 307 VLNEEPPLLPGH-MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE 356 (391)
T ss_pred HHhcCCCCCCcc-cCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence 888655322221 34899999999999999999999999999999997654
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=264.39 Aligned_cols=199 Identities=31% Similarity=0.589 Sum_probs=166.6
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||+.++ ..+..|+|+||+.|++|.+++.. +++++..+..++.|++.||+|||++|++||||+|+||++
T Consensus 73 ~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~-- 148 (285)
T cd06648 73 YQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILL-- 148 (285)
T ss_pred cCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEE--
Confidence 4799999998 35889999999999999998765 579999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC-CcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
+.++.++|+|||++....... ......|++.|+|||.+.+ .++.++|+||+||++|+|++|+.||...+.......+
T Consensus 149 -~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~ 227 (285)
T cd06648 149 -TSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRI 227 (285)
T ss_pred -cCCCcEEEcccccchhhccCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHH
Confidence 567899999999876543322 2233568999999998854 5889999999999999999999999887776666666
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENR 205 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~~ 205 (389)
....+... .....++..+.+++.+||..+|.+|||+.++++||||.....
T Consensus 228 ~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 228 RDNLPPKL-KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGP 277 (285)
T ss_pred HhcCCCCC-cccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCC
Confidence 55432211 112347899999999999999999999999999999987653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=262.75 Aligned_cols=192 Identities=31% Similarity=0.534 Sum_probs=162.2
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|.||||+.++ .....|+|+||+.|++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||++
T Consensus 57 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~-- 133 (258)
T cd05578 57 LNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILL-- 133 (258)
T ss_pred CCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE--
Confidence 5799999987 467899999999999999988665 689999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCh---hHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTE---SGIFR 152 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~ 152 (389)
++++.++|+|||.+.............|+..|+|||.+.. .++.++|+||+|+++|+|++|..||...+. .....
T Consensus 134 -~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 212 (258)
T cd05578 134 -DEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRA 212 (258)
T ss_pred -cCCCCEEEeecccccccCCCccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHH
Confidence 5678899999999887655444445678899999998854 578999999999999999999999987764 33333
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCH--HHHhCCCCC
Q 016471 153 SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTA--AQALTHPWL 200 (389)
Q Consensus 153 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~--~e~l~h~~~ 200 (389)
........ ..+.++..+.++|.+||..+|.+||++ +++++||||
T Consensus 213 ~~~~~~~~----~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 213 KQETADVL----YPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred Hhcccccc----CcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 22222222 224578999999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=261.78 Aligned_cols=196 Identities=28% Similarity=0.423 Sum_probs=155.9
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCC--CHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEE
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRY--LEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLF 74 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l--~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill 74 (389)
+.||||++++ ..+.+++|+||++|++|.+++..+.+.+ ++..+..++.||+.||.|||++||+||||||+||++
T Consensus 62 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~ 141 (268)
T cd06624 62 LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLV 141 (268)
T ss_pred cCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE
Confidence 5799999988 4578999999999999999887654556 888999999999999999999999999999999999
Q ss_pred eecCCCCCEEEeecCCccccCCCC-CcccccccCCccccccccc---cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHH
Q 016471 75 TTREEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLHR---SYNVEGDMWSIGVITYILLCGSRPFWARTESGI 150 (389)
Q Consensus 75 ~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 150 (389)
+ ..++.++|+|||.+....... ......|++.|+|||.+.+ .++.++|+||+|+++|+|++|..||........
T Consensus 142 ~--~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~ 219 (268)
T cd06624 142 N--TYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA 219 (268)
T ss_pred c--CCCCeEEEecchhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh
Confidence 5 235689999999987654322 2233468899999998743 378899999999999999999999965433211
Q ss_pred -HHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCC
Q 016471 151 -FRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 151 -~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~ 200 (389)
...... . .........+++++++++.+||..+|.+|||+.+++.||||
T Consensus 220 ~~~~~~~-~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 220 AMFKVGM-F-KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred hHhhhhh-h-ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 111110 0 01111113578999999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=261.69 Aligned_cols=194 Identities=23% Similarity=0.451 Sum_probs=157.4
Q ss_pred CCCccccceee------cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEE
Q 016471 1 MYHQKLQHLFY------SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLF 74 (389)
Q Consensus 1 l~Hpni~~~~~------~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill 74 (389)
|.||||+.++. ...++++|||+++++|.+++.+. +.+++..+..++.|++.||.|||++||+||||+|+||++
T Consensus 61 l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~ 139 (266)
T cd06651 61 LQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILR 139 (266)
T ss_pred cCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE
Confidence 57999999882 25689999999999999988655 578999999999999999999999999999999999999
Q ss_pred eecCCCCCEEEeecCCccccCCC----CCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhH
Q 016471 75 TTREEDAPLKVIDFGLSDFVRPD----QRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESG 149 (389)
Q Consensus 75 ~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 149 (389)
+.++.+||+|||++...... .......++..|+|||.+.+ .++.++|+||+||++|++++|+.||.......
T Consensus 140 ---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~ 216 (266)
T cd06651 140 ---DSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA 216 (266)
T ss_pred ---CCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH
Confidence 56788999999998754321 11223468889999998854 58899999999999999999999998766555
Q ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCC
Q 016471 150 IFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLH 201 (389)
Q Consensus 150 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~ 201 (389)
....+...... + .....+++.+++++ +||..+|.+||++++++.||||+
T Consensus 217 ~~~~~~~~~~~-~-~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 217 AIFKIATQPTN-P-QLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HHHHHhcCCCC-C-CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 44444332211 1 11134688999999 67778999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=267.32 Aligned_cols=196 Identities=27% Similarity=0.456 Sum_probs=155.9
Q ss_pred CCCccccceee------------cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCC
Q 016471 1 MYHQKLQHLFY------------SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLK 68 (389)
Q Consensus 1 l~Hpni~~~~~------------~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlk 68 (389)
+.||||++++. ....|+|||||.+ +|.+.+......+++.++..++.||+.||+|||++|++|||||
T Consensus 68 l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~ 146 (310)
T cd07865 68 LKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMK 146 (310)
T ss_pred CCCCCccceEEEEecccccccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCC
Confidence 57999999883 1456999999975 8888777665679999999999999999999999999999999
Q ss_pred CCcEEEeecCCCCCEEEeecCCccccCCCC-----CcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCCCC
Q 016471 69 PENFLFTTREEDAPLKVIDFGLSDFVRPDQ-----RLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRP 141 (389)
Q Consensus 69 p~Nill~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~p 141 (389)
|+||++ +.++.+||+|||++....... ......++..|+|||.+.+ .++.++|+||+|+++|+|++|.+|
T Consensus 147 p~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~ 223 (310)
T cd07865 147 AANILI---TKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPI 223 (310)
T ss_pred HHHEEE---CCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCC
Confidence 999999 567899999999987653321 1233467889999998743 378899999999999999999999
Q ss_pred CCCCChhHHHHHHHhcCCCCCCCCC----------------------------CCCCHHHHHHHHhhhccCcCCCCCHHH
Q 016471 142 FWARTESGIFRSVLRADPNFHDSPW----------------------------PSVSPEAKDFVRRLLNKDHRKRMTAAQ 193 (389)
Q Consensus 142 f~~~~~~~~~~~i~~~~~~~~~~~~----------------------------~~~~~~~~~li~~~l~~~p~~R~s~~e 193 (389)
|.+.+.......+.+.....+...+ ...++.+.++|.+||..+|.+|||+++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e 303 (310)
T cd07865 224 MQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADT 303 (310)
T ss_pred CCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHH
Confidence 9887665444433332211111110 013577889999999999999999999
Q ss_pred HhCCCCC
Q 016471 194 ALTHPWL 200 (389)
Q Consensus 194 ~l~h~~~ 200 (389)
+++||||
T Consensus 304 ~l~h~~f 310 (310)
T cd07865 304 ALNHDFF 310 (310)
T ss_pred HhcCCCC
Confidence 9999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=262.54 Aligned_cols=193 Identities=22% Similarity=0.387 Sum_probs=157.4
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||+.++ ..+..++||||+++|+|..+ ..+++..+..++.|++.||.|||++||+|+||||+||++
T Consensus 56 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill-- 128 (279)
T cd06619 56 CDSPYIIGFYGAFFVENRISICTEFMDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLV-- 128 (279)
T ss_pred CCCCCeeeEEEEEEECCEEEEEEecCCCCChHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEE--
Confidence 5799999988 45789999999999998643 358899999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCh-------h
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTE-------S 148 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~ 148 (389)
+.++.++|+|||++...... ......||+.|+|||++. ..++.++|+||+||++|+|++|+.||..... .
T Consensus 129 -~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~ 206 (279)
T cd06619 129 -NTRGQVKLCDFGVSTQLVNS-IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPL 206 (279)
T ss_pred -CCCCCEEEeeCCcceecccc-cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchH
Confidence 56789999999998765432 234567999999999885 4689999999999999999999999965322 1
Q ss_pred HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 149 GIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 149 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
.....+.... .+.......++++++++.+||..+|.+||++++++.||||...+
T Consensus 207 ~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~ 260 (279)
T cd06619 207 QLLQCIVDED--PPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYN 260 (279)
T ss_pred HHHHHHhccC--CCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccccccc
Confidence 2222222211 12222345789999999999999999999999999999997764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=264.00 Aligned_cols=196 Identities=26% Similarity=0.437 Sum_probs=158.1
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEe
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 75 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~ 75 (389)
+.||||++++ ..+..|+||||+. ++|.+++... .+.+++..+..++.|++.||+|||++|++||||+|+||++
T Consensus 56 l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill- 133 (284)
T cd07860 56 LNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI- 133 (284)
T ss_pred cCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE-
Confidence 5799999988 4578999999996 5888877643 3568999999999999999999999999999999999999
Q ss_pred ecCCCCCEEEeecCCccccCCCC-CcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 016471 76 TREEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFR 152 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 152 (389)
+.++.+||+|||++....... ......+++.|+|||++.+ .++.++|+||+||++|+|++|+.||.+.+......
T Consensus 134 --~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~ 211 (284)
T cd07860 134 --NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF 211 (284)
T ss_pred --CCCCCEEEeeccchhhcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 567899999999987654322 2233457889999998753 36888999999999999999999998876655444
Q ss_pred HHHhcCCCCCC-------------------------CCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCC
Q 016471 153 SVLRADPNFHD-------------------------SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 153 ~i~~~~~~~~~-------------------------~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~ 200 (389)
.+......... ...+.+++.++++|.+||..||.+|||+++++.||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 212 RIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 43322111110 0123578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=264.50 Aligned_cols=197 Identities=27% Similarity=0.446 Sum_probs=156.8
Q ss_pred CCccccceee----cCe-----EEEEEEccCCCChHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCC
Q 016471 2 YHQKLQHLFY----SNS-----FLFFTRFCEGGELLDRILSRG----GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLK 68 (389)
Q Consensus 2 ~Hpni~~~~~----~~~-----~~lv~E~~~gg~L~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlk 68 (389)
+||||++++. ... .|+|||||++ +|.+++.... ..+++..++.++.||+.||.|||++||+||||+
T Consensus 59 ~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~ 137 (295)
T cd07837 59 ESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLK 137 (295)
T ss_pred CCCCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCC
Confidence 4799999883 222 7999999996 8888876532 358999999999999999999999999999999
Q ss_pred CCcEEEeecCCCCCEEEeecCCccccCCC-CCcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 016471 69 PENFLFTTREEDAPLKVIDFGLSDFVRPD-QRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWAR 145 (389)
Q Consensus 69 p~Nill~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~ 145 (389)
|+||+++ ..++.+||+|||++...... .......+++.|+|||++.+ .++.++|+||+|+++|+|++|..||.+.
T Consensus 138 ~~nil~~--~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~ 215 (295)
T cd07837 138 PQNLLVD--KQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGD 215 (295)
T ss_pred hHHEEEe--cCCCeEEEeecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Confidence 9999995 23788999999998765332 12233457889999998743 4789999999999999999999999887
Q ss_pred ChhHHHHHHHhcCCCCCC------------------------CCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCC
Q 016471 146 TESGIFRSVLRADPNFHD------------------------SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLH 201 (389)
Q Consensus 146 ~~~~~~~~i~~~~~~~~~------------------------~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~ 201 (389)
+.......+......... ...+.+++.+.++|.+||..+|.+|||+.+++.||||+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 216 SELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred CHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 766555544432111110 01145789999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=262.60 Aligned_cols=195 Identities=28% Similarity=0.495 Sum_probs=158.0
Q ss_pred CCccccceee----------cCeEEEEEEccCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCC
Q 016471 2 YHQKLQHLFY----------SNSFLFFTRFCEGGELLDRILSR---GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLK 68 (389)
Q Consensus 2 ~Hpni~~~~~----------~~~~~lv~E~~~gg~L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlk 68 (389)
.||||++++. ...+|+|||||++|+|.+++... +..+++..+..++.|++.||.|||++|++||||+
T Consensus 61 ~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~ 140 (275)
T cd06608 61 NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIK 140 (275)
T ss_pred CCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCC
Confidence 6999999882 23489999999999999887542 3679999999999999999999999999999999
Q ss_pred CCcEEEeecCCCCCEEEeecCCccccCCC-CCcccccccCCcccccccc------ccCCCchhHHHHHHHHHHHHhCCCC
Q 016471 69 PENFLFTTREEDAPLKVIDFGLSDFVRPD-QRLNDIVGSAYYVAPEVLH------RSYNVEGDMWSIGVITYILLCGSRP 141 (389)
Q Consensus 69 p~Nill~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~p 141 (389)
|+||++ +.++.+||+|||++...... .......|++.|+|||++. ..++.++|+||+||++|+|++|+.|
T Consensus 141 p~ni~~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p 217 (275)
T cd06608 141 GQNILL---TKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217 (275)
T ss_pred HHHEEE---ccCCeEEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCC
Confidence 999999 46788999999998765332 2233456899999999873 2367889999999999999999999
Q ss_pred CCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCC
Q 016471 142 FWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 142 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~ 200 (389)
|...........+....... ......++..++++|.+||..||.+|||+.+++.|||+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 218 LCDMHPMRALFKIPRNPPPT-LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred ccccchHHHHHHhhccCCCC-CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 98765555555444332211 11112378899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=259.65 Aligned_cols=194 Identities=29% Similarity=0.488 Sum_probs=163.9
Q ss_pred CCCccccceee------cCeEEEEEEccCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH-----HCCCEecC
Q 016471 1 MYHQKLQHLFY------SNSFLFFTRFCEGGELLDRILSR---GGRYLEEDAKTIVEKILNIVAFCH-----LQGVVHRD 66 (389)
Q Consensus 1 l~Hpni~~~~~------~~~~~lv~E~~~gg~L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH-----~~~i~Hrd 66 (389)
+.||||++++. ...+|++||||++|+|.+++... .+.+++..++.++.||+.||.||| +.+++|||
T Consensus 56 l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~d 135 (265)
T cd08217 56 LKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRD 135 (265)
T ss_pred cCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecC
Confidence 57999999872 34689999999999999988653 467999999999999999999999 99999999
Q ss_pred CCCCcEEEeecCCCCCEEEeecCCccccCCCCC-cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCC
Q 016471 67 LKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR-LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWA 144 (389)
Q Consensus 67 lkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~ 144 (389)
|+|+||+++ .++.+||+|||++........ .....+++.|+|||.+. ..++.++|+||+|+++|+|++|..||..
T Consensus 136 l~p~nili~---~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 212 (265)
T cd08217 136 LKPANIFLD---ANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTA 212 (265)
T ss_pred CCHHHEEEe---cCCCEEEecccccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccC
Confidence 999999994 678999999999887654432 34457899999999885 4588899999999999999999999988
Q ss_pred CChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCC
Q 016471 145 RTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 145 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~ 200 (389)
.+.......+....... ....++..+.+++.+||..+|.+|||+.++++|||+
T Consensus 213 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 213 RNQLQLASKIKEGKFRR---IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred cCHHHHHHHHhcCCCCC---CccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 77666666655443221 113678999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=264.03 Aligned_cols=196 Identities=26% Similarity=0.486 Sum_probs=155.0
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
++||||++++ ..+..|+||||+.+ +|.+++....+.+++..++.++.|++.||.|||++||+||||||+||++
T Consensus 60 l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~-- 136 (291)
T cd07844 60 LKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLI-- 136 (291)
T ss_pred CCCcceeeEEEEEecCCeEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEE--
Confidence 5799999998 35789999999985 9999887766678999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC-CcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCC-hhHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWART-ESGIFR 152 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~ 152 (389)
+.++.+||+|||++....... ......++..|+|||++.+ .++.++|+||+||++|+|++|+.||.+.. ..+...
T Consensus 137 -~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~ 215 (291)
T cd07844 137 -SERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLH 215 (291)
T ss_pred -cCCCCEEECccccccccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHH
Confidence 567889999999986543221 1223456889999998743 47889999999999999999999997655 222222
Q ss_pred HHHhcCCCCC--------------------------CCCCCCCC--HHHHHHHHhhhccCcCCCCCHHHHhCCCCC
Q 016471 153 SVLRADPNFH--------------------------DSPWPSVS--PEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 153 ~i~~~~~~~~--------------------------~~~~~~~~--~~~~~li~~~l~~~p~~R~s~~e~l~h~~~ 200 (389)
.+........ ....+.++ ..+.+++.+||..+|.+|||+.+++.||||
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 216 KIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred HHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 2221110000 00112344 889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=259.94 Aligned_cols=197 Identities=30% Similarity=0.541 Sum_probs=166.1
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ .....|+||||+.||+|.+++.+. +.+++..+..++.||+.||.|||++|++||||+|+||++
T Consensus 50 ~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~-- 126 (265)
T cd05579 50 AQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENV-GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILI-- 126 (265)
T ss_pred CCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEE--
Confidence 4699999987 457799999999999999988665 579999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC---------CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ---------RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWART 146 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 146 (389)
+.++.++|+|||++....... ......++..|+|||... ..++.++|+||+|+++|++++|..||....
T Consensus 127 -~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 205 (265)
T cd05579 127 -DSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET 205 (265)
T ss_pred -cCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 567899999999987543321 223356788999999875 458889999999999999999999998888
Q ss_pred hhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCH---HHHhCCCCCCCC
Q 016471 147 ESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTA---AQALTHPWLHDE 203 (389)
Q Consensus 147 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~---~e~l~h~~~~~~ 203 (389)
.......+.......+.. ..++..+.+++.+||+.+|.+|||+ .++++||||++.
T Consensus 206 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 206 PEEIFQNILNGKIEWPED--VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred HHHHHHHHhcCCcCCCcc--ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence 777777766544332221 2358999999999999999999999 999999999754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=261.82 Aligned_cols=198 Identities=22% Similarity=0.414 Sum_probs=158.2
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|+||||++++ ..+.+++||||++||+|.+++... +.+++..+..++.||+.||+|||++|++||||+|+||+++
T Consensus 60 l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~- 137 (268)
T cd06630 60 LNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLID- 137 (268)
T ss_pred cCCCceehhhceeccCCeEEEEEeccCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc-
Confidence 5799999999 357899999999999999987654 6799999999999999999999999999999999999994
Q ss_pred cCCCCCEEEeecCCccccCCCC-----CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ-----RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGI 150 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 150 (389)
..+..+||+|||.+....... ......|+..|+|||.+. ..++.++|+||+|+++|++++|..||........
T Consensus 138 -~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 216 (268)
T cd06630 138 -STGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH 216 (268)
T ss_pred -CCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch
Confidence 233469999999987654321 112346888999999875 4688999999999999999999999975543332
Q ss_pred HHHHHhcCC-CCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCC
Q 016471 151 FRSVLRADP-NFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLH 201 (389)
Q Consensus 151 ~~~i~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~ 201 (389)
...+.+... .......+.+++++.+++.+||..+|.+|||+.++++||||+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 217 LALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 222222111 111112235789999999999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=262.80 Aligned_cols=197 Identities=26% Similarity=0.459 Sum_probs=160.8
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCEecCCCCCcEEEe
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHL-QGVVHRDLKPENFLFT 75 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~-~~i~Hrdlkp~Nill~ 75 (389)
+.||||++++ ....+|+|+||+.|++|.+++......+++..+..++.|++.||+|||+ .|++||||||+||++
T Consensus 56 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~- 134 (265)
T cd06605 56 CNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILV- 134 (265)
T ss_pred CCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEE-
Confidence 4799999987 4678999999999999999887655789999999999999999999999 999999999999999
Q ss_pred ecCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCC-----hhH
Q 016471 76 TREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWART-----ESG 149 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~-----~~~ 149 (389)
+.++.++|+|||.+........ ....++..|+|||.+.+ .++.++|+||+|+++|+|++|..||.... ...
T Consensus 135 --~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 211 (265)
T cd06605 135 --NSRGQIKLCDFGVSGQLVNSLA-KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFE 211 (265)
T ss_pred --CCCCCEEEeecccchhhHHHHh-hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHH
Confidence 4678899999999876533222 12678899999998754 68899999999999999999999996542 223
Q ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCC
Q 016471 150 IFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 150 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~ 203 (389)
....+..... +..+...+++.++++|.+||..+|.+|||+.+++.||||+..
T Consensus 212 ~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 212 LLQYIVNEPP--PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred HHHHHhcCCC--CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 3333333221 111111278999999999999999999999999999999653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=262.96 Aligned_cols=191 Identities=18% Similarity=0.281 Sum_probs=159.8
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG---------------GRYLEEDAKTIVEKILNIVAFCHLQG 61 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~~lH~~~ 61 (389)
+.||||+.++ .....|++|||+++|+|.+++.... +.+++..+..++.|++.||.|||++|
T Consensus 65 l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~ 144 (283)
T cd05048 65 LQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH 144 (283)
T ss_pred cCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 5799999988 3467999999999999999886542 45888999999999999999999999
Q ss_pred CEecCCCCCcEEEeecCCCCCEEEeecCCccccCCCC---CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh
Q 016471 62 VVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ---RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC 137 (389)
Q Consensus 62 i~Hrdlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~ 137 (389)
++||||||+||++ ++++.+||+|||++....... ......+++.|+|||.+. +.++.++|+||+||++|+|++
T Consensus 145 i~H~dlkp~Nil~---~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~ 221 (283)
T cd05048 145 FVHRDLAARNCLV---GEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221 (283)
T ss_pred eeccccccceEEE---cCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHc
Confidence 9999999999999 467889999999987653222 123345678899999874 568999999999999999998
Q ss_pred -CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCC
Q 016471 138 -GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 197 (389)
Q Consensus 138 -g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h 197 (389)
|..||.+....+....+........ ...+++.+.+++.+||..+|.+||++.+++++
T Consensus 222 ~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 222 YGLQPYYGFSNQEVIEMIRSRQLLPC---PEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred CCCCCCCCCCHHHHHHHHHcCCcCCC---cccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999998888777777665432221 24689999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=263.54 Aligned_cols=195 Identities=24% Similarity=0.400 Sum_probs=161.5
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ ..+..|+||||+.| +|.+.+....+.+++..+..++.|++.||.|||++|++||||+|+||++
T Consensus 72 l~h~niv~~~~~~~~~~~~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~-- 148 (307)
T cd06607 72 LRHPNTIEYKGCYLREHTAWLVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILL-- 148 (307)
T ss_pred CCCCCEEEEEEEEEeCCeEEEEHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEE--
Confidence 5799999987 45789999999985 7777776555679999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc----ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH----RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFR 152 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 152 (389)
+.++.++|+|||++...... ....+++.|+|||++. +.++.++||||+|+++|+|++|+.||.+........
T Consensus 149 -~~~~~~kL~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~ 224 (307)
T cd06607 149 -TEPGTVKLADFGSASLVSPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY 224 (307)
T ss_pred -CCCCCEEEeecCcceecCCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHH
Confidence 56789999999998765432 3456888999999873 358889999999999999999999998877665544
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 153 SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 153 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
.+..... +......++..++++|.+||..+|.+||++.+++.||||....
T Consensus 225 ~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 225 HIAQNDS--PTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred HHhcCCC--CCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 4433221 1111134688999999999999999999999999999997654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=263.37 Aligned_cols=195 Identities=28% Similarity=0.473 Sum_probs=157.0
Q ss_pred CCccccceee---------cCeEEEEEEccCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCC
Q 016471 2 YHQKLQHLFY---------SNSFLFFTRFCEGGELLDRILS---RGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKP 69 (389)
Q Consensus 2 ~Hpni~~~~~---------~~~~~lv~E~~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp 69 (389)
.||||++++. +..+|+|||||+||+|.+.+.. ..+.+++..+..++.|++.||.|||+++++||||||
T Consensus 73 ~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp 152 (286)
T cd06638 73 DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKG 152 (286)
T ss_pred cCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCH
Confidence 5999999873 2468999999999999987642 335689999999999999999999999999999999
Q ss_pred CcEEEeecCCCCCEEEeecCCccccCCCC-CcccccccCCcccccccc------ccCCCchhHHHHHHHHHHHHhCCCCC
Q 016471 70 ENFLFTTREEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLH------RSYNVEGDMWSIGVITYILLCGSRPF 142 (389)
Q Consensus 70 ~Nill~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~pf 142 (389)
+||++ +.++.+||+|||++....... ......|++.|+|||++. ..++.++|+||+||++|+|++|+.||
T Consensus 153 ~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~ 229 (286)
T cd06638 153 NNILL---TTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229 (286)
T ss_pred HhEEE---CCCCCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCC
Confidence 99999 467789999999987654322 233457899999999873 24788999999999999999999999
Q ss_pred CCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCC
Q 016471 143 WARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 143 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~ 200 (389)
...........+...... .......++..+.+++.+||..+|.+|||+.++++|+||
T Consensus 230 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 230 ADLHPMRALFKIPRNPPP-TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred CCCchhHHHhhccccCCC-cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 876654444333222111 111112357899999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=257.91 Aligned_cols=190 Identities=23% Similarity=0.398 Sum_probs=159.1
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ ....+|+||||++||+|.+++....+.+++..+..++.|++.||+|||++|++||||||+||++
T Consensus 56 l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i-- 133 (256)
T cd05114 56 LSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLV-- 133 (256)
T ss_pred CCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEE--
Confidence 5799999988 3567999999999999999887655679999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCCc--ccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRL--NDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFR 152 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 152 (389)
+.++.+||+|||.+......... ....++..|+|||++. ..++.++|+||+|+++|+|++ |+.||...+..+...
T Consensus 134 -~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~ 212 (256)
T cd05114 134 -SSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVE 212 (256)
T ss_pred -cCCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 46788999999998765332211 2223556899999885 468899999999999999999 999998888777777
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 153 SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 153 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
.+.+......+ ...+..+.+++.+||..+|.+|||++++++
T Consensus 213 ~i~~~~~~~~~---~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 213 MISRGFRLYRP---KLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHHCCCCCCCC---CCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 77664332211 236788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=258.47 Aligned_cols=194 Identities=22% Similarity=0.455 Sum_probs=164.2
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEe
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 75 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~ 75 (389)
+.||||+.++ ..+..|+||||+.||+|.+++.... ..+++..+..++.|++.||.|||++|++|+||+|+||++
T Consensus 56 l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~- 134 (256)
T cd08218 56 MKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL- 134 (256)
T ss_pred CCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE-
Confidence 5799999988 3578999999999999999886543 368999999999999999999999999999999999999
Q ss_pred ecCCCCCEEEeecCCccccCCCCC-cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016471 76 TREEDAPLKVIDFGLSDFVRPDQR-LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRS 153 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 153 (389)
+.++.++++|||++........ .....|++.|+|||++. +.++.++|+||+||++|+|++|..||...........
T Consensus 135 --~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~ 212 (256)
T cd08218 135 --TKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLK 212 (256)
T ss_pred --cCCCCEEEeeccceeecCcchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHH
Confidence 4678899999999876543321 22346888999999875 4678899999999999999999999988877777776
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCC
Q 016471 154 VLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 154 i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~ 200 (389)
+........ ...++.++.++|.+||+.+|.+||++.++++||||
T Consensus 213 ~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 213 IIRGSYPPV---SSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HhcCCCCCC---cccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 665442211 24578999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=259.67 Aligned_cols=196 Identities=27% Similarity=0.497 Sum_probs=160.9
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||+.++ ..+.+++||||+.||+|.+++.+. +.+++..+..++.||+.||.|||++|++||||+|+||++
T Consensus 65 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~-- 141 (272)
T cd06629 65 LDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLV-- 141 (272)
T ss_pred cCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEE--
Confidence 5799999988 357799999999999999988665 689999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC---CcccccccCCccccccccc---cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ---RLNDIVGSAYYVAPEVLHR---SYNVEGDMWSIGVITYILLCGSRPFWARTESGI 150 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 150 (389)
+.++.++|+|||++....... ......|+..|+|||.+.. .++.++|+||+|+++|++++|..||........
T Consensus 142 -~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 220 (272)
T cd06629 142 -DADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA 220 (272)
T ss_pred -cCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH
Confidence 567899999999987643211 1234568899999998743 378899999999999999999999976555444
Q ss_pred HHHHHhc--CCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCC
Q 016471 151 FRSVLRA--DPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 151 ~~~i~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~ 200 (389)
...+... ....+....+.++..++++|.+||.++|.+|||++++++|||+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 221 MFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred HHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 3333222 1222233335678999999999999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=260.07 Aligned_cols=190 Identities=16% Similarity=0.303 Sum_probs=158.0
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ ..+..|+||||+++|+|.+++.+..+.+++..+..++.||+.||+|||++|++||||||+||++
T Consensus 63 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili-- 140 (266)
T cd05064 63 FDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLV-- 140 (266)
T ss_pred CCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEE--
Confidence 5799999988 3578999999999999999887766689999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCCcc--cccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLN--DIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFR 152 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~--~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 152 (389)
+.++.+|++|||.+.......... ...++..|+|||.+. ..++.++||||+||++|++++ |..||.+.+......
T Consensus 141 -~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~ 219 (266)
T cd05064 141 -NSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIK 219 (266)
T ss_pred -cCCCcEEECCCcccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHH
Confidence 467899999999876543222111 223567899999875 568999999999999999775 999999888877777
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 153 SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 153 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
.+...... + ..+.++..+.+++.+||..+|.+|||++++++
T Consensus 220 ~~~~~~~~-~--~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 220 AVEDGFRL-P--APRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHCCCCC-C--CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 66544321 1 22467899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=264.84 Aligned_cols=196 Identities=27% Similarity=0.460 Sum_probs=160.9
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||+.++ ....+|+|||||+||+|.+++.. +.+++..+..++.|++.||.|||++|++|+||+|+||++.
T Consensus 59 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~- 135 (277)
T cd06642 59 CDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLS- 135 (277)
T ss_pred CCCCccHhhhcccccCCceEEEEEccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEe-
Confidence 5799999988 45779999999999999987743 5789999999999999999999999999999999999994
Q ss_pred cCCCCCEEEeecCCccccCCCC-CcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
.++.++|+|||++....... ......|+..|+|||.+.+ .++.++|+||+||++|+|++|..||...........+
T Consensus 136 --~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~ 213 (277)
T cd06642 136 --EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI 213 (277)
T ss_pred --CCCCEEEccccccccccCcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhh
Confidence 67889999999987654332 2223468889999998854 5888999999999999999999999766555444433
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
..... ......++..+.+++.+||..+|.+|||+.+++.||||....
T Consensus 214 ~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06642 214 PKNSP---PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYT 260 (277)
T ss_pred hcCCC---CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHh
Confidence 22221 111134788999999999999999999999999999985543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=274.18 Aligned_cols=196 Identities=30% Similarity=0.525 Sum_probs=166.2
Q ss_pred cccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeecCC
Q 016471 4 QKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREE 79 (389)
Q Consensus 4 pni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~~~ 79 (389)
+=||++| +.+++|+||+|++||++...+.+. |-|.|..++.++.++..|+++.|..|+|||||||+|||| |.
T Consensus 689 ~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIrm-gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILI---Dr 764 (1034)
T KOG0608|consen 689 EWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM-GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI---DR 764 (1034)
T ss_pred cceEEEEEEeccCCceEEEEeccCCccHHHHHHHh-ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEE---cc
Confidence 3467777 468899999999999999988876 789999999999999999999999999999999999999 78
Q ss_pred CCCEEEeecCCccccCC---------C------------------CC----------------cccccccCCcccccccc
Q 016471 80 DAPLKVIDFGLSDFVRP---------D------------------QR----------------LNDIVGSAYYVAPEVLH 116 (389)
Q Consensus 80 ~~~~kl~Dfg~a~~~~~---------~------------------~~----------------~~~~~gt~~y~aPE~~~ 116 (389)
+|.|||+|||+|+.+.. + .+ ....+||+.|+|||++.
T Consensus 765 dGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~ 844 (1034)
T KOG0608|consen 765 DGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLA 844 (1034)
T ss_pred CCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhc
Confidence 99999999999864310 0 00 02347999999999986
Q ss_pred c-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCC---HH
Q 016471 117 R-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMT---AA 192 (389)
Q Consensus 117 ~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s---~~ 192 (389)
+ .|+..||+||.|||||||+.|++||...++.+...++.+....+..+.-.++|+++.++|.++. -+++.|.. ++
T Consensus 845 r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d 923 (1034)
T KOG0608|consen 845 RTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGAD 923 (1034)
T ss_pred ccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhhcccchh
Confidence 5 7999999999999999999999999999888877777776655555555689999999999865 56888874 77
Q ss_pred HHhCCCCCCCCC
Q 016471 193 QALTHPWLHDEN 204 (389)
Q Consensus 193 e~l~h~~~~~~~ 204 (389)
++..||||+..+
T Consensus 924 ~vKaHpfFkgID 935 (1034)
T KOG0608|consen 924 QVKAHPFFKGID 935 (1034)
T ss_pred hhhcCccccccc
Confidence 899999998764
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=257.31 Aligned_cols=194 Identities=27% Similarity=0.462 Sum_probs=161.8
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ ....+|+||||++|++|.+++.+. +.+++..+..++.||+.||.|||+.|++|+||+|+||++
T Consensus 59 ~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~-- 135 (258)
T cd06632 59 LQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILV-- 135 (258)
T ss_pred cCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE--
Confidence 4799999988 347799999999999999988655 578999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc-c-CCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-S-YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
+.++.+||+|||++.............|++.|+|||.+.. . ++.++|+||+||++|++++|+.||...........+
T Consensus 136 -~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 214 (258)
T cd06632 136 -DTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKI 214 (258)
T ss_pred -CCCCCEEEccCccceeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHH
Confidence 4678999999999877654443445678999999998753 4 789999999999999999999999776654444444
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~ 200 (389)
..... .+ ...+.+++.+.+++.+||..+|.+||++.+++.|||+
T Consensus 215 ~~~~~-~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 215 GRSKE-LP-PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred Hhccc-CC-CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 33111 11 1224578999999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=263.30 Aligned_cols=201 Identities=27% Similarity=0.419 Sum_probs=160.2
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEe
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGG-RYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 75 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~-~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~ 75 (389)
+.||||++++ ....+|+||||+++ +|.+++....+ .+++..+..++.||+.||+|||++|++||||+|+||+++
T Consensus 58 l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~ 136 (294)
T PLN00009 58 MQHGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLID 136 (294)
T ss_pred ccCCCEeeEEEEEecCCeEEEEEecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEE
Confidence 5799999998 45789999999964 88887765432 367888999999999999999999999999999999995
Q ss_pred ecCCCCCEEEeecCCccccCCCC-CcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 016471 76 TREEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFR 152 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 152 (389)
..++.+||+|||++....... ......+++.|+|||++.+ .++.++|+||+||++|+|++|.+||.+.+..+...
T Consensus 137 --~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~ 214 (294)
T PLN00009 137 --RRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELF 214 (294)
T ss_pred --CCCCEEEEcccccccccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 245679999999987653322 2234567899999998743 47889999999999999999999998877665555
Q ss_pred HHHhcCCCCCCC-------------------------CCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 153 SVLRADPNFHDS-------------------------PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 153 ~i~~~~~~~~~~-------------------------~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
.+.......... ..+.+++.+.+++.+||..+|.+||++.+++.||||.+.+
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~ 291 (294)
T PLN00009 215 KIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG 291 (294)
T ss_pred HHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence 543321111100 1245789999999999999999999999999999997653
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=274.18 Aligned_cols=190 Identities=21% Similarity=0.361 Sum_probs=153.1
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcC------------------------------------------
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG------------------------------------------ 35 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~------------------------------------------ 35 (389)
.||||++++ ....+|+|||||++|+|.+++..+.
T Consensus 100 ~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (374)
T cd05106 100 QHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSD 179 (374)
T ss_pred cCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccc
Confidence 799999998 3577999999999999999885431
Q ss_pred ---------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeecCCCCCEEEeec
Q 016471 36 ---------------------------GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDF 88 (389)
Q Consensus 36 ---------------------------~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~~~~~~~kl~Df 88 (389)
.++++..++.++.||+.||.|||++||+||||||+||++ ++++.+||+||
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~---~~~~~~kL~Df 256 (374)
T cd05106 180 TYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLL---TDGRVAKICDF 256 (374)
T ss_pred cccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEE---eCCCeEEEeec
Confidence 247888999999999999999999999999999999999 46788999999
Q ss_pred CCccccCCCCC---cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCC
Q 016471 89 GLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHD 163 (389)
Q Consensus 89 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 163 (389)
|++........ .....+++.|+|||++. ..++.++||||+||++|+|++ |+.||...........+.........
T Consensus 257 Gla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~ 336 (374)
T cd05106 257 GLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSR 336 (374)
T ss_pred eeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccC
Confidence 99876543221 11233556799999875 569999999999999999997 99999876655444444443322222
Q ss_pred CCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 164 SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 164 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
+ ..+++++.+++.+||..+|.+|||+.++++
T Consensus 337 ~--~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 337 P--DFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred C--CCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1 346899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=258.42 Aligned_cols=194 Identities=25% Similarity=0.473 Sum_probs=158.1
Q ss_pred CCCccccceee------cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEE
Q 016471 1 MYHQKLQHLFY------SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLF 74 (389)
Q Consensus 1 l~Hpni~~~~~------~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill 74 (389)
+.||||+.++. ...+|+||||++||+|.+++.+. +.+++..+..++.|++.||+|||++|++|+||||+||++
T Consensus 61 l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~ 139 (265)
T cd06652 61 LLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILR 139 (265)
T ss_pred cCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEe
Confidence 57999999883 24588999999999999988655 578999999999999999999999999999999999999
Q ss_pred eecCCCCCEEEeecCCccccCCC----CCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhH
Q 016471 75 TTREEDAPLKVIDFGLSDFVRPD----QRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESG 149 (389)
Q Consensus 75 ~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 149 (389)
+.++.++|+|||++...... .......|+..|+|||++. ..++.++|+||+||++|+|++|+.||.......
T Consensus 140 ---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~ 216 (265)
T cd06652 140 ---DSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA 216 (265)
T ss_pred ---cCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH
Confidence 46788999999998765321 1223356889999999875 468899999999999999999999998765555
Q ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCC
Q 016471 150 IFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLH 201 (389)
Q Consensus 150 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~ 201 (389)
....+...... + ...+.++..+.++|.+|+. +|.+||+++++++|||++
T Consensus 217 ~~~~~~~~~~~-~-~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 217 AIFKIATQPTN-P-VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHhcCCCC-C-CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 44444332211 1 1123578889999999995 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=257.07 Aligned_cols=196 Identities=27% Similarity=0.485 Sum_probs=159.2
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ ..+.+++|+||+++++|.+++... +.+++..+..++.|++.||.|||++|++|+||+|+||++
T Consensus 56 l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~-- 132 (264)
T cd06626 56 LKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFL-- 132 (264)
T ss_pred CCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE--
Confidence 5799999988 357899999999999999987654 568999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCC-----cccccccCCccccccccc-c---CCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQR-----LNDIVGSAYYVAPEVLHR-S---YNVEGDMWSIGVITYILLCGSRPFWARTE 147 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~-~---~~~~~DiwslG~il~~ll~g~~pf~~~~~ 147 (389)
+.++.+||+|||++........ .....+++.|+|||++.. . ++.++|+||+|+++|++++|+.||.....
T Consensus 133 -~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~ 211 (264)
T cd06626 133 -DHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN 211 (264)
T ss_pred -CCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc
Confidence 4678899999999877643322 123567889999998853 3 78899999999999999999999976543
Q ss_pred hHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCC
Q 016471 148 SGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 148 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~ 200 (389)
................+.+..+++.+.++|.+||..+|.+|||+.+++.|||+
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 212 EFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred hHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 32222222222222222334568999999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=261.92 Aligned_cols=199 Identities=24% Similarity=0.406 Sum_probs=159.0
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC-CCEecCCCCCcE
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILS---RGGRYLEEDAKTIVEKILNIVAFCHLQ-GVVHRDLKPENF 72 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~~-~i~Hrdlkp~Ni 72 (389)
+.||||++++ ..+.+|+||||++ |+|.+++.. ....+++..+..++.||+.||.|||++ +++||||||+||
T Consensus 57 ~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~ni 135 (283)
T cd06617 57 VDCPYTVTFYGALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNV 135 (283)
T ss_pred cCCCCeeeeeEEEecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHE
Confidence 3699999988 3578999999997 578776643 235689999999999999999999997 999999999999
Q ss_pred EEeecCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc-----ccCCCchhHHHHHHHHHHHHhCCCCCCCC-C
Q 016471 73 LFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-----RSYNVEGDMWSIGVITYILLCGSRPFWAR-T 146 (389)
Q Consensus 73 ll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~DiwslG~il~~ll~g~~pf~~~-~ 146 (389)
++ +.++.+||+|||++.............|+..|+|||.+. ..++.++|+||+||++|+|++|+.||... .
T Consensus 136 l~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 212 (283)
T cd06617 136 LI---NRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT 212 (283)
T ss_pred EE---CCCCCEEEeecccccccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc
Confidence 99 567899999999987654333333456889999999874 24688999999999999999999999653 2
Q ss_pred hhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCCC
Q 016471 147 ESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENR 205 (389)
Q Consensus 147 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~~ 205 (389)
..+....+..... +..+...+|.++.++|.+||..+|.+|||+.+++.||||.....
T Consensus 213 ~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 269 (283)
T cd06617 213 PFQQLKQVVEEPS--PQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLS 269 (283)
T ss_pred CHHHHHHHHhcCC--CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhccc
Confidence 2233333333211 11122357899999999999999999999999999999987653
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=266.70 Aligned_cols=200 Identities=21% Similarity=0.325 Sum_probs=156.5
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEe
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 75 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~ 75 (389)
+.||||+.++ ..+..|++||||++|+|.+++... ...+++..+..++.|++.||+|||++||+||||||+||+++
T Consensus 56 l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~ 135 (314)
T cd08216 56 LQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLS 135 (314)
T ss_pred cCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEe
Confidence 5799999987 457899999999999999988753 34689999999999999999999999999999999999994
Q ss_pred ecCCCCCEEEeecCCccccCCCC--------CcccccccCCccccccccc---cCCCchhHHHHHHHHHHHHhCCCCCCC
Q 016471 76 TREEDAPLKVIDFGLSDFVRPDQ--------RLNDIVGSAYYVAPEVLHR---SYNVEGDMWSIGVITYILLCGSRPFWA 144 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~ 144 (389)
.++.+||+|||.+....... ......++..|+|||++.. .++.++|+||+||++|+|++|..||..
T Consensus 136 ---~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~ 212 (314)
T cd08216 136 ---GDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKD 212 (314)
T ss_pred ---cCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 57889999999886543211 1223457788999998853 488999999999999999999999977
Q ss_pred CChhHHH-HHHHhcCCC------CC-----------------------CCCCCCCCHHHHHHHHhhhccCcCCCCCHHHH
Q 016471 145 RTESGIF-RSVLRADPN------FH-----------------------DSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQA 194 (389)
Q Consensus 145 ~~~~~~~-~~i~~~~~~------~~-----------------------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~ 194 (389)
....... ..+....+. .+ ......++.++.+++.+||..+|++|||+.++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~l 292 (314)
T cd08216 213 MPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQL 292 (314)
T ss_pred CCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHH
Confidence 5543332 222111000 00 00001235788999999999999999999999
Q ss_pred hCCCCCCCC
Q 016471 195 LTHPWLHDE 203 (389)
Q Consensus 195 l~h~~~~~~ 203 (389)
++||||+..
T Consensus 293 l~~p~~~~~ 301 (314)
T cd08216 293 LNHSFFKQC 301 (314)
T ss_pred hcCchHhhh
Confidence 999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=262.50 Aligned_cols=196 Identities=24% Similarity=0.443 Sum_probs=158.4
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ .....|+||||++++.|..... ..+.+++..+..++.||+.||.|||+.|++||||+|+||++
T Consensus 57 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~-- 133 (286)
T cd07846 57 LRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEK-YPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILV-- 133 (286)
T ss_pred cCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE--
Confidence 5799999888 4578999999999988876544 33569999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC-CcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRS 153 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 153 (389)
+.++.++|+|||++....... ......++..|+|||++.+ .++.++||||+||++|+|++|++||.+.........
T Consensus 134 -~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~ 212 (286)
T cd07846 134 -SQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYH 212 (286)
T ss_pred -CCCCcEEEEeeeeeeeccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHH
Confidence 567899999999987654332 2334568899999998753 477899999999999999999999987665444433
Q ss_pred HHhcCCCC-------------------CC--------CCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCC
Q 016471 154 VLRADPNF-------------------HD--------SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 154 i~~~~~~~-------------------~~--------~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~ 200 (389)
+....... +. ..++.++..+.+++.+||..+|.+||++.+++.||||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 213 IIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred HHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 33211110 00 0134678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=267.86 Aligned_cols=201 Identities=26% Similarity=0.397 Sum_probs=163.2
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||+.++ ....+|+||||+. |+|.+++... ..+++..+..++.|++.||+|||++|++||||+|+||++
T Consensus 77 l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill-- 152 (335)
T PTZ00024 77 IKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRK-IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFI-- 152 (335)
T ss_pred CCCcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEE--
Confidence 5799999988 3578999999997 5898877654 679999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCC---------------CCCcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCC
Q 016471 77 REEDAPLKVIDFGLSDFVRP---------------DQRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGS 139 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~---------------~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~ 139 (389)
+.++.++|+|||.+..... ........+++.|+|||.+.+ .++.++|+||+||++|+|++|.
T Consensus 153 -~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~ 231 (335)
T PTZ00024 153 -NSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231 (335)
T ss_pred -CCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 5678899999999876541 111223456889999998753 4789999999999999999999
Q ss_pred CCCCCCChhHHHHHHHhcCCCCCCC------------------------CCCCCCHHHHHHHHhhhccCcCCCCCHHHHh
Q 016471 140 RPFWARTESGIFRSVLRADPNFHDS------------------------PWPSVSPEAKDFVRRLLNKDHRKRMTAAQAL 195 (389)
Q Consensus 140 ~pf~~~~~~~~~~~i~~~~~~~~~~------------------------~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l 195 (389)
+||.+.+..+.+..+.......... ..+..+..+.++|.+||..+|.+|||+++++
T Consensus 232 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l 311 (335)
T PTZ00024 232 PLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEAL 311 (335)
T ss_pred CCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHh
Confidence 9998887776665554422111111 0124578899999999999999999999999
Q ss_pred CCCCCCCCCCC
Q 016471 196 THPWLHDENRP 206 (389)
Q Consensus 196 ~h~~~~~~~~~ 206 (389)
.||||+....+
T Consensus 312 ~~~~~~~~~~~ 322 (335)
T PTZ00024 312 KHEYFKSDPLP 322 (335)
T ss_pred cCcccCCCCCC
Confidence 99999877544
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=259.94 Aligned_cols=195 Identities=23% Similarity=0.377 Sum_probs=162.5
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.|||++.++ .....|+|||||. |+|.+.+....+.+++.++..++.||+.||.|||++|++||||+|+||++
T Consensus 78 l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili-- 154 (313)
T cd06633 78 LKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL-- 154 (313)
T ss_pred CCCCCCccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEE--
Confidence 5799999988 4577999999996 47888777666779999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc----ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH----RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFR 152 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 152 (389)
+.++.+||+|||++.... ......|+..|+|||++. +.++.++|+||+||++|+|++|..||..........
T Consensus 155 -~~~~~~kL~dfg~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~ 230 (313)
T cd06633 155 -TEPGQVKLADFGSASKSS---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY 230 (313)
T ss_pred -CCCCCEEEeecCCCcccC---CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 467889999999886532 223457899999999873 357889999999999999999999998876655555
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 153 SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 153 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
.+..... +....+.++..+++++.+||..+|.+||++.+++.||||....
T Consensus 231 ~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~ 280 (313)
T cd06633 231 HIAQNDS--PTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDR 280 (313)
T ss_pred HHHhcCC--CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 5543322 2222345778899999999999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=260.92 Aligned_cols=201 Identities=30% Similarity=0.561 Sum_probs=165.9
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||+.++ ..+..|+||||+++++|.+++. . +.+++..+..++.|++.||+|||++|++||||+|+||++
T Consensus 74 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv-- 149 (292)
T cd06657 74 YQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT-H-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILL-- 149 (292)
T ss_pred cCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHh-c-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE--
Confidence 5799999988 4688999999999999988653 3 468999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC-CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
+.++.++|+|||++....... ......|++.|+|||.+. ..++.++|+||+|+++|+|++|..||.+.........+
T Consensus 150 -~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~ 228 (292)
T cd06657 150 -THDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 228 (292)
T ss_pred -CCCCCEEEcccccceecccccccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 567889999999887554322 223356889999999875 45789999999999999999999999887766655555
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPV 207 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~~~~ 207 (389)
....+.. ......+++.+.+++.+||..+|.+||++.+++.||||.....+.
T Consensus 229 ~~~~~~~-~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~~~ 280 (292)
T cd06657 229 RDNLPPK-LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPS 280 (292)
T ss_pred HhhCCcc-cCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCCCc
Confidence 4332221 112245789999999999999999999999999999998776443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=255.79 Aligned_cols=190 Identities=16% Similarity=0.270 Sum_probs=157.7
Q ss_pred CCCcccccee---ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 1 MYHQKLQHLF---YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 1 l~Hpni~~~~---~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
|.||||++++ .....++||||++||+|.+++..+.+.+++..+..++.|++.||.|||++|++||||||+||++
T Consensus 52 l~h~~ii~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~--- 128 (257)
T cd05115 52 LDNPYIVRMIGVCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLL--- 128 (257)
T ss_pred cCCCCeEEEEEEEcCCCeEEEEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEE---
Confidence 5799999998 3467899999999999999887666789999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCCccccCCCCC----cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 016471 78 EEDAPLKVIDFGLSDFVRPDQR----LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIF 151 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~ 151 (389)
+.++.+||+|||++........ .....+++.|+|||.+. ..++.++|+|||||++|++++ |..||.+.......
T Consensus 129 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~ 208 (257)
T cd05115 129 VNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM 208 (257)
T ss_pred cCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHH
Confidence 4678899999999876543221 11122356899999875 468899999999999999996 99999888877776
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 152 RSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 152 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
..+.++.... ..+..++++.+++.+||..+|++||++.++.+
T Consensus 209 ~~~~~~~~~~---~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 209 SFIEQGKRLD---CPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred HHHHCCCCCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 6665543221 12457899999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=284.70 Aligned_cols=187 Identities=26% Similarity=0.428 Sum_probs=156.1
Q ss_pred Cccccceee-----------cCeEEEEEEccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--CEecCCC
Q 016471 3 HQKLQHLFY-----------SNSFLFFTRFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQG--VVHRDLK 68 (389)
Q Consensus 3 Hpni~~~~~-----------~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~--i~Hrdlk 68 (389)
|||||.|++ .-.++|.||||.||.|.|++.++ ..+|+|.+|+.|+.|+++|+.+||... |||||||
T Consensus 94 h~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLK 173 (738)
T KOG1989|consen 94 HKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLK 173 (738)
T ss_pred CCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhh
Confidence 999999995 23589999999999999999743 246999999999999999999999997 9999999
Q ss_pred CCcEEEeecCCCCCEEEeecCCccccCCCCCc----------ccccccCCcccccccc----ccCCCchhHHHHHHHHHH
Q 016471 69 PENFLFTTREEDAPLKVIDFGLSDFVRPDQRL----------NDIVGSAYYVAPEVLH----RSYNVEGDMWSIGVITYI 134 (389)
Q Consensus 69 p~Nill~~~~~~~~~kl~Dfg~a~~~~~~~~~----------~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ 134 (389)
-+|||| ..++.+||||||-|+..-..... -...-|+.|+|||++. ...+.|+|||+|||+||-
T Consensus 174 iENvLl---s~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYk 250 (738)
T KOG1989|consen 174 IENVLL---SADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYK 250 (738)
T ss_pred hhheEE---cCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHH
Confidence 999999 47789999999988654322211 1134689999999883 258999999999999999
Q ss_pred HHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCC
Q 016471 135 LLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHP 198 (389)
Q Consensus 135 ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~ 198 (389)
|.....||...... .|+.+.+.+|.. |.++..+++||+.||+.||.+||++.+++.+-
T Consensus 251 LCy~t~PFe~sg~l----aIlng~Y~~P~~--p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~ 308 (738)
T KOG1989|consen 251 LCYFTTPFEESGKL----AILNGNYSFPPF--PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEI 308 (738)
T ss_pred HHHhCCCcCcCcce----eEEeccccCCCC--ccHHHHHHHHHHHHhccCcccCCCHHHHHHHH
Confidence 99999999776543 455566555543 78999999999999999999999999888653
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=255.97 Aligned_cols=191 Identities=23% Similarity=0.369 Sum_probs=159.1
Q ss_pred CCCccccceee----cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLFY----SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~~----~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++. ...+|+||||+++|+|.+++......+++..+..++.||+.||.|||++|++|+||||+||++
T Consensus 56 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili-- 133 (256)
T cd05113 56 LSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLV-- 133 (256)
T ss_pred CCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE--
Confidence 57999999982 456899999999999999887655679999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCC--cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQR--LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFR 152 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 152 (389)
+.++.+||+|||.+........ .....++..|+|||.+. ..++.++|+||+||++|+|++ |..||..........
T Consensus 134 -~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~ 212 (256)
T cd05113 134 -DDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVE 212 (256)
T ss_pred -cCCCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHH
Confidence 4678899999999876543221 11233566799999885 468899999999999999998 999998877777777
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCC
Q 016471 153 SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 197 (389)
Q Consensus 153 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h 197 (389)
.+.+....... ...+..+++++.+||..+|.+|||+.+++.+
T Consensus 213 ~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 213 KVSQGLRLYRP---HLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHhcCCCCCCC---CCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 77655433222 2468999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=259.18 Aligned_cols=201 Identities=28% Similarity=0.512 Sum_probs=158.5
Q ss_pred CCCccccceee------cCeEEEEEEccCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCc
Q 016471 1 MYHQKLQHLFY------SNSFLFFTRFCEGGELLDRILS---RGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPEN 71 (389)
Q Consensus 1 l~Hpni~~~~~------~~~~~lv~E~~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~N 71 (389)
+.||||+.++. .+.+|+|||||+||+|.+++.. ....+++..+..++.||+.||.|||+.|++|+||+|+|
T Consensus 56 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~n 135 (287)
T cd06621 56 CKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSN 135 (287)
T ss_pred CCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHH
Confidence 58999999872 2468999999999999887642 34568999999999999999999999999999999999
Q ss_pred EEEeecCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC----
Q 016471 72 FLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWART---- 146 (389)
Q Consensus 72 ill~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~---- 146 (389)
|++ +.++.++|+|||++....... .....++..|+|||.+. ..++.++|+||+||++|+|++|..||....
T Consensus 136 il~---~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~ 211 (287)
T cd06621 136 ILL---TRKGQVKLCDFGVSGELVNSL-AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPL 211 (287)
T ss_pred EEE---ecCCeEEEeeccccccccccc-cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCC
Confidence 999 467789999999987553322 12346788999999875 468999999999999999999999997652
Q ss_pred -hhHHHHHHHhcCCC-CCCCCC--CCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCCC
Q 016471 147 -ESGIFRSVLRADPN-FHDSPW--PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENR 205 (389)
Q Consensus 147 -~~~~~~~i~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~~ 205 (389)
..+....+...... .+.... ..+++.+.+++.+||..+|.+|||+.|++.||||.....
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~ 274 (287)
T cd06621 212 GPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMK 274 (287)
T ss_pred ChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccccc
Confidence 23333333332111 111110 135678999999999999999999999999999966543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=255.48 Aligned_cols=185 Identities=24% Similarity=0.348 Sum_probs=152.2
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
.||||+.++ ..+.+|+||||++||+|.+++.+. +.+++..+..++.|++.||.|||++|++||||||+||++
T Consensus 43 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~--- 118 (237)
T cd05576 43 CVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF-LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILL--- 118 (237)
T ss_pred CCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---
Confidence 589999988 357899999999999999988765 569999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCCccccCCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 016471 78 EEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLR 156 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 156 (389)
+.++.++++|||.+...... .....++..|+|||.+. ..++.++|+||+|+++|+|++|..|+...... + .
T Consensus 119 ~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~-~ 190 (237)
T cd05576 119 DDRGHIQLTYFSRWSEVEDS--CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----I-N 190 (237)
T ss_pred cCCCCEEEecccchhccccc--cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----c-c
Confidence 56788999999987655432 23445677899999885 46889999999999999999999987543221 0 0
Q ss_pred cCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCH-----HHHhCCCCC
Q 016471 157 ADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTA-----AQALTHPWL 200 (389)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~-----~e~l~h~~~ 200 (389)
....... .+.+++.++++|.+||+.||++||++ +++++||||
T Consensus 191 ~~~~~~~--~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 191 THTTLNI--PEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred cccccCC--cccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 0011111 13478999999999999999999986 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=255.48 Aligned_cols=189 Identities=19% Similarity=0.294 Sum_probs=156.6
Q ss_pred CCCcccccee---ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 1 MYHQKLQHLF---YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 1 l~Hpni~~~~---~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
+.||||++++ ..+..++||||+++|+|.+++... +.+++..+..++.|++.||+|||++||+||||||+||++
T Consensus 53 l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill--- 128 (257)
T cd05116 53 LDNPYIVRMIGICEAESWMLVMELAELGPLNKFLQKN-KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLL--- 128 (257)
T ss_pred CCCCCcceEEEEEcCCCcEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEE---
Confidence 5799999998 356789999999999999988654 579999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCCccccCCCCC----cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 016471 78 EEDAPLKVIDFGLSDFVRPDQR----LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIF 151 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~ 151 (389)
+.++.+||+|||++........ .....+++.|+|||.+. ..++.++|+||+||++|+|++ |..||.+.......
T Consensus 129 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~ 208 (257)
T cd05116 129 VTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVT 208 (257)
T ss_pred cCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 4678899999999876543321 11223457899999875 468889999999999999998 99999887777776
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 152 RSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 152 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
..+.+... .+ ..+.+++++.++|.+||+.+|++||+++++..
T Consensus 209 ~~i~~~~~-~~--~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 209 QMIESGER-ME--CPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred HHHHCCCC-CC--CCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 66655432 11 12458999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=258.80 Aligned_cols=201 Identities=25% Similarity=0.443 Sum_probs=165.3
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ .+..+|+|||||+||+|.+++.. +.+++..+..++.|++.|+.|||++|++|+||+|+||++
T Consensus 59 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i-- 134 (277)
T cd06641 59 CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL-- 134 (277)
T ss_pred cCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEE--
Confidence 5799999998 45789999999999999987753 468999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC-CcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
++++.++|+|||++....... ......++..|+|||.+.. ..+.++|+||+||++|+|++|..||...........+
T Consensus 135 -~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 213 (277)
T cd06641 135 -SEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLI 213 (277)
T ss_pred -CCCCCEEEeecccceecccchhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHH
Confidence 467889999999987654322 2233568889999998753 5788999999999999999999999876665555544
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCCCCCCc
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPL 209 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~~~~~~ 209 (389)
..... ......++..+.+++.+||..+|.+||++.++++||||.......+.
T Consensus 214 ~~~~~---~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~~~~~~~ 265 (277)
T cd06641 214 PKNNP---PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFAKKTSY 265 (277)
T ss_pred hcCCC---CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhhhhccch
Confidence 33221 11123578999999999999999999999999999999876544433
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=259.42 Aligned_cols=194 Identities=17% Similarity=0.260 Sum_probs=157.3
Q ss_pred CCCccccceee----cCeEEEEEEccCCCChHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCC
Q 016471 1 MYHQKLQHLFY----SNSFLFFTRFCEGGELLDRILSRG------GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPE 70 (389)
Q Consensus 1 l~Hpni~~~~~----~~~~~lv~E~~~gg~L~~~l~~~~------~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~ 70 (389)
+.||||++++. ....|+||||+.||+|.+++.... ..+++..+..++.||+.||+|||++|++||||||+
T Consensus 66 l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~ 145 (277)
T cd05036 66 FNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAAR 145 (277)
T ss_pred CCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchh
Confidence 57999999983 467899999999999999886543 25889999999999999999999999999999999
Q ss_pred cEEEeecCCCCCEEEeecCCccccCCCCC---cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCC
Q 016471 71 NFLFTTREEDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWAR 145 (389)
Q Consensus 71 Nill~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~ 145 (389)
||+++..+....+||+|||++........ .....++..|+|||++. ..++.++||||+||++|+|++ |..||.+.
T Consensus 146 nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~ 225 (277)
T cd05036 146 NCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGR 225 (277)
T ss_pred eEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 99997544455799999999886532211 11223356799999875 569999999999999999997 99999887
Q ss_pred ChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCC
Q 016471 146 TESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 197 (389)
Q Consensus 146 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h 197 (389)
+.......+...... . ..+.+++.+.+++.+||..+|++|||+.++++|
T Consensus 226 ~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 226 TNQEVMEFVTGGGRL-D--PPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CHHHHHHHHHcCCcC-C--CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 777766655443221 1 124578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=271.47 Aligned_cols=190 Identities=24% Similarity=0.378 Sum_probs=152.2
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcC------------------------------------------
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG------------------------------------------ 35 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~------------------------------------------ 35 (389)
+||||++++ .....|+|||||+||+|.+++..+.
T Consensus 97 ~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 176 (375)
T cd05104 97 NHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVS 176 (375)
T ss_pred CCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcc
Confidence 799999998 3577999999999999999886532
Q ss_pred --------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeecCCCCCE
Q 016471 36 --------------------------------GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPL 83 (389)
Q Consensus 36 --------------------------------~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~~~~~~~ 83 (389)
..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~---~~~~~ 253 (375)
T cd05104 177 YVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLT---HGRIT 253 (375)
T ss_pred cccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEE---CCCcE
Confidence 1477888999999999999999999999999999999994 57789
Q ss_pred EEeecCCccccCCCCC---cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcC
Q 016471 84 KVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRAD 158 (389)
Q Consensus 84 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~ 158 (389)
||+|||++........ .....++..|+|||++. ..++.++||||+||++|+|++ |..||.+..............
T Consensus 254 kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~ 333 (375)
T cd05104 254 KICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEG 333 (375)
T ss_pred EEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhC
Confidence 9999999876543321 11233556799999885 468999999999999999998 899997765444433333332
Q ss_pred CCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 159 PNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 159 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
..... ....+.++++++.+||..+|.+|||+.++++
T Consensus 334 ~~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 369 (375)
T cd05104 334 YRMLS--PECAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369 (375)
T ss_pred ccCCC--CCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 22111 1346789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=260.23 Aligned_cols=196 Identities=29% Similarity=0.531 Sum_probs=158.8
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEE
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG--GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLF 74 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill 74 (389)
+.||||++++ ..+..++||||++| +|.+++.... ..+++..+..++.|++.||.|||++|++||||+|+||++
T Consensus 55 l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~ 133 (284)
T cd07836 55 LKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLI 133 (284)
T ss_pred hcCCCEeeeeeeEeeCCcEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE
Confidence 5799999998 35779999999986 8888876543 468999999999999999999999999999999999999
Q ss_pred eecCCCCCEEEeecCCccccCCCC-CcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHH
Q 016471 75 TTREEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIF 151 (389)
Q Consensus 75 ~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 151 (389)
++++.++|+|||++....... ......+++.|+|||.+.+ .++.++|+||+||++|++++|+.||.+.+..+..
T Consensus 134 ---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~ 210 (284)
T cd07836 134 ---NKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQL 210 (284)
T ss_pred ---CCCCcEEEeecchhhhhcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence 567889999999987553322 2234567889999998743 4788999999999999999999999887766655
Q ss_pred HHHHhcCCCCCCC-------------------------CCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCC
Q 016471 152 RSVLRADPNFHDS-------------------------PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 152 ~~i~~~~~~~~~~-------------------------~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~ 200 (389)
..+.......... ..+.+++.+++++.+||+.+|.+||++.++++||||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 211 LKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred HHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 5443321100000 013467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=255.78 Aligned_cols=191 Identities=25% Similarity=0.455 Sum_probs=160.9
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEe
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 75 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~ 75 (389)
+.||||+.++ ....+|+||||+++|+|.+++... ...++++.+..++.|++.||.|||++||+|+||||+||++
T Consensus 55 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili- 133 (255)
T cd08219 55 MKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFL- 133 (255)
T ss_pred CCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEE-
Confidence 5799999988 467899999999999999988653 3468999999999999999999999999999999999999
Q ss_pred ecCCCCCEEEeecCCccccCCCC-CcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016471 76 TREEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRS 153 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 153 (389)
+.++.++++|||.+....... ......|++.|+|||++.+ .++.++|+||+|+++|+|++|..||...+.......
T Consensus 134 --~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~ 211 (255)
T cd08219 134 --TQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILK 211 (255)
T ss_pred --CCCCcEEEcccCcceeecccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHH
Confidence 567889999999987664322 2234578899999999854 588999999999999999999999988877766666
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCC
Q 016471 154 VLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 197 (389)
Q Consensus 154 i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h 197 (389)
+........ ...++..++++|.+||..+|.+|||+.+++.-
T Consensus 212 ~~~~~~~~~---~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 212 VCQGSYKPL---PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HhcCCCCCC---CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 655433221 13578899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=257.90 Aligned_cols=190 Identities=18% Similarity=0.317 Sum_probs=156.6
Q ss_pred CCCcccccee---ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 1 MYHQKLQHLF---YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 1 l~Hpni~~~~---~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
+.||||++++ .....++|+||+++|+|.+++..+.+.+++..+..++.||+.||.|||++|++||||||+||++
T Consensus 66 l~h~~iv~~~~~~~~~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili--- 142 (279)
T cd05111 66 LDHAYIVRLLGICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILL--- 142 (279)
T ss_pred CCCCCcceEEEEECCCccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE---
Confidence 4799999998 3466889999999999999998766789999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCCccccCCCCC---cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHH
Q 016471 78 EEDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFR 152 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 152 (389)
+.++.+||+|||++........ .....++..|+|||.+. +.++.++|+||+||++|++++ |..||.+........
T Consensus 143 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~ 222 (279)
T cd05111 143 KSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPD 222 (279)
T ss_pred cCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 5678899999999976543321 22345677899999875 568999999999999999998 999998876655444
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 153 SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 153 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
.+..+. ..+.+ ...+.++.+++.+||..+|.+|||+.++++
T Consensus 223 ~~~~~~-~~~~~--~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 223 LLEKGE-RLAQP--QICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred HHHCCC-cCCCC--CCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 443322 22211 235788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=259.28 Aligned_cols=196 Identities=27% Similarity=0.432 Sum_probs=157.9
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEe
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 75 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~ 75 (389)
+.||||++++ .....|+||||+. ++|.+++.... ..+++..+..++.|++.||+|||++|++||||+|+||++
T Consensus 55 l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~- 132 (283)
T cd07835 55 LNHPNIVRLLDVVHSENKLYLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLI- 132 (283)
T ss_pred cCCCCccCHhheeccCCeEEEEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE-
Confidence 4799999887 4578999999995 58998876553 368999999999999999999999999999999999999
Q ss_pred ecCCCCCEEEeecCCccccCCCC-CcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 016471 76 TREEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFR 152 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 152 (389)
+.++.++|+|||++....... ......+++.|+|||++.+ .++.++|+||+|+++|+|++|++||.+.+......
T Consensus 133 --~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 210 (283)
T cd07835 133 --DREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLF 210 (283)
T ss_pred --cCCCcEEEeecccccccCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 457899999999987553222 2233457889999998743 46889999999999999999999998776654444
Q ss_pred HHHhcCCCC-------------------------CCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCC
Q 016471 153 SVLRADPNF-------------------------HDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 153 ~i~~~~~~~-------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~ 200 (389)
.+.+..... .....+.++..+.++|.+||..+|.+|||+.+++.||||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 211 RIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred HHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 433221100 011124578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=255.26 Aligned_cols=195 Identities=24% Similarity=0.469 Sum_probs=161.9
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEe
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 75 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~ 75 (389)
+.||||++++ .....|+|+||+++++|.+++.... ..+++..+..++.|++.||.|||++|++|+||||+||+++
T Consensus 56 ~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~ 135 (257)
T cd08225 56 MKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLS 135 (257)
T ss_pred CCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEc
Confidence 4799999988 4578999999999999999887543 3589999999999999999999999999999999999995
Q ss_pred ecCCCCCEEEeecCCccccCCCCC-cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016471 76 TREEDAPLKVIDFGLSDFVRPDQR-LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRS 153 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 153 (389)
+++..+||+|||.+........ .....|++.|+|||++. ..++.++|+||+|+++|++++|..||...+..+....
T Consensus 136 --~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 213 (257)
T cd08225 136 --KNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLK 213 (257)
T ss_pred --CCCCeEEecccccchhccCCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence 2334579999999876644322 22346889999999875 4688999999999999999999999987776666655
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCC
Q 016471 154 VLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 154 i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~ 200 (389)
+...... ...+.++.+++++|.+||..+|.+|||+.+++.||||
T Consensus 214 ~~~~~~~---~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 214 ICQGYFA---PISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HhcccCC---CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 5443221 1224678999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=257.07 Aligned_cols=196 Identities=27% Similarity=0.494 Sum_probs=163.7
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCEecCCCCCcEEEe
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHL-QGVVHRDLKPENFLFT 75 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~-~~i~Hrdlkp~Nill~ 75 (389)
++||||++++ ....+++||||++|++|.+++... +.+++..+..++.|++.||.|||+ +|++||||+|+||++
T Consensus 56 l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~- 133 (264)
T cd06623 56 CESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLI- 133 (264)
T ss_pred cCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEE-
Confidence 5799999998 457899999999999999988765 679999999999999999999999 999999999999999
Q ss_pred ecCCCCCEEEeecCCccccCCCCCc-ccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC---hhHH
Q 016471 76 TREEDAPLKVIDFGLSDFVRPDQRL-NDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWART---ESGI 150 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~~~~~-~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~ 150 (389)
+.++.++|+|||.+......... ....++..|+|||.+. ..++.++|+||||+++|+|++|..||.... ..+.
T Consensus 134 --~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~ 211 (264)
T cd06623 134 --NSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFEL 211 (264)
T ss_pred --CCCCCEEEccCccceecccCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHH
Confidence 56889999999998876543322 2456889999999875 458889999999999999999999997763 3444
Q ss_pred HHHHHhcCCCCCCCCCCC-CCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCC
Q 016471 151 FRSVLRADPNFHDSPWPS-VSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 151 ~~~i~~~~~~~~~~~~~~-~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~ 203 (389)
...+..... +.. ... ++..+.++|.+||..+|.+|||+.++++|||++..
T Consensus 212 ~~~~~~~~~--~~~-~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 212 MQAICDGPP--PSL-PAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred HHHHhcCCC--CCC-CcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 444443221 111 123 78999999999999999999999999999999653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=259.31 Aligned_cols=190 Identities=18% Similarity=0.368 Sum_probs=158.4
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEe
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG------------GRYLEEDAKTIVEKILNIVAFCHLQGVVH 64 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~------------~~l~~~~~~~i~~qi~~~L~~lH~~~i~H 64 (389)
+.||||+.++ ....+|+||||+++|+|.+++.... ..+++..+..++.|++.||+|||++|++|
T Consensus 64 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H 143 (288)
T cd05093 64 LQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVH 143 (288)
T ss_pred CCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeee
Confidence 5799999998 3578999999999999999887542 24899999999999999999999999999
Q ss_pred cCCCCCcEEEeecCCCCCEEEeecCCccccCCCC---CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CC
Q 016471 65 RDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ---RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GS 139 (389)
Q Consensus 65 rdlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~ 139 (389)
|||||+||++ ++++.+||+|||++....... ......+++.|+|||++. ..++.++|+|||||++|+|++ |.
T Consensus 144 ~dlkp~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~ 220 (288)
T cd05093 144 RDLATRNCLV---GENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGK 220 (288)
T ss_pred cccCcceEEE---ccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 9999999999 567899999999987653322 112334577899999885 468899999999999999998 99
Q ss_pred CCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 140 RPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 140 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
+||.+.........+.+...... ...+++.+.+++.+||..+|.+|||+.+++.
T Consensus 221 ~p~~~~~~~~~~~~i~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 221 QPWYQLSNNEVIECITQGRVLQR---PRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred CCCCCCCHHHHHHHHHcCCcCCC---CCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 99988877777777766543211 1357899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=268.97 Aligned_cols=196 Identities=24% Similarity=0.407 Sum_probs=156.4
Q ss_pred CCCccccceee----------cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCC
Q 016471 1 MYHQKLQHLFY----------SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPE 70 (389)
Q Consensus 1 l~Hpni~~~~~----------~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~ 70 (389)
+.||||++++. ....|+|||||.+ +|.+.+.. .+++..+..++.|++.||+|||++||+||||||+
T Consensus 72 l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~ 147 (353)
T cd07850 72 VNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPS 147 (353)
T ss_pred cCCCCCcceeeeeccCCCccccCcEEEEEeccCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHH
Confidence 57999999872 1357999999975 88887643 3899999999999999999999999999999999
Q ss_pred cEEEeecCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhH
Q 016471 71 NFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESG 149 (389)
Q Consensus 71 Nill~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 149 (389)
||++ +.++.+||+|||++.............+++.|+|||.+. ..++.++||||+||++|+|++|+.||.+.+...
T Consensus 148 Nil~---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~ 224 (353)
T cd07850 148 NIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHID 224 (353)
T ss_pred HEEE---CCCCCEEEccCccceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHH
Confidence 9999 567899999999998765444444567899999999875 468999999999999999999999998776554
Q ss_pred HHHHHHhcCCCC----------------------C---------CCC--------CCCCCHHHHHHHHhhhccCcCCCCC
Q 016471 150 IFRSVLRADPNF----------------------H---------DSP--------WPSVSPEAKDFVRRLLNKDHRKRMT 190 (389)
Q Consensus 150 ~~~~i~~~~~~~----------------------~---------~~~--------~~~~~~~~~~li~~~l~~~p~~R~s 190 (389)
.+..+....... . ... ....++.++++|.+||..||++|||
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 304 (353)
T cd07850 225 QWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRIS 304 (353)
T ss_pred HHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcC
Confidence 444433211100 0 000 1124567899999999999999999
Q ss_pred HHHHhCCCCCCCC
Q 016471 191 AAQALTHPWLHDE 203 (389)
Q Consensus 191 ~~e~l~h~~~~~~ 203 (389)
+.++|.||||...
T Consensus 305 ~~eiL~~~~~~~~ 317 (353)
T cd07850 305 VDDALQHPYINVW 317 (353)
T ss_pred HHHHhcChhHhhc
Confidence 9999999988643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=258.27 Aligned_cols=196 Identities=22% Similarity=0.485 Sum_probs=161.1
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
.|||+++++ .+...|+||||++|++|.+++.. +.+++..+..++.|++.||.|||+.||+||||+|+||++
T Consensus 60 ~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i--- 134 (277)
T cd06917 60 QPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILV--- 134 (277)
T ss_pred CCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEE---
Confidence 499999977 45779999999999999987744 479999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCCccccCCCC-CcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 78 EEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
+.++.++|+|||++....... ......|+..|+|||.+.+ .++.++|+||+||++|+|++|..||.+.........+
T Consensus 135 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~ 214 (277)
T cd06917 135 TNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI 214 (277)
T ss_pred cCCCCEEEccCCceeecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcc
Confidence 467889999999987765433 2334578999999998753 4688999999999999999999999776554443332
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
... ..+......++.++.+++.+||..+|.+||++.+++.|+||+...
T Consensus 215 ~~~--~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 215 PKS--KPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred ccC--CCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 222 112222224788999999999999999999999999999997754
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=261.16 Aligned_cols=199 Identities=23% Similarity=0.386 Sum_probs=155.7
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHH---HHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CCEecCCCCCcE
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDR---ILS-RGGRYLEEDAKTIVEKILNIVAFCHLQ-GVVHRDLKPENF 72 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~---l~~-~~~~l~~~~~~~i~~qi~~~L~~lH~~-~i~Hrdlkp~Ni 72 (389)
.||||++++ .....+++|||+.+ ++.+. +.. ..+.+++..+..++.|++.||+|||+. |++||||||+||
T Consensus 61 ~~~~iv~~~~~~~~~~~~~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Ni 139 (288)
T cd06616 61 DCPYIVKFYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNI 139 (288)
T ss_pred CCCCEeeeeeEEecCCcEEEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHE
Confidence 499999987 35778999999875 54443 222 236799999999999999999999975 999999999999
Q ss_pred EEeecCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc----cCCCchhHHHHHHHHHHHHhCCCCCCCCCh-
Q 016471 73 LFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR----SYNVEGDMWSIGVITYILLCGSRPFWARTE- 147 (389)
Q Consensus 73 ll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~~ll~g~~pf~~~~~- 147 (389)
++ +.++.+||+|||++.............|++.|+|||++.+ .++.++|+||+||++|+|++|+.||.....
T Consensus 140 l~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~ 216 (288)
T cd06616 140 LL---DRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV 216 (288)
T ss_pred EE---ccCCcEEEeecchhHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchH
Confidence 99 4678899999999876544333344578999999998853 488999999999999999999999976542
Q ss_pred hHHHHHHHhcC-CCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 148 SGIFRSVLRAD-PNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 148 ~~~~~~i~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
.+....+.... +..+......++..+.+|+.+||..+|.+|||+++++.||||+...
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~ 274 (288)
T cd06616 217 FDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE 274 (288)
T ss_pred HHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence 12222222221 2222222245889999999999999999999999999999997643
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=267.89 Aligned_cols=198 Identities=26% Similarity=0.422 Sum_probs=158.5
Q ss_pred CCCccccceee---------cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCc
Q 016471 1 MYHQKLQHLFY---------SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPEN 71 (389)
Q Consensus 1 l~Hpni~~~~~---------~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~N 71 (389)
+.||||++++. ...+|+||||+. ++|.+++... +.+++..+..++.|++.||.|||++|++||||||+|
T Consensus 61 l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~N 138 (337)
T cd07858 61 LDHENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSN 138 (337)
T ss_pred cCCCCccchHHheecccccccCcEEEEEeCCC-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHH
Confidence 47999999872 135899999996 5888877554 689999999999999999999999999999999999
Q ss_pred EEEeecCCCCCEEEeecCCccccCCC-CCcccccccCCcccccccc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCChh
Q 016471 72 FLFTTREEDAPLKVIDFGLSDFVRPD-QRLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILLCGSRPFWARTES 148 (389)
Q Consensus 72 ill~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 148 (389)
|++ +.++.+||+|||++...... .......++..|+|||.+. ..++.++|+||+||++|+|++|++||.+.+..
T Consensus 139 il~---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 215 (337)
T cd07858 139 LLL---NANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV 215 (337)
T ss_pred EEE---cCCCCEEECcCccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH
Confidence 999 46788999999998766433 2233456889999999874 35889999999999999999999999776543
Q ss_pred HHHHHHHhcC-----------------------CCCC----CCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCC
Q 016471 149 GIFRSVLRAD-----------------------PNFH----DSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLH 201 (389)
Q Consensus 149 ~~~~~i~~~~-----------------------~~~~----~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~ 201 (389)
.....+.... +..+ ...++.+++.+.++|.+||..+|.+|||++++++||||.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~ 295 (337)
T cd07858 216 HQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLA 295 (337)
T ss_pred HHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchh
Confidence 3332222110 0000 011346889999999999999999999999999999997
Q ss_pred CC
Q 016471 202 DE 203 (389)
Q Consensus 202 ~~ 203 (389)
..
T Consensus 296 ~~ 297 (337)
T cd07858 296 SL 297 (337)
T ss_pred hh
Confidence 64
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=259.64 Aligned_cols=196 Identities=26% Similarity=0.442 Sum_probs=153.4
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|.||||+.++ .....|+||||+. ++|.+.+....+.+++..+..++.||+.||.|||++||+||||||+||++
T Consensus 60 l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~-- 136 (291)
T cd07870 60 LKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLI-- 136 (291)
T ss_pred cCCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE--
Confidence 5799999888 3567999999996 68878776655678899999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCC-CCcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChh-HHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPD-QRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTES-GIFR 152 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~ 152 (389)
+.++.+||+|||++...... .......+++.|+|||.+.+ .++.++|+||+||++|+|++|..||.+.... +.+.
T Consensus 137 -~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~ 215 (291)
T cd07870 137 -SYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLE 215 (291)
T ss_pred -cCCCcEEEeccccccccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHH
Confidence 46788999999998754322 22234567899999998753 4788999999999999999999999765432 2222
Q ss_pred HHHhcCC--------------CCCCC------------CCC--CCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCC
Q 016471 153 SVLRADP--------------NFHDS------------PWP--SVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 153 ~i~~~~~--------------~~~~~------------~~~--~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~ 200 (389)
.+....+ .+... .+. ..++.+.+++.+||..||.+|||+.+++.||||
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 216 KIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred HHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 2211000 00000 011 125789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=254.75 Aligned_cols=191 Identities=22% Similarity=0.341 Sum_probs=162.0
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCC
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSR--------GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLK 68 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~--------~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlk 68 (389)
+.||||++++ ....+++||||++||+|.+++... ...+++..+..++.|++.||.|||++|++||||+
T Consensus 53 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~ 132 (262)
T cd00192 53 LGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLA 132 (262)
T ss_pred cCCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccC
Confidence 4699999988 357799999999999999988765 4779999999999999999999999999999999
Q ss_pred CCcEEEeecCCCCCEEEeecCCccccCCCC---CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCC
Q 016471 69 PENFLFTTREEDAPLKVIDFGLSDFVRPDQ---RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFW 143 (389)
Q Consensus 69 p~Nill~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~ 143 (389)
|+||++ +.++.+||+|||.+....... ......+++.|+|||.+. ..++.++|+||+||++|+|++ |..||.
T Consensus 133 p~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~ 209 (262)
T cd00192 133 ARNCLV---GEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYP 209 (262)
T ss_pred cceEEE---CCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCC
Confidence 999999 567899999999998765432 233456788999999875 468899999999999999999 699998
Q ss_pred CCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCC
Q 016471 144 ARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 197 (389)
Q Consensus 144 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h 197 (389)
..........+..... .. ....+++++.+++.+||..+|.+|||+.+++.+
T Consensus 210 ~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 210 GLSNEEVLEYLRKGYR-LP--KPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred CCCHHHHHHHHHcCCC-CC--CCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 8887777777665321 11 124578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=257.58 Aligned_cols=190 Identities=21% Similarity=0.356 Sum_probs=158.9
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCCE
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG-------------GRYLEEDAKTIVEKILNIVAFCHLQGVV 63 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~-------------~~l~~~~~~~i~~qi~~~L~~lH~~~i~ 63 (389)
+.||||++++ .....|+||||++||+|.+++...+ ..+++..+..++.|++.||.|||++|++
T Consensus 65 l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~ 144 (280)
T cd05049 65 FQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFV 144 (280)
T ss_pred cCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCee
Confidence 5799999998 4578999999999999999986542 3478899999999999999999999999
Q ss_pred ecCCCCCcEEEeecCCCCCEEEeecCCccccCCCC---CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-C
Q 016471 64 HRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ---RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-G 138 (389)
Q Consensus 64 Hrdlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g 138 (389)
||||||+||++ +.++.+||+|||++....... ......+++.|+|||++. ..++.++||||+||++|+|++ |
T Consensus 145 h~dlkp~nili---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g 221 (280)
T cd05049 145 HRDLATRNCLV---GYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYG 221 (280)
T ss_pred ccccccceEEE---cCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcC
Confidence 99999999999 467899999999987543221 112334678899999885 468999999999999999998 9
Q ss_pred CCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 139 SRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 139 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
..||.+....+....+........ ...++..+++++.+||..+|.+||++.++++
T Consensus 222 ~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 222 KQPWYGLSNEEVIECITQGRLLQR---PRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CCCCCCCCHHHHHHHHHcCCcCCC---CCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 999988887777777765443222 2457899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=280.11 Aligned_cols=200 Identities=21% Similarity=0.286 Sum_probs=151.8
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcE
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG----GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENF 72 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Ni 72 (389)
|.||||++++ ..+..|+|+|++.+ +|.+++.... .......++.++.||+.||+|||++||+||||||+||
T Consensus 220 l~HpnIv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NI 298 (501)
T PHA03210 220 LNHENILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENI 298 (501)
T ss_pred CCCCCcCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 5899999998 46789999999964 7888775431 2345677889999999999999999999999999999
Q ss_pred EEeecCCCCCEEEeecCCccccCCCC--CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCC-C--C
Q 016471 73 LFTTREEDAPLKVIDFGLSDFVRPDQ--RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWA-R--T 146 (389)
Q Consensus 73 ll~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~-~--~ 146 (389)
|+ +.++.+||+|||++....... .....+||+.|+|||++. ..++.++||||+||++|+|++|..|+.+ . .
T Consensus 299 Ll---~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~ 375 (501)
T PHA03210 299 FL---NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGK 375 (501)
T ss_pred EE---CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCC
Confidence 99 567889999999998764332 223467999999999985 4689999999999999999998765433 2 1
Q ss_pred hhHHHHHHHhcCC----CCCCC------------------------CCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCC
Q 016471 147 ESGIFRSVLRADP----NFHDS------------------------PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHP 198 (389)
Q Consensus 147 ~~~~~~~i~~~~~----~~~~~------------------------~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~ 198 (389)
....+..+..... .++.. ....++.++.++|.+||.+||.+|||+.|+|.||
T Consensus 376 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp 455 (501)
T PHA03210 376 PGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALP 455 (501)
T ss_pred HHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhCh
Confidence 2222222221110 00000 0013567888999999999999999999999999
Q ss_pred CCCCCC
Q 016471 199 WLHDEN 204 (389)
Q Consensus 199 ~~~~~~ 204 (389)
||....
T Consensus 456 ~f~~~~ 461 (501)
T PHA03210 456 LFSAEE 461 (501)
T ss_pred hhhcCC
Confidence 997653
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=254.04 Aligned_cols=190 Identities=23% Similarity=0.371 Sum_probs=157.6
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ .....|+||||++||+|.+++..+.+.+++..+..++.|++.||.|||++|++||||||+||++
T Consensus 56 l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i-- 133 (256)
T cd05059 56 LSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLV-- 133 (256)
T ss_pred CCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEE--
Confidence 5799999988 3567899999999999999987766689999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCCc--ccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRL--NDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFR 152 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 152 (389)
+.++.+||+|||++......... ....++..|+|||.+. ..++.++|+||+|+++|++++ |..||...+..+...
T Consensus 134 -~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~ 212 (256)
T cd05059 134 -GEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVE 212 (256)
T ss_pred -CCCCcEEECCcccceecccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Confidence 56788999999998765332211 1122345799999875 468899999999999999999 899998877777766
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 153 SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 153 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
.+...... . ..+..+..+.+++.+||..+|++|||+.++++
T Consensus 213 ~~~~~~~~-~--~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~ 253 (256)
T cd05059 213 SVSAGYRL-Y--RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLS 253 (256)
T ss_pred HHHcCCcC-C--CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 66543221 1 12357899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=261.00 Aligned_cols=193 Identities=18% Similarity=0.260 Sum_probs=152.2
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcC------------------CCCCHHHHHHHHHHHHHHHHHHH
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG------------------GRYLEEDAKTIVEKILNIVAFCH 58 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~------------------~~l~~~~~~~i~~qi~~~L~~lH 58 (389)
|.||||++++ ..+..|+|||||++|+|.+++.... ..+++..+..++.||+.||.|||
T Consensus 76 l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH 155 (304)
T cd05096 76 LKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS 155 (304)
T ss_pred cCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 5799999998 3577999999999999999885431 23677889999999999999999
Q ss_pred HCCCEecCCCCCcEEEeecCCCCCEEEeecCCccccCCCCC---cccccccCCcccccccc-ccCCCchhHHHHHHHHHH
Q 016471 59 LQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYI 134 (389)
Q Consensus 59 ~~~i~Hrdlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ 134 (389)
++||+||||||+|||+ +.++.+||+|||++........ .....++..|+|||++. +.++.++||||+||++|+
T Consensus 156 ~~~ivH~dlkp~Nill---~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~e 232 (304)
T cd05096 156 SLNFVHRDLATRNCLV---GENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWE 232 (304)
T ss_pred HCCccccCcchhheEE---cCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHH
Confidence 9999999999999999 4678899999999876543221 12334578899999874 568999999999999999
Q ss_pred HHh--CCCCCCCCChhHHHHHHHhc----CCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 135 LLC--GSRPFWARTESGIFRSVLRA----DPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 135 ll~--g~~pf~~~~~~~~~~~i~~~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
|++ +..||.+.+..+....+... .........+.+++.+.+++.+||..+|.+|||+.++..
T Consensus 233 l~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 233 ILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred HHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 986 66788776666555443221 111111112457899999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=267.67 Aligned_cols=199 Identities=29% Similarity=0.462 Sum_probs=158.7
Q ss_pred CCCccccceee--------cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcE
Q 016471 1 MYHQKLQHLFY--------SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENF 72 (389)
Q Consensus 1 l~Hpni~~~~~--------~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Ni 72 (389)
|.||||++++. ...+|+||||+. |+|.+.+... +.+++..+..++.||+.||.|||++||+||||||+||
T Consensus 61 l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Ni 138 (334)
T cd07855 61 FKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNL 138 (334)
T ss_pred cCCCCccCHHHhccccCCCCceEEEEEehhh-hhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence 57999998762 256899999996 5888876544 6799999999999999999999999999999999999
Q ss_pred EEeecCCCCCEEEeecCCccccCCCC-----CcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 016471 73 LFTTREEDAPLKVIDFGLSDFVRPDQ-----RLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWAR 145 (389)
Q Consensus 73 ll~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~ 145 (389)
++ +.++.+||+|||++....... ......|+..|+|||.+.+ .++.++|+||+||++|+|++|+.||.+.
T Consensus 139 l~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 215 (334)
T cd07855 139 LV---NEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGK 215 (334)
T ss_pred EE---cCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCC
Confidence 99 578899999999987653321 1224578899999998743 4889999999999999999999999876
Q ss_pred ChhHHHHHHHhcCC-----------------------CCCCCC----CCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCC
Q 016471 146 TESGIFRSVLRADP-----------------------NFHDSP----WPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHP 198 (389)
Q Consensus 146 ~~~~~~~~i~~~~~-----------------------~~~~~~----~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~ 198 (389)
+.......+..... ...... .+..++.+.++|++||+.+|.+|||+.+++.||
T Consensus 216 ~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~ 295 (334)
T cd07855 216 NYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP 295 (334)
T ss_pred ChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence 65443333222111 111111 245789999999999999999999999999999
Q ss_pred CCCCCC
Q 016471 199 WLHDEN 204 (389)
Q Consensus 199 ~~~~~~ 204 (389)
||....
T Consensus 296 ~~~~~~ 301 (334)
T cd07855 296 FLAQYH 301 (334)
T ss_pred hhhhcc
Confidence 997653
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=258.96 Aligned_cols=196 Identities=32% Similarity=0.526 Sum_probs=161.5
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ ....+|+||||+++ +|.+++..+.+.+++..+..++.||+.||.|||++||+|+||+|+||++
T Consensus 55 l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili-- 131 (283)
T cd05118 55 LNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLI-- 131 (283)
T ss_pred hcCCCcchHHHhhccCCCEEEEEeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEE--
Confidence 4799999988 46789999999986 8888887766789999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC-CcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRS 153 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 153 (389)
+.++.++|+|||.+....... ......++..|+|||.+.+ .++.++|+||+|+++|+|++|+.||.+.+..+....
T Consensus 132 -~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~ 210 (283)
T cd05118 132 -NTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFK 210 (283)
T ss_pred -CCCCcEEEeeeeeeEecCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 567889999999987765443 2334568889999998743 578999999999999999999999988776555444
Q ss_pred HHhcCCCCCC--------------------------CCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCC
Q 016471 154 VLRADPNFHD--------------------------SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 154 i~~~~~~~~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~ 200 (389)
+......... ..++.++..++++|.+||..+|.+||++.+++.||||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 211 IFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred HHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 4322111000 1123468899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=254.72 Aligned_cols=188 Identities=15% Similarity=0.256 Sum_probs=150.6
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||+.++ .....++|||||.+|+|.+++..+...+++..+..++.||+.||+|||++||+||||||+||+++.
T Consensus 56 ~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~ 135 (258)
T cd05078 56 LSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIR 135 (258)
T ss_pred CCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEec
Confidence 5799999998 347799999999999999988776567899999999999999999999999999999999999964
Q ss_pred cCC-----CCCEEEeecCCccccCCCCCcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCC-CCCCCCChh
Q 016471 77 REE-----DAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGS-RPFWARTES 148 (389)
Q Consensus 77 ~~~-----~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~-~pf~~~~~~ 148 (389)
.+. .+.++++|||++...... ....+++.|+|||++.+ .++.++|+||+||++|+|++|. .||......
T Consensus 136 ~~~~~~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~ 212 (258)
T cd05078 136 EEDRKTGNPPFIKLSDPGISITVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ 212 (258)
T ss_pred ccccccCCCceEEecccccccccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH
Confidence 221 123799999988655332 23568889999999864 4789999999999999999984 666554443
Q ss_pred HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 149 GIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 149 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
... .+.......+ +..+.++.+++.+||+.+|++|||++++++
T Consensus 213 ~~~-~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 255 (258)
T cd05078 213 KKL-QFYEDRHQLP----APKWTELANLINQCMDYEPDFRPSFRAIIR 255 (258)
T ss_pred HHH-HHHHccccCC----CCCcHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 332 2333332222 235688999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=258.57 Aligned_cols=190 Identities=19% Similarity=0.353 Sum_probs=157.6
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG---------------GRYLEEDAKTIVEKILNIVAFCHLQG 61 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~~lH~~~ 61 (389)
+.||||+.++ .....++||||++||+|.+++..+. +.+++..++.++.||+.||+|||++|
T Consensus 64 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ 143 (291)
T cd05094 64 LQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH 143 (291)
T ss_pred CCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 5799999988 3577999999999999999886532 34889999999999999999999999
Q ss_pred CEecCCCCCcEEEeecCCCCCEEEeecCCccccCCCC---CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh
Q 016471 62 VVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ---RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC 137 (389)
Q Consensus 62 i~Hrdlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~ 137 (389)
|+||||||+||++ +.++.++|+|||++....... ......+++.|+|||.+. ..++.++||||+||++|+|++
T Consensus 144 i~H~dlkp~Nil~---~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t 220 (291)
T cd05094 144 FVHRDLATRNCLV---GANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220 (291)
T ss_pred eeecccCcceEEE---ccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHh
Confidence 9999999999999 567899999999987653322 122345678899999875 468899999999999999998
Q ss_pred -CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 138 -GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 138 -g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
|..||...+..+....+....... .....+..+.+++.+||..+|.+|||+.++++
T Consensus 221 ~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 221 YGKQPWFQLSNTEVIECITQGRVLE---RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred CCCCCCCCCCHHHHHHHHhCCCCCC---CCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 999998877777666655433221 12347889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=257.91 Aligned_cols=196 Identities=28% Similarity=0.451 Sum_probs=160.2
Q ss_pred CCCccccceee----cCe-----EEEEEEccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCC
Q 016471 1 MYHQKLQHLFY----SNS-----FLFFTRFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPE 70 (389)
Q Consensus 1 l~Hpni~~~~~----~~~-----~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~ 70 (389)
+.||||++++. ... ++++|||+.+ +|.+++.... ..+++..+..++.|++.||.|||++|++|+||+|+
T Consensus 58 ~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~ 136 (287)
T cd07838 58 FEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQ 136 (287)
T ss_pred cCCCCcceEEEEEeeccCCCCceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChh
Confidence 36999999982 233 9999999985 8988776543 35899999999999999999999999999999999
Q ss_pred cEEEeecCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhH
Q 016471 71 NFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESG 149 (389)
Q Consensus 71 Nill~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 149 (389)
||++ +.++.+||+|||.+.............+++.|+|||++. ..++.++|+||+||++|+|++|.+||.+.+..+
T Consensus 137 nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~ 213 (287)
T cd07838 137 NILV---TSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD 213 (287)
T ss_pred hEEE---ccCCCEEEeccCcceeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH
Confidence 9999 467899999999987765444444556888999999875 468899999999999999999999998888776
Q ss_pred HHHHHHhcCCCC----------------C-------CCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCC
Q 016471 150 IFRSVLRADPNF----------------H-------DSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 150 ~~~~i~~~~~~~----------------~-------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~ 200 (389)
....+....... + ....+.+++.+.++|.+||..+|.+||++.+++.||||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 214 QLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred HHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 666654421100 0 00012456889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=261.18 Aligned_cols=198 Identities=25% Similarity=0.478 Sum_probs=162.0
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||+.++ ..+..|+|+||++||+|.+++.+ ..+++..+..++.|++.||.|||++|++||||+|+||++
T Consensus 73 l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili-- 148 (293)
T cd06647 73 NKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL-- 148 (293)
T ss_pred cCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEE--
Confidence 4799999988 45789999999999999998754 368899999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC-CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
+.++.++|+|||++....... ......|++.|+|||.+. +.++.++|+||+||++|++++|+.||...+.......+
T Consensus 149 -~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~ 227 (293)
T cd06647 149 -GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI 227 (293)
T ss_pred -cCCCCEEEccCcceecccccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh
Confidence 467889999999887654332 233456889999999875 45889999999999999999999999876654433332
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
.... .........++..+++++.+||..+|.+||++.+++.||||+...
T Consensus 228 ~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 228 ATNG-TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred hcCC-CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 2211 111112235788999999999999999999999999999998765
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=263.07 Aligned_cols=191 Identities=20% Similarity=0.298 Sum_probs=157.7
Q ss_pred CCCccccceee---cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 1 MYHQKLQHLFY---SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 1 l~Hpni~~~~~---~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
+.||||+.++. ....++|+||+++|+|.+++......+++..+..++.||+.||+|||++||+||||||+||++
T Consensus 66 l~h~niv~~~g~~~~~~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill--- 142 (316)
T cd05108 66 VDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLV--- 142 (316)
T ss_pred CCCCCCCeEEEEEcCCCceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEe---
Confidence 57999999993 456789999999999999998776779999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCCccccCCCCCc---ccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHH
Q 016471 78 EEDAPLKVIDFGLSDFVRPDQRL---NDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFR 152 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 152 (389)
+.++.+||+|||++......... ....++..|+|||.+. ..++.++||||+||++|+|++ |..||.+....+...
T Consensus 143 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~ 222 (316)
T cd05108 143 KTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS 222 (316)
T ss_pred cCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 46788999999999876543321 1223466799999875 468999999999999999997 999998776665543
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCC
Q 016471 153 SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 197 (389)
Q Consensus 153 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h 197 (389)
+.......+.+ +..+.++.+++.+||..+|.+|||+.+++.+
T Consensus 223 -~~~~~~~~~~~--~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 223 -ILEKGERLPQP--PICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred -HHhCCCCCCCC--CCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 33333222222 4578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=257.23 Aligned_cols=198 Identities=23% Similarity=0.380 Sum_probs=164.5
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.|||+++++ .+...|+|||||.| +|.+.+......+++.++..++.|++.||.|||++|++||||+|+||++
T Consensus 82 l~h~~iv~~~~~~~~~~~~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~-- 158 (317)
T cd06635 82 IKHPNSIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL-- 158 (317)
T ss_pred CCCCCEEEEEEEEeeCCeEEEEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEE--
Confidence 5799999988 35778999999975 7888776666779999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc----ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH----RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFR 152 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 152 (389)
+.++.+||+|||++..... .....|++.|+|||.+. +.++.++|+||+||++|+|++|+.||..........
T Consensus 159 -~~~~~~kl~dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~ 234 (317)
T cd06635 159 -TEPGQVKLADFGSASIASP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY 234 (317)
T ss_pred -CCCCCEEEecCCCccccCC---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHH
Confidence 4678899999998865432 23456889999999862 358899999999999999999999998877666666
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCCCCC
Q 016471 153 SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPV 207 (389)
Q Consensus 153 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~~~~ 207 (389)
.+....... .....+++.+++++.+||..+|.+||++.+++.|+|+.......
T Consensus 235 ~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~ 287 (317)
T cd06635 235 HIAQNESPT--LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPET 287 (317)
T ss_pred HHHhccCCC--CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCccc
Confidence 555443221 22245788999999999999999999999999999997654433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=258.47 Aligned_cols=196 Identities=29% Similarity=0.494 Sum_probs=160.6
Q ss_pred CCCcccccee----ec--CeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEE
Q 016471 1 MYHQKLQHLF----YS--NSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLF 74 (389)
Q Consensus 1 l~Hpni~~~~----~~--~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill 74 (389)
+.|||++.++ .. +..|+||||+++ +|.+++......+++..+..++.||+.||+|||++|++|+||+|+||++
T Consensus 55 l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~ 133 (287)
T cd07840 55 LRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILI 133 (287)
T ss_pred ccCCCeeeheeeEecCCCCcEEEEeccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE
Confidence 4799999988 23 689999999985 8988876655689999999999999999999999999999999999999
Q ss_pred eecCCCCCEEEeecCCccccCCCC--CcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHH
Q 016471 75 TTREEDAPLKVIDFGLSDFVRPDQ--RLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGI 150 (389)
Q Consensus 75 ~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 150 (389)
++++.+||+|||++....... ......++..|+|||.+.+ .++.++|+||+|+++|+|++|+.||...+....
T Consensus 134 ---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~ 210 (287)
T cd07840 134 ---NNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ 210 (287)
T ss_pred ---cCCCCEEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 568899999999987664432 2234467889999997643 478999999999999999999999988777666
Q ss_pred HHHHHhcCCCCCCCCCC--------------------------C-CCHHHHHHHHhhhccCcCCCCCHHHHhCCCCC
Q 016471 151 FRSVLRADPNFHDSPWP--------------------------S-VSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 151 ~~~i~~~~~~~~~~~~~--------------------------~-~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~ 200 (389)
...+...........|+ . +++.+.+++.+||..+|.+||++.+++.||||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 211 LEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred HHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 65555432221111111 1 28899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=258.91 Aligned_cols=195 Identities=31% Similarity=0.551 Sum_probs=159.9
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
+||||+.++ .+..+|+||||++||+|.+++..+ +.+++..+..++.|++.||.|||++|++||||+|+||++
T Consensus 63 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~--- 138 (290)
T cd05613 63 QSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILL--- 138 (290)
T ss_pred cCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE---
Confidence 589999987 356789999999999999988765 578999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCCccccCCCC--CcccccccCCccccccccc---cCCCchhHHHHHHHHHHHHhCCCCCCCCCh----h
Q 016471 78 EEDAPLKVIDFGLSDFVRPDQ--RLNDIVGSAYYVAPEVLHR---SYNVEGDMWSIGVITYILLCGSRPFWARTE----S 148 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~ 148 (389)
+.++.+||+|||++....... ......|+..|+|||.+.. .++.++|+||+|+++|+|++|..||..... .
T Consensus 139 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~ 218 (290)
T cd05613 139 DSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQA 218 (290)
T ss_pred CCCCCEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHH
Confidence 467899999999987654322 2234568999999998753 467899999999999999999999964332 2
Q ss_pred HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCC-----CHHHHhCCCCCCCCC
Q 016471 149 GIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRM-----TAAQALTHPWLHDEN 204 (389)
Q Consensus 149 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----s~~e~l~h~~~~~~~ 204 (389)
.....+....+.+ .+.+++.+.+++.+||..+|.+|| ++++++.||||....
T Consensus 219 ~~~~~~~~~~~~~----~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 219 EISRRILKSEPPY----PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred HHHHHhhccCCCC----CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 3333333332222 135789999999999999999997 899999999997764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=252.70 Aligned_cols=190 Identities=19% Similarity=0.294 Sum_probs=154.7
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ ....+|+||||++||+|.+++......+++..+..++.|++.||.|||++|++||||||+||++
T Consensus 50 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~-- 127 (252)
T cd05084 50 YSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLV-- 127 (252)
T ss_pred CCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEE--
Confidence 5799999988 4577999999999999999887665678999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCCc---ccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRL---NDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIF 151 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~ 151 (389)
+.++.+||+|||++......... ....++..|+|||.+. +.++.++|+||+||++|+|++ |..||.........
T Consensus 128 -~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~ 206 (252)
T cd05084 128 -TEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTR 206 (252)
T ss_pred -cCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHH
Confidence 46778999999998764322111 1112345699999875 468899999999999999998 99999777666655
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 152 RSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 152 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
..+...... .....++..+.+++.+||..+|.+|||+.++++
T Consensus 207 ~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 207 EAIEQGVRL---PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HHHHcCCCC---CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 555443221 122357899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=258.53 Aligned_cols=196 Identities=29% Similarity=0.522 Sum_probs=156.7
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ ..+..|+||||++++.+.. +..+...+++..+..++.||+.||.|||++|++||||+|+||++
T Consensus 57 l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~-~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~-- 133 (288)
T cd07833 57 LRHENIVNLKEAFRRKGRLYLVFEYVERTLLEL-LEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILV-- 133 (288)
T ss_pred cCCCCeeehhheEEECCEEEEEEecCCCCHHHH-HHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE--
Confidence 4699999987 4578999999999866654 44444679999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC--CcccccccCCcccccccc-c-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ--RLNDIVGSAYYVAPEVLH-R-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFR 152 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 152 (389)
++++.+||+|||++....... ......++..|+|||++. . .++.++|+||+|+++|+|++|++||.+........
T Consensus 134 -~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~ 212 (288)
T cd07833 134 -SESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLY 212 (288)
T ss_pred -CCCCCEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 568899999999987765433 333457889999999874 4 57899999999999999999999998766544433
Q ss_pred HHHhcCCC-------------------CCCC--------CCC-CCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCC
Q 016471 153 SVLRADPN-------------------FHDS--------PWP-SVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 153 ~i~~~~~~-------------------~~~~--------~~~-~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~ 200 (389)
.+...... .+.. .++ .+++.++++|++||..+|.+|||+++++.||||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 213 LIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred HHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 32211100 0000 011 248899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=257.86 Aligned_cols=199 Identities=27% Similarity=0.499 Sum_probs=165.2
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ .....|+|+||++|++|.+++......+++..+..++.|++.||.|||+.|++|+||+|+||++
T Consensus 72 l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i-- 149 (286)
T cd06614 72 CKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILL-- 149 (286)
T ss_pred CCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEE--
Confidence 5799999988 4688999999999999999887764479999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC-CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
+.++.++|+|||++....... ......+++.|+|||.+. ..++.++|+||+||++|+|++|..||...........+
T Consensus 150 -~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~ 228 (286)
T cd06614 150 -SKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLI 228 (286)
T ss_pred -cCCCCEEECccchhhhhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 467889999999876553321 223445788999999875 45889999999999999999999999877666555554
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~ 203 (389)
...... .......++..++++|.+||..+|.+|||+.+++.|+||...
T Consensus 229 ~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 276 (286)
T cd06614 229 TTKGIP-PLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA 276 (286)
T ss_pred HhcCCC-CCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhcc
Confidence 433221 111223478999999999999999999999999999999774
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=251.43 Aligned_cols=192 Identities=34% Similarity=0.652 Sum_probs=163.9
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||+.++ ....+|+||||+++++|.+++... +.+++..+..++.|++.||.|||+.|++|+||+|+||++
T Consensus 50 l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~-- 126 (250)
T cd05123 50 INHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKE-GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILL-- 126 (250)
T ss_pred cCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEE--
Confidence 5799999987 467899999999999999988655 579999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCC-CCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPD-QRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
+.++.++|+|||.+...... .......++..|+|||.+.+ ..+.++|+||+|+++|++++|..||...........+
T Consensus 127 -~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~ 205 (250)
T cd05123 127 -DADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKI 205 (250)
T ss_pred -cCCCcEEEeecCcceecccCCCcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 46788999999998766443 23345578889999998754 5788999999999999999999999887776666666
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCH---HHHhCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTA---AQALTHPWL 200 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~---~e~l~h~~~ 200 (389)
.......+ ..++..+.+++++||..+|.+||++ .++++||||
T Consensus 206 ~~~~~~~~----~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 206 LKDPLRFP----EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred hcCCCCCC----CCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 65333222 3468999999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=256.68 Aligned_cols=194 Identities=31% Similarity=0.494 Sum_probs=160.1
Q ss_pred Ccccccee----ecCeEEEEEEccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 3 HQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 3 Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
||||+.++ .....|+||||+ +|+|.+++.... ..+++..+..++.|++.||.|||++|++|+||+|+||++
T Consensus 57 h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i--- 132 (283)
T cd07830 57 HPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLV--- 132 (283)
T ss_pred CCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---
Confidence 99999988 467899999999 789999887653 478999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCCccccCCCCCcccccccCCcccccccc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 016471 78 EEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVL 155 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 155 (389)
+.++.++|+|||++.............++..|+|||++. ..++.++|+||+|+++|+|++|++||.+.........+.
T Consensus 133 ~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~ 212 (283)
T cd07830 133 SGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKIC 212 (283)
T ss_pred cCCCCEEEeecccceeccCCCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHH
Confidence 568899999999998765444444567889999999874 347899999999999999999999998876655554443
Q ss_pred hcCCCCCC--------------------------CCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCC
Q 016471 156 RADPNFHD--------------------------SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 156 ~~~~~~~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~ 200 (389)
........ ...+..+..+.++|.+||..+|.+|||+.+++.||||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 213 SVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred HhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 32111110 0012346889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=265.39 Aligned_cols=200 Identities=19% Similarity=0.291 Sum_probs=155.5
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEe
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 75 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~ 75 (389)
+.||||++++ ....+|+||||+.+|+|.+++.... ..+++..+..++.|++.||+|||++|++||||||+||++
T Consensus 56 l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill- 134 (328)
T cd08226 56 FRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILI- 134 (328)
T ss_pred CCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE-
Confidence 5799999988 4578999999999999999876542 358999999999999999999999999999999999999
Q ss_pred ecCCCCCEEEeecCCccccCCCC-C-------cccccccCCccccccccc---cCCCchhHHHHHHHHHHHHhCCCCCCC
Q 016471 76 TREEDAPLKVIDFGLSDFVRPDQ-R-------LNDIVGSAYYVAPEVLHR---SYNVEGDMWSIGVITYILLCGSRPFWA 144 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~~~-~-------~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~ 144 (389)
+.++.++++||+.+....... . .....++..|+|||++.+ .++.++|+||+||++|+|++|+.||.+
T Consensus 135 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~ 212 (328)
T cd08226 135 --SGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQD 212 (328)
T ss_pred --eCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 467889999998653321110 0 011235667999999853 378999999999999999999999987
Q ss_pred CChhHHHHHHHhcCCCCC-------------------------------------------CCCCCCCCHHHHHHHHhhh
Q 016471 145 RTESGIFRSVLRADPNFH-------------------------------------------DSPWPSVSPEAKDFVRRLL 181 (389)
Q Consensus 145 ~~~~~~~~~i~~~~~~~~-------------------------------------------~~~~~~~~~~~~~li~~~l 181 (389)
..............+..+ .+....+++.+.+|+++||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 292 (328)
T cd08226 213 MLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCL 292 (328)
T ss_pred cChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHc
Confidence 665544433332211100 0001235678999999999
Q ss_pred ccCcCCCCCHHHHhCCCCCCCC
Q 016471 182 NKDHRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 182 ~~~p~~R~s~~e~l~h~~~~~~ 203 (389)
..||.+|||+.++++||||...
T Consensus 293 ~~dP~~Rpta~e~l~~~~~~~~ 314 (328)
T cd08226 293 QQDPEKRPSASSLLSHAFFKQV 314 (328)
T ss_pred cCCcccCCCHHHHhhCHHHHHH
Confidence 9999999999999999999554
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=250.72 Aligned_cols=194 Identities=29% Similarity=0.538 Sum_probs=161.4
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||+|+.++ .....++++||++|++|.+++....+.+++..+..++.|++.||.|||++|++||||+|+||++
T Consensus 54 l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i-- 131 (253)
T cd05122 54 CKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILL-- 131 (253)
T ss_pred CCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEE--
Confidence 5799999988 3578999999999999999887665689999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVL 155 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 155 (389)
++++.++|+|||.+.............++..|+|||.+. ..++.++|+||+|+++|+|++|..||...+.......+.
T Consensus 132 -~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 210 (253)
T cd05122 132 -TSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIA 210 (253)
T ss_pred -ccCCeEEEeeccccccccccccccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH
Confidence 467889999999988765543234567889999999885 357889999999999999999999998775544444333
Q ss_pred hcCCCCCCCCC-CCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCC
Q 016471 156 RADPNFHDSPW-PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPW 199 (389)
Q Consensus 156 ~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~ 199 (389)
... .+.... ..++..+.++|.+||..+|.+|||+.+++.|||
T Consensus 211 ~~~--~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 211 TNG--PPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred hcC--CCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 321 111111 234899999999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=256.63 Aligned_cols=197 Identities=23% Similarity=0.360 Sum_probs=160.2
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCEecCCCCCcEEEe
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHL-QGVVHRDLKPENFLFT 75 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~-~~i~Hrdlkp~Nill~ 75 (389)
+.||||++++ ....+|+||||+++|+|.+++.+. +.+++..+..++.|++.||.|||+ .|++||||+|+||++
T Consensus 60 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~- 137 (284)
T cd06620 60 CRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKG-GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILV- 137 (284)
T ss_pred cCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEE-
Confidence 5799999998 457899999999999998877654 679999999999999999999997 699999999999999
Q ss_pred ecCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChh------
Q 016471 76 TREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTES------ 148 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------ 148 (389)
++++.++|+|||++...... ......|+..|+|||++. ..++.++|+||+||++|++++|..||......
T Consensus 138 --~~~~~~~l~d~gl~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~ 214 (284)
T cd06620 138 --NSRGQIKLCDFGVSGELINS-IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDD 214 (284)
T ss_pred --CCCCcEEEccCCcccchhhh-ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhh
Confidence 56788999999998654322 223457899999999874 56889999999999999999999999765432
Q ss_pred -----HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 149 -----GIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 149 -----~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
.....+.... .+..+...++..+.+|+.+||..+|.+|||+.++++|+||....
T Consensus 215 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~ 273 (284)
T cd06620 215 PMGILDLLQQIVQEP--PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL 273 (284)
T ss_pred hhHHHHHHHHHhhcc--CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 2233333221 11112224788999999999999999999999999999996653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=259.08 Aligned_cols=189 Identities=19% Similarity=0.275 Sum_probs=154.2
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG---------------GRYLEEDAKTIVEKILNIVAFCHLQGV 62 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~~lH~~~i 62 (389)
.||||++++ ....+|+||||+++|+|.+++.+.. +.+++..++.++.|++.||+|||++||
T Consensus 61 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~i 140 (297)
T cd05089 61 HHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQF 140 (297)
T ss_pred CCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 699999998 3466899999999999999886532 358899999999999999999999999
Q ss_pred EecCCCCCcEEEeecCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCC
Q 016471 63 VHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSR 140 (389)
Q Consensus 63 ~Hrdlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~ 140 (389)
+||||||+||++ +.++.+||+|||++..............+..|+|||++. ..++.++|||||||++|+|++ |..
T Consensus 141 vH~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~ 217 (297)
T cd05089 141 IHRDLAARNVLV---GENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGT 217 (297)
T ss_pred ccCcCCcceEEE---CCCCeEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCC
Confidence 999999999999 467889999999986432211111122345799999875 468999999999999999997 999
Q ss_pred CCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 141 PFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 141 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
||.+.........+.+... ......++..+++++.+||..+|.+|||++++++
T Consensus 218 pf~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 270 (297)
T cd05089 218 PYCGMTCAELYEKLPQGYR---MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISV 270 (297)
T ss_pred CCCCCCHHHHHHHHhcCCC---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9998887777766654321 1112358899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=253.31 Aligned_cols=190 Identities=22% Similarity=0.333 Sum_probs=157.2
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEe
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 75 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~ 75 (389)
+.||||++++ .+..+++||||+++|+|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||++
T Consensus 59 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~- 137 (263)
T cd05052 59 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV- 137 (263)
T ss_pred CCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE-
Confidence 5799999998 3577999999999999999886543 458999999999999999999999999999999999999
Q ss_pred ecCCCCCEEEeecCCccccCCCCCc--ccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 016471 76 TREEDAPLKVIDFGLSDFVRPDQRL--NDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIF 151 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~ 151 (389)
++++.+||+|||++......... ....+++.|+|||.+. ..++.++|||||||++|+|++ |..||.+....+..
T Consensus 138 --~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~ 215 (263)
T cd05052 138 --GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 215 (263)
T ss_pred --cCCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 46788999999998765432211 1223456799999875 468899999999999999998 99999888777776
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 152 RSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 152 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
..+..... ......+++.+.+++.+||..+|++|||+.++++
T Consensus 216 ~~~~~~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 216 ELLEKGYR---MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred HHHHCCCC---CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 66654321 1122467899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=254.89 Aligned_cols=189 Identities=16% Similarity=0.232 Sum_probs=149.9
Q ss_pred CCCccccceee----cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLFY----SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~~----~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||+.++. ....++|||||++|+|..++..+.+.+++..+..++.||+.||+|||++||+||||||+|||+..
T Consensus 61 l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~ 140 (262)
T cd05077 61 VSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAR 140 (262)
T ss_pred CCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEec
Confidence 57999999983 46789999999999998877666677999999999999999999999999999999999999953
Q ss_pred cCC----CCCEEEeecCCccccCCCCCcccccccCCcccccccc--ccCCCchhHHHHHHHHHHHH-hCCCCCCCCChhH
Q 016471 77 REE----DAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILL-CGSRPFWARTESG 149 (389)
Q Consensus 77 ~~~----~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~ 149 (389)
.+. ...++++|||++..... .....++..|+|||.+. +.++.++||||+||++|+|+ .|..||......+
T Consensus 141 ~~~~~~~~~~~~l~d~g~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~ 217 (262)
T cd05077 141 EGIDGECGPFIKLSDPGIPITVLS---RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE 217 (262)
T ss_pred CCccCCCCceeEeCCCCCCccccC---cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH
Confidence 211 12389999998865432 22346788999999874 45889999999999999998 5888887655443
Q ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCC
Q 016471 150 IFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 197 (389)
Q Consensus 150 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h 197 (389)
... ........ ....+.++.+++.+||..+|.+||++.+++.+
T Consensus 218 ~~~-~~~~~~~~----~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 218 KER-FYEGQCML----VTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred HHH-HHhcCccC----CCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 322 22221111 12346789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=265.29 Aligned_cols=198 Identities=26% Similarity=0.472 Sum_probs=156.2
Q ss_pred CCCccccceee---------cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCc
Q 016471 1 MYHQKLQHLFY---------SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPEN 71 (389)
Q Consensus 1 l~Hpni~~~~~---------~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~N 71 (389)
++||||++++. ....|+|+||+.+ +|.+.+.. +.+++..+..++.|++.||.|||++||+||||||+|
T Consensus 60 l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~N 136 (336)
T cd07849 60 FKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSN 136 (336)
T ss_pred CCCCCcCchhheeecccccccceEEEEehhccc-CHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHH
Confidence 57999999872 1358999999975 88776643 579999999999999999999999999999999999
Q ss_pred EEEeecCCCCCEEEeecCCccccCCCC----CcccccccCCcccccccc--ccCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 016471 72 FLFTTREEDAPLKVIDFGLSDFVRPDQ----RLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILLCGSRPFWAR 145 (389)
Q Consensus 72 ill~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~ 145 (389)
|++ +.++.+||+|||++....... ......||+.|+|||.+. ..++.++|+||+||++|+|++|++||.+.
T Consensus 137 ill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~ 213 (336)
T cd07849 137 LLL---NTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGK 213 (336)
T ss_pred EEE---CCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999 567889999999987653322 123357899999999863 35889999999999999999999999776
Q ss_pred ChhHHHHHHHhcCC-----------------------CCCCC----CCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCC
Q 016471 146 TESGIFRSVLRADP-----------------------NFHDS----PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHP 198 (389)
Q Consensus 146 ~~~~~~~~i~~~~~-----------------------~~~~~----~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~ 198 (389)
+.......+..... ..... ..+..++.+.++|.+||..+|.+|||+.++++||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp 293 (336)
T cd07849 214 DYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHP 293 (336)
T ss_pred CHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence 54433322221100 00000 1245688999999999999999999999999999
Q ss_pred CCCCCC
Q 016471 199 WLHDEN 204 (389)
Q Consensus 199 ~~~~~~ 204 (389)
||....
T Consensus 294 ~~~~~~ 299 (336)
T cd07849 294 YLEQYH 299 (336)
T ss_pred cccccC
Confidence 997653
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=255.60 Aligned_cols=190 Identities=17% Similarity=0.258 Sum_probs=155.0
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCC
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG---------GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDL 67 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~---------~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdl 67 (389)
+.||||++++ .....++||||+++|+|.+++.+.. ..++...+..++.|++.||.|||+.|++||||
T Consensus 66 l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dl 145 (277)
T cd05062 66 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDL 145 (277)
T ss_pred CCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCc
Confidence 5799999998 3567999999999999999886532 23567888999999999999999999999999
Q ss_pred CCCcEEEeecCCCCCEEEeecCCccccCCCCC---cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCC
Q 016471 68 KPENFLFTTREEDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPF 142 (389)
Q Consensus 68 kp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf 142 (389)
||+||++ +.++.++|+|||++........ .....+++.|+|||++. +.++.++|+|||||++|+|++ |..||
T Consensus 146 kp~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~ 222 (277)
T cd05062 146 AARNCMV---AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY 222 (277)
T ss_pred chheEEE---cCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCC
Confidence 9999999 4678899999999875533221 11234577899999885 468999999999999999999 78999
Q ss_pred CCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 143 WARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 143 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
.+.........+........ ...++..+++++.+||+.+|.+|||+.+++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 273 (277)
T cd05062 223 QGMSNEQVLRFVMEGGLLDK---PDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 273 (277)
T ss_pred CCCCHHHHHHHHHcCCcCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 88877776666554432111 1357889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=254.47 Aligned_cols=194 Identities=28% Similarity=0.486 Sum_probs=161.9
Q ss_pred CCCccccceee----------cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCC
Q 016471 1 MYHQKLQHLFY----------SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPE 70 (389)
Q Consensus 1 l~Hpni~~~~~----------~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~ 70 (389)
++|+||+.++. -..+|+||||+.. +|.+.+. -.+.-+.+..++.|++.|++|||+.||+||||||+
T Consensus 72 v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~~-nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPs 147 (369)
T KOG0665|consen 72 VNHKNIISLLNVFTPQKTLEEFQEVYLVMELMDA-NLCQVIL---MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPS 147 (369)
T ss_pred hcccceeeeeeccCccccHHHHHhHHHHHHhhhh-HHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcc
Confidence 58999999982 2568999999986 8888776 35788899999999999999999999999999999
Q ss_pred cEEEeecCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhH
Q 016471 71 NFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESG 149 (389)
Q Consensus 71 Nill~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 149 (389)
||++ ..+..+||.|||+|........++..+.|.+|.|||++.+ .|...+||||+|||+.||++|+..|.|.+.-+
T Consensus 148 nivv---~~~~~lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~id 224 (369)
T KOG0665|consen 148 NIVV---NSDCTLKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHID 224 (369)
T ss_pred ccee---cchhheeeccchhhcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHH
Confidence 9999 5778899999999998776667788899999999998753 69999999999999999999999998887665
Q ss_pred HHHHHHhcCCC-------------------------------CCCCCCC-------CCCHHHHHHHHhhhccCcCCCCCH
Q 016471 150 IFRSVLRADPN-------------------------------FHDSPWP-------SVSPEAKDFVRRLLNKDHRKRMTA 191 (389)
Q Consensus 150 ~~~~i~~~~~~-------------------------------~~~~~~~-------~~~~~~~~li~~~l~~~p~~R~s~ 191 (389)
.+.++...... ++...|+ .-+..+++++.+||..+|++|.|+
T Consensus 225 Q~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv 304 (369)
T KOG0665|consen 225 QWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISV 304 (369)
T ss_pred HHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccH
Confidence 55554322111 1111121 124679999999999999999999
Q ss_pred HHHhCCCCCC
Q 016471 192 AQALTHPWLH 201 (389)
Q Consensus 192 ~e~l~h~~~~ 201 (389)
+++|.|||++
T Consensus 305 ~daL~HPY~~ 314 (369)
T KOG0665|consen 305 DDALRHPYIK 314 (369)
T ss_pred HHHhcCCeee
Confidence 9999999996
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=251.42 Aligned_cols=194 Identities=26% Similarity=0.511 Sum_probs=165.0
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEE
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSR---GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFL 73 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nil 73 (389)
+.|||++.+. .....++|+||++|++|.+++... ...+++..+..++.|++.||.|||++|++|+||+|+||+
T Consensus 56 l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil 135 (258)
T cd08215 56 LNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIF 135 (258)
T ss_pred cCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeE
Confidence 4799999988 358899999999999999988764 377999999999999999999999999999999999999
Q ss_pred EeecCCCCCEEEeecCCccccCCCC-CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHH
Q 016471 74 FTTREEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIF 151 (389)
Q Consensus 74 l~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 151 (389)
++ .++.++|+|||++....... ......|++.|+|||.+. ..++.++|+||+|+++|+|++|..||.........
T Consensus 136 ~~---~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~ 212 (258)
T cd08215 136 LT---SNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELA 212 (258)
T ss_pred Ec---CCCcEEECCccceeecccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHH
Confidence 94 67889999999987664432 233457889999999875 45889999999999999999999999887776666
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCC
Q 016471 152 RSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 152 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~ 200 (389)
...........+ ..++..+.+++.+||..+|.+|||+.++++||||
T Consensus 213 ~~~~~~~~~~~~---~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 213 LKILKGQYPPIP---SQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHHhcCCCCCCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 666554322111 2578999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=252.74 Aligned_cols=190 Identities=23% Similarity=0.417 Sum_probs=158.1
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEe
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 75 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~ 75 (389)
+.||||++++ ..+..|+||||++||+|.+++... ...+++..+..++.|++.||+|||++|++||||||+||++
T Consensus 58 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili- 136 (261)
T cd05072 58 LQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLV- 136 (261)
T ss_pred CCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEe-
Confidence 5799999988 357789999999999999988654 3568899999999999999999999999999999999999
Q ss_pred ecCCCCCEEEeecCCccccCCCCC--cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 016471 76 TREEDAPLKVIDFGLSDFVRPDQR--LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIF 151 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~ 151 (389)
+.++.++|+|||++........ .....++..|+|||.+. +.++.++|+||+||++|+|++ |..||.+.......
T Consensus 137 --~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~ 214 (261)
T cd05072 137 --SESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVM 214 (261)
T ss_pred --cCCCcEEECCCccceecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHH
Confidence 5678899999999976543221 12234567899999875 468889999999999999998 99999888777777
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 152 RSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 152 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
..+..... . +....++..+.+++.+||..+|++|||++++.+
T Consensus 215 ~~~~~~~~-~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 215 SALQRGYR-M--PRMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHHcCCC-C--CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 66654422 1 222467899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=255.27 Aligned_cols=197 Identities=18% Similarity=0.284 Sum_probs=159.3
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCC
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG---------GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDL 67 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~---------~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdl 67 (389)
+.||||++++ .....|+|||||++|+|.+++.... ..++...+..++.|++.||.|||++||+||||
T Consensus 66 l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~di 145 (288)
T cd05061 66 FTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDL 145 (288)
T ss_pred CCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCC
Confidence 5799999988 3567999999999999999986532 23456788999999999999999999999999
Q ss_pred CCCcEEEeecCCCCCEEEeecCCccccCCCCC---cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCC
Q 016471 68 KPENFLFTTREEDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPF 142 (389)
Q Consensus 68 kp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf 142 (389)
||+||++ +.++.++|+|||++........ .....++..|+|||.+. +.++.++|+||+||++|+|++ |..||
T Consensus 146 kp~nili---~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~ 222 (288)
T cd05061 146 AARNCMV---AHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPY 222 (288)
T ss_pred ChheEEE---cCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCC
Confidence 9999999 4678899999999875432221 11224567899999875 468999999999999999998 88999
Q ss_pred CCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC------CCCCCCC
Q 016471 143 WARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT------HPWLHDE 203 (389)
Q Consensus 143 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~------h~~~~~~ 203 (389)
.+....+....+........ ....++.+++++.+||..+|.+|||+.++++ ||||++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~ 286 (288)
T cd05061 223 QGLSNEQVLKFVMDGGYLDQ---PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286 (288)
T ss_pred CCCCHHHHHHHHHcCCCCCC---CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence 88777776666654322111 1246789999999999999999999999986 8998764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=256.19 Aligned_cols=196 Identities=23% Similarity=0.378 Sum_probs=161.4
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.|||++.+. .....|+||||+. |+|.+.+......+++..+..++.|++.||.|||++|++||||+|+||++
T Consensus 72 l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~-- 148 (308)
T cd06634 72 LRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL-- 148 (308)
T ss_pred CCCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEE--
Confidence 5799999987 4577899999997 58888776665679999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc----ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH----RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFR 152 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 152 (389)
+.++.++|+|||++...... ....|++.|+|||.+. +.++.++||||+||++|+|++|..||..........
T Consensus 149 -~~~~~~kl~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~ 224 (308)
T cd06634 149 -SEPGLVKLGDFGSASIMAPA---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY 224 (308)
T ss_pred -CCCCcEEECCcccceeecCc---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH
Confidence 46788999999998765432 3456889999999863 357889999999999999999999997766555444
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCCC
Q 016471 153 SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENR 205 (389)
Q Consensus 153 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~~ 205 (389)
.+..... +......++..+.++|.+||..+|.+||++.+++.|||+.....
T Consensus 225 ~~~~~~~--~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~ 275 (308)
T cd06634 225 HIAQNES--PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 275 (308)
T ss_pred HHhhcCC--CCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccCC
Confidence 4443322 11112357889999999999999999999999999999977543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=270.61 Aligned_cols=191 Identities=18% Similarity=0.330 Sum_probs=164.2
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|.||||+.+| ....+|+|||+|+||+|.+++.+..+.++..+...++.+.+.||+|||+++++||||-.+|+|++
T Consensus 218 l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~- 296 (474)
T KOG0194|consen 218 LNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYS- 296 (474)
T ss_pred CCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheec-
Confidence 6899999999 47899999999999999999998866799999999999999999999999999999999999994
Q ss_pred cCCCCCEEEeecCCccccCCCCCcc-cccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLN-DIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRS 153 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~-~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~ 153 (389)
.+..+||+|||+++....-.... ...-...|+|||.+. +.|+.++||||+||++||+++ |..||.+....++...
T Consensus 297 --~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~k 374 (474)
T KOG0194|consen 297 --KKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAK 374 (474)
T ss_pred --CCCeEEeCccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHH
Confidence 56778999999987654211111 112446799999985 579999999999999999999 8999999999999999
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 154 VLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 154 i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
|.......+.+ +..++.+..++.+|+..+|..|||+.++.+
T Consensus 375 I~~~~~r~~~~--~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 375 IVKNGYRMPIP--SKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHhcCccCCCC--CCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 96655444433 367889999999999999999999988765
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=254.65 Aligned_cols=189 Identities=20% Similarity=0.301 Sum_probs=153.0
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG---------------GRYLEEDAKTIVEKILNIVAFCHLQGV 62 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~~lH~~~i 62 (389)
.||||++++ ....+|+||||+++|+|.+++..+. ..+++..+..++.|++.||+|||++|+
T Consensus 54 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i 133 (270)
T cd05047 54 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQF 133 (270)
T ss_pred cCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 699999988 3467899999999999999886532 247899999999999999999999999
Q ss_pred EecCCCCCcEEEeecCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCC
Q 016471 63 VHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSR 140 (389)
Q Consensus 63 ~Hrdlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~ 140 (389)
+||||||+||++ +.++.+||+|||++..............+..|+|||++. ..++.++|+|||||++|+|++ |..
T Consensus 134 ~H~dikp~nili---~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~ 210 (270)
T cd05047 134 IHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT 210 (270)
T ss_pred eecccccceEEE---cCCCeEEECCCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCC
Confidence 999999999999 567889999999986432211111223456799999875 468899999999999999997 999
Q ss_pred CCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 141 PFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 141 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
||.+.+.......+.... .. .....++.++.+++.+||..+|.+|||+.+++.
T Consensus 211 pf~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 211 PYCGMTCAELYEKLPQGY-RL--EKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred CccccCHHHHHHHHhCCC-CC--CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 998877766666554321 11 112357889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=254.29 Aligned_cols=190 Identities=19% Similarity=0.273 Sum_probs=156.1
Q ss_pred CCCcccccee---ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 1 MYHQKLQHLF---YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 1 l~Hpni~~~~---~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
+.||||+.++ .....++++||+++|+|.+++..+.+.+++..+..++.||+.||.|||++||+||||||+||+++
T Consensus 66 ~~~~~i~~~~~~~~~~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~-- 143 (279)
T cd05109 66 VGSPYVCRLLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVK-- 143 (279)
T ss_pred cCCCCCceEEEEEcCCCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc--
Confidence 4799999887 34567899999999999999877667899999999999999999999999999999999999994
Q ss_pred CCCCCEEEeecCCccccCCCCC---cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHH
Q 016471 78 EEDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFR 152 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 152 (389)
+++.+||+|||++........ .....+++.|+|||.+. ..++.++||||+||++|+|++ |..||..........
T Consensus 144 -~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~ 222 (279)
T cd05109 144 -SPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPD 222 (279)
T ss_pred -CCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 567899999999887643322 11223467899999875 468999999999999999998 999997766665555
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 153 SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 153 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
.+..... .+ ..+..+.++.+++.+||..+|.+||++.+++.
T Consensus 223 ~~~~~~~-~~--~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 223 LLEKGER-LP--QPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred HHHCCCc-CC--CCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 4443322 22 12457899999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=260.07 Aligned_cols=190 Identities=20% Similarity=0.290 Sum_probs=153.9
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG---------------GRYLEEDAKTIVEKILNIVAFCHLQGV 62 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~~lH~~~i 62 (389)
.||||++++ .++.+|+||||++||+|.+++.... ..+++..++.++.|++.||+|||++|+
T Consensus 66 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi 145 (303)
T cd05088 66 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQF 145 (303)
T ss_pred CCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 799999988 3577999999999999999886432 357899999999999999999999999
Q ss_pred EecCCCCCcEEEeecCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCC
Q 016471 63 VHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSR 140 (389)
Q Consensus 63 ~Hrdlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~ 140 (389)
+||||||+||++ +.++.+||+|||++.............++..|+|||.+. ..++.++||||+||++|+|++ |..
T Consensus 146 ~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~ 222 (303)
T cd05088 146 IHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT 222 (303)
T ss_pred cccccchheEEe---cCCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCC
Confidence 999999999999 467889999999986432211112223456799999875 357899999999999999998 999
Q ss_pred CCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCC
Q 016471 141 PFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 197 (389)
Q Consensus 141 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h 197 (389)
||.+.+..+....+.... .......+++.+.+++.+||..+|.+||++++++.+
T Consensus 223 p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 223 PYCGMTCAELYEKLPQGY---RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred CcccCChHHHHHHHhcCC---cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 998877766665553321 111123478999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=252.40 Aligned_cols=193 Identities=25% Similarity=0.476 Sum_probs=160.2
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEE
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILS---RGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFL 73 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nil 73 (389)
++||||++++ .....++||||+++++|.+.+.. ....+++..+..++.|++.||.|||++|++|+||+|+||+
T Consensus 59 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nil 138 (260)
T cd08222 59 LDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIF 138 (260)
T ss_pred CCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheE
Confidence 5799999988 45779999999999999887753 3457999999999999999999999999999999999999
Q ss_pred EeecCCCCCEEEeecCCccccCCCC-CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHH
Q 016471 74 FTTREEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIF 151 (389)
Q Consensus 74 l~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 151 (389)
++ ++.++|+|||++....... ......|++.|+|||.+. ..++.++|+||+|+++|+|++|..||.+.......
T Consensus 139 i~----~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~ 214 (260)
T cd08222 139 LK----NNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVV 214 (260)
T ss_pred ee----cCCEeecccCceeecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHH
Confidence 94 3569999999987654332 223456888999999875 45788999999999999999999999877666655
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCC
Q 016471 152 RSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 152 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~ 200 (389)
..+....... ....++.++.++|.+||..+|.+||++.++++||||
T Consensus 215 ~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 215 LRIVEGPTPS---LPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHcCCCCC---CcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 5554432211 113578999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=250.93 Aligned_cols=189 Identities=18% Similarity=0.271 Sum_probs=156.8
Q ss_pred CCCcccccee---ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 1 MYHQKLQHLF---YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 1 l~Hpni~~~~---~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
+.||||++++ ....+++||||+.+|+|.+++... +.+++..+..++.|++.||.|||++|++||||||+||++
T Consensus 53 l~h~~iv~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili--- 128 (257)
T cd05060 53 LDHPCIVRLIGVCKGEPLMLVMELAPLGPLLKYLKKR-REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLL--- 128 (257)
T ss_pred cCCCCeeeEEEEEcCCceEEEEEeCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEE---
Confidence 4799999998 346789999999999999988765 579999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCCccccCCCCCc----ccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 016471 78 EEDAPLKVIDFGLSDFVRPDQRL----NDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIF 151 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~ 151 (389)
+.++.+||+|||++......... ....++..|+|||.+. ..++.++|+||+||++|++++ |.+||...+..+..
T Consensus 129 ~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~ 208 (257)
T cd05060 129 VNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVI 208 (257)
T ss_pred cCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHH
Confidence 46788999999998866433221 1112346799999875 468899999999999999998 99999887777666
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 152 RSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 152 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
..+...... .....+++.+++++.+||..+|.+|||+.++++
T Consensus 209 ~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 209 AMLESGERL---PRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred HHHHcCCcC---CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 666554322 122457899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=257.79 Aligned_cols=196 Identities=26% Similarity=0.447 Sum_probs=157.6
Q ss_pred CCCccccceee--------------cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecC
Q 016471 1 MYHQKLQHLFY--------------SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRD 66 (389)
Q Consensus 1 l~Hpni~~~~~--------------~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrd 66 (389)
++||||++++. ...+|+|+||+++ ++.+.+......+++..+..++.||+.||.|||+.||+|||
T Consensus 63 l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~d 141 (302)
T cd07864 63 LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRD 141 (302)
T ss_pred CCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 57999999872 1278999999987 77777766556799999999999999999999999999999
Q ss_pred CCCCcEEEeecCCCCCEEEeecCCccccCCCC--CcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCCCCC
Q 016471 67 LKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ--RLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPF 142 (389)
Q Consensus 67 lkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf 142 (389)
|+|+||++ ++++.+||+|||++....... ......++..|+|||.+.+ .++.++||||+||++|+|++|++||
T Consensus 142 l~p~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~ 218 (302)
T cd07864 142 IKCSNILL---NNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIF 218 (302)
T ss_pred CCHHHEEE---CCCCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCC
Confidence 99999999 567899999999987654332 1223356788999998743 4788999999999999999999999
Q ss_pred CCCChhHHHHHHHhcCCCCCC--------------------------CCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 143 WARTESGIFRSVLRADPNFHD--------------------------SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 143 ~~~~~~~~~~~i~~~~~~~~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
...........+.+....... ..+..+++.+.+++.+||..+|.+|||+.+++.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 219 QANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 876665554444332111100 012347899999999999999999999999999
Q ss_pred CCCC
Q 016471 197 HPWL 200 (389)
Q Consensus 197 h~~~ 200 (389)
||||
T Consensus 299 ~~~~ 302 (302)
T cd07864 299 SPWL 302 (302)
T ss_pred CCCC
Confidence 9997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=252.54 Aligned_cols=191 Identities=22% Similarity=0.375 Sum_probs=159.5
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ ..+.+|+||||+++|+|.+++....+.+++..+..++.|++.||.|||++||+||||||+||++
T Consensus 62 l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili-- 139 (266)
T cd05033 62 FDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILV-- 139 (266)
T ss_pred CCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE--
Confidence 5799999988 3577999999999999999987766789999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCC-CCc--ccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPD-QRL--NDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIF 151 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~-~~~--~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~ 151 (389)
+.++.++|+|||++...... ... ....+++.|+|||.+. ..++.++|+||+|+++|+|++ |..||......+..
T Consensus 140 -~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~ 218 (266)
T cd05033 140 -NSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVI 218 (266)
T ss_pred -cCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHH
Confidence 46788999999999876421 111 1223457899999885 468899999999999999998 99999887777776
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCC
Q 016471 152 RSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 197 (389)
Q Consensus 152 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h 197 (389)
..+...... + .....++.+.+++.+||..+|.+||++.+++++
T Consensus 219 ~~~~~~~~~-~--~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 219 KAVEDGYRL-P--PPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHcCCCC-C--CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 666543221 1 123578999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=260.91 Aligned_cols=199 Identities=29% Similarity=0.444 Sum_probs=152.2
Q ss_pred CCCccccceee----c--CeEEEEEEccCCCChHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCC
Q 016471 1 MYHQKLQHLFY----S--NSFLFFTRFCEGGELLDRILSR----GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPE 70 (389)
Q Consensus 1 l~Hpni~~~~~----~--~~~~lv~E~~~gg~L~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~ 70 (389)
+.||||++++. . ..+|+|||||.+ +|.+.+... ...+++..+..++.||+.||+|||++||+||||||+
T Consensus 59 l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~ 137 (316)
T cd07842 59 LKHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPA 137 (316)
T ss_pred cCCCCccceEEEEeCCCCceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHH
Confidence 57999999882 3 679999999986 677766432 136899999999999999999999999999999999
Q ss_pred cEEEeec-CCCCCEEEeecCCccccCCCC----CcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCC
Q 016471 71 NFLFTTR-EEDAPLKVIDFGLSDFVRPDQ----RLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFW 143 (389)
Q Consensus 71 Nill~~~-~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~ 143 (389)
||+++.. +.++.+||+|||++....... ......+++.|+|||++.+ .++.++|+||+||++|+|++|++||.
T Consensus 138 Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~ 217 (316)
T cd07842 138 NILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFK 217 (316)
T ss_pred HEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCc
Confidence 9999421 127889999999988654322 1234568899999998743 47899999999999999999999997
Q ss_pred CCChhH---------HHHHHHhcCC---------------------CCCCCCCC------------CCCHHHHHHHHhhh
Q 016471 144 ARTESG---------IFRSVLRADP---------------------NFHDSPWP------------SVSPEAKDFVRRLL 181 (389)
Q Consensus 144 ~~~~~~---------~~~~i~~~~~---------------------~~~~~~~~------------~~~~~~~~li~~~l 181 (389)
+..... .+..+..... .......+ ..+..+.+++.+||
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 297 (316)
T cd07842 218 GREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLL 297 (316)
T ss_pred CCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHh
Confidence 654321 1111111000 00001111 46778999999999
Q ss_pred ccCcCCCCCHHHHhCCCCC
Q 016471 182 NKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 182 ~~~p~~R~s~~e~l~h~~~ 200 (389)
..+|.+|||+.+++.||||
T Consensus 298 ~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 298 EYDPTKRITAEEALEHPYF 316 (316)
T ss_pred cCCcccCcCHHHHhcCCCC
Confidence 9999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=253.98 Aligned_cols=189 Identities=19% Similarity=0.243 Sum_probs=151.7
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ .....|+|||||+||+|..++....+.+++..+..++.||+.||+|||++||+||||||+||+++.
T Consensus 73 l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~ 152 (274)
T cd05076 73 VSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLAR 152 (274)
T ss_pred CCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEec
Confidence 5799999999 356789999999999998888766678999999999999999999999999999999999999963
Q ss_pred cC----CCCCEEEeecCCccccCCCCCcccccccCCccccccccc--cCCCchhHHHHHHHHHHHH-hCCCCCCCCChhH
Q 016471 77 RE----EDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILL-CGSRPFWARTESG 149 (389)
Q Consensus 77 ~~----~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~ 149 (389)
.+ ....+|++|||++...... ....++..|+|||.+.+ .++.++|+||+||++|+++ +|..||.+.....
T Consensus 153 ~~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 153 LGLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred cCcccCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 21 1235899999987643221 23457888999998753 5889999999999999985 6999998766554
Q ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCC
Q 016471 150 IFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 197 (389)
Q Consensus 150 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h 197 (389)
.... .......+ ...++.+.++|.+||..+|.+|||+.+++++
T Consensus 230 ~~~~-~~~~~~~~----~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 230 KERF-YEKKHRLP----EPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HHHH-HHhccCCC----CCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 4332 22222222 1246789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=247.88 Aligned_cols=195 Identities=26% Similarity=0.506 Sum_probs=166.3
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
+||.+|.+. .+..+++|.||++||+|.-.+..+ .+++|+.++.+...|+.||+|||++||++||||.+|+|+
T Consensus 309 n~pflvglhscfqtesrlffvieyv~ggdlmfhmqrq-rklpeeharfys~ei~lal~flh~rgiiyrdlkldnvll--- 384 (593)
T KOG0695|consen 309 NNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLL--- 384 (593)
T ss_pred CCCeEEehhhhhcccceEEEEEEEecCcceeeehhhh-hcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEE---
Confidence 689999887 467899999999999998877665 689999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCCcccc-CCCCCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCC-------C-Ch
Q 016471 78 EEDAPLKVIDFGLSDFV-RPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWA-------R-TE 147 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~-~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~-------~-~~ 147 (389)
+..+.+||+|+|+++.. .++....++||||.|+|||++.+ .|+..+|+|+|||+++||+.|+.||.- . +.
T Consensus 385 daeghikltdygmcke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~nte 464 (593)
T KOG0695|consen 385 DAEGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTE 464 (593)
T ss_pred ccCCceeecccchhhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchh
Confidence 67899999999998753 55667788999999999999975 699999999999999999999999942 1 22
Q ss_pred hHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCC------CHHHHhCCCCCCCCC
Q 016471 148 SGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRM------TAAQALTHPWLHDEN 204 (389)
Q Consensus 148 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~------s~~e~l~h~~~~~~~ 204 (389)
.-+++-|+.....+|. ++|-.+..+++..|++||.+|. ...++..|+||+..+
T Consensus 465 dylfqvilekqiripr----slsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~id 523 (593)
T KOG0695|consen 465 DYLFQVILEKQIRIPR----SLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSID 523 (593)
T ss_pred HHHHHHHhhhcccccc----eeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCC
Confidence 2345556655555443 4788899999999999999996 468999999997553
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=263.22 Aligned_cols=199 Identities=30% Similarity=0.503 Sum_probs=156.8
Q ss_pred CCCccccceee------------------cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 016471 1 MYHQKLQHLFY------------------SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGV 62 (389)
Q Consensus 1 l~Hpni~~~~~------------------~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i 62 (389)
+.||||++++. ...+|+||||+++ +|.+++.. +.+++..++.++.||+.||+|||++||
T Consensus 59 l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~gi 135 (342)
T cd07854 59 LDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSANV 135 (342)
T ss_pred cCCCcchhhHhhhcccccccccccccccccceEEEEeecccc-cHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 57999999872 1358999999974 88876643 479999999999999999999999999
Q ss_pred EecCCCCCcEEEeecCCCCCEEEeecCCccccCCCC----CcccccccCCcccccccc--ccCCCchhHHHHHHHHHHHH
Q 016471 63 VHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ----RLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILL 136 (389)
Q Consensus 63 ~Hrdlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll 136 (389)
+||||||+||+++ ..++.+||+|||++....... ......++..|+|||.+. ..++.++||||+||++|+|+
T Consensus 136 vH~dikp~Nili~--~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~ 213 (342)
T cd07854 136 LHRDLKPANVFIN--TEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEML 213 (342)
T ss_pred ccCCCCHHHEEEc--CCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHH
Confidence 9999999999995 245679999999987653221 112235788999999764 35788999999999999999
Q ss_pred hCCCCCCCCChhHHHHHHHhcCCCC----------------------CC----CCCCCCCHHHHHHHHhhhccCcCCCCC
Q 016471 137 CGSRPFWARTESGIFRSVLRADPNF----------------------HD----SPWPSVSPEAKDFVRRLLNKDHRKRMT 190 (389)
Q Consensus 137 ~g~~pf~~~~~~~~~~~i~~~~~~~----------------------~~----~~~~~~~~~~~~li~~~l~~~p~~R~s 190 (389)
+|+.||.+.........+....+.. .. ...+.++.++.+||.+||..+|.+|||
T Consensus 214 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 293 (342)
T cd07854 214 TGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLT 293 (342)
T ss_pred hCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccC
Confidence 9999998776655544443321110 00 012357889999999999999999999
Q ss_pred HHHHhCCCCCCCCC
Q 016471 191 AAQALTHPWLHDEN 204 (389)
Q Consensus 191 ~~e~l~h~~~~~~~ 204 (389)
+.+++.||||+...
T Consensus 294 ~~ell~h~~~~~~~ 307 (342)
T cd07854 294 AEEALMHPYMSCYS 307 (342)
T ss_pred HHHHhCCCcccccc
Confidence 99999999997543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=249.99 Aligned_cols=191 Identities=21% Similarity=0.390 Sum_probs=159.6
Q ss_pred CCCcccccee---ecCeEEEEEEccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF---YSNSFLFFTRFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~---~~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
++||||+.++ .....++||||+++|+|.+++.... ..+++..+..++.|++.||.|||++|++||||+|+||++.
T Consensus 53 l~h~~iv~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~- 131 (257)
T cd05040 53 LDHENLIRLYGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLA- 131 (257)
T ss_pred cCCCCccceeEEEcCCeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEe-
Confidence 5799999988 2378999999999999999987764 4689999999999999999999999999999999999994
Q ss_pred cCCCCCEEEeecCCccccCCCC----CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ----RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGI 150 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~ 150 (389)
.++.+||+|||++....... ......++..|+|||.+. ..++.++|+||+||++|+|++ |..||...+..+.
T Consensus 132 --~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~ 209 (257)
T cd05040 132 --SDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI 209 (257)
T ss_pred --cCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 66889999999987664321 112245678899999885 468999999999999999998 9999988777777
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 151 FRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 151 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
...+.......+.+ ...+..+.+++.+||..+|.+|||+.++++
T Consensus 210 ~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 210 LKKIDKEGERLERP--EACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HHHHHhcCCcCCCC--ccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 77666533322221 357899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=258.60 Aligned_cols=196 Identities=23% Similarity=0.420 Sum_probs=156.9
Q ss_pred CCCccccceee------------cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCC
Q 016471 1 MYHQKLQHLFY------------SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLK 68 (389)
Q Consensus 1 l~Hpni~~~~~------------~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlk 68 (389)
+.||||++++. ...+|+||||+.+ +|...+......+++..+..++.|++.||.|||++||+|||||
T Consensus 64 l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~ 142 (311)
T cd07866 64 LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIK 142 (311)
T ss_pred cCCCCccchhhheecccccccccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 57999999872 2347999999976 7777776655689999999999999999999999999999999
Q ss_pred CCcEEEeecCCCCCEEEeecCCccccCCCCC------------cccccccCCccccccccc--cCCCchhHHHHHHHHHH
Q 016471 69 PENFLFTTREEDAPLKVIDFGLSDFVRPDQR------------LNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYI 134 (389)
Q Consensus 69 p~Nill~~~~~~~~~kl~Dfg~a~~~~~~~~------------~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ 134 (389)
|+||++ +.++.++|+|||++........ .....+++.|+|||.+.+ .++.++|+||+||++|+
T Consensus 143 p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e 219 (311)
T cd07866 143 AANILI---DNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAE 219 (311)
T ss_pred HHHEEE---CCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHH
Confidence 999999 5778999999999875532211 123357888999998743 47899999999999999
Q ss_pred HHhCCCCCCCCChhHHHHHHHhcCCCCCCC--------------------------CCCCCCHHHHHHHHhhhccCcCCC
Q 016471 135 LLCGSRPFWARTESGIFRSVLRADPNFHDS--------------------------PWPSVSPEAKDFVRRLLNKDHRKR 188 (389)
Q Consensus 135 ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~--------------------------~~~~~~~~~~~li~~~l~~~p~~R 188 (389)
|++|++||.+.+.......+.......... .+..+++.+.++|.+||..+|.+|
T Consensus 220 l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 299 (311)
T cd07866 220 MFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKR 299 (311)
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccC
Confidence 999999998877766555544321111100 112456789999999999999999
Q ss_pred CCHHHHhCCCCC
Q 016471 189 MTAAQALTHPWL 200 (389)
Q Consensus 189 ~s~~e~l~h~~~ 200 (389)
||+.+++.||||
T Consensus 300 ~t~~ell~~~~f 311 (311)
T cd07866 300 LTASDALEHPYF 311 (311)
T ss_pred cCHHHHhcCCCC
Confidence 999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=254.35 Aligned_cols=190 Identities=17% Similarity=0.297 Sum_probs=158.0
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSR---------------GGRYLEEDAKTIVEKILNIVAFCHLQG 61 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~---------------~~~l~~~~~~~i~~qi~~~L~~lH~~~ 61 (389)
+.||||++++ .....++++||+.+++|.+++... ...+++..+..++.|++.||.|||++|
T Consensus 65 l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g 144 (283)
T cd05091 65 LQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH 144 (283)
T ss_pred CCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC
Confidence 5799999998 346799999999999999988532 235888899999999999999999999
Q ss_pred CEecCCCCCcEEEeecCCCCCEEEeecCCccccCCCCC---cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh
Q 016471 62 VVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC 137 (389)
Q Consensus 62 i~Hrdlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~ 137 (389)
|+||||||+||++ ++++.+||+|||++........ .....+++.|+|||.+. +.++.++||||+||++|+|++
T Consensus 145 i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~ 221 (283)
T cd05091 145 VVHKDLATRNVLV---FDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221 (283)
T ss_pred ccccccchhheEe---cCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHc
Confidence 9999999999999 4677899999999876533221 22345678899999874 568999999999999999998
Q ss_pred -CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 138 -GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 138 -g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
|..||.+....+....+........ ...++..+.+++.+||+.+|.+||++++++.
T Consensus 222 ~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~ 278 (283)
T cd05091 222 YGLQPYCGYSNQDVIEMIRNRQVLPC---PDDCPAWVYTLMLECWNEFPSRRPRFKDIHS 278 (283)
T ss_pred CCCCCCCCCCHHHHHHHHHcCCcCCC---CCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 8899988888777777766543221 1358899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=261.51 Aligned_cols=191 Identities=21% Similarity=0.367 Sum_probs=153.3
Q ss_pred CCccccceee-----cCeEEEEEEccCCCChHHHHHhcC-----------------------------------------
Q 016471 2 YHQKLQHLFY-----SNSFLFFTRFCEGGELLDRILSRG----------------------------------------- 35 (389)
Q Consensus 2 ~Hpni~~~~~-----~~~~~lv~E~~~gg~L~~~l~~~~----------------------------------------- 35 (389)
.||||+.++. +..+++||||++||+|.+++....
T Consensus 69 ~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (337)
T cd05054 69 HHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFI 148 (337)
T ss_pred cCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccc
Confidence 6999999983 356899999999999999886431
Q ss_pred -------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeecCCCCCEEEeecCCccccCC
Q 016471 36 -------------------GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP 96 (389)
Q Consensus 36 -------------------~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~ 96 (389)
..+++..+..++.||+.||+|||++||+||||||+||++. .++.+||+|||++.....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~---~~~~vkL~DfG~a~~~~~ 225 (337)
T cd05054 149 EDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYK 225 (337)
T ss_pred cCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEe---CCCcEEEeccccchhccc
Confidence 2578999999999999999999999999999999999994 678899999999986533
Q ss_pred CC---CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 016471 97 DQ---RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSP 171 (389)
Q Consensus 97 ~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 171 (389)
.. ......++..|+|||++. ..++.++||||+||++|+|++ |..||.+....+.............. ....++
T Consensus 226 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 303 (337)
T cd05054 226 DPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRA--PEYATP 303 (337)
T ss_pred CcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCC--CccCCH
Confidence 22 122345667899999875 569999999999999999998 99999875544444333333222111 135688
Q ss_pred HHHHHHHhhhccCcCCCCCHHHHhCC
Q 016471 172 EAKDFVRRLLNKDHRKRMTAAQALTH 197 (389)
Q Consensus 172 ~~~~li~~~l~~~p~~R~s~~e~l~h 197 (389)
.+.+++.+||+.+|.+||++.++++|
T Consensus 304 ~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 304 EIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=254.47 Aligned_cols=190 Identities=33% Similarity=0.664 Sum_probs=162.5
Q ss_pred Ccccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeecC
Q 016471 3 HQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE 78 (389)
Q Consensus 3 Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~~ 78 (389)
||||++++ ..+.+++||||+++|+|.+++.+. +.+++..+..++.|++.||.|||++|++|+||+|+||++ +
T Consensus 61 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i---~ 136 (280)
T cd05581 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILL---D 136 (280)
T ss_pred CCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---C
Confidence 99999988 457899999999999999988665 579999999999999999999999999999999999999 4
Q ss_pred CCCCEEEeecCCccccCCCC---------------------CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHH
Q 016471 79 EDAPLKVIDFGLSDFVRPDQ---------------------RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILL 136 (389)
Q Consensus 79 ~~~~~kl~Dfg~a~~~~~~~---------------------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll 136 (389)
.++.++|+|||++....... ......++..|+|||+.. ..++.++|+||+|+++|+++
T Consensus 137 ~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~ 216 (280)
T cd05581 137 KDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQML 216 (280)
T ss_pred CCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHH
Confidence 67889999999987654322 112345788999999875 45888999999999999999
Q ss_pred hCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCH----HHHhCCCCC
Q 016471 137 CGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTA----AQALTHPWL 200 (389)
Q Consensus 137 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~----~e~l~h~~~ 200 (389)
+|+.||...+.......+.......+ ..+++.+.++|.+||..+|.+|||+ .++++||||
T Consensus 217 ~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 217 TGKPPFRGSNEYLTFQKILKLEYSFP----PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred hCCCCCCCccHHHHHHHHHhcCCCCC----CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 99999988877666666654433333 3578999999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=263.23 Aligned_cols=199 Identities=32% Similarity=0.493 Sum_probs=163.4
Q ss_pred CCCccccceee----c-----CeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCc
Q 016471 1 MYHQKLQHLFY----S-----NSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPEN 71 (389)
Q Consensus 1 l~Hpni~~~~~----~-----~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~N 71 (389)
+.||||+.++. . ..+|+||||+.+ +|.+.+... +.+++..+..++.||+.||+|||++||+||||||+|
T Consensus 56 l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~n 133 (330)
T cd07834 56 LRHENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSP-QPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSN 133 (330)
T ss_pred cCCcchhhhhhhhcccCcccccceEEEecchhh-hHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 47999998882 2 378999999985 888877554 589999999999999999999999999999999999
Q ss_pred EEEeecCCCCCEEEeecCCccccCCCC----CcccccccCCcccccccc-c-cCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 016471 72 FLFTTREEDAPLKVIDFGLSDFVRPDQ----RLNDIVGSAYYVAPEVLH-R-SYNVEGDMWSIGVITYILLCGSRPFWAR 145 (389)
Q Consensus 72 ill~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~-~-~~~~~~DiwslG~il~~ll~g~~pf~~~ 145 (389)
|++ +.++.++|+|||++....... ......+++.|+|||.+. . .++.++|+||+|+++|+|++|.+||.+.
T Consensus 134 ili---~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~ 210 (330)
T cd07834 134 ILV---NSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGR 210 (330)
T ss_pred EEE---cCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCC
Confidence 999 467899999999998765432 234456889999999885 3 5889999999999999999999999888
Q ss_pred ChhHHHHHHHhcCCCCCCC---------------------------CCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCC
Q 016471 146 TESGIFRSVLRADPNFHDS---------------------------PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHP 198 (389)
Q Consensus 146 ~~~~~~~~i~~~~~~~~~~---------------------------~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~ 198 (389)
+..+....+.......... ..+.+++.+.++|.+||..+|.+|||+++++.||
T Consensus 211 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 290 (330)
T cd07834 211 DYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHP 290 (330)
T ss_pred CHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCc
Confidence 7766666555432211110 0134688999999999999999999999999999
Q ss_pred CCCCCC
Q 016471 199 WLHDEN 204 (389)
Q Consensus 199 ~~~~~~ 204 (389)
||....
T Consensus 291 ~~~~~~ 296 (330)
T cd07834 291 YLAQLH 296 (330)
T ss_pred cHHhhc
Confidence 997653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=253.79 Aligned_cols=190 Identities=19% Similarity=0.363 Sum_probs=156.8
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG--------------GRYLEEDAKTIVEKILNIVAFCHLQGV 62 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~--------------~~l~~~~~~~i~~qi~~~L~~lH~~~i 62 (389)
+.||||++++ .....|+||||+++|+|.+++.... ..+++..+..++.|++.||+|||++|+
T Consensus 64 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i 143 (280)
T cd05092 64 LQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHF 143 (280)
T ss_pred CCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 5799999998 3567999999999999999887542 248899999999999999999999999
Q ss_pred EecCCCCCcEEEeecCCCCCEEEeecCCccccCCCCC---cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-
Q 016471 63 VHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC- 137 (389)
Q Consensus 63 ~Hrdlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~- 137 (389)
+||||||+||++ ++++.+||+|||++........ .....+++.|+|||.+. ..++.++|+|||||++|+|++
T Consensus 144 ~H~dlkp~nil~---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~ 220 (280)
T cd05092 144 VHRDLATRNCLV---GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTY 220 (280)
T ss_pred ecccccHhhEEE---cCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcC
Confidence 999999999999 4678899999999875533221 12234567899999875 468999999999999999998
Q ss_pred CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 138 GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 138 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
|.+||...........+....... ....+++.+.+++.+||..+|.+||++.+++.
T Consensus 221 g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 221 GKQPWYQLSNTEAIECITQGRELE---RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred CCCCCccCCHHHHHHHHHcCccCC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 999998877776666665543221 12357899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=252.35 Aligned_cols=190 Identities=19% Similarity=0.249 Sum_probs=155.3
Q ss_pred CCCccccceee----------cCeEEEEEEccCCCChHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCCEec
Q 016471 1 MYHQKLQHLFY----------SNSFLFFTRFCEGGELLDRILSR-----GGRYLEEDAKTIVEKILNIVAFCHLQGVVHR 65 (389)
Q Consensus 1 l~Hpni~~~~~----------~~~~~lv~E~~~gg~L~~~l~~~-----~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hr 65 (389)
++||||++++. ....++||||+.+|+|.+++... ...+++..+..++.|++.||.|||++||+||
T Consensus 57 l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~ 136 (272)
T cd05075 57 FDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHR 136 (272)
T ss_pred CCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence 57999999872 12468999999999999887532 2348899999999999999999999999999
Q ss_pred CCCCCcEEEeecCCCCCEEEeecCCccccCCCCC---cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCC
Q 016471 66 DLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSR 140 (389)
Q Consensus 66 dlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~ 140 (389)
||||+||++ +.++.+||+|||++........ .....+++.|+|||.+. ..++.++|+||+||++|+|++ |+.
T Consensus 137 dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~ 213 (272)
T cd05075 137 DLAARNCML---NENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQT 213 (272)
T ss_pred ccchhheEE---cCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCC
Confidence 999999999 5678899999999887643321 12234567899999885 468999999999999999999 899
Q ss_pred CCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 141 PFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 141 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
||.+....+....+...... + ..+.++..+.+++.+||..+|.+|||+.++++
T Consensus 214 p~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~ 266 (272)
T cd05075 214 PYPGVENSEIYDYLRQGNRL-K--QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRC 266 (272)
T ss_pred CCCCCCHHHHHHHHHcCCCC-C--CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 99887777776666554321 1 12467899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=254.04 Aligned_cols=196 Identities=28% Similarity=0.503 Sum_probs=160.0
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||+.++ ....+++||||+++ +|.+++.+....+++..+..++.|++.||.|||++||+||||+|+||++
T Consensus 55 ~~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~-- 131 (282)
T cd07829 55 LKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILI-- 131 (282)
T ss_pred cCCCCHHHHHhhhhcCCceEEEecCcCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEE--
Confidence 4699999988 45789999999985 8999887664679999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC-CcccccccCCcccccccc-c-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLH-R-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRS 153 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~-~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 153 (389)
++++.++|+|||.+....... ......++..|+|||.+. . .++.++|+||+||++|++++|.+||.+.+....+..
T Consensus 132 -~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~ 210 (282)
T cd07829 132 -NRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFK 210 (282)
T ss_pred -cCCCCEEEecCCcccccCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence 467899999999987664432 223345678899999874 3 688999999999999999999999988776555444
Q ss_pred HHhcCCCC------------------C-------CCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCC
Q 016471 154 VLRADPNF------------------H-------DSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 154 i~~~~~~~------------------~-------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~ 200 (389)
+.+..... + ...++.++..+.++|.+||..+|.+||++.+++.||||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 211 IFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred HHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 43211100 0 01224568899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=256.19 Aligned_cols=190 Identities=23% Similarity=0.387 Sum_probs=154.8
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
.||||++++ ..+..|+||||+++|+|.+++.... ..+++.++..++.|++.||.|||++||+|+||||+||++
T Consensus 97 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~-- 174 (302)
T cd05055 97 NHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLL-- 174 (302)
T ss_pred CCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEE--
Confidence 699999998 3567999999999999999886543 338999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCC---cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIF 151 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~ 151 (389)
+.++.++++|||++........ .....+++.|+|||.+. ..++.++||||+||++|+|++ |..||.+.......
T Consensus 175 -~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~ 253 (302)
T cd05055 175 -THGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF 253 (302)
T ss_pred -cCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHH
Confidence 4678899999999876543221 12234577899999875 468999999999999999998 99999876665554
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 152 RSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 152 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
........... .....++.+.+++.+||..+|++|||+.+++.
T Consensus 254 ~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 254 YKLIKEGYRMA--QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred HHHHHcCCcCC--CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 44443322221 12357899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-33 Score=249.95 Aligned_cols=188 Identities=22% Similarity=0.336 Sum_probs=155.9
Q ss_pred CCCccccceee-----cCeEEEEEEccCCCChHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEE
Q 016471 1 MYHQKLQHLFY-----SNSFLFFTRFCEGGELLDRILSRGG-RYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLF 74 (389)
Q Consensus 1 l~Hpni~~~~~-----~~~~~lv~E~~~gg~L~~~l~~~~~-~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill 74 (389)
+.|||+++++. ...+|+||||+++|+|.+++.++.. .+++..+..++.||+.||+|||++|++||||||+||++
T Consensus 56 l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~ 135 (256)
T cd05082 56 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLV 135 (256)
T ss_pred CCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEE
Confidence 57999999772 3568999999999999998876533 48899999999999999999999999999999999999
Q ss_pred eecCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHH
Q 016471 75 TTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFR 152 (389)
Q Consensus 75 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 152 (389)
+.++.+||+|||++....... ....++..|+|||++. ..++.++|+||+||++|+|++ |+.||......+...
T Consensus 136 ---~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~ 210 (256)
T cd05082 136 ---SEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP 210 (256)
T ss_pred ---cCCCcEEecCCccceeccccC--CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 467899999999987643322 2334566899999875 468899999999999999997 999998877777666
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 153 SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 153 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
.+.+... ....+.+++.+.+++.+||..+|.+|||+.++++
T Consensus 211 ~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 211 RVEKGYK---MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHhcCCC---CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 6654322 1222467899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=263.32 Aligned_cols=198 Identities=29% Similarity=0.538 Sum_probs=160.5
Q ss_pred CCCcccccee----ecC------eEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCC
Q 016471 1 MYHQKLQHLF----YSN------SFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPE 70 (389)
Q Consensus 1 l~Hpni~~~~----~~~------~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~ 70 (389)
+.||||+.+. ..+ .+|+|+||+ |++|.+++.. +++++..+..++.|++.||.|||+.||+||||+|+
T Consensus 71 l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~ 147 (343)
T cd07851 71 MDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPS 147 (343)
T ss_pred ccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHH
Confidence 4799998876 122 389999999 5699887754 47999999999999999999999999999999999
Q ss_pred cEEEeecCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChh
Q 016471 71 NFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTES 148 (389)
Q Consensus 71 Nill~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 148 (389)
||++ +.++.++|+|||++...... .....+++.|+|||.+.+ .++.++|+||+||++|++++|+.||.+....
T Consensus 148 Nill---~~~~~~kL~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~ 222 (343)
T cd07851 148 NIAV---NEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI 222 (343)
T ss_pred HeEE---CCCCCEEEcccccccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH
Confidence 9999 46788999999998765432 344578899999998743 5788999999999999999999999887766
Q ss_pred HHHHHHHhcCCCCCC---------------------------CCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCC
Q 016471 149 GIFRSVLRADPNFHD---------------------------SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLH 201 (389)
Q Consensus 149 ~~~~~i~~~~~~~~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~ 201 (389)
..+..+.......+. ..++.+++.+.++|.+||..+|.+|||+.+++.||||.
T Consensus 223 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~ 302 (343)
T cd07851 223 DQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLA 302 (343)
T ss_pred HHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCcc
Confidence 655555443211110 01134689999999999999999999999999999998
Q ss_pred CCCCC
Q 016471 202 DENRP 206 (389)
Q Consensus 202 ~~~~~ 206 (389)
....+
T Consensus 303 ~~~~~ 307 (343)
T cd07851 303 EYHDP 307 (343)
T ss_pred ccCCC
Confidence 76443
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=255.13 Aligned_cols=198 Identities=25% Similarity=0.421 Sum_probs=159.1
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCEecCCCCCcEEEee
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHL-QGVVHRDLKPENFLFTT 76 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~-~~i~Hrdlkp~Nill~~ 76 (389)
.||||+.++ ....+|+||||+.+ +|.+.+....+.+++..+..++.||+.||.|||+ .||+||||+|+||++
T Consensus 72 ~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill-- 148 (296)
T cd06618 72 DCPYIVKCYGYFITDSDVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILL-- 148 (296)
T ss_pred CCCchHhhheeeecCCeEEEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEE--
Confidence 489999988 45789999999864 7777666655689999999999999999999997 599999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc-----cCCCchhHHHHHHHHHHHHhCCCCCCCCCh-hHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-----SYNVEGDMWSIGVITYILLCGSRPFWARTE-SGI 150 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~ 150 (389)
++++.+||+|||++.............+++.|+|||.+.+ .++.++|+||+|+++|+|++|+.||..... .+.
T Consensus 149 -~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~ 227 (296)
T cd06618 149 -DASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEV 227 (296)
T ss_pred -cCCCCEEECccccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHH
Confidence 5678999999999876644333344567889999998853 378899999999999999999999976332 344
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 151 FRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 151 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
+..+....... .+....++..+.+++.+||..+|.+||++.+++.||||....
T Consensus 228 ~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 280 (296)
T cd06618 228 LTKILQEEPPS-LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE 280 (296)
T ss_pred HHHHhcCCCCC-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence 44444433211 111124789999999999999999999999999999997643
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=248.57 Aligned_cols=194 Identities=28% Similarity=0.493 Sum_probs=160.5
Q ss_pred CCCcccccee----ec--CeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEE
Q 016471 1 MYHQKLQHLF----YS--NSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLF 74 (389)
Q Consensus 1 l~Hpni~~~~----~~--~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill 74 (389)
+.||||+.++ .. ..+++|+||+++++|.+++.+. ..+++..+..++.|++.||.|||+.|++|+||+|+||++
T Consensus 56 l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i 134 (260)
T cd06606 56 LQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKF-GKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILV 134 (260)
T ss_pred cCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE
Confidence 5799999988 23 6799999999999999988765 489999999999999999999999999999999999999
Q ss_pred eecCCCCCEEEeecCCccccCCCCC---cccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCC-hhH
Q 016471 75 TTREEDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWART-ESG 149 (389)
Q Consensus 75 ~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~ 149 (389)
+ .++.++|+|||.+........ .....++..|+|||.+.. .++.++|+||+|+++|+|++|..||.... ...
T Consensus 135 ~---~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~ 211 (260)
T cd06606 135 D---SDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMA 211 (260)
T ss_pred c---CCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH
Confidence 4 578899999999887655442 345678899999998854 58899999999999999999999997765 222
Q ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCC
Q 016471 150 IFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 150 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~ 200 (389)
....+..... .+ .....++..+.+++.+||..+|.+||++.+++.||||
T Consensus 212 ~~~~~~~~~~-~~-~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 212 ALYKIGSSGE-PP-EIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HHHhccccCC-Cc-CCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 2222222111 11 1113568999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=260.25 Aligned_cols=198 Identities=29% Similarity=0.474 Sum_probs=158.3
Q ss_pred CCccccceeec--------CeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEE
Q 016471 2 YHQKLQHLFYS--------NSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFL 73 (389)
Q Consensus 2 ~Hpni~~~~~~--------~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nil 73 (389)
.||||++++.. ..+|+++||+. ++|.+.+... +.+++..++.++.||+.||+|||++||+||||||+||+
T Consensus 60 ~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nil 137 (332)
T cd07857 60 GHKNITCLYDMDIVFPGNFNELYLYEELME-ADLHQIIRSG-QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLL 137 (332)
T ss_pred CCCChheeeeeeeeccccCCcEEEEEeccc-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeE
Confidence 59999999831 45789999986 5898877554 67999999999999999999999999999999999999
Q ss_pred EeecCCCCCEEEeecCCccccCCCC-----CcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 016471 74 FTTREEDAPLKVIDFGLSDFVRPDQ-----RLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWART 146 (389)
Q Consensus 74 l~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~ 146 (389)
+ +.++.+||+|||++....... ......||+.|+|||.+.+ .++.++|+||+||++|++++|.+||.+.+
T Consensus 138 i---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~ 214 (332)
T cd07857 138 V---NADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKD 214 (332)
T ss_pred E---cCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCC
Confidence 9 567889999999987654321 1234578999999998643 58899999999999999999999998766
Q ss_pred hhHHHHHHHhcCCC-----------------------CC----CCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCC
Q 016471 147 ESGIFRSVLRADPN-----------------------FH----DSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPW 199 (389)
Q Consensus 147 ~~~~~~~i~~~~~~-----------------------~~----~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~ 199 (389)
.......+...... .+ ...++..+..+.+++.+||+.+|.+|||+.+++.|||
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~ 294 (332)
T cd07857 215 YVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPY 294 (332)
T ss_pred HHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChh
Confidence 54444333321110 00 1123456889999999999999999999999999999
Q ss_pred CCCCC
Q 016471 200 LHDEN 204 (389)
Q Consensus 200 ~~~~~ 204 (389)
+....
T Consensus 295 ~~~~~ 299 (332)
T cd07857 295 LAIWH 299 (332)
T ss_pred hhhhc
Confidence 97553
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=253.42 Aligned_cols=191 Identities=17% Similarity=0.316 Sum_probs=156.8
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcC----------------CCCCHHHHHHHHHHHHHHHHHHHHC
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG----------------GRYLEEDAKTIVEKILNIVAFCHLQ 60 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~----------------~~l~~~~~~~i~~qi~~~L~~lH~~ 60 (389)
+.||||++++ .....|+||||+.+|+|.+++..+. ..+++..+..++.|++.||.|||++
T Consensus 64 l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~ 143 (283)
T cd05090 64 LHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH 143 (283)
T ss_pred CCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc
Confidence 5799999988 3577999999999999999885331 2478899999999999999999999
Q ss_pred CCEecCCCCCcEEEeecCCCCCEEEeecCCccccCCCC---CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHH
Q 016471 61 GVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ---RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILL 136 (389)
Q Consensus 61 ~i~Hrdlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll 136 (389)
|++||||||+||++ +.++.+||+|||++....... ......++..|+|||++. ..++.++|+||+||++|+|+
T Consensus 144 ~i~H~dlkp~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~ 220 (283)
T cd05090 144 FFVHKDLAARNILI---GEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIF 220 (283)
T ss_pred CeehhccccceEEE---cCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHH
Confidence 99999999999999 467889999999987653322 123344667899999875 46899999999999999999
Q ss_pred h-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCC
Q 016471 137 C-GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 197 (389)
Q Consensus 137 ~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h 197 (389)
+ |..||.+.........+..... .+ ....+++.+.+++.+||..+|.+||++.+++++
T Consensus 221 ~~g~~p~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 221 SFGLQPYYGFSNQEVIEMVRKRQL-LP--CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred cCCCCCCCCCCHHHHHHHHHcCCc-CC--CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 8 9999988777666665554332 11 224578999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=251.10 Aligned_cols=192 Identities=18% Similarity=0.301 Sum_probs=151.5
Q ss_pred CCCccccceee----cCeEEEEEEccCCCChHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcE
Q 016471 1 MYHQKLQHLFY----SNSFLFFTRFCEGGELLDRILSRG----GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENF 72 (389)
Q Consensus 1 l~Hpni~~~~~----~~~~~lv~E~~~gg~L~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Ni 72 (389)
+.||||++++. ...+|+||||+++|+|.+++.... ...++..+..++.||+.||+|||++||+||||||+||
T Consensus 52 l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Ni 131 (269)
T cd05042 52 LNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNC 131 (269)
T ss_pred CCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhhe
Confidence 57999999983 577999999999999999886543 2346788899999999999999999999999999999
Q ss_pred EEeecCCCCCEEEeecCCccccCCCC---CcccccccCCcccccccc--------ccCCCchhHHHHHHHHHHHHh-CCC
Q 016471 73 LFTTREEDAPLKVIDFGLSDFVRPDQ---RLNDIVGSAYYVAPEVLH--------RSYNVEGDMWSIGVITYILLC-GSR 140 (389)
Q Consensus 73 ll~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~--------~~~~~~~DiwslG~il~~ll~-g~~ 140 (389)
++ +.++.+||+|||++....... ......+++.|+|||++. ..++.++||||+||++|+|++ |..
T Consensus 132 ll---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~ 208 (269)
T cd05042 132 QL---TADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQ 208 (269)
T ss_pred Ee---cCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCC
Confidence 99 567899999999986543221 112334567899999863 236789999999999999999 888
Q ss_pred CCCCCChhHHHHHHHhcC-CCCCCCC-CCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 141 PFWARTESGIFRSVLRAD-PNFHDSP-WPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 141 pf~~~~~~~~~~~i~~~~-~~~~~~~-~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
||......+....+.... ...+.+. ...+++.+.+++..|+ .+|.+|||++++++
T Consensus 209 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 209 PYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred CCCcCCHHHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 998777666655554432 2222222 2357888999999998 59999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=249.60 Aligned_cols=193 Identities=23% Similarity=0.455 Sum_probs=158.2
Q ss_pred CCCccccceee------cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEE
Q 016471 1 MYHQKLQHLFY------SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLF 74 (389)
Q Consensus 1 l~Hpni~~~~~------~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill 74 (389)
+.||||+.++. ...+++||||++|++|.+++... +.+++..+..++.||+.||.|||++|++||||||+||++
T Consensus 61 l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i 139 (264)
T cd06653 61 LRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILR 139 (264)
T ss_pred cCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE
Confidence 57999999882 24689999999999999988655 568999999999999999999999999999999999999
Q ss_pred eecCCCCCEEEeecCCccccCCC----CCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhH
Q 016471 75 TTREEDAPLKVIDFGLSDFVRPD----QRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESG 149 (389)
Q Consensus 75 ~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 149 (389)
+.++.++|+|||++...... .......|+..|+|||.+.+ .++.++|+||+||++|++++|+.||.......
T Consensus 140 ---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 216 (264)
T cd06653 140 ---DSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA 216 (264)
T ss_pred ---cCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH
Confidence 46788999999998765321 12234568899999998854 57889999999999999999999998766555
Q ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCC
Q 016471 150 IFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 150 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~ 200 (389)
....+...... ....+.+++.+.+++.+||. +|.+||++.+++.|||.
T Consensus 217 ~~~~~~~~~~~--~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 217 AIFKIATQPTK--PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHHcCCCC--CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 54444332211 11224688999999999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=249.97 Aligned_cols=190 Identities=22% Similarity=0.335 Sum_probs=158.0
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEe
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 75 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~ 75 (389)
|.||||+.++ ....+|+|||||++|+|.+++.+. ...+++..+..++.||+.||.|||++|++||||+|+||++
T Consensus 59 l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv- 137 (261)
T cd05148 59 LRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILV- 137 (261)
T ss_pred CCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEE-
Confidence 5799999988 357799999999999999998753 3468999999999999999999999999999999999999
Q ss_pred ecCCCCCEEEeecCCccccCCCCC-cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHH
Q 016471 76 TREEDAPLKVIDFGLSDFVRPDQR-LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFR 152 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 152 (389)
++++.+||+|||++........ .....++..|+|||.+. +.++.++|+||+|+++|+|++ |+.||.+.+..+...
T Consensus 138 --~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~ 215 (261)
T cd05148 138 --GEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYD 215 (261)
T ss_pred --cCCceEEEccccchhhcCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence 4678899999999876543221 12334567899999875 468899999999999999998 899998887777777
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 153 SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 153 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
.+..... .+ .....++.+.+++.+||..+|.+|||+.++++
T Consensus 216 ~~~~~~~-~~--~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 216 QITAGYR-MP--CPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHhCCc-CC--CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 6664321 11 22467899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=254.97 Aligned_cols=190 Identities=23% Similarity=0.421 Sum_probs=152.7
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEe
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 75 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~ 75 (389)
++||||++++ ..+.+++|||||++|+|.+++... ...+++..+..++.||+.||.|||+++++|++|+|+||+++
T Consensus 58 l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~ 137 (259)
T PF07714_consen 58 LRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLD 137 (259)
T ss_dssp HSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 4799999999 246799999999999999999876 56799999999999999999999999999999999999994
Q ss_pred ecCCCCCEEEeecCCccccCCCCC---cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHH
Q 016471 76 TREEDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGI 150 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~ 150 (389)
.++.+||+|||++........ .....+...|+|||.+. ..++.++||||||+++||+++ |+.||...+..+.
T Consensus 138 ---~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~ 214 (259)
T PF07714_consen 138 ---SNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEI 214 (259)
T ss_dssp ---TTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHH
T ss_pred ---ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 678999999999887632221 22345677899999985 458999999999999999999 7899988888777
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 151 FRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 151 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
...+...... + ....++..+.++|.+||..+|.+|||+.++++
T Consensus 215 ~~~~~~~~~~-~--~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 215 IEKLKQGQRL-P--IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHHHTTEET-T--SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred cccccccccc-e--eccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 7777544332 2 12457999999999999999999999999874
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=249.33 Aligned_cols=190 Identities=19% Similarity=0.268 Sum_probs=153.5
Q ss_pred CCCccccceee-----cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEe
Q 016471 1 MYHQKLQHLFY-----SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 75 (389)
Q Consensus 1 l~Hpni~~~~~-----~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~ 75 (389)
+.||||+.++. +...++||||+.+|+|.+++.+....+++..+..++.||+.||.|||+.|++||||||+||++
T Consensus 53 l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili- 131 (262)
T cd05058 53 FSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCML- 131 (262)
T ss_pred CCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE-
Confidence 57999999883 345899999999999999887665667888899999999999999999999999999999999
Q ss_pred ecCCCCCEEEeecCCccccCCCC-----CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChh
Q 016471 76 TREEDAPLKVIDFGLSDFVRPDQ-----RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTES 148 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~ 148 (389)
+.++.+||+|||++....... ......+++.|+|||.+. ..++.++||||+||++|+|++ |.+||......
T Consensus 132 --~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~ 209 (262)
T cd05058 132 --DESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF 209 (262)
T ss_pred --cCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 467889999999987543211 112234567899999875 468899999999999999999 56777776666
Q ss_pred HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 149 GIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 149 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
.....+......... ..+++.+.+++.+||..+|++||++.+++.
T Consensus 210 ~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 210 DITVYLLQGRRLLQP---EYCPDPLYEVMLSCWHPKPEMRPTFSELVS 254 (262)
T ss_pred HHHHHHhcCCCCCCC---CcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 666655544322111 246889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=246.71 Aligned_cols=193 Identities=31% Similarity=0.542 Sum_probs=161.9
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.|||++.++ ....+++||||+++++|.+++... +.+++..+..++.|++.||.|||++||+||||+|+||+++
T Consensus 56 l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~- 133 (254)
T cd06627 56 LKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTT- 133 (254)
T ss_pred CCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEC-
Confidence 5799999987 357899999999999999988665 6899999999999999999999999999999999999994
Q ss_pred cCCCCCEEEeecCCccccCCCCC-cccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQR-LNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
.++.++|+|||++........ .....++..|+|||.+.+ .++.++|+||+|+++|+|++|..||...........+
T Consensus 134 --~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~ 211 (254)
T cd06627 134 --KDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRI 211 (254)
T ss_pred --CCCCEEEeccccceecCCCcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 578899999999887654332 234568899999998753 5788999999999999999999999876655444444
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~ 200 (389)
..... + ...+.++..+++++.+||..+|++|||+.+++.||||
T Consensus 212 ~~~~~--~-~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 212 VQDDH--P-PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred hccCC--C-CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 32221 1 1224678999999999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=246.75 Aligned_cols=190 Identities=19% Similarity=0.260 Sum_probs=156.7
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||+.++ ..+..++||||++||+|.+++......+++..+..++.|++.||.|||++|++||||||+||++
T Consensus 49 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili-- 126 (250)
T cd05085 49 YDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLV-- 126 (250)
T ss_pred CCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEE--
Confidence 5799999988 3567999999999999999887665678999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCCc--ccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRL--NDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFR 152 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 152 (389)
+.++.+||+|||++......... ....+++.|+|||++. +.++.++|+||+|+++|++++ |..||.+........
T Consensus 127 -~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~ 205 (250)
T cd05085 127 -GENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQARE 205 (250)
T ss_pred -cCCCeEEECCCccceeccccccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Confidence 46788999999998754332211 1223456799999885 468899999999999999998 999998877766666
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 153 SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 153 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
.+..... ......++..+.+++.+||..+|.+|||+.++++
T Consensus 206 ~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 206 QVEKGYR---MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred HHHcCCC---CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 5554321 1122457899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=249.21 Aligned_cols=190 Identities=22% Similarity=0.327 Sum_probs=156.8
Q ss_pred CCCcccccee---ecCeEEEEEEccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF---YSNSFLFFTRFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~---~~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||+.++ .....|+||||+++|+|.+++.+.. ..+++..+..++.|++.||.|||++|++||||||+||++
T Consensus 58 l~~~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill-- 135 (262)
T cd05071 58 LRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV-- 135 (262)
T ss_pred CCCCCcceEEEEECCCCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEE--
Confidence 5799999988 3567899999999999999987532 458899999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCC--cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQR--LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFR 152 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 152 (389)
++++.+||+|||.+........ .....++..|+|||... ..++.++|+||+||++|++++ |..||.+........
T Consensus 136 -~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~ 214 (262)
T cd05071 136 -GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD 214 (262)
T ss_pred -cCCCcEEeccCCceeeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHH
Confidence 4678899999999876543322 12334667899999875 468999999999999999999 889998877777666
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 153 SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 153 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
.+...... + ..+.++..+.+++.+||+.+|.+||++.++++
T Consensus 215 ~~~~~~~~-~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 215 QVERGYRM-P--CPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHhcCCCC-C--CccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 66543221 1 12457899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=254.85 Aligned_cols=195 Identities=31% Similarity=0.570 Sum_probs=158.1
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
.||||+.++ ....+|+||||+.||+|.+++... +.+++..++.++.|++.||.|||+.|++||||+|+||++
T Consensus 63 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~--- 138 (288)
T cd05583 63 RCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILL--- 138 (288)
T ss_pred CCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---
Confidence 589999987 357799999999999999988665 579999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCCccccCCCCC--cccccccCCccccccccc---cCCCchhHHHHHHHHHHHHhCCCCCCCCCh----h
Q 016471 78 EEDAPLKVIDFGLSDFVRPDQR--LNDIVGSAYYVAPEVLHR---SYNVEGDMWSIGVITYILLCGSRPFWARTE----S 148 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~ 148 (389)
+.++.++|+|||++........ .....|+..|+|||.+.+ ..+.++|+||+|+++|+|++|..||..... .
T Consensus 139 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~ 218 (288)
T cd05583 139 DSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQS 218 (288)
T ss_pred CCCCCEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHH
Confidence 5678899999999876543321 223468899999998753 267899999999999999999999964322 2
Q ss_pred HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCC---HHHHhCCCCCCCCC
Q 016471 149 GIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMT---AAQALTHPWLHDEN 204 (389)
Q Consensus 149 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s---~~e~l~h~~~~~~~ 204 (389)
.....+....+.. ...+++.+.+++.+||..+|++||| +.++++||||+...
T Consensus 219 ~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~ 273 (288)
T cd05583 219 EISRRILKSKPPF----PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGID 273 (288)
T ss_pred HHHHHHHccCCCC----CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCC
Confidence 3333333332221 2357899999999999999999998 56789999997764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=250.15 Aligned_cols=190 Identities=22% Similarity=0.395 Sum_probs=158.0
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ .++..|+||||++||+|.+++....+.+++.++..++.|++.||.|||++|++||||||+||++
T Consensus 62 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili-- 139 (267)
T cd05066 62 FDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILV-- 139 (267)
T ss_pred CCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEE--
Confidence 5799999998 3578999999999999999987766778999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCC----cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQR----LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGI 150 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~ 150 (389)
+.++.++|+|||++........ .....++..|+|||.+. +.++.++|+||+||++|++++ |..||......+.
T Consensus 140 -~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~ 218 (267)
T cd05066 140 -NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV 218 (267)
T ss_pred -CCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH
Confidence 4678899999999876543221 11122356799999886 468999999999999999886 9999988777766
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 151 FRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 151 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
...+.... ..+ ....+++.+.+++.+||+.+|.+||++.++++
T Consensus 219 ~~~~~~~~-~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 219 IKAIEEGY-RLP--APMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHHhCCC-cCC--CCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 66665442 122 22457899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=249.63 Aligned_cols=190 Identities=19% Similarity=0.346 Sum_probs=157.5
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ ..+..|+||||+++|+|.+++..+.+.+++..+..++.|++.||+|||+.|++||||||+||++
T Consensus 63 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili-- 140 (268)
T cd05063 63 FSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILV-- 140 (268)
T ss_pred CCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEE--
Confidence 4799999988 3577899999999999999887766789999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCCc--c--cccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRL--N--DIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGI 150 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~--~--~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~ 150 (389)
+.++.+||+|||++......... . ....++.|+|||++. +.++.++|+||+||++|++++ |..||...+....
T Consensus 141 -~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~ 219 (268)
T cd05063 141 -NSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEV 219 (268)
T ss_pred -cCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHH
Confidence 46788999999998765432211 1 112345799999875 468899999999999999997 9999988887777
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 151 FRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 151 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
...+...... + ....++..+.+++.+||..+|++||++.++++
T Consensus 220 ~~~i~~~~~~-~--~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 220 MKAINDGFRL-P--APMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHHHhcCCCC-C--CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 7776543221 1 12357899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=251.55 Aligned_cols=190 Identities=18% Similarity=0.310 Sum_probs=156.9
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCC
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG---------GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDL 67 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~---------~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdl 67 (389)
+.||||++++ .....|+||||+++|+|.+++.... +.+++..+..++.|++.||.|||++|++||||
T Consensus 66 ~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di 145 (277)
T cd05032 66 FNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDL 145 (277)
T ss_pred CCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccc
Confidence 4799999998 3577999999999999999886432 24678899999999999999999999999999
Q ss_pred CCCcEEEeecCCCCCEEEeecCCccccCCCC---CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCC
Q 016471 68 KPENFLFTTREEDAPLKVIDFGLSDFVRPDQ---RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPF 142 (389)
Q Consensus 68 kp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf 142 (389)
||+||++ +.++.+||+|||++....... ......++..|+|||.+. +.++.++|+|||||++|++++ |..||
T Consensus 146 ~p~nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 222 (277)
T cd05032 146 AARNCMV---AEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPY 222 (277)
T ss_pred ChheEEE---cCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCC
Confidence 9999999 567899999999987654322 122345678899999875 468899999999999999998 99999
Q ss_pred CCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 143 WARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 143 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
.+.+..+....+..... ... ...++..+.+++.+||..+|.+|||+.++++
T Consensus 223 ~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 223 QGLSNEEVLKFVIDGGH-LDL--PENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred ccCCHHHHHHHHhcCCC-CCC--CCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 88887777766653321 111 1346899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=248.42 Aligned_cols=190 Identities=21% Similarity=0.331 Sum_probs=156.6
Q ss_pred CCCcccccee---ecCeEEEEEEccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF---YSNSFLFFTRFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~---~~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.|||++.++ ..+..|+||||+.+|+|.+++.... ..+++..+..++.|++.||.|||+.|++||||||+||++
T Consensus 58 l~h~~i~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill-- 135 (260)
T cd05069 58 LRHDKLVPLYAVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILV-- 135 (260)
T ss_pred CCCCCeeeEEEEEcCCCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE--
Confidence 5799999987 3466899999999999999886543 348899999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCC--cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQR--LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFR 152 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 152 (389)
++++.++|+|||++........ .....++..|+|||... +.++.++|+||+||++|+|++ |..||.+....+...
T Consensus 136 -~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~ 214 (260)
T cd05069 136 -GDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLE 214 (260)
T ss_pred -cCCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 5678899999999876543221 12234567899999875 468899999999999999999 999998877777766
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 153 SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 153 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
.+..... . +....++..+++++.+||.++|.+||+++++++
T Consensus 215 ~~~~~~~-~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 215 QVERGYR-M--PCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHcCCC-C--CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 6654321 1 222457899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=250.24 Aligned_cols=191 Identities=23% Similarity=0.449 Sum_probs=154.3
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEE
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILS---RGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFL 73 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nil 73 (389)
+.||||+.++ ..+..++||||++||+|.+++.. ..+.+++..+..++.||+.||.|||++|++|+||||+||+
T Consensus 59 ~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nil 138 (267)
T cd08229 59 LNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVF 138 (267)
T ss_pred ccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEE
Confidence 5799999988 45789999999999999987753 2356899999999999999999999999999999999999
Q ss_pred EeecCCCCCEEEeecCCccccCCCC-CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChh--H
Q 016471 74 FTTREEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTES--G 149 (389)
Q Consensus 74 l~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~ 149 (389)
+ +.++.++|+|||++....... ......|++.|+|||.+. ..++.++|+||+|+++|+|++|..||.+.... .
T Consensus 139 i---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~ 215 (267)
T cd08229 139 I---TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS 215 (267)
T ss_pred E---cCCCCEEECcchhhhccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHH
Confidence 9 467889999999987654332 223457889999999885 46888999999999999999999999765432 2
Q ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 150 IFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 150 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
....+... ..+..+...+++.+++++.+||..+|.+|||+.++++
T Consensus 216 ~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 216 LCKKIEQC--DYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HhhhhhcC--CCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 23333322 1222233457899999999999999999999997764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=259.72 Aligned_cols=197 Identities=28% Similarity=0.461 Sum_probs=158.5
Q ss_pred CCccccceee------cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEe
Q 016471 2 YHQKLQHLFY------SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 75 (389)
Q Consensus 2 ~Hpni~~~~~------~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~ 75 (389)
.||||++++. ....|+||||+.+ +|.+++... .+++..+..++.||+.||.|||++||+||||||+||++
T Consensus 65 ~h~ni~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill- 140 (337)
T cd07852 65 DHPNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILL- 140 (337)
T ss_pred CCCCccceeeeeccCCCceEEEEeccccc-CHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE-
Confidence 7999999883 2358999999985 998877543 78899999999999999999999999999999999999
Q ss_pred ecCCCCCEEEeecCCccccCCCC------CcccccccCCcccccccc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 016471 76 TREEDAPLKVIDFGLSDFVRPDQ------RLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILLCGSRPFWARTE 147 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~~~------~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 147 (389)
+.++.+||+|||++....... ......||+.|+|||.+. ..++.++|+||+|+++|+|++|+.||.+...
T Consensus 141 --~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~ 218 (337)
T cd07852 141 --NSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTST 218 (337)
T ss_pred --cCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCCh
Confidence 578899999999987653321 223456899999999874 3578899999999999999999999987665
Q ss_pred hHHHHHHHhcCCC---------------------------CCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCC
Q 016471 148 SGIFRSVLRADPN---------------------------FHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 148 ~~~~~~i~~~~~~---------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~ 200 (389)
......+...... ......+.++..+.++|.+||..+|.+|||+.++++|||+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~ 298 (337)
T cd07852 219 LNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYV 298 (337)
T ss_pred HHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhh
Confidence 5444333222111 0111224578999999999999999999999999999999
Q ss_pred CCCC
Q 016471 201 HDEN 204 (389)
Q Consensus 201 ~~~~ 204 (389)
+...
T Consensus 299 ~~~~ 302 (337)
T cd07852 299 AQFH 302 (337)
T ss_pred hhhc
Confidence 7653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=250.45 Aligned_cols=191 Identities=22% Similarity=0.421 Sum_probs=154.4
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEE
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILS---RGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFL 73 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nil 73 (389)
+.||||++++ ..+.+|+||||+++|+|.+.+.. +...+++..+..++.|++.||.|||++|++||||||+||+
T Consensus 59 l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil 138 (267)
T cd08228 59 LNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVF 138 (267)
T ss_pred CCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEE
Confidence 5799999988 35789999999999999887743 2345899999999999999999999999999999999999
Q ss_pred EeecCCCCCEEEeecCCccccCCCC-CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCh--hH
Q 016471 74 FTTREEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTE--SG 149 (389)
Q Consensus 74 l~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~ 149 (389)
+ +.++.++|+|||++....... ......|++.|+|||.+. ..++.++|+||+|+++|+|++|+.||..... ..
T Consensus 139 ~---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~ 215 (267)
T cd08228 139 I---TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFS 215 (267)
T ss_pred E---cCCCCEEECccccceeccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHH
Confidence 9 467889999999987664322 223456889999999875 4688899999999999999999999966432 23
Q ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 150 IFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 150 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
....+.... .++.....++..+.+++.+||..+|.+|||+.++++
T Consensus 216 ~~~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 216 LCQKIEQCD--YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred HHHHHhcCC--CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence 333333222 222222357889999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=255.24 Aligned_cols=190 Identities=21% Similarity=0.347 Sum_probs=156.3
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSR---------------GGRYLEEDAKTIVEKILNIVAFCHLQGV 62 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~---------------~~~l~~~~~~~i~~qi~~~L~~lH~~~i 62 (389)
.||||++++ ....+|+||||+++|+|.+++..+ .+.+++..+..++.|++.||+|||++||
T Consensus 74 ~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~i 153 (293)
T cd05053 74 KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKC 153 (293)
T ss_pred CCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 699999988 356799999999999999988642 3568899999999999999999999999
Q ss_pred EecCCCCCcEEEeecCCCCCEEEeecCCccccCCCCC---cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-
Q 016471 63 VHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC- 137 (389)
Q Consensus 63 ~Hrdlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~- 137 (389)
+||||||+||++ +.++.+||+|||++........ .....++..|+|||++. ..++.++||||+||++|++++
T Consensus 154 vH~dlkp~Nil~---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~ 230 (293)
T cd05053 154 IHRDLAARNVLV---TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTL 230 (293)
T ss_pred cccccceeeEEE---cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcC
Confidence 999999999999 4678899999999876543221 11223456799999875 468999999999999999997
Q ss_pred CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCC
Q 016471 138 GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 197 (389)
Q Consensus 138 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h 197 (389)
|..||.+....+....+..... .. .....+..+.+++.+||..+|.+|||+.+++++
T Consensus 231 g~~p~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 231 GGSPYPGIPVEELFKLLKEGYR-ME--KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred CCCCCCCCCHHHHHHHHHcCCc-CC--CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 9999988877777666554321 11 123578999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=247.88 Aligned_cols=190 Identities=22% Similarity=0.326 Sum_probs=156.5
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEe
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 75 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~ 75 (389)
++||||++++ ..+..|+||||++||+|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||++
T Consensus 58 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~- 136 (261)
T cd05068 58 LRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLV- 136 (261)
T ss_pred CCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEE-
Confidence 5799999988 3567899999999999999886543 468999999999999999999999999999999999999
Q ss_pred ecCCCCCEEEeecCCccccCCCCCc--ccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 016471 76 TREEDAPLKVIDFGLSDFVRPDQRL--NDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIF 151 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~ 151 (389)
+.++.+||+|||++......... ....++..|+|||.+. ..++.++|+||+|+++|+|++ |+.||.+.......
T Consensus 137 --~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~ 214 (261)
T cd05068 137 --GENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVL 214 (261)
T ss_pred --cCCCCEEECCcceEEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 46788999999998876432211 1122345799999875 468899999999999999999 99999888777777
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 152 RSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 152 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
..+.+... .+ ....++..+.+++.+||..+|.+||++.+++.
T Consensus 215 ~~~~~~~~-~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 215 QQVDQGYR-MP--CPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHHcCCC-CC--CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 66654322 11 12457899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=249.87 Aligned_cols=190 Identities=19% Similarity=0.294 Sum_probs=157.3
Q ss_pred CCCcccccee---ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 1 MYHQKLQHLF---YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 1 l~Hpni~~~~---~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
+.||||++++ .....|+|||||++|+|.+++.+....+++..+..++.|++.||+|||++|++||||||+||+++
T Consensus 64 ~~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~-- 141 (270)
T cd05056 64 FDHPHIVKLIGVITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVS-- 141 (270)
T ss_pred CCCCchhceeEEEcCCCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEe--
Confidence 4799999998 35678999999999999999876655789999999999999999999999999999999999994
Q ss_pred CCCCCEEEeecCCccccCCCCCc--ccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHH
Q 016471 78 EEDAPLKVIDFGLSDFVRPDQRL--NDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRS 153 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~ 153 (389)
.++.+||+|||++......... ....+++.|+|||.+. ..++.++|+||+||++|++++ |..||.+.+..+....
T Consensus 142 -~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~ 220 (270)
T cd05056 142 -SPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGR 220 (270)
T ss_pred -cCCCeEEccCceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Confidence 5778999999998765433211 1223456799999875 468899999999999999986 9999988877766666
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 154 VLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 154 i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
+.+.... ...+.++..+.+++.+|+..+|.+|||+.+++.
T Consensus 221 ~~~~~~~---~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~ 260 (270)
T cd05056 221 IENGERL---PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA 260 (270)
T ss_pred HHcCCcC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 5544322 122467899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=270.27 Aligned_cols=277 Identities=18% Similarity=0.210 Sum_probs=179.3
Q ss_pred cCeEEEEEEccCCCChHHHHHhcCCC-------------------CCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcE
Q 016471 12 SNSFLFFTRFCEGGELLDRILSRGGR-------------------YLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENF 72 (389)
Q Consensus 12 ~~~~~lv~E~~~gg~L~~~l~~~~~~-------------------l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Ni 72 (389)
...+++||||+.+|+|.+++..+... ..+..+..++.||+.||.|||++||+||||||+||
T Consensus 207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NI 286 (566)
T PLN03225 207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNI 286 (566)
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHE
Confidence 46799999999999999988644211 12345678999999999999999999999999999
Q ss_pred EEeecCCCCCEEEeecCCccccCCC--CCcccccccCCccccccccc-----------------------cCCCchhHHH
Q 016471 73 LFTTREEDAPLKVIDFGLSDFVRPD--QRLNDIVGSAYYVAPEVLHR-----------------------SYNVEGDMWS 127 (389)
Q Consensus 73 ll~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~-----------------------~~~~~~Diws 127 (389)
|++ +.++.+||+|||+|...... ......++|+.|+|||.+.. .++.++||||
T Consensus 287 Ll~--~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS 364 (566)
T PLN03225 287 IFS--EGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 364 (566)
T ss_pred EEe--CCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence 995 34578999999999765432 22345689999999996521 1234569999
Q ss_pred HHHHHHHHHhCCCCCCCCChhHHHHHHHh-cCCC-------CCCCC----------CCCCCHHHHHHHHhhhccCcCCCC
Q 016471 128 IGVITYILLCGSRPFWARTESGIFRSVLR-ADPN-------FHDSP----------WPSVSPEAKDFVRRLLNKDHRKRM 189 (389)
Q Consensus 128 lG~il~~ll~g~~pf~~~~~~~~~~~i~~-~~~~-------~~~~~----------~~~~~~~~~~li~~~l~~~p~~R~ 189 (389)
+||++|+|+++..|+.. ....+..++. .... ..... ....+....+||.+||.+||.+||
T Consensus 365 lGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ 442 (566)
T PLN03225 365 AGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRI 442 (566)
T ss_pred HHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCC
Confidence 99999999997666432 2111221111 1100 00000 001233456899999999999999
Q ss_pred CHHHHhCCCCCCCCCCCCCccHHHHHHHHHHhhcChhHHHHHHHHHHhcCHHHHHHHHHHhhhcCC-CCCcccHHHHHHH
Q 016471 190 TAAQALTHPWLHDENRPVPLDILIYKLVKSYLRATPLKRAALKALSKALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVA 268 (389)
Q Consensus 190 s~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~i~~~l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~ 268 (389)
|+.++|+||||........... + ..... ..+...... .+-...+......-.. .+|..+..+++..
T Consensus 443 ta~e~L~Hpff~~~~~~~~~~~---~---~~~~~--~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~ 509 (566)
T PLN03225 443 SAKAALAHPYFDREGLLGLSVM---Q---NLRLQ--LFRATQQDY-----GEAAAWVVFLMAKSGTEKEGGFTEAQLQEL 509 (566)
T ss_pred CHHHHhCCcCcCCCCccccccc---c---ccccc--cchhhHHHH-----HHHHHHHHHHHHhcCCCCCCCccHHHHHHh
Confidence 9999999999987653211100 0 00000 000000000 1112233334444455 7888999999884
Q ss_pred HHHhccccCCHHHHHH--HHhhcCCCCCcceeHHHHHHHHhc
Q 016471 269 LMRQATDAMTDSRVFE--ILNVMEPLSDQKLAYEEFCAAATS 308 (389)
Q Consensus 269 l~~~~~~~~~~~~~~~--~~~~~d~~~~g~i~~~eF~~~~~~ 308 (389)
. ..+. ..+.+..+ +...++.+..|...+++++.....
T Consensus 510 ~-~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (566)
T PLN03225 510 R-EKEP--KKKGSAQRNALASALRLQRKGVKTVARTVDEIPG 548 (566)
T ss_pred h-hhcC--cchhhhhhhhHHHHHhhhhhhhhhhhhhhhcccc
Confidence 4 4442 23344444 777888888899999999874443
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=254.88 Aligned_cols=189 Identities=20% Similarity=0.327 Sum_probs=155.3
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG---------------GRYLEEDAKTIVEKILNIVAFCHLQGV 62 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~~lH~~~i 62 (389)
.||||++++ ....+|+||||+++|+|.+++.... ..++...+..++.||+.||.|||++|+
T Consensus 76 ~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi 155 (314)
T cd05099 76 KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRC 155 (314)
T ss_pred CCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 599999998 3567999999999999999986532 358889999999999999999999999
Q ss_pred EecCCCCCcEEEeecCCCCCEEEeecCCccccCCCCC---cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-
Q 016471 63 VHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC- 137 (389)
Q Consensus 63 ~Hrdlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~- 137 (389)
+||||||+||++ +.++.+||+|||++........ .....++..|+|||++. +.++.++||||+||++|++++
T Consensus 156 ~H~dlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~ 232 (314)
T cd05099 156 IHRDLAARNVLV---TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTL 232 (314)
T ss_pred eeccccceeEEE---cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhC
Confidence 999999999999 4678899999999976543211 11223446799999875 468899999999999999999
Q ss_pred CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 138 GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 138 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
|..||.+.+.......+...... .....++.++++++.+||..+|.+|||+.++++
T Consensus 233 g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 233 GGSPYPGIPVEELFKLLREGHRM---DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred CCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 89999888777777666543211 112457889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=246.82 Aligned_cols=193 Identities=25% Similarity=0.418 Sum_probs=162.4
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEE
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSR---GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFL 73 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nil 73 (389)
+.||||++++ .....|+||||++|++|.+++... ...+++..+..++.|++.||.|||++|++||||+|+||+
T Consensus 56 l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~ 135 (256)
T cd08530 56 VNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANIL 135 (256)
T ss_pred CCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEE
Confidence 5799999877 457899999999999999987652 356899999999999999999999999999999999999
Q ss_pred EeecCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 016471 74 FTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFR 152 (389)
Q Consensus 74 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 152 (389)
++ .++.+||+|||++...... ......+++.|+|||.+.+ .++.++|+||+|+++|++++|+.||...+......
T Consensus 136 ~~---~~~~~kl~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~ 211 (256)
T cd08530 136 LV---ANDLVKIGDLGISKVLKKN-MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRY 211 (256)
T ss_pred Ee---cCCcEEEeeccchhhhccC-CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 95 5778999999998776544 2334568899999998754 58889999999999999999999998887766666
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCC
Q 016471 153 SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 153 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~ 200 (389)
.+..... +... ..++.++++++.+||..+|.+|||+.++++||++
T Consensus 212 ~~~~~~~--~~~~-~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 212 KVQRGKY--PPIP-PIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHhcCCC--CCCc-hhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 5544332 2111 3578999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=252.87 Aligned_cols=190 Identities=29% Similarity=0.473 Sum_probs=152.3
Q ss_pred ecCeEEEEEEccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeecC-----------
Q 016471 11 YSNSFLFFTRFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE----------- 78 (389)
Q Consensus 11 ~~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~~----------- 78 (389)
+.+++|||+|.+ |-++++++.++ ..+++..+++.+..|++.+++|||+.+++|-||||+|||+.+.+
T Consensus 162 yrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 162 YRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred ccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCcc
Confidence 678999999998 44999999764 35699999999999999999999999999999999999996421
Q ss_pred ------CCCCEEEeecCCccccCCCCCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhH--
Q 016471 79 ------EDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESG-- 149 (389)
Q Consensus 79 ------~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-- 149 (389)
.+..|+++|||.|+..... ..+.+.|..|.|||++.+ +++.+|||||+||||+|+.+|...|++....+
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~e~--hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHL 318 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDHEH--HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHL 318 (415)
T ss_pred ceeccCCCcceEEEecCCcceeccC--cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHH
Confidence 2456999999998875433 367789999999998865 79999999999999999999999999877655
Q ss_pred -HHHHHHhcCCCCC-------------CCCCCC--------------------------CCHHHHHHHHhhhccCcCCCC
Q 016471 150 -IFRSVLRADPNFH-------------DSPWPS--------------------------VSPEAKDFVRRLLNKDHRKRM 189 (389)
Q Consensus 150 -~~~~i~~~~~~~~-------------~~~~~~--------------------------~~~~~~~li~~~l~~~p~~R~ 189 (389)
+.+.|+...|..- ...|++ -..++.+||++||.+||.+|+
T Consensus 319 aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~Ri 398 (415)
T KOG0671|consen 319 AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRI 398 (415)
T ss_pred HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccc
Confidence 3444432111000 011111 125688999999999999999
Q ss_pred CHHHHhCCCCCCCC
Q 016471 190 TAAQALTHPWLHDE 203 (389)
Q Consensus 190 s~~e~l~h~~~~~~ 203 (389)
|+.|||.||||...
T Consensus 399 Tl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 399 TLREALSHPFFARL 412 (415)
T ss_pred cHHHHhcCHHhhcC
Confidence 99999999999654
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=263.45 Aligned_cols=155 Identities=20% Similarity=0.326 Sum_probs=122.8
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeecCCCCCEEEeecCCccccCCCC---CcccccccCCccccc
Q 016471 37 RYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ---RLNDIVGSAYYVAPE 113 (389)
Q Consensus 37 ~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE 113 (389)
.+++..+..++.||+.||.|||++||+||||||+||+++ .++.+||+|||++....... ......+++.|+|||
T Consensus 233 ~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~---~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE 309 (400)
T cd05105 233 GLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLA---QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPE 309 (400)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEe---CCCEEEEEeCCcceeccccccccccCCcCCCcceEChh
Confidence 477888999999999999999999999999999999994 67789999999987653322 122345678899999
Q ss_pred ccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCH
Q 016471 114 VLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTA 191 (389)
Q Consensus 114 ~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~ 191 (389)
.+. ..++.++||||+||++|+|++ |..||...................+ ....++..+.+++.+||..+|.+|||+
T Consensus 310 ~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~ 387 (400)
T cd05105 310 SIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMA--KPDHATQEVYDIMVKCWNSEPEKRPSF 387 (400)
T ss_pred hhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCCC--CCccCCHHHHHHHHHHCccCHhHCcCH
Confidence 875 468999999999999999997 9999977554433333333222222 124578999999999999999999999
Q ss_pred HHHhC
Q 016471 192 AQALT 196 (389)
Q Consensus 192 ~e~l~ 196 (389)
.++.+
T Consensus 388 ~~l~~ 392 (400)
T cd05105 388 LHLSD 392 (400)
T ss_pred HHHHH
Confidence 88764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=249.41 Aligned_cols=190 Identities=23% Similarity=0.405 Sum_probs=156.7
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ .+..+++||||+++|+|.+++....+.+++.+++.++.|++.||.|||++|++||||||+||++
T Consensus 62 l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili-- 139 (269)
T cd05065 62 FDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILV-- 139 (269)
T ss_pred CCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEE--
Confidence 5799999998 3577999999999999999887666779999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCCc---cccc---ccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChh
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRL---NDIV---GSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTES 148 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~---gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~ 148 (389)
+.++.+||+|||++......... .... .+..|+|||.+. +.++.++|+||+||++|++++ |..||......
T Consensus 140 -~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~ 218 (269)
T cd05065 140 -NSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ 218 (269)
T ss_pred -cCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH
Confidence 56788999999998765432211 1111 234799999885 468899999999999999886 99999888777
Q ss_pred HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 149 GIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 149 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
.....+.... . .+..+.++..+.+++.+||..+|.+||++.+++.
T Consensus 219 ~~~~~i~~~~-~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 219 DVINAIEQDY-R--LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred HHHHHHHcCC-c--CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 7766664332 1 1222467899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=253.79 Aligned_cols=189 Identities=21% Similarity=0.322 Sum_probs=156.4
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG---------------GRYLEEDAKTIVEKILNIVAFCHLQGV 62 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~~lH~~~i 62 (389)
.||||++++ .....|+||||+++|+|.+++..+. ..++...+..++.||+.||.|||++|+
T Consensus 79 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~gi 158 (304)
T cd05101 79 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKC 158 (304)
T ss_pred cCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCe
Confidence 699999988 3567899999999999999887542 247788899999999999999999999
Q ss_pred EecCCCCCcEEEeecCCCCCEEEeecCCccccCCCCC---cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-
Q 016471 63 VHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC- 137 (389)
Q Consensus 63 ~Hrdlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~- 137 (389)
+||||||+||++ +.++.+||+|||++........ .....+++.|+|||++. ..++.++||||+|+++|++++
T Consensus 159 vH~dlkp~Nili---~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~ 235 (304)
T cd05101 159 IHRDLAARNVLV---TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 235 (304)
T ss_pred eecccccceEEE---cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcC
Confidence 999999999999 4678899999999886643221 22234567899999875 468999999999999999998
Q ss_pred CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 138 GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 138 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
|..||.+.+..+....+...... . ....++..+++++.+||..+|.+|||+.++++
T Consensus 236 g~~p~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~ 291 (304)
T cd05101 236 GGSPYPGIPVEELFKLLKEGHRM-D--KPANCTNELYMMMRDCWHAIPSHRPTFKQLVE 291 (304)
T ss_pred CCCCcccCCHHHHHHHHHcCCcC-C--CCCCCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 88999888877777766544322 1 12457899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=247.81 Aligned_cols=190 Identities=20% Similarity=0.336 Sum_probs=156.1
Q ss_pred CCCcccccee---ecCeEEEEEEccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF---YSNSFLFFTRFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~---~~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||+.++ .....|+||||+++|+|.+++... ...+++..+..++.|++.||.|||++|++||||||+||+++
T Consensus 58 l~~~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~- 136 (260)
T cd05070 58 LRHDKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVG- 136 (260)
T ss_pred cCCCceEEEEeEECCCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEe-
Confidence 5799999988 346689999999999999988654 34589999999999999999999999999999999999994
Q ss_pred cCCCCCEEEeecCCccccCCCCC--cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQR--LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFR 152 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 152 (389)
+++.++|+|||++........ .....++..|+|||.+. ..++.++|+||||+++|+|++ |..||.+.+..+...
T Consensus 137 --~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~ 214 (260)
T cd05070 137 --DGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLE 214 (260)
T ss_pred --CCceEEeCCceeeeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 678899999999976543321 11233556799999875 468899999999999999999 999998877777766
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 153 SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 153 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
.+..... . +.....+..+.+++.+||..+|.+|||+.++..
T Consensus 215 ~~~~~~~-~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 215 QVERGYR-M--PCPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHHcCCC-C--CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 6654321 1 112357899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=247.89 Aligned_cols=192 Identities=17% Similarity=0.276 Sum_probs=151.1
Q ss_pred CCCccccceee----cCeEEEEEEccCCCChHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEE
Q 016471 1 MYHQKLQHLFY----SNSFLFFTRFCEGGELLDRILSRG---GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFL 73 (389)
Q Consensus 1 l~Hpni~~~~~----~~~~~lv~E~~~gg~L~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nil 73 (389)
+.||||++++. ...+|+|||||++|+|.+++.+.. ...++..+..++.||+.||+|||+++++||||||+|||
T Consensus 52 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil 131 (268)
T cd05086 52 LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCF 131 (268)
T ss_pred cCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEE
Confidence 57999999983 467899999999999999886532 34667788899999999999999999999999999999
Q ss_pred EeecCCCCCEEEeecCCccccCCCC---CcccccccCCccccccccc--------cCCCchhHHHHHHHHHHHHh-CCCC
Q 016471 74 FTTREEDAPLKVIDFGLSDFVRPDQ---RLNDIVGSAYYVAPEVLHR--------SYNVEGDMWSIGVITYILLC-GSRP 141 (389)
Q Consensus 74 l~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~--------~~~~~~DiwslG~il~~ll~-g~~p 141 (389)
+ +.++.+||+|||++....... ......++..|+|||++.. .++.++||||+||++|+|++ |..|
T Consensus 132 ~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p 208 (268)
T cd05086 132 L---TSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQP 208 (268)
T ss_pred E---cCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCC
Confidence 9 567889999999876432211 1234568889999998732 25678999999999999997 6778
Q ss_pred CCCCChhHHHHHHHhcCC-CCCCCC-CCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 142 FWARTESGIFRSVLRADP-NFHDSP-WPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 142 f~~~~~~~~~~~i~~~~~-~~~~~~-~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
|...+..+.+..+.+... ....+. ...+++.+.+++.+|| .+|.+|||++++++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 209 YSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred CCCCCHHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 877777666666554322 222221 2347889999999999 67999999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=251.65 Aligned_cols=190 Identities=21% Similarity=0.304 Sum_probs=155.2
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHH
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG-----------------------GRYLEEDAKTIVEKILNI 53 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~-----------------------~~l~~~~~~~i~~qi~~~ 53 (389)
+.||||++++ ..+..|+|||||.+|+|.+++.... ..+++..+..++.|++.|
T Consensus 60 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~ 139 (290)
T cd05045 60 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRG 139 (290)
T ss_pred CCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHH
Confidence 5799999988 3577899999999999999875421 347889999999999999
Q ss_pred HHHHHHCCCEecCCCCCcEEEeecCCCCCEEEeecCCccccCCCC---CcccccccCCcccccccc-ccCCCchhHHHHH
Q 016471 54 VAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ---RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIG 129 (389)
Q Consensus 54 L~~lH~~~i~Hrdlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG 129 (389)
|.|||++|++||||||+||++ ++++.+||+|||++....... ......++..|+|||.+. ..++.++||||+|
T Consensus 140 l~~LH~~~ivH~dikp~nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG 216 (290)
T cd05045 140 MQYLAEMKLVHRDLAARNVLV---AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFG 216 (290)
T ss_pred HHHHHHCCeehhhhhhheEEE---cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHH
Confidence 999999999999999999999 467889999999987653221 112234567899999874 4688999999999
Q ss_pred HHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 130 VITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 130 ~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
+++|+|++ |..||.+.........+.... ..+ ....++..+.+++.+||..+|.+||++.+++.
T Consensus 217 ~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 217 VLLWEIVTLGGNPYPGIAPERLFNLLKTGY-RME--RPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHHHhcCCCCCCCCCHHHHHHHHhCCC-CCC--CCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 99999998 999998887777666554332 111 12457899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=249.20 Aligned_cols=190 Identities=19% Similarity=0.266 Sum_probs=155.2
Q ss_pred CCCccccceee----c------CeEEEEEEccCCCChHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCCEec
Q 016471 1 MYHQKLQHLFY----S------NSFLFFTRFCEGGELLDRILSR-----GGRYLEEDAKTIVEKILNIVAFCHLQGVVHR 65 (389)
Q Consensus 1 l~Hpni~~~~~----~------~~~~lv~E~~~gg~L~~~l~~~-----~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hr 65 (389)
+.||||+.++. . ...++||||+++|+|..++... ...+++..+..++.|++.||.|||++|++||
T Consensus 58 l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~ 137 (273)
T cd05035 58 FDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHR 137 (273)
T ss_pred CCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence 57999999882 1 2379999999999999887543 1368999999999999999999999999999
Q ss_pred CCCCCcEEEeecCCCCCEEEeecCCccccCCCCC---cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCC
Q 016471 66 DLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSR 140 (389)
Q Consensus 66 dlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~ 140 (389)
||||+||++ ++++.+||+|||++........ .....++..|+|||.+. ..++.++||||+||++|+|++ |.+
T Consensus 138 dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~ 214 (273)
T cd05035 138 DLAARNCML---REDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQT 214 (273)
T ss_pred ccchheEEE---CCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCC
Confidence 999999999 5678899999999876543221 11223567899999885 468899999999999999999 999
Q ss_pred CCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 141 PFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 141 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
||.+....+....+...... .. ...+++.+.+++.+||..+|.+|||+.+++.
T Consensus 215 p~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~ 267 (273)
T cd05035 215 PYPGVENHEIYDYLRHGNRL-KQ--PEDCLDELYDLMYSCWRADPKDRPTFTKLRE 267 (273)
T ss_pred CCCCCCHHHHHHHHHcCCCC-CC--CcCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99887777777666554322 11 1357899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=254.39 Aligned_cols=189 Identities=20% Similarity=0.331 Sum_probs=154.6
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG---------------GRYLEEDAKTIVEKILNIVAFCHLQGV 62 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~~lH~~~i 62 (389)
.||||++++ ..+.+|+|||||++|+|.+++..+. ..++...++.++.|++.||+|||++|+
T Consensus 82 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi 161 (307)
T cd05098 82 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKC 161 (307)
T ss_pred CCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 699999998 3578999999999999999987542 247889999999999999999999999
Q ss_pred EecCCCCCcEEEeecCCCCCEEEeecCCccccCCCCC---cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-
Q 016471 63 VHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC- 137 (389)
Q Consensus 63 ~Hrdlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~- 137 (389)
+||||||+||++ +.++.+||+|||.+........ .....+++.|+|||++. ..++.++|+||+||++|+|++
T Consensus 162 ~H~dlkp~Nill---~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~ 238 (307)
T cd05098 162 IHRDLAARNVLV---TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL 238 (307)
T ss_pred ccccccHHheEE---cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcC
Confidence 999999999999 4678899999999876543211 11223456899999875 468899999999999999998
Q ss_pred CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 138 GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 138 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
|..||.+....+....+..... . .....++.++.+++.+||..+|.+|||+.+++.
T Consensus 239 g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 294 (307)
T cd05098 239 GGSPYPGVPVEELFKLLKEGHR-M--DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 294 (307)
T ss_pred CCCCCCcCCHHHHHHHHHcCCC-C--CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 8999988777666665544321 1 122457899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=248.55 Aligned_cols=190 Identities=21% Similarity=0.284 Sum_probs=158.4
Q ss_pred CCCcccccee---ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 1 MYHQKLQHLF---YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 1 l~Hpni~~~~---~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
+.||||++++ .....++||||+++|+|.+++....+.+++..+..++.||+.||+|||++|++||||||+||++
T Consensus 66 l~h~~i~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~--- 142 (279)
T cd05057 66 VDHPHVVRLLGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLV--- 142 (279)
T ss_pred CCCCCcceEEEEEecCceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEE---
Confidence 5799999998 3478999999999999999988766779999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCCccccCCCCCcc---cccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHH
Q 016471 78 EEDAPLKVIDFGLSDFVRPDQRLN---DIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFR 152 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 152 (389)
+.++.+||+|||++.......... ...++..|+|||.+. ..++.++|+||+|+++|++++ |..||.+....+...
T Consensus 143 ~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~ 222 (279)
T cd05057 143 KTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPD 222 (279)
T ss_pred cCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Confidence 467789999999998765332211 122356799999875 568899999999999999998 999998887777766
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 153 SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 153 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
.+...... +. .+..+..+.+++.+||..+|..|||+.++++
T Consensus 223 ~~~~~~~~-~~--~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 223 LLEKGERL-PQ--PPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred HHhCCCCC-CC--CCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 66544322 21 1346889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=250.29 Aligned_cols=189 Identities=20% Similarity=0.288 Sum_probs=148.3
Q ss_pred CCCccccceee------cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEE
Q 016471 1 MYHQKLQHLFY------SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLF 74 (389)
Q Consensus 1 l~Hpni~~~~~------~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill 74 (389)
+.||||++++. ...+|+||||+++|+|.+++... .+++.+++.++.|++.||.|||++||+||||||+||++
T Consensus 63 l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili 140 (283)
T cd05080 63 LYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLL 140 (283)
T ss_pred CCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEE
Confidence 57999999883 24589999999999999988653 69999999999999999999999999999999999999
Q ss_pred eecCCCCCEEEeecCCccccCCCCC----cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhH
Q 016471 75 TTREEDAPLKVIDFGLSDFVRPDQR----LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESG 149 (389)
Q Consensus 75 ~~~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 149 (389)
+.++.+||+|||++........ .....++..|+|||.+. ..++.++||||+|+++|+|++|..||.......
T Consensus 141 ---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~ 217 (283)
T cd05080 141 ---DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF 217 (283)
T ss_pred ---cCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh
Confidence 4678899999999876543221 11234566799999875 468999999999999999999999985533210
Q ss_pred --------------HHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 150 --------------IFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 150 --------------~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
............+ ....++..+.+++.+||..+|++|||+++++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 218 EEMIGPKQGQMTVVRLIELLERGMRLP--CPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hhhhcccccccchhhhhhhhhcCCCCC--CCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0111111111111 11357899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=251.47 Aligned_cols=193 Identities=16% Similarity=0.238 Sum_probs=155.6
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHCCCEecC
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG----------GRYLEEDAKTIVEKILNIVAFCHLQGVVHRD 66 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~----------~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrd 66 (389)
|.||||++++ .+...++||||+.+|+|.+++.... ..+++..+..++.|++.||.|||++|++|||
T Consensus 76 l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~d 155 (296)
T cd05051 76 LSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRD 155 (296)
T ss_pred cCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccc
Confidence 5799999988 3578999999999999999886542 1689999999999999999999999999999
Q ss_pred CCCCcEEEeecCCCCCEEEeecCCccccCCCC---CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh--CCC
Q 016471 67 LKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ---RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC--GSR 140 (389)
Q Consensus 67 lkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~--g~~ 140 (389)
|||+||++ +.++.++|+|||++....... ......+++.|+|||.+. ..++.++||||+||++|+|++ |..
T Consensus 156 lkp~Nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 232 (296)
T cd05051 156 LATRNCLV---GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQ 232 (296)
T ss_pred cchhceee---cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCC
Confidence 99999999 466899999999987653322 122345677899999875 468999999999999999998 788
Q ss_pred CCCCCChhHHHHHHHhc----CCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 141 PFWARTESGIFRSVLRA----DPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 141 pf~~~~~~~~~~~i~~~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
||...+....+..+... .........+.++.++.+++.+||..+|.+|||+.++++
T Consensus 233 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 233 PYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred CCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 99777666666555432 111111112356789999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=257.72 Aligned_cols=195 Identities=29% Similarity=0.512 Sum_probs=158.0
Q ss_pred CCCccccceee----c------CeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCC
Q 016471 1 MYHQKLQHLFY----S------NSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPE 70 (389)
Q Consensus 1 l~Hpni~~~~~----~------~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~ 70 (389)
+.||||+.++. . ..+|+||||+ |++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+
T Consensus 71 l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~ 147 (343)
T cd07880 71 MKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPG 147 (343)
T ss_pred cCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 57999999873 1 2469999999 6788876643 57999999999999999999999999999999999
Q ss_pred cEEEeecCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChh
Q 016471 71 NFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTES 148 (389)
Q Consensus 71 Nill~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 148 (389)
||++ +.++.++|+|||++..... ......+++.|+|||.+.+ .++.++|+||+||++|++++|..||.+.+..
T Consensus 148 Nill---~~~~~~kl~dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~ 222 (343)
T cd07880 148 NLAV---NEDCELKILDFGLARQTDS--EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL 222 (343)
T ss_pred HEEE---cCCCCEEEeeccccccccc--CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999 4678899999999876543 2234567899999998753 4788999999999999999999999877665
Q ss_pred HHHHHHHhcCCCCC---------------------------CCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCC
Q 016471 149 GIFRSVLRADPNFH---------------------------DSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLH 201 (389)
Q Consensus 149 ~~~~~i~~~~~~~~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~ 201 (389)
.....+.+.....+ ...++.+++.+.++|.+||..+|.+|||+.+++.||||+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~ 302 (343)
T cd07880 223 DQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFE 302 (343)
T ss_pred HHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHh
Confidence 55444433221110 011245788999999999999999999999999999997
Q ss_pred CC
Q 016471 202 DE 203 (389)
Q Consensus 202 ~~ 203 (389)
..
T Consensus 303 ~~ 304 (343)
T cd07880 303 EF 304 (343)
T ss_pred hh
Confidence 65
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=247.30 Aligned_cols=192 Identities=19% Similarity=0.301 Sum_probs=149.1
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcE
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG----GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENF 72 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Ni 72 (389)
+.||||++++ ....+++|||||++|+|.+++.... ..+++..++.++.|++.||+|||++|++||||||+||
T Consensus 52 l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~ni 131 (269)
T cd05087 52 LQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNC 131 (269)
T ss_pred CCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceE
Confidence 5799999988 3466899999999999999886532 2456778889999999999999999999999999999
Q ss_pred EEeecCCCCCEEEeecCCccccCCCC---CcccccccCCccccccccc--------cCCCchhHHHHHHHHHHHHh-CCC
Q 016471 73 LFTTREEDAPLKVIDFGLSDFVRPDQ---RLNDIVGSAYYVAPEVLHR--------SYNVEGDMWSIGVITYILLC-GSR 140 (389)
Q Consensus 73 ll~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~--------~~~~~~DiwslG~il~~ll~-g~~ 140 (389)
++ +.++.+||+|||++....... ......+++.|+|||++.+ .++.++|+||+|+++|+|++ |..
T Consensus 132 l~---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~ 208 (269)
T cd05087 132 LL---TADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQ 208 (269)
T ss_pred EE---cCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCC
Confidence 99 467889999999986543222 1123457788999998742 25789999999999999996 999
Q ss_pred CCCCCChhHHHHHHHhc-CCCCCCCCC-CCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 141 PFWARTESGIFRSVLRA-DPNFHDSPW-PSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 141 pf~~~~~~~~~~~i~~~-~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
||......+........ ....+.+.. ...++.+.+++.+|+ .+|.+|||++++..
T Consensus 209 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 209 PYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CCCCCChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 99876655544333222 222222211 246788999999998 68999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=245.42 Aligned_cols=190 Identities=24% Similarity=0.404 Sum_probs=157.8
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ .....|+||||++||+|.+++....+.++++.+..++.|++.||+|||++|++||||||+||++
T Consensus 56 l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i-- 133 (256)
T cd05112 56 LSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLV-- 133 (256)
T ss_pred CCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEE--
Confidence 5799999998 3467999999999999999887766678999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCC--cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQR--LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFR 152 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 152 (389)
+.++.+||+|||++........ .....++..|+|||.+. +.++.++|+||+|+++|+|++ |..||..........
T Consensus 134 -~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 212 (256)
T cd05112 134 -GENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVE 212 (256)
T ss_pred -cCCCeEEECCCcceeecccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence 4678899999999875533211 12233557899999875 568899999999999999998 999998887777777
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 153 SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 153 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
.+........+ ...+..+.+++.+||..+|.+|||+.++++
T Consensus 213 ~~~~~~~~~~~---~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~ 253 (256)
T cd05112 213 TINAGFRLYKP---RLASQSVYELMQHCWKERPEDRPSFSLLLH 253 (256)
T ss_pred HHhCCCCCCCC---CCCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 66544222211 236889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=246.36 Aligned_cols=188 Identities=16% Similarity=0.203 Sum_probs=149.0
Q ss_pred CCCccccceee---cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 1 MYHQKLQHLFY---SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 1 l~Hpni~~~~~---~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
+.||||+.++. ....++|||||++|+|.+++......+++..+..++.||+.||.|||++||+||||||+||+++..
T Consensus 58 l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~ 137 (259)
T cd05037 58 LSHKHLVKLYGVCVRDENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARY 137 (259)
T ss_pred CCCcchhheeeEEecCCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecC
Confidence 57999999883 257899999999999999887664479999999999999999999999999999999999999632
Q ss_pred C----CCCCEEEeecCCccccCCCCCcccccccCCccccccccc---cCCCchhHHHHHHHHHHHHh-CCCCCCCCChhH
Q 016471 78 E----EDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR---SYNVEGDMWSIGVITYILLC-GSRPFWARTESG 149 (389)
Q Consensus 78 ~----~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~ 149 (389)
. ....+||+|||++..... .....++..|+|||++.. .++.++|+||+||++|++++ |..||...+...
T Consensus 138 ~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~ 214 (259)
T cd05037 138 GLNEGYVPFIKLSDPGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE 214 (259)
T ss_pred ccccCCceeEEeCCCCccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh
Confidence 1 112699999999876543 223457788999998853 58899999999999999999 688886665433
Q ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 150 IFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 150 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
...... .....+. ..+..+.+++.+||..+|.+|||+.++++
T Consensus 215 ~~~~~~-~~~~~~~----~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 215 KERFYQ-DQHRLPM----PDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred HHHHHh-cCCCCCC----CCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 333222 1111111 12378999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=235.76 Aligned_cols=192 Identities=21% Similarity=0.318 Sum_probs=151.6
Q ss_pred CCCcccccee---------ecCeEEEEEEccCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC--CEecC
Q 016471 1 MYHQKLQHLF---------YSNSFLFFTRFCEGGELLDRILSR---GGRYLEEDAKTIVEKILNIVAFCHLQG--VVHRD 66 (389)
Q Consensus 1 l~Hpni~~~~---------~~~~~~lv~E~~~gg~L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~~--i~Hrd 66 (389)
.+|||+++++ ..+..||+++|...|+|.+.+... +..++|.++..|+.+|++||++||+.. ++|||
T Consensus 75 f~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~D 154 (302)
T KOG2345|consen 75 FNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRD 154 (302)
T ss_pred hCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccC
Confidence 3689999988 245699999999999999998632 236999999999999999999999998 99999
Q ss_pred CCCCcEEEeecCCCCCEEEeecCCccccCCCC----------CcccccccCCccccccccc----cCCCchhHHHHHHHH
Q 016471 67 LKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ----------RLNDIVGSAYYVAPEVLHR----SYNVEGDMWSIGVIT 132 (389)
Q Consensus 67 lkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il 132 (389)
|||.|||++ +.+.++|+|||.++.....- ....-.+|..|.|||.+.- ..+.++|||||||++
T Consensus 155 iKP~NILls---~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtL 231 (302)
T KOG2345|consen 155 IKPANILLS---DSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTL 231 (302)
T ss_pred CCcceeEec---CCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHH
Confidence 999999995 57899999999876542211 1122357899999998842 378999999999999
Q ss_pred HHHHhCCCCCCCCCh--hHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCC
Q 016471 133 YILLCGSRPFWARTE--SGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 197 (389)
Q Consensus 133 ~~ll~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h 197 (389)
|.|+.|..||...-. ..+.-.+.+....+|.. +.+|..+.++|++||+.||.+||++.+++.+
T Consensus 232 Ya~mf~~sPfe~~~~~GgSlaLAv~n~q~s~P~~--~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 232 YAMMFGESPFERIYQQGGSLALAVQNAQISIPNS--SRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred HHHHHcCCcchHHhhcCCeEEEeeeccccccCCC--CCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 999999999943111 11112233334444443 3489999999999999999999999998863
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=277.10 Aligned_cols=192 Identities=24% Similarity=0.398 Sum_probs=150.3
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhc----------CCCCCHHHHHHHHHHHHHHHHHHHHCCCEecC
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSR----------GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRD 66 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~----------~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrd 66 (389)
|.||||++++ ..+..|+|||||+||+|.+++... ...++...+..++.||+.||+|||++||+|||
T Consensus 59 L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRD 138 (932)
T PRK13184 59 LIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRD 138 (932)
T ss_pred CCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccC
Confidence 5799999998 357899999999999999987532 12355677889999999999999999999999
Q ss_pred CCCCcEEEeecCCCCCEEEeecCCccccCCC-------------------CCcccccccCCcccccccc-ccCCCchhHH
Q 016471 67 LKPENFLFTTREEDAPLKVIDFGLSDFVRPD-------------------QRLNDIVGSAYYVAPEVLH-RSYNVEGDMW 126 (389)
Q Consensus 67 lkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~-------------------~~~~~~~gt~~y~aPE~~~-~~~~~~~Diw 126 (389)
|||+||++ +.++.+||+|||++...... ......+||+.|+|||++. ..++.++|||
T Consensus 139 LKPeNILL---d~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIW 215 (932)
T PRK13184 139 LKPDNILL---GLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIY 215 (932)
T ss_pred CchheEEE---cCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHH
Confidence 99999999 56788999999998765210 0112346999999999875 4689999999
Q ss_pred HHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 127 SIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 127 slG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
|+||++|+|++|..||................+ ....++..+++.+.+++.+||..+|++|++..+.+.
T Consensus 216 SLGVILyELLTG~~PF~~~~~~ki~~~~~i~~P-~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl 284 (932)
T PRK13184 216 ALGVILYQMLTLSFPYRRKKGRKISYRDVILSP-IEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELK 284 (932)
T ss_pred HHHHHHHHHHHCCCCCCCcchhhhhhhhhccCh-hhccccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 999999999999999987655443322111111 111223568899999999999999999988665553
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=273.35 Aligned_cols=213 Identities=28% Similarity=0.402 Sum_probs=163.5
Q ss_pred CCccccceee----cCeEEEEEEccCCCChHHHHHhcCCC---CCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEE
Q 016471 2 YHQKLQHLFY----SNSFLFFTRFCEGGELLDRILSRGGR---YLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLF 74 (389)
Q Consensus 2 ~Hpni~~~~~----~~~~~lv~E~~~gg~L~~~l~~~~~~---l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill 74 (389)
.||||++||+ ....||..|.|.- +|.+++...... ......+.++.|++.||++||+.+||||||||+|||+
T Consensus 561 ~H~NviRyyc~E~d~qF~YIalELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI 639 (903)
T KOG1027|consen 561 EHPNVIRYYCSEQDRQFLYIALELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILI 639 (903)
T ss_pred CCCceEEEEeeccCCceEEEEehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEE
Confidence 5999999994 4679999999987 999988763111 1114568899999999999999999999999999999
Q ss_pred eecC--CCCCEEEeecCCccccCCCC----CcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 016471 75 TTRE--EDAPLKVIDFGLSDFVRPDQ----RLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLC-GSRPFWART 146 (389)
Q Consensus 75 ~~~~--~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~-g~~pf~~~~ 146 (389)
+..+ ....++|+|||+++....+. ...+..||-+|+|||++.. .-+.++||+|+|||+|+.++ |.+||....
T Consensus 640 ~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~ 719 (903)
T KOG1027|consen 640 SVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSL 719 (903)
T ss_pred EccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchH
Confidence 8542 34578999999999887654 2445679999999999964 45678999999999999999 599994433
Q ss_pred hhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCCCCCCccHHHHHHHH
Q 016471 147 ESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDILIYKLVK 218 (389)
Q Consensus 147 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~~~~~~~~~~~~~~~ 218 (389)
+...+|+.+........ +.-...+++||.+|+.++|..||+|.++|.||+|++..++......+..++.
T Consensus 720 --~R~~NIl~~~~~L~~L~-~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekrL~Fl~dvSDRvE 788 (903)
T KOG1027|consen 720 --ERQANILTGNYTLVHLE-PLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEKRLSFLRDVSDRVE 788 (903)
T ss_pred --HhhhhhhcCccceeeec-cCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCChHHHHHHHHhhhhhhh
Confidence 33345665554433221 1122289999999999999999999999999999887655544444444433
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-32 Score=244.77 Aligned_cols=190 Identities=21% Similarity=0.357 Sum_probs=159.2
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEe
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGR-YLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 75 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~-l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~ 75 (389)
+.||||++++ ..+..|+||||++||+|.+++...... +++..+..++.|++.||.|||++|++||||+|+||++
T Consensus 58 l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~- 136 (258)
T smart00219 58 LDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLV- 136 (258)
T ss_pred cCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEE-
Confidence 4799999999 346799999999999999988765433 9999999999999999999999999999999999999
Q ss_pred ecCCCCCEEEeecCCccccCCCCCcc--cccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 016471 76 TREEDAPLKVIDFGLSDFVRPDQRLN--DIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIF 151 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~~~~~~--~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~ 151 (389)
+.++.++|+|||++.......... ...+++.|+|||.+. ..++.++|+||+|+++|+|++ |.+||...+.....
T Consensus 137 --~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~ 214 (258)
T smart00219 137 --GENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVL 214 (258)
T ss_pred --ccCCeEEEcccCCceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 567789999999987665432111 123678899999874 468999999999999999998 89999887777777
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 152 RSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 152 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
..+.+...... ...++..+.+++.+||..+|.+|||+.++++
T Consensus 215 ~~~~~~~~~~~---~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 215 EYLKKGYRLPK---PENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHhcCCCCCC---CCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 77765443222 2347899999999999999999999999885
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=258.64 Aligned_cols=197 Identities=29% Similarity=0.503 Sum_probs=156.3
Q ss_pred CCCccccceee----------cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCC
Q 016471 1 MYHQKLQHLFY----------SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPE 70 (389)
Q Consensus 1 l~Hpni~~~~~----------~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~ 70 (389)
++||||++++. ...+|++++++ |++|.+.+.. +.+++..+..++.|++.||.|||++||+||||||+
T Consensus 73 l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~ 149 (345)
T cd07877 73 MKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPS 149 (345)
T ss_pred cCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChH
Confidence 58999999872 13478888887 6789776543 46999999999999999999999999999999999
Q ss_pred cEEEeecCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChh
Q 016471 71 NFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTES 148 (389)
Q Consensus 71 Nill~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 148 (389)
||++ +.++.+||+|||++..... ......+++.|+|||.+.+ .++.++|+||+||++|+|++|+.||.+....
T Consensus 150 NIll---~~~~~~kl~dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~ 224 (345)
T cd07877 150 NLAV---NEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 224 (345)
T ss_pred HEEE---cCCCCEEEecccccccccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999 4678899999999876432 2334578899999998743 5788999999999999999999999876655
Q ss_pred HHHHHHHhcCC-----------------------CCCCC----CCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCC
Q 016471 149 GIFRSVLRADP-----------------------NFHDS----PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLH 201 (389)
Q Consensus 149 ~~~~~i~~~~~-----------------------~~~~~----~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~ 201 (389)
.....+..... ..+.. .....++.+.++|.+||..+|.+|||+.+++.||||+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~ 304 (345)
T cd07877 225 DQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 304 (345)
T ss_pred HHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhh
Confidence 44443322111 11110 0123578899999999999999999999999999998
Q ss_pred CCCC
Q 016471 202 DENR 205 (389)
Q Consensus 202 ~~~~ 205 (389)
....
T Consensus 305 ~~~~ 308 (345)
T cd07877 305 QYHD 308 (345)
T ss_pred hcCC
Confidence 6543
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-32 Score=244.66 Aligned_cols=188 Identities=24% Similarity=0.353 Sum_probs=156.0
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEe
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 75 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~ 75 (389)
+.||||++++ +....|+||||+++|+|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||++
T Consensus 57 l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili- 135 (256)
T cd05039 57 LRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLV- 135 (256)
T ss_pred cCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEE-
Confidence 5799999988 3678999999999999999886553 268999999999999999999999999999999999999
Q ss_pred ecCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHH
Q 016471 76 TREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRS 153 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~ 153 (389)
+.++.+||+|||.+........ ...++..|+|||.+. +.++.++|+||+|+++|++++ |..||...+.......
T Consensus 136 --~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~ 211 (256)
T cd05039 136 --SEDLVAKVSDFGLAKEASQGQD--SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPH 211 (256)
T ss_pred --eCCCCEEEcccccccccccccc--cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 4678899999999887633221 334456799999875 568889999999999999997 9999988777666655
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 154 VLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 154 i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
+..... . .....+++.+.++|.+||..+|.+|||+.+++.
T Consensus 212 ~~~~~~-~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 212 VEKGYR-M--EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HhcCCC-C--CCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 544321 1 112357899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=269.19 Aligned_cols=189 Identities=18% Similarity=0.361 Sum_probs=163.4
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCCE
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG-------------GRYLEEDAKTIVEKILNIVAFCHLQGVV 63 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~-------------~~l~~~~~~~i~~qi~~~L~~lH~~~i~ 63 (389)
|+|||||+++ .++.+|+|+|||..|||.+++..+. +.|+..+.+.|+.||+.|+.||-++.+|
T Consensus 546 l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FV 625 (774)
T KOG1026|consen 546 LQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFV 625 (774)
T ss_pred ccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCccc
Confidence 6899999999 5789999999999999999997642 1278899999999999999999999999
Q ss_pred ecCCCCCcEEEeecCCCCCEEEeecCCccccCCCCCcc---cccccCCccccccc-cccCCCchhHHHHHHHHHHHHh-C
Q 016471 64 HRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLN---DIVGSAYYVAPEVL-HRSYNVEGDMWSIGVITYILLC-G 138 (389)
Q Consensus 64 Hrdlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~-~~~~~~~~DiwslG~il~~ll~-g 138 (389)
||||-..|+|+ +++..|||+|||+++..-..+... ...-..+|||||.+ .+.++.++||||+||+|||+++ |
T Consensus 626 HRDLATRNCLV---ge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG 702 (774)
T KOG1026|consen 626 HRDLATRNCLV---GENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYG 702 (774)
T ss_pred ccchhhhhcee---ccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccc
Confidence 99999999999 578999999999998653322111 12234689999976 6889999999999999999999 9
Q ss_pred CCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHh
Q 016471 139 SRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQAL 195 (389)
Q Consensus 139 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l 195 (389)
..||.+-+..+++..|.++.. .+.+ ...+.++.+|+..||+.+|++|||+.||=
T Consensus 703 ~QPy~glSn~EVIe~i~~g~l-L~~P--e~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 703 KQPYYGLSNQEVIECIRAGQL-LSCP--ENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred cCcccccchHHHHHHHHcCCc-ccCC--CCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 999999999999999988765 4433 46899999999999999999999998874
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=257.40 Aligned_cols=195 Identities=30% Similarity=0.552 Sum_probs=156.0
Q ss_pred CCCccccceee----------cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCC
Q 016471 1 MYHQKLQHLFY----------SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPE 70 (389)
Q Consensus 1 l~Hpni~~~~~----------~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~ 70 (389)
+.||||++++. ...+|+||||+.+ +|.... +..+++..+..++.|++.||+|||++|++||||||+
T Consensus 71 l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~ 146 (342)
T cd07879 71 MQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPG 146 (342)
T ss_pred cCCCCccchhheecccccCCCCceEEEEeccccc-CHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHH
Confidence 57999998872 1357999999975 776543 246899999999999999999999999999999999
Q ss_pred cEEEeecCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChh
Q 016471 71 NFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTES 148 (389)
Q Consensus 71 Nill~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 148 (389)
||++ +.++.+||+|||++..... ......+++.|+|||++.+ .++.++|+||+||++|+|++|+.||.+.+..
T Consensus 147 NIll---~~~~~~kL~dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~ 221 (342)
T cd07879 147 NLAV---NEDCELKILDFGLARHADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL 221 (342)
T ss_pred HEEE---CCCCCEEEeeCCCCcCCCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999 5678999999999876432 2234578899999998753 4788999999999999999999999887655
Q ss_pred HHHHHHHhcCC-----------------------CCCCC----CCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCC
Q 016471 149 GIFRSVLRADP-----------------------NFHDS----PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLH 201 (389)
Q Consensus 149 ~~~~~i~~~~~-----------------------~~~~~----~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~ 201 (389)
..+..+....+ ..+.. .++..++.+.++|.+||+.+|.+||++.+++.||||.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~ 301 (342)
T cd07879 222 DQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFD 301 (342)
T ss_pred HHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchh
Confidence 44444332111 11111 1245788999999999999999999999999999997
Q ss_pred CCC
Q 016471 202 DEN 204 (389)
Q Consensus 202 ~~~ 204 (389)
...
T Consensus 302 ~~~ 304 (342)
T cd07879 302 SFR 304 (342)
T ss_pred hcc
Confidence 753
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=251.71 Aligned_cols=190 Identities=21% Similarity=0.297 Sum_probs=155.5
Q ss_pred CCCccccceee---cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 1 MYHQKLQHLFY---SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 1 l~Hpni~~~~~---~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
+.||||++++. ....++|+||+++|+|.+++..+...+++..+..++.|++.||.|||++||+||||||+||++
T Consensus 66 l~h~niv~~~~~~~~~~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill--- 142 (303)
T cd05110 66 MDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLV--- 142 (303)
T ss_pred CCCCCcccEEEEEcCCCceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeee---
Confidence 57999999983 456789999999999999987766679999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCCccccCCCCC---cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHH
Q 016471 78 EEDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFR 152 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 152 (389)
+.++.+||+|||++........ .....++..|+|||.+. ..++.++||||+||++|++++ |..||.+........
T Consensus 143 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~ 222 (303)
T cd05110 143 KSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPD 222 (303)
T ss_pred cCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 4677899999999986543221 12234567899999875 468899999999999999997 999997766554444
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 153 SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 153 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
.+ ......+. .+..+..+.+++.+||..+|.+||++.+++.
T Consensus 223 ~~-~~~~~~~~--~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~ 263 (303)
T cd05110 223 LL-EKGERLPQ--PPICTIDVYMVMVKCWMIDADSRPKFKELAA 263 (303)
T ss_pred HH-HCCCCCCC--CCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 33 33322222 2457889999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=267.90 Aligned_cols=197 Identities=29% Similarity=0.517 Sum_probs=166.0
Q ss_pred CCccccceee---------cCeEEEEEEccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCc
Q 016471 2 YHQKLQHLFY---------SNSFLFFTRFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPEN 71 (389)
Q Consensus 2 ~Hpni~~~~~---------~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~N 71 (389)
+|||++.+|+ .+++|||||||.||+.-|.++.. +.++.|+.++.|++.++.||.+||.+.++|||+|-.|
T Consensus 74 ~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~N 153 (953)
T KOG0587|consen 74 HHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQN 153 (953)
T ss_pred CCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCce
Confidence 6999999982 58899999999999999988643 4689999999999999999999999999999999999
Q ss_pred EEEeecCCCCCEEEeecCCccccCCC-CCcccccccCCcccccccc--c----cCCCchhHHHHHHHHHHHHhCCCCCCC
Q 016471 72 FLFTTREEDAPLKVIDFGLSDFVRPD-QRLNDIVGSAYYVAPEVLH--R----SYNVEGDMWSIGVITYILLCGSRPFWA 144 (389)
Q Consensus 72 ill~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~--~----~~~~~~DiwslG~il~~ll~g~~pf~~ 144 (389)
||++ .++.|||+|||++...... .+.++.+|||+|||||++. . .|+..+|+||||++..||.-|.+|+..
T Consensus 154 iLLT---~e~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~D 230 (953)
T KOG0587|consen 154 VLLT---ENAEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCD 230 (953)
T ss_pred EEEe---ccCcEEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccC
Confidence 9996 6788999999998766443 3556789999999999983 1 378899999999999999999999987
Q ss_pred CChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCC
Q 016471 145 RTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 202 (389)
Q Consensus 145 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~ 202 (389)
.-+...+-.|-+..+ +....+.++++.+.+||..||.+|..+||+..+++.|||+..
T Consensus 231 mHPmraLF~IpRNPP-PkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 231 MHPMRALFLIPRNPP-PKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred cchhhhhccCCCCCC-ccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 766544443332221 111124568999999999999999999999999999999983
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-32 Score=246.09 Aligned_cols=193 Identities=19% Similarity=0.328 Sum_probs=154.6
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCC
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSR------GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPE 70 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~------~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~ 70 (389)
+.||||+.++ .....|+||||++||+|.+++.+. ...+++..+..++.|++.||+|||++|++|+||||+
T Consensus 56 l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~ 135 (269)
T cd05044 56 FNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAAR 135 (269)
T ss_pred cCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChh
Confidence 5799999988 356799999999999999998643 234788999999999999999999999999999999
Q ss_pred cEEEeecC--CCCCEEEeecCCccccCCCC---CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCC
Q 016471 71 NFLFTTRE--EDAPLKVIDFGLSDFVRPDQ---RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFW 143 (389)
Q Consensus 71 Nill~~~~--~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~ 143 (389)
||+++..+ ....++++|||++....... ......++..|+|||.+. +.++.++|||||||++|+|++ |..||.
T Consensus 136 nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~ 215 (269)
T cd05044 136 NCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYP 215 (269)
T ss_pred eEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCc
Confidence 99996422 12379999999987653221 112234567899999885 468999999999999999998 999998
Q ss_pred CCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 144 ARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 144 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
..+..+....+..... + .....++..+.+++.+||..+|.+||+++++++
T Consensus 216 ~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 216 ALNNQEVLQHVTAGGR-L--QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred ccCHHHHHHHHhcCCc-c--CCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 7776666555543221 1 122457899999999999999999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-32 Score=245.04 Aligned_cols=190 Identities=21% Similarity=0.365 Sum_probs=156.9
Q ss_pred CCCcccccee---ecCeEEEEEEccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF---YSNSFLFFTRFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~---~~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
++||||++++ .....|+||||+.+|+|.+++... +..+++.++..++.|++.||+|||+.|++||||||+||++
T Consensus 58 l~h~~i~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i-- 135 (260)
T cd05067 58 LQHPRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILV-- 135 (260)
T ss_pred cCCcCeeeEEEEEccCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEE--
Confidence 5799999988 356789999999999999988653 3468999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCC--cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQR--LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFR 152 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 152 (389)
+.++.++|+|||++........ .....++..|+|||++. ..++.++|+||+|+++|++++ |++||.+.+..+...
T Consensus 136 -~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~ 214 (260)
T cd05067 136 -SETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQ 214 (260)
T ss_pred -cCCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHH
Confidence 4678899999999876542221 12334567899999885 468899999999999999999 999998887776666
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 153 SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 153 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
.+...... +.....+..+.+++.+||..+|++|||+++++.
T Consensus 215 ~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 215 NLERGYRM---PRPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHcCCCC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 65443221 122457889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-32 Score=243.45 Aligned_cols=188 Identities=20% Similarity=0.336 Sum_probs=155.6
Q ss_pred CCCcccccee---ecCeEEEEEEccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF---YSNSFLFFTRFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~---~~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||+.++ ..+..|+||||+.||+|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||++
T Consensus 56 ~~~~~i~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili-- 133 (254)
T cd05083 56 LHHKNLVRLLGVILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILV-- 133 (254)
T ss_pred CCCCCcCeEEEEEcCCCcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE--
Confidence 5799999998 2456899999999999999887543 358899999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i 154 (389)
+.++.+||+|||++...... ......+..|+|||.+. +.++.++|+||+||++|+|++ |..||...+..+....+
T Consensus 134 -~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~ 210 (254)
T cd05083 134 -SEDGVAKVSDFGLARVGSMG--VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECV 210 (254)
T ss_pred -cCCCcEEECCCccceecccc--CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH
Confidence 46788999999998764322 12234456799999875 468899999999999999997 99999888777666665
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
.+... . .....++..+.+++.+||..+|.+||++++++.
T Consensus 211 ~~~~~-~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 211 EKGYR-M--EPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred hCCCC-C--CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 54321 1 122467899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-32 Score=242.81 Aligned_cols=190 Identities=18% Similarity=0.263 Sum_probs=155.5
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||+.++ .....|+||||++|++|.+++......+++..+..++.|++.||.|||++|++||||+|+||++
T Consensus 49 l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili-- 126 (251)
T cd05041 49 YDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLV-- 126 (251)
T ss_pred CCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEE--
Confidence 5799999887 3577999999999999999987665678999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCCc---ccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRL---NDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIF 151 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~ 151 (389)
+.++.+||+|||++......... ....++..|+|||.+. +.++.++|+||+||++|+|++ |..||.+.......
T Consensus 127 -~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~ 205 (251)
T cd05041 127 -GENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTR 205 (251)
T ss_pred -cCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHH
Confidence 56788999999998765422111 1123356799999875 468899999999999999999 89999887766655
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 152 RSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 152 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
..+.... ..+ ....++..+.+++.+||..+|.+|||+.++++
T Consensus 206 ~~~~~~~-~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 206 ERIESGY-RMP--APQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred HHHhcCC-CCC--CCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 5554322 111 12357899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-32 Score=245.30 Aligned_cols=191 Identities=24% Similarity=0.464 Sum_probs=154.3
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEE
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILS---RGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFL 73 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nil 73 (389)
+.||||+.++ ..+..++||||++||+|.+++.. ....+++..+..++.|++.||.|||+.|++||||+|+||+
T Consensus 59 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil 138 (267)
T cd08224 59 LDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVF 138 (267)
T ss_pred CCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEE
Confidence 5799999988 45789999999999999988753 2355899999999999999999999999999999999999
Q ss_pred EeecCCCCCEEEeecCCccccCCCC-CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCh--hH
Q 016471 74 FTTREEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTE--SG 149 (389)
Q Consensus 74 l~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~ 149 (389)
+ +.++.++|+|||++....... ......+++.|+|||.+. ..++.++|+||+||++|+|++|+.||..... ..
T Consensus 139 ~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 215 (267)
T cd08224 139 I---TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS 215 (267)
T ss_pred E---CCCCcEEEeccceeeeccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHH
Confidence 9 467889999999987654322 223456889999999875 4688999999999999999999999965432 23
Q ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 150 IFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 150 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
....+.... .+..+.+.++..+.++|.+||..+|++|||+.++++
T Consensus 216 ~~~~~~~~~--~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 216 LCKKIEKCD--YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHhhhhcCC--CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 333333322 222223467889999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-32 Score=245.17 Aligned_cols=192 Identities=23% Similarity=0.460 Sum_probs=159.7
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCEecCCCCCcE
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRIL---SRGGRYLEEDAKTIVEKILNIVAFCHL-QGVVHRDLKPENF 72 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~---~~~~~l~~~~~~~i~~qi~~~L~~lH~-~~i~Hrdlkp~Ni 72 (389)
+.||||+.++ .++..|+||||++|++|.+.+. .....+++..++.++.|++.||.|||+ .|++||||+|+||
T Consensus 66 ~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~ni 145 (269)
T cd08528 66 LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNI 145 (269)
T ss_pred CCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHE
Confidence 4699999988 3688999999999999988774 344679999999999999999999996 7899999999999
Q ss_pred EEeecCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHH
Q 016471 73 LFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIF 151 (389)
Q Consensus 73 ll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 151 (389)
++ +.++.+||+|||.+.............|+..|+|||.+. +.++.++|+||+|+++|+|++|+.||.........
T Consensus 146 l~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~ 222 (269)
T cd08528 146 ML---GEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLA 222 (269)
T ss_pred EE---CCCCcEEEecccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHH
Confidence 99 467889999999988765544445567899999999885 45889999999999999999999999877666666
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCC
Q 016471 152 RSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 197 (389)
Q Consensus 152 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h 197 (389)
..+...... +.....+++.+.+++.+||..||.+||++.++..+
T Consensus 223 ~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 223 TKIVEAVYE--PLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred HHHhhccCC--cCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 555543322 11223578999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-32 Score=246.00 Aligned_cols=192 Identities=16% Similarity=0.298 Sum_probs=157.3
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCC
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG--------GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLK 68 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~--------~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlk 68 (389)
+.||||++++ .....|+|||||++|+|.+++.... ..+++..+..++.|++.||+|||++||+|||||
T Consensus 65 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlk 144 (275)
T cd05046 65 LSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLA 144 (275)
T ss_pred cCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCc
Confidence 5799999988 3467999999999999999886543 158999999999999999999999999999999
Q ss_pred CCcEEEeecCCCCCEEEeecCCccccCCCC--CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCC
Q 016471 69 PENFLFTTREEDAPLKVIDFGLSDFVRPDQ--RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWA 144 (389)
Q Consensus 69 p~Nill~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~ 144 (389)
|+||+++ .++.++++|||++....... ......+++.|+|||.+. ..++.++||||+|+++|++++ |..||..
T Consensus 145 p~Nili~---~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~ 221 (275)
T cd05046 145 ARNCLVS---SQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYG 221 (275)
T ss_pred cceEEEe---CCCcEEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 9999994 57889999999986543221 223345677899999875 457889999999999999998 8899987
Q ss_pred CChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCC
Q 016471 145 RTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 197 (389)
Q Consensus 145 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h 197 (389)
.........+.......+. ...++..+.+++.+||..+|.+|||+.+++..
T Consensus 222 ~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 222 LSDEEVLNRLQAGKLELPV--PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred cchHHHHHHHHcCCcCCCC--CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 7776666666544333222 23578999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.7e-32 Score=252.26 Aligned_cols=197 Identities=31% Similarity=0.523 Sum_probs=155.4
Q ss_pred CCCccccceee-----cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEe
Q 016471 1 MYHQKLQHLFY-----SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 75 (389)
Q Consensus 1 l~Hpni~~~~~-----~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~ 75 (389)
+.||||+++.. ....|+||||+ +++|.+.+.. +.+++..+..++.|++.||.|||++||+||||+|+||++
T Consensus 66 l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili- 141 (328)
T cd07856 66 LRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILI- 141 (328)
T ss_pred cCCCCeeeEeeeEecCCCcEEEEeehh-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeE-
Confidence 57999999772 35689999999 4588776543 468999999999999999999999999999999999999
Q ss_pred ecCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016471 76 TREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRS 153 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 153 (389)
+.++.++|+|||.+..... ......+++.|+|||.+.+ .++.++|+||+||++|+|++|++||.+.........
T Consensus 142 --~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~ 217 (328)
T cd07856 142 --NENCDLKICDFGLARIQDP--QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSI 217 (328)
T ss_pred --CCCCCEEeCccccccccCC--CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 5678899999999875432 2334567889999998743 588999999999999999999999977654332221
Q ss_pred HHhcC-----------------------CC----CCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCCC
Q 016471 154 VLRAD-----------------------PN----FHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENR 205 (389)
Q Consensus 154 i~~~~-----------------------~~----~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~~ 205 (389)
+.+.. .. ......+.++..+.++|.+||..+|.+|||+++++.||||.....
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~ 296 (328)
T cd07856 218 ITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHD 296 (328)
T ss_pred HHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccC
Confidence 11100 00 000112457889999999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.5e-32 Score=253.06 Aligned_cols=190 Identities=21% Similarity=0.329 Sum_probs=155.6
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG---------------GRYLEEDAKTIVEKILNIVAFCHLQGV 62 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~~lH~~~i 62 (389)
.||||++++ ..+.+|+||||+++|+|.+++.... ..++...+..++.|++.||.|||++|+
T Consensus 76 ~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi 155 (334)
T cd05100 76 KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKC 155 (334)
T ss_pred CCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 699999988 3567999999999999999887532 247778899999999999999999999
Q ss_pred EecCCCCCcEEEeecCCCCCEEEeecCCccccCCCCC---cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-
Q 016471 63 VHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC- 137 (389)
Q Consensus 63 ~Hrdlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~- 137 (389)
+||||||+||++ +.++.+||+|||++........ .....++..|+|||++. ..++.++||||+||++|+|++
T Consensus 156 vH~dlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~ 232 (334)
T cd05100 156 IHRDLAARNVLV---TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTL 232 (334)
T ss_pred eccccccceEEE---cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhc
Confidence 999999999999 4678899999999876543221 11223456799999885 468899999999999999998
Q ss_pred CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCC
Q 016471 138 GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 197 (389)
Q Consensus 138 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h 197 (389)
|..||.+.+..+....+...... + ....++..+.+++.+||..+|.+|||+.+++.+
T Consensus 233 g~~p~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 233 GGSPYPGIPVEELFKLLKEGHRM-D--KPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred CCCCCCCCCHHHHHHHHHcCCCC-C--CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 89999888877777666543221 1 123578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=247.76 Aligned_cols=193 Identities=17% Similarity=0.250 Sum_probs=152.7
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHHCCCEec
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG-----------GRYLEEDAKTIVEKILNIVAFCHLQGVVHR 65 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~-----------~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hr 65 (389)
+.||||+.++ .....|+|||||.||+|.+++.... ..+++..+..++.|++.||.|||++|++||
T Consensus 74 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~ 153 (295)
T cd05097 74 LKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHR 153 (295)
T ss_pred CCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeecc
Confidence 5799999998 3578999999999999999885431 136788999999999999999999999999
Q ss_pred CCCCCcEEEeecCCCCCEEEeecCCccccCCCCC---cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh--CC
Q 016471 66 DLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC--GS 139 (389)
Q Consensus 66 dlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~--g~ 139 (389)
||||+||++ +.++.+||+|||++........ .....+++.|+|||++. +.++.++|+|||||++|+|++ |.
T Consensus 154 dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~ 230 (295)
T cd05097 154 DLATRNCLV---GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKE 230 (295)
T ss_pred ccChhhEEE---cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCC
Confidence 999999999 4677899999999876533221 12234567899999874 568999999999999999988 67
Q ss_pred CCCCCCChhHHHHHHHhcC----CCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 140 RPFWARTESGIFRSVLRAD----PNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 140 ~pf~~~~~~~~~~~i~~~~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
.||...+..+....+.... ........+.+++.+.+++.+||..+|.+|||++++++
T Consensus 231 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 231 QPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred CCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 8888776666555443211 11111122457899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.4e-32 Score=247.96 Aligned_cols=191 Identities=21% Similarity=0.339 Sum_probs=149.7
Q ss_pred CCCccccceee------cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEE
Q 016471 1 MYHQKLQHLFY------SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLF 74 (389)
Q Consensus 1 l~Hpni~~~~~------~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill 74 (389)
+.||||++++. ...+++||||++||+|.+++.+....+++..+..++.|++.||+|||++|++||||||+||++
T Consensus 63 l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~ 142 (284)
T cd05079 63 LYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV 142 (284)
T ss_pred CCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEE
Confidence 57999999872 256899999999999999887655568999999999999999999999999999999999999
Q ss_pred eecCCCCCEEEeecCCccccCCCCC----cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCh--
Q 016471 75 TTREEDAPLKVIDFGLSDFVRPDQR----LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTE-- 147 (389)
Q Consensus 75 ~~~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-- 147 (389)
+ .++.++|+|||++........ .....++..|+|||++. +.++.++||||+||++|+|+++..|+.....
T Consensus 143 ~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~ 219 (284)
T cd05079 143 E---SEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLF 219 (284)
T ss_pred c---CCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchh
Confidence 4 678899999999886543321 12345677899999875 4688999999999999999998776532110
Q ss_pred ------------hHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 148 ------------SGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 148 ------------~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
.............. +....++..+.+|+.+||..+|.+|||+.++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 278 (284)
T cd05079 220 LKMIGPTHGQMTVTRLVRVLEEGKRL--PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278 (284)
T ss_pred hhhcccccccccHHHHHHHHHcCccC--CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 01111111111111 123468899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=246.84 Aligned_cols=190 Identities=19% Similarity=0.302 Sum_probs=155.4
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcC---------------------CCCCHHHHHHHHHHHHHHHH
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG---------------------GRYLEEDAKTIVEKILNIVA 55 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~---------------------~~l~~~~~~~i~~qi~~~L~ 55 (389)
|.||||++++ ....+|+||||+++|+|.+++.... ..+++..+..++.|++.||.
T Consensus 65 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~ 144 (288)
T cd05050 65 FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMA 144 (288)
T ss_pred cCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHH
Confidence 5799999988 3467899999999999999986432 24778889999999999999
Q ss_pred HHHHCCCEecCCCCCcEEEeecCCCCCEEEeecCCccccCCCC---CcccccccCCcccccccc-ccCCCchhHHHHHHH
Q 016471 56 FCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ---RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVI 131 (389)
Q Consensus 56 ~lH~~~i~Hrdlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~i 131 (389)
|||++|++||||||+||++ +.++.++|+|||++....... ......+++.|+|||.+. ..++.++|+||+||+
T Consensus 145 ~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i 221 (288)
T cd05050 145 YLSERKFVHRDLATRNCLV---GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVV 221 (288)
T ss_pred HHHhCCeecccccHhheEe---cCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHH
Confidence 9999999999999999999 567889999999987543221 112233566799999875 568999999999999
Q ss_pred HHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 132 TYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 132 l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
+|+|++ |..||.+.+..+....+...... +. ...++..+.+++.+||..+|.+|||+.|+++
T Consensus 222 l~el~~~~~~p~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 222 LWEIFSYGMQPYYGMAHEEVIYYVRDGNVL-SC--PDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHhCCCCCCCCCCHHHHHHHHhcCCCC-CC--CCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 999997 88999888777777766544322 11 1357899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=242.66 Aligned_cols=190 Identities=23% Similarity=0.370 Sum_probs=157.0
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEe
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 75 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~ 75 (389)
+.||||+.++ .....++||||+++|+|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||++
T Consensus 58 l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili- 136 (261)
T cd05034 58 LRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILV- 136 (261)
T ss_pred CCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEE-
Confidence 5799999998 2477999999999999999887643 468999999999999999999999999999999999999
Q ss_pred ecCCCCCEEEeecCCccccCCCCC--cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 016471 76 TREEDAPLKVIDFGLSDFVRPDQR--LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIF 151 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~ 151 (389)
+.++.+||+|||.+........ .....++..|+|||.+. ..++.++|+||+|+++|++++ |+.||.+.......
T Consensus 137 --~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~ 214 (261)
T cd05034 137 --GENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVL 214 (261)
T ss_pred --cCCCCEEECccccceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 4678999999999876643211 11223456899999875 468899999999999999998 99999888777777
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 152 RSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 152 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
..+...... +.....+..+.+++.+||..+|.+||+++++..
T Consensus 215 ~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 215 EQVERGYRM---PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHHHcCCCC---CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 766553221 112346889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.8e-33 Score=260.15 Aligned_cols=192 Identities=23% Similarity=0.411 Sum_probs=158.4
Q ss_pred CCcccccee---ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeecC
Q 016471 2 YHQKLQHLF---YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE 78 (389)
Q Consensus 2 ~Hpni~~~~---~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~~ 78 (389)
+|-||+=+- ....+.||+.+|+|-+|+.++.-...+|.-...+.|++||++|+.|||.++|||||||..||++ .
T Consensus 446 RH~NIlLFMG~~~~p~~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl---~ 522 (678)
T KOG0193|consen 446 RHENILLFMGACMNPPLAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFL---H 522 (678)
T ss_pred chhhheeeehhhcCCceeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEE---c
Confidence 588888655 3566799999999999999997666789999999999999999999999999999999999999 5
Q ss_pred CCCCEEEeecCCccccC---CCCCcccccccCCcccccccc----ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHH
Q 016471 79 EDAPLKVIDFGLSDFVR---PDQRLNDIVGSAYYVAPEVLH----RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIF 151 (389)
Q Consensus 79 ~~~~~kl~Dfg~a~~~~---~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 151 (389)
+++.|||+|||++..-. .........|...|||||++. .+|++++||||||||+|||++|..||......+++
T Consensus 523 ~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIi 602 (678)
T KOG0193|consen 523 EDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQII 602 (678)
T ss_pred cCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheE
Confidence 67999999999986432 223344567889999999983 36999999999999999999999999877776666
Q ss_pred HHHHhcCCCCCC-CCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 152 RSVLRADPNFHD-SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 152 ~~i~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
-.+-++...... ....+.++++++|+..||.+++++||+..++|.
T Consensus 603 fmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 603 FMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred EEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 555444222211 122456779999999999999999999998886
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=272.74 Aligned_cols=99 Identities=28% Similarity=0.506 Sum_probs=85.2
Q ss_pred cccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhc
Q 016471 104 VGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLN 182 (389)
Q Consensus 104 ~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~ 182 (389)
+||+.|+|||++. ..++.++||||+||++|||++|.+||.+......+..++.....++... ..++..+.+++.+||.
T Consensus 541 vGT~~Y~APE~l~~~~~~~~~DiwSlG~il~ElltG~~pf~~~~~~~~~~~il~~~~~~p~~~-~~~~~~~~~~l~~lL~ 619 (669)
T cd05610 541 LGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWPEGE-EKLSVNAQNAIEILLT 619 (669)
T ss_pred eeCccccCHHHcCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCccc-ccCCHHHHHHHHHHcc
Confidence 4688999999875 4689999999999999999999999999888888888876654444332 3678899999999999
Q ss_pred cCcCCCCCHHHHhCCCCCCCC
Q 016471 183 KDHRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 183 ~~p~~R~s~~e~l~h~~~~~~ 203 (389)
.+|.+||++.+++.||||...
T Consensus 620 ~dP~~R~ta~e~l~h~~~~~~ 640 (669)
T cd05610 620 MDPTKRAGLKELKQHPLFHGV 640 (669)
T ss_pred cChhHCcCHHHHHhCHhhcCC
Confidence 999999999999999999654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=253.42 Aligned_cols=191 Identities=23% Similarity=0.391 Sum_probs=150.0
Q ss_pred CCccccceee-----cCeEEEEEEccCCCChHHHHHhcC-----------------------------------------
Q 016471 2 YHQKLQHLFY-----SNSFLFFTRFCEGGELLDRILSRG----------------------------------------- 35 (389)
Q Consensus 2 ~Hpni~~~~~-----~~~~~lv~E~~~gg~L~~~l~~~~----------------------------------------- 35 (389)
+||||++++. ...+++|||||++|+|.+++..+.
T Consensus 69 ~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (343)
T cd05103 69 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSA 148 (343)
T ss_pred CCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccc
Confidence 6899999882 356899999999999999886432
Q ss_pred -------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeecCCCCCEEEeecCC
Q 016471 36 -------------------------GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGL 90 (389)
Q Consensus 36 -------------------------~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~~~~~~~kl~Dfg~ 90 (389)
..++...+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~---~~~~~~kl~dfg~ 225 (343)
T cd05103 149 SSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGL 225 (343)
T ss_pred cccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEE---cCCCcEEEEeccc
Confidence 236778889999999999999999999999999999999 4678999999999
Q ss_pred ccccCCCC---CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCC
Q 016471 91 SDFVRPDQ---RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSP 165 (389)
Q Consensus 91 a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 165 (389)
+....... ......+++.|+|||.+. ..++.++|+||+|+++|+|++ |..||.+...................+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~- 304 (343)
T cd05103 226 ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAP- 304 (343)
T ss_pred ccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCC-
Confidence 87653221 112234567799999874 468999999999999999997 999997754433333333222222222
Q ss_pred CCCCCHHHHHHHHhhhccCcCCCCCHHHHhCC
Q 016471 166 WPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 197 (389)
Q Consensus 166 ~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h 197 (389)
...++.+.+++.+||..+|.+|||+.++++|
T Consensus 305 -~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 305 -DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred -CCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 2367899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=246.37 Aligned_cols=193 Identities=15% Similarity=0.228 Sum_probs=151.5
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHCCCEecC
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG----------GRYLEEDAKTIVEKILNIVAFCHLQGVVHRD 66 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~----------~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrd 66 (389)
+.||||+.++ .....|+||||+.+|+|.+++.... ..+++..+..++.|++.||+|||++|++|||
T Consensus 76 l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~d 155 (296)
T cd05095 76 LKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRD 155 (296)
T ss_pred CCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeeccc
Confidence 5799999988 3577999999999999999886542 2367788999999999999999999999999
Q ss_pred CCCCcEEEeecCCCCCEEEeecCCccccCCCCC---cccccccCCccccccc-cccCCCchhHHHHHHHHHHHHh--CCC
Q 016471 67 LKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVL-HRSYNVEGDMWSIGVITYILLC--GSR 140 (389)
Q Consensus 67 lkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~-~~~~~~~~DiwslG~il~~ll~--g~~ 140 (389)
|||+||+++ .++.++|+|||++........ .....+++.|+|||.. .+.++.++|+||+||++|+|++ |..
T Consensus 156 lkp~Nili~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~ 232 (296)
T cd05095 156 LATRNCLVG---KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQ 232 (296)
T ss_pred CChheEEEc---CCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCC
Confidence 999999994 678899999999876533221 1223346789999976 4578999999999999999998 789
Q ss_pred CCCCCChhHHHHHHHh---cC-CCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 141 PFWARTESGIFRSVLR---AD-PNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 141 pf~~~~~~~~~~~i~~---~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
||...+..+....... .. .....+..+.+++.+.+++.+||..+|.+|||+.++.+
T Consensus 233 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 233 PYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred CccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 9977666555443321 10 01111112357799999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=256.22 Aligned_cols=154 Identities=21% Similarity=0.319 Sum_probs=123.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeecCCCCCEEEeecCCccccCCCC---CcccccccCCcccccc
Q 016471 38 YLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ---RLNDIVGSAYYVAPEV 114 (389)
Q Consensus 38 l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~ 114 (389)
+++..++.++.||+.||.|||++|++||||||+|||++ .++.+||+|||++....... ......+++.|+|||.
T Consensus 236 l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~---~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~ 312 (401)
T cd05107 236 LSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLIC---EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPES 312 (401)
T ss_pred CCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEe---CCCEEEEEecCcceecccccccccCCCcCCCCceeChHH
Confidence 56778889999999999999999999999999999994 57889999999987653222 1223457788999998
Q ss_pred cc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHH
Q 016471 115 LH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAA 192 (389)
Q Consensus 115 ~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~ 192 (389)
+. ..++.++|+||+||++|+|++ |..||......+............+ ..+.++..+.+++.+||..+|.+||++.
T Consensus 313 ~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~--~p~~~~~~l~~li~~cl~~~P~~RPs~~ 390 (401)
T cd05107 313 IFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMA--KPAHASDEIYEIMQKCWEEKFEIRPDFS 390 (401)
T ss_pred hcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCCC--CCCCCCHHHHHHHHHHcCCChhHCcCHH
Confidence 85 458899999999999999998 8999977665555444433322222 1235789999999999999999999999
Q ss_pred HHhC
Q 016471 193 QALT 196 (389)
Q Consensus 193 e~l~ 196 (389)
+++.
T Consensus 391 ell~ 394 (401)
T cd05107 391 QLVH 394 (401)
T ss_pred HHHH
Confidence 9985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-31 Score=241.08 Aligned_cols=190 Identities=22% Similarity=0.355 Sum_probs=156.1
Q ss_pred CCCcccccee---ecCeEEEEEEccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF---YSNSFLFFTRFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~---~~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ .....|+||||+++|+|.+++.+. ...++...+..++.|++.||.|||++|++||||+|+||++
T Consensus 58 l~~~~i~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i-- 135 (260)
T cd05073 58 LQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV-- 135 (260)
T ss_pred cCCCCcceEEEEEcCCCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE--
Confidence 5799999998 346789999999999999998754 3457888999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCC--cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQR--LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFR 152 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 152 (389)
+..+.+||+|||.+........ .....++..|+|||++. +.++.++|+||+||++|++++ |..||.+.+......
T Consensus 136 -~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~ 214 (260)
T cd05073 136 -SASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIR 214 (260)
T ss_pred -cCCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 4678999999999876543221 12234566799999885 458889999999999999998 999998877776666
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 153 SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 153 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
.+..... .+.....+.++.+++.+||..+|++||++.+++.
T Consensus 215 ~~~~~~~---~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 215 ALERGYR---MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHhCCCC---CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 6554322 1222468899999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-31 Score=244.91 Aligned_cols=191 Identities=20% Similarity=0.309 Sum_probs=149.0
Q ss_pred CCCccccceee------cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEE
Q 016471 1 MYHQKLQHLFY------SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLF 74 (389)
Q Consensus 1 l~Hpni~~~~~------~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill 74 (389)
+.||||+.++. ...+|+||||++||+|.+++.+..+.+++..+..++.|++.||.|||++|++||||||+||++
T Consensus 62 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili 141 (284)
T cd05081 62 LQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILV 141 (284)
T ss_pred CCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEE
Confidence 57999999872 246899999999999999987665679999999999999999999999999999999999999
Q ss_pred eecCCCCCEEEeecCCccccCCCCCc----ccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhH
Q 016471 75 TTREEDAPLKVIDFGLSDFVRPDQRL----NDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESG 149 (389)
Q Consensus 75 ~~~~~~~~~kl~Dfg~a~~~~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 149 (389)
+.++.+||+|||++......... ....++..|+|||++. ..++.++|+||+||++|+|++|..|+.......
T Consensus 142 ---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~ 218 (284)
T cd05081 142 ---ESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEF 218 (284)
T ss_pred ---CCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhh
Confidence 56788999999998866433211 1112345699999875 468899999999999999999887764332110
Q ss_pred ---------------HHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 150 ---------------IFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 150 ---------------~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
....+.......+ ....++..+.+++.+||..+|.+|||+.+++.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 219 MRMMGNDKQGQMIVYHLIELLKNNGRLP--APPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred hhhcccccccccchHHHHHHHhcCCcCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 0111222221111 22467899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-31 Score=243.40 Aligned_cols=190 Identities=17% Similarity=0.235 Sum_probs=155.4
Q ss_pred CCCccccceee-----cCeEEEEEEccCCCChHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCC
Q 016471 1 MYHQKLQHLFY-----SNSFLFFTRFCEGGELLDRILSRG-------GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLK 68 (389)
Q Consensus 1 l~Hpni~~~~~-----~~~~~lv~E~~~gg~L~~~l~~~~-------~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlk 68 (389)
|.||||+.++. ....++++||+.+|+|.+++.... ..+++..+..++.|++.||+|||++|++|||||
T Consensus 65 l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~ 144 (280)
T cd05043 65 LSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIA 144 (280)
T ss_pred CCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccC
Confidence 57999999873 367899999999999999886532 358899999999999999999999999999999
Q ss_pred CCcEEEeecCCCCCEEEeecCCccccCCCCC---cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCC
Q 016471 69 PENFLFTTREEDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFW 143 (389)
Q Consensus 69 p~Nill~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~ 143 (389)
|+||+++ .++.+||+|||+++....... .....++..|+|||++. ..++.++||||+||++|++++ |+.||.
T Consensus 145 p~nil~~---~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 221 (280)
T cd05043 145 ARNCVID---EELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYV 221 (280)
T ss_pred HhhEEEc---CCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcC
Confidence 9999994 678899999999976543221 12234567899999875 458899999999999999998 999998
Q ss_pred CCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 144 ARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 144 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
..+..+....+.... ... ....+++.+.+++.+||..+|++|||+.+++.
T Consensus 222 ~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 222 EIDPFEMAAYLKDGY-RLA--QPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred cCCHHHHHHHHHcCC-CCC--CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 877666655554432 222 22357899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=242.67 Aligned_cols=186 Identities=13% Similarity=0.187 Sum_probs=144.6
Q ss_pred CCCccccceeec--------CeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcE
Q 016471 1 MYHQKLQHLFYS--------NSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENF 72 (389)
Q Consensus 1 l~Hpni~~~~~~--------~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Ni 72 (389)
+.|++|+.++.. ...++++|++.. ++.+.+... ...++..+..++.|++.||.|||++||+||||||+||
T Consensus 80 ~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Ni 157 (294)
T PHA02882 80 IDHLGIPKYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENI 157 (294)
T ss_pred CCCCCCCcEEEeeeEecCCceEEEEEEehhcc-CHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 368999998842 134788898754 565554433 4578899999999999999999999999999999999
Q ss_pred EEeecCCCCCEEEeecCCccccCCCC--------CcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCC
Q 016471 73 LFTTREEDAPLKVIDFGLSDFVRPDQ--------RLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFW 143 (389)
Q Consensus 73 ll~~~~~~~~~kl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~ 143 (389)
|+ +.++.++|+|||+|....... ......||+.|+|||+..+ .++.++||||+||++|+|++|..||.
T Consensus 158 ll---~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~ 234 (294)
T PHA02882 158 MV---DGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWK 234 (294)
T ss_pred EE---cCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 99 467889999999997653221 1123469999999998754 68999999999999999999999998
Q ss_pred CCCh-hHH--------HHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 144 ARTE-SGI--------FRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 144 ~~~~-~~~--------~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
+... ... ...+.... ...+..++.+.+++..|+..+|.+||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 235 GFGHNGNLIHAAKCDFIKRLHEGK-----IKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred ccccchHHHHHhHHHHHHHhhhhh-----hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 7633 221 12222211 122456899999999999999999999999875
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=269.07 Aligned_cols=190 Identities=20% Similarity=0.349 Sum_probs=163.0
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCC
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSR------GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPE 70 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~------~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~ 70 (389)
+.||||+++. .....+|++|||+||+|..+|.+. ...++..+...++.||+.|.+||+++++|||||..+
T Consensus 752 f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaR 831 (1025)
T KOG1095|consen 752 FDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAAR 831 (1025)
T ss_pred CCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhh
Confidence 4799999998 578899999999999999999876 566889999999999999999999999999999999
Q ss_pred cEEEeecCCCCCEEEeecCCccccCCCCC--cccc-cccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCC
Q 016471 71 NFLFTTREEDAPLKVIDFGLSDFVRPDQR--LNDI-VGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWAR 145 (389)
Q Consensus 71 Nill~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~-~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~ 145 (389)
|+||+ ....|||+|||+|+..-.... .... .-...|||||.+. +.++.++|||||||++||+++ |..||.+.
T Consensus 832 NCLL~---~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~ 908 (1025)
T KOG1095|consen 832 NCLLD---ERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSR 908 (1025)
T ss_pred heeec---ccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCc
Confidence 99994 678999999999984422211 1111 2235799999986 679999999999999999999 99999999
Q ss_pred ChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 146 TESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 146 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
+..+++..+..+. ..+.+ +.++..+.+++..||+.+|.+||++..+++
T Consensus 909 ~n~~v~~~~~~gg-RL~~P--~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 909 SNFEVLLDVLEGG-RLDPP--SYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred chHHHHHHHHhCC-ccCCC--CCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 9999888777665 44443 458889999999999999999999999987
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=242.62 Aligned_cols=200 Identities=30% Similarity=0.544 Sum_probs=162.7
Q ss_pred CCCcccccee-----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--CCEecCCCCCcEE
Q 016471 1 MYHQKLQHLF-----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQ--GVVHRDLKPENFL 73 (389)
Q Consensus 1 l~Hpni~~~~-----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~--~i~Hrdlkp~Nil 73 (389)
|-||.||++| +.+.+|-|+|||+|.+|.-|+ ++.+.++|.+++.|+.||+.||.||.+. .|+|-||||.|||
T Consensus 524 LDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYL-KQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNIL 602 (775)
T KOG1151|consen 524 LDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYL-KQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNIL 602 (775)
T ss_pred cCcceeeeeeeeeeeccccceeeeeecCCCchhHHH-HhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEE
Confidence 5699999999 468899999999999985555 5557899999999999999999999976 6999999999999
Q ss_pred EeecCCCCCEEEeecCCccccCCCCC--------cccccccCCcccccccc-c----cCCCchhHHHHHHHHHHHHhCCC
Q 016471 74 FTTREEDAPLKVIDFGLSDFVRPDQR--------LNDIVGSAYYVAPEVLH-R----SYNVEGDMWSIGVITYILLCGSR 140 (389)
Q Consensus 74 l~~~~~~~~~kl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~-~----~~~~~~DiwslG~il~~ll~g~~ 140 (389)
+.+-...|.+||+|||+++.+..... .....||-+|+|||.+- + ..+.++||||+|||+|.++.|+.
T Consensus 603 Lv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrK 682 (775)
T KOG1151|consen 603 LVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRK 682 (775)
T ss_pred EecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCC
Confidence 98655678899999999998754321 23357999999999762 2 37899999999999999999999
Q ss_pred CCCCCC-hhHHHH--HHHhc-CCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCC
Q 016471 141 PFWART-ESGIFR--SVLRA-DPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 141 pf~~~~-~~~~~~--~i~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~ 203 (389)
||...- ...++. .|++. ...+|. -|.+++++++||++||.+--..|....++..||+|...
T Consensus 683 PFGhnqsQQdILqeNTIlkAtEVqFP~--KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh 747 (775)
T KOG1151|consen 683 PFGHNQSQQDILQENTILKATEVQFPP--KPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPH 747 (775)
T ss_pred CCCCchhHHHHHhhhchhcceeccCCC--CCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccch
Confidence 995432 223322 23332 222333 36799999999999999999999999999999999654
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=232.24 Aligned_cols=195 Identities=39% Similarity=0.742 Sum_probs=162.2
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ .....++|+||+.+++|.+++... ..++...+..++.+++.++.|||+.|++|+||+|+||+++
T Consensus 44 l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~- 121 (244)
T smart00220 44 LKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKR-GRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLD- 121 (244)
T ss_pred CCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEEC-
Confidence 4799999888 347899999999999999988665 3489999999999999999999999999999999999994
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCC-CChhHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWA-RTESGIFRSV 154 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i 154 (389)
+++.++++|||.+.............++..|+|||.+. ..++.++|+||+|+++|++++|..||.. .........+
T Consensus 122 --~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~ 199 (244)
T smart00220 122 --EDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKI 199 (244)
T ss_pred --CCCcEEEccccceeeeccccccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Confidence 56899999999998776554455667889999999875 5688899999999999999999999987 4444444444
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~ 200 (389)
...... ....+..++..+.+++.+||..+|++||++.++++||||
T Consensus 200 ~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 200 GKPKPP-FPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred hccCCC-CccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 333322 222222378999999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=256.04 Aligned_cols=144 Identities=26% Similarity=0.515 Sum_probs=126.7
Q ss_pred CCCccccceee----------cCeEEEEEEccCCCChHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCC
Q 016471 1 MYHQKLQHLFY----------SNSFLFFTRFCEGGELLDRILS--RGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLK 68 (389)
Q Consensus 1 l~Hpni~~~~~----------~~~~~lv~E~~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlk 68 (389)
|+|||||++|. ...-.+|||||+||||+..+.+ +...|+|.+++.++..++.||+|||++||+|||||
T Consensus 68 Lnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlK 147 (732)
T KOG4250|consen 68 LNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLK 147 (732)
T ss_pred cCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCC
Confidence 68999999993 2345899999999999998853 22459999999999999999999999999999999
Q ss_pred CCcEEEeecC-CCCCEEEeecCCccccCCCCCcccccccCCcccccccc--ccCCCchhHHHHHHHHHHHHhCCCCCCC
Q 016471 69 PENFLFTTRE-EDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILLCGSRPFWA 144 (389)
Q Consensus 69 p~Nill~~~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~ 144 (389)
|.||++..-. +....||+|||.|+....+....+.+||+.|.+||++. +.|+..+|.||+||++|++.||..||..
T Consensus 148 P~NIvl~~Gedgq~IyKLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 148 PGNIVLQIGEDGQSIYKLTDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred CCcEEEeecCCCceEEeeecccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence 9999996522 23346999999999999888889999999999999997 5699999999999999999999999954
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=250.56 Aligned_cols=189 Identities=20% Similarity=0.368 Sum_probs=163.1
Q ss_pred CCCcccccee---ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 1 MYHQKLQHLF---YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 1 l~Hpni~~~~---~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
..||||+++. .+...|||||.|+-|+|..|+..++..++.....-++.||+.||.|||++++|||||...|||++
T Consensus 448 fdHphIikLIGv~~e~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVs-- 525 (974)
T KOG4257|consen 448 FDHPHIIKLIGVCVEQPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVS-- 525 (974)
T ss_pred CCCcchhheeeeeeccceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeec--
Confidence 3699999999 57899999999999999999998888999999999999999999999999999999999999994
Q ss_pred CCCCCEEEeecCCccccCCCCCcccccc--cCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHH
Q 016471 78 EEDAPLKVIDFGLSDFVRPDQRLNDIVG--SAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRS 153 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~g--t~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~ 153 (389)
....|||+|||+++............| ...|||||.++ +.++.++|||-|||.+||++. |..||.+-...+++-.
T Consensus 526 -Sp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~ 604 (974)
T KOG4257|consen 526 -SPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGH 604 (974)
T ss_pred -CcceeeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEE
Confidence 677899999999999876654433344 34699999885 789999999999999999988 9999999877777666
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHh
Q 016471 154 VLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQAL 195 (389)
Q Consensus 154 i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l 195 (389)
+.++.. .|.+ +++++.+..|+.+||.++|.+||+..++.
T Consensus 605 iEnGeR-lP~P--~nCPp~LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 605 IENGER-LPCP--PNCPPALYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred ecCCCC-CCCC--CCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence 655542 2322 67999999999999999999999876554
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=239.78 Aligned_cols=191 Identities=20% Similarity=0.316 Sum_probs=151.6
Q ss_pred CCCccccceee------cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEE
Q 016471 1 MYHQKLQHLFY------SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLF 74 (389)
Q Consensus 1 l~Hpni~~~~~------~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill 74 (389)
+.||||+.++. ....++||||+++|+|.+++......+++..+..++.|++.||+|||++|++||||||+||++
T Consensus 63 l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~ 142 (284)
T cd05038 63 LDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILV 142 (284)
T ss_pred CCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE
Confidence 57999999872 346899999999999999987765579999999999999999999999999999999999999
Q ss_pred eecCCCCCEEEeecCCccccCCCCCc----ccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhH
Q 016471 75 TTREEDAPLKVIDFGLSDFVRPDQRL----NDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESG 149 (389)
Q Consensus 75 ~~~~~~~~~kl~Dfg~a~~~~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 149 (389)
+.++.++|+|||.+......... ....++..|+|||.+. ..++.++|+||+|+++|+|++|..||.......
T Consensus 143 ---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~ 219 (284)
T cd05038 143 ---ESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEF 219 (284)
T ss_pred ---cCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchh
Confidence 46789999999998876532211 1223456799999875 468889999999999999999999986543221
Q ss_pred --------------HHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 150 --------------IFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 150 --------------~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
............+. ...++..+.+++.+||..+|.+|||+.++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 220 LRMIGIAQGQMIVTRLLELLKEGERLPR--PPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred ccccccccccccHHHHHHHHHcCCcCCC--CccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 11222222222221 2356789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=276.86 Aligned_cols=185 Identities=18% Similarity=0.246 Sum_probs=139.2
Q ss_pred CeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee----------------
Q 016471 13 NSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT---------------- 76 (389)
Q Consensus 13 ~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~---------------- 76 (389)
..++.++||+ +++|.+++....+.+++.++..++.||+.||.|||++||+||||||+|||++.
T Consensus 53 ~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~ 131 (793)
T PLN00181 53 DSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSG 131 (793)
T ss_pred chhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCccc
Confidence 4678889987 55999988665567999999999999999999999999999999999999952
Q ss_pred cCCCCCEEEeecCCccccCCC-----------------CCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhC
Q 016471 77 REEDAPLKVIDFGLSDFVRPD-----------------QRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCG 138 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~-----------------~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g 138 (389)
.+.++.+|++|||+++..... ......+||++|+|||++. ..|+.++||||+||++|||++|
T Consensus 132 ~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~ 211 (793)
T PLN00181 132 SDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCP 211 (793)
T ss_pred ccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhC
Confidence 123456778888877542110 0011246899999999875 4699999999999999999999
Q ss_pred CCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCC
Q 016471 139 SRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 139 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~ 203 (389)
.+|+.... .....+.... .+.. .....+....++.+||.++|.+||++.++++||||...
T Consensus 212 ~~~~~~~~--~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~ 271 (793)
T PLN00181 212 VSSREEKS--RTMSSLRHRV--LPPQ-ILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP 271 (793)
T ss_pred CCchhhHH--HHHHHHHHhh--cChh-hhhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence 98875322 1222222111 1111 11234567899999999999999999999999999764
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-32 Score=233.28 Aligned_cols=199 Identities=19% Similarity=0.292 Sum_probs=162.2
Q ss_pred Ccccccee----ecCeEEEEEEccCCCChHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCEecCCCCCcEE
Q 016471 3 HQKLQHLF----YSNSFLFFTRFCEGGELLDRIL----SRGGRYLEEDAKTIVEKILNIVAFCHL-QGVVHRDLKPENFL 73 (389)
Q Consensus 3 Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~----~~~~~l~~~~~~~i~~qi~~~L~~lH~-~~i~Hrdlkp~Nil 73 (389)
-||||++| .++..||.||+|.- +|..+.+ .++.+++|+-+-.|....+.||.||-+ .+|+|||+||+|||
T Consensus 122 cp~IVkfyGa~F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNIL 200 (361)
T KOG1006|consen 122 CPNIVKFYGALFSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNIL 200 (361)
T ss_pred CcHHHHHhhhhhcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheE
Confidence 48999999 57889999999976 6544332 234679999999999999999999985 58999999999999
Q ss_pred EeecCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc---ccCCCchhHHHHHHHHHHHHhCCCCCCCCCh-hH
Q 016471 74 FTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH---RSYNVEGDMWSIGVITYILLCGSRPFWARTE-SG 149 (389)
Q Consensus 74 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~ 149 (389)
+ +..|.|||||||++.....+-..+.-.|..+|||||.+. ..|+.++|+||||++|||+.||..|+.+-+. .+
T Consensus 201 l---dr~G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfe 277 (361)
T KOG1006|consen 201 L---DRHGDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFE 277 (361)
T ss_pred E---ecCCCEeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHH
Confidence 9 688999999999988766555555567999999999884 2599999999999999999999999977443 45
Q ss_pred HHHHHHhcCCCCCCCCC--CCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCCC
Q 016471 150 IFRSVLRADPNFHDSPW--PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENR 205 (389)
Q Consensus 150 ~~~~i~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~~ 205 (389)
.+..+..+.+..-.... ..++..+..+|.-||.+|-+.||...+++.+||++....
T Consensus 278 ql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~ 335 (361)
T KOG1006|consen 278 QLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAV 335 (361)
T ss_pred HHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhh
Confidence 55566665544332221 247899999999999999999999999999999976543
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=259.15 Aligned_cols=181 Identities=33% Similarity=0.538 Sum_probs=141.2
Q ss_pred CeEEEEEEccCCCChHHHHHhcCCCC-CHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeecCCCCCEEEeecCCc
Q 016471 13 NSFLFFTRFCEGGELLDRILSRGGRY-LEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS 91 (389)
Q Consensus 13 ~~~~lv~E~~~gg~L~~~l~~~~~~l-~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~~~~~~~kl~Dfg~a 91 (389)
..+||-||||+.-.|.+++ .++... ....++.+++||++||.|+|++|||||||||.||++ +.+..|||+|||+|
T Consensus 669 ~~LYIQMEyCE~~ll~~iI-~~N~~~~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFL---d~~~~VKIGDFGLA 744 (1351)
T KOG1035|consen 669 LILYIQMEYCEKTLLRDII-RRNHFNSQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFL---DSRNSVKIGDFGLA 744 (1351)
T ss_pred eEEEEEHhhhhhhHHHHHH-HhcccchhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEE---cCCCCeeecccccc
Confidence 4689999999996665554 443333 478899999999999999999999999999999999 57888999999999
Q ss_pred cccC-------------------CCCCcccccccCCccccccccc----cCCCchhHHHHHHHHHHHHhCCCCCCCCChh
Q 016471 92 DFVR-------------------PDQRLNDIVGSAYYVAPEVLHR----SYNVEGDMWSIGVITYILLCGSRPFWARTES 148 (389)
Q Consensus 92 ~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 148 (389)
+... .....+..+||..|+|||++.+ .|+.|+|+||||||++||+. ||...-..
T Consensus 745 t~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMER 821 (1351)
T KOG1035|consen 745 TDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMER 821 (1351)
T ss_pred hhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHH
Confidence 8621 1113456789999999999852 59999999999999999995 67554333
Q ss_pred -HHHHHHHhcCCCCCCC--CCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCC
Q 016471 149 -GIFRSVLRADPNFHDS--PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 202 (389)
Q Consensus 149 -~~~~~i~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~ 202 (389)
.++..+.+ +.+|.+ .+..--+.-..+|+.||+.||++||||.|+|++.||..
T Consensus 822 a~iL~~LR~--g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llpp 876 (1351)
T KOG1035|consen 822 ASILTNLRK--GSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLPP 876 (1351)
T ss_pred HHHHHhccc--CCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCCc
Confidence 23344433 333333 12233466778999999999999999999999999964
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=234.52 Aligned_cols=190 Identities=17% Similarity=0.272 Sum_probs=152.8
Q ss_pred CCCccccceeec----------CeEEEEEEccCCCChHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCCEec
Q 016471 1 MYHQKLQHLFYS----------NSFLFFTRFCEGGELLDRILSRG-----GRYLEEDAKTIVEKILNIVAFCHLQGVVHR 65 (389)
Q Consensus 1 l~Hpni~~~~~~----------~~~~lv~E~~~gg~L~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hr 65 (389)
+.||||++++.. ...++++||+.+|+|.+++.... ..+++..+..++.||+.||+|||++||+||
T Consensus 58 l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~ 137 (273)
T cd05074 58 FDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHR 137 (273)
T ss_pred CCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeec
Confidence 579999999941 12478999999999988775321 247899999999999999999999999999
Q ss_pred CCCCCcEEEeecCCCCCEEEeecCCccccCCCC---CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCC
Q 016471 66 DLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ---RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSR 140 (389)
Q Consensus 66 dlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~ 140 (389)
||||+||++ +.++.+||+|||++....... ......+++.|++||.+. +.++.++||||+||++|+|++ |++
T Consensus 138 dikp~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~ 214 (273)
T cd05074 138 DLAARNCML---NENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQT 214 (273)
T ss_pred ccchhhEEE---cCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCC
Confidence 999999999 467889999999988654322 112334567899999875 468889999999999999999 899
Q ss_pred CCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 141 PFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 141 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
||.+.+.......+...... . ..+..+..+.+++.+||..+|..|||+.+++.
T Consensus 215 p~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~ 267 (273)
T cd05074 215 PYAGVENSEIYNYLIKGNRL-K--QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD 267 (273)
T ss_pred CCCCCCHHHHHHHHHcCCcC-C--CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99887776666655543321 1 11457899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=244.97 Aligned_cols=193 Identities=24% Similarity=0.378 Sum_probs=148.7
Q ss_pred CCCcccccee-e---cC-eEEEEEEccCCCChHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCCCc
Q 016471 1 MYHQKLQHLF-Y---SN-SFLFFTRFCEGGELLDRILSRGG-RYLEEDAKTIVEKILNIVAFCHLQG---VVHRDLKPEN 71 (389)
Q Consensus 1 l~Hpni~~~~-~---~~-~~~lv~E~~~gg~L~~~l~~~~~-~l~~~~~~~i~~qi~~~L~~lH~~~---i~Hrdlkp~N 71 (389)
++||||+.+. + .+ +.+||+||+++|+|.+++..... .+++.....|+.+++.||+|||+.. |+||||||+|
T Consensus 128 l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssN 207 (361)
T KOG1187|consen 128 LRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSN 207 (361)
T ss_pred CCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHH
Confidence 6899999999 2 34 58999999999999999987655 8999999999999999999999854 9999999999
Q ss_pred EEEeecCCCCCEEEeecCCccccCC-CCCcccc-cccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC--
Q 016471 72 FLFTTREEDAPLKVIDFGLSDFVRP-DQRLNDI-VGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWART-- 146 (389)
Q Consensus 72 ill~~~~~~~~~kl~Dfg~a~~~~~-~~~~~~~-~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~-- 146 (389)
||| |.+...||+|||+|..... .....+. .||..|+|||.+. +..+.++|||||||++.|+++|+.|.....
T Consensus 208 ILL---D~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~ 284 (361)
T KOG1187|consen 208 ILL---DEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPR 284 (361)
T ss_pred eeE---CCCCCEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCc
Confidence 999 7899999999999976654 3333333 8999999999885 679999999999999999999998886432
Q ss_pred -hhHHHH---HHHhcC--CCCCCCCC--CCCC-----HHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 147 -ESGIFR---SVLRAD--PNFHDSPW--PSVS-----PEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 147 -~~~~~~---~i~~~~--~~~~~~~~--~~~~-----~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
...... ...... ..+..+.. ...+ ..+..+..+|+..+|..||++.++..
T Consensus 285 ~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 285 GELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred ccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 111111 111111 01111111 1122 23567788999999999999988643
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-31 Score=219.10 Aligned_cols=194 Identities=29% Similarity=0.597 Sum_probs=159.1
Q ss_pred Cccccceee------cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 3 HQKLQHLFY------SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 3 Hpni~~~~~------~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
||||+++++ +..-.+|+||.++.+..... ..++.-.++.++.|++.||.|||++||+|||+||.|+++..
T Consensus 92 g~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh 167 (338)
T KOG0668|consen 92 GPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDH 167 (338)
T ss_pred CCCeeehhhhhcCccccCchhHhhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeech
Confidence 899999993 56678999999997776543 56889999999999999999999999999999999999963
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc--ccCCCchhHHHHHHHHHHHHhCCCCCC-CCChhHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILLCGSRPFW-ARTESGIFRS 153 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~-~~~~~~~~~~ 153 (389)
....++|+|+|+|....++...+-++.+.+|-.||.+- +.|+.+-|+||+||++..|...+.||. |.+..+.+-+
T Consensus 168 --~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVk 245 (338)
T KOG0668|consen 168 --ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVK 245 (338)
T ss_pred --hhceeeeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHH
Confidence 46679999999999999988888899999999999874 569999999999999999999999975 3443333333
Q ss_pred HHhc-----------------CC-------CCCCCCCC---------CCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCC
Q 016471 154 VLRA-----------------DP-------NFHDSPWP---------SVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 154 i~~~-----------------~~-------~~~~~~~~---------~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~ 200 (389)
|.+. .+ .....+|. -.++++.+|+.++|.+|-++|+|+.|++.||||
T Consensus 246 IakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF 325 (338)
T KOG0668|consen 246 IAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYF 325 (338)
T ss_pred HHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchH
Confidence 2211 01 11111221 247999999999999999999999999999999
Q ss_pred CC
Q 016471 201 HD 202 (389)
Q Consensus 201 ~~ 202 (389)
..
T Consensus 326 ~~ 327 (338)
T KOG0668|consen 326 AP 327 (338)
T ss_pred HH
Confidence 54
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=253.52 Aligned_cols=189 Identities=22% Similarity=0.415 Sum_probs=167.0
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
-||||+++. -.+.+.||+|||++|+|..++.++.|.++..+...+++-|+.|++||-+.|.|||||...|||+
T Consensus 688 dHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILV--- 764 (996)
T KOG0196|consen 688 DHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILV--- 764 (996)
T ss_pred CCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheee---
Confidence 499999999 4688999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCCccccCCCC--Cccccccc--CCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 016471 78 EEDAPLKVIDFGLSDFVRPDQ--RLNDIVGS--AYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIF 151 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt--~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~ 151 (389)
+.+..+|++|||+++....+. ..++..|. ..|.|||.+. +.++.++||||+||++||.++ |..||+..+..+++
T Consensus 765 NsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVI 844 (996)
T KOG0196|consen 765 NSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI 844 (996)
T ss_pred ccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHH
Confidence 678899999999999776544 22233333 5799999884 789999999999999999877 99999999999999
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 152 RSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 152 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
+.|.++-. +|++ ..++..+.+|+..||++|-.+||...+++.
T Consensus 845 kaIe~gyR-LPpP--mDCP~aL~qLMldCWqkdR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 845 KAIEQGYR-LPPP--MDCPAALYQLMLDCWQKDRNRRPKFAQIVS 886 (996)
T ss_pred HHHHhccC-CCCC--CCCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence 99987543 3332 579999999999999999999999999876
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-30 Score=240.28 Aligned_cols=191 Identities=26% Similarity=0.456 Sum_probs=158.2
Q ss_pred ceeecCeEEEEEEccCCCChHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeecCCCCCEEE
Q 016471 8 HLFYSNSFLFFTRFCEGGELLDRILSRG--GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKV 85 (389)
Q Consensus 8 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~~~~~~~kl 85 (389)
+|++.+|+|||+|-+.- +|.+.+++-+ -.|....++.++.|+..||..|-..||+|.||||+|||+. .....+||
T Consensus 502 ~F~hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVN--E~k~iLKL 578 (752)
T KOG0670|consen 502 HFKHKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVN--ESKNILKL 578 (752)
T ss_pred HhhhcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEec--cCcceeee
Confidence 34478999999999976 9999887643 3478899999999999999999999999999999999996 45678999
Q ss_pred eecCCccccCCCCCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCC
Q 016471 86 IDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDS 164 (389)
Q Consensus 86 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 164 (389)
||||.|.....+. .+.+.-+..|.|||++.+ .|++..|+||+||.||||.||+..|.|.+..+++...+.....+|..
T Consensus 579 CDfGSA~~~~ene-itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~K 657 (752)
T KOG0670|consen 579 CDFGSASFASENE-ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNK 657 (752)
T ss_pred ccCcccccccccc-ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHH
Confidence 9999987766544 345566789999998765 79999999999999999999999999999888877665544444431
Q ss_pred CC-------------------------------------C-------------------CCCHHHHHHHHhhhccCcCCC
Q 016471 165 PW-------------------------------------P-------------------SVSPEAKDFVRRLLNKDHRKR 188 (389)
Q Consensus 165 ~~-------------------------------------~-------------------~~~~~~~~li~~~l~~~p~~R 188 (389)
.. | .+-.++++|+.+||..||++|
T Consensus 658 mlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KR 737 (752)
T KOG0670|consen 658 MLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKR 737 (752)
T ss_pred HhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhc
Confidence 10 0 011578999999999999999
Q ss_pred CCHHHHhCCCCCCC
Q 016471 189 MTAAQALTHPWLHD 202 (389)
Q Consensus 189 ~s~~e~l~h~~~~~ 202 (389)
+|..++|.||||..
T Consensus 738 it~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 738 ITVNQALKHPFITE 751 (752)
T ss_pred CCHHHHhcCCcccC
Confidence 99999999999964
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-29 Score=241.45 Aligned_cols=185 Identities=24% Similarity=0.304 Sum_probs=139.0
Q ss_pred CeEEEEEEccCCCChHHHHHhcCC-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCC
Q 016471 13 NSFLFFTRFCEGGELLDRILSRGG-----------------------RYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKP 69 (389)
Q Consensus 13 ~~~~lv~E~~~gg~L~~~l~~~~~-----------------------~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp 69 (389)
...|+||||+++|+|.+++....+ .+++..++.++.|++.||.|||+++|+||||||
T Consensus 258 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp 337 (507)
T PLN03224 258 GSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKP 337 (507)
T ss_pred CceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCch
Confidence 568999999999999998754221 234567889999999999999999999999999
Q ss_pred CcEEEeecCCCCCEEEeecCCccccCCCCCcccc--cccCCcccccccccc---------------------CC--Cchh
Q 016471 70 ENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDI--VGSAYYVAPEVLHRS---------------------YN--VEGD 124 (389)
Q Consensus 70 ~Nill~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~--~gt~~y~aPE~~~~~---------------------~~--~~~D 124 (389)
+||++ +.++.+||+|||++............ .+|+.|+|||.+... |+ .+.|
T Consensus 338 ~NILl---~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~D 414 (507)
T PLN03224 338 ENLLV---TVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFD 414 (507)
T ss_pred HhEEE---CCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccc
Confidence 99999 46788999999998765433222222 347899999987321 11 2479
Q ss_pred HHHHHHHHHHHHhCCC-CCCCCChh-----------HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCc---CCCC
Q 016471 125 MWSIGVITYILLCGSR-PFWARTES-----------GIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDH---RKRM 189 (389)
Q Consensus 125 iwslG~il~~ll~g~~-pf~~~~~~-----------~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p---~~R~ 189 (389)
+||+|||+|+|++|.. ||.+.... ..+..+.... +....+...++..++|+.+||..+| .+|+
T Consensus 415 vwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~--~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~Rl 492 (507)
T PLN03224 415 SYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK--YDFSLLDRNKEAGWDLACKLITKRDQANRGRL 492 (507)
T ss_pred hhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC--CCcccccccChHHHHHHHHHhccCCCCcccCC
Confidence 9999999999999875 77532111 1122222222 2223456789999999999999876 6899
Q ss_pred CHHHHhCCCCCCC
Q 016471 190 TAAQALTHPWLHD 202 (389)
Q Consensus 190 s~~e~l~h~~~~~ 202 (389)
|++|+|+||||..
T Consensus 493 Sa~eaL~Hp~f~~ 505 (507)
T PLN03224 493 SVGQALSHRFFLP 505 (507)
T ss_pred CHHHHhCCCCcCC
Confidence 9999999999964
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-30 Score=243.25 Aligned_cols=190 Identities=19% Similarity=0.335 Sum_probs=164.2
Q ss_pred CCCccccceee---cCeEEEEEEccCCCChHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLFY---SNSFLFFTRFCEGGELLDRILS-RGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~~---~~~~~lv~E~~~gg~L~~~l~~-~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|.|||++++|. +....+|||+|++|+|.+++.+ ....|.......|+.||+.|+.||.++++|||||-..|+|+.
T Consensus 168 L~H~hliRLyGvVl~qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNllla- 246 (1039)
T KOG0199|consen 168 LQHPHLIRLYGVVLDQPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLA- 246 (1039)
T ss_pred ccCcceeEEeeeeccchhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheec-
Confidence 68999999993 5889999999999999999987 556788999999999999999999999999999999999995
Q ss_pred cCCCCCEEEeecCCccccCCCCCccccc----ccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIV----GSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGI 150 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~----gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~ 150 (389)
....|||+|||+.+....+.....+. -...|+|||.+. +.++.++|+|++||++|||++ |+.||.|....++
T Consensus 247 --sprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qI 324 (1039)
T KOG0199|consen 247 --SPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQI 324 (1039)
T ss_pred --ccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHH
Confidence 46789999999998887655433222 234699999985 689999999999999999999 9999999999999
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 151 FRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 151 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
+++|-.+ ...+.+ +.++.++.++++.||..+|..|||+..+.+
T Consensus 325 L~~iD~~-erLpRP--k~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 325 LKNIDAG-ERLPRP--KYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred HHhcccc-ccCCCC--CCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 9988743 334433 358999999999999999999999987754
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=236.47 Aligned_cols=188 Identities=23% Similarity=0.380 Sum_probs=158.4
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEe
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGG-RYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 75 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~-~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~ 75 (389)
++|||+|++. .+-.+|||+|||..|+|.+|+..+++ .++......++.||..|++||..+++|||||-..|+|+
T Consensus 320 ikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLV- 398 (1157)
T KOG4278|consen 320 IKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV- 398 (1157)
T ss_pred hcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccc-
Confidence 6899999999 35779999999999999999987653 35666678899999999999999999999999999999
Q ss_pred ecCCCCCEEEeecCCccccCCCCCcccccc---cCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHH
Q 016471 76 TREEDAPLKVIDFGLSDFVRPDQRLNDIVG---SAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGI 150 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~g---t~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~ 150 (389)
+++..||++|||+++.+..+.. +...| ...|.|||.+. +.++.++|||+|||+|||+.| |-.||.|.+..++
T Consensus 399 --gEnhiVKvADFGLsRlMtgDTY-TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqV 475 (1157)
T KOG4278|consen 399 --GENHIVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV 475 (1157)
T ss_pred --cccceEEeeccchhhhhcCCce-ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHH
Confidence 5788999999999998865432 22223 45699999884 679999999999999999999 9999999988888
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHh
Q 016471 151 FRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQAL 195 (389)
Q Consensus 151 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l 195 (389)
+..+.++ .....+ ..+++.+.+|++.||+.+|..||+++|+-
T Consensus 476 Y~LLEkg-yRM~~P--eGCPpkVYeLMraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 476 YGLLEKG-YRMDGP--EGCPPKVYELMRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred HHHHhcc-ccccCC--CCCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence 7766543 233322 46899999999999999999999998774
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=214.17 Aligned_cols=162 Identities=28% Similarity=0.358 Sum_probs=128.3
Q ss_pred CChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeecCCCCCEEEeecCCccccCCCCCccccc
Q 016471 25 GELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIV 104 (389)
Q Consensus 25 g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 104 (389)
|+|.+++..+++.+++..++.++.||+.||.|||+++ ||+||++ +.++.+|+ ||++...... ...
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~---~~~~~~~~--fG~~~~~~~~----~~~ 65 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILL---TWDGLLKL--DGSVAFKTPE----QSR 65 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeE---cCccceee--ccceEeeccc----cCC
Confidence 7899988776667999999999999999999999998 9999999 56788898 9998765432 236
Q ss_pred ccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCh-hHHHHHHHhcCCCCCCC---CCCCCCH--HHHHHH
Q 016471 105 GSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTE-SGIFRSVLRADPNFHDS---PWPSVSP--EAKDFV 177 (389)
Q Consensus 105 gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~~~---~~~~~~~--~~~~li 177 (389)
||+.|+|||++. ..++.++||||+||++|+|++|+.||..... ......+.......... ....++. .+++++
T Consensus 66 g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 145 (176)
T smart00750 66 VDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM 145 (176)
T ss_pred CcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence 899999999985 4689999999999999999999999976543 23333333322221111 1112333 699999
Q ss_pred HhhhccCcCCCCCHHHHhCCCCCC
Q 016471 178 RRLLNKDHRKRMTAAQALTHPWLH 201 (389)
Q Consensus 178 ~~~l~~~p~~R~s~~e~l~h~~~~ 201 (389)
.+||..+|.+||++.+++.|+|+.
T Consensus 146 ~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 146 RVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHHhcccccccCHHHHHHHHHHH
Confidence 999999999999999999999873
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=205.87 Aligned_cols=152 Identities=24% Similarity=0.434 Sum_probs=129.6
Q ss_pred Ccccccee----ecCeEEEEEEccCCCChHHHH---HhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CCEecCCCCCcEEE
Q 016471 3 HQKLQHLF----YSNSFLFFTRFCEGGELLDRI---LSRGGRYLEEDAKTIVEKILNIVAFCHLQ-GVVHRDLKPENFLF 74 (389)
Q Consensus 3 Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l---~~~~~~l~~~~~~~i~~qi~~~L~~lH~~-~i~Hrdlkp~Nill 74 (389)
-|.+|++| .+..+||.||.|.. +|..+. .++++..+|..+-+|+..|+.||.|||++ .++|||+||+|||+
T Consensus 104 CPf~V~FyGa~~regdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLI 182 (282)
T KOG0984|consen 104 CPFTVHFYGALFREGDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILI 182 (282)
T ss_pred CCeEEEeehhhhccccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEE
Confidence 37888988 57889999999987 665444 35678999999999999999999999986 89999999999999
Q ss_pred eecCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc-----ccCCCchhHHHHHHHHHHHHhCCCCCCC-CChh
Q 016471 75 TTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-----RSYNVEGDMWSIGVITYILLCGSRPFWA-RTES 148 (389)
Q Consensus 75 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~ 148 (389)
+..|+||+||||.+.....+...+.-.|...|||||.+. ..|+.++||||||+.+.||.+++.||.. .++.
T Consensus 183 ---n~~GqVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF 259 (282)
T KOG0984|consen 183 ---NYDGQVKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPF 259 (282)
T ss_pred ---ccCCcEEEcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHH
Confidence 689999999999998876655444467889999999884 2589999999999999999999999965 5677
Q ss_pred HHHHHHHhcC
Q 016471 149 GIFRSVLRAD 158 (389)
Q Consensus 149 ~~~~~i~~~~ 158 (389)
+.++++....
T Consensus 260 ~qLkqvVeep 269 (282)
T KOG0984|consen 260 QQLKQVVEEP 269 (282)
T ss_pred HHHHHHhcCC
Confidence 7888877654
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-29 Score=233.09 Aligned_cols=193 Identities=18% Similarity=0.274 Sum_probs=156.7
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCC-CHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEe
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRY-LEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 75 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l-~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~ 75 (389)
|+||||++++ .++.+++||||+++|+|.+++.++.-.. .......|+.||+.|++||.+.++|||||.+.|+|+
T Consensus 592 LkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv- 670 (807)
T KOG1094|consen 592 LKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLV- 670 (807)
T ss_pred cCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceee-
Confidence 6899999999 3799999999999999999998774332 445567799999999999999999999999999999
Q ss_pred ecCCCCCEEEeecCCccccCCCCCc---ccccccCCccccccc-cccCCCchhHHHHHHHHHHHHh--CCCCCCCCChhH
Q 016471 76 TREEDAPLKVIDFGLSDFVRPDQRL---NDIVGSAYYVAPEVL-HRSYNVEGDMWSIGVITYILLC--GSRPFWARTESG 149 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~-~~~~~~~~DiwslG~il~~ll~--g~~pf~~~~~~~ 149 (389)
++++++||+|||+++..-.+... ...+-...|||||.+ .+.++.++|+|++|+++||+++ ...||...+.++
T Consensus 671 --~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~ 748 (807)
T KOG1094|consen 671 --DGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ 748 (807)
T ss_pred --cCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH
Confidence 78999999999999866443321 123456789999965 6889999999999999999765 889998888887
Q ss_pred HHHHHHhcCCCCCCC----CCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 150 IFRSVLRADPNFHDS----PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 150 ~~~~i~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
...+........+.. ..+-++..+.+++-+||..+-.+|||.+++-.
T Consensus 749 vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 749 VVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred HHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 776654322221111 11346788999999999999999999998743
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=236.97 Aligned_cols=198 Identities=25% Similarity=0.427 Sum_probs=167.2
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
.||||+-|| ....+|+.||||.||+|.+...-. +.++|.++..+++..+.||+|||++|-+|||||-.||+++
T Consensus 70 ~h~nivay~gsylr~dklwicMEycgggslQdiy~~T-gplselqiayvcRetl~gl~ylhs~gk~hRdiKGanillt-- 146 (829)
T KOG0576|consen 70 RHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLT-- 146 (829)
T ss_pred CCcChHHHHhhhhhhcCcEEEEEecCCCcccceeeec-ccchhHHHHHHHhhhhccchhhhcCCcccccccccceeec--
Confidence 699999999 468899999999999999865544 7899999999999999999999999999999999999995
Q ss_pred CCCCCEEEeecCCccccCCC-CCcccccccCCccccccc----cccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 016471 78 EEDAPLKVIDFGLSDFVRPD-QRLNDIVGSAYYVAPEVL----HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFR 152 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 152 (389)
+.+.+|++|||.+..+... .+...+.|||+|||||+. .+.|+..||+|++|+..-|+---++|-...-+.+...
T Consensus 147 -d~gDvklaDfgvsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~ 225 (829)
T KOG0576|consen 147 -DEGDVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALF 225 (829)
T ss_pred -ccCceeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHH
Confidence 6788999999998765432 244578999999999986 3579999999999999999998888876666665555
Q ss_pred HHHhcCCCCCCCCC-CCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCC
Q 016471 153 SVLRADPNFHDSPW-PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 153 ~i~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~ 203 (389)
...+..+..+.... .+.++.+-+|++.+|.++|++|||++.+|.|||....
T Consensus 226 LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 226 LMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred HhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 55555444433222 3578999999999999999999999999999998665
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-30 Score=219.87 Aligned_cols=186 Identities=28% Similarity=0.449 Sum_probs=150.9
Q ss_pred CeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeecCCCCCEEEeecCCcc
Q 016471 13 NSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 92 (389)
Q Consensus 13 ~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~~~~~~~kl~Dfg~a~ 92 (389)
..+|+|+|.+.. +|...|..- ..++...+..++.||++||+|||+.||.||||||.|.|+ +.+-.+||||||+++
T Consensus 130 qEiYV~TELmQS-DLHKIIVSP-Q~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLV---NSNCvLKICDFGLAR 204 (449)
T KOG0664|consen 130 QELYVLTELMQS-DLHKIIVSP-QALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLV---NSNCILKICDFGLAR 204 (449)
T ss_pred HHHHHHHHHHHh-hhhheeccC-CCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEe---ccCceEEeccccccc
Confidence 457899999976 888877654 689999999999999999999999999999999999999 567889999999999
Q ss_pred ccCCCC--CcccccccCCcccccccc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc-----------
Q 016471 93 FVRPDQ--RLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRA----------- 157 (389)
Q Consensus 93 ~~~~~~--~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~----------- 157 (389)
...... .++..+-|.+|.|||++. +.|+.++||||+|||+.|++..+..|+..++.+.+..|...
T Consensus 205 vee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ 284 (449)
T KOG0664|consen 205 TWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKY 284 (449)
T ss_pred ccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHH
Confidence 876544 345567889999999985 46999999999999999999999999988877666555321
Q ss_pred ------------CCCCCCCC-C------CCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCC
Q 016471 158 ------------DPNFHDSP-W------PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 158 ------------~~~~~~~~-~------~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~ 203 (389)
....+..+ . ..-..+...++.++|.++|++|++.++++.|++....
T Consensus 285 ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 285 ACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred HhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 11111110 0 0123567889999999999999999999999998654
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=239.57 Aligned_cols=189 Identities=22% Similarity=0.398 Sum_probs=155.0
Q ss_pred CCccccceee----cCeEEEEEEccCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 016471 2 YHQKLQHLFY----SNSFLFFTRFCEGGELLDRILSRG---------------GRYLEEDAKTIVEKILNIVAFCHLQGV 62 (389)
Q Consensus 2 ~Hpni~~~~~----~~~~~lv~E~~~gg~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~~lH~~~i 62 (389)
+||||+.+.. ...+++|+|||..|+|.+++.+++ ..++..+...++.||+.|++||+++++
T Consensus 360 ~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~ 439 (609)
T KOG0200|consen 360 KHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPC 439 (609)
T ss_pred CCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCc
Confidence 6999999983 467999999999999999998764 238899999999999999999999999
Q ss_pred EecCCCCCcEEEeecCCCCCEEEeecCCccccCCCCCc--ccccccC--Ccccccccc-ccCCCchhHHHHHHHHHHHHh
Q 016471 63 VHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRL--NDIVGSA--YYVAPEVLH-RSYNVEGDMWSIGVITYILLC 137 (389)
Q Consensus 63 ~Hrdlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~gt~--~y~aPE~~~-~~~~~~~DiwslG~il~~ll~ 137 (389)
+||||-..|||++ .+..+||+|||+|+........ ....|+. .|||||.+. ..|+.++||||+||++||+++
T Consensus 440 vHRDLAaRNVLi~---~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~Eifs 516 (609)
T KOG0200|consen 440 VHRDLAARNVLIT---KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFT 516 (609)
T ss_pred cchhhhhhhEEec---CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhh
Confidence 9999999999994 6788999999999865443322 1222223 499999986 479999999999999999999
Q ss_pred -CCCCCCCCC-hhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 138 -GSRPFWART-ESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 138 -g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
|..||.+-. ..+++..+..+. ....+ ..+++++.++++.||+.+|.+||+..++..
T Consensus 517 LG~~PYp~~~~~~~l~~~l~~G~-r~~~P--~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 517 LGGTPYPGIPPTEELLEFLKEGN-RMEQP--EHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred CCCCCCCCCCcHHHHHHHHhcCC-CCCCC--CCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 999998855 555655444433 33332 346999999999999999999999988864
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=218.59 Aligned_cols=186 Identities=25% Similarity=0.397 Sum_probs=146.2
Q ss_pred CCCccccceee--------cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---------CCE
Q 016471 1 MYHQKLQHLFY--------SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQ---------GVV 63 (389)
Q Consensus 1 l~Hpni~~~~~--------~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---------~i~ 63 (389)
|+|+||++|+. ...++||+||.+.|+|.+++..+ .+++.+..+++..+++||+|||+- .|+
T Consensus 261 m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~Ia 338 (534)
T KOG3653|consen 261 MKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIA 338 (534)
T ss_pred ccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccc
Confidence 78999999992 24799999999999999999766 799999999999999999999984 599
Q ss_pred ecCCCCCcEEEeecCCCCCEEEeecCCccccCCCCC---cccccccCCccccccccccCC-------CchhHHHHHHHHH
Q 016471 64 HRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLHRSYN-------VEGDMWSIGVITY 133 (389)
Q Consensus 64 Hrdlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~-------~~~DiwslG~il~ 133 (389)
|||||..|||+ .+++...|+|||+|..+.++.. ....+||.+|||||++.+..+ .+.||||+|.|+|
T Consensus 339 HRDlkSkNVLv---K~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLW 415 (534)
T KOG3653|consen 339 HRDLKSKNVLV---KNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLW 415 (534)
T ss_pred cccccccceEE---ccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHH
Confidence 99999999999 5789999999999998876543 334789999999999976543 3479999999999
Q ss_pred HHHhCCC------------CCC-----CCChhHHHHHHHhcC--CCCCCCCCCC--CCHHHHHHHHhhhccCcCCCCCHH
Q 016471 134 ILLCGSR------------PFW-----ARTESGIFRSVLRAD--PNFHDSPWPS--VSPEAKDFVRRLLNKDHRKRMTAA 192 (389)
Q Consensus 134 ~ll~g~~------------pf~-----~~~~~~~~~~i~~~~--~~~~~~~~~~--~~~~~~~li~~~l~~~p~~R~s~~ 192 (389)
|+++.-. ||. ..+.+++...+++.+ |.++.. |.. --..+++.+..||..||.-|.|+.
T Consensus 416 Ei~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~-W~~h~~~~~l~et~EeCWDhDaeARLTA~ 494 (534)
T KOG3653|consen 416 EIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDA-WRKHAGMAVLCETIEECWDHDAEARLTAG 494 (534)
T ss_pred HHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhh-hhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence 9998643 332 122234444444433 222221 211 235688999999999999999975
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=254.74 Aligned_cols=185 Identities=21% Similarity=0.277 Sum_probs=137.3
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCCCcEE
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCH---LQGVVHRDLKPENFL 73 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~i~Hrdlkp~Nil 73 (389)
++||||++++ .....|+|||||+||+|.+++. .+++..+..++.||+.||+||| +.+|+||||||+||+
T Consensus 740 l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil 815 (968)
T PLN00113 740 LQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKII 815 (968)
T ss_pred CCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEE
Confidence 5799999999 3567899999999999999873 4889999999999999999999 669999999999999
Q ss_pred EeecCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCh--hHH
Q 016471 74 FTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTE--SGI 150 (389)
Q Consensus 74 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~ 150 (389)
+ +.+...++. ||.+..... .....||+.|+|||++. ..++.++||||+||++|||++|+.||..... ...
T Consensus 816 ~---~~~~~~~~~-~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~ 888 (968)
T PLN00113 816 I---DGKDEPHLR-LSLPGLLCT---DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSI 888 (968)
T ss_pred E---CCCCceEEE-ecccccccc---CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcH
Confidence 9 455566654 555433221 12346889999999885 4699999999999999999999999854221 111
Q ss_pred H--HHHHhcC--------CCCCCC--CCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 151 F--RSVLRAD--------PNFHDS--PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 151 ~--~~i~~~~--------~~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
. ....... +..... ..+....++.+++.+||..+|.+|||+.++++
T Consensus 889 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 946 (968)
T PLN00113 889 VEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLK 946 (968)
T ss_pred HHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHH
Confidence 1 1110000 000000 00011235778999999999999999999986
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-27 Score=213.94 Aligned_cols=133 Identities=25% Similarity=0.407 Sum_probs=114.5
Q ss_pred CCCccccceee--------cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--------CCEe
Q 016471 1 MYHQKLQHLFY--------SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQ--------GVVH 64 (389)
Q Consensus 1 l~Hpni~~~~~--------~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~--------~i~H 64 (389)
|+|+||..|.. -.++|||++|.+.|||+||+... .++.+....++..++.||++||.. .|+|
T Consensus 262 LRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~--tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAH 339 (513)
T KOG2052|consen 262 LRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRN--TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAH 339 (513)
T ss_pred hccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhhc--cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhc
Confidence 68999999992 25799999999999999999764 799999999999999999999975 5999
Q ss_pred cCCCCCcEEEeecCCCCCEEEeecCCccccCCC-----CCcccccccCCccccccccccCC-------CchhHHHHHHHH
Q 016471 65 RDLKPENFLFTTREEDAPLKVIDFGLSDFVRPD-----QRLNDIVGSAYYVAPEVLHRSYN-------VEGDMWSIGVIT 132 (389)
Q Consensus 65 rdlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~-------~~~DiwslG~il 132 (389)
||||..|||+ .+++...|+|+|+|...... ...+..+||..|||||++....+ ..+||||||+|+
T Consensus 340 RDlKSKNILV---Kkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVl 416 (513)
T KOG2052|consen 340 RDLKSKNILV---KKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVL 416 (513)
T ss_pred cccccccEEE---ccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHH
Confidence 9999999999 57899999999999766543 23466899999999999965432 348999999999
Q ss_pred HHHHhC
Q 016471 133 YILLCG 138 (389)
Q Consensus 133 ~~ll~g 138 (389)
||+...
T Consensus 417 WEiarR 422 (513)
T KOG2052|consen 417 WEIARR 422 (513)
T ss_pred HHHHHH
Confidence 998753
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.9e-27 Score=213.94 Aligned_cols=192 Identities=29% Similarity=0.471 Sum_probs=143.8
Q ss_pred cCeEEEEEEccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH-CCCEecCCCCCcEEEee-------------
Q 016471 12 SNSFLFFTRFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHL-QGVVHRDLKPENFLFTT------------- 76 (389)
Q Consensus 12 ~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~-~~i~Hrdlkp~Nill~~------------- 76 (389)
+.|+|+|+|++ |-+|+..|.+. .+.++...++.|++||+.||.|||+ .||+|-||||+|||+..
T Consensus 158 G~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~~a~ 236 (590)
T KOG1290|consen 158 GQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDAREAG 236 (590)
T ss_pred CcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhhhhc
Confidence 57899999998 55888888754 3569999999999999999999996 49999999999999710
Q ss_pred --------------------------------------------------------------------------------
Q 016471 77 -------------------------------------------------------------------------------- 76 (389)
Q Consensus 77 -------------------------------------------------------------------------------- 76 (389)
T Consensus 237 e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~~v 316 (590)
T KOG1290|consen 237 EATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNESTV 316 (590)
T ss_pred cccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccccch
Confidence
Q ss_pred --------------------c--------------------------------------------------CCCCCEEEe
Q 016471 77 --------------------R--------------------------------------------------EEDAPLKVI 86 (389)
Q Consensus 77 --------------------~--------------------------------------------------~~~~~~kl~ 86 (389)
. ..+..|||+
T Consensus 317 ~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vKIa 396 (590)
T KOG1290|consen 317 ERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVKIA 396 (590)
T ss_pred hhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeEEEe
Confidence 0 001246788
Q ss_pred ecCCccccCCCCCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCh------hHHHHHHHhcCC
Q 016471 87 DFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTE------SGIFRSVLRADP 159 (389)
Q Consensus 87 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~i~~~~~ 159 (389)
|||.|++... ..+.-+-|..|+|||++.+ .|+..+||||++|++|||+||...|...+. ++-+..|+....
T Consensus 397 DlGNACW~~k--hFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG 474 (590)
T KOG1290|consen 397 DLGNACWVHK--HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLG 474 (590)
T ss_pred eccchhhhhh--hhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHh
Confidence 8888776532 2334467889999999865 799999999999999999999999854321 222222221111
Q ss_pred CCC-------------------------CCCCC---------CC----CHHHHHHHHhhhccCcCCCCCHHHHhCCCCCC
Q 016471 160 NFH-------------------------DSPWP---------SV----SPEAKDFVRRLLNKDHRKRMTAAQALTHPWLH 201 (389)
Q Consensus 160 ~~~-------------------------~~~~~---------~~----~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~ 201 (389)
.+| -.+|| .+ ..++.+||.-||+++|.+||||.++|+|||+.
T Consensus 475 ~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hPwLn 554 (590)
T KOG1290|consen 475 KIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHPWLN 554 (590)
T ss_pred hccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcCcccc
Confidence 111 01222 11 36788999999999999999999999999998
Q ss_pred CCCCC
Q 016471 202 DENRP 206 (389)
Q Consensus 202 ~~~~~ 206 (389)
....+
T Consensus 555 ~~~~~ 559 (590)
T KOG1290|consen 555 PVAGP 559 (590)
T ss_pred CCCCC
Confidence 77655
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.5e-27 Score=202.25 Aligned_cols=182 Identities=24% Similarity=0.406 Sum_probs=140.2
Q ss_pred CCcccccee-----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 2 YHQKLQHLF-----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 2 ~Hpni~~~~-----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
.|.||+.-| ..+.++++||||+.|+|..-+... .+-|.....++.|+++|+.|+|++++||||||.+|||+-.
T Consensus 79 ~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~~--GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~ 156 (378)
T KOG1345|consen 79 PHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEAA--GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFD 156 (378)
T ss_pred cchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCcc--cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEec
Confidence 589999988 457889999999999999877553 4788999999999999999999999999999999999976
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc----c--cCCCchhHHHHHHHHHHHHhCCCCCCCCChh-H
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH----R--SYNVEGDMWSIGVITYILLCGSRPFWARTES-G 149 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~----~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~ 149 (389)
. +..+|||||||.++..+... ...--+..|.|||.+. + ...+.+|+|.||+|+|.+++|.+||+..... .
T Consensus 157 ~-df~rvKlcDFG~t~k~g~tV--~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~ 233 (378)
T KOG1345|consen 157 A-DFYRVKLCDFGLTRKVGTTV--KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDK 233 (378)
T ss_pred C-CccEEEeeecccccccCcee--hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCc
Confidence 4 34589999999887653221 2223456799999762 2 2678899999999999999999999753221 1
Q ss_pred HH---HHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCC
Q 016471 150 IF---RSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKR 188 (389)
Q Consensus 150 ~~---~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 188 (389)
.+ .+..+......+..+..+++.+..+.++-|..+|.+|
T Consensus 234 ~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~dr 275 (378)
T KOG1345|consen 234 PYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDR 275 (378)
T ss_pred hHHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCccccc
Confidence 12 2222222222222345689999999999999999998
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=210.08 Aligned_cols=195 Identities=25% Similarity=0.423 Sum_probs=146.0
Q ss_pred Ccccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeecC
Q 016471 3 HQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE 78 (389)
Q Consensus 3 Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~~ 78 (389)
+.||+.+. .++++.+|+||++.-+..+++ ..++..+++.+++.++.||.++|++|||||||||+|+|.+ .
T Consensus 94 ~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~----~~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n--~ 167 (418)
T KOG1167|consen 94 SDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLY----RSLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYN--R 167 (418)
T ss_pred chhhhcchhhhccCCeeEEEecccCccCHHHHH----hcCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccc--c
Confidence 45666666 568999999999998887765 3477899999999999999999999999999999999996 3
Q ss_pred CCCCEEEeecCCccccC-----------------C--C---------------C-----------CcccccccCCccccc
Q 016471 79 EDAPLKVIDFGLSDFVR-----------------P--D---------------Q-----------RLNDIVGSAYYVAPE 113 (389)
Q Consensus 79 ~~~~~kl~Dfg~a~~~~-----------------~--~---------------~-----------~~~~~~gt~~y~aPE 113 (389)
..+.-.|+|||+|.... + + . ..-...||++|.|||
T Consensus 168 ~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPE 247 (418)
T KOG1167|consen 168 RTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPE 247 (418)
T ss_pred ccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchH
Confidence 56778999999986210 0 0 0 001246999999999
Q ss_pred cccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChh-HHHHHHH--------------hcC------CC----------
Q 016471 114 VLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTES-GIFRSVL--------------RAD------PN---------- 160 (389)
Q Consensus 114 ~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~--------------~~~------~~---------- 160 (389)
++.+ ..++++||||.|||+.-++++..||...... ..+..+. -+. .+
T Consensus 248 vL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~ 327 (418)
T KOG1167|consen 248 VLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVN 327 (418)
T ss_pred HHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhc
Confidence 9854 5789999999999999999999999543221 0000000 000 00
Q ss_pred ----------------CCCCCCC-CCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCC
Q 016471 161 ----------------FHDSPWP-SVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 161 ----------------~~~~~~~-~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~ 203 (389)
.....|. ..+..+.+|+.+||..||.+|+|++++|.||||...
T Consensus 328 f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~ 387 (418)
T KOG1167|consen 328 FETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA 387 (418)
T ss_pred hhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence 0111111 235589999999999999999999999999999754
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-26 Score=222.89 Aligned_cols=190 Identities=22% Similarity=0.331 Sum_probs=162.4
Q ss_pred CCCcccccee---ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 1 MYHQKLQHLF---YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 1 l~Hpni~~~~---~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
|-||||+++. -...+-||++|+++|.|.+++..++..+-.+..+.|..||++|+.|||.+++|||||-..|+|+.
T Consensus 755 ldHpnl~RLLgvc~~s~~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVk-- 832 (1177)
T KOG1025|consen 755 LDHPNLLRLLGVCMLSTLQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVK-- 832 (1177)
T ss_pred CCCchHHHHhhhcccchHHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeec--
Confidence 5799999998 24558899999999999999998888999999999999999999999999999999999999994
Q ss_pred CCCCCEEEeecCCccccCCCCCcc-c--ccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHH
Q 016471 78 EEDAPLKVIDFGLSDFVRPDQRLN-D--IVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFR 152 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~~~~~~-~--~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 152 (389)
....+|++|||+|+........- . ..-.+.|||-|.+. +.|++++||||+||++||++| |..|+.+....++-.
T Consensus 833 -sP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~d 911 (1177)
T KOG1025|consen 833 -SPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPD 911 (1177)
T ss_pred -CCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhH
Confidence 67789999999999887654322 2 22345689999774 679999999999999999999 999999988887776
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 153 SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 153 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
.+..+.. .+.+ |..+.++.-++.+||..|+..||+++++..
T Consensus 912 lle~geR-LsqP--piCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 912 LLEKGER-LSQP--PICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHhcccc-CCCC--CCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 6655543 4443 568999999999999999999999988764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.2e-27 Score=233.60 Aligned_cols=199 Identities=29% Similarity=0.477 Sum_probs=156.5
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|.|||++... ....++-+||||++ +|+.++... ++++..++..+++|++.||+|+|+.||.|||+||+|++++
T Consensus 378 l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~- 454 (601)
T KOG0590|consen 378 LSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVT- 454 (601)
T ss_pred ccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEe-
Confidence 5789987655 23344444999999 999988665 6899999999999999999999999999999999999995
Q ss_pred cCCCCCEEEeecCCccccCCCC-----CcccccccCCccccccccc-cCC-CchhHHHHHHHHHHHHhCCCCCCCCChhH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ-----RLNDIVGSAYYVAPEVLHR-SYN-VEGDMWSIGVITYILLCGSRPFWARTESG 149 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~ 149 (389)
.++.+||+|||.+..+...- .....+|+.+|+|||++.+ .|. ...||||.|+|+..|.+|+.||......+
T Consensus 455 --~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~ 532 (601)
T KOG0590|consen 455 --ENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSD 532 (601)
T ss_pred --cCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccc
Confidence 67799999999987664322 3456789999999999864 565 45899999999999999999996654432
Q ss_pred HH-HHHHh-cCCCCC---CCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 150 IF-RSVLR-ADPNFH---DSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 150 ~~-~~i~~-~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
.. ..... ...... ...+..++...+.+|.+||+.+|.+|+|+++|++.+||+...
T Consensus 533 ~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 533 NSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred cchhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence 21 11111 111111 112345788999999999999999999999999999998764
|
|
| >COG5126 FRQ1 Ca2+-binding protein (EF-Hand superfamily) [Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.2e-24 Score=172.18 Aligned_cols=142 Identities=19% Similarity=0.366 Sum_probs=125.4
Q ss_pred HHHhcCHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHH
Q 016471 234 LSKALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQL 312 (389)
Q Consensus 234 i~~~l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~ 312 (389)
....+++++++.+++.|..+|+ ++|.|+.+||..+|+.+|.. +++.++.+++..+|. +++.|+|.+|+.++......
T Consensus 10 ~~~~~t~~qi~~lkeaF~l~D~d~~G~I~~~el~~ilr~lg~~-~s~~ei~~l~~~~d~-~~~~idf~~Fl~~ms~~~~~ 87 (160)
T COG5126 10 TFTQLTEEQIQELKEAFQLFDRDSDGLIDRNELGKILRSLGFN-PSEAEINKLFEEIDA-GNETVDFPEFLTVMSVKLKR 87 (160)
T ss_pred hcccCCHHHHHHHHHHHHHhCcCCCCCCcHHHHHHHHHHcCCC-CcHHHHHHHHHhccC-CCCccCHHHHHHHHHHHhcc
Confidence 3457899999999999999999 99999999999999988874 799999999999999 99999999999987765543
Q ss_pred HhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHhC-----CchH-HHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 313 EALERWDQIAITAFDYFEQEGNRVISVEELALELN-----LAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 313 ~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~-----~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
... ++++++||+.||+|+||+|+.+||++++. ++.+ ++++++++|.|++|+|+|++|++++...+
T Consensus 88 ~~~---~Eel~~aF~~fD~d~dG~Is~~eL~~vl~~lge~~~deev~~ll~~~d~d~dG~i~~~eF~~~~~~~~ 158 (160)
T COG5126 88 GDK---EEELREAFKLFDKDHDGYISIGELRRVLKSLGERLSDEEVEKLLKEYDEDGDGEIDYEEFKKLIKDSP 158 (160)
T ss_pred CCc---HHHHHHHHHHhCCCCCceecHHHHHHHHHhhcccCCHHHHHHHHHhcCCCCCceEeHHHHHHHHhccC
Confidence 332 56799999999999999999999999993 2233 99999999999999999999999987654
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.9e-24 Score=185.09 Aligned_cols=160 Identities=40% Similarity=0.740 Sum_probs=137.5
Q ss_pred CCCccccceee----cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLFY----SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~~----~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.|++|..++. ....++++||+.|++|.+++......+++..+..++.+++.+|++||++|++|+||+|.||++.
T Consensus 48 l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~- 126 (215)
T cd00180 48 LNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLD- 126 (215)
T ss_pred cCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEe-
Confidence 46888888882 3578999999999999998765534689999999999999999999999999999999999995
Q ss_pred cCC-CCCEEEeecCCccccCCCC-CcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 016471 77 REE-DAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFR 152 (389)
Q Consensus 77 ~~~-~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 152 (389)
. .+.++|+|||.+....... ......+...|++||.+.. .++.+.|+|++|++++++
T Consensus 127 --~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------- 187 (215)
T cd00180 127 --SDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------- 187 (215)
T ss_pred --CCCCcEEEecCCceEEccCCcchhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------
Confidence 4 6889999999987664432 1233567889999998854 678899999999999999
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCC
Q 016471 153 SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHP 198 (389)
Q Consensus 153 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~ 198 (389)
..+.+++.+|+..+|.+||++.++++++
T Consensus 188 ------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 5789999999999999999999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-24 Score=202.78 Aligned_cols=137 Identities=29% Similarity=0.566 Sum_probs=120.1
Q ss_pred Ccccccee----ecCeEEEEEEccC-CCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 3 HQKLQHLF----YSNSFLFFTRFCE-GGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 3 Hpni~~~~----~~~~~~lv~E~~~-gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
||||+++. +++.+||+||-.. |-+|+++|.-+ .+++|.++..|++||+.|+++||++||||||||-+|+.+
T Consensus 628 H~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~k-p~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenviv--- 703 (772)
T KOG1152|consen 628 HENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFK-PRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIV--- 703 (772)
T ss_pred ccchhhhhheeecCCeeEEEecCCCCCcchhhhhhcc-CccchHHHHHHHHHHHhccccccccCceecccccccEEE---
Confidence 99999876 5788999999754 45899988655 789999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCCccccCCCCCcccccccCCccccccccc-c-CCCchhHHHHHHHHHHHHhCCCCCCC
Q 016471 78 EEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-S-YNVEGDMWSIGVITYILLCGSRPFWA 144 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~-~~~~~DiwslG~il~~ll~g~~pf~~ 144 (389)
+.+|-+||+|||.|..... .....++||..|.|||++.+ . .+...|||++|++||.+.....||+.
T Consensus 704 d~~g~~klidfgsaa~~ks-gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 704 DSNGFVKLIDFGSAAYTKS-GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred ecCCeEEEeeccchhhhcC-CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 6899999999998876553 34567899999999999975 3 46778999999999999999999853
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.6e-23 Score=183.84 Aligned_cols=190 Identities=15% Similarity=0.188 Sum_probs=154.1
Q ss_pred CCCcccccee-----ecCeEEEEEEccCCCChHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCC
Q 016471 1 MYHQKLQHLF-----YSNSFLFFTRFCEGGELLDRILSR-------GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLK 68 (389)
Q Consensus 1 l~Hpni~~~~-----~~~~~~lv~E~~~gg~L~~~l~~~-------~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlk 68 (389)
+.|||+...- ....=+.++.+..-|+|..++.-. .+.++..+...++.|++.|+.|||++|++|.||.
T Consensus 344 ~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiA 423 (563)
T KOG1024|consen 344 ASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIA 423 (563)
T ss_pred CcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhh
Confidence 4699998876 234457788999999999988732 2346778888999999999999999999999999
Q ss_pred CCcEEEeecCCCCCEEEeecCCccccCCCCC---cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCC
Q 016471 69 PENFLFTTREEDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFW 143 (389)
Q Consensus 69 p~Nill~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~ 143 (389)
..|+++ ++..+|||+|=.+++..-+... ...-.....||+||.+. ..|+..+|+|||||++|||.| |+.|+-
T Consensus 424 aRNCvI---dd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pya 500 (563)
T KOG1024|consen 424 ARNCVI---DDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYA 500 (563)
T ss_pred hhccee---hhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcc
Confidence 999999 6778999999998876543321 11122345799999986 479999999999999999998 999999
Q ss_pred CCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 144 ARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 144 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
.-++.++...+..+.. ...+ .+++.++..++.-||...|++||+.+++..
T Consensus 501 eIDPfEm~~ylkdGyR-laQP--~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 501 EIDPFEMEHYLKDGYR-LAQP--FNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred ccCHHHHHHHHhccce-ecCC--CCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 9888888777765532 2222 468999999999999999999999988764
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=179.54 Aligned_cols=155 Identities=37% Similarity=0.686 Sum_probs=128.1
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.|+|++.++ .....++++||+.+++|.+++......+++..+..++.+++.++.+||++|++|+||+|.||+++
T Consensus 54 ~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~- 132 (225)
T smart00221 54 LKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLG- 132 (225)
T ss_pred CCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc-
Confidence 4689999987 34779999999999999998876532289999999999999999999999999999999999994
Q ss_pred cCCCCCEEEeecCCccccCCCC--CcccccccCCccccccc-c-ccCCCchhHHHHHHHHHHHHhCCCCCCC-CCh-hHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ--RLNDIVGSAYYVAPEVL-H-RSYNVEGDMWSIGVITYILLCGSRPFWA-RTE-SGI 150 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~-~-~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~-~~~ 150 (389)
.++.++|+|||.+....... ......++..|++||.+ . ..++.++|+|++|+++|+|++|+.||.. ... ..+
T Consensus 133 --~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~ 210 (225)
T smart00221 133 --MDGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLL 210 (225)
T ss_pred --CCCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHH
Confidence 56899999999988765432 33455788899999987 3 3577899999999999999999999977 344 455
Q ss_pred HHHHHhcC
Q 016471 151 FRSVLRAD 158 (389)
Q Consensus 151 ~~~i~~~~ 158 (389)
...+..+.
T Consensus 211 ~~~~~~~~ 218 (225)
T smart00221 211 SDVWSFGV 218 (225)
T ss_pred HHHHhcCC
Confidence 66665554
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0027 consensus Calmodulin and related proteins (EF-Hand superfamily) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.7e-22 Score=166.00 Aligned_cols=141 Identities=21% Similarity=0.377 Sum_probs=120.9
Q ss_pred cCHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhH
Q 016471 238 LTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALE 316 (389)
Q Consensus 238 l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~ 316 (389)
++.++...++.+|..+|. ++|+|+..||..+++.+|.. +++.++..++..+|.+++|.|+|+||+..+..........
T Consensus 2 ~~~~~~~el~~~F~~fD~d~~G~i~~~el~~~lr~lg~~-~t~~el~~~~~~~D~dg~g~I~~~eF~~l~~~~~~~~~~~ 80 (151)
T KOG0027|consen 2 LSEEQILELKEAFQLFDKDGDGKISVEELGAVLRSLGQN-PTEEELRDLIKEIDLDGDGTIDFEEFLDLMEKLGEEKTDE 80 (151)
T ss_pred CCHHHHHHHHHHHHHHCCCCCCcccHHHHHHHHHHcCCC-CCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHhhhcccccc
Confidence 356778899999999999 99999999999999999974 8999999999999999999999999998766543322211
Q ss_pred -HHHHHHHHHHHHHcccCCCcccHHHHHHHh---CC--chH-HHHHHHHHccCCCCceeHHHHHHHHccc
Q 016471 317 -RWDQIAITAFDYFEQEGNRVISVEELALEL---NL--APA-AYSLLNDCIRNSDGKLSFLGYKRFLHGV 379 (389)
Q Consensus 317 -~~~~~l~~aF~~~D~d~~G~I~~~el~~~l---~~--~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~ 379 (389)
...+.+++||+.||+|++|+||++||+++| |. ... +.++++++|.|+||.|+|+||+.+|...
T Consensus 81 ~~~~~el~eaF~~fD~d~~G~Is~~el~~~l~~lg~~~~~~e~~~mi~~~d~d~dg~i~f~ef~~~m~~~ 150 (151)
T KOG0027|consen 81 EASSEELKEAFRVFDKDGDGFISASELKKVLTSLGEKLTDEECKEMIREVDVDGDGKVNFEEFVKMMSGK 150 (151)
T ss_pred cccHHHHHHHHHHHccCCCCcCcHHHHHHHHHHhCCcCCHHHHHHHHHhcCCCCCCeEeHHHHHHHHhcC
Confidence 013479999999999999999999999999 32 233 9999999999999999999999999753
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.6e-23 Score=199.46 Aligned_cols=186 Identities=25% Similarity=0.440 Sum_probs=161.8
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
.||.++.+. .+..+|+++++..||+|+.++.+. ..+.+..++.+...++.|++++|+.||+|||+|++||++
T Consensus 55 ~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~-~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enill--- 130 (612)
T KOG0603|consen 55 NTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKE-VMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLL--- 130 (612)
T ss_pred CCCceeeeeeeeccccchhHhhhhcccchhhhccccC-CchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceee---
Confidence 388888888 367899999999999999987655 678899999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCCccccCCCCCcccccccCCccccccccccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc
Q 016471 78 EEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRA 157 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 157 (389)
+.+|.+++.|||+++........ |||..|||||++. .....+|+||+|+++++|++|..||.+ ++...|.+.
T Consensus 131 d~~Ghi~~tdfglske~v~~~~~---cgt~eymApEI~~-gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~ 202 (612)
T KOG0603|consen 131 LLEGHIKLTDFGLSKEAVKEKIA---CGTYEYRAPEIIN-GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKA 202 (612)
T ss_pred cccCccccCCchhhhHhHhhhhc---ccchhhhhhHhhh-ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhh
Confidence 68999999999998876443322 9999999999987 677889999999999999999999977 677777776
Q ss_pred CCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCC-----HHHHhCCCCCCCC
Q 016471 158 DPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMT-----AAQALTHPWLHDE 203 (389)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s-----~~e~l~h~~~~~~ 203 (389)
....+ ..++..+++++..++..+|..|.. +.++++|++|+..
T Consensus 203 ~~~~p----~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i 249 (612)
T KOG0603|consen 203 ELEMP----RELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSI 249 (612)
T ss_pred ccCCc----hhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheee
Confidence 55554 357899999999999999999985 4799999999765
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.5e-21 Score=174.69 Aligned_cols=175 Identities=26% Similarity=0.405 Sum_probs=132.0
Q ss_pred CeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeecC-CCCCEEEeecCCc
Q 016471 13 NSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE-EDAPLKVIDFGLS 91 (389)
Q Consensus 13 ~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~~-~~~~~kl~Dfg~a 91 (389)
..+|+||.-+.. +|.+++..+ ..+....+-++.|+++|+.|||++||.|||||.+|||+.-++ .-..+.++|||.+
T Consensus 316 ~tlylvMkrY~~-tLr~yl~~~--~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCc 392 (598)
T KOG4158|consen 316 KTLYLVMKRYRQ-TLREYLWTR--HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCC 392 (598)
T ss_pred ceEEEehhcchh-hHHHHHhcC--CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEccccee
Confidence 569999999987 999998765 577888899999999999999999999999999999997543 3346899999976
Q ss_pred cccCC-------CCCcccccccCCccccccccc---c----CCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc
Q 016471 92 DFVRP-------DQRLNDIVGSAYYVAPEVLHR---S----YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRA 157 (389)
Q Consensus 92 ~~~~~-------~~~~~~~~gt~~y~aPE~~~~---~----~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 157 (389)
--... ....-...|.-..||||+... . --.++|.|+.|.+.||++....||++......-..-.+.
T Consensus 393 LAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe 472 (598)
T KOG4158|consen 393 LADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQE 472 (598)
T ss_pred eeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhh
Confidence 43221 111223457778999998742 1 125789999999999999999999885443221111221
Q ss_pred CCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHH
Q 016471 158 DPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAA 192 (389)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~ 192 (389)
. ..|.. ...+++.+++++..+|+.||++|+|..
T Consensus 473 ~-qLPal-p~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 473 S-QLPAL-PSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred h-hCCCC-cccCChHHHHHHHHHhcCCccccCCcc
Confidence 1 12211 146899999999999999999999854
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3e-20 Score=172.76 Aligned_cols=200 Identities=32% Similarity=0.570 Sum_probs=155.0
Q ss_pred CCCc-ccccee----ecCeEEEEEEccCCCChHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEE
Q 016471 1 MYHQ-KLQHLF----YSNSFLFFTRFCEGGELLDRILSRG--GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFL 73 (389)
Q Consensus 1 l~Hp-ni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nil 73 (389)
+.|+ +|+.++ .....+++++++.|+++.+.+.... ..+++..+..++.|++.++.|+|+.|++|||+||+||+
T Consensus 54 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil 133 (384)
T COG0515 54 LNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENIL 133 (384)
T ss_pred ccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHee
Confidence 3456 688876 2345799999999999996655442 27999999999999999999999999999999999999
Q ss_pred EeecCCCC-CEEEeecCCccccCCCC-------CcccccccCCccccccccc----cCCCchhHHHHHHHHHHHHhCCCC
Q 016471 74 FTTREEDA-PLKVIDFGLSDFVRPDQ-------RLNDIVGSAYYVAPEVLHR----SYNVEGDMWSIGVITYILLCGSRP 141 (389)
Q Consensus 74 l~~~~~~~-~~kl~Dfg~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~~ll~g~~p 141 (389)
+. ... .++++|||.+....... ......||..|+|||.+.. .++...|+||+|++++++++|..|
T Consensus 134 ~~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p 210 (384)
T COG0515 134 LD---RDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPP 210 (384)
T ss_pred ec---CCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCC
Confidence 94 445 69999999987554332 2456789999999998853 678899999999999999999999
Q ss_pred CCCCCh----hHHHHHHHhcCCC-CCCCCCCCC----CHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCC
Q 016471 142 FWARTE----SGIFRSVLRADPN-FHDSPWPSV----SPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 142 f~~~~~----~~~~~~i~~~~~~-~~~~~~~~~----~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~ 203 (389)
|..... ......+...... ......+.. ...+.+++.+++..+|..|.+......+++....
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 211 FEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred CCCCCccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 877663 3444444443322 121111111 2579999999999999999999998888665443
|
|
| >KOG0028 consensus Ca2+-binding protein (centrin/caltractin), EF-Hand superfamily protein [Cytoskeleton; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.1e-19 Score=143.26 Aligned_cols=139 Identities=19% Similarity=0.313 Sum_probs=121.9
Q ss_pred hcCHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhh
Q 016471 237 ALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEAL 315 (389)
Q Consensus 237 ~l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~ 315 (389)
.+..++.+.++..|..+|. .+|+|+.+||+.+++.+|+. +.++++..++..+|.++.|.|+|++|+..+.........
T Consensus 26 ~l~~~q~q~i~e~f~lfd~~~~g~iD~~EL~vAmralGFE-~~k~ei~kll~d~dk~~~g~i~fe~f~~~mt~k~~e~dt 104 (172)
T KOG0028|consen 26 ELTEEQKQEIKEAFELFDPDMAGKIDVEELKVAMRALGFE-PKKEEILKLLADVDKEGSGKITFEDFRRVMTVKLGERDT 104 (172)
T ss_pred cccHHHHhhHHHHHHhhccCCCCcccHHHHHHHHHHcCCC-cchHHHHHHHHhhhhccCceechHHHHHHHHHHHhccCc
Confidence 4567777889999999999 99999999999999999985 788999999999999999999999999876655443332
Q ss_pred HHHHHHHHHHHHHHcccCCCcccHHHHHHHh---CC--chH-HHHHHHHHccCCCCceeHHHHHHHHccc
Q 016471 316 ERWDQIAITAFDYFEQEGNRVISVEELALEL---NL--APA-AYSLLNDCIRNSDGKLSFLGYKRFLHGV 379 (389)
Q Consensus 316 ~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l---~~--~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~ 379 (389)
.+.++.||+.+|.|++|.|+..+|+.+. |- ... +.+|++++|.++||.|+-+||+.+|++.
T Consensus 105 ---~eEi~~afrl~D~D~~Gkis~~~lkrvakeLgenltD~El~eMIeEAd~d~dgevneeEF~~imk~t 171 (172)
T KOG0028|consen 105 ---KEEIKKAFRLFDDDKTGKISQRNLKRVAKELGENLTDEELMEMIEEADRDGDGEVNEEEFIRIMKKT 171 (172)
T ss_pred ---HHHHHHHHHcccccCCCCcCHHHHHHHHHHhCccccHHHHHHHHHHhcccccccccHHHHHHHHhcC
Confidence 5679999999999999999999999988 32 222 9999999999999999999999999874
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.1e-20 Score=188.75 Aligned_cols=152 Identities=32% Similarity=0.569 Sum_probs=130.4
Q ss_pred HHHHHHHHHCCCEecCCCCCcEEEeecCCCCCEEEeecCCccccCCCC----------------CcccccccCCcccccc
Q 016471 51 LNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ----------------RLNDIVGSAYYVAPEV 114 (389)
Q Consensus 51 ~~~L~~lH~~~i~Hrdlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~----------------~~~~~~gt~~y~aPE~ 114 (389)
+.+++|||+.||+|||+||+|.+++ .-|.+|++|||+++...... .....+|||.|+|||+
T Consensus 153 vla~Eylh~ygivhrdlkpdnllIT---~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeV 229 (1205)
T KOG0606|consen 153 VLAVEYLHSYGIVHRDLKPDNLLIT---SMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEV 229 (1205)
T ss_pred hHHhHhhccCCeecCCCCCCcceee---ecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhh
Confidence 6789999999999999999999997 46789999999976432100 1123589999999998
Q ss_pred cc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCC---C
Q 016471 115 LH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRM---T 190 (389)
Q Consensus 115 ~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~---s 190 (389)
+. ..|+..+|+|++|+|+|+.+.|..||.+.++++++..++.....++.. ...+++++++++.++|+.+|..|. .
T Consensus 230 ilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~-dea~p~Ea~dli~~LL~qnp~~Rlgt~g 308 (1205)
T KOG0606|consen 230 ILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEE-DEALPPEAQDLIEQLLRQNPLCRLGTGG 308 (1205)
T ss_pred hhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccccc-CcCCCHHHHHHHHHHHHhChHhhcccch
Confidence 75 579999999999999999999999999999999999999888777777 356889999999999999999996 5
Q ss_pred HHHHhCCCCCCCCCCC
Q 016471 191 AAQALTHPWLHDENRP 206 (389)
Q Consensus 191 ~~e~l~h~~~~~~~~~ 206 (389)
+-++.+|+||+..++.
T Consensus 309 a~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 309 ALEVKQHGFFQLLDWK 324 (1205)
T ss_pred hhhhhhccceeecccc
Confidence 7789999999876543
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.3e-19 Score=172.61 Aligned_cols=218 Identities=24% Similarity=0.342 Sum_probs=160.8
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCC-EecCCCCCcEEEe
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGV-VHRDLKPENFLFT 75 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i-~Hrdlkp~Nill~ 75 (389)
|.|.|+..++ .....++|.+||+.|+|.|.+......++.-....++++|+.||.|||+..| .|+.|++.|+++
T Consensus 4 l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nClv- 82 (484)
T KOG1023|consen 4 LDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCLV- 82 (484)
T ss_pred cchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccccee-
Confidence 5799999998 5688999999999999999998877788899999999999999999998876 999999999999
Q ss_pred ecCCCCCEEEeecCCccccCCC---CCcccccccCCcccccccccc--------CCCchhHHHHHHHHHHHHhCCCCCCC
Q 016471 76 TREEDAPLKVIDFGLSDFVRPD---QRLNDIVGSAYYVAPEVLHRS--------YNVEGDMWSIGVITYILLCGSRPFWA 144 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~--------~~~~~DiwslG~il~~ll~g~~pf~~ 144 (389)
+....+||+|||+....... .......-...|.|||.+... .+.++|+||+|++++|+++.+.||..
T Consensus 83 --d~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 83 --DSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred --eeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 67889999999997665321 111122344579999998532 46779999999999999999999965
Q ss_pred C----ChhHHHHHHHhcCCC-CCCCCC--CCCCHHHHHHHHhhhccCcCCCCCHHHHhCCC--CCCCCCCCCCccHHHHH
Q 016471 145 R----TESGIFRSVLRADPN-FHDSPW--PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHP--WLHDENRPVPLDILIYK 215 (389)
Q Consensus 145 ~----~~~~~~~~i~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~--~~~~~~~~~~~~~~~~~ 215 (389)
. ...++...+.+.... +.+..+ ....+.+..++.+||..+|..||+++++-..- .+........+...+..
T Consensus 161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~~~~~nl~D~m~~ 240 (484)
T KOG1023|consen 161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGGSSKGNLMDSLFR 240 (484)
T ss_pred ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccccccchhHHHHHH
Confidence 2 223455555552222 222111 14566899999999999999999998876521 11111112244445555
Q ss_pred HHHHHh
Q 016471 216 LVKSYL 221 (389)
Q Consensus 216 ~~~~~~ 221 (389)
.+..+.
T Consensus 241 ~le~Y~ 246 (484)
T KOG1023|consen 241 MLESYA 246 (484)
T ss_pred HHHHHH
Confidence 555554
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.7e-20 Score=174.22 Aligned_cols=176 Identities=27% Similarity=0.443 Sum_probs=134.0
Q ss_pred CeEEEEEEccCCCChHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeecCCCCCEEEeecCC
Q 016471 13 NSFLFFTRFCEGGELLDRILSR--GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGL 90 (389)
Q Consensus 13 ~~~~lv~E~~~gg~L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~~~~~~~kl~Dfg~ 90 (389)
.+.||.|++|.-++|.+.+..+ ....+......++.|+..|++| +|.+|||+||.||++. .+..+||.|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~---~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFS---DDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccc---cchhhhhhhhhh
Confidence 4689999999999999988633 2346677889999999999999 9999999999999995 456899999999
Q ss_pred ccccCCCC-------CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChh-HHHHHHHhcCCCC
Q 016471 91 SDFVRPDQ-------RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTES-GIFRSVLRADPNF 161 (389)
Q Consensus 91 a~~~~~~~-------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~ 161 (389)
........ ..+..+||+.||+||.+. +.|+.++||||||+|++|++. +|...... .....+..+ .+
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~---~f~T~~er~~t~~d~r~g--~i 477 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI---QFSTQFERIATLTDIRDG--II 477 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH---HhccHHHHHHhhhhhhcC--CC
Confidence 87665443 445678999999999986 579999999999999999997 23221111 112222221 22
Q ss_pred CCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCC
Q 016471 162 HDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 162 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~ 200 (389)
|+..+.+ -|.-..|+.+||...|.+||++.+.-.|+|.
T Consensus 478 p~~~~~d-~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 478 PPEFLQD-YPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred ChHHhhc-CcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 3222222 2556789999999999999988777777764
|
|
| >PTZ00183 centrin; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=6e-18 Score=141.47 Aligned_cols=141 Identities=19% Similarity=0.321 Sum_probs=119.8
Q ss_pred hcCHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhh
Q 016471 237 ALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEAL 315 (389)
Q Consensus 237 ~l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~ 315 (389)
.++..+...+...|..+|. ++|.|+.+||..++...+.. .+..++..++..+|.+++|.|+|+||+.++.........
T Consensus 10 ~~~~~~~~~~~~~F~~~D~~~~G~i~~~e~~~~l~~~g~~-~~~~~~~~l~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~ 88 (158)
T PTZ00183 10 GLTEDQKKEIREAFDLFDTDGSGTIDPKELKVAMRSLGFE-PKKEEIKQMIADVDKDGSGKIDFEEFLDIMTKKLGERDP 88 (158)
T ss_pred CCCHHHHHHHHHHHHHhCCCCCCcccHHHHHHHHHHhCCC-CCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHHhcCCCc
Confidence 4667888899999999999 99999999999999988763 677889999999999999999999999865532211111
Q ss_pred HHHHHHHHHHHHHHcccCCCcccHHHHHHHh---C--CchH-HHHHHHHHccCCCCceeHHHHHHHHccccC
Q 016471 316 ERWDQIAITAFDYFEQEGNRVISVEELALEL---N--LAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVTV 381 (389)
Q Consensus 316 ~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l---~--~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~ 381 (389)
++.++.+|+.+|+|++|+|+.+|+..++ | +... +..++..+|.+++|.|+|++|+.+|++.+.
T Consensus 89 ---~~~l~~~F~~~D~~~~G~i~~~e~~~~l~~~~~~l~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~ 157 (158)
T PTZ00183 89 ---REEILKAFRLFDDDKTGKISLKNLKRVAKELGETITDEELQEMIDEADRNGDGEISEEEFYRIMKKTNL 157 (158)
T ss_pred ---HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHhcccC
Confidence 3568999999999999999999999988 3 3344 899999999999999999999999988663
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.1e-19 Score=182.05 Aligned_cols=188 Identities=21% Similarity=0.290 Sum_probs=135.2
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
++|||...|- .++..|||-+|... +|+|++-.+ .-+...+.+-|+.|++.||.-||..||+|||||.+|||++
T Consensus 78 ~~~pn~lPfqk~~~t~kAAylvRqyvkh-nLyDRlSTR-PFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiT- 154 (1431)
T KOG1240|consen 78 MKAPNCLPFQKVLVTDKAAYLVRQYVKH-NLYDRLSTR-PFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILIT- 154 (1431)
T ss_pred hcCCcccchHHHHHhhHHHHHHHHHHhh-hhhhhhccc-hHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEe-
Confidence 4788888877 46778999999987 999998554 6788888889999999999999999999999999999997
Q ss_pred cCCCCCEEEeecCCcccc--CCCCC--c----ccccccCCccccccccc-----------c-CCCchhHHHHHHHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFV--RPDQR--L----NDIVGSAYYVAPEVLHR-----------S-YNVEGDMWSIGVITYILL 136 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~--~~~~~--~----~~~~gt~~y~aPE~~~~-----------~-~~~~~DiwslG~il~~ll 136 (389)
.-+.+.|+||.--+.. .++.. . .+...-.+|+|||.+.. . .+++-||||+||+++|++
T Consensus 155 --SWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf 232 (1431)
T KOG1240|consen 155 --SWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELF 232 (1431)
T ss_pred --eechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHH
Confidence 3567999999743321 11111 1 11223347999996521 1 467889999999999999
Q ss_pred h-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCC-CCHHHHHHHHhhhccCcCCCCCHHHHhCC
Q 016471 137 C-GSRPFWARTESGIFRSVLRADPNFHDSPWPS-VSPEAKDFVRRLLNKDHRKRMTAAQALTH 197 (389)
Q Consensus 137 ~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~-~~~~~~~li~~~l~~~p~~R~s~~e~l~h 197 (389)
+ |++||.- .+++ ...++....+...... -+..++.+|..|++.||.+|.||++.|+.
T Consensus 233 ~Eg~PlF~L---SQL~-aYr~~~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 233 LEGRPLFTL---SQLL-AYRSGNADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred hcCCCcccH---HHHH-hHhccCccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 9 8999821 1111 1111100000000000 14479999999999999999999999985
|
|
| >KOG0044 consensus Ca2+ sensor (EF-Hand superfamily) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.9e-18 Score=144.92 Aligned_cols=143 Identities=16% Similarity=0.207 Sum_probs=119.7
Q ss_pred HhcCHHHHHHHHHHhhhcCCCCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhh
Q 016471 236 KALTEEELVYLRAQFMLLEPKDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEAL 315 (389)
Q Consensus 236 ~~l~~ee~~~l~~~F~~~D~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~ 315 (389)
..++..++..+..-|..-++ +|.++.++|+.++...+...-...-++.+|+.+|.|+||.|+|.||+.+++...+...
T Consensus 21 t~f~~~ei~~~Yr~Fk~~cP-~G~~~~~~F~~i~~~~fp~gd~~~y~~~vF~~fD~~~dg~i~F~Efi~als~~~rGt~- 98 (193)
T KOG0044|consen 21 TKFSKKEIQQWYRGFKNECP-SGRLTLEEFREIYASFFPDGDASKYAELVFRTFDKNKDGTIDFLEFICALSLTSRGTL- 98 (193)
T ss_pred cCCCHHHHHHHHHHhcccCC-CCccCHHHHHHHHHHHCCCCCHHHHHHHHHHHhcccCCCCcCHHHHHHHHHHHcCCcH-
Confidence 46788888888888887554 8999999999999888754445666789999999999999999999988776544433
Q ss_pred HHHHHHHHHHHHHHcccCCCcccHHHHHHHh-------CC---c-----hH--HHHHHHHHccCCCCceeHHHHHHHHcc
Q 016471 316 ERWDQIAITAFDYFEQEGNRVISVEELALEL-------NL---A-----PA--AYSLLNDCIRNSDGKLSFLGYKRFLHG 378 (389)
Q Consensus 316 ~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l-------~~---~-----~~--~~~~~~~~d~~~~g~i~~~ef~~~~~~ 378 (389)
+++++++|++||.|+||+|+++|+-.++ +. + +. +..+|+.+|.|+||.||++||+..++.
T Consensus 99 ---eekl~w~F~lyD~dgdG~It~~Eml~iv~~i~~m~~~~~~~~~~~~~~~~v~~if~k~D~n~Dg~lT~eef~~~~~~ 175 (193)
T KOG0044|consen 99 ---EEKLKWAFRLYDLDGDGYITKEEMLKIVQAIYQMTGSKALPEDEETPEERVDKIFSKMDKNKDGKLTLEEFIEGCKA 175 (193)
T ss_pred ---HHHhhhhheeecCCCCceEcHHHHHHHHHHHHHHcccccCCcccccHHHHHHHHHHHcCCCCCCcccHHHHHHHhhh
Confidence 6789999999999999999999999977 21 1 11 889999999999999999999999988
Q ss_pred ccCCC
Q 016471 379 VTVRS 383 (389)
Q Consensus 379 ~~~~~ 383 (389)
.++..
T Consensus 176 d~~i~ 180 (193)
T KOG0044|consen 176 DPSIL 180 (193)
T ss_pred CHHHH
Confidence 87543
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=7.2e-18 Score=157.59 Aligned_cols=184 Identities=20% Similarity=0.209 Sum_probs=133.2
Q ss_pred cCeEEEEEEccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeecCCC--CCEEEeec
Q 016471 12 SNSFLFFTRFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREED--APLKVIDF 88 (389)
Q Consensus 12 ~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~~~~--~~~kl~Df 88 (389)
...-|+||+.+ |.+|.+...... ++++...+..++.|++.+|++||+.|++||||||+|+.++..... ..+.|.||
T Consensus 93 ~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 93 EDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred CceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEec
Confidence 34679999998 569988665454 789999999999999999999999999999999999999743212 56999999
Q ss_pred CCccccC---CC------C-C-cccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 016471 89 GLSDFVR---PD------Q-R-LNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLR 156 (389)
Q Consensus 89 g~a~~~~---~~------~-~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 156 (389)
|+|+... .. . . .....||..|+++.+..+ ..+.+-|+||++-++.+++.|..||.+.........+.+
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~ 251 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEK 251 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHH
Confidence 9998322 11 0 1 123569999999998754 689999999999999999999999977554322332222
Q ss_pred cCCCCCCC-CCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 157 ADPNFHDS-PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 157 ~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
........ .....+..+..+...+-..+...+|....+..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~ 292 (322)
T KOG1164|consen 252 DPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAE 292 (322)
T ss_pred HhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHH
Confidence 21111111 11224566777776666677777777655543
|
|
| >PTZ00184 calmodulin; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=6.1e-18 Score=139.88 Aligned_cols=138 Identities=17% Similarity=0.357 Sum_probs=116.6
Q ss_pred hcCHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhh
Q 016471 237 ALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEAL 315 (389)
Q Consensus 237 ~l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~ 315 (389)
.+++++...+...|..+|. ++|.|+.+||..++..++.. ++..++..++..+|.+++|.|+|+||+.++.........
T Consensus 4 ~~~~~~~~~~~~~F~~~D~~~~G~i~~~e~~~~l~~~~~~-~~~~~~~~~~~~~d~~~~g~i~~~ef~~~l~~~~~~~~~ 82 (149)
T PTZ00184 4 QLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQN-PTEAELQDMINEVDADGNGTIDFPEFLTLMARKMKDTDS 82 (149)
T ss_pred ccCHHHHHHHHHHHHHHcCCCCCcCCHHHHHHHHHHhCCC-CCHHHHHHHHHhcCcCCCCcCcHHHHHHHHHHhccCCcH
Confidence 4677888899999999999 99999999999999888763 567889999999999999999999999876543221111
Q ss_pred HHHHHHHHHHHHHHcccCCCcccHHHHHHHh---CC--chH-HHHHHHHHccCCCCceeHHHHHHHHcc
Q 016471 316 ERWDQIAITAFDYFEQEGNRVISVEELALEL---NL--APA-AYSLLNDCIRNSDGKLSFLGYKRFLHG 378 (389)
Q Consensus 316 ~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l---~~--~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~ 378 (389)
+..++.+|+.||.|++|+|+.+|+..++ |. ... +..++..+|.+++|.|+|+||+.+|..
T Consensus 83 ---~~~~~~~F~~~D~~~~g~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~ 148 (149)
T PTZ00184 83 ---EEEIKEAFKVFDRDGNGFISAAELRHVMTNLGEKLTDEEVDEMIREADVDGDGQINYEEFVKMMMS 148 (149)
T ss_pred ---HHHHHHHHHhhCCCCCCeEeHHHHHHHHHHHCCCCCHHHHHHHHHhcCCCCCCcCcHHHHHHHHhc
Confidence 3568999999999999999999999988 33 223 889999999999999999999988753
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.76 E-value=8.4e-19 Score=157.41 Aligned_cols=161 Identities=24% Similarity=0.390 Sum_probs=104.9
Q ss_pred eEEEEEEccCCCChHHHHH---hcCCC-CCH--HHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeecCCCCCEEEee
Q 016471 14 SFLFFTRFCEGGELLDRIL---SRGGR-YLE--EDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVID 87 (389)
Q Consensus 14 ~~~lv~E~~~gg~L~~~l~---~~~~~-l~~--~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~~~~~~~kl~D 87 (389)
+++++|+-+.+ +|.+.+. ..... ... ..-..+..|++..+++||+.|++|+||+|+|+++ +.+|.++|+|
T Consensus 113 n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll---~~~G~v~Lg~ 188 (288)
T PF14531_consen 113 NRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLL---DQDGGVFLGD 188 (288)
T ss_dssp SEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE----TTS-EEE--
T ss_pred hhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEE---cCCCCEEEcC
Confidence 45788888865 8877653 22111 111 2224466899999999999999999999999999 5789999999
Q ss_pred cCCccccCCCCCcccccccCCccccccccc---------cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcC
Q 016471 88 FGLSDFVRPDQRLNDIVGSAYYVAPEVLHR---------SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRAD 158 (389)
Q Consensus 88 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 158 (389)
|+.....+. .......+..|.|||.... .++.+.|.|++|+++|.+++|..||...........
T Consensus 189 F~~~~r~g~--~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~----- 261 (288)
T PF14531_consen 189 FSSLVRAGT--RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW----- 261 (288)
T ss_dssp GGGEEETTE--EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG-----
T ss_pred hHHHeecCc--eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc-----
Confidence 987655432 2221344577999997632 378889999999999999999999976544322211
Q ss_pred CCCCCCCCCCCCHHHHHHHHhhhccCcCCC
Q 016471 159 PNFHDSPWPSVSPEAKDFVRRLLNKDHRKR 188 (389)
Q Consensus 159 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 188 (389)
.+... ..++..++.||..+|+.+|.+|
T Consensus 262 -~f~~C--~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 262 -DFSRC--RDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp -GGTTS--S---HHHHHHHHHHT-SSGGGS
T ss_pred -cchhc--CCcCHHHHHHHHHHccCCcccC
Confidence 12222 2578999999999999999987
|
|
| >KOG0034 consensus Ca2+/calmodulin-dependent protein phosphatase (calcineurin subunit B), EF-Hand superfamily protein [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=2e-17 Score=138.82 Aligned_cols=139 Identities=19% Similarity=0.258 Sum_probs=114.0
Q ss_pred HhcCHHHHHHHHHHhhhcCC--CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcc-eeHHHHHHHHhchhHH
Q 016471 236 KALTEEELVYLRAQFMLLEP--KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQK-LAYEEFCAAATSVYQL 312 (389)
Q Consensus 236 ~~l~~ee~~~l~~~F~~~D~--~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~-i~~~eF~~~~~~~~~~ 312 (389)
..++..|+..+...|..+|. ++|.++++||..+.. ...+.+ .++|++.++.+++|. |+|++|+..+......
T Consensus 25 ~~fs~~EI~~L~~rF~kl~~~~~~g~lt~eef~~i~~-~~~Np~----~~rI~~~f~~~~~~~~v~F~~Fv~~ls~f~~~ 99 (187)
T KOG0034|consen 25 TQFSANEIERLYERFKKLDRNNGDGYLTKEEFLSIPE-LALNPL----ADRIIDRFDTDGNGDPVDFEEFVRLLSVFSPK 99 (187)
T ss_pred cccCHHHHHHHHHHHHHhccccccCccCHHHHHHHHH-HhcCcH----HHHHHHHHhccCCCCccCHHHHHHHHhhhcCC
Confidence 34788899999999999998 689999999999773 322212 679999999998888 9999999876654333
Q ss_pred HhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHh----C--Cc--hH-----HHHHHHHHccCCCCceeHHHHHHHHccc
Q 016471 313 EALERWDQIAITAFDYFEQEGNRVISVEELALEL----N--LA--PA-----AYSLLNDCIRNSDGKLSFLGYKRFLHGV 379 (389)
Q Consensus 313 ~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l----~--~~--~~-----~~~~~~~~d~~~~g~i~~~ef~~~~~~~ 379 (389)
... +++++-||++||.+++|+|+.+||++++ + .. .+ ++.++.++|.|+||+|+|+||++.+.+-
T Consensus 100 ~~~---~~Kl~faF~vYD~~~~G~I~reel~~iv~~~~~~~~~~~~e~~~~i~d~t~~e~D~d~DG~IsfeEf~~~v~~~ 176 (187)
T KOG0034|consen 100 ASK---REKLRFAFRVYDLDGDGFISREELKQILRMMVGENDDMSDEQLEDIVDKTFEEADTDGDGKISFEEFCKVVEKQ 176 (187)
T ss_pred ccH---HHHHHHHHHHhcCCCCCcCcHHHHHHHHHHHHccCCcchHHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHcC
Confidence 222 4589999999999999999999999988 2 22 22 8889999999999999999999999887
Q ss_pred cCC
Q 016471 380 TVR 382 (389)
Q Consensus 380 ~~~ 382 (389)
|..
T Consensus 177 P~~ 179 (187)
T KOG0034|consen 177 PDL 179 (187)
T ss_pred ccH
Confidence 643
|
|
| >KOG0031 consensus Myosin regulatory light chain, EF-Hand protein superfamily [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.74 E-value=5.6e-17 Score=126.95 Aligned_cols=140 Identities=11% Similarity=0.246 Sum_probs=122.5
Q ss_pred HHHHHhcCHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchh
Q 016471 232 KALSKALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVY 310 (389)
Q Consensus 232 ~~i~~~l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~ 310 (389)
..+...+.+.+++.++++|..+|. ++|.|++++|+..|.++|.. +++++++.|+... .|.|+|.-||.+.-..-
T Consensus 20 SnvFamf~q~QIqEfKEAF~~mDqnrDG~IdkeDL~d~~aSlGk~-~~d~elDaM~~Ea----~gPINft~FLTmfGekL 94 (171)
T KOG0031|consen 20 SNVFAMFDQSQIQEFKEAFNLMDQNRDGFIDKEDLRDMLASLGKI-ASDEELDAMMKEA----PGPINFTVFLTMFGEKL 94 (171)
T ss_pred chHHHHhhHHHHHHHHHHHHHHhccCCCcccHHHHHHHHHHcCCC-CCHHHHHHHHHhC----CCCeeHHHHHHHHHHHh
Confidence 556678899999999999999999 99999999999999999986 8999999999886 78999999998655443
Q ss_pred HHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHh-----CCchH-HHHHHHHHccCCCCceeHHHHHHHHccc
Q 016471 311 QLEALERWDQIAITAFDYFEQEGNRVISVEELALEL-----NLAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHGV 379 (389)
Q Consensus 311 ~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l-----~~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~ 379 (389)
..... ++.+..||+.||.+++|.|..+.|+++| ...++ |++|+..+-.|..|.|+|.+|+.+|+..
T Consensus 95 ~gtdp---e~~I~~AF~~FD~~~~G~I~~d~lre~Ltt~gDr~~~eEV~~m~r~~p~d~~G~~dy~~~~~~ithG 166 (171)
T KOG0031|consen 95 NGTDP---EEVILNAFKTFDDEGSGKIDEDYLRELLTTMGDRFTDEEVDEMYREAPIDKKGNFDYKAFTYIITHG 166 (171)
T ss_pred cCCCH---HHHHHHHHHhcCccCCCccCHHHHHHHHHHhcccCCHHHHHHHHHhCCcccCCceeHHHHHHHHHcc
Confidence 33332 6789999999999999999999999999 23444 9999999999999999999999999843
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=5.2e-18 Score=158.74 Aligned_cols=105 Identities=23% Similarity=0.265 Sum_probs=83.6
Q ss_pred CCCccccc-eeecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCC-CCCcEEEeecC
Q 016471 1 MYHQKLQH-LFYSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDL-KPENFLFTTRE 78 (389)
Q Consensus 1 l~Hpni~~-~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdl-kp~Nill~~~~ 78 (389)
|.|||++. ++.....|+|||||+|++|.. + .. .. ...++.|++.||.|||++||+|||| ||+|||+ +
T Consensus 78 L~h~~iv~~l~~~~~~~LVmE~~~G~~L~~-~-~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv---~ 146 (365)
T PRK09188 78 VRGIGVVPQLLATGKDGLVRGWTEGVPLHL-A-RP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLM---G 146 (365)
T ss_pred ccCCCCCcEEEEcCCcEEEEEccCCCCHHH-h-Cc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEE---c
Confidence 57999984 666678999999999999963 2 11 11 1468899999999999999999999 9999999 4
Q ss_pred CCCCEEEeecCCccccCCCC---------CcccccccCCcccccccc
Q 016471 79 EDAPLKVIDFGLSDFVRPDQ---------RLNDIVGSAYYVAPEVLH 116 (389)
Q Consensus 79 ~~~~~kl~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~ 116 (389)
.++.+||+|||+|....... ...+..+++.|.|||.+.
T Consensus 147 ~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 147 PDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred CCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 56789999999998664332 123457888999999984
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=4.3e-19 Score=176.59 Aligned_cols=197 Identities=28% Similarity=0.495 Sum_probs=162.5
Q ss_pred Ccccccee----ecCeEEEEEEccCCCChHHHH-HhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCCEecCCCCCcEEEee
Q 016471 3 HQKLQHLF----YSNSFLFFTRFCEGGELLDRI-LSRGGRYLEEDAKTIVEKILNIVAFCH-LQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 3 Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l-~~~~~~l~~~~~~~i~~qi~~~L~~lH-~~~i~Hrdlkp~Nill~~ 76 (389)
|+|+++++ +....+++++|..||++++.+ .......+...+..++.|+..++.|+| ..++.|||+||+|.+++
T Consensus 80 h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~- 158 (601)
T KOG0590|consen 80 HSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLD- 158 (601)
T ss_pred cccccccCCccCCCcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhc-
Confidence 99999999 457899999999999999987 333226778889999999999999999 99999999999999994
Q ss_pred cCCCC-CEEEeecCCccccCC-CC---Ccccccc-cCCccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChh
Q 016471 77 REEDA-PLKVIDFGLSDFVRP-DQ---RLNDIVG-SAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTES 148 (389)
Q Consensus 77 ~~~~~-~~kl~Dfg~a~~~~~-~~---~~~~~~g-t~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 148 (389)
.++ .++++|||+|..... .. .....+| ++.|+|||...+ ...+..|+||.|+++.-+++|..|+......
T Consensus 159 --~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~ 236 (601)
T KOG0590|consen 159 --ESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRK 236 (601)
T ss_pred --cCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccc
Confidence 555 899999999987755 22 2344678 999999998865 4678899999999999999999998665443
Q ss_pred HHH-HHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCC
Q 016471 149 GIF-RSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 202 (389)
Q Consensus 149 ~~~-~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~ 202 (389)
... .........+...+|..++....+++.+++..+|..|.+.+++..+||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 237 DGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred cccceeecccccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 321 222222233345677899999999999999999999999999999999987
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.3e-17 Score=138.27 Aligned_cols=134 Identities=19% Similarity=0.249 Sum_probs=99.9
Q ss_pred CccccceeecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCC-CCCcEEEeecCCCC
Q 016471 3 HQKLQHLFYSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDL-KPENFLFTTREEDA 81 (389)
Q Consensus 3 Hpni~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdl-kp~Nill~~~~~~~ 81 (389)
|+++..++.-+..|++|||+.|++|..... .. ...++.|++.+|+++|++||+|||| ||+|||+ +.++
T Consensus 61 ~~~vP~ll~~~~~~lvmeyI~G~~L~~~~~-------~~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv---~~~g 129 (218)
T PRK12274 61 LPRTPRLLHWDGRHLDRSYLAGAAMYQRPP-------RG-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLV---QEDG 129 (218)
T ss_pred CCCCCEEEEEcCEEEEEeeecCccHHhhhh-------hh-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEE---cCCC
Confidence 466777764466899999999998865321 11 2357889999999999999999999 7999999 4567
Q ss_pred CEEEeecCCccccCCCCCc--------------ccccccCCccccccc--cccCC-CchhHHHHHHHHHHHHhCCCCCCC
Q 016471 82 PLKVIDFGLSDFVRPDQRL--------------NDIVGSAYYVAPEVL--HRSYN-VEGDMWSIGVITYILLCGSRPFWA 144 (389)
Q Consensus 82 ~~kl~Dfg~a~~~~~~~~~--------------~~~~gt~~y~aPE~~--~~~~~-~~~DiwslG~il~~ll~g~~pf~~ 144 (389)
.++|+|||+|......... .-...++.|++|+-- ....+ ...++++.|.-+|.++|+..|+++
T Consensus 130 ~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 130 SPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred CEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 8999999999865543321 012357778888743 22333 556888899999999999999876
Q ss_pred CCh
Q 016471 145 RTE 147 (389)
Q Consensus 145 ~~~ 147 (389)
...
T Consensus 210 ~~~ 212 (218)
T PRK12274 210 DNE 212 (218)
T ss_pred cCC
Confidence 543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.5e-17 Score=139.15 Aligned_cols=183 Identities=17% Similarity=0.202 Sum_probs=138.8
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCCCcEEE
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQG--VVHRDLKPENFLF 74 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~--i~Hrdlkp~Nill 74 (389)
.||||.... ...++.++..|++.|+|+..+.... -..+..++.+++.++++|+.|||+.. |.--.|....+++
T Consensus 245 shpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmi 324 (448)
T KOG0195|consen 245 SHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMI 324 (448)
T ss_pred cCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEe
Confidence 599999988 3467899999999999999886442 23667899999999999999999974 4444788888998
Q ss_pred eecCCCCCEEE--eecCCccccCCCCCcccccccCCcccccccccc----CCCchhHHHHHHHHHHHHhCCCCCCCCChh
Q 016471 75 TTREEDAPLKV--IDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRS----YNVEGDMWSIGVITYILLCGSRPFWARTES 148 (389)
Q Consensus 75 ~~~~~~~~~kl--~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 148 (389)
|++...+| +|--++.. .....-.|.|++||.+++. --.++|+|||.+++||+.|...||..-++-
T Consensus 325 ---dedltarismad~kfsfq------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspm 395 (448)
T KOG0195|consen 325 ---DEDLTARISMADTKFSFQ------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPM 395 (448)
T ss_pred ---cchhhhheecccceeeee------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCch
Confidence 55555554 34332221 1234457899999999653 236789999999999999999999888877
Q ss_pred HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHh
Q 016471 149 GIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQAL 195 (389)
Q Consensus 149 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l 195 (389)
+.--+|.-....... .|.+++....|+.-|++.||.+||..+.+.
T Consensus 396 ecgmkialeglrv~i--ppgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 396 ECGMKIALEGLRVHI--PPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred hhhhhhhhccccccC--CCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 765555433322222 267999999999999999999999876553
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=2e-16 Score=134.30 Aligned_cols=186 Identities=18% Similarity=0.259 Sum_probs=138.0
Q ss_pred Cccccceee-cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeecCCCC
Q 016471 3 HQKLQHLFY-SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDA 81 (389)
Q Consensus 3 Hpni~~~~~-~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~~~~~ 81 (389)
-|+|.++.. ..+-.+||+.. |-+|.+.+.-+..+++-..+.-++-|++.-++|+|.++++||||||+|+|.+-.-...
T Consensus 73 iP~i~~y~~e~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~ 151 (341)
T KOG1163|consen 73 IPHIRHYGTEKDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCN 151 (341)
T ss_pred Cchhhhhccccccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccc
Confidence 367777774 45668999998 5699888876677899999999999999999999999999999999999996544456
Q ss_pred CEEEeecCCccccCCCC--------CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCh---hH
Q 016471 82 PLKVIDFGLSDFVRPDQ--------RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTE---SG 149 (389)
Q Consensus 82 ~~kl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~ 149 (389)
.+.++|||+|+...... ......||..|.+--... ...+..-|+=|+|.++.+...|..||++-.. .+
T Consensus 152 kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~Q 231 (341)
T KOG1163|consen 152 KLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQ 231 (341)
T ss_pred eEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHH
Confidence 79999999998764321 123457899998866543 2467788999999999999999999998544 45
Q ss_pred HHHHHHhcCCCCCCCC-CCCCCHHHHHHHHhhhccCcCCCC
Q 016471 150 IFRSVLRADPNFHDSP-WPSVSPEAKDFVRRLLNKDHRKRM 189 (389)
Q Consensus 150 ~~~~i~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~R~ 189 (389)
.+.+|.......+... -..+|.++.-.+.-|-..--.+-|
T Consensus 232 KyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~P 272 (341)
T KOG1163|consen 232 KYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKP 272 (341)
T ss_pred HHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCC
Confidence 5666665544433221 134667777777666444333334
|
|
| >KOG0037 consensus Ca2+-binding protein, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.5e-16 Score=131.28 Aligned_cols=135 Identities=15% Similarity=0.208 Sum_probs=117.4
Q ss_pred HHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHH
Q 016471 243 LVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQI 321 (389)
Q Consensus 243 ~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~ 321 (389)
...+...|...|. +.|.|+.+|++++|.......++.+.+.-|+..+|.+++|+|+|+||.+.+-... .
T Consensus 56 ~~~~~~~f~~vD~d~sg~i~~~eLq~aLsn~~~~~Fs~~TcrlmI~mfd~~~~G~i~f~EF~~Lw~~i~----------~ 125 (221)
T KOG0037|consen 56 FPQLAGWFQSVDRDRSGRILAKELQQALSNGTWSPFSIETCRLMISMFDRDNSGTIGFKEFKALWKYIN----------Q 125 (221)
T ss_pred cHHHHHHHHhhCccccccccHHHHHHHhhcCCCCCCCHHHHHHHHHHhcCCCCCccCHHHHHHHHHHHH----------H
Confidence 3456788999999 9999999999999987766678999999999999999999999999999655442 2
Q ss_pred HHHHHHHHcccCCCcccHHHHHHHh---C--CchH-HHHHHHHHccCCCCceeHHHHHHHHccccCCCcccc
Q 016471 322 AITAFDYFEQEGNRVISVEELALEL---N--LAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVTVRSSNTR 387 (389)
Q Consensus 322 l~~aF~~~D~d~~G~I~~~el~~~l---~--~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~~~~~ 387 (389)
.+.+|+.||+|++|.|+..||+.+| | +++. .+.+++.+|..++|.|.|++|+..+-.+.+.+..+|
T Consensus 126 Wr~vF~~~D~D~SG~I~~sEL~~Al~~~Gy~Lspq~~~~lv~kyd~~~~g~i~FD~FI~ccv~L~~lt~~Fr 197 (221)
T KOG0037|consen 126 WRNVFRTYDRDRSGTIDSSELRQALTQLGYRLSPQFYNLLVRKYDRFGGGRIDFDDFIQCCVVLQRLTEAFR 197 (221)
T ss_pred HHHHHHhcccCCCCcccHHHHHHHHHHcCcCCCHHHHHHHHHHhccccCCceeHHHHHHHHHHHHHHHHHHH
Confidence 6889999999999999999999999 3 4566 778899999887999999999999988887776655
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.8e-15 Score=134.20 Aligned_cols=145 Identities=21% Similarity=0.373 Sum_probs=117.6
Q ss_pred ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeecC--CCCCEEEeec
Q 016471 11 YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE--EDAPLKVIDF 88 (389)
Q Consensus 11 ~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~~--~~~~~kl~Df 88 (389)
++.+-.||||++ |-+|.|.+--++.+|+...++-++.|++.-++|+|++.+|+|||||+|+||+.-+ +...|.++||
T Consensus 95 eG~~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDF 173 (449)
T KOG1165|consen 95 EGKYNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDF 173 (449)
T ss_pred ccchhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEec
Confidence 456678999998 5699998877888999999999999999999999999999999999999996422 3356899999
Q ss_pred CCccccCCCC--------CcccccccCCccccccc-cccCCCchhHHHHHHHHHHHHhCCCCCCCC---ChhHHHHHHHh
Q 016471 89 GLSDFVRPDQ--------RLNDIVGSAYYVAPEVL-HRSYNVEGDMWSIGVITYILLCGSRPFWAR---TESGIFRSVLR 156 (389)
Q Consensus 89 g~a~~~~~~~--------~~~~~~gt~~y~aPE~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~~~~~i~~ 156 (389)
|+|+...... ......||..||+=-.. .+..+..-|+=|||-++.+.|.|..||+|- +..+.+++|-.
T Consensus 174 GmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe 253 (449)
T KOG1165|consen 174 GMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGE 253 (449)
T ss_pred cchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcc
Confidence 9998764322 12345799999997754 456888999999999999999999999884 34455555543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.8e-15 Score=130.15 Aligned_cols=75 Identities=21% Similarity=0.268 Sum_probs=65.3
Q ss_pred EEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH-HHCCCEecCCCCCcEEEeecCCCCCEEEeecCCccc
Q 016471 15 FLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFC-HLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 93 (389)
Q Consensus 15 ~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~l-H~~~i~Hrdlkp~Nill~~~~~~~~~kl~Dfg~a~~ 93 (389)
.+||||||+|+++.....+. +.+++..+..++.|++.+|.|+ |+.||+||||||+||+++ ++.++|+|||+|..
T Consensus 92 ~~iVmE~i~g~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~----~~~v~LiDFG~a~~ 166 (190)
T cd05147 92 HVLVMEFIGDDGWAAPRLKD-APLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH----DGKLYIIDVSQSVE 166 (190)
T ss_pred CEEEEEEeCCCCCcchhhhc-CCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE----CCcEEEEEcccccc
Confidence 38999999998876554443 6799999999999999999999 799999999999999994 36799999999875
Q ss_pred c
Q 016471 94 V 94 (389)
Q Consensus 94 ~ 94 (389)
.
T Consensus 167 ~ 167 (190)
T cd05147 167 H 167 (190)
T ss_pred C
Confidence 4
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0030 consensus Myosin essential light chain, EF-Hand protein superfamily [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.61 E-value=7e-15 Score=113.31 Aligned_cols=137 Identities=20% Similarity=0.315 Sum_probs=113.1
Q ss_pred cCHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCC--CCcceeHHHHHHHHhchhHHHh
Q 016471 238 LTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPL--SDQKLAYEEFCAAATSVYQLEA 314 (389)
Q Consensus 238 l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~--~~g~i~~~eF~~~~~~~~~~~~ 314 (389)
++.++...++++|..+|. .+|+|+......+|+.+|.. +++.++.+.+...+++ +-..|+|++|+..+....+...
T Consensus 5 ~~~d~~~e~ke~F~lfD~~gD~ki~~~q~gdvlRalG~n-PT~aeV~k~l~~~~~~~~~~~rl~FE~fLpm~q~vaknk~ 83 (152)
T KOG0030|consen 5 FTPDQMEEFKEAFLLFDRTGDGKISGSQVGDVLRALGQN-PTNAEVLKVLGQPKRREMNVKRLDFEEFLPMYQQVAKNKD 83 (152)
T ss_pred cCcchHHHHHHHHHHHhccCcccccHHHHHHHHHHhcCC-CcHHHHHHHHcCcccchhhhhhhhHHHHHHHHHHHHhccc
Confidence 456677889999999999 99999999999999999984 8999999999999877 5579999999987665444322
Q ss_pred hHHHHHHHHHHHHHHcccCCCcccHHHHHHHh---C--CchH-HHHHHHHHccCCCCceeHHHHHHHHc
Q 016471 315 LERWDQIAITAFDYFEQEGNRVISVEELALEL---N--LAPA-AYSLLNDCIRNSDGKLSFLGYKRFLH 377 (389)
Q Consensus 315 ~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l---~--~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~ 377 (389)
.-+ -+.+.+.++.||++++|.|...||+++| | +..+ +++++... .|++|.|+|+.|++.+-
T Consensus 84 q~t-~edfvegLrvFDkeg~G~i~~aeLRhvLttlGekl~eeEVe~Llag~-eD~nG~i~YE~fVk~i~ 150 (152)
T KOG0030|consen 84 QGT-YEDFVEGLRVFDKEGNGTIMGAELRHVLTTLGEKLTEEEVEELLAGQ-EDSNGCINYEAFVKHIM 150 (152)
T ss_pred cCc-HHHHHHHHHhhcccCCcceeHHHHHHHHHHHHhhccHHHHHHHHccc-cccCCcCcHHHHHHHHh
Confidence 111 3567889999999999999999999999 2 3333 88888875 57899999999998764
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.60 E-value=7.1e-16 Score=134.54 Aligned_cols=112 Identities=21% Similarity=0.341 Sum_probs=81.3
Q ss_pred CCccccceee------------cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCC
Q 016471 2 YHQKLQHLFY------------SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKP 69 (389)
Q Consensus 2 ~Hpni~~~~~------------~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp 69 (389)
.||+|..... +...++||||++|.+|.+.. .+++ ....+++.+|..||+.|++|||+||
T Consensus 93 ~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~-----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp 163 (232)
T PRK10359 93 RSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP-----EISE----DVKAKIKASIESLHQHGMVSGDPHK 163 (232)
T ss_pred HHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhh-----hccH----HHHHHHHHHHHHHHHcCCccCCCCh
Confidence 4666666551 24589999999999997752 2333 2456999999999999999999999
Q ss_pred CcEEEeecCCCCCEEEeecCCccccCCCCCcccccccCCccccccccccCCCchhHHHHHHHHHHHH
Q 016471 70 ENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILL 136 (389)
Q Consensus 70 ~Nill~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll 136 (389)
+||+++ .++ ++|+|||............. =++.+.|+.++|+||||+++....
T Consensus 164 ~Nili~---~~g-i~liDfg~~~~~~e~~a~d~----------~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 164 GNFIVS---KNG-LRIIDLSGKRCTAQRKAKDR----------IDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred HHEEEe---CCC-EEEEECCCcccccchhhHHH----------HHHHhHhcccccccceeEeehHHH
Confidence 999995 455 99999997765432211100 022456778999999999887554
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.59 E-value=3.3e-15 Score=128.83 Aligned_cols=77 Identities=21% Similarity=0.232 Sum_probs=66.1
Q ss_pred eEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCEecCCCCCcEEEeecCCCCCEEEeecCCcc
Q 016471 14 SFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHL-QGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 92 (389)
Q Consensus 14 ~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~-~~i~Hrdlkp~Nill~~~~~~~~~kl~Dfg~a~ 92 (389)
..|+||||++|+++....... ..+++..+..++.|++.+|.++|+ +||+||||||+||+++ ++.++|+|||++.
T Consensus 91 ~~~lVmE~~~g~~~~~~~l~~-~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~----~~~~~liDFG~a~ 165 (190)
T cd05145 91 KNVLVMEFIGDDGSPAPRLKD-VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH----DGKPYIIDVSQAV 165 (190)
T ss_pred CCEEEEEEecCCCchhhhhhh-ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE----CCCEEEEEcccce
Confidence 358999999998665543333 578899999999999999999999 9999999999999994 5789999999987
Q ss_pred ccC
Q 016471 93 FVR 95 (389)
Q Consensus 93 ~~~ 95 (389)
...
T Consensus 166 ~~~ 168 (190)
T cd05145 166 ELD 168 (190)
T ss_pred ecC
Confidence 654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.9e-15 Score=151.75 Aligned_cols=199 Identities=29% Similarity=0.477 Sum_probs=163.3
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
+||-++..+ .....++|++|..||+|...+.+- +..+++-++.++..+..+++|||+..+.|||++|.|++.
T Consensus 862 ~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~-~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~--- 937 (1205)
T KOG0606|consen 862 RSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNS-GCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLI--- 937 (1205)
T ss_pred CCCceecccCCCCCCCCcchhhHHhccCCchhhhhcC-CCcccccccchhHHHHhhhhccccchhhcccccccchhh---
Confidence 356666666 347899999999999999877554 678888899999999999999999999999999999999
Q ss_pred CCCCCEEEeecCCccccC---------------------CC-----------CCcccccccCCcccccccc-ccCCCchh
Q 016471 78 EEDAPLKVIDFGLSDFVR---------------------PD-----------QRLNDIVGSAYYVAPEVLH-RSYNVEGD 124 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~---------------------~~-----------~~~~~~~gt~~y~aPE~~~-~~~~~~~D 124 (389)
..++..+++|||...... .. .......||+.|.+||.+. ......+|
T Consensus 938 ~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad 1017 (1205)
T KOG0606|consen 938 AYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAAD 1017 (1205)
T ss_pred cccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcch
Confidence 578899999998432110 00 0012346899999999875 46788899
Q ss_pred HHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHH---HHhCCCCCC
Q 016471 125 MWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAA---QALTHPWLH 201 (389)
Q Consensus 125 iwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~---e~l~h~~~~ 201 (389)
+|+.|+++++.++|.+||......+++.+|.+....++..+ -..+..+++++.+++..+|.+|..+. +.-.|+||+
T Consensus 1018 ~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~g~-~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~ 1096 (1205)
T KOG0606|consen 1018 WWSSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPWPEGP-EEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQ 1096 (1205)
T ss_pred hhhhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCCCCCc-cccChhhhhhhhhhhccCchhccCcccccccccCCccC
Confidence 99999999999999999999999999998887766555433 35789999999999999999999887 899999998
Q ss_pred CCCC
Q 016471 202 DENR 205 (389)
Q Consensus 202 ~~~~ 205 (389)
..++
T Consensus 1097 ~~~~ 1100 (1205)
T KOG0606|consen 1097 DVDW 1100 (1205)
T ss_pred CCCc
Confidence 7654
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.3e-14 Score=148.14 Aligned_cols=129 Identities=22% Similarity=0.361 Sum_probs=111.4
Q ss_pred ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee----cCCCCCEEEe
Q 016471 11 YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT----REEDAPLKVI 86 (389)
Q Consensus 11 ~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~----~~~~~~~kl~ 86 (389)
+.+..++|+||.+.|+|.+++. ..+.+++.-+..+..|++..++.||..+|||+||||+|++|.. ..++..++|+
T Consensus 765 ~~~~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 765 FQNASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred cCCcceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEE
Confidence 4577899999999999999775 5578999999999999999999999999999999999999963 2235569999
Q ss_pred ecCCcccc---CCCCCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCC
Q 016471 87 DFGLSDFV---RPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSR 140 (389)
Q Consensus 87 Dfg~a~~~---~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~ 140 (389)
|||.+..+ ..+.+....++|-.+-++|+..+ ++++++|.|.++-++|-||.|+.
T Consensus 844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 99998654 33446667788999999999864 79999999999999999999864
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.54 E-value=2.4e-14 Score=124.41 Aligned_cols=86 Identities=16% Similarity=0.154 Sum_probs=66.8
Q ss_pred CCccccceee---c----CeEE-EEEEc--cCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHH-HHHHHCCCEecCCCCC
Q 016471 2 YHQKLQHLFY---S----NSFL-FFTRF--CEGGELLDRILSRGGRYLEEDAKTIVEKILNIV-AFCHLQGVVHRDLKPE 70 (389)
Q Consensus 2 ~Hpni~~~~~---~----~~~~-lv~E~--~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L-~~lH~~~i~Hrdlkp~ 70 (389)
.||||+++|. . ..++ +|||| +.+|+|.+++.+ +.+++. ..++.|++.++ +|||+++|+||||||+
T Consensus 59 ~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~--~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~ 134 (210)
T PRK10345 59 DWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQ--CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQ 134 (210)
T ss_pred CCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHc--ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHH
Confidence 5899999992 2 2334 78999 668999998854 356666 35688888887 9999999999999999
Q ss_pred cEEEeecC-CCCCEEEeecCCc
Q 016471 71 NFLFTTRE-EDAPLKVIDFGLS 91 (389)
Q Consensus 71 Nill~~~~-~~~~~kl~Dfg~a 91 (389)
|||++..+ .+..++|+|++.+
T Consensus 135 NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 135 NILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred HEEEeccCCCCCcEEEEECCCC
Confidence 99997433 3458999995433
|
|
| >KOG0036 consensus Predicted mitochondrial carrier protein [Nucleotide transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.6e-13 Score=124.38 Aligned_cols=134 Identities=16% Similarity=0.223 Sum_probs=116.5
Q ss_pred cCHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhH
Q 016471 238 LTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALE 316 (389)
Q Consensus 238 l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~ 316 (389)
..++...+++..|+.+|. ++|.++..++.+.|..+..++...+-+..++..+|.|.||.+||+||...+.+.
T Consensus 8 ~~~er~~r~~~lf~~lD~~~~g~~d~~~l~k~~~~l~~~~~~~~~~~~l~~~~d~~~dg~vDy~eF~~Y~~~~------- 80 (463)
T KOG0036|consen 8 TDEERDIRIRCLFKELDSKNDGQVDLDQLEKGLEKLDHPKPNYEAAKMLFSAMDANRDGRVDYSEFKRYLDNK------- 80 (463)
T ss_pred CcHHHHHHHHHHHHHhccCCCCceeHHHHHHHHHhcCCCCCchHHHHHHHHhcccCcCCcccHHHHHHHHHHh-------
Confidence 345566678999999999 999999999999999998766677778899999999999999999999865544
Q ss_pred HHHHHHHHHHHHHcccCCCcccHHHHHHHh---CC--chH-HHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 317 RWDQIAITAFDYFEQEGNRVISVEELALEL---NL--APA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 317 ~~~~~l~~aF~~~D~d~~G~I~~~el~~~l---~~--~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
|.++.+.|...|.|+||.|+..|+.+.| |. +.+ +.++++.+|.+++++|+++||.+.+.-.+
T Consensus 81 --E~~l~~~F~~iD~~hdG~i~~~Ei~~~l~~~gi~l~de~~~k~~e~~d~~g~~~I~~~e~rd~~ll~p 148 (463)
T KOG0036|consen 81 --ELELYRIFQSIDLEHDGKIDPNEIWRYLKDLGIQLSDEKAAKFFEHMDKDGKATIDLEEWRDHLLLYP 148 (463)
T ss_pred --HHHHHHHHhhhccccCCccCHHHHHHHHHHhCCccCHHHHHHHHHHhccCCCeeeccHHHHhhhhcCC
Confidence 3458899999999999999999999988 33 333 88999999999999999999999887655
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.41 E-value=5.2e-13 Score=118.78 Aligned_cols=81 Identities=23% Similarity=0.219 Sum_probs=67.0
Q ss_pred eeecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC-CEecCCCCCcEEEeecCCCCCEEEee
Q 016471 9 LFYSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQG-VVHRDLKPENFLFTTREEDAPLKVID 87 (389)
Q Consensus 9 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~-i~Hrdlkp~Nill~~~~~~~~~kl~D 87 (389)
.+.....++||||+.|++|....... ..+.+..+..++.||+.+|.+||++| ++||||||+||++. ++.++|+|
T Consensus 117 ~~~~~~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~----~~~i~LiD 191 (237)
T smart00090 117 PIAWRRNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH----DGKVVIID 191 (237)
T ss_pred eeEecCceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE----CCCEEEEE
Confidence 33334568999999998887654333 45677778899999999999999999 99999999999994 57899999
Q ss_pred cCCcccc
Q 016471 88 FGLSDFV 94 (389)
Q Consensus 88 fg~a~~~ 94 (389)
||.|...
T Consensus 192 Fg~a~~~ 198 (237)
T smart00090 192 VSQSVEL 198 (237)
T ss_pred Chhhhcc
Confidence 9988754
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.40 E-value=6.2e-13 Score=118.13 Aligned_cols=191 Identities=14% Similarity=0.205 Sum_probs=132.8
Q ss_pred CCcccccee--e-------cCeEEEEEEccCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC--CCEecCC
Q 016471 2 YHQKLQHLF--Y-------SNSFLFFTRFCEGGELLDRILS---RGGRYLEEDAKTIVEKILNIVAFCHLQ--GVVHRDL 67 (389)
Q Consensus 2 ~Hpni~~~~--~-------~~~~~lv~E~~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~~--~i~Hrdl 67 (389)
-|.||+++. + ...+.+++||++.|++..++++ +...+......+|+-||+.||.|||+. -|+|+++
T Consensus 125 vHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppiihgnl 204 (458)
T KOG1266|consen 125 VHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNL 204 (458)
T ss_pred HHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCc
Confidence 377888766 1 2347899999999999998864 335688899999999999999999987 5999999
Q ss_pred CCCcEEEeecCCCCCEEEeecCCccccCCCC------CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCC
Q 016471 68 KPENFLFTTREEDAPLKVIDFGLSDFVRPDQ------RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSR 140 (389)
Q Consensus 68 kp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~ 140 (389)
..+.|++. .++-+|+.--.... ..+.. ....-.+-++|.|||.=. ...+.++|||++|+-..+|..+..
T Consensus 205 Tc~tifiq---~ngLIkig~~ap~s-~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEi 280 (458)
T KOG1266|consen 205 TCDTIFIQ---HNGLIKIGSVAPDS-THPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEI 280 (458)
T ss_pred chhheeec---CCceEEecccCccc-cchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhee
Confidence 99999995 56777765322111 11100 111123567899999743 356778999999999999988764
Q ss_pred C-CCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCC
Q 016471 141 P-FWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 141 p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~ 203 (389)
- -.+.+....-..+.+..... -..--++++.+|++..|..||++.+++.||.+-+.
T Consensus 281 q~tnseS~~~~ee~ia~~i~~l-------en~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeV 337 (458)
T KOG1266|consen 281 QSTNSESKVEVEENIANVIIGL-------ENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEV 337 (458)
T ss_pred ccCCCcceeehhhhhhhheeec-------cCccccCcCcccccCCCCCCcchhhhhcCceeeec
Confidence 3 22222222222222111111 12234678999999999999999999999977543
|
|
| >KOG0038 consensus Ca2+-binding kinase interacting protein (KIP) (EF-Hand protein superfamily) [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.39 E-value=7.5e-13 Score=102.72 Aligned_cols=99 Identities=20% Similarity=0.321 Sum_probs=83.9
Q ss_pred HHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHh------CCchH-----
Q 016471 283 FEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALEL------NLAPA----- 351 (389)
Q Consensus 283 ~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l------~~~~~----- 351 (389)
.+|-+.+..+|.|-++|++|+.+.+.......+ +-++..||+.||-|+|++|..++|.+.+ ++++.
T Consensus 74 ~ri~e~FSeDG~GnlsfddFlDmfSV~sE~APr---dlK~~YAFkIYDfd~D~~i~~~DL~~~l~~lTr~eLs~eEv~~i 150 (189)
T KOG0038|consen 74 RRICEVFSEDGRGNLSFDDFLDMFSVFSEMAPR---DLKAKYAFKIYDFDGDEFIGHDDLEKTLTSLTRDELSDEEVELI 150 (189)
T ss_pred HHHHHHhccCCCCcccHHHHHHHHHHHHhhChH---HhhhhheeEEeecCCCCcccHHHHHHHHHHHhhccCCHHHHHHH
Confidence 367777888999999999999988777665554 4568899999999999999999999988 44444
Q ss_pred HHHHHHHHccCCCCceeHHHHHHHHccccCCCc
Q 016471 352 AYSLLNDCIRNSDGKLSFLGYKRFLHGVTVRSS 384 (389)
Q Consensus 352 ~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~~ 384 (389)
++++++++|.|+||++++.||.+++.+++---+
T Consensus 151 ~ekvieEAD~DgDgkl~~~eFe~~i~raPDFls 183 (189)
T KOG0038|consen 151 CEKVIEEADLDGDGKLSFAEFEHVILRAPDFLS 183 (189)
T ss_pred HHHHHHHhcCCCCCcccHHHHHHHHHhCcchHh
Confidence 888999999999999999999999998874333
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.36 E-value=8.6e-13 Score=126.40 Aligned_cols=194 Identities=20% Similarity=0.238 Sum_probs=149.1
Q ss_pred Ccccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHH----HHHHHHHCCCEecCCCCCcEEE
Q 016471 3 HQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILN----IVAFCHLQGVVHRDLKPENFLF 74 (389)
Q Consensus 3 Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~----~L~~lH~~~i~Hrdlkp~Nill 74 (389)
|+|.+..+ ..+..|+-+|+|. .+|..+.......+++..++..+.+... ||..+|+.+++|-|+||.||+.
T Consensus 177 ~~~~v~~~~~~e~~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~ 255 (524)
T KOG0601|consen 177 HENPVRDSPAWEGSGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFT 255 (524)
T ss_pred cccccccCcccccCCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheec
Confidence 67777755 4578899999997 5888888766666899999999999999 9999999999999999999999
Q ss_pred eecCCC-CCEEEeecCCccccCCCCC------cccccccCCccccccccccCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 016471 75 TTREED-APLKVIDFGLSDFVRPDQR------LNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWARTE 147 (389)
Q Consensus 75 ~~~~~~-~~~kl~Dfg~a~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 147 (389)
. .+ ...+++|||+...+....- .....|...|++||...+.++...|++++|.+..+..+|..+......
T Consensus 256 ~---~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~ 332 (524)
T KOG0601|consen 256 T---SDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKN 332 (524)
T ss_pred c---cccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCC
Confidence 5 44 7899999999877654431 112256778999999999999999999999999999888776543310
Q ss_pred hHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCC
Q 016471 148 SGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 148 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~ 203 (389)
..+..+.+.. .+.......+..+...+..|+..+|..|++++.+++|+++...
T Consensus 333 -~~W~~~r~~~--ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 333 -SSWSQLRQGY--IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK 385 (524)
T ss_pred -CCcccccccc--CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence 0111111111 1222222456677779999999999999999999999998643
|
|
| >KOG4223 consensus Reticulocalbin, calumenin, DNA supercoiling factor, and related Ca2+-binding proteins of the CREC family (EF-Hand protein superfamily) [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.9e-11 Score=108.18 Aligned_cols=141 Identities=20% Similarity=0.236 Sum_probs=109.7
Q ss_pred CHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchh-------
Q 016471 239 TEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVY------- 310 (389)
Q Consensus 239 ~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~------- 310 (389)
..+....+..++..+|. ++|.|+..|++.+.+..... ....++.+-+...|.+.||.|+|+|++..+....
T Consensus 72 ~ee~~~rl~~l~~~iD~~~Dgfv~~~El~~wi~~s~k~-~v~~~~~~~~~~~d~~~Dg~i~~eey~~~~~~~~~~~~~~~ 150 (325)
T KOG4223|consen 72 PEESQERLGKLVPKIDSDSDGFVTESELKAWIMQSQKK-YVVEEAARRWDEYDKNKDGFITWEEYLPQTYGRVDLPDEFP 150 (325)
T ss_pred cchhHHHHHHHHhhhcCCCCCceeHHHHHHHHHHHHHH-HHHHHHHHHHHHhccCccceeeHHHhhhhhhhcccCccccc
Confidence 34456678889999999 99999999999998776553 4566788889999999999999999998776421
Q ss_pred HHHhhHHHH---HHHHHHHHHHcccCCCcccHHHHHHHhCCc--hH-----HHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 311 QLEALERWD---QIAITAFDYFEQEGNRVISVEELALELNLA--PA-----AYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 311 ~~~~~~~~~---~~l~~aF~~~D~d~~G~I~~~el~~~l~~~--~~-----~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
......... ..=++-|+.-|.|+||.+|.+|+...|... +. |.+.+.++|+|+||+|+++||+.-|.+-.
T Consensus 151 d~e~~~~~~km~~rDe~rFk~AD~d~dg~lt~EEF~aFLHPEe~p~M~~iVi~Etl~d~Dkn~DG~I~~eEfigd~~~~~ 230 (325)
T KOG4223|consen 151 DEEDNEEYKKMIARDEERFKAADQDGDGSLTLEEFTAFLHPEEHPHMKDIVIAETLEDIDKNGDGKISLEEFIGDLYSHE 230 (325)
T ss_pred cchhcHHHHHHHHHHHHHHhhcccCCCCcccHHHHHhccChhhcchHHHHHHHHHHhhcccCCCCceeHHHHHhHHhhcc
Confidence 100000001 112568999999999999999999998432 22 88999999999999999999998876543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.31 E-value=5.3e-12 Score=110.65 Aligned_cols=74 Identities=28% Similarity=0.506 Sum_probs=64.5
Q ss_pred ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeecCCCCCEEEeecCC
Q 016471 11 YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGL 90 (389)
Q Consensus 11 ~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~~~~~~~kl~Dfg~ 90 (389)
.....++||||++|++|.+.+... .. ....++.+++.+|.++|+.|++|||++|.||++. ++.++++|||.
T Consensus 70 ~~~~~~lv~e~~~G~~L~~~~~~~----~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~----~~~~~liDf~~ 140 (211)
T PRK14879 70 DPENFIIVMEYIEGEPLKDLINSN----GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS----GGKIYLIDFGL 140 (211)
T ss_pred eCCCCEEEEEEeCCcCHHHHHHhc----cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE----CCCEEEEECCc
Confidence 567789999999999999877543 12 7888999999999999999999999999999994 57799999998
Q ss_pred ccc
Q 016471 91 SDF 93 (389)
Q Consensus 91 a~~ 93 (389)
+..
T Consensus 141 a~~ 143 (211)
T PRK14879 141 AEF 143 (211)
T ss_pred ccC
Confidence 765
|
|
| >KOG4223 consensus Reticulocalbin, calumenin, DNA supercoiling factor, and related Ca2+-binding proteins of the CREC family (EF-Hand protein superfamily) [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.31 E-value=6.5e-12 Score=111.11 Aligned_cols=132 Identities=23% Similarity=0.258 Sum_probs=101.6
Q ss_pred HHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHH
Q 016471 243 LVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQI 321 (389)
Q Consensus 243 ~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~ 321 (389)
+.+=.+.|..-|. ++|.++.+||-.+|..--.+.+..--+.+-+..+|+|+||+|+++||+.-+.........+.|...
T Consensus 162 ~~rDe~rFk~AD~d~dg~lt~EEF~aFLHPEe~p~M~~iVi~Etl~d~Dkn~DG~I~~eEfigd~~~~~~~~~epeWv~~ 241 (325)
T KOG4223|consen 162 IARDEERFKAADQDGDGSLTLEEFTAFLHPEEHPHMKDIVIAETLEDIDKNGDGKISLEEFIGDLYSHEGNEEEPEWVLT 241 (325)
T ss_pred HHHHHHHHhhcccCCCCcccHHHHHhccChhhcchHHHHHHHHHHhhcccCCCCceeHHHHHhHHhhccCCCCCcccccc
Confidence 3344677899999 999999999999887665556667778899999999999999999999877765442222233211
Q ss_pred H-HHHHHHHcccCCCcccHHHHHHHhC---CchH---HHHHHHHHccCCCCceeHHHHHH
Q 016471 322 A-ITAFDYFEQEGNRVISVEELALELN---LAPA---AYSLLNDCIRNSDGKLSFLGYKR 374 (389)
Q Consensus 322 l-~~aF~~~D~d~~G~I~~~el~~~l~---~~~~---~~~~~~~~d~~~~g~i~~~ef~~ 374 (389)
= .+.|...|+|+||+++.+||+.-+- ..-. +..++.++|.|+||++|++|=+.
T Consensus 242 Ere~F~~~~DknkDG~L~~dEl~~WI~P~~~d~A~~EA~hL~~eaD~dkD~kLs~eEIl~ 301 (325)
T KOG4223|consen 242 EREQFFEFRDKNKDGKLDGDELLDWILPSEQDHAKAEARHLLHEADEDKDGKLSKEEILE 301 (325)
T ss_pred cHHHHHHHhhcCCCCccCHHHHhcccCCCCccHHHHHHHHHhhhhccCccccccHHHHhh
Confidence 2 3455666999999999999998662 2211 88899999999999999998643
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.30 E-value=4e-12 Score=110.35 Aligned_cols=80 Identities=21% Similarity=0.323 Sum_probs=64.7
Q ss_pred ccceeecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeecCCCCCEEE
Q 016471 6 LQHLFYSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKV 85 (389)
Q Consensus 6 i~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~~~~~~~kl 85 (389)
+...+.....++||||++|++|..... ...+..++.+++.++.++|+.||+||||||+||++ +.++.++|
T Consensus 97 v~~~~~~~~~~lv~e~~~g~~L~~~~~-------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill---~~~~~~~l 166 (198)
T cd05144 97 VPKPIDWNRHAVVMEYIDGVELYRVRV-------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILV---DDDEKIYI 166 (198)
T ss_pred CCceeecCCceEEEEEeCCcchhhccc-------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEE---cCCCcEEE
Confidence 333444556799999999998865321 13456788999999999999999999999999999 46789999
Q ss_pred eecCCccccC
Q 016471 86 IDFGLSDFVR 95 (389)
Q Consensus 86 ~Dfg~a~~~~ 95 (389)
+|||.+....
T Consensus 167 iDfg~~~~~~ 176 (198)
T cd05144 167 IDWPQMVSTD 176 (198)
T ss_pred EECCccccCC
Confidence 9999986654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.29 E-value=6.9e-12 Score=125.26 Aligned_cols=81 Identities=28% Similarity=0.426 Sum_probs=67.8
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|+|+++.... .....++||||++|++|.+++. ....++.|++.+|.|||+.|++||||||+||++.
T Consensus 393 l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~- 462 (535)
T PRK09605 393 ARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR- 462 (535)
T ss_pred hcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-
Confidence 4677776533 3457889999999999988774 3467899999999999999999999999999993
Q ss_pred cCCCCCEEEeecCCcccc
Q 016471 77 REEDAPLKVIDFGLSDFV 94 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~ 94 (389)
++.++|+|||++...
T Consensus 463 ---~~~~~liDFGla~~~ 477 (535)
T PRK09605 463 ---DDRLYLIDFGLGKYS 477 (535)
T ss_pred ---CCcEEEEeCcccccC
Confidence 567999999998764
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.28 E-value=6.6e-12 Score=109.04 Aligned_cols=72 Identities=29% Similarity=0.463 Sum_probs=61.5
Q ss_pred ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeecCCCCCEEEeecCC
Q 016471 11 YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGL 90 (389)
Q Consensus 11 ~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~~~~~~~kl~Dfg~ 90 (389)
.....++||||++|++|.+.+... +. .++.|++.+|.+||+.|++|||++|.||++. ++.++++|||.
T Consensus 68 ~~~~~~lv~e~~~g~~l~~~~~~~-~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~----~~~~~liDfg~ 135 (199)
T TIGR03724 68 DPDNKTIVMEYIEGKPLKDVIEEG-ND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR----DDKLYLIDFGL 135 (199)
T ss_pred ECCCCEEEEEEECCccHHHHHhhc-HH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE----CCcEEEEECCC
Confidence 456679999999999998876432 11 7899999999999999999999999999994 67899999998
Q ss_pred cccc
Q 016471 91 SDFV 94 (389)
Q Consensus 91 a~~~ 94 (389)
+...
T Consensus 136 a~~~ 139 (199)
T TIGR03724 136 GKYS 139 (199)
T ss_pred CcCC
Confidence 8653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05022 S-100A13 S-100A13: S-100A13 domain found in proteins similar to S100A13 | Back alignment and domain information |
|---|
Probab=99.25 E-value=4.8e-12 Score=93.51 Aligned_cols=65 Identities=15% Similarity=0.189 Sum_probs=56.3
Q ss_pred HHHHHHHHHHcc-cCCCcccHHHHHHHhCC------ch-H-HHHHHHHHccCCCCceeHHHHHHHHccccCCCc
Q 016471 320 QIAITAFDYFEQ-EGNRVISVEELALELNL------AP-A-AYSLLNDCIRNSDGKLSFLGYKRFLHGVTVRSS 384 (389)
Q Consensus 320 ~~l~~aF~~~D~-d~~G~I~~~el~~~l~~------~~-~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~~ 384 (389)
..++.+|+.||+ +++|+|+.+||+.+|.. .. . +++|++++|.|+||.|+|+||+.+|.++...-.
T Consensus 8 ~~l~~~F~~fd~~~~~g~i~~~ELk~ll~~elg~~ls~~~~v~~mi~~~D~d~DG~I~F~EF~~l~~~l~~~~~ 81 (89)
T cd05022 8 ETLVSNFHKASVKGGKESLTASEFQELLTQQLPHLLKDVEGLEEKMKNLDVNQDSKLSFEEFWELIGELAKAVK 81 (89)
T ss_pred HHHHHHHHHHhCCCCCCeECHHHHHHHHHHHhhhhccCHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHHHHHH
Confidence 468999999999 99999999999999822 23 3 999999999999999999999999988765433
|
S100A13 is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100A13 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100A13 is involved in the cellular export of interleukin-1 (IL-1) and of fibroblast growth factor-1 (FGF-1), which plays an important role in angiogenesis and tissue regeneration. Export is based on the CuII-dependent formation of multiprotein complexes containing the S100A13 protein. Assembly of these complexes occurs near the inner surface of the plasma membrane. Binding of two Ca(II) ions per monomer triggers key conformational changes leading to the creation of two identical and symmetrical Cu(II)-binding sites on the surface of the protein, close to the interface between the two monomers. These Cu |
| >PF13499 EF-hand_7: EF-hand domain pair; PDB: 1TCF_A 2TN4_A 1TN4_A 1A2X_A 2CT9_B 2OTG_B 2OS8_B 1SNL_A 3O4Y_A 3J04_E | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.9e-11 Score=85.97 Aligned_cols=55 Identities=27% Similarity=0.459 Sum_probs=48.5
Q ss_pred HHHHHHHHcccCCCcccHHHHHHHh---CCc--hH-----HHHHHHHHccCCCCceeHHHHHHHH
Q 016471 322 AITAFDYFEQEGNRVISVEELALEL---NLA--PA-----AYSLLNDCIRNSDGKLSFLGYKRFL 376 (389)
Q Consensus 322 l~~aF~~~D~d~~G~I~~~el~~~l---~~~--~~-----~~~~~~~~d~~~~g~i~~~ef~~~~ 376 (389)
++++|+.||+|++|+|+.+||+.++ +.. .. ++.+++.+|.|+||.|+|+||+.+|
T Consensus 2 l~~~F~~~D~d~~G~i~~~el~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~i~~~Ef~~~~ 66 (66)
T PF13499_consen 2 LKEAFKKFDKDGDGYISKEELRRALKHLGRDMSDEESDEMIDQIFREFDTDGDGRISFDEFLNFM 66 (66)
T ss_dssp HHHHHHHHSTTSSSEEEHHHHHHHHHHTTSHSTHHHHHHHHHHHHHHHTTTSSSSEEHHHHHHHH
T ss_pred HHHHHHHHcCCccCCCCHHHHHHHHHHhcccccHHHHHHHHHHHHHHhCCCCcCCCcHHHHhccC
Confidence 7889999999999999999999999 221 22 7778999999999999999999986
|
... |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.23 E-value=3.1e-11 Score=107.63 Aligned_cols=70 Identities=27% Similarity=0.374 Sum_probs=57.7
Q ss_pred EEEEEccCC-CChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeecCCCCCEEEeecCCcccc
Q 016471 16 LFFTRFCEG-GELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFV 94 (389)
Q Consensus 16 ~lv~E~~~g-g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~~~~~~~kl~Dfg~a~~~ 94 (389)
++|||+++| ++|.+.+.. +.+++.. +.||+.+|.+||++||+||||||.|||++ .++.++|+|||.+...
T Consensus 122 ~lV~e~l~G~~~L~~~l~~--~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~---~~~~v~LIDfg~~~~~ 192 (239)
T PRK01723 122 DILIERIEGARDLVALLQE--APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLD---PDGKFWLIDFDRGELR 192 (239)
T ss_pred eEEEEecCCCCCHHHHHhc--CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEc---CCCCEEEEECCCcccC
Confidence 599999998 688776543 4566543 56899999999999999999999999994 4568999999987653
|
|
| >PLN02964 phosphatidylserine decarboxylase | Back alignment and domain information |
|---|
Probab=99.19 E-value=8.5e-11 Score=116.25 Aligned_cols=103 Identities=20% Similarity=0.283 Sum_probs=85.2
Q ss_pred hcCHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHH---HHHHHhhcCCCCCcceeHHHHHHHHhchhHH
Q 016471 237 ALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSR---VFEILNVMEPLSDQKLAYEEFCAAATSVYQL 312 (389)
Q Consensus 237 ~l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~---~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~ 312 (389)
.+...+...+++.|..+|+ ++|.+ +..+++.+|...+++.+ +.++|+.+|.+++|.|+|+||+.++......
T Consensus 136 ~f~~kqi~elkeaF~lfD~dgdG~i----Lg~ilrslG~~~pte~e~~fi~~mf~~~D~DgdG~IdfdEFl~lL~~lg~~ 211 (644)
T PLN02964 136 DFVTQEPESACESFDLLDPSSSNKV----VGSIFVSCSIEDPVETERSFARRILAIVDYDEDGQLSFSEFSDLIKAFGNL 211 (644)
T ss_pred hccHHHHHHHHHHHHHHCCCCCCcC----HHHHHHHhCCCCCCHHHHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHhccC
Confidence 3556678889999999999 99997 78888888832367666 8999999999999999999999876643221
Q ss_pred HhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHhC
Q 016471 313 EALERWDQIAITAFDYFEQEGNRVISVEELALELN 347 (389)
Q Consensus 313 ~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~ 347 (389)
.. +++++.||+.||+|++|+|+.+||+++|.
T Consensus 212 ~s----eEEL~eaFk~fDkDgdG~Is~dEL~~vL~ 242 (644)
T PLN02964 212 VA----ANKKEELFKAADLNGDGVVTIDELAALLA 242 (644)
T ss_pred CC----HHHHHHHHHHhCCCCCCcCCHHHHHHHHH
Confidence 11 45799999999999999999999999983
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.15 E-value=8.5e-11 Score=100.93 Aligned_cols=80 Identities=24% Similarity=0.309 Sum_probs=62.1
Q ss_pred eecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCEecCCCCCcEEEeecCCCCCEEEeec
Q 016471 10 FYSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHL-QGVVHRDLKPENFLFTTREEDAPLKVIDF 88 (389)
Q Consensus 10 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~-~~i~Hrdlkp~Nill~~~~~~~~~kl~Df 88 (389)
+.....++||||++||.+........ .. ...+..++.+++.++.++|+ .||+||||||+||+++ ++.++++||
T Consensus 85 ~~~~~~~lv~e~~~g~~~~~~~l~~~-~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~----~~~~~liDf 158 (187)
T cd05119 85 IDLNRHVLVMEFIGGDGIPAPRLKDV-RL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD----DGKVYIIDV 158 (187)
T ss_pred EecCCCEEEEEEeCCCCccChhhhhh-hh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE----CCcEEEEEC
Confidence 33456789999999965533222211 11 16788999999999999999 9999999999999994 678999999
Q ss_pred CCccccC
Q 016471 89 GLSDFVR 95 (389)
Q Consensus 89 g~a~~~~ 95 (389)
|.+....
T Consensus 159 g~a~~~~ 165 (187)
T cd05119 159 PQAVEID 165 (187)
T ss_pred ccccccc
Confidence 9986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.13 E-value=4.8e-10 Score=108.92 Aligned_cols=129 Identities=16% Similarity=0.184 Sum_probs=96.8
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCCEecCCCCCcEEEe
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCH-LQGVVHRDLKPENFLFT 75 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH-~~~i~Hrdlkp~Nill~ 75 (389)
|+||+|+.|+ .+..+|||+|-+.- |-.++.+ +....+.-.+.||+.||.||| ..+++|++|.-+.+++
T Consensus 66 lRHP~Il~yL~t~e~~~~~ylvTErV~P--l~~~lk~----l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfV- 138 (690)
T KOG1243|consen 66 LRHPNILSYLDTTEEEGTLYLVTERVRP--LETVLKE----LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFV- 138 (690)
T ss_pred ccCchhhhhhhhhcccCceEEEeecccc--HHHHHHH----hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEE-
Confidence 6899999999 35789999999864 5555543 347888889999999999997 6789999999999999
Q ss_pred ecCCCCCEEEeecCCccccCCCCC-cccccccCCccccccccccCCCchhHHHHHHHHHHHHhCC
Q 016471 76 TREEDAPLKVIDFGLSDFVRPDQR-LNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGS 139 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~ 139 (389)
+..|..||++|.++........ .....--..|..|+.+.. -....|.|.|||++++++.|.
T Consensus 139 --n~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~-s~~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 139 --NESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDP-SEWSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred --cCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCc-cccchhhhhHHHHHHHHhCcc
Confidence 5789999999988755432221 111122234566665421 124579999999999999983
|
|
| >cd05026 S-100Z S-100Z: S-100Z domain found in proteins similar to S100Z | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.9e-10 Score=86.46 Aligned_cols=62 Identities=27% Similarity=0.419 Sum_probs=53.1
Q ss_pred HHHHHHHHHHc-ccCCC-cccHHHHHHHhCC----------chH-HHHHHHHHccCCCCceeHHHHHHHHccccC
Q 016471 320 QIAITAFDYFE-QEGNR-VISVEELALELNL----------APA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVTV 381 (389)
Q Consensus 320 ~~l~~aF~~~D-~d~~G-~I~~~el~~~l~~----------~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~ 381 (389)
..++++|..|| +|++| +|+.+||+.+|+. .+. ++++++++|.|+||.|+|+||+.+|..+..
T Consensus 10 ~~~~~~F~~~dd~dgdg~~Is~~EL~~ll~~~~~~~~~~~~~~~~v~~i~~elD~n~dG~Idf~EF~~l~~~l~~ 84 (93)
T cd05026 10 DTLIRIFHNYSGKEGDRYKLSKGELKELLQRELTDFLSSQKDPMLVDKIMNDLDSNKDNEVDFNEFVVLVAALTV 84 (93)
T ss_pred HHHHHHHHHHHccCCCCCEECHHHHHHHHHHHhHHhcccccCHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHH
Confidence 45888999998 88999 5999999999921 112 999999999999999999999999987654
|
S100Z is a member of the S100 domain family within the EF-hand Ca2+-binding proteins superfamily. Note that the S-100 hierarchy, to which this S-100Z group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately.S100 proteins exhibit unique patterns of tissue- and cell type-specific expression and have been implicated in the Ca2+-dependent regulation of diverse physiological processes, including cell cycle regulation, differentiation, growth, and metabolic control. S100Z is normally expressed in various tissues, with its highest level of expression being in spleen and leukocytes. The function of S100Z remains unclear. Preliminary structural data suggests that S100Z is homodimer, however a heterodimer with S100P has been reported. S100Z is capable of binding calcium ions. When calcium binds to S110Z, the protein experiences a conformational change, which exposes hydrophobic surfac |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.07 E-value=8.2e-11 Score=114.60 Aligned_cols=154 Identities=22% Similarity=0.301 Sum_probs=112.2
Q ss_pred HHHHHHHHHHHHHHC-CCEecCCCCCcEEEeecCCCCCEEEeecCCccccCCCCC---------cc-cccccCCcccccc
Q 016471 46 IVEKILNIVAFCHLQ-GVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR---------LN-DIVGSAYYVAPEV 114 (389)
Q Consensus 46 i~~qi~~~L~~lH~~-~i~Hrdlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~~---------~~-~~~gt~~y~aPE~ 114 (389)
=+.+++.|+.|+|.. ++||++|.|++|.+ +.++.+||+.|+++........ .. .......|.|||+
T Consensus 104 nl~~v~dgl~flh~sAk~VH~ni~p~~i~~---na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~ 180 (700)
T KOG2137|consen 104 NLGNVADGLAFLHRSAKVVHGNIQPEAIVV---NANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEY 180 (700)
T ss_pred hhhcccchhhhhccCcceeecccchhheee---ccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchh
Confidence 344566899999965 89999999999999 5789999999998765543211 11 1124557999998
Q ss_pred ccc-cCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCC-CCCCCHHHHHHHHhhhccCcCCCCCH
Q 016471 115 LHR-SYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSP-WPSVSPEAKDFVRRLLNKDHRKRMTA 191 (389)
Q Consensus 115 ~~~-~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~R~s~ 191 (389)
+.. ..+.++|++|+||++|.+.. |+..+.+......+. ......+..... ..++++++++=+.+++..++..||++
T Consensus 181 ~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~-~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~ 259 (700)
T KOG2137|consen 181 LLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS-FSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTL 259 (700)
T ss_pred hccccccccccceeeeeEEEEEecCCcchhhccCCcchhh-hhhcccccccccccccCcHHHHHHHHHHhcCCcccCcch
Confidence 864 57899999999999999995 555554433222222 222111111111 14689999999999999999999999
Q ss_pred HHHhCCCCCCCC
Q 016471 192 AQALTHPWLHDE 203 (389)
Q Consensus 192 ~e~l~h~~~~~~ 203 (389)
..++..|||.+.
T Consensus 260 ~~l~~~~ff~D~ 271 (700)
T KOG2137|consen 260 DLLLSIPFFSDP 271 (700)
T ss_pred hhhhcccccCCc
Confidence 999999999875
|
|
| >cd05027 S-100B S-100B: S-100B domain found in proteins similar to S100B | Back alignment and domain information |
|---|
Probab=99.05 E-value=2.2e-10 Score=84.88 Aligned_cols=61 Identities=21% Similarity=0.343 Sum_probs=52.9
Q ss_pred HHHHHHHHHHc-ccCCC-cccHHHHHHHhCC----------chH-HHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 320 QIAITAFDYFE-QEGNR-VISVEELALELNL----------APA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 320 ~~l~~aF~~~D-~d~~G-~I~~~el~~~l~~----------~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
..++++|+.|| +|++| +|+.+||+.+|.. +++ ++++++++|.|++|.|+|+||+.++....
T Consensus 8 ~~l~~aF~~fD~~dgdG~~I~~~eL~~ll~~~~~~~lg~~~~~~~v~~~i~~~D~n~dG~v~f~eF~~li~~~~ 81 (88)
T cd05027 8 VALIDVFHQYSGREGDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLDSDGDGECDFQEFMAFVAMVT 81 (88)
T ss_pred HHHHHHHHHhcccCCCcCEECHHHHHHHHHHHhHHHhcCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHH
Confidence 45899999998 89999 5999999999832 122 99999999999999999999999987654
|
S100B is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100B group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100B is most abundant in glial cells of the central nervous system, predominately in astrocytes. S100B is involved in signal transduction via the inhibition of protein phoshorylation, regulation of enzyme activity and by affecting the calcium homeostasis. Upon calcium binding the S100B homodimer changes conformation to expose a hydrophobic cleft, which represents the interaction site of S100B with its more than 20 known target proteins. These target proteins include several cellular architecture proteins such as tubulin and GFAP; S100B can inhibit polymerization of these oligomeric molecules. Furthermore, S100B i |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.02 E-value=3.7e-10 Score=92.80 Aligned_cols=79 Identities=24% Similarity=0.346 Sum_probs=63.1
Q ss_pred cccccee-ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCCCcEEEeecCC
Q 016471 4 QKLQHLF-YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQ---GVVHRDLKPENFLFTTREE 79 (389)
Q Consensus 4 pni~~~~-~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~i~Hrdlkp~Nill~~~~~ 79 (389)
|.++.++ ..+..+++|||+.|+.+... +......++.+++.+|.++|.. +++|+|++|.||+++ .
T Consensus 56 p~~~~~~~~~~~~~~v~e~~~g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~---~ 124 (155)
T cd05120 56 PKVLASGESDGWSYLLMEWIEGETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD---D 124 (155)
T ss_pred CeEEEEcCCCCccEEEEEecCCeecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEE---C
Confidence 3443333 23579999999999877543 5566678899999999999985 799999999999995 4
Q ss_pred CCCEEEeecCCccc
Q 016471 80 DAPLKVIDFGLSDF 93 (389)
Q Consensus 80 ~~~~kl~Dfg~a~~ 93 (389)
.+.++++|||.+..
T Consensus 125 ~~~~~l~Df~~~~~ 138 (155)
T cd05120 125 GKILGIIDWEYAGY 138 (155)
T ss_pred CcEEEEEecccccC
Confidence 67899999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05025 S-100A1 S-100A1: S-100A1 domain found in proteins similar to S100A1 | Back alignment and domain information |
|---|
Probab=99.01 E-value=6e-10 Score=83.81 Aligned_cols=64 Identities=22% Similarity=0.353 Sum_probs=55.0
Q ss_pred HHHHHHHHHHHc-ccCCCc-ccHHHHHHHhCC----------chH-HHHHHHHHccCCCCceeHHHHHHHHccccCC
Q 016471 319 DQIAITAFDYFE-QEGNRV-ISVEELALELNL----------APA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVTVR 382 (389)
Q Consensus 319 ~~~l~~aF~~~D-~d~~G~-I~~~el~~~l~~----------~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~ 382 (389)
.+.++++|+.|| +|++|+ |+.+||+.+|.. ... ++++++++|.|++|.|+|+||+.+|.+..+.
T Consensus 8 ~~~l~~~F~~fDd~dg~G~~Is~~El~~~l~~~lg~~~~~~~s~~~v~~i~~~~D~d~~G~I~f~eF~~l~~~~~~~ 84 (92)
T cd05025 8 METLINVFHAHSGKEGDKYKLSKKELKDLLQTELSDFLDAQKDADAVDKIMKELDENGDGEVDFQEFVVLVAALTVA 84 (92)
T ss_pred HHHHHHHHHHHhcccCCCCeECHHHHHHHHHHHHHHHccCCCCHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHHHH
Confidence 456999999997 999995 999999999831 122 9999999999999999999999999876543
|
S100A1 is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100A1 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. As is the case with many other members of S100 protein family, S100A1 is implicated in intracellular and extracellular regulatory activities, including interaction with myosin-associated twitchin kinase, actin-capping protein CapZ, sinapsin I, and tubulin. Structural data suggests that S100A1 proteins exist within cells as antiparallel homodimers, while heterodimers with S100A4 and S100B also has been reported. Upon binding calcium S100A1 changes conformation to expose a hydrophobic cleft which is the interaction site of S100A1 with its more that 20 known target proteins. |
| >cd05023 S-100A11 S-100A11: S-100A11 domain found in proteins similar to S100A11 | Back alignment and domain information |
|---|
Probab=98.96 E-value=9.7e-10 Score=81.51 Aligned_cols=62 Identities=24% Similarity=0.402 Sum_probs=53.4
Q ss_pred HHHHHHHHH-HcccCCC-cccHHHHHHHhCCc----------hH-HHHHHHHHccCCCCceeHHHHHHHHccccC
Q 016471 320 QIAITAFDY-FEQEGNR-VISVEELALELNLA----------PA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVTV 381 (389)
Q Consensus 320 ~~l~~aF~~-~D~d~~G-~I~~~el~~~l~~~----------~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~ 381 (389)
..+..+|+. +|+|++| +|+.+||+.+++.. +. ++++++++|.|+||.|+|+||+.+|..+..
T Consensus 9 ~~l~~~F~~y~~~dg~~~~Ls~~Elk~ll~~e~~~~~~~~~~~~~~~~ll~~~D~d~DG~I~f~EF~~l~~~l~~ 83 (89)
T cd05023 9 ESLIAVFQKYAGKDGDSYQLSKTEFLSFMNTELASFTKNQKDPGVLDRMMKKLDLNSDGQLDFQEFLNLIGGLAV 83 (89)
T ss_pred HHHHHHHHHHhccCCCcCeECHHHHHHHHHHhhhHhhcCCCCHHHHHHHHHHcCCCCCCcCcHHHHHHHHHHHHH
Confidence 468999999 7888986 99999999999322 22 999999999999999999999999987653
|
S100A11 is a member of the S-100 domain family within EF-hand Ca2+-binding proteins superfamily. Note that the S-100 hierarchy, to which this S-100A11 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins exhibit unique patterns of tissue- and cell type-specific expression and have been implicated in the Ca2+-dependent regulation of diverse physiological processes, including cell cycle regulation, differentiation, growth, and metabolic control . S100 proteins have also been associated with a variety of pathological events, including neoplastic transformation and neurodegenerative diseases such as Alzheimer's, usually via over expression of the protein. S100A11 is expressed in smooth muscle and other tissues and involves in calcium-dependent membrane aggregation, which is important for cell vesiculation . As is the case for many other S100 proteins, S |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.96 E-value=2.5e-10 Score=109.65 Aligned_cols=187 Identities=19% Similarity=0.186 Sum_probs=134.0
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
.|++++.++ ...+.|+=-|||+||++..... ....+.+...+.+..|++.++.++|++.++|+|+||+||++.+.
T Consensus 324 ~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~-~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~ 402 (524)
T KOG0601|consen 324 SHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSV-TSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISND 402 (524)
T ss_pred cccccCCCCCCccccccccCchhhhcCcchhhhhH-HHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccc
Confidence 467777766 3577889999999998877663 23568889999999999999999999999999999999999632
Q ss_pred CCCCCEEEeecCCccccCCCCCcccccccCCcc-ccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 78 EEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV-APEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~-aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
++..++.|||....+.... ......-++. .+|++.. .+..++|++|||.-+.+..+|...-... ..+..+
T Consensus 403 --~~~~~~~~~~~~t~~~~~~--~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~---~~~~~i 475 (524)
T KOG0601|consen 403 --GFFSKLGDFGCWTRLAFSS--GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG---VQSLTI 475 (524)
T ss_pred --hhhhhccccccccccceec--ccccccccccccchhhccccccccccccccccccccccccCcccCccc---ccceee
Confidence 2788999999876532211 1122223344 3555433 5778999999999999999886532111 112222
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~ 200 (389)
..+. .+. .+..+.++..+.+.+...++..|+++.++..|+=|
T Consensus 476 ~~~~--~p~--~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 476 RSGD--TPN--LPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred eccc--ccC--CCchHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 2221 111 13345788899999999999999999998887644
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.96 E-value=2.2e-09 Score=91.86 Aligned_cols=78 Identities=19% Similarity=0.242 Sum_probs=61.8
Q ss_pred CeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH-HHCCCEecCCCCCcEEEeecCCCCCEEEeecCCc
Q 016471 13 NSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFC-HLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS 91 (389)
Q Consensus 13 ~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~l-H~~~i~Hrdlkp~Nill~~~~~~~~~kl~Dfg~a 91 (389)
..-+|||||+.++.+..-..+. ..++++++..+..+++.+|..+ |+.||+|+||++.||++. ++.+.++|||.+
T Consensus 97 ~~~~lvME~Ig~~~~~~~~Lkd-~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~~----~~~v~iIDF~qa 171 (197)
T cd05146 97 KKHVLVMSFIGDDQVPAPKLKD-AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLWH----DGKVWFIDVSQS 171 (197)
T ss_pred cCCEEEEEEcCCCCccchhhhc-cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEE----CCcEEEEECCCc
Confidence 5668899999876553322332 3566677888899999999999 899999999999999994 467999999987
Q ss_pred cccC
Q 016471 92 DFVR 95 (389)
Q Consensus 92 ~~~~ 95 (389)
....
T Consensus 172 v~~~ 175 (197)
T cd05146 172 VEPT 175 (197)
T ss_pred eeCC
Confidence 6543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >smart00027 EH Eps15 homology domain | Back alignment and domain information |
|---|
Probab=98.96 E-value=2.5e-09 Score=81.14 Aligned_cols=62 Identities=13% Similarity=0.114 Sum_probs=55.2
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHh---CCchH-HHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 319 DQIAITAFDYFEQEGNRVISVEELALEL---NLAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 319 ~~~l~~aF~~~D~d~~G~I~~~el~~~l---~~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
...++.+|+.||+|++|.|+.+||+++| |.+.+ +.+++..+|.+++|.|+|+||+.+|....
T Consensus 9 ~~~l~~~F~~~D~d~~G~Is~~el~~~l~~~~~~~~ev~~i~~~~d~~~~g~I~~~eF~~~~~~~~ 74 (96)
T smart00027 9 KAKYEQIFRSLDKNQDGTVTGAQAKPILLKSGLPQTLLAKIWNLADIDNDGELDKDEFALAMHLIY 74 (96)
T ss_pred HHHHHHHHHHhCCCCCCeEeHHHHHHHHHHcCCCHHHHHHHHHHhcCCCCCCcCHHHHHHHHHHHH
Confidence 4568999999999999999999999998 55555 99999999999999999999999886544
|
Pair of EF hand motifs that recognise proteins containing Asn-Pro-Phe (NPF) sequences. |
| >cd05031 S-100A10_like S-100A10_like: S-100A10 domain found in proteins similar to S100A10 | Back alignment and domain information |
|---|
Probab=98.95 E-value=1.2e-09 Score=82.55 Aligned_cols=63 Identities=22% Similarity=0.435 Sum_probs=53.4
Q ss_pred HHHHHHHHHHHcc-cC-CCcccHHHHHHHhCC--------c--hH-HHHHHHHHccCCCCceeHHHHHHHHccccC
Q 016471 319 DQIAITAFDYFEQ-EG-NRVISVEELALELNL--------A--PA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVTV 381 (389)
Q Consensus 319 ~~~l~~aF~~~D~-d~-~G~I~~~el~~~l~~--------~--~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~ 381 (389)
...++.+|..||. |+ +|+|+.+||+.+|.. . .. ++++++++|.+++|.|+|+||+.+|.+.+.
T Consensus 7 ~~~l~~~F~~~D~~dg~dG~Is~~El~~~l~~~~g~~lg~~~s~~ei~~~~~~~D~~~dg~I~f~eF~~l~~~~~~ 82 (94)
T cd05031 7 MESLILTFHRYAGKDGDKNTLSRKELKKLMEKELSEFLKNQKDPMAVDKIMKDLDQNRDGKVNFEEFVSLVAGLSI 82 (94)
T ss_pred HHHHHHHHHHHhccCCCCCeECHHHHHHHHHHHhHHHhhccccHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHHH
Confidence 3468999999997 97 699999999998731 2 22 999999999999999999999999986653
|
S100A10 is a member of the S100 family of EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100A1_like group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins are expressed exclusively in vertebrates, and are implicated in intracellular and extracellular regulatory activities. A unique feature of S100A10 is that it contains mutation in both of the calcium binding sites, making it calcium insensitive. S100A10 has been detected in brain, heart, gastrointestinal tract, kidney, liver, lung, spleen, testes, epidermis, aorta, and thymus. Structural data supports the homo- and hetero-dimeric as well as hetero-tetrameric nature of the protein. S100A10 has multiple binding partners in its calcium free state and is therefore involved in many diverse biological functions. |
| >cd00252 SPARC_EC SPARC_EC; extracellular Ca2+ binding domain (containing 2 EF-hand motifs) of SPARC and related proteins (QR1, SC1/hevin, testican and tsc-36/FRP) | Back alignment and domain information |
|---|
Probab=98.93 E-value=3.1e-09 Score=82.61 Aligned_cols=58 Identities=16% Similarity=0.159 Sum_probs=51.5
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHh-CCchH-HHHHHHHHccCCCCceeHHHHHHHH
Q 016471 319 DQIAITAFDYFEQEGNRVISVEELALEL-NLAPA-AYSLLNDCIRNSDGKLSFLGYKRFL 376 (389)
Q Consensus 319 ~~~l~~aF~~~D~d~~G~I~~~el~~~l-~~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~ 376 (389)
...+..+|..+|.|+||+|+.+||..+. +.... +..+++.+|.|+||.||++||+..+
T Consensus 47 ~~~l~w~F~~lD~d~DG~Ls~~EL~~~~l~~~e~~~~~f~~~~D~n~Dg~IS~~Ef~~cl 106 (116)
T cd00252 47 KDPVGWMFNQLDGNYDGKLSHHELAPIRLDPNEHCIKPFFESCDLDKDGSISLDEWCYCF 106 (116)
T ss_pred HHHHHHHHHHHCCCCCCcCCHHHHHHHHccchHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 5679999999999999999999999986 22223 8899999999999999999999988
|
SPARC (BM-40) is a multifunctional glycoprotein, a matricellular protein, that functions to regulate cell-matrix interactions; binds to such proteins as collagen and vitronectin and binds to endothelial cells thus inhibiting cellular proliferation. The EC domain interacts with a follistatin-like (FS) domain which appears to stabilize Ca2+ binding. The two EF-hands interact canonically but their conserved disulfide bonds confer a tight association between the EF-hand pair and an acid/amphiphilic N-terminal helix. Proposed active form involves a Ca2+ dependent symmetric homodimerization of EC-FS modules. |
| >cd00052 EH Eps15 homology domain; found in proteins implicated in endocytosis, vesicle transport, and signal transduction | Back alignment and domain information |
|---|
Probab=98.93 E-value=2.1e-09 Score=75.63 Aligned_cols=58 Identities=21% Similarity=0.250 Sum_probs=51.5
Q ss_pred HHHHHHHcccCCCcccHHHHHHHh---CCchH-HHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 323 ITAFDYFEQEGNRVISVEELALEL---NLAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 323 ~~aF~~~D~d~~G~I~~~el~~~l---~~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
+.+|+.+|+|++|.|+.+|++.++ |...+ +.++++.+|.+++|.|+|+||+.+|....
T Consensus 2 ~~~F~~~D~~~~G~i~~~el~~~l~~~g~~~~~~~~i~~~~d~~~~g~i~~~ef~~~~~~~~ 63 (67)
T cd00052 2 DQIFRSLDPDGDGLISGDEARPFLGKSGLPRSVLAQIWDLADTDKDGKLDKEEFAIAMHLIA 63 (67)
T ss_pred hHHHHHhCCCCCCcCcHHHHHHHHHHcCCCHHHHHHHHHHhcCCCCCcCCHHHHHHHHHHHH
Confidence 568999999999999999999988 65444 99999999999999999999999986543
|
The alignment contains a pair of EF-hand motifs, typically one of them is canonical and binds to Ca2+, while the other may not bind to Ca2+. A hydrophobic binding pocket is formed by residues from both EF-hand motifs. The EH domain binds to proteins containing NPF (class I), [WF]W or SWG (class II), or H[TS]F (class III) sequence motifs. |
| >KOG0037 consensus Ca2+-binding protein, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.93 E-value=1.6e-08 Score=85.04 Aligned_cols=85 Identities=11% Similarity=0.212 Sum_probs=75.4
Q ss_pred HHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHH
Q 016471 243 LVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQI 321 (389)
Q Consensus 243 ~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~ 321 (389)
+...+.+|+.+|. ++|.|+..||++||..+|. .++.+-++-+++.+|..++|.|+|++|+..+.... .
T Consensus 123 i~~Wr~vF~~~D~D~SG~I~~sEL~~Al~~~Gy-~Lspq~~~~lv~kyd~~~~g~i~FD~FI~ccv~L~----------~ 191 (221)
T KOG0037|consen 123 INQWRNVFRTYDRDRSGTIDSSELRQALTQLGY-RLSPQFYNLLVRKYDRFGGGRIDFDDFIQCCVVLQ----------R 191 (221)
T ss_pred HHHHHHHHHhcccCCCCcccHHHHHHHHHHcCc-CCCHHHHHHHHHHhccccCCceeHHHHHHHHHHHH----------H
Confidence 6678899999999 9999999999999999998 58999999999999988899999999999665442 3
Q ss_pred HHHHHHHHcccCCCccc
Q 016471 322 AITAFDYFEQEGNRVIS 338 (389)
Q Consensus 322 l~~aF~~~D~d~~G~I~ 338 (389)
+-++|+.+|.+.+|.|+
T Consensus 192 lt~~Fr~~D~~q~G~i~ 208 (221)
T KOG0037|consen 192 LTEAFRRRDTAQQGSIT 208 (221)
T ss_pred HHHHHHHhccccceeEE
Confidence 67799999999999865
|
|
| >cd05029 S-100A6 S-100A6: S-100A6 domain found in proteins similar to S100A6 | Back alignment and domain information |
|---|
Probab=98.93 E-value=2.1e-09 Score=79.55 Aligned_cols=61 Identities=26% Similarity=0.421 Sum_probs=52.8
Q ss_pred HHHHHHHHHHcc-cC-CCcccHHHHHHHhC------C--chH-HHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 320 QIAITAFDYFEQ-EG-NRVISVEELALELN------L--APA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 320 ~~l~~aF~~~D~-d~-~G~I~~~el~~~l~------~--~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
..+...|..||. |+ +|+|+.+||+++|. . ..+ ++++++++|.|++|.|+|+||+.+|.++.
T Consensus 10 ~~~i~~F~~y~~~~~~~g~Is~~EL~~~l~~~~~lg~k~t~~ev~~m~~~~D~d~dG~Idf~EFv~lm~~l~ 81 (88)
T cd05029 10 GLLVAIFHKYSGREGDKNTLSKKELKELIQKELTIGSKLQDAEIAKLMEDLDRNKDQEVNFQEYVTFLGALA 81 (88)
T ss_pred HHHHHHHHHHHccCCCCCEECHHHHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCCCcHHHHHHHHHHHH
Confidence 457889999998 77 89999999999992 2 222 99999999999999999999999998764
|
S100A6 is a member of the S100 domain family within EF-hand Ca2+-binding proteins superfamily. Note that the S-100 hierarchy, to which this S-100A6 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins exhibit unique patterns of tissue- and cell type-specific expression and have been implicated in the Ca2+-dependent regulation of diverse physiological processes, including cell cycle regulation, differentiation, growth, and metabolic control . S100A6 is normally expressed in the G1 phase of the cell cycle in neuronal cells. The function of S100A6 remains unclear, but evidence suggests that it is involved in cell cycle regulation and exocytosis. S100A6 may also be involved in tumorigenesis; the protein is overexpressed in several tumors. Ca2+ binding to S100A6 leads to a conformational change in the protein, which exposes a hydrophobic surface for interact |
| >PF13499 EF-hand_7: EF-hand domain pair; PDB: 1TCF_A 2TN4_A 1TN4_A 1A2X_A 2CT9_B 2OTG_B 2OS8_B 1SNL_A 3O4Y_A 3J04_E | Back alignment and domain information |
|---|
Probab=98.91 E-value=2.7e-09 Score=74.92 Aligned_cols=61 Identities=21% Similarity=0.392 Sum_probs=45.2
Q ss_pred HHHHHhhhcCC-CCCcccHHHHHHHHHHhccc---cCCHHHHHHHHhhcCCCCCcceeHHHHHHH
Q 016471 245 YLRAQFMLLEP-KDGCVSLNNFKVALMRQATD---AMTDSRVFEILNVMEPLSDQKLAYEEFCAA 305 (389)
Q Consensus 245 ~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~---~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~ 305 (389)
+++..|..+|. ++|+|+.+||..++..++.. ....+.+..+|+.+|.+++|.|+|+||+.+
T Consensus 1 ~l~~~F~~~D~d~~G~i~~~el~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~i~~~Ef~~~ 65 (66)
T PF13499_consen 1 RLKEAFKKFDKDGDGYISKEELRRALKHLGRDMSDEESDEMIDQIFREFDTDGDGRISFDEFLNF 65 (66)
T ss_dssp HHHHHHHHHSTTSSSEEEHHHHHHHHHHTTSHSTHHHHHHHHHHHHHHHTTTSSSSEEHHHHHHH
T ss_pred CHHHHHHHHcCCccCCCCHHHHHHHHHHhcccccHHHHHHHHHHHHHHhCCCCcCCCcHHHHhcc
Confidence 36778888888 88888888888888888742 122344555688888888888888888764
|
... |
| >PTZ00183 centrin; Provisional | Back alignment and domain information |
|---|
Probab=98.89 E-value=1e-08 Score=85.32 Aligned_cols=100 Identities=11% Similarity=0.174 Sum_probs=80.1
Q ss_pred HHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHH
Q 016471 245 YLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAI 323 (389)
Q Consensus 245 ~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~ 323 (389)
.+...|..+|. ++|.|+.+||..++............+..+|..+|.+++|.|+.+||...+........ ...+.
T Consensus 54 ~~~~l~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~l~~~F~~~D~~~~G~i~~~e~~~~l~~~~~~l~----~~~~~ 129 (158)
T PTZ00183 54 EIKQMIADVDKDGSGKIDFEEFLDIMTKKLGERDPREEILKAFRLFDDDKTGKISLKNLKRVAKELGETIT----DEELQ 129 (158)
T ss_pred HHHHHHHHhCCCCCCcEeHHHHHHHHHHHhcCCCcHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCC----HHHHH
Confidence 35577777898 99999999999887654323345678999999999999999999999987664322222 34688
Q ss_pred HHHHHHcccCCCcccHHHHHHHhCC
Q 016471 324 TAFDYFEQEGNRVISVEELALELNL 348 (389)
Q Consensus 324 ~aF~~~D~d~~G~I~~~el~~~l~~ 348 (389)
.+|..+|.|++|.|+.+|+..++..
T Consensus 130 ~~~~~~d~~~~g~i~~~ef~~~~~~ 154 (158)
T PTZ00183 130 EMIDEADRNGDGEISEEEFYRIMKK 154 (158)
T ss_pred HHHHHhCCCCCCcCcHHHHHHHHhc
Confidence 9999999999999999999998843
|
|
| >KOG0027 consensus Calmodulin and related proteins (EF-Hand superfamily) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.89 E-value=8.9e-09 Score=85.11 Aligned_cols=99 Identities=17% Similarity=0.160 Sum_probs=83.0
Q ss_pred HHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHhCC-------c--
Q 016471 279 DSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALELNL-------A-- 349 (389)
Q Consensus 279 ~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~-------~-- 349 (389)
..++.++|..+|.+++|.|+-.|+-..+.......+ +..+...++.+|.|++|.|+.+|+..++.. .
T Consensus 7 ~~el~~~F~~fD~d~~G~i~~~el~~~lr~lg~~~t----~~el~~~~~~~D~dg~g~I~~~eF~~l~~~~~~~~~~~~~ 82 (151)
T KOG0027|consen 7 ILELKEAFQLFDKDGDGKISVEELGAVLRSLGQNPT----EEELRDLIKEIDLDGDGTIDFEEFLDLMEKLGEEKTDEEA 82 (151)
T ss_pred HHHHHHHHHHHCCCCCCcccHHHHHHHHHHcCCCCC----HHHHHHHHHHhCCCCCCeEcHHHHHHHHHhhhcccccccc
Confidence 356789999999999999999999886665544333 467899999999999999999999999821 1
Q ss_pred -h-HHHHHHHHHccCCCCceeHHHHHHHHccccC
Q 016471 350 -P-AAYSLLNDCIRNSDGKLSFLGYKRFLHGVTV 381 (389)
Q Consensus 350 -~-~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~ 381 (389)
. .+.++|+.+|.|++|.|+.+|+.++|+...-
T Consensus 83 ~~~el~eaF~~fD~d~~G~Is~~el~~~l~~lg~ 116 (151)
T KOG0027|consen 83 SSEELKEAFRVFDKDGDGFISASELKKVLTSLGE 116 (151)
T ss_pred cHHHHHHHHHHHccCCCCcCcHHHHHHHHHHhCC
Confidence 1 2889999999999999999999999987653
|
|
| >cd05022 S-100A13 S-100A13: S-100A13 domain found in proteins similar to S100A13 | Back alignment and domain information |
|---|
Probab=98.88 E-value=7.7e-09 Score=76.46 Aligned_cols=67 Identities=18% Similarity=0.260 Sum_probs=58.1
Q ss_pred HHHHHHHHHhhhcCC--CCCcccHHHHHHHHHH-hccccCCH-HHHHHHHhhcCCCCCcceeHHHHHHHHhc
Q 016471 241 EELVYLRAQFMLLEP--KDGCVSLNNFKVALMR-QATDAMTD-SRVFEILNVMEPLSDQKLAYEEFCAAATS 308 (389)
Q Consensus 241 ee~~~l~~~F~~~D~--~~G~i~~~el~~~l~~-~~~~~~~~-~~~~~~~~~~d~~~~g~i~~~eF~~~~~~ 308 (389)
..+..+..+|..+|. ++|+|+.+||+..+.. ++. .++. ++++++++.+|.|+||.|+|+||+..+..
T Consensus 5 ~ai~~l~~~F~~fd~~~~~g~i~~~ELk~ll~~elg~-~ls~~~~v~~mi~~~D~d~DG~I~F~EF~~l~~~ 75 (89)
T cd05022 5 KAIETLVSNFHKASVKGGKESLTASEFQELLTQQLPH-LLKDVEGLEEKMKNLDVNQDSKLSFEEFWELIGE 75 (89)
T ss_pred HHHHHHHHHHHHHhCCCCCCeECHHHHHHHHHHHhhh-hccCHHHHHHHHHHhCCCCCCCCcHHHHHHHHHH
Confidence 346678899999998 8999999999999998 764 3676 89999999999999999999999886554
|
S100A13 is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100A13 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100A13 is involved in the cellular export of interleukin-1 (IL-1) and of fibroblast growth factor-1 (FGF-1), which plays an important role in angiogenesis and tissue regeneration. Export is based on the CuII-dependent formation of multiprotein complexes containing the S100A13 protein. Assembly of these complexes occurs near the inner surface of the plasma membrane. Binding of two Ca(II) ions per monomer triggers key conformational changes leading to the creation of two identical and symmetrical Cu(II)-binding sites on the surface of the protein, close to the interface between the two monomers. These Cu |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.84 E-value=6.5e-09 Score=100.78 Aligned_cols=77 Identities=19% Similarity=0.312 Sum_probs=58.8
Q ss_pred cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHH-HHHHHHHCCCEecCCCCCcEEEeecCCCCCEEEeecCC
Q 016471 12 SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILN-IVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGL 90 (389)
Q Consensus 12 ~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~-~L~~lH~~~i~Hrdlkp~Nill~~~~~~~~~kl~Dfg~ 90 (389)
+..-++||||++|++|.+.......... ...++.+++. .+..+|..|++|+|+||.||++ ..++.++++|||+
T Consensus 230 ~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~~H~D~hPgNilv---~~~g~i~liDfG~ 303 (437)
T TIGR01982 230 TSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGFFHADLHPGNIFV---LKDGKIIALDFGI 303 (437)
T ss_pred cCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCceeCCCCcccEEE---CCCCcEEEEeCCC
Confidence 4557899999999999886543211222 2345555555 4788999999999999999999 4678899999998
Q ss_pred cccc
Q 016471 91 SDFV 94 (389)
Q Consensus 91 a~~~ 94 (389)
+...
T Consensus 304 ~~~l 307 (437)
T TIGR01982 304 VGRL 307 (437)
T ss_pred eeEC
Confidence 8654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd00213 S-100 S-100: S-100 domain, which represents the largest family within the superfamily of proteins carrying the Ca-binding EF-hand motif | Back alignment and domain information |
|---|
Probab=98.83 E-value=7.5e-09 Score=77.18 Aligned_cols=63 Identities=22% Similarity=0.332 Sum_probs=54.3
Q ss_pred HHHHHHHHHHHcc--cCCCcccHHHHHHHhCC------c----hH-HHHHHHHHccCCCCceeHHHHHHHHccccC
Q 016471 319 DQIAITAFDYFEQ--EGNRVISVEELALELNL------A----PA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVTV 381 (389)
Q Consensus 319 ~~~l~~aF~~~D~--d~~G~I~~~el~~~l~~------~----~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~ 381 (389)
.+.++.+|..||+ |++|+|+.+||+.++.. . .. +..++..+|.+++|.|+|+||+.+|.....
T Consensus 7 ~~~l~~~F~~~D~~~~~~G~Is~~el~~~l~~~~g~~~~~~~~~~ei~~i~~~~d~~~~g~I~f~eF~~~~~~~~~ 82 (88)
T cd00213 7 IETIIDVFHKYSGKEGDKDTLSKKELKELLETELPNFLKNQKDPEAVDKIMKDLDVNKDGKVDFQEFLVLIGKLAV 82 (88)
T ss_pred HHHHHHHHHHHhhccCCCCcCcHHHHHHHHHHHhhhhccCCCCHHHHHHHHHHhccCCCCcCcHHHHHHHHHHHHH
Confidence 4568999999999 89999999999998721 1 22 999999999999999999999999987643
|
Note that this S-100 hierarchy contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins are expressed exclusively in vertebrates, and are implicated in intracellular and extracellular regulatory activities. Intracellularly, S100 proteins act as Ca-signaling or Ca-buffering proteins. The most unusual characteristic of certain S100 proteins is their occurrence in extracellular space, where they act in a cytokine-like manner through RAGE, the receptor for advanced glycation products. Structural data suggest that many S100 members exist within cells as homo- or heterodimers and even oligomers; oligomerization contributes to their functional diversification. Upon binding calcium, most S100 proteins change conformation to a more open structure exposing a hydrophobic cleft. This hydrophobic surface represents th |
| >smart00027 EH Eps15 homology domain | Back alignment and domain information |
|---|
Probab=98.81 E-value=2.5e-08 Score=75.62 Aligned_cols=72 Identities=24% Similarity=0.360 Sum_probs=63.0
Q ss_pred hcCHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhH
Q 016471 237 ALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQ 311 (389)
Q Consensus 237 ~l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~ 311 (389)
.++.++...++..|..+|. ++|.|+.+|++.+++..+ ++.+++.+++..+|.+++|.|+|+||+.++....+
T Consensus 3 ~ls~~~~~~l~~~F~~~D~d~~G~Is~~el~~~l~~~~---~~~~ev~~i~~~~d~~~~g~I~~~eF~~~~~~~~~ 75 (96)
T smart00027 3 AISPEDKAKYEQIFRSLDKNQDGTVTGAQAKPILLKSG---LPQTLLAKIWNLADIDNDGELDKDEFALAMHLIYR 75 (96)
T ss_pred CCCHHHHHHHHHHHHHhCCCCCCeEeHHHHHHHHHHcC---CCHHHHHHHHHHhcCCCCCCcCHHHHHHHHHHHHH
Confidence 3567889999999999999 999999999999998864 57788999999999999999999999986554433
|
Pair of EF hand motifs that recognise proteins containing Asn-Pro-Phe (NPF) sequences. |
| >cd05027 S-100B S-100B: S-100B domain found in proteins similar to S100B | Back alignment and domain information |
|---|
Probab=98.80 E-value=2.5e-08 Score=73.87 Aligned_cols=65 Identities=15% Similarity=0.188 Sum_probs=57.0
Q ss_pred HHHHHHHHhhhcC-C-CCC-cccHHHHHHHHHH-----hccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHh
Q 016471 242 ELVYLRAQFMLLE-P-KDG-CVSLNNFKVALMR-----QATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAAT 307 (389)
Q Consensus 242 e~~~l~~~F~~~D-~-~~G-~i~~~el~~~l~~-----~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~ 307 (389)
-+..+..+|..+| . ++| .|+.+||+.+|+. ++. ..++++++++++.+|.|++|.|+|+||+..+.
T Consensus 6 ~~~~l~~aF~~fD~~dgdG~~I~~~eL~~ll~~~~~~~lg~-~~~~~~v~~~i~~~D~n~dG~v~f~eF~~li~ 78 (88)
T cd05027 6 AMVALIDVFHQYSGREGDKHKLKKSELKELINNELSHFLEE-IKEQEVVDKVMETLDSDGDGECDFQEFMAFVA 78 (88)
T ss_pred HHHHHHHHHHHhcccCCCcCEECHHHHHHHHHHHhHHHhcC-CCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHH
Confidence 4667899999998 6 899 5999999999998 665 46888999999999999999999999987544
|
S100B is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100B group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100B is most abundant in glial cells of the central nervous system, predominately in astrocytes. S100B is involved in signal transduction via the inhibition of protein phoshorylation, regulation of enzyme activity and by affecting the calcium homeostasis. Upon calcium binding the S100B homodimer changes conformation to expose a hydrophobic cleft, which represents the interaction site of S100B with its more than 20 known target proteins. These target proteins include several cellular architecture proteins such as tubulin and GFAP; S100B can inhibit polymerization of these oligomeric molecules. Furthermore, S100B i |
| >COG5126 FRQ1 Ca2+-binding protein (EF-Hand superfamily) [Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only] | Back alignment and domain information |
|---|
Probab=98.78 E-value=6.5e-08 Score=78.80 Aligned_cols=90 Identities=12% Similarity=0.202 Sum_probs=57.9
Q ss_pred cCCCCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHHHHHccc
Q 016471 253 LEPKDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQE 332 (389)
Q Consensus 253 ~D~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D~d 332 (389)
+|.+.|.|+..+|-.++........+.+++...|+.+|.|++|.|+..|....+........ ++.+...++.+|.|
T Consensus 65 ~d~~~~~idf~~Fl~~ms~~~~~~~~~Eel~~aF~~fD~d~dG~Is~~eL~~vl~~lge~~~----deev~~ll~~~d~d 140 (160)
T COG5126 65 IDAGNETVDFPEFLTVMSVKLKRGDKEEELREAFKLFDKDHDGYISIGELRRVLKSLGERLS----DEEVEKLLKEYDED 140 (160)
T ss_pred ccCCCCccCHHHHHHHHHHHhccCCcHHHHHHHHHHhCCCCCceecHHHHHHHHHhhcccCC----HHHHHHHHHhcCCC
Confidence 33356777777777766555433345677777777777777777777777765543322222 34567777777777
Q ss_pred CCCcccHHHHHHHh
Q 016471 333 GNRVISVEELALEL 346 (389)
Q Consensus 333 ~~G~I~~~el~~~l 346 (389)
++|+|+.+++.+.+
T Consensus 141 ~dG~i~~~eF~~~~ 154 (160)
T COG5126 141 GDGEIDYEEFKKLI 154 (160)
T ss_pred CCceEeHHHHHHHH
Confidence 77777777777654
|
|
| >KOG0044 consensus Ca2+ sensor (EF-Hand superfamily) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.78 E-value=5.7e-08 Score=81.98 Aligned_cols=116 Identities=16% Similarity=0.244 Sum_probs=87.7
Q ss_pred HHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHh----
Q 016471 240 EEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEA---- 314 (389)
Q Consensus 240 ~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~---- 314 (389)
.........+|..+|. ++|.|+..||-.+|...-.. -.++-+.=.|+.+|.|++|.|+++|++..+........
T Consensus 60 gd~~~y~~~vF~~fD~~~dg~i~F~Efi~als~~~rG-t~eekl~w~F~lyD~dgdG~It~~Eml~iv~~i~~m~~~~~~ 138 (193)
T KOG0044|consen 60 GDASKYAELVFRTFDKNKDGTIDFLEFICALSLTSRG-TLEEKLKWAFRLYDLDGDGYITKEEMLKIVQAIYQMTGSKAL 138 (193)
T ss_pred CCHHHHHHHHHHHhcccCCCCcCHHHHHHHHHHHcCC-cHHHHhhhhheeecCCCCceEcHHHHHHHHHHHHHHcccccC
Confidence 3345566788999999 99999999998888766432 23445677799999999999999999876554433322
Q ss_pred ---hHHHHHHHHHHHHHHcccCCCcccHHHHHHHhCCchHHHHHH
Q 016471 315 ---LERWDQIAITAFDYFEQEGNRVISVEELALELNLAPAAYSLL 356 (389)
Q Consensus 315 ---~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~~~~~~~~ 356 (389)
.+.-++.....|+.+|.|+||.||.+|+.......+.+-.++
T Consensus 139 ~~~~~~~~~~v~~if~k~D~n~Dg~lT~eef~~~~~~d~~i~~~l 183 (193)
T KOG0044|consen 139 PEDEETPEERVDKIFSKMDKNKDGKLTLEEFIEGCKADPSILRAL 183 (193)
T ss_pred CcccccHHHHHHHHHHHcCCCCCCcccHHHHHHHhhhCHHHHHHh
Confidence 111256788999999999999999999999986666633333
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.77 E-value=4.9e-07 Score=85.91 Aligned_cols=167 Identities=15% Similarity=0.237 Sum_probs=122.5
Q ss_pred CCCcccccee--------ecCeEEEEEEccCC-CChHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHH
Q 016471 1 MYHQKLQHLF--------YSNSFLFFTRFCEG-GELLDRILSR--------------GGRYLEEDAKTIVEKILNIVAFC 57 (389)
Q Consensus 1 l~Hpni~~~~--------~~~~~~lv~E~~~g-g~L~~~l~~~--------------~~~l~~~~~~~i~~qi~~~L~~l 57 (389)
+.|+|+|.+. .+..+++|++|+++ ++|.++.... +...+|..++.++.|+..||.++
T Consensus 330 l~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sI 409 (655)
T KOG3741|consen 330 LCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSI 409 (655)
T ss_pred hccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHH
Confidence 5799999876 46789999999988 6888766432 23467899999999999999999
Q ss_pred HHCCCEecCCCCCcEEEeecCCCCCEEEeecCCccccCCCCCcccccccCCccccccccccCCCchhHHHHHHHHHHHHh
Q 016471 58 HLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLC 137 (389)
Q Consensus 58 H~~~i~Hrdlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~ 137 (389)
|+.|+.-+-|.|.+|+++ ++.+++|+..|.......+.. +.+. --.+-|.=.||.+++.|.+
T Consensus 410 HssGLAck~L~~~kIlv~---G~~RIriS~C~i~Dvl~~d~~-------------~~le--~~Qq~D~~~lG~ll~aLAt 471 (655)
T KOG3741|consen 410 HSSGLACKTLDLKKILVT---GKMRIRISGCGIMDVLQEDPT-------------EPLE--SQQQNDLRDLGLLLLALAT 471 (655)
T ss_pred HhcCceeecccHhHeEee---CcceEEEecccceeeecCCCC-------------cchh--HHhhhhHHHHHHHHHHHhh
Confidence 999999999999999995 556899988887665544330 1111 1234688899999999999
Q ss_pred CCCCC-CCCChhHH-HHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCC
Q 016471 138 GSRPF-WARTESGI-FRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 197 (389)
Q Consensus 138 g~~pf-~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h 197 (389)
|..-- ........ ...|. +.+|.+++++|.-+...+++. -++.+++.+
T Consensus 472 ~~~ns~~~d~~~~s~~~~I~-----------~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 472 GTENSNRTDSTQSSHLTRIT-----------TTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred cccccccccchHHHHHHHhh-----------hhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 85431 11122221 22221 347889999999998888886 677777754
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.77 E-value=1.4e-07 Score=87.33 Aligned_cols=176 Identities=18% Similarity=0.257 Sum_probs=122.3
Q ss_pred eEEEEEEccCCCChHHHHHh---cC---CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeecCCCCCEEEee
Q 016471 14 SFLFFTRFCEGGELLDRILS---RG---GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVID 87 (389)
Q Consensus 14 ~~~lv~E~~~gg~L~~~l~~---~~---~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~~~~~~~kl~D 87 (389)
.+-+.|..++|..-...+.+ +. ....+..+....+.++.+..-||..|.+-+|+.++|+|++ +.+.|.|+|
T Consensus 84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVs---d~~~V~LVd 160 (637)
T COG4248 84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVS---DDSKVVLVD 160 (637)
T ss_pred eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeee---cCceEEEEc
Confidence 36788999988644333321 12 2345688999999999999999999999999999999995 677899988
Q ss_pred cCCccccCCCCCcccccccCCcccccccc-c-----cCCCchhHHHHHHHHHHHHhC-CCCCCCCCh----hHHHH-HHH
Q 016471 88 FGLSDFVRPDQRLNDIVGSAYYVAPEVLH-R-----SYNVEGDMWSIGVITYILLCG-SRPFWARTE----SGIFR-SVL 155 (389)
Q Consensus 88 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~-----~~~~~~DiwslG~il~~ll~g-~~pf~~~~~----~~~~~-~i~ 155 (389)
-.--.....+......+|.+.|.+||.-. + .-+...|.|.|||++++++.| ++||.|... ..-+. .|.
T Consensus 161 sDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia 240 (637)
T COG4248 161 SDSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIA 240 (637)
T ss_pred ccceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhh
Confidence 54322223333344568999999999643 2 246778999999999999985 999965321 00011 111
Q ss_pred h---------c---CCCCCCCCCCCCCHHHHHHHHhhhccC--cCCCCCHH
Q 016471 156 R---------A---DPNFHDSPWPSVSPEAKDFVRRLLNKD--HRKRMTAA 192 (389)
Q Consensus 156 ~---------~---~~~~~~~~~~~~~~~~~~li~~~l~~~--p~~R~s~~ 192 (389)
. . .+.....+|.-+++++..+..+|+... +.-|||++
T Consensus 241 ~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~ 291 (637)
T COG4248 241 HGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK 291 (637)
T ss_pred cceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence 1 1 111223345568999999999998764 56899874
|
|
| >PF13833 EF-hand_8: EF-hand domain pair; PDB: 3KF9_A 1TTX_A 1WLZ_A 1ALV_A 1NX3_A 1ALW_A 1NX2_A 1NX1_A 1NX0_A 1DF0_A | Back alignment and domain information |
|---|
Probab=98.74 E-value=2.6e-08 Score=66.76 Aligned_cols=52 Identities=19% Similarity=0.406 Sum_probs=46.2
Q ss_pred CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHh
Q 016471 256 KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAAT 307 (389)
Q Consensus 256 ~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~ 307 (389)
++|.|+.++|+.++..+|...++++++..+|..+|.+++|.|+|+||+.++.
T Consensus 1 ~~G~i~~~~~~~~l~~~g~~~~s~~e~~~l~~~~D~~~~G~I~~~EF~~~~~ 52 (54)
T PF13833_consen 1 KDGKITREEFRRALSKLGIKDLSEEEVDRLFREFDTDGDGYISFDEFISMMQ 52 (54)
T ss_dssp SSSEEEHHHHHHHHHHTTSSSSCHHHHHHHHHHHTTSSSSSEEHHHHHHHHH
T ss_pred CcCEECHHHHHHHHHHhCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Confidence 4799999999999977776338999999999999999999999999998653
|
... |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.74 E-value=3.8e-08 Score=81.72 Aligned_cols=72 Identities=26% Similarity=0.466 Sum_probs=58.2
Q ss_pred ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeecCCCCCEEEeecCC
Q 016471 11 YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGL 90 (389)
Q Consensus 11 ~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~~~~~~~kl~Dfg~ 90 (389)
+.....|+|||.+|-.|.+.+... ...+++.|=.-+.-||..||+|+||.++||+++ ++.+.++|||+
T Consensus 70 D~~~~~I~me~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~----~~~i~~IDfGL 137 (204)
T COG3642 70 DPDNGLIVMEYIEGELLKDALEEA--------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILS----GGRIYFIDFGL 137 (204)
T ss_pred cCCCCEEEEEEeCChhHHHHHHhc--------chHHHHHHHHHHHHHHhcCeecCCCccceEEEe----CCcEEEEECCc
Confidence 456678999999998888877544 145666676777889999999999999999995 44599999999
Q ss_pred cccc
Q 016471 91 SDFV 94 (389)
Q Consensus 91 a~~~ 94 (389)
+...
T Consensus 138 g~~s 141 (204)
T COG3642 138 GEFS 141 (204)
T ss_pred cccc
Confidence 8753
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.73 E-value=8.3e-08 Score=86.69 Aligned_cols=80 Identities=24% Similarity=0.257 Sum_probs=64.9
Q ss_pred CeEEEEEEccCCC-ChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee----cCCCCCEEEe
Q 016471 13 NSFLFFTRFCEGG-ELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT----REEDAPLKVI 86 (389)
Q Consensus 13 ~~~~lv~E~~~gg-~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~----~~~~~~~kl~ 86 (389)
...++|||+++|- +|.+++... ....++.....++.+++..+.-||..||+|+|+++.|||+.. .++...+.++
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LI 187 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVI 187 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEE
Confidence 3578999999986 787776432 234667788899999999999999999999999999999963 1235679999
Q ss_pred ecCCcc
Q 016471 87 DFGLSD 92 (389)
Q Consensus 87 Dfg~a~ 92 (389)
||+.+.
T Consensus 188 Dl~r~~ 193 (268)
T PRK15123 188 DLHRAQ 193 (268)
T ss_pred ECCccc
Confidence 999775
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.71 E-value=7.1e-08 Score=79.84 Aligned_cols=84 Identities=24% Similarity=0.366 Sum_probs=66.9
Q ss_pred ecCeEEEEEEccCC-CChHHHHHhcCCCCCHHHH-HHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeecCCCCCEEEeec
Q 016471 11 YSNSFLFFTRFCEG-GELLDRILSRGGRYLEEDA-KTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDF 88 (389)
Q Consensus 11 ~~~~~~lv~E~~~g-g~L~~~l~~~~~~l~~~~~-~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~~~~~~~kl~Df 88 (389)
+...-.|+|||..| .++.+++......-.+... ..++++|=+.+.-||.++|+|+||..+||++...++...+.++||
T Consensus 81 D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdf 160 (229)
T KOG3087|consen 81 DTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDF 160 (229)
T ss_pred ecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEee
Confidence 34556789999988 5788888776544444444 788899999999999999999999999999986555556799999
Q ss_pred CCcccc
Q 016471 89 GLSDFV 94 (389)
Q Consensus 89 g~a~~~ 94 (389)
|++...
T Consensus 161 gls~~s 166 (229)
T KOG3087|consen 161 GLSSVS 166 (229)
T ss_pred cchhcc
Confidence 997653
|
|
| >cd05026 S-100Z S-100Z: S-100Z domain found in proteins similar to S100Z | Back alignment and domain information |
|---|
Probab=98.70 E-value=6.6e-08 Score=72.60 Aligned_cols=68 Identities=19% Similarity=0.240 Sum_probs=54.9
Q ss_pred HHHHHHHHhhhcC-C-CCC-cccHHHHHHHHHHh-c---cccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhch
Q 016471 242 ELVYLRAQFMLLE-P-KDG-CVSLNNFKVALMRQ-A---TDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSV 309 (389)
Q Consensus 242 e~~~l~~~F~~~D-~-~~G-~i~~~el~~~l~~~-~---~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~ 309 (389)
-+..+..+|..+| . ++| .|+.+||+.++... + ....+..+++++++.+|.|++|.|+|+||+..+...
T Consensus 8 a~~~~~~~F~~~dd~dgdg~~Is~~EL~~ll~~~~~~~~~~~~~~~~v~~i~~elD~n~dG~Idf~EF~~l~~~l 82 (93)
T cd05026 8 AMDTLIRIFHNYSGKEGDRYKLSKGELKELLQRELTDFLSSQKDPMLVDKIMNDLDSNKDNEVDFNEFVVLVAAL 82 (93)
T ss_pred HHHHHHHHHHHHHccCCCCCEECHHHHHHHHHHHhHHhcccccCHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 3566788899999 4 777 59999999999763 2 122467789999999999999999999999865544
|
S100Z is a member of the S100 domain family within the EF-hand Ca2+-binding proteins superfamily. Note that the S-100 hierarchy, to which this S-100Z group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately.S100 proteins exhibit unique patterns of tissue- and cell type-specific expression and have been implicated in the Ca2+-dependent regulation of diverse physiological processes, including cell cycle regulation, differentiation, growth, and metabolic control. S100Z is normally expressed in various tissues, with its highest level of expression being in spleen and leukocytes. The function of S100Z remains unclear. Preliminary structural data suggests that S100Z is homodimer, however a heterodimer with S100P has been reported. S100Z is capable of binding calcium ions. When calcium binds to S110Z, the protein experiences a conformational change, which exposes hydrophobic surfac |
| >KOG0028 consensus Ca2+-binding protein (centrin/caltractin), EF-Hand superfamily protein [Cytoskeleton; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.70 E-value=6.2e-08 Score=77.18 Aligned_cols=98 Identities=15% Similarity=0.171 Sum_probs=78.0
Q ss_pred HHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHh----CC--chH-
Q 016471 279 DSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALEL----NL--APA- 351 (389)
Q Consensus 279 ~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l----~~--~~~- 351 (389)
.+++...|..+|.+++|.||++|+-.++...--... .+.+.+.-.-+|+++.|.|+.+++++++ +. +.+
T Consensus 32 ~q~i~e~f~lfd~~~~g~iD~~EL~vAmralGFE~~----k~ei~kll~d~dk~~~g~i~fe~f~~~mt~k~~e~dt~eE 107 (172)
T KOG0028|consen 32 KQEIKEAFELFDPDMAGKIDVEELKVAMRALGFEPK----KEEILKLLADVDKEGSGKITFEDFRRVMTVKLGERDTKEE 107 (172)
T ss_pred HhhHHHHHHhhccCCCCcccHHHHHHHHHHcCCCcc----hHHHHHHHHhhhhccCceechHHHHHHHHHHHhccCcHHH
Confidence 356889999999999999999999544433221111 3457777888999999999999999987 22 222
Q ss_pred HHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 352 AYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 352 ~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
+..+|+..|.|++|+|++.+|+.++..+.
T Consensus 108 i~~afrl~D~D~~Gkis~~~lkrvakeLg 136 (172)
T KOG0028|consen 108 IKKAFRLFDDDKTGKISQRNLKRVAKELG 136 (172)
T ss_pred HHHHHHcccccCCCCcCHHHHHHHHHHhC
Confidence 89999999999999999999999998775
|
|
| >PTZ00184 calmodulin; Provisional | Back alignment and domain information |
|---|
Probab=98.69 E-value=1.2e-07 Score=77.86 Aligned_cols=98 Identities=14% Similarity=0.204 Sum_probs=77.4
Q ss_pred HHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHH
Q 016471 245 YLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAI 323 (389)
Q Consensus 245 ~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~ 323 (389)
.+...|..+|. ++|.|+.+||..++............+..+|..+|.+++|.|+.+||..++........ .+.+.
T Consensus 48 ~~~~~~~~~d~~~~g~i~~~ef~~~l~~~~~~~~~~~~~~~~F~~~D~~~~g~i~~~e~~~~l~~~~~~~~----~~~~~ 123 (149)
T PTZ00184 48 ELQDMINEVDADGNGTIDFPEFLTLMARKMKDTDSEEEIKEAFKVFDRDGNGFISAAELRHVMTNLGEKLT----DEEVD 123 (149)
T ss_pred HHHHHHHhcCcCCCCcCcHHHHHHHHHHhccCCcHHHHHHHHHHhhCCCCCCeEeHHHHHHHHHHHCCCCC----HHHHH
Confidence 45677888888 89999999999887654332345567899999999999999999999876543321112 34578
Q ss_pred HHHHHHcccCCCcccHHHHHHHh
Q 016471 324 TAFDYFEQEGNRVISVEELALEL 346 (389)
Q Consensus 324 ~aF~~~D~d~~G~I~~~el~~~l 346 (389)
.+|..+|.+++|.|+.+|+..++
T Consensus 124 ~~~~~~d~~~~g~i~~~ef~~~~ 146 (149)
T PTZ00184 124 EMIREADVDGDGQINYEEFVKMM 146 (149)
T ss_pred HHHHhcCCCCCCcCcHHHHHHHH
Confidence 89999999999999999998876
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.67 E-value=3.8e-08 Score=82.88 Aligned_cols=68 Identities=32% Similarity=0.502 Sum_probs=54.0
Q ss_pred CeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCC-----EecCCCCCcEEEeecCCCCCEEEee
Q 016471 13 NSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGV-----VHRDLKPENFLFTTREEDAPLKVID 87 (389)
Q Consensus 13 ~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i-----~Hrdlkp~Nill~~~~~~~~~kl~D 87 (389)
..-++||||++|.++.+. ......++.+++.+|..||+.++ +|+|++|.||+++ ++.++++|
T Consensus 64 ~~~~lv~e~i~G~~l~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~----~~~~~liD 130 (170)
T cd05151 64 ETGVLITEFIEGSELLTE---------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD----DGRLWLID 130 (170)
T ss_pred CCCeEEEEecCCCccccc---------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE----CCeEEEEe
Confidence 345899999999888642 01123466799999999999985 9999999999994 45799999
Q ss_pred cCCccc
Q 016471 88 FGLSDF 93 (389)
Q Consensus 88 fg~a~~ 93 (389)
||.+..
T Consensus 131 f~~a~~ 136 (170)
T cd05151 131 WEYAGM 136 (170)
T ss_pred cccccC
Confidence 998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0041 consensus Predicted Ca2+-binding protein, EF-Hand protein superfamily [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.64 E-value=6.9e-08 Score=79.60 Aligned_cols=61 Identities=18% Similarity=0.310 Sum_probs=54.3
Q ss_pred HHHHHHHHHcccCCCcccHHHHHHHh---CCchH---HHHHHHHHccCCCCceeHHHHHHHHccccC
Q 016471 321 IAITAFDYFEQEGNRVISVEELALEL---NLAPA---AYSLLNDCIRNSDGKLSFLGYKRFLHGVTV 381 (389)
Q Consensus 321 ~l~~aF~~~D~d~~G~I~~~el~~~l---~~~~~---~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~ 381 (389)
.+..+|+.||.+.||+|+..||+.+| |.+.+ +..|++++|.|.||+|+|-||.-+...+.+
T Consensus 100 ~~~~~Fk~yDe~rDgfIdl~ELK~mmEKLgapQTHL~lK~mikeVded~dgklSfreflLIfrkaaa 166 (244)
T KOG0041|consen 100 DAESMFKQYDEDRDGFIDLMELKRMMEKLGAPQTHLGLKNMIKEVDEDFDGKLSFREFLLIFRKAAA 166 (244)
T ss_pred HHHHHHHHhcccccccccHHHHHHHHHHhCCchhhHHHHHHHHHhhcccccchhHHHHHHHHHHHhc
Confidence 47889999999999999999999999 55544 899999999999999999999998877654
|
|
| >cd05029 S-100A6 S-100A6: S-100A6 domain found in proteins similar to S100A6 | Back alignment and domain information |
|---|
Probab=98.62 E-value=1.5e-07 Score=69.73 Aligned_cols=66 Identities=14% Similarity=0.266 Sum_probs=54.9
Q ss_pred HHHHHHHHhhhcCC--C-CCcccHHHHHHHHHH---hccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhc
Q 016471 242 ELVYLRAQFMLLEP--K-DGCVSLNNFKVALMR---QATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATS 308 (389)
Q Consensus 242 e~~~l~~~F~~~D~--~-~G~i~~~el~~~l~~---~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~ 308 (389)
.+..+-..|..+|. + +|.|+.+||+.++.+ +|. .++.++++++++.+|.|++|.|+|+||+..+..
T Consensus 8 ~~~~~i~~F~~y~~~~~~~g~Is~~EL~~~l~~~~~lg~-k~t~~ev~~m~~~~D~d~dG~Idf~EFv~lm~~ 79 (88)
T cd05029 8 AIGLLVAIFHKYSGREGDKNTLSKKELKELIQKELTIGS-KLQDAEIAKLMEDLDRNKDQEVNFQEYVTFLGA 79 (88)
T ss_pred HHHHHHHHHHHHHccCCCCCEECHHHHHHHHHHHHhcCC-CCCHHHHHHHHHHhcCCCCCCCcHHHHHHHHHH
Confidence 45567778888886 3 679999999999964 454 479999999999999999999999999875443
|
S100A6 is a member of the S100 domain family within EF-hand Ca2+-binding proteins superfamily. Note that the S-100 hierarchy, to which this S-100A6 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins exhibit unique patterns of tissue- and cell type-specific expression and have been implicated in the Ca2+-dependent regulation of diverse physiological processes, including cell cycle regulation, differentiation, growth, and metabolic control . S100A6 is normally expressed in the G1 phase of the cell cycle in neuronal cells. The function of S100A6 remains unclear, but evidence suggests that it is involved in cell cycle regulation and exocytosis. S100A6 may also be involved in tumorigenesis; the protein is overexpressed in several tumors. Ca2+ binding to S100A6 leads to a conformational change in the protein, which exposes a hydrophobic surface for interact |
| >KOG0377 consensus Protein serine/threonine phosphatase RDGC/PPEF, contains STphosphatase and EF-hand domains [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.59 E-value=1.1e-06 Score=81.09 Aligned_cols=143 Identities=21% Similarity=0.272 Sum_probs=95.5
Q ss_pred HHHHHHHhcCHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHh--hcCCCCCcceeHHHHHHHH
Q 016471 230 ALKALSKALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILN--VMEPLSDQKLAYEEFCAAA 306 (389)
Q Consensus 230 ~l~~i~~~l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~--~~d~~~~g~i~~~eF~~~~ 306 (389)
+++.+...+. .....+...|+..|. ++|.|+...-..++.....-.+.= ++++ ....+.||.+.|.+-+..+
T Consensus 451 Alk~Lrerl~-s~~sdL~~eF~~~D~~ksG~lsis~Wa~~mE~i~~L~LPW----r~L~~kla~~s~d~~v~Y~~~~~~l 525 (631)
T KOG0377|consen 451 ALKELRERLR-SHRSDLEDEFRKYDPKKSGKLSISHWAKCMENITGLNLPW----RLLRPKLANGSDDGKVEYKSTLDNL 525 (631)
T ss_pred HHHHHHHHHH-hhhhHHHHHHHhcChhhcCeeeHHHHHHHHHHHhcCCCcH----HHhhhhccCCCcCcceehHhHHHHh
Confidence 3444433332 234568889999999 999999999888876543212221 1222 2234557899998776432
Q ss_pred hchhHHH--------hhHHHHHHHHHHHHHHcccCCCcccHHHHHHHhCC---------chH-HHHHHHHHccCCCCcee
Q 016471 307 TSVYQLE--------ALERWDQIAITAFDYFEQEGNRVISVEELALELNL---------APA-AYSLLNDCIRNSDGKLS 368 (389)
Q Consensus 307 ~~~~~~~--------~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~---------~~~-~~~~~~~~d~~~~g~i~ 368 (389)
-.-.... +...-...+..+|+..|.|++|.||.+|++.+..+ ..+ +.++-..+|.|+||+|+
T Consensus 526 ~~e~~~~ea~~slvetLYr~ks~LetiF~~iD~D~SG~isldEF~~a~~l~~sh~~~~i~~~~i~~la~~mD~NkDG~ID 605 (631)
T KOG0377|consen 526 DTEVILEEAGSSLVETLYRNKSSLETIFNIIDADNSGEISLDEFRTAWKLLSSHMNGAISDDEILELARSMDLNKDGKID 605 (631)
T ss_pred hhhhHHHHHHhHHHHHHHhchhhHHHHHHHhccCCCCceeHHHHHHHHHHHHhhcCCCcCHHHHHHHHHhhccCCCCccc
Confidence 2111000 00011356788999999999999999999997621 222 88889999999999999
Q ss_pred HHHHHHHHc
Q 016471 369 FLGYKRFLH 377 (389)
Q Consensus 369 ~~ef~~~~~ 377 (389)
++||.+..+
T Consensus 606 lNEfLeAFr 614 (631)
T KOG0377|consen 606 LNEFLEAFR 614 (631)
T ss_pred HHHHHHHHh
Confidence 999998764
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.59 E-value=2e-07 Score=81.24 Aligned_cols=79 Identities=20% Similarity=0.333 Sum_probs=65.5
Q ss_pred eEEEEEEccCCC-ChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeecCCCCCEEEeecCCcc
Q 016471 14 SFLFFTRFCEGG-ELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 92 (389)
Q Consensus 14 ~~~lv~E~~~gg-~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~~~~~~~kl~Dfg~a~ 92 (389)
..++|||+++|- +|.+.+... ..++......++.+++..+.-||.+||+|+|++|.|||+...++...+.++||+.+.
T Consensus 91 ~s~lite~l~~~~~L~~~~~~~-~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~ 169 (206)
T PF06293_consen 91 RSYLITEALPGAQDLRDLLQQW-EQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMR 169 (206)
T ss_pred eEEEEEEeCCCcccHHHHHHhh-cccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhce
Confidence 468999999985 687776553 337778888999999999999999999999999999999654334579999999765
Q ss_pred c
Q 016471 93 F 93 (389)
Q Consensus 93 ~ 93 (389)
.
T Consensus 170 ~ 170 (206)
T PF06293_consen 170 F 170 (206)
T ss_pred e
Confidence 4
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF13833 EF-hand_8: EF-hand domain pair; PDB: 3KF9_A 1TTX_A 1WLZ_A 1ALV_A 1NX3_A 1ALW_A 1NX2_A 1NX1_A 1NX0_A 1DF0_A | Back alignment and domain information |
|---|
Probab=98.57 E-value=1.3e-07 Score=63.41 Aligned_cols=46 Identities=20% Similarity=0.308 Sum_probs=39.3
Q ss_pred CCCcccHHHHHHHh---CCc---hH-HHHHHHHHccCCCCceeHHHHHHHHcc
Q 016471 333 GNRVISVEELALEL---NLA---PA-AYSLLNDCIRNSDGKLSFLGYKRFLHG 378 (389)
Q Consensus 333 ~~G~I~~~el~~~l---~~~---~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~ 378 (389)
++|+|+.+||+.+| |.. ++ +..++..+|.|++|.|+|+||+.+|++
T Consensus 1 ~~G~i~~~~~~~~l~~~g~~~~s~~e~~~l~~~~D~~~~G~I~~~EF~~~~~~ 53 (54)
T PF13833_consen 1 KDGKITREEFRRALSKLGIKDLSEEEVDRLFREFDTDGDGYISFDEFISMMQR 53 (54)
T ss_dssp SSSEEEHHHHHHHHHHTTSSSSCHHHHHHHHHHHTTSSSSSEEHHHHHHHHHH
T ss_pred CcCEECHHHHHHHHHHhCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Confidence 47899999999988 433 33 999999999999999999999999864
|
... |
| >cd00052 EH Eps15 homology domain; found in proteins implicated in endocytosis, vesicle transport, and signal transduction | Back alignment and domain information |
|---|
Probab=98.57 E-value=2.3e-07 Score=65.14 Aligned_cols=59 Identities=27% Similarity=0.336 Sum_probs=52.0
Q ss_pred HHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhc
Q 016471 247 RAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATS 308 (389)
Q Consensus 247 ~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~ 308 (389)
+..|..+|. ++|.|+.+|++.+++..+ .+.+++.+++..+|.+++|.|+|+||+..+..
T Consensus 2 ~~~F~~~D~~~~G~i~~~el~~~l~~~g---~~~~~~~~i~~~~d~~~~g~i~~~ef~~~~~~ 61 (67)
T cd00052 2 DQIFRSLDPDGDGLISGDEARPFLGKSG---LPRSVLAQIWDLADTDKDGKLDKEEFAIAMHL 61 (67)
T ss_pred hHHHHHhCCCCCCcCcHHHHHHHHHHcC---CCHHHHHHHHHHhcCCCCCcCCHHHHHHHHHH
Confidence 467899999 999999999999998875 37788999999999999999999999986543
|
The alignment contains a pair of EF-hand motifs, typically one of them is canonical and binds to Ca2+, while the other may not bind to Ca2+. A hydrophobic binding pocket is formed by residues from both EF-hand motifs. The EH domain binds to proteins containing NPF (class I), [WF]W or SWG (class II), or H[TS]F (class III) sequence motifs. |
| >cd05025 S-100A1 S-100A1: S-100A1 domain found in proteins similar to S100A1 | Back alignment and domain information |
|---|
Probab=98.57 E-value=2.5e-07 Score=69.49 Aligned_cols=66 Identities=17% Similarity=0.173 Sum_probs=55.4
Q ss_pred HHHHHHHhhhcC-C-CCC-cccHHHHHHHHHH-hccc---cCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhc
Q 016471 243 LVYLRAQFMLLE-P-KDG-CVSLNNFKVALMR-QATD---AMTDSRVFEILNVMEPLSDQKLAYEEFCAAATS 308 (389)
Q Consensus 243 ~~~l~~~F~~~D-~-~~G-~i~~~el~~~l~~-~~~~---~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~ 308 (389)
+..+.++|..+| . ++| .|+.+||+.+|+. ++.. .++.+++++++..+|.+++|.|+|+||+..+..
T Consensus 8 ~~~l~~~F~~fDd~dg~G~~Is~~El~~~l~~~lg~~~~~~~s~~~v~~i~~~~D~d~~G~I~f~eF~~l~~~ 80 (92)
T cd05025 8 METLINVFHAHSGKEGDKYKLSKKELKDLLQTELSDFLDAQKDADAVDKIMKELDENGDGEVDFQEFVVLVAA 80 (92)
T ss_pred HHHHHHHHHHHhcccCCCCeECHHHHHHHHHHHHHHHccCCCCHHHHHHHHHHHCCCCCCcCcHHHHHHHHHH
Confidence 456889999997 8 999 5999999999975 4421 247889999999999999999999999985543
|
S100A1 is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100A1 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. As is the case with many other members of S100 protein family, S100A1 is implicated in intracellular and extracellular regulatory activities, including interaction with myosin-associated twitchin kinase, actin-capping protein CapZ, sinapsin I, and tubulin. Structural data suggests that S100A1 proteins exist within cells as antiparallel homodimers, while heterodimers with S100A4 and S100B also has been reported. Upon binding calcium S100A1 changes conformation to expose a hydrophobic cleft which is the interaction site of S100A1 with its more that 20 known target proteins. |
| >PF14658 EF-hand_9: EF-hand domain | Back alignment and domain information |
|---|
Probab=98.57 E-value=9.6e-08 Score=65.09 Aligned_cols=56 Identities=23% Similarity=0.366 Sum_probs=49.8
Q ss_pred HHHHHHcccCCCcccHHHHHHHh---CC-chH---HHHHHHHHccCCC-CceeHHHHHHHHccc
Q 016471 324 TAFDYFEQEGNRVISVEELALEL---NL-APA---AYSLLNDCIRNSD-GKLSFLGYKRFLHGV 379 (389)
Q Consensus 324 ~aF~~~D~d~~G~I~~~el~~~l---~~-~~~---~~~~~~~~d~~~~-g~i~~~ef~~~~~~~ 379 (389)
.+|.+||.++.|.|...+|..+| +. .|+ ++++.+++|+++. |.|+++.|+.+|+++
T Consensus 2 ~~F~~fD~~~tG~V~v~~l~~~Lra~~~~~p~e~~Lq~l~~elDP~g~~~~v~~d~F~~iM~~w 65 (66)
T PF14658_consen 2 TAFDAFDTQKTGRVPVSDLITYLRAVTGRSPEESELQDLINELDPEGRDGSVNFDTFLAIMRDW 65 (66)
T ss_pred cchhhcCCcCCceEeHHHHHHHHHHHcCCCCcHHHHHHHHHHhCCCCCCceEeHHHHHHHHHHh
Confidence 37999999999999999999988 33 443 9999999999987 999999999999875
|
|
| >cd05023 S-100A11 S-100A11: S-100A11 domain found in proteins similar to S100A11 | Back alignment and domain information |
|---|
Probab=98.57 E-value=3.3e-07 Score=68.00 Aligned_cols=69 Identities=16% Similarity=0.169 Sum_probs=54.5
Q ss_pred HHHHHHHHHhhh-cCC-CCC-cccHHHHHHHHHHhcc----ccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhch
Q 016471 241 EELVYLRAQFML-LEP-KDG-CVSLNNFKVALMRQAT----DAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSV 309 (389)
Q Consensus 241 ee~~~l~~~F~~-~D~-~~G-~i~~~el~~~l~~~~~----~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~ 309 (389)
..+..+..+|.. .|. ++| .|+.+||+..+..... ......+++++++.+|.|+||.|+|+||+..+...
T Consensus 6 ~~i~~l~~~F~~y~~~dg~~~~Ls~~Elk~ll~~e~~~~~~~~~~~~~~~~ll~~~D~d~DG~I~f~EF~~l~~~l 81 (89)
T cd05023 6 RCIESLIAVFQKYAGKDGDSYQLSKTEFLSFMNTELASFTKNQKDPGVLDRMMKKLDLNSDGQLDFQEFLNLIGGL 81 (89)
T ss_pred HHHHHHHHHHHHHhccCCCcCeECHHHHHHHHHHhhhHhhcCCCCHHHHHHHHHHcCCCCCCcCcHHHHHHHHHHH
Confidence 346677888998 666 654 9999999999877631 12456789999999999999999999999855543
|
S100A11 is a member of the S-100 domain family within EF-hand Ca2+-binding proteins superfamily. Note that the S-100 hierarchy, to which this S-100A11 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins exhibit unique patterns of tissue- and cell type-specific expression and have been implicated in the Ca2+-dependent regulation of diverse physiological processes, including cell cycle regulation, differentiation, growth, and metabolic control . S100 proteins have also been associated with a variety of pathological events, including neoplastic transformation and neurodegenerative diseases such as Alzheimer's, usually via over expression of the protein. S100A11 is expressed in smooth muscle and other tissues and involves in calcium-dependent membrane aggregation, which is important for cell vesiculation . As is the case for many other S100 proteins, S |
| >PLN02964 phosphatidylserine decarboxylase | Back alignment and domain information |
|---|
Probab=98.56 E-value=3.5e-07 Score=91.00 Aligned_cols=125 Identities=14% Similarity=0.101 Sum_probs=84.3
Q ss_pred HhhhcCCCCCcccHHHHHHHHHH--hccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHH
Q 016471 249 QFMLLEPKDGCVSLNNFKVALMR--QATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAF 326 (389)
Q Consensus 249 ~F~~~D~~~G~i~~~el~~~l~~--~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF 326 (389)
.|..+|. ..++.+++...... ..+..-..+++.+.|..+|.|++|.+ +...+..+-... ..+.....++.+|
T Consensus 112 ~~~~~~~--~~~s~n~lv~~~e~~~t~f~~kqi~elkeaF~lfD~dgdG~i-Lg~ilrslG~~~---pte~e~~fi~~mf 185 (644)
T PLN02964 112 RISVFET--NRLSKNTLVGYCELDLFDFVTQEPESACESFDLLDPSSSNKV-VGSIFVSCSIED---PVETERSFARRIL 185 (644)
T ss_pred EEEEEec--CCCCHHHhhhheeecHhhccHHHHHHHHHHHHHHCCCCCCcC-HHHHHHHhCCCC---CCHHHHHHHHHHH
Confidence 3444443 44666665542211 01111123557788999999999997 555554332100 1110022489999
Q ss_pred HHHcccCCCcccHHHHHHHh---CC--chH-HHHHHHHHccCCCCceeHHHHHHHHccc
Q 016471 327 DYFEQEGNRVISVEELALEL---NL--APA-AYSLLNDCIRNSDGKLSFLGYKRFLHGV 379 (389)
Q Consensus 327 ~~~D~d~~G~I~~~el~~~l---~~--~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~ 379 (389)
+.+|.|++|.|+.+|+..++ +. ..+ +.++|+.+|.|++|.|+++||+++|+..
T Consensus 186 ~~~D~DgdG~IdfdEFl~lL~~lg~~~seEEL~eaFk~fDkDgdG~Is~dEL~~vL~~~ 244 (644)
T PLN02964 186 AIVDYDEDGQLSFSEFSDLIKAFGNLVAANKKEELFKAADLNGDGVVTIDELAALLALQ 244 (644)
T ss_pred HHhCCCCCCeEcHHHHHHHHHHhccCCCHHHHHHHHHHhCCCCCCcCCHHHHHHHHHhc
Confidence 99999999999999999888 22 222 8999999999999999999999999884
|
|
| >KOG0040 consensus Ca2+-binding actin-bundling protein (spectrin), alpha chain (EF-Hand protein superfamily) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.55 E-value=6.9e-07 Score=92.76 Aligned_cols=139 Identities=22% Similarity=0.283 Sum_probs=111.1
Q ss_pred HHhcCHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhcccc-CCHH-----HHHHHHhhcCCCCCcceeHHHHHHHHh
Q 016471 235 SKALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDA-MTDS-----RVFEILNVMEPLSDQKLAYEEFCAAAT 307 (389)
Q Consensus 235 ~~~l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~-~~~~-----~~~~~~~~~d~~~~g~i~~~eF~~~~~ 307 (389)
....+++.+..+...|+.||. ++|.++..+|+.||+++|.+- +-++ ++++++...|++.+|.|+..+|++.+.
T Consensus 2244 ~~GVtEe~L~EFs~~fkhFDkek~G~Ldhq~F~sCLrslgY~lpmvEe~~~~p~fe~~ld~vDP~r~G~Vsl~dY~afmi 2323 (2399)
T KOG0040|consen 2244 HNGVTEEQLKEFSMMFKHFDKEKNGRLDHQHFKSCLRSLGYDLPMVEEGEPEPEFEEILDLVDPNRDGYVSLQDYMAFMI 2323 (2399)
T ss_pred cCCCCHHHHHHHHHHHHHhchhhccCCcHHHHHHHHHhcCCCCcccccCCCChhHHHHHHhcCCCCcCcccHHHHHHHHH
Confidence 345688999999999999999 999999999999999999653 2344 689999999999999999999999888
Q ss_pred chhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHhCCchH---HHHHHHHHccC----CCCceeHHHHHHHH
Q 016471 308 SVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALELNLAPA---AYSLLNDCIRN----SDGKLSFLGYKRFL 376 (389)
Q Consensus 308 ~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~~~---~~~~~~~~d~~----~~g~i~~~ef~~~~ 376 (389)
.....--.+ .+.+..||+.+|. +..||+++++...|..... +..|-..+|+. ..+.++|.+|++-+
T Consensus 2324 ~~ETeNI~s--~~eIE~AfraL~a-~~~yvtke~~~~~ltreqaefc~s~m~~~~e~~~~~s~q~~l~y~dfv~sl 2396 (2399)
T KOG0040|consen 2324 SKETENILS--SEEIEDAFRALDA-GKPYVTKEELYQNLTREQAEFCMSKMKPYAETSSGRSDQVALDYKDFVNSL 2396 (2399)
T ss_pred hcccccccc--hHHHHHHHHHhhc-CCccccHHHHHhcCCHHHHHHHHHHhhhhcccccCCCccccccHHHHHHHH
Confidence 654332111 3479999999999 7789999999888743322 66777777763 35679999998754
|
|
| >cd00213 S-100 S-100: S-100 domain, which represents the largest family within the superfamily of proteins carrying the Ca-binding EF-hand motif | Back alignment and domain information |
|---|
Probab=98.54 E-value=3.7e-07 Score=67.94 Aligned_cols=70 Identities=16% Similarity=0.161 Sum_probs=58.4
Q ss_pred HHHHHHHHHHhhhcCC---CCCcccHHHHHHHHHH-hccc---cCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhch
Q 016471 240 EEELVYLRAQFMLLEP---KDGCVSLNNFKVALMR-QATD---AMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSV 309 (389)
Q Consensus 240 ~ee~~~l~~~F~~~D~---~~G~i~~~el~~~l~~-~~~~---~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~ 309 (389)
++++..++..|..+|. ++|.|+.+||..+++. ++.. ..+..++.+++..+|.+++|.|+|+||+..+...
T Consensus 4 ~~~~~~l~~~F~~~D~~~~~~G~Is~~el~~~l~~~~g~~~~~~~~~~ei~~i~~~~d~~~~g~I~f~eF~~~~~~~ 80 (88)
T cd00213 4 EKAIETIIDVFHKYSGKEGDKDTLSKKELKELLETELPNFLKNQKDPEAVDKIMKDLDVNKDGKVDFQEFLVLIGKL 80 (88)
T ss_pred HHHHHHHHHHHHHHhhccCCCCcCcHHHHHHHHHHHhhhhccCCCCHHHHHHHHHHhccCCCCcCcHHHHHHHHHHH
Confidence 4567788999999999 7899999999999876 4431 2358899999999999999999999999865543
|
Note that this S-100 hierarchy contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins are expressed exclusively in vertebrates, and are implicated in intracellular and extracellular regulatory activities. Intracellularly, S100 proteins act as Ca-signaling or Ca-buffering proteins. The most unusual characteristic of certain S100 proteins is their occurrence in extracellular space, where they act in a cytokine-like manner through RAGE, the receptor for advanced glycation products. Structural data suggest that many S100 members exist within cells as homo- or heterodimers and even oligomers; oligomerization contributes to their functional diversification. Upon binding calcium, most S100 proteins change conformation to a more open structure exposing a hydrophobic cleft. This hydrophobic surface represents th |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 389 | ||||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-43 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 7e-43 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 7e-43 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 8e-43 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-42 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-42 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-42 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-42 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-42 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-42 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-42 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 6e-42 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 7e-42 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 7e-42 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-40 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-40 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-40 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 7e-40 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 9e-40 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-39 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-39 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-36 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-36 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-35 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 7e-35 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-34 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-34 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 8e-34 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 8e-34 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 9e-34 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-33 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-33 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-33 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-33 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-33 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-33 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-33 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-33 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-33 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-33 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-33 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-33 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-33 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-33 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-33 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-33 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-33 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-33 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-33 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-32 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-32 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-32 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-32 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-32 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-32 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-32 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-32 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-32 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-32 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-32 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-32 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-32 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-31 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-31 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-31 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-31 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-31 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-31 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-31 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-31 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-31 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-31 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-31 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-31 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-31 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 4e-31 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-31 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-31 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 7e-31 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 7e-31 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 8e-31 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-30 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-30 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 6e-30 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 7e-30 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-29 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-29 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 4e-29 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 8e-29 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-28 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 9e-28 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-27 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-27 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-27 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-27 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-26 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 7e-26 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 8e-26 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 9e-26 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-24 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-24 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-24 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-24 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-22 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-22 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-22 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-22 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-22 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-22 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-22 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-22 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-22 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-22 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-22 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-22 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-22 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-22 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-22 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-22 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-22 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-22 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-22 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-22 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-22 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-22 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-22 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 7e-22 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 7e-22 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 7e-22 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 7e-22 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-22 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 9e-22 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-21 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-21 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-21 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-21 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-21 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-21 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-21 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-21 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-21 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-21 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-21 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-21 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-21 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-21 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-21 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-21 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-21 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-21 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-21 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-21 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-21 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-21 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-21 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-21 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-21 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-21 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-21 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-21 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-21 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-20 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-20 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-20 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-20 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-20 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-20 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-20 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-20 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-20 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-20 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-20 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-20 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-20 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-20 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-20 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-20 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-20 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-20 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-20 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-20 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-20 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-20 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-20 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-20 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 7e-20 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 9e-20 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-19 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-19 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 1e-19 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-19 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 2e-19 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 2e-19 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 2e-19 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 2e-19 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 2e-19 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 2e-19 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 2e-19 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 2e-19 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-19 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 2e-19 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 2e-19 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-19 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 3e-19 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-19 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 4e-19 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 4e-19 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-19 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-19 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 9e-19 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-18 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-18 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 1e-18 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 1e-18 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-18 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 1e-18 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 1e-18 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 1e-18 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 1e-18 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-18 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 1e-18 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 1e-18 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-18 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-18 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-18 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-18 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-18 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-18 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-18 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-18 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-18 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-18 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-18 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-18 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-18 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-18 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-18 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-18 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-18 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-18 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-18 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-18 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-18 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-18 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-18 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-18 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-18 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-18 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-18 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-18 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-18 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-18 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-18 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 7e-18 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-17 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-17 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-17 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-17 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-17 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-17 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-17 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-17 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-17 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-17 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-17 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-17 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-17 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-17 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-17 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-17 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-17 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-17 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-17 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-17 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-17 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-17 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-17 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-17 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-17 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-17 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-17 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-17 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-17 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-17 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-17 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-17 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-17 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-17 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-17 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-17 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-17 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-17 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-17 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-17 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-17 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 6e-17 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-17 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 6e-17 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-17 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-17 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 6e-17 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 6e-17 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 6e-17 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 6e-17 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-17 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-17 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 6e-17 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 6e-17 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-17 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 7e-17 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 7e-17 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 7e-17 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 8e-17 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 9e-17 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-17 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 9e-17 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-16 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-16 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-16 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-16 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-16 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-16 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-16 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-16 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-16 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-16 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 5e-16 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-16 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-15 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-15 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-15 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-15 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-15 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-15 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-15 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-15 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-15 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-15 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-15 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-15 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-15 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-15 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-15 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-15 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 4e-15 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 4e-15 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-15 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-15 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-15 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-15 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-15 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 5e-15 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-15 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-15 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 5e-15 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-15 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 5e-15 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 5e-15 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-15 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-15 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 5e-15 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-15 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 5e-15 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 5e-15 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 5e-15 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 5e-15 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 5e-15 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 6e-15 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-15 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 6e-15 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 6e-15 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 6e-15 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-15 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 6e-15 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-15 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 7e-15 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 7e-15 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-15 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 7e-15 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-15 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 7e-15 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 7e-15 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 7e-15 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-15 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-15 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 9e-15 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 9e-15 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-15 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 9e-15 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 9e-15 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 9e-15 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-14 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-14 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-14 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-14 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-14 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-14 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-14 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-14 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-14 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-14 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-14 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-14 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-14 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-14 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-14 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-14 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-14 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-14 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-14 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-14 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-14 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-14 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 4e-14 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-14 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-14 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 6e-14 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 6e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 7e-14 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 8e-14 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 8e-14 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-13 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-13 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-13 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-13 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-13 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-13 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-13 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-13 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-13 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-13 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-13 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-13 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-13 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-13 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-13 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-13 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-13 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-13 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-13 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-13 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-13 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-13 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-13 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-13 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-13 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-13 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-13 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-13 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-13 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-13 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-13 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-13 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 5e-13 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 5e-13 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-13 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-13 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 7e-13 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 7e-13 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 8e-13 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 8e-13 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 8e-13 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 9e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-12 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-12 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-12 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-12 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-12 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-12 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-12 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-12 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-12 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-12 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-12 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-12 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-12 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-12 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-12 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-12 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-12 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-12 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-12 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-12 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-12 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-12 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-12 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-12 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-12 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-12 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-12 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-12 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-12 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-12 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-12 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-12 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-12 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-12 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-12 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-12 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-12 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-12 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-12 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-12 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-12 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-12 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-12 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-12 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-12 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-12 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-12 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-12 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-12 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-12 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-12 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-12 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-12 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-12 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-12 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-12 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-12 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-12 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-12 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-12 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-12 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 5e-12 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 5e-12 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 6e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-12 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 7e-12 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 7e-12 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 7e-12 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 8e-12 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 8e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 8e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 9e-12 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-11 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-11 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-11 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-11 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-11 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-11 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-11 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-11 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-11 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-11 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-11 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-11 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-11 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-11 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-11 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 6e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 7e-11 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 7e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-10 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-10 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-10 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-10 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-10 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-10 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-10 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-10 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-10 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-10 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 6e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 6e-10 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 6e-10 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 6e-10 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 6e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 6e-10 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 7e-10 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 7e-10 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 7e-10 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 7e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 7e-10 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 7e-10 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 7e-10 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 7e-10 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 7e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 8e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-09 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-09 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 5e-09 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 8e-09 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 9e-09 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 9e-09 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-08 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-08 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-08 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-08 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-08 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-08 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-08 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-08 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 5e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 5e-08 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-08 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-08 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-08 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 7e-08 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 7e-08 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 8e-08 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 8e-08 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 8e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 8e-08 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 9e-08 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 9e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 9e-08 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 9e-08 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-07 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-07 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-07 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-07 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-07 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-07 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-07 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-07 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-07 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-07 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-07 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-07 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-07 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-07 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-07 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-07 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 3e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-07 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 3e-07 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 3e-07 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-07 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-07 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 3e-07 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-07 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 4e-07 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 4e-07 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-07 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-07 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-07 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 6e-07 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-07 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-07 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 6e-07 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 6e-07 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-07 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 7e-07 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 7e-07 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 8e-07 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 8e-07 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-06 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-06 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-06 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-06 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-06 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-06 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-06 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-06 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-06 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-06 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-06 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-06 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-06 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-06 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-06 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 3e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-06 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 3e-06 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-06 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-06 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-06 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-06 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-06 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-06 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 6e-06 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 6e-06 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 7e-06 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 7e-06 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 7e-06 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 7e-06 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 7e-06 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 7e-06 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 8e-06 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-06 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 9e-06 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 9e-06 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 1e-05 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-05 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 1e-05 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 1e-05 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-05 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-05 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-05 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-05 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-05 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-05 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-05 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-05 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-05 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-05 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-05 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-05 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-05 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-05 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-05 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-05 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-05 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-05 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-05 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-05 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-05 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-05 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-05 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-05 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-05 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-05 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-05 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-05 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-05 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-05 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-05 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-05 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-05 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-05 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-05 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-05 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-05 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-05 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-05 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-05 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-05 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-05 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-05 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 5e-05 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 7e-05 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 7e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 8e-05 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-04 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-04 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-04 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-04 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-04 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-04 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-04 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-04 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-04 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-04 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-04 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-04 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-04 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-04 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-04 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-04 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-04 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-04 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-04 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-04 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-04 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-04 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-04 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 2e-04 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 2e-04 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-04 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-04 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-04 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-04 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-04 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 2e-04 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-04 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-04 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-04 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-04 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-04 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-04 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-04 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-04 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-04 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-04 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-04 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-04 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-04 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-04 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 5e-04 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 5e-04 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-04 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-04 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-04 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 6e-04 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-04 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-04 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-04 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 6e-04 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 6e-04 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-04 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-04 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 7e-04 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 7e-04 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 7e-04 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 7e-04 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 7e-04 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 8e-04 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 8e-04 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 8e-04 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-04 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 8e-04 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 8e-04 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 8e-04 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 8e-04 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 8e-04 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-04 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 8e-04 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 9e-04 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 9e-04 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-04 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-04 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 9e-04 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 9e-04 |
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 449 bits (1157), Expect = e-156
Identities = 113/399 (28%), Positives = 187/399 (46%), Gaps = 24/399 (6%)
Query: 5 KLQHLFYSNSFLFF-TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVV 63
KL +F + + T F EGGEL ++I++R ++ E DA I+++IL+ + + H +V
Sbjct: 110 KLFDVFEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYLHKHNIV 168
Query: 64 HRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEG 123
HRD+KPEN L + +K++DFGLS F D +L D +G+AYY+APEVL + YN +
Sbjct: 169 HRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKC 228
Query: 124 DMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNK 183
D+WS GVI YILLCG PF + + I + V + F + W ++S EAK+ ++ +L
Sbjct: 229 DVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTY 288
Query: 184 DHRKRMTAAQALTHPWLHDENRPV-----PLDILIYKLVKSYLRATPLKRAALKALSKAL 238
D+ KR TA +AL W+ + ++ + + L +AA+ + L
Sbjct: 289 DYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNMRKFEGSQKLAQAAILFIGSKL 348
Query: 239 TE-EELVYLRAQFMLLEP-KDGCVSLNNFKVALMR-------QATDAMTDSRVFEILNVM 289
T EE L F L+ DG + + V IL +
Sbjct: 349 TTLEERKELTDIFKKLDKNGDGQLDKKELIEGYNVLRNFKNELGELKNVEEEVDNILKEV 408
Query: 290 EPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALELNLA 349
+ + + Y EF + L ++ AF+ F+ + + I+ EELA L
Sbjct: 409 DFDKNGYIEYSEFISVCMDKQILF----SEERLRRAFNLFDTDKSGKITKEELANLFGLT 464
Query: 350 PAAYS----LLNDCIRNSDGKLSFLGYKRFLHGVTVRSS 384
+ +L + +N D + F + +H + +
Sbjct: 465 SISEKTWNDVLGEADQNKDNMIDFDEFVSMMHKICDHKT 503
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 445 bits (1147), Expect = e-155
Identities = 115/382 (30%), Positives = 197/382 (51%), Gaps = 24/382 (6%)
Query: 21 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREED 80
+GGEL D I+ R ++ E DA I++++L+ V + H +VHRDLKPEN L ++E+D
Sbjct: 117 CYKGGELFDEIIHRM-KFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKD 175
Query: 81 APLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSR 140
A +K++DFGLS +++ + +G+AYY+APEVL + Y+ + D+WSIGVI +ILL G
Sbjct: 176 ALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYP 235
Query: 141 PFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200
PF +T+ I R V + F W +VS AKD ++++L D ++R++A QAL HPW+
Sbjct: 236 PFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWI 295
Query: 201 ------HDENRPVPLDILIYKLVKSYLRATPLKRAALKALSKAL-TEEELVYLRAQFMLL 253
+ +P + ++ + + L +AAL ++ L ++EE L F +
Sbjct: 296 KEMCSKKESGIELPSLANAIENMRKFQNSQKLAQAALLYMASKLTSQEETKELTDIFRHI 355
Query: 254 EP-KDGCVSLNNFKVALMRQATDAMT-------DSRVFEILNVMEPLSDQKLAYEEFCAA 305
+ DG + + + + + +S V IL + + + Y EF
Sbjct: 356 DKNGDGQLDRQELIDGYSKLSGEEVAVFDLPQIESEVDAILGAADFDRNGYIDYSEFVTV 415
Query: 306 ATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALELNLAPAAYS----LLNDCIR 361
A L + ++ + AF F+Q+GN ISV+ELA L +++
Sbjct: 416 AMDRKSLLSKDKLES----AFQKFDQDGNGKISVDELASVFGLDHLESKTWKEMISGIDS 471
Query: 362 NSDGKLSFLGYKRFLHGVTVRS 383
N+DG + F + + + + +
Sbjct: 472 NNDGDVDFEEFCKMIQKLCSNN 493
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 440 bits (1133), Expect = e-153
Identities = 111/387 (28%), Positives = 188/387 (48%), Gaps = 32/387 (8%)
Query: 21 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREED 80
GGEL D I+ R R+ E DA I++++ + + + H +VHRDLKPEN L ++E+D
Sbjct: 102 LYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKD 160
Query: 81 APLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSR 140
+K+IDFGLS + + ++ D +G+AYY+APEVL +Y+ + D+WS GVI YILL G+
Sbjct: 161 CDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTP 220
Query: 141 PFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200
PF+ + E I + V F W ++S +AKD +R++L R+TA Q L HPW+
Sbjct: 221 PFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWI 280
Query: 201 HDENR------PVPLDILIYKLVKSYLRATPLKRAALKALSKALTE-EELVYLRAQFMLL 253
+ +P ++ + L +AAL ++ LT +E L F L
Sbjct: 281 QKYSSETPTISDLPSLESAMTNIRQFQAEKKLAQAALLYMASKLTTLDETKQLTEIFRKL 340
Query: 254 EP-KDGCVSLNNFKVALMR-------------QATDAMTDSRVFEILNVMEPLSDQKLAY 299
+ DG + + Q + + ++ ++ +++ + Y
Sbjct: 341 DTNNDGMLDRDELVRGYHEFMRLKGVDSNSLIQNEGSTIEDQIDSLMPLLDMDGSGSIEY 400
Query: 300 EEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALELNLAPAAYS----- 354
EF A+A L + ER ++ AF F+++G+ IS +EL + A ++
Sbjct: 401 SEFIASAIDRTILLSRERMER----AFKMFDKDGSGKISTKELFKLFSQADSSIQMEELE 456
Query: 355 -LLNDCIRNSDGKLSFLGYKRFLHGVT 380
++ N DG++ F + L
Sbjct: 457 SIIEQVDNNKDGEVDFNEFVEMLQNFV 483
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 436 bits (1123), Expect = e-151
Identities = 113/381 (29%), Positives = 186/381 (48%), Gaps = 26/381 (6%)
Query: 21 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREED 80
GGEL D I+SR R+ E DA I+ ++L+ + + H +VHRDLKPEN L ++ +D
Sbjct: 107 VYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKD 165
Query: 81 APLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSR 140
A +++IDFGLS +++ D +G+AYY+APEVLH +Y+ + D+WS GVI YILL G
Sbjct: 166 ANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCP 225
Query: 141 PFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200
PF E I + V + F W VS AKD +R++L R++A AL H W+
Sbjct: 226 PFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWI 285
Query: 201 HDENR-----PVPLDILIYKLVKSYLRATPLKRAALKALSKAL-TEEELVYLRAQFMLLE 254
+ VP ++ + L +AAL + L +++E L A F ++
Sbjct: 286 QTYTKEQISVDVPSLDNAILNIRQFQGTQKLAQAALLYMGSKLTSQDETKELTAIFHKMD 345
Query: 255 P-KDGCVSLNNFKVALMRQAT----------DAMTDSRVFEILNVMEPLSDQKLAYEEFC 303
DG + + + V ++L+ ++ + + Y EF
Sbjct: 346 KNGDGQLDRAELIEGYKELMRMKGQDASMLDASAVEHEVDQVLDAVDFDKNGYIEYSEFV 405
Query: 304 AAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALELNLAP----AAYSLLNDC 359
A L + ER ++ AF F+ + + IS ELA ++ S+L++
Sbjct: 406 TVAMDRKTLLSRERLER----AFRMFDSDNSGKISSTELATIFGVSDVDSETWKSVLSEV 461
Query: 360 IRNSDGKLSFLGYKRFLHGVT 380
+N+DG++ F +++ L +
Sbjct: 462 DKNNDGEVDFDEFQQMLLKLC 482
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 347 bits (893), Expect = e-117
Identities = 96/358 (26%), Positives = 158/358 (44%), Gaps = 25/358 (6%)
Query: 22 CEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDA 81
GGEL + I++R Y E DA +++IL V CH GVVHR+LKPEN L ++ + A
Sbjct: 92 VTGGELFEDIVARE-YYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGA 150
Query: 82 PLKVIDFGLSDFVR-PDQRLNDIVGSAYYVAPEVLHRS-YNVEGDMWSIGVITYILLCGS 139
+K+ DFGL+ V Q G+ Y++PEVL + Y D+W+ GVI YILL G
Sbjct: 151 AVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGY 210
Query: 140 RPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPW 199
PFW + +++ + +F W +V+PEAKD + ++L + KR+TAA+AL HPW
Sbjct: 211 PPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPW 270
Query: 200 L--HDENRPVPLDILIYKLVKSYLRATPLKRAALK--ALSKALTEEELVYLRAQFMLLEP 255
+ +K + LK A L ++ + + ++ L+E
Sbjct: 271 ISHRSTVASCMHRQETVDCLKKFNARRKLKGAILTVMLATRNFSVRKQEIIKVTEQLIE- 329
Query: 256 KDGCVSLNNFKVALMRQATDA-MTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEA 314
+++N + D MT + N++E L + F +++ +
Sbjct: 330 -----AISNGDFESYTKMCDPGMTAFEPEALGNLVE-----GLDFHRFYFE--NLWSRNS 377
Query: 315 LERWDQIAITAFDYFEQEGNRVISVEEL--AL-ELNLAPAAYSLLNDCIRNSDGKLSF 369
I + + + + I+ + L + A S DGK
Sbjct: 378 KPVHTTI-LNPHIHLMGDESACIAYIRITQYLDAGGIPRTAQSEETRVWHRRDGKWQI 434
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 338 bits (870), Expect = e-116
Identities = 70/237 (29%), Positives = 117/237 (49%), Gaps = 4/237 (1%)
Query: 21 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREED 80
F G ++ +RI + E + + V ++ + F H + H D++PEN ++ TR
Sbjct: 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRR-S 140
Query: 81 APLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL-HRSYNVEGDMWSIGVITYILLCGS 139
+ +K+I+FG + ++P + + Y APEV H + DMWS+G + Y+LL G
Sbjct: 141 STIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGI 200
Query: 140 RPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPW 199
PF A T I +++ A+ F + + +S EA DFV RLL K+ + RMTA++AL HPW
Sbjct: 201 NPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPW 260
Query: 200 LHDENRPVPLDILIYKLVKSYLRATPLKRAALKALSKALTEEELVYLRAQFMLLEPK 256
L + V ++ + Y L + L + A +R+Q + K
Sbjct: 261 LKQKIERVSTKVIRTLKHRRYYHT--LIKKDLNMVVSAARISCGGAIRSQKGVSVAK 315
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 331 bits (852), Expect = e-113
Identities = 83/191 (43%), Positives = 119/191 (62%), Gaps = 1/191 (0%)
Query: 22 CEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDA 81
C GGEL +R++ + + E DA I++ +L+ VA+CH V HRDLKPENFLF T D+
Sbjct: 88 CTGGELFERVVHKR-VFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDS 146
Query: 82 PLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRP 141
PLK+IDFGL+ +P + + VG+ YYV+P+VL Y E D WS GV+ Y+LLCG P
Sbjct: 147 PLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPP 206
Query: 142 FWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLH 201
F A T+S + + F + W +VSP+A+ +RRLL K ++R+T+ QAL H W
Sbjct: 207 FSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFE 266
Query: 202 DENRPVPLDIL 212
+ P ++L
Sbjct: 267 KQLSSSPRNLL 277
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 325 bits (835), Expect = e-111
Identities = 75/184 (40%), Positives = 114/184 (61%), Gaps = 1/184 (0%)
Query: 22 CEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDA 81
GGEL D I+ R R+ E DA I++++ + + + H +VHRDLKPEN L ++E+D
Sbjct: 103 YTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDC 161
Query: 82 PLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRP 141
+K+IDFGLS + + ++ D +G+AYY+APEVL +Y+ + D+WS GVI YILL G+ P
Sbjct: 162 DIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPP 221
Query: 142 FWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLH 201
F+ + E I + V F W ++S +AKD +R++L R+TA Q L HPW+
Sbjct: 222 FYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQ 281
Query: 202 DENR 205
+
Sbjct: 282 KYSS 285
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 320 bits (823), Expect = e-108
Identities = 73/257 (28%), Positives = 120/257 (46%), Gaps = 9/257 (3%)
Query: 5 KLQHLFYSNSFLFF-TRFCEGGELLDRILSRG---GRYLEEDAKTIVEKILNIVAFCHLQ 60
+L + S+ L+ F +G +L I+ R Y E A + +IL + +CH
Sbjct: 90 ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN 149
Query: 61 GVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVLHRS- 118
++HRD+KP L ++E AP+K+ FG++ VG+ +++APEV+ R
Sbjct: 150 NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREP 209
Query: 119 YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVR 178
Y D+W GVI +ILL G PF+ T+ +F +++ + W +S AKD VR
Sbjct: 210 YGKPVDVWGCGVILFILLSGCLPFYG-TKERLFEGIIKGKYKMNPRQWSHISESAKDLVR 268
Query: 179 RLLNKDHRKRMTAAQALTHPWLHDENR--PVPLDILIYKLVKSYLRATPLKRAALKALSK 236
R+L D +R+T +AL HPWL + +R + ++ + LK A L A+S
Sbjct: 269 RMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARRKLKGAVLAAVSS 328
Query: 237 ALTEEELVYLRAQFMLL 253
+
Sbjct: 329 HKFNSFYGDPPEELPDF 345
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 317 bits (815), Expect = e-108
Identities = 70/182 (38%), Positives = 108/182 (59%), Gaps = 4/182 (2%)
Query: 22 CEGGELLDRILSR---GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE 78
CEGGELL+RI+S G E ++++++N +A+ H Q VVH+DLKPEN LF
Sbjct: 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTS 161
Query: 79 EDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCG 138
+P+K+IDFGL++ + D+ + G+A Y+APEV R + D+WS GV+ Y LL G
Sbjct: 162 PHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTG 221
Query: 139 SRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHP 198
PF + + + +PN+ P ++P+A D ++++L KD +R +AAQ L H
Sbjct: 222 CLPFTGTSLEEVQQKATYKEPNYAVECRP-LTPQAVDLLKQMLTKDPERRPSAAQVLHHE 280
Query: 199 WL 200
W
Sbjct: 281 WF 282
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 316 bits (811), Expect = e-106
Identities = 75/225 (33%), Positives = 118/225 (52%), Gaps = 4/225 (1%)
Query: 22 CEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDA 81
GGEL + I++R Y E DA +++IL +A+CH G+VHR+LKPEN L ++ + A
Sbjct: 110 VTGGELFEDIVARE-FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGA 168
Query: 82 PLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRS-YNVEGDMWSIGVITYILLCGSR 140
+K+ DFGL+ V + + G+ Y++PEVL + Y+ D+W+ GVI YILL G
Sbjct: 169 AVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYP 228
Query: 141 PFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200
PFW + ++ + ++ W +V+PEAK + +L + +KR+TA QAL PW+
Sbjct: 229 PFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 288
Query: 201 HDENR--PVPLDILIYKLVKSYLRATPLKRAALKALSKALTEEEL 243
+ R +K + LK A L + L
Sbjct: 289 CNRERVASAIHRQDTVDCLKKFNARRKLKGAILTTMIATRNLSNL 333
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 313 bits (803), Expect = e-105
Identities = 66/186 (35%), Positives = 100/186 (53%), Gaps = 11/186 (5%)
Query: 22 CEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDA 81
GEL D + + E++ ++I+ +L V+F H +VHRDLKPEN L +++
Sbjct: 182 MRKGELFDYLTEKV-ALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILL---DDNM 237
Query: 82 PLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL-------HRSYNVEGDMWSIGVITYI 134
+++ DFG S + P ++L ++ G+ Y+APE+L H Y E D+W+ GVI +
Sbjct: 238 QIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFT 297
Query: 135 LLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQA 194
LL GS PFW R + + R ++ F W S KD + RLL D R+TA QA
Sbjct: 298 LLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQA 357
Query: 195 LTHPWL 200
L HP+
Sbjct: 358 LQHPFF 363
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 309 bits (795), Expect = e-105
Identities = 69/188 (36%), Positives = 109/188 (57%), Gaps = 2/188 (1%)
Query: 22 CEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDA 81
GGEL + I++R Y E DA +++IL +A+CH G+VHR+LKPEN L ++ + A
Sbjct: 87 VTGGELFEDIVARE-FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGA 145
Query: 82 PLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRS-YNVEGDMWSIGVITYILLCGSR 140
+K+ DFGL+ V + + G+ Y++PEVL + Y+ D+W+ GVI YILL G
Sbjct: 146 AVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYP 205
Query: 141 PFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200
PFW + ++ + ++ W +V+PEAK + +L + +KR+TA QAL PW+
Sbjct: 206 PFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 265
Query: 201 HDENRPVP 208
+ R
Sbjct: 266 CNRERVAS 273
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 309 bits (793), Expect = e-104
Identities = 62/215 (28%), Positives = 107/215 (49%), Gaps = 5/215 (2%)
Query: 21 FCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREE 79
+ GGE+ L E D ++++IL V + H +VH DLKP+N L ++
Sbjct: 110 YAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYP 169
Query: 80 DAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRS-YNVEGDMWSIGVITYILLCG 138
+K++DFG+S + L +I+G+ Y+APE+L+ DMW+IG+I Y+LL
Sbjct: 170 LGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229
Query: 139 SRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHP 198
+ PF + ++ + + ++ + + SVS A DF++ LL K+ KR TA L+H
Sbjct: 230 TSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHS 289
Query: 199 WLHD---ENRPVPLDILIYKLVKSYLRATPLKRAA 230
WL EN P + + + + + +
Sbjct: 290 WLQQWDFENLFHPEETSSSSQTQDHSVRSSEDKTS 324
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 308 bits (792), Expect = e-103
Identities = 91/213 (42%), Positives = 120/213 (56%), Gaps = 3/213 (1%)
Query: 22 CEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDA 81
GGEL DRI+ +G Y E DA V++IL VA+ H G+VHRDLKPEN L+ T DA
Sbjct: 130 VTGGELFDRIVEKG-YYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDA 188
Query: 82 PLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSR 140
PLK+ DFGLS V + + G+ Y APE+L +Y E DMWS+G+ITYILLCG
Sbjct: 189 PLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFE 248
Query: 141 PFWART-ESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPW 199
PF+ + +FR +L + F W VS AKD VR+L+ D +KR+T QAL HPW
Sbjct: 249 PFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPW 308
Query: 200 LHDENRPVPLDILIYKLVKSYLRATPLKRAALK 232
+ + K ++ + LK A
Sbjct: 309 VTGKAANFVHMDTAQKKLQEFNARRKLKAAVKA 341
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 310 bits (795), Expect = e-103
Identities = 77/234 (32%), Positives = 115/234 (49%), Gaps = 9/234 (3%)
Query: 22 CEGGELLDRILSRGGR-YLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREED 80
+GGEL RI RG + + E +A I++ I + + H + HRD+KPEN L+T++ +
Sbjct: 141 LDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPN 200
Query: 81 APLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGS 139
A LK+ DFG + L + YYVAPEVL Y+ DMWS+GVI YILLCG
Sbjct: 201 AILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGY 260
Query: 140 RPFWA----RTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQAL 195
PF++ G+ + F + W VS E K +R LL + +RMT + +
Sbjct: 261 PPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFM 320
Query: 196 THPWLHDENR--PVPLDILIYKLVKSYLRATPLKRAALKALSKALTEEELVYLR 247
HPW+ + PL L + R +K AL+ + E + ++
Sbjct: 321 NHPWIMQSTKVPQTPLHTSR-VLKEDKERWEDVKEEMTSALATMRVDYEQIKIK 373
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 309 bits (793), Expect = e-101
Identities = 79/268 (29%), Positives = 120/268 (44%), Gaps = 10/268 (3%)
Query: 21 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREED 80
F GGEL +++ + E++A + ++ + H VH DLKPEN +FTT+ +
Sbjct: 235 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSN 294
Query: 81 APLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL-HRSYNVEGDMWSIGVITYILLCGS 139
LK+IDFGL+ + P Q + G+A + APEV + DMWS+GV++YILL G
Sbjct: 295 E-LKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGL 353
Query: 140 RPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPW 199
PF + R+V D N DS + +S + KDF+R+LL D RMT QAL HPW
Sbjct: 354 SPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPW 413
Query: 200 LHDENRP---VPLDILIYKLVKSYLRATPLKRAALKALSKALTEEELVYLRAQFMLLEPK 256
L N P + Y ++ ++ K A L + + +
Sbjct: 414 LTPGNAPGRDSQIPSSRYTKIRDSIK---TKYDAWPEPLPPL--GRISNYSSLRKHRPQE 468
Query: 257 DGCVSLNNFKVALMRQATDAMTDSRVFE 284
+ + + V E
Sbjct: 469 YSIRDAFWDRSEAQPRFIVKPYGTEVGE 496
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 299 bits (767), Expect = e-100
Identities = 71/207 (34%), Positives = 108/207 (52%), Gaps = 12/207 (5%)
Query: 5 KLQHLFYSNSFLFF-TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVV 63
+L+ + +N+F F + GEL D + + E++ + I+ +L ++ H +V
Sbjct: 88 QLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALHKLNIV 146
Query: 64 HRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL-------H 116
HRDLKPEN L ++D +K+ DFG S + P ++L ++ G+ Y+APE++ H
Sbjct: 147 HRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNH 203
Query: 117 RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDF 176
Y E DMWS GVI Y LL GS PFW R + + R ++ + F W S KD
Sbjct: 204 PGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDL 263
Query: 177 VRRLLNKDHRKRMTAAQALTHPWLHDE 203
V R L +KR TA +AL HP+
Sbjct: 264 VSRFLVVQPQKRYTAEEALAHPFFQQY 290
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 301 bits (772), Expect = e-100
Identities = 72/223 (32%), Positives = 113/223 (50%), Gaps = 4/223 (1%)
Query: 21 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREED 80
F GGEL DRI + + E + + + + H +VH D+KPEN + T++
Sbjct: 129 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKK-A 187
Query: 81 APLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGS 139
+ +K+IDFGL+ + PD+ + +A + APE++ R DMW+IGV+ Y+LL G
Sbjct: 188 SSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGL 247
Query: 140 RPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPW 199
PF + ++V R D F + + SVSPEAKDF++ LL K+ RKR+T AL HPW
Sbjct: 248 SPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPW 307
Query: 200 L--HDENRPVPLDILIYKLVKSYLRATPLKRAALKALSKALTE 240
L N + Y ++ ++ A + +
Sbjct: 308 LKGDHSNLTSRIPSSRYNKIRQKIKEKYADWPAPQPAIGRIAN 350
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 296 bits (761), Expect = e-100
Identities = 68/187 (36%), Positives = 108/187 (57%), Gaps = 3/187 (1%)
Query: 21 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR-EE 79
GGEL D + + E++A +++IL+ V + H + + H DLKPEN + +
Sbjct: 89 LVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVP 147
Query: 80 DAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCG 138
+ +K+IDFG++ + +I G+ +VAPE+++ +E DMWSIGVITYILL G
Sbjct: 148 NPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207
Query: 139 SRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHP 198
+ PF T+ ++ + +F + + + S AKDF+RRLL KD ++RMT AQ+L H
Sbjct: 208 ASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHS 267
Query: 199 WLHDENR 205
W+ R
Sbjct: 268 WIKAIRR 274
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 298 bits (764), Expect = 1e-99
Identities = 79/235 (33%), Positives = 115/235 (48%), Gaps = 11/235 (4%)
Query: 21 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR-EE 79
GGEL D + + EE+A +++ILN V + H + H DLKPEN + R
Sbjct: 95 LVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVP 153
Query: 80 DAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCG 138
+K+IDFGL+ + +I G+ +VAPE+++ +E DMWSIGVITYILL G
Sbjct: 154 KPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
Query: 139 SRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHP 198
+ PF T+ +V + F D + + S AKDF+RRLL KD +KRMT +L HP
Sbjct: 214 ASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHP 273
Query: 199 WLHDENRPVPLDILIYKLVKSYLRATPLKRAALKALSKALTEEELVYLRAQFMLL 253
W+ ++ L + K+ A + S + L F
Sbjct: 274 WIKPKDTQQALSRKASAVNME-----KFKKFAARKKSNNGSGGG---LNDIFEAQ 320
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 295 bits (756), Expect = 8e-98
Identities = 68/203 (33%), Positives = 108/203 (53%), Gaps = 2/203 (0%)
Query: 21 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREED 80
+ +GGEL DRI+ E D +++I + H ++H DLKPEN L R+
Sbjct: 167 YVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAK 226
Query: 81 APLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRS-YNVEGDMWSIGVITYILLCGS 139
+K+IDFGL+ +P ++L G+ ++APEV++ + DMWS+GVI Y+LL G
Sbjct: 227 -QIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGL 285
Query: 140 RPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPW 199
PF ++ ++L + D + +S EAK+F+ +LL K+ R++A++AL HPW
Sbjct: 286 SPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPW 345
Query: 200 LHDENRPVPLDILIYKLVKSYLR 222
L D L K S +
Sbjct: 346 LSDHKLHSRLSAQKKKNRGSDAQ 368
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 289 bits (742), Expect = 2e-96
Identities = 79/239 (33%), Positives = 122/239 (51%), Gaps = 24/239 (10%)
Query: 22 CEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDA 81
GGEL +RI + + E +A I+ K+++ V+ H GVVHRDLKPEN LFT ++
Sbjct: 88 LNGGELFERIKKKK-HFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNL 146
Query: 82 PLKVIDFGLSDFVRPD-QRLNDIVGSAYYVAPEVLHRS-YNVEGDMWSIGVITYILLCGS 139
+K+IDFG + PD Q L + +Y APE+L+++ Y+ D+WS+GVI Y +L G
Sbjct: 147 EIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQ 206
Query: 140 RPFWARTES-------GIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAA 192
PF + S I + + + D +F W +VS EAKD ++ LL D KR+ +
Sbjct: 207 VPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMS 266
Query: 193 QALTHPWLHDE----NRPVPLDILIYK---LVKSYLRAT-----PLKRAALK--ALSKA 237
+ WL D + P+ ++ V + ++AT KR + KA
Sbjct: 267 GLRYNEWLQDGSQLSSNPLMTPDILGSSGAAVHTCVKATFHAFNKYKREGFCLQNVDKA 325
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 287 bits (736), Expect = 2e-95
Identities = 71/216 (32%), Positives = 114/216 (52%), Gaps = 3/216 (1%)
Query: 21 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREED 80
GGEL D + + EE+A + +++IL+ V + H + + H DLKPEN + +
Sbjct: 96 LVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIP 154
Query: 81 AP-LKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCG 138
P +K+IDFGL+ + +I G+ +VAPE+++ +E DMWSIGVITYILL G
Sbjct: 155 IPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
Query: 139 SRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHP 198
+ PF T+ ++ +F + + S AKDF+R+LL K+ RKR+T +AL HP
Sbjct: 215 ASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHP 274
Query: 199 WLHDENRPVPLDILIYKLVKSYLRATPLKRAALKAL 234
W+ + + + R ++R +
Sbjct: 275 WITPVDNQQAMVRRESVVNLENFRKQYVRRRWKLSF 310
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 286 bits (735), Expect = 4e-95
Identities = 82/223 (36%), Positives = 115/223 (51%), Gaps = 12/223 (5%)
Query: 22 CEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREED 80
EGGEL RI RG + E +A I+ I + F H + HRD+KPEN L+T++E+D
Sbjct: 108 MEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKD 167
Query: 81 APLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGS 139
A LK+ DFG + + L + YYVAPEVL Y+ DMWS+GVI YILLCG
Sbjct: 168 AVLKLTDFGFAKETTQNA-LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGF 226
Query: 140 RPFWARTES----GIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQAL 195
PF++ T G+ R + F + W VS +AK +R LL D +R+T Q +
Sbjct: 227 PPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFM 286
Query: 196 THPWLHDENRP--VPLDIL-IYKLVKSYLRATPLKRAALKALS 235
HPW++ PL + + K + +K AL+
Sbjct: 287 NHPWINQSMVVPQTPLHTARVLQEDKDHWDE--VKEEMTSALA 327
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 286 bits (735), Expect = 9e-95
Identities = 74/246 (30%), Positives = 121/246 (49%), Gaps = 6/246 (2%)
Query: 21 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREED 80
GGEL D + + EE+A + +++IL+ V + H + + H DLKPEN + +
Sbjct: 96 LVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIP 154
Query: 81 AP-LKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCG 138
P +K+IDFGL+ + +I G+ +VAPE+++ +E DMWSIGVITYILL G
Sbjct: 155 IPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
Query: 139 SRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHP 198
+ PF T+ ++ +F + + S AKDF+R+LL K+ RKR+T +AL HP
Sbjct: 215 ASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHP 274
Query: 199 WLHDENRPVPLDILIYKLVKSYLRATPLKR---AALKALSKALTEEELVYLRAQFMLLEP 255
W+ + + + + ++R + +S + + E
Sbjct: 275 WITPVDTQQAMVRRESVVNLENFKKQYVRRRWKLSFSIVSLCNHLTRSLMKKVHLRTSED 334
Query: 256 KDGCVS 261
C S
Sbjct: 335 LRNCES 340
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 285 bits (731), Expect = 1e-94
Identities = 79/243 (32%), Positives = 118/243 (48%), Gaps = 10/243 (4%)
Query: 5 KLQHLFYSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVH 64
K+++ F + + EGGEL D+++ R E K ++L V + H G++H
Sbjct: 79 KIKNFFDAEDYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLHENGIIH 137
Query: 65 RDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL----HRSYN 120
RDLKPEN L +++EED +K+ DFG S + + + G+ Y+APEVL YN
Sbjct: 138 RDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYN 197
Query: 121 VEGDMWSIGVITYILLCGSRPFWA-RTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRR 179
D WS+GVI +I L G PF RT+ + + NF W VS +A D V++
Sbjct: 198 RAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKK 257
Query: 180 LLNKDHRKRMTAAQALTHPWLHDENRPVPLDILIYKLVKSYLRATPLKRAALKALSKALT 239
LL D + R T +AL HPWL DE + L+ +T L + + +
Sbjct: 258 LLVVDPKARFTTEEALRHPWLQDE----DMKRKFQDLLSEENESTALPQVLAQPSTSRKR 313
Query: 240 EEE 242
E
Sbjct: 314 PRE 316
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 281 bits (722), Expect = 2e-93
Identities = 70/218 (32%), Positives = 106/218 (48%), Gaps = 30/218 (13%)
Query: 22 CEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDA 81
GG +L I R + E +A +V+ + + + F H +G+ HRDLKPEN L + +
Sbjct: 93 MRGGSILSHIHKRR-HFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVS 151
Query: 82 PLKVIDFGLSDFVRPDQRLNDI--------VGSAYYVAPEVL------HRSYNVEGDMWS 127
P+K+ DF L ++ + + I GSA Y+APEV+ Y+ D+WS
Sbjct: 152 PVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWS 211
Query: 128 IGVITYILLCGSRPFWAR---------------TESGIFRSVLRADPNFHDSPWPSVSPE 172
+GVI YILL G PF R ++ +F S+ F D W +S
Sbjct: 212 LGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCA 271
Query: 173 AKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLD 210
AKD + +LL +D ++R++AAQ L HPW+ L
Sbjct: 272 AKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLP 309
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 277 bits (711), Expect = 2e-91
Identities = 76/231 (32%), Positives = 116/231 (50%), Gaps = 15/231 (6%)
Query: 22 CEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDA 81
+GGELLD+IL + + E +A ++ I V + H QGVVHRDLKP N L+ +
Sbjct: 98 MKGGELLDKILRQK-FFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNP 156
Query: 82 -PLKVIDFGLSDFVRPDQR-LNDIVGSAYYVAPEVLHRS-YNVEGDMWSIGVITYILLCG 138
+++ DFG + +R + L +A +VAPEVL R Y+ D+WS+GV+ Y +L G
Sbjct: 157 ESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216
Query: 139 SRPFWAR---TESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQAL 195
PF T I + + W SVS AKD V ++L+ D +R+TAA L
Sbjct: 217 YTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVL 276
Query: 196 THPWLHDENR--PVPLDILI-YKLVKSYLRAT-----PLKRAALKALSKAL 238
HPW+ ++ L+ LVK + AT + L+ + ++
Sbjct: 277 RHPWIVHWDQLPQYQLNRQDAPHLVKGAMAATYSALNRNQSPVLEPVGRST 327
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 275 bits (705), Expect = 4e-91
Identities = 69/221 (31%), Positives = 100/221 (45%), Gaps = 28/221 (12%)
Query: 22 CEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREED 80
+GGEL RI RG + E +A I++ I + + H + HRD+KPEN L+T++ +
Sbjct: 97 LDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPN 156
Query: 81 APLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSR 140
A LK+ DFG A E Y+ DMWS+GVI YILLCG
Sbjct: 157 AILKLTDFGF--------------------AKETTGEKYDKSCDMWSLGVIMYILLCGYP 196
Query: 141 PFWA----RTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196
PF++ G+ + F + W VS E K +R LL + +RMT + +
Sbjct: 197 PFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256
Query: 197 HPWLHDENR--PVPLDILIYKLVKSYLRATPLKRAALKALS 235
HPW+ + PL L + R +K AL+
Sbjct: 257 HPWIMQSTKVPQTPLHTSR-VLKEDKERWEDVKEEMTSALA 296
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 275 bits (705), Expect = 1e-90
Identities = 66/244 (27%), Positives = 104/244 (42%), Gaps = 48/244 (19%)
Query: 12 SNSFLFFTRFCEGGELLDRILSRGGR---------------------------------- 37
C GG LLD++
Sbjct: 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRE 159
Query: 38 -----YLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 92
E+ I+ +I + + + H QG+ HRD+KPENFLF+T + +K++DFGLS
Sbjct: 160 SLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNK-SFEIKLVDFGLSK 218
Query: 93 FVRP-----DQRLNDIVGSAYYVAPEVLH---RSYNVEGDMWSIGVITYILLCGSRPFWA 144
+ G+ Y+VAPEVL+ SY + D WS GV+ ++LL G+ PF
Sbjct: 219 EFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPG 278
Query: 145 RTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204
++ VL F + + +SP A+D + LLN++ +R A +AL HPW+ +
Sbjct: 279 VNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS 338
Query: 205 RPVP 208
+
Sbjct: 339 DKIY 342
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 274 bits (703), Expect = 3e-89
Identities = 75/205 (36%), Positives = 109/205 (53%), Gaps = 6/205 (2%)
Query: 5 KLQHLFYSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVH 64
K+++ F + + EGGEL D+++ R E K ++L V + H G++H
Sbjct: 204 KIKNFFDAEDYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLHENGIIH 262
Query: 65 RDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL----HRSYN 120
RDLKPEN L +++EED +K+ DFG S + + + G+ Y+APEVL YN
Sbjct: 263 RDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYN 322
Query: 121 VEGDMWSIGVITYILLCGSRPFWA-RTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRR 179
D WS+GVI +I L G PF RT+ + + NF W VS +A D V++
Sbjct: 323 RAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKK 382
Query: 180 LLNKDHRKRMTAAQALTHPWLHDEN 204
LL D + R T +AL HPWL DE+
Sbjct: 383 LLVVDPKARFTTEEALRHPWLQDED 407
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 235 bits (602), Expect = 6e-74
Identities = 58/355 (16%), Positives = 128/355 (36%), Gaps = 21/355 (5%)
Query: 5 KLQHLFYSNSFLF-FTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVV 63
+ F + C L + + + +L + T++++ + +A H +V
Sbjct: 82 RYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIV 140
Query: 64 HRDLKPENFLFTTREEDAPLKVI--DFGLSDFVRPDQ----RLNDIVGSAYYVAPEVL-- 115
HRDLKP N L + +K + DFGL + + R + + G+ ++APE+L
Sbjct: 141 HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSE 200
Query: 116 --HRSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNF-HDSPWPSVSP 171
+ D++S G + Y ++ GS PF + +L + P
Sbjct: 201 DCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN--ILLGACSLDCLHPEKHEDV 258
Query: 172 EAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDILIYKLVKSYLRATPLKRAAL 231
A++ + +++ D +KR +A L HP+ + + + ++ P+ +
Sbjct: 259 IARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQFFQDVSDRIEKESLDGPIVKQLE 318
Query: 232 KALSKALTEEELVYLRAQFMLLEPKDGCVSLNNFK--VALMRQATDAMTDSRVFEILNVM 289
+ + + + K + + + MR + E+ +
Sbjct: 319 RGGRAVVKMDWRENITVPLQTDLRKFRTYKGGSVRDLLRAMRNKKHHYRELPA-EVRETL 377
Query: 290 EPLSDQKLAY--EEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEEL 342
L D + Y F Y+ L +++ + + E ++ + L
Sbjct: 378 GTLPDDFVCYFTSRFPHLLAHTYRAMELCSHERLFQPYYFHEPPEPQPPVTPDAL 432
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 230 bits (587), Expect = 1e-71
Identities = 73/337 (21%), Positives = 131/337 (38%), Gaps = 49/337 (14%)
Query: 5 KLQHLFYSNSFLFF-TRFCEGGELLDRILSRG------GRYLEEDAKTIVEKILNIVAFC 57
+ ++ FL+ C L D + S+ E + +++ +I + VA
Sbjct: 73 RYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131
Query: 58 HLQGVVHRDLKPENFLFTTRE----------EDAPLKVIDFGLSDFVRPDQ-----RLND 102
H ++HRDLKP+N L +T E+ + + DFGL + Q LN+
Sbjct: 132 HSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNN 191
Query: 103 IVGSAYYVAPEVL--------HRSYNVEGDMWSIGVITYILLC-GSRPFWAR--TESGIF 151
G++ + APE+L R D++S+G + Y +L G PF + ES I
Sbjct: 192 PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNII 251
Query: 152 RSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDI 211
R + D S+ EA D + ++++ D KR TA + L HP +++ + +
Sbjct: 252 RGIFSLDE-MKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKSKKLEFLL 310
Query: 212 LIYKLVKSYLRATPLKRAALKALSKALTEEELVYLRAQFMLLEPKDGCVSLNNFKVALMR 271
+ ++ R P A L + V + + K +L ++
Sbjct: 311 KVSDRLEIENRDPP--SALLMKFDAG---SDFVIPSGDWTVKFDKTFMDNLERYRKYHSS 365
Query: 272 QATDAMTDSR---------VFEILNVMEPLSDQKLAY 299
+ D + R +I +M P+ D Y
Sbjct: 366 KLMDLLRALRNKYHHFMDLPEDIAELMGPVPDGFYDY 402
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 3e-62
Identities = 56/207 (27%), Positives = 86/207 (41%), Gaps = 23/207 (11%)
Query: 12 SNSFLFF-TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPE 70
S LF +CE G L D I S ++ + +IL +++ H QG++HRDLKP
Sbjct: 86 KKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPM 145
Query: 71 NFLFTTREEDAPLKVIDFGLS---------------DFVRPDQRLNDIVGSAYYVAPEVL 115
N E +K+ DFGL+ + L +G+A YVA EVL
Sbjct: 146 NIFID---ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVL 202
Query: 116 HRS--YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEA 173
+ YN + DM+S+G+I + ++ I + + F +
Sbjct: 203 DGTGHYNEKIDMYSLGIIFFEMIYP--FSTGMERVNILKKLRSVSIEFPPDFDDNKMKVE 260
Query: 174 KDFVRRLLNKDHRKRMTAAQALTHPWL 200
K +R L++ D KR A L WL
Sbjct: 261 KKIIRLLIDHDPNKRPGARTLLNSGWL 287
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 3e-58
Identities = 52/202 (25%), Positives = 89/202 (44%), Gaps = 21/202 (10%)
Query: 22 CEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDA 81
C +L + + + K+ + +L V H G+VH DLKP NFL D
Sbjct: 109 CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DG 163
Query: 82 PLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLHRS------------YNVEGDMW 126
LK+IDFG+++ ++PD + VG+ Y+ PE + + + D+W
Sbjct: 164 MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 223
Query: 127 SIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHR 186
S+G I Y + G PF I + DPN + +D ++ L +D +
Sbjct: 224 SLGCILYYMTYGKTPFQQIINQ-ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPK 282
Query: 187 KRMTAAQALTHPWLHDENRPVP 208
+R++ + L HP++ + PV
Sbjct: 283 QRISIPELLAHPYVQIQTHPVN 304
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 2e-57
Identities = 52/202 (25%), Positives = 89/202 (44%), Gaps = 21/202 (10%)
Query: 22 CEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDA 81
C +L + + + K+ + +L V H G+VH DLKP NFL D
Sbjct: 90 CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DG 144
Query: 82 PLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLHRS------------YNVEGDMW 126
LK+IDFG+++ ++PD + VG+ Y+ PE + + + D+W
Sbjct: 145 MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 204
Query: 127 SIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHR 186
S+G I Y + G PF I + DPN + +D ++ L +D +
Sbjct: 205 SLGCILYYMTYGKTPFQQIINQ-ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPK 263
Query: 187 KRMTAAQALTHPWLHDENRPVP 208
+R++ + L HP++ + PV
Sbjct: 264 QRISIPELLAHPYVQIQTHPVN 285
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 5e-57
Identities = 41/217 (18%), Positives = 73/217 (33%), Gaps = 37/217 (17%)
Query: 21 FCEGGELLDRILSRG--GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE 78
FC G L + E + ++ ++ + G+VHR++KP N + E
Sbjct: 90 FCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGE 149
Query: 79 -EDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL---------HRSYNVEGDMWSI 128
+ K+ DFG + + D++ + G+ Y+ P++ + Y D+WSI
Sbjct: 150 DGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSI 209
Query: 129 GVITYILLCGSRPFWA----RTESGIFRSVLRADPN-----------------FHDSPWP 167
GV Y GS PF R + ++ P+
Sbjct: 210 GVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSC 269
Query: 168 SVSPEAKD----FVRRLLNKDHRKRMTAAQALTHPWL 200
S+S + + +L D K Q
Sbjct: 270 SLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 9e-56
Identities = 52/202 (25%), Positives = 89/202 (44%), Gaps = 21/202 (10%)
Query: 22 CEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDA 81
C +L + + + K+ + +L V H G+VH DLKP NFL D
Sbjct: 137 CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DG 191
Query: 82 PLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLHRS------------YNVEGDMW 126
LK+IDFG+++ ++PD + VG+ Y+ PE + + + D+W
Sbjct: 192 MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 251
Query: 127 SIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHR 186
S+G I Y + G PF I + DPN + +D ++ L +D +
Sbjct: 252 SLGCILYYMTYGKTPFQQIINQ-ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPK 310
Query: 187 KRMTAAQALTHPWLHDENRPVP 208
+R++ + L HP++ + PV
Sbjct: 311 QRISIPELLAHPYVQIQTHPVN 332
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 186 bits (473), Expect = 1e-55
Identities = 33/187 (17%), Positives = 58/187 (31%), Gaps = 13/187 (6%)
Query: 22 CEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDA 81
LD + G + +++ + A +G+VH P+N D
Sbjct: 175 ELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIM---PDG 231
Query: 82 PLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRS---YNVEGDMWSIGVITYILLCG 138
L + D + R Y E L+ S + + W +G+ Y + C
Sbjct: 232 RLMLGDVSAL--WKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289
Query: 139 SRPFWARTESGIFRSVLRAD-----PNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQ 193
PF T + + + K + R LN D R+R+ +
Sbjct: 290 FLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLE 349
Query: 194 ALTHPWL 200
A+ P
Sbjct: 350 AMETPEF 356
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 9e-55
Identities = 55/198 (27%), Positives = 102/198 (51%), Gaps = 10/198 (5%)
Query: 5 KLQHLFYSNSFLFFT-RFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVV 63
+L + F +++++ C GE+ + +R + E +A+ + +I+ + + H G++
Sbjct: 75 ELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGIL 134
Query: 64 HRDLKPENFLFTTREEDAPLKVIDFGLSDFV-RPDQRLNDIVGSAYYVAPEVL-HRSYNV 121
HRDL N L T +K+ DFGL+ + P ++ + G+ Y++PE+ ++ +
Sbjct: 135 HRDLTLSNLLLTRNMN---IKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGL 191
Query: 122 EGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLL 181
E D+WS+G + Y LL G PF T V+ AD P +S EAKD + +LL
Sbjct: 192 ESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEM---P-SFLSIEAKDLIHQLL 247
Query: 182 NKDHRKRMTAAQALTHPW 199
++ R++ + L HP+
Sbjct: 248 RRNPADRLSLSSVLDHPF 265
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 183 bits (465), Expect = 2e-54
Identities = 32/211 (15%), Positives = 65/211 (30%), Gaps = 26/211 (12%)
Query: 16 LFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 75
+ GE+L S + + +++ ++A H G+VH L+P + +
Sbjct: 181 RMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD 240
Query: 76 TREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRS------------YNVEG 123
+ + + F D S + PE+ R
Sbjct: 241 ---QRGGVFLTGFEHL---VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSF 294
Query: 124 DMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNK 183
D W++G++ Y + C P G + R+ N + + + L
Sbjct: 295 DAWALGLVIYWIWCADLPITKDAALGGSEWIFRSCKN--------IPQPVRALLEGFLRY 346
Query: 184 DHRKRMTAAQALTHPWLHDENRPVPLDILIY 214
R+ QA+ P + + +Y
Sbjct: 347 PKEDRLLPLQAMETPEYEQLRTELSAALPLY 377
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 178 bits (455), Expect = 7e-54
Identities = 59/197 (29%), Positives = 102/197 (51%), Gaps = 11/197 (5%)
Query: 5 KLQHLFYSNSFLFFT-RFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVV 63
+L F+ + ++ + G + L + ++ E+ T + ++ N +++CH + V+
Sbjct: 73 RLYGYFHDATRVYLILEYAPLGTVYRE-LQKLSKFDEQRTATYITELANALSYCHSKRVI 131
Query: 64 HRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL-HRSYNVE 122
HRD+KPEN L + E LK+ DFG S P R D+ G+ Y+ PE++ R ++ +
Sbjct: 132 HRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTDLCGTLDYLPPEMIEGRMHDEK 187
Query: 123 GDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLN 182
D+WS+GV+ Y L G PF A T ++ + R + F P V+ A+D + RLL
Sbjct: 188 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF---P-DFVTEGARDLISRLLK 243
Query: 183 KDHRKRMTAAQALTHPW 199
+ +R + L HPW
Sbjct: 244 HNPSQRPMLREVLEHPW 260
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 2e-53
Identities = 58/210 (27%), Positives = 91/210 (43%), Gaps = 11/210 (5%)
Query: 5 KLQHLFYSNSFLFFT-RFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVV 63
F N F+F C LL+ R E +A+ + +I+ + H V+
Sbjct: 79 GFHGFFEDNDFVFVVLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLHRNRVI 137
Query: 64 HRDLKPENFLFTTREEDAPLKVIDFGLSDFV-RPDQRLNDIVGSAYYVAPEVL-HRSYNV 121
HRDLK N E +K+ DFGL+ V +R + G+ Y+APEVL + ++
Sbjct: 138 HRDLKLGNLFLNEDLE---VKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSF 194
Query: 122 EGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLL 181
E D+WSIG I Y LL G PF + + + + + P ++P A ++++L
Sbjct: 195 EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSI---P-KHINPVAASLIQKML 250
Query: 182 NKDHRKRMTAAQALTHPWLHDENRPVPLDI 211
D R T + L + P L I
Sbjct: 251 QTDPTARPTINELLNDEFFTSGYIPARLPI 280
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 2e-53
Identities = 60/206 (29%), Positives = 107/206 (51%), Gaps = 11/206 (5%)
Query: 5 KLQHLFYSNSFLFF-TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVV 63
++ + F+ ++ F GEL L + GR+ E+ + T +E++ + + +CH + V+
Sbjct: 78 RMYNYFHDRKRIYLMLEFAPRGELYKE-LQKHGRFDEQRSATFMEELADALHYCHERKVI 136
Query: 64 HRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL-HRSYNVE 122
HRD+KPEN L + E LK+ DFG S P R + G+ Y+ PE++ ++++ +
Sbjct: 137 HRDIKPENLLMGYKGE---LKIADFGWSVHA-PSLRRRTMCGTLDYLPPEMIEGKTHDEK 192
Query: 123 GDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLN 182
D+W GV+ Y L G PF + + + R ++ D F P P +S +KD + +LL
Sbjct: 193 VDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKF---P-PFLSDGSKDLISKLLR 248
Query: 183 KDHRKRMTAAQALTHPWLHDENRPVP 208
+R+ + HPW+ +R V
Sbjct: 249 YHPPQRLPLKGVMEHPWVKANSRRVL 274
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 7e-53
Identities = 61/235 (25%), Positives = 100/235 (42%), Gaps = 12/235 (5%)
Query: 5 KLQHLFYSNSFLFFT-RFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVV 63
F N F+F C LL+ R E +A+ + +I+ + H V+
Sbjct: 105 GFHGFFEDNDFVFVVLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLHRNRVI 163
Query: 64 HRDLKPENFLFTTREEDAPLKVIDFGLSDFV-RPDQRLNDIVGSAYYVAPEVL-HRSYNV 121
HRDLK N E +K+ DFGL+ V +R + G+ Y+APEVL + ++
Sbjct: 164 HRDLKLGNLFLNEDLE---VKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSF 220
Query: 122 EGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLL 181
E D+WSIG I Y LL G PF + + + + + P ++P A ++++L
Sbjct: 221 EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSI---P-KHINPVAASLIQKML 276
Query: 182 NKDHRKRMTAAQALTHPWLHDENRPVPLDILIYKLVKSY-LRATPLKRAALKALS 235
D R T + L + P L I + + + + L + K L+
Sbjct: 277 QTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIAPSSLDPSNRKPLT 331
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 7e-52
Identities = 59/195 (30%), Positives = 103/195 (52%), Gaps = 10/195 (5%)
Query: 21 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREED 80
+ GGE+ D +++ G R E++A++ +I++ V +CH + +VHRDLK EN L + D
Sbjct: 95 YASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLL---DAD 150
Query: 81 APLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYN-VEGDMWSIGVITYILLCG 138
+K+ DFG S+ +L+ G+ Y APE+ + Y+ E D+WS+GVI Y L+ G
Sbjct: 151 MNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 210
Query: 139 SRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHP 198
S PF + + VLR + + +S + ++ ++R L + KR T Q +
Sbjct: 211 SLPFDGQNLKELRERVLRGK--YRIPFY--MSTDCENLLKRFLVLNPIKRGTLEQIMKDR 266
Query: 199 WLHDENRPVPLDILI 213
W++ + L +
Sbjct: 267 WINAGHEEDELKPFV 281
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 7e-52
Identities = 44/274 (16%), Positives = 87/274 (31%), Gaps = 42/274 (15%)
Query: 21 FCEGGELLDRILSRG--GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE 78
FC G L + E + ++ ++ + G+VHR++KP N + E
Sbjct: 90 FCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGE 149
Query: 79 -EDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL---------HRSYNVEGDMWSI 128
+ K+ DFG + + D++ + G+ Y+ P++ + Y D+WSI
Sbjct: 150 DGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSI 209
Query: 129 GVITYILLCGSRPFWA----RTESGIFRSVLRADPNFHDSPW------------------ 166
GV Y GS PF R + ++ P+ S
Sbjct: 210 GVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSC 269
Query: 167 ---PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPV-PLDILIYKLVKSYLR 222
+ + +L D K Q + + K Y+
Sbjct: 270 SLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRMVIHVFSLQQMTAHKIYIH 329
Query: 223 ATPLKRAALKALSKALTEEELVYLRAQFMLLEPK 256
+ + + ++ + Q ++ E +
Sbjct: 330 SYNT----ATIFHELVYKQTKIISSNQELIYEGR 359
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 181 bits (459), Expect = 3e-51
Identities = 59/276 (21%), Positives = 111/276 (40%), Gaps = 25/276 (9%)
Query: 4 QKLQHLFYSNSFLFFTRFCEGGELLDRILSRG--GRYLEEDAKTIVEKILNIVAFCHLQG 61
LQ L ++ L +CEGG+L + E +T++ I + + + H
Sbjct: 82 DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR 141
Query: 62 VVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL-HRSYN 120
++HRDLKPEN + + K+ID G + + + + VG+ Y+APE+L + Y
Sbjct: 142 IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYT 201
Query: 121 VEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPW-------------- 166
V D WS G + + + G RPF + + +R N H +
Sbjct: 202 VTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLP 261
Query: 167 ------PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDIL-IYKLVKS 219
++ + + +++ +L R+R T Q + + L +L + +V
Sbjct: 262 TPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLKLLSVMNMVSG 321
Query: 220 YLRATPLKRA-ALKALSKALTEEELVYLRAQFMLLE 254
+ P+ L+ L L ++ + Q +L
Sbjct: 322 RVHTYPVTENENLQNLKSWLQQDTGIPEEEQELLQA 357
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 3e-51
Identities = 48/185 (25%), Positives = 89/185 (48%), Gaps = 12/185 (6%)
Query: 21 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREED 80
G +++ E+ A+ + ++ + + H Q ++HRD+KP N L ED
Sbjct: 119 LVNQGPVMEVP--TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVG---ED 173
Query: 81 APLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVL---HRSYN-VEGDMWSIGVITYIL 135
+K+ DFG+S +F D L++ VG+ ++APE L + ++ D+W++GV Y
Sbjct: 174 GHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCF 233
Query: 136 LCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQAL 195
+ G PF + + F D P ++ + KD + R+L+K+ R+ +
Sbjct: 234 VFGQCPFMDERIMCLHSKIKSQALEFPD--QPDIAEDLKDLITRMLDKNPESRIVVPEIK 291
Query: 196 THPWL 200
HPW+
Sbjct: 292 LHPWV 296
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 1e-49
Identities = 65/182 (35%), Positives = 90/182 (49%), Gaps = 10/182 (5%)
Query: 21 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREED 80
+ GGEL D I G R E +A+ + ++IL+ V +CH VVHRDLKPEN L +
Sbjct: 92 YVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLL---DAH 147
Query: 81 APLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL-HRSYN-VEGDMWSIGVITYILLCG 138
K+ DFGLS+ + + L GS Y APEV+ R Y E D+WS GVI Y LLCG
Sbjct: 148 MNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCG 207
Query: 139 SRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHP 198
+ PF +F+ + F+ + ++ + +L D KR T H
Sbjct: 208 TLPFDDEHVPTLFKKIRGGV--FYIPEY--LNRSVATLLMHMLQVDPLKRATIKDIREHE 263
Query: 199 WL 200
W
Sbjct: 264 WF 265
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 1e-48
Identities = 55/189 (29%), Positives = 90/189 (47%), Gaps = 12/189 (6%)
Query: 17 FFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76
F +C GGEL DRI E DA+ +++ V + H G+ HRD+KPEN L
Sbjct: 82 LFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL-- 138
Query: 77 REEDAPLKVIDFGLSDFVRP---DQRLNDIVGSAYYVAPEVL-HRSYN-VEGDMWSIGVI 131
+E LK+ DFGL+ R ++ LN + G+ YVAPE+L R ++ D+WS G++
Sbjct: 139 -DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIV 197
Query: 132 TYILLCGSRPFWARTES-GIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMT 190
+L G P+ ++S + + +PW + + ++L ++ R+T
Sbjct: 198 LTAMLAGELPWDQPSDSCQEYSDWKEKK--TYLNPWKKIDSAPLALLHKILVENPSARIT 255
Query: 191 AAQALTHPW 199
W
Sbjct: 256 IPDIKKDRW 264
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 2e-48
Identities = 56/198 (28%), Positives = 88/198 (44%), Gaps = 16/198 (8%)
Query: 15 FLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLF 74
L R +L D I +G E ++ +++ + CH +GVVHRD+K EN L
Sbjct: 114 MLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILI 172
Query: 75 TTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL-HRSYN-VEGDMWSIGVIT 132
R K+IDFG + D+ D G+ Y PE + Y+ + +WS+G++
Sbjct: 173 DLRRGC--AKLIDFGSGALL-HDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILL 229
Query: 133 YILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAA 192
Y ++CG PF + +L A+ H VSP+ +RR L R +
Sbjct: 230 YDMVCGDIPFERD------QEILEAE--LHFPAH--VSPDCCALIRRCLAPKPSSRPSLE 279
Query: 193 QALTHPWLHDENRPVPLD 210
+ L PW+ VPL+
Sbjct: 280 EILLDPWMQTPAEDVPLN 297
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 6e-48
Identities = 44/224 (19%), Positives = 93/224 (41%), Gaps = 32/224 (14%)
Query: 5 KLQHLFYSNSFLFF-TRFCEGGELLDRILSRG-------GRYLEEDAKTIVEKILNIVAF 56
+ + + ++ + E +L + K I++ +LN ++
Sbjct: 107 TCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSY 166
Query: 57 CHLQ-GVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL 115
H + + HRD+KP N L +++ +K+ DFG S+++ D+++ G+ ++ PE
Sbjct: 167 IHNEKNICHRDVKPSNILM---DKNGRVKLSDFGESEYM-VDKKIKGSRGTYEFMPPEFF 222
Query: 116 HRS---YNVEGDMWSIGVITYILLCGSRPFWA-RTESGIFRSVLRADPNF---------- 161
+ D+WS+G+ Y++ PF + +F ++ + +
Sbjct: 223 SNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYP 282
Query: 162 -----HDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200
+S E DF++ L K+ +R+T+ AL H WL
Sbjct: 283 LTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWL 326
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 1e-47
Identities = 55/189 (29%), Positives = 90/189 (47%), Gaps = 12/189 (6%)
Query: 17 FFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76
F +C GGEL DRI E DA+ +++ V + H G+ HRD+KPEN L
Sbjct: 82 LFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL-- 138
Query: 77 REEDAPLKVIDFGLSDFVRP---DQRLNDIVGSAYYVAPEVL-HRSYN-VEGDMWSIGVI 131
+E LK+ DFGL+ R ++ LN + G+ YVAPE+L R ++ D+WS G++
Sbjct: 139 -DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIV 197
Query: 132 TYILLCGSRPFWARTES-GIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMT 190
+L G P+ ++S + + +PW + + ++L ++ R+T
Sbjct: 198 LTAMLAGELPWDQPSDSCQEYSDWKEKK--TYLNPWKKIDSAPLALLHKILVENPSARIT 255
Query: 191 AAQALTHPW 199
W
Sbjct: 256 IPDIKKDRW 264
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 3e-47
Identities = 56/210 (26%), Positives = 86/210 (40%), Gaps = 18/210 (8%)
Query: 5 KLQHLFYSNSFLFFT--RFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGV 62
K+ +F + F + G +L I R E A I ++++ V + L+ +
Sbjct: 93 KVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFRQLVSAVGYLRLKDI 151
Query: 63 VHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYN- 120
+HRD+K EN + ED +K+IDFG + ++ + G+ Y APEVL Y
Sbjct: 152 IHRDIKDENIVI---AEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRG 208
Query: 121 VEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRL 180
E +MWS+GV Y L+ PF + A H VS E V L
Sbjct: 209 PELEMWSLGVTLYTLVFEENPFCE------LEETVEAA--IHPPYL--VSKELMSLVSGL 258
Query: 181 LNKDHRKRMTAAQALTHPWLHDENRPVPLD 210
L +R T + +T PW+
Sbjct: 259 LQPVPERRTTLEKLVTDPWVTQPVNLADYT 288
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 4e-47
Identities = 58/179 (32%), Positives = 95/179 (53%), Gaps = 10/179 (5%)
Query: 24 GGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPL 83
GGEL D I+ + R E++ + ++I+ + +CH +VHRDLKPEN L +++ +
Sbjct: 92 GGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLL---DDNLNV 147
Query: 84 KVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL-HRSYN-VEGDMWSIGVITYILLCGSRP 141
K+ DFGLS+ + L GS Y APEV+ + Y E D+WS G++ Y++L G P
Sbjct: 148 KIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLP 207
Query: 142 FWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200
F +F+ V + + +SP A+ +RR++ D +R+T + PW
Sbjct: 208 FDDEFIPNLFKKVNSCV--YVMPDF--LSPGAQSLIRRMIVADPMQRITIQEIRRDPWF 262
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 4e-47
Identities = 62/186 (33%), Positives = 95/186 (51%), Gaps = 12/186 (6%)
Query: 21 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREED 80
+ GGEL +RI + G R+ E++A+ +++L+ V++CH + HRDLK EN L
Sbjct: 97 YASGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLD--GSP 153
Query: 81 AP-LKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL-HRSYN-VEGDMWSIGVITYILLC 137
AP LK+ DFG S + VG+ Y+APEVL + Y+ D+WS GV Y++L
Sbjct: 154 APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLV 213
Query: 138 GSRPFWARTESGIFR----SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQ 193
G+ PF E +R +L + D +SPE + R+ D R++ +
Sbjct: 214 GAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIR--ISPECCHLISRIFVADPATRISIPE 271
Query: 194 ALTHPW 199
TH W
Sbjct: 272 IKTHSW 277
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 4e-47
Identities = 56/188 (29%), Positives = 82/188 (43%), Gaps = 16/188 (8%)
Query: 24 GGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPL 83
+L D I RG EE A++ ++L V CH GV+HRD+K EN L + L
Sbjct: 133 VQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE--L 189
Query: 84 KVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL-HRSYN-VEGDMWSIGVITYILLCGSRP 141
K+IDFG + D D G+ Y PE + + Y+ +WS+G++ Y ++CG P
Sbjct: 190 KLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 248
Query: 142 FWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLH 201
F + I R + VS E + +R L R T + HPW+
Sbjct: 249 F--EHDEEIIRGQVF-FRQR-------VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 298
Query: 202 DENRPVPL 209
D P
Sbjct: 299 DVLLPQET 306
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 166 bits (421), Expect = 4e-47
Identities = 65/182 (35%), Positives = 93/182 (51%), Gaps = 10/182 (5%)
Query: 21 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREED 80
+ GGEL D I G R E++++ + ++IL+ V +CH VVHRDLKPEN L +
Sbjct: 97 YVSGGELFDYICKNG-RLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLL---DAH 152
Query: 81 APLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL-HRSYN-VEGDMWSIGVITYILLCG 138
K+ DFGLS+ + + L GS Y APEV+ R Y E D+WS GVI Y LLCG
Sbjct: 153 MNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCG 212
Query: 139 SRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHP 198
+ PF +F+ + F+ + ++P ++ +L D KR T H
Sbjct: 213 TLPFDDDHVPTLFKKICDGI--FYTPQY--LNPSVISLLKHMLQVDPMKRATIKDIREHE 268
Query: 199 WL 200
W
Sbjct: 269 WF 270
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-45
Identities = 52/196 (26%), Positives = 90/196 (45%), Gaps = 18/196 (9%)
Query: 21 FCEGGELLDRI--LSRGGRYLEED-AKTIVEKILNIVAFCH-----LQGVVHRDLKPENF 72
+CEGG+L I ++ +YL+E+ ++ ++ + CH V+HRDLKP N
Sbjct: 88 YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANV 147
Query: 73 LFTTREEDAPLKVIDFGLSDFVRPDQRL-NDIVGSAYYVAPEVL-HRSYNVEGDMWSIGV 130
+K+ DFGL+ + D VG+ YY++PE + SYN + D+WS+G
Sbjct: 148 FLD---GKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGC 204
Query: 131 ITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSV-SPEAKDFVRRLLNKDHRKRM 189
+ Y L PF A ++ + + P S E + + R+LN R
Sbjct: 205 LLYELCALMPPFTAFSQKELAGKIREGKF----RRIPYRYSDELNEIITRMLNLKDYHRP 260
Query: 190 TAAQALTHPWLHDENR 205
+ + L +P + + +
Sbjct: 261 SVEEILENPLILEHHH 276
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 8e-45
Identities = 44/188 (23%), Positives = 78/188 (41%), Gaps = 17/188 (9%)
Query: 21 FCEGG--ELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE 78
+C G E+LD + R+ A ++++ + + H QG+VH+D+KP N L T
Sbjct: 89 YCVCGMQEMLDSVPE--KRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLT--- 143
Query: 79 EDAPLKVIDFGLS---DFVRPDQRLNDIVGSAYYVAPEVL--HRSYN-VEGDMWSIGVIT 132
LK+ G++ D GS + PE+ +++ + D+WS GV
Sbjct: 144 TGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTL 203
Query: 133 YILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAA 192
Y + G PF +F ++ + + P D ++ +L + KR +
Sbjct: 204 YNITTGLYPFEGDNIYKLFENIGKGS--YAIPGD--CGPPLSDLLKGMLEYEPAKRFSIR 259
Query: 193 QALTHPWL 200
Q H W
Sbjct: 260 QIRQHSWF 267
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-44
Identities = 47/193 (24%), Positives = 70/193 (36%), Gaps = 12/193 (6%)
Query: 10 FYSNSFLFF-TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLK 68
+ L+ T C G L + G E + L +A H QG+VH D+K
Sbjct: 126 WEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVK 184
Query: 69 PENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSI 128
P N K+ DFGL + G Y+APE+L SY D++S+
Sbjct: 185 PANIFLG---PRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSL 241
Query: 129 GVITYILLCG-SRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRK 187
G+ + C P + + L +S E + + +L D +
Sbjct: 242 GLTILEVACNMELPHGGEGWQQLRQGYL------PPEFTAGLSSELRSVLVMMLEPDPKL 295
Query: 188 RMTAAQALTHPWL 200
R TA L P L
Sbjct: 296 RATAEALLALPVL 308
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 3e-44
Identities = 46/196 (23%), Positives = 90/196 (45%), Gaps = 12/196 (6%)
Query: 10 FYSNSFLF-FTRFCEGGELLDRILSRGGRYLEED-AKTIVEKILNIVAFCHLQGVVHRDL 67
F N L+ +CEGG+L RI ++ G +ED +I + H + ++HRD+
Sbjct: 92 FEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDI 151
Query: 68 KPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVL-HRSYNVEGDM 125
K +N T +D +++ DFG++ + +G+ YY++PE+ ++ YN + D+
Sbjct: 152 KSQNIFLT---KDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDI 208
Query: 126 WSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPS-VSPEAKDFVRRLLNKD 184
W++G + Y L F A + + ++ P S + + V +L ++
Sbjct: 209 WALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF----PPVSLHYSYDLRSLVSQLFKRN 264
Query: 185 HRKRMTAAQALTHPWL 200
R R + L ++
Sbjct: 265 PRDRPSVNSILEKGFI 280
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 3e-43
Identities = 43/182 (23%), Positives = 81/182 (44%), Gaps = 13/182 (7%)
Query: 21 FCEGGELLDRILSRGGRYLEED-AKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREE 79
FC+ G L I R G L++ A + E+I V + H + +++RDLKP N +
Sbjct: 101 FCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV---D 157
Query: 80 DAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL-HRSYNVEGDMWSIGVITYILLCG 138
+K+ DFGL ++ D + G+ Y++PE + + Y E D++++G+I LL
Sbjct: 158 TKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV 217
Query: 139 SRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHP 198
+ ++ F + + K +++LL+K R ++ L
Sbjct: 218 CDTAFETSK--FFTDLRDG------IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTL 269
Query: 199 WL 200
+
Sbjct: 270 TV 271
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 6e-43
Identities = 31/196 (15%), Positives = 61/196 (31%), Gaps = 23/196 (11%)
Query: 23 EGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAP 82
GE+L S + + +++ ++A H G+VH L+P + + +
Sbjct: 193 TFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD---QRGG 249
Query: 83 LKVIDFGLSDFVRPDQRLNDIVGSAY----YVAPEVLHRS------YNVEGDMWSIGVIT 132
+ + F VR +G + A +L D W++G+
Sbjct: 250 VFLTGFEHL--VRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307
Query: 133 YILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAA 192
Y + C P G + R+ N + + + L R+
Sbjct: 308 YWIWCADLPNTDDAALGGSEWIFRSCKN--------IPQPVRALLEGFLRYPKEDRLLPL 359
Query: 193 QALTHPWLHDENRPVP 208
QA+ P +
Sbjct: 360 QAMETPEYEQLRTELS 375
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 9e-39
Identities = 64/206 (31%), Positives = 103/206 (50%), Gaps = 19/206 (9%)
Query: 5 KLQHLFYSNSFLFF-TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVV 63
KL F + L+F + + GELL + + G + E + +I++ + + H +G++
Sbjct: 94 KLYFTFQDDEKLYFGLSYAKNGELLKY-IRKIGSFDETCTRFYTAEIVSALEYLHGKGII 152
Query: 64 HRDLKPENFLFTTREEDAPLKVIDFGLS---DFVRPDQRLNDIVGSAYYVAPEVLHRS-Y 119
HRDLKPEN L ED +++ DFG + R N VG+A YV+PE+L
Sbjct: 153 HRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 209
Query: 120 NVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRR 179
D+W++G I Y L+ G PF A E IF+ +++ + +F P P+A+D V +
Sbjct: 210 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF---P-EKFFPKARDLVEK 265
Query: 180 LLNKDHRKRMTAAQA------LTHPW 199
LL D KR+ + HP+
Sbjct: 266 LLVLDATKRLGCEEMEGYGPLKAHPF 291
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 8e-38
Identities = 34/212 (16%), Positives = 70/212 (33%), Gaps = 25/212 (11%)
Query: 5 KLQHLF-YSNSFLFFTRFCEGGELLDRILSRG----GRYLEEDAKTIVEKILNIVAFCHL 59
K + N + G LL+ I + + ++L ++ H
Sbjct: 131 KFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD 190
Query: 60 QGVVHRDLKPENFLFTTREEDAP--------LKVIDFGLSDFVR---PDQRLNDIVGSAY 108
++H D+KP+NF+ + L +ID G S ++ ++
Sbjct: 191 CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSG 250
Query: 109 YVAPEVL-HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWP 167
+ E+L ++ +N + D + + Y +L G+ + E G + H W
Sbjct: 251 FQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKV-KNEGGECKPEGLFRRLPHLDMW- 308
Query: 168 SVSPEAKDFVRRLLNKDHRKRMTAAQALTHPW 199
+F +LN + + L
Sbjct: 309 ------NEFFHVMLNIPDCHHLPSLDLLRQKL 334
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-37
Identities = 53/202 (26%), Positives = 82/202 (40%), Gaps = 24/202 (11%)
Query: 21 FCEGGELLDRILSRGGRYL--EEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE 78
C L D + R I +I V F H +G++HRDLKP N FT
Sbjct: 96 LCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFT--- 152
Query: 79 EDAPLKVIDFGLS-------------DFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGD 124
D +KV DFGL + R VG+ Y++PE +H SY+ + D
Sbjct: 153 MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVD 212
Query: 125 MWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKD 184
++S+G+I + LL PF + E + +R + F P V+ +L+
Sbjct: 213 IFSLGLILFELLY---PFSTQMERVRTLTDVR-NLKFPPLF-TQKYPCEYVMVQDMLSPS 267
Query: 185 HRKRMTAAQALTHPWLHDENRP 206
+R A + + D + P
Sbjct: 268 PMERPEAINIIENAVFEDLDFP 289
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-36
Identities = 39/196 (19%), Positives = 67/196 (34%), Gaps = 21/196 (10%)
Query: 21 FCEGGELLDRI---LSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77
F + G L + I +G E+ ++ I + H +G HRDLKP N L
Sbjct: 111 FFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLG-- 168
Query: 78 EEDAPLKVIDFGLSDFVRPD----------QRLNDIVGSAYYVAPEVL----HRSYNVEG 123
++ ++D G + Q + Y APE+ H +
Sbjct: 169 -DEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERT 227
Query: 124 DMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNK 183
D+WS+G + Y ++ G P+ + G L P S + ++
Sbjct: 228 DVWSLGCVLYAMMFGEGPYDMVFQKGDSV-ALAVQNQLSIPQSPRHSSALWQLLNSMMTV 286
Query: 184 DHRKRMTAAQALTHPW 199
D +R L+
Sbjct: 287 DPHQRPHIPLLLSQLE 302
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-35
Identities = 47/201 (23%), Positives = 81/201 (40%), Gaps = 17/201 (8%)
Query: 10 FYSNSFLF-FTRFCEGGELLDRI--LSRGGRYLEEDA-KTIVEKILNIVAFCHLQGVVHR 65
F ++ L + G+L I + R + E ++ + + H + V+HR
Sbjct: 101 FIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHR 160
Query: 66 DLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRL-NDIVGSAYYVAPEVL-HRSYNVEG 123
D+KP N T +K+ D GL F + +VG+ YY++PE + YN +
Sbjct: 161 DIKPANVFIT---ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKS 217
Query: 124 DMWSIGVITYILLCGSRPFWARTES--GIFRSVLRADPNFHDSPWPS--VSPEAKDFVRR 179
D+WS+G + Y + PF+ + + + + + D P PS S E + V
Sbjct: 218 DIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDY----PPLPSDHYSEELRQLVNM 273
Query: 180 LLNKDHRKRMTAAQALTHPWL 200
+N D KR
Sbjct: 274 CINPDPEKRPDVTYVYDVAKR 294
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-35
Identities = 52/216 (24%), Positives = 99/216 (45%), Gaps = 25/216 (11%)
Query: 4 QKLQH-----LFYS---NSFLFF-TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIV 54
Q L+H L+YS +F GG+L L + + EE K + +++ +
Sbjct: 70 QGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYH-LQQNVHFKEETVKLFICELVMAL 128
Query: 55 AFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEV 114
+ Q ++HRD+KP+N L +E + + DF ++ + + ++ + G+ Y+APE+
Sbjct: 129 DYLQNQRIIHRDMKPDNILL---DEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEM 185
Query: 115 LHRS----YNVEGDMWSIGVITYILLCGSRPFWARTESG---IFRSVLRADPNFHDSPWP 167
Y+ D WS+GV Y LL G RP+ R+ + I + + P
Sbjct: 186 FSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTY---P-S 241
Query: 168 SVSPEAKDFVRRLLNKDHRKRMTAAQAL-THPWLHD 202
+ S E +++LL + +R + + P+++D
Sbjct: 242 AWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND 277
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-35
Identities = 48/198 (24%), Positives = 81/198 (40%), Gaps = 24/198 (12%)
Query: 21 FCEGGELLDRILSRGGRYLEED--AKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE 78
C L D + R E I +I V F H +G++HRDLKP N FT +
Sbjct: 142 LCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD 201
Query: 79 EDAPLKVIDFGLS-------------DFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGD 124
+KV DFGL + VG+ Y++PE +H +Y+ + D
Sbjct: 202 V---VKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVD 258
Query: 125 MWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKD 184
++S+G+I + LL F + E + +R + F + P+ V+ +L+
Sbjct: 259 IFSLGLILFELLY---SFSTQMERVRIITDVR-NLKF-PLLFTQKYPQEHMMVQDMLSPS 313
Query: 185 HRKRMTAAQALTHPWLHD 202
+R A + + +
Sbjct: 314 PTERPEATDIIENAIFEN 331
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-34
Identities = 61/204 (29%), Positives = 99/204 (48%), Gaps = 15/204 (7%)
Query: 6 LQHLFYS---NSFLFF-TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQG 61
L H+F + LFF + GG+L+ I ++ A +I+ + F H +G
Sbjct: 80 LTHMFCTFQTKENLFFVMEYLNGGDLMYHI-QSCHKFDLSRATFYAAEIILGLQFLHSKG 138
Query: 62 VVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVLHR-SY 119
+V+RDLK +N L D +K+ DFG+ + + D + N G+ Y+APE+L Y
Sbjct: 139 IVYRDLKLDNILLDK---DGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKY 195
Query: 120 NVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRR 179
N D WS GV+ Y +L G PF + E +F S+ +P + P + EAKD + +
Sbjct: 196 NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY---P-RWLEKEAKDLLVK 251
Query: 180 LLNKDHRKRMTAAQAL-THPWLHD 202
L ++ KR+ + HP +
Sbjct: 252 LFVREPEKRLGVRGDIRQHPLFRE 275
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 6e-34
Identities = 45/225 (20%), Positives = 83/225 (36%), Gaps = 31/225 (13%)
Query: 15 FLFFTRFCEGGELLDRILSR--GGRYLEEDAKTIVEKILNIVAFCHLQG--VVHRDLKPE 70
FL T C+G L++ + G + I + V H Q ++HRDLK E
Sbjct: 109 FLLLTELCKGQ-LVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVE 167
Query: 71 NFLFTTREEDAPLKVIDFGLSDFVRPD-------------QRLNDIVGSAYYVAPEVL-- 115
N L + +K+ DFG + + + + Y PE++
Sbjct: 168 NLLLS---NQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDL 224
Query: 116 --HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEA 173
+ + D+W++G I Y+L PF E G ++ + P +
Sbjct: 225 YSNFPIGEKQDIWALGCILYLLCFRQHPF----EDGAKLRIVNG--KYSIPPHDTQYTVF 278
Query: 174 KDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDILIYKLVK 218
+R +L + +R++ A+ + R V I +L++
Sbjct: 279 HSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPITELLE 323
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 6e-34
Identities = 60/205 (29%), Positives = 92/205 (44%), Gaps = 17/205 (8%)
Query: 5 KLQHLFYSNSFLFF-TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVV 63
KL+ F NS L+ + GGE+ L R GR+ E A+ +I+ + H ++
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMF-SHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 64 HRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRS-YNVE 122
+RDLKPEN L + ++V DFG + V R + G+ +APE++ YN
Sbjct: 164 YRDLKPENLLID---QQGYIQVTDFGFAKRV--KGRTWTLCGTPEALAPEIILSKGYNKA 218
Query: 123 GDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLN 182
D W++GV+ Y + G PF+A I+ ++ F P S + KD +R LL
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF---P-SHFSSDLKDLLRNLLQ 274
Query: 183 KDHRKRMTAAQA-----LTHPWLHD 202
D KR + H W
Sbjct: 275 VDLTKRFGNLKNGVNDIKNHKWFAT 299
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-33
Identities = 42/190 (22%), Positives = 82/190 (43%), Gaps = 17/190 (8%)
Query: 21 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREED 80
EGG L ++ + G E+ A + + L + + H + ++H D+K +N L + +
Sbjct: 131 LLEGGSLGQ-LIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLS--SDG 187
Query: 81 APLKVIDFGLSDFVRPDQ------RLNDIVGSAYYVAPEVLHRS-YNVEGDMWSIGVITY 133
+ + DFG + ++PD + I G+ ++APEV+ + + D+WS
Sbjct: 188 SRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSC-CMM 246
Query: 134 I-LLCGSRPFWARTESG--IFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMT 190
+ +L G P W + G + + P + P PS +P ++ L K+ R +
Sbjct: 247 LHMLNGCHP-WTQYFRGPLCLK-IASEPPPIREIP-PSCAPLTAQAIQEGLRKEPVHRAS 303
Query: 191 AAQALTHPWL 200
A +
Sbjct: 304 AMELRRKVGK 313
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-33
Identities = 53/211 (25%), Positives = 96/211 (45%), Gaps = 17/211 (8%)
Query: 5 KLQHLFYSNSFLFF-TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVV 63
+L + F + +L+ + GG+L+ ++S E+ A+ +++ + H G +
Sbjct: 133 QLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFI 190
Query: 64 HRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPD--QRLNDIVGSAYYVAPEVL-----H 116
HRD+KP+N L ++ LK+ DFG + + R + VG+ Y++PEVL
Sbjct: 191 HRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 247
Query: 117 RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDF 176
Y E D WS+GV Y +L G PF+A + G + ++ + +S EAK+
Sbjct: 248 GYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNL 307
Query: 177 VRRLLNKDHRKRMTAAQAL---THPWLHDEN 204
+ L D R+ H + ++
Sbjct: 308 ICAFL-TDREVRLGRNGVEEIKRHLFFKNDQ 337
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-33
Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 19/206 (9%)
Query: 8 HLFYS---NSFLFF-TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVV 63
L Y+ L+ F GG+L R LS+ + EED K + ++ + H G++
Sbjct: 90 KLHYAFQTEGKLYLILDFLRGGDLFTR-LSKEVMFTEEDVKFYLAELALALDHLHSLGII 148
Query: 64 HRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVLHRS-YNV 121
+RDLKPEN L E+ +K+ DFGLS + + +++ G+ Y+APEV++R +
Sbjct: 149 YRDLKPENILLD---EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQ 205
Query: 122 EGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLL 181
D WS GV+ + +L G+ PF + +L+A P +SPEA+ +R L
Sbjct: 206 SADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGM---P-QFLSPEAQSLLRMLF 261
Query: 182 NKDHRKRM-----TAAQALTHPWLHD 202
++ R+ + H +
Sbjct: 262 KRNPANRLGAGPDGVEEIKRHSFFST 287
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 124 bits (315), Expect = 6e-33
Identities = 55/187 (29%), Positives = 93/187 (49%), Gaps = 14/187 (7%)
Query: 8 HLFYS---NSFLFF-TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVV 63
L Y+ L+ + GGEL + L R G ++E+ A + +I + H +G++
Sbjct: 85 DLIYAFQTGGKLYLILEYLSGGELFMQ-LEREGIFMEDTACFYLAEISMALGHLHQKGII 143
Query: 64 HRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVLHRS-YNV 121
+RDLKPEN + +K+ DFGL + + + G+ Y+APE+L RS +N
Sbjct: 144 YRDLKPENIMLN---HQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNR 200
Query: 122 EGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLL 181
D WS+G + Y +L G+ PF +L+ N P P ++ EA+D +++LL
Sbjct: 201 AVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNL---P-PYLTQEARDLLKKLL 256
Query: 182 NKDHRKR 188
++ R
Sbjct: 257 KRNAASR 263
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-32
Identities = 56/205 (27%), Positives = 95/205 (46%), Gaps = 17/205 (8%)
Query: 5 KLQHLFYSNSFLFF-TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVV 63
++ F +F + EGGEL L + R+ AK ++ + + H + ++
Sbjct: 70 RMWGTFQDAQQIFMIMDYIEGGELFSL-LRKSQRFPNPVAKFYAAEVCLALEYLHSKDII 128
Query: 64 HRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRS-YNVE 122
+RDLKPEN L ++ +K+ DFG + +V + G+ Y+APEV+ YN
Sbjct: 129 YRDLKPENILLD---KNGHIKITDFGFAKYV--PDVTYTLCGTPDYIAPEVVSTKPYNKS 183
Query: 123 GDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLN 182
D WS G++ Y +L G PF+ + +L A+ F P P + + KD + RL+
Sbjct: 184 IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF---P-PFFNEDVKDLLSRLIT 239
Query: 183 KDHRKRM-----TAAQALTHPWLHD 202
+D +R+ HPW +
Sbjct: 240 RDLSQRLGNLQNGTEDVKNHPWFKE 264
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-32
Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 20/209 (9%)
Query: 6 LQHLFYS---NSFLFF-TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQG 61
L LF LFF F GG+L+ I + R+ E A+ +I++ + F H +G
Sbjct: 86 LTQLFCCFQTPDRLFFVMEFVNGGDLMFHI-QKSRRFDEARARFYAAEIISALMFLHDKG 144
Query: 62 VVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVLHR-SY 119
+++RDLK +N L + K+ DFG+ + + G+ Y+APE+L Y
Sbjct: 145 IIYRDLKLDNVLLD---HEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLY 201
Query: 120 NVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRR 179
D W++GV+ Y +LCG PF A E +F ++L + + P + +A ++
Sbjct: 202 GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVY---P-TWLHEDATGILKS 257
Query: 180 LLNKDHRKRM-----TAAQAL-THPWLHD 202
+ K+ R+ A+ HP+ +
Sbjct: 258 FMTKNPTMRLGSLTQGGEHAILRHPFFKE 286
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-32
Identities = 52/208 (25%), Positives = 91/208 (43%), Gaps = 19/208 (9%)
Query: 6 LQHLFYS---NSFLFF-TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQG 61
L L L+F + GG+L+ I + GR+ E A +I + F +G
Sbjct: 83 LTQLHSCFQTMDRLYFVMEYVNGGDLMYHI-QQVGRFKEPHAVFYAAEIAIGLFFLQSKG 141
Query: 62 VVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVLHR-SY 119
+++RDLK +N + + + +K+ DFG+ + + G+ Y+APE++ Y
Sbjct: 142 IIYRDLKLDNVMLDS---EGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPY 198
Query: 120 NVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRR 179
D W+ GV+ Y +L G PF E +F+S++ + + P S+S EA +
Sbjct: 199 GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY---P-KSMSKEAVAICKG 254
Query: 180 LLNKDHRKRMTAAQA-----LTHPWLHD 202
L+ K KR+ H +
Sbjct: 255 LMTKHPGKRLGCGPEGERDIKEHAFFRY 282
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-32
Identities = 52/198 (26%), Positives = 80/198 (40%), Gaps = 15/198 (7%)
Query: 21 FCEGGELLDRILSRGGR--YLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE 78
GG L + S+ G E+ ++IL + + H +VHRD+K +N L T
Sbjct: 100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINT-- 157
Query: 79 EDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVLH---RSYNVEGDMWSIGVITYI 134
LK+ DFG S + G+ Y+APE++ R Y D+WS+G T I
Sbjct: 158 YSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLG-CTII 216
Query: 135 -LLCGSRPFWARTESGIFRSVLRADPNFHDSPW--PSVSPEAKDFVRRLLNKDHRKRMTA 191
+ G P + + + F P S+S EAK F+ + D KR A
Sbjct: 217 EMATGKPP-FYELGEPQ--AAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACA 273
Query: 192 AQALTHPWLHDENRPVPL 209
L +L ++
Sbjct: 274 NDLLVDEFLKVSSKKKKT 291
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 7e-32
Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 19/215 (8%)
Query: 5 KLQHLFYSNSFLFF-TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVV 63
+L F ++L+ + GG+LL + G R E A+ + +I+ + H G V
Sbjct: 125 QLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYV 184
Query: 64 HRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ--RLNDIVGSAYYVAPEVLHR---- 117
HRD+KP+N L +++ DFG +R D R VG+ Y++PE+L
Sbjct: 185 HRDIKPDNILLD---RCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGG 241
Query: 118 ----SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPS-VSPE 172
SY E D W++GV Y + G PF+A + + + ++ + V E
Sbjct: 242 PGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEE 301
Query: 173 AKDFVRRLLNKDHRKRMTAAQAL---THPWLHDEN 204
A+DF++RLL R+ A THP+ +
Sbjct: 302 ARDFIQRLLCPP-ETRLGRGGAGDFRTHPFFFGLD 335
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 8e-32
Identities = 62/208 (29%), Positives = 101/208 (48%), Gaps = 19/208 (9%)
Query: 6 LQHLFYS---NSFLFF-TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQG 61
L L Y+ + L F + GGEL LSR + EE A+ +I++ + + H +
Sbjct: 67 LTALKYAFQTHDRLCFVMEYANGGELFFH-LSRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 62 VVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVLHR-SY 119
VV+RD+K EN + D +K+ DFGL + + + G+ Y+APEVL Y
Sbjct: 126 VVYRDIKLENLMLDK---DGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 182
Query: 120 NVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRR 179
D W +GV+ Y ++CG PF+ + +F +L + F P ++SPEAK +
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF---P-RTLSPEAKSLLAG 238
Query: 180 LLNKDHRKRMTAAQA-----LTHPWLHD 202
LL KD ++R+ + + H +
Sbjct: 239 LLKKDPKQRLGGGPSDAKEVMEHRFFLS 266
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 8e-32
Identities = 55/213 (25%), Positives = 95/213 (44%), Gaps = 17/213 (7%)
Query: 5 KLQHLFYSNSFLFF-TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVV 63
L + F ++ L+ + GG+LL + R EE A+ + +++ + H V
Sbjct: 138 TLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYV 197
Query: 64 HRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ--RLNDIVGSAYYVAPEVL------ 115
HRD+KP+N L + + +++ DFG + D + + VG+ Y++PE+L
Sbjct: 198 HRDIKPDNILM---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGG 254
Query: 116 HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPS-VSPEAK 174
Y E D WS+GV Y +L G PF+A + + ++ F + VS AK
Sbjct: 255 KGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAK 314
Query: 175 DFVRRLLNKDHRKRMTAAQAL---THPWLHDEN 204
D +RRL+ R+ HP+ +
Sbjct: 315 DLIRRLICSR-EHRLGQNGIEDFKKHPFFSGID 346
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-31
Identities = 54/199 (27%), Positives = 88/199 (44%), Gaps = 38/199 (19%)
Query: 40 EEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR 99
+ D + + +IL + +CH G++HRD+KP N + E L++ID+GL++F P Q
Sbjct: 129 DYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQE 186
Query: 100 LNDIVGSAYYVAPEVL--HRSYNVEGDMWSIGVITYILLCGSRPF--------------- 142
N V S Y+ PE+L ++ Y+ DMWS+G + ++ PF
Sbjct: 187 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 246
Query: 143 ----------WARTESGIFRSVLRADPNFHDSPW---------PSVSPEAKDFVRRLLNK 183
+ + W VSPEA DF+ +LL
Sbjct: 247 VLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRY 306
Query: 184 DHRKRMTAAQALTHPWLHD 202
DH+ R+TA +A+ HP+ +
Sbjct: 307 DHQSRLTAREAMEHPYFYT 325
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 52/208 (25%), Positives = 91/208 (43%), Gaps = 19/208 (9%)
Query: 6 LQHLFYS---NSFLFF-TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQG 61
L L L+F + GG+L+ I + GR+ E A +I + F +G
Sbjct: 404 LTQLHSCFQTMDRLYFVMEYVNGGDLMYHI-QQVGRFKEPHAVFYAAEIAIGLFFLQSKG 462
Query: 62 VVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVLHR-SY 119
+++RDLK +N + + + +K+ DFG+ + + G+ Y+APE++ Y
Sbjct: 463 IIYRDLKLDNVMLDS---EGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPY 519
Query: 120 NVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRR 179
D W+ GV+ Y +L G PF E +F+S++ + + P S+S EA +
Sbjct: 520 GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY---P-KSMSKEAVAICKG 575
Query: 180 LLNKDHRKRMTAAQA-----LTHPWLHD 202
L+ K KR+ H +
Sbjct: 576 LMTKHPGKRLGCGPEGERDIKEHAFFRY 603
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 2e-31
Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 18/207 (8%)
Query: 6 LQHLFYS---NSFLFF-TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQG 61
L L +S L+F + GGEL L R +LE A+ +I + + + H
Sbjct: 101 LVGLHFSFQTADKLYFVLDYINGGELFYH-LQRERCFLEPRARFYAAEIASALGYLHSLN 159
Query: 62 VVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVLHRS-Y 119
+V+RDLKPEN L + + DFGL + + + + G+ Y+APEVLH+ Y
Sbjct: 160 IVYRDLKPENILLD---SQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPY 216
Query: 120 NVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRR 179
+ D W +G + Y +L G PF++R + ++ ++L P+++ A+ +
Sbjct: 217 DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQL---K-PNITNSARHLLEG 272
Query: 180 LLNKDHRKRM----TAAQALTHPWLHD 202
LL KD KR+ + +H +
Sbjct: 273 LLQKDRTKRLGAKDDFMEIKSHVFFSL 299
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 4e-31
Identities = 38/214 (17%), Positives = 79/214 (36%), Gaps = 33/214 (15%)
Query: 10 FYSNSFLF-FTRFCEGGELLDRILSRG--GRYLEEDA-KTIVEKILNIVAFCHLQGVVHR 65
+ + + +C GG L D I Y +E K ++ ++ + + H +VH
Sbjct: 80 WAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHM 139
Query: 66 DLKPENFLFT----------------TREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYY 109
D+KP N + K+ D G V G + +
Sbjct: 140 DIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH---VTRISSPQVEEGDSRF 196
Query: 110 VAPEVLH--RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWP 167
+A EVL ++ + D++++ +T + G+ P + + + + P
Sbjct: 197 LANEVLQENYTHLPKADIFALA-LTVVCAAGAEPLPRNGDQ--WHEIRQGRL----PRIP 249
Query: 168 SV-SPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200
V S E + ++ +++ D +R +A + H L
Sbjct: 250 QVLSQEFTELLKVMIHPDPERRPSAMALVKHSVL 283
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 7e-31
Identities = 62/209 (29%), Positives = 101/209 (48%), Gaps = 20/209 (9%)
Query: 6 LQHLFYS---NSFLFF-TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQ- 60
L L YS + L F + GGEL LSR + E+ A+ +I++ + + H +
Sbjct: 210 LTALKYSFQTHDRLCFVMEYANGGELFFH-LSRERVFSEDRARFYGAEIVSALDYLHSEK 268
Query: 61 GVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVLHRS- 118
VV+RDLK EN + D +K+ DFGL + ++ + G+ Y+APEVL +
Sbjct: 269 NVVYRDLKLENLMLDK---DGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND 325
Query: 119 YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVR 178
Y D W +GV+ Y ++CG PF+ + +F +L + F P ++ PEAK +
Sbjct: 326 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF---P-RTLGPEAKSLLS 381
Query: 179 RLLNKDHRKRMTAAQA-----LTHPWLHD 202
LL KD ++R+ + H +
Sbjct: 382 GLLKKDPKQRLGGGSEDAKEIMQHRFFAG 410
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-30
Identities = 61/213 (28%), Positives = 104/213 (48%), Gaps = 26/213 (12%)
Query: 8 HLFYS---NSFLFF-TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVV 63
L Y+ + L + GGEL LS+ R+ E + + V +I+ + H G++
Sbjct: 123 TLHYAFQTETKLHLILDYINGGELFTH-LSQRERFTEHEVQIYVGEIVLALEHLHKLGII 181
Query: 64 HRDLKPENFLFTTREEDAPLKVIDFGLS--DFVRPDQRLNDIVGSAYYVAPEVLHRS--- 118
+RD+K EN L + + + DFGLS +R D G+ Y+AP+++
Sbjct: 182 YRDIKLENILLD---SNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSG 238
Query: 119 YNVEGDMWSIGVITYILLCGSRPFWA----RTESGIFRSVLRADPNFHDSPWPSVSPEAK 174
++ D WS+GV+ Y LL G+ PF +++ I R +L+++P + P +S AK
Sbjct: 239 HDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY---P-QEMSALAK 294
Query: 175 DFVRRLLNKDHRKRM-----TAAQALTHPWLHD 202
D ++RLL KD +KR+ A + H +
Sbjct: 295 DLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-30
Identities = 40/195 (20%), Positives = 80/195 (41%), Gaps = 11/195 (5%)
Query: 13 NSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQG--VVHRDLKPE 70
+ T G L L R + ++ +IL + F H + ++HRDLK +
Sbjct: 102 KCIVLVTELMTSGTLKT-YLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCD 160
Query: 71 NFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGV 130
N T +K+ D GL+ R ++G+ ++APE+ Y+ D+++ G
Sbjct: 161 NIFITG--PTGSVKIGDLGLATLKRASFA-KAVIGTPEFMAPEMYEEKYDESVDVYAFG- 216
Query: 131 ITYILLCGSRPFWARTESG--IFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKR 188
+ + + S ++ ++ I+R V S PE K+ + + ++ +R
Sbjct: 217 MCMLEMATSEYPYSECQNAAQIYRRVTSGVKP--ASFDKVAIPEVKEIIEGCIRQNKDER 274
Query: 189 MTAAQALTHPWLHDE 203
+ L H + +E
Sbjct: 275 YSIKDLLNHAFFQEE 289
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 7e-30
Identities = 57/218 (26%), Positives = 101/218 (46%), Gaps = 29/218 (13%)
Query: 6 LQHLFYS---NSFLFF-TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQG 61
L L S LFF + GG+L+ + R + EE A+ +I + + H +G
Sbjct: 72 LVGLHSCFQTESRLFFVIEYVNGGDLMFH-MQRQRKLPEEHARFYSAEISLALNYLHERG 130
Query: 62 VVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVLHR-SY 119
+++RDLK +N L + +K+ D+G+ + +RP + G+ Y+APE+L Y
Sbjct: 131 IIYRDLKLDNVLLD---SEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY 187
Query: 120 NVEGDMWSIGVITYILLCGSRPFW---------ARTESGIFRSVLRADPNFHDSPWPSVS 170
D W++GV+ + ++ G PF TE +F+ +L P S+S
Sbjct: 188 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI---P-RSLS 243
Query: 171 PEAKDFVRRLLNKDHRKRM-----TAAQAL-THPWLHD 202
+A ++ LNKD ++R+ T + HP+ +
Sbjct: 244 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 8e-30
Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 20/211 (9%)
Query: 5 KLQHLFYSNSFLFF-TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVV 63
+ + F++ L F GG+L LS+ G + E D + +I+ + H + VV
Sbjct: 256 CMSYAFHTPDKLSFILDLMNGGDLHYH-LSQHGVFSEADMRFYAAEIILGLEHMHNRFVV 314
Query: 64 HRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR--SYNV 121
+RDLKP N L E +++ D GL+ ++ + VG+ Y+APEVL + +Y+
Sbjct: 315 YRDLKPANILLD---EHGHVRISDLGLACDF-SKKKPHASVGTHGYMAPEVLQKGVAYDS 370
Query: 122 EGDMWSIGVITYILLCGSRPFWARTESG---IFRSVLRADPNFHDSPWPSVSPEAKDFVR 178
D +S+G + + LL G PF I R L S SPE + +
Sbjct: 371 SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP----DSFSPELRSLLE 426
Query: 179 RLLNKDHRKRM-----TAAQALTHPWLHDEN 204
LL +D +R+ A + P+ +
Sbjct: 427 GLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 457
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-29
Identities = 54/198 (27%), Positives = 95/198 (47%), Gaps = 23/198 (11%)
Query: 6 LQHLFYS---NSFLFF-TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQG 61
L L S LFF + GG+L+ + R + EE A+ +I + + H +G
Sbjct: 115 LVGLHSCFQTESRLFFVIEYVNGGDLMFH-MQRQRKLPEEHARFYSAEISLALNYLHERG 173
Query: 62 VVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVLHR-SY 119
+++RDLK +N L + + +K+ D+G+ + +RP + G+ Y+APE+L Y
Sbjct: 174 IIYRDLKLDNVLLDS---EGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY 230
Query: 120 NVEGDMWSIGVITYILLCGSRPFW---------ARTESGIFRSVLRADPNFHDSPWPSVS 170
D W++GV+ + ++ G PF TE +F+ +L P S+S
Sbjct: 231 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI---P-RSLS 286
Query: 171 PEAKDFVRRLLNKDHRKR 188
+A ++ LNKD ++R
Sbjct: 287 VKAASVLKSFLNKDPKER 304
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 22/210 (10%)
Query: 10 FYSNSFLFF-TRFCEGGEL---LDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHR 65
F + + L GG++ + + + E A +I++ + H + +++R
Sbjct: 254 FETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYR 313
Query: 66 DLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEG 123
DLKPEN L +D +++ D GL+ + + G+ ++APE+L Y+
Sbjct: 314 DLKPENVLLD---DDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSV 370
Query: 124 DMWSIGVITYILLCGSRPFWARTESG----IFRSVLRADPNFHDSPWPSVSPEAKDFVRR 179
D +++GV Y ++ PF AR E + + VL + D SP +KDF
Sbjct: 371 DYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPD----KFSPASKDFCEA 426
Query: 180 LLNKDHRKRM-----TAAQALTHPWLHDEN 204
LL KD KR+ + THP D +
Sbjct: 427 LLQKDPEKRLGFRDGSCDGLRTHPLFRDIS 456
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 55/211 (26%), Positives = 89/211 (42%), Gaps = 19/211 (9%)
Query: 6 LQHLFYSNSFLFF-TRFCEGGELLDRILSRGGRYLEED-AKTIVEKILNIVAFCHLQGVV 63
L + + + L GG+L I G E A +I + H + +V
Sbjct: 249 LAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIV 308
Query: 64 HRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVE 122
+RDLKPEN L + +++ D GL+ V Q + VG+ Y+APEV+ Y
Sbjct: 309 YRDLKPENILLD---DHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFS 365
Query: 123 GDMWSIGVITYILLCGSRPFWARTESG----IFRSVLRADPNFHDSPWPSVSPEAKDFVR 178
D W++G + Y ++ G PF R + + R V + + SP+A+
Sbjct: 366 PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSE----RFSPQARSLCS 421
Query: 179 RLLNKDHRKRM-----TAAQALTHPWLHDEN 204
+LL KD +R+ +A + HP N
Sbjct: 422 QLLCKDPAERLGCRGGSAREVKEHPLFKKLN 452
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-28
Identities = 61/217 (28%), Positives = 101/217 (46%), Gaps = 27/217 (12%)
Query: 21 FCEGGELLDRILSRGGRYLEEDA-KTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREE 79
FC G + D I + G L+E+ I +IL ++ H V+HRD+K +N L T E
Sbjct: 108 FCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT---E 164
Query: 80 DAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVLHR------SYNVEGDMWSIGVIT 132
+A +K++DFG+S R R N +G+ Y++APEV+ +Y+ + D+WS+G IT
Sbjct: 165 NAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLG-IT 223
Query: 133 YILL-------CGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDH 185
I + C P A +F P W S + + F+ L K+H
Sbjct: 224 AIEMAEGAPPLCDMHPMRA-----LFLIPRNPAPRLKSKKW---SKKFQSFIESCLVKNH 275
Query: 186 RKRMTAAQALTHPWLHDENRPVPLDILIYKLVKSYLR 222
+R Q + HP++ D+ + I + + +
Sbjct: 276 SQRPATEQLMKHPFIRDQPNERQVRIQLKDHIDRTKK 312
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 3e-28
Identities = 54/214 (25%), Positives = 86/214 (40%), Gaps = 35/214 (16%)
Query: 27 LLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVI 86
+L + E K+I + L V FCH +HRD+KPEN L T +K+
Sbjct: 88 VLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSV---IKLC 144
Query: 87 DFGLS-DFVRPDQRLNDIVGSAYYVAPEVL--HRSYNVEGDMWSIGVITYILLCGSRPFW 143
DFG + P +D V + +Y +PE+L Y D+W+IG + LL G P W
Sbjct: 145 DFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSG-VPLW 203
Query: 144 -ARTE----SGIFR----------SVLRADPNFHDSP-------------WPSVSPEAKD 175
+++ I + V + F +P++S A
Sbjct: 204 PGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALG 263
Query: 176 FVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPL 209
++ L+ D +R+T Q L HP+ + L
Sbjct: 264 LLKGCLHMDPTERLTCEQLLHHPYFENIREIEDL 297
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 7e-28
Identities = 58/203 (28%), Positives = 91/203 (44%), Gaps = 32/203 (15%)
Query: 33 SRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS- 91
S G E K+ + ++L + FCH + V+HRDLKP+N L E LK+ +FGL+
Sbjct: 93 SCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE---LKLANFGLAR 149
Query: 92 DFVRPDQRLNDIVGSAYYVAPEVL--HRSYNVEGDMWSIGVITYILLCGSRP-FWARTE- 147
F P + + V + +Y P+VL + Y+ DMWS G I L RP F
Sbjct: 150 AFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD 209
Query: 148 ---SGIFRSV----------LRADPNFHDSP-----------WPSVSPEAKDFVRRLLNK 183
IFR + + P++ P P ++ +D ++ LL
Sbjct: 210 DQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKC 269
Query: 184 DHRKRMTAAQALTHPWLHDENRP 206
+ +R++A +AL HP+ D P
Sbjct: 270 NPVQRISAEEALQHPYFSDFCPP 292
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-27
Identities = 47/214 (21%), Positives = 84/214 (39%), Gaps = 35/214 (16%)
Query: 27 LLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVI 86
+LD + + + + +I+N + FCH ++HRD+KPEN L + +K+
Sbjct: 110 ILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGV---VKLC 166
Query: 87 DFGLS-DFVRPDQRLNDIVGSAYYVAPEVL--HRSYNVEGDMWSIGVITYILLCGSRPFW 143
DFG + P + +D V + +Y APE+L Y D+W+IG + + G P +
Sbjct: 167 DFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG-EPLF 225
Query: 144 -ARTE----SGIFR----------SVLRADPNFHD-------------SPWPSVSPEAKD 175
++ I + +P F +P +S D
Sbjct: 226 PGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVID 285
Query: 176 FVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPL 209
++ L+ D KR A+ L H + +
Sbjct: 286 LAKKCLHIDPDKRPFCAELLHHDFFQMDGFAERF 319
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-26
Identities = 58/214 (27%), Positives = 93/214 (43%), Gaps = 39/214 (18%)
Query: 28 LDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE--EDAPLKV 85
L + + + K+ + +++N V FCH + +HRDLKP+N L + + E LK+
Sbjct: 119 LKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKI 178
Query: 86 IDFGLS-DFVRPDQRLNDIVGSAYYVAPEVL--HRSYNVEGDMWSIGVITYILLCGSRPF 142
DFGL+ F P ++ + + +Y PE+L R Y+ D+WSI I +L + F
Sbjct: 179 GDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLF 238
Query: 143 WARTE----SGIFRSVLRADPNFHDSPWPSVS--------------------------PE 172
+E IF VL P+ D+ WP V+ E
Sbjct: 239 PGDSEIDQLFKIFE-VLGL-PD--DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDE 294
Query: 173 AKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRP 206
D + +L D KR++A AL HP+ +
Sbjct: 295 GLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFD 328
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-26
Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 31/200 (15%)
Query: 33 SRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS- 91
G AK+ + ++LN +A+CH + V+HRDLKP+N L E LK+ DFGL+
Sbjct: 92 VCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE---LKIADFGLAR 148
Query: 92 DFVRPDQRLNDIVGSAYYVAPEVL--HRSYNVEGDMWSIGVITYILLCGSRPFWARTE-- 147
F P ++ + + +Y AP+VL + Y+ D+WS+G I ++ G+ F +E
Sbjct: 149 AFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD 208
Query: 148 --SGIFR-------------SVLR-ADPNFHDSP-------WPSVSPEAKDFVRRLLNKD 184
IFR + L DPNF + D + ++L D
Sbjct: 209 QLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLD 268
Query: 185 HRKRMTAAQALTHPWLHDEN 204
+R+TA QAL H + + N
Sbjct: 269 PNQRITAKQALEHAYFKENN 288
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-26
Identities = 47/244 (19%), Positives = 80/244 (32%), Gaps = 54/244 (22%)
Query: 28 LDRILSRGGRYLEED-AKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVI 86
L +++ + + + IL + H GVVHRDL P N L ++ + +
Sbjct: 120 LAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLA---DNNDITIC 176
Query: 87 DFGLSDFVRPDQRLNDIVGSAYYVAPEVL--HRSYNVEGDMWSIGVITYILLCG------ 138
DF L+ D V +Y APE++ + + DMWS G + +
Sbjct: 177 DFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRG 236
Query: 139 -----------------SRPFWARTESGIFRSVLRAD-PNFHDSPW----PSVSPEAKDF 176
S R LR N W P+ P A D
Sbjct: 237 STFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDL 296
Query: 177 VRRLLNKDHRKRMTAAQALTHPWL------HDENRPVPLDI--------------LIYKL 216
+ ++L + ++R++ QAL HP+ D + +
Sbjct: 297 IAKMLEFNPQRRISTEQALRHPYFESLFDPLDLTEGLSERFHFDESVTDVYDMHKIFTAE 356
Query: 217 VKSY 220
V+ +
Sbjct: 357 VERF 360
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-26
Identities = 54/205 (26%), Positives = 89/205 (43%), Gaps = 32/205 (15%)
Query: 33 SRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS- 91
G + K + ++L +A+CH Q V+HRDLKP+N L R E LK+ DFGL+
Sbjct: 92 DCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGE---LKLADFGLAR 148
Query: 92 DFVRPDQRLNDIVGSAYYVAPEVL--HRSYNVEGDMWSIGVITYILLCGSRPFWARTE-- 147
P + ++ V + +Y P++L Y+ + DMW +G I Y + G F T
Sbjct: 149 AKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE 208
Query: 148 --SGIFRSV----------LRADPNFHD------------SPWPSVSPEAKDFVRRLLNK 183
IFR + + ++ F S P + + D + +LL
Sbjct: 209 QLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQF 268
Query: 184 DHRKRMTAAQALTHPWLHDENRPVP 208
+ R R++A A+ HP+ +
Sbjct: 269 EGRNRISAEDAMKHPFFLSLGERIH 293
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 8e-26
Identities = 58/198 (29%), Positives = 90/198 (45%), Gaps = 12/198 (6%)
Query: 21 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREED 80
+C G + D I R E++ TI++ L + + H +HRD+K N L +
Sbjct: 105 YCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLN---TE 161
Query: 81 APLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVLHRS-YNVEGDMWSIGVITYILLCG 138
K+ DFG++ + N ++G+ +++APEV+ YN D+WS+G IT I +
Sbjct: 162 GHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLG-ITAIEMAE 220
Query: 139 SRPFWARTE--SGIFRSVLRADPNFHD-SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQAL 195
+P +A IF P F W S DFV++ L K +R TA Q L
Sbjct: 221 GKPPYADIHPMRAIFMIPTNPPPTFRKPELW---SDNFTDFVKQCLVKSPEQRATATQLL 277
Query: 196 THPWLHDENRPVPLDILI 213
HP++ L LI
Sbjct: 278 QHPFVRSAKGVSILRDLI 295
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 8e-26
Identities = 57/217 (26%), Positives = 89/217 (41%), Gaps = 33/217 (15%)
Query: 21 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQG---------VVHRDLKPEN 71
D+ L+ I E+IL + ++ ++HRD+KP N
Sbjct: 102 LMSTS--FDKFYKYVYSVLD---DVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSN 156
Query: 72 FLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVLH-----RSYNVEGDM 125
L +K+ DFG+S V + D G Y+APE + + Y+V D+
Sbjct: 157 ILLDRSGN---IKLCDFGISGQLVDSIAKTRD-AGCRPYMAPERIDPSASRQGYDVRSDV 212
Query: 126 WSIGVITYI-LLCGSRPFWARTESGIFR---SVLRAD-PNFHDSPWPSVSPEAKDFVRRL 180
WS+G IT L G P+ + +F V++ D P +S SP +FV
Sbjct: 213 WSLG-ITLYELATGRFPY--PKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLC 269
Query: 181 LNKDHRKRMTAAQALTHPWL-HDENRPVPLDILIYKL 216
L KD KR + L HP++ E R V + + K+
Sbjct: 270 LTKDESKRPKYKELLKHPFILMYEERAVEVACYVCKI 306
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-25
Identities = 54/216 (25%), Positives = 86/216 (39%), Gaps = 42/216 (19%)
Query: 30 RILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFG 89
+ + K ++L +AFCH ++HRDLKP+N L R + LK+ DFG
Sbjct: 97 TVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQ---LKLGDFG 153
Query: 90 LS-DFVRPDQRLNDIVGSAYYVAPEVL--HRSYNVEGDMWSIGVITYILLCGSRPFWART 146
L+ F P + V + +Y AP+VL R+Y+ D+WS G I ++ G F
Sbjct: 154 LARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN 213
Query: 147 E----SGIFR-------------SVLRADPNFHDS----------------PWPSVSPEA 173
+ IF + L P ++ + +
Sbjct: 214 DEEQLKLIFDIMGTPNESLWPSVTKL---PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNL 270
Query: 174 KDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPL 209
DF+ LL + R++A QAL HPW + +
Sbjct: 271 MDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHASM 306
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 62/221 (28%), Positives = 91/221 (41%), Gaps = 55/221 (24%)
Query: 50 ILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYY 109
+L + + H GVVHRDLKP N ED LK++DFGL+ + + V + +Y
Sbjct: 135 MLKGLKYIHSAGVVHRDLKPGNLAVN---EDCELKILDFGLARHADAE--MTGYVVTRWY 189
Query: 110 VAPEVL--HRSYNVEGDMWSIGVITYILLCG-----------------------SRPFWA 144
APEV+ YN D+WS+G I +L G F
Sbjct: 190 RAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ 249
Query: 145 RTESGIFRSVLRADPNFHDSPW----PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200
+ +S +++ P + P SP+A D + ++L D KR+TAAQALTHP+
Sbjct: 250 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 309
Query: 201 ---HDENR----PVPLDI--------------LIYKLVKSY 220
D P D IYK + ++
Sbjct: 310 EPFRDPEEETEAQQPFDDSLEHEKLTVDEWKQHIYKEIVNF 350
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 49/208 (23%), Positives = 90/208 (43%), Gaps = 25/208 (12%)
Query: 21 FCEGG--ELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQG-VVHRDLKPENFLFTTR 77
+ + +++ +G E+ I I+ + H + V+HRD+KP N L
Sbjct: 87 LMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINAL 146
Query: 78 EEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVLH-----RSYNVEGDMWSIGVI 131
+ +K+ DFG+S V + + G Y+APE ++ + Y+V+ D+WS+G I
Sbjct: 147 GQ---VKMCDFGISGYLVDDVAK-DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLG-I 201
Query: 132 TYI-LLCGSRPFWARTESGIFRS----VLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHR 186
T I L P+ + F+ V P + S E DF + L K+ +
Sbjct: 202 TMIELAILRFPY--DSWGTPFQQLKQVVEEPSPQLPADKF---SAEFVDFTSQCLKKNSK 256
Query: 187 KRMTAAQALTHPWLHD-ENRPVPLDILI 213
+R T + + HP+ E++ + +
Sbjct: 257 ERPTYPELMQHPFFTLHESKGTDVASFV 284
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 55/192 (28%), Positives = 80/192 (41%), Gaps = 38/192 (19%)
Query: 50 ILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYY 109
+ +A+ H G+ HRD+KP+N L + A LK+ DFG + + + + S YY
Sbjct: 165 LFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 222
Query: 110 VAPEVLHRS--YNVEGDMWSIGVITYILLCGSRPFWARTESG------IFRSVL----RA 157
APE++ + Y D+WS G + LL G +P + +SG I + VL R
Sbjct: 223 RAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIF-PGDSGVDQLVEIIK-VLGTPTRE 279
Query: 158 D-------------PNFHDSPW-----PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPW 199
P PW P PEA RLL R+T +A H +
Sbjct: 280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 339
Query: 200 ---LHDENRPVP 208
L D N +P
Sbjct: 340 FDELRDPNVKLP 351
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-25
Identities = 54/207 (26%), Positives = 83/207 (40%), Gaps = 38/207 (18%)
Query: 33 SRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS- 91
+ K + ++L VA CH ++HRDLKP+N L + LK+ DFGL+
Sbjct: 111 ENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGA---LKLADFGLAR 167
Query: 92 DFVRPDQRLNDIVGSAYYVAPEVL--HRSYNVEGDMWSIGVITYILLCGSRPFWARTE-- 147
F P + V + +Y AP+VL + Y+ D+WSIG I ++ G F T+
Sbjct: 168 AFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD 227
Query: 148 --SGIFR-------------SVLRADPNFHDSP------------WPSVSPEAKDFVRRL 180
IF L P + P E D + +
Sbjct: 228 QLPKIFSILGTPNPREWPQVQEL---PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNM 284
Query: 181 LNKDHRKRMTAAQALTHPWLHDENRPV 207
L D KR++A A+ HP+ D + +
Sbjct: 285 LCFDPNKRISARDAMNHPYFKDLDPQI 311
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 17/203 (8%)
Query: 21 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREED 80
FC GG + +L E + + ++L + F H + ++HRDLK N L T +
Sbjct: 97 FCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMT---LE 153
Query: 81 APLKVIDFGLSDFVRPD-QRLNDIVGSAYYVAPEVLHR------SYNVEGDMWSIGVITY 133
+++ DFG+S Q+ + +G+ Y++APEV+ Y+ + D+WS+G IT
Sbjct: 154 GDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLG-ITL 212
Query: 134 ILLCGSRPFWARTE--SGIFRSVLRADPNFHD-SPWPSVSPEAKDFVRRLLNKDHRKRMT 190
I + P + + P S W S E +DF++ L+K+ R +
Sbjct: 213 IEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKW---SVEFRDFLKIALDKNPETRPS 269
Query: 191 AAQALTHPWLHDENRPVPLDILI 213
AAQ L HP++ L L+
Sbjct: 270 AAQLLEHPFVSSITSNKALRELV 292
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 49/218 (22%), Positives = 85/218 (38%), Gaps = 47/218 (21%)
Query: 40 EEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR 99
E ++ ++L + H G++HRDLKP N + D LK++DFGL+
Sbjct: 163 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILDFGLARTAGTSFM 219
Query: 100 LNDIVGSAYYVAPEV-LHRSYNVEGDMWSIGVITYILLCG-------------------- 138
+ V + YY APEV L Y D+WS+G I ++
Sbjct: 220 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 279
Query: 139 ---SRPFWARTESGIFRSVLRADPNFHDSPWPSV----------------SPEAKDFVRR 179
F + + + R+ + P + +P + + +A+D + +
Sbjct: 280 GTPCPEFMKKLQPTV-RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSK 338
Query: 180 LLNKDHRKRMTAAQALTHPWL---HDENRPVPLDILIY 214
+L D KR++ AL HP++ +D IY
Sbjct: 339 MLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIY 376
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-25
Identities = 53/194 (27%), Positives = 80/194 (41%), Gaps = 29/194 (14%)
Query: 40 EEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR 99
E K ++ ++L + F H VVHRDLKP+N L T+ + +K+ DFGL+
Sbjct: 119 TETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ---IKLADFGLARIYSFQMA 175
Query: 100 LNDIVGSAYYVAPEVL-HRSYNVEGDMWSIGVITYILLCGSRPFWARTE----SGIFR-- 152
L +V + +Y APEVL SY D+WS+G I + F ++ I
Sbjct: 176 LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 235
Query: 153 -----------SVLRADPNFHDSP-------WPSVSPEAKDFVRRLLNKDHRKRMTAAQA 194
L FH + KD + + L + KR++A A
Sbjct: 236 GLPGEEDWPRDVALP-RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 294
Query: 195 LTHPWLHDENRPVP 208
L+HP+ D R
Sbjct: 295 LSHPYFQDLERCKE 308
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-25
Identities = 57/217 (26%), Positives = 87/217 (40%), Gaps = 41/217 (18%)
Query: 28 LDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVID 87
L +L G LEE A+ + ++L + + H V+HRDLKP N T ED LK+ D
Sbjct: 108 LANVL-EQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT--EDLVLKIGD 164
Query: 88 FGLSDFVRPDQRLNDI----VGSAYYVAPEVL--HRSYNVEGDMWSIGVITYILLCG--- 138
FGL+ + P + + +Y +P +L +Y DMW+ G I +L G
Sbjct: 165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTL 224
Query: 139 --------------------SRPFWARTESGIFRSVLRADPNFHDSPW----PSVSPEAK 174
S +R D P P +S EA
Sbjct: 225 FAGAHELEQMQLILESIPVVHEEDRQELLSV-IPVYIRNDMTEPHKPLTQLLPGISREAV 283
Query: 175 DFVRRLLNKDHRKRMTAAQALTHPWL---HDENR-PV 207
DF+ ++L R+TA +AL+HP++ P+
Sbjct: 284 DFLEQILTFSPMDRLTAEEALSHPYMSIYSFPMDEPI 320
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-25
Identities = 70/212 (33%), Positives = 100/212 (47%), Gaps = 42/212 (19%)
Query: 21 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREED 80
F +GG L D + R EE T+ E +L +A+ H QGV+HRD+K ++ L T D
Sbjct: 123 FLQGGALTD--IVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLT---LD 177
Query: 81 APLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLHRS-YNVEGDMWSIGVITYILLCG 138
+K+ DFG + D + +VG+ Y++APEV+ RS Y E D+WS+G I I +
Sbjct: 178 GRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLG-IMVIEMVD 236
Query: 139 SRPFWARTESGIFRSVLRADPNFHDSP-----------------WPSVSPEAKDFVRRLL 181
P P F DSP VSP +DF+ R+L
Sbjct: 237 GEP-----------------PYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERML 279
Query: 182 NKDHRKRMTAAQALTHPWLHDENRPVPLDILI 213
+D ++R TA + L HP+L P L LI
Sbjct: 280 VRDPQERATAQELLDHPFLLQTGLPECLVPLI 311
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-25
Identities = 49/188 (26%), Positives = 81/188 (43%), Gaps = 37/188 (19%)
Query: 50 ILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYY 109
+L + + H G++HRDLKP N ED LK++DFGL+ + + V + +Y
Sbjct: 137 MLKGLRYIHAAGIIHRDLKPGNLAVN---EDCELKILDFGLARQADSE--MTGYVVTRWY 191
Query: 110 VAPEVL--HRSYNVEGDMWSIGVITYILLCG-----------------------SRPFWA 144
APEV+ Y D+WS+G I ++ G F
Sbjct: 192 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 251
Query: 145 RTESGIFRSVLRADPNFHDSPW----PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200
R +S ++ ++ P + + SP A + + ++L D +R+TA +AL HP+
Sbjct: 252 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 311
Query: 201 ---HDENR 205
HD
Sbjct: 312 ESLHDTED 319
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-25
Identities = 51/215 (23%), Positives = 85/215 (39%), Gaps = 26/215 (12%)
Query: 21 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQ-GVVHRDLKPENFLFTTREE 79
G E + I+ + + + GV+HRD+KP N L R +
Sbjct: 105 LMGTC-AEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQ 163
Query: 80 DAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL------HRSYNVEGDMWSIGVITY 133
+K+ DFG+S + D+ + G A Y+APE + Y++ D+WS+G I+
Sbjct: 164 ---IKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLG-ISL 219
Query: 134 I-LLCGSRPFWARTESGIFRSVLRADPNF------HDSPWPSVSPEAKDFVRRLLNKDHR 186
+ L G P+ + F VL + S + + FV+ L KDHR
Sbjct: 220 VELATGQFPY--KNCKTDFE-VLTKVLQEEPPLLPGHMGF---SGDFQSFVKDCLTKDHR 273
Query: 187 KRMTAAQALTHPWL-HDENRPVPLDILIYKLVKSY 220
KR + L H ++ E V + ++
Sbjct: 274 KRPKYNKLLEHSFIKRYETLEVDVASWFKDVMAKT 308
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 6e-25
Identities = 50/192 (26%), Positives = 74/192 (38%), Gaps = 38/192 (19%)
Query: 50 ILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYY 109
+L +A+ H G+ HRD+KP+N L LK+IDFG + + + + S YY
Sbjct: 150 LLRSLAYIHSIGICHRDIKPQNLLLD--PPSGVLKLIDFGSAKILIAGEPNVSYICSRYY 207
Query: 110 VAPEVLHRS--YNVEGDMWSIGVITYILLCG-----------------------SRPFWA 144
APE++ + Y D+WS G + L+ G SR
Sbjct: 208 RAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIK 267
Query: 145 RTESGIFRSVLRADPNFHDSPW-----PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPW 199
P P+ P P+A D + RLL R+TA +AL HP+
Sbjct: 268 TMNPNYMEHKF---PQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPF 324
Query: 200 ---LHDENRPVP 208
L +P
Sbjct: 325 FDELRTGEARMP 336
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 8e-25
Identities = 52/211 (24%), Positives = 80/211 (37%), Gaps = 38/211 (18%)
Query: 33 SRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS- 91
K + L + + H ++HRDLKP N L LK+ DFGL+
Sbjct: 104 DNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV---LKLADFGLAK 160
Query: 92 DFVRPDQRLNDIVGSAYYVAPEVL--HRSYNVEGDMWSIGVITYILLCGSRPFWA-RTE- 147
F P++ V + +Y APE+L R Y V DMW++G I LL PF ++
Sbjct: 161 SFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLR-VPFLPGDSDL 219
Query: 148 ---SGIFR-------------SVLRADPNFHDSP----------WPSVSPEAKDFVRRLL 181
+ IF L P++ + + + D ++ L
Sbjct: 220 DQLTRIFETLGTPTEEQWPDMCSL---PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLF 276
Query: 182 NKDHRKRMTAAQALTHPWLHDENRPVPLDIL 212
+ R+TA QAL + + P P L
Sbjct: 277 LFNPCARITATQALKMKYFSNRPGPTPGCQL 307
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 9e-25
Identities = 53/193 (27%), Positives = 80/193 (41%), Gaps = 28/193 (14%)
Query: 40 EEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR 99
E K ++ + L + F H +VHRDLKPEN L T+ +K+ DFGL+
Sbjct: 119 AETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGT---VKLADFGLARIYSYQMA 175
Query: 100 LNDIVGSAYYVAPEVL-HRSYNVEGDMWSIGVITYILLCGSRPFWARTE----SGIFRSV 154
L +V + +Y APEVL +Y DMWS+G I + F +E IF +
Sbjct: 176 LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI 235
Query: 155 ----------LRADPNFHDSPW---------PSVSPEAKDFVRRLLNKDHRKRMTAAQAL 195
+ P P P + + +L + KR++A +AL
Sbjct: 236 GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRAL 295
Query: 196 THPWLHDENRPVP 208
H +LH + P
Sbjct: 296 QHSYLHKDE-GNP 307
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 52/199 (26%), Positives = 84/199 (42%), Gaps = 17/199 (8%)
Query: 21 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREED 80
+C G D + E + + L +A+ H ++HRD+K N L + E
Sbjct: 135 YCLGS-ASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS---EP 190
Query: 81 APLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRS----YNVEGDMWSIGVITYILL 136
+K+ DFG + + N VG+ Y++APEV+ Y+ + D+WS+G IT I L
Sbjct: 191 GLVKLGDFGSASIM---APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG-ITCIEL 246
Query: 137 CGSRPFWARTE--SGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQA 194
+P S ++ P W S ++FV L K + R T+
Sbjct: 247 AERKPPLFNMNAMSALYHIAQNESPALQSGHW---SEYFRNFVDSCLQKIPQDRPTSEVL 303
Query: 195 LTHPWLHDENRPVPLDILI 213
L H ++ E P + LI
Sbjct: 304 LKHRFVLRERPPTVIMDLI 322
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 54/211 (25%), Positives = 91/211 (43%), Gaps = 40/211 (18%)
Query: 28 LDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVID 87
L+ I+ + + ++ + ++ +IL + + H ++HRDLKP N ED LK++D
Sbjct: 120 LNNIV-KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILD 175
Query: 88 FGLSDFVRP-DQRLNDIVGSAYYVAPEVL--HRSYNVEGDMWSIGVITYILLCG------ 138
FGL+ R + V + +Y APE++ YN D+WS+G I LL G
Sbjct: 176 FGLA---RHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 232
Query: 139 -----------------SRPFWARTESGIFRSVLRADPNFHDSPW----PSVSPEAKDFV 177
+ S R+ +++ + +P A D +
Sbjct: 233 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 292
Query: 178 RRLLNKDHRKRMTAAQALTHPWL---HDENR 205
++L D KR+TAAQAL H + HD +
Sbjct: 293 EKMLVLDSDKRITAAQALAHAYFAQYHDPDD 323
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 54/225 (24%), Positives = 86/225 (38%), Gaps = 57/225 (25%)
Query: 50 ILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDI----VG 105
IL + + H V+HRDLKP N L LK+ DFGL+ PD V
Sbjct: 137 ILRGLKYIHSANVLHRDLKPSNLLLN---TTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 106 SAYYVAPEVL--HRSYNVEGDMWSIGVITYILLCG-----------------------SR 140
+ +Y APE++ + Y D+WS+G I +L S+
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 253
Query: 141 PFWARTESGIFRSVLRADPNFHDSPW----PSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196
+ R+ L + P+ + PW P+ +A D + ++L + KR+ QAL
Sbjct: 254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313
Query: 197 HPWL---HDENR----PVPLDI--------------LIYKLVKSY 220
HP+L +D + P LI++ +
Sbjct: 314 HPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARF 358
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 54/197 (27%), Positives = 87/197 (44%), Gaps = 12/197 (6%)
Query: 21 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREED 80
+ GG L D + E + + L + F H V+HRD+K +N L D
Sbjct: 98 YLAGGSLTD--VVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG---MD 152
Query: 81 APLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLHRS-YNVEGDMWSIGVITYILLCG 138
+K+ DFG + P+Q + + +VG+ Y++APEV+ R Y + D+WS+G I I +
Sbjct: 153 GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG-IMAIEMIE 211
Query: 139 SRPFWARTE--SGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196
P + ++ P + +S +DF+ R L D KR +A + L
Sbjct: 212 GEPPYLNENPLRALYLIATNGTPELQN--PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269
Query: 197 HPWLHDENRPVPLDILI 213
H +L L LI
Sbjct: 270 HQFLKIAKPLSSLTPLI 286
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 15/205 (7%)
Query: 21 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREED 80
+ GG LD L G E TI+ +IL + + H + +HRD+K N L + E
Sbjct: 101 YLGGGSALD--LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS---EH 155
Query: 81 APLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVLHRS-YNVEGDMWSIGVITYI-LLC 137
+K+ DFG++ + N VG+ +++APEV+ +S Y+ + D+WS+G IT I L
Sbjct: 156 GEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLG-ITAIELAR 214
Query: 138 GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 197
G P + + + +P + + S K+FV LNK+ R TA + L H
Sbjct: 215 GEPPHSELHPMKVLFLIPKNNPPTLEGNY---SKPLKEFVEACLNKEPSFRPTAKELLKH 271
Query: 198 PWLHDENRPVPLDILIYKLVKSYLR 222
++ + + +L+ Y R
Sbjct: 272 KFILRNAKKTS---YLTELIDRYKR 293
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 2e-23
Identities = 47/208 (22%), Positives = 81/208 (38%), Gaps = 47/208 (22%)
Query: 50 ILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYY 109
+L + H G++HRDLKP N + D LK++DFGL+ + V + YY
Sbjct: 136 MLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILDFGLARTAGTSFMMTPYVVTRYY 192
Query: 110 VAPEV-LHRSYNVEGDMWSIGVITYILLCG-----------------------SRPFWAR 145
APEV L Y D+WS+G I ++ G F +
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 252
Query: 146 TESGIFRSVLRADPNFHDSPW----------------PSVSPEAKDFVRRLLNKDHRKRM 189
+ + R+ + P + + + +A+D + ++L D KR+
Sbjct: 253 LQPTV-RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 311
Query: 190 TAAQALTHPWL---HDENRPVPLDILIY 214
+ +AL HP++ +D + I
Sbjct: 312 SVDEALQHPYINVWYDPSEAEAPPPKIP 339
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 2e-23
Identities = 48/208 (23%), Positives = 74/208 (35%), Gaps = 51/208 (24%)
Query: 44 KTIVEKILNIVAFCHLQ-GVVHRDLKPENFLFTTR---EEDAPLKVIDFGLSDFVRPDQR 99
K I +++L + + H + G++H D+KPEN L E +K+ D G + + D+
Sbjct: 134 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY--DEH 191
Query: 100 LNDIVGSAYYVAPEV-LHRSYNVEGDMWSIGVITYILLCGSRPFWARTESG--------- 149
+ + + Y +PEV L + D+WS + + L+ G F
Sbjct: 192 YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 251
Query: 150 ----------------------IFRSVLRADPNFHDSPWP----------SVSPEAK--- 174
F S WP EAK
Sbjct: 252 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEIS 311
Query: 175 DFVRRLLNKDHRKRMTAAQALTHPWLHD 202
DF+ +L D RKR A + HPWL D
Sbjct: 312 DFLSPMLQLDPRKRADAGGLVNHPWLKD 339
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 3e-23
Identities = 58/221 (26%), Positives = 76/221 (34%), Gaps = 60/221 (27%)
Query: 44 KTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDI 103
+ IL + H ++H DLKPEN L + + +KVIDFG S + QR+
Sbjct: 203 RKFAHSILQCLDALHKNRIIHCDLKPENILLKQQ-GRSGIKVIDFGSSCYE--HQRVYTY 259
Query: 104 VGSAYYVAPEV-LHRSYNVEGDMWSIGVITYILLCGSRPFWARTE--------------- 147
+ S +Y APEV L Y + DMWS+G I LL G E
Sbjct: 260 IQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPS 319
Query: 148 ----------------SGIFRSV---------------------LRADPNFHDSPWPSVS 170
G R LR P +
Sbjct: 320 QKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKG 379
Query: 171 PEAKDF---VRRLLNKDHRKRMTAAQALTHPWLHDENRPVP 208
+ F +++ L D RMT QAL HPWL P P
Sbjct: 380 CDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLR-RRLPKP 419
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 1e-22
Identities = 49/226 (21%), Positives = 86/226 (38%), Gaps = 55/226 (24%)
Query: 21 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQG-VVHRDLKPENFLFTTREE 79
+GG LD++L + GR E+ + ++ + + + ++HRD+KP N L +R E
Sbjct: 112 HMDGG-SLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE 170
Query: 80 DAPLKVIDFG----LSDFVRPDQRLNDIVGSAYYVAPEVLHRS-YNVEGDMWSIGVITYI 134
+K+ DFG L D + N VG+ Y++PE L + Y+V+ D+WS+G+
Sbjct: 171 ---IKLCDFGVSGQLIDSMA-----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVE 222
Query: 135 LLCGSRPF--------------------WARTESGIFRSVLRADPNFHDSPWPSV----- 169
+ G P P ++
Sbjct: 223 MAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLD 282
Query: 170 ---------------SPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200
S E +DFV + L K+ +R Q + H ++
Sbjct: 283 YIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 328
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 98.4 bits (245), Expect = 2e-22
Identities = 41/175 (23%), Positives = 71/175 (40%), Gaps = 20/175 (11%)
Query: 21 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREED 80
+ G L G + +A + +IL +++ H G+V+ DLKPEN + T +
Sbjct: 165 YVGGQSLKRSK---GQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ-- 219
Query: 81 APLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSR 140
LK+ID G V + G+ + APE++ V D++++G L
Sbjct: 220 --LKLIDLGA---VSRINSFGYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLP 274
Query: 141 PFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQAL 195
+G + L D P +RR ++ D R+R T A+ +
Sbjct: 275 TR-----NGRYVDGLPEDD-----PVLKTYDSYGRLLRRAIDPDPRQRFTTAEEM 319
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 2e-22
Identities = 47/228 (20%), Positives = 77/228 (33%), Gaps = 55/228 (24%)
Query: 27 LLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVI 86
LL + ++ + K +++ +LN + + H ++HRD+K N L T LK+
Sbjct: 113 LLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV---LKLA 166
Query: 87 DFGLSDFVRPDQRLNDIVGSAY--------YVAPEVL--HRSYNVEGDMWSIGVITYILL 136
DFGL+ R + + Y Y PE+L R Y D+W G I +
Sbjct: 167 DFGLA---RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMW 223
Query: 137 CGSRP-FWARTESG----IFR-------------SVLRADPNFHDS-------------- 164
P TE I + +
Sbjct: 224 TR-SPIMQGNTEQHQLALISQLCGSITPEVWPNVDNY---ELYEKLELVKGQKRKVKDRL 279
Query: 165 PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDIL 212
P A D + +LL D +R+ + AL H + + P L +
Sbjct: 280 KAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSDLKGM 327
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-22
Identities = 56/204 (27%), Positives = 88/204 (43%), Gaps = 28/204 (13%)
Query: 20 RFCEGGELLD------RILSRGGRYLEEDA-KTIVEKILNIVAFCHLQGVVHRDLKPENF 72
+ GG +LD L+E TI+ ++L + + H G +HRD+K N
Sbjct: 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNI 152
Query: 73 LFTTREEDAPLKVIDFGLS-------DFVRPDQRLNDIVGSAYYVAPEVLHRS--YNVEG 123
L ED +++ DFG+S D R R VG+ ++APEV+ + Y+ +
Sbjct: 153 LLG---EDGSVQIADFGVSAFLATGGDITRNKVR-KTFVGTPCWMAPEVMEQVRGYDFKA 208
Query: 124 DMWSIGVITYI-LLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSV------SPEAKDF 176
D+WS G IT I L G+ P+ + L+ DP ++ +
Sbjct: 209 DIWSFG-ITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKM 267
Query: 177 VRRLLNKDHRKRMTAAQALTHPWL 200
+ L KD KR TAA+ L H +
Sbjct: 268 ISLCLQKDPEKRPTAAELLRHKFF 291
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 3e-22
Identities = 52/205 (25%), Positives = 77/205 (37%), Gaps = 49/205 (23%)
Query: 50 ILNIVAFCHLQ--GVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSA 107
++ + HL V HRD+KP N L E D LK+ DFG + + P + + S
Sbjct: 138 LIRSIGCLHLPSVNVCHRDIKPHNVLVN--EADGTLKLCDFGSAKKLSPSEPNVAYICSR 195
Query: 108 YYVAPEVL--HRSYNVEGDMWSIGVITYILLCG-----------------------SRPF 142
YY APE++ ++ Y D+WS+G I ++ G SR
Sbjct: 196 YYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREV 255
Query: 143 WARTESGIFRSVLRADPNFHDSPW--------PSVSPEAKDFVRRLLNKDHRKRMTAAQA 194
+ N PW + EA D + LL +RM +A
Sbjct: 256 LRKLNPSHTD---VDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEA 312
Query: 195 LTHPW---LHDEN------RPVPLD 210
L HP+ LHD + +P D
Sbjct: 313 LCHPYFDELHDPATKLPNNKDLPED 337
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 6e-22
Identities = 49/215 (22%), Positives = 82/215 (38%), Gaps = 50/215 (23%)
Query: 44 KTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDA-PLKVIDFGL----SDFVRPDQ 98
K+++ +IL+ + + H V+HRDLKP N L + +K+ D G + ++P
Sbjct: 131 KSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLA 190
Query: 99 RLNDIVGSAYYVAPEVL--HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLR 156
L+ +V + +Y APE+L R Y D+W+IG I LL F R E +
Sbjct: 191 DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH 250
Query: 157 AD-----------------PNFHDSPW--------------------------PSVSPEA 173
D + P +A
Sbjct: 251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKA 310
Query: 174 KDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVP 208
+++LL D KR+T+ QA+ P+ ++ P
Sbjct: 311 FHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPTS 345
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 7e-22
Identities = 62/223 (27%), Positives = 90/223 (40%), Gaps = 50/223 (22%)
Query: 28 LDRILSRGGRYLEED-AKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVI 86
L R++S + L +D + + + L V H V+HRDLKP N L + LKV
Sbjct: 100 LHRVIS--TQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLIN---SNCDLKVC 154
Query: 87 DFGLSDFVRPDQRLNDIVGSA-----------YYVAPEVL--HRSYNVEGDMWSIGVITY 133
DFGL+ + N +Y APEV+ Y+ D+WS G I
Sbjct: 155 DFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILA 214
Query: 134 ILLCG------------------------SRPFWARTESGIFRSVLRADPNFHDSPW--- 166
L S ES R +++ P + +P
Sbjct: 215 ELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKM 274
Query: 167 -PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL---HDENR 205
P V+P+ D ++R+L D KR+TA +AL HP+L HD N
Sbjct: 275 FPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPND 317
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 8e-22
Identities = 48/214 (22%), Positives = 77/214 (35%), Gaps = 59/214 (27%)
Query: 44 KTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE----------------EDAPLKVID 87
+ + ++ + + F H + H DLKPEN LF E ++ ++V D
Sbjct: 126 RHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVAD 185
Query: 88 FGLSDFVRPDQRLNDIVGSAYYVAPEV-LHRSYNVEGDMWSIGVITYILLCGSRPFWART 146
FG + F + IV + +Y PEV L + D+WSIG I + G F
Sbjct: 186 FGSATFD--HEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE 243
Query: 147 ES----------GIF-RSVLRADP---NFHDS--PWPSVSPEAK---------------- 174
G ++ F+ W S + +
Sbjct: 244 NREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQD 303
Query: 175 --------DFVRRLLNKDHRKRMTAAQALTHPWL 200
D +RR+L D +R+T A+AL HP+
Sbjct: 304 SLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFF 337
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 9e-22
Identities = 46/180 (25%), Positives = 81/180 (45%), Gaps = 16/180 (8%)
Query: 25 GELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLK 84
G L I+ G + A ++ + F H G++HRD+KP N + + +K
Sbjct: 100 GVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS---ATNAVK 156
Query: 85 VIDFGL----SDFVRPDQRLNDIVGSAYYVAPE-VLHRSYNVEGDMWSIGVITYILLCGS 139
V+DFG+ +D + ++G+A Y++PE S + D++S+G + Y +L G
Sbjct: 157 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216
Query: 140 RPFWARTESGIFRSV----LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQAL 195
PF +S + SV +R DP + +S + V + L K+ R A +
Sbjct: 217 PPFTG--DSPV--SVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEM 272
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 2e-21
Identities = 49/221 (22%), Positives = 81/221 (36%), Gaps = 59/221 (26%)
Query: 44 KTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE----------------EDAPLKVID 87
+ + +I V F H + H DLKPEN LF + + +KV+D
Sbjct: 121 RKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD 180
Query: 88 FGLSDFVRPDQRLNDIVGSAYYVAPEV-LHRSYNVEGDMWSIGVITYILLCGSRPFWART 146
FG + + D+ + +V + +Y APEV L ++ D+WSIG I G F
Sbjct: 181 FGSATYD--DEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238
Query: 147 ES----------GIF-RSVLRADP---NFHDS--PWPSVSPEAK---------------- 174
G + +++ FH W S +
Sbjct: 239 SKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQ 298
Query: 175 --------DFVRRLLNKDHRKRMTAAQALTHPWLHDENRPV 207
D ++++L D KR+T +AL HP+ + +
Sbjct: 299 DVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKSI 339
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 6e-21
Identities = 42/189 (22%), Positives = 71/189 (37%), Gaps = 38/189 (20%)
Query: 50 ILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYY 109
+ V F H G+ HRD+KP+N L + +D LK+ DFG + + P + + S +Y
Sbjct: 150 LFRAVGFIHSLGICHRDIKPQNLLVNS--KDNTLKLCDFGSAKKLIPSEPSVAYICSRFY 207
Query: 110 VAPEVLH--RSYNVEGDMWSIGVITYILLCG-----------------------SRPFWA 144
APE++ Y D+WSIG + L+ G ++
Sbjct: 208 RAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMI 267
Query: 145 RTESGIFRSVLRADPNFHDSPWPSV-----SPEAKDFVRRLLNKDHRKRMTAAQALTHPW 199
R P W + A D + ++L + R+ +A+ HP+
Sbjct: 268 RMNPHYTEVRF---PTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPF 324
Query: 200 ---LHDENR 205
L +
Sbjct: 325 FDHLRNSYE 333
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 1e-20
Identities = 43/175 (24%), Positives = 75/175 (42%), Gaps = 7/175 (4%)
Query: 25 GELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLK 84
G L + G + A +IL+ + H +VHRD+KP+N L + LK
Sbjct: 95 GPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILID---SNKTLK 151
Query: 85 VIDFGLSDFVRPDQ--RLNDIVGSAYYVAPE-VLHRSYNVEGDMWSIGVITYILLCGSRP 141
+ DFG++ + + N ++G+ Y +PE + + D++SIG++ Y +L G P
Sbjct: 152 IFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211
Query: 142 FWARTESGI-FRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQAL 195
F T I + + + PN + + + R KD R Q +
Sbjct: 212 FNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEM 266
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 91.1 bits (226), Expect = 1e-20
Identities = 52/277 (18%), Positives = 96/277 (34%), Gaps = 61/277 (22%)
Query: 21 FCEGGELLDRILSRGGRYLEEDA-KTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREE 79
F G D I + + E A I++ +L + + H G VHR +K + L +
Sbjct: 107 FMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILIS---V 163
Query: 80 DAPLKVIDFGLS-DFVRPDQRLN-------DIVGSAYYVAPEVLHRS---YNVEGDMWSI 128
D + + + + QR V +++PEVL ++ Y+ + D++S+
Sbjct: 164 DGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSV 223
Query: 129 GVITYI-LLCGSRPF------------------------------------WARTESGIF 151
G IT L G PF + SG+
Sbjct: 224 G-ITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLS 282
Query: 152 RSVLRADPNFHDSPWPSV------SPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENR 205
S+ + P + PS SP FV + L ++ R +A+ L H + + +
Sbjct: 283 DSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK-QIK 341
Query: 206 PVPLDILIYKLVKSYLRATPLKRAALKALSKALTEEE 242
+ L +L++ T + + + S
Sbjct: 342 RRASEALP-ELLRPVTPITNFEGSQSQDHSGIFGLVT 377
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 4e-20
Identities = 47/185 (25%), Positives = 77/185 (41%), Gaps = 29/185 (15%)
Query: 25 GELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLK 84
G L +L R G A IV +I + + H G HRD+KPEN L + D
Sbjct: 118 GVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVS---ADDFAY 174
Query: 85 VIDFGLSDFVRPDQRL---NDIVGSAYYVAPE------VLHRSYNVEGDMWSIGVITYIL 135
++DFG++ D++L + VG+ YY+APE +R+ D++++ + Y
Sbjct: 175 LVDFGIASAT-TDEKLTQLGNTVGTLYYMAPERFSESHATYRA-----DIYALTCVLYEC 228
Query: 136 LCGSRPFWARTESGIFRSVLRADPNFHDSPWPS-----VSPEAKDFVRRLLNKDHRKRMT 190
L GS P+ S + + + P PS + + R + K+ R
Sbjct: 229 LTGSPPYQGDQLS-VMGAHINQAI-----PRPSTVRPGIPVAFDAVIARGMAKNPEDRYV 282
Query: 191 AAQAL 195
L
Sbjct: 283 TCGDL 287
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 5e-20
Identities = 46/222 (20%), Positives = 72/222 (32%), Gaps = 67/222 (30%)
Query: 44 KTIVEKILNIVAFCHLQGVVHRDLKPENFLFT----------------------TREEDA 81
K +IL + + + H DLKPEN L R +
Sbjct: 140 KLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKST 199
Query: 82 PLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEV-LHRSYNVEGDMWSIGVITYILLCGSR 140
+K+IDFG + F I+ + Y APEV L+ ++V DMWS G + L GS
Sbjct: 200 GIKLIDFGCATFK--SDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSL 257
Query: 141 PFWARTE---------------SGIFRSVLRADPNFHDS------PWPSVS--------- 170
F + + + + + + WP +
Sbjct: 258 LFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHV 317
Query: 171 ------------PEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200
DF+ +L D R + A+ L H +L
Sbjct: 318 KKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 3e-18
Identities = 33/132 (25%), Positives = 57/132 (43%), Gaps = 14/132 (10%)
Query: 19 TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAF-------CHLQGVVHRDLKPEN 71
+ EGG L +L A + + + ++HRDLKP N
Sbjct: 78 MEYAEGGSL-YNVLHGAEPLPYYTAAHAM-SWCLQCSQGVAYLHSMQPKALIHRDLKPPN 135
Query: 72 FLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL-HRSYNVEGDMWSIGV 130
L LK+ DFG + + + + GSA ++APEV +Y+ + D++S G+
Sbjct: 136 LLLV--AGGTVLKICDFGTACDI--QTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGI 191
Query: 131 ITYILLCGSRPF 142
I + ++ +PF
Sbjct: 192 ILWEVITRRKPF 203
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 3e-17
Identities = 38/134 (28%), Positives = 63/134 (47%), Gaps = 15/134 (11%)
Query: 19 TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNI---VAFCHLQG--VVHRDLKPENFL 73
F G+L R+L + + +L+I + + Q +VHRDL+ N
Sbjct: 100 MEFVPCGDLYHRLLDKAHPI---KWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIF 156
Query: 74 FTTREEDAP--LKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL---HRSYNVEGDMWSI 128
+ +E+AP KV DFGLS ++ ++G+ ++APE + SY + D +S
Sbjct: 157 LQSLDENAPVCAKVADFGLSQQS--VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSF 214
Query: 129 GVITYILLCGSRPF 142
+I Y +L G PF
Sbjct: 215 AMILYTILTGEGPF 228
|
| >3k21_A PFCDPK3, calcium-dependent protein kinase 3; calcium kinase structural genomics malaria, structural genom consortium, SGC, ATP-binding; 1.15A {Plasmodium falciparum} PDB: 3o4y_A Length = 191 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 4e-17
Identities = 38/189 (20%), Positives = 76/189 (40%), Gaps = 21/189 (11%)
Query: 195 LTHPWLHDENRP--VPLDILIYKLVKSYLRATPLKRAALKALSKALTEEELVYLRAQFML 252
+ H H R I + + K+Y ++ A+ +++ + ++ L++ F++
Sbjct: 1 MHHHHHHSSGRENLYFQGIHVLENFKNYGLLLKFQKLAMTIIAQQSNDYDVEKLKSTFLV 60
Query: 253 LEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQ 311
L+ G ++ K L + + +L+ ++ K+ Y EF AAA Q
Sbjct: 61 LDEDGKGYITKEQLKKGLEKDGLKLPYN--FDLLLDQIDSDGSGKIDYTEFIAAALDRKQ 118
Query: 312 LEALERWDQIAITAFDYFEQEGNRVISVEELA-------LELNLAPAAYSLLNDCIR--- 361
L + AF F+ + + I+ ELA + N+ + + IR
Sbjct: 119 LSKKLIYC-----AFRVFDVDNDGEITTAELAHILYNGNKKGNITQRDVNRVKRMIRDVD 173
Query: 362 -NSDGKLSF 369
N+DGK+ F
Sbjct: 174 KNNDGKIDF 182
|
| >3pm8_A PFCDPK2, calcium-dependent protein kinase 2; malaria, structural genomics, structural genomics CONS SGC; 2.00A {Plasmodium falciparum K1} Length = 197 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 7e-17
Identities = 40/189 (21%), Positives = 73/189 (38%), Gaps = 17/189 (8%)
Query: 193 QALTHPWLHD---ENRPVPLDILIYKLVKSYLRATPLKRAALKALSKALTEEELVYLRAQ 249
H + V L + K +K++ + LK+ AL ++K L + E+ LR
Sbjct: 3 HHHHHSSGRENLYFQGHVELSSTLLKNLKNFKKENELKKIALTIIAKHLCDVEINNLRNI 62
Query: 250 FMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATS 308
F+ L+ G +S +++ + ++L ++ + ++ Y +F AA
Sbjct: 63 FIALDVDNSGTLSSQEILDG-LKKIGYQKIPPDIHQVLRDIDSNASGQIHYTDFLAATID 121
Query: 309 VYQLEALERWDQIAITAFDYFEQEGNRVISVEEL--ALELNLAPAAYS------LLNDCI 360
E F +F+ +GN ISVEEL + LL +
Sbjct: 122 KQTYLKKEVCLI----PFKFFDIDGNGKISVEELKRIFGRDDIENPLIDKAIDSLLQEVD 177
Query: 361 RNSDGKLSF 369
N DG++ F
Sbjct: 178 LNGDGEIDF 186
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 9e-17
Identities = 50/226 (22%), Positives = 79/226 (34%), Gaps = 73/226 (32%)
Query: 50 ILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSA-- 107
++ ++ + H G++HRD+KP N L + +KV DFGLS +R+ + + +
Sbjct: 118 LIKVIKYLHSGGLLHRDMKPSNILLN---AECHVKVADFGLSRSFVNIRRVTNNIPLSIN 174
Query: 108 --------------------YYVAPEVL--HRSYNVEGDMWSIGVITYILLCG------- 138
+Y APE+L Y DMWS+G I +LCG
Sbjct: 175 ENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234
Query: 139 ----------------------------------SRPFWARTESGIFRSVLRADPNFHDS 164
S R + N
Sbjct: 235 STMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLK 294
Query: 165 --PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL---HDENR 205
P + EA D + +LL + KR++A AL HP++ H+ N
Sbjct: 295 INPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNE 340
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 79.6 bits (196), Expect = 1e-16
Identities = 45/268 (16%), Positives = 77/268 (28%), Gaps = 96/268 (35%)
Query: 26 ELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQ-GVVHRDLKPENFLFTTRE------ 78
+ + + S K I++++L + + H + ++H D+KPEN L + E
Sbjct: 133 KWIIK--SNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRL 190
Query: 79 ----------------------------------------EDAPLKVIDFGLSDFVRPDQ 98
E +K+ D G + +
Sbjct: 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNA--CWVHK 248
Query: 99 RLNDIVGSAYYVAPEV-LHRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV--- 154
+ + + Y + EV + YN D+WS + + L G F + R
Sbjct: 249 HFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHI 308
Query: 155 ------------------------------LRADPNFHDSPWPSVSPE-----------A 173
L+ V E
Sbjct: 309 ALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGF 368
Query: 174 KDFVRRLLNKDHRKRMTAAQALTHPWLH 201
DF+ +L KR TAA+ L HPWL+
Sbjct: 369 TDFLLPMLELIPEKRATAAECLRHPWLN 396
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 7e-16
Identities = 32/107 (29%), Positives = 53/107 (49%), Gaps = 6/107 (5%)
Query: 44 KTIVEKILNIVAFCHLQ--GVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLN 101
+ +++ + F ++H DLKPEN L + + +K++DFG S + QR+
Sbjct: 160 RKFAQQMCTALLFLATPELSIIHCDLKPENILLCN-PKRSAIKIVDFGSSCQL--GQRIY 216
Query: 102 DIVGSAYYVAPEV-LHRSYNVEGDMWSIGVITYILLCGSRPFWARTE 147
+ S +Y +PEV L Y++ DMWS+G I + G F E
Sbjct: 217 QYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 1e-05
Identities = 9/27 (33%), Positives = 15/27 (55%)
Query: 174 KDFVRRLLNKDHRKRMTAAQALTHPWL 200
KD + R+L+ D + R+ AL H +
Sbjct: 350 KDLILRMLDYDPKTRIQPYYALQHSFF 376
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 9e-16
Identities = 33/131 (25%), Positives = 63/131 (48%), Gaps = 10/131 (7%)
Query: 19 TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE 78
T++CEG L + + ++ + I + + + H + ++HRDLK N
Sbjct: 98 TQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFL---H 154
Query: 79 EDAPLKVIDFGLS---DFVRPDQRLNDIVGSAYYVAPEVL----HRSYNVEGDMWSIGVI 131
ED +K+ DFGL+ + + GS ++APEV+ Y+ + D+++ G++
Sbjct: 155 EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIV 214
Query: 132 TYILLCGSRPF 142
Y L+ G P+
Sbjct: 215 LYELMTGQLPY 225
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 2e-15
Identities = 35/131 (26%), Positives = 59/131 (45%), Gaps = 11/131 (8%)
Query: 19 TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNI---VAFCHLQG--VVHRDLKPENFL 73
T + G L +L + G + D + + ++ + + H + +VHR+LK N L
Sbjct: 113 TEYLSRGSLYR-LLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLL 171
Query: 74 FTTREEDAPLKVIDFGLSDFVRPD-QRLNDIVGSAYYVAPEVL-HRSYNVEGDMWSIGVI 131
+ +KV DFGLS G+ ++APEVL N + D++S GVI
Sbjct: 172 VD---KKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVI 228
Query: 132 TYILLCGSRPF 142
+ L +P+
Sbjct: 229 LWELATLQQPW 239
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-15
Identities = 30/143 (20%), Positives = 57/143 (39%), Gaps = 26/143 (18%)
Query: 19 TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNI---VAFCHLQGVVHRDLKPENFLFT 75
T C+G L + D + I + + H +G++H+DLK +N +
Sbjct: 108 TSLCKGRTLYSVVRDAKIVL---DVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFY- 163
Query: 76 TREEDAPLKVIDFGLS------DFVRPDQRLNDIVGSAYYVAPEVL----------HRSY 119
++ + + DFGL R + +L G ++APE++ +
Sbjct: 164 ---DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPF 220
Query: 120 NVEGDMWSIGVITYILLCGSRPF 142
+ D++++G I Y L PF
Sbjct: 221 SKHSDVFALGTIWYELHAREWPF 243
|
| >1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A Length = 323 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 7e-15
Identities = 29/215 (13%), Positives = 67/215 (31%), Gaps = 20/215 (9%)
Query: 163 DSPWPSVSPEAKDFVRRL--LNKDHRKRMTAAQALTHPWLHDENRPVPLDILIYKLVKSY 220
D ++ + ++ +L ++ + A + + L+K
Sbjct: 40 DRLEAQIAQKEQEQKAKLAEYDQKVQNEFDARERAEREREAARGDAAAEKQRLASLLKDL 99
Query: 221 LRATPLKRAALKALSKALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTD 279
L+ L+EE+ LR F+ G S + K + + D + +
Sbjct: 100 ED-DASGYNRLRPSKPMLSEEDTNILRQLFLSSAVSGSGKFSFQDLKQV-LAKYADTIPE 157
Query: 280 SRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISV 339
+ ++ ++E + +++Y A A + L A F + N +S
Sbjct: 158 GPLKKLFVMVENDTKGRMSYITLVAVANDLAALVA----------DFRKIDTNSNGTLSR 207
Query: 340 EEL-----ALELNLAPAAYSLLNDCIRNSDGKLSF 369
+E L + +L + + F
Sbjct: 208 KEFREHFVRLGFDKKSVQDALFRYADEDESDDVGF 242
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 7e-15
Identities = 26/133 (19%), Positives = 49/133 (36%), Gaps = 18/133 (13%)
Query: 19 TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNI---VAFCHLQG--VVHRDLKPENFL 73
T + G L + + + D V+ L++ +AF H + L + +
Sbjct: 88 THWMPYGSLYNVLHEGTNFVV--DQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVM 145
Query: 74 FTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL-HRSYNVEG---DMWSIG 129
ED ++ + + R + + +VAPE L + + DMWS
Sbjct: 146 ID---EDMTARISMADVKFSFQSPGR----MYAPAWVAPEALQKKPEDTNRRSADMWSFA 198
Query: 130 VITYILLCGSRPF 142
V+ + L+ PF
Sbjct: 199 VLLWELVTREVPF 211
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 8e-15
Identities = 54/262 (20%), Positives = 85/262 (32%), Gaps = 88/262 (33%)
Query: 28 LDRILSRGGRYLEED-AKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVI 86
L ++ + +L E+ KTI+ +L F H G++HRDLKP N L +D +KV
Sbjct: 116 LKKLF-KTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLN---QDCSVKVC 171
Query: 87 DFGLSDFVRPDQRLNDIVGSA-----------------------YYVAPEVL--HRSYNV 121
DFGL+ + ++ N + +Y APE++ +Y
Sbjct: 172 DFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTK 231
Query: 122 EGDMWSIGVI----------TYILLCGSRPF----WARTESGIFRSVLRADPNFHD---- 163
D+WS G I P S S + + D
Sbjct: 232 SIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNI 291
Query: 164 ------SPWPSV-----SPEAKDFVRR----------------------LLNK----DHR 186
+P PE +++ LL +
Sbjct: 292 IFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPN 351
Query: 187 KRMTAAQALTHPWL---HDENR 205
KR+T QAL HP+L +
Sbjct: 352 KRITIDQALDHPYLKDVRKKKL 373
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 53/270 (19%), Positives = 84/270 (31%), Gaps = 96/270 (35%)
Query: 28 LDRILSRGGRYLEED-AKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVI 86
++ R YL E KT++ +L V + H G++HRDLKP N L +D +KV
Sbjct: 143 FKKLF-RTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVN---QDCSVKVC 198
Query: 87 DFGLSDFVRPDQRLNDIVGSA----------------------------YYVAPEVL--H 116
DFGL+ V + N + + +Y APE++
Sbjct: 199 DFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQ 258
Query: 117 RSYNVEGDMWSIGVI----------TYILLCGSRP-------FWARTESGIFRSVLRADP 159
+Y D+WSIG I P F +
Sbjct: 259 ENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTR 318
Query: 160 NFHD----------SP----WPSV-SPEAKDFVRR----------------------LLN 182
D +P ++ +AK ++R LL
Sbjct: 319 GNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLK 378
Query: 183 K----DHRKRMTAAQALTHPWL---HDENR 205
+ + KR+T + L HP+
Sbjct: 379 RMLVFNPNKRITINECLAHPFFKEVRIAEV 408
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 1e-14
Identities = 36/136 (26%), Positives = 61/136 (44%), Gaps = 18/136 (13%)
Query: 19 TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNI---VAFCHLQG---VVHRDLKPENF 72
F GG L + + +V + I + + H + ++HRDLK N
Sbjct: 85 MEFARGGPLNRVLSGK-----RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNI 139
Query: 73 LFTTREEDAP-----LKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL-HRSYNVEGDMW 126
L + E+ LK+ DFGL+ +++ G+ ++APEV+ ++ D+W
Sbjct: 140 LILQKVENGDLSNKILKITDFGLAREWHRTTKMSA-AGAYAWMAPEVIRASMFSKGSDVW 198
Query: 127 SIGVITYILLCGSRPF 142
S GV+ + LL G PF
Sbjct: 199 SYGVLLWELLTGEVPF 214
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 5e-14
Identities = 35/143 (24%), Positives = 64/143 (44%), Gaps = 25/143 (17%)
Query: 19 TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNI---VAFCHLQGVVHRDLKPENFLFT 75
T + +GG L I S +Y V +I +A+ H ++HRDL N L
Sbjct: 86 TEYIKGGTLRGIIKSMDSQY---PWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVR 142
Query: 76 TREEDAPLKVIDFGLSDFVRPDQRLND---------------IVGSAYYVAPEVL-HRSY 119
E+ + V DFGL+ + ++ + +VG+ Y++APE++ RSY
Sbjct: 143 ---ENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSY 199
Query: 120 NVEGDMWSIGVITYILLCGSRPF 142
+ + D++S G++ ++
Sbjct: 200 DEKVDVFSFGIVLCEIIGRVNAD 222
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 5e-13
Identities = 22/175 (12%), Positives = 36/175 (20%), Gaps = 34/175 (19%)
Query: 23 EGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAP 82
GG L + A ++ + H GV P + D
Sbjct: 114 RGGSLQEVA---DTSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSI---DGD 167
Query: 83 LKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPF 142
+ + P+ + D+ IG Y LL P
Sbjct: 168 VVLAYPA--------------------TMPDANPQD-----DIRGIGASLYALLVNRWPL 202
Query: 143 WARTESGIFRSVLRADPNFHDSPW---PSVSPEAKDFVRRLLNKDHRKRMTAAQA 194
R P + + R + D R +
Sbjct: 203 PEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIRSASTLL 257
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 67.6 bits (164), Expect = 3e-12
Identities = 67/445 (15%), Positives = 138/445 (31%), Gaps = 146/445 (32%)
Query: 12 SNSFLFFTRFCEGGE-LLDRILSRGGRYLEEDAKTIVEKI--------LNIVAFCHLQGV 62
S + F E ++ + + L + K ++ I + + +
Sbjct: 62 SGTLRLFWTLLSKQEEMVQKFV---EEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDR 118
Query: 63 VHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIV----GSAYYV-APEVLHR 117
++ D + +R + P + L + +RP + + ++ GS A +V
Sbjct: 119 LYNDNQVFAKYNVSRLQ--PYLKLRQALLE-LRPAKNV--LIDGVLGSGKTWVALDVC-L 172
Query: 118 SYNVEGDMWSIGVITYILLCGSRPFWA-----RTESGIFRSV----LRADPNFHDSPWPS 168
SY V+ M + FW + + + + DPN+ S
Sbjct: 173 SYKVQCKM-DFKI-----------FWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHS 220
Query: 169 VSP-----EAKDFVRRLL-NKDHRKRMTAAQALT------HPWLHDENRPVPLD----IL 212
+ + +RRLL +K + L + + + IL
Sbjct: 221 SNIKLRIHSIQAELRRLLKSKPYEN------CLLVLLNVQNAKAWN-----AFNLSCKIL 269
Query: 213 I---YKLVKSYLRATPLKRAALKALSKALTEEELVYLRAQFMLLEPKD----GC------ 259
+ +K V +L A +L S LT +E+ L +++ P+D
Sbjct: 270 LTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRR 329
Query: 260 VSL------------NNFKVALMRQATDAMTDSRVFEI-LNVMEPLSDQKLAYEEFCAAA 306
+S+ +N+K D +T + E LNV+EP +K+ ++
Sbjct: 330 LSIIAESIRDGLATWDNWK----HVNCDKLT--TIIESSLNVLEPAEYRKM-FDRL---- 378
Query: 307 TSVYQ---------LEALERWDQIAITAFDYFEQEGNRVISVEELALELNLAPAAYSLLN 357
SV+ L + W + + V + +L YSL+
Sbjct: 379 -SVFPPSAHIPTILLSLI--WFDV-----IKSD--------VMVVVNKL----HKYSLVE 418
Query: 358 DCIRNSDGKLSFLGYKRFLHGVTVR 382
+ + + +
Sbjct: 419 ---KQPK------ESTISIPSIYLE 434
|
| >2aao_A CDPK, calcium-dependent protein kinase, isoform AK1; calmodulin-like domain, EF calcium binding protein, transferase; 2.00A {Arabidopsis thaliana} Length = 166 | Back alignment and structure |
|---|
Score = 62.5 bits (153), Expect = 6e-12
Identities = 31/152 (20%), Positives = 77/152 (50%), Gaps = 16/152 (10%)
Query: 226 LKRAALKALSKALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFE 284
K+ AL+ ++++L+EEE+ L+ F +++ K G ++ K +++ + +S + +
Sbjct: 9 FKKMALRVIAESLSEEEIAGLKEMFNMIDADKSGQITFEELKAG-LKRVGANLKESEILD 67
Query: 285 ILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEEL-- 342
++ + + + Y+EF AA + ++E + AF YF+++G+ I+ +EL
Sbjct: 68 LMQAADVDNSGTIDYKEFIAATLHLNKIEREDHLFA----AFTYFDKDGSGYITPDELQQ 123
Query: 343 -ALELNLAPAAYSLLNDCIR----NSDGKLSF 369
E + + + +R ++DG++ +
Sbjct: 124 ACEEFGVEDVR---IEELMRDVDQDNDGRIDY 152
|
| >3cs1_A Flagellar calcium-binding protein; myristoylated, palmitoylated, SEN membrane targeting, EF-hand, cell projection, cilium; 2.00A {Trypanosoma cruzi} Length = 219 | Back alignment and structure |
|---|
Score = 63.8 bits (155), Expect = 6e-12
Identities = 26/165 (15%), Positives = 51/165 (30%), Gaps = 25/165 (15%)
Query: 226 LKRAALK----ALSKALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDS 280
++ A + A+ + T E F + + G + + + S
Sbjct: 26 DRKEAWERIRQAIPREKTAEAKQRRIELFKKFDKNETGKLCYDEVYSGCLEVLKLDEFTS 85
Query: 281 RVFEILNVMEPLSDQKLA---------YEEFCAAATSVYQLEALERWDQIAITAFDYFEQ 331
RV +I S + + EF L + + ++ FD +
Sbjct: 86 RVRDITKRAFDKSRTLGSKLENKGSEDFVEFLEFRL---MLCYIYDFFEL-TVMFDEIDA 141
Query: 332 EGNRVISVEEL--AL-ELNLAPAAYSLLNDCIR----NSDGKLSF 369
GN ++ EE A+ +L A + N G ++F
Sbjct: 142 SGNMLVDEEEFKRAVPKLEAWGAKVEDPAALFKELDKNGTGSVTF 186
|
| >3mse_B Calcium-dependent protein kinase, putative; CDPKS, malaria, structural genomics consortium, SGC, transfe; 2.10A {Plasmodium falciparum} Length = 180 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 6e-12
Identities = 22/173 (12%), Positives = 60/173 (34%), Gaps = 15/173 (8%)
Query: 209 LDILIYKLVKSYLRATPLKRAALKALSKALT--EEELVYLRAQFMLLEP-KDGCVSLNNF 265
+ + +KSY++ + ++ + ++ L+ + Y+ F L+ +G +S
Sbjct: 2 ISPNVLNNMKSYMKHSNIRNIIINIMAHELSVINNHIKYINELFYKLDTNHNGSLSHREI 61
Query: 266 KVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITA 325
L + + IL ++ + Y EF A +E+ A
Sbjct: 62 YTVLASVG---IKKWDINRILQALDINDRGNITYTEFMAGCYRWKNIESTFLKA-----A 113
Query: 326 FDYFEQEGNRVISVEELALELNLAPAAYSLLNDCIR----NSDGKLSFLGYKR 374
F+ +++ + IS ++ ++ + +++ G +
Sbjct: 114 FNKIDKDEDGYISKSDIVSLVHDKVLDNNDIDNFFLSVHSIKKGIPREHIINK 166
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 9e-12
Identities = 33/174 (18%), Positives = 66/174 (37%), Gaps = 42/174 (24%)
Query: 19 TRFCEGGELLD-------------RI---LSRGGRYLEEDAKTIVEKILNIVAFCHLQGV 62
+ + E G L D ++ + G +L + K +
Sbjct: 119 SDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP----------AI 168
Query: 63 VHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDI-----VGSAYYVAPEVLHR 117
HRDLK +N L ++ + D GL+ DI VG+ Y+APEVL
Sbjct: 169 AHRDLKSKNILVK---KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 225
Query: 118 SYNVEG-------DMWSIGVITYILLCGSRPFWARTESGI-FRSVLRADPNFHD 163
S N++ D++++G++ + + + + + ++ +DP+ +
Sbjct: 226 SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 279
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 3e-11
Identities = 31/116 (26%), Positives = 50/116 (43%), Gaps = 16/116 (13%)
Query: 61 GVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDI-----VGSAYYVAPEVL 115
+ HRDLK +N L ++ + D GL+ D DI VG+ Y+ PEVL
Sbjct: 162 AIAHRDLKSKNILVK---KNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVL 218
Query: 116 HRSYNVEG-------DMWSIGVITYILLCGSRPFWARTESGI-FRSVLRADPNFHD 163
S N DM+S G+I + + E + + ++ +DP++ D
Sbjct: 219 DESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYED 274
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 3e-11
Identities = 30/116 (25%), Positives = 50/116 (43%), Gaps = 16/116 (13%)
Query: 61 GVVHRDLKPENFLFTTREEDAPLKVIDFGLS-----DFVRPDQRLNDIVGSAYYVAPEVL 115
+ HRDLK +N L ++ + D GL+ + D N VG+ Y+APEVL
Sbjct: 133 AIAHRDLKSKNILVK---KNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189
Query: 116 HRSYNVEG-------DMWSIGVITYILLCGSRPFWARTESGI-FRSVLRADPNFHD 163
+ V+ D+W+ G++ + + + F V+ DP+F D
Sbjct: 190 DETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFED 245
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 7e-11
Identities = 27/113 (23%), Positives = 49/113 (43%), Gaps = 14/113 (12%)
Query: 62 VVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDI---VGSAYYVAPEVLHRS 118
+ HRD+K +N L + + + DFGL+ + D VG+ Y+APEVL +
Sbjct: 152 ISHRDIKSKNVLL---KNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGA 208
Query: 119 YNVEG------DMWSIGVITYILLCGSRPFWARTESGI--FRSVLRADPNFHD 163
N + DM+++G++ + L + + F + P+ D
Sbjct: 209 INFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLED 261
|
| >3khe_A Calmodulin-like domain protein kinase isoform 3; calcium dependent kinase, structural genomics, structural GE consortium, SGC, ATP-binding; 1.95A {Toxoplasma gondii} Length = 191 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 9e-11
Identities = 37/178 (20%), Positives = 66/178 (37%), Gaps = 20/178 (11%)
Query: 208 PLDILIYKLVKSYLRATPLKRAALKAL-SKALTEEELVYLRAQFMLLEP-KDGCVSLNNF 265
+K + + L +AA+ + SK T EE L F L+ DG +
Sbjct: 3 HALTGALGNMKKFQSSQKLAQAAMLFMGSKLTTLEETKELTQIFRQLDNNGDGQLDRKEL 62
Query: 266 KVAL----------MRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEAL 315
+ + ++ V IL ++ + + Y EF L +
Sbjct: 63 IEGYRKLMQWKGDTVSDLDSSQIEAEVDHILQSVDFDRNGYIEYSEFVTVCMDKQLLLSR 122
Query: 316 ERWDQIAITAFDYFEQEGNRVISVEEL---ALELNLAPAAY-SLLNDCIRNSDGKLSF 369
ER AF F+ +G+ I+ EEL + + +L +C +N+DG++ F
Sbjct: 123 ERLLA----AFQQFDSDGSGKITNEELGRLFGVTEVDDETWHQVLQECDKNNDGEVDF 176
|
| >2jul_A Calsenilin; EF-hand, calcium, LXXLL, DNA binding protein, dimer, alternative splicing, apoptosis, cytoplasm, endoplasmic reticulum, golgi apparatus; NMR {Mus musculus} Length = 256 | Back alignment and structure |
|---|
Score = 58.5 bits (141), Expect = 6e-10
Identities = 39/245 (15%), Positives = 75/245 (30%), Gaps = 34/245 (13%)
Query: 143 WARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 202
++L P E+ + R + R W+
Sbjct: 4 TKEAVKASDGNLL-----GDPGRIPLSKRESIKWQRPRFTRQALMR-----CCLIKWILS 53
Query: 203 ENRPVPLDILIYKLVKSYLRATPLKRAALKALSKALTEEELVYLRAQFMLLEPKDGCVSL 262
P D +L S +R P L+A +K T++EL L F P G V
Sbjct: 54 SAAPQGSDSSDSELELSTVRHQPEGLDQLQAQTK-FTKKELQSLYRGFKNECP-TGLVDE 111
Query: 263 NNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIA 322
+ FK+ + + + N + + + +E+F + + + E+
Sbjct: 112 DTFKLIYSQFFPQGDATTYAHFLFNAFDADGNGAIHFEDFVVGLSILLRGTVHEK----L 167
Query: 323 ITAFDYFEQEGNRVISVEEL------ALELNLAPAAYSLLNDCIR------------NSD 364
AF+ ++ + I+ EE+ ++ L D N D
Sbjct: 168 KWAFNLYDINKDGCITKEEMLAIMKSIYDMMGRHTYPILREDAPLEHVERFFQKMDRNQD 227
Query: 365 GKLSF 369
G ++
Sbjct: 228 GVVTI 232
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 1e-09
Identities = 24/111 (21%), Positives = 44/111 (39%), Gaps = 19/111 (17%)
Query: 46 IVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDI-- 103
+ +IL+I+ + H VH D+K N L + D + ++D+GL+ P+
Sbjct: 157 LSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQ-VYLVDYGLAYRYCPEGVHKAYAA 215
Query: 104 ------VGSAYYVAPEVLHRSYNVE----GDMWSIG-VITYILLCGSRPFW 143
G+ + + + V GD+ +G + L G P W
Sbjct: 216 DPKRCHDGTIEFTS---IDAHNGVAPSRRGDLEILGYCMIQ-WLTGHLP-W 261
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 2e-09
Identities = 38/159 (23%), Positives = 60/159 (37%), Gaps = 44/159 (27%)
Query: 19 TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCH----------LQGVVHRDLK 68
T+ G LLD Y+ E I ++ +C + +VHRDL
Sbjct: 95 TQLMPFGCLLD--------YVREHKDNI--GSQYLLNWCVQIAKGMNYLEDRRLVHRDLA 144
Query: 69 PENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV-----------APEVL-H 116
N L T + +K+ DFGL+ + + Y A E + H
Sbjct: 145 ARNVLVKTPQH---VKITDFGLAKLLGAE--------EKEYHAEGGKVPIKWMALESILH 193
Query: 117 RSYNVEGDMWSIGVITY-ILLCGSRPFWARTESGIFRSV 154
R Y + D+WS GV + ++ GS+P+ S I +
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 3e-09
Identities = 28/132 (21%), Positives = 51/132 (38%), Gaps = 19/132 (14%)
Query: 25 GELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLK 84
G L +I + G + + + ++L+++ + H VH D+K N L + D +
Sbjct: 135 GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQ-VY 193
Query: 85 VIDFGLSDFVRPDQRLNDI--------VGSAYYVAPEVLHRSYNVE----GDMWSIG-VI 131
+ D+GLS P+ G+ + H+ V D+ +G +
Sbjct: 194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEF-TSLDAHK--GVALSRRSDVEILGYCM 250
Query: 132 TYILLCGSRPFW 143
LCG P W
Sbjct: 251 LR-WLCGKLP-W 260
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 2e-08
Identities = 36/154 (23%), Positives = 66/154 (42%), Gaps = 30/154 (19%)
Query: 19 TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIV---AFCHLQGVVHRDLKPENFLFT 75
T + E G L+D + + G L +++ I AF + +HRDL+ N L +
Sbjct: 86 TEYMENGSLVDFLKTPSGIKL--TINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS 143
Query: 76 TREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV-----------APEVL-HRSYNVEG 123
+ K+ DFGL+ R I + Y APE + + ++ ++
Sbjct: 144 ---DTLSCKIADFGLA---R------LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 124 DMWSIGVITY-ILLCGSRPFWARTESGIFRSVLR 156
D+WS G++ I+ G P+ T + +++ R
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 225
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 34/150 (22%), Positives = 56/150 (37%), Gaps = 42/150 (28%)
Query: 19 TRFCEGGELLDRILSRGGRYLEEDAKTI-VEKILNIV-------AFCHLQGVVHRDLKPE 70
+GG+ L +L + + V+ +L +V + + +HRDL
Sbjct: 191 MELVQGGDFLT--------FLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAAR 242
Query: 71 NFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV------------APEVL-HR 117
N L T E LK+ DFG+S Y APE L +
Sbjct: 243 NCLVT---EKNVLKISDFGMSREEADGV---------YAASGGLRQVPVKWTAPEALNYG 290
Query: 118 SYNVEGDMWSIGVITY-ILLCGSRPFWART 146
Y+ E D+WS G++ + G+ P+ +
Sbjct: 291 RYSSESDVWSFGILLWETFSLGASPYPNLS 320
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 2e-08
Identities = 36/155 (23%), Positives = 61/155 (39%), Gaps = 32/155 (20%)
Query: 19 TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIV---AFCHLQGVVHRDLKPENFLFT 75
T F G LLD + + + A ++ I + + +HRDL N L
Sbjct: 88 TEFMTYGNLLDYLRECNRQEV--SAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG 145
Query: 76 TREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV------------APEVL-HRSYNVE 122
E+ +KV DFGLS + D Y APE L + ++++
Sbjct: 146 ---ENHLVKVADFGLSRLMTGD----------TYTAHAGAKFPIKWTAPESLAYNKFSIK 192
Query: 123 GDMWSIGVITY-ILLCGSRPFWARTESGIFRSVLR 156
D+W+ GV+ + I G P+ S ++ + +
Sbjct: 193 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 227
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 2e-08
Identities = 17/111 (15%), Positives = 39/111 (35%), Gaps = 19/111 (17%)
Query: 46 IVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRP--------D 97
+ ++L+ + F H VH ++ EN ++ + + +G + P +
Sbjct: 164 VACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQ-VTLAGYGFAFRYCPSGKHVAYVE 222
Query: 98 QRLNDIVGSAYYVAPEVLHRSYNVE----GDMWSIG-VITYILLCGSRPFW 143
+ G +++ + D+ S+G + L G P W
Sbjct: 223 GSRSPHEGDLEFIS---MDLHKGCGPSRRSDLQSLGYCMLK-WLYGFLP-W 268
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 40/173 (23%), Positives = 66/173 (38%), Gaps = 33/173 (19%)
Query: 3 HQKLQHLF---YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIV---AF 56
H KL L T F G LLD + S G +++ I AF
Sbjct: 242 HDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQP--LPKLIDFSAQIAEGMAF 299
Query: 57 CHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV------ 110
+ +HRDL+ N L + K+ DFGL+ + ++ Y
Sbjct: 300 IEQRNYIHRDLRAANILVS---ASLVCKIADFGLARVIEDNE---------YTAREGAKF 347
Query: 111 -----APEVL-HRSYNVEGDMWSIGVITY-ILLCGSRPFWARTESGIFRSVLR 156
APE + S+ ++ D+WS G++ I+ G P+ + + R++ R
Sbjct: 348 PIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER 400
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 4e-08
Identities = 38/159 (23%), Positives = 60/159 (37%), Gaps = 44/159 (27%)
Query: 19 TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCH----------LQGVVHRDLK 68
T+ G LLD Y+ E I ++ +C + +VHRDL
Sbjct: 95 TQLMPFGCLLD--------YVREHKDNI--GSQYLLNWCVQIAKGMNYLEDRRLVHRDLA 144
Query: 69 PENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV-----------APEVL-H 116
N L T + +K+ DFGL+ + + Y A E + H
Sbjct: 145 ARNVLVKTPQH---VKITDFGLAKLLGAE--------EKEYHAEGGKVPIKWMALESILH 193
Query: 117 RSYNVEGDMWSIGVITY-ILLCGSRPFWARTESGIFRSV 154
R Y + D+WS GV + ++ GS+P+ S I +
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 4e-08
Identities = 32/141 (22%), Positives = 57/141 (40%), Gaps = 25/141 (17%)
Query: 19 TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE 78
T + G LL+ + R+ + + + + + + + +HRDL N L
Sbjct: 98 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN--- 154
Query: 79 EDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV-----------APEVL-HRSYNVEGDMW 126
+ +KV DFGLS R ++ Y PEVL + ++ + D+W
Sbjct: 155 DQGVVKVSDFGLS---R------YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 205
Query: 127 SIGVITY-ILLCGSRPFWART 146
+ GV+ + I G P+ T
Sbjct: 206 AFGVLMWEIYSLGKMPYERFT 226
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 4e-08
Identities = 39/141 (27%), Positives = 61/141 (43%), Gaps = 25/141 (17%)
Query: 19 TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE 78
T F E G L D + ++ G + E + + +A+ V+HRDL N L
Sbjct: 82 TEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG--- 138
Query: 79 EDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV-----------APEVL-HRSYNVEGDMW 126
E+ +KV DFG++ FV DQ Y +PEV Y+ + D+W
Sbjct: 139 ENQVIKVSDFGMTRFVLDDQ---------YTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 189
Query: 127 SIGVITY-ILLCGSRPFWART 146
S GV+ + + G P+ R+
Sbjct: 190 SFGVLMWEVFSEGKIPYENRS 210
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 5e-08
Identities = 32/146 (21%), Positives = 50/146 (34%), Gaps = 45/146 (30%)
Query: 19 TRFCEGGELLDRI----------------LSRGGRYLEEDAKTIVEKILNIVAFCHLQGV 62
+ G L + ++RG YL + I
Sbjct: 91 MEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAIS-------- 142
Query: 63 VHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRL---------NDIVGSAYYVAPE 113
HRDL N L D + DFGLS + ++ + VG+ Y+APE
Sbjct: 143 -HRDLNSRNVLVK---NDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPE 198
Query: 114 VLHRSYNVEG--------DMWSIGVI 131
VL + N+ DM+++G+I
Sbjct: 199 VLEGAVNLRDXESALKQVDMYALGLI 224
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 5e-08
Identities = 34/151 (22%), Positives = 55/151 (36%), Gaps = 45/151 (29%)
Query: 19 TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCH----------LQGVVHRDLK 68
T + G LL+ YL K + L + C+ +HRDL
Sbjct: 82 TEYISNGCLLN--------YLRSHGKGLEPSQL--LEMCYDVCEGMAFLESHQFIHRDLA 131
Query: 69 PENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV-----------APEVL-H 116
N L D +KV DFG++ R ++ Y APEV +
Sbjct: 132 ARNCLVD---RDLCVKVSDFGMT---R------YVLDDQYVSSVGTKFPVKWSAPEVFHY 179
Query: 117 RSYNVEGDMWSIGVITY-ILLCGSRPFWART 146
Y+ + D+W+ G++ + + G P+ T
Sbjct: 180 FKYSSKSDVWAFGILMWEVFSLGKMPYDLYT 210
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 5e-08
Identities = 39/154 (25%), Positives = 59/154 (38%), Gaps = 30/154 (19%)
Query: 19 TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIV---AFCHLQGVVHRDLKPENFLFT 75
T + G LLD + G+YL +V+ I A+ VHRDL+ N L
Sbjct: 340 TEYMSKGSLLDFLKGETGKYL--RLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG 397
Query: 76 TREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV-----------APEVL-HRSYNVEG 123
E+ KV DFGL+ R I + Y APE + + ++
Sbjct: 398 ---ENLVCKVADFGLA---R------LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 445
Query: 124 DMWSIGVITY-ILLCGSRPFWARTESGIFRSVLR 156
D+WS G++ + G P+ + V R
Sbjct: 446 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 479
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 6e-08
Identities = 39/154 (25%), Positives = 59/154 (38%), Gaps = 30/154 (19%)
Query: 19 TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIV---AFCHLQGVVHRDLKPENFLFT 75
T + G LLD + G+YL +V+ I A+ VHRDL+ N L
Sbjct: 257 TEYMSKGSLLDFLKGETGKYL--RLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG 314
Query: 76 TREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV-----------APEVL-HRSYNVEG 123
E+ KV DFGL+ R I + Y APE + + ++
Sbjct: 315 ---ENLVCKVADFGLA---R------LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362
Query: 124 DMWSIGVITY-ILLCGSRPFWARTESGIFRSVLR 156
D+WS G++ + G P+ + V R
Sbjct: 363 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 396
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 7e-08
Identities = 33/149 (22%), Positives = 59/149 (39%), Gaps = 20/149 (13%)
Query: 19 TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIV-------AFCHLQGVVHRDLKPEN 71
T F G LLD + + + +L + + + +HR+L N
Sbjct: 295 TEFMTYGNLLDYLRECNRQEVS------AVVLLYMATQISSAMEYLEKKNFIHRNLAARN 348
Query: 72 FLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYY--VAPEVL-HRSYNVEGDMWSI 128
L E+ +KV DFGLS + D APE L + ++++ D+W+
Sbjct: 349 CLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAF 405
Query: 129 GVITY-ILLCGSRPFWARTESGIFRSVLR 156
GV+ + I G P+ S ++ + +
Sbjct: 406 GVLLWEIATYGMSPYPGIDLSQVYELLEK 434
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 53.1 bits (127), Expect = 7e-08
Identities = 33/111 (29%), Positives = 56/111 (50%), Gaps = 18/111 (16%)
Query: 46 IVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR--------PD 97
+ ++++N V F H + +HRD+KP+NFL + +IDFGL+ R P
Sbjct: 108 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPY 167
Query: 98 QRLNDIVGSAYYVAPEVLHRSYNVEG----DMWSIG-VITYILLCGSRPFW 143
+ ++ G+A Y + ++ +E D+ S+G V+ Y L GS P W
Sbjct: 168 RENKNLTGTARYAS---VNTHLGIEQSRRDDLESLGYVLMY-FLRGSLP-W 213
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 8e-08
Identities = 33/159 (20%), Positives = 59/159 (37%), Gaps = 45/159 (28%)
Query: 19 TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCH----------LQGVVHRDLK 68
C GEL +L+ ++ + +++ + + + VHRD+
Sbjct: 469 MELCTLGELRS--------FLQVRKFSL--DLASLILYAYQLSTALAYLESKRFVHRDIA 518
Query: 69 PENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV-----------APEVL-H 116
N L + + +K+ DFGLS + S YY APE +
Sbjct: 519 ARNVLVS---SNDCVKLGDFGLSR---------YMEDSTYYKASKGKLPIKWMAPESINF 566
Query: 117 RSYNVEGDMWSIGVITY-ILLCGSRPFWARTESGIFRSV 154
R + D+W GV + IL+ G +PF + + +
Sbjct: 567 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 605
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 8e-08
Identities = 28/118 (23%), Positives = 60/118 (50%), Gaps = 23/118 (19%)
Query: 44 KTIV---EKILNIVAFCHLQGVVHRDLKPENFLF--TTREEDAPLKVIDFGLS-DFVRPD 97
KT++ ++++ + + H + +++RD+KPENFL + + +IDF L+ +++ P+
Sbjct: 105 KTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE 164
Query: 98 QRL-------NDIVGSAYYVAPEVLHRSYNVEG----DMWSIG-VITYILLCGSRPFW 143
+ + G+A Y++ ++ E D+ ++G + Y L GS P W
Sbjct: 165 TKKHIPYREHKSLTGTARYMS---INTHLGKEQSRRDDLEALGHMFMY-FLRGSLP-W 217
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 9e-08
Identities = 29/111 (26%), Positives = 57/111 (51%), Gaps = 18/111 (16%)
Query: 46 IVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVR--------PD 97
+ +++++ + + H + +HRD+KP+NFL ++ + +IDFGL+ R P
Sbjct: 110 LADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPY 169
Query: 98 QRLNDIVGSAYYVAPEVLHRSYNVEG----DMWSIG-VITYILLCGSRPFW 143
+ ++ G+A Y + ++ +E D+ S+G V+ Y GS P W
Sbjct: 170 RENKNLTGTARYAS---INTHLGIEQSRRDDLESLGYVLMY-FNLGSLP-W 215
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 1e-07
Identities = 30/152 (19%), Positives = 49/152 (32%), Gaps = 43/152 (28%)
Query: 19 TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCH----------LQGVVHRDLK 68
F + G L YL+++ I IL + ++H ++
Sbjct: 91 QEFVKFGSLDT--------YLKKNKNCI--NILWKLEVAKQLAAAMHFLEENTLIHGNVC 140
Query: 69 PENFLFTTREEDAPL-----KVIDFGLSDFVRPDQRLNDIVGSAYY------VAPEVLH- 116
+N L E+ K+ D G+S V P V PE +
Sbjct: 141 AKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD---------ILQERIPWVPPECIEN 191
Query: 117 -RSYNVEGDMWSIGVITY-ILLCGSRPFWART 146
++ N+ D WS G + I G +P A
Sbjct: 192 PKNLNLATDKWSFGTTLWEICSGGDKPLSALD 223
|
| >1q80_A SCP, sarcoplasmic calcium-binding protein; all-alpha, metal binding protein; NMR {Neanthes diversicolor} SCOP: a.39.1.5 PDB: 2scp_A Length = 174 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-07
Identities = 21/147 (14%), Positives = 54/147 (36%), Gaps = 16/147 (10%)
Query: 239 TEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDA-MTDSRVFEILNVMEPLS--- 293
++ + ++ F ++ KDG ++ +F+ R A ++ M +++ + +
Sbjct: 1 SDLWVQKMKTYFNRIDFDKDGAITRMDFESMAERFAKESEMKAEHAKVLMDSLTGVWDNF 60
Query: 294 ------DQKLAYEEFCAAATSVYQLEALERWDQIAITA-FDYFEQEGNRVISVEELAL-- 344
+ + F + + + + + + F + + IS +E +
Sbjct: 61 LTAVAGGKGIDETTFINSMKEMVKNPEAKSVVEGPLPLFFRAVDTNEDNNISRDEYGIFF 120
Query: 345 -ELNLAPA-AYSLLNDCIRNSDGKLSF 369
L L A + + N+DG LS
Sbjct: 121 GMLGLDKTMAPASFDAIDTNNDGLLSL 147
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 30/161 (18%), Positives = 61/161 (37%), Gaps = 44/161 (27%)
Query: 19 TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCH----------LQGVVHRDLK 68
T++ G LLD ++ + + ++L + + G+VHR+L
Sbjct: 93 TQYLPLGSLLD--------HVRQHRGALGPQLL--LNWGVQIAKGMYYLEEHGMVHRNLA 142
Query: 69 PENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV-----------APEVL-H 116
N L + ++V DFG++D + PD + A E +
Sbjct: 143 ARNVLLK---SPSQVQVADFGVADLLPPD--------DKQLLYSEAKTPIKWMALESIHF 191
Query: 117 RSYNVEGDMWSIGVITY-ILLCGSRPFWARTESGIFRSVLR 156
Y + D+WS GV + ++ G+ P+ + + + +
Sbjct: 192 GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK 232
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 29/117 (24%), Positives = 55/117 (47%), Gaps = 21/117 (17%)
Query: 44 KTIV---EKILNIVAFCHLQGVVHRDLKPENFLF--TTREEDAPLKVIDFGLS-DFVRPD 97
KT+ +++L V H + +V+RD+KP+NFL + + V+DFG+ + P
Sbjct: 106 KTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 165
Query: 98 QRL-------NDIVGSAYYVAPEVLHRSYNVEG----DMWSIGVITYILLCGSRPFW 143
+ ++ G+A Y++ ++ E D+ ++G + L GS P W
Sbjct: 166 TKQHIPYREKKNLSGTARYMS---INTHLGREQSRRDDLEALGHVFMYFLRGSLP-W 218
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 37/159 (23%), Positives = 56/159 (35%), Gaps = 43/159 (27%)
Query: 19 TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCH----------LQGVVHRDLK 68
T + E G L +L E L V VHRDL
Sbjct: 125 TEYMENGALDK--------FLREKDGEFSVLQL--VGMLRGIAAGMKYLANMNYVHRDLA 174
Query: 69 PENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV-----------APEVL-H 116
N L + KV DFGLS + D A Y APE + +
Sbjct: 175 ARNILVN---SNLVCKVSDFGLSRVLEDDP-------EATYTTSGGKIPIRWTAPEAISY 224
Query: 117 RSYNVEGDMWSIGVITY-ILLCGSRPFWARTESGIFRSV 154
R + D+WS G++ + ++ G RP+W + + +++
Sbjct: 225 RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI 263
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 33/149 (22%), Positives = 50/149 (33%), Gaps = 45/149 (30%)
Query: 19 TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCH----------LQGVVHRDLK 68
GG L ++ + + N+ H + VHR+L
Sbjct: 414 MEMAGGGPLHKFLVGKREEI----------PVSNVAELLHQVSMGMKYLEEKNFVHRNLA 463
Query: 69 PENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV------------APEVL- 115
N L R K+ DFGLS + D +YY APE +
Sbjct: 464 ARNVLLVNRHY---AKISDFGLSKALGADD--------SYYTARSAGKWPLKWYAPECIN 512
Query: 116 HRSYNVEGDMWSIGVITY-ILLCGSRPFW 143
R ++ D+WS GV + L G +P+
Sbjct: 513 FRKFSSRSDVWSYGVTMWEALSYGQKPYK 541
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 2e-07
Identities = 35/151 (23%), Positives = 57/151 (37%), Gaps = 23/151 (15%)
Query: 19 TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE 78
T G LLDR+ G +L ++ + + + +HRDL N L TR+
Sbjct: 99 TELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD 158
Query: 79 EDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV-----------APEVL-HRSYNVEGDMW 126
+K+ DFGL + + Y + APE L R+++ D W
Sbjct: 159 L---VKIGDFGLMRALPQND-------DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTW 208
Query: 127 SIGVITY-ILLCGSRPFWARTESGIFRSVLR 156
GV + + G P+ S I + +
Sbjct: 209 MFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 239
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 2e-07
Identities = 26/106 (24%), Positives = 41/106 (38%), Gaps = 23/106 (21%)
Query: 63 VHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV------------ 110
+HRD+ N L T K+ DFG++ R DI + YY
Sbjct: 203 IHRDIAARNCLLTCPGPGRVAKIGDFGMA---R------DIYRAGYYRKGGCAMLPVKWM 253
Query: 111 APEVL-HRSYNVEGDMWSIGVITY-ILLCGSRPFWARTESGIFRSV 154
PE + + D WS GV+ + I G P+ +++ + V
Sbjct: 254 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 299
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 2e-07
Identities = 25/98 (25%), Positives = 40/98 (40%), Gaps = 23/98 (23%)
Query: 63 VHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV------------ 110
+HRD+ N L T K+ DFG++ R DI ++YY
Sbjct: 162 IHRDIAARNCLLTCPGPGRVAKIGDFGMA---R------DIYRASYYRKGGCAMLPVKWM 212
Query: 111 APEVL-HRSYNVEGDMWSIGVITY-ILLCGSRPFWART 146
PE + + D WS GV+ + I G P+ +++
Sbjct: 213 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 250
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 2e-07
Identities = 34/159 (21%), Positives = 60/159 (37%), Gaps = 45/159 (28%)
Query: 19 TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCH----------LQGVVHRDLK 68
C GEL +L+ ++ + +++ + + + VHRD+
Sbjct: 94 MELCTLGELRS--------FLQVRKYSL--DLASLILYAYQLSTALAYLESKRFVHRDIA 143
Query: 69 PENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV-----------APEVL-H 116
N L + + +K+ DFGLS R + S YY APE +
Sbjct: 144 ARNVLVS---SNDCVKLGDFGLS---R------YMEDSTYYKASKGKLPIKWMAPESINF 191
Query: 117 RSYNVEGDMWSIGVITY-ILLCGSRPFWARTESGIFRSV 154
R + D+W GV + IL+ G +PF + + +
Sbjct: 192 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 230
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 3e-07
Identities = 39/148 (26%), Positives = 52/148 (35%), Gaps = 43/148 (29%)
Query: 19 TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCH----------LQGVVHRDLK 68
T + E G L +L L V G VHRDL
Sbjct: 129 TEYMENGSLDT--------FLRTHDGQFTIMQL--VGMLRGVGAGMRYLSDLGYVHRDLA 178
Query: 69 PENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV-----------APEVL-H 116
N L + KV DFGLS + D A Y APE +
Sbjct: 179 ARNVLVD---SNLVCKVSDFGLSRVLEDDP-------DAAYTTTGGKIPIRWTAPEAIAF 228
Query: 117 RSYNVEGDMWSIGVITY-ILLCGSRPFW 143
R+++ D+WS GV+ + +L G RP+W
Sbjct: 229 RTFSSASDVWSFGVVMWEVLAYGERPYW 256
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 4e-07
Identities = 36/161 (22%), Positives = 55/161 (34%), Gaps = 45/161 (27%)
Query: 19 TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCH----------LQGVVHRDLK 68
GEL YLE + ++ K+L +V + VHRD+
Sbjct: 91 MELYPYGELGH--------YLERNKNSL--KVLTLVLYSLQICKAMAYLESINCVHRDIA 140
Query: 69 PENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV-----------APEVL-H 116
N L +K+ DFGLS R I YY +PE +
Sbjct: 141 VRNILVA---SPECVKLGDFGLS---R------YIEDEDYYKASVTRLPIKWMSPESINF 188
Query: 117 RSYNVEGDMWSIGVITY-ILLCGSRPFWARTESGIFRSVLR 156
R + D+W V + IL G +PF+ + + +
Sbjct: 189 RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEK 229
|
| >3sjs_A URE3-BP sequence specific DNA binding protein; EF-hand, structural genomics, seattle S genomics center for infectious disease, ssgcid; 1.90A {Entamoeba histolytica} PDB: 3sia_A 3sib_A Length = 220 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 6e-07
Identities = 17/170 (10%), Positives = 49/170 (28%), Gaps = 17/170 (10%)
Query: 206 PVPLDILIYKLVKSYLRATPLKRAALKALSKALTEEELVYLRAQFMLLEP-KDGCVSLNN 264
P+ Y ++ L + ++ + FM ++ + G + +N
Sbjct: 13 LQPIQGSWMGAACIYQMPPSVRNTWWFPLLNTIPLDQYTRIYQWFMGVDRDRSGTLEINE 72
Query: 265 FKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAIT 324
+ ++ ++ + + + +++ EF A + +E
Sbjct: 73 LMMGQ-FPGGIRLSPQTALRMMRIFDTDFNGHISFYEFMAM------YKFMELA----YN 121
Query: 325 AFDYFEQEGNRVISVEEL--ALE---LNLAPAAYSLLNDCIRNSDGKLSF 369
F + + + E+ AL+ + LL+
Sbjct: 122 LFVMNARARSGTLEPHEILPALQQLGFYINQRTSLLLHRLFARGMAFCDL 171
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 6e-07
Identities = 36/150 (24%), Positives = 60/150 (40%), Gaps = 26/150 (17%)
Query: 19 TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIV---AFCHLQGVVHRDLKPENFLFT 75
T + G L+D + SRG L +++ L++ + VHRDL N L +
Sbjct: 266 TEYMAKGSLVDYLRSRGRSVL--GGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS 323
Query: 76 TREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV-------APEVL-HRSYNVEGDMWS 127
ED KV DFGL+ + + APE L + ++ + D+WS
Sbjct: 324 ---EDNVAKVSDFGLTK---------EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWS 371
Query: 128 IGVITY-ILLCGSRPFWARTESGIFRSVLR 156
G++ + I G P+ + V +
Sbjct: 372 FGILLWEIYSFGRVPYPRIPLKDVVPRVEK 401
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 6e-07
Identities = 34/149 (22%), Positives = 54/149 (36%), Gaps = 40/149 (26%)
Query: 19 TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIV-------AFCHLQGVVHRDLKPEN 71
E G L YL+++ + I+ +V + VHRDL N
Sbjct: 96 MEMAELGPLNK--------YLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARN 147
Query: 72 FLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV------------APEVL-HRS 118
L K+ DFGLS +R D+ YY APE + +
Sbjct: 148 VLLV---TQHYAKISDFGLSKALRADE--------NYYKAQTHGKWPVKWYAPECINYYK 196
Query: 119 YNVEGDMWSIGVITY-ILLCGSRPFWART 146
++ + D+WS GV+ + G +P+
Sbjct: 197 FSSKSDVWSFGVLMWEAFSYGQKPYRGMK 225
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 7e-07
Identities = 37/157 (23%), Positives = 59/157 (37%), Gaps = 40/157 (25%)
Query: 19 TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFC--------HL--QGVVHRDLK 68
T + G L+D + SRG L ++ F +L VHRDL
Sbjct: 94 TEYMAKGSLVDYLRSRGRSVL---------GGDCLLKFSLDVCEAMEYLEGNNFVHRDLA 144
Query: 69 PENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV-------APEVL-HRSYN 120
N L + ED KV DFGL+ + + + APE L + ++
Sbjct: 145 ARNVLVS---EDNVAKVSDFGLT---K------EASSTQDTGKLPVKWTAPEALREKKFS 192
Query: 121 VEGDMWSIGVITY-ILLCGSRPFWARTESGIFRSVLR 156
+ D+WS G++ + I G P+ + V +
Sbjct: 193 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 229
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 8e-07
Identities = 36/159 (22%), Positives = 56/159 (35%), Gaps = 43/159 (27%)
Query: 19 TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCH----------LQGVVHRDLK 68
T + E G L +L + L V G VHRDL
Sbjct: 125 TEYMENGSLDS--------FLRKHDAQFTVIQL--VGMLRGIASGMKYLSDMGYVHRDLA 174
Query: 69 PENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV-----------APEVL-H 116
N L + KV DFGL + D A Y +PE + +
Sbjct: 175 ARNILIN---SNLVCKVSDFGLGRVLEDDP-------EAAYTTRGGKIPIRWTSPEAIAY 224
Query: 117 RSYNVEGDMWSIGVITY-ILLCGSRPFWARTESGIFRSV 154
R + D+WS G++ + ++ G RP+W + + ++V
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 8e-07
Identities = 36/152 (23%), Positives = 51/152 (33%), Gaps = 45/152 (29%)
Query: 19 TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCH----------LQGVVHRDLK 68
GG L +L + I + N+ H + VHRDL
Sbjct: 88 MEMAGGGPLHK--------FLVGKREEI--PVSNVAELLHQVSMGMKYLEEKNFVHRDLA 137
Query: 69 PENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV------------APEVL- 115
N L R K+ DFGLS + D +YY APE +
Sbjct: 138 ARNVLLVNRHY---AKISDFGLSKALGADD--------SYYTARSAGKWPLKWYAPECIN 186
Query: 116 HRSYNVEGDMWSIGVITY-ILLCGSRPFWART 146
R ++ D+WS GV + L G +P+
Sbjct: 187 FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 218
|
| >2hpk_A Photoprotein berovin; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics, secsg; 2.00A {Beroe abyssicola} Length = 208 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 1e-06
Identities = 23/152 (15%), Positives = 47/152 (30%), Gaps = 20/152 (13%)
Query: 238 LTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMR-----QATDAMTDSRVFEILNVMEP 291
L + L L +F + DG + ++ R ATD + +
Sbjct: 30 LHPKMLSRLYKRFDTFDLDSDGKMEMDEVLYWPDRMRQLVNATDEQVEKMRDAVRVFFLH 89
Query: 292 L---SDQKLAYEEFCAAATSV-------YQLEALERWDQIAITAFDYFEQEGNRVISVEE 341
L E++ A + ++ + +D + +G+ + V+E
Sbjct: 90 KGVEPVNGLLREDWVEANRVFAEAERERERRGEPSLIALLSNSYYDVLDDDGDGTVDVDE 149
Query: 342 LAL---ELNLAPA-AYSLLNDCIRNSDGKLSF 369
L ++ AY+ + GKL
Sbjct: 150 LKTMMKAFDVPQEAAYTFFEKADTDKSGKLER 181
|
| >1qv0_A Obelin, OBL; photoprotein, bioluminescence, atomic resolution, Ca binding, EF-hand, luminescent protein; HET: CZH; 1.10A {Obelia longissima} SCOP: a.39.1.5 PDB: 1qv1_A* 1sl9_A* 1el4_A* 2f8p_A* 1sl7_A 1jf2_A* 1s36_A* 1jf0_A* 3kpx_A* Length = 195 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 1e-06
Identities = 17/166 (10%), Positives = 51/166 (30%), Gaps = 23/166 (13%)
Query: 227 KRAALKALSKALTEEELVYLRAQFMLLEP-KDGCVSL----NNFKVALMRQATDAMTDSR 281
+ A+K + + + F L+ +G ++L + + + ++
Sbjct: 3 SKYAVKLKTDFDNPRWIKRHKHMFDFLDINGNGKITLDEIVSKASDDICAKLEATPEQTK 62
Query: 282 VFEILN-VMEPLSDQKLA----YEEFCAAATSVYQLEAL-------ERWDQIAITAFDYF 329
++ + + +F + E + FD F
Sbjct: 63 RHQVCVEAFFRGCGMEYGKEIAFPQFLDGWKQLATSELKKWARNEPTLIREWGDAVFDIF 122
Query: 330 EQEGNRVISVEEL-----ALELNLAPA-AYSLLNDCIRNSDGKLSF 369
+++G+ I+++E ++ + + C ++ G L
Sbjct: 123 DKDGSGTITLDEWKAYGKISGISPSQEDCEATFRHCDLDNAGDLDV 168
|
| >2hps_A Coelenterazine-binding protein with bound coelent; bioluminescence, southeast collabora structural genomics, secsg, structural genomics, PSI; HET: CTZ; 1.72A {Renilla muelleri} PDB: 2hq8_A Length = 186 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-06
Identities = 26/154 (16%), Positives = 60/154 (38%), Gaps = 18/154 (11%)
Query: 234 LSKALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFE-----ILN 287
++++ L ++ + ++ DG +S ++++ +R A A + E L
Sbjct: 4 ITESERAYHLRKMKTRMQRVDVTGDGFISREDYELIAVRIAKIAKLSAEKAEETRQEFLR 63
Query: 288 VMEPL---SDQKLAYEEFCAAATSVYQL---EALERWDQIAITAFDYFEQEGNRVISVEE 341
V + L +++ EE AT E ++ +D + + + +S+ E
Sbjct: 64 VADQLGLAPGVRISVEEAAVNATDSLLKMKGEEKAMAVIQSLIMYDCIDTDKDGYVSLPE 123
Query: 342 L-----ALELNLAPA-AYSLLNDCIRNSDGKLSF 369
A+ +L A + N N +G++S
Sbjct: 124 FKAFLQAVGPDLTDDKAITCFNTLDFNKNGQISR 157
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 36/164 (21%), Positives = 58/164 (35%), Gaps = 48/164 (29%)
Query: 19 TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCH----------LQGVVHRDLK 68
+ G+LL ++ + K L ++F Q VHRDL
Sbjct: 102 LPYMCHGDLLQ--------FIRSPQRNPTVKDL--ISFGLQVARGMEYLAEQKFVHRDLA 151
Query: 69 PENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV--------------APEV 114
N + E +KV DFGL+ R DI+ YY A E
Sbjct: 152 ARNCMLD---ESFTVKVADFGLA---R------DILDREYYSVQQHRHARLPVKWTALES 199
Query: 115 LH-RSYNVEGDMWSIGVITY-ILLCGSRPFWARTESGIFRSVLR 156
L + + D+WS GV+ + +L G+ P+ + + +
Sbjct: 200 LQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ 243
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 36/159 (22%), Positives = 54/159 (33%), Gaps = 25/159 (15%)
Query: 19 TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE 78
+ G L D + R +I + + + VHRDL N L E
Sbjct: 105 MEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILV---E 161
Query: 79 EDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV------------APEVL-HRSYNVEGDM 125
+A +K+ DFGL+ + D YYV APE L ++ + D+
Sbjct: 162 SEAHVKIADFGLAKLLPLD--------KDYYVVREPGQSPIFWYAPESLSDNIFSRQSDV 213
Query: 126 WSIGVITY-ILLCGSRPFWARTESGIFRSVLRADPNFHD 163
WS GV+ Y + + E R P
Sbjct: 214 WSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR 252
|
| >1s6i_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 Length = 188 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 2e-06
Identities = 29/140 (20%), Positives = 71/140 (50%), Gaps = 16/140 (11%)
Query: 238 LTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQK 296
L+EEE+ L+ F +++ G ++ + K +++ + +S + ++++ +
Sbjct: 4 LSEEEIGGLKELFKMIDTDNSGTITFDELKDG-LKRVGSELMESEIKDLMDAADIDKSGT 62
Query: 297 LAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEEL---ALELNLAPAAY 353
+ Y EF AA + +LE E ++AF YF+++G+ I+++E+ + L
Sbjct: 63 IDYGEFIAATVHLNKLEREEN----LVSAFSYFDKDGSGYITLDEIQQACKDFGLDDIH- 117
Query: 354 SLLNDCIR----NSDGKLSF 369
++D I+ ++DG++ +
Sbjct: 118 --IDDMIKEIDQDNDGQIDY 135
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 3e-06
Identities = 32/136 (23%), Positives = 53/136 (38%), Gaps = 38/136 (27%)
Query: 21 FCEGGELLDRILSRGGRYLEEDAKTIVEKILN---IVAFC--------HL--QGVVHRDL 67
+C G+LL+ + + + A I + ++ F L + +HRD+
Sbjct: 131 YCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDV 190
Query: 68 KPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV------------APEVL 115
N L T K+ DFGL+ R DI+ + Y+ APE +
Sbjct: 191 AARNVLLT---NGHVAKIGDFGLA-------R--DIMNDSNYIVKGNARLPVKWMAPESI 238
Query: 116 -HRSYNVEGDMWSIGV 130
Y V+ D+WS G+
Sbjct: 239 FDCVYTVQSDVWSYGI 254
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 4e-06
Identities = 34/155 (21%), Positives = 60/155 (38%), Gaps = 41/155 (26%)
Query: 21 FCEGGELLD--RILSRGGRYLEEDAKTIVEKILNIVAFCHL-------------QGVVHR 65
+C G+L + + S D V+ L F HL VVH+
Sbjct: 93 YCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHK 152
Query: 66 DLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV------------APE 113
DL N L + +K+ D GL R ++ + YY APE
Sbjct: 153 DLATRNVLVY---DKLNVKISDLGLF-------R--EVYAADYYKLLGNSLLPIRWMAPE 200
Query: 114 -VLHRSYNVEGDMWSIGVITY-ILLCGSRPFWART 146
+++ ++++ D+WS GV+ + + G +P+ +
Sbjct: 201 AIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS 235
|
| >2ggz_A Guanylyl cyclase-activating protein 3; EF hand, guanylate cyclase activating protein, GCAP, GCAP3, GCAP-3, lyase activator; 3.00A {Homo sapiens} Length = 211 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 5e-06
Identities = 33/149 (22%), Positives = 58/149 (38%), Gaps = 21/149 (14%)
Query: 235 SKALTEEELVYLRAQFMLLEPKDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSD 294
KA+ +E FM+ P G +L+ FK L Q + + + ++ N + D
Sbjct: 13 QKAVPTQETHVWYRTFMMEYP-SGLQTLHEFKTLLGLQGLNQKANKHIDQVYNTFDTNKD 71
Query: 295 QKLAYEEFCAAATSVYQLEALE--RWDQIAITAFDYFEQEGNRVISVEEL--------AL 344
+ + EF AA + Q + + +W F ++ +GN I EL AL
Sbjct: 72 GFVDFLEFIAAVNLIMQEKMEQKLKW------YFKLYDADGNGSIDKNELLDMFMAVQAL 125
Query: 345 ELNLAPAAYSLLNDCIR----NSDGKLSF 369
+ +N N+DG+L+
Sbjct: 126 NGQQTLSPEEFINLVFHKIDINNDGELTL 154
|
| >3fwb_A Cell division control protein 31; gene gating, complex, cell cycle, cell division, mitosis, MR transport, nuclear pore complex, nucleus, phosphoprotein; 2.50A {Saccharomyces cerevisiae} PDB: 2gv5_A 2doq_A 3fwc_A Length = 161 | Back alignment and structure |
|---|
Score = 45.2 bits (108), Expect = 5e-06
Identities = 22/117 (18%), Positives = 47/117 (40%), Gaps = 5/117 (4%)
Query: 227 KRAALKALSKALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEI 285
L+ L EE+ + F L + DG + + KVA M+ + + ++
Sbjct: 6 SSLQSGPLNSELLEEQKQEIYEAFSLFDMNNDGFLDYHELKVA-MKALGFELPKREILDL 64
Query: 286 LNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEEL 342
++ + + Y++F ++ + D+I AF F+ + IS++ L
Sbjct: 65 IDEYDSEGRHLMKYDDFYIVMGE--KILKRDPLDEI-KRAFQLFDDDHTGKISIKNL 118
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 6e-06
Identities = 37/163 (22%), Positives = 60/163 (36%), Gaps = 44/163 (26%)
Query: 21 FCEGGELLD-----RILSRGGRYLEEDAKTIVEKILNIVAFC--------HL--QGVVHR 65
+ G LLD R+L + ++ ++ F +L + +HR
Sbjct: 107 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHR 166
Query: 66 DLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV------------APE 113
DL N L E+ K+ DFGLS R + YV A E
Sbjct: 167 DLAARNILVG---ENYVAKIADFGLS-------RGQE-----VYVKKTMGRLPVRWMAIE 211
Query: 114 VL-HRSYNVEGDMWSIGVITY-ILLCGSRPFWARTESGIFRSV 154
L + Y D+WS GV+ + I+ G P+ T + ++ +
Sbjct: 212 SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 254
|
| >2obh_A Centrin-2; DNA repair complex EF hand superfamily protein-peptide compl cycle; 1.80A {Homo sapiens} SCOP: a.39.1.5 PDB: 3kf9_A 1m39_A 2a4j_A 2k2i_A 1oqp_A Length = 143 | Back alignment and structure |
|---|
Score = 44.4 bits (106), Expect = 7e-06
Identities = 22/105 (20%), Positives = 46/105 (43%), Gaps = 5/105 (4%)
Query: 239 TEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKL 297
TEE+ +R F L + G + + KVA MR + ++++ ++ K+
Sbjct: 1 TEEQKQEIREAFDLFDADGTGTIDVKELKVA-MRALGFEPKKEEIKKMISEIDKEGTGKM 59
Query: 298 AYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEEL 342
+ +F T ++ + ++I + AF F+ + IS + L
Sbjct: 60 NFGDFLTVMTQ--KMSEKDTKEEI-LKAFKLFDDDETGKISFKNL 101
|
| >1nya_A Calerythrin; EF-hand, metal binding protein; NMR {Saccharopolyspora erythraea} SCOP: a.39.1.5 Length = 176 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 8e-06
Identities = 22/157 (14%), Positives = 50/157 (31%), Gaps = 29/157 (18%)
Query: 239 TEEELVYLRAQFMLLEP-KDGCVSLNNFKVA---LMRQATDAMTDSRVFEILNVMEPL-- 292
T L+ +F + +G + +F+ + + V + N L
Sbjct: 2 TAIASDRLKKRFDRWDFDGNGALERADFEKEAQHIAEAFGKDAGAAEVQTLKNAFGGLFD 61
Query: 293 ---------SDQKLAYEEFCAAATSVYQLEALERWDQIAIT----AFDYFEQEGNRVISV 339
SD L E+F ++ + ++++ ++ + I+
Sbjct: 62 YLAKEAGVGSDGSLTEEQFIRVTENLIFEQGEASFNRVLGPVVKGIVGMCDKNADGQINA 121
Query: 340 EELAL---ELNLAPAAYSLLNDCIR----NSDGKLSF 369
+E A L ++ A + N +G+LS
Sbjct: 122 DEFAAWLTALGMSKAE---AAEAFNQVDTNGNGELSL 155
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 8e-06
Identities = 37/157 (23%), Positives = 59/157 (37%), Gaps = 35/157 (22%)
Query: 21 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNI---VAF--CHL--QGVVHRDLKPENFL 73
F + G+L + R E ++ ++ +A +L + +HRDL N +
Sbjct: 112 FMKHGDLHAFL--LASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCM 169
Query: 74 FTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV------------APEVLH-RSYN 120
ED + V DFGLS R I YY A E L Y
Sbjct: 170 LA---EDMTVCVADFGLS---R------KIYSGDYYRQGCASKLPVKWLALESLADNLYT 217
Query: 121 VEGDMWSIGVITY-ILLCGSRPFWARTESGIFRSVLR 156
V D+W+ GV + I+ G P+ + I+ ++
Sbjct: 218 VHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG 254
|
| >3e3r_A Calcyphosin, calcyphosine; human calcyphosine, EF-hand, phosphoprotein, calcium binding; 2.65A {Homo sapiens} Length = 204 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 9e-06
Identities = 18/113 (15%), Positives = 38/113 (33%), Gaps = 6/113 (5%)
Query: 231 LKALSKALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVM 289
L+A + + L F L+ + + F+ L + + + +
Sbjct: 24 LRAQCLSRGASGIQGLARFFRQLDRDGSRSLDADEFRQGLAKLGLV-LDQAEAEGVCRKW 82
Query: 290 EPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEEL 342
+ L EEF A + AF ++ G+ V++V++L
Sbjct: 83 DRNGSGTLDLEEFLRALRPPMSQAREA----VIAAAFAKLDRSGDGVVTVDDL 131
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 9e-06
Identities = 32/160 (20%), Positives = 60/160 (37%), Gaps = 48/160 (30%)
Query: 21 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFC--------HL--QGVVHRDLKPE 70
+ + G+L + ++ + + +++ F +L + VHRDL
Sbjct: 108 YMKHGDLRN--------FIRNETHNP--TVKDLIGFGLQVAKGMKYLASKKFVHRDLAAR 157
Query: 71 NFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV--------------APEVLH 116
N + E +KV DFGL+ R D+ YY A E L
Sbjct: 158 NCMLD---EKFTVKVADFGLA---R------DMYDKEYYSVHNKTGAKLPVKWMALESLQ 205
Query: 117 -RSYNVEGDMWSIGVITY-ILLCGSRPFWARTESGIFRSV 154
+ + + D+WS GV+ + ++ G+ P+ I +
Sbjct: 206 TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 245
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 39/186 (20%), Positives = 59/186 (31%), Gaps = 45/186 (24%)
Query: 19 TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE 78
+ G L D + R +I + + + +HRDL N L E
Sbjct: 123 MEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV---E 179
Query: 79 EDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV------------APEVL-HRSYNVEGDM 125
+ +K+ DFGL+ + D+ YY APE L ++V D+
Sbjct: 180 NENRVKIGDFGLTKVLPQDK--------EYYKVKEPGESPIFWYAPESLTESKFSVASDV 231
Query: 126 WSIGV-----ITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRL 180
WS GV TYI S P G + + + L
Sbjct: 232 WSFGVVLYELFTYIEKSKSPPAEFMRMIG-------------NDKQGQMIVFH---LIEL 275
Query: 181 LNKDHR 186
L + R
Sbjct: 276 LKNNGR 281
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 1e-05
Identities = 35/157 (22%), Positives = 57/157 (36%), Gaps = 35/157 (22%)
Query: 21 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNI---VAF--CHL--QGVVHRDLKPENFL 73
F + G+L + R ++ +L +A +L + +HRDL N +
Sbjct: 122 FMKYGDLHTYL--LYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCM 179
Query: 74 FTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV------------APEVL-HRSYN 120
+D + V DFGLS + I YY A E L R Y
Sbjct: 180 LR---DDMTVCVADFGLS---K------KIYSGDYYRQGRIAKMPVKWIAIESLADRVYT 227
Query: 121 VEGDMWSIGVITY-ILLCGSRPFWARTESGIFRSVLR 156
+ D+W+ GV + I G P+ ++ +L
Sbjct: 228 SKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLH 264
|
| >3qrx_A Centrin; calcium-binding, EF-hand, cell division, calcium binding, ME binding protein-toxin complex; 2.20A {Chlamydomonas reinhardtii} PDB: 2ggm_A 2ami_A 1zmz_A Length = 169 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 1e-05
Identities = 26/126 (20%), Positives = 56/126 (44%), Gaps = 6/126 (4%)
Query: 219 SYLRATPLKRAALKALSKA-LTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDA 276
SY T + + + LTEE+ +R F L + G + KVA MR
Sbjct: 2 SYKAKTVVSARRDQKKGRVGLTEEQKQEIREAFDLFDTDGSGTIDAKELKVA-MRALGFE 60
Query: 277 MTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRV 336
+ ++++ ++ + +EEF T+ ++ + ++I + AF F+ + +
Sbjct: 61 PKKEEIKKMISEIDKDGSGTIDFEEFLTMMTA--KMGERDSREEI-LKAFRLFDDDNSGT 117
Query: 337 ISVEEL 342
I++++L
Sbjct: 118 ITIKDL 123
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 45.2 bits (108), Expect = 1e-05
Identities = 33/139 (23%), Positives = 50/139 (35%), Gaps = 36/139 (25%)
Query: 55 AFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLND----------IV 104
F H +HRD+K N L +E K+ DFGL+ R ++ IV
Sbjct: 147 NFLHENHHIHRDIKSANILL---DEAFTAKISDFGLA-------RASEKFAQTVMTSRIV 196
Query: 105 GSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPF-----------WAR---TESGI 150
G+ Y+APE L + D++S GV+ ++ G E
Sbjct: 197 GTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKT 256
Query: 151 FRSVLRADPNFHDSPWPSV 169
D +D+ SV
Sbjct: 257 IEDY--IDKKMNDADSTSV 273
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 2e-05
Identities = 34/149 (22%), Positives = 52/149 (34%), Gaps = 29/149 (19%)
Query: 19 TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE 78
+ G L D + R +I + + + +HRDL N L E
Sbjct: 92 MEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV---E 148
Query: 79 EDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV------------APEVL-HRSYNVEGDM 125
+ +K+ DFGL+ + D+ ++ APE L ++V D+
Sbjct: 149 NENRVKIGDFGLTKVLPQDK--------EFFKVKEPGESPIFWYAPESLTESKFSVASDV 200
Query: 126 WSIGV-----ITYILLCGSRPFWARTESG 149
WS GV TYI S P G
Sbjct: 201 WSFGVVLYELFTYIEKSKSPPAEFMRMIG 229
|
| >1uhk_A Aequorin 2, aequorin; EF-hand motif, complex, luminescent protein; HET: CZN; 1.60A {Aequorea victoria} SCOP: a.39.1.5 PDB: 1ej3_A* 1uhi_A* 1uhj_A* 1uhh_A* 1sl8_A Length = 191 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 2e-05
Identities = 18/164 (10%), Positives = 43/164 (26%), Gaps = 23/164 (14%)
Query: 229 AALKALSKALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAM----TDSRVF 283
A K S + + F L+ +G +SL+ + + ++
Sbjct: 1 ANSKLTSDFDNPRWIGRHKHMFNFLDVNHNGKISLDEMVYKASDIVINNLGATPEQAKRH 60
Query: 284 EILNVM-----EPLSDQKLAYEEFCAAATSVYQLEAL-------ERWDQIAITAFDYFEQ 331
+ + + + + E FD ++
Sbjct: 61 KDAVEAFFGGAGMKYGVETDWPAYIEGWKKLATDELEKYAKNEPTLIRIWGDALFDIVDK 120
Query: 332 EGNRVISVEEL-----ALELNLAPA-AYSLLNDCIRNSDGKLSF 369
+ N I+++E A + + C + G+L
Sbjct: 121 DQNGAITLDEWKAYTKAAGIIQSSEDCEETFRVCDIDESGQLDV 164
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 3e-05
Identities = 32/160 (20%), Positives = 57/160 (35%), Gaps = 48/160 (30%)
Query: 21 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFC--------HL--QGVVHRDLKPE 70
+ + G+L + ++ + K L + F L + VHRDL
Sbjct: 172 YMKHGDLRN--------FIRNETHNPTVKDL--IGFGLQVAKGMKFLASKKFVHRDLAAR 221
Query: 71 NFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV--------------APEVLH 116
N + E +KV DFGL+ R D+ + A E L
Sbjct: 222 NCMLD---EKFTVKVADFGLA---R------DMYDKEFDSVHNKTGAKLPVKWMALESLQ 269
Query: 117 -RSYNVEGDMWSIGVITY-ILLCGSRPFWARTESGIFRSV 154
+ + + D+WS GV+ + ++ G+ P+ I +
Sbjct: 270 TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 309
|
| >1dtl_A Cardiac troponin C; helix-turn-helix, structural protein; HET: BEP; 2.15A {Gallus gallus} SCOP: a.39.1.5 PDB: 1j1d_A 1j1e_A 2jt3_A 2jt0_A 1la0_A 2jtz_A* 2jt8_A* 2kfx_T* 1wrk_A* 1wrl_A* 1ap4_A 1lxf_C* 1mxl_C 1spy_A 2krd_C* 2l1r_A* 3rv5_A* 2ctn_A 2kgb_C 2jxl_A ... Length = 161 | Back alignment and structure |
|---|
Score = 42.9 bits (102), Expect = 3e-05
Identities = 23/113 (20%), Positives = 48/113 (42%), Gaps = 3/113 (2%)
Query: 232 KALSKALTEEELVYLRAQFMLL--EPKDGCVSLNNFKVALMRQATDAMTDSRVFEILNVM 289
KA + LTEE+ +A F + +DG +S MR T + E+++ +
Sbjct: 6 KAAVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKV-MRMLGQNPTPEELQEMIDEV 64
Query: 290 EPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEEL 342
+ + ++EF + ++ + ++ F F++ + I +EEL
Sbjct: 65 DEDGSGTVDFDEFLVMMVRSMKDDSKGKSEEELSDLFRMFDKNADGYIDLEEL 117
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 4e-05
Identities = 29/96 (30%), Positives = 40/96 (41%), Gaps = 26/96 (27%)
Query: 60 QGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV--------- 110
+ +HRDL N L T K+ DFGL+ R DI + YV
Sbjct: 164 KNCIHRDLAARNILLT---HGRITKICDFGLA---R------DIKNDSNYVVKGNARLPV 211
Query: 111 ---APEVL-HRSYNVEGDMWSIGVITY-ILLCGSRP 141
APE + + Y E D+WS G+ + + GS P
Sbjct: 212 KWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >4ds7_A Calmodulin, CAM; protein binding, metal binding, structura; 2.15A {Kluyveromyces lactis} PDB: 1lkj_A 1f54_A 1f55_A Length = 147 | Back alignment and structure |
|---|
Score = 42.1 bits (100), Expect = 4e-05
Identities = 26/109 (23%), Positives = 55/109 (50%), Gaps = 5/109 (4%)
Query: 235 SKALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLS 293
S+ LTEE++ + F L + G +S + MR + +++ V +++N ++
Sbjct: 2 SQNLTEEQIAEFKEAFALFDKDNSGSISASELATV-MRSLGLSPSEAEVADLMNEIDVDG 60
Query: 294 DQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEEL 342
+ + + EF A + QL+ + ++ + AF F++ G+ +IS EL
Sbjct: 61 NHAIEFSEFLALMSR--QLKCNDSEQEL-LEAFKVFDKNGDGLISAAEL 106
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 5e-05
Identities = 32/154 (20%), Positives = 50/154 (32%), Gaps = 45/154 (29%)
Query: 19 TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFC----------HLQGVVHRDLK 68
F G L + YL ++ I + + + + VHRDL
Sbjct: 104 MEFLPSGSLKE--------YLPKNKNKI--NLKQQLKYAVQICKGMDYLGSRQYVHRDLA 153
Query: 69 PENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV------------APEVL- 115
N L E + +K+ DFGL+ + D+ YY APE L
Sbjct: 154 ARNVLV---ESEHQVKIGDFGLTKAIETDK--------EYYTVKDDRDSPVFWYAPECLM 202
Query: 116 HRSYNVEGDMWSIGVITY-ILLCGSRPFWARTES 148
+ + D+WS GV + +L
Sbjct: 203 QSKFYIASDVWSFGVTLHELLTYCDSDSSPMALF 236
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 5e-05
Identities = 29/101 (28%), Positives = 44/101 (43%), Gaps = 26/101 (25%)
Query: 60 QGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV--------- 110
VHRDL N L + +K+ DFG+S R DI + YY
Sbjct: 177 LHFVHRDLATRNCLVG---QGLVVKIGDFGMS---R------DIYSTDYYRVGGRTMLPI 224
Query: 111 ---APEVL-HRSYNVEGDMWSIGVITY-ILLCGSRPFWART 146
PE + +R + E D+WS GV+ + I G +P++ +
Sbjct: 225 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS 265
|
| >2f2o_A Calmodulin fused with calmodulin-binding domain of calcineurin; EF-hands, calcium, metal binding protein; 2.17A {Bos taurus} PDB: 2f2p_A Length = 179 | Back alignment and structure |
|---|
Score = 42.5 bits (101), Expect = 5e-05
Identities = 24/109 (22%), Positives = 51/109 (46%), Gaps = 5/109 (4%)
Query: 235 SKALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLS 293
+ LTEE++ + F L + DG ++ MR T++ + +++N ++
Sbjct: 2 ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTV-MRSLGQNPTEAELQDMINEVDADG 60
Query: 294 DQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEEL 342
+ + + EF +++ + ++I AF F+++GN IS EL
Sbjct: 61 NGTIDFPEFLTMMAR--KMKDTDSEEEI-REAFRVFDKDGNGYISAAEL 106
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 6e-05
Identities = 38/152 (25%), Positives = 59/152 (38%), Gaps = 41/152 (26%)
Query: 21 FCEGGELLD-----RILSRGGRYLEEDAKTIVEKILNIVAFC--------HL--QGVVHR 65
FC+ G L R + ED + +++ + L + +HR
Sbjct: 113 FCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHR 172
Query: 66 DLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV------------APE 113
DL N L + E +K+ DFGL+ R DI YV APE
Sbjct: 173 DLAARNILLS---EKNVVKICDFGLA---R------DIYKDPDYVRKGDARLPLKWMAPE 220
Query: 114 VL-HRSYNVEGDMWSIGVITY-ILLCGSRPFW 143
+ R Y ++ D+WS GV+ + I G+ P+
Sbjct: 221 TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 6e-05
Identities = 41/167 (24%), Positives = 63/167 (37%), Gaps = 41/167 (24%)
Query: 19 TRFCEGGELLD--RILSRGGRYLEEDAKTIVEKILN---IVAFC--------HL--QGVV 63
+ G L + + G + E+ L+ +V+ +L + +
Sbjct: 154 VEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCI 213
Query: 64 HRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV------------A 111
HRDL N L T ED +K+ DFGL+ R DI YY A
Sbjct: 214 HRDLAARNVLVT---EDNVMKIADFGLA---R------DIHHIDYYKKTTNGRLPVKWMA 261
Query: 112 PEVL-HRSYNVEGDMWSIGVITY-ILLCGSRPFWARTESGIFRSVLR 156
PE L R Y + D+WS GV+ + I G P+ +F+ +
Sbjct: 262 PEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE 308
|
| >1top_A Troponin C; contractIle system protein; 1.78A {Gallus gallus} SCOP: a.39.1.5 PDB: 1ncy_A 1ncz_A 1ncx_A 1ytz_C* 1yv0_C 1tnw_A 1tnx_A 5tnc_A 2w49_0 2w4u_0 4tnc_A 1a2x_A 1tcf_A 1tn4_A 2tn4_A 1aj4_A 1jc2_A 1fi5_A 1sbj_A 1scv_A ... Length = 162 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 7e-05
Identities = 21/106 (19%), Positives = 42/106 (39%), Gaps = 2/106 (1%)
Query: 238 LTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQK 296
L+EE + +A F + + G +S MR T + I+ ++
Sbjct: 14 LSEEMIAEFKAAFDMFDADGGGDISTKELGTV-MRMLGQNPTKEELDAIIEEVDEDGSGT 72
Query: 297 LAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEEL 342
+ +EEF + +A + ++ F F++ + I +EEL
Sbjct: 73 IDFEEFLVMMVRQMKEDAKGKSEEELANCFRIFDKNADGFIDIEEL 118
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 43.4 bits (102), Expect = 7e-05
Identities = 30/96 (31%), Positives = 43/96 (44%), Gaps = 26/96 (27%)
Query: 60 QGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV--------- 110
+ +HRDL N L + E +K+ DFGL+ R DI YV
Sbjct: 212 RKCIHRDLAARNILLS---EKNVVKICDFGLA---R------DIYKDPDYVRKGDARLPL 259
Query: 111 ---APEVL-HRSYNVEGDMWSIGVITY-ILLCGSRP 141
APE + R Y ++ D+WS GV+ + I G+ P
Sbjct: 260 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >1exr_A Calmodulin; high resolution, disorder, metal transport; 1.00A {Paramecium tetraurelia} SCOP: a.39.1.5 PDB: 1n0y_A 1osa_A 1clm_A 1mxe_A 2bbm_A 2bbn_A 4cln_A 4djc_A 2wel_D* 2x51_B 2vas_B* 2bkh_B 3gn4_B 3l9i_C 2ygg_B* 2w73_A 1lvc_D* 1wrz_A 2bki_B 2r28_A ... Length = 148 | Back alignment and structure |
|---|
Score = 41.3 bits (98), Expect = 8e-05
Identities = 24/109 (22%), Positives = 55/109 (50%), Gaps = 5/109 (4%)
Query: 235 SKALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLS 293
++ LTEE++ + F L + DG ++ MR T++ + +++N ++
Sbjct: 1 AEQLTEEQIAEFKEAFALFDKDGDGTITTKELGTV-MRSLGQNPTEAELQDMINEVDADG 59
Query: 294 DQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEEL 342
+ + + EF + +++ + +++ I AF F+++GN +IS EL
Sbjct: 60 NGTIDFPEFLSLMAR--KMKEQDSEEEL-IEAFKVFDRDGNGLISAAEL 105
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 9e-05
Identities = 31/128 (24%), Positives = 52/128 (40%), Gaps = 30/128 (23%)
Query: 55 AFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQ-----RLNDIVGSAY 108
+ H + ++HRD+K N L +E+ K+ DFG+S DQ + G+
Sbjct: 153 HYLHTRAIIHRDVKSINILL---DENFVPKITDFGISKKGTELDQTHLSTV---VKGTLG 206
Query: 109 YVAPEVLHRSY-NVEGDMWSIGVITYILLCGSRPF-------------WART--ESGIFR 152
Y+ PE + + D++S GV+ + +LC WA +G
Sbjct: 207 YIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE 266
Query: 153 SVLRADPN 160
+ DPN
Sbjct: 267 QI--VDPN 272
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 1e-04
Identities = 36/155 (23%), Positives = 58/155 (37%), Gaps = 41/155 (26%)
Query: 21 FCEGGELLD--RILSRGGRYLEEDAKTIVEKILNIVAFCHL-------------QGVVHR 65
+ + G+L R L + + L + H+ Q VHR
Sbjct: 98 YMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHR 157
Query: 66 DLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV------------APE 113
DL N L + +K+ DFG+S R D+ + YY PE
Sbjct: 158 DLATRNCLVG---ANLLVKIGDFGMS-------R--DVYSTDYYRVGGHTMLPIRWMPPE 205
Query: 114 VL-HRSYNVEGDMWSIGVITY-ILLCGSRPFWART 146
+ +R + E D+WS GVI + I G +P++ +
Sbjct: 206 SIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS 240
|
| >1bjf_A Neurocalcin delta; calcium-binding, myristoylation, neuronal specific guanylate cyclase activator; 2.40A {Bos taurus} SCOP: a.39.1.5 Length = 193 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 1e-04
Identities = 31/167 (18%), Positives = 59/167 (35%), Gaps = 31/167 (18%)
Query: 226 LKRAALKALSKA--LTEEELVYLRAQFMLLEPKDGCVSLNNFKVALMRQATDAMTDSRVF 283
L+ ++ L ++ TE E+ F+ P G +S+ FK
Sbjct: 8 LRPEVMQDLLESTDFTEHEIQEWYKGFLRDCP-SGHLSMEEFKKIYGNFFPYGDASKFAE 66
Query: 284 EILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELA 343
+ + D + + EF A + + + ++ AF ++ +GN IS E+
Sbjct: 67 HVFRTFDANGDGTIDFREFIIALSVTSRGKLEQK----LKWAFSMYDLDGNGYISKAEM- 121
Query: 344 LELNLAPAAYSLLNDCIR---------------------NSDGKLSF 369
L + A Y +++ ++ N DGKLS
Sbjct: 122 --LEIVQAIYKMVSSVMKMPEDESTPEKRTEKIFRQMDTNRDGKLSL 166
|
| >2ct9_A Calcium-binding protein P22; EF-hand, metal binding protein; 2.20A {Rattus norvegicus} PDB: 2e30_A Length = 208 | Back alignment and structure |
|---|
Score = 41.7 bits (98), Expect = 1e-04
Identities = 26/172 (15%), Positives = 63/172 (36%), Gaps = 31/172 (18%)
Query: 224 TPLKRAALKALSKA--LTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDS 280
T L+ L+ + K + ++ L ++F L+ ++G +S +F+ + +
Sbjct: 7 TLLRDEELEEIKKETGFSHSQITRLYSRFTSLDKGENGTLSREDFQ--RIPELAINPLGD 64
Query: 281 RVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAIT------------AFDY 328
R+ N + ++ + F +E E+ + AF
Sbjct: 65 RII---NAFFSEGEDQVNFRGFMRTLAHFRPIEDNEKSKDVNGPEPLNSRSNKLHFAFRL 121
Query: 329 FEQEGNRVISVEELA------LELNLAPAAYSLLNDCI-----RNSDGKLSF 369
++ + + IS +EL + +N++ + D ++ D +SF
Sbjct: 122 YDLDKDDKISRDELLQVLRMMVGVNISDEQLGSIADRTIQEADQDGDSAISF 173
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 31/150 (20%), Positives = 51/150 (34%), Gaps = 37/150 (24%)
Query: 21 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFC--------HL--QGVVHRDLKPE 70
G+L + S + ++ +L VHRDL
Sbjct: 109 LMTRGDLKSYLRSLRPAMANNPVLAPP-SLSKMIQMAGEIADGMAYLNANKFVHRDLAAR 167
Query: 71 NFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV------------APEVL-HR 117
N + ED +K+ DFG++ R DI + YY +PE L
Sbjct: 168 NCMVA---EDFTVKIGDFGMT---R------DIYETDYYRKGGKGLLPVRWMSPESLKDG 215
Query: 118 SYNVEGDMWSIGVITY-ILLCGSRPFWART 146
+ D+WS GV+ + I +P+ +
Sbjct: 216 VFTTYSDVWSFGVVLWEIATLAEQPYQGLS 245
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 38/138 (27%), Positives = 54/138 (39%), Gaps = 40/138 (28%)
Query: 21 FCEGGELLD--RILSRGGRYLEEDAKTIVEKIL---NIVAFC--------HL--QGVVHR 65
+ G L + R G D + E+ + ++V+ +L Q +HR
Sbjct: 122 YASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHR 181
Query: 66 DLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV------------APE 113
DL N L T E+ +K+ DFGL+ R DI YY APE
Sbjct: 182 DLAARNVLVT---ENNVMKIADFGLA---R------DINNIDYYKKTTNGRLPVKWMAPE 229
Query: 114 VL-HRSYNVEGDMWSIGV 130
L R Y + D+WS GV
Sbjct: 230 ALFDRVYTHQSDVWSFGV 247
|
| >2l2e_A Calcium-binding protein NCS-1; NCS1P, myristoylated, metal binding protein; HET: MYR; NMR {Schizosaccharomyces pombe} Length = 190 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 2e-04
Identities = 29/167 (17%), Positives = 64/167 (38%), Gaps = 31/167 (18%)
Query: 226 LKRAALKALSKA--LTEEELVYLRAQFMLLEPKDGCVSLNNFKVALMRQATDAMTDSRVF 283
L + L+ L ++ ++EL F P G ++ + F+ + +
Sbjct: 8 LSQDQLQDLVRSTRFDKKELQQWYKGFFKDCP-SGHLNKSEFQKIYKQFFPFGDPSAFAE 66
Query: 284 EILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELA 343
+ NV + + + ++EF A + + E ++ I AF ++ + N +IS +E+
Sbjct: 67 YVFNVFDADKNGYIDFKEFICALSVTSRGELNDK----LIWAFQLYDLDNNGLISYDEM- 121
Query: 344 LELNLAPAAYSLLNDCIR---------------------NSDGKLSF 369
L + A Y ++ ++ N DG+L+
Sbjct: 122 --LRIVDAIYKMVGSMVKLPEDEDTPEKRVNKIFNMMDKNKDGQLTL 166
|
| >3ox6_A Calcium-binding protein 1; EF-hand, calcium-sensor; 2.40A {Homo sapiens} PDB: 3ox5_A 2lan_A 2lap_A 2k7b_A 2k7c_A 2k7d_A Length = 153 | Back alignment and structure |
|---|
Score = 40.6 bits (96), Expect = 2e-04
Identities = 23/110 (20%), Positives = 42/110 (38%), Gaps = 3/110 (2%)
Query: 235 SKALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLS 293
++L EE+ LR F + KDG ++ + MR T+ + E+ +
Sbjct: 2 DRSLRPEEIEELREAFREFDKDKDGYINCRDLGNC-MRTMGYMPTEMELIELSQQINMNL 60
Query: 294 DQKLAYEEFCAAATSVYQLEALERWDQIAI-TAFDYFEQEGNRVISVEEL 342
+ +++F E + + AF F+ G+ IS EL
Sbjct: 61 GGHVDFDDFVELMGPKLLAETADMIGVKELRDAFREFDTNGDGEISTSEL 110
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 27/84 (32%), Positives = 37/84 (44%), Gaps = 25/84 (29%)
Query: 60 QGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV--------- 110
+ VHRDL N L T +K+ DFGL+ R DI+ + YV
Sbjct: 191 KSCVHRDLAARNVLVT---HGKVVKICDFGLA---R------DIMSDSNYVVRGNARLPV 238
Query: 111 ---APEVL-HRSYNVEGDMWSIGV 130
APE L Y ++ D+WS G+
Sbjct: 239 KWMAPESLFEGIYTIKSDVWSYGI 262
|
| >2ehb_A Calcineurin B-like protein 4; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} PDB: 1v1g_A 1v1f_A Length = 207 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 2e-04
Identities = 33/168 (19%), Positives = 58/168 (34%), Gaps = 32/168 (19%)
Query: 225 PLKRAALKALSKA--LTEEELVYLRAQFMLLEP---KDGCVSLNNFKVALMRQATDAMTD 279
P + L+ T EE+ L F L DG + F++AL R
Sbjct: 16 PPGYEDPELLASVTPFTVEEVEALYELFKKLSSSIIDDGLIHKEEFQLALFRNRNRRNLF 75
Query: 280 -SRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALE---RWDQIAITAFDYFEQEGNR 335
R+F++ +V + + + EF + + + ++ AF ++
Sbjct: 76 ADRIFDVFDVK---RNGVIEFGEFVRSLGVFHPSAPVHEKVKF------AFKLYDLRQTG 126
Query: 336 VISVEELAL---------ELNLAPAAYSLLNDCI-----RNSDGKLSF 369
I EEL EL L+ ++ D R +DGK+
Sbjct: 127 FIEREELKEMVVALLHESELVLSEDMIEVMVDKAFVQADRKNDGKIDI 174
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 38/138 (27%), Positives = 54/138 (39%), Gaps = 40/138 (28%)
Query: 21 FCEGGELLD--RILSRGGRYLEEDAKTIVEKIL---NIVAFC--------HL--QGVVHR 65
+ G L + R G D + E+ + ++V+ +L Q +HR
Sbjct: 168 YASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHR 227
Query: 66 DLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV------------APE 113
DL N L T E+ +K+ DFGL+ R DI YY APE
Sbjct: 228 DLAARNVLVT---ENNVMKIADFGLA-------R--DINNIDYYKKTTNGRLPVKWMAPE 275
Query: 114 VL-HRSYNVEGDMWSIGV 130
L R Y + D+WS GV
Sbjct: 276 ALFDRVYTHQSDVWSFGV 293
|
| >3sg6_A Gcamp2, myosin light chain kinase, green fluorescent PROT calmodulin chimera; calcium sensor, fluorescent protein; HET: CRO; 1.70A {Gallus gallus} PDB: 3evu_A* 3ek4_A* 3ek7_A* 3evv_A* 3ek8_A* 3ekh_A* 3sg2_A* 3sg3_A* 3sg7_A* 3ekj_A* 3sg4_A* 3sg5_A* 3evr_A* 3o78_A* 3o77_A* 1trf_A Length = 450 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 3e-04
Identities = 24/106 (22%), Positives = 50/106 (47%), Gaps = 5/106 (4%)
Query: 238 LTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQK 296
LTEE++ + F L + DG ++ MR T++ + +++N ++ +
Sbjct: 306 LTEEQIAEFKEAFSLFDKDGDGTITTKELGTV-MRSLGQNPTEAELQDMINEVDADGNGT 364
Query: 297 LAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEEL 342
+ + EF +++ + ++I AF F+++GN IS EL
Sbjct: 365 IDFPEFLTMMAR--KMKDTDSEEEI-REAFRVFDKDGNGYISAAEL 407
|
| >2jnf_A Troponin C; stretch activated muscle contraction, EF-hand, metal binding protein; NMR {Lethocerus indicus} PDB: 2k2a_A Length = 158 | Back alignment and structure |
|---|
Score = 40.2 bits (95), Expect = 3e-04
Identities = 19/108 (17%), Positives = 41/108 (37%), Gaps = 4/108 (3%)
Query: 238 LTEEELVYLRAQFMLL--EPKDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQ 295
L+ ++ L F G VS + + + T S + ++++ +P +
Sbjct: 7 LSSNQVKLLETAFRDFETPEGSGRVSTDQIGII-LEVLGIQQTKSTIRQLIDEFDPFGNG 65
Query: 296 KLAYEEFCAAATSVYQLEALERWDQIAI-TAFDYFEQEGNRVISVEEL 342
+ ++ F E Q + AF +++EGN IS + +
Sbjct: 66 DIDFDSFKIIGARFLGEEVNPEQMQQELREAFRLYDKEGNGYISTDVM 113
|
| >3dd4_A KV channel-interacting protein 4; EF-hands protein, ION transport, ionic channel, membrane, PO potassium channel, potassium transport, transport; 3.00A {Mus musculus} PDB: 2e6w_A Length = 229 | Back alignment and structure |
|---|
Score = 41.0 bits (96), Expect = 3e-04
Identities = 29/167 (17%), Positives = 60/167 (35%), Gaps = 31/167 (18%)
Query: 226 LKRAALKALSKA--LTEEELVYLRAQFMLLEPKDGCVSLNNFKVALMRQATDAMTDSRVF 283
+ AL+ L T++EL L F P G V+ FK + + +
Sbjct: 47 HRPEALELLEAQSKFTKKELQILYRGFKNECP-SGVVNEETFKEIYSQFFPQGDSTTYAH 105
Query: 284 EILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELA 343
+ N + + +++E+F + + + E+ AF+ ++ + I+ EE+
Sbjct: 106 FLFNAFDTDHNGAVSFEDFIKGLSILLRGTVQEK----LNWAFNLYDINKDGYITKEEM- 160
Query: 344 LELNLAPAAYSLLNDCIR---------------------NSDGKLSF 369
L++ A Y ++ C N DG ++
Sbjct: 161 --LDIMKAIYDMMGKCTYPVLKEDAPRQHVETFFQKMDKNKDGVVTI 205
|
| >2zfd_A Calcineurin B-like protein 2; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} SCOP: a.39.1.5 PDB: 1uhn_A Length = 226 | Back alignment and structure |
|---|
Score = 40.6 bits (95), Expect = 4e-04
Identities = 25/184 (13%), Positives = 57/184 (30%), Gaps = 30/184 (16%)
Query: 208 PLDILIYKLVKSYLRATPLKRAALKALSKA--LTEEELVYLRAQFMLLEP---KDGCVSL 262
L + L + L++ + E+ L F + DG ++
Sbjct: 10 HLCTSVLGCFDLDLYKQSGGLGDPELLARDTVFSVSEIEALYELFKKISSAVIDDGLINK 69
Query: 263 NNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALE---RWD 319
F++AL + + ++ + + L +EEF A + + ++ +
Sbjct: 70 EEFQLALFKTNKKE--SLFADRVFDLFDTKHNGILGFEEFARALSVFHPNAPIDDKIHF- 126
Query: 320 QIAITAFDYFEQEGNRVISVEELA---------LELNLAPAAYSLLNDCI-----RNSDG 365
+F ++ + I +E+ +NL + D DG
Sbjct: 127 -----SFQLYDLKQQGFIERQEVKQMVVATLAESGMNLKDTVIEDIIDKTFEEADTKHDG 181
Query: 366 KLSF 369
K+
Sbjct: 182 KIDK 185
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 4e-04
Identities = 27/84 (32%), Positives = 33/84 (39%), Gaps = 25/84 (29%)
Query: 60 QGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV--------- 110
+VHRDL N L E +K+ DFGLS R D+ YV
Sbjct: 169 MKLVHRDLAARNILVA---EGRKMKISDFGLS-------R--DVYEEDSYVKRSQGRIPV 216
Query: 111 ---APEVL-HRSYNVEGDMWSIGV 130
A E L Y + D+WS GV
Sbjct: 217 KWMAIESLFDHIYTTQSDVWSFGV 240
|
| >3akb_A Putative calcium binding protein; EF-hand, metal binding protein; 1.50A {Streptomyces coelicolor} PDB: 3aka_A Length = 166 | Back alignment and structure |
|---|
Score = 39.7 bits (93), Expect = 5e-04
Identities = 20/138 (14%), Positives = 43/138 (31%), Gaps = 27/138 (19%)
Query: 256 KDGCVSLNNFKVA---LMRQATDAMTDSRVFEILNVMEPL-----------SDQKLAYEE 301
+G + ++F A ++ + A R + E L DQ++ EE
Sbjct: 17 GNGHIDRSDFSGAAKAMLAEFGVAARSDRGQALYGGAEALWQGLAGIADRDGDQRITREE 76
Query: 302 FCAAATSVYQL--EALERWDQIAI-TAFDYFEQEGNRVISVEELAL---ELNLAPAAYSL 355
F A + + + + A + +G+ ++V + A +
Sbjct: 77 FVTGAVKRLRDKPDRFAEMARPFLHAALGVADTDGDGAVTVADTARALTAFGVPEDL--- 133
Query: 356 LNDCIR----NSDGKLSF 369
+ DGK+
Sbjct: 134 ARQAAAALDTDGDGKVGE 151
|
| >1jfj_A Ehcabp, calcium-binding protein; EF-hand, helix-loop-helix, metal binding protein; NMR {Entamoeba histolytica} SCOP: a.39.1.5 PDB: 1jfk_A 2nxq_A 3px1_A 3qjk_A 2jnx_A 2i18_A Length = 134 | Back alignment and structure |
|---|
Score = 39.0 bits (92), Expect = 5e-04
Identities = 12/87 (13%), Positives = 32/87 (36%), Gaps = 2/87 (2%)
Query: 256 KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEAL 315
DG VS K + + + + I ++ + ++ EF S+ +
Sbjct: 13 GDGAVSYEEVKAF-VSKKRAIKNEQLLQLIFKSIDADGNGEIDQNEFAKFYGSIQGQDLS 71
Query: 316 ERWDQIAITAFDYFEQEGNRVISVEEL 342
+ + + + +G+ ++ EE+
Sbjct: 72 DDKIGL-KVLYKLMDVDGDGKLTKEEV 97
|
| >2r2i_A Guanylyl cyclase-activating protein 1; EF hand, GCAP, guanylate cyclase activating protein, GCAP1, GCAP-1, calcium, lipoprotein, myristate; HET: MYR; 2.00A {Gallus gallus} Length = 198 | Back alignment and structure |
|---|
Score = 39.8 bits (93), Expect = 6e-04
Identities = 29/152 (19%), Positives = 53/152 (34%), Gaps = 19/152 (12%)
Query: 231 LKALSKALTEEELVYLRAQFMLLEPKDGCVSLNNFKVALMRQATDAMTDSRVFEILNVME 290
KA+ + L+ E +FM P G ++L FK + + V ++ +
Sbjct: 5 SKAVEE-LSATECHQWYKKFMTECP-SGQLTLYEFKQFFGLKNLSPSANKYVEQMFETFD 62
Query: 291 PLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALELNLAP 350
D + + E+ AA + V + + ++ F ++ +GN I EL +
Sbjct: 63 FNKDGYIDFMEYVAALSLVLKGKVDQKLRW----YFKLYDVDGNGCIDRGELLNIIKAIR 118
Query: 351 AAYSLLNDCI-------------RNSDGKLSF 369
A N DG+LS
Sbjct: 119 AINRCNEAMTAEEFTNMVFDKIDINGDGELSL 150
|
| >1w7j_B Myosin light chain 1; motor protein, unconventional myosin, myosin V, chicken, molecular motor, ATPase, ELC, IQ motif, muscle protein, ATP-binding; HET: ADP; 2A {Homo sapiens} SCOP: a.39.1.5 PDB: 1w7i_B* 1oe9_B* 3j04_C 1br1_B* 1br4_B* 1i84_T* 3dtp_C 2w4a_C 2w4g_C 2w4h_C Length = 151 | Back alignment and structure |
|---|
Score = 38.7 bits (91), Expect = 7e-04
Identities = 22/112 (19%), Positives = 47/112 (41%), Gaps = 13/112 (11%)
Query: 238 LTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAM----TDSRVFEILNV--ME 290
+++L + F L + DG + + MR A+ T++ V ++L +
Sbjct: 4 FNKDQLEEFKEAFELFDRVGDGKILYSQCGDV-MR----ALGQNPTNAEVLKVLGNPKSD 58
Query: 291 PLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEEL 342
L +++ +E F +V + ++ + F F++EGN + EL
Sbjct: 59 ELKSRRVDFETFLPMLQAVAKNRGQGTYEDY-LEGFRVFDKEGNGKVMGAEL 109
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 7e-04
Identities = 36/149 (24%), Positives = 51/149 (34%), Gaps = 39/149 (26%)
Query: 19 TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIV------AFCHLQGVVHRDLKPENF 72
+ G L D YL + + + +L A+ H Q +HRDL N
Sbjct: 114 MEYVPLGSLRD--------YLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNV 165
Query: 73 LFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV------------APEVL-HRSY 119
L + D +K+ DFGL+ V YY APE L +
Sbjct: 166 LL---DNDRLVKIGDFGLAKAVPEGHE--------YYRVREDGDSPVFWYAPECLKEYKF 214
Query: 120 NVEGDMWSIGVITY-ILLCGSRPFWARTE 147
D+WS GV Y +L T+
Sbjct: 215 YYASDVWSFGVTLYELLTHCDSSQSPPTK 243
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 389 | |||
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3pm8_A | 197 | PFCDPK2, calcium-dependent protein kinase 2; malar | 99.95 | |
| 3k21_A | 191 | PFCDPK3, calcium-dependent protein kinase 3; calci | 99.94 | |
| 2lhi_A | 176 | Calmodulin, serine/threonine-protein phosphatase c | 99.91 | |
| 2lmt_A | 148 | Calmodulin-related protein 97A; spermatogenesis, m | 99.91 | |
| 2obh_A | 143 | Centrin-2; DNA repair complex EF hand superfamily | 99.91 | |
| 3u0k_A | 440 | Rcamp; fluorescent protein, calcium binding, EF-ha | 99.91 | |
| 3mse_B | 180 | Calcium-dependent protein kinase, putative; CDPKS, | 99.9 | |
| 3khe_A | 191 | Calmodulin-like domain protein kinase isoform 3; c | 99.9 | |
| 3i5g_C | 159 | Myosin catalytic light chain LC-1, mantle muscle; | 99.89 | |
| 1exr_A | 148 | Calmodulin; high resolution, disorder, metal trans | 99.89 | |
| 2aao_A | 166 | CDPK, calcium-dependent protein kinase, isoform AK | 99.89 | |
| 3i5g_B | 153 | Myosin regulatory light chain LC-2, mantle muscle; | 99.88 | |
| 3qrx_A | 169 | Centrin; calcium-binding, EF-hand, cell division, | 99.88 | |
| 4ds7_A | 147 | Calmodulin, CAM; protein binding, metal binding, s | 99.87 | |
| 2f2o_A | 179 | Calmodulin fused with calmodulin-binding domain of | 99.87 | |
| 1top_A | 162 | Troponin C; contractIle system protein; 1.78A {Gal | 99.87 | |
| 3fwb_A | 161 | Cell division control protein 31; gene gating, com | 99.86 | |
| 1dtl_A | 161 | Cardiac troponin C; helix-turn-helix, structural p | 99.86 | |
| 3ox6_A | 153 | Calcium-binding protein 1; EF-hand, calcium-sensor | 99.86 | |
| 2bl0_C | 142 | Myosin regulatory light chain; muscle protein, sli | 99.86 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.86 | |
| 2jnf_A | 158 | Troponin C; stretch activated muscle contraction, | 99.85 | |
| 2ovk_C | 159 | Myosin catalytic light chain LC-1, mantle muscle, | 99.85 | |
| 2mys_B | 166 | Myosin; muscle protein, motor protein; HET: MLY; 2 | 99.84 | |
| 1s6i_A | 188 | CDPK, calcium-dependent protein kinase SK5; EF-han | 99.84 | |
| 3j04_B | 143 | Myosin regulatory light chain 2, smooth muscle MA | 99.84 | |
| 3sjs_A | 220 | URE3-BP sequence specific DNA binding protein; EF- | 99.84 | |
| 2mys_C | 149 | Myosin; muscle protein, motor protein; HET: MLY; 2 | 99.83 | |
| 1m45_A | 148 | MLC1P, myosin light chain; protein-peptide complex | 99.83 | |
| 2hpk_A | 208 | Photoprotein berovin; structural genomics, PSI, pr | 99.83 | |
| 1w7j_B | 151 | Myosin light chain 1; motor protein, unconventiona | 99.82 | |
| 1wdc_C | 156 | Scallop myosin; calcium binding protein, muscle pr | 99.82 | |
| 3e3r_A | 204 | Calcyphosin, calcyphosine; human calcyphosine, EF- | 99.82 | |
| 2ccm_A | 191 | Calexcitin; EF hand, calcium, signaling protein; 1 | 99.82 | |
| 1nya_A | 176 | Calerythrin; EF-hand, metal binding protein; NMR { | 99.82 | |
| 2sas_A | 185 | Sarcoplasmic calcium-binding protein; 2.40A {Branc | 99.82 | |
| 1wdc_B | 156 | Scallop myosin; calcium binding protein, muscle pr | 99.82 | |
| 1qv0_A | 195 | Obelin, OBL; photoprotein, bioluminescence, atomic | 99.82 | |
| 2bl0_B | 145 | Myosin regulatory light chain; muscle protein, sli | 99.82 | |
| 1q80_A | 174 | SCP, sarcoplasmic calcium-binding protein; all-alp | 99.82 | |
| 2lvv_A | 226 | Flagellar calcium-binding protein TB-24; EF-hand, | 99.81 | |
| 3ll8_B | 155 | Calcineurin subunit B type 1; protein-peptide dock | 99.81 | |
| 2ovk_B | 153 | RLC, myosin regulatory light chain LC-2, mantle mu | 99.81 | |
| 1s6c_A | 183 | KV4 potassium channel-interacting protein kchip1B; | 99.81 | |
| 1uhk_A | 191 | Aequorin 2, aequorin; EF-hand motif, complex, lumi | 99.81 | |
| 3sg6_A | 450 | Gcamp2, myosin light chain kinase, green fluoresce | 99.81 | |
| 2bec_A | 202 | Calcineurin B homologous protein 2; calcineurin-ho | 99.81 | |
| 3a8r_A | 179 | Putative uncharacterized protein; EF-hand, membran | 99.8 | |
| 3dd4_A | 229 | KV channel-interacting protein 4; EF-hands protein | 99.8 | |
| 3akb_A | 166 | Putative calcium binding protein; EF-hand, metal b | 99.8 | |
| 3dtp_E | 196 | RLC, myosin regulatory light chain; muscle protein | 99.8 | |
| 1jfj_A | 134 | Ehcabp, calcium-binding protein; EF-hand, helix-lo | 99.8 | |
| 2znd_A | 172 | Programmed cell death protein 6; penta-EF-hand pro | 99.79 | |
| 3cs1_A | 219 | Flagellar calcium-binding protein; myristoylated, | 99.79 | |
| 1s1e_A | 224 | KV channel interacting protein 1; kchip, calcium-b | 99.79 | |
| 1y1x_A | 191 | Leishmania major homolog of programmed cell death | 99.79 | |
| 2ehb_A | 207 | Calcineurin B-like protein 4; protein complex, Ca( | 99.78 | |
| 2zfd_A | 226 | Calcineurin B-like protein 2; calcium binding prot | 99.78 | |
| 2ct9_A | 208 | Calcium-binding protein P22; EF-hand, metal bindin | 99.78 | |
| 1g8i_A | 190 | Frequenin, neuronal calcium sensor 1; calcium bind | 99.78 | |
| 1ggw_A | 140 | Protein (CDC4P); light chain, cytokinesis, cell cy | 99.77 | |
| 1alv_A | 173 | Calpain, S-camld; calcium binding, calmodulin like | 99.77 | |
| 2i7a_A | 174 | Calpain 13; calcium-dependent cytoplasmic cysteine | 99.77 | |
| 1dgu_A | 183 | Calcium-saturated CIB; helical, EF-hands, blood cl | 99.77 | |
| 1fpw_A | 190 | Yeast frequenin, calcium-binding protein NCS-1; EF | 99.76 | |
| 2l2e_A | 190 | Calcium-binding protein NCS-1; NCS1P, myristoylate | 99.76 | |
| 1jba_A | 204 | GCAP-2, protein (guanylate cyclase activating prot | 99.76 | |
| 2qac_A | 146 | Myosin A tail domain interacting protein MTIP; mal | 99.76 | |
| 1ij5_A | 323 | Plasmodial specific LAV1-2 protein; fourty kDa cal | 99.76 | |
| 1bjf_A | 193 | Neurocalcin delta; calcium-binding, myristoylation | 99.75 | |
| 2l4h_A | 214 | Calcium and integrin-binding protein 1; metal bind | 99.75 | |
| 1gjy_A | 167 | Sorcin, CP-22, V19; calcium binding, calcium-bindi | 99.75 | |
| 1k94_A | 165 | Grancalcin; penta-EF-hand protein, calcium binding | 99.75 | |
| 2d8n_A | 207 | Recoverin; structural genomics, NPPSFA, national p | 99.74 | |
| 1juo_A | 198 | Sorcin; calcium-binding proteins, penta-EF-hand, P | 99.74 | |
| 2r2i_A | 198 | Guanylyl cyclase-activating protein 1; EF hand, GC | 99.74 | |
| 2ggz_A | 211 | Guanylyl cyclase-activating protein 3; EF hand, gu | 99.74 | |
| 2jul_A | 256 | Calsenilin; EF-hand, calcium, LXXLL, DNA binding p | 99.73 | |
| 2hps_A | 186 | Coelenterazine-binding protein with bound coelent; | 99.72 | |
| 2f33_A | 263 | Calbindin; EF-hand, Ca2+-binding, metal binding pr | 99.72 | |
| 2be4_A | 272 | Hypothetical protein LOC449832; DR.36843, BC083168 | 99.71 | |
| 2f33_A | 263 | Calbindin; EF-hand, Ca2+-binding, metal binding pr | 99.71 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.7 | |
| 1ij5_A | 323 | Plasmodial specific LAV1-2 protein; fourty kDa cal | 99.7 | |
| 3fs7_A | 109 | Parvalbumin, thymic; calcium-binding protein, EF-h | 99.66 | |
| 5pal_A | 109 | Parvalbumin; calcium-binding protein; 1.54A {Triak | 99.65 | |
| 2be4_A | 272 | Hypothetical protein LOC449832; DR.36843, BC083168 | 99.64 | |
| 3bow_A | 714 | Calpain-2 catalytic subunit; cysteine protease, in | 99.64 | |
| 1bu3_A | 109 | Calcium-binding protein; 1.65A {Merluccius bilinea | 99.64 | |
| 2pvb_A | 108 | Protein (parvalbumin); calcium binding protein, me | 99.64 | |
| 1rwy_A | 109 | Parvalbumin alpha; EF-hand, calcium-binding, calci | 99.63 | |
| 3h4s_E | 135 | KCBP interacting Ca2+-binding protein; kinesin, mo | 99.63 | |
| 1pva_A | 110 | Parvalbumin; calcium binding; 1.65A {Esox lucius} | 99.63 | |
| 1sjj_A | 863 | Actinin; 3-helix bundle, calponin homology domain, | 99.62 | |
| 1rro_A | 108 | RAT oncomodulin; calcium-binding protein; 1.30A {R | 99.62 | |
| 1djx_A | 624 | PLC-D1, phosphoinositide-specific phospholipase C, | 99.6 | |
| 1y1x_A | 191 | Leishmania major homolog of programmed cell death | 99.53 | |
| 2d8n_A | 207 | Recoverin; structural genomics, NPPSFA, national p | 99.51 | |
| 1qxp_A | 900 | MU-like calpain; M-calpain, MU-calpain, catalytic | 99.49 | |
| 2kyc_A | 108 | Parvalbumin-3, parvalbumin, thymic CPV3; EF-hand p | 99.49 | |
| 2znd_A | 172 | Programmed cell death protein 6; penta-EF-hand pro | 99.48 | |
| 1bjf_A | 193 | Neurocalcin delta; calcium-binding, myristoylation | 99.47 | |
| 1eg3_A | 261 | Dystrophin; EF-hand like domain, WW domain, struct | 99.46 | |
| 3a4u_B | 143 | Multiple coagulation factor deficiency protein 2; | 99.46 | |
| 2ggz_A | 211 | Guanylyl cyclase-activating protein 3; EF hand, gu | 99.45 | |
| 2zkm_X | 799 | 1-phosphatidylinositol-4,5-bisphosphate phosphodie | 99.45 | |
| 3sjs_A | 220 | URE3-BP sequence specific DNA binding protein; EF- | 99.44 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.43 | |
| 2l2e_A | 190 | Calcium-binding protein NCS-1; NCS1P, myristoylate | 99.43 | |
| 2i7a_A | 174 | Calpain 13; calcium-dependent cytoplasmic cysteine | 99.41 | |
| 2kld_A | 123 | Polycystin-2; PC2, PKD2, calcium binding domain, E | 99.41 | |
| 1qxp_A | 900 | MU-like calpain; M-calpain, MU-calpain, catalytic | 99.41 | |
| 2lv7_A | 100 | Calcium-binding protein 7; metal binding protein; | 99.4 | |
| 1alv_A | 173 | Calpain, S-camld; calcium binding, calmodulin like | 99.35 | |
| 1s6c_A | 183 | KV4 potassium channel-interacting protein kchip1B; | 99.34 | |
| 1s1e_A | 224 | KV channel interacting protein 1; kchip, calcium-b | 99.31 | |
| 1gjy_A | 167 | Sorcin, CP-22, V19; calcium binding, calcium-bindi | 99.3 | |
| 4drw_A | 121 | Protein S100-A10/annexin A2 chimeric protein; atyp | 99.29 | |
| 1fpw_A | 190 | Yeast frequenin, calcium-binding protein NCS-1; EF | 99.29 | |
| 3nso_A | 101 | Protein S100-A3; EF-hand, Ca2+, Zn2+ binding, meta | 99.29 | |
| 1k94_A | 165 | Grancalcin; penta-EF-hand protein, calcium binding | 99.29 | |
| 1jfj_A | 134 | Ehcabp, calcium-binding protein; EF-hand, helix-lo | 99.29 | |
| 2r2i_A | 198 | Guanylyl cyclase-activating protein 1; EF hand, GC | 99.29 | |
| 1g8i_A | 190 | Frequenin, neuronal calcium sensor 1; calcium bind | 99.28 | |
| 1juo_A | 198 | Sorcin; calcium-binding proteins, penta-EF-hand, P | 99.28 | |
| 3n22_A | 98 | Protein S100-A2; EF-hand, calcium-binding, zinc-bi | 99.27 | |
| 4eto_A | 93 | Protein S100-A4; calcium-binding protein, EF-hand, | 99.25 | |
| 2lv7_A | 100 | Calcium-binding protein 7; metal binding protein; | 99.25 | |
| 1fi6_A | 92 | EH domain protein REPS1; EPS15 homology domain, EF | 99.25 | |
| 3zwh_A | 104 | Protein S100-A4; Ca-binding protein-motor protein | 99.25 | |
| 1iq3_A | 110 | Ralbp1-interacting protein (partner of ralbp1); EF | 99.24 | |
| 2ehb_A | 207 | Calcineurin B-like protein 4; protein complex, Ca( | 99.24 | |
| 1c07_A | 95 | Protein (epidermal growth factor receptor pathway | 99.23 | |
| 2jjz_A | 150 | Ionized calcium-binding adapter molecule 2; EF-han | 99.23 | |
| 1jba_A | 204 | GCAP-2, protein (guanylate cyclase activating prot | 99.23 | |
| 1s6j_A | 87 | CDPK, calcium-dependent protein kinase SK5; EF-han | 99.22 | |
| 1qjt_A | 99 | EH1, epidermal growth factor receptor substrate su | 99.22 | |
| 3khe_A | 191 | Calmodulin-like domain protein kinase isoform 3; c | 99.21 | |
| 1wy9_A | 147 | Allograft inflammatory factor 1; EF-hand, calucium | 99.2 | |
| 4drw_A | 121 | Protein S100-A10/annexin A2 chimeric protein; atyp | 99.2 | |
| 2lnk_A | 113 | Protein S100-A4; EF-hand, calcium binding, all alp | 99.2 | |
| 3dd4_A | 229 | KV channel-interacting protein 4; EF-hands protein | 99.19 | |
| 3ohm_B | 885 | 1-phosphatidylinositol-4,5-bisphosphate phosphodi | 99.19 | |
| 2jjz_A | 150 | Ionized calcium-binding adapter molecule 2; EF-han | 99.19 | |
| 2opo_A | 86 | Polcalcin CHE A 3; calcium-binding protein, dimer, | 99.18 | |
| 1h8b_A | 75 | ACT-EF34, alpha-actinin 2, skeletal muscle isoform | 99.18 | |
| 3nxa_A | 100 | Protein S100-A16; S100 family, calcium binding pro | 99.17 | |
| 2jul_A | 256 | Calsenilin; EF-hand, calcium, LXXLL, DNA binding p | 99.17 | |
| 2joj_A | 77 | Centrin protein; N-terminal domain, centrin soluti | 99.17 | |
| 2h2k_A | 106 | Protein S100-A13; calcium binding protein, metal b | 99.16 | |
| 2kgr_A | 111 | Intersectin-1; structure, alternative splicing, ca | 99.15 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.15 | |
| 2y5i_A | 99 | S100Z, S100 calcium binding protein Z; metal-bindi | 99.15 | |
| 2bl0_C | 142 | Myosin regulatory light chain; muscle protein, sli | 99.15 | |
| 1tiz_A | 67 | Calmodulin-related protein, putative; helix-turn-h | 99.15 | |
| 2kz2_A | 94 | Calmodulin, CAM; TR2C, metal binding protein; NMR | 99.14 | |
| 2kax_A | 92 | Protein S100-A5; EF-hand, calcium binding protien, | 99.14 | |
| 2sas_A | 185 | Sarcoplasmic calcium-binding protein; 2.40A {Branc | 99.14 | |
| 1eh2_A | 106 | EPS15; calcium binding, signaling domain, NPF bind | 99.14 | |
| 2wcb_A | 95 | Protein S100-A12; calcium signalling, HOST-parasit | 99.14 | |
| 2jq6_A | 139 | EH domain-containing protein 1; metal binding prot | 99.14 | |
| 2ktg_A | 85 | Calmodulin, putative; ehcam, Ca-binding protein, p | 99.14 | |
| 1wlz_A | 105 | DJBP, CAP-binding protein complex interacting prot | 99.14 | |
| 2pmy_A | 91 | RAS and EF-hand domain-containing protein; rasef, | 99.14 | |
| 3li6_A | 66 | Calcium-binding protein; calcium signaling protein | 99.13 | |
| 1j55_A | 95 | S-100P protein; metal binding protein; 2.00A {Homo | 99.13 | |
| 2opo_A | 86 | Polcalcin CHE A 3; calcium-binding protein, dimer, | 99.12 | |
| 3e3r_A | 204 | Calcyphosin, calcyphosine; human calcyphosine, EF- | 99.11 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.11 | |
| 2b1u_A | 71 | Calmodulin-like protein 5; CLSP, calmodulin-like S | 99.11 | |
| 3a4u_B | 143 | Multiple coagulation factor deficiency protein 2; | 99.11 | |
| 1avs_A | 90 | Troponin C; muscle contraction, calcium-activated, | 99.11 | |
| 3mse_B | 180 | Calcium-dependent protein kinase, putative; CDPKS, | 99.11 | |
| 2obh_A | 143 | Centrin-2; DNA repair complex EF hand superfamily | 99.1 | |
| 3qrx_A | 169 | Centrin; calcium-binding, EF-hand, cell division, | 99.1 | |
| 1qx2_A | 76 | Vitamin D-dependent calcium-binding protein, INTE; | 99.1 | |
| 1nya_A | 176 | Calerythrin; EF-hand, metal binding protein; NMR { | 99.1 | |
| 2kn2_A | 92 | Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco | 99.1 | |
| 2kn2_A | 92 | Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco | 99.09 | |
| 2aao_A | 166 | CDPK, calcium-dependent protein kinase, isoform AK | 99.09 | |
| 3bow_A | 714 | Calpain-2 catalytic subunit; cysteine protease, in | 99.09 | |
| 4ds7_A | 147 | Calmodulin, CAM; protein binding, metal binding, s | 99.09 | |
| 1k9u_A | 78 | Polcalcin PHL P 7; pollen allergen, calcium-bindin | 99.09 | |
| 3ll8_B | 155 | Calcineurin subunit B type 1; protein-peptide dock | 99.08 | |
| 1c7v_A | 81 | CAVP, calcium vector protein; EF-hand family, calc | 99.08 | |
| 3pm8_A | 197 | PFCDPK2, calcium-dependent protein kinase 2; malar | 99.08 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.08 | |
| 3fwb_A | 161 | Cell division control protein 31; gene gating, com | 99.07 | |
| 3rm1_A | 92 | Protein S100-B; alpha-helical, EF hand, metal bind | 99.07 | |
| 3fs7_A | 109 | Parvalbumin, thymic; calcium-binding protein, EF-h | 99.07 | |
| 2jnf_A | 158 | Troponin C; stretch activated muscle contraction, | 99.06 | |
| 1exr_A | 148 | Calmodulin; high resolution, disorder, metal trans | 99.06 | |
| 2ccm_A | 191 | Calexcitin; EF hand, calcium, signaling protein; 1 | 99.06 | |
| 1avs_A | 90 | Troponin C; muscle contraction, calcium-activated, | 99.06 | |
| 2zfd_A | 226 | Calcineurin B-like protein 2; calcium binding prot | 99.06 | |
| 3h4s_E | 135 | KCBP interacting Ca2+-binding protein; kinesin, mo | 99.05 | |
| 1psr_A | 100 | Psoriasin, S100A7; EF-hand protein, MAD phasing, p | 99.05 | |
| 1s6i_A | 188 | CDPK, calcium-dependent protein kinase SK5; EF-han | 99.04 | |
| 1fi6_A | 92 | EH domain protein REPS1; EPS15 homology domain, EF | 99.04 | |
| 5pal_A | 109 | Parvalbumin; calcium-binding protein; 1.54A {Triak | 99.04 | |
| 1xk4_C | 113 | Calgranulin B; S100 family, heterotetramer, metal | 99.04 | |
| 2d58_A | 107 | Allograft inflammatory factor 1; EF-hand, metal bi | 99.03 | |
| 1eh2_A | 106 | EPS15; calcium binding, signaling domain, NPF bind | 99.03 | |
| 1xk4_A | 93 | Calgranulin A; S100 family, heterotetramer, metal | 99.03 | |
| 2joj_A | 77 | Centrin protein; N-terminal domain, centrin soluti | 99.03 | |
| 3qr0_A | 816 | Phospholipase C-beta (PLC-beta); PH domain, EF han | 99.02 | |
| 3akb_A | 166 | Putative calcium binding protein; EF-hand, metal b | 99.01 | |
| 1xk4_C | 113 | Calgranulin B; S100 family, heterotetramer, metal | 99.01 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.01 | |
| 1dtl_A | 161 | Cardiac troponin C; helix-turn-helix, structural p | 99.01 | |
| 2ktg_A | 85 | Calmodulin, putative; ehcam, Ca-binding protein, p | 99.01 | |
| 2pvb_A | 108 | Protein (parvalbumin); calcium binding protein, me | 99.0 | |
| 1bu3_A | 109 | Calcium-binding protein; 1.65A {Merluccius bilinea | 99.0 | |
| 1a4p_A | 96 | S100A10; S100 family, EF-hand protein, ligand of a | 99.0 | |
| 3ox6_A | 153 | Calcium-binding protein 1; EF-hand, calcium-sensor | 99.0 | |
| 1k8u_A | 90 | S100A6, calcyclin, CACY; calcium regulatory protei | 99.0 | |
| 1k9u_A | 78 | Polcalcin PHL P 7; pollen allergen, calcium-bindin | 99.0 | |
| 3k21_A | 191 | PFCDPK3, calcium-dependent protein kinase 3; calci | 98.99 | |
| 3nso_A | 101 | Protein S100-A3; EF-hand, Ca2+, Zn2+ binding, meta | 98.99 | |
| 3nxa_A | 100 | Protein S100-A16; S100 family, calcium binding pro | 98.99 | |
| 1yx7_A | 83 | Calsensin, LAN3-6 antigen; calcium-binding protein | 98.99 | |
| 3u0k_A | 440 | Rcamp; fluorescent protein, calcium binding, EF-ha | 98.99 | |
| 1rwy_A | 109 | Parvalbumin alpha; EF-hand, calcium-binding, calci | 98.98 | |
| 2pmy_A | 91 | RAS and EF-hand domain-containing protein; rasef, | 98.98 | |
| 3n22_A | 98 | Protein S100-A2; EF-hand, calcium-binding, zinc-bi | 98.98 | |
| 2f2o_A | 179 | Calmodulin fused with calmodulin-binding domain of | 98.98 | |
| 2lmt_A | 148 | Calmodulin-related protein 97A; spermatogenesis, m | 98.97 | |
| 2lhi_A | 176 | Calmodulin, serine/threonine-protein phosphatase c | 98.97 | |
| 1cb1_A | 78 | Calbindin D9K; calcium-binding protein; NMR {Sus s | 98.97 | |
| 1rro_A | 108 | RAT oncomodulin; calcium-binding protein; 1.30A {R | 98.97 | |
| 2l4h_A | 214 | Calcium and integrin-binding protein 1; metal bind | 98.96 | |
| 4eto_A | 93 | Protein S100-A4; calcium-binding protein, EF-hand, | 98.96 | |
| 1k2h_A | 93 | S100A1, S-100 protein, alpha chain; non-covalent h | 98.96 | |
| 2lnk_A | 113 | Protein S100-A4; EF-hand, calcium binding, all alp | 98.96 | |
| 1pva_A | 110 | Parvalbumin; calcium binding; 1.65A {Esox lucius} | 98.96 | |
| 1c07_A | 95 | Protein (epidermal growth factor receptor pathway | 98.95 | |
| 3zwh_A | 104 | Protein S100-A4; Ca-binding protein-motor protein | 98.95 | |
| 1top_A | 162 | Troponin C; contractIle system protein; 1.78A {Gal | 98.95 | |
| 1dgu_A | 183 | Calcium-saturated CIB; helical, EF-hands, blood cl | 98.95 | |
| 2h2k_A | 106 | Protein S100-A13; calcium binding protein, metal b | 98.95 | |
| 2bec_A | 202 | Calcineurin B homologous protein 2; calcineurin-ho | 98.94 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 98.94 | |
| 1m45_A | 148 | MLC1P, myosin light chain; protein-peptide complex | 98.94 | |
| 3rm1_A | 92 | Protein S100-B; alpha-helical, EF hand, metal bind | 98.94 | |
| 2bl0_B | 145 | Myosin regulatory light chain; muscle protein, sli | 98.93 | |
| 1j7q_A | 86 | CAVP, calcium vector protein; EF-hand family, calc | 98.92 | |
| 1qls_A | 99 | S100C protein, calgizzarin; metal-binding protein/ | 98.92 | |
| 2kgr_A | 111 | Intersectin-1; structure, alternative splicing, ca | 98.91 | |
| 1j55_A | 95 | S-100P protein; metal binding protein; 2.00A {Homo | 98.91 |
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-69 Score=532.05 Aligned_cols=376 Identities=31% Similarity=0.555 Sum_probs=331.1
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|.||||++++ ....+|+|||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 93 l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~ 171 (494)
T 3lij_A 93 LDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLES 171 (494)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESC
T ss_pred CCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeC
Confidence 5899999999 357899999999999999988776 67999999999999999999999999999999999999975
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCccccccccccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLR 156 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 156 (389)
.+.++.+||+|||++............+||+.|+|||++.+.|+.++||||+||++|+|++|.+||.+.+..+....+..
T Consensus 172 ~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 251 (494)
T 3lij_A 172 KEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEK 251 (494)
T ss_dssp SSTTCCEEECCCTTCEECBTTBCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCCCCcEEEEECCCCeECCCCccccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 45567799999999988776666667889999999999988899999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCC------CCCCCccHHHHHHHHHHhhcChhHHHH
Q 016471 157 ADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE------NRPVPLDILIYKLVKSYLRATPLKRAA 230 (389)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~------~~~~~~~~~~~~~~~~~~~~~~l~~~~ 230 (389)
....++.+.|+.+|+.+++||.+||..+|.+|||+.++++||||+.. ....+........++.+.....+++++
T Consensus 252 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~qa~ 331 (494)
T 3lij_A 252 GKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQKLAQAA 331 (494)
T ss_dssp TCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHHHHHHC---CCCCSSHHHHHHTTTTCCHHHHHH
T ss_pred CCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCcccccccccccccHHHHHHHHHHHHhHHHHHHH
Confidence 88888877888999999999999999999999999999999999753 122233334567788888899999999
Q ss_pred HHHHHHhc-CHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccc-------cCCHHHHHHHHhhcCCCCCcceeHHH
Q 016471 231 LKALSKAL-TEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATD-------AMTDSRVFEILNVMEPLSDQKLAYEE 301 (389)
Q Consensus 231 l~~i~~~l-~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~-------~~~~~~~~~~~~~~d~~~~g~i~~~e 301 (389)
+..+...+ ++++...+++.|..+|. ++|.|+.+||..++..++.. ..+..++.++|+.+|.|++|.|+|+|
T Consensus 332 l~~ia~~~~~~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~~G~I~~~E 411 (494)
T 3lij_A 332 LLYMASKLTSQEETKELTDIFRHIDKNGDGQLDRQELIDGYSKLSGEEVAVFDLPQIESEVDAILGAADFDRNGYIDYSE 411 (494)
T ss_dssp HHHHHHHSCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHTTHHHHSSCCCCC--CHHHHHHHHHHHHHCTTCSSSEEHHH
T ss_pred HHHHHHhcccHHHHHHHHHHHHHhCcCCCCeEcHHHHHHHHHHhcccccccccccccHHHHHHHHHHhCCCCCCcCcHHH
Confidence 99998777 89999999999999999 99999999999999988642 23478899999999999999999999
Q ss_pred HHHHHhchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHhCC---chH-HHHHHHHHccCCCCceeHHHHHHHHc
Q 016471 302 FCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALELNL---APA-AYSLLNDCIRNSDGKLSFLGYKRFLH 377 (389)
Q Consensus 302 F~~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~---~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~ 377 (389)
|+.++........ ++.++.+|+.||+|+||+|+.+||+.+++. ..+ ++++++++|.|+||.|+|+||+.+|+
T Consensus 412 F~~~~~~~~~~~~----~~~~~~~F~~~D~d~~G~Is~~El~~~l~~~~~~~~~~~~~~~~~D~d~dG~I~~~EF~~~~~ 487 (494)
T 3lij_A 412 FVTVAMDRKSLLS----KDKLESAFQKFDQDGNGKISVDELASVFGLDHLESKTWKEMISGIDSNNDGDVDFEEFCKMIQ 487 (494)
T ss_dssp HHHHHSCHHHHTC----HHHHHHHHHHHCTTCSSEECHHHHHHHC-CCSCCCHHHHHHHHTTCSSSSSSEEHHHHHHHHH
T ss_pred HHHHHHhhhcccc----HHHHHHHHHHHCCCCCCcCCHHHHHHHHHhcCCCHHHHHHHHHHhCCCCCCcCCHHHHHHHHH
Confidence 9998776543332 456899999999999999999999999953 333 99999999999999999999999998
Q ss_pred cccC
Q 016471 378 GVTV 381 (389)
Q Consensus 378 ~~~~ 381 (389)
+...
T Consensus 488 ~~~~ 491 (494)
T 3lij_A 488 KLCS 491 (494)
T ss_dssp HHSS
T ss_pred hhcc
Confidence 7654
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-68 Score=528.40 Aligned_cols=375 Identities=30% Similarity=0.501 Sum_probs=328.3
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|.||||++++ ....+|+|||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 103 l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~ 181 (504)
T 3q5i_A 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLEN 181 (504)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESS
T ss_pred CCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEec
Confidence 5799999999 357899999999999999988776 67999999999999999999999999999999999999964
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCccccccccccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLR 156 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 156 (389)
.+....+||+|||++............+||+.|+|||++.+.++.++||||+||++|+|++|.+||.+.+..+....+..
T Consensus 182 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 261 (504)
T 3q5i_A 182 KNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEK 261 (504)
T ss_dssp TTCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence 33334799999999988776666677889999999999988899999999999999999999999999999999999998
Q ss_pred cCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCCCCCC-----ccHHHHHHHHHHhhcChhHHHHH
Q 016471 157 ADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVP-----LDILIYKLVKSYLRATPLKRAAL 231 (389)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~~~l 231 (389)
+...++...|+.+|+.+++||.+||..||.+|||++++++||||+....... ........++++.....++++++
T Consensus 262 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~~a~l 341 (504)
T 3q5i_A 262 GKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNMRKFEGSQKLAQAAI 341 (504)
T ss_dssp CCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCCCCGGGHHHHHHHHHHHHHCCCCSHHHHHHH
T ss_pred CCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhcccccchhhHHHHHHHHHHHHHHHHHHHHHH
Confidence 8777776667789999999999999999999999999999999987644322 12234556777888888999999
Q ss_pred HHHHHhc-CHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhcc-------ccCCHHHHHHHHhhcCCCCCcceeHHHH
Q 016471 232 KALSKAL-TEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQAT-------DAMTDSRVFEILNVMEPLSDQKLAYEEF 302 (389)
Q Consensus 232 ~~i~~~l-~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~-------~~~~~~~~~~~~~~~d~~~~g~i~~~eF 302 (389)
..+...+ ++++...+++.|..+|. ++|.|+.+||..++..++. ...+..++.++|..+|.|++|.|+|+||
T Consensus 342 ~~i~~~~~~~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~I~~~EF 421 (504)
T 3q5i_A 342 LFIGSKLTTLEERKELTDIFKKLDKNGDGQLDKKELIEGYNVLRNFKNELGELKNVEEEVDNILKEVDFDKNGYIEYSEF 421 (504)
T ss_dssp HHHHHHTSCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHHHC--CCSCCCHHHHHHHHHHHHCTTCSSSEEHHHH
T ss_pred HHhhccCCcHHHHHHHHHHHHeeCCCCCCeEcHHHHHHHHHHhhhcccccccccccHHHHHHHHHHhCCCCCCcEeHHHH
Confidence 8888766 89999999999999999 9999999999999988732 1356789999999999999999999999
Q ss_pred HHHHhchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHhC---CchH-HHHHHHHHccCCCCceeHHHHHHHHcc
Q 016471 303 CAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALELN---LAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHG 378 (389)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~---~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~ 378 (389)
+.++........ ++.++.+|+.||+|+||+|+.+||+.+++ ...+ ++++++++|.|+||.|+|+||+.+|++
T Consensus 422 ~~~~~~~~~~~~----~~~~~~~F~~~D~d~dG~Is~~El~~~l~~~~~~~~~~~~~~~~~D~d~dG~I~~~EF~~~~~~ 497 (504)
T 3q5i_A 422 ISVCMDKQILFS----EERLRRAFNLFDTDKSGKITKEELANLFGLTSISEKTWNDVLGEADQNKDNMIDFDEFVSMMHK 497 (504)
T ss_dssp HHHHSCHHHHTC----HHHHHHHHHHHCTTCCSEECHHHHHHHTTCSCCCHHHHHHHHHTTCSSCSSSEEHHHHHHHHHH
T ss_pred HHHHHhhhcccC----HHHHHHHHHHhcCCCCCcCcHHHHHHHHhhCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHH
Confidence 998776533322 45789999999999999999999999984 3334 999999999999999999999999987
Q ss_pred cc
Q 016471 379 VT 380 (389)
Q Consensus 379 ~~ 380 (389)
..
T Consensus 498 ~~ 499 (504)
T 3q5i_A 498 IC 499 (504)
T ss_dssp HC
T ss_pred hc
Confidence 64
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-68 Score=527.70 Aligned_cols=374 Identities=31% Similarity=0.532 Sum_probs=325.4
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|.||||++++ ....+|+|||||.||+|.+++..+ +.+++..++.++.||+.||.|||++||+||||||+|||+..
T Consensus 83 l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~ 161 (484)
T 3nyv_A 83 LDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR-KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLES 161 (484)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTC-SCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESS
T ss_pred CCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEec
Confidence 5899999999 357899999999999999988765 68999999999999999999999999999999999999965
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCccccccccccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLR 156 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 156 (389)
.+.++.+||+|||++............+||+.|+|||++.+.++.++||||+||++|+|++|.+||.+.+..+....+.+
T Consensus 162 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 241 (484)
T 3nyv_A 162 KSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK 241 (484)
T ss_dssp SSTTCCEEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCCCCcEEEEeeeeeEEcccccccccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc
Confidence 45678899999999988776666667789999999999988899999999999999999999999999999999999998
Q ss_pred cCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCCC-----CCCccHHHHHHHHHHhhcChhHHHHH
Q 016471 157 ADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENR-----PVPLDILIYKLVKSYLRATPLKRAAL 231 (389)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~l~~~~l 231 (389)
....++.+.|+.+|+.+++||.+||..+|.+|||+.++++||||+.... ..+........++.+.....++++++
T Consensus 242 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~qa~l 321 (484)
T 3nyv_A 242 GKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQKLAQAAL 321 (484)
T ss_dssp CCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC-----CCCBCHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccccccccccccchHHHHHHHHHHhhhhHHHHHHH
Confidence 8877777777889999999999999999999999999999999975432 33444555667778888888899988
Q ss_pred HHHHHhc-CHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHh----ccccCC-------HHHHHHHHhhcCCCCCccee
Q 016471 232 KALSKAL-TEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQ----ATDAMT-------DSRVFEILNVMEPLSDQKLA 298 (389)
Q Consensus 232 ~~i~~~l-~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~----~~~~~~-------~~~~~~~~~~~d~~~~g~i~ 298 (389)
..+...+ ++++...++..|..+|. ++|.|+.+||..++... |.. ++ +.++.++|+.+|.|++|.|+
T Consensus 322 ~~i~~~~~~~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~g~~-~~~~~~~~~~~~~~~~~~~~D~d~~g~i~ 400 (484)
T 3nyv_A 322 LYMGSKLTSQDETKELTAIFHKMDKNGDGQLDRAELIEGYKELMRMKGQD-ASMLDASAVEHEVDQVLDAVDFDKNGYIE 400 (484)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHC----C-GGGCSHHHHHHHHHHHHHHHTCCTTSEEE
T ss_pred HHHHhccCcHHHHHHHHHHHHHhCcCCCceEeHHHHHHHHHHHhhhcccc-cccccccccHHHHHHHHHHhCCCCCCeEe
Confidence 8888665 78889999999999999 99999999996555443 432 34 68899999999999999999
Q ss_pred HHHHHHHHhchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHhC---CchH-HHHHHHHHccCCCCceeHHHHHH
Q 016471 299 YEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALELN---LAPA-AYSLLNDCIRNSDGKLSFLGYKR 374 (389)
Q Consensus 299 ~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~---~~~~-~~~~~~~~d~~~~g~i~~~ef~~ 374 (389)
|+||+.++........ ++.++.+|+.||+|+||+|+.+||+.+++ ...+ ++++|+++|.|+||.|+|+||+.
T Consensus 401 ~~Ef~~~~~~~~~~~~----~~~~~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~~~~~~~D~d~dG~i~~~Ef~~ 476 (484)
T 3nyv_A 401 YSEFVTVAMDRKTLLS----RERLERAFRMFDSDNSGKISSTELATIFGVSDVDSETWKSVLSEVDKNNDGEVDFDEFQQ 476 (484)
T ss_dssp HHHHHHHHHHHHHHHH----HHHHHHHHHHHCTTCCSEEEHHHHHHHHHHTTCCHHHHHHHHHHHCTTCCSEEEHHHHHH
T ss_pred HHHHHHHHHhccccCc----HHHHHHHHHHHCCCCCCcCCHHHHHHHHHhcCCCHHHHHHHHHHhcCCCCCcCCHHHHHH
Confidence 9999987665533222 46799999999999999999999999994 3444 99999999999999999999999
Q ss_pred HHcccc
Q 016471 375 FLHGVT 380 (389)
Q Consensus 375 ~~~~~~ 380 (389)
+|.+..
T Consensus 477 ~~~~~~ 482 (484)
T 3nyv_A 477 MLLKLC 482 (484)
T ss_dssp HHHHTT
T ss_pred HHHhhh
Confidence 998753
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-68 Score=523.59 Aligned_cols=375 Identities=31% Similarity=0.554 Sum_probs=313.0
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|.||||++++ ....+|+|||||.||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+..
T Consensus 78 l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~ 156 (486)
T 3mwu_A 78 LDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLES 156 (486)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESS
T ss_pred CCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEec
Confidence 5899999999 357899999999999999988776 68999999999999999999999999999999999999975
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCccccccccccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLR 156 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 156 (389)
.+.++.+||+|||++............+||+.|+|||++.+.|+.++||||+||++|+|++|.+||.+.+..+....+..
T Consensus 157 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 236 (486)
T 3mwu_A 157 KEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET 236 (486)
T ss_dssp SSTTCCEEECSCSCTTTBCCC----CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCCCCCEEEEECCcCeECCCCCccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 55667899999999987766666667789999999999988899999999999999999999999999999999999998
Q ss_pred cCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCCCCCC------ccHHHHHHHHHHhhcChhHHHH
Q 016471 157 ADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVP------LDILIYKLVKSYLRATPLKRAA 230 (389)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~~~ 230 (389)
....++.+.|+.+|+++++||.+||..+|.+|||+.++++||||+......+ ........++.+.....+++++
T Consensus 237 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (486)
T 3mwu_A 237 GKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIRQFQAEKKLAQAA 316 (486)
T ss_dssp TCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCCCCCCGGGHHHHHHHHHHHHHHHHSCHHHHHH
T ss_pred CCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcccCccccccccHHHHHHHHHHHHHHHHHHHHH
Confidence 8877777777889999999999999999999999999999999987644332 1123445677788888999999
Q ss_pred HHHHHHhc-CHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHh----cccc---------CCHHHHHHHHhhcCCCCCc
Q 016471 231 LKALSKAL-TEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQ----ATDA---------MTDSRVFEILNVMEPLSDQ 295 (389)
Q Consensus 231 l~~i~~~l-~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~----~~~~---------~~~~~~~~~~~~~d~~~~g 295 (389)
+..+...+ +.++...++..|..+|. ++|.|+.+||..++... |... ...+++.++|..+|.|++|
T Consensus 317 l~~ia~~l~~~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG 396 (486)
T 3mwu_A 317 LLYMASKLTTLDETKQLTEIFRKLDTNNDGMLDRDELVRGYHEFMRLKGVDSNSLIQNEGSTIEDQIDSLMPLLDMDGSG 396 (486)
T ss_dssp HHHHHHHHCCHHHHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHHHHHTCCGGGHHHHTSSCHHHHHHHHHHHHCTTCCS
T ss_pred HHHHHHHhccHHHHHHHHHHHHHhCCCCCceeeHHHHHHHHHHhhhhhcccchhcccccchhhHHHHHHHHHHhcCCCCC
Confidence 99888766 88999999999999999 99999999997666544 3321 2277899999999999999
Q ss_pred ceeHHHHHHHHhchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHhCC-----chH-HHHHHHHHccCCCCceeH
Q 016471 296 KLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALELNL-----APA-AYSLLNDCIRNSDGKLSF 369 (389)
Q Consensus 296 ~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~-----~~~-~~~~~~~~d~~~~g~i~~ 369 (389)
.|+|+||+.++........ ++.++.+|+.||+|+||+|+.+||+.++.. ... ++++++++|.|+||.|+|
T Consensus 397 ~I~~~Ef~~~~~~~~~~~~----~~~~~~~F~~~D~d~dG~Is~~El~~~l~~~g~~~~~~~~~~~~~~~D~d~dG~I~~ 472 (486)
T 3mwu_A 397 SIEYSEFIASAIDRTILLS----RERMERAFKMFDKDGSGKISTKELFKLFSQADSSIQMEELESIIEQVDNNKDGEVDF 472 (486)
T ss_dssp SBCHHHHHHHHSCTTTTCC----HHHHHHHHHHHCSSCSSSBCSSCC--------------------CCCCSSCSSSBCH
T ss_pred cCcHHHHHHHHHhhhccch----HHHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCcEeH
Confidence 9999999987765543332 356899999999999999999999999932 222 899999999999999999
Q ss_pred HHHHHHHcccc
Q 016471 370 LGYKRFLHGVT 380 (389)
Q Consensus 370 ~ef~~~~~~~~ 380 (389)
+||+.+|++..
T Consensus 473 ~EF~~~~~~~~ 483 (486)
T 3mwu_A 473 NEFVEMLQNFV 483 (486)
T ss_dssp HHHHHHHHHHC
T ss_pred HHHHHHHHHhh
Confidence 99999998653
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-53 Score=391.03 Aligned_cols=197 Identities=32% Similarity=0.613 Sum_probs=178.0
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|+||||+++| +++.+|||||||+||+|.+++.+. +.++|.+++.++.||+.||+|||++||+||||||+|||+
T Consensus 89 l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~~-~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl-- 165 (311)
T 4aw0_A 89 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL-- 165 (311)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--
T ss_pred CCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEE--
Confidence 6899999999 468899999999999999998776 789999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCC---CCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPD---QRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFR 152 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 152 (389)
+.++.+||+|||+|+..... ....+.+||+.|||||++. ..|+.++||||+||++|+|++|++||.+.+..+++.
T Consensus 166 -~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~ 244 (311)
T 4aw0_A 166 -NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFA 244 (311)
T ss_dssp -CTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred -cCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 57889999999999876533 2355779999999999986 469999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHH------HhCCCCCCCCCC
Q 016471 153 SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQ------ALTHPWLHDENR 205 (389)
Q Consensus 153 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e------~l~h~~~~~~~~ 205 (389)
+|.+....++ ..+|+++++||.+||++||.+|||++| +++||||++.++
T Consensus 245 ~i~~~~~~~p----~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw 299 (311)
T 4aw0_A 245 KIIKLEYDFP----EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTW 299 (311)
T ss_dssp HHHHTCCCCC----TTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCC
T ss_pred HHHcCCCCCC----cccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCH
Confidence 9998876654 358999999999999999999999988 589999987654
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-53 Score=392.16 Aligned_cols=200 Identities=30% Similarity=0.573 Sum_probs=177.3
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|+||||+++| ..+.+|||||||+||+|.+++.+ +++++.+++.++.||+.||+|||++||+||||||+|||+
T Consensus 128 l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl-- 203 (346)
T 4fih_A 128 YQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL-- 203 (346)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--
T ss_pred CCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEE--
Confidence 6899999999 46889999999999999997754 479999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCC-CCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPD-QRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
+.++.+||+|||+|+..... ....+.+||+.|||||++. ..|+.++||||+||++|||++|++||.+.+..+.+..+
T Consensus 204 -~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i 282 (346)
T 4fih_A 204 -THDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 282 (346)
T ss_dssp -CTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred -CCCCCEEEecCcCceecCCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH
Confidence 57889999999999876543 3456789999999999986 46999999999999999999999999999998888888
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRP 206 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~~~ 206 (389)
....+. ....++.+|+++++||.+||.+||.+|||++|+|+||||+....+
T Consensus 283 ~~~~~~-~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~~p 333 (346)
T 4fih_A 283 RDNLPP-RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP 333 (346)
T ss_dssp HHSSCC-CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred HcCCCC-CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCCCC
Confidence 765432 223346799999999999999999999999999999999876544
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=383.20 Aligned_cols=196 Identities=19% Similarity=0.369 Sum_probs=167.3
Q ss_pred CCCccccceee--------cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCCC
Q 016471 1 MYHQKLQHLFY--------SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQG--VVHRDLKPE 70 (389)
Q Consensus 1 l~Hpni~~~~~--------~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--i~Hrdlkp~ 70 (389)
|+||||+++|+ ...+|||||||+||+|.+++.+. +.+++..++.++.||+.||+|||++| |+||||||+
T Consensus 82 l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~ 160 (290)
T 3fpq_A 82 LQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCD 160 (290)
T ss_dssp CCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGG
T ss_pred CCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChh
Confidence 68999999993 24589999999999999998766 68999999999999999999999999 999999999
Q ss_pred cEEEeecCCCCCEEEeecCCccccCCCCCcccccccCCccccccccccCCCchhHHHHHHHHHHHHhCCCCCCCCChh-H
Q 016471 71 NFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWARTES-G 149 (389)
Q Consensus 71 Nill~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~ 149 (389)
|||++ +.++.+||+|||+|+... .....+.+||+.|||||++.+.|+.++||||+||++|+|++|++||.+.... .
T Consensus 161 NILl~--~~~g~vKl~DFGla~~~~-~~~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~ 237 (290)
T 3fpq_A 161 NIFIT--GPTGSVKIGDLGLATLKR-ASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ 237 (290)
T ss_dssp GEEES--STTSCEEECCTTGGGGCC-TTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH
T ss_pred heeEE--CCCCCEEEEeCcCCEeCC-CCccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH
Confidence 99995 346899999999997643 3345677999999999999888999999999999999999999999875544 4
Q ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCC
Q 016471 150 IFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 202 (389)
Q Consensus 150 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~ 202 (389)
+...+..... +....+.+++++++||.+||.+||.+|||++++|+||||++
T Consensus 238 ~~~~i~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 238 IYRRVTSGVK--PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHTTTCC--CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHHcCCC--CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 4455544322 22222457899999999999999999999999999999975
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-53 Score=380.38 Aligned_cols=194 Identities=31% Similarity=0.631 Sum_probs=163.6
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|+||||++++ +.+.+|+||||| +|+|.+++.++ +++++.+++.++.||+.||+|||++||+||||||+|||+
T Consensus 70 l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl-- 145 (275)
T 3hyh_A 70 LRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQR-DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLL-- 145 (275)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHHHS-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE--
T ss_pred CCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEE--
Confidence 6899999999 468899999999 67999988766 789999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc-cC-CCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SY-NVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
+.++.+||+|||+|+.........+.+||+.|+|||++.+ .| +.++||||+||++|+|++|++||.+.+...++..+
T Consensus 146 -~~~~~vkl~DFGla~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i 224 (275)
T 3hyh_A 146 -DEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNI 224 (275)
T ss_dssp -CTTCCEEECCSSCC---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred -CCCCCEEEeecCCCeecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 5778999999999988766666677899999999999864 44 68999999999999999999999999998999998
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~ 203 (389)
.+....++ ..+|+++++||.+||++||.+|||++|+++||||+..
T Consensus 225 ~~~~~~~p----~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~~ 269 (275)
T 3hyh_A 225 SNGVYTLP----KFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKVD 269 (275)
T ss_dssp HHTCCCCC----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHTT
T ss_pred HcCCCCCC----CCCCHHHHHHHHHHccCChhHCcCHHHHHcCcccccC
Confidence 88766544 3589999999999999999999999999999999653
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-52 Score=384.22 Aligned_cols=196 Identities=28% Similarity=0.524 Sum_probs=175.1
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|+||||++++ +++.+|||||||+||+|.+++.+. +.+++.+++.++.||+.||+|||++||+||||||+|||+
T Consensus 83 l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl-- 159 (304)
T 3ubd_A 83 VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL-- 159 (304)
T ss_dssp CCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE--
T ss_pred CCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEE--
Confidence 6899999999 468899999999999999998776 689999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCC-CCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRP-DQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
+.++.+||+|||+|+.... .....+.+||+.|||||++. ..|+.++||||+||++|+|++|++||.+.+..+++..+
T Consensus 160 -~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i 238 (304)
T 3ubd_A 160 -DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI 238 (304)
T ss_dssp -CTTSCEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred -cCCCCEEecccccceeccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHH
Confidence 5788999999999986543 33456789999999999985 57999999999999999999999999999999999999
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCC-----HHHHhCCCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMT-----AAQALTHPWLHDEN 204 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s-----~~e~l~h~~~~~~~ 204 (389)
.+....++ +.+|+++++||.+||++||.+||| ++|+++||||++.+
T Consensus 239 ~~~~~~~p----~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~id 289 (304)
T 3ubd_A 239 LKAKLGMP----QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTID 289 (304)
T ss_dssp HHCCCCCC----TTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCC
T ss_pred HcCCCCCC----CcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCC
Confidence 88766544 458999999999999999999998 47999999998753
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=392.87 Aligned_cols=200 Identities=30% Similarity=0.573 Sum_probs=177.4
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|+||||+++| ..+.+|||||||+||+|.+++.. +++++.+++.++.||+.||+|||++||+||||||+|||+
T Consensus 205 l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl-- 280 (423)
T 4fie_A 205 YQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL-- 280 (423)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEE--
T ss_pred CCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE--
Confidence 6899999999 46889999999999999997754 479999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCC-CCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPD-QRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
+.++.+||+|||+|...... ....+.+||+.|||||++. ..|+.++||||+||++|+|++|++||.+.+..+.+..+
T Consensus 281 -~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i 359 (423)
T 4fie_A 281 -THDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 359 (423)
T ss_dssp -CTTCCEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred -cCCCCEEEecCccceECCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH
Confidence 57889999999999876543 3456789999999999986 46999999999999999999999999999998888888
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRP 206 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~~~ 206 (389)
....+. ....+..+|+++++||.+||.+||.+|||++|+|+||||+....+
T Consensus 360 ~~~~~~-~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~~p 410 (423)
T 4fie_A 360 RDNLPP-RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP 410 (423)
T ss_dssp HHSCCC-CCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred HcCCCC-CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCCCC
Confidence 765432 233456799999999999999999999999999999999876543
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-52 Score=388.27 Aligned_cols=197 Identities=21% Similarity=0.434 Sum_probs=175.1
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEe
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 75 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~ 75 (389)
|+||||+++| +.+.+|||||||+||+|.+++..++ ..+++..++.|+.||+.||+|||++||+||||||+|||+
T Consensus 80 l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl- 158 (350)
T 4b9d_A 80 MKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL- 158 (350)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEE-
T ss_pred CCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE-
Confidence 6899999999 4688999999999999999997553 457999999999999999999999999999999999999
Q ss_pred ecCCCCCEEEeecCCccccCCCC-CcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016471 76 TREEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRS 153 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 153 (389)
+.++.+||+|||+|+...... ...+.+||+.|||||++.+ .|+.++||||+||++|+|++|++||.+.+..+++..
T Consensus 159 --~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~ 236 (350)
T 4b9d_A 159 --TKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLK 236 (350)
T ss_dssp --CTTCCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred --CCCCCEEEcccccceeecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH
Confidence 577899999999998765432 2345689999999999864 699999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCC
Q 016471 154 VLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 154 i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~ 203 (389)
+.+.... +.+..+|+++++||.+||.+||.+|||++|+|+||||+..
T Consensus 237 i~~~~~~---~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 237 IISGSFP---PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp HHHTCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred HHcCCCC---CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence 9887543 2235689999999999999999999999999999999754
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=381.90 Aligned_cols=202 Identities=23% Similarity=0.373 Sum_probs=173.0
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|+||||+++| +.+.+|||||||+||+|.+++.+. +.+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 107 l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~- 184 (336)
T 4g3f_A 107 LSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLS- 184 (336)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEC-
T ss_pred CCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEe-
Confidence 6899999999 467899999999999999988766 6899999999999999999999999999999999999994
Q ss_pred cCCCC-CEEEeecCCccccCCCC------CcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChh
Q 016471 77 REEDA-PLKVIDFGLSDFVRPDQ------RLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTES 148 (389)
Q Consensus 77 ~~~~~-~~kl~Dfg~a~~~~~~~------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 148 (389)
.++ .+||+|||+|+...... .....+||+.|||||++.+ .|+.++||||+||++|+|++|++||.+.+..
T Consensus 185 --~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~ 262 (336)
T 4g3f_A 185 --SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG 262 (336)
T ss_dssp --TTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCS
T ss_pred --CCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH
Confidence 455 69999999998765432 1234689999999999864 6999999999999999999999999998888
Q ss_pred HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHH-------------hCCCCCCCCCCCC
Q 016471 149 GIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQA-------------LTHPWLHDENRPV 207 (389)
Q Consensus 149 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~-------------l~h~~~~~~~~~~ 207 (389)
.+...+....+... ..++.+|+.+++||.+||.+||.+|||+.|+ ++|||+.....|.
T Consensus 263 ~~~~~i~~~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~Pr 333 (336)
T 4g3f_A 263 PLCLKIASEPPPIR-EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEPR 333 (336)
T ss_dssp CCHHHHHHSCCGGG-GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCCC
T ss_pred HHHHHHHcCCCCch-hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCCC
Confidence 88888887654332 2236799999999999999999999999997 6899998765443
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-49 Score=391.49 Aligned_cols=205 Identities=38% Similarity=0.655 Sum_probs=188.1
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|+||||++++ ....+|||||||+||+|++++..+.+.+++.+++.++.||+.||+|||++||+||||||+|||++.
T Consensus 211 l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~ 290 (573)
T 3uto_A 211 LRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT 290 (573)
T ss_dssp TCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS
T ss_pred CCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccC
Confidence 6899999999 468899999999999999999776678999999999999999999999999999999999999963
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVL 155 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 155 (389)
+..+.+||+|||+|+.........+.+||+.|+|||++.+ .|+.++||||+||++|+|++|.+||.+.+..+.+..|.
T Consensus 291 -~~~~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~ 369 (573)
T 3uto_A 291 -KRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK 369 (573)
T ss_dssp -SSCCCEEECCCSSCEECCTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH
T ss_pred -CCCCCEEEeeccceeEccCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH
Confidence 2357899999999998877777778899999999999864 69999999999999999999999999999999999999
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCCCC
Q 016471 156 RADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRP 206 (389)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~~~ 206 (389)
+....++...++.+|+++++||.+||.+||.+|||++|+|+||||+....+
T Consensus 370 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~ 420 (573)
T 3uto_A 370 SCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 420 (573)
T ss_dssp TTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCT
T ss_pred hCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCC
Confidence 988888777788899999999999999999999999999999999876543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=370.73 Aligned_cols=198 Identities=25% Similarity=0.387 Sum_probs=169.6
Q ss_pred CCCccccceee----------cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCC
Q 016471 1 MYHQKLQHLFY----------SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPE 70 (389)
Q Consensus 1 l~Hpni~~~~~----------~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~ 70 (389)
|+||||+++++ .+++|||||||. |+|.+++.++ +.+++.+++.++.||+.||+|||++||+||||||+
T Consensus 110 l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~~~-~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~ 187 (398)
T 4b99_A 110 FKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQIIHSS-QPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPS 187 (398)
T ss_dssp CCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHHHHHTSS-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGG
T ss_pred cCCCCcceEeeeeecccccccCCEEEEEEeCCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCcc
Confidence 68999999983 257999999996 5799887654 78999999999999999999999999999999999
Q ss_pred cEEEeecCCCCCEEEeecCCccccCC-----CCCcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCC
Q 016471 71 NFLFTTREEDAPLKVIDFGLSDFVRP-----DQRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFW 143 (389)
Q Consensus 71 Nill~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~ 143 (389)
|||+ +.++.+||+|||+|+.... .....+.+||+.|+|||++.+ .|+.++||||+|||+|+|++|++||.
T Consensus 188 NIl~---~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~ 264 (398)
T 4b99_A 188 NLLV---NENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFP 264 (398)
T ss_dssp GEEE---CTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSC
T ss_pred cccc---CCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCC
Confidence 9999 5788999999999986533 223456799999999998754 57999999999999999999999999
Q ss_pred CCChhHHHHHHHhcCCCCCCC---------------------------CCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 144 ARTESGIFRSVLRADPNFHDS---------------------------PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 144 ~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
+.+..+.+..|......++.. .++.+|+++++||.+||.+||.+|||++|+|+
T Consensus 265 g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 265 GKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp CSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 999988888877543332211 12457999999999999999999999999999
Q ss_pred CCCCCCC
Q 016471 197 HPWLHDE 203 (389)
Q Consensus 197 h~~~~~~ 203 (389)
||||+..
T Consensus 345 Hp~f~~~ 351 (398)
T 4b99_A 345 HPFLAKY 351 (398)
T ss_dssp SGGGTTT
T ss_pred CHhhCcC
Confidence 9999865
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=357.28 Aligned_cols=193 Identities=20% Similarity=0.376 Sum_probs=159.9
Q ss_pred CCCcccccee---ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 1 MYHQKLQHLF---YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 1 l~Hpni~~~~---~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
|+||||+.++ .++.+|||||||+||+|.+++....+++++.++..|+.||+.||+|||++||+||||||+|||+
T Consensus 89 l~HpNIV~l~g~~~~~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl--- 165 (307)
T 3omv_A 89 TRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFL--- 165 (307)
T ss_dssp CCCTTBCCEEEEECSSSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEE---
T ss_pred CCCCCEeeEEEEEECCeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEE---
Confidence 6899999999 3577999999999999999998777889999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCCccccCCC---CCcccccccCCcccccccc----ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHH
Q 016471 78 EEDAPLKVIDFGLSDFVRPD---QRLNDIVGSAYYVAPEVLH----RSYNVEGDMWSIGVITYILLCGSRPFWARTESGI 150 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 150 (389)
+.++.+||+|||+|+..... ......+||+.|||||++. +.|+.++|||||||++|||+||+.||.+.+....
T Consensus 166 ~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~ 245 (307)
T 3omv_A 166 HEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ 245 (307)
T ss_dssp ETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH
T ss_pred CCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH
Confidence 46789999999999865432 2345678999999999984 2489999999999999999999999988766655
Q ss_pred HHHHHhcCCCCC--CCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 151 FRSVLRADPNFH--DSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 151 ~~~i~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
...+.......+ ...++.+++.+.+|+.+||..||.+|||+.++++
T Consensus 246 ~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~ 293 (307)
T 3omv_A 246 IIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILS 293 (307)
T ss_dssp HHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred HHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 554444332222 2234578999999999999999999999998754
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=365.56 Aligned_cols=196 Identities=27% Similarity=0.466 Sum_probs=158.6
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
.||||++++ ..+++|+|||||+||+|.+++ +.+++.+++.++.||+.||+|||++||+||||||+|||++
T Consensus 78 ~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~----~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~-- 151 (361)
T 4f9c_A 78 GQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDIL----NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYN-- 151 (361)
T ss_dssp SBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHH----TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--
T ss_pred CCCCCceEEEEEEECCEEEEEEeCCCcccHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEe--
Confidence 699999988 468999999999999999987 4699999999999999999999999999999999999996
Q ss_pred CCCCCEEEeecCCccccCCC-----------------------------CCcccccccCCccccccccc--cCCCchhHH
Q 016471 78 EEDAPLKVIDFGLSDFVRPD-----------------------------QRLNDIVGSAYYVAPEVLHR--SYNVEGDMW 126 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~~-----------------------------~~~~~~~gt~~y~aPE~~~~--~~~~~~Diw 126 (389)
.+.+.+||+|||+|+..... ....+.+||+.|+|||++.+ .|+.++|||
T Consensus 152 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiW 231 (361)
T 4f9c_A 152 RRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMW 231 (361)
T ss_dssp TTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHH
T ss_pred CCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchh
Confidence 34478999999999754321 12334689999999998854 489999999
Q ss_pred HHHHHHHHHHhCCCCCCCCC-hhHHHHHHHhcC--------------------------------------C--------
Q 016471 127 SIGVITYILLCGSRPFWART-ESGIFRSVLRAD--------------------------------------P-------- 159 (389)
Q Consensus 127 slG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~--------------------------------------~-------- 159 (389)
|+|||+|+|++|+.||.+.+ ..+.+..|.... .
T Consensus 232 SlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~ 311 (361)
T 4f9c_A 232 SAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSD 311 (361)
T ss_dssp HHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC------------
T ss_pred hhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccc
Confidence 99999999999999996543 334343332200 0
Q ss_pred ----CCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCC
Q 016471 160 ----NFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 160 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~ 203 (389)
......|+.+|+++++||++||++||.+|||++|+|+||||++.
T Consensus 312 ~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 312 IQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp ----------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred cccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 01112356789999999999999999999999999999999864
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=380.40 Aligned_cols=194 Identities=27% Similarity=0.434 Sum_probs=170.2
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ +.+.+|||||||+||+|.+++.+. +.+++..++.|+.||+.||+|||++|||||||||+|||+
T Consensus 249 ~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~~-~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILl-- 325 (689)
T 3v5w_A 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL-- 325 (689)
T ss_dssp SCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE--
T ss_pred CCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEE--
Confidence 4799999998 468899999999999999998766 789999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc-c-cCCCchhHHHHHHHHHHHHhCCCCCCCCC---hhHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-R-SYNVEGDMWSIGVITYILLCGSRPFWART---ESGIF 151 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~-~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~ 151 (389)
+.++.+||+|||+|+..... ...+.+||+.|||||++. + .|+.++||||+||++|+|++|.+||.+.+ ..++.
T Consensus 326 -d~~G~vKL~DFGlA~~~~~~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~ 403 (689)
T 3v5w_A 326 -DEHGHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 403 (689)
T ss_dssp -CTTSCEEECCCTTCEECSSC-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHH
T ss_pred -eCCCCEEecccceeeecCCC-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 57899999999999876543 345679999999999985 3 69999999999999999999999997643 33455
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCC-----HHHHhCCCCCCCC
Q 016471 152 RSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMT-----AAQALTHPWLHDE 203 (389)
Q Consensus 152 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s-----~~e~l~h~~~~~~ 203 (389)
..+......++ ..+|+++++||.+||.+||.+|++ ++++++||||++.
T Consensus 404 ~~i~~~~~~~p----~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~i 456 (689)
T 3v5w_A 404 RMTLTMAVELP----DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 456 (689)
T ss_dssp HHHHHCCCCCC----TTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTC
T ss_pred HhhcCCCCCCC----ccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCC
Confidence 56666554443 468999999999999999999998 7999999999864
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-47 Score=346.16 Aligned_cols=189 Identities=18% Similarity=0.350 Sum_probs=164.8
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEe
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG------------GRYLEEDAKTIVEKILNIVAFCHLQGVVH 64 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~------------~~l~~~~~~~i~~qi~~~L~~lH~~~i~H 64 (389)
|+||||+++| ..+.+|||||||+||+|.+++.+++ ..+++.++..++.||+.||+|||+++|+|
T Consensus 72 l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiH 151 (299)
T 4asz_A 72 LQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVH 151 (299)
T ss_dssp CCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred CCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 6899999999 3578999999999999999997542 46999999999999999999999999999
Q ss_pred cCCCCCcEEEeecCCCCCEEEeecCCccccCCCCC---cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CC
Q 016471 65 RDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GS 139 (389)
Q Consensus 65 rdlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~ 139 (389)
|||||+|||+ +.++.+||+|||+|+....... .....||+.|||||++. +.|+.++|||||||++|||+| |+
T Consensus 152 RDlKp~NILl---~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~ 228 (299)
T 4asz_A 152 RDLATRNCLV---GENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGK 228 (299)
T ss_dssp SCCSGGGEEE---CGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred CccCHhhEEE---CCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCC
Confidence 9999999999 5678999999999986543322 23356999999999985 579999999999999999998 99
Q ss_pred CCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHh
Q 016471 140 RPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQAL 195 (389)
Q Consensus 140 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l 195 (389)
.||.+.+..++...+.++..... .+.+|+++.+|+.+||+.||.+|||++++.
T Consensus 229 ~Pf~~~~~~~~~~~i~~~~~~~~---p~~~~~~~~~li~~cl~~dP~~RPs~~~i~ 281 (299)
T 4asz_A 229 QPWYQLSNNEVIECITQGRVLQR---PRTCPQEVYELMLGCWQREPHMRKNIKGIH 281 (299)
T ss_dssp CTTTTSCHHHHHHHHHHTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCCCCHHHHHHHHHcCCCCCC---CccchHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 99999999998888887653211 246899999999999999999999999984
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=348.68 Aligned_cols=196 Identities=28% Similarity=0.446 Sum_probs=148.8
Q ss_pred CCCccccceeec----------------CeEEEEEEccCCCChHHHHHhcCCC---CCHHHHHHHHHHHHHHHHHHHHCC
Q 016471 1 MYHQKLQHLFYS----------------NSFLFFTRFCEGGELLDRILSRGGR---YLEEDAKTIVEKILNIVAFCHLQG 61 (389)
Q Consensus 1 l~Hpni~~~~~~----------------~~~~lv~E~~~gg~L~~~l~~~~~~---l~~~~~~~i~~qi~~~L~~lH~~~ 61 (389)
|+||||+++|+. .++|+|||||+||+|.+++..+ +. .++..++.++.||+.||+|||++|
T Consensus 60 l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~al~ylH~~~ 138 (299)
T 4g31_A 60 LEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGR-CTIEERERSVCLHIFLQIAEAVEFLHSKG 138 (299)
T ss_dssp CCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTC-CSGGGSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhc-CCCChhHHHHHHHHHHHHHHHHHHHHHCc
Confidence 689999999931 1379999999999999988755 33 345668899999999999999999
Q ss_pred CEecCCCCCcEEEeecCCCCCEEEeecCCccccCCCC-------------CcccccccCCccccccccc-cCCCchhHHH
Q 016471 62 VVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ-------------RLNDIVGSAYYVAPEVLHR-SYNVEGDMWS 127 (389)
Q Consensus 62 i~Hrdlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~-------------~~~~~~gt~~y~aPE~~~~-~~~~~~Diws 127 (389)
|+||||||+|||+ +.++.+||+|||+|+...... ...+.+||+.|||||++.+ .|+.++||||
T Consensus 139 IiHRDlKp~NILl---~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwS 215 (299)
T 4g31_A 139 LMHRDLKPSNIFF---TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFS 215 (299)
T ss_dssp CCCCCCCGGGEEE---CTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHH
T ss_pred CccccCcHHHeEE---CCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHH
Confidence 9999999999999 567899999999998764322 1234689999999999864 6999999999
Q ss_pred HHHHHHHHHhCCCCCCCCChh-HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCCCC
Q 016471 128 IGVITYILLCGSRPFWARTES-GIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRP 206 (389)
Q Consensus 128 lG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~~~ 206 (389)
+||++|||++ ||.+.... ..+..+.... ++ +.++..++.+.+||.+||++||.+|||+.++++||||++.+.+
T Consensus 216 lGvilyell~---Pf~~~~~~~~~~~~~~~~~--~p-~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~p 289 (299)
T 4g31_A 216 LGLILFELLY---PFSTQMERVRTLTDVRNLK--FP-PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFP 289 (299)
T ss_dssp HHHHHHHHHS---CCSSHHHHHHHHHHHHTTC--CC-HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC---
T ss_pred HHHHHHHHcc---CCCCccHHHHHHHHHhcCC--CC-CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCCC
Confidence 9999999996 88653322 2233333221 21 1223467888999999999999999999999999999876543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=343.23 Aligned_cols=191 Identities=18% Similarity=0.307 Sum_probs=165.6
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG---------------GRYLEEDAKTIVEKILNIVAFCHLQG 61 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~~lH~~~ 61 (389)
|+||||++++ ..+.+|||||||+||+|.+++..+. +.+++.++..++.||+.||+|||+++
T Consensus 86 l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~ 165 (308)
T 4gt4_A 86 LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH 165 (308)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 6899999999 3577999999999999999996532 45899999999999999999999999
Q ss_pred CEecCCCCCcEEEeecCCCCCEEEeecCCccccCCCC---CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh
Q 016471 62 VVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ---RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC 137 (389)
Q Consensus 62 i~Hrdlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~ 137 (389)
|+||||||+|||+ ++++.+||+|||+|+...... .....+||+.|||||++. +.|+.++|||||||++|||+|
T Consensus 166 iiHRDLK~~NILl---~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t 242 (308)
T 4gt4_A 166 VVHKDLATRNVLV---YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242 (308)
T ss_dssp CCCSCCSGGGEEE---CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred CCCCCccccceEE---CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHh
Confidence 9999999999999 577899999999998654322 234568999999999885 579999999999999999998
Q ss_pred -CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCC
Q 016471 138 -GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 197 (389)
Q Consensus 138 -g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h 197 (389)
|..||.+.+..++...+..+... + ..+.+++.+.+|+.+||..||.+|||+.+++++
T Consensus 243 ~g~~Pf~~~~~~~~~~~i~~~~~~-~--~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 243 YGLQPYCGYSNQDVVEMIRNRQVL-P--CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp TTCCTTTTCCHHHHHHHHHTTCCC-C--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHcCCCC-C--CcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 89999999998888888765432 2 124689999999999999999999999999764
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=346.45 Aligned_cols=190 Identities=19% Similarity=0.349 Sum_probs=158.3
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG--------------GRYLEEDAKTIVEKILNIVAFCHLQGV 62 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~--------------~~l~~~~~~~i~~qi~~~L~~lH~~~i 62 (389)
|+||||++++ ..+.+|||||||+||+|.+++.+.. +.+++.++..|+.||+.||.|||+++|
T Consensus 100 l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~i 179 (329)
T 4aoj_A 100 LQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHF 179 (329)
T ss_dssp CCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred CCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCe
Confidence 6899999999 3578999999999999999986532 469999999999999999999999999
Q ss_pred EecCCCCCcEEEeecCCCCCEEEeecCCccccCCCC---CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-
Q 016471 63 VHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ---RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC- 137 (389)
Q Consensus 63 ~Hrdlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~- 137 (389)
+||||||+|||+ +.++.+||+|||+|+...... .....+||+.|||||++. +.|+.++|||||||++|||+|
T Consensus 180 iHRDLKp~NILl---~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~ 256 (329)
T 4aoj_A 180 VHRDLATRNCLV---GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTY 256 (329)
T ss_dssp CCSCCCGGGEEE---ETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTT
T ss_pred ecccccHhhEEE---CCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcC
Confidence 999999999999 467899999999998664332 223467999999999986 479999999999999999999
Q ss_pred CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 138 GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 138 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
|+.||.+.+..+....+.++... + ..+.+++++.+|+.+||..||.+|||+++++.
T Consensus 257 G~~Pf~~~~~~~~~~~i~~g~~~-~--~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 312 (329)
T 4aoj_A 257 GKQPWYQLSNTEAIDCITQGREL-E--RPRACPPEVYAIMRGCWQREPQQRHSIKDVHA 312 (329)
T ss_dssp SCCTTCSSCHHHHHHHHHHTCCC-C--CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHcCCCC-C--CcccccHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 99999999988888888775422 1 12468999999999999999999999999875
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=345.36 Aligned_cols=191 Identities=23% Similarity=0.376 Sum_probs=159.3
Q ss_pred CCccccceee-----cCeEEEEEEccCCCChHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 016471 2 YHQKLQHLFY-----SNSFLFFTRFCEGGELLDRILSR---------------GGRYLEEDAKTIVEKILNIVAFCHLQG 61 (389)
Q Consensus 2 ~Hpni~~~~~-----~~~~~lv~E~~~gg~L~~~l~~~---------------~~~l~~~~~~~i~~qi~~~L~~lH~~~ 61 (389)
+||||++++. ++.+|||||||+||+|.+++.+. ...+++.++..++.||+.||+|||+++
T Consensus 126 hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~ 205 (353)
T 4ase_A 126 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK 205 (353)
T ss_dssp CCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC
Confidence 5699999982 24689999999999999999753 235899999999999999999999999
Q ss_pred CEecCCCCCcEEEeecCCCCCEEEeecCCccccCCCC---CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh
Q 016471 62 VVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ---RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC 137 (389)
Q Consensus 62 i~Hrdlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~ 137 (389)
|+||||||+|||+ +.++.+||+|||+|+...... .....+||+.|||||++. +.|+.++|||||||++|||+|
T Consensus 206 iiHRDLK~~NILl---~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t 282 (353)
T 4ase_A 206 CIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282 (353)
T ss_dssp CCCSCCSGGGEEE---CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTT
T ss_pred eecCccCccceee---CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHh
Confidence 9999999999999 567899999999998764433 234567999999999885 579999999999999999998
Q ss_pred -CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCC
Q 016471 138 -GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 197 (389)
Q Consensus 138 -g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h 197 (389)
|..||.+.+..+.+..+......++.+ +.+++++.+++.+||..||.+|||+.++++|
T Consensus 283 ~G~~Pf~~~~~~~~~~~~i~~g~~~~~p--~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 283 LGASPYPGVKIDEEFCRRLKEGTRMRAP--DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp TSCCSSTTCCCSHHHHHHHHHTCCCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCCCCC--ccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 999998876544444443333222222 4589999999999999999999999999875
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=341.10 Aligned_cols=231 Identities=32% Similarity=0.628 Sum_probs=194.8
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|.||||++++ ..+.+|+|||||.||+|.+++..+ +.+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 85 l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~ 163 (362)
T 2bdw_A 85 LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLAS 163 (362)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTC-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESC
T ss_pred CCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEec
Confidence 6899999998 357899999999999999988655 67999999999999999999999999999999999999975
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVL 155 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 155 (389)
.+.++.+||+|||++............+||+.|+|||++.+ .++.++||||+||++|+|++|.+||.+.+.......+.
T Consensus 164 ~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~ 243 (362)
T 2bdw_A 164 KAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK 243 (362)
T ss_dssp SSTTCCEEECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCCCCCEEEeecCcceEecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 44556799999999988766555566789999999999864 69999999999999999999999999999989999998
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC--CCCCccHHHHHHHHHHhhcChhHHHHHH
Q 016471 156 RADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN--RPVPLDILIYKLVKSYLRATPLKRAALK 232 (389)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~l~ 232 (389)
.....++...|+.+++.+++||.+||..||.+|||+.++++||||.... ............++.+.....++.+.+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 322 (362)
T 2bdw_A 244 AGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCLKKFNARRKLKGAILT 322 (362)
T ss_dssp HTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTHHHHSCCCCCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred hCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCCcccccccchhhHHHHHHHHHHHHHHHHHHHH
Confidence 8887777777788999999999999999999999999999999997532 1111223344555555555555555443
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=352.75 Aligned_cols=202 Identities=37% Similarity=0.723 Sum_probs=183.5
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|.||||++++ ..+.+|+|||||.||+|.+++..+ +.+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 67 l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~ 145 (444)
T 3soa_A 67 LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLAS 145 (444)
T ss_dssp CCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESB
T ss_pred CCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEec
Confidence 5899999999 457899999999999999988776 67999999999999999999999999999999999999975
Q ss_pred cCCCCCEEEeecCCccccCCCC-CcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
...++.+||+|||++....... .....+||+.|+|||++.+ .++.++||||+||++|+|++|.+||.+.+.......+
T Consensus 146 ~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i 225 (444)
T 3soa_A 146 KLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQI 225 (444)
T ss_dssp SSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cCCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 4467889999999997765433 3456789999999999864 6999999999999999999999999999999999999
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~ 203 (389)
..+...++.+.|+.+++.+++||.+||..||.+|||+.++++||||+..
T Consensus 226 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 226 KAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp HHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred HhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence 9988888888888999999999999999999999999999999999643
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=338.12 Aligned_cols=202 Identities=35% Similarity=0.647 Sum_probs=179.9
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|.||||++++ ....+|+|||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||++..
T Consensus 72 l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~ 150 (361)
T 2yab_A 72 VLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLD 150 (361)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTC-SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESC
T ss_pred CCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeC
Confidence 5799999998 357899999999999999988654 68999999999999999999999999999999999999953
Q ss_pred cCC-CCCEEEeecCCccccCCCCCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 REE-DAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~~-~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
.+. ...+||+|||++............+||+.|+|||++.+ .++.++||||+||++|+|++|.+||.+.+..+.+..+
T Consensus 151 ~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i 230 (361)
T 2yab_A 151 KNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI 230 (361)
T ss_dssp TTSSSCCEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH
T ss_pred CCCCccCEEEEecCCceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 211 12799999999988776666667789999999999864 6999999999999999999999999999999999999
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~ 203 (389)
......++...|+.+++.+++||.+||..||.+|||+.++++||||+..
T Consensus 231 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 279 (361)
T 2yab_A 231 TAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (361)
T ss_dssp HTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred HhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence 8887777666667899999999999999999999999999999999754
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=329.43 Aligned_cols=196 Identities=31% Similarity=0.613 Sum_probs=176.7
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ ..+.+|+|||||+||+|.+++..+ +++++..++.++.||+.||+|||++||+||||||+||++
T Consensus 71 l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll-- 147 (328)
T 3fe3_A 71 LNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLL-- 147 (328)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--
T ss_pred CCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEE--
Confidence 5799999999 357899999999999999998776 679999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc-cC-CCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SY-NVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
+.++.+||+|||++............+||+.|+|||++.+ .+ +.++||||+||++|+|++|+.||.+.+.......+
T Consensus 148 -~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i 226 (328)
T 3fe3_A 148 -DADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV 226 (328)
T ss_dssp -CTTSCEEECSTTCCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred -cCCCCEEEeeccCceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 5788999999999988776666677899999999999854 44 47899999999999999999999999999988888
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
.......+ ..+++++.+||++||..||.+|||++++++||||+...
T Consensus 227 ~~~~~~~p----~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 227 LRGKYRIP----FYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp HHCCCCCC----TTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred HhCCCCCC----CCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 88766544 24799999999999999999999999999999998653
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=334.52 Aligned_cols=202 Identities=31% Similarity=0.615 Sum_probs=182.3
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|.||||++++ ..+.+|+|||||+||+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 58 l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~ 137 (321)
T 1tki_A 58 ARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT 137 (321)
T ss_dssp SCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS
T ss_pred CCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcc
Confidence 5799999998 458899999999999999988766567999999999999999999999999999999999999953
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVL 155 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 155 (389)
+.++.+||+|||++.............||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+.......+.
T Consensus 138 -~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 216 (321)
T 1tki_A 138 -RRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIM 216 (321)
T ss_dssp -SSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred -CCCCCEEEEECCCCeECCCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHH
Confidence 1268899999999988776666666789999999999865 57999999999999999999999999999999999998
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCC
Q 016471 156 RADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~ 203 (389)
.....++...++.+++++++||.+||..||.+|||+.++++||||+..
T Consensus 217 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 217 NAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred cCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 887777666667899999999999999999999999999999999765
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=329.17 Aligned_cols=230 Identities=40% Similarity=0.689 Sum_probs=180.9
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|.||||++++ ....+|+|||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||+++.
T Consensus 105 l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~ 183 (349)
T 2w4o_A 105 LSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEK-GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYAT 183 (349)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTC-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESS
T ss_pred CCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEec
Confidence 5799999998 357899999999999999988654 67999999999999999999999999999999999999964
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhH-HHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESG-IFRSV 154 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i 154 (389)
.+.++.+||+|||++............+||+.|+|||++.+ .++.++||||+||++|+|++|..||.+..... ....+
T Consensus 184 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i 263 (349)
T 2w4o_A 184 PAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRI 263 (349)
T ss_dssp SSTTCCEEECCCC----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHH
T ss_pred CCCCCCEEEccCccccccCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHH
Confidence 34578999999999987655544556789999999999864 68999999999999999999999998766544 66777
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCCCCCCccHHHHHHHHHHhhcChhHHHHH
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDILIYKLVKSYLRATPLKRAAL 231 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l 231 (389)
.......+.+.++.++..+++||.+||..||.+|||+.++++||||................++.+....+++++..
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (349)
T 2w4o_A 264 LNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANFVHMDTAQKKLQEFNARRKLKAAVK 340 (349)
T ss_dssp HTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTCCCSCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred HhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCccchhhhcchHHHHHHHHHHHHHHHHHH
Confidence 77766666666778999999999999999999999999999999998876544433444555566655555555543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=324.28 Aligned_cols=195 Identities=30% Similarity=0.568 Sum_probs=174.0
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
++||||+.++ ..+.+|+|||||+||+|.+++.+. +.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 62 l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll-- 138 (337)
T 1o6l_A 62 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML-- 138 (337)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE--
T ss_pred CCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEE--
Confidence 5799999998 357899999999999999988765 689999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccC-CCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVR-PDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
+.++.+||+|||++.... ........+||+.|+|||++. ..++.++|+||+||++|+|++|..||.+.+.......+
T Consensus 139 -~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i 217 (337)
T 1o6l_A 139 -DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217 (337)
T ss_dssp -CTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred -CCCCCEEEeeccchhhcccCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 578899999999998643 333456678999999999985 46899999999999999999999999999888888888
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCC-----CHHHHhCCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRM-----TAAQALTHPWLHDE 203 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----s~~e~l~h~~~~~~ 203 (389)
......++ ..++++++++|.+||..||.+|| +++++++||||...
T Consensus 218 ~~~~~~~p----~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~ 267 (337)
T 1o6l_A 218 LMEEIRFP----RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp HHCCCCCC----TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HcCCCCCC----CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence 87665544 35899999999999999999999 89999999999765
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=329.74 Aligned_cols=194 Identities=28% Similarity=0.559 Sum_probs=170.0
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
.||||++++ ..+.+|+|||||+||+|.+++.+. +.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 82 ~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl--- 157 (353)
T 3txo_A 82 NHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLL--- 157 (353)
T ss_dssp TCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---
T ss_pred CCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEE---
Confidence 699999998 357899999999999999988766 689999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCCccccCC-CCCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 016471 78 EEDAPLKVIDFGLSDFVRP-DQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVL 155 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 155 (389)
+.++.+||+|||+|..... .....+.+||+.|+|||++.+ .++.++||||+||++|+|++|.+||.+.+..+.+..+.
T Consensus 158 ~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~ 237 (353)
T 3txo_A 158 DHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL 237 (353)
T ss_dssp CTTSCEEECCCTTCBCSCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCCCCEEEccccceeecccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 5788999999999986432 334456789999999999864 69999999999999999999999999999999999998
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCH------HHHhCCCCCCCC
Q 016471 156 RADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTA------AQALTHPWLHDE 203 (389)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~------~e~l~h~~~~~~ 203 (389)
.....++. .+++.++++|++||..||.+||++ +++++||||++.
T Consensus 238 ~~~~~~p~----~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~ 287 (353)
T 3txo_A 238 NDEVVYPT----WLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI 287 (353)
T ss_dssp HCCCCCCT----TSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred cCCCCCCC----CCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence 87765543 489999999999999999999998 899999999875
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=331.23 Aligned_cols=202 Identities=32% Similarity=0.632 Sum_probs=173.6
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEE
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSR---GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFL 73 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nil 73 (389)
|+||||++++ ..+.+|+|||||+||+|.+++.++ +..+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 83 l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl 162 (351)
T 3c0i_A 83 LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVL 162 (351)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred CCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeE
Confidence 5899999998 467899999999999999888643 235899999999999999999999999999999999999
Q ss_pred EeecCCCCCEEEeecCCccccCCCCC-cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHH
Q 016471 74 FTTREEDAPLKVIDFGLSDFVRPDQR-LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIF 151 (389)
Q Consensus 74 l~~~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 151 (389)
++..+....+||+|||++........ ....+||+.|+|||++. ..++.++||||+||++|+|++|..||.+. .....
T Consensus 163 ~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~ 241 (351)
T 3c0i_A 163 LASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLF 241 (351)
T ss_dssp ECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHH
T ss_pred EecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHH
Confidence 97544456699999999987654432 44568999999999986 46899999999999999999999999875 45566
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCC
Q 016471 152 RSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 152 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~ 203 (389)
..+.......+...|+.+++.+++||.+||..||.+|||+.++++||||+..
T Consensus 242 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 242 EGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp HHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred HHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 7777766655555556789999999999999999999999999999999764
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=331.23 Aligned_cols=203 Identities=35% Similarity=0.647 Sum_probs=181.7
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|+||||++++ ....+|+|||||+||+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 105 l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~ 184 (387)
T 1kob_A 105 LHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET 184 (387)
T ss_dssp CCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS
T ss_pred CCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEec
Confidence 5899999998 357899999999999999988766568999999999999999999999999999999999999953
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVL 155 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 155 (389)
+..+.+||+|||++............+||+.|+|||++. ..++.++||||+||++|+|++|..||.+.+..+....+.
T Consensus 185 -~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~ 263 (387)
T 1kob_A 185 -KKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVK 263 (387)
T ss_dssp -TTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH
T ss_pred -CCCCceEEEecccceecCCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 235789999999998876655555678999999999986 468999999999999999999999999998888888888
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 156 RADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
.....++...++.+++++++||.+||..||.+|||+.++++||||+...
T Consensus 264 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 264 RCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp HCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred hCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 8777777666778999999999999999999999999999999998764
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=324.68 Aligned_cols=203 Identities=37% Similarity=0.669 Sum_probs=177.9
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|.||||++++ ....+|+|||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||+++.
T Consensus 71 l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~ 149 (326)
T 2y0a_A 71 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLD 149 (326)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTS-SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESC
T ss_pred CCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEec
Confidence 5799999998 357899999999999999987554 67999999999999999999999999999999999999953
Q ss_pred cC-CCCCEEEeecCCccccCCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 RE-EDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
.+ ....+||+|||++.............||+.|+|||++. ..++.++||||+||++|+|++|..||.+.+..+....+
T Consensus 150 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~ 229 (326)
T 2y0a_A 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV 229 (326)
T ss_dssp SSSSSCCEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH
T ss_pred CCCCCCCEEEEECCCCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH
Confidence 21 12379999999998876555566678999999999986 46899999999999999999999999999888888888
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
......++...++.+++.+++||.+||..||.+|||+.++++||||+...
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 279 (326)
T 2y0a_A 230 SAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 279 (326)
T ss_dssp HHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred HhcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence 87766665555567899999999999999999999999999999997653
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=324.89 Aligned_cols=196 Identities=31% Similarity=0.564 Sum_probs=174.6
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ ..+.+|+|||||+||+|.+++.+. +.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 75 ~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll-- 151 (345)
T 1xjd_A 75 WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL-- 151 (345)
T ss_dssp TTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE--
T ss_pred CCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEE--
Confidence 3799999998 357899999999999999988765 679999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCC-CCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRP-DQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
+.++.+||+|||++..... .......+||+.|+|||++. ..++.++|+||+||++|+|++|..||.+.+..+.+..+
T Consensus 152 -~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i 230 (345)
T 1xjd_A 152 -DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI 230 (345)
T ss_dssp -CTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred -CCCCCEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 5778999999999986432 23455678999999999985 46899999999999999999999999999999999888
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHH-HHhCCCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAA-QALTHPWLHDEN 204 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~-e~l~h~~~~~~~ 204 (389)
....+.++ ..+++++++||.+||..||.+||++. ++++||||+..+
T Consensus 231 ~~~~~~~p----~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~ 277 (345)
T 1xjd_A 231 RMDNPFYP----RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 277 (345)
T ss_dssp HHCCCCCC----TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred HhCCCCCC----cccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCC
Confidence 88765544 34899999999999999999999998 999999998753
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=325.95 Aligned_cols=199 Identities=31% Similarity=0.570 Sum_probs=154.0
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|+||||++++ ....+|+|||||+||+|.+++... +++++..++.++.||+.||.|||++||+||||||+||+++.
T Consensus 73 l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~ 151 (361)
T 3uc3_A 73 LRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNA-GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDG 151 (361)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECS
T ss_pred CCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcC
Confidence 5899999998 357899999999999999988765 67999999999999999999999999999999999999952
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc-cCCCc-hhHHHHHHHHHHHHhCCCCCCCCCh----hHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVE-GDMWSIGVITYILLCGSRPFWARTE----SGI 150 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~-~DiwslG~il~~ll~g~~pf~~~~~----~~~ 150 (389)
+..+.+||+|||++............+||+.|+|||++.+ .++.+ +||||+||++|+|++|+.||.+... ...
T Consensus 152 -~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~ 230 (361)
T 3uc3_A 152 -SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKT 230 (361)
T ss_dssp -SSSCCEEECCCCCC---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHH
T ss_pred -CCCceEEEeecCccccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHH
Confidence 1234599999999986554444556789999999998853 45544 8999999999999999999987544 344
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCC
Q 016471 151 FRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 151 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~ 203 (389)
...+.......+. ...+++.+++||.+||..+|.+|||+.++++||||...
T Consensus 231 ~~~~~~~~~~~~~--~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 231 IQRILSVKYSIPD--DIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp HHHHHTTCCCCCT--TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred HHHHhcCCCCCCC--cCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 4455544433332 34689999999999999999999999999999999654
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=333.37 Aligned_cols=200 Identities=25% Similarity=0.466 Sum_probs=174.3
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
++||||++++ ....+|+|||||+||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 126 l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl-- 201 (410)
T 3v8s_A 126 ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL-- 201 (410)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--
T ss_pred CCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeE--
Confidence 5799999998 45789999999999999998754 469999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC--CcccccccCCccccccccc-c----CCCchhHHHHHHHHHHHHhCCCCCCCCChhH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ--RLNDIVGSAYYVAPEVLHR-S----YNVEGDMWSIGVITYILLCGSRPFWARTESG 149 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~----~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 149 (389)
+.++.+||+|||+|....... ...+.+||+.|+|||++.+ . ++.++||||+||++|+|++|++||.+.+...
T Consensus 202 -~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~ 280 (410)
T 3v8s_A 202 -DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG 280 (410)
T ss_dssp -CTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred -CCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh
Confidence 578899999999998765443 2346789999999998853 2 7899999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCC--CCCHHHHhCCCCCCCCCC
Q 016471 150 IFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRK--RMTAAQALTHPWLHDENR 205 (389)
Q Consensus 150 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~--R~s~~e~l~h~~~~~~~~ 205 (389)
.+..+.........+.++.+|+++++||++||..+|.+ |++++++++||||++..+
T Consensus 281 ~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w 338 (410)
T 3v8s_A 281 TYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW 338 (410)
T ss_dssp HHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSC
T ss_pred HHHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCH
Confidence 98888875433333344579999999999999999988 999999999999987643
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=332.13 Aligned_cols=204 Identities=34% Similarity=0.657 Sum_probs=168.0
Q ss_pred CCCccccceee--------cCeEEEEEEccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCc
Q 016471 1 MYHQKLQHLFY--------SNSFLFFTRFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPEN 71 (389)
Q Consensus 1 l~Hpni~~~~~--------~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~N 71 (389)
+.||||++++. ..++|+|||||+||+|.+++..+. ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 112 ~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 191 (400)
T 1nxk_A 112 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPEN 191 (400)
T ss_dssp TTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred cCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcce
Confidence 37999999872 456899999999999999987643 369999999999999999999999999999999999
Q ss_pred EEEeecCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChh--
Q 016471 72 FLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTES-- 148 (389)
Q Consensus 72 ill~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-- 148 (389)
||++..+.++.+||+|||++............+||+.|+|||++. ..++.++||||+||++|+|++|..||.+....
T Consensus 192 ill~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~ 271 (400)
T 1nxk_A 192 LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI 271 (400)
T ss_dssp EEESSSSTTCCEEECCCTTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSS
T ss_pred EEEecCCCCccEEEEecccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccc
Confidence 999643347899999999998776555556778999999999985 46999999999999999999999999876543
Q ss_pred --HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 149 --GIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 149 --~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
.....+......++...|..+++++++||.+||..||.+|||+.++++||||....
T Consensus 272 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 272 SPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp CCSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred cHHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence 24566666666677777788999999999999999999999999999999997654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=329.83 Aligned_cols=202 Identities=34% Similarity=0.640 Sum_probs=181.6
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|.||||++++ ..+.+|+|||||+||+|.+++......+++..++.++.||+.||.|||++||+||||||+|||+..
T Consensus 143 l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~ 222 (373)
T 2x4f_A 143 LDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVN 222 (373)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEE
T ss_pred CCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEec
Confidence 5899999998 357899999999999999998876667999999999999999999999999999999999999964
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVL 155 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 155 (389)
+.++.+||+|||++............+||+.|+|||++. ..++.++||||+||++|+|++|..||.+.+..+.+..+.
T Consensus 223 -~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~ 301 (373)
T 2x4f_A 223 -RDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNIL 301 (373)
T ss_dssp -TTTTEEEECCCSSCEECCTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred -CCCCcEEEEeCCCceecCCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 345789999999998876666566678999999999885 468899999999999999999999999999988999998
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCC
Q 016471 156 RADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~ 203 (389)
.....++...++.+++.+++||.+||..||.+|||+.++++||||.+.
T Consensus 302 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 302 ACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp HTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred hccCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 887766666667899999999999999999999999999999999653
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=314.11 Aligned_cols=199 Identities=24% Similarity=0.453 Sum_probs=170.6
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ ..+.+|+|||||+||+|.+++... .+++..++.++.|++.||.|||++||+||||||+||++
T Consensus 74 l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~-- 149 (297)
T 3fxz_A 74 NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL-- 149 (297)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--
T ss_pred CCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEE--
Confidence 5799999998 467899999999999999988654 69999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC-CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
+.++.+||+|||++....... ......||+.|+|||++. ..++.++||||+||++|+|++|..||.+.........+
T Consensus 150 -~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~ 228 (297)
T 3fxz_A 150 -GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI 228 (297)
T ss_dssp -CTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred -CCCCCEEEeeCCCceecCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 567899999999988765433 344568999999999885 46899999999999999999999999988877766665
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENR 205 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~~ 205 (389)
....... ......+++.++++|.+||..||.+|||++++++||||+....
T Consensus 229 ~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~ 278 (297)
T 3fxz_A 229 ATNGTPE-LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKP 278 (297)
T ss_dssp HHHCSCC-CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred HhCCCCC-CCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccCc
Confidence 5433221 1122468999999999999999999999999999999986543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=326.88 Aligned_cols=194 Identities=27% Similarity=0.541 Sum_probs=168.3
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
.||||++++ ..+.+|+|||||+||+|..++.+. +.+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 111 ~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl--- 186 (396)
T 4dc2_A 111 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL--- 186 (396)
T ss_dssp TCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---
T ss_pred CCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE---
Confidence 799999998 357899999999999999988766 689999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCCcccc-CCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCC---------C
Q 016471 78 EEDAPLKVIDFGLSDFV-RPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWAR---------T 146 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~-~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~---------~ 146 (389)
+.++.+||+|||+|+.. .......+.+||+.|+|||++. ..++.++||||+||++|+|++|++||.+. .
T Consensus 187 ~~~g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~ 266 (396)
T 4dc2_A 187 DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT 266 (396)
T ss_dssp CTTSCEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CC
T ss_pred CCCCCEEEeecceeeecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhh
Confidence 57889999999999863 3344566789999999999986 46999999999999999999999999643 2
Q ss_pred hhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCH------HHHhCCCCCCCC
Q 016471 147 ESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTA------AQALTHPWLHDE 203 (389)
Q Consensus 147 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~------~e~l~h~~~~~~ 203 (389)
.......+......++ +.+++++++||++||..||.+||++ +++++||||++.
T Consensus 267 ~~~~~~~i~~~~~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i 325 (396)
T 4dc2_A 267 EDYLFQVILEKQIRIP----RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 325 (396)
T ss_dssp HHHHHHHHHHCCCCCC----TTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred HHHHHHHHhccccCCC----CcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence 2345566666655544 3589999999999999999999985 799999999765
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=317.52 Aligned_cols=193 Identities=27% Similarity=0.606 Sum_probs=173.3
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ ....+|+|||||+||+|.+++.+. +.+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 63 l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll-- 139 (318)
T 1fot_A 63 VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL-- 139 (318)
T ss_dssp CCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE--
T ss_pred CCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEE--
Confidence 5799999998 357899999999999999988665 689999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVL 155 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 155 (389)
+.++.+||+|||++..... ...+.+||+.|+|||++. ..++.++|+||+||++|+|++|..||.+.+....+..+.
T Consensus 140 -~~~g~~kL~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~ 216 (318)
T 1fot_A 140 -DKNGHIKITDFGFAKYVPD--VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL 216 (318)
T ss_dssp -CTTSCEEECCCSSCEECSS--CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred -cCCCCEEEeecCcceecCC--ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 5788999999999987543 334578999999999885 468999999999999999999999999999888888888
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCC-----CHHHHhCCCCCCCC
Q 016471 156 RADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRM-----TAAQALTHPWLHDE 203 (389)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----s~~e~l~h~~~~~~ 203 (389)
.....++ +.++++++++|.+||..||.+|| +++++++||||++.
T Consensus 217 ~~~~~~p----~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~ 265 (318)
T 1fot_A 217 NAELRFP----PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 265 (318)
T ss_dssp HCCCCCC----TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred hCCCCCC----CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCC
Confidence 8765544 35899999999999999999999 89999999999864
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=313.31 Aligned_cols=202 Identities=41% Similarity=0.806 Sum_probs=182.3
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|.||||++++ ....+|+|||||+||+|.+++... +.+++..++.++.|++.||.|||++||+||||||+||++..
T Consensus 63 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~ 141 (277)
T 3f3z_A 63 LDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLT 141 (277)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESS
T ss_pred CCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEec
Confidence 5799999998 357799999999999999988766 67999999999999999999999999999999999999965
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCccccccccccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLR 156 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 156 (389)
.+.++.+||+|||++.............||+.|+|||++.+.++.++||||+|+++|+|++|..||.+....+....+..
T Consensus 142 ~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 221 (277)
T 3f3z_A 142 DSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIRE 221 (277)
T ss_dssp SSTTCCEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCCCCcEEEEecccceeccCccchhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh
Confidence 45678899999999988776666667789999999999988899999999999999999999999999998888888888
Q ss_pred cCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCC
Q 016471 157 ADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~ 203 (389)
.....+...+..+++.+.++|.+||..+|.+|||+.++++||||++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 222 GTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp CCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred CCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 77666655556789999999999999999999999999999999654
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=319.57 Aligned_cols=191 Identities=18% Similarity=0.257 Sum_probs=146.4
Q ss_pred CCCccccceee----c----CeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--------CCEe
Q 016471 1 MYHQKLQHLFY----S----NSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQ--------GVVH 64 (389)
Q Consensus 1 l~Hpni~~~~~----~----~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~--------~i~H 64 (389)
|+||||++++. . ..+|||||||+||+|.+++... .++++.+..++.|++.||.|||++ ||+|
T Consensus 54 l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiH 131 (303)
T 3hmm_A 54 LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAH 131 (303)
T ss_dssp CCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEEC
T ss_pred CCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEee
Confidence 58999999992 1 2589999999999999988654 699999999999999999999987 9999
Q ss_pred cCCCCCcEEEeecCCCCCEEEeecCCccccCCCC-----CcccccccCCccccccccc-------cCCCchhHHHHHHHH
Q 016471 65 RDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ-----RLNDIVGSAYYVAPEVLHR-------SYNVEGDMWSIGVIT 132 (389)
Q Consensus 65 rdlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~-------~~~~~~DiwslG~il 132 (389)
|||||+|||+ +.++.+||+|||+|+...... .....+||+.|||||++.+ .|+.++|||||||++
T Consensus 132 RDlKp~NILl---~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl 208 (303)
T 3hmm_A 132 RDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVF 208 (303)
T ss_dssp SCCCGGGEEE---CTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHH
T ss_pred ccCCcccEEE---CCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHH
Confidence 9999999999 578999999999998764432 1234589999999999853 367789999999999
Q ss_pred HHHHhCCCCCCCCC---------------hhHHHHHHHhcCCCCCCCC-C--CCCCHHHHHHHHhhhccCcCCCCCHHHH
Q 016471 133 YILLCGSRPFWART---------------ESGIFRSVLRADPNFHDSP-W--PSVSPEAKDFVRRLLNKDHRKRMTAAQA 194 (389)
Q Consensus 133 ~~ll~g~~pf~~~~---------------~~~~~~~i~~~~~~~~~~~-~--~~~~~~~~~li~~~l~~~p~~R~s~~e~ 194 (389)
|||+||.+||.... .......+......++.+. + ...+..+.+|+.+||..||.+|||+.++
T Consensus 209 ~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei 288 (303)
T 3hmm_A 209 WEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 288 (303)
T ss_dssp HHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHH
T ss_pred HHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHH
Confidence 99999977653211 1233333333222211110 0 1123578899999999999999999998
Q ss_pred hC
Q 016471 195 LT 196 (389)
Q Consensus 195 l~ 196 (389)
++
T Consensus 289 ~~ 290 (303)
T 3hmm_A 289 KK 290 (303)
T ss_dssp HH
T ss_pred HH
Confidence 75
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=321.20 Aligned_cols=194 Identities=26% Similarity=0.479 Sum_probs=173.3
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
+||||+.++ ..+.+|+|||||+||+|.+++.+. +.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 79 ~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll--- 154 (353)
T 2i0e_A 79 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML--- 154 (353)
T ss_dssp CCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---
T ss_pred CCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE---
Confidence 699999998 357899999999999999988765 679999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCCccccC-CCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 016471 78 EEDAPLKVIDFGLSDFVR-PDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVL 155 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 155 (389)
+.++.+||+|||++.... ........+||+.|+|||++. ..++.++|+||+||++|+|++|+.||.+.+..+++..+.
T Consensus 155 ~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~ 234 (353)
T 2i0e_A 155 DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 234 (353)
T ss_dssp CTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred cCCCcEEEEeCCcccccccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 578899999999998643 233455678999999999985 468999999999999999999999999999999999998
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCC-----HHHHhCCCCCCCC
Q 016471 156 RADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMT-----AAQALTHPWLHDE 203 (389)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s-----~~e~l~h~~~~~~ 203 (389)
.....++ +.+++++++||.+||..||.+||+ ++++++||||+..
T Consensus 235 ~~~~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~ 283 (353)
T 2i0e_A 235 EHNVAYP----KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 283 (353)
T ss_dssp HCCCCCC----TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTC
T ss_pred hCCCCCC----CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCC
Confidence 8766554 358999999999999999999994 6999999999764
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=333.26 Aligned_cols=202 Identities=26% Similarity=0.457 Sum_probs=174.4
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||+.++ ..+.+|+|||||+||+|.+++.+..+.+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 131 ~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl-- 208 (437)
T 4aw2_A 131 GDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM-- 208 (437)
T ss_dssp SCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--
T ss_pred CCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeE--
Confidence 5799999998 3578999999999999999987756789999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCC--cccccccCCcccccccc------ccCCCchhHHHHHHHHHHHHhCCCCCCCCChh
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQR--LNDIVGSAYYVAPEVLH------RSYNVEGDMWSIGVITYILLCGSRPFWARTES 148 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 148 (389)
+.++.+||+|||+|........ ....+||+.|+|||++. +.|+.++||||+||++|+|++|++||.+.+..
T Consensus 209 -~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~ 287 (437)
T 4aw2_A 209 -DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 287 (437)
T ss_dssp -CTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred -cCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh
Confidence 5788999999999977654332 33468999999999874 35899999999999999999999999999998
Q ss_pred HHHHHHHhcCCCCCC-CCCCCCCHHHHHHHHhhhccCcCC--CCCHHHHhCCCCCCCCCC
Q 016471 149 GIFRSVLRADPNFHD-SPWPSVSPEAKDFVRRLLNKDHRK--RMTAAQALTHPWLHDENR 205 (389)
Q Consensus 149 ~~~~~i~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~--R~s~~e~l~h~~~~~~~~ 205 (389)
+.+..+......+.. ..++.+++++++||++||..+|.+ |++++++++||||++.++
T Consensus 288 ~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w 347 (437)
T 4aw2_A 288 ETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDW 347 (437)
T ss_dssp HHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCT
T ss_pred HHHHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCH
Confidence 888888754322221 123568999999999999998888 999999999999987643
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=322.90 Aligned_cols=195 Identities=28% Similarity=0.545 Sum_probs=173.8
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ ..+.+|+|||||+||+|.+++.+. +.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 96 ~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll-- 172 (373)
T 2r5t_A 96 VKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL-- 172 (373)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE--
T ss_pred CCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE--
Confidence 5799999998 357899999999999999988765 679999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccC-CCCCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVR-PDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
+.++.+||+|||++.... ........+||+.|+|||++.+ .++.++|+||+||++|+|++|..||.+.+..+.+..+
T Consensus 173 -~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i 251 (373)
T 2r5t_A 173 -DSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI 251 (373)
T ss_dssp -CTTSCEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHH
T ss_pred -CCCCCEEEeeCccccccccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 578899999999998643 3344566789999999999864 6899999999999999999999999999999999999
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCH----HHHhCCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTA----AQALTHPWLHDE 203 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~----~e~l~h~~~~~~ 203 (389)
......++ +.+++.+++||.+||..||.+||++ .++++||||+..
T Consensus 252 ~~~~~~~~----~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~ 300 (373)
T 2r5t_A 252 LNKPLQLK----PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI 300 (373)
T ss_dssp HHSCCCCC----SSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTC
T ss_pred HhcccCCC----CCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCC
Confidence 88755443 4589999999999999999999986 699999999765
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=322.25 Aligned_cols=201 Identities=36% Similarity=0.615 Sum_probs=175.1
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
.||||++++ ....+|+|||||+||+|.+++..+ +.+++..++.++.||+.||.|||++||+||||||+|||+...
T Consensus 74 ~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~ 152 (342)
T 2qr7_A 74 QHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQ-KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDE 152 (342)
T ss_dssp TSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSS
T ss_pred CCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecC
Confidence 699999998 357899999999999999988765 679999999999999999999999999999999999999632
Q ss_pred C-CCCCEEEeecCCccccCCC-CCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCC---CChhHHH
Q 016471 78 E-EDAPLKVIDFGLSDFVRPD-QRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWA---RTESGIF 151 (389)
Q Consensus 78 ~-~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~---~~~~~~~ 151 (389)
+ ..+.+||+|||++...... ....+.+||+.|+|||++.+ .++.++||||+||++|+|++|..||.+ .+..++.
T Consensus 153 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~ 232 (342)
T 2qr7_A 153 SGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL 232 (342)
T ss_dssp SCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHH
T ss_pred CCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHH
Confidence 2 2245999999999876443 33456789999999999864 588999999999999999999999976 3556778
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCC
Q 016471 152 RSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 152 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~ 203 (389)
..+.......+...|+.+++.+++||.+||..||.+|||+.++++||||...
T Consensus 233 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 233 ARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp HHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred HHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 8888887777777778899999999999999999999999999999999653
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=310.51 Aligned_cols=203 Identities=34% Similarity=0.708 Sum_probs=182.6
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|+||||++++ .....|+|||||+||+|.+.+..+ +.+++..+..++.|++.||.|||++||+||||||+||+++.
T Consensus 62 l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~ 140 (284)
T 3kk8_A 62 LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLAS 140 (284)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESS
T ss_pred cCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEec
Confidence 5799999998 357789999999999999988776 67999999999999999999999999999999999999975
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVL 155 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 155 (389)
.+..+.+||+|||++.............||+.|+|||++.+ .++.++||||+|+++|+|++|..||.+.........+.
T Consensus 141 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 220 (284)
T 3kk8_A 141 KAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK 220 (284)
T ss_dssp SSTTCCEEECCCTTCEECCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCCCCcEEEeeceeeEEcccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHH
Confidence 44556699999999987766555566789999999998854 68999999999999999999999999999988888888
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 156 RADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
......+.+.++.+++.+.++|.+||..+|.+|||+.++++||||++..
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (284)
T 3kk8_A 221 AGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRE 269 (284)
T ss_dssp HTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred hccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCCh
Confidence 8887777777788999999999999999999999999999999997653
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=319.46 Aligned_cols=193 Identities=27% Similarity=0.524 Sum_probs=173.7
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ ....+|+|||||+||+|.+++.+. +.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 98 l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll-- 174 (350)
T 1rdq_E 98 VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI-- 174 (350)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--
T ss_pred CCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEE--
Confidence 5799999998 357899999999999999988766 679999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVL 155 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 155 (389)
+.++.+||+|||++...... ....+||+.|+|||++. ..++.++||||+||++|+|++|.+||.+.+..+.+..+.
T Consensus 175 -~~~g~~kL~DFg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~ 251 (350)
T 1rdq_E 175 -DQQGYIQVTDFGFAKRVKGR--TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 251 (350)
T ss_dssp -CTTSCEEECCCTTCEECSSC--BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred -CCCCCEEEcccccceeccCC--cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHH
Confidence 57789999999999876432 34678999999999885 468999999999999999999999999999999999998
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCC-----HHHHhCCCCCCCC
Q 016471 156 RADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMT-----AAQALTHPWLHDE 203 (389)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s-----~~e~l~h~~~~~~ 203 (389)
.....++ +.+++.++++|.+||..||.+||+ ++++++||||...
T Consensus 252 ~~~~~~p----~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~ 300 (350)
T 1rdq_E 252 SGKVRFP----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp HCCCCCC----TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred cCCCCCC----CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCC
Confidence 8765544 358999999999999999999998 9999999999764
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=311.74 Aligned_cols=201 Identities=36% Similarity=0.705 Sum_probs=169.1
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEE
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILS---RGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFL 73 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nil 73 (389)
|.||||++++ ....+|+|||||+||+|.+++.. ..+.+++..++.++.||+.||.|||++||+||||||+||+
T Consensus 77 l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl 156 (285)
T 3is5_A 77 LDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENIL 156 (285)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEE
T ss_pred CCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEE
Confidence 5799999999 35789999999999999998854 3467999999999999999999999999999999999999
Q ss_pred EeecCCCCCEEEeecCCccccCCCCCcccccccCCccccccccccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016471 74 FTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRS 153 (389)
Q Consensus 74 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 153 (389)
+...+.++.+||+|||++.............||+.|+|||++.+.++.++||||+||++|+|++|..||.+.+.......
T Consensus 157 ~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~ 236 (285)
T 3is5_A 157 FQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQK 236 (285)
T ss_dssp ESSSSTTCCEEECCCCCCCC----------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred EecCCCCCCEEEEeeecceecCCcccCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhh
Confidence 96544567899999999987665555566789999999999988899999999999999999999999999888877777
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCC
Q 016471 154 VLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 202 (389)
Q Consensus 154 i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~ 202 (389)
+....+..... ...+++.+.++|.+||..||.+|||+.++++||||++
T Consensus 237 ~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 237 ATYKEPNYAVE-CRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp HHHCCCCCCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred hccCCcccccc-cCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 76655544332 2347999999999999999999999999999999975
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=315.17 Aligned_cols=201 Identities=27% Similarity=0.445 Sum_probs=168.4
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|+||||++++ ....+|+|||||+| +|.+.+....+.+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 76 l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~-- 152 (311)
T 3niz_A 76 LHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLI-- 152 (311)
T ss_dssp CCCTTBCCEEEEECCSSCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE--
T ss_pred cCCCCEeeeeeEEccCCEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEE--
Confidence 5899999999 35789999999986 8888888776779999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCC-CCcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPD-QRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRS 153 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 153 (389)
+.++.+||+|||++...... .......||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+.+.......
T Consensus 153 -~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 231 (311)
T 3niz_A 153 -NSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPK 231 (311)
T ss_dssp -CTTCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHH
T ss_pred -CCCCCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 56789999999999876533 23445678999999998753 589999999999999999999999998877776666
Q ss_pred HHhcCCCCCCCC--------------------------CCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCCC
Q 016471 154 VLRADPNFHDSP--------------------------WPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENR 205 (389)
Q Consensus 154 i~~~~~~~~~~~--------------------------~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~~ 205 (389)
+........... .+.+++++.+||.+||..||.+|||++++++||||++.+.
T Consensus 232 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 309 (311)
T 3niz_A 232 IFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP 309 (311)
T ss_dssp HHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCT
T ss_pred HHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCc
Confidence 654222211111 1347889999999999999999999999999999987653
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=327.48 Aligned_cols=201 Identities=28% Similarity=0.478 Sum_probs=171.9
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
++||||+.++ ..+.+|+|||||+||+|.+++.+.+..+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 118 ~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl-- 195 (412)
T 2vd5_A 118 GDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILL-- 195 (412)
T ss_dssp SCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--
T ss_pred cCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeee--
Confidence 4799999998 3578999999999999999998765689999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCC--cccccccCCcccccccc--------ccCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQR--LNDIVGSAYYVAPEVLH--------RSYNVEGDMWSIGVITYILLCGSRPFWART 146 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~--------~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 146 (389)
+.++.+||+|||++........ ....+||+.|+|||++. +.|+.++||||+||++|+|++|+.||.+.+
T Consensus 196 -d~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 274 (412)
T 2vd5_A 196 -DRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS 274 (412)
T ss_dssp -CTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred -cCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC
Confidence 5788999999999987654432 23468999999999885 358999999999999999999999999999
Q ss_pred hhHHHHHHHhcCCCCCCC-CCCCCCHHHHHHHHhhhccCcCCC---CCHHHHhCCCCCCCCCC
Q 016471 147 ESGIFRSVLRADPNFHDS-PWPSVSPEAKDFVRRLLNKDHRKR---MTAAQALTHPWLHDENR 205 (389)
Q Consensus 147 ~~~~~~~i~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~R---~s~~e~l~h~~~~~~~~ 205 (389)
..+.+..+.........+ ....+|+++++||++||. +|.+| ++++++++||||++.++
T Consensus 275 ~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w 336 (412)
T 2vd5_A 275 TAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDW 336 (412)
T ss_dssp HHHHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCS
T ss_pred HHHHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCH
Confidence 888888887533211111 124689999999999999 99998 58999999999987654
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=320.17 Aligned_cols=202 Identities=36% Similarity=0.644 Sum_probs=155.1
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
.||||++++ ....+|+|||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||+++..
T Consensus 64 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~ 142 (325)
T 3kn6_A 64 GHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKK-KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDE 142 (325)
T ss_dssp TCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC-
T ss_pred CCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecC
Confidence 399999998 357899999999999999988765 689999999999999999999999999999999999999754
Q ss_pred CCCCCEEEeecCCccccCCC-CCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCh-------h
Q 016471 78 EEDAPLKVIDFGLSDFVRPD-QRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTE-------S 148 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~ 148 (389)
+.+..+||+|||++...... ......+||+.|+|||++. ..++.++||||+||++|+|++|..||.+... .
T Consensus 143 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~ 222 (325)
T 3kn6_A 143 NDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAV 222 (325)
T ss_dssp ---CEEEECCCTTCEECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHH
T ss_pred CCcccEEEeccccceecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHH
Confidence 44458999999999865443 2345667899999999985 4689999999999999999999999976433 4
Q ss_pred HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 149 GIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 149 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
+....+......++...|+.+++++++||.+||..||.+|||++++++||||++..
T Consensus 223 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~ 278 (325)
T 3kn6_A 223 EIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS 278 (325)
T ss_dssp HHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred HHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence 56677776666665555567899999999999999999999999999999998764
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=317.84 Aligned_cols=194 Identities=27% Similarity=0.533 Sum_probs=167.2
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
.||||++++ ..+.+|+|||||+||+|.+++.+. +.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 68 ~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll--- 143 (345)
T 3a8x_A 68 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL--- 143 (345)
T ss_dssp TCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---
T ss_pred CCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---
Confidence 799999998 357899999999999999988765 689999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCCccccC-CCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCC---------CC
Q 016471 78 EEDAPLKVIDFGLSDFVR-PDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWA---------RT 146 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~---------~~ 146 (389)
+.++.+||+|||++.... ........+||+.|+|||++. ..++.++|+||+||++|+|++|+.||.. ..
T Consensus 144 ~~~g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~ 223 (345)
T 3a8x_A 144 DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT 223 (345)
T ss_dssp CTTSCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------C
T ss_pred CCCCCEEEEeccccccccCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCccccccccccc
Confidence 578899999999998643 334456678999999999986 4689999999999999999999999965 23
Q ss_pred hhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCH------HHHhCCCCCCCC
Q 016471 147 ESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTA------AQALTHPWLHDE 203 (389)
Q Consensus 147 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~------~e~l~h~~~~~~ 203 (389)
.......+......++ +.+++.++++|.+||..||.+||++ +++++||||++.
T Consensus 224 ~~~~~~~i~~~~~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 282 (345)
T 3a8x_A 224 EDYLFQVILEKQIRIP----RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 282 (345)
T ss_dssp HHHHHHHHHHCCCCCC----TTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred HHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence 3345566666554443 3589999999999999999999995 899999999765
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=322.74 Aligned_cols=194 Identities=31% Similarity=0.638 Sum_probs=166.9
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ ....+|+||||| +|+|.+++..+ +.+++.+++.++.||+.||.|||++||+||||||+|||+
T Consensus 66 l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll-- 141 (336)
T 3h4j_B 66 LRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLL-- 141 (336)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEE--
T ss_pred CCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEE--
Confidence 5799999999 357899999999 67999988776 689999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc-cC-CCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SY-NVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
+.++.+||+|||++............+||+.|+|||++.+ .+ +.++||||+||++|+|++|..||.+.........+
T Consensus 142 -~~~~~~kl~DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i 220 (336)
T 3h4j_B 142 -DDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV 220 (336)
T ss_dssp -CTTCCEEECCSSCTBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC
T ss_pred -cCCCCEEEEEeccceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 5778999999999988776666677889999999999864 33 78999999999999999999999876655444333
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~ 203 (389)
.......+ ..+++.+++||.+||..||.+|||++++++||||+..
T Consensus 221 ~~~~~~~p----~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 221 NSCVYVMP----DFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp CSSCCCCC----TTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred HcCCCCCc----ccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 32222221 3589999999999999999999999999999999754
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=320.09 Aligned_cols=195 Identities=24% Similarity=0.509 Sum_probs=169.5
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ ....+|+|||||.||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 72 l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll-- 148 (384)
T 4fr4_A 72 LEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQN-VHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILL-- 148 (384)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--
T ss_pred CCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE--
Confidence 5799999998 357899999999999999887654 689999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc----ccCCCchhHHHHHHHHHHHHhCCCCCCCCC---hhH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH----RSYNVEGDMWSIGVITYILLCGSRPFWART---ESG 149 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~ 149 (389)
+.++.+||+|||++............+||+.|+|||++. ..|+.++||||+||++|+|++|..||.+.. ...
T Consensus 149 -~~~g~vkL~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~ 227 (384)
T 4fr4_A 149 -DEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKE 227 (384)
T ss_dssp -CTTSCEEECCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHH
T ss_pred -CCCCCEEEeccceeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHH
Confidence 578899999999998877666667789999999999984 248999999999999999999999997543 344
Q ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCC-HHHHhCCCCCCCC
Q 016471 150 IFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMT-AAQALTHPWLHDE 203 (389)
Q Consensus 150 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s-~~e~l~h~~~~~~ 203 (389)
....+......++ +.+++.+.+||.+||..||.+||+ ++++++||||.+.
T Consensus 228 ~~~~~~~~~~~~p----~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~ 278 (384)
T 4fr4_A 228 IVHTFETTVVTYP----SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI 278 (384)
T ss_dssp HHHHHHHCCCCCC----TTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTC
T ss_pred HHHHHhhcccCCC----CcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcC
Confidence 4555555444333 358999999999999999999998 8999999999765
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=310.34 Aligned_cols=199 Identities=26% Similarity=0.456 Sum_probs=163.9
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|+||||++++ ..+.+|+|||||.+ +|.+++....+.+++..++.++.||+.||.|||++||+||||||+||++
T Consensus 57 l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~-- 133 (288)
T 1ob3_A 57 LKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI-- 133 (288)
T ss_dssp CCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--
T ss_pred cCCCCEeeeeeEEccCCeEEEEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE--
Confidence 5899999998 35789999999986 8999887766789999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCC-CCcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPD-QRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRS 153 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 153 (389)
+.++.+||+|||++...... .......||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+.......
T Consensus 134 -~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~ 212 (288)
T 1ob3_A 134 -NREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMR 212 (288)
T ss_dssp -CTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred -cCCCCEEEeECccccccCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 57789999999998766432 23345678999999998853 589999999999999999999999999887777666
Q ss_pred HHhcCCCCCCC-------------------------CCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCC
Q 016471 154 VLRADPNFHDS-------------------------PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 154 i~~~~~~~~~~-------------------------~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~ 203 (389)
+.+........ ..+.+++.+.+||.+||..||.+|||++++++||||++.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 213 IFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp HHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred HHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 65421111110 113578999999999999999999999999999999764
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=315.28 Aligned_cols=202 Identities=36% Similarity=0.649 Sum_probs=163.9
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
.||||++++ ..+.+|+|||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||+++..
T Consensus 69 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~ 147 (316)
T 2ac3_A 69 GHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHP 147 (316)
T ss_dssp CCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCS
T ss_pred CCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccC
Confidence 699999998 467899999999999999988766 679999999999999999999999999999999999999643
Q ss_pred CCCCCEEEeecCCccccCCC--------CCcccccccCCcccccccc------ccCCCchhHHHHHHHHHHHHhCCCCCC
Q 016471 78 EEDAPLKVIDFGLSDFVRPD--------QRLNDIVGSAYYVAPEVLH------RSYNVEGDMWSIGVITYILLCGSRPFW 143 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~~--------~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~pf~ 143 (389)
+....+||+|||++...... ......+||+.|+|||++. ..++.++||||+||++|+|++|+.||.
T Consensus 148 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 227 (316)
T 2ac3_A 148 NQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFV 227 (316)
T ss_dssp SSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCc
Confidence 33345999999998765321 1223456999999999884 348899999999999999999999998
Q ss_pred CCCh---------------hHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 144 ARTE---------------SGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 144 ~~~~---------------~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
+... ......+......++...++.+++.+++||.+||..||.+|||++++++||||+...
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 228 GRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp CCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred ccccccccccccccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 7542 335566666665555444457899999999999999999999999999999998754
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=308.05 Aligned_cols=200 Identities=28% Similarity=0.477 Sum_probs=165.5
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ .++.+|+|||||.| +|.+.+....+.+++..++.++.||+.||.|||++||+||||||+||++
T Consensus 58 l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~-- 134 (292)
T 3o0g_A 58 LKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI-- 134 (292)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--
T ss_pred CCCCCEeeEEeEEEeCCEEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE--
Confidence 5799999998 46889999999986 6777777766889999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCC-CCcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCCCC-CCCCChhHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPD-QRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRP-FWARTESGIFR 152 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~p-f~~~~~~~~~~ 152 (389)
+.++.+||+|||++...... .......||+.|+|||++.+ .++.++||||+||++|+|++|..| |.+.+......
T Consensus 135 -~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~ 213 (292)
T 3o0g_A 135 -NRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK 213 (292)
T ss_dssp -CTTSCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHH
T ss_pred -cCCCCEEEeecccceecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHH
Confidence 56789999999999876433 33445689999999998853 389999999999999999988777 55566666666
Q ss_pred HHHhcCCCCCCC-------------------------CCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 153 SVLRADPNFHDS-------------------------PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 153 ~i~~~~~~~~~~-------------------------~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
.+.+........ ..+.+++.+++||.+||..||.+|||++++++||||++..
T Consensus 214 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 290 (292)
T 3o0g_A 214 RIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp HHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred HHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence 665432221111 1235789999999999999999999999999999998753
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=309.65 Aligned_cols=199 Identities=26% Similarity=0.433 Sum_probs=167.9
Q ss_pred CCccccceee----cC-----eEEEEEEccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCc
Q 016471 2 YHQKLQHLFY----SN-----SFLFFTRFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPEN 71 (389)
Q Consensus 2 ~Hpni~~~~~----~~-----~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~N 71 (389)
.||||++++. .. .+++|||||.| +|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|
T Consensus 72 ~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~N 150 (308)
T 3g33_A 72 EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPEN 150 (308)
T ss_dssp CCTTBCCEEEEEEECCSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTT
T ss_pred CCCCeEEeeeeeeccCCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHH
Confidence 5999999982 11 58999999985 9999887653 239999999999999999999999999999999999
Q ss_pred EEEeecCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHH
Q 016471 72 FLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGI 150 (389)
Q Consensus 72 ill~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 150 (389)
|++ +.++.+||+|||++.............||+.|+|||++. ..++.++||||+||++|+|++|++||.+.+....
T Consensus 151 il~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 227 (308)
T 3g33_A 151 ILV---TSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ 227 (308)
T ss_dssp EEE---CTTSCEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH
T ss_pred EEE---cCCCCEEEeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 999 567899999999998776666666778999999999884 5799999999999999999999999999988888
Q ss_pred HHHHHhcCCCCCCCCC-----------------------CCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 151 FRSVLRADPNFHDSPW-----------------------PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 151 ~~~i~~~~~~~~~~~~-----------------------~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
...+.......+...| +.+++.+.+||.+||..||.+|||+.++++||||+...
T Consensus 228 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~ 304 (308)
T 3g33_A 228 LGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE 304 (308)
T ss_dssp HHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred HHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence 7777654332222222 35789999999999999999999999999999997653
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=313.20 Aligned_cols=195 Identities=27% Similarity=0.525 Sum_probs=168.8
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|+||||++++ ..+.+|+|||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 78 l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill-- 154 (327)
T 3a62_A 78 VKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLERE-GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIML-- 154 (327)
T ss_dssp CCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE--
T ss_pred CCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEE--
Confidence 5799999988 357899999999999999988765 679999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCC-CCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRP-DQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
+.++.+||+|||++..... .......+||+.|+|||++. ..++.++||||+||++|+|++|..||.+.+.......+
T Consensus 155 -~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i 233 (327)
T 3a62_A 155 -NHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKI 233 (327)
T ss_dssp -CTTSCEEECCCSCC----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred -CCCCcEEEEeCCcccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 5678999999999876432 22344568999999999885 46899999999999999999999999999888888888
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCC-----CHHHHhCCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRM-----TAAQALTHPWLHDE 203 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----s~~e~l~h~~~~~~ 203 (389)
.+....++ +.+++.++++|.+||..||.+|| ++.++++||||+..
T Consensus 234 ~~~~~~~p----~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~ 283 (327)
T 3a62_A 234 LKCKLNLP----PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI 283 (327)
T ss_dssp HHTCCCCC----TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred HhCCCCCC----CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence 87765544 35899999999999999999999 88999999999764
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=325.61 Aligned_cols=195 Identities=29% Similarity=0.563 Sum_probs=172.2
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCEecCCCCCcEEEe
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHL-QGVVHRDLKPENFLFT 75 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~-~~i~Hrdlkp~Nill~ 75 (389)
+.||||+.++ ..+.+|+|||||+||+|.+++... +.+++..++.++.||+.||+|||+ +||+||||||+|||+
T Consensus 205 l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll- 282 (446)
T 4ejn_A 205 SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML- 282 (446)
T ss_dssp CSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEE-
T ss_pred CCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEE-
Confidence 5799999998 457899999999999999988765 689999999999999999999998 999999999999999
Q ss_pred ecCCCCCEEEeecCCccccCC-CCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016471 76 TREEDAPLKVIDFGLSDFVRP-DQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRS 153 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 153 (389)
+.++.+||+|||+|..... .......+||+.|+|||++. ..++.++||||+||++|+|++|+.||.+.+.......
T Consensus 283 --~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~ 360 (446)
T 4ejn_A 283 --DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 360 (446)
T ss_dssp --CSSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred --CCCCCEEEccCCCceeccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHH
Confidence 5678999999999976432 33455678999999999985 5699999999999999999999999999998888888
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCC-----CHHHHhCCCCCCCC
Q 016471 154 VLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRM-----TAAQALTHPWLHDE 203 (389)
Q Consensus 154 i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----s~~e~l~h~~~~~~ 203 (389)
+......++ +.+++.+.+||.+||..||.+|| |++++++||||.+.
T Consensus 361 i~~~~~~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~ 411 (446)
T 4ejn_A 361 ILMEEIRFP----RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411 (446)
T ss_dssp HHHCCCCCC----TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHhCCCCCC----ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence 887765544 35899999999999999999999 99999999999875
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=328.70 Aligned_cols=202 Identities=36% Similarity=0.642 Sum_probs=165.0
Q ss_pred CCCcccccee---ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 1 MYHQKLQHLF---YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 1 l~Hpni~~~~---~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
|.||||++++ ..+.+|+|||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++..
T Consensus 197 l~hpniv~l~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~ 275 (419)
T 3i6u_A 197 LNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQ 275 (419)
T ss_dssp CCCTTBCCCCEEEESSEEEEEEECCTTCBGGGGTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSS
T ss_pred CCCCCEeeEEEEEecCceEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecC
Confidence 5899999987 467799999999999999977654 689999999999999999999999999999999999999755
Q ss_pred CCCCCEEEeecCCccccCCCCCcccccccCCcccccccc----ccCCCchhHHHHHHHHHHHHhCCCCCCCCChh-HHHH
Q 016471 78 EEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH----RSYNVEGDMWSIGVITYILLCGSRPFWARTES-GIFR 152 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~ 152 (389)
+.+..+||+|||++............+||+.|+|||++. ..++.++||||+||++|+|++|.+||.+.... ....
T Consensus 276 ~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~ 355 (419)
T 3i6u_A 276 EEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKD 355 (419)
T ss_dssp SSSCCEEECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHH
T ss_pred CCcceEEEeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHH
Confidence 556679999999998876655556778999999999874 35788999999999999999999999775443 4445
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCC
Q 016471 153 SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 153 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~ 203 (389)
.+........+..++.+++.+.+||.+||..||.+|||++++++||||++.
T Consensus 356 ~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 406 (419)
T 3i6u_A 356 QITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 406 (419)
T ss_dssp HHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred HHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence 555555555444456789999999999999999999999999999999653
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=312.82 Aligned_cols=199 Identities=35% Similarity=0.670 Sum_probs=175.7
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|.||||++++ ....+|+|||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||+++
T Consensus 72 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~- 149 (321)
T 2a2a_A 72 VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLL- 149 (321)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTC-SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEES-
T ss_pred CCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEe-
Confidence 5799999998 357899999999999999988654 6799999999999999999999999999999999999995
Q ss_pred cCCCC----CEEEeecCCccccCCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHH
Q 016471 77 REEDA----PLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIF 151 (389)
Q Consensus 77 ~~~~~----~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 151 (389)
.++ .+||+|||++.............||+.|+|||++. ..++.++||||+||++|+|++|..||.+.+..+..
T Consensus 150 --~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 227 (321)
T 2a2a_A 150 --DKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 227 (321)
T ss_dssp --CTTSSSCCEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH
T ss_pred --cCCCCcCCEEEccCccceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 334 79999999998776655556678999999999885 46899999999999999999999999999888888
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCC
Q 016471 152 RSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 152 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~ 203 (389)
..+.......+...++.+++.+.++|.+||..||.+|||+.++++||||...
T Consensus 228 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~ 279 (321)
T 2a2a_A 228 ANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (321)
T ss_dssp HHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred HHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence 8887766555444345789999999999999999999999999999999764
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=310.02 Aligned_cols=201 Identities=27% Similarity=0.445 Sum_probs=168.3
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCc
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG-----GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPEN 71 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~N 71 (389)
|.||||++++ ..+.+|+|||||.| +|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 60 l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~N 138 (317)
T 2pmi_A 60 LKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQN 138 (317)
T ss_dssp CCBTTBCCEEEEECCTTEEEEEEECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred cCCCCcceEEEEEEECCeEEEEEEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHH
Confidence 5799999999 35789999999994 9999886542 458999999999999999999999999999999999
Q ss_pred EEEeecCCCCCEEEeecCCccccCCC-CCcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChh
Q 016471 72 FLFTTREEDAPLKVIDFGLSDFVRPD-QRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTES 148 (389)
Q Consensus 72 ill~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 148 (389)
|++ +.++.+||+|||++...... .......||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+.+..
T Consensus 139 Il~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 215 (317)
T 2pmi_A 139 LLI---NKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE 215 (317)
T ss_dssp EEE---CTTCCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred eEE---cCCCCEEECcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 999 56789999999999876433 23445689999999998853 5899999999999999999999999998888
Q ss_pred HHHHHHHhcCCCCCCC------------------------------CCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCC
Q 016471 149 GIFRSVLRADPNFHDS------------------------------PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHP 198 (389)
Q Consensus 149 ~~~~~i~~~~~~~~~~------------------------------~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~ 198 (389)
+....+.......+.. ....+++++.+||.+||..||.+|||++++++||
T Consensus 216 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp 295 (317)
T 2pmi_A 216 EQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHP 295 (317)
T ss_dssp HHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSG
T ss_pred HHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCCh
Confidence 7777665422111110 0124788999999999999999999999999999
Q ss_pred CCCCCCC
Q 016471 199 WLHDENR 205 (389)
Q Consensus 199 ~~~~~~~ 205 (389)
||++...
T Consensus 296 ~f~~~~~ 302 (317)
T 2pmi_A 296 WFAEYYH 302 (317)
T ss_dssp GGGGGCC
T ss_pred hhhcccc
Confidence 9987643
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=312.99 Aligned_cols=205 Identities=29% Similarity=0.559 Sum_probs=175.9
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
.||||++++ ....+|+|||||.||+|.+++... .+.+++..++.++.||+.||.|||++||+||||||+||+++.
T Consensus 87 ~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~ 166 (327)
T 3lm5_A 87 SCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSS 166 (327)
T ss_dssp TCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESC
T ss_pred CCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEec
Confidence 579999998 357899999999999999987533 367999999999999999999999999999999999999964
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVL 155 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 155 (389)
...++.+||+|||++.............||+.|+|||++. ..++.++||||+||++|+|++|..||.+.+.......+.
T Consensus 167 ~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 246 (327)
T 3lm5_A 167 IYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNIS 246 (327)
T ss_dssp BTTBCCEEECCGGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCCCCcEEEeeCccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHH
Confidence 3346889999999998876555556678999999999986 468999999999999999999999999999888888888
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCCCC
Q 016471 156 RADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRP 206 (389)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~~~ 206 (389)
......+...++.+++.+.++|.+||..||.+|||++++++||||+.....
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~ 297 (327)
T 3lm5_A 247 QVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFE 297 (327)
T ss_dssp HTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTT
T ss_pred hcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccc
Confidence 877777777778899999999999999999999999999999999876543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=313.21 Aligned_cols=206 Identities=26% Similarity=0.437 Sum_probs=174.3
Q ss_pred CCCccccceee------------cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCC
Q 016471 1 MYHQKLQHLFY------------SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLK 68 (389)
Q Consensus 1 l~Hpni~~~~~------------~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlk 68 (389)
|.||||++++. .+.+|+|||||.| +|.+.+....+.+++..++.++.||+.||.|||++||+|||||
T Consensus 73 l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk 151 (351)
T 3mi9_A 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMK 151 (351)
T ss_dssp CCCTTBCCEEEEEEEC--------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred ccCCCcccHhheeeccccccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCC
Confidence 57999999983 3568999999986 8888887766789999999999999999999999999999999
Q ss_pred CCcEEEeecCCCCCEEEeecCCccccCCC-----CCcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCCCC
Q 016471 69 PENFLFTTREEDAPLKVIDFGLSDFVRPD-----QRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRP 141 (389)
Q Consensus 69 p~Nill~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~p 141 (389)
|+|||+ +.++.+||+|||++...... .......||+.|+|||++.+ .++.++||||+||++|+|++|.+|
T Consensus 152 p~NIl~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p 228 (351)
T 3mi9_A 152 AANVLI---TRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI 228 (351)
T ss_dssp GGGEEE---CTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred HHHEEE---cCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCC
Confidence 999999 56789999999999765422 23345678999999998753 589999999999999999999999
Q ss_pred CCCCChhHHHHHHHhcCCCCCCCCCCCC----------------------------CHHHHHHHHhhhccCcCCCCCHHH
Q 016471 142 FWARTESGIFRSVLRADPNFHDSPWPSV----------------------------SPEAKDFVRRLLNKDHRKRMTAAQ 193 (389)
Q Consensus 142 f~~~~~~~~~~~i~~~~~~~~~~~~~~~----------------------------~~~~~~li~~~l~~~p~~R~s~~e 193 (389)
|.+.+.......+.+.....+...++.. ++.+.+||.+||..||.+|||+++
T Consensus 229 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 308 (351)
T 3mi9_A 229 MQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD 308 (351)
T ss_dssp CCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred CCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHH
Confidence 9999888887777665545444444432 778999999999999999999999
Q ss_pred HhCCCCCCCCCCCCCcc
Q 016471 194 ALTHPWLHDENRPVPLD 210 (389)
Q Consensus 194 ~l~h~~~~~~~~~~~~~ 210 (389)
+++||||+....+....
T Consensus 309 ~l~hp~f~~~~~~~~~~ 325 (351)
T 3mi9_A 309 ALNHDFFWSDPMPSDLK 325 (351)
T ss_dssp HHTSGGGGSSSCCCCSH
T ss_pred HhCCCCcCCCCCccccc
Confidence 99999998876655543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=328.08 Aligned_cols=195 Identities=33% Similarity=0.597 Sum_probs=173.9
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ ..+.+|+|||||+||+|.+++.++ +.+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 73 l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll-- 149 (476)
T 2y94_A 73 FRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKN-GRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLL-- 149 (476)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTSS-SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEE--
T ss_pred CCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEE--
Confidence 5799999999 357899999999999999988654 689999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc-c-CCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-S-YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
+.++.+||+|||++..........+.+||+.|+|||++.+ . ++.++||||+||++|+|++|..||.+.........+
T Consensus 150 -~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i 228 (476)
T 2y94_A 150 -DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKI 228 (476)
T ss_dssp -CTTCCEEECCCSSCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHH
T ss_pred -ecCCCeEEEeccchhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHH
Confidence 5778999999999988766666667789999999999865 3 368999999999999999999999998888888888
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~ 203 (389)
..+....+ ..+++.+.+||.+||..||.+|||+.++++||||+..
T Consensus 229 ~~~~~~~p----~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 229 CDGIFYTP----QYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp HTTCCCCC----TTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred hcCCcCCC----ccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 87654433 3579999999999999999999999999999999764
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=317.10 Aligned_cols=196 Identities=35% Similarity=0.686 Sum_probs=176.5
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
.||||+.++ .....|+|||||+||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+||++
T Consensus 158 ~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~--- 233 (365)
T 2y7j_A 158 GHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILL--- 233 (365)
T ss_dssp TCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---
T ss_pred CCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---
Confidence 699999988 357899999999999999988765 679999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCCccccCCCCCcccccccCCccccccccc-------cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHH
Q 016471 78 EEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-------SYNVEGDMWSIGVITYILLCGSRPFWARTESGI 150 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 150 (389)
+.++.+||+|||++............+||+.|+|||++.+ .++.++||||+||++|+|++|..||.+......
T Consensus 234 ~~~~~ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 313 (365)
T 2y7j_A 234 DDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILM 313 (365)
T ss_dssp CTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred CCCCCEEEEecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHH
Confidence 5778999999999988776666667789999999998742 478899999999999999999999999888888
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCC
Q 016471 151 FRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLH 201 (389)
Q Consensus 151 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~ 201 (389)
...+......++.+.|..+++.+.++|.+||..||.+|||+.++++||||+
T Consensus 314 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 314 LRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp HHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred HHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 888887776665555667899999999999999999999999999999996
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=305.96 Aligned_cols=202 Identities=42% Similarity=0.785 Sum_probs=178.7
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|.||||++++ ....+|+|||||+||+|.+++... +.+++..+..++.|++.||.|||++||+||||||+||++..
T Consensus 63 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~ 141 (304)
T 2jam_A 63 IKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLT 141 (304)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESS
T ss_pred CCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEec
Confidence 5799999988 357899999999999999988766 67999999999999999999999999999999999999954
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVL 155 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 155 (389)
.+.++.+||+|||++..... .......||+.|+|||++. ..++.++||||+||++|+|++|..||.+.........+.
T Consensus 142 ~~~~~~~kl~Dfg~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~ 220 (304)
T 2jam_A 142 PEENSKIMITDFGLSKMEQN-GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIK 220 (304)
T ss_dssp SSTTCCEEBCSCSTTCCCCC-BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred CCCCCCEEEccCCcceecCC-CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 45678899999999876432 2334457999999999985 468999999999999999999999999998888888888
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 156 RADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
.....++...++.+++.+.++|.+||..||.+|||+.++++||||....
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 221 EGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp HCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred cCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence 8777666666678999999999999999999999999999999997654
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=310.78 Aligned_cols=200 Identities=27% Similarity=0.491 Sum_probs=165.7
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|.||||++++ ..+.+|+|||||.| +|.+++......+++..++.++.||+.||.|||++||+||||||+||++
T Consensus 57 l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~-- 133 (324)
T 3mtl_A 57 LKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLI-- 133 (324)
T ss_dssp CCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEE--
T ss_pred cCCCCCCeeeeEEeeCCEEEEEeccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEE--
Confidence 5799999998 35789999999985 9999888776779999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCC-CCcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPD-QRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRS 153 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 153 (389)
+.++.+||+|||++...... .......||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+.+..+....
T Consensus 134 -~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~ 212 (324)
T 3mtl_A 134 -NERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHF 212 (324)
T ss_dssp -CTTCCEEECSSSEEECC------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred -CCCCCEEEccCcccccccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 56789999999998765432 23345678999999998753 589999999999999999999999999988887777
Q ss_pred HHhcCCCCCCCCC--------------------------CCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 154 VLRADPNFHDSPW--------------------------PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 154 i~~~~~~~~~~~~--------------------------~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
+.+.........| +.+++++.+||.+||..||.+|||++|+++||||.+..
T Consensus 213 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 289 (324)
T 3mtl_A 213 IFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289 (324)
T ss_dssp HHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred HHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence 7654333322222 34689999999999999999999999999999998664
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=310.93 Aligned_cols=193 Identities=24% Similarity=0.306 Sum_probs=161.3
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
.||||+.++ ..+.+|+||||| +|+|.+++...+..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 115 ~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll--- 190 (311)
T 3p1a_A 115 QHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFL--- 190 (311)
T ss_dssp CCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---
T ss_pred CCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---
Confidence 799999998 467899999999 669999988877789999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCCccccCCCCCcccccccCCccccccccccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc
Q 016471 78 EEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRA 157 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 157 (389)
+.++.+||+|||++.............||+.|+|||++.+.++.++||||+||++|+|++|..|+.+.. ....+...
T Consensus 191 ~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~---~~~~~~~~ 267 (311)
T 3p1a_A 191 GPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGE---GWQQLRQG 267 (311)
T ss_dssp CGGGCEEECCCTTCEECC------CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSSHH---HHHHHTTT
T ss_pred CCCCCEEEccceeeeecccCCCCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHhcc
Confidence 567899999999998776555555667999999999998889999999999999999999977775532 23333332
Q ss_pred CCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCC
Q 016471 158 DPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~ 203 (389)
. .+....+.+++.+.++|.+||..||.+|||++++++||||+++
T Consensus 268 ~--~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~p 311 (311)
T 3p1a_A 268 Y--LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQP 311 (311)
T ss_dssp C--CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSCC
T ss_pred C--CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccCC
Confidence 2 1222234689999999999999999999999999999999763
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=335.88 Aligned_cols=195 Identities=26% Similarity=0.482 Sum_probs=175.3
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
+||+|+.++ ..+.+|+|||||+||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 400 ~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl--- 475 (674)
T 3pfq_A 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML--- 475 (674)
T ss_dssp CCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEE---
T ss_pred CCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEE---
Confidence 699999988 357899999999999999988766 689999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCCccccC-CCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 016471 78 EEDAPLKVIDFGLSDFVR-PDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVL 155 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 155 (389)
+.++.+||+|||+|.... ......+.+||+.|+|||++. ..|+.++|||||||++|||++|++||.+.+..+++..|.
T Consensus 476 ~~~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~ 555 (674)
T 3pfq_A 476 DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 555 (674)
T ss_dssp CSSSCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred cCCCcEEEeecceeeccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 578899999999998643 334456678999999999986 579999999999999999999999999999999999999
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCH-----HHHhCCCCCCCCC
Q 016471 156 RADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTA-----AQALTHPWLHDEN 204 (389)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~-----~e~l~h~~~~~~~ 204 (389)
.....++ +.+++++++||++||..||.+||++ +++++||||+..+
T Consensus 556 ~~~~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~ 605 (674)
T 3pfq_A 556 EHNVAYP----KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 605 (674)
T ss_dssp SSCCCCC----TTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCC
T ss_pred hCCCCCC----ccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCC
Confidence 8776655 3589999999999999999999997 9999999998753
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=307.42 Aligned_cols=202 Identities=30% Similarity=0.566 Sum_probs=172.2
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
++||||+.++ ..+.+|+|||||+||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||++
T Consensus 99 l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll-- 174 (321)
T 2c30_A 99 YQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILL-- 174 (321)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--
T ss_pred CCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE--
Confidence 5799999988 46789999999999999987643 579999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC-CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
+.++.+||+|||++....... ......||+.|+|||++. ..++.++||||+||++|+|++|+.||.+.........+
T Consensus 175 -~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~ 253 (321)
T 2c30_A 175 -TLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL 253 (321)
T ss_dssp -CTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred -CCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 567899999999988765432 334568999999999885 46899999999999999999999999988887777777
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVP 208 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~~~~~ 208 (389)
....... ......+++.++++|.+||..||.+|||+.++++||||.....+..
T Consensus 254 ~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~~~ 306 (321)
T 2c30_A 254 RDSPPPK-LKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLPEC 306 (321)
T ss_dssp HHSSCCC-CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCCCGGG
T ss_pred hcCCCCC-cCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCCCccc
Confidence 6543321 1122458999999999999999999999999999999987654443
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=306.48 Aligned_cols=194 Identities=25% Similarity=0.517 Sum_probs=166.7
Q ss_pred CCCccccceee------cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEE
Q 016471 1 MYHQKLQHLFY------SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLF 74 (389)
Q Consensus 1 l~Hpni~~~~~------~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill 74 (389)
|.||||++++. ...+|+|||||++|+|.+++ ..+.+++..++.++.||+.||.|||++||+||||||+||++
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~ 170 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP--TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV 170 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS--CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence 57999999982 46799999999999998754 33579999999999999999999999999999999999999
Q ss_pred eecCCCCCEEEeecCCccccCCCC-CcccccccCCcccccccccc----CCCchhHHHHHHHHHHHHhCCCCCCCCChhH
Q 016471 75 TTREEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLHRS----YNVEGDMWSIGVITYILLCGSRPFWARTESG 149 (389)
Q Consensus 75 ~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 149 (389)
+.++.+||+|||++....... ......||+.|+|||++.+. ++.++||||+||++|+|++|..||.+.....
T Consensus 171 ---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 247 (298)
T 2zv2_A 171 ---GEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC 247 (298)
T ss_dssp ---CTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred ---CCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHH
Confidence 567899999999998765432 23456899999999998542 3778999999999999999999999888777
Q ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCC
Q 016471 150 IFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLH 201 (389)
Q Consensus 150 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~ 201 (389)
....+......++. .+.+++.+.++|.+||..||.+|||+.++++||||+
T Consensus 248 ~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 248 LHSKIKSQALEFPD--QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HHHHHHHCCCCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred HHHHHhcccCCCCC--ccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 77777665544332 357899999999999999999999999999999984
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=310.28 Aligned_cols=202 Identities=26% Similarity=0.447 Sum_probs=163.3
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|+||||++++ ..+.+|+|||||.| +|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 90 l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~ 167 (329)
T 3gbz_A 90 LQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKN-PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSV 167 (329)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC
T ss_pred cCCCCcceEEEEEecCCEEEEEEecCCC-CHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEec
Confidence 5799999998 46889999999985 999988665 67999999999999999999999999999999999999963
Q ss_pred cC--CCCCEEEeecCCccccCCC-CCcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHH
Q 016471 77 RE--EDAPLKVIDFGLSDFVRPD-QRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIF 151 (389)
Q Consensus 77 ~~--~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 151 (389)
.+ ..+.+||+|||++...... ......+||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.......
T Consensus 168 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~ 247 (329)
T 3gbz_A 168 SDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQL 247 (329)
T ss_dssp -----CCEEEECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred CCCCccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHH
Confidence 22 3456999999999876432 23345678999999998854 4899999999999999999999999998888777
Q ss_pred HHHHhcCCCCCCCCCC--------------------------CCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 152 RSVLRADPNFHDSPWP--------------------------SVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 152 ~~i~~~~~~~~~~~~~--------------------------~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
..+...........|+ .+++++.+||.+||..||.+|||++++++||||++..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 326 (329)
T 3gbz_A 248 FKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND 326 (329)
T ss_dssp HHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSC
T ss_pred HHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCC
Confidence 7776543322222221 1679999999999999999999999999999998764
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=319.44 Aligned_cols=196 Identities=28% Similarity=0.466 Sum_probs=161.6
Q ss_pred CCccccceee------cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEe
Q 016471 2 YHQKLQHLFY------SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 75 (389)
Q Consensus 2 ~Hpni~~~~~------~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~ 75 (389)
.||||++++. ...+|+|||||.| +|.+++.. +.+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 67 ~h~niv~l~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll- 142 (388)
T 3oz6_A 67 GHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL- 142 (388)
T ss_dssp TCTTBCCEEEEEECTTSSCEEEEEECCSE-EHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE-
T ss_pred CCCCCCeeeeEEecCCCCEEEEEecccCc-CHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEE-
Confidence 3999999983 2369999999985 89887755 479999999999999999999999999999999999999
Q ss_pred ecCCCCCEEEeecCCccccCC----------------------CCCcccccccCCcccccccc--ccCCCchhHHHHHHH
Q 016471 76 TREEDAPLKVIDFGLSDFVRP----------------------DQRLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVI 131 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~----------------------~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~i 131 (389)
+.++.+||+|||+|+.... .......+||+.|+|||++. ..++.++||||+||+
T Consensus 143 --~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~i 220 (388)
T 3oz6_A 143 --NAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCI 220 (388)
T ss_dssp --CTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHH
T ss_pred --cCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHH
Confidence 5778999999999976532 11234468999999999885 368999999999999
Q ss_pred HHHHHhCCCCCCCCChhHHHHHHHhcCCCCCC-------------------------------------------CCCCC
Q 016471 132 TYILLCGSRPFWARTESGIFRSVLRADPNFHD-------------------------------------------SPWPS 168 (389)
Q Consensus 132 l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~-------------------------------------------~~~~~ 168 (389)
+|+|++|++||.+.+....+..+......+.. .+...
T Consensus 221 l~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (388)
T 3oz6_A 221 LGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKAD 300 (388)
T ss_dssp HHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCC
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhccccccccc
Confidence 99999999999998888777776542211110 01126
Q ss_pred CCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCC
Q 016471 169 VSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 169 ~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~ 203 (389)
+++++.+||.+||..||.+|||++++++||||+..
T Consensus 301 ~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~~ 335 (388)
T 3oz6_A 301 CNEEALDLLDKLLQFNPNKRISANDALKHPFVSIF 335 (388)
T ss_dssp CCHHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTTT
T ss_pred CCHHHHHHHHHhhccCcccCCCHHHHhCCHHHHHh
Confidence 78999999999999999999999999999999754
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=331.36 Aligned_cols=196 Identities=27% Similarity=0.473 Sum_probs=170.1
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEe
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 75 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~ 75 (389)
++||||+.++ ..+.+|+|||||+||+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 241 l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILl- 319 (576)
T 2acx_A 241 VNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL- 319 (576)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE-
T ss_pred cCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEE-
Confidence 5899999998 3578999999999999999887542 349999999999999999999999999999999999999
Q ss_pred ecCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCC----hhHH
Q 016471 76 TREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWART----ESGI 150 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~ 150 (389)
+.++.+||+|||++............+||+.|+|||++.+ .++.++||||+||++|+|++|.+||.+.. ...+
T Consensus 320 --d~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i 397 (576)
T 2acx_A 320 --DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV 397 (576)
T ss_dssp --CTTSCEEECCCTTCEECCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHH
T ss_pred --eCCCCeEEEecccceecccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHH
Confidence 5788999999999988766655666799999999999864 69999999999999999999999998754 2445
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCC-----CHHHHhCCCCCCCC
Q 016471 151 FRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRM-----TAAQALTHPWLHDE 203 (389)
Q Consensus 151 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----s~~e~l~h~~~~~~ 203 (389)
...+......++ ..+++++++||.+||..||.+|| +++++++||||+..
T Consensus 398 ~~~i~~~~~~~p----~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i 451 (576)
T 2acx_A 398 ERLVKEVPEEYS----ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451 (576)
T ss_dssp HHHHHHCCCCCC----TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred HHHhhcccccCC----ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence 555555443333 46899999999999999999999 78999999999864
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=303.57 Aligned_cols=202 Identities=40% Similarity=0.790 Sum_probs=179.9
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|.||||++++ ....+|+|||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||+++.
T Consensus 78 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~ 156 (287)
T 2wei_A 78 LDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLES 156 (287)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESC
T ss_pred ccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEec
Confidence 5799999998 357899999999999999988766 57999999999999999999999999999999999999965
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCccccccccccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLR 156 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 156 (389)
.+.+..+||+|||++.............||+.|+|||++.+.++.++||||+|+++|+|++|..||.+.+.......+..
T Consensus 157 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 236 (287)
T 2wei_A 157 KEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET 236 (287)
T ss_dssp SSTTCCEEECSTTGGGTBCCCSSCSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCCcccEEEeccCcceeecCCCccccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence 44456899999999987765555556679999999999988899999999999999999999999999988888888887
Q ss_pred cCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCC
Q 016471 157 ADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~ 203 (389)
.....+.+.+..+++.+.++|.+||..+|.+|||+.++++||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 237 GKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp CCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred CCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 76666655567899999999999999999999999999999999643
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=301.04 Aligned_cols=199 Identities=35% Similarity=0.658 Sum_probs=178.4
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
.||||++++ ....+|+|||||+||+|.+++..+ +.+++..+..++.||+.||.|||++||+||||||+||++
T Consensus 82 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~--- 157 (298)
T 1phk_A 82 GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL--- 157 (298)
T ss_dssp TCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---
T ss_pred CCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---
Confidence 499999998 357899999999999999988765 679999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCCccccCCCCCcccccccCCcccccccc-------ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHH
Q 016471 78 EEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-------RSYNVEGDMWSIGVITYILLCGSRPFWARTESGI 150 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 150 (389)
+.++.+||+|||++.............||+.|+|||++. ..++.++||||+|+++|+|++|..||.+.+....
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~ 237 (298)
T 1phk_A 158 DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM 237 (298)
T ss_dssp CTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred cCCCcEEEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHH
Confidence 567889999999998876665566678999999999873 2478899999999999999999999999888888
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 151 FRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 151 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
...+.......+.+.++.+++.+.++|.+||..||.+|||+.++++||||++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 238 LRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp HHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred HHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 888888777766666678999999999999999999999999999999998653
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=309.69 Aligned_cols=197 Identities=29% Similarity=0.557 Sum_probs=164.7
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|.||||++++ ..+..|+|||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 62 l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll-- 138 (323)
T 3tki_A 62 LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL-- 138 (323)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--
T ss_pred CCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEE--
Confidence 5899999999 357899999999999999977544 679999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCC---CCcccccccCCccccccccc-c-CCCchhHHHHHHHHHHHHhCCCCCCCCChhHH-
Q 016471 77 REEDAPLKVIDFGLSDFVRPD---QRLNDIVGSAYYVAPEVLHR-S-YNVEGDMWSIGVITYILLCGSRPFWARTESGI- 150 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~-~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~- 150 (389)
+.++.+||+|||++...... ......+||+.|+|||++.+ . ++.++||||+||++|+|++|..||.+......
T Consensus 139 -~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 217 (323)
T 3tki_A 139 -DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217 (323)
T ss_dssp -CTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH
T ss_pred -eCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH
Confidence 56789999999999765322 22345689999999999854 3 47789999999999999999999987665433
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCC
Q 016471 151 FRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 151 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~ 203 (389)
......... ....+..+++.+.+||.+||..||.+|||++++++||||+..
T Consensus 218 ~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 218 YSDWKEKKT--YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp HHHHHTTCT--TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHHHhcccc--cCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence 333332222 222346789999999999999999999999999999999865
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=325.40 Aligned_cols=196 Identities=25% Similarity=0.417 Sum_probs=156.7
Q ss_pred CCCccccceeec----------CeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCC
Q 016471 1 MYHQKLQHLFYS----------NSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPE 70 (389)
Q Consensus 1 l~Hpni~~~~~~----------~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~ 70 (389)
|.||||++++.. ..+|+|||||.++ |.+.+. ..+++..++.++.||+.||+|||++||+||||||+
T Consensus 118 l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~~-l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~ 193 (464)
T 3ttj_A 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPS 193 (464)
T ss_dssp CCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEE-HHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred CCCCCCCcEEEEEccCCccccCCeEEEEEeCCCCC-HHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChH
Confidence 589999999831 4689999999875 666552 35999999999999999999999999999999999
Q ss_pred cEEEeecCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhH
Q 016471 71 NFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESG 149 (389)
Q Consensus 71 Nill~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 149 (389)
|||+ +.++.+||+|||+|............+||+.|+|||++. ..|+.++||||+||++|+|++|++||.+.+..+
T Consensus 194 NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~ 270 (464)
T 3ttj_A 194 NIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 270 (464)
T ss_dssp GEEE---CTTSCEEECCCCCC-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred hEEE---eCCCCEEEEEEEeeeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999 577899999999998876655566789999999999885 479999999999999999999999999988877
Q ss_pred HHHHHHhcCCCC----------------------CCCCCC----C------------CCHHHHHHHHhhhccCcCCCCCH
Q 016471 150 IFRSVLRADPNF----------------------HDSPWP----S------------VSPEAKDFVRRLLNKDHRKRMTA 191 (389)
Q Consensus 150 ~~~~i~~~~~~~----------------------~~~~~~----~------------~~~~~~~li~~~l~~~p~~R~s~ 191 (389)
.+..+.+..... ....++ . .++++++||.+||.+||.+|||+
T Consensus 271 ~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta 350 (464)
T 3ttj_A 271 QWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 350 (464)
T ss_dssp HHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCH
T ss_pred HHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCH
Confidence 777665432211 110000 0 15679999999999999999999
Q ss_pred HHHhCCCCCCCC
Q 016471 192 AQALTHPWLHDE 203 (389)
Q Consensus 192 ~e~l~h~~~~~~ 203 (389)
+|+|+||||+..
T Consensus 351 ~e~L~Hp~~~~~ 362 (464)
T 3ttj_A 351 DDALQHPYINVW 362 (464)
T ss_dssp HHHHTSTTTGGG
T ss_pred HHHhcChhhhhc
Confidence 999999999753
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=310.34 Aligned_cols=202 Identities=24% Similarity=0.375 Sum_probs=171.1
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|.||||++++ ....+|+|||||.+ +|.+++......+++..++.++.|++.||.|||++||+||||||+||++
T Consensus 69 l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~-- 145 (346)
T 1ua2_A 69 LSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL-- 145 (346)
T ss_dssp CCCTTBCCEEEEECCTTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE--
T ss_pred CCCCCCCeEEEEEeeCCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEE--
Confidence 5799999998 35789999999997 8888887666679999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCC-CCcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPD-QRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRS 153 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 153 (389)
+.++.+||+|||++...... ......+||+.|+|||++.+ .++.++||||+||++|+|++|.+||.+.+....+..
T Consensus 146 -~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~ 224 (346)
T 1ua2_A 146 -DENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTR 224 (346)
T ss_dssp -CTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred -cCCCCEEEEecccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 56789999999999876432 33455689999999998853 488999999999999999999999999988888777
Q ss_pred HHhcCCCCCCCCC------------------------CCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCCCC
Q 016471 154 VLRADPNFHDSPW------------------------PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRP 206 (389)
Q Consensus 154 i~~~~~~~~~~~~------------------------~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~~~ 206 (389)
+...........| +.+++++++||.+||..||.+|||++++++||||.+...+
T Consensus 225 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~ 301 (346)
T 1ua2_A 225 IFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP 301 (346)
T ss_dssp HHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred HHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCC
Confidence 7654322222111 3467899999999999999999999999999999876433
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=315.13 Aligned_cols=202 Identities=21% Similarity=0.300 Sum_probs=161.6
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEe
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 75 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~ 75 (389)
|+||||++++ ..+.+|+|||||+||+|.+++... .+.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 83 l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll- 161 (389)
T 3gni_B 83 FNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI- 161 (389)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE-
T ss_pred CCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE-
Confidence 5899999998 468899999999999999988754 3569999999999999999999999999999999999999
Q ss_pred ecCCCCCEEEeecCCccccCCC--------CCcccccccCCccccccccc---cCCCchhHHHHHHHHHHHHhCCCCCCC
Q 016471 76 TREEDAPLKVIDFGLSDFVRPD--------QRLNDIVGSAYYVAPEVLHR---SYNVEGDMWSIGVITYILLCGSRPFWA 144 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~~--------~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~ 144 (389)
+.++.+||+|||.+...... ......+||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+
T Consensus 162 --~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 239 (389)
T 3gni_B 162 --SVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 239 (389)
T ss_dssp --CTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred --cCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 57789999999987643211 11233578999999999854 589999999999999999999999988
Q ss_pred CChhHHHHHHHhcCCC------------------------------------------CCCCCCCCCCHHHHHHHHhhhc
Q 016471 145 RTESGIFRSVLRADPN------------------------------------------FHDSPWPSVSPEAKDFVRRLLN 182 (389)
Q Consensus 145 ~~~~~~~~~i~~~~~~------------------------------------------~~~~~~~~~~~~~~~li~~~l~ 182 (389)
.+.......+...... ...+....+++.+++||.+||.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~ 319 (389)
T 3gni_B 240 MPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQ 319 (389)
T ss_dssp CCSTTHHHHC--------------------------------------------------------CCHHHHHHHHHHTC
T ss_pred CCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhh
Confidence 6665554433322110 0001224578999999999999
Q ss_pred cCcCCCCCHHHHhCCCCCCCCCC
Q 016471 183 KDHRKRMTAAQALTHPWLHDENR 205 (389)
Q Consensus 183 ~~p~~R~s~~e~l~h~~~~~~~~ 205 (389)
.||.+|||++++++||||+....
T Consensus 320 ~dP~~Rpta~ell~hp~f~~~~~ 342 (389)
T 3gni_B 320 RNPDARPSASTLLNHSFFKQIKR 342 (389)
T ss_dssp SCTTTSCCHHHHTTSGGGGGC--
T ss_pred cCcccCCCHHHHhcCHHHHHHhh
Confidence 99999999999999999987643
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=309.53 Aligned_cols=202 Identities=36% Similarity=0.642 Sum_probs=169.0
Q ss_pred CCCcccccee---ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 1 MYHQKLQHLF---YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 1 l~Hpni~~~~---~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
|.||||++++ ....+|+|||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||+++..
T Consensus 72 l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~ 150 (322)
T 2ycf_A 72 LNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQ 150 (322)
T ss_dssp CCCTTBCCEEEEEESSSEEEEEECCTTEETHHHHSTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSS
T ss_pred CCCCCCceEeeEEcCCceEEEEecCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecC
Confidence 5799999988 356699999999999999987654 689999999999999999999999999999999999999644
Q ss_pred CCCCCEEEeecCCccccCCCCCcccccccCCcccccccc----ccCCCchhHHHHHHHHHHHHhCCCCCCCCChh-HHHH
Q 016471 78 EEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH----RSYNVEGDMWSIGVITYILLCGSRPFWARTES-GIFR 152 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~ 152 (389)
+.+..+||+|||++.............||+.|+|||++. ..++.++||||+||++|+|++|..||...... ....
T Consensus 151 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 230 (322)
T 2ycf_A 151 EEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKD 230 (322)
T ss_dssp SSSCCEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHH
T ss_pred CCCCeEEEccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHH
Confidence 445569999999998765544444567999999999862 45889999999999999999999999775443 3444
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCC
Q 016471 153 SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 153 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~ 203 (389)
.+........+..++.+++.+.++|.+||..||.+|||+.++++||||+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~ 281 (322)
T 2ycf_A 231 QITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 281 (322)
T ss_dssp HHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred HHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence 555554444333345789999999999999999999999999999999753
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=298.66 Aligned_cols=197 Identities=20% Similarity=0.378 Sum_probs=164.1
Q ss_pred CCCccccceee--------cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCCC
Q 016471 1 MYHQKLQHLFY--------SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQG--VVHRDLKPE 70 (389)
Q Consensus 1 l~Hpni~~~~~--------~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--i~Hrdlkp~ 70 (389)
|.||||++++. ...+|+|||||+||+|.+++... +.+++..++.++.||+.||.|||++| |+||||||+
T Consensus 82 l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~ 160 (290)
T 1t4h_A 82 LQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCD 160 (290)
T ss_dssp CCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGG
T ss_pred CCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHH
Confidence 57999999983 25589999999999999988765 67999999999999999999999999 999999999
Q ss_pred cEEEeecCCCCCEEEeecCCccccCCCCCcccccccCCccccccccccCCCchhHHHHHHHHHHHHhCCCCCCCCChhH-
Q 016471 71 NFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWARTESG- 149 (389)
Q Consensus 71 Nill~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~- 149 (389)
||+++ +.++.+||+|||++...... ......||+.|+|||++.+.++.++||||+||++|+|++|+.||.+.....
T Consensus 161 Nil~~--~~~~~~kl~Dfg~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 237 (290)
T 1t4h_A 161 NIFIT--GPTGSVKIGDLGLATLKRAS-FAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ 237 (290)
T ss_dssp GEEES--STTSCEEECCTTGGGGCCTT-SBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH
T ss_pred HEEEE--CCCCCEEEeeCCCccccccc-ccccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH
Confidence 99994 35789999999999754432 334567999999999998889999999999999999999999998855444
Q ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCC
Q 016471 150 IFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 150 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~ 203 (389)
....+..... +.......++.+.++|.+||..+|.+|||++++++||||++.
T Consensus 238 ~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 238 IYRRVTSGVK--PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp HHHHHTTTCC--CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred HHHHHhccCC--ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence 3444433221 111223567999999999999999999999999999999764
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=306.49 Aligned_cols=198 Identities=23% Similarity=0.384 Sum_probs=169.8
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|.||||++++ ..+..|+|||||. |+|.+.+....+.+++..++.++.|++.||.|||++||+||||||+|||++
T Consensus 111 l~hpniv~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~- 188 (348)
T 1u5q_A 111 LRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS- 188 (348)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE-
T ss_pred CCCCCEeeEEEEEEECCeEEEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC-
Confidence 5899999988 4678999999998 588888876667899999999999999999999999999999999999994
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc----ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH----RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFR 152 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 152 (389)
.++.+||+|||++..... .....||+.|+|||++. +.++.++||||+||++|+|++|..||.+.+......
T Consensus 189 --~~~~~kL~DfG~a~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~ 263 (348)
T 1u5q_A 189 --EPGLVKLGDFGSASIMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY 263 (348)
T ss_dssp --TTTEEEECCCTTCBSSSS---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred --CCCCEEEeeccCceecCC---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 678999999999976543 23567999999999873 468999999999999999999999999888777766
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCCCCC
Q 016471 153 SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPV 207 (389)
Q Consensus 153 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~~~~ 207 (389)
.+....... .....+++.++++|.+||..+|.+|||++++++||||.....+.
T Consensus 264 ~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~~~ 316 (348)
T 1u5q_A 264 HIAQNESPA--LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPT 316 (348)
T ss_dssp HHHHSCCCC--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCCTT
T ss_pred HHHhcCCCC--CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhccCCcc
Confidence 666554322 22246899999999999999999999999999999997765443
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=321.96 Aligned_cols=196 Identities=27% Similarity=0.457 Sum_probs=169.2
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEE
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSR---GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFL 73 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nil 73 (389)
++||||+.++ ....+|+|||||+||+|.+++... .+.+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 242 l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NIL 321 (543)
T 3c4z_A 242 VHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVL 321 (543)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred cCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEE
Confidence 5899999988 357899999999999999988654 246999999999999999999999999999999999999
Q ss_pred EeecCCCCCEEEeecCCccccCCCCC-cccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCC----h
Q 016471 74 FTTREEDAPLKVIDFGLSDFVRPDQR-LNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWART----E 147 (389)
Q Consensus 74 l~~~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~----~ 147 (389)
+ +.++.+||+|||++........ ....+||+.|+|||++.+ .|+.++||||+||++|+|++|++||.+.. .
T Consensus 322 l---~~~g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~ 398 (543)
T 3c4z_A 322 L---DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN 398 (543)
T ss_dssp E---CTTSCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH
T ss_pred E---eCCCCEEEeecceeeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhH
Confidence 9 5788999999999987655433 344689999999999864 69999999999999999999999998753 3
Q ss_pred hHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCC-----HHHHhCCCCCCCC
Q 016471 148 SGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMT-----AAQALTHPWLHDE 203 (389)
Q Consensus 148 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s-----~~e~l~h~~~~~~ 203 (389)
..+...+......++ +.+++.+++||.+||..||.+||+ ++++++||||++.
T Consensus 399 ~~~~~~i~~~~~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i 455 (543)
T 3c4z_A 399 KELKQRVLEQAVTYP----DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455 (543)
T ss_dssp HHHHHHHHHCCCCCC----TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred HHHHHHHhhcccCCC----cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence 556666766554443 468999999999999999999996 5899999999875
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=298.33 Aligned_cols=197 Identities=28% Similarity=0.555 Sum_probs=145.3
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|+||||++++ ..+.+|+|||||++|+|.+++....+.+++..++.++.|++.||.|||++||+||||||+||++
T Consensus 68 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili-- 145 (278)
T 3cok_A 68 LKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLL-- 145 (278)
T ss_dssp BCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEE--
T ss_pred CCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE--
Confidence 5799999998 3578999999999999999887766789999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCC-CCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPD-QRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
+.++.+||+|||++...... .......||+.|+|||++.+ .++.++||||+|+++|+|++|+.||...........+
T Consensus 146 -~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 224 (278)
T 3cok_A 146 -TRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV 224 (278)
T ss_dssp -CTTCCEEECCCTTCEECC----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----C
T ss_pred -cCCCCEEEEeecceeeccCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHH
Confidence 56789999999999876432 22335679999999998854 6889999999999999999999999887665555544
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
....... ...++.++.++|.+||..||.+|||++++++||||....
T Consensus 225 ~~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 225 VLADYEM----PSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp CSSCCCC----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred hhcccCC----ccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence 3332222 135799999999999999999999999999999997654
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=299.51 Aligned_cols=201 Identities=34% Similarity=0.671 Sum_probs=170.2
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|.||||++++ ....+|+|||||+||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+||+++.
T Consensus 65 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~ 143 (283)
T 3bhy_A 65 IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLD 143 (283)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESC
T ss_pred CCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEec
Confidence 5799999998 357899999999999999988765 67999999999999999999999999999999999999953
Q ss_pred cC-CCCCEEEeecCCccccCCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 RE-EDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
.+ ....+||+|||++.............||+.|+|||++. ..++.++||||+|+++|+|++|..||.+.........+
T Consensus 144 ~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 223 (283)
T 3bhy_A 144 KNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNI 223 (283)
T ss_dssp SSSSSCCEEECCCTTCEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred CCCCCCceEEEecccceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHh
Confidence 21 12379999999998776555555667999999999885 46899999999999999999999999998888888887
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 202 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~ 202 (389)
.......+...++.+++.+.++|.+||..+|.+|||+.++++||||+.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 271 (283)
T 3bhy_A 224 SAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271 (283)
T ss_dssp HTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred HhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence 776655544444678999999999999999999999999999999954
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=302.69 Aligned_cols=201 Identities=25% Similarity=0.456 Sum_probs=161.4
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|.||||++++ ..+.+++|||||+||+|.+++.. .+.+++..+..++.|++.||.|||++||+||||||+||++
T Consensus 59 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~-- 135 (311)
T 4agu_A 59 LKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRY-QRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILI-- 135 (311)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--
T ss_pred CCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhh-hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEE--
Confidence 5799999998 45789999999999998876644 4679999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCC-CCcccccccCCcccccccc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPD-QRLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRS 153 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 153 (389)
+.++.+||+|||++...... .......||+.|+|||++. ..++.++||||+||++|+|++|.+||.+....+....
T Consensus 136 -~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~ 214 (311)
T 4agu_A 136 -TKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYL 214 (311)
T ss_dssp -CTTSCEEECCCTTCEECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred -cCCCCEEEeeCCCchhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 56789999999999876532 2334568999999999884 3589999999999999999999999998887766555
Q ss_pred HHhcCCC-------------------CCCC--------CCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCCC
Q 016471 154 VLRADPN-------------------FHDS--------PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENR 205 (389)
Q Consensus 154 i~~~~~~-------------------~~~~--------~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~~ 205 (389)
+...... .+.. .++.+++.+.+||.+||..||.+|||++++++||||++...
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 293 (311)
T 4agu_A 215 IRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE 293 (311)
T ss_dssp HHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC-
T ss_pred HHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccC
Confidence 4332110 1110 12468999999999999999999999999999999987643
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=312.66 Aligned_cols=201 Identities=24% Similarity=0.382 Sum_probs=165.1
Q ss_pred CCCccccceee----c------CeEEEEEEccCCCChHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCC
Q 016471 1 MYHQKLQHLFY----S------NSFLFFTRFCEGGELLDRIL---SRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDL 67 (389)
Q Consensus 1 l~Hpni~~~~~----~------~~~~lv~E~~~gg~L~~~l~---~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdl 67 (389)
|+||||++++. . ..+|+|||||+++.+ ..+. ...+.+++..++.++.||+.||.|||++||+||||
T Consensus 89 l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~-~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDl 167 (394)
T 4e7w_A 89 VKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVY-RASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDI 167 (394)
T ss_dssp CCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEEHH-HHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred CCCCCcceEEEEEEecCCCCCceEEEEEeeccCccHH-HHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCC
Confidence 58999999872 1 128899999998543 3332 23468999999999999999999999999999999
Q ss_pred CCCcEEEeecCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 016471 68 KPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWAR 145 (389)
Q Consensus 68 kp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~ 145 (389)
||+|||++ ..++.+||+|||+|.............||+.|+|||++.+ .++.++||||+||++|+|++|++||.+.
T Consensus 168 kp~Nill~--~~~~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 245 (394)
T 4e7w_A 168 KPQNLLLD--PPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGE 245 (394)
T ss_dssp SGGGEEEE--TTTTEEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CHHHEEEc--CCCCcEEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999995 2578899999999988766655667789999999998753 5899999999999999999999999998
Q ss_pred ChhHHHHHHHhcCCC-----------------CC---CC-----CCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCC
Q 016471 146 TESGIFRSVLRADPN-----------------FH---DS-----PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 146 ~~~~~~~~i~~~~~~-----------------~~---~~-----~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~ 200 (389)
+....+..+.+.... ++ .. ..+.+++++.+||.+||..||.+|||+.++++||||
T Consensus 246 ~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f 325 (394)
T 4e7w_A 246 SGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFF 325 (394)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGG
T ss_pred CHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhh
Confidence 887776666542111 00 00 113478999999999999999999999999999999
Q ss_pred CCCC
Q 016471 201 HDEN 204 (389)
Q Consensus 201 ~~~~ 204 (389)
+...
T Consensus 326 ~~~~ 329 (394)
T 4e7w_A 326 DELR 329 (394)
T ss_dssp STTT
T ss_pred hhhc
Confidence 8653
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=310.96 Aligned_cols=203 Identities=33% Similarity=0.614 Sum_probs=170.2
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhc---------------------------------------CCC
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSR---------------------------------------GGR 37 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~---------------------------------------~~~ 37 (389)
|+||||++++ ..+.+|+|||||+||+|.+++... ...
T Consensus 85 l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (345)
T 3hko_A 85 LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFV 164 (345)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHH
T ss_pred CCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhccccccccccccccccccccccccccccccccccccccccc
Confidence 5799999998 357899999999999999877310 112
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeecCCCCCEEEeecCCccccCCCC-----CcccccccCCcccc
Q 016471 38 YLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ-----RLNDIVGSAYYVAP 112 (389)
Q Consensus 38 l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aP 112 (389)
+++..++.++.||+.||.|||++||+||||||+||+++. +....+||+|||++....... ......||+.|+||
T Consensus 165 ~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~-~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aP 243 (345)
T 3hko_A 165 QREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFST-NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAP 243 (345)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESC-SSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCH
T ss_pred ccHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEec-CCCceEEEeeccccccccccCccccccccccCCCccccCc
Confidence 467889999999999999999999999999999999952 223489999999997653211 23456799999999
Q ss_pred cccc---ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCC
Q 016471 113 EVLH---RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRM 189 (389)
Q Consensus 113 E~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~ 189 (389)
|++. ..++.++||||+||++|+|++|+.||.+....+....+......++.+.++.+++.++++|.+||..+|.+||
T Consensus 244 E~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 323 (345)
T 3hko_A 244 EVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERF 323 (345)
T ss_dssp HHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSC
T ss_pred hhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCC
Confidence 9884 4688999999999999999999999999999888888888777666666667899999999999999999999
Q ss_pred CHHHHhCCCCCCCCC
Q 016471 190 TAAQALTHPWLHDEN 204 (389)
Q Consensus 190 s~~e~l~h~~~~~~~ 204 (389)
|+.++++||||++..
T Consensus 324 s~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 324 DAMRALQHPWISQFS 338 (345)
T ss_dssp CHHHHHHSHHHHTTS
T ss_pred CHHHHhcChhhccCh
Confidence 999999999997754
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=297.57 Aligned_cols=195 Identities=28% Similarity=0.576 Sum_probs=168.0
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ ....+|+|||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||++
T Consensus 66 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili-- 142 (279)
T 3fdn_A 66 LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL-- 142 (279)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEE--
T ss_pred CCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEE--
Confidence 5799999998 357899999999999999988766 679999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVL 155 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 155 (389)
+.++.+||+|||++...... ......||+.|+|||++.+ .++.++||||+|+++|+|++|..||.+.+.......+.
T Consensus 143 -~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 220 (279)
T 3fdn_A 143 -GSAGELKIADFGWSVHAPSS-RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS 220 (279)
T ss_dssp -CTTSCEEECSCCEESCC---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred -cCCCCEEEEeccccccCCcc-cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHH
Confidence 57789999999988654332 2345679999999998864 58899999999999999999999999988888888887
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 156 RADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
......+ ..+++.+.+||.+||..+|.+|||+.++++||||+...
T Consensus 221 ~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 221 RVEFTFP----DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp HTCCCCC----TTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred hCCCCCC----CcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCc
Confidence 7655443 34789999999999999999999999999999997653
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=309.99 Aligned_cols=197 Identities=25% Similarity=0.401 Sum_probs=163.1
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
.||||++++ ..+.+|+||||| ||+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+..
T Consensus 94 ~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~ 172 (360)
T 3llt_A 94 NNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDD 172 (360)
T ss_dssp TGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESC
T ss_pred CCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcc
Confidence 599999998 467899999999 889999887653 35999999999999999999999999999999999999952
Q ss_pred c----------------------CCCCCEEEeecCCccccCCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHH
Q 016471 77 R----------------------EEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITY 133 (389)
Q Consensus 77 ~----------------------~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ 133 (389)
. ..++.+||+|||++..... ......||+.|+|||++. ..++.++||||+||++|
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 250 (360)
T 3llt_A 173 PYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLA 250 (360)
T ss_dssp TTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred ccccccccchhcccccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHH
Confidence 1 1267899999999986543 234568999999999885 46999999999999999
Q ss_pred HHHhCCCCCCCCChhHHHHHHHhcCCCCCCC---------------------CCC---------------------CCCH
Q 016471 134 ILLCGSRPFWARTESGIFRSVLRADPNFHDS---------------------PWP---------------------SVSP 171 (389)
Q Consensus 134 ~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~---------------------~~~---------------------~~~~ 171 (389)
+|++|+.||.+.+..+....+.......+.. .|+ ..++
T Consensus 251 ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (360)
T 3llt_A 251 ELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHE 330 (360)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCH
T ss_pred HHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHH
Confidence 9999999999888777766665443322210 011 1247
Q ss_pred HHHHHHHhhhccCcCCCCCHHHHhCCCCCC
Q 016471 172 EAKDFVRRLLNKDHRKRMTAAQALTHPWLH 201 (389)
Q Consensus 172 ~~~~li~~~l~~~p~~R~s~~e~l~h~~~~ 201 (389)
.+.+||.+||+.||.+|||++++|+||||+
T Consensus 331 ~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 331 LFCDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 788999999999999999999999999995
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=314.06 Aligned_cols=205 Identities=26% Similarity=0.422 Sum_probs=156.9
Q ss_pred CCCccccceee------cCeEEEEEEccCCCChHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCCEecC
Q 016471 1 MYHQKLQHLFY------SNSFLFFTRFCEGGELLDRILSR--------GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRD 66 (389)
Q Consensus 1 l~Hpni~~~~~------~~~~~lv~E~~~gg~L~~~l~~~--------~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrd 66 (389)
|.||||++++. ...+|+|||||.| +|.+++... ...+++..++.++.||+.||.|||++||+|||
T Consensus 75 l~hpniv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~D 153 (405)
T 3rgf_A 75 LKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRD 153 (405)
T ss_dssp CCCTTBCCCCEEEEETTTTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred cCCCCeeeEeeEEecCCCCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCC
Confidence 68999999872 4679999999985 888877532 12499999999999999999999999999999
Q ss_pred CCCCcEEEeec-CCCCCEEEeecCCccccCCC----CCcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCC
Q 016471 67 LKPENFLFTTR-EEDAPLKVIDFGLSDFVRPD----QRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGS 139 (389)
Q Consensus 67 lkp~Nill~~~-~~~~~~kl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~ 139 (389)
|||+|||+... +.++.+||+|||+|...... ......+||+.|+|||++.+ .++.++||||+||++|+|++|.
T Consensus 154 lkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~ 233 (405)
T 3rgf_A 154 LKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233 (405)
T ss_dssp CCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSS
T ss_pred cCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCC
Confidence 99999999543 35688999999999876432 23345689999999998854 4899999999999999999999
Q ss_pred CCCCCCCh---------hHHHHHHHhcCCCCCCCCCCC----------------------------------CCHHHHHH
Q 016471 140 RPFWARTE---------SGIFRSVLRADPNFHDSPWPS----------------------------------VSPEAKDF 176 (389)
Q Consensus 140 ~pf~~~~~---------~~~~~~i~~~~~~~~~~~~~~----------------------------------~~~~~~~l 176 (389)
+||.+... ...+..+.......+...|+. .++.+.+|
T Consensus 234 ~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L 313 (405)
T 3rgf_A 234 PIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHL 313 (405)
T ss_dssp CTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHH
T ss_pred CCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHH
Confidence 99977554 244444444333333222221 27789999
Q ss_pred HHhhhccCcCCCCCHHHHhCCCCCCCCCCC
Q 016471 177 VRRLLNKDHRKRMTAAQALTHPWLHDENRP 206 (389)
Q Consensus 177 i~~~l~~~p~~R~s~~e~l~h~~~~~~~~~ 206 (389)
|.+||..||.+|||++++|+||||.....+
T Consensus 314 l~~~L~~dP~~R~ta~e~L~hp~f~~~~~~ 343 (405)
T 3rgf_A 314 LQKLLTMDPIKRITSEQAMQDPYFLEDPLP 343 (405)
T ss_dssp HHHHSCSSGGGSCCHHHHHTSGGGTSSSCC
T ss_pred HHHHccCCcccCCCHHHHhcChhhccCCCC
Confidence 999999999999999999999999876443
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=296.50 Aligned_cols=195 Identities=28% Similarity=0.588 Sum_probs=171.3
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|.||||++++ ..+.+|+|||||++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+||++
T Consensus 71 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~-- 147 (284)
T 2vgo_A 71 LRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLM-- 147 (284)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE--
T ss_pred CCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE--
Confidence 5799999998 357899999999999999988766 679999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVL 155 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 155 (389)
+.++.+||+|||++...... ......||+.|+|||++.+ .++.++||||+|+++|+|++|..||.+.........+.
T Consensus 148 -~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 225 (284)
T 2vgo_A 148 -GYKGELKIADFGWSVHAPSL-RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV 225 (284)
T ss_dssp -CTTCCEEECCCTTCEECSSS-CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred -cCCCCEEEecccccccCccc-ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHh
Confidence 56789999999998765432 2345679999999998864 68999999999999999999999999888888877777
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 156 RADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
.....++ +.++..++++|.+||..+|.+|||+.++++||||+...
T Consensus 226 ~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 226 NVDLKFP----PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp TTCCCCC----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred ccccCCC----CcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence 6554433 45899999999999999999999999999999997653
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=307.31 Aligned_cols=196 Identities=28% Similarity=0.498 Sum_probs=165.5
Q ss_pred CCCccccceee----c------CeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCC
Q 016471 1 MYHQKLQHLFY----S------NSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPE 70 (389)
Q Consensus 1 l~Hpni~~~~~----~------~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~ 70 (389)
|+||||++++. . ..+|+||||| |++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+
T Consensus 81 l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~ 157 (367)
T 1cm8_A 81 MRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPG 157 (367)
T ss_dssp CCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred CCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHH
Confidence 57999999882 1 3469999999 7899887754 57999999999999999999999999999999999
Q ss_pred cEEEeecCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCChh
Q 016471 71 NFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILLCGSRPFWARTES 148 (389)
Q Consensus 71 Nill~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 148 (389)
||++ +.++.+||+|||++..... .....+||+.|+|||++. ..++.++||||+||++|+|++|++||.+.+..
T Consensus 158 NIll---~~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 232 (367)
T 1cm8_A 158 NLAV---NEDCELKILDFGLARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL 232 (367)
T ss_dssp GEEE---CTTCCEEECCCTTCEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred HEEE---cCCCCEEEEeeeccccccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999 5678999999999987543 345668999999999875 36899999999999999999999999998877
Q ss_pred HHHHHHHhcCCCC-----------------------CC----CCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCC
Q 016471 149 GIFRSVLRADPNF-----------------------HD----SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLH 201 (389)
Q Consensus 149 ~~~~~i~~~~~~~-----------------------~~----~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~ 201 (389)
..+..+.+..... .. ..++.+++.+.+||.+||..||.+|||++++++||||.
T Consensus 233 ~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~ 312 (367)
T 1cm8_A 233 DQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 312 (367)
T ss_dssp HHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGT
T ss_pred HHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHH
Confidence 7766665422211 11 12346799999999999999999999999999999998
Q ss_pred CCC
Q 016471 202 DEN 204 (389)
Q Consensus 202 ~~~ 204 (389)
...
T Consensus 313 ~~~ 315 (367)
T 1cm8_A 313 SLH 315 (367)
T ss_dssp TTC
T ss_pred hhc
Confidence 653
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=302.32 Aligned_cols=190 Identities=29% Similarity=0.478 Sum_probs=161.6
Q ss_pred CCCcccccee----ecCeEEEEEEccCCC-ChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEe
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGG-ELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 75 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg-~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~ 75 (389)
|.||||++++ ..+.+++|||||.+| +|.+++... +.+++..++.++.||+.||.|||++||+||||||+||++
T Consensus 86 l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll- 163 (335)
T 3dls_A 86 VEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRH-PRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVI- 163 (335)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHTC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE-
T ss_pred CCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEE-
Confidence 5799999998 357899999999777 998877554 689999999999999999999999999999999999999
Q ss_pred ecCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc-cC-CCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016471 76 TREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SY-NVEGDMWSIGVITYILLCGSRPFWARTESGIFRS 153 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 153 (389)
+.++.+||+|||++............+||+.|+|||++.+ .+ +.++||||+||++|+|++|..||.....
T Consensus 164 --~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------ 235 (335)
T 3dls_A 164 --AEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------ 235 (335)
T ss_dssp --CTTSCEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------
T ss_pred --cCCCcEEEeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------
Confidence 5678999999999988766665666789999999998854 44 7889999999999999999999965322
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 154 VLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 154 i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
...... .....+++.+.+||.+||..+|.+|||++++++||||+...
T Consensus 236 ~~~~~~----~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 282 (335)
T 3dls_A 236 TVEAAI----HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPV 282 (335)
T ss_dssp GTTTCC----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred HHhhcc----CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCCc
Confidence 111111 11235899999999999999999999999999999998754
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=306.64 Aligned_cols=202 Identities=38% Similarity=0.699 Sum_probs=146.0
Q ss_pred CCCccccceee--------cCeEEEEEEccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCc
Q 016471 1 MYHQKLQHLFY--------SNSFLFFTRFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPEN 71 (389)
Q Consensus 1 l~Hpni~~~~~--------~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~N 71 (389)
+.||||++++. ...+|+|||||+||+|.+++..+. ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 79 ~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~N 158 (336)
T 3fhr_A 79 SGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPEN 158 (336)
T ss_dssp TTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred cCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 47999999882 345899999999999999887653 369999999999999999999999999999999999
Q ss_pred EEEeecCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHH
Q 016471 72 FLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGI 150 (389)
Q Consensus 72 ill~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 150 (389)
|+++..+.++.+||+|||++...... ......||+.|+|||++. ..++.++||||+||++|+|++|..||.+......
T Consensus 159 Ill~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 237 (336)
T 3fhr_A 159 LLYTSKEKDAVLKLTDFGFAKETTQN-ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAI 237 (336)
T ss_dssp EEESCSSTTCCEEECCCTTCEEC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred EEEEecCCCceEEEeccccceecccc-ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhh
Confidence 99975555677999999999865432 334567899999999985 4688999999999999999999999977655433
Q ss_pred ----HHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCC
Q 016471 151 ----FRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 151 ----~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~ 203 (389)
...+.......+...+..+++.+++||.+||..||.+|||++++++||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 238 SPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp -------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred hhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 23333344445555567899999999999999999999999999999999765
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=316.14 Aligned_cols=199 Identities=26% Similarity=0.438 Sum_probs=154.0
Q ss_pred CCCccccceeec---------CeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCc
Q 016471 1 MYHQKLQHLFYS---------NSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPEN 71 (389)
Q Consensus 1 l~Hpni~~~~~~---------~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~N 71 (389)
|.||||++++.. ..+|+|||||. |+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|
T Consensus 109 l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~N 186 (458)
T 3rp9_A 109 LNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPAN 186 (458)
T ss_dssp CCCTTBCCEEEECCCSCTTTCCCEEEEECCCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGG
T ss_pred CCCCCCCceEEEEecCCcccCceEEEEEeccc-cchhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhh
Confidence 589999999931 56999999985 6898877554 689999999999999999999999999999999999
Q ss_pred EEEeecCCCCCEEEeecCCccccCCCC----------------------------CcccccccCCccccccc-c-ccCCC
Q 016471 72 FLFTTREEDAPLKVIDFGLSDFVRPDQ----------------------------RLNDIVGSAYYVAPEVL-H-RSYNV 121 (389)
Q Consensus 72 ill~~~~~~~~~kl~Dfg~a~~~~~~~----------------------------~~~~~~gt~~y~aPE~~-~-~~~~~ 121 (389)
||+ +.++.+||+|||+|....... .....+||+.|+|||++ . ..|+.
T Consensus 187 ILl---~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~ 263 (458)
T 3rp9_A 187 CLV---NQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTE 263 (458)
T ss_dssp EEE---CTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCT
T ss_pred EEE---CCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCc
Confidence 999 577899999999998654221 23456789999999976 3 46999
Q ss_pred chhHHHHHHHHHHHHh-----------CCCCCCCCCh--------------------hHHHHHHHhcC------------
Q 016471 122 EGDMWSIGVITYILLC-----------GSRPFWARTE--------------------SGIFRSVLRAD------------ 158 (389)
Q Consensus 122 ~~DiwslG~il~~ll~-----------g~~pf~~~~~--------------------~~~~~~i~~~~------------ 158 (389)
++||||+|||+|||++ |++||.+.+. ...+..+....
T Consensus 264 ~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 343 (458)
T 3rp9_A 264 AIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALE 343 (458)
T ss_dssp HHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSS
T ss_pred HhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcC
Confidence 9999999999999998 7777766541 12222222110
Q ss_pred -----------CCCC----CCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 159 -----------PNFH----DSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 159 -----------~~~~----~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
+... ...++.+++++.+||.+||.+||.+|||++|+|+||||+...
T Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~ 404 (458)
T 3rp9_A 344 KEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR 404 (458)
T ss_dssp CHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred CHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcC
Confidence 0000 112456799999999999999999999999999999998763
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=294.67 Aligned_cols=195 Identities=34% Similarity=0.617 Sum_probs=162.0
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ ..+.+|+|||||+||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+||++
T Consensus 68 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~-- 144 (276)
T 2h6d_A 68 FRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLL-- 144 (276)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEE--
T ss_pred CCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEE--
Confidence 5799999998 357899999999999999988766 679999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCcccccccccc-C-CCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRS-Y-NVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
+.++.+||+|||++.............||+.|+|||++.+. + +.++|+||+|+++|+|++|..||.+.........+
T Consensus 145 -~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 223 (276)
T 2h6d_A 145 -DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKI 223 (276)
T ss_dssp -CTTSCEEECCCCGGGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred -CCCCCEEEeecccccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHh
Confidence 56789999999999877655545566899999999998653 3 67899999999999999999999988888887777
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~ 203 (389)
.......+ ..+++.+.++|.+||..||.+|||+.++++||||++.
T Consensus 224 ~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 224 RGGVFYIP----EYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp HHCCCCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred hcCcccCc----hhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 76554333 3478999999999999999999999999999999765
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=298.70 Aligned_cols=202 Identities=25% Similarity=0.455 Sum_probs=167.1
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ ..+.+|+|||||+||+|.+++....+.+++..++.++.||+.||.|||++|++||||||+||++
T Consensus 73 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~-- 150 (302)
T 2j7t_A 73 CDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLM-- 150 (302)
T ss_dssp CCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE--
T ss_pred CCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE--
Confidence 5799999998 3578999999999999999887766789999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCC-CCcccccccCCcccccccc------ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhH
Q 016471 77 REEDAPLKVIDFGLSDFVRPD-QRLNDIVGSAYYVAPEVLH------RSYNVEGDMWSIGVITYILLCGSRPFWARTESG 149 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 149 (389)
+.++.+||+|||++...... .......||+.|+|||++. ..++.++||||+||++|+|++|..||...+...
T Consensus 151 -~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 229 (302)
T 2j7t_A 151 -TLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR 229 (302)
T ss_dssp -CTTSCEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred -CCCCCEEEEECCCCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH
Confidence 56788999999987543211 1223457999999999872 358899999999999999999999999888777
Q ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCCCC
Q 016471 150 IFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRP 206 (389)
Q Consensus 150 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~~~ 206 (389)
....+........ .....++..+.++|.+||..+|.+|||+.++++||||......
T Consensus 230 ~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~ 285 (302)
T 2j7t_A 230 VLLKIAKSDPPTL-LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSN 285 (302)
T ss_dssp HHHHHHHSCCCCC-SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCCC
T ss_pred HHHHHhccCCccc-CCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhccc
Confidence 7766665543221 1224578999999999999999999999999999999876543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=310.60 Aligned_cols=200 Identities=25% Similarity=0.400 Sum_probs=163.3
Q ss_pred CCCccccceee----------cCeEEEEEEccCCCChHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCC
Q 016471 1 MYHQKLQHLFY----------SNSFLFFTRFCEGGELLDRIL---SRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDL 67 (389)
Q Consensus 1 l~Hpni~~~~~----------~~~~~lv~E~~~gg~L~~~l~---~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdl 67 (389)
|.||||+++++ ...+++|||||.+ +|.+.+. ...+.+++..++.++.||+.||.|||++||+||||
T Consensus 104 l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDl 182 (420)
T 1j1b_A 104 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDI 182 (420)
T ss_dssp CCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCC
T ss_pred cCCCCccceeeEEeccCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC
Confidence 58999999862 1237899999997 5655553 33568999999999999999999999999999999
Q ss_pred CCCcEEEeecCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 016471 68 KPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWAR 145 (389)
Q Consensus 68 kp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~ 145 (389)
||+|||++ .+.+.+||+|||+++...........+||+.|+|||++.+ .++.++||||+||++|+|++|++||.+.
T Consensus 183 kp~NILl~--~~~~~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~ 260 (420)
T 1j1b_A 183 KPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 260 (420)
T ss_dssp SGGGEEEE--TTTTEEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ChhhEEEe--CCCCeEEeccchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 99999995 2456789999999987765555556789999999998853 5899999999999999999999999998
Q ss_pred ChhHHHHHHHhcC------------CCCCCC--------C-----CCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCC
Q 016471 146 TESGIFRSVLRAD------------PNFHDS--------P-----WPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 146 ~~~~~~~~i~~~~------------~~~~~~--------~-----~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~ 200 (389)
+..+.+..+.+.. +.+... + .+.+++++++||.+||.+||.+|||+.++++||||
T Consensus 261 ~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f 340 (420)
T 1j1b_A 261 SGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 340 (420)
T ss_dssp SHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred CHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhh
Confidence 8776666655421 111111 1 13568999999999999999999999999999999
Q ss_pred CCC
Q 016471 201 HDE 203 (389)
Q Consensus 201 ~~~ 203 (389)
...
T Consensus 341 ~~~ 343 (420)
T 1j1b_A 341 DEL 343 (420)
T ss_dssp GGG
T ss_pred ccc
Confidence 654
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=293.39 Aligned_cols=199 Identities=28% Similarity=0.473 Sum_probs=172.5
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ ..+.+|+|||||+||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+||++
T Consensus 72 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~-- 148 (294)
T 2rku_A 72 LAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL-- 148 (294)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE--
T ss_pred CCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEE--
Confidence 5799999998 357799999999999999987665 679999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCC-CCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPD-QRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
+.++.+||+|||++...... .......||+.|+|||++.+ .++.++|+||+|+++|+|++|..||.+....+....+
T Consensus 149 -~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 227 (294)
T 2rku_A 149 -NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI 227 (294)
T ss_dssp -CTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred -cCCCCEEEEeccCceecccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 56789999999999876432 23445679999999998854 5889999999999999999999999998888777777
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPV 207 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~~~~ 207 (389)
.......+ ..+++.+.++|.+||..+|.+|||++++++||||.....+.
T Consensus 228 ~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~ 276 (294)
T 2rku_A 228 KKNEYSIP----KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA 276 (294)
T ss_dssp HTTCCCCC----TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred hhccCCCc----cccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcCC
Confidence 66554333 35789999999999999999999999999999998764433
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=299.64 Aligned_cols=197 Identities=27% Similarity=0.465 Sum_probs=172.2
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|.||||++++ ..+.+|+|||||.||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||++
T Consensus 98 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~-- 174 (335)
T 2owb_A 98 LAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL-- 174 (335)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE--
T ss_pred CCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEE--
Confidence 5799999998 357799999999999999987665 679999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCC-CCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPD-QRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
+.++.+||+|||++...... .......||+.|+|||++. ..++.++||||+||++|+|++|+.||.+....+.+..+
T Consensus 175 -~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 253 (335)
T 2owb_A 175 -NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI 253 (335)
T ss_dssp -CTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred -cCCCCEEEeeccCceecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH
Confidence 56788999999999876432 2344567999999999885 46899999999999999999999999988888777777
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENR 205 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~~ 205 (389)
.......+ ..+++.+.++|.+||..||.+|||+.++++||||.....
T Consensus 254 ~~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~ 300 (335)
T 2owb_A 254 KKNEYSIP----KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI 300 (335)
T ss_dssp HHTCCCCC----TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred hcCCCCCC----ccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCc
Confidence 76654433 357899999999999999999999999999999987643
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=306.05 Aligned_cols=194 Identities=30% Similarity=0.546 Sum_probs=163.4
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
.||||+.++ ....+|+|||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 117 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll--- 192 (355)
T 1vzo_A 117 QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL--- 192 (355)
T ss_dssp TCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---
T ss_pred CCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---
Confidence 599999988 357899999999999999988766 679999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCCccccCCCC--CcccccccCCccccccccc---cCCCchhHHHHHHHHHHHHhCCCCCCCCC----hh
Q 016471 78 EEDAPLKVIDFGLSDFVRPDQ--RLNDIVGSAYYVAPEVLHR---SYNVEGDMWSIGVITYILLCGSRPFWART----ES 148 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~ 148 (389)
+.++.+||+|||++....... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.... ..
T Consensus 193 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~ 272 (355)
T 1vzo_A 193 DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA 272 (355)
T ss_dssp CTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH
T ss_pred CCCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHH
Confidence 577899999999997653322 2344679999999999853 47899999999999999999999997543 23
Q ss_pred HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCC-----CHHHHhCCCCCCCC
Q 016471 149 GIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRM-----TAAQALTHPWLHDE 203 (389)
Q Consensus 149 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----s~~e~l~h~~~~~~ 203 (389)
.+...+....+.++ +.+++.+++||.+||..||.+|| |++++++||||...
T Consensus 273 ~~~~~~~~~~~~~~----~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~ 328 (355)
T 1vzo_A 273 EISRRILKSEPPYP----QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328 (355)
T ss_dssp HHHHHHHHCCCCCC----TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred HHHHHHhccCCCCC----cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence 44445554443332 46899999999999999999999 99999999999764
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=309.65 Aligned_cols=200 Identities=28% Similarity=0.456 Sum_probs=155.0
Q ss_pred CCCccccceee----c-----CeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCc
Q 016471 1 MYHQKLQHLFY----S-----NSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPEN 71 (389)
Q Consensus 1 l~Hpni~~~~~----~-----~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~N 71 (389)
|+||||+.++. . ..+|+|||||.| +|.+++... +.+++..++.++.||+.||+|||++||+||||||+|
T Consensus 82 l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~N 159 (432)
T 3n9x_A 82 LKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTP-IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPAN 159 (432)
T ss_dssp CCCTTBCCEEEECCCSCTTTCCCEEEEEECCSE-EHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred cCCCCcceEEEEEecCCCCcCCeEEEEEecCCc-CHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 57999999993 2 569999999975 999877554 679999999999999999999999999999999999
Q ss_pred EEEeecCCCCCEEEeecCCccccCCCC-----------------------CcccccccCCccccccc-c-ccCCCchhHH
Q 016471 72 FLFTTREEDAPLKVIDFGLSDFVRPDQ-----------------------RLNDIVGSAYYVAPEVL-H-RSYNVEGDMW 126 (389)
Q Consensus 72 ill~~~~~~~~~kl~Dfg~a~~~~~~~-----------------------~~~~~~gt~~y~aPE~~-~-~~~~~~~Diw 126 (389)
||+ +.++.+||+|||+|....... .....+||+.|+|||++ . ..|+.++|||
T Consensus 160 ILl---~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~Diw 236 (432)
T 3n9x_A 160 CLL---NQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIW 236 (432)
T ss_dssp EEE---CTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHH
T ss_pred eEE---CCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccc
Confidence 999 577899999999998764321 23567899999999985 3 4699999999
Q ss_pred HHHHHHHHHHh-----------CCCCCCCCCh-----------------hHHHHHHHh----------------------
Q 016471 127 SIGVITYILLC-----------GSRPFWARTE-----------------SGIFRSVLR---------------------- 156 (389)
Q Consensus 127 slG~il~~ll~-----------g~~pf~~~~~-----------------~~~~~~i~~---------------------- 156 (389)
|+||++|+|++ |.++|.+.+. ...+..+..
T Consensus 237 SlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~ 316 (432)
T 3n9x_A 237 STGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYI 316 (432)
T ss_dssp HHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHH
T ss_pred hHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHH
Confidence 99999999998 4444544331 112222211
Q ss_pred -cCCCCCCC----CCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCCC
Q 016471 157 -ADPNFHDS----PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENR 205 (389)
Q Consensus 157 -~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~~ 205 (389)
..+..... .++.+++.+.+||.+||..||.+|||++++|+||||++...
T Consensus 317 ~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 370 (432)
T 3n9x_A 317 KLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRK 370 (432)
T ss_dssp HTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCC
T ss_pred HhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccC
Confidence 11111111 12568999999999999999999999999999999987643
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=307.95 Aligned_cols=194 Identities=25% Similarity=0.494 Sum_probs=159.2
Q ss_pred Ccccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeecC
Q 016471 3 HQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE 78 (389)
Q Consensus 3 Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~~ 78 (389)
||||+.++ ..+.+|+||| |.+|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+.
T Consensus 115 ~~~iv~~~~~~~~~~~~~lv~E-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~--- 189 (390)
T 2zmd_A 115 SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV--- 189 (390)
T ss_dssp CTTBCCEEEEEECSSEEEEEEE-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES---
T ss_pred CCeEEEEEEEEecCCEEEEEEe-cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE---
Confidence 79999999 3577999999 6788999988765 6899999999999999999999999999999999999993
Q ss_pred CCCCEEEeecCCccccCCCC---CcccccccCCccccccccc------------cCCCchhHHHHHHHHHHHHhCCCCCC
Q 016471 79 EDAPLKVIDFGLSDFVRPDQ---RLNDIVGSAYYVAPEVLHR------------SYNVEGDMWSIGVITYILLCGSRPFW 143 (389)
Q Consensus 79 ~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~------------~~~~~~DiwslG~il~~ll~g~~pf~ 143 (389)
++.+||+|||++....... .....+||+.|+|||++.+ .++.++||||+||++|+|++|..||.
T Consensus 190 -~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~ 268 (390)
T 2zmd_A 190 -DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 268 (390)
T ss_dssp -SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred -CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcch
Confidence 4789999999998765432 2345689999999998743 58889999999999999999999998
Q ss_pred CCCh-hHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 144 ARTE-SGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 144 ~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
+... ...+..+.........+ ...++.+.+||.+||..||.+|||+.++++||||+...
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 269 QIINQISKLHAIIDPNHEIEFP--DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp TCCCHHHHHHHHHCTTSCCCCC--CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred hhhHHHHHHHHHhCccccCCCC--ccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 7543 34455555443332222 23578999999999999999999999999999997654
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=297.01 Aligned_cols=202 Identities=26% Similarity=0.390 Sum_probs=169.8
Q ss_pred CCCccccceee---------cCeEEEEEEccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCC
Q 016471 1 MYHQKLQHLFY---------SNSFLFFTRFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPE 70 (389)
Q Consensus 1 l~Hpni~~~~~---------~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~ 70 (389)
+.||||++++. ...+++||||+. |+|.+++.... +.+++..++.++.||+.||.|||++||+||||||+
T Consensus 71 ~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~ 149 (326)
T 1blx_A 71 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQ 149 (326)
T ss_dssp TCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred cCCCCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHH
Confidence 47999999982 356899999998 59999887653 35999999999999999999999999999999999
Q ss_pred cEEEeecCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhH
Q 016471 71 NFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESG 149 (389)
Q Consensus 71 Nill~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 149 (389)
||++ +.++.+||+|||++.............||+.|+|||++. ..++.++||||+||++|+|++|+.||.+.....
T Consensus 150 Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 226 (326)
T 1blx_A 150 NILV---TSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD 226 (326)
T ss_dssp GEEE---CTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred HeEE---cCCCCEEEecCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH
Confidence 9999 567899999999998765444455678999999999885 468999999999999999999999999988877
Q ss_pred HHHHHHhcCCCCCC-----------------------CCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCCCC
Q 016471 150 IFRSVLRADPNFHD-----------------------SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRP 206 (389)
Q Consensus 150 ~~~~i~~~~~~~~~-----------------------~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~~~ 206 (389)
....+......... ...+.+++.+++||.+||..||.+|||+.++++||||++....
T Consensus 227 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~ 306 (326)
T 1blx_A 227 QLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC 306 (326)
T ss_dssp HHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred HHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchh
Confidence 77766542111110 1124688999999999999999999999999999999876543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=296.13 Aligned_cols=197 Identities=23% Similarity=0.370 Sum_probs=152.7
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC-CCEecCCCCCcE
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILS---RGGRYLEEDAKTIVEKILNIVAFCHLQ-GVVHRDLKPENF 72 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~~-~i~Hrdlkp~Ni 72 (389)
+.||||++++ ..+.+|+|||||+| +|.+++.. ..+.+++..++.++.||+.||.|||++ ||+||||||+||
T Consensus 63 ~~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Ni 141 (290)
T 3fme_A 63 VDCPFTVTFYGALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNV 141 (290)
T ss_dssp CCCTTBCCEEEEEECSSSEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGC
T ss_pred CCCCeEEEEeeeeeccCCEEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHE
Confidence 4799999998 35789999999985 88776643 457899999999999999999999998 999999999999
Q ss_pred EEeecCCCCCEEEeecCCccccCCCCCcccccccCCccccccc----c-ccCCCchhHHHHHHHHHHHHhCCCCCCC-CC
Q 016471 73 LFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL----H-RSYNVEGDMWSIGVITYILLCGSRPFWA-RT 146 (389)
Q Consensus 73 ll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~----~-~~~~~~~DiwslG~il~~ll~g~~pf~~-~~ 146 (389)
++ +.++.+||+|||++.............||+.|+|||++ . ..++.++||||+||++|+|++|..||.. ..
T Consensus 142 l~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 218 (290)
T 3fme_A 142 LI---NALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT 218 (290)
T ss_dssp EE---CTTCCEEBCCC---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC
T ss_pred EE---CCCCCEEEeecCCcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc
Confidence 99 56789999999999877655555556899999999986 2 3588999999999999999999999976 33
Q ss_pred hhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCC
Q 016471 147 ESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 147 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~ 203 (389)
.............. ......+++.+.++|.+||..+|.+|||+.++++||||+..
T Consensus 219 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 219 PFQQLKQVVEEPSP--QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp HHHHHHHHHHSCCC--CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred hHHHHHHHhccCCC--CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 44444444443222 22224689999999999999999999999999999999654
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=295.21 Aligned_cols=203 Identities=24% Similarity=0.430 Sum_probs=171.5
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ ..+.+|+|||||+||+|.+++....+.+++..+..++.||+.||.|||++|++||||||+||++
T Consensus 81 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~-- 158 (314)
T 3com_A 81 CDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILL-- 158 (314)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--
T ss_pred CCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEE--
Confidence 5799999998 3578999999999999999887666789999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC-CcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
+.++.+||+|||++....... ......||+.|+|||++.+ .++.++||||+|+++|+|++|..||...........+
T Consensus 159 -~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 237 (314)
T 3com_A 159 -NTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMI 237 (314)
T ss_dssp -CTTCCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred -CCCCCEEEeecccchhhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 567899999999997664432 2345679999999998854 6899999999999999999999999887776665555
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPV 207 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~~~~ 207 (389)
....... ......+++.+.++|.+||..||.+|||+.++++||||+......
T Consensus 238 ~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~~~ 289 (314)
T 3com_A 238 PTNPPPT-FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVS 289 (314)
T ss_dssp HHSCCCC-CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCCGG
T ss_pred hcCCCcc-cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCCcch
Confidence 4433221 111235789999999999999999999999999999998765433
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=310.96 Aligned_cols=197 Identities=28% Similarity=0.412 Sum_probs=161.3
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
.||||++++ ...++|+|||||. |+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 157 ~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~- 234 (429)
T 3kvw_A 157 NTMNVIHMLENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLK- 234 (429)
T ss_dssp SCSCBCCEEEEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEES-
T ss_pred CCcCEEEEEeecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEc-
Confidence 689999998 3688999999997 58999887653 4599999999999999999999999999999999999995
Q ss_pred cCCCCC--EEEeecCCccccCCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016471 77 REEDAP--LKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRS 153 (389)
Q Consensus 77 ~~~~~~--~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 153 (389)
.++. +||+|||++..... ...+.+||+.|+|||++. ..++.++||||+||++|+|++|.+||.+.+..+.+..
T Consensus 235 --~~~~~~vkL~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~ 310 (429)
T 3kvw_A 235 --QQGRSGIKVIDFGSSCYEHQ--RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLAC 310 (429)
T ss_dssp --STTSCCEEECCCTTCEETTC--CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred --cCCCcceEEeecccceecCC--cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 4444 99999999976532 344678999999999885 4699999999999999999999999999888777666
Q ss_pred HHhcCCCCCCC--------------------------------------------------C-----CCCCCHHHHHHHH
Q 016471 154 VLRADPNFHDS--------------------------------------------------P-----WPSVSPEAKDFVR 178 (389)
Q Consensus 154 i~~~~~~~~~~--------------------------------------------------~-----~~~~~~~~~~li~ 178 (389)
+.......+.. . ....++.+.+||.
T Consensus 311 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~ 390 (429)
T 3kvw_A 311 MIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLK 390 (429)
T ss_dssp HHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHH
T ss_pred HHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHH
Confidence 55321111000 0 0123788999999
Q ss_pred hhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 179 RLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 179 ~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
+||..||.+|||++|+|+||||+...
T Consensus 391 ~~L~~dP~~Rpta~e~L~Hpw~~~~~ 416 (429)
T 3kvw_A 391 QCLEWDPAVRMTPGQALRHPWLRRRL 416 (429)
T ss_dssp HHTCSSTTTSCCHHHHHTSTTTC---
T ss_pred HHCCCChhhCCCHHHHhCChhhccCC
Confidence 99999999999999999999998753
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=301.23 Aligned_cols=198 Identities=22% Similarity=0.429 Sum_probs=163.1
Q ss_pred CCCccccceeec--------CeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcE
Q 016471 1 MYHQKLQHLFYS--------NSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENF 72 (389)
Q Consensus 1 l~Hpni~~~~~~--------~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Ni 72 (389)
|.||||++++.. ...|+|||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||
T Consensus 69 l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Ni 147 (311)
T 3ork_A 69 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANI 147 (311)
T ss_dssp CCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred CCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHE
Confidence 579999999831 2359999999999999988765 6799999999999999999999999999999999999
Q ss_pred EEeecCCCCCEEEeecCCccccCCCC----CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 016471 73 LFTTREEDAPLKVIDFGLSDFVRPDQ----RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTE 147 (389)
Q Consensus 73 ll~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 147 (389)
+++ .++.+||+|||++....... ......||+.|+|||++. ..++.++||||+||++|+|++|+.||.+...
T Consensus 148 l~~---~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~ 224 (311)
T 3ork_A 148 MIS---ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224 (311)
T ss_dssp EEE---TTSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred EEc---CCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 994 67889999999997654322 223457999999999885 4689999999999999999999999999888
Q ss_pred hHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCC
Q 016471 148 SGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 202 (389)
Q Consensus 148 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~ 202 (389)
......+.......+....+.+++++.++|.+||..||.+||++.+++.|+|++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 225 VSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp HHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred HHHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 8777777766554443344568999999999999999999999999999999863
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=290.78 Aligned_cols=198 Identities=29% Similarity=0.549 Sum_probs=164.7
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ ..+..|+|||||+||+|.+++... +.+++..+..++.|++.||.|||++||+||||||+||++
T Consensus 62 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~-- 138 (276)
T 2yex_A 62 LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL-- 138 (276)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--
T ss_pred cCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEE--
Confidence 5799999998 457899999999999999977543 679999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC---CcccccccCCccccccccc-c-CCCchhHHHHHHHHHHHHhCCCCCCCCChh-HH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ---RLNDIVGSAYYVAPEVLHR-S-YNVEGDMWSIGVITYILLCGSRPFWARTES-GI 150 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~ 150 (389)
+.++.+||+|||.+....... ......||+.|+|||++.+ . ++.++||||+|+++|+|++|..||.+.... ..
T Consensus 139 -~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 217 (276)
T 2yex_A 139 -DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217 (276)
T ss_dssp -CTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH
T ss_pred -ccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH
Confidence 567889999999987653221 2345679999999999854 3 467899999999999999999999876554 23
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 151 FRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 151 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
+..+...... ...++.+++.+.++|.+||..||.+|||++++++||||+...
T Consensus 218 ~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (276)
T 2yex_A 218 YSDWKEKKTY--LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (276)
T ss_dssp HHHHHTTCTT--STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHHhhhcccc--cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence 3333332222 223457899999999999999999999999999999998764
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=304.44 Aligned_cols=185 Identities=23% Similarity=0.402 Sum_probs=155.4
Q ss_pred EEEEEEccCCCChHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeecCCCCCEEEeecCCc
Q 016471 15 FLFFTRFCEGGELLDRIL---SRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS 91 (389)
Q Consensus 15 ~~lv~E~~~gg~L~~~l~---~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~~~~~~~kl~Dfg~a 91 (389)
+++|||||+| +|.+.+. ..++.+++..++.++.||+.||.|||++||+||||||+||+++ ..++.+||+|||+|
T Consensus 113 ~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~--~~~~~~kl~Dfg~a 189 (383)
T 3eb0_A 113 LNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVN--SKDNTLKLCDFGSA 189 (383)
T ss_dssp EEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEE--TTTTEEEECCCTTC
T ss_pred EEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEc--CCCCcEEEEECCCC
Confidence 8899999995 7766664 3457899999999999999999999999999999999999995 35678999999999
Q ss_pred cccCCCCCcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCC---------
Q 016471 92 DFVRPDQRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPN--------- 160 (389)
Q Consensus 92 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~--------- 160 (389)
.............||+.|+|||++.+ .++.++||||+||++|+|++|++||.+.+..+.+..+.+....
T Consensus 190 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~ 269 (383)
T 3eb0_A 190 KKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRM 269 (383)
T ss_dssp EECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred cccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 88766666667789999999998753 4899999999999999999999999998887777666542111
Q ss_pred ---CCC--------C-----CCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCC
Q 016471 161 ---FHD--------S-----PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 202 (389)
Q Consensus 161 ---~~~--------~-----~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~ 202 (389)
+.. . ....+++++.+||.+||..+|.+|||+.++++||||+.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 327 (383)
T 3eb0_A 270 NPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDH 327 (383)
T ss_dssp CTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHH
T ss_pred CcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHH
Confidence 100 0 01247899999999999999999999999999999954
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=306.84 Aligned_cols=196 Identities=25% Similarity=0.435 Sum_probs=152.1
Q ss_pred CCCccccceee----c------CeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCC
Q 016471 1 MYHQKLQHLFY----S------NSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPE 70 (389)
Q Consensus 1 l~Hpni~~~~~----~------~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~ 70 (389)
|.||||++++. . ..+|+|||||.| +|.+.+. ..+++..+..++.||+.||.|||++||+||||||+
T Consensus 81 l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~ 156 (371)
T 2xrw_A 81 VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPS 156 (371)
T ss_dssp CCCTTBCCEEEEECSCCSTTTCCEEEEEEECCSE-EHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred cCCCCccceEEeeccccccccccceEEEEEcCCC-CHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHH
Confidence 58999999983 1 278999999986 7878764 45999999999999999999999999999999999
Q ss_pred cEEEeecCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhH
Q 016471 71 NFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESG 149 (389)
Q Consensus 71 Nill~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 149 (389)
|||+ +.++.+||+|||++............+||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+...
T Consensus 157 NIl~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 233 (371)
T 2xrw_A 157 NIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID 233 (371)
T ss_dssp GEEE---CTTSCEEECCCCC----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred HEEE---cCCCCEEEEEeecccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999 5678999999999987655444556789999999998854 68999999999999999999999999988877
Q ss_pred HHHHHHhcCCCCCC-----------------CCC--------------CC-------CCHHHHHHHHhhhccCcCCCCCH
Q 016471 150 IFRSVLRADPNFHD-----------------SPW--------------PS-------VSPEAKDFVRRLLNKDHRKRMTA 191 (389)
Q Consensus 150 ~~~~i~~~~~~~~~-----------------~~~--------------~~-------~~~~~~~li~~~l~~~p~~R~s~ 191 (389)
.+..+.+......+ +.+ +. .++.+++||.+||..||.+|||+
T Consensus 234 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~ 313 (371)
T 2xrw_A 234 QWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 313 (371)
T ss_dssp HHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCH
T ss_pred HHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCH
Confidence 77777654322110 000 00 15689999999999999999999
Q ss_pred HHHhCCCCCCCC
Q 016471 192 AQALTHPWLHDE 203 (389)
Q Consensus 192 ~e~l~h~~~~~~ 203 (389)
+++++||||+..
T Consensus 314 ~e~l~hp~~~~~ 325 (371)
T 2xrw_A 314 DEALQHPYINVW 325 (371)
T ss_dssp HHHHHSHHHHTT
T ss_pred HHHhCCcchhhh
Confidence 999999999653
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=293.03 Aligned_cols=201 Identities=27% Similarity=0.506 Sum_probs=162.3
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCC
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILS-------RGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKP 69 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~-------~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp 69 (389)
++||||++++ ..+.+|+|||||+||+|.+++.. ..+.+++..+..++.||+.||.|||++||+||||||
T Consensus 70 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p 149 (303)
T 2vwi_A 70 CHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKA 149 (303)
T ss_dssp CCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSG
T ss_pred cCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 5799999998 35789999999999999998864 245699999999999999999999999999999999
Q ss_pred CcEEEeecCCCCCEEEeecCCccccCCCC------CcccccccCCcccccccc--ccCCCchhHHHHHHHHHHHHhCCCC
Q 016471 70 ENFLFTTREEDAPLKVIDFGLSDFVRPDQ------RLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILLCGSRP 141 (389)
Q Consensus 70 ~Nill~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~p 141 (389)
+||++ +.++.+||+|||++....... ......||+.|+|||++. ..++.++||||+||++|+|++|..|
T Consensus 150 ~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p 226 (303)
T 2vwi_A 150 GNILL---GEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226 (303)
T ss_dssp GGEEE---CTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCT
T ss_pred hhEEE---cCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCC
Confidence 99999 567899999999987654321 123457999999999885 3589999999999999999999999
Q ss_pred CCCCChhHHHHHHHhcCCCCC------CCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 142 FWARTESGIFRSVLRADPNFH------DSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 142 f~~~~~~~~~~~i~~~~~~~~------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
|.+.................. ....+.+++.+.++|.+||..||.+|||+.++++||||+...
T Consensus 227 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 295 (303)
T 2vwi_A 227 YHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 295 (303)
T ss_dssp TTTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred CccCchhhHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence 988777666655554332211 112346889999999999999999999999999999997653
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=303.68 Aligned_cols=201 Identities=22% Similarity=0.351 Sum_probs=158.9
Q ss_pred CCCccccceee---------cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCc
Q 016471 1 MYHQKLQHLFY---------SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPEN 71 (389)
Q Consensus 1 l~Hpni~~~~~---------~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~N 71 (389)
|+||||++++. ...+|+|||||. |+|.+.+....+.+++..+..++.||+.||.|||++||+||||||+|
T Consensus 86 l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N 164 (362)
T 3pg1_A 86 FHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGN 164 (362)
T ss_dssp CCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred CCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHH
Confidence 58999999872 136899999998 58989888776789999999999999999999999999999999999
Q ss_pred EEEeecCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhH
Q 016471 72 FLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILLCGSRPFWARTESG 149 (389)
Q Consensus 72 ill~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 149 (389)
|++ +.++.+||+|||++.............||+.|+|||++. ..++.++||||+||++|+|++|+.||.+.+...
T Consensus 165 Il~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 241 (362)
T 3pg1_A 165 ILL---ADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN 241 (362)
T ss_dssp EEE---CTTCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred EEE---cCCCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence 999 567889999999998665555555678999999999875 468999999999999999999999999988777
Q ss_pred HHHHHHhcCCC------------------------CCCC----CCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCC
Q 016471 150 IFRSVLRADPN------------------------FHDS----PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLH 201 (389)
Q Consensus 150 ~~~~i~~~~~~------------------------~~~~----~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~ 201 (389)
....+...... .+.. ..+.+++.+.+||.+||..||.+|||+.++++||||+
T Consensus 242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~ 321 (362)
T 3pg1_A 242 QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFE 321 (362)
T ss_dssp HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGT
T ss_pred HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhh
Confidence 66665432111 1111 1135689999999999999999999999999999998
Q ss_pred CCCC
Q 016471 202 DENR 205 (389)
Q Consensus 202 ~~~~ 205 (389)
....
T Consensus 322 ~~~~ 325 (362)
T 3pg1_A 322 SLFD 325 (362)
T ss_dssp TTCC
T ss_pred hccC
Confidence 7643
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=300.82 Aligned_cols=199 Identities=25% Similarity=0.437 Sum_probs=160.6
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|.||||++++ ..+.+|+|||||.|++|.++.. ..+.+++..+..++.||+.||.|||++||+||||||+||++
T Consensus 81 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~-- 157 (331)
T 4aaa_A 81 LRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLEL-FPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILV-- 157 (331)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHH-STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE--
T ss_pred CCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEE--
Confidence 5799999998 4678999999999988877554 44679999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCC-CCcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPD-QRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRS 153 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 153 (389)
+.++.+||+|||++...... .......||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+.......
T Consensus 158 -~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 236 (331)
T 4aaa_A 158 -SQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYH 236 (331)
T ss_dssp -CTTSCEEECCCTTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred -cCCCcEEEEeCCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence 56789999999999765432 23445679999999998854 588999999999999999999999998887766555
Q ss_pred HHhcCCCC-------------------CC--------CCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCC
Q 016471 154 VLRADPNF-------------------HD--------SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 154 i~~~~~~~-------------------~~--------~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~ 203 (389)
+....... +. ..++.+++.+.+||.+||..||.+|||+.++++||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 237 IMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp HHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred HHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence 44321110 00 0124679999999999999999999999999999999654
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=295.83 Aligned_cols=198 Identities=27% Similarity=0.497 Sum_probs=161.4
Q ss_pred CCccccceee----------cCeEEEEEEccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCC
Q 016471 2 YHQKLQHLFY----------SNSFLFFTRFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPE 70 (389)
Q Consensus 2 ~Hpni~~~~~----------~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~ 70 (389)
.||||+.++. ...+|+|||||+||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+
T Consensus 79 ~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 158 (326)
T 2x7f_A 79 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQ 158 (326)
T ss_dssp CSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGG
T ss_pred CCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHH
Confidence 6999999982 35799999999999999988754 257999999999999999999999999999999999
Q ss_pred cEEEeecCCCCCEEEeecCCccccCCCC-CcccccccCCcccccccc------ccCCCchhHHHHHHHHHHHHhCCCCCC
Q 016471 71 NFLFTTREEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLH------RSYNVEGDMWSIGVITYILLCGSRPFW 143 (389)
Q Consensus 71 Nill~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~pf~ 143 (389)
||++ +.++.+||+|||++....... ......||+.|+|||++. ..++.++||||+||++|+|++|..||.
T Consensus 159 NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 235 (326)
T 2x7f_A 159 NVLL---TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC 235 (326)
T ss_dssp GEEE---CTTCCEEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTT
T ss_pred HEEE---cCCCCEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCC
Confidence 9999 567889999999987654322 234567999999999874 358899999999999999999999998
Q ss_pred CCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 144 ARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 144 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
+.........+...... ......+++.+.++|.+||..||.+|||+.++++||||++..
T Consensus 236 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 294 (326)
T 2x7f_A 236 DMHPMRALFLIPRNPAP--RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP 294 (326)
T ss_dssp TSCHHHHHHHHHHSCCC--CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred CCcHHHHHHHhhcCccc--cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence 88777666655554322 222356899999999999999999999999999999997654
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=305.16 Aligned_cols=196 Identities=29% Similarity=0.505 Sum_probs=151.4
Q ss_pred CCCccccceee----------cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCC
Q 016471 1 MYHQKLQHLFY----------SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPE 70 (389)
Q Consensus 1 l~Hpni~~~~~----------~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~ 70 (389)
|+||||++++. ...+|+||||+ |++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+
T Consensus 85 l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~ 161 (367)
T 2fst_X 85 MKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPS 161 (367)
T ss_dssp CCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred CCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHh
Confidence 58999999883 15689999999 6799887754 57999999999999999999999999999999999
Q ss_pred cEEEeecCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChh
Q 016471 71 NFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTES 148 (389)
Q Consensus 71 Nill~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 148 (389)
||++ +.++.+||+|||++..... .....+||+.|+|||++.+ .++.++||||+||++|+|++|++||.+.+..
T Consensus 162 NIll---~~~~~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 236 (367)
T 2fst_X 162 NLAV---NEDCELKILDFGLARHTAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 236 (367)
T ss_dssp GEEE---CTTCCEEECC-----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred hEEE---CCCCCEEEeeccccccccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999 5778999999999976543 2345689999999998753 6899999999999999999999999998877
Q ss_pred HHHHHHHhcCCC-----------------------CCCC----CCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCC
Q 016471 149 GIFRSVLRADPN-----------------------FHDS----PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLH 201 (389)
Q Consensus 149 ~~~~~i~~~~~~-----------------------~~~~----~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~ 201 (389)
..+..+.+.... .+.. .++..++.+.+||.+||..||.+|||+.++|+||||.
T Consensus 237 ~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~ 316 (367)
T 2fst_X 237 DQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 316 (367)
T ss_dssp HHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred HHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhh
Confidence 766665542111 1111 1245789999999999999999999999999999998
Q ss_pred CCC
Q 016471 202 DEN 204 (389)
Q Consensus 202 ~~~ 204 (389)
...
T Consensus 317 ~~~ 319 (367)
T 2fst_X 317 QYH 319 (367)
T ss_dssp TTC
T ss_pred hcc
Confidence 653
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=291.31 Aligned_cols=200 Identities=26% Similarity=0.451 Sum_probs=170.5
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ ....+|+|||||+||+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||++
T Consensus 77 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~-- 152 (303)
T 3a7i_A 77 CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL-- 152 (303)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--
T ss_pred CCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEE--
Confidence 5799999998 35789999999999999997743 579999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC-CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
+.++.+||+|||++....... ......||+.|+|||++. ..++.++||||+|+++|+|++|..||...........+
T Consensus 153 -~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 231 (303)
T 3a7i_A 153 -SEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLI 231 (303)
T ss_dssp -CTTSCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred -CCCCCEEEeecccceecCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHh
Confidence 567899999999997765432 334567999999999985 46899999999999999999999999888777766666
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVP 208 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~~~~~ 208 (389)
...... .....+++.+.++|.+||..+|.+|||+.++++||||........
T Consensus 232 ~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~ 282 (303)
T 3a7i_A 232 PKNNPP---TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTS 282 (303)
T ss_dssp HHSCCC---CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHCCCGG
T ss_pred hcCCCC---CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcCCCccH
Confidence 554322 122468999999999999999999999999999999976554443
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=286.96 Aligned_cols=194 Identities=18% Similarity=0.292 Sum_probs=156.7
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEE
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSR---GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLF 74 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill 74 (389)
.||||++++ ..+.+|+|||||+||+|.+++... .+.+++..++.++.||+.||.|||++||+||||||+||++
T Consensus 69 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~ 148 (289)
T 1x8b_A 69 QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFI 148 (289)
T ss_dssp SCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred CCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEE
Confidence 799999998 468899999999999999988654 2569999999999999999999999999999999999999
Q ss_pred eecC----------------CCCCEEEeecCCccccCCCCCcccccccCCccccccccc--cCCCchhHHHHHHHHHHHH
Q 016471 75 TTRE----------------EDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILL 136 (389)
Q Consensus 75 ~~~~----------------~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll 136 (389)
+..+ ....+||+|||.+...... ....||+.|+|||++.+ .++.++||||+||++|+|+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~ 225 (289)
T 1x8b_A 149 SRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAA 225 (289)
T ss_dssp C--------------------CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHT
T ss_pred cCCCCCcccccccccccccCCceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHh
Confidence 6332 4557999999999876543 23469999999999864 3557999999999999999
Q ss_pred hCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 137 CGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 137 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
+|.+|+.... ....+...... ...+.+++.+.++|.+||..||.+|||+.++++||||.+..
T Consensus 226 ~~~~~~~~~~---~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 287 (289)
T 1x8b_A 226 GAEPLPRNGD---QWHEIRQGRLP---RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 287 (289)
T ss_dssp TCCCCCSSSH---HHHHHHTTCCC---CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC----
T ss_pred cCCCCCcchh---HHHHHHcCCCC---CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhhc
Confidence 9998775432 33344433221 11246899999999999999999999999999999997653
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=290.90 Aligned_cols=197 Identities=29% Similarity=0.504 Sum_probs=159.1
Q ss_pred CCCccccceee-----------------cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCE
Q 016471 1 MYHQKLQHLFY-----------------SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVV 63 (389)
Q Consensus 1 l~Hpni~~~~~-----------------~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~ 63 (389)
|.||||++++. ...+|+|||||+||+|.+++......+++..++.++.||+.||.|||++||+
T Consensus 59 l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~ 138 (303)
T 1zy4_A 59 LNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGII 138 (303)
T ss_dssp CCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred cCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCee
Confidence 57999999873 4678999999999999999987766789999999999999999999999999
Q ss_pred ecCCCCCcEEEeecCCCCCEEEeecCCccccCCC---------------CCcccccccCCccccccccc--cCCCchhHH
Q 016471 64 HRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPD---------------QRLNDIVGSAYYVAPEVLHR--SYNVEGDMW 126 (389)
Q Consensus 64 Hrdlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~---------------~~~~~~~gt~~y~aPE~~~~--~~~~~~Diw 126 (389)
||||||+||++ +.++.+||+|||++...... .......||+.|+|||++.+ .++.++|||
T Consensus 139 H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~ 215 (303)
T 1zy4_A 139 HRDLKPMNIFI---DESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMY 215 (303)
T ss_dssp CSCCCGGGEEE---CTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHH
T ss_pred cccCCHHhEEE---cCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHH
Confidence 99999999999 56788999999998765421 12334579999999999853 589999999
Q ss_pred HHHHHHHHHHhCCCCCCC-CChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCC
Q 016471 127 SIGVITYILLCGSRPFWA-RTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 127 slG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~ 203 (389)
|+||++|+|++ ||.. .........+......++.......++.++++|.+||..||.+|||+.++++||||...
T Consensus 216 slG~il~~l~~---p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 216 SLGIIFFEMIY---PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp HHHHHHHHHHS---CCSSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred HHHHHHHHHHh---ccCCchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 99999999998 5543 23344555555555555544445678899999999999999999999999999999654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=298.09 Aligned_cols=195 Identities=25% Similarity=0.489 Sum_probs=155.5
Q ss_pred Ccccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeecC
Q 016471 3 HQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE 78 (389)
Q Consensus 3 Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~~ 78 (389)
||||+.++ ....+|+||| |.+|+|.+++... +.+++.+++.++.||+.||.|||++||+||||||+|||++
T Consensus 68 ~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~--- 142 (343)
T 3dbq_A 68 SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV--- 142 (343)
T ss_dssp CTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE---
T ss_pred CCceEEEeeeEeeCCEEEEEEe-CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE---
Confidence 39999999 3578999999 6688999988765 6899999999999999999999999999999999999994
Q ss_pred CCCCEEEeecCCccccCCCC---CcccccccCCcccccccc------------ccCCCchhHHHHHHHHHHHHhCCCCCC
Q 016471 79 EDAPLKVIDFGLSDFVRPDQ---RLNDIVGSAYYVAPEVLH------------RSYNVEGDMWSIGVITYILLCGSRPFW 143 (389)
Q Consensus 79 ~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~------------~~~~~~~DiwslG~il~~ll~g~~pf~ 143 (389)
++.+||+|||++....... .....+||+.|+|||++. ..++.++||||+||++|+|++|+.||.
T Consensus 143 -~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 221 (343)
T 3dbq_A 143 -DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 221 (343)
T ss_dssp -TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred -CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcch
Confidence 4679999999998765432 233567999999999874 357889999999999999999999997
Q ss_pred CCChh-HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCCC
Q 016471 144 ARTES-GIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENR 205 (389)
Q Consensus 144 ~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~~ 205 (389)
+.... .....+........ .....++.+.++|.+||..||.+|||+.++++||||+....
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~ 282 (343)
T 3dbq_A 222 QIINQISKLHAIIDPNHEIE--FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 282 (343)
T ss_dssp TCCSHHHHHHHHHCTTSCCC--CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC
T ss_pred hhhhHHHHHHHHhcCCcccC--CcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCC
Confidence 74433 33444443322221 11346789999999999999999999999999999976543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=301.54 Aligned_cols=197 Identities=25% Similarity=0.445 Sum_probs=164.1
Q ss_pred CCCccccceee---------cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCc
Q 016471 1 MYHQKLQHLFY---------SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPEN 71 (389)
Q Consensus 1 l~Hpni~~~~~---------~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~N 71 (389)
|.||||++++. ...+|+|||||.| +|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|
T Consensus 82 l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~~-~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~N 158 (364)
T 3qyz_A 82 FRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSN 158 (364)
T ss_dssp CCCTTBCCCCEEECCSSTTTCCCEEEEEECCSE-EHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred cCCCCCccceeEEecCCccccceEEEEEcccCc-CHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHh
Confidence 58999999873 1468999999985 89887754 469999999999999999999999999999999999
Q ss_pred EEEeecCCCCCEEEeecCCccccCCCC----CcccccccCCcccccccc--ccCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 016471 72 FLFTTREEDAPLKVIDFGLSDFVRPDQ----RLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILLCGSRPFWAR 145 (389)
Q Consensus 72 ill~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~ 145 (389)
|++ +.++.+||+|||++....... .....+||+.|+|||++. ..++.++||||+||++|+|++|++||.+.
T Consensus 159 Il~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 235 (364)
T 3qyz_A 159 LLL---NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK 235 (364)
T ss_dssp EEE---CTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEE---CCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCC
Confidence 999 577889999999998664322 134568999999999863 34899999999999999999999999998
Q ss_pred ChhHHHHHHHhcCCCCC-----------------------CC----CCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCC
Q 016471 146 TESGIFRSVLRADPNFH-----------------------DS----PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHP 198 (389)
Q Consensus 146 ~~~~~~~~i~~~~~~~~-----------------------~~----~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~ 198 (389)
+..+....+.......+ .. ..+.+++++.+||.+||..||.+|||+.++++||
T Consensus 236 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 315 (364)
T 3qyz_A 236 HYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 315 (364)
T ss_dssp SGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred ChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 87777666653211111 01 1246789999999999999999999999999999
Q ss_pred CCCCC
Q 016471 199 WLHDE 203 (389)
Q Consensus 199 ~~~~~ 203 (389)
||+..
T Consensus 316 ~~~~~ 320 (364)
T 3qyz_A 316 YLEQY 320 (364)
T ss_dssp GGTTT
T ss_pred chhhc
Confidence 99875
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=309.28 Aligned_cols=184 Identities=18% Similarity=0.258 Sum_probs=146.9
Q ss_pred CeEEEEEEccCCCChHHHHHhcCCCCCHHHH------HHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeecCCCCCEEEe
Q 016471 13 NSFLFFTRFCEGGELLDRILSRGGRYLEEDA------KTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVI 86 (389)
Q Consensus 13 ~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~------~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~~~~~~~kl~ 86 (389)
.++|+|||||+ |+|.+++...+..+++... ..++.||+.||+|||++||+||||||+|||+ +.++.+||+
T Consensus 161 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll---~~~~~~kL~ 236 (371)
T 3q60_A 161 ANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFI---MPDGRLMLG 236 (371)
T ss_dssp EEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEE---CTTSCEEEC
T ss_pred eeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEE---CCCCCEEEE
Confidence 44899999999 7999999865445555555 6777999999999999999999999999999 567899999
Q ss_pred ecCCccccCCCCCcccccccCCccccccccc---cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHH--HHH---HHhcC
Q 016471 87 DFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR---SYNVEGDMWSIGVITYILLCGSRPFWARTESGI--FRS---VLRAD 158 (389)
Q Consensus 87 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~---i~~~~ 158 (389)
|||+|..... ......+|+.|+|||++.+ .++.++||||+||++|+|++|+.||.+...... +.. .....
T Consensus 237 DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 314 (371)
T 3q60_A 237 DVSALWKVGT--RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGT 314 (371)
T ss_dssp CGGGEEETTC--EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCC
T ss_pred ecceeeecCC--CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhccc
Confidence 9999986642 2224567799999999853 589999999999999999999999987643211 100 01111
Q ss_pred CCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCC
Q 016471 159 PNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 202 (389)
Q Consensus 159 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~ 202 (389)
.....+.++.+++.+.+||.+||..||.+|||+.++++||||+.
T Consensus 315 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 358 (371)
T 3q60_A 315 DSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358 (371)
T ss_dssp CSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred cccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence 12222333578999999999999999999999999999999954
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=294.50 Aligned_cols=197 Identities=28% Similarity=0.501 Sum_probs=159.6
Q ss_pred CCccccceee------cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEe
Q 016471 2 YHQKLQHLFY------SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 75 (389)
Q Consensus 2 ~Hpni~~~~~------~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~ 75 (389)
.||||+.++. ....++|||||.+|+|.+++ ..+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 89 ~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~ 164 (330)
T 3nsz_A 89 GGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID 164 (330)
T ss_dssp TSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHG----GGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE
T ss_pred CCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHH----HhCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEc
Confidence 3999999982 46789999999999998866 3589999999999999999999999999999999999995
Q ss_pred ecCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCC-hhHHHH
Q 016471 76 TREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILLCGSRPFWART-ESGIFR 152 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~ 152 (389)
.++..+||+|||++.............||+.|+|||++. ..++.++||||+||++|+|++|..||.... ......
T Consensus 165 --~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~ 242 (330)
T 3nsz_A 165 --HEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 242 (330)
T ss_dssp --TTTTEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHH
T ss_pred --CCCCEEEEEeCCCceEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHH
Confidence 234489999999998776666666778999999999875 358999999999999999999999995533 222222
Q ss_pred HHH-------------hcCCCCC--------------------CCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCC
Q 016471 153 SVL-------------RADPNFH--------------------DSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPW 199 (389)
Q Consensus 153 ~i~-------------~~~~~~~--------------------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~ 199 (389)
.+. ....... ......+++.+++||.+||..||.+|||++++++|||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~ 322 (330)
T 3nsz_A 243 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 322 (330)
T ss_dssp HHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGG
T ss_pred HHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCcc
Confidence 211 1111110 0111237999999999999999999999999999999
Q ss_pred CCCCC
Q 016471 200 LHDEN 204 (389)
Q Consensus 200 ~~~~~ 204 (389)
|++..
T Consensus 323 f~~~~ 327 (330)
T 3nsz_A 323 FYTVV 327 (330)
T ss_dssp GTTCC
T ss_pred Hhhhc
Confidence 98754
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=299.54 Aligned_cols=196 Identities=22% Similarity=0.378 Sum_probs=161.1
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CCEecCCCCCcEEEe
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQ-GVVHRDLKPENFLFT 75 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~-~i~Hrdlkp~Nill~ 75 (389)
+.||||++++ ..+.+|+|||||+||+|.+++... +.+++..+..++.|++.||.|||++ ||+||||||+||++
T Consensus 88 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~- 165 (360)
T 3eqc_A 88 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV- 165 (360)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE-
T ss_pred CCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEE-
Confidence 5799999998 467899999999999999988765 6799999999999999999999996 99999999999999
Q ss_pred ecCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHH-
Q 016471 76 TREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRS- 153 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~- 153 (389)
+.++.+||+|||++...... ......||+.|+|||++.+ .++.++||||+||++|+|++|..||...+.......
T Consensus 166 --~~~~~~kl~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 242 (360)
T 3eqc_A 166 --NSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF 242 (360)
T ss_dssp --CTTCCEEECCCCCCHHHHHH-C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHH
T ss_pred --CCCCCEEEEECCCCcccccc-cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Confidence 56788999999998654321 2334679999999998864 689999999999999999999999987665443221
Q ss_pred -----------------------------------------HHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHH
Q 016471 154 -----------------------------------------VLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAA 192 (389)
Q Consensus 154 -----------------------------------------i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~ 192 (389)
+.... .+..+...++.++.+||.+||..||.+|||++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 320 (360)
T 3eqc_A 243 GCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEP--PPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 320 (360)
T ss_dssp C------------------------------CCCHHHHHHHHHHSC--CCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHH
T ss_pred cccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccC--CCCCCcccccHHHHHHHHHHhhcChhhCCCHH
Confidence 11111 11112235789999999999999999999999
Q ss_pred HHhCCCCCCCC
Q 016471 193 QALTHPWLHDE 203 (389)
Q Consensus 193 e~l~h~~~~~~ 203 (389)
++++||||+..
T Consensus 321 ell~hp~~~~~ 331 (360)
T 3eqc_A 321 QLMVHAFIKRS 331 (360)
T ss_dssp HHHTSHHHHHH
T ss_pred HHhhChHhhcc
Confidence 99999999764
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=297.73 Aligned_cols=200 Identities=24% Similarity=0.454 Sum_probs=168.9
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHH------HHhc-CCCCCHHHHHHHHHHHHHHHHHHHH-CCCEecCCC
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDR------ILSR-GGRYLEEDAKTIVEKILNIVAFCHL-QGVVHRDLK 68 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~------l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~-~~i~Hrdlk 68 (389)
|.||||++++ ..+.+|+|||||+||+|.++ +... .+.+++..++.++.||+.||.|||+ +||+|||||
T Consensus 100 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~ 179 (348)
T 2pml_X 100 IKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVK 179 (348)
T ss_dssp CCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCC
T ss_pred CCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCC
Confidence 5799999988 35789999999999999987 5432 4679999999999999999999999 999999999
Q ss_pred CCcEEEeecCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc--cCCC-chhHHHHHHHHHHHHhCCCCCCCC
Q 016471 69 PENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR--SYNV-EGDMWSIGVITYILLCGSRPFWAR 145 (389)
Q Consensus 69 p~Nill~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~-~~DiwslG~il~~ll~g~~pf~~~ 145 (389)
|+||++ +.++.+||+|||.+...... ......||+.|+|||++.+ .++. ++||||+||++|+|++|..||.+.
T Consensus 180 p~Nil~---~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 255 (348)
T 2pml_X 180 PSNILM---DKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLK 255 (348)
T ss_dssp GGGEEE---CTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred hHhEEE---cCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999 56789999999999876443 3445679999999999864 3555 899999999999999999999887
Q ss_pred Ch-hHHHHHHHhcCCCCCCCC---------------CCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 146 TE-SGIFRSVLRADPNFHDSP---------------WPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 146 ~~-~~~~~~i~~~~~~~~~~~---------------~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
.. .+....+.......+... .+.+++.+.+||.+||..||.+|||+.++++||||.+..
T Consensus 256 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~ 330 (348)
T 2pml_X 256 ISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN 330 (348)
T ss_dssp SCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred CcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence 76 677777766554444210 146899999999999999999999999999999997653
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=301.63 Aligned_cols=197 Identities=23% Similarity=0.355 Sum_probs=159.3
Q ss_pred Ccccccee----ecCeEEEEEEccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--HCCCEecCCCCCcEEEe
Q 016471 3 HQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCH--LQGVVHRDLKPENFLFT 75 (389)
Q Consensus 3 Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH--~~~i~Hrdlkp~Nill~ 75 (389)
|++|+.++ ..+.+|+|||||.| +|.+++.... +.+++..++.++.||+.||.||| +.||+||||||+|||++
T Consensus 115 ~~~iv~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~ 193 (382)
T 2vx3_A 115 KYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLC 193 (382)
T ss_dssp GGGBCCEEEEEEETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEES
T ss_pred ceeEEEeeeeeccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEe
Confidence 34577766 46889999999975 9999887654 56999999999999999999999 57999999999999995
Q ss_pred ecCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 76 TREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
. +.++.+||+|||++..... ......||+.|+|||++.+ .++.++||||+||++|+|++|++||.+.+..+.+..+
T Consensus 194 ~-~~~~~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i 270 (382)
T 2vx3_A 194 N-PKRSAIKIVDFGSSCQLGQ--RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKI 270 (382)
T ss_dssp S-TTSCCEEECCCTTCEETTC--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred c-CCCCcEEEEeccCceeccc--ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 3 2467899999999987643 3345789999999998854 6999999999999999999999999998887777766
Q ss_pred HhcCCCCCC-----------------------------------CCCCC-------------------------CCHHHH
Q 016471 155 LRADPNFHD-----------------------------------SPWPS-------------------------VSPEAK 174 (389)
Q Consensus 155 ~~~~~~~~~-----------------------------------~~~~~-------------------------~~~~~~ 174 (389)
.......+. +.... .++.++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (382)
T 2vx3_A 271 VEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFK 350 (382)
T ss_dssp HHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHH
T ss_pred HHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHH
Confidence 543211110 00000 013789
Q ss_pred HHHHhhhccCcCCCCCHHHHhCCCCCCCC
Q 016471 175 DFVRRLLNKDHRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 175 ~li~~~l~~~p~~R~s~~e~l~h~~~~~~ 203 (389)
+||.+||..||.+|||++++|+||||+..
T Consensus 351 dli~~mL~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 351 DLILRMLDYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp HHHHHHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred HHHHHhcCCChhhCCCHHHHhcCcccccC
Confidence 99999999999999999999999999764
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=297.73 Aligned_cols=201 Identities=24% Similarity=0.352 Sum_probs=164.0
Q ss_pred CCCccccceee----cC-------eEEEEEEccCCCChHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHH--HCCCEe
Q 016471 1 MYHQKLQHLFY----SN-------SFLFFTRFCEGGELLDRIL---SRGGRYLEEDAKTIVEKILNIVAFCH--LQGVVH 64 (389)
Q Consensus 1 l~Hpni~~~~~----~~-------~~~lv~E~~~gg~L~~~l~---~~~~~l~~~~~~~i~~qi~~~L~~lH--~~~i~H 64 (389)
+.||||++++. .. .+++|||||.| +|.+.+. .....+++..+..++.|++.||.||| ++||+|
T Consensus 76 l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH 154 (360)
T 3e3p_A 76 LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCH 154 (360)
T ss_dssp HCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBC
T ss_pred cCCCCcccHHHhhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeec
Confidence 47999999872 11 28999999997 4544443 24567999999999999999999999 999999
Q ss_pred cCCCCCcEEEeecCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCCCCC
Q 016471 65 RDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPF 142 (389)
Q Consensus 65 rdlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf 142 (389)
|||||+|||++ ..++.+||+|||++.............||+.|+|||++.+ .++.++||||+||++|+|++|+.||
T Consensus 155 ~Dlkp~NIll~--~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf 232 (360)
T 3e3p_A 155 RDIKPHNVLVN--EADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIF 232 (360)
T ss_dssp SCCCGGGEEEE--TTTTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred CcCCHHHEEEe--CCCCcEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCc
Confidence 99999999995 3378999999999988766655566789999999998743 4899999999999999999999999
Q ss_pred CCCChhHHHHHHHhcCCCCCC----------------------------CCCCCCCHHHHHHHHhhhccCcCCCCCHHHH
Q 016471 143 WARTESGIFRSVLRADPNFHD----------------------------SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQA 194 (389)
Q Consensus 143 ~~~~~~~~~~~i~~~~~~~~~----------------------------~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~ 194 (389)
.+.+....+..+.+.....+. ......++.+.+||.+||..||.+|||+.++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~ 312 (360)
T 3e3p_A 233 RGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEA 312 (360)
T ss_dssp CCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHH
Confidence 998887777766542111100 0012357899999999999999999999999
Q ss_pred hCCCCCCCCC
Q 016471 195 LTHPWLHDEN 204 (389)
Q Consensus 195 l~h~~~~~~~ 204 (389)
++||||+...
T Consensus 313 l~hp~f~~~~ 322 (360)
T 3e3p_A 313 LCHPYFDELH 322 (360)
T ss_dssp TTSGGGGGGG
T ss_pred hcCccccccC
Confidence 9999998653
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=295.90 Aligned_cols=180 Identities=26% Similarity=0.423 Sum_probs=143.3
Q ss_pred EEEEEEccCCCChHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeecCCCCCEEEeecCCcc
Q 016471 15 FLFFTRFCEGGELLDRILSRG--GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSD 92 (389)
Q Consensus 15 ~~lv~E~~~gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~~~~~~~kl~Dfg~a~ 92 (389)
+|+|||||+||+|.+++.... ...++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++.
T Consensus 136 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~ 212 (332)
T 3qd2_B 136 LYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVKVGDFGLVT 212 (332)
T ss_dssp EEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCE
T ss_pred EEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEE---eCCCCEEEeecCccc
Confidence 899999999999999887542 224566789999999999999999999999999999999 567899999999998
Q ss_pred ccCCCC-------------CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcC
Q 016471 93 FVRPDQ-------------RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRAD 158 (389)
Q Consensus 93 ~~~~~~-------------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 158 (389)
...... .....+||+.|+|||++. ..++.++||||+||++|+|++|..|+.. .......+....
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~ 290 (332)
T 3qd2_B 213 AMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLK 290 (332)
T ss_dssp ECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTC
T ss_pred ccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccC
Confidence 765432 223457999999999885 4689999999999999999998777521 112222222221
Q ss_pred CCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCC
Q 016471 159 PNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 202 (389)
Q Consensus 159 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~ 202 (389)
.+ ..++..++.+.++|.+||..||.+|||++++++||||++
T Consensus 291 --~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 291 --FP-LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp --CC-HHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred --CC-cccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence 11 112346788999999999999999999999999999975
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=309.34 Aligned_cols=173 Identities=17% Similarity=0.246 Sum_probs=141.9
Q ss_pred eEEEEEEccCCCChHHHHHhcCCCCCH-------HHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeecCCCCCEEEe
Q 016471 14 SFLFFTRFCEGGELLDRILSRGGRYLE-------EDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVI 86 (389)
Q Consensus 14 ~~~lv~E~~~gg~L~~~l~~~~~~l~~-------~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~~~~~~~kl~ 86 (389)
..|+||||| +|+|.+++... +.+++ ..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+
T Consensus 174 ~~~lv~E~~-~g~L~~~l~~~-~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll---~~~~~~kL~ 248 (377)
T 3byv_A 174 SRFFLYPRM-QSNLQTFGEVL-LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL---DQRGGVFLT 248 (377)
T ss_dssp SEEEEEECC-SEEHHHHHHHH-HHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEEC
T ss_pred EEEEEEecc-CCCHHHHHHhc-cccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEE
Confidence 389999999 67999998765 34555 7788899999999999999999999999999999 567899999
Q ss_pred ecCCccccCCCCCcccccccCCcccccccc-c-----------cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 87 DFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-R-----------SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 87 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~-----------~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
|||+|.... ......+| +.|+|||++. . .++.++|||||||++|+|++|+.||.+.........+
T Consensus 249 DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~ 325 (377)
T 3byv_A 249 GFEHLVRDG--ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWI 325 (377)
T ss_dssp CGGGCEETT--CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGG
T ss_pred echhheecC--CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhh
Confidence 999998643 23445678 9999999985 3 5899999999999999999999999776544333332
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 202 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~ 202 (389)
.. .++.+++.+.+||.+||..||.+|||+.++++||||+.
T Consensus 326 ~~--------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 326 FR--------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp GS--------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred hh--------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 22 12568999999999999999999999999999999943
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=295.86 Aligned_cols=198 Identities=21% Similarity=0.380 Sum_probs=160.7
Q ss_pred CCCccccceee------cCeEEEEEEccCCCChHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcE
Q 016471 1 MYHQKLQHLFY------SNSFLFFTRFCEGGELLDRILSRG--GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENF 72 (389)
Q Consensus 1 l~Hpni~~~~~------~~~~~lv~E~~~gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Ni 72 (389)
|.||||++++. ...+|+|||||+||+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus 64 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NI 143 (319)
T 4euu_A 64 LNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNI 143 (319)
T ss_dssp CCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred cCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHE
Confidence 57999999982 237899999999999999887542 2399999999999999999999999999999999999
Q ss_pred EEeec-CCCCCEEEeecCCccccCCCCCcccccccCCcccccccc---------ccCCCchhHHHHHHHHHHHHhCCCCC
Q 016471 73 LFTTR-EEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH---------RSYNVEGDMWSIGVITYILLCGSRPF 142 (389)
Q Consensus 73 ll~~~-~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~DiwslG~il~~ll~g~~pf 142 (389)
++... +.++.+||+|||++.............||+.|+|||++. ..++.++||||+||++|+|++|+.||
T Consensus 144 ll~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf 223 (319)
T 4euu_A 144 MRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223 (319)
T ss_dssp EEEECTTSCEEEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSE
T ss_pred EEeccCCCCceEEEccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 98432 345679999999998876666666778999999999874 46889999999999999999999999
Q ss_pred CCCC----hhHHHHHHHhcCCCC-------------------CC--CCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCC
Q 016471 143 WART----ESGIFRSVLRADPNF-------------------HD--SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 197 (389)
Q Consensus 143 ~~~~----~~~~~~~i~~~~~~~-------------------~~--~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h 197 (389)
.... ..+....+....+.. +. .....+++.+.++|.+||..||.+|||++|+++|
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h 303 (319)
T 4euu_A 224 RPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (319)
T ss_dssp ECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred CCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhc
Confidence 6433 244555555544311 10 0011245688999999999999999999999998
Q ss_pred C
Q 016471 198 P 198 (389)
Q Consensus 198 ~ 198 (389)
|
T Consensus 304 ~ 304 (319)
T 4euu_A 304 T 304 (319)
T ss_dssp H
T ss_pred c
Confidence 7
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=289.35 Aligned_cols=196 Identities=23% Similarity=0.434 Sum_probs=158.1
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|.||||++++ ..+.+|+|||||+||+|.+++... +.+++..++.++.|++.||.|||++||+||||||+||++
T Consensus 68 l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~-- 144 (294)
T 4eqm_A 68 LSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILI-- 144 (294)
T ss_dssp CCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE--
T ss_pred CCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE--
Confidence 5799999999 357899999999999999988766 679999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC--CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ--RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRS 153 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 153 (389)
+.++.+||+|||++....... ......||+.|+|||++. ..++.++||||+||++|+|++|+.||.+.+.......
T Consensus 145 -~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~ 223 (294)
T 4eqm_A 145 -DSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIK 223 (294)
T ss_dssp -CTTSCEEECCCSSSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHH
T ss_pred -CCCCCEEEEeCCCccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 567899999999998764332 233467999999999885 4688999999999999999999999998887766555
Q ss_pred HHhcCCC-CCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCC
Q 016471 154 VLRADPN-FHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 154 i~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~ 200 (389)
....... .+....+.+++.+.++|.+||..||.+||+..+.+.+.|.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~ 271 (294)
T 4eqm_A 224 HIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLS 271 (294)
T ss_dssp HHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHH
T ss_pred HhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHH
Confidence 5543322 1122335689999999999999999999965555555543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=287.22 Aligned_cols=200 Identities=26% Similarity=0.397 Sum_probs=159.8
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEE
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGG--RYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLF 74 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill 74 (389)
+.||||++++ ..+.+++|||||+||+|.+++....+ .+++..+..++.||+.||.|||++||+||||||+||++
T Consensus 76 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~ 155 (295)
T 2clq_A 76 LKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLI 155 (295)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred CCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEE
Confidence 5799999998 45789999999999999998876533 46689999999999999999999999999999999999
Q ss_pred eecCCCCCEEEeecCCccccCCCC-CcccccccCCccccccccc---cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHH
Q 016471 75 TTREEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLHR---SYNVEGDMWSIGVITYILLCGSRPFWARTESGI 150 (389)
Q Consensus 75 ~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 150 (389)
+ ..++.+||+|||++....... ......||+.|+|||++.+ .++.++||||+|+++|+|++|..||........
T Consensus 156 ~--~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 233 (295)
T 2clq_A 156 N--TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA 233 (295)
T ss_dssp E--TTTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH
T ss_pred E--CCCCCEEEeecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH
Confidence 5 237899999999998764322 2345679999999999853 378999999999999999999999976433222
Q ss_pred -HHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 151 -FRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 151 -~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
........ ........+++.+.++|.+||..||.+|||+.++++||||+...
T Consensus 234 ~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 234 AMFKVGMFK--VHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp HHHHHHHHC--CCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred HHHhhcccc--ccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence 21111111 11112246899999999999999999999999999999997654
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=305.13 Aligned_cols=200 Identities=23% Similarity=0.348 Sum_probs=154.4
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
.||||++++ ....+|+|||||. |+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++..
T Consensus 76 ~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~ 154 (432)
T 3p23_A 76 EHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMP 154 (432)
T ss_dssp CCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCC
T ss_pred CCCCcCeEEEEEecCCEEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecC
Confidence 699999999 4577999999997 59999988776667777888999999999999999999999999999999632
Q ss_pred C--CCCCEEEeecCCccccCCCC----CcccccccCCcccccccc----ccCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 016471 78 E--EDAPLKVIDFGLSDFVRPDQ----RLNDIVGSAYYVAPEVLH----RSYNVEGDMWSIGVITYILLC-GSRPFWART 146 (389)
Q Consensus 78 ~--~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~-g~~pf~~~~ 146 (389)
+ ....+||+|||+|....... .....+||+.|+|||++. ..++.++||||+||++|+|++ |..||....
T Consensus 155 ~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~ 234 (432)
T 3p23_A 155 NAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL 234 (432)
T ss_dssp BTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTT
T ss_pred CCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhh
Confidence 2 23468899999998765332 334567999999999985 346789999999999999999 999996554
Q ss_pred hhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCC
Q 016471 147 ESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 147 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~ 203 (389)
...... +...............+..+++||.+||..||.+|||+.++++||||+..
T Consensus 235 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~ 290 (432)
T 3p23_A 235 QRQANI-LLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290 (432)
T ss_dssp THHHHH-HTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred HHHHHH-HhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence 443322 22211111111112345678999999999999999999999999999764
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=299.80 Aligned_cols=197 Identities=16% Similarity=0.209 Sum_probs=167.0
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCC
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG------GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPE 70 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~------~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~ 70 (389)
|.||||++++ .....|+|||||+||+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+
T Consensus 131 l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~ 210 (367)
T 3l9p_A 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAAR 210 (367)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred CCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChh
Confidence 5899999999 3567899999999999999987653 35899999999999999999999999999999999
Q ss_pred cEEEeecCCCCCEEEeecCCccccCC---CCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCC
Q 016471 71 NFLFTTREEDAPLKVIDFGLSDFVRP---DQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWAR 145 (389)
Q Consensus 71 Nill~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~ 145 (389)
|||++..+.+..+||+|||++..... ........||+.|+|||++. ..++.++|||||||++|+|++ |..||.+.
T Consensus 211 NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~ 290 (367)
T 3l9p_A 211 NCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 290 (367)
T ss_dssp GEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred hEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99996544556799999999875421 12334457899999999884 579999999999999999998 99999999
Q ss_pred ChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCC
Q 016471 146 TESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 146 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~ 200 (389)
...+....+........ ...+++.+.+++.+||..+|.+|||+.+++++.++
T Consensus 291 ~~~~~~~~i~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~ 342 (367)
T 3l9p_A 291 SNQEVLEFVTSGGRMDP---PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 342 (367)
T ss_dssp CHHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CHHHHHHHHHcCCCCCC---CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 88888887776543222 24689999999999999999999999999987665
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=289.10 Aligned_cols=191 Identities=21% Similarity=0.323 Sum_probs=153.7
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCCCcE
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG--GRYLEEDAKTIVEKILNIVAFCHLQG--VVHRDLKPENF 72 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~lH~~~--i~Hrdlkp~Ni 72 (389)
|+||||++++ ....+|+|||||+||+|.+++.+.. ..+++..+..++.||+.||.|||++| |+||||||+||
T Consensus 91 l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NI 170 (309)
T 3p86_A 91 LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNL 170 (309)
T ss_dssp CCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGE
T ss_pred CCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhE
Confidence 5799999999 3567999999999999999886542 13999999999999999999999999 99999999999
Q ss_pred EEeecCCCCCEEEeecCCccccCCCC-CcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHH
Q 016471 73 LFTTREEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGI 150 (389)
Q Consensus 73 ll~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 150 (389)
++ +.++.+||+|||++....... ......||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+..+.
T Consensus 171 ll---~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~ 247 (309)
T 3p86_A 171 LV---DKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV 247 (309)
T ss_dssp EE---CTTCCEEECCCC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHH
T ss_pred EE---eCCCcEEECCCCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99 577899999999997654332 2345679999999999864 589999999999999999999999999888877
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 151 FRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 151 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
...+......... ...+++.+.++|.+||..+|.+|||++++++
T Consensus 248 ~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 291 (309)
T 3p86_A 248 VAAVGFKCKRLEI--PRNLNPQVAAIIEGCWTNEPWKRPSFATIMD 291 (309)
T ss_dssp HHHHHHSCCCCCC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhcCCCCCC--CccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 7766544333222 2468999999999999999999999999986
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=283.17 Aligned_cols=191 Identities=24% Similarity=0.387 Sum_probs=164.8
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|+||||++++ ....+|+|||||+||+|.+++....+.+++..+..++.|++.||.|||++||+||||||+||++
T Consensus 62 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~-- 139 (269)
T 4hcu_A 62 LSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV-- 139 (269)
T ss_dssp CCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--
T ss_pred CCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEE--
Confidence 5799999998 3577999999999999999998776789999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC--CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ--RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFR 152 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 152 (389)
+.++.+||+|||++....... ......+|+.|+|||++. ..++.++||||+|+++|+|++ |..||.+........
T Consensus 140 -~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~ 218 (269)
T 4hcu_A 140 -GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE 218 (269)
T ss_dssp -CGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred -cCCCCEEeccccccccccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Confidence 467889999999998654322 223456778899999985 568999999999999999999 999999988888888
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCC
Q 016471 153 SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 197 (389)
Q Consensus 153 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h 197 (389)
.+........+ ..+++.+.+++.+||..+|.+|||+.++++|
T Consensus 219 ~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 219 DISTGFRLYKP---RLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HHHTTCCCCCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhcCccCCCC---CcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 77765332222 3579999999999999999999999999864
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=281.60 Aligned_cols=191 Identities=24% Similarity=0.364 Sum_probs=164.5
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|+||||++++ ....+|+|||||+||+|.+++......+++..++.++.|++.||.|||++||+||||||+||++
T Consensus 60 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~-- 137 (268)
T 3sxs_A 60 LSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLV-- 137 (268)
T ss_dssp CCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEE--
T ss_pred CCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEE--
Confidence 5799999999 3577999999999999999998776679999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCC--cccccccCCccccccccc-cCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQR--LNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFR 152 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 152 (389)
+.++.+||+|||++........ .....+|+.|+|||++.+ .++.++||||+|+++|+|++ |..||..........
T Consensus 138 -~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~ 216 (268)
T 3sxs_A 138 -DRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVL 216 (268)
T ss_dssp -CTTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH
T ss_pred -CCCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHH
Confidence 5778999999999986654332 233456778999999854 68999999999999999999 999999888888877
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCC
Q 016471 153 SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 197 (389)
Q Consensus 153 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h 197 (389)
.+........+ ...++.+.+++.+||..+|.+|||+.+++++
T Consensus 217 ~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 217 KVSQGHRLYRP---HLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp HHHTTCCCCCC---TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCCCCC---CcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 77665433322 3478999999999999999999999999874
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=294.41 Aligned_cols=189 Identities=20% Similarity=0.323 Sum_probs=161.5
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG---------------GRYLEEDAKTIVEKILNIVAFCHLQGV 62 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~~lH~~~i 62 (389)
+||||++++ ..+.+|+|||||+||+|.+++.... ..+++..+..++.||+.||+|||++||
T Consensus 145 ~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i 224 (370)
T 2psq_A 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC 224 (370)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred CCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 799999999 3577999999999999999987653 358899999999999999999999999
Q ss_pred EecCCCCCcEEEeecCCCCCEEEeecCCccccCCCC---CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-
Q 016471 63 VHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ---RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC- 137 (389)
Q Consensus 63 ~Hrdlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~- 137 (389)
+||||||+|||+ +.++.+||+|||++....... ......+|+.|+|||++. ..++.++|||||||++|+|++
T Consensus 225 vHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~ 301 (370)
T 2psq_A 225 IHRDLAARNVLV---TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 301 (370)
T ss_dssp ECSCCCGGGEEE---CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTT
T ss_pred eccccchhhEEE---CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcC
Confidence 999999999999 577899999999998664332 223346788999999885 468999999999999999999
Q ss_pred CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 138 GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 138 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
|..||.+....+....+....... ....+++.+.++|.+||..+|.+|||+.++++
T Consensus 302 g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 357 (370)
T 2psq_A 302 GGSPYPGIPVEELFKLLKEGHRMD---KPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 357 (370)
T ss_dssp SCCSSTTCCGGGHHHHHHTTCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHhcCCCCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999988888777766543221 12468999999999999999999999999986
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=292.12 Aligned_cols=198 Identities=28% Similarity=0.463 Sum_probs=161.8
Q ss_pred CCCccccceee---------cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCc
Q 016471 1 MYHQKLQHLFY---------SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPEN 71 (389)
Q Consensus 1 l~Hpni~~~~~---------~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~N 71 (389)
|.||||++++. ...+|+|||||. |+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|
T Consensus 66 l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~N 142 (353)
T 2b9h_A 66 FKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSN 142 (353)
T ss_dssp CCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred CcCCCcCCeeeeecccccCccceEEEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHH
Confidence 57999999983 267899999998 489887755 479999999999999999999999999999999999
Q ss_pred EEEeecCCCCCEEEeecCCccccCCCC-----------CcccccccCCcccccccc--ccCCCchhHHHHHHHHHHHHhC
Q 016471 72 FLFTTREEDAPLKVIDFGLSDFVRPDQ-----------RLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILLCG 138 (389)
Q Consensus 72 ill~~~~~~~~~kl~Dfg~a~~~~~~~-----------~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g 138 (389)
|++ +.++.+||+|||++....... .....+||+.|+|||++. ..++.++||||+||++|+|++|
T Consensus 143 il~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g 219 (353)
T 2b9h_A 143 LLI---NSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR 219 (353)
T ss_dssp EEE---CTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHS
T ss_pred eEE---cCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhC
Confidence 999 567899999999998654321 122357899999999874 4689999999999999999999
Q ss_pred CCCCCCCChhHHHHHHHhcCCC------------------------CCCC----CCCCCCHHHHHHHHhhhccCcCCCCC
Q 016471 139 SRPFWARTESGIFRSVLRADPN------------------------FHDS----PWPSVSPEAKDFVRRLLNKDHRKRMT 190 (389)
Q Consensus 139 ~~pf~~~~~~~~~~~i~~~~~~------------------------~~~~----~~~~~~~~~~~li~~~l~~~p~~R~s 190 (389)
..||.+.+.......+...... .+.. .++.+++.+.+||.+||..||.+|||
T Consensus 220 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 299 (353)
T 2b9h_A 220 RPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRIT 299 (353)
T ss_dssp SCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCC
T ss_pred CCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCC
Confidence 9999988776655544331111 1111 12468999999999999999999999
Q ss_pred HHHHhCCCCCCCCC
Q 016471 191 AAQALTHPWLHDEN 204 (389)
Q Consensus 191 ~~e~l~h~~~~~~~ 204 (389)
+.++++||||+...
T Consensus 300 ~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 300 AKEALEHPYLQTYH 313 (353)
T ss_dssp HHHHHTSGGGTTTC
T ss_pred HHHHhcCccccccC
Confidence 99999999998753
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=291.25 Aligned_cols=202 Identities=31% Similarity=0.524 Sum_probs=164.5
Q ss_pred CCCccccceee------------------cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 016471 1 MYHQKLQHLFY------------------SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGV 62 (389)
Q Consensus 1 l~Hpni~~~~~------------------~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i 62 (389)
|.||||++++. ...+|+|||||. |+|.+++.. +.+++..++.++.||+.||+|||++||
T Consensus 65 l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i 141 (320)
T 2i6l_A 65 LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSANV 141 (320)
T ss_dssp CCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred cCCCCeeEEEEeccccccccccccccccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCCE
Confidence 57999999972 267899999998 599887743 579999999999999999999999999
Q ss_pred EecCCCCCcEEEeecCCCCCEEEeecCCccccCCC----CCcccccccCCcccccccc--ccCCCchhHHHHHHHHHHHH
Q 016471 63 VHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPD----QRLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILL 136 (389)
Q Consensus 63 ~Hrdlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll 136 (389)
+||||||+||+++ ..++.+||+|||++...... .......+|+.|+|||++. ..++.++||||+||++|+|+
T Consensus 142 ~H~dlkp~Nil~~--~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~ 219 (320)
T 2i6l_A 142 LHRDLKPANLFIN--TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEML 219 (320)
T ss_dssp BCCCCSGGGEEEE--TTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEc--CCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHH
Confidence 9999999999995 34678999999999865432 1233456799999999874 46899999999999999999
Q ss_pred hCCCCCCCCChhHHHHHHHhcCCCCC----------------------CC----CCCCCCHHHHHHHHhhhccCcCCCCC
Q 016471 137 CGSRPFWARTESGIFRSVLRADPNFH----------------------DS----PWPSVSPEAKDFVRRLLNKDHRKRMT 190 (389)
Q Consensus 137 ~g~~pf~~~~~~~~~~~i~~~~~~~~----------------------~~----~~~~~~~~~~~li~~~l~~~p~~R~s 190 (389)
+|+.||.+.........+....+... .. ..+.+++.++++|.+||..||.+|||
T Consensus 220 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 299 (320)
T 2i6l_A 220 TGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLT 299 (320)
T ss_dssp HSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCC
T ss_pred hCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCC
Confidence 99999999888777666655432211 00 12468999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCC
Q 016471 191 AAQALTHPWLHDENRPV 207 (389)
Q Consensus 191 ~~e~l~h~~~~~~~~~~ 207 (389)
++++++||||+....+.
T Consensus 300 ~~ell~hp~~~~~~~p~ 316 (320)
T 2i6l_A 300 AEEALSHPYMSIYSFPM 316 (320)
T ss_dssp HHHHHTSHHHHTTCC--
T ss_pred HHHHhCCcccccccCcc
Confidence 99999999998765443
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=290.04 Aligned_cols=190 Identities=23% Similarity=0.356 Sum_probs=161.8
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|.||||++++ ..+.+|+|||||+||+|.+++....+.+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 107 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll-- 184 (325)
T 3kul_A 107 FDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLV-- 184 (325)
T ss_dssp CCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--
T ss_pred CCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE--
Confidence 5899999999 3577999999999999999987776789999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCC----cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQR----LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGI 150 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~ 150 (389)
+.++.+||+|||++........ .....+|+.|+|||++. ..++.++||||+||++|+|++ |..||.+......
T Consensus 185 -~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~ 263 (325)
T 3kul_A 185 -DSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV 263 (325)
T ss_dssp -CTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH
T ss_pred -CCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence 5788999999999987644321 22234677899999985 568999999999999999999 9999999988888
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 151 FRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 151 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
...+....... ....+++.+.++|.+||..+|.+|||+.++++
T Consensus 264 ~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 264 ISSVEEGYRLP---APMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp HHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHcCCCCC---CCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 88777653221 22468999999999999999999999999985
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=285.36 Aligned_cols=198 Identities=26% Similarity=0.481 Sum_probs=166.7
Q ss_pred CCCccccceee------cCeEEEEEEccCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC-----CEecC
Q 016471 1 MYHQKLQHLFY------SNSFLFFTRFCEGGELLDRILSR---GGRYLEEDAKTIVEKILNIVAFCHLQG-----VVHRD 66 (389)
Q Consensus 1 l~Hpni~~~~~------~~~~~lv~E~~~gg~L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~~-----i~Hrd 66 (389)
|+||||++++. ...+|+|||||+||+|.+++... ...+++..++.++.|++.||.|||++| |+|||
T Consensus 62 l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~d 141 (279)
T 2w5a_A 62 LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRD 141 (279)
T ss_dssp CCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCC
T ss_pred cCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEec
Confidence 58999999983 46799999999999999988653 234999999999999999999999999 99999
Q ss_pred CCCCcEEEeecCCCCCEEEeecCCccccCCCCC-cccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCC
Q 016471 67 LKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR-LNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWA 144 (389)
Q Consensus 67 lkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~ 144 (389)
|||+||++ +.++.+||+|||++........ .....||+.|+|||++.+ .++.++||||+|+++|+|++|..||.+
T Consensus 142 l~p~NIl~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 218 (279)
T 2w5a_A 142 LKPANVFL---DGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA 218 (279)
T ss_dssp CSGGGEEE---CSSSCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cchhhEEE---cCCCCEEEecCchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcc
Confidence 99999999 5678899999999877644322 234578999999998854 689999999999999999999999998
Q ss_pred CChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 145 RTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 145 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
.+.......+........ ...+++.+.++|.+||..+|.+|||+.++++|+|+..+.
T Consensus 219 ~~~~~~~~~i~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~ 275 (279)
T 2w5a_A 219 FSQKELAGKIREGKFRRI---PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH 275 (279)
T ss_dssp SSHHHHHHHHHHTCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred cCHHHHHHHHhhcccccC---CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence 888777777776543211 135899999999999999999999999999999997754
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=292.06 Aligned_cols=191 Identities=20% Similarity=0.323 Sum_probs=161.9
Q ss_pred CCCcccccee---ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 1 MYHQKLQHLF---YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 1 l~Hpni~~~~---~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
+.||||++++ .+...++|||||.||+|.+++....+.+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 72 l~h~~iv~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~--- 148 (325)
T 3kex_A 72 LDHAHIVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLL--- 148 (325)
T ss_dssp CCCTTBCCEEEEECBSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEE---
T ss_pred CCCCCcCeEEEEEcCCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEE---
Confidence 5799999998 3578999999999999999987766789999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCCccccCCCC---CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHH
Q 016471 78 EEDAPLKVIDFGLSDFVRPDQ---RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFR 152 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 152 (389)
+.++.+||+|||++....... ......||+.|+|||++. +.++.++||||+||++|+|++ |..||.+........
T Consensus 149 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~ 228 (325)
T 3kex_A 149 KSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPD 228 (325)
T ss_dssp SSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHH
T ss_pred CCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHH
Confidence 567889999999998764432 223456888999999985 579999999999999999999 999999888777777
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCC
Q 016471 153 SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 197 (389)
Q Consensus 153 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h 197 (389)
.+........+ ..+++.+.+++.+||..+|.+|||+.+++++
T Consensus 229 ~~~~~~~~~~~---~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 229 LLEKGERLAQP---QICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp HHHTTCBCCCC---TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred HHHcCCCCCCC---CcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 76654322221 3478889999999999999999999999875
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=285.40 Aligned_cols=190 Identities=19% Similarity=0.313 Sum_probs=153.6
Q ss_pred CCCcccccee---ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 1 MYHQKLQHLF---YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 1 l~Hpni~~~~---~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
|.||||++++ .++.+|+|||||++|+|.+++..+...+++..+..++.|++.||.|||++||+||||||+||+++
T Consensus 73 l~h~~iv~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~-- 150 (281)
T 1mp8_A 73 FDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS-- 150 (281)
T ss_dssp CCCTTBCCEEEEECSSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE--
T ss_pred CCCCccceEEEEEccCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEEC--
Confidence 5799999998 35778999999999999999887766799999999999999999999999999999999999995
Q ss_pred CCCCCEEEeecCCccccCCCCC--cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHH
Q 016471 78 EEDAPLKVIDFGLSDFVRPDQR--LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRS 153 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~ 153 (389)
.++.+||+|||++........ .....+|+.|+|||++. ..++.++||||+||++|+|++ |..||.+....+....
T Consensus 151 -~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~ 229 (281)
T 1mp8_A 151 -SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR 229 (281)
T ss_dssp -ETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH
T ss_pred -CCCCEEECccccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHH
Confidence 567899999999987644322 22345678899999885 568999999999999999997 9999999888888877
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 154 VLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 154 i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
+....... ..+.+++.+.+++.+||..+|.+|||+.++++
T Consensus 230 i~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 269 (281)
T 1mp8_A 230 IENGERLP---MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 269 (281)
T ss_dssp HHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHcCCCCC---CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 76654221 22568999999999999999999999999885
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=286.54 Aligned_cols=195 Identities=22% Similarity=0.437 Sum_probs=165.8
Q ss_pred CCCccccceee------cCeEEEEEEccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEE
Q 016471 1 MYHQKLQHLFY------SNSFLFFTRFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFL 73 (389)
Q Consensus 1 l~Hpni~~~~~------~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nil 73 (389)
|+||||++++. ...+|+|||||.+| |.+.+... .+.+++..+..++.||+.||.|||++||+||||||+||+
T Consensus 63 l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl 141 (305)
T 2wtk_C 63 LRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLL 141 (305)
T ss_dssp CCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred cCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEE
Confidence 57999999983 34789999999987 76766543 467999999999999999999999999999999999999
Q ss_pred EeecCCCCCEEEeecCCccccCCC---CCcccccccCCccccccccc---cCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 016471 74 FTTREEDAPLKVIDFGLSDFVRPD---QRLNDIVGSAYYVAPEVLHR---SYNVEGDMWSIGVITYILLCGSRPFWARTE 147 (389)
Q Consensus 74 l~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 147 (389)
+ +.++.+||+|||++...... .......||+.|+|||++.+ .++.++||||+||++|+|++|..||.+...
T Consensus 142 ~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 218 (305)
T 2wtk_C 142 L---TTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI 218 (305)
T ss_dssp E---CTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred E---cCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH
Confidence 9 56789999999999876432 22345579999999998854 247789999999999999999999999888
Q ss_pred hHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCC
Q 016471 148 SGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 148 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~ 203 (389)
......+.......+ ..+++.+.++|.+||..||.+|||++++++||||+..
T Consensus 219 ~~~~~~i~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 270 (305)
T 2wtk_C 219 YKLFENIGKGSYAIP----GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270 (305)
T ss_dssp HHHHHHHHHCCCCCC----SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHhcCCCCCC----CccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence 888888777654433 3589999999999999999999999999999999765
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=288.45 Aligned_cols=199 Identities=24% Similarity=0.373 Sum_probs=160.1
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
.|++++.++ ..+.+|+||||| +|+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+||+++.
T Consensus 75 ~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~ 153 (339)
T 1z57_A 75 STFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQ 153 (339)
T ss_dssp CTTCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESC
T ss_pred CceeeEeeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEec
Confidence 355688776 467899999999 889999887653 36899999999999999999999999999999999999953
Q ss_pred cCC----------------CCCEEEeecCCccccCCCCCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCC
Q 016471 77 REE----------------DAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGS 139 (389)
Q Consensus 77 ~~~----------------~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~ 139 (389)
.+. ++.+||+|||++..... ......||+.|+|||++.+ .++.++||||+||++|+|++|.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~ 231 (339)
T 1z57_A 154 SDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGF 231 (339)
T ss_dssp CCEEEEEC----CEEEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSS
T ss_pred cccccccCCccccccccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCC
Confidence 211 56899999999986543 2345689999999998854 6899999999999999999999
Q ss_pred CCCCCCChhHHHHHHHhcCCCCCC----------------CCC------------------------CCCCHHHHHHHHh
Q 016471 140 RPFWARTESGIFRSVLRADPNFHD----------------SPW------------------------PSVSPEAKDFVRR 179 (389)
Q Consensus 140 ~pf~~~~~~~~~~~i~~~~~~~~~----------------~~~------------------------~~~~~~~~~li~~ 179 (389)
.||.+.+..+....+.......+. ..| ...++.+.+||.+
T Consensus 232 ~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 311 (339)
T 1z57_A 232 TVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQK 311 (339)
T ss_dssp CSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHH
T ss_pred CCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHH
Confidence 999988776655544332221111 001 1134678999999
Q ss_pred hhccCcCCCCCHHHHhCCCCCCCC
Q 016471 180 LLNKDHRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 180 ~l~~~p~~R~s~~e~l~h~~~~~~ 203 (389)
||..||.+|||+.++++||||+..
T Consensus 312 ~L~~dP~~Rpt~~ell~hp~f~~~ 335 (339)
T 1z57_A 312 MLEYDPAKRITLREALKHPFFDLL 335 (339)
T ss_dssp HTCSSTTTSCCHHHHTTSGGGGGG
T ss_pred HhCcCcccccCHHHHhcCHHHHHH
Confidence 999999999999999999999754
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=296.64 Aligned_cols=194 Identities=34% Similarity=0.567 Sum_probs=157.3
Q ss_pred CCCccccceee----cCe------EEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCC
Q 016471 1 MYHQKLQHLFY----SNS------FLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPE 70 (389)
Q Consensus 1 l~Hpni~~~~~----~~~------~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~ 70 (389)
|+||||++++. ... +|+|||||. |+|.+.+ ...+++..++.++.||+.||+|||++||+||||||+
T Consensus 98 l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~ 173 (371)
T 4exu_A 98 MQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIM---GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPG 173 (371)
T ss_dssp CCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred cCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHHHHh---hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHH
Confidence 58999999882 222 499999998 4887765 245999999999999999999999999999999999
Q ss_pred cEEEeecCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChh
Q 016471 71 NFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTES 148 (389)
Q Consensus 71 Nill~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 148 (389)
||++ +.++.+||+|||++..... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+.+..
T Consensus 174 NIll---~~~~~~kL~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 248 (371)
T 4exu_A 174 NLAV---NEDCELKILDFGLARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL 248 (371)
T ss_dssp GEEE---CTTCCEEECSTTCC----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred HeEE---CCCCCEEEEecCccccccc--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH
Confidence 9999 5778999999999986543 3345688999999998754 6899999999999999999999999988877
Q ss_pred HHHHHHHhcCCCC-----------------------CCC----CCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCC
Q 016471 149 GIFRSVLRADPNF-----------------------HDS----PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLH 201 (389)
Q Consensus 149 ~~~~~i~~~~~~~-----------------------~~~----~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~ 201 (389)
+....+....... +.. .++.+++.+.+||.+||..||.+|||++++++||||+
T Consensus 249 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~ 328 (371)
T 4exu_A 249 DQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE 328 (371)
T ss_dssp HHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred HHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccc
Confidence 7666654422111 110 1245799999999999999999999999999999997
Q ss_pred CC
Q 016471 202 DE 203 (389)
Q Consensus 202 ~~ 203 (389)
..
T Consensus 329 ~~ 330 (371)
T 4exu_A 329 PF 330 (371)
T ss_dssp TT
T ss_pred cC
Confidence 64
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=286.92 Aligned_cols=198 Identities=26% Similarity=0.432 Sum_probs=155.1
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CCEecCCCCCcEEEe
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQ-GVVHRDLKPENFLFT 75 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~-~i~Hrdlkp~Nill~ 75 (389)
+.||||++++ ..+.+|+||||| ++.+........+.+++..+..++.||+.||.|||++ ||+||||||+||++
T Consensus 81 ~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~- 158 (318)
T 2dyl_A 81 HDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL- 158 (318)
T ss_dssp TTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEE-
T ss_pred cCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEE-
Confidence 4799999998 357899999999 5555555445457899999999999999999999995 99999999999999
Q ss_pred ecCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc------ccCCCchhHHHHHHHHHHHHhCCCCCCC-CChh
Q 016471 76 TREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH------RSYNVEGDMWSIGVITYILLCGSRPFWA-RTES 148 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~ 148 (389)
+.++.+||+|||++.............||+.|+|||++. ..++.++||||+||++|+|++|..||.. ....
T Consensus 159 --~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 236 (318)
T 2dyl_A 159 --DERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF 236 (318)
T ss_dssp --CTTSCEEECCCTTC--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH
T ss_pred --CCCCCEEEEECCCchhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH
Confidence 567899999999997765544445567999999999973 3578999999999999999999999987 3455
Q ss_pred HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCC
Q 016471 149 GIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 149 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~ 203 (389)
.....+........ +....+++.+.++|.+||..||.+|||++++++||||+..
T Consensus 237 ~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 237 EVLTKVLQEEPPLL-PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY 290 (318)
T ss_dssp HHHHHHHHSCCCCC-CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred HHHHHHhccCCCCC-CccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence 56666665543322 2234689999999999999999999999999999999654
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=299.96 Aligned_cols=198 Identities=24% Similarity=0.410 Sum_probs=153.7
Q ss_pred CCccccceee--------cCeEEEEEEccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC-CCEecCCCCCc
Q 016471 2 YHQKLQHLFY--------SNSFLFFTRFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQ-GVVHRDLKPEN 71 (389)
Q Consensus 2 ~Hpni~~~~~--------~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~-~i~Hrdlkp~N 71 (389)
+||||++++. ...+|+||||| +|+|.+.+.... +.+++..++.++.||+.||.|||++ ||+||||||+|
T Consensus 99 ~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~N 177 (397)
T 1wak_A 99 NREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPEN 177 (397)
T ss_dssp GGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGG
T ss_pred CcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHH
Confidence 3889999883 24799999999 567777776553 5799999999999999999999999 99999999999
Q ss_pred EEEeecC----------------------------------------------CCCCEEEeecCCccccCCCCCcccccc
Q 016471 72 FLFTTRE----------------------------------------------EDAPLKVIDFGLSDFVRPDQRLNDIVG 105 (389)
Q Consensus 72 ill~~~~----------------------------------------------~~~~~kl~Dfg~a~~~~~~~~~~~~~g 105 (389)
||++..+ ....+||+|||++..... .....+|
T Consensus 178 Ill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--~~~~~~g 255 (397)
T 1wak_A 178 ILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQ 255 (397)
T ss_dssp EEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--CSCSCCS
T ss_pred eeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc--cCccCCC
Confidence 9995211 113799999999987643 2345689
Q ss_pred cCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCh------hHHHHHHHhcCCCCCC---------------
Q 016471 106 SAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTE------SGIFRSVLRADPNFHD--------------- 163 (389)
Q Consensus 106 t~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~i~~~~~~~~~--------------- 163 (389)
|+.|+|||++. ..++.++|||||||++|+|++|..||.+.+. ......+.......+.
T Consensus 256 t~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 335 (397)
T 1wak_A 256 TRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTK 335 (397)
T ss_dssp CGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCT
T ss_pred CCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCC
Confidence 99999999885 4699999999999999999999999976542 2222222221111100
Q ss_pred ----------CC-------------CCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCC
Q 016471 164 ----------SP-------------WPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 202 (389)
Q Consensus 164 ----------~~-------------~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~ 202 (389)
.+ ....++.+.+||.+||..||.+|||++++++||||++
T Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 336 KGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp TSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred ccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 00 0123467899999999999999999999999999963
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=287.13 Aligned_cols=197 Identities=20% Similarity=0.293 Sum_probs=153.8
Q ss_pred CCCccccceee----cCe------EEEEEEccCCCChHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCCEec
Q 016471 1 MYHQKLQHLFY----SNS------FLFFTRFCEGGELLDRILSRG-----GRYLEEDAKTIVEKILNIVAFCHLQGVVHR 65 (389)
Q Consensus 1 l~Hpni~~~~~----~~~------~~lv~E~~~gg~L~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hr 65 (389)
|+||||++++. ... .++|||||.||+|.+++.... ..+++..++.++.||+.||.|||++||+||
T Consensus 82 l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~ 161 (323)
T 3qup_A 82 FDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHR 161 (323)
T ss_dssp CCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred CCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccC
Confidence 57999999982 222 399999999999999886432 159999999999999999999999999999
Q ss_pred CCCCCcEEEeecCCCCCEEEeecCCccccCCCCC---cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCC
Q 016471 66 DLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSR 140 (389)
Q Consensus 66 dlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~ 140 (389)
||||+||++ +.++.+||+|||++........ .....+++.|+|||++. ..++.++||||+||++|+|++ |..
T Consensus 162 Dikp~NIli---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~ 238 (323)
T 3qup_A 162 DLAARNCML---AEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQT 238 (323)
T ss_dssp CCSGGGEEE---CTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred CCCcceEEE---cCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCC
Confidence 999999999 5678999999999976644321 22345678899999885 468999999999999999999 999
Q ss_pred CCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCC-------HHHHhCCCCCCCC
Q 016471 141 PFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMT-------AAQALTHPWLHDE 203 (389)
Q Consensus 141 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s-------~~e~l~h~~~~~~ 203 (389)
||.+.........+........ .+.+++.+.+++.+||..||.+||| +++++.|||+...
T Consensus 239 p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 239 PYAGIENAEIYNYLIGGNRLKQ---PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp TTTTCCGGGHHHHHHTTCCCCC---CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred CccccChHHHHHHHhcCCCCCC---CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence 9999888888887776543222 2568999999999999999999999 7888899999765
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=281.66 Aligned_cols=191 Identities=21% Similarity=0.362 Sum_probs=164.5
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|.||||++++ ..+.+|+|||||.||+|.+++....+.+++..++.++.|++.||.|||++||+||||||+||++
T Consensus 76 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili-- 153 (283)
T 3gen_A 76 LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV-- 153 (283)
T ss_dssp CCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE--
T ss_pred CCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEE--
Confidence 5799999998 3577999999999999999987755789999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC--CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ--RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFR 152 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 152 (389)
+.++.+||+|||++....... ......+|+.|+|||++. ..++.++||||+|+++|+|++ |..||.+........
T Consensus 154 -~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~ 232 (283)
T 3gen_A 154 -NDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE 232 (283)
T ss_dssp -CTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH
T ss_pred -cCCCCEEEccccccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHH
Confidence 577899999999997654322 223345778899999885 568999999999999999998 999999988888888
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCC
Q 016471 153 SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 197 (389)
Q Consensus 153 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h 197 (389)
.+........+ ...++.+.++|.+||..+|.+|||+.++++|
T Consensus 233 ~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 233 HIAQGLRLYRP---HLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp HHHTTCCCCCC---TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHhcccCCCCC---CcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 77765433222 3578999999999999999999999999864
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-37 Score=280.58 Aligned_cols=192 Identities=22% Similarity=0.359 Sum_probs=156.8
Q ss_pred CCCcccccee--ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF--YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQG--VVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~--~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--i~Hrdlkp~Nill~~ 76 (389)
|+||||++++ .....++|||||+||+|.+++......+++..+..++.|++.||.|||++| |+||||||+||+++.
T Consensus 80 l~h~~i~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~ 159 (287)
T 4f0f_A 80 LNHPNIVKLYGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQS 159 (287)
T ss_dssp CCCTTBCCEEEEETTTTEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESC
T ss_pred CCCCCchhhheeecCCCeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEec
Confidence 5799999999 344458999999999999999877778999999999999999999999999 999999999999953
Q ss_pred cCC--CCCEEEeecCCccccCCCCCcccccccCCcccccccc---ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHH-
Q 016471 77 REE--DAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH---RSYNVEGDMWSIGVITYILLCGSRPFWARTESGI- 150 (389)
Q Consensus 77 ~~~--~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~- 150 (389)
.+. ...+||+|||++..... ......||+.|+|||++. ..++.++||||+||++|+|++|..||........
T Consensus 160 ~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 237 (287)
T 4f0f_A 160 LDENAPVCAKVADFGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK 237 (287)
T ss_dssp CCTTCSCCEEECCCTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH
T ss_pred cCCCCceeEEeCCCCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH
Confidence 211 12399999999975433 344568999999999983 3478899999999999999999999987654433
Q ss_pred -HHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 151 -FRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 151 -~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
...+...... ......+++.+.++|.+||..||.+|||+.++++
T Consensus 238 ~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 238 FINMIREEGLR--PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp HHHHHHHSCCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhccCCC--CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 3333333222 2223568999999999999999999999999875
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-37 Score=288.86 Aligned_cols=196 Identities=23% Similarity=0.378 Sum_probs=157.2
Q ss_pred ccccee----ecCeEEEEEEccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec--
Q 016471 5 KLQHLF----YSNSFLFFTRFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR-- 77 (389)
Q Consensus 5 ni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~-- 77 (389)
+++.++ ....+|+||||| +|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+...
T Consensus 83 ~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~ 161 (355)
T 2eu9_A 83 LCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEF 161 (355)
T ss_dssp CBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCE
T ss_pred eEEEeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccc
Confidence 366655 467899999999 567878777653 579999999999999999999999999999999999999432
Q ss_pred --------------CCCCCEEEeecCCccccCCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCC
Q 016471 78 --------------EEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPF 142 (389)
Q Consensus 78 --------------~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf 142 (389)
+.++.+||+|||++..... ......||+.|+|||++. ..++.++||||+||++|+|++|..||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 239 (355)
T 2eu9_A 162 ETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE--HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLF 239 (355)
T ss_dssp EEEECCC-CCCEEEESCCCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred cccccccccccccccCCCcEEEeecCccccccc--cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCC
Confidence 2468899999999986533 234568999999999885 46899999999999999999999999
Q ss_pred CCCChhHHHHHHHhcCCCCCCC----------------CC------------------------CCCCHHHHHHHHhhhc
Q 016471 143 WARTESGIFRSVLRADPNFHDS----------------PW------------------------PSVSPEAKDFVRRLLN 182 (389)
Q Consensus 143 ~~~~~~~~~~~i~~~~~~~~~~----------------~~------------------------~~~~~~~~~li~~~l~ 182 (389)
.+.........+.......+.. .| ...++.+.+||.+||.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 319 (355)
T 2eu9_A 240 QTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLE 319 (355)
T ss_dssp CCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred CCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhc
Confidence 9887766555443322211110 01 1124578999999999
Q ss_pred cCcCCCCCHHHHhCCCCCCCC
Q 016471 183 KDHRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 183 ~~p~~R~s~~e~l~h~~~~~~ 203 (389)
.||.+|||+.++++||||...
T Consensus 320 ~dP~~Rpt~~e~l~hp~f~~~ 340 (355)
T 2eu9_A 320 FDPAQRITLAEALLHPFFAGL 340 (355)
T ss_dssp SSTTTSCCHHHHTTSGGGGGC
T ss_pred CChhhCcCHHHHhcChhhcCC
Confidence 999999999999999999865
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=287.75 Aligned_cols=191 Identities=19% Similarity=0.271 Sum_probs=162.0
Q ss_pred CCCcccccee---ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 1 MYHQKLQHLF---YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 1 l~Hpni~~~~---~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
|+||||++++ .....++|+||+.+|+|.+++....+.+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 74 l~h~~iv~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~-- 151 (327)
T 3poz_A 74 VDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK-- 151 (327)
T ss_dssp CCBTTBCCEEEEEESSSEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE--
T ss_pred CCCCCEeEEEEEEecCCeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEEC--
Confidence 5899999999 35678999999999999999988778899999999999999999999999999999999999995
Q ss_pred CCCCCEEEeecCCccccCCCCC---cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHH
Q 016471 78 EEDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFR 152 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 152 (389)
.++.+||+|||++........ .....||+.|+|||++. ..++.++||||+||++|+|++ |..||.+.+......
T Consensus 152 -~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 230 (327)
T 3poz_A 152 -TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS 230 (327)
T ss_dssp -ETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH
T ss_pred -CCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHH
Confidence 567899999999987644332 22345688999999875 568999999999999999999 999999888877766
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCC
Q 016471 153 SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 197 (389)
Q Consensus 153 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h 197 (389)
.+...... + ..+.++..+.+++.+||..+|.+|||+.+++++
T Consensus 231 ~~~~~~~~-~--~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 231 ILEKGERL-P--QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHTTCCC-C--CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred HHHcCCCC-C--CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 66554322 2 124589999999999999999999999999863
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=299.79 Aligned_cols=199 Identities=27% Similarity=0.441 Sum_probs=150.4
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCC------CCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCc
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGR------YLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPEN 71 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~------l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~N 71 (389)
.||||++++ ..+.+|+|||||. |+|.+++...... .++..++.++.||+.||+|||++||+||||||+|
T Consensus 67 ~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~N 145 (434)
T 2rio_A 67 DHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQN 145 (434)
T ss_dssp TSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred CCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHh
Confidence 799999999 3577999999996 5999988654211 1233457899999999999999999999999999
Q ss_pred EEEeec----------CCCCCEEEeecCCccccCCCC-----CcccccccCCcccccccc--------ccCCCchhHHHH
Q 016471 72 FLFTTR----------EEDAPLKVIDFGLSDFVRPDQ-----RLNDIVGSAYYVAPEVLH--------RSYNVEGDMWSI 128 (389)
Q Consensus 72 ill~~~----------~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~--------~~~~~~~Diwsl 128 (389)
||++.. +.+..+||+|||++....... .....+||+.|+|||++. ..++.++||||+
T Consensus 146 ILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSl 225 (434)
T 2rio_A 146 ILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSM 225 (434)
T ss_dssp EEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHH
T ss_pred EEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhH
Confidence 999642 234689999999998765432 123457999999999884 358899999999
Q ss_pred HHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCC---CCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCC
Q 016471 129 GVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSP---WPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 129 G~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~ 203 (389)
||++|+|++ |..||.+..... ..+.......+... .+.+++++.++|.+||..||.+|||+.++++||||+..
T Consensus 226 G~il~ellt~g~~Pf~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~ 302 (434)
T 2rio_A 226 GCVFYYILSKGKHPFGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK 302 (434)
T ss_dssp HHHHHHHHTTSCCTTCSTTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCH
T ss_pred HHHHHHHHhCCCCCCCCchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCCc
Confidence 999999999 999997654433 33444433332221 12346889999999999999999999999999999653
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=288.75 Aligned_cols=194 Identities=33% Similarity=0.553 Sum_probs=157.2
Q ss_pred CCCccccceee----c------CeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCC
Q 016471 1 MYHQKLQHLFY----S------NSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPE 70 (389)
Q Consensus 1 l~Hpni~~~~~----~------~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~ 70 (389)
|+||||++++. . ..+|+|||||. |+|.+++. ..+++..++.++.||+.||.|||++||+||||||+
T Consensus 80 l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~ 155 (353)
T 3coi_A 80 MQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPG 155 (353)
T ss_dssp CCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGG
T ss_pred cCCCCcccHhheEecccccccceeEEEEecccc-CCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHH
Confidence 57999999882 1 23599999998 58887652 45999999999999999999999999999999999
Q ss_pred cEEEeecCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChh
Q 016471 71 NFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTES 148 (389)
Q Consensus 71 Nill~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 148 (389)
||++ +.++.+||+|||++..... ......||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+..
T Consensus 156 NIl~---~~~~~~kl~Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 230 (353)
T 3coi_A 156 NLAV---NEDCELKILDFGLARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL 230 (353)
T ss_dssp GEEE---CTTCCEEECSTTCTTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH
T ss_pred HEeE---CCCCcEEEeecccccCCCC--CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999 5678999999999976543 2345678999999998753 6899999999999999999999999988876
Q ss_pred HHHHHHHhcCC-----------------------CCC----CCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCC
Q 016471 149 GIFRSVLRADP-----------------------NFH----DSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLH 201 (389)
Q Consensus 149 ~~~~~i~~~~~-----------------------~~~----~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~ 201 (389)
..+..+.+... ..+ ...++.+++.+.+||.+||..||.+|||++++++||||.
T Consensus 231 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~ 310 (353)
T 3coi_A 231 DQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE 310 (353)
T ss_dssp HHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred HHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchh
Confidence 66655543211 001 112346799999999999999999999999999999997
Q ss_pred CC
Q 016471 202 DE 203 (389)
Q Consensus 202 ~~ 203 (389)
..
T Consensus 311 ~~ 312 (353)
T 3coi_A 311 PF 312 (353)
T ss_dssp TT
T ss_pred hc
Confidence 64
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=282.07 Aligned_cols=193 Identities=21% Similarity=0.424 Sum_probs=149.9
Q ss_pred CCCcccccee---ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 1 MYHQKLQHLF---YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 1 l~Hpni~~~~---~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
++||||+.++ ....+++|||||.||+|.+++......+++..+..++.||+.||.|||++||+||||||+||+++
T Consensus 77 l~h~~iv~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~-- 154 (289)
T 3og7_A 77 TRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLH-- 154 (289)
T ss_dssp CCCTTBCCEEEEECSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE--
T ss_pred CCCCcEEEEEeeccCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEEC--
Confidence 5799999998 35678999999999999998876667899999999999999999999999999999999999994
Q ss_pred CCCCCEEEeecCCccccCC---CCCcccccccCCcccccccc----ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHH
Q 016471 78 EEDAPLKVIDFGLSDFVRP---DQRLNDIVGSAYYVAPEVLH----RSYNVEGDMWSIGVITYILLCGSRPFWARTESGI 150 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 150 (389)
.++.+||+|||++..... ........||+.|+|||++. ..++.++||||+||++|+|++|+.||.+......
T Consensus 155 -~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~ 233 (289)
T 3og7_A 155 -EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 233 (289)
T ss_dssp -TTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH
T ss_pred -CCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH
Confidence 678899999999876543 22234467999999999874 3578899999999999999999999988665544
Q ss_pred HHHHH-hcCCCCC-CCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 151 FRSVL-RADPNFH-DSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 151 ~~~i~-~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
..... ....... ......+++.+.++|.+||..+|.+|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 234 IIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp HHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 44433 3322221 1123468899999999999999999999999885
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=291.73 Aligned_cols=191 Identities=23% Similarity=0.377 Sum_probs=157.6
Q ss_pred CCccccceee-----cCeEEEEEEccCCCChHHHHHhcCC----------------------------------------
Q 016471 2 YHQKLQHLFY-----SNSFLFFTRFCEGGELLDRILSRGG---------------------------------------- 36 (389)
Q Consensus 2 ~Hpni~~~~~-----~~~~~lv~E~~~gg~L~~~l~~~~~---------------------------------------- 36 (389)
+||||++++. ...+|+|||||+||+|.+++.....
T Consensus 84 ~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (359)
T 3vhe_A 84 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSA 163 (359)
T ss_dssp CCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------
T ss_pred CCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccc
Confidence 6999999993 3459999999999999999876532
Q ss_pred -------------------------CCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeecCCCCCEEEeecCCc
Q 016471 37 -------------------------RYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS 91 (389)
Q Consensus 37 -------------------------~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~~~~~~~kl~Dfg~a 91 (389)
.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kl~Dfg~a 240 (359)
T 3vhe_A 164 SSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLA 240 (359)
T ss_dssp --------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCGGG
T ss_pred ccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---cCCCcEEEEeccce
Confidence 18999999999999999999999999999999999999 46788999999999
Q ss_pred cccCCCC---CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCC
Q 016471 92 DFVRPDQ---RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPW 166 (389)
Q Consensus 92 ~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 166 (389)
....... ......||+.|+|||++. ..++.++||||+||++|+|++ |..||.+...................+
T Consensus 241 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~-- 318 (359)
T 3vhe_A 241 RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAP-- 318 (359)
T ss_dssp SCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCC--
T ss_pred eeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCC--
Confidence 8654332 233457899999999885 568999999999999999998 999998877555544444433222222
Q ss_pred CCCCHHHHHHHHhhhccCcCCCCCHHHHhCC
Q 016471 167 PSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 197 (389)
Q Consensus 167 ~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h 197 (389)
..+++.+.+++.+||..+|.+|||+.++++|
T Consensus 319 ~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 319 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 4589999999999999999999999999874
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=288.08 Aligned_cols=187 Identities=24% Similarity=0.363 Sum_probs=154.3
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|+||||++++ ....+|+|||||+||+|.+++....+.+++..+..++.||+.||.|||++||+||||||+||++
T Consensus 64 l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~-- 141 (310)
T 3s95_A 64 LEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLV-- 141 (310)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE--
T ss_pred CCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEE--
Confidence 5899999998 4688999999999999999998767889999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCC---------------cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCC
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQR---------------LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSR 140 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~---------------~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~ 140 (389)
+.++.+||+|||++........ ....+||+.|+|||++. ..++.++||||+||++|+|++|..
T Consensus 142 -~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~ 220 (310)
T 3s95_A 142 -RENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVN 220 (310)
T ss_dssp -CTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCC
T ss_pred -CCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCC
Confidence 5778899999999976543221 11467999999999986 468999999999999999999999
Q ss_pred CCCCCChhH-----HHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 141 PFWARTESG-----IFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 141 pf~~~~~~~-----~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
||....... ......... ..+.+++.+.+++.+||..||.+|||+.++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 221 ADPDYLPRTMDFGLNVRGFLDRY------CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp SSTTTSCBCTTSSBCHHHHHHHT------CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCcchhhhHHHHhhhhhcccccc------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 986533211 111111111 11457889999999999999999999999985
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=292.49 Aligned_cols=190 Identities=18% Similarity=0.272 Sum_probs=160.6
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|.||||++++ ..+.+|+|||||+||+|.+++...+..+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 169 l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~-- 246 (377)
T 3cbl_A 169 YSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLV-- 246 (377)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--
T ss_pred CCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEE--
Confidence 5799999999 3477999999999999999998776679999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCC---cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIF 151 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~ 151 (389)
+.++.+||+|||++........ .....+++.|+|||++. +.++.++||||+||++|+|++ |..||.+.+..+..
T Consensus 247 -~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~ 325 (377)
T 3cbl_A 247 -TEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTR 325 (377)
T ss_dssp -CTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHH
T ss_pred -cCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 5678999999999976543221 11234577899999885 568999999999999999998 99999988877776
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 152 RSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 152 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
..+..... .+. ...+++.+.++|.+||..+|.+|||+.++++
T Consensus 326 ~~~~~~~~-~~~--~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 326 EFVEKGGR-LPC--PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp HHHHTTCC-CCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcCCC-CCC--CCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 66655432 221 1457899999999999999999999999875
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=289.85 Aligned_cols=190 Identities=20% Similarity=0.333 Sum_probs=163.1
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG---------------GRYLEEDAKTIVEKILNIVAFCHLQGV 62 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~~lH~~~i 62 (389)
.||||++++ ..+.+|+|||||+||+|.+++.... +.+++..++.++.||+.||.|||++||
T Consensus 133 ~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i 212 (382)
T 3tt0_A 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKC 212 (382)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred CCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 799999999 3577999999999999999987653 359999999999999999999999999
Q ss_pred EecCCCCCcEEEeecCCCCCEEEeecCCccccCCCC---CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-
Q 016471 63 VHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ---RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC- 137 (389)
Q Consensus 63 ~Hrdlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~- 137 (389)
+||||||+|||+ +.++.+||+|||++....... ......+|+.|+|||++. ..++.++||||+||++|+|++
T Consensus 213 vH~Dlkp~NIll---~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~ 289 (382)
T 3tt0_A 213 IHRDLAARNVLV---TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL 289 (382)
T ss_dssp CCSCCCGGGEEE---CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTT
T ss_pred ecCCCCcceEEE---cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhC
Confidence 999999999999 567899999999998664432 233456788999999885 468999999999999999999
Q ss_pred CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCC
Q 016471 138 GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 197 (389)
Q Consensus 138 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h 197 (389)
|..||.+....+....+........ ...+++.+.++|.+||..+|.+|||+.+++++
T Consensus 290 g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 290 GGSPYPGVPVEELFKLLKEGHRMDK---PSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp SCCSSTTCCHHHHHHHHHTTCCCCC---CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCCC---CccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999888888777765532221 24689999999999999999999999999863
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=295.42 Aligned_cols=194 Identities=14% Similarity=0.192 Sum_probs=153.6
Q ss_pred CCCccccceee--------cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcE
Q 016471 1 MYHQKLQHLFY--------SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENF 72 (389)
Q Consensus 1 l~Hpni~~~~~--------~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Ni 72 (389)
+.||||++++. ....|+||||| ||+|.+++....+.+++..++.++.||+.||.|||++||+||||||+||
T Consensus 105 l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Ni 183 (364)
T 3op5_A 105 LKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNL 183 (364)
T ss_dssp CSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred ccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHE
Confidence 57999999982 14589999999 9999999887767899999999999999999999999999999999999
Q ss_pred EEeecCCCCCEEEeecCCccccCCCC--------CcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCC
Q 016471 73 LFTTREEDAPLKVIDFGLSDFVRPDQ--------RLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFW 143 (389)
Q Consensus 73 ll~~~~~~~~~kl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~ 143 (389)
|++. +.++.+||+|||++....... .....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.
T Consensus 184 ll~~-~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~ 262 (364)
T 3op5_A 184 LLNY-KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWE 262 (364)
T ss_dssp EEES-SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEec-CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9953 257889999999997654321 1234569999999998864 58999999999999999999999998
Q ss_pred CCChhHHHHHHHhc--CCCCC-----CCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 144 ARTESGIFRSVLRA--DPNFH-----DSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 144 ~~~~~~~~~~i~~~--~~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
+............. ....+ ......+++.+.+++.+||..+|.+||++.++++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 263 DNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp GGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred ccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 64332221111100 00000 0011357899999999999999999999988875
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=289.99 Aligned_cols=199 Identities=23% Similarity=0.357 Sum_probs=142.5
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC-CCEecCCCCCc
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILS----RGGRYLEEDAKTIVEKILNIVAFCHLQ-GVVHRDLKPEN 71 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~----~~~~l~~~~~~~i~~qi~~~L~~lH~~-~i~Hrdlkp~N 71 (389)
+.||||++++ ..+.+|+|||||.| +|.+++.. ..+.+++..+..++.|++.||.|||++ ||+||||||+|
T Consensus 78 ~~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~N 156 (327)
T 3aln_A 78 SDCPYIVQFYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSN 156 (327)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGG
T ss_pred CCCCcEeeeeeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHH
Confidence 4799999998 35789999999996 77776653 246799999999999999999999999 99999999999
Q ss_pred EEEeecCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc-----ccCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 016471 72 FLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-----RSYNVEGDMWSIGVITYILLCGSRPFWART 146 (389)
Q Consensus 72 ill~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 146 (389)
|+++ .++.+||+|||++.............||+.|+|||++. ..++.++||||+||++|+|++|..||.+..
T Consensus 157 Ill~---~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 233 (327)
T 3aln_A 157 ILLD---RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWN 233 (327)
T ss_dssp EEEE---TTTEEEECCCSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-
T ss_pred EEEc---CCCCEEEccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 9994 67889999999998765544444557999999999972 358899999999999999999999997643
Q ss_pred hh-HHHHHHHhcC-CCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCC
Q 016471 147 ES-GIFRSVLRAD-PNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 147 ~~-~~~~~i~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~ 203 (389)
.. +....+.... +..+....+.+++.+.++|.+||..||.+|||+.++++||||...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 234 SVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292 (327)
T ss_dssp ------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred hHHHHHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence 22 2222222221 122222335689999999999999999999999999999999654
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=286.02 Aligned_cols=190 Identities=20% Similarity=0.289 Sum_probs=160.0
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG---------------GRYLEEDAKTIVEKILNIVAFCHLQGV 62 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~~lH~~~i 62 (389)
.||||++++ ..+.+|+|||||+||+|.+++.... ..+++..++.++.||+.||.|||++||
T Consensus 84 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i 163 (327)
T 1fvr_A 84 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQF 163 (327)
T ss_dssp CCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred CCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 799999998 4678999999999999999887542 469999999999999999999999999
Q ss_pred EecCCCCCcEEEeecCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCC
Q 016471 63 VHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSR 140 (389)
Q Consensus 63 ~Hrdlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~ 140 (389)
+||||||+||++ +.++.+||+|||++.............+++.|+|||++. ..++.++||||+||++|+|++ |..
T Consensus 164 vH~dlkp~NIl~---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~ 240 (327)
T 1fvr_A 164 IHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT 240 (327)
T ss_dssp ECSCCSGGGEEE---CGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred cCCCCccceEEE---cCCCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCC
Confidence 999999999999 467889999999987544333334456788999999885 458999999999999999998 999
Q ss_pred CCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCC
Q 016471 141 PFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 197 (389)
Q Consensus 141 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h 197 (389)
||.+.........+...... .....+++.+.++|.+||..+|.+|||+.+++++
T Consensus 241 pf~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 241 PYCGMTCAELYEKLPQGYRL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp TTTTCCHHHHHHHGGGTCCC---CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCcHHHHHHHhhcCCCC---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99998888777776654221 1224689999999999999999999999999874
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=276.77 Aligned_cols=192 Identities=22% Similarity=0.331 Sum_probs=153.4
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCCCcEE
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQG---VVHRDLKPENFL 73 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---i~Hrdlkp~Nil 73 (389)
++||||++++ ..+.+|+|||||+||+|.+++. .+.+++..++.++.|++.||.|||++| |+||||||+||+
T Consensus 63 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil 140 (271)
T 3dtc_A 63 LKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNIL 140 (271)
T ss_dssp CCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEE
T ss_pred cCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEE
Confidence 5799999998 3567899999999999988763 357999999999999999999999999 899999999999
Q ss_pred EeecC-----CCCCEEEeecCCccccCCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 016471 74 FTTRE-----EDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTE 147 (389)
Q Consensus 74 l~~~~-----~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 147 (389)
++... .++.+||+|||++....... .....||+.|+|||++. ..++.++||||+|+++|+|++|+.||.+.+.
T Consensus 141 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 219 (271)
T 3dtc_A 141 ILQKVENGDLSNKILKITDFGLAREWHRTT-KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG 219 (271)
T ss_dssp ESSCCSSSCCSSCCEEECCCCC--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH
T ss_pred EecccccccccCcceEEccCCccccccccc-ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 95321 26789999999997654433 23457999999999885 4689999999999999999999999998887
Q ss_pred hHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCC
Q 016471 148 SGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 197 (389)
Q Consensus 148 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h 197 (389)
......+.......+. ...+++.+.+++.+||..+|.+|||+.+++++
T Consensus 220 ~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 220 LAVAYGVAMNKLALPI--PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp HHHHHHHHTSCCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhhhcCCCCCCC--CcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 7776666655433332 24689999999999999999999999999863
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=288.70 Aligned_cols=191 Identities=22% Similarity=0.358 Sum_probs=159.9
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcCC----------------------CCCHHHHHHHHHHHHHHHH
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGG----------------------RYLEEDAKTIVEKILNIVA 55 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~----------------------~l~~~~~~~i~~qi~~~L~ 55 (389)
.||||++++ ..+.+|+|||||+||+|.+++..... .+++..+..++.||+.||.
T Consensus 107 ~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~ 186 (344)
T 1rjb_A 107 SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGME 186 (344)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHH
T ss_pred CCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHH
Confidence 799999998 35789999999999999999876533 3789999999999999999
Q ss_pred HHHHCCCEecCCCCCcEEEeecCCCCCEEEeecCCccccCCCCC---cccccccCCcccccccc-ccCCCchhHHHHHHH
Q 016471 56 FCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVI 131 (389)
Q Consensus 56 ~lH~~~i~Hrdlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~i 131 (389)
|||++||+||||||+||+++ .++.+||+|||++........ .....||+.|+|||++. +.++.++||||+||+
T Consensus 187 ~LH~~~ivH~Dikp~NIll~---~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i 263 (344)
T 1rjb_A 187 FLEFKSCVHRDLAARNVLVT---HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGIL 263 (344)
T ss_dssp HHHHTTEEETTCSGGGEEEE---TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred HHHhCCcccCCCChhhEEEc---CCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHH
Confidence 99999999999999999994 678999999999976543322 23456788999999875 568999999999999
Q ss_pred HHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCC
Q 016471 132 TYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 197 (389)
Q Consensus 132 l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h 197 (389)
+|+|++ |..||.+.........+.......+. ...+++.+.++|.+||..||.+|||+.+++++
T Consensus 264 l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 328 (344)
T 1rjb_A 264 LWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQ--PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328 (344)
T ss_dssp HHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCCCCcccCCcHHHHHHHHhcCCCCCC--CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 999998 99999887766555555554333222 24579999999999999999999999999875
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-37 Score=282.91 Aligned_cols=190 Identities=21% Similarity=0.291 Sum_probs=161.5
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHH
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG-----------------------GRYLEEDAKTIVEKILNI 53 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~-----------------------~~l~~~~~~~i~~qi~~~ 53 (389)
|.||||++++ ..+.+|+|||||.||+|.+++.... ..+++..++.++.||+.|
T Consensus 83 l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 162 (314)
T 2ivs_A 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQG 162 (314)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHH
T ss_pred CCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHH
Confidence 5799999998 3577999999999999999987642 238999999999999999
Q ss_pred HHHHHHCCCEecCCCCCcEEEeecCCCCCEEEeecCCccccCCCCC---cccccccCCcccccccc-ccCCCchhHHHHH
Q 016471 54 VAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIG 129 (389)
Q Consensus 54 L~~lH~~~i~Hrdlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG 129 (389)
|.|||++||+||||||+||+++ .++.+||+|||++........ .....+|+.|+|||++. ..++.++||||+|
T Consensus 163 l~~lH~~~ivH~dikp~NIli~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 239 (314)
T 2ivs_A 163 MQYLAEMKLVHRDLAARNILVA---EGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFG 239 (314)
T ss_dssp HHHHHHTTEECCCCSGGGEEEE---TTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHH
T ss_pred HHHHHHCCCcccccchheEEEc---CCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHH
Confidence 9999999999999999999994 678899999999986644321 23345788899999885 4689999999999
Q ss_pred HHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 130 VITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 130 ~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
|++|+|++ |..||.+.........+...... .....+++.+.++|.+||..||.+|||+.++++
T Consensus 240 ~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~ 304 (314)
T 2ivs_A 240 VLLWEIVTLGGNPYPGIPPERLFNLLKTGHRM---ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISK 304 (314)
T ss_dssp HHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhCCCCCCCCCCHHHHHHHhhcCCcC---CCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 99999999 99999998888777776654322 122468999999999999999999999999986
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=280.35 Aligned_cols=192 Identities=18% Similarity=0.281 Sum_probs=164.4
Q ss_pred CCCcccccee---ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 1 MYHQKLQHLF---YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 1 l~Hpni~~~~---~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
|.||||++++ ..+.+|+|||||.||+|.+++....+.+++..++.++.||+.||.|||++||+||||||+||+++
T Consensus 67 l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~-- 144 (287)
T 1u59_A 67 LDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV-- 144 (287)
T ss_dssp CCCTTBCCEEEEEESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--
T ss_pred CCCCCEeEEEEEecCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEc--
Confidence 5799999998 35779999999999999998876667799999999999999999999999999999999999995
Q ss_pred CCCCCEEEeecCCccccCCCCC----cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 016471 78 EEDAPLKVIDFGLSDFVRPDQR----LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIF 151 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~ 151 (389)
.++.+||+|||++........ .....||+.|+|||++. ..++.++||||+||++|+|++ |..||.+....+..
T Consensus 145 -~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 223 (287)
T 1u59_A 145 -NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM 223 (287)
T ss_dssp -ETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH
T ss_pred -CCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH
Confidence 567899999999987644322 22345688999999885 568999999999999999998 99999988887777
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCC
Q 016471 152 RSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHP 198 (389)
Q Consensus 152 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~ 198 (389)
..+....... ..+.+++.+.++|.+||..+|.+|||+.+++++.
T Consensus 224 ~~i~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 267 (287)
T 1u59_A 224 AFIEQGKRME---CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 267 (287)
T ss_dssp HHHHTTCCCC---CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred HHHhcCCcCC---CCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 7776643221 1246899999999999999999999999999753
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-37 Score=279.23 Aligned_cols=190 Identities=18% Similarity=0.273 Sum_probs=159.8
Q ss_pred CCCcccccee---ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 1 MYHQKLQHLF---YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 1 l~Hpni~~~~---~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
|.||||++++ ..+..|+|||||.||+|.+++......+++..+..++.|++.||.|||++||+||||||+||+++
T Consensus 70 l~h~~i~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~-- 147 (281)
T 3cc6_A 70 LDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVA-- 147 (281)
T ss_dssp HCCTTBCCEEEEECSSSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEE--
T ss_pred CCCCCcceEEEEEcCCCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEC--
Confidence 4799999998 35678999999999999999987767799999999999999999999999999999999999995
Q ss_pred CCCCCEEEeecCCccccCCCC--CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHH
Q 016471 78 EEDAPLKVIDFGLSDFVRPDQ--RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRS 153 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~ 153 (389)
.++.+||+|||++....... ......+|+.|+|||++. ..++.++||||+|+++|+|++ |+.||...........
T Consensus 148 -~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~ 226 (281)
T 3cc6_A 148 -SPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGV 226 (281)
T ss_dssp -ETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHH
T ss_pred -CCCcEEeCccCCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHH
Confidence 56789999999988664432 223345788999999885 568999999999999999998 9999988777777766
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 154 VLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 154 i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
+........ ...+++.+.++|.+||..+|.+|||+.++++
T Consensus 227 ~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 266 (281)
T 3cc6_A 227 LEKGDRLPK---PDLCPPVLYTLMTRCWDYDPSDRPRFTELVC 266 (281)
T ss_dssp HHHTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HhcCCCCCC---CCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 665432211 2458999999999999999999999999986
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=275.92 Aligned_cols=190 Identities=24% Similarity=0.388 Sum_probs=163.4
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|.||||++++ ..+.+|+|||||+||+|.+++....+.+++..+..++.|++.||.|||++|++||||||+||++
T Consensus 60 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili-- 137 (267)
T 3t9t_A 60 LSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV-- 137 (267)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE--
T ss_pred CCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEE--
Confidence 5799999998 3578999999999999999998776789999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC--CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ--RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFR 152 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 152 (389)
+.++.+||+|||++....... ......+|+.|+|||++. ..++.++||||+|+++|+|++ |..||.+........
T Consensus 138 -~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~ 216 (267)
T 3t9t_A 138 -GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE 216 (267)
T ss_dssp -CGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred -CCCCCEEEcccccccccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHH
Confidence 467889999999987654321 223346788899999985 568999999999999999999 999999988888887
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 153 SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 153 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
.+........ ...+++.+.+++.+||..+|.+|||+.++++
T Consensus 217 ~i~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 257 (267)
T 3t9t_A 217 DISTGFRLYK---PRLASTHVYQIMNHCWRERPEDRPAFSRLLR 257 (267)
T ss_dssp HHHTTCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhcCCcCCC---CccCcHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 7766533222 2357899999999999999999999999986
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=287.32 Aligned_cols=191 Identities=16% Similarity=0.218 Sum_probs=154.2
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
.||||+.++ ..+..|+||||| ||+|.+++....+.+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 63 ~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~-- 139 (330)
T 2izr_A 63 SGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIG-- 139 (330)
T ss_dssp SCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC--
T ss_pred CCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeec--
Confidence 799999998 467889999999 9999999887667899999999999999999999999999999999999995
Q ss_pred CCCCC-----EEEeecCCccccCCCCC--------cccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCC
Q 016471 78 EEDAP-----LKVIDFGLSDFVRPDQR--------LNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFW 143 (389)
Q Consensus 78 ~~~~~-----~kl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~ 143 (389)
.++. +||+|||++........ .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.
T Consensus 140 -~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~ 218 (330)
T 2izr_A 140 -RPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQ 218 (330)
T ss_dssp -CGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred -cCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcc
Confidence 3444 99999999986543221 245689999999999864 68999999999999999999999998
Q ss_pred CCCh---hHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 144 ARTE---SGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 144 ~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
+.+. .+.+..+.......+........+.+.+++.+||..+|.+||+++++.+
T Consensus 219 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 219 GLKADTLKERYQKIGDTKRATPIEVLCENFPEMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp TCCCSSHHHHHHHHHHHHHHSCHHHHTTTCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ccccccHHHHHHHHHhhhccCCHHHHhccChHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 7543 3334444332222221111112349999999999999999999988775
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-37 Score=286.82 Aligned_cols=190 Identities=18% Similarity=0.281 Sum_probs=161.5
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHH
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG-----------------------GRYLEEDAKTIVEKILNI 53 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~-----------------------~~l~~~~~~~i~~qi~~~ 53 (389)
|.||||++++ ..+.+|+|||||+||+|.+++.... +.+++.+++.++.||+.|
T Consensus 107 l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~ 186 (343)
T 1luf_A 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAG 186 (343)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHH
T ss_pred CCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHH
Confidence 5799999999 3578999999999999999987642 579999999999999999
Q ss_pred HHHHHHCCCEecCCCCCcEEEeecCCCCCEEEeecCCccccCCCC---CcccccccCCcccccccc-ccCCCchhHHHHH
Q 016471 54 VAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ---RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIG 129 (389)
Q Consensus 54 L~~lH~~~i~Hrdlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG 129 (389)
|.|||++||+||||||+||++ +.++.+||+|||++....... ......||+.|+|||++. ..++.++||||+|
T Consensus 187 l~~LH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG 263 (343)
T 1luf_A 187 MAYLSERKFVHRDLATRNCLV---GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYG 263 (343)
T ss_dssp HHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred HHHHHhCCeecCCCCcceEEE---CCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHH
Confidence 999999999999999999999 467899999999987653321 223456889999999875 5689999999999
Q ss_pred HHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 130 VITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 130 ~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
|++|+|++ |..||.+....+....+........ ...+++.+.+++.+||..+|.+|||+.++++
T Consensus 264 ~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~ 328 (343)
T 1luf_A 264 VVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILAC---PENCPLELYNLMRLCWSKLPADRPSFCSIHR 328 (343)
T ss_dssp HHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhcCCCcCCCCChHHHHHHHhCCCcCCC---CCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 99999999 9999999888888877766543221 2468999999999999999999999999875
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=284.54 Aligned_cols=190 Identities=20% Similarity=0.282 Sum_probs=157.0
Q ss_pred CCCcccccee---ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 1 MYHQKLQHLF---YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 1 l~Hpni~~~~---~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
+.||||++++ .....++|+||+.+|+|.+++....+.+++..++.++.||+.||.|||++||+||||||+||+++
T Consensus 74 l~hp~iv~~~~~~~~~~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~-- 151 (327)
T 3lzb_A 74 VDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK-- 151 (327)
T ss_dssp CCBTTBCCCCEEEESSSEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE--
T ss_pred CCCCCeeEEEEEEecCCceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEc--
Confidence 5799999988 35679999999999999999988778899999999999999999999999999999999999995
Q ss_pred CCCCCEEEeecCCccccCCCCC---cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHH
Q 016471 78 EEDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFR 152 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 152 (389)
.++.+||+|||++........ .....+|+.|+|||++. ..++.++||||+||++|+|++ |..||.+........
T Consensus 152 -~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~ 230 (327)
T 3lzb_A 152 -TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS 230 (327)
T ss_dssp -ETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH
T ss_pred -CCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH
Confidence 567899999999987643322 23345678899999885 468999999999999999999 999999988887777
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 153 SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 153 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
.+........ .+.+++++.++|.+||..+|.+|||+.++++
T Consensus 231 ~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 231 ILEKGERLPQ---PPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp HHHTTCCCCC---CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHcCCCCCC---CccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 6665432221 2458999999999999999999999999986
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-37 Score=289.63 Aligned_cols=190 Identities=19% Similarity=0.270 Sum_probs=152.7
Q ss_pred CCCccccceee-----cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEe
Q 016471 1 MYHQKLQHLFY-----SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 75 (389)
Q Consensus 1 l~Hpni~~~~~-----~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~ 75 (389)
|.||||++++. ++..|+|||||+||+|.+++......+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 147 l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll- 225 (373)
T 3c1x_A 147 FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML- 225 (373)
T ss_dssp CCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE-
T ss_pred CCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEE-
Confidence 57999999982 357899999999999999997766779999999999999999999999999999999999999
Q ss_pred ecCCCCCEEEeecCCccccCCCC-----CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChh
Q 016471 76 TREEDAPLKVIDFGLSDFVRPDQ-----RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTES 148 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~ 148 (389)
+.++.+||+|||++....... ......+|+.|+|||++. ..++.++||||+||++|+|++ |.+||.+.+..
T Consensus 226 --~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~ 303 (373)
T 3c1x_A 226 --DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 303 (373)
T ss_dssp --CTTCCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS
T ss_pred --CCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH
Confidence 567899999999997653322 123346788999999885 568999999999999999999 78888887777
Q ss_pred HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 149 GIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 149 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
+....+........+ ..+++.+.+++.+||..+|.+|||+.++++
T Consensus 304 ~~~~~~~~~~~~~~p---~~~~~~l~~li~~cl~~dp~~RPs~~ell~ 348 (373)
T 3c1x_A 304 DITVYLLQGRRLLQP---EYCPDPLYEVMLKCWHPKAEMRPSFSELVS 348 (373)
T ss_dssp CHHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCCCCCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 776666655432221 458899999999999999999999999986
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=288.81 Aligned_cols=190 Identities=21% Similarity=0.366 Sum_probs=151.7
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|.||||++++ ....+|+|||||+||+|.+++.+....+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 103 l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll-- 180 (373)
T 2qol_A 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI-- 180 (373)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--
T ss_pred CCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE--
Confidence 5799999999 3577999999999999999988776689999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCC----cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQR----LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGI 150 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~ 150 (389)
+.++.+||+|||++........ .....+|+.|+|||++. +.++.++||||+||++|+|++ |..||.+.+..+.
T Consensus 181 -~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~ 259 (373)
T 2qol_A 181 -NSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV 259 (373)
T ss_dssp -CTTCCEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHH
T ss_pred -cCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 5778999999999987643321 11224577899999885 568999999999999999998 9999999888877
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 151 FRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 151 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
...+...... + ....++..+.+++.+||..+|.+|||+.++++
T Consensus 260 ~~~i~~~~~~-~--~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 260 IKAVDEGYRL-P--PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp HHHHHTTEEC-C--CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHcCCCC-C--CCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 7776654221 1 12467899999999999999999999999875
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=281.10 Aligned_cols=194 Identities=25% Similarity=0.489 Sum_probs=154.4
Q ss_pred Ccccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeecC
Q 016471 3 HQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE 78 (389)
Q Consensus 3 Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~~ 78 (389)
||||+.++ ....+|+||| +.+|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||+++
T Consensus 87 ~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~--- 161 (313)
T 3cek_A 87 SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV--- 161 (313)
T ss_dssp CTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE---
T ss_pred CCceEEEEEEeecCCEEEEEEe-cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE---
Confidence 69999998 3578999999 6788999988765 6899999999999999999999999999999999999994
Q ss_pred CCCCEEEeecCCccccCCCC---CcccccccCCccccccccc------------cCCCchhHHHHHHHHHHHHhCCCCCC
Q 016471 79 EDAPLKVIDFGLSDFVRPDQ---RLNDIVGSAYYVAPEVLHR------------SYNVEGDMWSIGVITYILLCGSRPFW 143 (389)
Q Consensus 79 ~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~------------~~~~~~DiwslG~il~~ll~g~~pf~ 143 (389)
++.+||+|||++....... ......||+.|+|||++.+ .++.++||||+||++|+|++|..||.
T Consensus 162 -~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 240 (313)
T 3cek_A 162 -DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 240 (313)
T ss_dssp -TTEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred -CCeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchh
Confidence 4789999999998764332 1234579999999998753 57889999999999999999999997
Q ss_pred CCChh-HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 144 ARTES-GIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 144 ~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
..... .....+......... ....++.+.++|.+||..||.+|||+.++++||||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 300 (313)
T 3cek_A 241 QIINQISKLHAIIDPNHEIEF--PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 300 (313)
T ss_dssp TCCSHHHHHHHHHCTTSCCCC--CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred hHHHHHHHHHHHHhcccccCC--cccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence 75433 334444433222221 134688999999999999999999999999999997654
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=281.45 Aligned_cols=190 Identities=15% Similarity=0.229 Sum_probs=152.5
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|.||||++++ ..+..|+|||||.||+|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.
T Consensus 69 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~ 148 (289)
T 4fvq_A 69 LSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIR 148 (289)
T ss_dssp SCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEE
T ss_pred CCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEec
Confidence 5799999999 357789999999999999998876556999999999999999999999999999999999999964
Q ss_pred cCC-----CCCEEEeecCCccccCCCCCcccccccCCcccccccc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhH
Q 016471 77 REE-----DAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILLCGSRPFWARTESG 149 (389)
Q Consensus 77 ~~~-----~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 149 (389)
.+. .+.+||+|||++...... ....||+.|+|||++. ..++.++||||+||++|+|++|..|+.......
T Consensus 149 ~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~ 225 (289)
T 4fvq_A 149 EEDRKTGNPPFIKLSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ 225 (289)
T ss_dssp CCBGGGTBCCEEEECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred CCcccccccceeeeccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH
Confidence 211 112999999998754322 3456889999999885 458999999999999999999655544443333
Q ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCC
Q 016471 150 IFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 197 (389)
Q Consensus 150 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h 197 (389)
............+ +..++.+.+++.+||..||.+|||+.+++++
T Consensus 226 ~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 226 RKLQFYEDRHQLP----APKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp HHHHHHHTTCCCC----CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HHHHHhhccCCCC----CCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 3333444333333 2357889999999999999999999999874
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=282.29 Aligned_cols=190 Identities=24% Similarity=0.379 Sum_probs=159.5
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcCC-----------------CCCHHHHHHHHHHHHHHHHHHHHC
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGG-----------------RYLEEDAKTIVEKILNIVAFCHLQ 60 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~-----------------~l~~~~~~~i~~qi~~~L~~lH~~ 60 (389)
.||||++++ ..+..|+|||||+||+|.+++..... .+++..++.++.||+.||.|||++
T Consensus 85 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 164 (313)
T 1t46_A 85 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK 164 (313)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred cCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC
Confidence 799999998 35779999999999999999876533 489999999999999999999999
Q ss_pred CCEecCCCCCcEEEeecCCCCCEEEeecCCccccCCCCC---cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHH
Q 016471 61 GVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILL 136 (389)
Q Consensus 61 ~i~Hrdlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll 136 (389)
||+||||||+||+++ .++.+||+|||++........ .....||+.|+|||++. ..++.++||||+||++|+|+
T Consensus 165 ~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell 241 (313)
T 1t46_A 165 NCIHRDLAARNILLT---HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 241 (313)
T ss_dssp TCCCSCCSGGGEEEE---TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred CeecCCCccceEEEc---CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHH
Confidence 999999999999994 678899999999987654332 23456788999999874 56899999999999999999
Q ss_pred h-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 137 C-GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 137 ~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
+ |..||.+.................. ....+++.+.++|.+||..||.+|||+.++++
T Consensus 242 t~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 300 (313)
T 1t46_A 242 SLGSSPYPGMPVDSKFYKMIKEGFRML--SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (313)
T ss_dssp TTTCCSSTTCCSSHHHHHHHHHTCCCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hCCCCCCCcccchhHHHHHhccCCCCC--CcccCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 9 9999988776555555444332222 22468999999999999999999999999986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-37 Score=290.89 Aligned_cols=200 Identities=23% Similarity=0.357 Sum_probs=154.6
Q ss_pred CCccccceee----c----CeEEEEEEccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC-CCEecCCCCCc
Q 016471 2 YHQKLQHLFY----S----NSFLFFTRFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQ-GVVHRDLKPEN 71 (389)
Q Consensus 2 ~Hpni~~~~~----~----~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~-~i~Hrdlkp~N 71 (389)
.||||++++. . ..+++||||+ ||+|.+++... .+.+++..++.++.||+.||.|||++ ||+||||||+|
T Consensus 84 ~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~N 162 (373)
T 1q8y_A 84 GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPEN 162 (373)
T ss_dssp HHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGG
T ss_pred ccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHH
Confidence 3899999882 1 2789999999 88999988764 35699999999999999999999998 99999999999
Q ss_pred EEEeecC---CCCCEEEeecCCccccCCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 016471 72 FLFTTRE---EDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTE 147 (389)
Q Consensus 72 ill~~~~---~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 147 (389)
||++..+ ..+.+||+|||++..... ......||+.|+|||++. ..++.++||||+||++|+|++|..||.+...
T Consensus 163 Ill~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 240 (373)
T 1q8y_A 163 VLMEIVDSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEG 240 (373)
T ss_dssp EEEEEEETTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred eEEeccCCCcCcceEEEcccccccccCC--CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcc
Confidence 9996432 334799999999987643 234568999999999985 4689999999999999999999999976542
Q ss_pred ------hHHHHHHHhcCCCCCC--------------------------------------CCCCCCCHHHHHHHHhhhcc
Q 016471 148 ------SGIFRSVLRADPNFHD--------------------------------------SPWPSVSPEAKDFVRRLLNK 183 (389)
Q Consensus 148 ------~~~~~~i~~~~~~~~~--------------------------------------~~~~~~~~~~~~li~~~l~~ 183 (389)
......+.......+. ...+.+++.+.+||.+||..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 320 (373)
T 1q8y_A 241 HSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL 320 (373)
T ss_dssp ----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCS
T ss_pred cccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhcc
Confidence 2222222221111100 00012457899999999999
Q ss_pred CcCCCCCHHHHhCCCCCCCCC
Q 016471 184 DHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 184 ~p~~R~s~~e~l~h~~~~~~~ 204 (389)
||.+|||++++++||||++..
T Consensus 321 dP~~Rpt~~ell~hp~f~~~~ 341 (373)
T 1q8y_A 321 DPRKRADAGGLVNHPWLKDTL 341 (373)
T ss_dssp STTTCBCHHHHHTCGGGTTCT
T ss_pred CccccCCHHHHhhChhhhccc
Confidence 999999999999999998753
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=285.55 Aligned_cols=197 Identities=16% Similarity=0.227 Sum_probs=165.3
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCC
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG------GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPE 70 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~------~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~ 70 (389)
|.||||++++ ....+|+|||||+||+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+
T Consensus 90 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~ 169 (327)
T 2yfx_A 90 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAAR 169 (327)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred CCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHh
Confidence 5899999999 3467899999999999999987653 34899999999999999999999999999999999
Q ss_pred cEEEeecCCCCCEEEeecCCccccCCCC---CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCC
Q 016471 71 NFLFTTREEDAPLKVIDFGLSDFVRPDQ---RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWAR 145 (389)
Q Consensus 71 Nill~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~ 145 (389)
||+++..+.+..+||+|||++....... ......||+.|+|||++. ..++.++||||+||++|+|++ |..||.+.
T Consensus 170 NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 249 (327)
T 2yfx_A 170 NCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 249 (327)
T ss_dssp GEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred HEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCc
Confidence 9999654456679999999987543221 223456889999999884 568999999999999999998 99999988
Q ss_pred ChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCC
Q 016471 146 TESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 146 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~ 200 (389)
........+....... ..+.+++.+.++|.+||..+|.+|||+.+++++.|+
T Consensus 250 ~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 301 (327)
T 2yfx_A 250 SNQEVLEFVTSGGRMD---PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 301 (327)
T ss_dssp CHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CHHHHHHHHhcCCCCC---CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 8877777776553322 124689999999999999999999999999998765
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=279.03 Aligned_cols=194 Identities=16% Similarity=0.226 Sum_probs=155.1
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
.|||++.++ .....|+||||| ||+|.+++....+.+++..+..++.||+.||.|||++||+||||||+||+++..
T Consensus 64 ~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~ 142 (298)
T 1csn_A 64 GCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRP 142 (298)
T ss_dssp TCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCS
T ss_pred cCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccC
Confidence 577777777 467899999999 999999998766679999999999999999999999999999999999999532
Q ss_pred C--CCCCEEEeecCCccccCCCC--------CcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 016471 78 E--EDAPLKVIDFGLSDFVRPDQ--------RLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWART 146 (389)
Q Consensus 78 ~--~~~~~kl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~ 146 (389)
+ ....+||+|||++....... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+..
T Consensus 143 ~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 222 (298)
T 1csn_A 143 NSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 222 (298)
T ss_dssp SSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred CCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhh
Confidence 1 22349999999998664432 1345679999999999854 68999999999999999999999998743
Q ss_pred ---hhHHHHHHHhcCCCCC-CCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 147 ---ESGIFRSVLRADPNFH-DSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 147 ---~~~~~~~i~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
....+..+.......+ ....+.+++.+.+++.+||..+|.+|||++++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 223 AATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp SCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 3333444333221111 1112468999999999999999999999998875
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=278.15 Aligned_cols=191 Identities=19% Similarity=0.334 Sum_probs=162.7
Q ss_pred CCCcccccee---ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 1 MYHQKLQHLF---YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 1 l~Hpni~~~~---~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
|.||||++++ .....++||||+.+|+|.+++....+.+++..+..++.||+.||.|||++||+||||||+||+++
T Consensus 78 l~h~~i~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~-- 155 (291)
T 1u46_A 78 LDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA-- 155 (291)
T ss_dssp CCCTTBCCEEEEECSSSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE--
T ss_pred CCCCCcccEEEEEccCCceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEc--
Confidence 5799999999 34568999999999999999987667899999999999999999999999999999999999995
Q ss_pred CCCCCEEEeecCCccccCCCCC----cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 016471 78 EEDAPLKVIDFGLSDFVRPDQR----LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIF 151 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~ 151 (389)
.++.+||+|||++........ .....+|+.|+|||++. ..++.++||||+|+++|+|++ |..||.+.+..+..
T Consensus 156 -~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~ 234 (291)
T 1u46_A 156 -TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL 234 (291)
T ss_dssp -ETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH
T ss_pred -CCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHH
Confidence 567899999999987654322 22346788899999885 468899999999999999999 99999998888888
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 152 RSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 152 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
..+.......+. ...+++.+.++|.+||..+|.+|||+.++++
T Consensus 235 ~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 235 HKIDKEGERLPR--PEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp HHHHTSCCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHccCCCCCC--CcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 887765544332 2468999999999999999999999999986
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=277.55 Aligned_cols=190 Identities=18% Similarity=0.266 Sum_probs=160.1
Q ss_pred CCCccccceee-----cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEe
Q 016471 1 MYHQKLQHLFY-----SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 75 (389)
Q Consensus 1 l~Hpni~~~~~-----~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~ 75 (389)
|.||||++++. ++..|+|||||.||+|.+++....+.+++..+..++.|++.||.|||++||+||||||+||++
T Consensus 83 l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~- 161 (298)
T 3f66_A 83 FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCML- 161 (298)
T ss_dssp CCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE-
T ss_pred CCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE-
Confidence 57999999983 457899999999999999987766779999999999999999999999999999999999999
Q ss_pred ecCCCCCEEEeecCCccccCCCC-----CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChh
Q 016471 76 TREEDAPLKVIDFGLSDFVRPDQ-----RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTES 148 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~ 148 (389)
+.++.+||+|||++....... ......||+.|+|||++. ..++.++||||+|+++|+|++ |.+||.+....
T Consensus 162 --~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~ 239 (298)
T 3f66_A 162 --DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 239 (298)
T ss_dssp --CTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT
T ss_pred --CCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH
Confidence 577899999999997654322 223456788999999885 468999999999999999999 67778777777
Q ss_pred HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 149 GIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 149 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
.....+........+ ..+++.+.+++.+||..+|.+|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 240 DITVYLLQGRRLLQP---EYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp THHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhcCCCCCCC---ccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 777766665443322 357899999999999999999999999985
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=281.11 Aligned_cols=190 Identities=19% Similarity=0.357 Sum_probs=157.2
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|.||||++++ ..+.+|+|||||+||+|.+++....+.+++..++.++.||+.||.|||++||+||||||+||++
T Consensus 103 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~-- 180 (333)
T 1mqb_A 103 FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV-- 180 (333)
T ss_dssp CCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--
T ss_pred CCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEE--
Confidence 5799999998 3578999999999999999988776789999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCC----cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQR----LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGI 150 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~ 150 (389)
+.++.+||+|||++........ .....+|+.|+|||++. ..++.++||||+||++|+|++ |..||.+....+.
T Consensus 181 -~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~ 259 (333)
T 1mqb_A 181 -NSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV 259 (333)
T ss_dssp -CTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred -CCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence 5678999999999987643321 12234678899999885 568999999999999999998 9999998888887
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 151 FRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 151 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
...+...... + ....+++.+.+++.+||..+|.+|||+.++++
T Consensus 260 ~~~~~~~~~~-~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 302 (333)
T 1mqb_A 260 MKAINDGFRL-P--TPMDCPSAIYQLMMQCWQQERARRPKFADIVS 302 (333)
T ss_dssp HHHHHTTCCC-C--CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHCCCcC-C--CcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 7777654321 1 12468999999999999999999999999886
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=291.97 Aligned_cols=188 Identities=23% Similarity=0.342 Sum_probs=158.6
Q ss_pred CCCccccceee-----cCeEEEEEEccCCCChHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEE
Q 016471 1 MYHQKLQHLFY-----SNSFLFFTRFCEGGELLDRILSRGG-RYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLF 74 (389)
Q Consensus 1 l~Hpni~~~~~-----~~~~~lv~E~~~gg~L~~~l~~~~~-~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill 74 (389)
|+||||++++. ...+|+|||||+||+|.+++.++.. .+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 243 l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill 322 (450)
T 1k9a_A 243 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV 322 (450)
T ss_dssp CCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred ccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE
Confidence 58999999983 2379999999999999999987643 37999999999999999999999999999999999999
Q ss_pred eecCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHH
Q 016471 75 TTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFR 152 (389)
Q Consensus 75 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 152 (389)
+.++.+||+|||++....... ....+++.|+|||++. ..++.++|||||||++|+|++ |..||.+.+..+...
T Consensus 323 ---~~~~~~kl~DfG~a~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~ 397 (450)
T 1k9a_A 323 ---SEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP 397 (450)
T ss_dssp ---CTTSCEEECCCTTCEECC--------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHH
T ss_pred ---CCCCCEEEeeCCCcccccccc--cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 567899999999998653322 2336788999999985 569999999999999999998 999999888877777
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 153 SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 153 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
.+.++.. .+ ..+.+++.+.++|.+||..+|.+|||+.+++.
T Consensus 398 ~i~~~~~-~~--~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 398 RVEKGYK-MD--APDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp HHHTTCC-CC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHcCCC-CC--CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 7765432 11 22468999999999999999999999999874
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=279.31 Aligned_cols=190 Identities=17% Similarity=0.247 Sum_probs=150.8
Q ss_pred CCCccccceee------cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEE
Q 016471 1 MYHQKLQHLFY------SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLF 74 (389)
Q Consensus 1 l~Hpni~~~~~------~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill 74 (389)
|+||||++++. ...+|+|||||+||+|.+++......+++..+..++.||+.||.|||++||+||||||+||++
T Consensus 68 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~ 147 (295)
T 3ugc_A 68 LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV 147 (295)
T ss_dssp CCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEE
Confidence 57999999983 356899999999999999998766679999999999999999999999999999999999999
Q ss_pred eecCCCCCEEEeecCCccccCCCC----CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChh-
Q 016471 75 TTREEDAPLKVIDFGLSDFVRPDQ----RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTES- 148 (389)
Q Consensus 75 ~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~- 148 (389)
+ .++.+||+|||++....... ......+++.|+|||++. ..++.++||||+||++|+|++|..||......
T Consensus 148 ~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~ 224 (295)
T 3ugc_A 148 E---NENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEF 224 (295)
T ss_dssp E---ETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHH
T ss_pred c---CCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHH
Confidence 5 56789999999998764432 122345778899999885 56899999999999999999999998543211
Q ss_pred ---------------HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 149 ---------------GIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 149 ---------------~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
.....+.. ....+ ....+++.+.++|.+||..+|.+|||+.++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 225 MRMIGNDKQGQMIVFHLIELLKN-NGRLP--RPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHCTTCCTHHHHHHHHHHHHT-TCCCC--CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HhhhcCccccchhHHHHHHHHhc-cCcCC--CCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 11122222 22222 22468999999999999999999999999875
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=279.41 Aligned_cols=188 Identities=30% Similarity=0.533 Sum_probs=158.6
Q ss_pred Ccccccee----ecCeEEEEEEccCC-CChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 3 HQKLQHLF----YSNSFLFFTRFCEG-GELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 3 Hpni~~~~----~~~~~~lv~E~~~g-g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
||||+.++ ..+.+++|||++.+ |+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||+++
T Consensus 107 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~-- 183 (320)
T 3a99_A 107 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID-- 183 (320)
T ss_dssp SCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--
T ss_pred CCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEe--
Confidence 79999988 35789999999986 8999988765 6899999999999999999999999999999999999995
Q ss_pred CCCCCEEEeecCCccccCCCCCcccccccCCccccccccc-c-CCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 016471 78 EEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-S-YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVL 155 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 155 (389)
.+++.+||+|||++...... ......||+.|+|||++.+ . ++.++||||+||++|+|++|..||.... .+.
T Consensus 184 ~~~~~~kL~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~ 256 (320)
T 3a99_A 184 LNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EII 256 (320)
T ss_dssp TTTTEEEECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHH
T ss_pred CCCCCEEEeeCccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhh
Confidence 25678999999999876533 3345679999999998853 3 4688999999999999999999996532 222
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 156 RADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
......+ +.+++.+.++|.+||..||.+|||++++++||||++..
T Consensus 257 ~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 257 RGQVFFR----QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp HCCCCCS----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred ccccccc----ccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 3222222 45899999999999999999999999999999998764
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=283.71 Aligned_cols=191 Identities=20% Similarity=0.293 Sum_probs=150.1
Q ss_pred CCCccccceee--------cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC----------CC
Q 016471 1 MYHQKLQHLFY--------SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQ----------GV 62 (389)
Q Consensus 1 l~Hpni~~~~~--------~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~----------~i 62 (389)
|+||||++++. ...+|+|||||+||+|.+++..+ .+++..++.++.||+.||.|||++ ||
T Consensus 75 l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~i 152 (322)
T 3soc_A 75 MKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAI 152 (322)
T ss_dssp CCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEE
T ss_pred CCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCE
Confidence 57999999992 23479999999999999988653 699999999999999999999999 99
Q ss_pred EecCCCCCcEEEeecCCCCCEEEeecCCccccCCCC---CcccccccCCccccccccc------cCCCchhHHHHHHHHH
Q 016471 63 VHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ---RLNDIVGSAYYVAPEVLHR------SYNVEGDMWSIGVITY 133 (389)
Q Consensus 63 ~Hrdlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~------~~~~~~DiwslG~il~ 133 (389)
+||||||+|||+ +.++.+||+|||++....... ......||+.|+|||++.+ .++.++||||+||++|
T Consensus 153 vH~Dlkp~Nill---~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~ 229 (322)
T 3soc_A 153 SHRDIKSKNVLL---KNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLW 229 (322)
T ss_dssp ECSCCSGGGEEE---CTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHH
T ss_pred EeCCCChHhEEE---CCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHH
Confidence 999999999999 577899999999997764432 2334679999999998854 3567889999999999
Q ss_pred HHHhCCCCCCCCCh----------------hHHHHHHHhcCCCCCCCC-C--CCCCHHHHHHHHhhhccCcCCCCCHHHH
Q 016471 134 ILLCGSRPFWARTE----------------SGIFRSVLRADPNFHDSP-W--PSVSPEAKDFVRRLLNKDHRKRMTAAQA 194 (389)
Q Consensus 134 ~ll~g~~pf~~~~~----------------~~~~~~i~~~~~~~~~~~-~--~~~~~~~~~li~~~l~~~p~~R~s~~e~ 194 (389)
+|++|+.||.+... ......+........... + ...++.+.++|.+||..||.+|||+.++
T Consensus 230 el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el 309 (322)
T 3soc_A 230 ELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCV 309 (322)
T ss_dssp HHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHH
Confidence 99999999976432 122222222221111110 0 1123569999999999999999999999
Q ss_pred hC
Q 016471 195 LT 196 (389)
Q Consensus 195 l~ 196 (389)
++
T Consensus 310 l~ 311 (322)
T 3soc_A 310 GE 311 (322)
T ss_dssp HH
T ss_pred HH
Confidence 85
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=295.12 Aligned_cols=190 Identities=22% Similarity=0.344 Sum_probs=161.8
Q ss_pred CCCcccccee---ecCeEEEEEEccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF---YSNSFLFFTRFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~---~~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|+||||++++ ....+|+|||||++|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 240 l~h~~iv~l~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill-- 317 (454)
T 1qcf_A 240 LQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV-- 317 (454)
T ss_dssp CCCTTBCCEEEEECSSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE--
T ss_pred CCCCCEeeEEEEEeCCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE--
Confidence 6899999998 3577999999999999999987442 368999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC--CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ--RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFR 152 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 152 (389)
+.++.+||+|||++....... ......+|+.|+|||++. +.++.++|||||||++|+|++ |..||.+.+..+...
T Consensus 318 -~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~ 396 (454)
T 1qcf_A 318 -SASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIR 396 (454)
T ss_dssp -CTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred -CCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 567899999999998764321 122345678899999985 579999999999999999999 999999988888887
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 153 SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 153 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
.+...... +. ...+++.+.++|.+||..||.+|||+++++.
T Consensus 397 ~i~~~~~~-~~--~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 397 ALERGYRM-PR--PENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp HHHHTCCC-CC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHcCCCC-CC--CCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 77665322 21 2468999999999999999999999998875
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=278.89 Aligned_cols=194 Identities=14% Similarity=0.203 Sum_probs=154.7
Q ss_pred CCcccccee-----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 2 YHQKLQHLF-----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 2 ~Hpni~~~~-----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
.|++++..+ .....|+||||| +|+|.+++....+.+++..+..++.||+.||.|||++||+||||||+||+++.
T Consensus 62 ~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~ 140 (296)
T 3uzp_A 62 QGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGL 140 (296)
T ss_dssp TTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECC
T ss_pred hcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEec
Confidence 566655544 357789999999 89999998766678999999999999999999999999999999999999964
Q ss_pred cCCCCCEEEeecCCccccCCCCC--------cccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQR--------LNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTE 147 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 147 (389)
.+.++.+||+|||++........ .....||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+...
T Consensus 141 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 220 (296)
T 3uzp_A 141 GKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 220 (296)
T ss_dssp GGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred CCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCc
Confidence 44678899999999987654321 245679999999999864 689999999999999999999999976432
Q ss_pred ---hHHHHHHHhcCCCCC-CCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 148 ---SGIFRSVLRADPNFH-DSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 148 ---~~~~~~i~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
...+..+.......+ ....+.+++.+.+++.+||..+|.+|||+.++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 221 ATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp SSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhhhhhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 233333332211111 1112457899999999999999999999998875
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=279.76 Aligned_cols=191 Identities=17% Similarity=0.259 Sum_probs=161.9
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCC
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG---------GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDL 67 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~---------~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdl 67 (389)
|.||||++++ ..+.+|+|||||+||+|.+++.... ..+++..+..++.||+.||.|||++||+||||
T Consensus 85 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di 164 (322)
T 1p4o_A 85 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDL 164 (322)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCC
T ss_pred cCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCC
Confidence 5799999998 3577999999999999999886532 45789999999999999999999999999999
Q ss_pred CCCcEEEeecCCCCCEEEeecCCccccCCCC---CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCC
Q 016471 68 KPENFLFTTREEDAPLKVIDFGLSDFVRPDQ---RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPF 142 (389)
Q Consensus 68 kp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf 142 (389)
||+||++ +.++.+||+|||++....... ......||+.|+|||++. ..++.++||||+||++|+|++ |..||
T Consensus 165 kp~NIli---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~ 241 (322)
T 1p4o_A 165 AARNCMV---AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY 241 (322)
T ss_dssp SGGGEEE---CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTT
T ss_pred ccceEEE---cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCcc
Confidence 9999999 567899999999987654322 123346788999999885 468999999999999999999 89999
Q ss_pred CCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCC
Q 016471 143 WARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 197 (389)
Q Consensus 143 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h 197 (389)
.+.+..+....+....... ..+.+++.+.++|.+||..+|.+|||+.+++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 242 QGLSNEQVLRFVMEGGLLD---KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp TTSCHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccCCHHHHHHHHHcCCcCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 9988888777776644321 124689999999999999999999999999975
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=277.41 Aligned_cols=184 Identities=33% Similarity=0.647 Sum_probs=146.1
Q ss_pred CCCccccceee--------cCeEEEEEEccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCc
Q 016471 1 MYHQKLQHLFY--------SNSFLFFTRFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPEN 71 (389)
Q Consensus 1 l~Hpni~~~~~--------~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~N 71 (389)
+.||||++++. ...+|+|||||+||+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 68 ~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~N 147 (299)
T 3m2w_A 68 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPEN 147 (299)
T ss_dssp TTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred ccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHH
Confidence 47999999882 466899999999999999987653 369999999999999999999999999999999999
Q ss_pred EEEeecCCCCCEEEeecCCccccCCCCCcccccccCCccccccccccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHH
Q 016471 72 FLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIF 151 (389)
Q Consensus 72 ill~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 151 (389)
|+++..+.++.+||+|||++..... ..++.++||||+||++|+|++|..||.+.......
T Consensus 148 il~~~~~~~~~~kl~Dfg~a~~~~~--------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~ 207 (299)
T 3m2w_A 148 LLYTSKRPNAILKLTDFGFAKETTG--------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS 207 (299)
T ss_dssp EEESSSSTTCCEEECCCTTCEECTT--------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------
T ss_pred EEEecCCCCCcEEEecccccccccc--------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh
Confidence 9996433378899999998865321 34678899999999999999999999776544332
Q ss_pred HHHHh----cCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 152 RSVLR----ADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 152 ~~i~~----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
..+.. .....+...+..+++++.++|.+||..||.+|||+.++++||||.+..
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 208 PGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred HHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 21111 111111112246899999999999999999999999999999997764
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-36 Score=270.75 Aligned_cols=187 Identities=18% Similarity=0.211 Sum_probs=157.8
Q ss_pred CCCccccceee----c--CeEEEEEEccCCCChHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCCCc
Q 016471 1 MYHQKLQHLFY----S--NSFLFFTRFCEGGELLDRILSRGG-RYLEEDAKTIVEKILNIVAFCHLQG--VVHRDLKPEN 71 (389)
Q Consensus 1 l~Hpni~~~~~----~--~~~~lv~E~~~gg~L~~~l~~~~~-~l~~~~~~~i~~qi~~~L~~lH~~~--i~Hrdlkp~N 71 (389)
+.||||++++. . ..+++|||||+||+|.+++....+ .+++..+..++.||+.||.|||++| |+||||||+|
T Consensus 64 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~N 143 (271)
T 3kmu_A 64 FSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRS 143 (271)
T ss_dssp CSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGG
T ss_pred cCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccce
Confidence 57999999993 2 678999999999999998876533 5899999999999999999999999 9999999999
Q ss_pred EEEeecCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc-cC---CCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 016471 72 FLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SY---NVEGDMWSIGVITYILLCGSRPFWARTE 147 (389)
Q Consensus 72 ill~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~---~~~~DiwslG~il~~ll~g~~pf~~~~~ 147 (389)
|++ +.++.++++|||++.... .....||+.|+|||++.+ .+ +.++||||+||++|+|++|+.||.+.+.
T Consensus 144 il~---~~~~~~~l~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 216 (271)
T 3kmu_A 144 VMI---DEDMTARISMADVKFSFQ----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN 216 (271)
T ss_dssp EEE---CTTSCEEEEGGGSCCTTS----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH
T ss_pred EEE---cCCcceeEEeccceeeec----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh
Confidence 999 567889999988865432 234578999999999853 23 3479999999999999999999998888
Q ss_pred hHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 148 SGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 148 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
......+......... .+.+++.+.+++.+||..||.+|||++++++
T Consensus 217 ~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 217 MEIGMKVALEGLRPTI--PPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp HHHHHHHHHSCCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhcCCCCCC--CCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 8777766655433322 2568999999999999999999999999875
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-36 Score=274.54 Aligned_cols=189 Identities=19% Similarity=0.285 Sum_probs=160.0
Q ss_pred CCCcccccee---ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 1 MYHQKLQHLF---YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 1 l~Hpni~~~~---~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
|.||||++++ ..+.+|+|||||+||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+||+++
T Consensus 75 l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~-- 151 (291)
T 1xbb_A 75 LDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV-- 151 (291)
T ss_dssp CCCTTBCCEEEEEESSSEEEEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--
T ss_pred CCCCCEEEEEEEECCCCcEEEEEeCCCCCHHHHHHhC-cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEe--
Confidence 5799999999 457899999999999999988765 6799999999999999999999999999999999999995
Q ss_pred CCCCCEEEeecCCccccCCCCC----cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 016471 78 EEDAPLKVIDFGLSDFVRPDQR----LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIF 151 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~ 151 (389)
.++.+||+|||++........ .....+|+.|+|||++. ..++.++||||+|+++|+|++ |..||.+.......
T Consensus 152 -~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~ 230 (291)
T 1xbb_A 152 -TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 230 (291)
T ss_dssp -ETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH
T ss_pred -CCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 567899999999987654332 12234678899999885 468899999999999999999 99999998888777
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 152 RSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 152 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
..+....... ..+.+++.+.++|.+||..||.+|||+.++++
T Consensus 231 ~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 231 AMLEKGERMG---CPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp HHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHcCCCCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 7766543221 12468999999999999999999999999875
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-36 Score=276.39 Aligned_cols=191 Identities=22% Similarity=0.357 Sum_probs=149.9
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|.||||++++ ..+.+|+|||||+||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+||++
T Consensus 91 l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~-- 167 (309)
T 2h34_A 91 LQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILV-- 167 (309)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--
T ss_pred cCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEE--
Confidence 5799999998 467899999999999999988765 679999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC--CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ--RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRS 153 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 153 (389)
+.++.+||+|||++....... ......||+.|+|||++. ..++.++||||+|+++|+|++|..||.+.........
T Consensus 168 -~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 246 (309)
T 2h34_A 168 -SADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAH 246 (309)
T ss_dssp -CTTSCEEECSCCC----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHH
T ss_pred -cCCCCEEEecCccCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHH
Confidence 567899999999987654332 233557999999999885 4688999999999999999999999988766544444
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCC-CHHHHhC
Q 016471 154 VLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRM-TAAQALT 196 (389)
Q Consensus 154 i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-s~~e~l~ 196 (389)
+.. ....+....+.+++.+.++|.+||..||.+|| |++++++
T Consensus 247 ~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 247 INQ-AIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHS-CCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred hcc-CCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 433 32223233467899999999999999999999 7877764
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=278.70 Aligned_cols=192 Identities=28% Similarity=0.561 Sum_probs=156.3
Q ss_pred CCcccccee----ecCeEEEEEEc-cCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 2 YHQKLQHLF----YSNSFLFFTRF-CEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~-~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
.||||++++ ..+.+++|||| +.||+|.+++..+ +.+++..++.++.||+.||.|||++||+||||||+||+++
T Consensus 96 ~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~- 173 (312)
T 2iwi_A 96 GHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEK-GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILID- 173 (312)
T ss_dssp CCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEE-
T ss_pred CCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEe-
Confidence 799999998 35778999999 7999999988765 5799999999999999999999999999999999999995
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc-cC-CCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SY-NVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
..++.+||+|||++...... ......||+.|+|||++.+ .+ +.++||||+||++|+|++|+.||.... .+
T Consensus 174 -~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~ 245 (312)
T 2iwi_A 174 -LRRGCAKLIDFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EI 245 (312)
T ss_dssp -TTTTEEEECCCSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HH
T ss_pred -CCCCeEEEEEcchhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HH
Confidence 25788999999999876543 3345679999999998853 33 458999999999999999999996531 22
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPV 207 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~~~~ 207 (389)
......++ ..+++.+.++|.+||..+|.+|||++++++||||+......
T Consensus 246 ~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~~~ 294 (312)
T 2iwi_A 246 LEAELHFP----AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDV 294 (312)
T ss_dssp HHTCCCCC----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-----
T ss_pred hhhccCCc----ccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchhcc
Confidence 23332222 45899999999999999999999999999999998765433
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=274.52 Aligned_cols=191 Identities=24% Similarity=0.395 Sum_probs=159.4
Q ss_pred CCCccccceee--------------------cCeEEEEEEccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH
Q 016471 1 MYHQKLQHLFY--------------------SNSFLFFTRFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHL 59 (389)
Q Consensus 1 l~Hpni~~~~~--------------------~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~ 59 (389)
|.||||++++. ...+|+|||||++|+|.+++... ...+++..+..++.||+.||.|||+
T Consensus 61 l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~ 140 (284)
T 2a19_B 61 LDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS 140 (284)
T ss_dssp CCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 58999999873 34489999999999999998754 3579999999999999999999999
Q ss_pred CCCEecCCCCCcEEEeecCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhC
Q 016471 60 QGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCG 138 (389)
Q Consensus 60 ~~i~Hrdlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g 138 (389)
+||+||||||+||+++ .++.+||+|||++.............||+.|+|||++. ..++.++||||+|+++|+|++|
T Consensus 141 ~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~ 217 (284)
T 2a19_B 141 KKLINRDLKPSNIFLV---DTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV 217 (284)
T ss_dssp TTEECSCCSGGGEEEE---ETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSC
T ss_pred CCeeeccCCHHHEEEc---CCCCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhc
Confidence 9999999999999995 56789999999998876655555678999999999885 4689999999999999999999
Q ss_pred CCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCC
Q 016471 139 SRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 202 (389)
Q Consensus 139 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~ 202 (389)
..||... ......+.... .+ ..+++.++++|.+||..||.+|||+.+++++.+...
T Consensus 218 ~~~~~~~--~~~~~~~~~~~--~~----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 218 CDTAFET--SKFFTDLRDGI--IS----DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp CSSHHHH--HHHHHHHHTTC--CC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred CCcchhH--HHHHHHhhccc--cc----ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 9987432 22233333221 11 357899999999999999999999999999876533
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-36 Score=272.52 Aligned_cols=190 Identities=20% Similarity=0.358 Sum_probs=161.1
Q ss_pred CCCcccccee---ecCeEEEEEEccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF---YSNSFLFFTRFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~---~~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|.||||++++ ..+..|+|||||+||+|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||++
T Consensus 65 l~h~~i~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~-- 142 (279)
T 1qpc_A 65 LQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV-- 142 (279)
T ss_dssp CCCTTBCCEEEEECSSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--
T ss_pred CCCcCcceEEEEEcCCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEE--
Confidence 5799999998 3567899999999999999885432 269999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC--CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ--RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFR 152 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 152 (389)
+.++.+||+|||++....... ......+++.|+|||++. +.++.++||||+|+++|+|++ |..||.+....+...
T Consensus 143 -~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 221 (279)
T 1qpc_A 143 -SDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ 221 (279)
T ss_dssp -CTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH
T ss_pred -cCCCCEEECCCcccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHH
Confidence 567899999999998765432 123345788999999985 568999999999999999999 999999988887777
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 153 SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 153 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
.+....... ....+++.+.+++.+||..+|.+|||+.++++
T Consensus 222 ~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 222 NLERGYRMV---RPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp HHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhcccCCC---CcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 776543221 22468999999999999999999999999875
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=278.63 Aligned_cols=191 Identities=23% Similarity=0.332 Sum_probs=150.5
Q ss_pred CCCccccceee--------cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------HCCCEe
Q 016471 1 MYHQKLQHLFY--------SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCH--------LQGVVH 64 (389)
Q Consensus 1 l~Hpni~~~~~--------~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH--------~~~i~H 64 (389)
+.||||++++. ...+|+|||||+||+|.+++. .+.+++..+..++.||+.||.||| ++||+|
T Consensus 59 l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH 136 (301)
T 3q4u_A 59 LRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAH 136 (301)
T ss_dssp CCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHT--TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEEC
T ss_pred ccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHh--hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeec
Confidence 57999999982 245899999999999999883 357999999999999999999999 999999
Q ss_pred cCCCCCcEEEeecCCCCCEEEeecCCccccCCCCC-----cccccccCCccccccccc-------cCCCchhHHHHHHHH
Q 016471 65 RDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR-----LNDIVGSAYYVAPEVLHR-------SYNVEGDMWSIGVIT 132 (389)
Q Consensus 65 rdlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~-------~~~~~~DiwslG~il 132 (389)
|||||+|||+ +.++.+||+|||++........ .....||+.|+|||++.+ .++.++||||+||++
T Consensus 137 ~Dlkp~Nill---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il 213 (301)
T 3q4u_A 137 RDLKSKNILV---KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVL 213 (301)
T ss_dssp SCCCGGGEEE---CTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHH
T ss_pred CCCChHhEEE---cCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHH
Confidence 9999999999 5678999999999976543322 234579999999998854 244689999999999
Q ss_pred HHHHhC----------CCCCCCCCh----hHHHHHHHhcCCCCCCCCC----CCCCHHHHHHHHhhhccCcCCCCCHHHH
Q 016471 133 YILLCG----------SRPFWARTE----SGIFRSVLRADPNFHDSPW----PSVSPEAKDFVRRLLNKDHRKRMTAAQA 194 (389)
Q Consensus 133 ~~ll~g----------~~pf~~~~~----~~~~~~i~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~R~s~~e~ 194 (389)
|+|++| ..||..... ..............+..+. ...++.+.+++.+||..||.+|||+.++
T Consensus 214 ~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i 293 (301)
T 3q4u_A 214 WEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRI 293 (301)
T ss_dssp HHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred HHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHH
Confidence 999999 889865322 2233333322222111110 1245789999999999999999999998
Q ss_pred hC
Q 016471 195 LT 196 (389)
Q Consensus 195 l~ 196 (389)
++
T Consensus 294 ~~ 295 (301)
T 3q4u_A 294 KK 295 (301)
T ss_dssp HH
T ss_pred HH
Confidence 75
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-37 Score=287.39 Aligned_cols=193 Identities=15% Similarity=0.179 Sum_probs=152.1
Q ss_pred CCCccccceee--------cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcE
Q 016471 1 MYHQKLQHLFY--------SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENF 72 (389)
Q Consensus 1 l~Hpni~~~~~--------~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Ni 72 (389)
+.||||+.++. ...+|+||||| ||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+||
T Consensus 105 l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 182 (345)
T 2v62_A 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN-GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANL 182 (345)
T ss_dssp CSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG-GBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred ccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHE
Confidence 47999999982 46789999999 99999987655 4899999999999999999999999999999999999
Q ss_pred EEeecCCCCCEEEeecCCccccCCCC--------CcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCC
Q 016471 73 LFTTREEDAPLKVIDFGLSDFVRPDQ--------RLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFW 143 (389)
Q Consensus 73 ll~~~~~~~~~kl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~ 143 (389)
|++.. ..+.+||+|||++....... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||.
T Consensus 183 ll~~~-~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~ 261 (345)
T 2v62_A 183 LLGYK-NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWE 261 (345)
T ss_dssp EEESS-STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTG
T ss_pred EEccC-CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 99631 22489999999997653221 1244579999999999864 58999999999999999999999996
Q ss_pred CC--ChhHHHHHHHhcCCCCCCC-----CCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 144 AR--TESGIFRSVLRADPNFHDS-----PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 144 ~~--~~~~~~~~i~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
+. ................+.. ....+++.+.++|.+||..+|.+|||++++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 262 QNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp GGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred ccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 53 2222221111111111110 11268899999999999999999999998876
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-36 Score=273.26 Aligned_cols=190 Identities=21% Similarity=0.319 Sum_probs=161.7
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEe
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 75 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~ 75 (389)
|+||||++++ ....+|+|||||+||+|.+++... ...+++..+..++.||+.||.|||++||+||||||+||++
T Consensus 66 l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~- 144 (288)
T 3kfa_A 66 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV- 144 (288)
T ss_dssp CCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEE-
T ss_pred CCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEE-
Confidence 5799999999 357799999999999999988764 3459999999999999999999999999999999999999
Q ss_pred ecCCCCCEEEeecCCccccCCCC--CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 016471 76 TREEDAPLKVIDFGLSDFVRPDQ--RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIF 151 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~ 151 (389)
+.++.+||+|||++....... ......+|+.|+|||++. ..++.++||||+|+++|+|++ |..||.+.......
T Consensus 145 --~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~ 222 (288)
T 3kfa_A 145 --GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 222 (288)
T ss_dssp --CGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred --cCCCCEEEccCccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 467889999999998765433 223345788999999885 568999999999999999999 99999988887777
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 152 RSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 152 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
..+...... .....+++.+.+++.+||..||.+|||+.++++
T Consensus 223 ~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 223 ELLEKDYRM---ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp HHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhccCCC---CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 766654322 222568999999999999999999999999975
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=274.59 Aligned_cols=188 Identities=24% Similarity=0.406 Sum_probs=147.6
Q ss_pred CCCcccccee--ecCeEEEEEEccCCCChHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCCCcEE
Q 016471 1 MYHQKLQHLF--YSNSFLFFTRFCEGGELLDRILSRGG--RYLEEDAKTIVEKILNIVAFCHL---QGVVHRDLKPENFL 73 (389)
Q Consensus 1 l~Hpni~~~~--~~~~~~lv~E~~~gg~L~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~lH~---~~i~Hrdlkp~Nil 73 (389)
|+||||++++ ..+..|+|||||+||+|.+++..... .+++..+..++.|++.||.|||+ +||+||||||+||+
T Consensus 58 l~hp~iv~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIl 137 (307)
T 2eva_A 58 VNHPNIVKLYGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLL 137 (307)
T ss_dssp CCCTTBCCEEEBCTTTTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEE
T ss_pred CCCCCcCeEEEEEcCCcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEE
Confidence 5899999999 34678999999999999998865432 47899999999999999999999 89999999999999
Q ss_pred EeecCCCC-CEEEeecCCccccCCCCCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChh--H
Q 016471 74 FTTREEDA-PLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTES--G 149 (389)
Q Consensus 74 l~~~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~ 149 (389)
++ .++ .+||+|||++...... .....||+.|+|||++.+ .++.++||||+||++|+|++|+.||...... .
T Consensus 138 l~---~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~ 212 (307)
T 2eva_A 138 LV---AGGTVLKICDFGTACDIQTH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR 212 (307)
T ss_dssp EE---TTTTEEEECCCCC--------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH
T ss_pred Ee---CCCCEEEEcccccccccccc--cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH
Confidence 95 344 4899999998765432 234579999999999864 6899999999999999999999999764332 2
Q ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 150 IFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 150 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
....+..... ....+.+++.+.+++.+||..+|.+|||++++++
T Consensus 213 ~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 213 IMWAVHNGTR---PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp HHHHHHTTCC---CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhcCCC---CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 3333333221 1223568999999999999999999999999987
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=283.54 Aligned_cols=190 Identities=20% Similarity=0.334 Sum_probs=158.6
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhc-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCEe
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSR-------------GGRYLEEDAKTIVEKILNIVAFCHLQGVVH 64 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~-------------~~~l~~~~~~~i~~qi~~~L~~lH~~~i~H 64 (389)
.||||++++ ..+.+|+|||||+||+|.+++... ...+++..+..++.||+.||.|||++||+|
T Consensus 108 ~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH 187 (333)
T 2i1m_A 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIH 187 (333)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred CCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCccc
Confidence 699999999 357899999999999999988753 246899999999999999999999999999
Q ss_pred cCCCCCcEEEeecCCCCCEEEeecCCccccCCCCC---cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CC
Q 016471 65 RDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GS 139 (389)
Q Consensus 65 rdlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~ 139 (389)
|||||+||+++ .++.+||+|||++........ .....||+.|+|||++. ..++.++||||+||++|+|++ |.
T Consensus 188 ~Dlkp~NIl~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 264 (333)
T 2i1m_A 188 RDVAARNVLLT---NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGL 264 (333)
T ss_dssp SCCSGGGCEEE---GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred CCcccceEEEC---CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCC
Confidence 99999999995 567899999999976543321 23456788999999875 568999999999999999998 99
Q ss_pred CCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 140 RPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 140 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
.||.+.........+......... ....++.+.++|.+||..+|.+|||+.++++
T Consensus 265 ~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 265 NPYPGILVNSKFYKLVKDGYQMAQ--PAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp CSSTTCCSSHHHHHHHHHTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCcccchhHHHHHHHhcCCCCCC--CCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 999887766655555554433222 2457899999999999999999999999985
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=276.06 Aligned_cols=194 Identities=14% Similarity=0.206 Sum_probs=154.5
Q ss_pred CCcccccee-----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 2 YHQKLQHLF-----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 2 ~Hpni~~~~-----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
.|++++..+ .....++||||| ||+|.+++....+.+++..++.++.||+.||.|||++||+||||||+||++..
T Consensus 62 ~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~ 140 (296)
T 4hgt_A 62 QGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGL 140 (296)
T ss_dssp TTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECC
T ss_pred cCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeec
Confidence 466666554 357789999999 89999988766678999999999999999999999999999999999999954
Q ss_pred cCCCCCEEEeecCCccccCCCC--------CcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ--------RLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTE 147 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 147 (389)
.+.++.+||+|||++....... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+...
T Consensus 141 ~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 220 (296)
T 4hgt_A 141 GKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 220 (296)
T ss_dssp GGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred cCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccch
Confidence 4467889999999998764432 1235679999999998864 689999999999999999999999976433
Q ss_pred h---HHHHHHHhcCCCCC-CCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 148 S---GIFRSVLRADPNFH-DSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 148 ~---~~~~~i~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
. .....+.......+ ....+.+++.+.+++.+||..+|.+|||++++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 221 ATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp SSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhhhhhhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 2 22333222211111 1112457899999999999999999999999885
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-36 Score=278.01 Aligned_cols=190 Identities=18% Similarity=0.332 Sum_probs=157.6
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
++||||++++ ....+++|||||.||+|.+++......+++..+..++.||+.||.|||++||+||||||+||+++
T Consensus 86 l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~- 164 (319)
T 2y4i_B 86 TRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD- 164 (319)
T ss_dssp CCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC-
T ss_pred CCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-
Confidence 5799999988 35679999999999999998876656799999999999999999999999999999999999993
Q ss_pred cCCCCCEEEeecCCccccCC------CCCcccccccCCccccccccc----------cCCCchhHHHHHHHHHHHHhCCC
Q 016471 77 REEDAPLKVIDFGLSDFVRP------DQRLNDIVGSAYYVAPEVLHR----------SYNVEGDMWSIGVITYILLCGSR 140 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~------~~~~~~~~gt~~y~aPE~~~~----------~~~~~~DiwslG~il~~ll~g~~ 140 (389)
++.+||+|||++..... ........||+.|+|||++.. .++.++||||+||++|+|++|..
T Consensus 165 ---~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~ 241 (319)
T 2y4i_B 165 ---NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREW 241 (319)
T ss_dssp -----CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred ---CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCC
Confidence 56899999999765432 122334569999999998742 36889999999999999999999
Q ss_pred CCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 141 PFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 141 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
||.+.........+...... ......+++.+.+++.+||..+|.+|||+.++++
T Consensus 242 p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 242 PFKTQPAEAIIWQMGTGMKP--NLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp SSSSCCHHHHHHHHHTTCCC--CCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred CCCCCCHHHHHHHhccCCCC--CCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 99988888777776654332 2222357899999999999999999999999986
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=279.44 Aligned_cols=191 Identities=22% Similarity=0.365 Sum_probs=156.7
Q ss_pred CCccccceee-----cCeEEEEEEccCCCChHHHHHhcCCC---------------CCHHHHHHHHHHHHHHHHHHHHCC
Q 016471 2 YHQKLQHLFY-----SNSFLFFTRFCEGGELLDRILSRGGR---------------YLEEDAKTIVEKILNIVAFCHLQG 61 (389)
Q Consensus 2 ~Hpni~~~~~-----~~~~~lv~E~~~gg~L~~~l~~~~~~---------------l~~~~~~~i~~qi~~~L~~lH~~~ 61 (389)
+||||++++. +..+|+|||||+||+|.+++...... +++..++.++.||+.||.|||++|
T Consensus 89 ~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ 168 (316)
T 2xir_A 89 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK 168 (316)
T ss_dssp CCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT
T ss_pred cCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC
Confidence 6999999983 34599999999999999988765322 899999999999999999999999
Q ss_pred CEecCCCCCcEEEeecCCCCCEEEeecCCccccCCCCC---cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh
Q 016471 62 VVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC 137 (389)
Q Consensus 62 i~Hrdlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~ 137 (389)
|+||||||+||++ +.++.+||+|||++........ .....||+.|+|||++. ..++.++||||+||++|+|++
T Consensus 169 i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t 245 (316)
T 2xir_A 169 CIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245 (316)
T ss_dssp CCCSCCSGGGEEE---CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred cccccCccceEEE---CCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHh
Confidence 9999999999999 4678899999999986643322 23456888999999885 568999999999999999998
Q ss_pred -CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCC
Q 016471 138 -GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 197 (389)
Q Consensus 138 -g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h 197 (389)
|..||.+................... ...+++.+.++|.+||..+|.+|||+.++++|
T Consensus 246 ~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 246 LGASPYPGVKIDEEFCRRLKEGTRMRA--PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp TSCCSSTTCCCSHHHHHHHHHTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCcccchhHHHHHHhccCccCCC--CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999886654444333332222221 14579999999999999999999999999874
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=282.38 Aligned_cols=194 Identities=20% Similarity=0.284 Sum_probs=153.1
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEE
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG---GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFL 73 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nil 73 (389)
++||||++++ ..+.+|+|||||+||+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||+
T Consensus 92 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil 171 (321)
T 2qkw_B 92 CRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINIL 171 (321)
T ss_dssp CCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEE
T ss_pred CCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEE
Confidence 5799999998 3578999999999999999875432 35899999999999999999999999999999999999
Q ss_pred EeecCCCCCEEEeecCCccccCCCC---CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhH
Q 016471 74 FTTREEDAPLKVIDFGLSDFVRPDQ---RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESG 149 (389)
Q Consensus 74 l~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 149 (389)
+ +.++.+||+|||++....... ......||+.|+|||++. +.++.++||||+||++|+|++|+.||.+.....
T Consensus 172 ~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~ 248 (321)
T 2qkw_B 172 L---DENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE 248 (321)
T ss_dssp E---CTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSS
T ss_pred E---CCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHH
Confidence 9 578899999999997653221 223456899999999874 579999999999999999999999997654422
Q ss_pred HHHH-----HHhcCCCC--------CCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCC
Q 016471 150 IFRS-----VLRADPNF--------HDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 197 (389)
Q Consensus 150 ~~~~-----i~~~~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h 197 (389)
.... ........ .....+..+..+.+++.+||..||.+|||+.+++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 309 (321)
T 2qkw_B 249 MVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK 309 (321)
T ss_dssp CCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1100 00111111 111112345779999999999999999999999864
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-36 Score=293.19 Aligned_cols=190 Identities=21% Similarity=0.324 Sum_probs=161.3
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEe
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 75 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~ 75 (389)
|+||||++++ ....+|+|||||+||+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 273 l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll- 351 (495)
T 1opk_A 273 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLV- 351 (495)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE-
T ss_pred cCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEE-
Confidence 5899999999 3578999999999999999987643 469999999999999999999999999999999999999
Q ss_pred ecCCCCCEEEeecCCccccCCCC--CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 016471 76 TREEDAPLKVIDFGLSDFVRPDQ--RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIF 151 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~ 151 (389)
+.++.+||+|||++....... ......+++.|+|||++. +.++.++|||||||++|+|++ |..||.+.+..+..
T Consensus 352 --~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~ 429 (495)
T 1opk_A 352 --GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 429 (495)
T ss_dssp --CGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred --CCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 567899999999998764332 122345678899999885 568999999999999999999 99999998887777
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 152 RSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 152 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
..+..... . .....+++.+.+||.+||..+|.+|||+.++++
T Consensus 430 ~~~~~~~~-~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 430 ELLEKDYR-M--ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp HHHHTTCC-C--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcCCC-C--CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 76655322 1 122468999999999999999999999999875
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=299.94 Aligned_cols=190 Identities=17% Similarity=0.290 Sum_probs=159.7
Q ss_pred CCCcccccee---ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 1 MYHQKLQHLF---YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 1 l~Hpni~~~~---~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
|.||||++++ ..+.+|+|||||.||+|.+++....+.+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 393 l~hpniv~l~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~-- 470 (613)
T 2ozo_A 393 LDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLV-- 470 (613)
T ss_dssp CCCTTBCCEEEEEESSSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE--
T ss_pred CCCCCEeeEEEEeccCCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEc--
Confidence 5899999999 35779999999999999999876667799999999999999999999999999999999999995
Q ss_pred CCCCCEEEeecCCccccCCCCC----cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 016471 78 EEDAPLKVIDFGLSDFVRPDQR----LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIF 151 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~ 151 (389)
.++.+||+|||++........ .....+|+.|+|||++. +.++.++|||||||++|||++ |..||.+.+..+..
T Consensus 471 -~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~ 549 (613)
T 2ozo_A 471 -NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM 549 (613)
T ss_dssp -ETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHH
T ss_pred -CCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH
Confidence 567899999999987643321 11234568899999985 579999999999999999998 99999998888888
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 152 RSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 152 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
..+.++... + ..+.+++.+.++|.+||..+|.+|||+.++++
T Consensus 550 ~~i~~~~~~-~--~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 550 AFIEQGKRM-E--CPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp HHHHTTCCC-C--CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred HHHHcCCCC-C--CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 877765422 1 12468999999999999999999999998864
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=277.20 Aligned_cols=189 Identities=20% Similarity=0.315 Sum_probs=161.1
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG---------------GRYLEEDAKTIVEKILNIVAFCHLQGV 62 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~~lH~~~i 62 (389)
.||||++++ ..+.+|+|||||.||+|.+++.... ..+++..++.++.||+.||.|||++||
T Consensus 99 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i 178 (334)
T 2pvf_A 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC 178 (334)
T ss_dssp CCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred cCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 799999998 3578999999999999999887543 248999999999999999999999999
Q ss_pred EecCCCCCcEEEeecCCCCCEEEeecCCccccCCCCC---cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-
Q 016471 63 VHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC- 137 (389)
Q Consensus 63 ~Hrdlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~- 137 (389)
+||||||+||++ +.++.+||+|||++........ .....+|+.|+|||++. ..++.++||||+||++|+|++
T Consensus 179 vH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~ 255 (334)
T 2pvf_A 179 IHRDLAARNVLV---TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 255 (334)
T ss_dssp ECSCCSGGGEEE---CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred eCCCCccceEEE---cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhC
Confidence 999999999999 5678999999999987654321 23345788999999875 468999999999999999999
Q ss_pred CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 138 GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 138 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
|..||.+.+..+....+....... ....+++.+.++|.+||..+|.+|||+.++++
T Consensus 256 g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 311 (334)
T 2pvf_A 256 GGSPYPGIPVEELFKLLKEGHRMD---KPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311 (334)
T ss_dssp SCCSSTTCCHHHHHHHHHHTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCcCcCCHHHHHHHHhcCCCCC---CCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 999999988888777776654221 12468999999999999999999999999986
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=272.15 Aligned_cols=190 Identities=20% Similarity=0.233 Sum_probs=157.6
Q ss_pred CCCccccceee----cC-eEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEe
Q 016471 1 MYHQKLQHLFY----SN-SFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 75 (389)
Q Consensus 1 l~Hpni~~~~~----~~-~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~ 75 (389)
|+||||++++. .+ ..++||||+.+|+|.+++....+.+++..++.++.|++.||+|||++||+||||||+||++
T Consensus 79 l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili- 157 (298)
T 3pls_A 79 LNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCML- 157 (298)
T ss_dssp CCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE-
T ss_pred CCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE-
Confidence 57999999982 23 3499999999999999998766789999999999999999999999999999999999999
Q ss_pred ecCCCCCEEEeecCCccccCCC-----CCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHh-CCCCCCCCChh
Q 016471 76 TREEDAPLKVIDFGLSDFVRPD-----QRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLC-GSRPFWARTES 148 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~ 148 (389)
+.++.+||+|||++...... .......+|+.|+|||.+.+ .++.++||||+||++|+|++ |.+||...+..
T Consensus 158 --~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~ 235 (298)
T 3pls_A 158 --DESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF 235 (298)
T ss_dssp --CTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG
T ss_pred --cCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH
Confidence 57789999999999755332 12234568899999999864 68999999999999999999 55556666666
Q ss_pred HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 149 GIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 149 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
.....+........ ...+++.+.+++.+||..+|.+|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 236 DLTHFLAQGRRLPQ---PEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp GHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhhcCCCCCC---CccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 66666655442222 2457899999999999999999999999885
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=291.23 Aligned_cols=196 Identities=22% Similarity=0.346 Sum_probs=159.6
Q ss_pred CCCcccccee---ecCeEEEEEEccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF---YSNSFLFFTRFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~---~~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|+||||++++ ..+.+|+|||||+||+|.+++... +..+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 236 l~hp~iv~~~~~~~~~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill-- 313 (452)
T 1fmk_A 236 LRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV-- 313 (452)
T ss_dssp CCCTTBCCEEEEECSSSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--
T ss_pred CCCCCEeeEEEEEcCCceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEE--
Confidence 5899999999 357799999999999999998643 3569999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC--CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ--RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFR 152 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 152 (389)
+.++.+||+|||++....... ......+++.|+|||++. +.++.++|||||||++|+|++ |..||.+....+...
T Consensus 314 -~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~ 392 (452)
T 1fmk_A 314 -GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD 392 (452)
T ss_dssp -CGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH
T ss_pred -CCCCCEEECCCccceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 467899999999998664322 122345678899999875 578999999999999999999 999999988888887
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC--CCCCCC
Q 016471 153 SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT--HPWLHD 202 (389)
Q Consensus 153 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~--h~~~~~ 202 (389)
.+..+... + ..+.+++.+.++|.+||..+|.+|||++++++ ..++..
T Consensus 393 ~i~~~~~~-~--~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 393 QVERGYRM-P--CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp HHHTTCCC-C--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred HHHcCCCC-C--CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 77654321 2 12468999999999999999999999999886 245443
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=274.86 Aligned_cols=190 Identities=18% Similarity=0.230 Sum_probs=154.2
Q ss_pred CCCccccceee----c-----CeEEEEEEccCCCChHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecC
Q 016471 1 MYHQKLQHLFY----S-----NSFLFFTRFCEGGELLDRILS-----RGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRD 66 (389)
Q Consensus 1 l~Hpni~~~~~----~-----~~~~lv~E~~~gg~L~~~l~~-----~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrd 66 (389)
|+||||++++. . ...|+|||||++|+|.+++.. ..+.+++..++.++.||+.||.|||++||+|||
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~d 172 (313)
T 3brb_A 93 FSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRD 172 (313)
T ss_dssp CCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCC
T ss_pred CCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 57999999983 1 246999999999999998853 235699999999999999999999999999999
Q ss_pred CCCCcEEEeecCCCCCEEEeecCCccccCCCC---CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCC
Q 016471 67 LKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ---RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRP 141 (389)
Q Consensus 67 lkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~p 141 (389)
|||+||++ +.++.+||+|||++....... ......+++.|+|||++. ..++.++||||+||++|+|++ |..|
T Consensus 173 ikp~NIli---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p 249 (313)
T 3brb_A 173 LAARNCML---RDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249 (313)
T ss_dssp CSGGGEEE---CTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred CCcceEEE---cCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCC
Confidence 99999999 567899999999997654332 123345788999999985 468999999999999999999 9999
Q ss_pred CCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 142 FWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 142 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
|.+.........+....... ..+.+++.+.++|.+||..+|.+|||+.++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 301 (313)
T 3brb_A 250 YPGVQNHEMYDYLLHGHRLK---QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRL 301 (313)
T ss_dssp STTCCGGGHHHHHHTTCCCC---CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred CccCCHHHHHHHHHcCCCCC---CCccccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99988888877776654221 22468999999999999999999999999986
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=274.01 Aligned_cols=191 Identities=19% Similarity=0.296 Sum_probs=154.7
Q ss_pred CCCccccceee----c--CeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEE
Q 016471 1 MYHQKLQHLFY----S--NSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLF 74 (389)
Q Consensus 1 l~Hpni~~~~~----~--~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill 74 (389)
|+||||++++. . ..+|+|||||+||+|.+++....+.+++..+..++.|++.||+|||++||+||||||+||++
T Consensus 80 l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~ 159 (302)
T 4e5w_A 80 LYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV 159 (302)
T ss_dssp CCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred CCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEE
Confidence 58999999982 2 66899999999999999997776789999999999999999999999999999999999999
Q ss_pred eecCCCCCEEEeecCCccccCCCC----CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCC----
Q 016471 75 TTREEDAPLKVIDFGLSDFVRPDQ----RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWAR---- 145 (389)
Q Consensus 75 ~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~---- 145 (389)
+ .++.+||+|||++....... ......||+.|+|||++. ..++.++||||+||++|+|++|..|+...
T Consensus 160 ~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 236 (302)
T 4e5w_A 160 E---SEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALF 236 (302)
T ss_dssp E---ETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH
T ss_pred c---CCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHH
Confidence 5 56789999999998765443 233456888899999885 46889999999999999999999886321
Q ss_pred ----------ChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 146 ----------TESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 146 ----------~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
................+ ..+.+++.+.++|.+||..||.+|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 237 LKMIGPTHGQMTVTRLVNTLKEGKRLP--CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHCSCCGGGHHHHHHHHHHTTCCCC--CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred hhccCCcccccCHHHHHHHHhccCCCC--CCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 11112222222222222 22568999999999999999999999999885
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-36 Score=271.71 Aligned_cols=188 Identities=21% Similarity=0.318 Sum_probs=152.9
Q ss_pred CCCccccceee-----cCeEEEEEEccCCCChHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEE
Q 016471 1 MYHQKLQHLFY-----SNSFLFFTRFCEGGELLDRILSRGG-RYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLF 74 (389)
Q Consensus 1 l~Hpni~~~~~-----~~~~~lv~E~~~gg~L~~~l~~~~~-~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill 74 (389)
|.||||++++. .+.+|+|||||+||+|.+++..... .+++..+..++.|++.||.|||++||+||||||+||++
T Consensus 71 l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~ 150 (278)
T 1byg_A 71 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV 150 (278)
T ss_dssp CCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEE
Confidence 57999999983 2468999999999999998875522 38999999999999999999999999999999999999
Q ss_pred eecCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHH
Q 016471 75 TTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFR 152 (389)
Q Consensus 75 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 152 (389)
+.++.+||+|||++...... .....+++.|+|||++. ..++.++||||+|+++|+|++ |..||..........
T Consensus 151 ---~~~~~~~l~Dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~ 225 (278)
T 1byg_A 151 ---SEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP 225 (278)
T ss_dssp ---CTTSCEEECCCCC--------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHH
T ss_pred ---eCCCcEEEeecccccccccc--ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 56789999999998765432 22346788999999985 468999999999999999998 999999888877777
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 153 SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 153 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
.+..... ......+++.+.++|.+||..+|.+|||+.++++
T Consensus 226 ~~~~~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 226 RVEKGYK---MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp HHTTTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhcCCC---CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 7655422 1222568999999999999999999999999875
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=271.89 Aligned_cols=191 Identities=23% Similarity=0.448 Sum_probs=147.5
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEE
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILS---RGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFL 73 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nil 73 (389)
|.||||++++ ..+.+++|||||.+|+|.+++.. ....+++..++.++.||+.||.|||++||+||||||+||+
T Consensus 89 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl 168 (310)
T 2wqm_A 89 LNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVF 168 (310)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred CCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEE
Confidence 5799999998 45789999999999999998864 3467999999999999999999999999999999999999
Q ss_pred EeecCCCCCEEEeecCCccccCCCC-CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCh--hH
Q 016471 74 FTTREEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTE--SG 149 (389)
Q Consensus 74 l~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~ 149 (389)
+ +.++.+||+|||++....... ......||+.|+|||++. ..++.++||||+|+++|+|++|..||.+... ..
T Consensus 169 ~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~ 245 (310)
T 2wqm_A 169 I---TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS 245 (310)
T ss_dssp E---CTTSCEEECCC------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHH
T ss_pred E---cCCCCEEEEeccceeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHH
Confidence 9 567899999999987654332 233457999999999885 4689999999999999999999999976532 33
Q ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 150 IFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 150 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
....+.... .+......+++.+.++|.+||..||.+|||+.++++
T Consensus 246 ~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 246 LCKKIEQCD--YPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp HHHHHHTTC--SCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhhccc--CCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 444444332 222333568999999999999999999999999985
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=279.51 Aligned_cols=191 Identities=18% Similarity=0.269 Sum_probs=155.7
Q ss_pred CCCccccceee------cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEE
Q 016471 1 MYHQKLQHLFY------SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLF 74 (389)
Q Consensus 1 l~Hpni~~~~~------~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill 74 (389)
|+||||+.++. ...+|+|||||+||+|.+++....+.+++..++.++.||+.||.|||++||+||||||+||++
T Consensus 81 l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~ 160 (327)
T 3lxl_A 81 LHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILV 160 (327)
T ss_dssp CCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred cCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEE
Confidence 57999999872 356999999999999999998765679999999999999999999999999999999999999
Q ss_pred eecCCCCCEEEeecCCccccCCCC----CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChh-
Q 016471 75 TTREEDAPLKVIDFGLSDFVRPDQ----RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTES- 148 (389)
Q Consensus 75 ~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~- 148 (389)
+ .++.+||+|||++....... ......||+.|+|||++. ..++.++||||+||++|+|++|..||......
T Consensus 161 ~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~ 237 (327)
T 3lxl_A 161 E---SEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEF 237 (327)
T ss_dssp E---ETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH
T ss_pred C---CCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchh
Confidence 5 57789999999998765432 223346888899999885 45889999999999999999999998654321
Q ss_pred --------------HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCC
Q 016471 149 --------------GIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 197 (389)
Q Consensus 149 --------------~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h 197 (389)
.....+... ...+ ..+.+++.+.++|.+||..||.+|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 238 LRMMGCERDVPALSRLLELLEEG-QRLP--APPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHCC----CCHHHHHHHHHHTT-CCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhhcccccccccHHHHHHHhhcc-cCCC--CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 122222222 2222 225689999999999999999999999999753
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=299.89 Aligned_cols=189 Identities=19% Similarity=0.289 Sum_probs=159.1
Q ss_pred CCCcccccee---ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 1 MYHQKLQHLF---YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 1 l~Hpni~~~~---~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
|+||||++++ ..+.+++|||||+||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 427 l~hpnIv~l~~~~~~~~~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~-- 503 (635)
T 4fl3_A 427 LDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV-- 503 (635)
T ss_dssp CCCTTBCCEEEEEESSSEEEEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE--
T ss_pred CCCCCEeeEEEEEecCCEEEEEEccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEe--
Confidence 5899999999 456799999999999999988654 6899999999999999999999999999999999999995
Q ss_pred CCCCCEEEeecCCccccCCCCC----cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 016471 78 EEDAPLKVIDFGLSDFVRPDQR----LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIF 151 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~ 151 (389)
.++.+||+|||++........ .....+|+.|+|||++. ..++.++||||+||++|+|++ |..||.+.+..+..
T Consensus 504 -~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~ 582 (635)
T 4fl3_A 504 -TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 582 (635)
T ss_dssp -ETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH
T ss_pred -CCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 567899999999987644321 22345678899999985 479999999999999999998 99999999888888
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 152 RSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 152 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
..+........ ...+++++.++|.+||..||.+|||++++++
T Consensus 583 ~~i~~~~~~~~---p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 583 AMLEKGERMGC---PAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp HHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHcCCCCCC---CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 77776542211 2468999999999999999999999999874
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-36 Score=276.48 Aligned_cols=193 Identities=22% Similarity=0.300 Sum_probs=155.0
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEE
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSR--GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLF 74 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill 74 (389)
|.||||++++ ..+.+|+|||||+||+|.+++... ...+++..+..++.||+.||.|||++||+||||||+||++
T Consensus 87 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili 166 (307)
T 2nru_A 87 CQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILL 166 (307)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred cCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEE
Confidence 5799999998 357899999999999999988643 3569999999999999999999999999999999999999
Q ss_pred eecCCCCCEEEeecCCccccCCCC---CcccccccCCccccccccccCCCchhHHHHHHHHHHHHhCCCCCCCCChhH--
Q 016471 75 TTREEDAPLKVIDFGLSDFVRPDQ---RLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWARTESG-- 149 (389)
Q Consensus 75 ~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-- 149 (389)
+.++.+||+|||++....... ......||+.|+|||++.+.++.++||||+|+++|+|++|..||.+.....
T Consensus 167 ---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~ 243 (307)
T 2nru_A 167 ---DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL 243 (307)
T ss_dssp ---CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBT
T ss_pred ---cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcchHHH
Confidence 577899999999987654322 123457999999999988889999999999999999999999997754432
Q ss_pred --HHHHHHhcCCCC-------CCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 150 --IFRSVLRADPNF-------HDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 150 --~~~~i~~~~~~~-------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
....+....... .....+..+..+.+++.+||..+|.+|||+.++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~ 299 (307)
T 2nru_A 244 LDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQ 299 (307)
T ss_dssp THHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 222222211110 00111234577999999999999999999999985
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-36 Score=279.84 Aligned_cols=199 Identities=20% Similarity=0.336 Sum_probs=148.6
Q ss_pred CCCccccceee---------cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---------CC
Q 016471 1 MYHQKLQHLFY---------SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQ---------GV 62 (389)
Q Consensus 1 l~Hpni~~~~~---------~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---------~i 62 (389)
+.||||++++. ...+|+|||||+||+|.+++... ..++..+..++.||+.||.|||++ ||
T Consensus 64 ~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~i 141 (336)
T 3g2f_A 64 MEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAI 141 (336)
T ss_dssp CCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCE
T ss_pred ccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHhhhccccccccce
Confidence 57999999972 23679999999999999988654 468999999999999999999999 99
Q ss_pred EecCCCCCcEEEeecCCCCCEEEeecCCccccCCC---------CCcccccccCCccccccccc--------cCCCchhH
Q 016471 63 VHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPD---------QRLNDIVGSAYYVAPEVLHR--------SYNVEGDM 125 (389)
Q Consensus 63 ~Hrdlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~---------~~~~~~~gt~~y~aPE~~~~--------~~~~~~Di 125 (389)
+||||||+|||+ +.++.+||+|||++...... ......+||+.|+|||++.+ .++.++||
T Consensus 142 vH~Dikp~Nill---~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Di 218 (336)
T 3g2f_A 142 SHRDLNSRNVLV---KNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDM 218 (336)
T ss_dssp ECSSCSGGGEEE---CTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHH
T ss_pred eecccccceEEE---cCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccch
Confidence 999999999999 56789999999999765432 12234579999999998854 35678999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCh-----------------hHHHHHHHhcCCCCCC--CCCC---CCCHHHHHHHHhhhcc
Q 016471 126 WSIGVITYILLCGSRPFWARTE-----------------SGIFRSVLRADPNFHD--SPWP---SVSPEAKDFVRRLLNK 183 (389)
Q Consensus 126 wslG~il~~ll~g~~pf~~~~~-----------------~~~~~~i~~~~~~~~~--~~~~---~~~~~~~~li~~~l~~ 183 (389)
||+||++|+|++|..||..... ..............+. ..++ .+++.+.++|.+||..
T Consensus 219 wslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 298 (336)
T 3g2f_A 219 YALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQ 298 (336)
T ss_dssp HHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCS
T ss_pred HHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcC
Confidence 9999999999999777643211 1111111111111111 1111 2456899999999999
Q ss_pred CcCCCCCHHHHhC------CCCCCCCC
Q 016471 184 DHRKRMTAAQALT------HPWLHDEN 204 (389)
Q Consensus 184 ~p~~R~s~~e~l~------h~~~~~~~ 204 (389)
||.+|||++++++ ++|-++..
T Consensus 299 dP~~Rps~~e~l~~L~~ll~~~~~~~~ 325 (336)
T 3g2f_A 299 DAEARLTAQXAEERMAELMMIWERNKS 325 (336)
T ss_dssp SGGGSCCHHHHHHHHHHHHHCCCC---
T ss_pred ChhhCcchHHHHHHHHHHHHHHHhccc
Confidence 9999999999954 56665543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=299.23 Aligned_cols=201 Identities=23% Similarity=0.403 Sum_probs=158.8
Q ss_pred CCCccccceee----------cCeEEEEEEccCCCChHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCC
Q 016471 1 MYHQKLQHLFY----------SNSFLFFTRFCEGGELLDRILSRG--GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLK 68 (389)
Q Consensus 1 l~Hpni~~~~~----------~~~~~lv~E~~~gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlk 68 (389)
|.||||++++. .+..|+|||||+||+|.+++.... ..+++..++.++.||+.||.|||++||+|||||
T Consensus 69 L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLK 148 (676)
T 3qa8_A 69 LNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLK 148 (676)
T ss_dssp CCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCC
T ss_pred CCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCC
Confidence 58999999872 567899999999999999887543 269999999999999999999999999999999
Q ss_pred CCcEEEeecCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 016471 69 PENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTE 147 (389)
Q Consensus 69 p~Nill~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 147 (389)
|+||+++..+....+||+|||++.............||+.|+|||++. ..++.++||||+||++|+|++|..||.+...
T Consensus 149 P~NILl~~~g~~~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~ 228 (676)
T 3qa8_A 149 PENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ 228 (676)
T ss_dssp STTEEEECCSSSCEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH
T ss_pred HHHeEeecCCCceeEEEcccccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc
Confidence 999999754344459999999998876665556678999999999986 4689999999999999999999999976533
Q ss_pred hHHHHHH--------------HhcCCCC------CCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCC
Q 016471 148 SGIFRSV--------------LRADPNF------HDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLH 201 (389)
Q Consensus 148 ~~~~~~i--------------~~~~~~~------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~ 201 (389)
...+... ..+...+ +....+.+++.+.++|.+||..||.+|||+.++++||||.
T Consensus 229 ~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~ 302 (676)
T 3qa8_A 229 PVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQ 302 (676)
T ss_dssp HHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHH
T ss_pred hhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHH
Confidence 2211100 0000011 0111123678999999999999999999999999999984
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=288.13 Aligned_cols=196 Identities=21% Similarity=0.393 Sum_probs=157.0
Q ss_pred CCCccccceee------cCeEEEEEEccCCCChHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcE
Q 016471 1 MYHQKLQHLFY------SNSFLFFTRFCEGGELLDRILSRG--GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENF 72 (389)
Q Consensus 1 l~Hpni~~~~~------~~~~~lv~E~~~gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Ni 72 (389)
|.||||++++. ....|+|||||+||+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus 64 l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 143 (396)
T 4eut_A 64 LNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNI 143 (396)
T ss_dssp CCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred cCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHE
Confidence 57999999982 237899999999999999886432 2399999999999999999999999999999999999
Q ss_pred EEeec-CCCCCEEEeecCCccccCCCCCcccccccCCcccccccc---------ccCCCchhHHHHHHHHHHHHhCCCCC
Q 016471 73 LFTTR-EEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH---------RSYNVEGDMWSIGVITYILLCGSRPF 142 (389)
Q Consensus 73 ll~~~-~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~DiwslG~il~~ll~g~~pf 142 (389)
++... +.++.+||+|||++.............||+.|+|||++. ..++.++||||+||++|+|++|+.||
T Consensus 144 ll~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf 223 (396)
T 4eut_A 144 MRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223 (396)
T ss_dssp EEEECTTSCEEEEECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSE
T ss_pred EEeecCCCceeEEEecCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 98432 345679999999998876655556678999999999874 35778999999999999999999999
Q ss_pred CC----CChhHHHHHHHhcCCCCCC-----------------CCC----CCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 143 WA----RTESGIFRSVLRADPNFHD-----------------SPW----PSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 143 ~~----~~~~~~~~~i~~~~~~~~~-----------------~~~----~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
.+ ....+....+....+.... +.. ..+++.+.++|.+||..||.+|||++++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 224 RPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp ECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred CCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 64 2334556666655432110 000 124567899999999999999999998864
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=298.14 Aligned_cols=190 Identities=19% Similarity=0.311 Sum_probs=160.8
Q ss_pred CCCcccccee---ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 1 MYHQKLQHLF---YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 1 l~Hpni~~~~---~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
|.||||++++ .++.+|+|||||+||+|.+++..+...+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 448 l~HpnIv~l~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~-- 525 (656)
T 2j0j_A 448 FDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS-- 525 (656)
T ss_dssp CCCTTBCCEEEEECSSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE--
T ss_pred CCCCCCCeEEEEEecCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEe--
Confidence 5799999998 35679999999999999999887766799999999999999999999999999999999999995
Q ss_pred CCCCCEEEeecCCccccCCCCC--cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHH
Q 016471 78 EEDAPLKVIDFGLSDFVRPDQR--LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRS 153 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~ 153 (389)
.++.+||+|||++........ .....+|+.|+|||++. ..++.++||||+||++|+|++ |..||.+....+....
T Consensus 526 -~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~ 604 (656)
T 2j0j_A 526 -SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR 604 (656)
T ss_dssp -ETTEEEECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH
T ss_pred -CCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Confidence 568899999999987644322 22345678999999885 568999999999999999997 9999999888888877
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 154 VLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 154 i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
+....... ..+.+++.+.++|.+||..||.+|||+.++++
T Consensus 605 i~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 605 IENGERLP---MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp HHHTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHcCCCCC---CCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 77654322 12468999999999999999999999999875
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=273.76 Aligned_cols=197 Identities=18% Similarity=0.182 Sum_probs=153.3
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCCC
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG---GRYLEEDAKTIVEKILNIVAFCHLQ---GVVHRDLKPE 70 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~lH~~---~i~Hrdlkp~ 70 (389)
+.||||++++ .....++|||||.||+|.+++.... ..+++..+..++.|++.||.|||++ ||+||||||+
T Consensus 84 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~ 163 (326)
T 3uim_A 84 AVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAA 163 (326)
T ss_dssp CCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGG
T ss_pred ccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchh
Confidence 5799999998 3577899999999999999887542 3499999999999999999999999 9999999999
Q ss_pred cEEEeecCCCCCEEEeecCCccccCCCC--CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCC---
Q 016471 71 NFLFTTREEDAPLKVIDFGLSDFVRPDQ--RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWA--- 144 (389)
Q Consensus 71 Nill~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~--- 144 (389)
||++ +.++.+||+|||++....... ......||+.|+|||++. ..++.++||||+||++|+|++|..||..
T Consensus 164 Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 240 (326)
T 3uim_A 164 NILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL 240 (326)
T ss_dssp GEEE---CTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHH
T ss_pred hEEE---CCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccccccc
Confidence 9999 577899999999998764332 233456999999999884 5689999999999999999999999952
Q ss_pred --CChhHHHHHHHhcCC--CCCC--------CCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCC
Q 016471 145 --RTESGIFRSVLRADP--NFHD--------SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 145 --~~~~~~~~~i~~~~~--~~~~--------~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~ 200 (389)
.........+..... .... ...+..++.+.+++.+||..+|.+|||+.++++|-.-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 241 ANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp TTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred ccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 111111111111000 0000 0011234789999999999999999999999987543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-35 Score=273.91 Aligned_cols=192 Identities=20% Similarity=0.298 Sum_probs=148.4
Q ss_pred CCCccccceee----c----CeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--------CCEe
Q 016471 1 MYHQKLQHLFY----S----NSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQ--------GVVH 64 (389)
Q Consensus 1 l~Hpni~~~~~----~----~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~--------~i~H 64 (389)
+.||||++++. . ..+|+|||||+||+|.+++... .+++..+..++.|++.||.|||++ ||+|
T Consensus 88 ~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH 165 (337)
T 3mdy_A 88 MRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAH 165 (337)
T ss_dssp CCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEEC
T ss_pred hcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEe
Confidence 48999999982 2 6799999999999999988553 699999999999999999999999 9999
Q ss_pred cCCCCCcEEEeecCCCCCEEEeecCCccccCCCCC-----cccccccCCccccccccc-cCCCc------hhHHHHHHHH
Q 016471 65 RDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR-----LNDIVGSAYYVAPEVLHR-SYNVE------GDMWSIGVIT 132 (389)
Q Consensus 65 rdlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~-~~~~~------~DiwslG~il 132 (389)
|||||+||++ +.++.+||+|||++........ .....||+.|+|||++.+ .++.. +||||+||++
T Consensus 166 ~Dikp~Nill---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il 242 (337)
T 3mdy_A 166 RDLKSKNILV---KKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLIL 242 (337)
T ss_dssp SCCCGGGEEE---CTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHH
T ss_pred cccchHHEEE---CCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHH
Confidence 9999999999 5678999999999976543321 234579999999999864 34443 8999999999
Q ss_pred HHHHhC----------CCCCCCCCh----hHHHHHHHhcCCCCCCCC----CCCCCHHHHHHHHhhhccCcCCCCCHHHH
Q 016471 133 YILLCG----------SRPFWARTE----SGIFRSVLRADPNFHDSP----WPSVSPEAKDFVRRLLNKDHRKRMTAAQA 194 (389)
Q Consensus 133 ~~ll~g----------~~pf~~~~~----~~~~~~i~~~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~R~s~~e~ 194 (389)
|+|++| ..||..... ..............+..+ ...+++.+.++|.+||..||.+|||+.++
T Consensus 243 ~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el 322 (337)
T 3mdy_A 243 WEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRV 322 (337)
T ss_dssp HHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred HHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHH
Confidence 999999 777754321 222222222211111111 01356779999999999999999999999
Q ss_pred hCC
Q 016471 195 LTH 197 (389)
Q Consensus 195 l~h 197 (389)
+++
T Consensus 323 l~~ 325 (337)
T 3mdy_A 323 KKT 325 (337)
T ss_dssp HHH
T ss_pred HHH
Confidence 863
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-36 Score=282.05 Aligned_cols=181 Identities=13% Similarity=0.189 Sum_probs=145.7
Q ss_pred cCeEEEEEEccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeecCCCC--CEEEeec
Q 016471 12 SNSFLFFTRFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDA--PLKVIDF 88 (389)
Q Consensus 12 ~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~~~~~--~~kl~Df 88 (389)
+..+|+||||| ||+|.+++... .+.+++..++.++.||+.||.|||++||+||||||+||+++ .++ .+||+||
T Consensus 130 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~---~~~~~~~kl~Df 205 (352)
T 2jii_A 130 DKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVD---PEDQSQVTLAGY 205 (352)
T ss_dssp TTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEE---TTEEEEEEECCG
T ss_pred CcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEc---CCCCceEEEecC
Confidence 57899999999 99999988754 36799999999999999999999999999999999999995 455 8999999
Q ss_pred CCccccCCCC--------CcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCC--hhHHHHHH---
Q 016471 89 GLSDFVRPDQ--------RLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWART--ESGIFRSV--- 154 (389)
Q Consensus 89 g~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~~i--- 154 (389)
|++....... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.. ........
T Consensus 206 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 285 (352)
T 2jii_A 206 GFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKF 285 (352)
T ss_dssp GGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHH
T ss_pred cceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhc
Confidence 9997654321 1234579999999999864 68999999999999999999999998753 22222222
Q ss_pred HhcCCCCC--CCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 155 LRADPNFH--DSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 155 ~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
......+. ...+..+++.+.++|.+||..||.+|||++++++
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 286 VDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp HHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred cCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 22222111 1122357999999999999999999999999875
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=273.19 Aligned_cols=191 Identities=20% Similarity=0.321 Sum_probs=152.4
Q ss_pred CCCccccceee--------cCeEEEEEEccCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCC
Q 016471 1 MYHQKLQHLFY--------SNSFLFFTRFCEGGELLDRILS---RGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKP 69 (389)
Q Consensus 1 l~Hpni~~~~~--------~~~~~lv~E~~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp 69 (389)
|.||||++++. ....|+|||||.+|+|.+++.. ..+.+++..++.++.||+.||.|||++||+||||||
T Consensus 83 l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp 162 (317)
T 2buj_A 83 FNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKP 162 (317)
T ss_dssp CCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred cCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCH
Confidence 57999999872 2478999999999999998875 356799999999999999999999999999999999
Q ss_pred CcEEEeecCCCCCEEEeecCCccccCCCCC----------cccccccCCccccccccc----cCCCchhHHHHHHHHHHH
Q 016471 70 ENFLFTTREEDAPLKVIDFGLSDFVRPDQR----------LNDIVGSAYYVAPEVLHR----SYNVEGDMWSIGVITYIL 135 (389)
Q Consensus 70 ~Nill~~~~~~~~~kl~Dfg~a~~~~~~~~----------~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~~l 135 (389)
+||++ +.++.+||+|||++........ .....||+.|+|||++.+ .++.++||||+||++|+|
T Consensus 163 ~NIl~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el 239 (317)
T 2buj_A 163 TNILL---GDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAM 239 (317)
T ss_dssp GGEEE---CTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHH
T ss_pred HHEEE---cCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHH
Confidence 99999 5678899999998876432111 123457999999998853 268999999999999999
Q ss_pred HhCCCCCCCCC--hhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCC
Q 016471 136 LCGSRPFWART--ESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 197 (389)
Q Consensus 136 l~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h 197 (389)
++|..||.... .......+. ..... +..+.+++.+.++|.+||..||.+|||+.+++++
T Consensus 240 ~~g~~p~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 240 MFGEGPYDMVFQKGDSVALAVQ-NQLSI--PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp HHSSCTTHHHHHTTSCHHHHHH-CC--C--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhCCCChhhhhcccchhhHHhh-ccCCC--CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 99999995411 111222222 22222 2235689999999999999999999999999975
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-35 Score=291.32 Aligned_cols=195 Identities=22% Similarity=0.353 Sum_probs=163.4
Q ss_pred CCCcccccee---ecCeEEEEEEccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF---YSNSFLFFTRFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~---~~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|+||||++++ ..+.+|+|||||.||+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 319 l~hpniv~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll-- 396 (535)
T 2h8h_A 319 LRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV-- 396 (535)
T ss_dssp CCCTTBCCEEEEECSSSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--
T ss_pred CCCCCEeeEEEEEeeccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE--
Confidence 6899999998 357799999999999999998643 3469999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC--CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ--RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFR 152 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 152 (389)
+.++.+||+|||++....... ......++..|+|||++. +.++.++|||||||++|+|++ |..||.+....+...
T Consensus 397 -~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~ 475 (535)
T 2h8h_A 397 -GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD 475 (535)
T ss_dssp -CGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHH
T ss_pred -cCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 467889999999998654321 122345678899999875 578999999999999999999 999999988888887
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCC--CCCC
Q 016471 153 SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH--PWLH 201 (389)
Q Consensus 153 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h--~~~~ 201 (389)
.+..... .+ ..+.++..+.+||.+||..+|.+|||+++++.. .++.
T Consensus 476 ~i~~~~~-~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 476 QVERGYR-MP--CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp HHHTTCC-CC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred HHHcCCC-CC--CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 7765432 11 124689999999999999999999999998763 4443
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=279.30 Aligned_cols=187 Identities=17% Similarity=0.263 Sum_probs=148.1
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEE
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILS----RGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFL 73 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~----~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nil 73 (389)
.||||+.++ ..+..|+|||||+||+|.+++.. ..+.+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 125 ~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIl 204 (365)
T 3e7e_A 125 MQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFI 204 (365)
T ss_dssp GGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEE
T ss_pred hhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEE
Confidence 389999998 35789999999999999999874 3467999999999999999999999999999999999999
Q ss_pred Eee--------cCCCCCEEEeecCCccccC---CCCCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCC
Q 016471 74 FTT--------REEDAPLKVIDFGLSDFVR---PDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRP 141 (389)
Q Consensus 74 l~~--------~~~~~~~kl~Dfg~a~~~~---~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~p 141 (389)
++. .+.++.+||+|||+|.... ........+||+.|+|||++.+ .++.++||||+||++|+|++|+.|
T Consensus 205 l~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 284 (365)
T 3e7e_A 205 LGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284 (365)
T ss_dssp ECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCC
T ss_pred ecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCc
Confidence 953 1127899999999996543 2334456789999999999864 589999999999999999999999
Q ss_pred CCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 142 FWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 142 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
|........ .....+.. ...++.+.+++.+||+.+|.+|++..+.+.
T Consensus 285 f~~~~~~~~-----~~~~~~~~---~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~ 331 (365)
T 3e7e_A 285 KVKNEGGEC-----KPEGLFRR---LPHLDMWNEFFHVMLNIPDCHHLPSLDLLR 331 (365)
T ss_dssp CEEEETTEE-----EECSCCTT---CSSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred cccCCCCce-----eechhccc---cCcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence 965432110 01111111 124678999999999999999976544443
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-35 Score=270.65 Aligned_cols=189 Identities=21% Similarity=0.307 Sum_probs=152.5
Q ss_pred CCCccccceee------cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEE
Q 016471 1 MYHQKLQHLFY------SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLF 74 (389)
Q Consensus 1 l~Hpni~~~~~------~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill 74 (389)
|+||||++++. ...+|+|||||++|+|.+++... .+++..++.++.||+.||.|||++||+||||||+||++
T Consensus 90 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~ 167 (318)
T 3lxp_A 90 LYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLL 167 (318)
T ss_dssp CCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred CCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE
Confidence 57999999882 36789999999999999987543 59999999999999999999999999999999999999
Q ss_pred eecCCCCCEEEeecCCccccCCCCC----cccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChh-
Q 016471 75 TTREEDAPLKVIDFGLSDFVRPDQR----LNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTES- 148 (389)
Q Consensus 75 ~~~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~- 148 (389)
+.++.+||+|||++........ .....||+.|+|||++.+ .++.++||||+||++|+|++|..||......
T Consensus 168 ---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~ 244 (318)
T 3lxp_A 168 ---DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF 244 (318)
T ss_dssp ---CTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH
T ss_pred ---cCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh
Confidence 5778999999999987654332 234468888999998854 6889999999999999999999999653221
Q ss_pred -------------HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 149 -------------GIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 149 -------------~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
.............+ ....+++.+.++|.+||..+|.+|||+.++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 245 LELIGIAQGQMTVLRLTELLERGERLP--RPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHHCSCCHHHHHHHHHHHHHTTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhhhcccccchhHHHHHHHHhcccCCC--CCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 01112222222222 22468999999999999999999999999985
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=270.32 Aligned_cols=191 Identities=18% Similarity=0.253 Sum_probs=153.1
Q ss_pred CCCccccceee------cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEE
Q 016471 1 MYHQKLQHLFY------SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLF 74 (389)
Q Consensus 1 l~Hpni~~~~~------~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill 74 (389)
|+||||++++. ...+++|||||+||+|.+++....+.+++..+..++.||+.||.|||++||+||||||+||++
T Consensus 99 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli 178 (326)
T 2w1i_A 99 LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV 178 (326)
T ss_dssp CCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred CCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEE
Confidence 57999999872 236899999999999999998776779999999999999999999999999999999999999
Q ss_pred eecCCCCCEEEeecCCccccCCCCC----cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChh-
Q 016471 75 TTREEDAPLKVIDFGLSDFVRPDQR----LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTES- 148 (389)
Q Consensus 75 ~~~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~- 148 (389)
+ .++.+||+|||++........ .....+++.|+|||++. ..++.++||||+||++|+|++|..||......
T Consensus 179 ~---~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~ 255 (326)
T 2w1i_A 179 E---NENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEF 255 (326)
T ss_dssp E---ETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHH
T ss_pred c---CCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHH
Confidence 5 567899999999987654332 22345778899999885 46889999999999999999999998542110
Q ss_pred -----------H---HHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 149 -----------G---IFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 149 -----------~---~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
. ............+ ..+.+++.+.++|.+||..+|.+|||+.++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 256 MRMIGNDKQGQMIVFHLIELLKNNGRLP--RPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHCTTCCTHHHHHHHHHHHHTTCCCC--CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHhhccccchhhhHHHHHHHhhcCCCCC--CCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0 1111222222222 22468999999999999999999999999985
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=270.75 Aligned_cols=192 Identities=20% Similarity=0.294 Sum_probs=151.1
Q ss_pred CCCccccceee----cC----eEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------HCCCEe
Q 016471 1 MYHQKLQHLFY----SN----SFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCH--------LQGVVH 64 (389)
Q Consensus 1 l~Hpni~~~~~----~~----~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH--------~~~i~H 64 (389)
+.||||++++. .. .+|+|||||++|+|.+++.+ ..+++..++.++.|++.||.||| ++||+|
T Consensus 93 l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH 170 (342)
T 1b6c_B 93 LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAH 170 (342)
T ss_dssp CCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEEC
T ss_pred cCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeee
Confidence 57999999982 22 79999999999999998865 36999999999999999999999 899999
Q ss_pred cCCCCCcEEEeecCCCCCEEEeecCCccccCCCC-----CcccccccCCcccccccccc-------CCCchhHHHHHHHH
Q 016471 65 RDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ-----RLNDIVGSAYYVAPEVLHRS-------YNVEGDMWSIGVIT 132 (389)
Q Consensus 65 rdlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~-------~~~~~DiwslG~il 132 (389)
|||||+||++ +.++.+||+|||++....... ......||+.|+|||++.+. ++.++||||+||++
T Consensus 171 ~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il 247 (342)
T 1b6c_B 171 RDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVF 247 (342)
T ss_dssp SCCSGGGEEE---CTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHH
T ss_pred CCCCHHHEEE---CCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHH
Confidence 9999999999 567899999999997665433 23455799999999998543 23689999999999
Q ss_pred HHHHhC----------CCCCCCCCh-----hHHHHHHHhcCCCCCCC-CC--CCCCHHHHHHHHhhhccCcCCCCCHHHH
Q 016471 133 YILLCG----------SRPFWARTE-----SGIFRSVLRADPNFHDS-PW--PSVSPEAKDFVRRLLNKDHRKRMTAAQA 194 (389)
Q Consensus 133 ~~ll~g----------~~pf~~~~~-----~~~~~~i~~~~~~~~~~-~~--~~~~~~~~~li~~~l~~~p~~R~s~~e~ 194 (389)
|+|++| ..||..... ......+.........+ .+ ...+..+.+++.+||..+|.+|||+.++
T Consensus 248 ~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i 327 (342)
T 1b6c_B 248 WEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 327 (342)
T ss_dssp HHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred HHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHH
Confidence 999999 789866422 23333333322111111 00 1234679999999999999999999999
Q ss_pred hCC
Q 016471 195 LTH 197 (389)
Q Consensus 195 l~h 197 (389)
+++
T Consensus 328 ~~~ 330 (342)
T 1b6c_B 328 KKT 330 (342)
T ss_dssp HHH
T ss_pred HHH
Confidence 863
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=282.43 Aligned_cols=185 Identities=17% Similarity=0.256 Sum_probs=149.3
Q ss_pred ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeecCCCCCEEEeecCC
Q 016471 11 YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGL 90 (389)
Q Consensus 11 ~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~~~~~~~kl~Dfg~ 90 (389)
.....|+||||| ||+|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|||+
T Consensus 74 ~~~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGl 152 (483)
T 3sv0_A 74 EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 152 (483)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTT
T ss_pred eCCEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCc
Confidence 467889999999 8999999887667899999999999999999999999999999999999995444678999999999
Q ss_pred ccccCCCCC--------cccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCh---hHHHHHHHhcC
Q 016471 91 SDFVRPDQR--------LNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTE---SGIFRSVLRAD 158 (389)
Q Consensus 91 a~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~ 158 (389)
+........ .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+... ...+..+....
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (483)
T 3sv0_A 153 AKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232 (483)
T ss_dssp CEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHH
T ss_pred ceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcc
Confidence 987654321 225679999999999854 689999999999999999999999987543 23333332221
Q ss_pred CCCC-CCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 159 PNFH-DSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 159 ~~~~-~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
.... ......+++++.++|.+||..+|.+||++.++++
T Consensus 233 ~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 233 VATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred ccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 1110 0011357899999999999999999999987764
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=271.61 Aligned_cols=187 Identities=22% Similarity=0.390 Sum_probs=134.0
Q ss_pred CCccccceee------------cCeEEEEEEccCCCChHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC--CEec
Q 016471 2 YHQKLQHLFY------------SNSFLFFTRFCEGGELLDRILS--RGGRYLEEDAKTIVEKILNIVAFCHLQG--VVHR 65 (389)
Q Consensus 2 ~Hpni~~~~~------------~~~~~lv~E~~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~~--i~Hr 65 (389)
.||||++++. ...+++|||||. |+|.+++.. ..+.+++..++.++.||+.||.|||++| |+||
T Consensus 84 ~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~ 162 (337)
T 3ll6_A 84 GHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHR 162 (337)
T ss_dssp TSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCC
T ss_pred cCCChhhccccccccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEc
Confidence 4999999972 234899999997 699998864 3467999999999999999999999999 9999
Q ss_pred CCCCCcEEEeecCCCCCEEEeecCCccccCCCCC-------------cccccccCCcccccccc----ccCCCchhHHHH
Q 016471 66 DLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR-------------LNDIVGSAYYVAPEVLH----RSYNVEGDMWSI 128 (389)
Q Consensus 66 dlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~~-------------~~~~~gt~~y~aPE~~~----~~~~~~~Diwsl 128 (389)
||||+|||+ +.++.+||+|||++........ .....||+.|+|||++. ..++.++||||+
T Consensus 163 Dikp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~sl 239 (337)
T 3ll6_A 163 DLKVENLLL---SNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWAL 239 (337)
T ss_dssp CCCGGGCEE---CTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHH
T ss_pred cCCcccEEE---CCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHH
Confidence 999999999 5678999999999987643321 12456999999999872 357889999999
Q ss_pred HHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCC
Q 016471 129 GVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHP 198 (389)
Q Consensus 129 G~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~ 198 (389)
||++|+|++|..||.+.......... .. .......+..+.++|.+||..+|.+|||+.+++++.
T Consensus 240 G~il~el~~g~~p~~~~~~~~~~~~~----~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l 303 (337)
T 3ll6_A 240 GCILYLLCFRQHPFEDGAKLRIVNGK----YS--IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL 303 (337)
T ss_dssp HHHHHHHHHSSCCC----------------CC--CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHhCCCCCcchhHHHhhcCc----cc--CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 99999999999999765544333222 11 122245778899999999999999999999999864
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=278.13 Aligned_cols=179 Identities=17% Similarity=0.197 Sum_probs=140.3
Q ss_pred cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCCEecCCCCCcEEEeecC------------
Q 016471 12 SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCH-LQGVVHRDLKPENFLFTTRE------------ 78 (389)
Q Consensus 12 ~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH-~~~i~Hrdlkp~Nill~~~~------------ 78 (389)
...+|+|||||++|++.+.+.+ +.+++..++.++.||+.||.||| ++||+||||||+|||++..+
T Consensus 134 ~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~ 211 (336)
T 2vuw_A 134 DDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKS 211 (336)
T ss_dssp TTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEE
T ss_pred cCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCcc
Confidence 5789999999999988887743 57899999999999999999999 99999999999999997432
Q ss_pred -----CCCCEEEeecCCccccCCCCCcccccccCCccccccccccCCCchhHHHHHHH-HHHHHhCCCCCCCCCh-hHHH
Q 016471 79 -----EDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVI-TYILLCGSRPFWARTE-SGIF 151 (389)
Q Consensus 79 -----~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~i-l~~ll~g~~pf~~~~~-~~~~ 151 (389)
....+||+|||+|+..... ..+||+.|+|||++.+..+.++||||+|++ .++++.|..||.+... ....
T Consensus 212 ~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~g~~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~ 287 (336)
T 2vuw_A 212 STIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLT 287 (336)
T ss_dssp EEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGCCCSSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHH
T ss_pred ccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhcCCCccceehhhhhCCCCcccccccCCCcchhhhhHHH
Confidence 1128999999999876432 458999999999997766889999998777 7789999999843211 1122
Q ss_pred HHHHhcCCC---CCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHh-CCCCCC
Q 016471 152 RSVLRADPN---FHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQAL-THPWLH 201 (389)
Q Consensus 152 ~~i~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l-~h~~~~ 201 (389)
..+...... .....++.+++++++||.+||..| |++++| +||||+
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 288 DKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp HHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred HhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 333322111 111112357899999999999976 999999 999995
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=277.63 Aligned_cols=174 Identities=17% Similarity=0.251 Sum_probs=143.9
Q ss_pred CeEEEEEEccCCCChHHHHH------hcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeecCCCCCEEEe
Q 016471 13 NSFLFFTRFCEGGELLDRIL------SRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVI 86 (389)
Q Consensus 13 ~~~~lv~E~~~gg~L~~~l~------~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~~~~~~~kl~ 86 (389)
..++++|+++ +|+|.+++. ...+.+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+
T Consensus 178 ~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl---~~~~~~kL~ 253 (413)
T 3dzo_A 178 LSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL---DQRGGVFLT 253 (413)
T ss_dssp CSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEEC
T ss_pred cceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEE---ecCCeEEEE
Confidence 3578888876 469998874 123457788899999999999999999999999999999999 567889999
Q ss_pred ecCCccccCCCCCcccccccCCccccccc----------cc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 016471 87 DFGLSDFVRPDQRLNDIVGSAYYVAPEVL----------HR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVL 155 (389)
Q Consensus 87 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~----------~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 155 (389)
|||++...... ....+| +.|+|||++ .+ .++.++|||||||++|+|++|+.||.+.........+.
T Consensus 254 DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~ 330 (413)
T 3dzo_A 254 GFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIF 330 (413)
T ss_dssp CGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGGG
T ss_pred eccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHHH
Confidence 99998765432 455678 999999988 32 37889999999999999999999998776554443332
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCC
Q 016471 156 RADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLH 201 (389)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~ 201 (389)
. .++.+++.+.+||.+||..||.+|||+.++++||||+
T Consensus 331 ~--------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~ 368 (413)
T 3dzo_A 331 R--------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYE 368 (413)
T ss_dssp S--------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHH
T ss_pred h--------hcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHH
Confidence 2 1246789999999999999999999999999999994
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=288.15 Aligned_cols=180 Identities=23% Similarity=0.342 Sum_probs=145.9
Q ss_pred CCCccccceee----cCe-----EEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCc
Q 016471 1 MYHQKLQHLFY----SNS-----FLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPEN 71 (389)
Q Consensus 1 l~Hpni~~~~~----~~~-----~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~N 71 (389)
|.||||++++. .+. .|+|||||+||+|.+.+. ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 136 l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~---~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~N 212 (681)
T 2pzi_A 136 VVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG---QKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPEN 212 (681)
T ss_dssp CCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred cCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHH
Confidence 57999999982 222 799999999999988653 379999999999999999999999999999999999
Q ss_pred EEEeecCCCCCEEEeecCCccccCCCCCcccccccCCccccccccccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHH
Q 016471 72 FLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIF 151 (389)
Q Consensus 72 ill~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 151 (389)
||++ . +.+||+|||++...... ....||+.|+|||++.+.++.++||||+||++|+|++|.+||.+.....
T Consensus 213 Ill~---~-~~~kl~DFG~a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-- 283 (681)
T 2pzi_A 213 IMLT---E-EQLKLIDLGAVSRINSF---GYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDG-- 283 (681)
T ss_dssp EEEC---S-SCEEECCCTTCEETTCC---SCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEECSS--
T ss_pred eEEe---C-CcEEEEecccchhcccC---CccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCccccccc--
Confidence 9994 3 48999999999876543 4567999999999987777899999999999999999999986532110
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCC
Q 016471 152 RSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 152 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~ 200 (389)
. ....+....++.+.++|.+||..||.+||+..+++.|+|+
T Consensus 284 ------~--~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 324 (681)
T 2pzi_A 284 ------L--PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT 324 (681)
T ss_dssp ------C--CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred ------c--cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence 0 0111111246889999999999999999998888887765
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.97 E-value=7.6e-32 Score=246.84 Aligned_cols=164 Identities=15% Similarity=0.108 Sum_probs=130.7
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ ..+..|+|||||+||+|.+++. + + ..+.++..++.||+.||+|||++||+||||||+|||++
T Consensus 88 l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~-~-~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~- 163 (286)
T 3uqc_A 88 IDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVAD-T-S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVS- 163 (286)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHT-T-C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEE-
T ss_pred CCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHh-c-C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEc-
Confidence 5899999998 4578999999999999999873 2 2 46778899999999999999999999999999999995
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCccccccccccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHH---H
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFR---S 153 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~---~ 153 (389)
.++.+||+++| |++| ++.++||||+||++|+|++|+.||.+.+....+. .
T Consensus 164 --~~g~~kl~~~~-------------------~~~~------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~ 216 (286)
T 3uqc_A 164 --IDGDVVLAYPA-------------------TMPD------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAER 216 (286)
T ss_dssp --TTSCEEECSCC-------------------CCTT------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCB
T ss_pred --CCCCEEEEecc-------------------ccCC------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHH
Confidence 67889998443 3333 6889999999999999999999998766533211 1
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 154 VLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 154 i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
........+....+.+++.+.++|.+||..||.+| |+.++++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~ 258 (286)
T 3uqc_A 217 DTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN 258 (286)
T ss_dssp CTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred HhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence 11111111111225689999999999999999999 9999986
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.8e-31 Score=263.71 Aligned_cols=174 Identities=17% Similarity=0.154 Sum_probs=117.1
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
.||||++++ +++.+|||||||+||+|.+++.+. +.+++. .|+.||+.||+|||++|||||||||+|||+
T Consensus 300 ~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~-~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL--- 372 (569)
T 4azs_A 300 AGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAG-EEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMV--- 372 (569)
T ss_dssp TTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTT-CCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEE---
T ss_pred CCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhC-CCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEE---
Confidence 589999888 467899999999999999988655 678765 478999999999999999999999999999
Q ss_pred CCCCCEEEeecCCccccCCC-CCcccccccCCccccccccccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 016471 78 EEDAPLKVIDFGLSDFVRPD-QRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLR 156 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 156 (389)
+.++.+||+|||+|+..... ....+.+||+.|+|||++.+.+..++|+||+|++++++.++..|+ ...+..
T Consensus 373 ~~dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~~~~~--------~~~l~~ 444 (569)
T 4azs_A 373 DARQHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQPWSNW--------LYAVWQ 444 (569)
T ss_dssp CTTSCEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC-----------------CCCCTTHHHH--------HHHHHT
T ss_pred CCCCCEEEeecccCeeCCCCCccccCceechhhccHHHhCCCCCCcccccccccchhhhccccchh--------HHHhhc
Confidence 57889999999999876543 344567899999999999888888999999999999887765443 111211
Q ss_pred cCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCC
Q 016471 157 ADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPW 199 (389)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~ 199 (389)
. +.. ...+..+...+...+|..|+.......++|
T Consensus 445 ~----~~~-----~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~ 478 (569)
T 4azs_A 445 E----PVE-----RWNFVLLLALFEKKAKLPSAEQQRGATEQW 478 (569)
T ss_dssp S----CGG-----GCSHHHHHHHHHTGGGSCCGGGSSCCHHHH
T ss_pred C----CCC-----CCcHHHHHHHHhCCCCCCCCChhhhccchh
Confidence 1 110 112455666667777777766544444443
|
| >3pm8_A PFCDPK2, calcium-dependent protein kinase 2; malaria, structural genomics, structural genomics CONS SGC; 2.00A {Plasmodium falciparum K1} | Back alignment and structure |
|---|
Probab=99.95 E-value=8.6e-27 Score=201.33 Aligned_cols=179 Identities=22% Similarity=0.324 Sum_probs=143.0
Q ss_pred CCCCCCCCC-CCCCccHHHHHHHHHHhhcChhHHHHHHHHHHhcCHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhc
Q 016471 196 THPWLHDEN-RPVPLDILIYKLVKSYLRATPLKRAALKALSKALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQA 273 (389)
Q Consensus 196 ~h~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~~~l~~i~~~l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~ 273 (389)
.|||.+... .+.+++..+...++.+...+.+++.++..+...++.+++..++..|..+|. ++|.|+.+||..+|..++
T Consensus 8 ~~~~~~~~~~~~~~l~~~~~~~l~~f~~~~~lk~~~l~~i~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~El~~~l~~~g 87 (197)
T 3pm8_A 8 SSGRENLYFQGHVELSSTLLKNLKNFKKENELKKIALTIIAKHLCDVEINNLRNIFIALDVDNSGTLSSQEILDGLKKIG 87 (197)
T ss_dssp ---------CCSCCCCTTHHHHHHHTTTSCHHHHHHHHHHHHHCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHC
T ss_pred cchHhhhccCCCCCCCHHHHHHHHHHHHccHHHHHHHHHHHHHCCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHhC
Confidence 488998764 567778888999999999999999999999999999999999999999999 999999999999999998
Q ss_pred cccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHhCCc----
Q 016471 274 TDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALELNLA---- 349 (389)
Q Consensus 274 ~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~---- 349 (389)
. .++..++.++|..+|.+++|.|+|+||+.++........ ++.++.+|+.||+|++|+|+.+||++++...
T Consensus 88 ~-~~~~~~~~~l~~~~D~d~~g~I~~~EF~~~~~~~~~~~~----~~~l~~~F~~~D~d~~G~Is~~El~~~l~~~~~~~ 162 (197)
T 3pm8_A 88 Y-QKIPPDIHQVLRDIDSNASGQIHYTDFLAATIDKQTYLK----KEVCLIPFKFFDIDGNGKISVEELKRIFGRDDIEN 162 (197)
T ss_dssp -----CHHHHHHHHC-------CEEHHHHHHTTCCHHHHCS----HHHHHHHHHHHCTTCSSEECHHHHHHHHC----CC
T ss_pred C-CCCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHHHhhhh----HHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCC
Confidence 6 478889999999999999999999999997776654433 4579999999999999999999999999533
Q ss_pred ---hH-HHHHHHHHccCCCCceeHHHHHHHHccc
Q 016471 350 ---PA-AYSLLNDCIRNSDGKLSFLGYKRFLHGV 379 (389)
Q Consensus 350 ---~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~ 379 (389)
.. +.+++.++|.|+||.|+|+||+.+|++.
T Consensus 163 ~~~~~~~~~l~~~~D~d~dG~Is~~EF~~~l~~~ 196 (197)
T 3pm8_A 163 PLIDKAIDSLLQEVDLNGDGEIDFHEFMLMMSKK 196 (197)
T ss_dssp HHHHHHHHHHHHHHCTTCSSSEEHHHHHHHHHCC
T ss_pred CCCHHHHHHHHHHHcCCCCCcCcHHHHHHHHHcC
Confidence 12 8999999999999999999999999864
|
| >3k21_A PFCDPK3, calcium-dependent protein kinase 3; calcium kinase structural genomics malaria, structural genom consortium, SGC, ATP-binding; 1.15A {Plasmodium falciparum} PDB: 3o4y_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-25 Score=193.34 Aligned_cols=174 Identities=20% Similarity=0.341 Sum_probs=147.5
Q ss_pred CCCCC-CCCCCCCccHHHHHHHHHHhhcChhHHHHHHHHHHhcCHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhcc
Q 016471 197 HPWLH-DENRPVPLDILIYKLVKSYLRATPLKRAALKALSKALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQAT 274 (389)
Q Consensus 197 h~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~i~~~l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~ 274 (389)
|||+. ....+.+++..+.+.++.+...+.+++.++..+...++.+++..++..|..+|. ++|.|+.+||..++..+|.
T Consensus 4 ~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~l~~~~l~~~~~~l~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~~g~ 83 (191)
T 3k21_A 4 HHHHSSGRENLYFQGIHVLENFKNYGLLLKFQKLAMTIIAQQSNDYDVEKLKSTFLVLDEDGKGYITKEQLKKGLEKDGL 83 (191)
T ss_dssp ----------CHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCCCHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTC
T ss_pred CccccCCccccccccHHHHHHHHHHHhhHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHcCC
Confidence 55554 445667788889999999999999999999999999999999999999999999 9999999999999999987
Q ss_pred ccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHhC-------
Q 016471 275 DAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALELN------- 347 (389)
Q Consensus 275 ~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~------- 347 (389)
. .+ .++.+++..+|.+++|.|+|+||+..+...... . ++.++.+|+.||+|++|+|+.+||+.++.
T Consensus 84 ~-~~-~~~~~l~~~~D~d~~g~i~~~EF~~~~~~~~~~-~----~~~l~~~F~~~D~d~~G~Is~~El~~~l~~~~~~~~ 156 (191)
T 3k21_A 84 K-LP-YNFDLLLDQIDSDGSGKIDYTEFIAAALDRKQL-S----KKLIYCAFRVFDVDNDGEITTAELAHILYNGNKKGN 156 (191)
T ss_dssp C-CC-TTHHHHHHHHCTTCSSSEEHHHHHHHHSCGGGC-C----HHHHHHHHHHHSTTCSSCBCHHHHHHHHHHSSSCSC
T ss_pred C-cH-HHHHHHHHHhCCCCCCeEeHHHHHHHHHhhhhc-c----HHHHHHHHHHhCCCCCCcCCHHHHHHHHHhcCCCCC
Confidence 4 45 789999999999999999999999977655431 1 45689999999999999999999999982
Q ss_pred Cch---H-HHHHHHHHccCCCCceeHHHHHHHHc
Q 016471 348 LAP---A-AYSLLNDCIRNSDGKLSFLGYKRFLH 377 (389)
Q Consensus 348 ~~~---~-~~~~~~~~d~~~~g~i~~~ef~~~~~ 377 (389)
+++ . +.++++.+|.|+||.|+|+||+.+|+
T Consensus 157 l~~~~~~~~~~~~~~~D~d~dG~Is~~EF~~~~~ 190 (191)
T 3k21_A 157 ITQRDVNRVKRMIRDVDKNNDGKIDFHEFSEMMK 190 (191)
T ss_dssp CCHHHHHHHHHHHHHHCSSSSSSBCHHHHHHHHC
T ss_pred CCHhHHHHHHHHHHHhcCCCCCeECHHHHHHHHc
Confidence 122 1 88999999999999999999999986
|
| >2lhi_A Calmodulin, serine/threonine-protein phosphatase catalytic subunit A1; yeast calmodulin, CNA1, metal binding protein; NMR {Saccharomyces cerevisiae} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.1e-24 Score=184.50 Aligned_cols=141 Identities=20% Similarity=0.387 Sum_probs=123.7
Q ss_pred hcCHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhh
Q 016471 237 ALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEAL 315 (389)
Q Consensus 237 ~l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~ 315 (389)
.++++++..++++|..+|. ++|.|+.+||..+|..+|.. +++.++.+++..+|.+++|.|+|.||+..+.........
T Consensus 4 ~Lt~eqi~elk~~F~~~D~d~dG~I~~~El~~~l~~lg~~-~~~~~~~~~~~~~d~d~~~~i~~~ef~~~~~~~~~~~~~ 82 (176)
T 2lhi_A 4 NLTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGLS-PSEAEVNDLMNEIDVDGNHQIEFSEFLALMSRQLKSNDS 82 (176)
T ss_dssp CCCTTGGGHHHHHHHTTCSSCSSCBCHHHHHHHHHHHTCC-CCHHHHHHHHTTTCSSCSSSBCTTHHHHHHTSSCCSSHH
T ss_pred cCCHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHcCCC-hhHHHHHHHHHHhCcCCCccchHHHHHHHHHHhcccCCc
Confidence 5778899999999999999 99999999999999999974 899999999999999999999999999876654333222
Q ss_pred HHHHHHHHHHHHHHcccCCCcccHHHHHHHh---C--CchH-HHHHHHHHccCCCCceeHHHHHHHHccccCC
Q 016471 316 ERWDQIAITAFDYFEQEGNRVISVEELALEL---N--LAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVTVR 382 (389)
Q Consensus 316 ~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l---~--~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~ 382 (389)
++.++.||+.||+|++|+|+.+||+++| | +... ++++++++| |+||+|+|+||+.+|++.++.
T Consensus 83 ---~~~l~~aF~~fD~d~~G~I~~~el~~~l~~~g~~~~~~ei~~l~~~~d-d~dG~I~~~EF~~~m~k~~~~ 151 (176)
T 2lhi_A 83 ---EQELLEAFKVFDKNGDGLISAAELKHVLTSIGEKLTDAEVDDMLREVS-DGSGEINIQQFAALLSKGSST 151 (176)
T ss_dssp ---HHHHHHHHHHHCSSCSSSBCHHHHHHHHHTTTCCCCHHHHHHHHHHHH-TTSSCBCTTHHHHHHTCCSSC
T ss_pred ---HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCcccchHHHHHHHHhhc-CCCCeEeHHHHHHHHHhcCCc
Confidence 4679999999999999999999999999 2 2333 999999999 999999999999999886643
|
| >2lmt_A Calmodulin-related protein 97A; spermatogenesis, metal binding protein; NMR {Drosophila melanogaster} PDB: 2lmu_A 2lmv_A | Back alignment and structure |
|---|
Probab=99.91 E-value=2.3e-24 Score=177.24 Aligned_cols=138 Identities=16% Similarity=0.334 Sum_probs=121.0
Q ss_pred hcCHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhh
Q 016471 237 ALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEAL 315 (389)
Q Consensus 237 ~l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~ 315 (389)
.++++++..++.+|..+|. ++|.|+.+||..+++.++. .++..++..++..+|.+++|.|+|.||+..+.........
T Consensus 3 ~lt~eqi~el~~~F~~~D~d~~G~I~~~El~~~l~~~~~-~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~~~ 81 (148)
T 2lmt_A 3 ELTEEQIAEFKDAFVQFDKEGTGKIATRELGTLMRTLGQ-NPTEAELQDLIAEAENNNNGQLNFTEFCGIMAKQMRETDT 81 (148)
T ss_dssp SCCSHHHHHHHHHHHHHHCSSCCEEEGGGHHHHHHHHTC-CCCHHHHHHHHHHHHTTSTTEEEHHHHHHHHHHTTTTTTT
T ss_pred CCCHHHHHHHHHHHHHHcCCCCCeECHHHHHHHHHhcCC-CchHHHHHHHHHhcccCCCCcccHHHHHHHHHHHhcccCc
Confidence 3678899999999999999 9999999999999999987 4789999999999999999999999999866543332222
Q ss_pred HHHHHHHHHHHHHHcccCCCcccHHHHHHHh---CC--chH-HHHHHHHHccCCCCceeHHHHHHHHcc
Q 016471 316 ERWDQIAITAFDYFEQEGNRVISVEELALEL---NL--APA-AYSLLNDCIRNSDGKLSFLGYKRFLHG 378 (389)
Q Consensus 316 ~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l---~~--~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~ 378 (389)
++.++.||+.||+|++|+|+.+||+.+| |. ... +.++++++|.|+||.|+|+||+++|++
T Consensus 82 ---~~~l~~aF~~~D~d~~G~I~~~El~~~l~~~g~~~~~~e~~~l~~~~D~d~dG~I~~~EF~~~m~~ 147 (148)
T 2lmt_A 82 ---EEEMREAFKIFDRDGDGFISPAELRFVMINLGEKVTDEEIDEMIREADFDGDGMINYEEFVWMISQ 147 (148)
T ss_dssp ---HHHHHHHHHHHHSSCSSEECHHHHHHHHHHHTCCCCHHHHHHHHHHHCCSCCSSEEHHHHHHHHTT
T ss_pred ---HHHHHHHHHHHCCCCcCcCcHHHHHHHHHHcCccccHHHHHHHHHHhCCCCCCeEeHHHHHHHHhc
Confidence 4579999999999999999999999998 33 333 999999999999999999999999986
|
| >2obh_A Centrin-2; DNA repair complex EF hand superfamily protein-peptide compl cycle; 1.80A {Homo sapiens} SCOP: a.39.1.5 PDB: 3kf9_A 1m39_A 2a4j_A 2k2i_A 1oqp_A | Back alignment and structure |
|---|
Probab=99.91 E-value=2.3e-23 Score=170.15 Aligned_cols=135 Identities=18% Similarity=0.324 Sum_probs=116.9
Q ss_pred HHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHH
Q 016471 240 EEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERW 318 (389)
Q Consensus 240 ~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~ 318 (389)
+++...++..|..+|. ++|.|+.+||..+|..+|.. ++..++.+++..+|.+++|.|+|+||+..+........ .
T Consensus 2 ~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~-~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~---~ 77 (143)
T 2obh_A 2 EEQKQEIREAFDLFDADGTGTIDVKELKVAMRALGFE-PKKEEIKKMISEIDKEGTGKMNFGDFLTVMTQKMSEKD---T 77 (143)
T ss_dssp HHHHHHHHHHHHTTCTTCCSEEEGGGHHHHHHHTTCC-CCHHHHHHHHHHHTTTCCSEEEHHHHHHHHHHHHHHHH---H
T ss_pred HHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCC-CCHHHHHHHHHHhCCCCCCeeeHHHHHHHHHHHhcccc---H
Confidence 5677889999999999 99999999999999999874 78999999999999999999999999986554322111 1
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHh---C--CchH-HHHHHHHHccCCCCceeHHHHHHHHcc
Q 016471 319 DQIAITAFDYFEQEGNRVISVEELALEL---N--LAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHG 378 (389)
Q Consensus 319 ~~~l~~aF~~~D~d~~G~I~~~el~~~l---~--~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~ 378 (389)
.+.++.||+.||+|++|+|+.+||++++ | +... +.++++++|.|+||.|+|+||+.+|++
T Consensus 78 ~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~D~d~dG~I~~~eF~~~~~~ 143 (143)
T 2obh_A 78 KEEILKAFKLFDDDETGKISFKNLKRVAKELGENLTDEELQEMIDEADRDGDGEVSEQEFLRIMKK 143 (143)
T ss_dssp HHHHHHHHHHHCTTCSSSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTSSSSBCHHHHHHHHCC
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHcC
Confidence 4568999999999999999999999998 3 2333 999999999999999999999999863
|
| >3u0k_A Rcamp; fluorescent protein, calcium binding, EF-hand, genetically E calcium indicator; HET: NFA CRK; 2.10A {Entacmaea quadricolor} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.2e-23 Score=195.59 Aligned_cols=140 Identities=18% Similarity=0.363 Sum_probs=121.5
Q ss_pred HHhcCHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHH
Q 016471 235 SKALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLE 313 (389)
Q Consensus 235 ~~~l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~ 313 (389)
...++++++..++++|..+|. ++|.|+.+||+.+|+.++.. ++++++.++|..+|.|++|.|+|+||+.++.......
T Consensus 293 ~E~Lt~EEI~ELREaF~~fDkDgdG~IS~eELk~aLrsLG~~-~TeeEI~~Lf~~~D~DgDG~IdFeEFl~lms~~lk~~ 371 (440)
T 3u0k_A 293 RDQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQN-PTEAELQDMINEVDADGDGTIDFPEFLIMMARKMKDT 371 (440)
T ss_dssp CBCCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCC-CCHHHHHHHHHHHCSSCSSSEEHHHHHHHHHTC----
T ss_pred HhhhhHHHHHHHHHHHHHHcCCCCCEECHHHHHHHHHHcCCC-CCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhcCC
Confidence 346889999999999999999 99999999999999999874 8999999999999999999999999998766543322
Q ss_pred hhHHHHHHHHHHHHHHcccCCCcccHHHHHHHh---C--CchH-HHHHHHHHccCCCCceeHHHHHHHHcc
Q 016471 314 ALERWDQIAITAFDYFEQEGNRVISVEELALEL---N--LAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHG 378 (389)
Q Consensus 314 ~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l---~--~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~ 378 (389)
.. ++.+++||+.||+|++|+|+.+||+++| | ++.+ ++++++++|.|+||.|+|+||+++|+.
T Consensus 372 d~---eeeLreAFk~fDkDgdG~IS~eELr~vL~~lGe~LSdeEIdeLfke~D~DgDGkIsyeEFvkmMtS 439 (440)
T 3u0k_A 372 DS---EEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMTA 439 (440)
T ss_dssp -----CHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTCCCCHHHHHHHHHHHCTTCSSSEEHHHHHHHHC-
T ss_pred Ch---HHHHHHHHHHHCCCCcCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHhCC
Confidence 22 4579999999999999999999999998 3 3344 999999999999999999999999964
|
| >3mse_B Calcium-dependent protein kinase, putative; CDPKS, malaria, structural genomics consortium, SGC, transfe; 2.10A {Plasmodium falciparum} | Back alignment and structure |
|---|
Probab=99.90 E-value=7.4e-23 Score=173.92 Aligned_cols=162 Identities=16% Similarity=0.308 Sum_probs=140.5
Q ss_pred cHHHHHHHHHHhhcChhHHHHHHHHHHhcC--HHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHH
Q 016471 210 DILIYKLVKSYLRATPLKRAALKALSKALT--EEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEIL 286 (389)
Q Consensus 210 ~~~~~~~~~~~~~~~~l~~~~l~~i~~~l~--~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~ 286 (389)
+..++..++.+...+.+++.++..+...++ +++...++..|..+|. ++|.|+.+||..++..++. ...++..+|
T Consensus 3 ~~~~~~~l~~~~~~~~l~~~~l~~~~~~l~~~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~~g~---~~~~~~~~~ 79 (180)
T 3mse_B 3 SPNVLNNMKSYMKHSNIRNIIINIMAHELSVINNHIKYINELFYKLDTNHNGSLSHREIYTVLASVGI---KKWDINRIL 79 (180)
T ss_dssp CHHHHHHHHHHTTSCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHTTC---CHHHHHHHH
T ss_pred CHHHHHHHHHHHHHhHHHHHHHHHHHHHccCCHHHHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCC---CHHHHHHHH
Confidence 356778899999999999999999999887 8899999999999999 9999999999999998875 357899999
Q ss_pred hhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHhC---CchH-HHHHHHHHccC
Q 016471 287 NVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALELN---LAPA-AYSLLNDCIRN 362 (389)
Q Consensus 287 ~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~---~~~~-~~~~~~~~d~~ 362 (389)
..+|.+++|.|+|+||+..+....... ++.++.+|+.||+|++|+|+.+||+.++. ++.. +.++++.+|.|
T Consensus 80 ~~~D~d~~g~i~~~Ef~~~~~~~~~~~-----~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~~~~~d~~ 154 (180)
T 3mse_B 80 QALDINDRGNITYTEFMAGCYRWKNIE-----STFLKAAFNKIDKDEDGYISKSDIVSLVHDKVLDNNDIDNFFLSVHSI 154 (180)
T ss_dssp HHHCTTCCSEECHHHHHHHHSCCTTC-------CHHHHHHHHHCTTCSSCBCHHHHHHHTTTSSCCHHHHHHHHHHHHTC
T ss_pred HHhCCCCCCcCcHHHHHHHHHhcccCC-----HHHHHHHHHHHCCCCCCCCCHHHHHHHHcCCCCCHHHHHHHHHHhhhc
Confidence 999999999999999998776543321 24689999999999999999999999994 3444 99999999999
Q ss_pred CC--------CceeHHHHHHHHccc
Q 016471 363 SD--------GKLSFLGYKRFLHGV 379 (389)
Q Consensus 363 ~~--------g~i~~~ef~~~~~~~ 379 (389)
+| |.|+|+||+.+|.+.
T Consensus 155 ~d~~~~~~~~G~i~~~eF~~~l~~~ 179 (180)
T 3mse_B 155 KKGIPREHIINKISFQEFKDYMLST 179 (180)
T ss_dssp ---------CCCBCHHHHHHHHHTT
T ss_pred cCcccccccCCeeeHHHHHHHHHhc
Confidence 88 999999999999753
|
| >3khe_A Calmodulin-like domain protein kinase isoform 3; calcium dependent kinase, structural genomics, structural GE consortium, SGC, ATP-binding; 1.95A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.90 E-value=5.9e-23 Score=175.88 Aligned_cols=168 Identities=20% Similarity=0.285 Sum_probs=147.3
Q ss_pred CccHHHHHHHHHHhhcChhHHHHHHHHHHhc-CHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHh-----------cc
Q 016471 208 PLDILIYKLVKSYLRATPLKRAALKALSKAL-TEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQ-----------AT 274 (389)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~l~~~~l~~i~~~l-~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~-----------~~ 274 (389)
|+...+...++.+...+.+++.++..+...+ ++++...++..|..+|. ++|.|+.+||..++..+ +.
T Consensus 3 ~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~ 82 (191)
T 3khe_A 3 HALTGALGNMKKFQSSQKLAQAAMLFMGSKLTTLEETKELTQIFRQLDNNGDGQLDRKELIEGYRKLMQWKGDTVSDLDS 82 (191)
T ss_dssp CHHHHHHHHHHHCCCCCHHHHHHHHHHHHHSSCTTTTHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHC-----CCHHHH
T ss_pred hHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCHHHHHHHHHHHHHHcCCCCCCCcHHHHHHHHHHHHhhcccccccccc
Confidence 4556778889999999999999999999888 88899999999999999 99999999999999877 54
Q ss_pred ccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHhC---CchH
Q 016471 275 DAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALELN---LAPA 351 (389)
Q Consensus 275 ~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~---~~~~ 351 (389)
..+..++..+|..+|.+++|.|+|+||+..+........ ++.++.+|+.+|.|++|+|+.+|++.++. ....
T Consensus 83 -~~~~~~~~~~~~~~D~d~~g~i~~~ef~~~~~~~~~~~~----~~~~~~~F~~~D~d~~G~I~~~E~~~~l~~~~~~~~ 157 (191)
T 3khe_A 83 -SQIEAEVDHILQSVDFDRNGYIEYSEFVTVCMDKQLLLS----RERLLAAFQQFDSDGSGKITNEELGRLFGVTEVDDE 157 (191)
T ss_dssp -HHHHHHHHHHHHHTCTTCSSSEEHHHHHHHHSCHHHHCC----HHHHHHHHHHHCTTCSSEECHHHHHHHTTSSCCCHH
T ss_pred -hhhHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHhcccch----HHHHHHHHHHHCCCCcCcCCHHHHHHHHccCCCCHH
Confidence 357888999999999999999999999997766543332 45689999999999999999999999995 2333
Q ss_pred -HHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 352 -AYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 352 -~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
+.+++..+|.|++|.|+|+||+.+|.+..
T Consensus 158 ~~~~~~~~~D~~~dg~i~~~eF~~~~~~~~ 187 (191)
T 3khe_A 158 TWHQVLQECDKNNDGEVDFEEFVEMMQKIC 187 (191)
T ss_dssp HHHHHHHHHCTTCSSSEEHHHHHHHHHHHH
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 99999999999999999999999998754
|
| >3i5g_C Myosin catalytic light chain LC-1, mantle muscle; rigor-like, squid, muscle myosin, contractIle protein; 2.60A {Todarodes pacificus} PDB: 3i5f_C 3i5h_C 3i5i_C | Back alignment and structure |
|---|
Probab=99.89 E-value=1.5e-23 Score=174.43 Aligned_cols=144 Identities=18% Similarity=0.237 Sum_probs=118.4
Q ss_pred hcCHHHHHHHHHHhhhcC--C-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHH
Q 016471 237 ALTEEELVYLRAQFMLLE--P-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLE 313 (389)
Q Consensus 237 ~l~~ee~~~l~~~F~~~D--~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~ 313 (389)
+++++++..++++|..+| . ++|.|+.+||+.+|+.+|.. +++.++.+++. .|.+++|.|+|+||+..+.......
T Consensus 2 qLt~eqi~elre~F~~fD~~~d~dG~I~~~El~~~lr~lG~~-~t~~el~~~~~-~d~~~~g~i~f~eFl~~~~~~~~~~ 79 (159)
T 3i5g_C 2 QLTKDEIEEVREVFDLFDFWDGRDGDVDAAKVGDLLRCLGMN-PTEAQVHQHGG-TKKMGEKAYKLEEILPIYEEMSSKD 79 (159)
T ss_dssp CCCHHHHHHHHHHHHHHHHHTTSSSCEEGGGHHHHHHHTTCC-CCHHHHHTTTC-CSSTTSCEECHHHHHHHHHHHTTCC
T ss_pred CCCHHHHHHHHHHHHHHCcCCCCCCeECHHHHHHHHHHcCCC-CCHHHHHHHHc-ccccCCCcccHHHHHHHHHHhhccc
Confidence 478899999999999998 3 78999999999999999974 79999988765 4778899999999998654332211
Q ss_pred hhHHHHHHHHHHHHHHcccCCCcccHHHHHHHh---CC--chH-HHHHHHHHcc--CCCCceeHHHHHHHHccccCCC
Q 016471 314 ALERWDQIAITAFDYFEQEGNRVISVEELALEL---NL--APA-AYSLLNDCIR--NSDGKLSFLGYKRFLHGVTVRS 383 (389)
Q Consensus 314 ~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l---~~--~~~-~~~~~~~~d~--~~~g~i~~~ef~~~~~~~~~~~ 383 (389)
... ..+.++.||+.||+|++|+|+.+||+++| |. +.. +.++++.+|. |+||.|+|+||+++|...+.-.
T Consensus 80 ~~~-~~~~l~~aF~~fD~d~~G~I~~~el~~~l~~~g~~ls~~e~~~l~~~~D~~~d~dG~I~~~EF~~~m~~~p~pd 156 (159)
T 3i5g_C 80 TGT-AADEFMEAFKTFDREGQGLISSAEIRNVLKMLGERITEDQCNDIFTFCDIREDIDGNIKYEDLMKKVMAGPFPD 156 (159)
T ss_dssp TTC-CHHHHHHHHHHHCTTSSSEECHHHHHHHHHHSSSCCCHHHHHHHHHHTTCCCCSSCCEEHHHHHHHHHHCSCCC
T ss_pred ccc-hHHHHHHHHHHHhcCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCcCCCCCCeEeHHHHHHHHHCCCCCC
Confidence 110 14569999999999999999999999998 43 344 9999999995 8899999999999998876543
|
| >1exr_A Calmodulin; high resolution, disorder, metal transport; 1.00A {Paramecium tetraurelia} SCOP: a.39.1.5 PDB: 1n0y_A 1osa_A 1clm_A 1mxe_A 2bbm_A 2bbn_A 4cln_A 4djc_A 2wel_D* 2x51_B 2vas_B* 2bkh_B 3gn4_B 3l9i_C 2ygg_B* 2w73_A 1lvc_D* 1wrz_A 2bki_B 2r28_A ... | Back alignment and structure |
|---|
Probab=99.89 E-value=1.9e-22 Score=165.56 Aligned_cols=138 Identities=19% Similarity=0.400 Sum_probs=119.8
Q ss_pred hcCHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhh
Q 016471 237 ALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEAL 315 (389)
Q Consensus 237 ~l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~ 315 (389)
.++++++..++..|..+|. ++|.|+.+||..+++.+|.. ++..++..++..+|.+++|.|+|+||+..+.........
T Consensus 3 ~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~-~~~~~~~~l~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~ 81 (148)
T 1exr_A 3 QLTEEQIAEFKEAFALFDKDGDGTITTKELGTVMRSLGQN-PTEAELQDMINEVDADGNGTIDFPEFLSLMARKMKEQDS 81 (148)
T ss_dssp CCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTCC-CCHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHHHHHHHH
T ss_pred cCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCCC-CCHHHHHHHHHHHCCCCCCcCcHHHHHHHHHhcccCCCc
Confidence 4677888999999999999 99999999999999999874 788999999999999999999999999876543322221
Q ss_pred HHHHHHHHHHHHHHcccCCCcccHHHHHHHh---C--CchH-HHHHHHHHccCCCCceeHHHHHHHHcc
Q 016471 316 ERWDQIAITAFDYFEQEGNRVISVEELALEL---N--LAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHG 378 (389)
Q Consensus 316 ~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l---~--~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~ 378 (389)
++.++.+|+.||+|++|+|+.+||++++ | +... +.+++.++|.|++|.|+|+||+.+|..
T Consensus 82 ---~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d~d~dg~i~~~eF~~~~~~ 147 (148)
T 1exr_A 82 ---EEELIEAFKVFDRDGNGLISAAELRHVMTNLGEKLTDDEVDEMIREADIDGDGHINYEEFVRMMVS 147 (148)
T ss_dssp ---HHHHHHHHHHHSTTCSSCBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCSSSSSSBCHHHHHHHHHC
T ss_pred ---HHHHHHHHHHhCCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHcc
Confidence 4568999999999999999999999998 3 3333 999999999999999999999999864
|
| >2aao_A CDPK, calcium-dependent protein kinase, isoform AK1; calmodulin-like domain, EF calcium binding protein, transferase; 2.00A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.4e-22 Score=169.44 Aligned_cols=156 Identities=21% Similarity=0.477 Sum_probs=130.5
Q ss_pred HhhcChhHHHHHHHHHHhcCHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCccee
Q 016471 220 YLRATPLKRAALKALSKALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLA 298 (389)
Q Consensus 220 ~~~~~~l~~~~l~~i~~~l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~ 298 (389)
+...+.+++.++..+...++.+++..++..|..+|. ++|.|+.+||..++..++. .++..++..++..+|.+++|.|+
T Consensus 3 f~~~~~~~~~~~~~~~~~l~~~~~~~l~~~F~~~D~~~~G~i~~~e~~~~l~~~~~-~~~~~~~~~~~~~~d~~~~g~i~ 81 (166)
T 2aao_A 3 FSAMNKFKKMALRVIAESLSEEEIAGLKEMFNMIDADKSGQITFEELKAGLKRVGA-NLKESEILDLMQAADVDNSGTID 81 (166)
T ss_dssp ---CHHHHHHHHHHHHHHSCHHHHHHHHHHHHHHCTTCCSSBCHHHHHHHGGGGTC-CCCHHHHHHHHHHHCTTCCSSBC
T ss_pred hhhHHHHHHHHHHHHHHhCCHHHHHHHHHHHHHhCCCCCCeEeHHHHHHHHHHhCC-CCCHHHHHHHHHHhCCCCCCeEc
Confidence 445566788888889999999999999999999999 9999999999999998876 47888999999999999999999
Q ss_pred HHHHHHHHhchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHh---CCchH-HHHHHHHHccCCCCceeHHHHHH
Q 016471 299 YEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALEL---NLAPA-AYSLLNDCIRNSDGKLSFLGYKR 374 (389)
Q Consensus 299 ~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l---~~~~~-~~~~~~~~d~~~~g~i~~~ef~~ 374 (389)
|+||+..+........ .+.++.+|+.+|.|++|+|+.+||+.++ |++++ +.+++..+|.|++|.|+|+||+.
T Consensus 82 ~~ef~~~~~~~~~~~~----~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~d~~~dg~i~~~eF~~ 157 (166)
T 2aao_A 82 YKEFIAATLHLNKIER----EDHLFAAFTYFDKDGSGYITPDELQQACEEFGVEDVRIEELMRDVDQDNDGRIDYNEFVA 157 (166)
T ss_dssp HHHHHHHHTTCHHHHT----THHHHHHHHHHCTTCSSSBCHHHHHHHTCC--------CCHHHHHCTTCSSSBCHHHHHH
T ss_pred HHHHHHHHHHHhhccc----HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCHHHHHHHHHHhCCCCCCcEeHHHHHH
Confidence 9999987765544322 3568999999999999999999999998 44444 88899999999999999999999
Q ss_pred HHcccc
Q 016471 375 FLHGVT 380 (389)
Q Consensus 375 ~~~~~~ 380 (389)
+|.+.+
T Consensus 158 ~~~~~~ 163 (166)
T 2aao_A 158 MMQKGS 163 (166)
T ss_dssp HHC---
T ss_pred HHHhcc
Confidence 998764
|
| >3i5g_B Myosin regulatory light chain LC-2, mantle muscle; rigor-like, squid, muscle myosin, contractIle protein; 2.60A {Todarodes pacificus} PDB: 3i5f_B 3i5h_B 3i5i_B | Back alignment and structure |
|---|
Probab=99.88 E-value=8.8e-23 Score=168.60 Aligned_cols=135 Identities=13% Similarity=0.236 Sum_probs=115.6
Q ss_pred hcCHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhh
Q 016471 237 ALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEAL 315 (389)
Q Consensus 237 ~l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~ 315 (389)
.++++++..++++|..+|. ++|.|+.+||+.+|+.+|.. ++..++..++.. +++.|+|+||+..+.........
T Consensus 9 ~Lt~~qi~elk~~F~~~D~d~dG~I~~~El~~~l~~lg~~-~~~~~~~~~~~~----~~~~i~f~ef~~~~~~~~~~~~~ 83 (153)
T 3i5g_B 9 KLSQRQMQELKEAFTMIDQDRDGFIGMEDLKDMFSSLGRV-PPDDELNAMLKE----CPGQLNFTAFLTLFGEKVSGTDP 83 (153)
T ss_dssp TCCHHHHHHHHHHHHHHCCSTTSCCCHHHHHHHHHHTTSC-CCHHHHHHHHHT----SSSCCCSHHHHHTTTTTTTTCCC
T ss_pred CCCHHHHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHcCCC-ccHHHHHHHHHh----ccCCccHHHHHHHHHhhhccccc
Confidence 5889999999999999999 99999999999999999974 788888877764 46789999999876654433222
Q ss_pred HHHHHHHHHHHHHHcccCCCcccHHHHHHHh---C--CchH-HHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 316 ERWDQIAITAFDYFEQEGNRVISVEELALEL---N--LAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 316 ~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l---~--~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
++.++.||+.||+|++|+|+.+||+++| | ++.+ +.+|++++|.+ ||.|+|+||+++|++..
T Consensus 84 ---~~~l~~aF~~fD~d~~G~I~~~el~~~l~~~g~~ls~~ei~~~~~~~D~~-dG~I~y~EF~~~m~~~~ 150 (153)
T 3i5g_B 84 ---EDALRNAFSMFDEDGQGFIPEDYLKDLLENMGDNFSKEEIKNVWKDAPLK-NKQFNYNKMVDIKGKAE 150 (153)
T ss_dssp ---HHHHHHHHHTTCSSCSSCCCHHHHHHHHHSSSSCCCHHHHHHHHTTCCEE-TTEECHHHHHHHHHCSC
T ss_pred ---HHHHHHHHhccccCCCCeEeHHHHHHHHHHcCCcCCHHHHHHHHHHhCCC-cCEEcHHHHHHHhcCCC
Confidence 4579999999999999999999999999 3 3333 99999999988 99999999999998764
|
| >3qrx_A Centrin; calcium-binding, EF-hand, cell division, calcium binding, ME binding protein-toxin complex; 2.20A {Chlamydomonas reinhardtii} PDB: 2ggm_A 2ami_A 1zmz_A | Back alignment and structure |
|---|
Probab=99.88 E-value=1.9e-21 Score=163.05 Aligned_cols=141 Identities=18% Similarity=0.306 Sum_probs=121.4
Q ss_pred HhcCHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHh
Q 016471 236 KALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEA 314 (389)
Q Consensus 236 ~~l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~ 314 (389)
..+++++...++..|..+|. ++|.|+.+||..++..++. .++..++..++..+|.+++|.|+|+||+..+........
T Consensus 20 ~~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~-~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~ 98 (169)
T 3qrx_A 20 VGLTEEQKQEIREAFDLFDTDGSGTIDAKELKVAMRALGF-EPKKEEIKKMISEIDKDGSGTIDFEEFLTMMTAKMGERD 98 (169)
T ss_dssp CCCCHHHHHHHHHHHHHHCTTCCSEECHHHHHHHHHHTSC-CCCHHHHHHHHHHHCSSSSSSEEHHHHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCC-CCCHHHHHHHHHHhcCCCCCcCCHHHHHHHHHHHhcccC
Confidence 45788899999999999999 9999999999999999987 478999999999999999999999999987665433222
Q ss_pred hHHHHHHHHHHHHHHcccCCCcccHHHHHHHh---C--CchH-HHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 315 LERWDQIAITAFDYFEQEGNRVISVEELALEL---N--LAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 315 ~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l---~--~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
. ...++.+|+.+|+|++|+|+.+||+.++ | +.+. +.++++.+|.|+||.|+|+||+.+|++.+
T Consensus 99 ~---~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~~~~ 167 (169)
T 3qrx_A 99 S---REEILKAFRLFDDDNSGTITIKDLRRVAKELGENLTEEELQEMIAEADRNDDNEIDEDEFIRIMKKTS 167 (169)
T ss_dssp H---HHHHHHHHHHHCTTCSSSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCCSSSSCBCHHHHHHHHC---
T ss_pred c---HHHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCCEeHHHHHHHHHhcc
Confidence 1 4568999999999999999999999998 3 3334 99999999999999999999999998765
|
| >4ds7_A Calmodulin, CAM; protein binding, metal binding, structura; 2.15A {Kluyveromyces lactis} PDB: 1lkj_A 2lhh_A 1f54_A 1f55_A | Back alignment and structure |
|---|
Probab=99.87 E-value=1.9e-21 Score=158.91 Aligned_cols=139 Identities=21% Similarity=0.405 Sum_probs=120.2
Q ss_pred HHhcCHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHH
Q 016471 235 SKALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLE 313 (389)
Q Consensus 235 ~~~l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~ 313 (389)
+..++.++...++..|..+|. ++|.|+.+||..++..++. .++..++..++..+|.+++|.|+|+||+..+.......
T Consensus 2 ~~~l~~~~~~~l~~~F~~~D~~~~G~i~~~e~~~~l~~~~~-~~~~~~~~~l~~~~d~~~~g~i~~~ef~~~~~~~~~~~ 80 (147)
T 4ds7_A 2 SQNLTEEQIAEFKEAFALFDKDNSGSISASELATVMRSLGL-SPSEAEVADLMNEIDVDGNHAIEFSEFLALMSRQLKCN 80 (147)
T ss_dssp --CCCHHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHTTC-CCCHHHHHHHHHHHCTTSSSEEEHHHHHHHHHHHHHTH
T ss_pred CCcCCHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHHhCC-CCCHHHHHHHHHHhccCCCCcCcHHHHHHHHHHhccCC
Confidence 456888999999999999999 9999999999999999887 47899999999999999999999999998765543222
Q ss_pred hhHHHHHHHHHHHHHHcccCCCcccHHHHHHHh---C--CchH-HHHHHHHHccCCCCceeHHHHHHHHcc
Q 016471 314 ALERWDQIAITAFDYFEQEGNRVISVEELALEL---N--LAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHG 378 (389)
Q Consensus 314 ~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l---~--~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~ 378 (389)
.. ++.++.+|+.+|+|++|+|+.+|++.++ | +... +..++..+| |++|.|+|+||+.+|++
T Consensus 81 ~~---~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d-~~dg~i~~~eF~~~l~k 147 (147)
T 4ds7_A 81 DS---EQELLEAFKVFDKNGDGLISAAELKHVLTSIGEKLTDAEVDEMLREVS-DGSGEINIKQFAALLSK 147 (147)
T ss_dssp HH---HHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHS-SSCSSEEHHHHHHHTTC
T ss_pred Cc---HHHHHHHHHHhCCCCCCeECHHHHHHHHHHcCCCCCHHHHHHHHHHhc-CCCCcCcHHHHHHHHhC
Confidence 21 4578999999999999999999999998 3 3334 899999999 99999999999999864
|
| >2f2o_A Calmodulin fused with calmodulin-binding domain of calcineurin; EF-hands, calcium, metal binding protein; 2.17A {Bos taurus} PDB: 2f2p_A | Back alignment and structure |
|---|
Probab=99.87 E-value=2.5e-21 Score=163.99 Aligned_cols=144 Identities=17% Similarity=0.336 Sum_probs=119.1
Q ss_pred HhcCHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHh
Q 016471 236 KALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEA 314 (389)
Q Consensus 236 ~~l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~ 314 (389)
..++.+++..++..|..+|. ++|.|+.+||..++..++.. ++..++..+|..+|.+++|.|+|+||+..+........
T Consensus 3 ~~l~~~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~-~~~~~~~~l~~~~D~~~~g~i~~~EF~~~~~~~~~~~~ 81 (179)
T 2f2o_A 3 DQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQN-PTEAELQDMINEVDADGNGTIDFPEFLTMMARKMKDTD 81 (179)
T ss_dssp ---CCSHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHTTCC-CCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHHHHHH
T ss_pred ccCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCCC-CCHHHHHHHHHHhccCCCCCCcHHHHHHHHHHHccCcc
Confidence 45677788999999999999 99999999999999998874 78899999999999999999999999987655432221
Q ss_pred hHHHHHHHHHHHHHHcccCCCcccHHHHHHHh---C--CchH-HHHHHHHHccCCCCceeHHHHHHHHccccCCC
Q 016471 315 LERWDQIAITAFDYFEQEGNRVISVEELALEL---N--LAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVTVRS 383 (389)
Q Consensus 315 ~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l---~--~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~ 383 (389)
. ...++.+|+.||+|++|+|+.+||+.++ | +... +..++..+|.|++|.|+|+||+.+|.......
T Consensus 82 ~---~~~~~~~F~~~D~d~~G~I~~~E~~~~l~~~g~~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~~~~~~~ 153 (179)
T 2f2o_A 82 S---EEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMTAKGGGG 153 (179)
T ss_dssp H---HHHHHHHHHHHCTTCSSEECHHHHHHHHHHC--CCCHHHHHHHHHHHCTTCSSSEEHHHHHHHSCC-----
T ss_pred c---HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHcCCCCCCcCcHHHHHHHHHHcCCCc
Confidence 1 4568999999999999999999999998 3 3333 99999999999999999999999998776443
|
| >1top_A Troponin C; contractIle system protein; 1.78A {Gallus gallus} SCOP: a.39.1.5 PDB: 1ncy_A 1ncz_A 1ncx_A 1ytz_C* 1yv0_C 1tnw_A 1tnx_A 5tnc_A 2w49_0 2w4u_0 4tnc_A 1a2x_A 1tcf_A 1tn4_A 2tn4_A 1aj4_A 1jc2_A 1fi5_A 1sbj_A 1scv_A ... | Back alignment and structure |
|---|
Probab=99.87 E-value=8.3e-21 Score=157.80 Aligned_cols=147 Identities=19% Similarity=0.336 Sum_probs=125.2
Q ss_pred HHHHHhcCHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchh
Q 016471 232 KALSKALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVY 310 (389)
Q Consensus 232 ~~i~~~l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~ 310 (389)
..+...++.+++..++..|..+|. ++|.|+.+||..++..++. .++..++..++..+|.+++|.|+|+||+..+....
T Consensus 8 ~~~~~~ls~~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~-~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 86 (162)
T 1top_A 8 AEARAFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQ-NPTKEELDAIIEEVDEDGSGTIDFEEFLVMMVRQM 86 (162)
T ss_dssp HHHHHHSCHHHHHHHHHHHHTTTCSCSSEEEGGGHHHHHHHTTC-CCCHHHHHHHHHHHCTTSCCEEEHHHHHHHHHHHH
T ss_pred HHhhhhcCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHcCC-CCCHHHHHHHHHHHcCCCCCcEeHHHHHHHHHHHh
Confidence 345567899999999999999999 9999999999999999886 47899999999999999999999999998765543
Q ss_pred HHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHh---C--CchH-HHHHHHHHccCCCCceeHHHHHHHHccc
Q 016471 311 QLEALERWDQIAITAFDYFEQEGNRVISVEELALEL---N--LAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHGV 379 (389)
Q Consensus 311 ~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l---~--~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~ 379 (389)
...........++.+|+.+|.|++|+|+.+|++.++ | +... +..++..+|.|++|.|+|+||+.+|...
T Consensus 87 ~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~e~~~~l~~~g~~~~~~~~~~~~~~~d~~~dg~i~~~eF~~~~~~~ 161 (162)
T 1top_A 87 KEDAKGKSEEELANCFRIFDKNADGFIDIEELGEILRATGEHVTEEDIEDLMKDSDKNNDGRIDFDEFLKMMEGV 161 (162)
T ss_dssp HHHHHHHHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHTTTCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHSC
T ss_pred ccccccccHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHhhc
Confidence 222111124678999999999999999999999998 3 3333 9999999999999999999999999764
|
| >3fwb_A Cell division control protein 31; gene gating, complex, cell cycle, cell division, mitosis, MR transport, nuclear pore complex, nucleus, phosphoprotein; 2.50A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2gv5_A 2doq_A 3fwc_A | Back alignment and structure |
|---|
Probab=99.86 E-value=3e-21 Score=160.30 Aligned_cols=139 Identities=15% Similarity=0.262 Sum_probs=121.4
Q ss_pred HhcCHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHh
Q 016471 236 KALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEA 314 (389)
Q Consensus 236 ~~l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~ 314 (389)
..++.++...++..|..+|. ++|.|+.+||..++..++. .++..++..++..+|.+++|.|+|+||+..+........
T Consensus 15 ~~l~~~~~~~l~~~F~~~D~~~~G~i~~~e~~~~l~~~~~-~~~~~~~~~l~~~~d~~~~g~i~~~eF~~~~~~~~~~~~ 93 (161)
T 3fwb_A 15 SELLEEQKQEIYEAFSLFDMNNDGFLDYHELKVAMKALGF-ELPKREILDLIDEYDSEGRHLMKYDDFYIVMGEKILKRD 93 (161)
T ss_dssp TTSCHHHHHHHHHHHHHHCTTSSSEECHHHHHHHHHHTTC-CCCHHHHHHHHHHHCTTSSSCEEHHHHHHHHHHHHHTCC
T ss_pred CCCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCC-CCCHHHHHHHHHHhCcCCCCeEeHHHHHHHHHHHHhcCC
Confidence 45788899999999999999 9999999999999999887 478999999999999999999999999987664432222
Q ss_pred hHHHHHHHHHHHHHHcccCCCcccHHHHHHHh---C--CchH-HHHHHHHHccCCCCceeHHHHHHHHcc
Q 016471 315 LERWDQIAITAFDYFEQEGNRVISVEELALEL---N--LAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHG 378 (389)
Q Consensus 315 ~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l---~--~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~ 378 (389)
. ...++.+|+.||.|++|+|+.+||+.++ | +... +..+++.+|.|++|.|+|+||+.+|++
T Consensus 94 ~---~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~ 160 (161)
T 3fwb_A 94 P---LDEIKRAFQLFDDDHTGKISIKNLRRVAKELGETLTDEELRAMIEEFDLDGDGEINENEFIAICTD 160 (161)
T ss_dssp H---HHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHTTCSSSSSSEEHHHHHHHHHH
T ss_pred c---HHHHHHHHHHHcCCCCCeEeHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHhc
Confidence 1 4568999999999999999999999998 3 2333 999999999999999999999999874
|
| >1dtl_A Cardiac troponin C; helix-turn-helix, structural protein; HET: BEP; 2.15A {Gallus gallus} SCOP: a.39.1.5 PDB: 1j1d_A 1j1e_A 2jt3_A 2jt0_A 1la0_A 2jtz_A* 2jt8_A* 2kfx_T* 1wrk_A* 1wrl_A* 1ap4_A 1lxf_C* 1mxl_C 1spy_A 2krd_C* 2l1r_A* 3rv5_A* 2ctn_A 2kgb_C 2jxl_A ... | Back alignment and structure |
|---|
Probab=99.86 E-value=1.7e-21 Score=161.92 Aligned_cols=144 Identities=19% Similarity=0.347 Sum_probs=121.3
Q ss_pred HHhcCHHHHHHHHHHhhhcCC-C-CCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHH
Q 016471 235 SKALTEEELVYLRAQFMLLEP-K-DGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQL 312 (389)
Q Consensus 235 ~~~l~~ee~~~l~~~F~~~D~-~-~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~ 312 (389)
...++++++..++..|..+|. + +|.|+.+||..++..++. .++..++.+++..+|.+++|.|+|+||+..+......
T Consensus 9 ~~~l~~~~~~~l~~~F~~~D~~~~~G~i~~~e~~~~l~~~~~-~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~ 87 (161)
T 1dtl_A 9 VEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQ-NPTPEELQEMIDEVDEDGSGTVDFDEFLVMMVRSMKD 87 (161)
T ss_dssp GGGSCHHHHHHHHHHHHHHTTTCGGGSBCHHHHHHHHHHTTC-CCCHHHHHHHHHHHCTTSSSSBCHHHHHHHHHHHHC-
T ss_pred HhhCCHHHHHHHHHHHHHHcCCCCCCcCcHHHHHHHHHHcCC-CCCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHHhcc
Confidence 456788899999999999999 8 999999999999999886 4789999999999999999999999999876654320
Q ss_pred HhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHhC-----CchH-HHHHHHHHccCCCCceeHHHHHHHHccc
Q 016471 313 EALERWDQIAITAFDYFEQEGNRVISVEELALELN-----LAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHGV 379 (389)
Q Consensus 313 ~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~-----~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~ 379 (389)
.........++.+|+.+|+|++|+|+.+||+.++. +... +..++..+|.|++|.|+|+||+.+|.+.
T Consensus 88 ~~~~~~~~~~~~~F~~~D~d~~G~i~~~El~~~l~~~g~~~~~~~~~~~~~~~D~d~dg~i~~~eF~~~~~~~ 160 (161)
T 1dtl_A 88 DSKGKSEEELSDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKDGDKNNDGRIDYDEFLEFMKGV 160 (161)
T ss_dssp ----CHHHHHHHHHHHHCTTCSSEEEHHHHGGGGTTC--CCCHHHHHHHHHHHCTTSSSEEEHHHHHHHHHC-
T ss_pred cccchHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHcC
Confidence 00001145689999999999999999999999983 2333 9999999999999999999999999764
|
| >3ox6_A Calcium-binding protein 1; EF-hand, calcium-sensor; 2.40A {Homo sapiens} PDB: 3ox5_A 2lan_A 2lap_A 2k7b_A 2k7c_A 2k7d_A | Back alignment and structure |
|---|
Probab=99.86 E-value=2.4e-21 Score=159.28 Aligned_cols=142 Identities=19% Similarity=0.294 Sum_probs=120.1
Q ss_pred HhcCHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHh
Q 016471 236 KALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEA 314 (389)
Q Consensus 236 ~~l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~ 314 (389)
+.++++++..+...|..+|. ++|.|+.+||..++..++. .++..++..++..+|.+++|.|+|+||+..+........
T Consensus 3 ~~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~-~~~~~~~~~l~~~~d~~~~g~i~~~eF~~~~~~~~~~~~ 81 (153)
T 3ox6_A 3 RSLRPEEIEELREAFREFDKDKDGYINCRDLGNCMRTMGY-MPTEMELIELSQQINMNLGGHVDFDDFVELMGPKLLAET 81 (153)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHCSSSCCHHHHHHHHHHTTC-CCCHHHHHHHHHHHHTTSTTCCCHHHHHHHHHHHHTTCC
T ss_pred ccCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCC-CCCHHHHHHHHHHhCCCCCccCcHHHHHHHHHHHhhccc
Confidence 45788899999999999999 9999999999999999987 478999999999999999999999999987643222111
Q ss_pred hH-HHHHHHHHHHHHHcccCCCcccHHHHHHHh----C--CchH-HHHHHHHHccCCCCceeHHHHHHHHcc
Q 016471 315 LE-RWDQIAITAFDYFEQEGNRVISVEELALEL----N--LAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHG 378 (389)
Q Consensus 315 ~~-~~~~~l~~aF~~~D~d~~G~I~~~el~~~l----~--~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~ 378 (389)
.+ ...+.++.+|+.+|+|++|+|+.+||+.++ | +... +..++..+|.|++|.|+|+||+.+|++
T Consensus 82 ~~~~~~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~eF~~~~~k 153 (153)
T 3ox6_A 82 ADMIGVKELRDAFREFDTNGDGEISTSELREAMRALLGHQVGHRDIEEIIRDVDLNGDGRVDFEEFVRMMSR 153 (153)
T ss_dssp HHHHCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHHSSCCCHHHHHHHHHHHCSSSSSSBCHHHHHHHTCC
T ss_pred cccccHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhcCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHhC
Confidence 10 013568999999999999999999999987 3 2333 999999999999999999999999874
|
| >2bl0_C Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} | Back alignment and structure |
|---|
Probab=99.86 E-value=2.2e-21 Score=157.77 Aligned_cols=133 Identities=17% Similarity=0.315 Sum_probs=114.8
Q ss_pred HHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHH
Q 016471 240 EEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERW 318 (389)
Q Consensus 240 ~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~ 318 (389)
+++...++..|..+|. ++|.|+.+||..++..++. .++..++..++..+|.+++|.|+|+||+..+.........
T Consensus 2 ~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~-~~~~~~~~~l~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~--- 77 (142)
T 2bl0_C 2 DDQVSEFKEAFELFDSERTGFITKEGLQTVLKQFGV-RVEPAAFNEMFNEADATGNGKIQFPEFLSMMGRRMKQTTS--- 77 (142)
T ss_dssp CHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHTC-CCCHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHTTCCC---
T ss_pred HHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCC-CCCHHHHHHHHHHhCcCCCCeeeHHHHHHHHHHHhcCCCh---
Confidence 4577889999999999 9999999999999999887 4788999999999999999999999999876542221111
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHh---C--CchH-HHHHHHHHccCCCCceeHHHHHHHHc
Q 016471 319 DQIAITAFDYFEQEGNRVISVEELALEL---N--LAPA-AYSLLNDCIRNSDGKLSFLGYKRFLH 377 (389)
Q Consensus 319 ~~~l~~aF~~~D~d~~G~I~~~el~~~l---~--~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~ 377 (389)
...++.+|+.+|+|++|+|+.+||+.++ | ++.. +..+++.+| |++|.|+|+||+.+|.
T Consensus 78 ~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d-~~dg~i~~~eF~~~~~ 141 (142)
T 2bl0_C 78 EDILRQAFRTFDPEGTGYIPKAALQDALLNLGDRLKPHEFAEFLGITE-TEKGQIRYDNFINTMF 141 (142)
T ss_dssp HHHHHHHHHHTCCSSCSCEEHHHHHHHHHHSSSCCCHHHHHHHHHHHC-CSSSEECSHHHHTTTC
T ss_pred HHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhC-CCCCcEeHHHHHHHHc
Confidence 4568999999999999999999999998 3 3333 999999999 9999999999998875
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=5e-23 Score=204.02 Aligned_cols=128 Identities=23% Similarity=0.295 Sum_probs=107.8
Q ss_pred CCCcccc--cee--ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQ--HLF--YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~--~~~--~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|+||||+ .++ ..+..|+|||||+||+|.+++.. +..++.|++.||+|||++||+||||||+|||++
T Consensus 396 l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~- 465 (540)
T 3en9_A 396 VKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFD- 465 (540)
T ss_dssp GGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEES-
T ss_pred cCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEEC-
Confidence 5799999 666 45678999999999999997743 568999999999999999999999999999994
Q ss_pred cCCCCCEEEeecCCccccCCCCC--------cccccccCCcccccccc---ccCCCchhHHHHHHHHHHHHhCCCCC
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQR--------LNDIVGSAYYVAPEVLH---RSYNVEGDMWSIGVITYILLCGSRPF 142 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~---~~~~~~~DiwslG~il~~ll~g~~pf 142 (389)
. .+||+|||+|+....... ....+||+.|+|||++. ..|+..+|+||.++-..+-..++.+|
T Consensus 466 --~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 466 --K--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp --S--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred --C--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 3 899999999988754321 13568999999999985 35888899999998888887776665
|
| >2jnf_A Troponin C; stretch activated muscle contraction, EF-hand, metal binding protein; NMR {Lethocerus indicus} PDB: 2k2a_A | Back alignment and structure |
|---|
Probab=99.85 E-value=2.4e-21 Score=160.56 Aligned_cols=139 Identities=19% Similarity=0.365 Sum_probs=119.8
Q ss_pred hcCHHHHHHHHHHhhhcC-C-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHH-
Q 016471 237 ALTEEELVYLRAQFMLLE-P-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLE- 313 (389)
Q Consensus 237 ~l~~ee~~~l~~~F~~~D-~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~- 313 (389)
.++++++..++..|..+| . ++|.|+.+||..++..++. .++..++..++..+|.+++|.|+|+||+..+.......
T Consensus 6 ~l~~~~~~~l~~~F~~~D~~~~~G~i~~~e~~~~l~~~~~-~~~~~~~~~l~~~~D~~~~g~i~~~eF~~~~~~~~~~~~ 84 (158)
T 2jnf_A 6 KLSSNQVKLLETAFRDFETPEGSGRVSTDQIGIILEVLGI-QQTKSTIRQLIDEFDPFGNGDIDFDSFKIIGARFLGEEV 84 (158)
T ss_dssp TSCHHHHHHHHHHHHHSBCSSSCSSEEHHHHHHHHHHTTC-SCSHHHHHHHHHHHCTTCCSEECHHHHHHHHHHHCCCCC
T ss_pred hCCHHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHHHhCC-CCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhcccc
Confidence 467888999999999999 8 9999999999999999886 47899999999999999999999999998765432110
Q ss_pred ---hhHHHHHHHHHHHHHHcccCCCcccHHHHHHHh---C--CchH-HHHHHHHHccCCCCceeHHHHHHHHccc
Q 016471 314 ---ALERWDQIAITAFDYFEQEGNRVISVEELALEL---N--LAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHGV 379 (389)
Q Consensus 314 ---~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l---~--~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~ 379 (389)
.. ...++.+|+.||+|++|+|+.+||+.++ | +... +..++..+|.|++|.|+|+||+.+|.+.
T Consensus 85 ~~~~~---~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~D~d~dg~i~~~eF~~~~~~~ 156 (158)
T 2jnf_A 85 NPEQM---QQELREAFRLYDKEGNGYISTDVMREILAELDETLSSEDLDAMIDEIDADGSGTVDFEEFMGVMTGG 156 (158)
T ss_dssp CTTTT---SSTHHHHHHHHCSSSSSSEEHHHHHHHHHHHCTTCCHHHHHHHHHHHCSSCCSEECSHHHHHHTSSC
T ss_pred chhhH---HHHHHHHHHHhCCCCCCeEcHHHHHHHHHHhCCcCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHhcc
Confidence 11 3458999999999999999999999998 3 2333 9999999999999999999999999764
|
| >2mys_B Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1i84_U* 1m8q_B* 1mvw_B* 1o18_E* 1o19_B* 1o1a_B* 1o1b_B* 1o1c_B* 1o1d_B* 1o1e_B* 1o1f_B* 1o1g_B* 2w4a_B 2w4g_B 2w4h_B | Back alignment and structure |
|---|
Probab=99.84 E-value=2.6e-20 Score=155.69 Aligned_cols=139 Identities=10% Similarity=0.211 Sum_probs=117.7
Q ss_pred HHhcCHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhcc-ccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHH
Q 016471 235 SKALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQAT-DAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQL 312 (389)
Q Consensus 235 ~~~l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~-~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~ 312 (389)
...++.++...++..|..+|. ++|.|+.+||..+|..++. . ++..++..++... +|.|+|+||+..+......
T Consensus 16 ~~~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~-~~~~~~~~l~~~~----dg~i~~~eF~~~~~~~~~~ 90 (166)
T 2mys_B 16 FSMFDETEIEDFKEAFTVIDQNADGIIDKDDLRETFAAMGRLN-VKNEELDAMIKEA----SGPINFTVFLTMFGEKLKG 90 (166)
T ss_pred hhhCCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHhCCCC-CCHHHHHHHHHHC----CCCcCHHHHHHHHHHHhcc
Confidence 346788899999999999999 9999999999999999886 4 6888899999865 7999999999876543221
Q ss_pred HhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHh---C--CchH-HHHHHHHHccCCCCceeHHHHHHHHccccC
Q 016471 313 EALERWDQIAITAFDYFEQEGNRVISVEELALEL---N--LAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVTV 381 (389)
Q Consensus 313 ~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l---~--~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~ 381 (389)
... .+.++.+|+.||.|++|+|+.+||+.++ | +... +..++..+|.|+||.|+|+||+.+|.+...
T Consensus 91 ~~~---~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~D~d~dg~I~~~eF~~~~~~~~~ 162 (166)
T 2mys_B 91 ADP---EDVIMGAFKVLDPDGKGSIKKSFLEELLTTGGGRFTPEEIKNMWAAFPPDVAGNVDYKNICYVITHGED 162 (166)
T ss_pred CCc---HHHHHHHHHHhCCCCCcceeHHHHHHHHHHcCCCCCHHHHHHHHHhcCCCCCCeEeHHHHHHHHHhccc
Confidence 111 4568999999999999999999999998 3 2333 999999999999999999999999987654
|
| >1s6i_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=99.84 E-value=8.8e-22 Score=168.50 Aligned_cols=140 Identities=20% Similarity=0.445 Sum_probs=120.0
Q ss_pred hcCHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhh
Q 016471 237 ALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEAL 315 (389)
Q Consensus 237 ~l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~ 315 (389)
.++++++..++..|..+|. ++|.|+.+||..+|..++. .++..++..+|..+|.+++|.|+|+||+..+........
T Consensus 3 ~ls~~~~~~l~~~F~~~D~d~dG~I~~~E~~~~l~~~g~-~~~~~~~~~l~~~~D~d~dG~I~~~EF~~~~~~~~~~~~- 80 (188)
T 1s6i_A 3 RLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGS-ELMESEIKDLMDAADIDKSGTIDYGEFIAATVHLNKLER- 80 (188)
T ss_dssp SSSCTTTCSHHHHHHTTSSSSSSCEEHHHHHHHHTTTTC-CCCHHHHHHHHHHTCTTCSSEECHHHHHHHHTTSSSSCC-
T ss_pred CCCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHcCC-CCCHHHHHHHHHHcCCCCCCeEeHHHHHHHHHHHhccCH-
Confidence 3556677789999999999 9999999999999998886 478899999999999999999999999987654432211
Q ss_pred HHHHHHHHHHHHHHcccCCCcccHHHHHHHh---CCchH-HHHHHHHHccCCCCceeHHHHHHHHccccC
Q 016471 316 ERWDQIAITAFDYFEQEGNRVISVEELALEL---NLAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVTV 381 (389)
Q Consensus 316 ~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l---~~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~ 381 (389)
++.++.+|+.||+|++|+|+.+||+.++ |+.+. +.++++.+|.|++|.|+|+||+.+|.+...
T Consensus 81 ---~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~g~~~~~~~~~~~~~D~d~dG~Is~~EF~~~~~~~~~ 147 (188)
T 1s6i_A 81 ---EENLVSAFSYFDKDGSGYITLDEIQQACKDFGLDDIHIDDMIKEIDQDNDGQIDYGEFAAMMRKRKG 147 (188)
T ss_dssp ---CCSTHHHHHHTTTTCSSEEEHHHHHHTTTTTTCCTTHHHHHHHHHCSSSSSEEETTHHHHTTSCCCS
T ss_pred ---HHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCCCHHHHHHHHHHHCCCCCCcEeHHHHHHHHHHcCC
Confidence 2358999999999999999999999998 44444 999999999999999999999999976553
|
| >3j04_B Myosin regulatory light chain 2, smooth muscle MA isoform; phosphorylation, 2D crystalline arrays, myosin regulation, M light chains, structural protein; 20.00A {Gallus gallus} | Back alignment and structure |
|---|
Probab=99.84 E-value=5e-21 Score=155.83 Aligned_cols=135 Identities=13% Similarity=0.274 Sum_probs=114.4
Q ss_pred cCHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhH
Q 016471 238 LTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALE 316 (389)
Q Consensus 238 l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~ 316 (389)
++++++..++..|..+|. ++|.|+.+||..+|..+|. .++..++..++.. ++|.|+|+||+..+.........
T Consensus 1 ls~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~-~~~~~~~~~~~~~----~~g~i~~~eF~~~~~~~~~~~~~- 74 (143)
T 3j04_B 1 FDQSQIQEFKEAFNMIDQNRDGFIDKEDLHDMLASMGK-NPTDEYLEGMMSE----APGPINFTMFLTMFGEKLNGTDP- 74 (143)
T ss_dssp CCHHHHHHHHHHHTTTCSSCTTCCCHHHHHHHHHHTSC-CCCHHHHHTTTTT----SSSCCCHHHHHHHHHHTTTSSCC-
T ss_pred CCHHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHHhCC-CCCHHHHHHHHHh----CCCCcCHHHHHHHHHHHhccCCc-
Confidence 467889999999999999 9999999999999999987 4788888777766 79999999999876643222211
Q ss_pred HHHHHHHHHHHHHcccCCCcccHHHHHHHh---C--CchH-HHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 317 RWDQIAITAFDYFEQEGNRVISVEELALEL---N--LAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 317 ~~~~~l~~aF~~~D~d~~G~I~~~el~~~l---~--~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
.+.++.+|+.||+|++|+|+.+||+.++ | ++.. +..+++.+|.|++|.|+|+||+.+|++.+
T Consensus 75 --~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~~~~~~D~d~dg~i~~~eF~~~~~~~~ 142 (143)
T 3j04_B 75 --EDVIRNAFACFDEEASGFIHEDHLRELLTTMGDRFTDEEVDEMYREAPIDKKGNFNYVEFTRILKHGA 142 (143)
T ss_dssp --HHHHHHHHTTSCSSSCCCCCTTTHHHHHHTSSSCCCHHHHHHHHHHTTCCSSSCCCSTHHHHHHHSSC
T ss_pred --HHHHHHHHHHHCCCCCCeEcHHHHHHHHHHcCCCCCHHHHHHHHHHcCCCCCCcCcHHHHHHHHhccC
Confidence 3568999999999999999999999999 3 2333 99999999999999999999999998753
|
| >3sjs_A URE3-BP sequence specific DNA binding protein; EF-hand, structural genomics, seattle S genomics center for infectious disease, ssgcid; 1.90A {Entamoeba histolytica} PDB: 3sia_A 3sib_A | Back alignment and structure |
|---|
Probab=99.84 E-value=1.7e-20 Score=164.47 Aligned_cols=142 Identities=9% Similarity=0.138 Sum_probs=121.4
Q ss_pred HHHHHHHHHHhcCHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHH
Q 016471 227 KRAALKALSKALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAA 305 (389)
Q Consensus 227 ~~~~l~~i~~~l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~ 305 (389)
++.....+...++.++...++..|..+|. ++|.|+.+||..++..++. .++..++..++..+|.+++|.|+|+||+..
T Consensus 34 ~~~~~~~~~~~l~~~e~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g~-~~~~~~~~~l~~~~D~d~dg~I~~~EF~~~ 112 (220)
T 3sjs_A 34 RNTWWFPLLNTIPLDQYTRIYQWFMGVDRDRSGTLEINELMMGQFPGGI-RLSPQTALRMMRIFDTDFNGHISFYEFMAM 112 (220)
T ss_dssp HTSTTGGGGGGCCHHHHHHHHHHHHHHCTTCCSSBCHHHHHHCCBGGGB-CCCHHHHHHHHHHHCTTCSSCBCHHHHHHH
T ss_pred HHHHHHHHHhcCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCC-CCCHHHHHHHHHHhCCCCCCcCCHHHHHHH
Confidence 33333445667899999999999999999 9999999999999998886 478999999999999999999999999986
Q ss_pred HhchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHh---C--CchH-HHHHHHHHccCCCCceeHHHHHHHHccc
Q 016471 306 ATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALEL---N--LAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHGV 379 (389)
Q Consensus 306 ~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l---~--~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~ 379 (389)
+... ..++.+|+.||+|++|+|+.+||++++ | +++. +..+++.+| |+||.|+|+||+.+|...
T Consensus 113 ~~~~----------~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~l~~~~d-d~dg~I~~~eF~~~~~~l 181 (220)
T 3sjs_A 113 YKFM----------ELAYNLFVMNARARSGTLEPHEILPALQQLGFYINQRTSLLLHRLFA-RGMAFCDLNCWIAICAFA 181 (220)
T ss_dssp HHHH----------HHHHHHHHHHCCSSTTEECHHHHHHHHHHHTCCCCHHHHHHHHHHHC---CCSEEHHHHHHHHHHH
T ss_pred HHHH----------HHHHHHHHHHCCCCCCCCcHHHHHHHHHHhCCCCCHHHHHHHHHHhc-CCCCcCcHHHHHHHHHHH
Confidence 5432 248899999999999999999999998 3 3333 999999999 999999999999999776
Q ss_pred c
Q 016471 380 T 380 (389)
Q Consensus 380 ~ 380 (389)
.
T Consensus 182 ~ 182 (220)
T 3sjs_A 182 A 182 (220)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >2mys_C Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1m8q_C* 1mvw_C* 1o18_F* 1o19_C* 1o1a_C* 1o1b_C* 1o1c_C* 1o1d_C* 1o1e_C* 1o1f_C* 1o1g_C* | Back alignment and structure |
|---|
Probab=99.83 E-value=5.5e-20 Score=150.49 Aligned_cols=137 Identities=15% Similarity=0.226 Sum_probs=116.6
Q ss_pred cCHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhc---CCCCCcceeHHHHHHHHhchhHHH
Q 016471 238 LTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVM---EPLSDQKLAYEEFCAAATSVYQLE 313 (389)
Q Consensus 238 l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~---d~~~~g~i~~~eF~~~~~~~~~~~ 313 (389)
++++++..++..|..+|. ++|.|+.+||..++..++. .++..++..++..+ |.++ |.|+|+||+..+.......
T Consensus 2 l~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~~~~-~~~~~~~~~l~~~~~~~d~~~-g~i~~~eF~~~~~~~~~~~ 79 (149)
T 2mys_C 2 FSKAAADDFKEAFLLFDRTGDAKITASQVGDIARALGQ-NPTNAEINKILGNPSKEEMNA-AAITFEEFLPMLQAAANNK 79 (149)
T ss_pred CCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCC-CCCHHHHHHHHHHhhhccccC-CcCcHHHHHHHHHHHhccC
Confidence 567888999999999999 9999999999999999987 47889999999999 9999 9999999998765541111
Q ss_pred hhHHHHHHHHHHHHHHcccCCCcccHHHHHHHh---C--CchH-HHHHHHHHccCCCCceeHHHHHHHHcc
Q 016471 314 ALERWDQIAITAFDYFEQEGNRVISVEELALEL---N--LAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHG 378 (389)
Q Consensus 314 ~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l---~--~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~ 378 (389)
.. .....++.+|+.||+|++|+|+.+||+.++ | +... +..+++. |.|++|.|+|+||+.+|.+
T Consensus 80 ~~-~~~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~-d~~~dg~i~~~eF~~~~~~ 148 (149)
T 2mys_C 80 DQ-GTFEDFVEGLRVFDKEGNGTVMGAELRHVLATLGEKMTEEEVEELMKG-QEDSNGCINYEAFVKHIMS 148 (149)
T ss_pred Cc-chHHHHHHHHHHhCCCCCceEcHHHHHHHHHHhCCCCCHHHHHHHHhh-CCCCCCcEeHHHHHHHHhc
Confidence 11 114568999999999999999999999998 3 2333 9999999 9999999999999999875
|
| >1m45_A MLC1P, myosin light chain; protein-peptide complex, myosin light chain, cell cycle protein; 1.65A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 1m46_A 1n2d_A 2fcd_A 2fce_A | Back alignment and structure |
|---|
Probab=99.83 E-value=3.1e-21 Score=158.06 Aligned_cols=133 Identities=17% Similarity=0.185 Sum_probs=109.6
Q ss_pred HHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhc-CCCCCcceeHHHHHHHHhchhHH---HhhHHH
Q 016471 244 VYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVM-EPLSDQKLAYEEFCAAATSVYQL---EALERW 318 (389)
Q Consensus 244 ~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~-d~~~~g~i~~~eF~~~~~~~~~~---~~~~~~ 318 (389)
..++..|..+|. ++|.|+.+||..+|..++. .++..++..++..+ |.+++|.|+|+||+..+...... .... .
T Consensus 4 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~-~~~~~~~~~l~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~-~ 81 (148)
T 1m45_A 4 RANKDIFTLFDKKGQGAIAKDSLGDYLRAIGY-NPTNQLVQDIINADSSLRDASSLTLDQITGLIEVNEKELDATTKA-K 81 (148)
T ss_dssp CCCTTCHHHHCTTCCSEEEGGGHHHHHHHTTC-CCCHHHHHHHHHC--CC--CCEEEHHHHHHHHHHTHHHHHGGGCC-C
T ss_pred HHHHHHHHHHCCCCCCCCCHHHHHHHHHHhCC-CCCHHHHHHHHHHhhCCCCCCeEcHHHHHHHHHHHHhhccccccc-c
Confidence 346778999999 9999999999999999987 47899999999999 99999999999999876655211 0000 1
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHh---CC--chH-HHHHHHHHccCCCCceeHHHHHHHHcc
Q 016471 319 DQIAITAFDYFEQEGNRVISVEELALEL---NL--APA-AYSLLNDCIRNSDGKLSFLGYKRFLHG 378 (389)
Q Consensus 319 ~~~l~~aF~~~D~d~~G~I~~~el~~~l---~~--~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~ 378 (389)
...++.+|+.||+|++|+|+.+||+.++ |. ... +..+++.+|.|++|.|+|+||+.+|.+
T Consensus 82 ~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d~d~dg~i~~~eF~~~~~~ 147 (148)
T 1m45_A 82 TEDFVKAFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAEVDELLKGVEVDSNGEIDYKKFIEDVLR 147 (148)
T ss_dssp THHHHHHHHTTCSSSSSEEEHHHHHHHHHHSTTCCCHHHHHHHHTTCCCCTTSEEEHHHHHHHHHC
T ss_pred HHHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHhc
Confidence 3568999999999999999999999998 32 333 999999999999999999999999864
|
| >2hpk_A Photoprotein berovin; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics, secsg; 2.00A {Beroe abyssicola} | Back alignment and structure |
|---|
Probab=99.83 E-value=2.1e-20 Score=162.40 Aligned_cols=145 Identities=16% Similarity=0.191 Sum_probs=114.2
Q ss_pred HhcCHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccc-cCCHHHHHHHH-------hhcCCCCCcceeHHHHHHHH
Q 016471 236 KALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATD-AMTDSRVFEIL-------NVMEPLSDQKLAYEEFCAAA 306 (389)
Q Consensus 236 ~~l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~-~~~~~~~~~~~-------~~~d~~~~g~i~~~eF~~~~ 306 (389)
..++.+++..++..|..+|. ++|.|+.+||..++..++.. .++..++.+++ ..+|.+++|.|+|+||+..+
T Consensus 28 ~~l~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~~~~~~~~~~~~~~~l~~~~~~lf~~~D~d~dg~i~~~EF~~~~ 107 (208)
T 2hpk_A 28 EDLHPKMLSRLYKRFDTFDLDSDGKMEMDEVLYWPDRMRQLVNATDEQVEKMRDAVRVFFLHKGVEPVNGLLREDWVEAN 107 (208)
T ss_dssp --------CHHHHHHHHHCTTCSSEECHHHHTHHHHHHHHHSCCCHHHHHHHHHHHHHHHHHTTCBTTTBEEGGGHHHHH
T ss_pred HHcCHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHhhcCCCHHHHHHHHHHHHHHHHHhCCCCCCeEcHHHHHHHH
Confidence 34567778899999999999 99999999999999988751 36888999999 99999999999999999876
Q ss_pred hc---h-h--HHH-hhHHHHHHHHHHHHHHcccCCCcccHHHHHHHh---CCchH-HHHHHHHHccCCCCceeHHHHHHH
Q 016471 307 TS---V-Y--QLE-ALERWDQIAITAFDYFEQEGNRVISVEELALEL---NLAPA-AYSLLNDCIRNSDGKLSFLGYKRF 375 (389)
Q Consensus 307 ~~---~-~--~~~-~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l---~~~~~-~~~~~~~~d~~~~g~i~~~ef~~~ 375 (389)
.. . . ... ..+..++.++.+|+.||+|++|+|+.+||+.++ |+.+. +.+++..+|.|+||.|+|+||+.+
T Consensus 108 ~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~Is~~El~~~l~~~g~~~~~~~~~~~~~D~d~dG~I~~~EF~~~ 187 (208)
T 2hpk_A 108 RVFAEAERERERRGEPSLIALLSNSYYDVLDDDGDGTVDVDELKTMMKAFDVPQEAAYTFFEKADTDKSGKLERTELVHL 187 (208)
T ss_dssp HHHHHHHHHHHHTTCCCHHHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHTTSCTTHHHHHHHHHCTTCCSSBCHHHHHHH
T ss_pred HHHhhhhhhhhccCChHHHHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHhCcCHHHHHHHHHHhCCCCCCcCcHHHHHHH
Confidence 41 0 0 111 111113347999999999999999999999988 64444 999999999999999999999999
Q ss_pred Hcccc
Q 016471 376 LHGVT 380 (389)
Q Consensus 376 ~~~~~ 380 (389)
|....
T Consensus 188 ~~~~~ 192 (208)
T 2hpk_A 188 FRKFW 192 (208)
T ss_dssp HHHHH
T ss_pred HHHHh
Confidence 97653
|
| >1w7j_B Myosin light chain 1; motor protein, unconventional myosin, myosin V, chicken, molecular motor, ATPase, ELC, IQ motif, muscle protein, ATP-binding; HET: ADP; 2A {Homo sapiens} SCOP: a.39.1.5 PDB: 1w7i_B* 1oe9_B* 3j04_C 1br1_B* 1br4_B* 1i84_T* 3dtp_C 2w4a_C 2w4g_C 2w4h_C | Back alignment and structure |
|---|
Probab=99.82 E-value=4e-21 Score=157.94 Aligned_cols=138 Identities=16% Similarity=0.278 Sum_probs=109.8
Q ss_pred cCHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCC--CCcceeHHHHHHHHhchhHHHh
Q 016471 238 LTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPL--SDQKLAYEEFCAAATSVYQLEA 314 (389)
Q Consensus 238 l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~--~~g~i~~~eF~~~~~~~~~~~~ 314 (389)
++++++..++..|..+|. ++|.|+.+||..+|..++.. ++..++.+++..+|.+ ++|.|+|+||+..+........
T Consensus 4 ls~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~-~~~~~~~~l~~~~d~~~~~~g~i~~~eF~~~~~~~~~~~~ 82 (151)
T 1w7j_B 4 FNKDQLEEFKEAFELFDRVGDGKILYSQCGDVMRALGQN-PTNAEVLKVLGNPKSDELKSRRVDFETFLPMLQAVAKNRG 82 (151)
T ss_dssp -------CHHHHHHHHCCSSSSEEESTTHHHHHHHTTCC-CCHHHHHHHTTCCCHHHHTTCEEEHHHHHHHHHHHCC---
T ss_pred CCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCCC-CCHHHHHHHHHHhCcCcCCCCcCcHHHHHHHHHHHhccCC
Confidence 567788889999999999 99999999999999998874 7889999999999999 9999999999987654322111
Q ss_pred hHHHHHHHHHHHHHHcccCCCcccHHHHHHHh---C--CchH-HHHHHHHHccCCCCceeHHHHHHHHcc
Q 016471 315 LERWDQIAITAFDYFEQEGNRVISVEELALEL---N--LAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHG 378 (389)
Q Consensus 315 ~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l---~--~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~ 378 (389)
. .....++.+|+.||+|++|+|+.+||+.++ | +... +..+++.+| |++|.|+|+||+.+|.+
T Consensus 83 ~-~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d-~~dg~i~~~eF~~~~~~ 150 (151)
T 1w7j_B 83 Q-GTYEDYLEGFRVFDKEGNGKVMGAELRHVLTTLGEKMTEEEVETVLAGHE-DSNGCINYEAFLKHILS 150 (151)
T ss_dssp ------CCHHHHHTTCTTSSSEEEHHHHHHHHHHSSSCCCHHHHHHHHTTCC-CTTSEEEHHHHHHHTC-
T ss_pred C-CcHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHhcc-CCCCeEeHHHHHHHHhc
Confidence 0 113457889999999999999999999998 3 3333 999999999 99999999999999875
|
| >1wdc_C Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Z 1kqm_C* 1kwo_C* 1l2o_C* 1qvi_Z* 1s5g_Z* 1sr6_C 1b7t_Z 3jvt_C 3jtd_C 1kk8_C* 2ec6_C 1dfk_Z 1dfl_Z* 2w4t_Z 2w4v_Z 2w4w_Z 2otg_C* 2os8_C* 3pn7_C ... | Back alignment and structure |
|---|
Probab=99.82 E-value=2.4e-20 Score=154.17 Aligned_cols=140 Identities=19% Similarity=0.285 Sum_probs=119.4
Q ss_pred hcCHHHHHHHHHHhhhcCC---CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHH-
Q 016471 237 ALTEEELVYLRAQFMLLEP---KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQL- 312 (389)
Q Consensus 237 ~l~~ee~~~l~~~F~~~D~---~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~- 312 (389)
.++++++..++..|..+|. ++|.|+.+||..+|..+|. .++..++.++ ..+|.+++|.|+|+||+..+......
T Consensus 2 ~ls~~~~~~l~~~F~~~D~~~d~~G~i~~~el~~~l~~~g~-~~~~~~~~~l-~~~D~~~~g~i~~~eF~~~~~~~~~~~ 79 (156)
T 1wdc_C 2 KLSQDEIDDLKDVFELFDFWDGRDGAVDAFKLGDVCRCLGI-NPRNEDVFAV-GGTHKMGEKSLPFEEFLPAYEGLMDCE 79 (156)
T ss_dssp -CCHHHHHHHHHHHHHHHHHTCSSSCEEGGGHHHHHHHTTC-CCCHHHHHHT-TCCSSTTSCEECHHHHHHHHHHHTTSC
T ss_pred CCCHHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHcCC-CCCHHHHHHH-HhhCCCCCCeeeHHHHHHHHHHHhhcc
Confidence 3677889999999999995 7999999999999999987 4788999999 99999999999999999876544321
Q ss_pred HhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHh---C--CchH-HHHHHHH--HccCCCCceeHHHHHHHHccccC
Q 016471 313 EALERWDQIAITAFDYFEQEGNRVISVEELALEL---N--LAPA-AYSLLND--CIRNSDGKLSFLGYKRFLHGVTV 381 (389)
Q Consensus 313 ~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l---~--~~~~-~~~~~~~--~d~~~~g~i~~~ef~~~~~~~~~ 381 (389)
... ...++.+|+.||+|++|+|+.+||+.++ | +... +..+++. +|.|++|.|+|+||+.+|.+.+.
T Consensus 80 ~~~---~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~~~D~d~dg~i~~~eF~~~~~~~~~ 153 (156)
T 1wdc_C 80 QGT---FADYMEAFKTFDREGQGFISGAELRHVLTALGERLSDEDVDEIIKLTDLQEDLEGNVKYEDFVKKVMAGPY 153 (156)
T ss_dssp CCC---HHHHHHHHHTTCSSSSSEEEHHHHHHHHHHSSSCCCHHHHHHHHHHHTCCCCTTSEEEHHHHHHHHHHCSC
T ss_pred CCh---HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCCCcEeHHHHHHHHhcCCC
Confidence 111 3568999999999999999999999998 3 2333 9999999 99999999999999999988654
|
| >3e3r_A Calcyphosin, calcyphosine; human calcyphosine, EF-hand, phosphoprotein, calcium binding; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=5e-20 Score=159.34 Aligned_cols=136 Identities=15% Similarity=0.266 Sum_probs=113.6
Q ss_pred HHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHH
Q 016471 240 EEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERW 318 (389)
Q Consensus 240 ~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~ 318 (389)
..++..++..|..+|. ++|.|+.+||..++..++.. ++..++.++|..+|.+++|.|+|+||+..+........
T Consensus 33 ~~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~-~~~~~~~~~~~~~D~d~dg~i~~~ef~~~~~~~~~~~~---- 107 (204)
T 3e3r_A 33 ASGIQGLARFFRQLDRDGSRSLDADEFRQGLAKLGLV-LDQAEAEGVCRKWDRNGSGTLDLEEFLRALRPPMSQAR---- 107 (204)
T ss_dssp -------CHHHHHHCTTCCSSBCHHHHHHHHHTTTCC-CCHHHHHHHHHHHCTTCSSSBCHHHHHHHTSCCCCHHH----
T ss_pred chhHHHHHHHHHHHccCCCCCcCHHHHHHHHHHcCCC-CCHHHHHHHHHHhccCCCCcCcHHHHHHHHHhhcCchH----
Confidence 4567889999999999 99999999999999999874 78999999999999999999999999997665433222
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHhCC------------chH-HHHHHHHHcc-CCCCceeHHHHHHHHcccc
Q 016471 319 DQIAITAFDYFEQEGNRVISVEELALELNL------------APA-AYSLLNDCIR-NSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 319 ~~~l~~aF~~~D~d~~G~I~~~el~~~l~~------------~~~-~~~~~~~~d~-~~~g~i~~~ef~~~~~~~~ 380 (389)
++.++.+|+.+|.|++|+|+.+||+.++.. ... +..+++.+|. |+||.|+|+||+.+|...+
T Consensus 108 ~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~D~~d~dg~Is~~EF~~~~~~~~ 183 (204)
T 3e3r_A 108 EAVIAAAFAKLDRSGDGVVTVDDLRGVYSGRAHPKVRSGEWTEDEVLRRFLDNFDSSEKDGQVTLAEFQDYYSGVS 183 (204)
T ss_dssp HHHHHHHHHHHCTTCSSEECHHHHHHHCCCTTCHHHHTTSSCHHHHHHHHHHHHSCSSCCSCEEHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhCcCCCCeEeHHHHHHHHccccCCccccCCCChHHHHHHHHHHhhccCCCCcCcHHHHHHHHHHcC
Confidence 457899999999999999999999999942 112 8899999998 9999999999999998876
|
| >2ccm_A Calexcitin; EF hand, calcium, signaling protein; 1.8A {Loligo pealeii} | Back alignment and structure |
|---|
Probab=99.82 E-value=1.8e-19 Score=154.15 Aligned_cols=143 Identities=12% Similarity=0.145 Sum_probs=119.1
Q ss_pred hcCHHHHHHHHHHhhhc-CC-CCCcccHHHHHHHHHHh----ccccCCHHHHHHHH-----------hhcCCCCCcceeH
Q 016471 237 ALTEEELVYLRAQFMLL-EP-KDGCVSLNNFKVALMRQ----ATDAMTDSRVFEIL-----------NVMEPLSDQKLAY 299 (389)
Q Consensus 237 ~l~~ee~~~l~~~F~~~-D~-~~G~i~~~el~~~l~~~----~~~~~~~~~~~~~~-----------~~~d~~~~g~i~~ 299 (389)
.++.++...++..|..+ |. ++|.|+.+||..++..+ +. .++..++.+++ ..+|.+++|.|+|
T Consensus 5 ~ls~~~~~~l~~~F~~~~D~d~dG~i~~~E~~~~l~~~~~~~g~-~~~~~~~~~l~~~~~~~~~~~~~~~D~d~dG~i~~ 83 (191)
T 2ccm_A 5 QLSDFQRNKILRVFNTFYDCNHDGVIEWDDFELAIKKICNLHSW-PTDGKKHNEARATLKLIWDGLRKYADENEDEQVTK 83 (191)
T ss_dssp CCCHHHHHHHHHHHHHHTCTTCSSEECHHHHHHHHHHHHHHHTC-CTTSHHHHHHHHHHHHHHHHHHHHHCTTCSSCEEH
T ss_pred hccHHHHHHHHHhccccccCCCCCeeeHHHHHHHHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCeECH
Confidence 45677888999999999 99 99999999999999888 65 36777888888 9999999999999
Q ss_pred HHHHHHHhchhHH---H--hhHHHHHHHHHHHHHHcccCCCcccHHHHHHHh---CCchH-HHHHHHHHccCCCCceeHH
Q 016471 300 EEFCAAATSVYQL---E--ALERWDQIAITAFDYFEQEGNRVISVEELALEL---NLAPA-AYSLLNDCIRNSDGKLSFL 370 (389)
Q Consensus 300 ~eF~~~~~~~~~~---~--~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l---~~~~~-~~~~~~~~d~~~~g~i~~~ 370 (389)
+||+..+...... . ........++.+|+.+|+|++|+|+.+|++.++ |+.+. +..+++.+|.|+||.|+|+
T Consensus 84 ~Ef~~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~dG~I~~~E~~~~l~~~g~~~~~~~~~~~~~D~d~dG~i~~~ 163 (191)
T 2ccm_A 84 EEWLKMWAECVKSVEKGESLPEWLTKYMNFMFDVNDTSGDNIIDKHEYSTVYMSYGIPKSDCDAAFDTLSDGGKTMVTRE 163 (191)
T ss_dssp HHHHHHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHCTTCSSBCCHHHHHHHHHTTTCCHHHHHHHHHHHTTTTTSCCBHH
T ss_pred HHHHHHHHHHhccccchhhchHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCHHHHHHHHHHhCCCCCCCcCHH
Confidence 9999876543210 0 001114568999999999999999999999988 54444 9999999999999999999
Q ss_pred HHHHHHcccc
Q 016471 371 GYKRFLHGVT 380 (389)
Q Consensus 371 ef~~~~~~~~ 380 (389)
||+.+|+...
T Consensus 164 Ef~~~~~~~~ 173 (191)
T 2ccm_A 164 IFARLWTEYF 173 (191)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHh
Confidence 9999997653
|
| >1nya_A Calerythrin; EF-hand, metal binding protein; NMR {Saccharopolyspora erythraea} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=99.82 E-value=1.3e-19 Score=152.66 Aligned_cols=142 Identities=16% Similarity=0.142 Sum_probs=117.5
Q ss_pred CHHHHHHHHHHhhhcCC-CCCcccHHHHHH----HHHHhccccCCHHHHH-----------HHHhhcCCCCCcceeHHHH
Q 016471 239 TEEELVYLRAQFMLLEP-KDGCVSLNNFKV----ALMRQATDAMTDSRVF-----------EILNVMEPLSDQKLAYEEF 302 (389)
Q Consensus 239 ~~ee~~~l~~~F~~~D~-~~G~i~~~el~~----~l~~~~~~~~~~~~~~-----------~~~~~~d~~~~g~i~~~eF 302 (389)
+++++..++..|..+|. ++|.|+.+||.. ++..+|.. ++..++. .+|..+|.+++|.|+|+||
T Consensus 2 s~~~~~~l~~~F~~~D~d~~G~i~~~el~~~~~~~l~~~g~~-~~~~~~~~l~~~~~~~~~~lf~~~D~d~dg~i~~~Ef 80 (176)
T 1nya_A 2 TAIASDRLKKRFDRWDFDGNGALERADFEKEAQHIAEAFGKD-AGAAEVQTLKNAFGGLFDYLAKEAGVGSDGSLTEEQF 80 (176)
T ss_dssp CSHHHHHHHHHHHHCCSSCCSSBCSHHHHHHHHHHHHHTSSC-SSSHHHHHHHHHHHHHHHHHHHHHTSCTTCCBCHHHH
T ss_pred cHHHHHHHHHHHHHHcCCCCCcccHHHHHHHHHHHHHHcCCC-CCcHHHHHHHHHHHHHHHHHHHHhCCCCCCeEcHHHH
Confidence 45678899999999999 999999999999 67777764 6767776 8899999999999999999
Q ss_pred HHHHhchhHHHh----hHHHHHHHHHHHHHHcccCCCcccHHHHHHHh---CCchH-HHHHHHHHccCCCCceeHHHHHH
Q 016471 303 CAAATSVYQLEA----LERWDQIAITAFDYFEQEGNRVISVEELALEL---NLAPA-AYSLLNDCIRNSDGKLSFLGYKR 374 (389)
Q Consensus 303 ~~~~~~~~~~~~----~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l---~~~~~-~~~~~~~~d~~~~g~i~~~ef~~ 374 (389)
+..+........ .+.....++.+|+.+|.|++|+|+.+|++.++ |.... +..+++.+|.|++|.|+|+||+.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~e~~~~l~~~g~~~~~~~~~~~~~D~d~dg~i~~~ef~~ 160 (176)
T 1nya_A 81 IRVTENLIFEQGEASFNRVLGPVVKGIVGMCDKNADGQINADEFAAWLTALGMSKAEAAEAFNQVDTNGNGELSLDELLT 160 (176)
T ss_dssp HHHHHHHHSSSCHHHHHHHHHHHHHHHHHHTCSSCCSEEEHHHHHHHHHHTTCCHHHHHHHHHHHCTTCSSEEEHHHHHH
T ss_pred HHHHHHHhcCCchhhHHHHHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhCCCHHHHHHHHHHhCCCCCCCCcHHHHHH
Confidence 987654322111 00113568999999999999999999999988 54444 99999999999999999999999
Q ss_pred HHccccC
Q 016471 375 FLHGVTV 381 (389)
Q Consensus 375 ~~~~~~~ 381 (389)
+|.....
T Consensus 161 ~~~~~~~ 167 (176)
T 1nya_A 161 AVRDFHF 167 (176)
T ss_dssp HHSCCSS
T ss_pred HHHHHhc
Confidence 9988764
|
| >2sas_A Sarcoplasmic calcium-binding protein; 2.40A {Branchiostoma lanceolatum} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=99.82 E-value=1.8e-19 Score=152.98 Aligned_cols=142 Identities=15% Similarity=0.191 Sum_probs=117.8
Q ss_pred cCHHHHHHHHHHhhhc-CC-CCCcccHHHHHHHHHHhc----cccCCHHHHHHH-----------HhhcCCCCCcceeHH
Q 016471 238 LTEEELVYLRAQFMLL-EP-KDGCVSLNNFKVALMRQA----TDAMTDSRVFEI-----------LNVMEPLSDQKLAYE 300 (389)
Q Consensus 238 l~~ee~~~l~~~F~~~-D~-~~G~i~~~el~~~l~~~~----~~~~~~~~~~~~-----------~~~~d~~~~g~i~~~ 300 (389)
+++++...++..|..+ |. ++|.|+.+||..++..++ . .++..++.++ |..+|.+++|.|+|+
T Consensus 2 ls~~~~~~l~~~F~~~~D~d~dG~i~~~E~~~~l~~~~~~~~~-~~~~~~~~~l~~~~~~~~~~~f~~~D~d~dG~I~~~ 80 (185)
T 2sas_A 2 LNDFQKQKIKFTFDFFLDMNHDGSIQDNDFEDMMTRYKEVNKG-SLSDADYKSMQASLEDEWRDLKGRADINKDDVVSWE 80 (185)
T ss_dssp CCHHHHHHHHHHHHHHTCTTCSSEECHHHHHHHHHHHHHHHGG-GSCHHHHHHHHHHHHHHHHHHHHHHCTTCSSCEEHH
T ss_pred cCHHHHHHHHHHHHHheeCCCCCeEcHHHHHHHHHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHhcCCCCCCeEcHH
Confidence 4667888999999999 99 999999999999998887 4 4677777755 999999999999999
Q ss_pred HHHHHHhchhHH---Hh--hHHHHHHHHHHHHHHcccCCCcccHHHHHHHh---CCchH-HHHHHHHHccCCCCceeHHH
Q 016471 301 EFCAAATSVYQL---EA--LERWDQIAITAFDYFEQEGNRVISVEELALEL---NLAPA-AYSLLNDCIRNSDGKLSFLG 371 (389)
Q Consensus 301 eF~~~~~~~~~~---~~--~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l---~~~~~-~~~~~~~~d~~~~g~i~~~e 371 (389)
||+.++...... .. ....+..++.+|+.+|+|++|+|+.+|++.++ |.+.. +.++++.+|.|++|.|+|+|
T Consensus 81 Ef~~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~dG~Is~~E~~~~l~~~g~~~~~~~~~~~~~D~d~dG~i~~~e 160 (185)
T 2sas_A 81 EYLAMWEKTIATCKSVADLPAWCQNRIPFLFKGMDVSGDGIVDLEEFQNYCKNFQLQCADVPAVYNVITDGGKVTFDLNR 160 (185)
T ss_dssp HHHHHHHHHHHTCCSGGGSCTTHHHHHHHHHHHHCTTSSSCCCHHHHHHHTTSSCCCCSSHHHHHHHHHTTTTSCCSHHH
T ss_pred HHHHHHHHHhccccchhhhhHHHHHHHHHHHHHHcCCCCCeEcHHHHHHHHHHhCCCHHHHHHHHHHhcCCCCCcCcHHH
Confidence 999876544221 00 00113568999999999999999999999999 43344 99999999999999999999
Q ss_pred HHHHHcccc
Q 016471 372 YKRFLHGVT 380 (389)
Q Consensus 372 f~~~~~~~~ 380 (389)
|+.+|+...
T Consensus 161 f~~~~~~~~ 169 (185)
T 2sas_A 161 YKELYYRLL 169 (185)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHh
Confidence 999997754
|
| >1wdc_B Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Y 1kqm_B* 1kwo_B* 1l2o_B* 1qvi_Y* 1s5g_Y* 1sr6_B 1b7t_Y 3jtd_B 3jvt_B 1scm_B 1kk8_B* 1dfk_Y 1dfl_Y* 2w4t_Y 2w4v_Y 2w4w_Y 2otg_B* 2os8_B* 3pn7_B ... | Back alignment and structure |
|---|
Probab=99.82 E-value=9.4e-20 Score=150.67 Aligned_cols=139 Identities=14% Similarity=0.284 Sum_probs=113.9
Q ss_pred HHHHhcCHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhH
Q 016471 233 ALSKALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQ 311 (389)
Q Consensus 233 ~i~~~l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~ 311 (389)
.+...++.++...++..|..+|. ++|.|+.+||..+|..+|. .++..++..++. +++|.|+|+||+..+.....
T Consensus 7 ~~~~~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~-~~~~~~~~~~~~----~~~g~i~~~eF~~~~~~~~~ 81 (156)
T 1wdc_B 7 GVLTKLPQKQIQEMKEAFSMIDVDRDGFVSKEDIKAISEQLGR-APDDKELTAMLK----EAPGPLNFTMFLSIFSDKLS 81 (156)
T ss_dssp -----CCHHHHHHHHHHHHHHCTTCSSSCCHHHHHHHHHHHSS-CCCHHHHHHHHT----TSSSCCCHHHHHHHHHHHTC
T ss_pred chhccCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCC-CCCHHHHHHHHH----hCCCcCcHHHHHHHHHHHhc
Confidence 34556788899999999999999 9999999999999999986 478888888886 46899999999987654321
Q ss_pred HHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHh---C--CchH-HHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 312 LEALERWDQIAITAFDYFEQEGNRVISVEELALEL---N--LAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 312 ~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l---~--~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
.... .+.++.+|+.||+|++|+|+.+||+.++ | +... +..+++.+|.| +|.|+|+||+.+|.+..
T Consensus 82 ~~~~---~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d~~-dg~i~~~eF~~~~~~~~ 152 (156)
T 1wdc_B 82 GTDS---EETIRNAFAMFDEQETKKLNIEYIKDLLENMGDNFNKDEMRMTFKEAPVE-GGKFDYVKFTAMIKGSG 152 (156)
T ss_dssp SCCC---HHHHHHHHHTTCTTCCSCEEHHHHHHHHHHSSSCCCHHHHHHHHHHCCEE-TTEECHHHHHHHHHTSC
T ss_pred CCCh---HHHHHHHHHHHCcCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHhcCCC-CCEEeHHHHHHHHhcCc
Confidence 1111 3568999999999999999999999998 3 2333 99999999999 99999999999998754
|
| >1qv0_A Obelin, OBL; photoprotein, bioluminescence, atomic resolution, Ca binding, EF-hand, luminescent protein; HET: CZH; 1.10A {Obelia longissima} SCOP: a.39.1.5 PDB: 1qv1_A* 1sl9_A* 1el4_A* 2f8p_A* 1sl7_A 1jf2_A* 1s36_A* 1jf0_A* 3kpx_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=3.7e-20 Score=158.89 Aligned_cols=145 Identities=13% Similarity=0.148 Sum_probs=112.0
Q ss_pred HHhcCHHHHHHHHHHhhhcCC-CCCcccHHHHH-----HHHHHhccccCCHH-----HHHHHHhhcCCCCCcceeHHHHH
Q 016471 235 SKALTEEELVYLRAQFMLLEP-KDGCVSLNNFK-----VALMRQATDAMTDS-----RVFEILNVMEPLSDQKLAYEEFC 303 (389)
Q Consensus 235 ~~~l~~ee~~~l~~~F~~~D~-~~G~i~~~el~-----~~l~~~~~~~~~~~-----~~~~~~~~~d~~~~g~i~~~eF~ 303 (389)
...++++++..++..|..+|. ++|.|+.+||. .++..+|.. ++.. ++.+++..+|.+++|.|+|+||+
T Consensus 11 ~~~~s~~~~~~l~~~F~~~D~d~~G~i~~~El~~~~~~~~l~~~g~~-~~~~~~~~~~~~~l~~~~D~d~~g~i~~~EF~ 89 (195)
T 1qv0_A 11 TDFDNPRWIKRHKHMFDFLDINGNGKITLDEIVSKASDDICAKLEAT-PEQTKRHQVCVEAFFRGCGMEYGKEIAFPQFL 89 (195)
T ss_dssp CCTTCHHHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHTHHHHTTCC-HHHHHHHHHHHHHHHHHTTCCTTCCBCHHHHH
T ss_pred cccCCHHHHHHHHHHHhHcCCCCCCcCcHHHHHHHHHHHHHHHcCCC-ccHHHHHHHHHHHHHHHcCCCCCceEcHHHHH
Confidence 344588899999999999999 99999999999 677777753 3444 58999999999999999999999
Q ss_pred HHHhchhHHHh-----h--HHHHHHHHHHHHHHcccCCCcccHHHHHHHh---CC--chH-HHHHHHHHccCCCCceeHH
Q 016471 304 AAATSVYQLEA-----L--ERWDQIAITAFDYFEQEGNRVISVEELALEL---NL--APA-AYSLLNDCIRNSDGKLSFL 370 (389)
Q Consensus 304 ~~~~~~~~~~~-----~--~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l---~~--~~~-~~~~~~~~d~~~~g~i~~~ 370 (389)
..+........ . +.....+..+|+.||+|++|+|+.+||+.++ |. ... +.++++.+|.|++|.|+|+
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~~~~~~D~d~dg~i~~~ 169 (195)
T 1qv0_A 90 DGWKQLATSELKKWARNEPTLIREWGDAVFDIFDKDGSGTITLDEWKAYGKISGISPSQEDCEATFRHCDLDNAGDLDVD 169 (195)
T ss_dssp HHHHHHHHHHHHHHHTTCCCHHHHHHHHHHHHTC----CEECHHHHHHHHHHHSSCCCHHHHHHHHHHSCCCTTSCEEHH
T ss_pred HHHHHHHhhhhhcccccHHHHHHHHHHHHHHHhcCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCCHH
Confidence 86554322110 0 0011223389999999999999999999998 43 333 9999999999999999999
Q ss_pred HHHHHHcccc
Q 016471 371 GYKRFLHGVT 380 (389)
Q Consensus 371 ef~~~~~~~~ 380 (389)
||+.+|....
T Consensus 170 eF~~~~~~~~ 179 (195)
T 1qv0_A 170 EMTRQHLGFW 179 (195)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHc
Confidence 9999997653
|
| >2bl0_B Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} | Back alignment and structure |
|---|
Probab=99.82 E-value=9e-20 Score=148.56 Aligned_cols=129 Identities=19% Similarity=0.285 Sum_probs=110.8
Q ss_pred HHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchh-HHHhhHHHHHHHH
Q 016471 246 LRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVY-QLEALERWDQIAI 323 (389)
Q Consensus 246 l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~-~~~~~~~~~~~l~ 323 (389)
++..|..+|. ++|.|+.+||..++..++. .++..++..++.. +++|.|+|+||+..+.... ..... ...++
T Consensus 7 l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~-~~~~~~~~~~~~~---~~~g~i~~~eF~~~~~~~~~~~~~~---~~~l~ 79 (145)
T 2bl0_B 7 IQECFQIFDKDNDGKVSIEELGSALRSLGK-NPTNAELNTIKGQ---LNAKEFDLATFKTVYRKPIKTPTEQ---SKEML 79 (145)
T ss_dssp HHHHHHHHCTTCSSCEEGGGHHHHHHHTTC-CCCHHHHHHHHHH---HTSSEECHHHHHHHHTSCCCCGGGG---HHHHH
T ss_pred HHHHHHHhCCCCcCccCHHHHHHHHHHhCC-CCCHHHHHHHHHh---cCCCeEcHHHHHHHHHHHhhcCccc---HHHHH
Confidence 8899999999 9999999999999999987 4788899999988 7899999999999776542 11111 45689
Q ss_pred HHHHHHcccCCCcccHHHHHHHh---C--CchH-HHHHHHHHccCCCCceeHHHHHHHHccccC
Q 016471 324 TAFDYFEQEGNRVISVEELALEL---N--LAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVTV 381 (389)
Q Consensus 324 ~aF~~~D~d~~G~I~~~el~~~l---~--~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~ 381 (389)
.+|+.+|+|++|+|+.+|++.++ | +... +..+++.+|.|++|.|+|+||+.+|.+...
T Consensus 80 ~~F~~~D~d~~G~i~~~e~~~~l~~~g~~~~~~~~~~~~~~~d~~~dg~i~~~eF~~~~~~~~~ 143 (145)
T 2bl0_B 80 DAFRALDKEGNGTIQEAELRQLLLNLGDALTSSEVEELMKEVSVSGDGAINYESFVDMLVTGYP 143 (145)
T ss_dssp HHHHHHCSSSSSEEEHHHHHHHHHHSSSCCCHHHHHHHHTTCCCCTTSEEEHHHHHHHHHHSSC
T ss_pred HHHHHhCCCCCCeEcHHHHHHHHHHcCCCCCHHHHHHHHHHcCCCCCCcEeHHHHHHHHHhcCC
Confidence 99999999999999999999998 3 2333 999999999999999999999999987543
|
| >1q80_A SCP, sarcoplasmic calcium-binding protein; all-alpha, metal binding protein; NMR {Neanthes diversicolor} SCOP: a.39.1.5 PDB: 2scp_A | Back alignment and structure |
|---|
Probab=99.82 E-value=2.2e-19 Score=151.09 Aligned_cols=139 Identities=14% Similarity=0.143 Sum_probs=114.3
Q ss_pred CHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhc----cccCCHHH-H--------HHHHhhcCCCCCcceeHHHHHH
Q 016471 239 TEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQA----TDAMTDSR-V--------FEILNVMEPLSDQKLAYEEFCA 304 (389)
Q Consensus 239 ~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~----~~~~~~~~-~--------~~~~~~~d~~~~g~i~~~eF~~ 304 (389)
++++...++..|..+|. ++|.|+.+||..++..++ . .++..+ + .+++..+| ++|.|+|+||+.
T Consensus 1 s~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~~~~~~g~-~~~~~~~~~~~~~~~~~~l~~~~D--~~g~i~~~EF~~ 77 (174)
T 1q80_A 1 SDLWVQKMKTYFNRIDFDKDGAITRMDFESMAERFAKESEM-KAEHAKVLMDSLTGVWDNFLTAVA--GGKGIDETTFIN 77 (174)
T ss_dssp CHHHHHHHHHHHHHHCTTCSSEESHHHHHHHHHHHHHHSSC-CTTHHHHHHHHHHHHHHHTGGGTT--TTSCEEHHHHHH
T ss_pred CHHHHHHHHHHHHhcCCCCCCcEeHHHHHHHHHHHHHHhCC-CCCcHHHHHHHHHHHHHHHHHhcC--CCCeEcHHHHHH
Confidence 35678889999999999 999999999999999887 4 466666 5 46788898 899999999998
Q ss_pred HHhchhHHHh-hHHHHHHHHHHHHHHcccCCCcccHHHHHHHh---CCchH-HHHHHHHHccCCCCceeHHHHHHHHccc
Q 016471 305 AATSVYQLEA-LERWDQIAITAFDYFEQEGNRVISVEELALEL---NLAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHGV 379 (389)
Q Consensus 305 ~~~~~~~~~~-~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l---~~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~ 379 (389)
.+........ .......++.+|+.+|+|++|+|+.+|++.++ |+... +..+++.+|.|++|.|+|+||+.+|.+.
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~g~~~~~~~~~~~~~D~d~dg~i~~~ef~~~~~~~ 157 (174)
T 1q80_A 78 SMKEMVKNPEAKSVVEGPLPLFFRAVDTNEDNNISRDEYGIFFGMLGLDKTMAPASFDAIDTNNDGLLSLEEFVIAGSDF 157 (174)
T ss_dssp HHHHHTTSTTCHHHHHTHHHHHHHHHCTTSSSSBCHHHHHHHHHHHTCCGGGHHHHHHHHCTTCSSSBCHHHHHHHHHHH
T ss_pred HHHHHcCcccHHHHHHHHHHHHHHHhCCCCCCcccHHHHHHHHHHcCCCHHHHHHHHHHhCCCCCceEeHHHHHHHHHHH
Confidence 6655432100 00113568999999999999999999999998 66655 9999999999999999999999999765
Q ss_pred c
Q 016471 380 T 380 (389)
Q Consensus 380 ~ 380 (389)
.
T Consensus 158 ~ 158 (174)
T 1q80_A 158 F 158 (174)
T ss_dssp H
T ss_pred h
Confidence 3
|
| >2lvv_A Flagellar calcium-binding protein TB-24; EF-hand, metal binding protein; NMR {Trypanosoma brucei brucei} | Back alignment and structure |
|---|
Probab=99.81 E-value=1.5e-20 Score=165.73 Aligned_cols=141 Identities=11% Similarity=0.107 Sum_probs=115.8
Q ss_pred HHhcCHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHH-hccccCCHHHHHHHHhhc---------CCCCCcceeHHHHH
Q 016471 235 SKALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMR-QATDAMTDSRVFEILNVM---------EPLSDQKLAYEEFC 303 (389)
Q Consensus 235 ~~~l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~-~~~~~~~~~~~~~~~~~~---------d~~~~g~i~~~eF~ 303 (389)
...++.++...++..|..+|. ++|.|+.+||..++.. ++. .++..++..++..+ |.+++|.|+|+||+
T Consensus 42 ~~~ls~~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~lg~-~~~~~~~~~~~~~~f~~~~~~~~D~d~~G~I~~~EF~ 120 (226)
T 2lvv_A 42 PRDKDAESKSRRIELFKQFDTNGTGKLGFREVLDGCYGILKL-DEFTTHLPDIVQRAFDKAKDLGNKVKGVGEEDLVEFL 120 (226)
T ss_dssp CSSCCHHHHHHHHHHHHHHGGGSCSCBCSHHHHHHHHHTTCC-TTTSSSCHHHHHHHHHHHHHHHHHHSCCCCCSCBCHH
T ss_pred chhCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHhCC-CCCHHHHHHHHHHHHHHhcccCCCCCCCCcCCHHHHH
Confidence 345688999999999999999 9999999999995544 454 35556677777766 99999999999999
Q ss_pred HHHhchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHh------CCchH-HHHHHHHHccCCCCceeHHHHHHHH
Q 016471 304 AAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALEL------NLAPA-AYSLLNDCIRNSDGKLSFLGYKRFL 376 (389)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l------~~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~ 376 (389)
..+........ ++.++.+|+.||+|++|+|+.+||+.++ |...+ +.++|..+|.|+||.|+|+||+.+|
T Consensus 121 ~~~~~~~~~~~----~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~~~g~~~~e~~~~~~~~D~d~dG~Is~~EF~~~~ 196 (226)
T 2lvv_A 121 EFRLMLCYIYD----IFELTVMFDTMDKDGSLLLELQEFKEALPKLKEWGVDITDATTVFNEIDTNGSGVVTFDEFSCWA 196 (226)
T ss_dssp HHHHHHHHHHH----HHHHHHHHHHHSCSSCCEECHHHHHHHHHHHHHHTCCCCSCHHHHHHHCCSCSSCEEHHHHHHHH
T ss_pred HHHHHHHhccC----HHHHHHHHHHHcCCCCCeEcHHHHHHHHHHHhhcCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHH
Confidence 86444333322 4578999999999999999999999998 44434 9999999999999999999999999
Q ss_pred cccc
Q 016471 377 HGVT 380 (389)
Q Consensus 377 ~~~~ 380 (389)
.+..
T Consensus 197 ~~~~ 200 (226)
T 2lvv_A 197 VTKK 200 (226)
T ss_dssp HHHH
T ss_pred HhcC
Confidence 6543
|
| >3ll8_B Calcineurin subunit B type 1; protein-peptide docking, protein targeting, AKA beta-augmentation, calmodulin-binding, membrane, hydrolase; 2.00A {Homo sapiens} PDB: 1mf8_B* 2p6b_B 1aui_B 1m63_B* 1tco_B* | Back alignment and structure |
|---|
Probab=99.81 E-value=8.9e-20 Score=150.36 Aligned_cols=135 Identities=18% Similarity=0.347 Sum_probs=111.1
Q ss_pred HHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHH
Q 016471 240 EEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERW 318 (389)
Q Consensus 240 ~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~ 318 (389)
++++..++..|..+|. ++|.|+.+|| .++..++.. .++.+++..+|.+++|.|+|+||+..+.........
T Consensus 2 ~~~~~~l~~~F~~~D~d~~G~i~~~el-~~l~~~~~~----~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~--- 73 (155)
T 3ll8_B 2 ADEIKRLGKRFKKLDLDNSGSLSVEEF-MSLPELQQN----PLVQRVIDIFDTDGNGEVDFKEFIEGVSQFSVKGDK--- 73 (155)
T ss_dssp CHHHHHHHHHHHHHCTTCSSSBCHHHH-TTSGGGTTC----TTHHHHHHHHCTTCSSSBCHHHHHHHHGGGCSSCCH---
T ss_pred HHHHHHHHHHHHHhCcCCCCeEcHHHH-HHhhccccc----hHHHHHHHHHCCCCCCcCcHHHHHHHHHHHcccCCH---
Confidence 4678899999999999 9999999999 566666542 268899999999999999999999977654322111
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHhCC------chH-HHHHHHH----HccCCCCceeHHHHHHHHccccCC
Q 016471 319 DQIAITAFDYFEQEGNRVISVEELALELNL------APA-AYSLLND----CIRNSDGKLSFLGYKRFLHGVTVR 382 (389)
Q Consensus 319 ~~~l~~aF~~~D~d~~G~I~~~el~~~l~~------~~~-~~~~~~~----~d~~~~g~i~~~ef~~~~~~~~~~ 382 (389)
.+.++.+|+.+|+|++|+|+.+||+.++.. ... +.++++. +|.|++|.|+|+||+.+|......
T Consensus 74 ~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~~~~~~ 148 (155)
T 3ll8_B 74 EQKLRFAFRIYDMDKDGYISNGELFQVLKMMVGNNLKDTQLQQIVDKTIINADKDGDGRISFEEFCAVVGGLDIH 148 (155)
T ss_dssp HHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHHGGGSCHHHHHHHHHHHHHHHCTTSSSSBCHHHHHHHHGGGCGG
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhccCCCHHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHhccCch
Confidence 456899999999999999999999998822 222 6777777 999999999999999999987643
|
| >1s6c_A KV4 potassium channel-interacting protein kchip1B; EF-hand, transport protein; 2.00A {Rattus norvegicus} SCOP: a.39.1.5 PDB: 2nz0_A 2i2r_E | Back alignment and structure |
|---|
Probab=99.81 E-value=3e-19 Score=151.67 Aligned_cols=140 Identities=15% Similarity=0.193 Sum_probs=118.1
Q ss_pred hcCHHHHHHHHHHhhhcCCCCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhH
Q 016471 237 ALTEEELVYLRAQFMLLEPKDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALE 316 (389)
Q Consensus 237 ~l~~ee~~~l~~~F~~~D~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~ 316 (389)
.++.+++..+...|...| ++|.|+.+||..++..++....+..++.++|..+|.+++|.|+|+||+.++........
T Consensus 14 ~~s~~~i~~l~~~fd~~d-~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~f~~~D~d~~g~i~~~Ef~~~~~~~~~~~~-- 90 (183)
T 1s6c_A 14 NFTKRELQVLYRGFKNEX-PSGVVNEETFKQIYAQFFPHGDASTYAHYLFNAFDTTQTGSVKFEDFVTALSILLRGTV-- 90 (183)
T ss_dssp SCCHHHHHHHHHHHHHHC-TTSEECHHHHHHHHHHHSTTSCCHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHCCH--
T ss_pred CCCHHHHHHHHHHHHHhC-CCCcCCHHHHHHHHHHHcCCCChHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHHcCCCH--
Confidence 567888888888888765 68999999999999988764468889999999999999999999999987665432222
Q ss_pred HHHHHHHHHHHHHcccCCCcccHHHHHHHh-------C------Cch----H-HHHHHHHHccCCCCceeHHHHHHHHcc
Q 016471 317 RWDQIAITAFDYFEQEGNRVISVEELALEL-------N------LAP----A-AYSLLNDCIRNSDGKLSFLGYKRFLHG 378 (389)
Q Consensus 317 ~~~~~l~~aF~~~D~d~~G~I~~~el~~~l-------~------~~~----~-~~~~~~~~d~~~~g~i~~~ef~~~~~~ 378 (389)
++.++.+|+.+|.|++|+|+.+|+..++ | ... . +.++++.+|.|++|.|+|+||+.+|.+
T Consensus 91 --~~~~~~~f~~~D~d~~G~i~~~e~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~i~~~Ef~~~~~~ 168 (183)
T 1s6c_A 91 --HEKLRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVLKEDTPRQHVDVFFQKMDKNKDGIVTLDEFLESXQE 168 (183)
T ss_dssp --HHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHHTC-----------CHHHHHHHHHHHCTTCSSEECHHHHHHHTTS
T ss_pred --HHHHHHHHHHhCCCCCCeEcHHHHHHHHHHHHHHhccccCcCccHHHHHHHHHHHHHHhCCCCCCcEeHHHHHHHHhc
Confidence 4578999999999999999999999987 3 111 3 889999999999999999999999987
Q ss_pred ccC
Q 016471 379 VTV 381 (389)
Q Consensus 379 ~~~ 381 (389)
.+.
T Consensus 169 ~~~ 171 (183)
T 1s6c_A 169 DDN 171 (183)
T ss_dssp CCH
T ss_pred ChH
Confidence 653
|
| >1uhk_A Aequorin 2, aequorin; EF-hand motif, complex, luminescent protein; HET: CZN; 1.60A {Aequorea victoria} SCOP: a.39.1.5 PDB: 1ej3_A* 1uhi_A* 1uhj_A* 1uhh_A* 1sl8_A | Back alignment and structure |
|---|
Probab=99.81 E-value=2.6e-19 Score=152.93 Aligned_cols=142 Identities=12% Similarity=0.123 Sum_probs=114.2
Q ss_pred cCHHHHHHHHHHhhhcCC-CCCcccHHHHH-----HHHHHhccccCCHH-----HHHHHHhhcCCCCCcceeHHHHHHHH
Q 016471 238 LTEEELVYLRAQFMLLEP-KDGCVSLNNFK-----VALMRQATDAMTDS-----RVFEILNVMEPLSDQKLAYEEFCAAA 306 (389)
Q Consensus 238 l~~ee~~~l~~~F~~~D~-~~G~i~~~el~-----~~l~~~~~~~~~~~-----~~~~~~~~~d~~~~g~i~~~eF~~~~ 306 (389)
.++++...++..|..+|. ++|.|+.+||. .++..+|.. ++.. ++..++..+|.+++|.|+|+||+..+
T Consensus 10 ~~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~~~~~~l~~~g~~-~~~~~~~~~~~~~l~~~~D~d~~g~i~~~EF~~~~ 88 (191)
T 1uhk_A 10 DNPRWIGRHKHMFNFLDVNHNGKISLDEMVYKASDIVINNLGAT-PEQAKRHKDAVEAFFGGAGMKYGVETDWPAYIEGW 88 (191)
T ss_dssp TCHHHHHHHHHHHHHHCTTCCSEEEHHHHHHHHHHHHHHTSCCC-HHHHHHHHHHHHHHHHHTTCCTTCEEEHHHHHHHH
T ss_pred CCHHHHHHHHHHHhhccCCCCCcCcHHHHHHHHHHHHHHHcCCC-chhHHHHHHHHHHHHHHhCcCCCCcCcHHHHHHHH
Confidence 367788899999999999 99999999999 778777753 4555 68999999999999999999999866
Q ss_pred hchhHHHhh---HHHHHHH----HHHHHHHcccCCCcccHHHHHHHh---CC--chH-HHHHHHHHccCCCCceeHHHHH
Q 016471 307 TSVYQLEAL---ERWDQIA----ITAFDYFEQEGNRVISVEELALEL---NL--APA-AYSLLNDCIRNSDGKLSFLGYK 373 (389)
Q Consensus 307 ~~~~~~~~~---~~~~~~l----~~aF~~~D~d~~G~I~~~el~~~l---~~--~~~-~~~~~~~~d~~~~g~i~~~ef~ 373 (389)
......... ....+.+ +.+|+.+|+|++|+|+.+||+.++ |. ... +..++..+|.|++|.|+|+||+
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~Is~~El~~~l~~~g~~~~~~~~~~~~~~~D~d~dG~i~~~eF~ 168 (191)
T 1uhk_A 89 KKLATDELEKYAKNEPTLIRIWGDALFDIVDKDQNGAITLDEWKAYTKAAGIIQSSEDCEETFRVCDIDESGQLDVDEMT 168 (191)
T ss_dssp HHHHHHHHHHHHTTCCCHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTSCCSHHHHHHHHHHSCCCTTSCEEHHHHH
T ss_pred HHHhcchhhhhhhhhHHHHHHHHHHHHHHhcCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCcHHHHH
Confidence 543221100 0001123 389999999999999999999998 43 333 9999999999999999999999
Q ss_pred HHHcccc
Q 016471 374 RFLHGVT 380 (389)
Q Consensus 374 ~~~~~~~ 380 (389)
.+|...-
T Consensus 169 ~~~~~~~ 175 (191)
T 1uhk_A 169 RQHLGFW 175 (191)
T ss_dssp HHHHHHH
T ss_pred HHHHHHh
Confidence 9998643
|
| >3sg6_A Gcamp2, myosin light chain kinase, green fluorescent PROT calmodulin chimera; calcium sensor, fluorescent protein; HET: CRO; 1.70A {Gallus gallus} PDB: 3evu_A* 3ek4_A* 3ek7_A* 3evv_A* 3ek8_A* 3ekh_A* 3sg2_A* 3sg3_A* 3sg7_A* 3ekj_A* 3sg4_A* 3sg5_A* 3evr_A* 3o78_A* 3o77_A* 1trf_A | Back alignment and structure |
|---|
Probab=99.81 E-value=4.1e-19 Score=169.04 Aligned_cols=139 Identities=17% Similarity=0.358 Sum_probs=118.8
Q ss_pred HhcCHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHh
Q 016471 236 KALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEA 314 (389)
Q Consensus 236 ~~l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~ 314 (389)
..++.++...++..|..+|. ++|.|+.+||+.+|..++. .++.+++.++|+.+|.+++|.|+|+||+..+........
T Consensus 304 ~~ls~eei~el~~~F~~fD~D~dG~Is~~EL~~~L~~lg~-~~s~eel~~Lf~~~D~DgdG~IsfeEFl~ll~~~~~~~~ 382 (450)
T 3sg6_A 304 DQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQ-NPTEAELQDMINEVDADGNGTIDFPEFLTMMARKMKDTD 382 (450)
T ss_dssp -CCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTC-CCCHHHHHHHHHTTCTTSSSSEEHHHHHHHHHC------
T ss_pred ccCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCC-CCCHHHHHHHHHHhccCCCCcccHHHHHHHHHhhccccc
Confidence 35678888999999999999 9999999999999999887 478999999999999999999999999987765433222
Q ss_pred hHHHHHHHHHHHHHHcccCCCcccHHHHHHHh---C--CchH-HHHHHHHHccCCCCceeHHHHHHHHcc
Q 016471 315 LERWDQIAITAFDYFEQEGNRVISVEELALEL---N--LAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHG 378 (389)
Q Consensus 315 ~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l---~--~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~ 378 (389)
. ++.++.+|+.||+|++|+|+.+||+.+| | ++.. +++++..+|.|+||.|+|+||+.+|..
T Consensus 383 ~---~e~l~~aFk~fD~D~dG~Is~eELr~~L~~lG~~ls~eei~~Lf~~~D~D~DG~IsfdEFv~~L~~ 449 (450)
T 3sg6_A 383 S---EEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMTA 449 (450)
T ss_dssp C---HHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTCCCCHHHHHHHHHHHCTTSSSSEEHHHHHHHHC-
T ss_pred h---hhHHHHHHHHhCCCCCCeEeHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHhc
Confidence 2 4568999999999999999999999998 3 3344 999999999999999999999999874
|
| >2bec_A Calcineurin B homologous protein 2; calcineurin-homologous protein, calcium-binding protein, NHE1 regulating protein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.81 E-value=1.9e-19 Score=155.62 Aligned_cols=136 Identities=18% Similarity=0.271 Sum_probs=114.4
Q ss_pred hcCHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhH----
Q 016471 237 ALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQ---- 311 (389)
Q Consensus 237 ~l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~---- 311 (389)
.++.+++..++..|..+|. ++|.|+.+||..+ ..++.. ++ +.++|..+|.+++|.|+|+||+..+.....
T Consensus 22 ~ls~~~~~~l~~~F~~~D~d~dG~I~~~El~~~-~~lg~~-~~---~~~l~~~~D~d~dg~i~~~EF~~~~~~~~~~~~~ 96 (202)
T 2bec_A 22 GFSQASLLRLHHRFRALDRNKKGYLSRMDLQQI-GALAVN-PL---GDRIIESFFPDGSQRVDFPGFVRVLAHFRPVEDE 96 (202)
T ss_dssp CCCHHHHHHHHHHHHHHCSSCSSCCCHHHHHTC-HHHHHS-TT---HHHHHHTTSCSSCCCCCHHHHHHHHGGGSCCCHH
T ss_pred CCCHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH-HhcCCC-cc---HHHHHHHhCCCCCCcCcHHHHHHHHHHhcccchh
Confidence 5788899999999999999 9999999999998 777753 33 889999999999999999999987765432
Q ss_pred ------------HHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHh----CC--chH-HHHHHHH----HccCCCCcee
Q 016471 312 ------------LEALERWDQIAITAFDYFEQEGNRVISVEELALEL----NL--APA-AYSLLND----CIRNSDGKLS 368 (389)
Q Consensus 312 ------------~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l----~~--~~~-~~~~~~~----~d~~~~g~i~ 368 (389)
... ..+.++.+|+.||.|++|+|+.+||+.++ |. ... +..++.. +|.|+||.|+
T Consensus 97 ~~~~~~~~~~~~~~~---~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~g~~~~~~~~~~~~~~~~~~~D~d~dG~Is 173 (202)
T 2bec_A 97 DTETQDPKKPEPLNS---RRNKLHYAFQLYDLDRDGKISRHEMLQVLRLMVGVQVTEEQLENIADRTVQEADEDGDGAVS 173 (202)
T ss_dssp HHC-----CCCCTTS---HHHHHHHHHHHHCTTCSSEECHHHHHHHHHHSCCSCCCHHHHHHHHHHHHHHHCSSCSSSEE
T ss_pred ccccccccccccccc---HHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHcCCCCCCcCc
Confidence 111 14578999999999999999999999998 42 233 6667776 9999999999
Q ss_pred HHHHHHHHcccc
Q 016471 369 FLGYKRFLHGVT 380 (389)
Q Consensus 369 ~~ef~~~~~~~~ 380 (389)
|+||+.+|.+..
T Consensus 174 ~~EF~~~~~~~~ 185 (202)
T 2bec_A 174 FVEFTKSLEKMD 185 (202)
T ss_dssp HHHHHHTTTTSC
T ss_pred HHHHHHHHHHhC
Confidence 999999998764
|
| >3a8r_A Putative uncharacterized protein; EF-hand, membrane, oxidoreductase, transmembrane, calcium BI protein; 2.40A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.80 E-value=1.3e-19 Score=153.61 Aligned_cols=145 Identities=13% Similarity=0.191 Sum_probs=111.6
Q ss_pred HHHHHHHHhcCHHHHHHHHHHhhhcCCCCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcC---CCCCcceeHHHHHHH
Q 016471 229 AALKALSKALTEEELVYLRAQFMLLEPKDGCVSLNNFKVALMRQATDAMTDSRVFEILNVME---PLSDQKLAYEEFCAA 305 (389)
Q Consensus 229 ~~l~~i~~~l~~ee~~~l~~~F~~~D~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d---~~~~g~i~~~eF~~~ 305 (389)
..+..+.......++..++..|..+| ++|.|+.+||..++ |. .++..++.+++..+| .+++|.|+|+||+..
T Consensus 13 ~~l~~~~~~~~~~~~~~~~~~F~~~D-~dG~I~~~el~~~l---g~-~~~~~~~~~i~~~~d~~~~~~~~~i~~~ef~~~ 87 (179)
T 3a8r_A 13 KGLQFVTAKVGNDGWAAVEKRFNQLQ-VDGVLLRSRFGKCI---GM-DGSDEFAVQMFDSLARKRGIVKQVLTKDELKDF 87 (179)
T ss_dssp HHHHHHHHHHCCCCHHHHHHHHHHHC-BTTBEEGGGHHHHH---TC-CSCHHHHHHHHHHHHHHHTCCSSEECHHHHHHH
T ss_pred HHHHHHHhccchhhHHHHHHHHhccC-CCCCCcHHHHHHHH---CC-CCcHHHHHHHHHHHHHhccCCCCCcCHHHHHHH
Confidence 33455555544456778889999999 89999999999865 44 357778889999887 467889999999986
Q ss_pred HhchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHhC----Cc-h------H---HHHHHHHHccCCCCceeHHH
Q 016471 306 ATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALELN----LA-P------A---AYSLLNDCIRNSDGKLSFLG 371 (389)
Q Consensus 306 ~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~----~~-~------~---~~~~~~~~d~~~~g~i~~~e 371 (389)
+...... . .++.++.+|+.||+|+||+|+.+||+.++. .. . + +.++++++|.|+||.|+|+|
T Consensus 88 ~~~~~~~-~---~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~g~~~~~~~~~~~~~~~~~~~~~~D~d~dG~I~~~E 163 (179)
T 3a8r_A 88 YEQLTDQ-G---FDNRLRTFFDMVDKNADGRLTAEEVKEIIALSASANKLSKIKERADEYTALIMEELDPTNLGYIEMED 163 (179)
T ss_dssp HHHHHCC-C---HHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHHHTTHHHHHHHHHHHHHHHHHHHHSTTCCSEECHHH
T ss_pred HHHHcCC-C---HHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHHhccccccccccchHHHHHHHHHHhCCCCCCcCcHHH
Confidence 5432110 1 146799999999999999999999999884 22 2 2 89999999999999999999
Q ss_pred HHHHHccccCC
Q 016471 372 YKRFLHGVTVR 382 (389)
Q Consensus 372 f~~~~~~~~~~ 382 (389)
|+.+|...++.
T Consensus 164 F~~~~~~~p~~ 174 (179)
T 3a8r_A 164 LEALLLQSPSE 174 (179)
T ss_dssp HHHHHC-----
T ss_pred HHHHHHhCcch
Confidence 99999987763
|
| >3dd4_A KV channel-interacting protein 4; EF-hands protein, ION transport, ionic channel, membrane, PO potassium channel, potassium transport, transport; 3.00A {Mus musculus} PDB: 2e6w_A | Back alignment and structure |
|---|
Probab=99.80 E-value=6.5e-19 Score=155.45 Aligned_cols=140 Identities=14% Similarity=0.172 Sum_probs=116.4
Q ss_pred hcCHHHHHHHHHHhhhcCCCCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhH
Q 016471 237 ALTEEELVYLRAQFMLLEPKDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALE 316 (389)
Q Consensus 237 ~l~~ee~~~l~~~F~~~D~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~ 316 (389)
.++.+++..+...|...| ++|.|+.+||+.++...+....+...+.++|+.+|.+++|.|+|+||+.++........
T Consensus 60 ~~s~~ei~~l~~~F~~~d-~~G~Is~~ef~~~l~~~~~~~~~~~~~~~lf~~~D~d~~G~I~~~Ef~~~l~~~~~~~~-- 136 (229)
T 3dd4_A 60 KFTKKELQILYRGFKNEC-PSGVVNEETFKEIYSQFFPQGDSTTYAHFLFNAFDTDHNGAVSFEDFIKGLSILLRGTV-- 136 (229)
T ss_dssp HHHHHHHHHHHHHHHTTC-CSCCCCHHHHHHHHHHHSCSSSHHHHHHHHHHTTCSSCCSSCCHHHHHHHHHHHHHSCH--
T ss_pred CCCHHHHHHHHHHHHhhC-CCCCcCHHHHHHHHHHHCCCCCcHHHHHHHHHHcCCCCCCeEeHHHHHHHHHHHcCCCh--
Confidence 466788888888887643 68999999999999886544456777899999999999999999999987665433222
Q ss_pred HHHHHHHHHHHHHcccCCCcccHHHHHHHhCC-----------------chH-HHHHHHHHccCCCCceeHHHHHHHHcc
Q 016471 317 RWDQIAITAFDYFEQEGNRVISVEELALELNL-----------------APA-AYSLLNDCIRNSDGKLSFLGYKRFLHG 378 (389)
Q Consensus 317 ~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~-----------------~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~ 378 (389)
++.++.+|+.||+|++|+|+.+|+..++.. ... +.++++.+|.|+||.|+|+||+.++++
T Consensus 137 --~~~l~~~F~~~D~d~dG~Is~~E~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~Is~~EF~~~~~~ 214 (229)
T 3dd4_A 137 --QEKLNWAFNLYDINKDGYITKEEMLDIMKAIYDMMGKCTYPVLKEDAPRQHVETFFQKMDKNKDGVVTIDEFIESCQK 214 (229)
T ss_dssp --HHHHHHHHHHHCTTCSSCCBHHHHHHHHHHHHHHCC-----------CCTHHHHHHHHHCSSCSSBCCHHHHHHHHHT
T ss_pred --HHHHHHHHHHhCCCCCCeECHHHHHHHHHHHHHHhccccCCCcchhhHHHHHHHHHHHhcCCCCCcEeHHHHHHHHHh
Confidence 467999999999999999999999998831 112 999999999999999999999999987
Q ss_pred ccC
Q 016471 379 VTV 381 (389)
Q Consensus 379 ~~~ 381 (389)
.+.
T Consensus 215 ~~~ 217 (229)
T 3dd4_A 215 DEN 217 (229)
T ss_dssp CHH
T ss_pred CHH
Confidence 654
|
| >3akb_A Putative calcium binding protein; EF-hand, metal binding protein; 1.50A {Streptomyces coelicolor} PDB: 3aka_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1.1e-18 Score=145.31 Aligned_cols=138 Identities=17% Similarity=0.167 Sum_probs=110.2
Q ss_pred HHHHHHHHhhhcCC-CCCcccHHHHHHHHH----HhccccCCHHHHHHH-----------HhhcCCCCCcceeHHHHHHH
Q 016471 242 ELVYLRAQFMLLEP-KDGCVSLNNFKVALM----RQATDAMTDSRVFEI-----------LNVMEPLSDQKLAYEEFCAA 305 (389)
Q Consensus 242 e~~~l~~~F~~~D~-~~G~i~~~el~~~l~----~~~~~~~~~~~~~~~-----------~~~~d~~~~g~i~~~eF~~~ 305 (389)
+...++..|..+|. ++|.|+.+||..++. .+|. .++..++.++ |..+|.+++|.|+|+||+..
T Consensus 2 ~~~~l~~~F~~~D~d~dG~i~~~E~~~~l~~~~~~~g~-~~~~~~~~~l~~~~~~~~~~~f~~~D~d~~g~i~~~ef~~~ 80 (166)
T 3akb_A 2 YERRIAARFTTFDQDGNGHIDRSDFSGAAKAMLAEFGV-AARSDRGQALYGGAEALWQGLAGIADRDGDQRITREEFVTG 80 (166)
T ss_dssp HHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHHHHTC-CTTSHHHHHHHHHHHHHHHHHHHHHCTTSSSCEEHHHHHHT
T ss_pred HHHHHHHHHhHHcCCCCCCcCHHHHHHHHHHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHhCCCCCCcCcHHHHHHH
Confidence 35678899999999 999999999999754 4455 3566667644 79999999999999999986
Q ss_pred HhchhHHHhh---HHHHHHHHHHHHHHcccCCCcccHHHHHHHh---CCchH-HHHHHHHHccCCCCceeHHHHHHHHcc
Q 016471 306 ATSVYQLEAL---ERWDQIAITAFDYFEQEGNRVISVEELALEL---NLAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHG 378 (389)
Q Consensus 306 ~~~~~~~~~~---~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l---~~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~ 378 (389)
+......... +.....++.+|+.+|+|++|+|+.+|++.++ |.... +..+++.+|.|+||.|+|+||+.+|.+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~i~~~E~~~~l~~~~~~~~~~~~~~~~~D~d~dg~i~~~ef~~~~~~ 160 (166)
T 3akb_A 81 AVKRLRDKPDRFAEMARPFLHAALGVADTDGDGAVTVADTARALTAFGVPEDLARQAAAALDTDGDGKVGETEIVPAFAR 160 (166)
T ss_dssp HHHHHHHSHHHHHHHHHHHHHHHHHHHCSSSSSCCBHHHHHHHHHHTTCCHHHHHHHHHHHCTTCSSBCCHHHHHHHHHH
T ss_pred HHHHhccCccchHHHHHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHhCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHH
Confidence 5544322110 0013458999999999999999999999988 54444 999999999999999999999999976
Q ss_pred cc
Q 016471 379 VT 380 (389)
Q Consensus 379 ~~ 380 (389)
..
T Consensus 161 ~~ 162 (166)
T 3akb_A 161 YF 162 (166)
T ss_dssp HT
T ss_pred Hh
Confidence 43
|
| >3dtp_E RLC, myosin regulatory light chain; muscle protein, smooth muscle, myosin subfragment 2, heavy meromyosin, essential light chain; 20.00A {Avicularia avicularia} | Back alignment and structure |
|---|
Probab=99.80 E-value=7.2e-20 Score=157.62 Aligned_cols=136 Identities=12% Similarity=0.214 Sum_probs=115.5
Q ss_pred hcCHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhh
Q 016471 237 ALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEAL 315 (389)
Q Consensus 237 ~l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~ 315 (389)
.++.+++..++..|..+|. ++|.|+.+||..+|..+|. .++..++..++..+ +|.|+|+||+..+.........
T Consensus 50 ~ls~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~lg~-~~~~~~~~~l~~~~----~g~i~~~eF~~~~~~~~~~~~~ 124 (196)
T 3dtp_E 50 MFTQHQVQEFKEAFQLIDQDKDGFISKNDIRATFDSLGR-LCTEQELDSMVAEA----PGPINFTMFLTIFGDRIAGTDE 124 (196)
T ss_dssp SSCTTTHHHHHHHHHHHCCSCSSBCCHHHHHHHHHTTSC-CCCHHHHHHHHTTS----SSCCBHHHHHHHHHHCCCSSCC
T ss_pred hCCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHhCC-CCCHHHHHHHHHHc----cCCCcHHHHHHHHHHHhcCCCc
Confidence 4567778889999999999 9999999999999999986 47899999999887 8999999999876543221111
Q ss_pred HHHHHHHHHHHHHHcccCCCcccHHHHHHHh--C--CchH-HHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 316 ERWDQIAITAFDYFEQEGNRVISVEELALEL--N--LAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 316 ~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l--~--~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
.+.++.+|+.||.|++|+|+.+||+.+| | +... +..++..+|.|+||.|+|+||+.+|.+.+
T Consensus 125 ---~~~l~~~F~~~D~d~~G~Is~~El~~~l~~g~~~~~~~~~~l~~~~D~d~dG~I~~~EF~~~l~~~~ 191 (196)
T 3dtp_E 125 ---EDVIVNAFNLFDEGDGKCKEETLKRSLTTWGEKFSQDEVDQALSEAPIDGNGLIDIKKFAQILTKGA 191 (196)
T ss_dssp ---HHHHHHHHHTTCSSSSCCBHHHHHHHHHHSSSCCCHHHHHHHHHSSCEETTEECHHHHHHHHHSSCC
T ss_pred ---HHHHHHHHHHHCCCCCCcCcHHHHHHHHHcCCCCCHHHHHHHHHHcCCCCCCEEeHHHHHHHHHcCC
Confidence 3568999999999999999999999998 2 2223 89999999999999999999999998765
|
| >1jfj_A Ehcabp, calcium-binding protein; EF-hand, helix-loop-helix, metal binding protein; NMR {Entamoeba histolytica} SCOP: a.39.1.5 PDB: 1jfk_A 2nxq_A 3px1_A 3qjk_A 2jnx_A 2i18_A | Back alignment and structure |
|---|
Probab=99.80 E-value=5.1e-19 Score=141.78 Aligned_cols=126 Identities=13% Similarity=0.174 Sum_probs=108.0
Q ss_pred HHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHh---chhHHHhhHHHHHH
Q 016471 246 LRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAAT---SVYQLEALERWDQI 321 (389)
Q Consensus 246 l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~---~~~~~~~~~~~~~~ 321 (389)
++..|..+|. ++|.|+.+||..++..++. .++..++..++..+|.+++|.|+|+||+..+. ....... ...
T Consensus 2 l~~~F~~~D~~~~g~i~~~e~~~~l~~~~~-~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~----~~~ 76 (134)
T 1jfj_A 2 AEALFKEIDVNGDGAVSYEEVKAFVSKKRA-IKNEQLLQLIFKSIDADGNGEIDQNEFAKFYGSIQGQDLSDD----KIG 76 (134)
T ss_dssp HHHHHHHHCTTCSSEEEHHHHHHHHHTTCC-SSHHHHHHHHHHHHCSSCCSEEEHHHHHHHTTCSSCCSSHHH----HHH
T ss_pred HHHHHHHHCCCCCCcCCHHHHHHHHHHcCC-CCCHHHHHHHHHHHcCCCCCeEcHHHHHHHHHHhcccccCCC----HHH
Confidence 5678999999 9999999999999988875 46788999999999999999999999998764 2111111 234
Q ss_pred HHHHHHHHcccCCCcccHHHHHHHhCCchH--HHHHHHHHccCCCCceeHHHHHHHH
Q 016471 322 AITAFDYFEQEGNRVISVEELALELNLAPA--AYSLLNDCIRNSDGKLSFLGYKRFL 376 (389)
Q Consensus 322 l~~aF~~~D~d~~G~I~~~el~~~l~~~~~--~~~~~~~~d~~~~g~i~~~ef~~~~ 376 (389)
++.+|+.+|.|++|+|+.+|++.++...+. +.+++..+|.|++|.|+|+||+.+|
T Consensus 77 ~~~~f~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~D~~~dg~i~~~ef~~~l 133 (134)
T 1jfj_A 77 LKVLYKLMDVDGDGKLTKEEVTSFFKKHGIEKVAEQVMKADANGDGYITLEEFLEFS 133 (134)
T ss_dssp HHHHHHHHCCSSSSEEEHHHHHHHHTTTTCHHHHHHHHHHHCSSSSEEEHHHHHHHH
T ss_pred HHHHHHHHCCCCCCccCHHHHHHHHHHhCHHHHHHHHHHhCCCCCCcEeHHHHHHHh
Confidence 899999999999999999999999954333 8899999999999999999999886
|
| >2znd_A Programmed cell death protein 6; penta-EF-hand protein, calcium binding protein, apoptosis, calcium, endoplasmic reticulum, membrane, nucleus; 1.70A {Homo sapiens} PDB: 2zn9_A 2zn8_A 1hqv_A 3aak_A 2zne_A 2zrs_A 2zrt_A 3aaj_A | Back alignment and structure |
|---|
Probab=99.79 E-value=3.4e-19 Score=149.91 Aligned_cols=128 Identities=15% Similarity=0.223 Sum_probs=111.0
Q ss_pred HHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHH
Q 016471 242 ELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQ 320 (389)
Q Consensus 242 e~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~ 320 (389)
+...++..|..+|. ++|.|+.+||..++..++...++..++..++..+|.+++|.|+|+||+..+.. ..
T Consensus 5 ~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~ef~~~~~~----------~~ 74 (172)
T 2znd_A 5 DQSFLWNVFQRVDKDRSGVISDTELQQALSNGTWTPFNPVTVRSIISMFDRENKAGVNFSEFTGVWKY----------IT 74 (172)
T ss_dssp -CHHHHHHHHHHCTTCSSCEEHHHHHHHCCCSSSSCCCHHHHHHHHHHHCSSSSSEECHHHHHHHHHH----------HH
T ss_pred chhHHHHHHHHhCCCCCCcCcHHHHHHHHHhcCCCCCCHHHHHHHHHHhCCCCCCcCCHHHHHHHHHH----------HH
Confidence 34568899999999 99999999999999888744578999999999999999999999999985432 23
Q ss_pred HHHHHHHHHcccCCCcccHHHHHHHh---CC--chH-HHHHHHHHccCCCCceeHHHHHHHHccc
Q 016471 321 IAITAFDYFEQEGNRVISVEELALEL---NL--APA-AYSLLNDCIRNSDGKLSFLGYKRFLHGV 379 (389)
Q Consensus 321 ~l~~aF~~~D~d~~G~I~~~el~~~l---~~--~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~ 379 (389)
.++.+|+.+|+|++|+|+.+|++.++ |. ... +..++..+|.|++|.|+|+||+.+|...
T Consensus 75 ~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d~~~dg~i~~~eF~~~~~~~ 139 (172)
T 2znd_A 75 DWQNVFRTYDRDNSGMIDKNELKQALSGFGYRLSDQFHDILIRKFDRQGRGQIAFDDFIQGCIVL 139 (172)
T ss_dssp HHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHH
T ss_pred HHHHHHHHHCCCCCCccCHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHH
Confidence 58899999999999999999999988 32 333 9999999999999999999999998654
|
| >3cs1_A Flagellar calcium-binding protein; myristoylated, palmitoylated, SEN membrane targeting, EF-hand, cell projection, cilium; 2.00A {Trypanosoma cruzi} | Back alignment and structure |
|---|
Probab=99.79 E-value=1.2e-19 Score=159.09 Aligned_cols=139 Identities=16% Similarity=0.171 Sum_probs=112.8
Q ss_pred HhcCHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHH-hccccCCHHHHHHHHhhc---------CCCCCcceeHHHHHH
Q 016471 236 KALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMR-QATDAMTDSRVFEILNVM---------EPLSDQKLAYEEFCA 304 (389)
Q Consensus 236 ~~l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~-~~~~~~~~~~~~~~~~~~---------d~~~~g~i~~~eF~~ 304 (389)
..++.+++..++..|..+|. ++|.|+.+||..+|.. ++.. ++..++.+++..+ +.+++|.|+|+||+.
T Consensus 40 ~~ls~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~lg~~-~~~~~~~~~~~~~~~~~~~~~~~~d~~g~I~~~EF~~ 118 (219)
T 3cs1_A 40 REKTAEAKQRRIELFKKFDKNETGKLCYDEVYSGCLEVLKLD-EFTSRVRDITKRAFDKSRTLGSKLENKGSEDFVEFLE 118 (219)
T ss_dssp CSSSHHHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHTTCGG-GTCSCHHHHHHHHHHHHHHHHHHHHTSCCCSSBCHHH
T ss_pred ccCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhCCC-ccHHHHHHHHHHHHHHHHhhhhccCCCCcCCHHHHHH
Confidence 35678899999999999999 9999999999999987 6653 4555566555422 337899999999998
Q ss_pred HHhchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHh---C---CchH-HHHHHHHHccCCCCceeHHHHHHHHc
Q 016471 305 AATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALEL---N---LAPA-AYSLLNDCIRNSDGKLSFLGYKRFLH 377 (389)
Q Consensus 305 ~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l---~---~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~ 377 (389)
.+........ .+.++.+|+.||+|++|+|+.+||+.++ | +..+ +..+++.+|.|+||.|+|+||+.+|.
T Consensus 119 ~~~~~~~~~~----~~~l~~~F~~~D~d~~G~Is~~El~~~l~~~g~~~~~~~e~~~l~~~~D~d~dG~I~~~EF~~~~~ 194 (219)
T 3cs1_A 119 FRLMLCYIYD----FFELTVMFDEIDASGNMLVDEEEFKRAVPKLEAWGAKVEDPAALFKELDKNGTGSVTFDEFAAWAS 194 (219)
T ss_dssp HHHHHHHHHH----HHHHHHHHHTTCSSSSSEEEHHHHHHHHHHHHHHTCCCSCHHHHHHHHCTTSSSEEEHHHHHHHHH
T ss_pred HHHHHhccch----HHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhcccCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHH
Confidence 6544333222 4568999999999999999999999998 2 3333 99999999999999999999999997
Q ss_pred cc
Q 016471 378 GV 379 (389)
Q Consensus 378 ~~ 379 (389)
+.
T Consensus 195 ~~ 196 (219)
T 3cs1_A 195 AV 196 (219)
T ss_dssp HH
T ss_pred Hh
Confidence 53
|
| >1s1e_A KV channel interacting protein 1; kchip, calcium-binding protein, EF-finger, transport protein; 2.30A {Homo sapiens} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=99.79 E-value=8.6e-19 Score=154.10 Aligned_cols=139 Identities=15% Similarity=0.189 Sum_probs=117.7
Q ss_pred hcCHHHHHHHHHHhhhcCCCCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhH
Q 016471 237 ALTEEELVYLRAQFMLLEPKDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALE 316 (389)
Q Consensus 237 ~l~~ee~~~l~~~F~~~D~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~ 316 (389)
.++.+++..+...|...| ++|.|+.+||..++..++....+..++.++|+.+|.+++|.|+|+||+.++........
T Consensus 47 ~~s~~ei~~l~~~Fd~~d-~~G~I~~~E~~~~l~~l~~~~~~~~~~~~~f~~~D~d~~G~I~~~Ef~~~l~~~~~~~~-- 123 (224)
T 1s1e_A 47 NFTKRELQVLYRGFKNEC-PSGVVNEETFKQIYAQFFPHGDASTYAHYLFNAFDTTQTGSVKFEDFVTALSILLRGTV-- 123 (224)
T ss_dssp SCCHHHHHHHHHHHHHHC-TTSCBCHHHHHHHHHTTCTTSCCHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHHHCCH--
T ss_pred CCCHHHHHHHHHHHHhhC-CCCCCCHHHHHHHHHHhcCCCCcHHHHHHHHHHhcCCCCCcEeHHHHHHHHHHHccCCH--
Confidence 477888888888887764 68999999999999988754468889999999999999999999999987665432222
Q ss_pred HHHHHHHHHHHHHcccCCCcccHHHHHHHh-------C------Cch----H-HHHHHHHHccCCCCceeHHHHHHHHcc
Q 016471 317 RWDQIAITAFDYFEQEGNRVISVEELALEL-------N------LAP----A-AYSLLNDCIRNSDGKLSFLGYKRFLHG 378 (389)
Q Consensus 317 ~~~~~l~~aF~~~D~d~~G~I~~~el~~~l-------~------~~~----~-~~~~~~~~d~~~~g~i~~~ef~~~~~~ 378 (389)
++.++.+|+.||.|++|+|+.+|+..++ | ... . +.++++.+|.|+||.|+|+||+.+|.+
T Consensus 124 --~~~l~~~F~~~D~d~dG~Is~~E~~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~Is~~EF~~~~~~ 201 (224)
T 1s1e_A 124 --HEKLRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVLKEDTPRQHVDVFFQKMDKNKDGIVTLDEFLESCQE 201 (224)
T ss_dssp --HHHHHHHHHHHCTTCCSEECHHHHHHHHHHHHHHHTTCCCGGGCSSSHHHHHHHHHHHHCTTCSSCEEHHHHHHHHHT
T ss_pred --HHHHHHHHHHHcCCCCCeECHHHHHHHHHHHHHHhcccCCCCCCHhHHHHHHHHHHHHhCCCCCCcEeHHHHHHHHHh
Confidence 4578999999999999999999999987 3 111 2 889999999999999999999999987
Q ss_pred cc
Q 016471 379 VT 380 (389)
Q Consensus 379 ~~ 380 (389)
.+
T Consensus 202 ~~ 203 (224)
T 1s1e_A 202 DD 203 (224)
T ss_dssp CH
T ss_pred CH
Confidence 65
|
| >1y1x_A Leishmania major homolog of programmed cell death protein; SGPP, structural genomics, PSI; 1.95A {Leishmania major} SCOP: a.39.1.8 | Back alignment and structure |
|---|
Probab=99.79 E-value=8.9e-19 Score=150.10 Aligned_cols=125 Identities=16% Similarity=0.219 Sum_probs=108.7
Q ss_pred HHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHH
Q 016471 244 VYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIA 322 (389)
Q Consensus 244 ~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l 322 (389)
..++..|..+|. ++|.|+.+||..++...+. .++..++..++..+|.+++|.|+|+||+..+.. ...+
T Consensus 27 ~~l~~~F~~~D~d~~G~I~~~El~~~l~~~~~-~~~~~~~~~l~~~~D~d~dG~I~~~EF~~~~~~----------~~~~ 95 (191)
T 1y1x_A 27 QELMEWFRAVDTDGSGAISVPELNAALSSAGV-PFSLATTEKLLHMYDKNHSGEITFDEFKDLHHF----------ILSM 95 (191)
T ss_dssp SCHHHHHHHHCTTCSSSBCHHHHHHHHCBTTB-CCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHH----------HHHH
T ss_pred HHHHHHHHHHcCCCCCcCcHHHHHHHHHHcCC-CCCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHH----------HHHH
Confidence 457788999999 9999999999999966554 478899999999999999999999999986442 2357
Q ss_pred HHHHHHHcccCCCcccHHHHHHHh---C--CchH-HHHHHHHHccCCCCceeHHHHHHHHccc
Q 016471 323 ITAFDYFEQEGNRVISVEELALEL---N--LAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHGV 379 (389)
Q Consensus 323 ~~aF~~~D~d~~G~I~~~el~~~l---~--~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~ 379 (389)
+.+|+.+|+|++|+|+.+|++.++ | .... +..+++.+|.|++|.|+|+||+.+|...
T Consensus 96 ~~~F~~~D~d~~G~i~~~e~~~~l~~~g~~~~~~~~~~~~~~~D~d~dg~i~~~eF~~~~~~~ 158 (191)
T 1y1x_A 96 REGFRKRDSSGDGRLDSNEVRAALLSSGYQVSEQTFQALMRKFDRQRRGSLGFDDYVELSIFV 158 (191)
T ss_dssp HHHHHHHCTTSSSCBCHHHHHHHHHTTSCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCCeEcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHHH
Confidence 899999999999999999999998 3 2333 9999999999999999999999998754
|
| >2ehb_A Calcineurin B-like protein 4; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} PDB: 1v1g_A 1v1f_A | Back alignment and structure |
|---|
Probab=99.78 E-value=2e-18 Score=149.68 Aligned_cols=140 Identities=21% Similarity=0.277 Sum_probs=114.6
Q ss_pred hcCHHHHHHHHHHhhhcCC---CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHH
Q 016471 237 ALTEEELVYLRAQFMLLEP---KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLE 313 (389)
Q Consensus 237 ~l~~ee~~~l~~~F~~~D~---~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~ 313 (389)
.++.+++..++..|..+|. ++|.|+.+||..+|... .......+.++|..+|.+++|.|+|+||+..+.......
T Consensus 30 ~~s~~~~~~l~~~F~~~D~d~~~~G~i~~~e~~~~l~~~--~~~~~~~~~~~f~~~D~d~~g~i~~~Ef~~~~~~~~~~~ 107 (207)
T 2ehb_A 30 PFTVEEVEALYELFKKLSSSIIDDGLIHKEEFQLALFRN--RNRRNLFADRIFDVFDVKRNGVIEFGEFVRSLGVFHPSA 107 (207)
T ss_dssp SCCHHHHHHHHHHHHHHTTSSSCSSCEEHHHHHHHHHSC--TTCCCHHHHHHHHHHCTTCSSEECHHHHHHHHGGGSTTS
T ss_pred CCCHHHHHHHHHHHHHhccccCCCCccCHHHHHHHHhcc--ccccHHHHHHHHHHhcCCCCCeEeHHHHHHHHHHHccCC
Confidence 5788899999999999996 68999999999998762 223445678899999999999999999998776543211
Q ss_pred hhHHHHHHHHHHHHHHcccCCCcccHHHHHHHh-------CC--chH-----HHHHHHHHccCCCCceeHHHHHHHHccc
Q 016471 314 ALERWDQIAITAFDYFEQEGNRVISVEELALEL-------NL--APA-----AYSLLNDCIRNSDGKLSFLGYKRFLHGV 379 (389)
Q Consensus 314 ~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l-------~~--~~~-----~~~~~~~~d~~~~g~i~~~ef~~~~~~~ 379 (389)
.. ++.++.+|+.||.|++|+|+.+||+.++ |. .+. +..+++.+|.|+||.|+|+||+.+|.+.
T Consensus 108 ~~---~~~l~~~F~~~D~d~~G~I~~~E~~~~l~~~~~~~g~~~~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~ 184 (207)
T 2ehb_A 108 PV---HEKVKFAFKLYDLRQTGFIEREELKEMVVALLHESELVLSEDMIEVMVDKAFVQADRKNDGKIDIDEWKDFVSLN 184 (207)
T ss_dssp CH---HHHHHHHHHHHCTTCCSSEEHHHHHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHC
T ss_pred CH---HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHHHHcccccCHHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHhC
Confidence 11 4568999999999999999999999987 32 222 4556679999999999999999999887
Q ss_pred cC
Q 016471 380 TV 381 (389)
Q Consensus 380 ~~ 381 (389)
+.
T Consensus 185 ~~ 186 (207)
T 2ehb_A 185 PS 186 (207)
T ss_dssp GG
T ss_pred hH
Confidence 64
|
| >2zfd_A Calcineurin B-like protein 2; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} SCOP: a.39.1.5 PDB: 1uhn_A | Back alignment and structure |
|---|
Probab=99.78 E-value=1.7e-18 Score=152.44 Aligned_cols=141 Identities=15% Similarity=0.250 Sum_probs=114.4
Q ss_pred hcCHHHHHHHHHHhhhcCC---CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHH
Q 016471 237 ALTEEELVYLRAQFMLLEP---KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLE 313 (389)
Q Consensus 237 ~l~~ee~~~l~~~F~~~D~---~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~ 313 (389)
.++.+++..++..|..+|. ++|.|+.+||..+|.... ......+.++|..+|.+++|.|+|+||+..+.......
T Consensus 41 ~ls~~ei~~l~~~F~~~D~d~~~~G~I~~~El~~~l~~~~--~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~~~~~ 118 (226)
T 2zfd_A 41 VFSVSEIEALYELFKKISSAVIDDGLINKEEFQLALFKTN--KKESLFADRVFDLFDTKHNGILGFEEFARALSVFHPNA 118 (226)
T ss_dssp SCCHHHHHHHHHHHHHHHTSSSCSSSBCHHHHHHHHHSCS--SCCCHHHHHHHHHHCSSCSSSBCHHHHHHHHHHTSTTS
T ss_pred CCCHHHHHHHHHHHHHhCcccCCCCeEcHHHHHHHHhccC--cccHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHccCC
Confidence 5789999999999999996 789999999999987622 23445678899999999999999999998765442211
Q ss_pred hhHHHHHHHHHHHHHHcccCCCcccHHHHHHHh-------C--CchH-----HHHHHHHHccCCCCceeHHHHHHHHccc
Q 016471 314 ALERWDQIAITAFDYFEQEGNRVISVEELALEL-------N--LAPA-----AYSLLNDCIRNSDGKLSFLGYKRFLHGV 379 (389)
Q Consensus 314 ~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l-------~--~~~~-----~~~~~~~~d~~~~g~i~~~ef~~~~~~~ 379 (389)
.. ++.++.+|+.||.|++|+|+.+||+.++ | ..+. +.++++.+|.|+||.|+|+||+.+|.+.
T Consensus 119 ~~---~~~l~~~F~~~D~d~~G~Is~~E~~~~l~~~~~~~g~~~~~~~~~~~~~~~f~~~D~d~dG~I~~~EF~~~~~~~ 195 (226)
T 2zfd_A 119 PI---DDKIHFSFQLYDLKQQGFIERQEVKQMVVATLAESGMNLKDTVIEDIIDKTFEEADTKHDGKIDKEEWRSLVLRH 195 (226)
T ss_dssp CH---HHHHHHHHHHHCTTSSSSEEHHHHHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHCSSCSSEECHHHHHHHHHHS
T ss_pred CH---HHHHHHHHHHhCCCCCCcccHHHHHHHHHHHHHHcCCCCCHHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHhC
Confidence 11 4568999999999999999999999987 2 2222 3556679999999999999999999877
Q ss_pred cCC
Q 016471 380 TVR 382 (389)
Q Consensus 380 ~~~ 382 (389)
+..
T Consensus 196 ~~~ 198 (226)
T 2zfd_A 196 PSL 198 (226)
T ss_dssp GGG
T ss_pred hHH
Confidence 643
|
| >2ct9_A Calcium-binding protein P22; EF-hand, metal binding protein; 2.20A {Rattus norvegicus} PDB: 2e30_A | Back alignment and structure |
|---|
Probab=99.78 E-value=7.6e-19 Score=152.59 Aligned_cols=141 Identities=18% Similarity=0.292 Sum_probs=112.9
Q ss_pred HhcCHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHh
Q 016471 236 KALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEA 314 (389)
Q Consensus 236 ~~l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~ 314 (389)
..++.+++..++..|..+|. ++|.|+.+||..++ .++.. ++ ..++++.+|.+++|.|+|+||+..+........
T Consensus 21 ~~ls~~~~~~l~~~F~~~D~d~dG~Is~~El~~~~-~lg~~-~~---~~~l~~~~d~~~~g~i~~~EF~~~~~~~~~~~~ 95 (208)
T 2ct9_A 21 TGFSHSQITRLYSRFTSLDKGENGTLSREDFQRIP-ELAIN-PL---GDRIINAFFSEGEDQVNFRGFMRTLAHFRPIED 95 (208)
T ss_dssp HCCCHHHHHHHHHHHHHHCTTCSSEECTGGGGGCH-HHHTS-TT---HHHHHHTTSCTTCSCEEHHHHHHHHHTTSCCC-
T ss_pred CCCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHH-HcCCC-Cc---HHHHHHHHcCCCCCcCcHHHHHHHHHhhccccc
Confidence 35788999999999999999 99999999999864 56543 33 357899999999999999999987665421110
Q ss_pred hH------------HHHHHHHHHHHHHcccCCCcccHHHHHHHh----CC--chH-HHHH----HHHHccCCCCceeHHH
Q 016471 315 LE------------RWDQIAITAFDYFEQEGNRVISVEELALEL----NL--APA-AYSL----LNDCIRNSDGKLSFLG 371 (389)
Q Consensus 315 ~~------------~~~~~l~~aF~~~D~d~~G~I~~~el~~~l----~~--~~~-~~~~----~~~~d~~~~g~i~~~e 371 (389)
.. ...+.++.+|+.||+|++|+|+.+||+.++ |. ... +.++ ++.+|.|+||.|+|+|
T Consensus 96 ~~~~~~~~~~~~~~~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~g~~~s~~~~~~l~~~~~~~~D~d~dG~Is~~E 175 (208)
T 2ct9_A 96 NEKSKDVNGPEPLNSRSNKLHFAFRLYDLDKDDKISRDELLQVLRMMVGVNISDEQLGSIADRTIQEADQDGDSAISFTE 175 (208)
T ss_dssp ----------CCTTSHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHSCTTCCHHHHHHHHHHHHHHHCSSSSSSEEHHH
T ss_pred hhhhcccccccccccHHHHHHHHHHHHCCCCCCEEcHHHHHHHHHHHhCCCCCHHHHHHHHHHHHHHhCCCCCCcCcHHH
Confidence 00 014679999999999999999999999988 32 222 5555 9999999999999999
Q ss_pred HHHHHccccC
Q 016471 372 YKRFLHGVTV 381 (389)
Q Consensus 372 f~~~~~~~~~ 381 (389)
|+.+|.+...
T Consensus 176 F~~~~~~~~~ 185 (208)
T 2ct9_A 176 FVKVLEKVDV 185 (208)
T ss_dssp HHHTTTTSCG
T ss_pred HHHHHhccCh
Confidence 9999987653
|
| >1g8i_A Frequenin, neuronal calcium sensor 1; calcium binding-protein, EF-hand, calcium ION, metal binding protein; HET: 1PE P6G; 1.90A {Homo sapiens} SCOP: a.39.1.5 PDB: 2lcp_A | Back alignment and structure |
|---|
Probab=99.78 E-value=3.3e-18 Score=146.03 Aligned_cols=149 Identities=16% Similarity=0.188 Sum_probs=116.8
Q ss_pred HHHHHHHHHH--hcCHHHHHHHHHHhhhcCCCCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHH
Q 016471 227 KRAALKALSK--ALTEEELVYLRAQFMLLEPKDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCA 304 (389)
Q Consensus 227 ~~~~l~~i~~--~l~~ee~~~l~~~F~~~D~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~ 304 (389)
++..+..+.. .++.+++..+...|... .++|.|+.+||..++..++.......++.++|..+|.+++|.|+|+||+.
T Consensus 9 ~~~~l~~l~~~~~~~~~~i~~~f~~fd~~-~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~f~~~D~d~~g~i~~~ef~~ 87 (190)
T 1g8i_A 9 KPEVVEELTRKTYFTEKEVQQWYKGFIKD-CPSGQLDAAGFQKIYKQFFPFGDPTKFATFVFNVFDENKDGRIEFSEFIQ 87 (190)
T ss_dssp CHHHHHHHHHTSSSCHHHHHHHHHHHHHH-CTTSEEEHHHHHHHHHHHCTTSCTHHHHHHHHHHHCTTCSSEEEHHHHHH
T ss_pred CHHHHHHHHHccCCCHHHHHHHHHHHHHh-CCCCcCCHHHHHHHHHHhCCCCChHHHHHHHHHHHhcCCCCeEeHHHHHH
Confidence 3444455544 45677776666666543 25899999999999988743234667899999999999999999999998
Q ss_pred HHhchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHhCC-----------------chH-HHHHHHHHccCCCCc
Q 016471 305 AATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALELNL-----------------APA-AYSLLNDCIRNSDGK 366 (389)
Q Consensus 305 ~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~-----------------~~~-~~~~~~~~d~~~~g~ 366 (389)
++........ ++.++.+|+.+|.|++|+|+.+|+..++.. ... +.++++.+|.|++|.
T Consensus 88 ~~~~~~~~~~----~~~~~~~f~~~D~d~~G~i~~~e~~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~ 163 (190)
T 1g8i_A 88 ALSVTSRGTL----DEKLRWAFKLYDLDNDGYITRNEMLDIVDAIYQMVGNTVELPEEENTPEKRVDRIFAMMDKNADGK 163 (190)
T ss_dssp HHHHHHHCCH----HHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHHHC-----CCGGGSSHHHHHHHHHHHHCSSCSSE
T ss_pred HHHHhcCCCH----HHHHHHHHHhhcCCCCCeECHHHHHHHHHHHHHHhCCccCCccccccHHHHHHHHHHHhcCCCCCc
Confidence 7655432221 456899999999999999999999998732 112 889999999999999
Q ss_pred eeHHHHHHHHcccc
Q 016471 367 LSFLGYKRFLHGVT 380 (389)
Q Consensus 367 i~~~ef~~~~~~~~ 380 (389)
|+|+||+.+|...+
T Consensus 164 i~~~ef~~~~~~~~ 177 (190)
T 1g8i_A 164 LTLQEFQEGSKADP 177 (190)
T ss_dssp EEHHHHHHHHHHCH
T ss_pred EeHHHHHHHHHhCh
Confidence 99999999998765
|
| >1ggw_A Protein (CDC4P); light chain, cytokinesis, cell cycle, EF-hand; NMR {Schizosaccharomyces pombe} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=99.77 E-value=7.5e-19 Score=142.38 Aligned_cols=128 Identities=16% Similarity=0.221 Sum_probs=106.7
Q ss_pred HHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHH
Q 016471 244 VYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIA 322 (389)
Q Consensus 244 ~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l 322 (389)
..++..|..+|. ++|.|+.+||..++..++. .++..++.+++. +++|.|+|+||+..+.........+ ....+
T Consensus 5 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~-~~~~~~~~~~~~----~~~g~i~~~eF~~~~~~~~~~~~~~-~~~~~ 78 (140)
T 1ggw_A 5 SPYKQAFSLFDRHGTGRIPKTSIGDLLRACGQ-NPTLAEITEIES----TLPAEVDMEQFLQVLNRPNGFDMPG-DPEEF 78 (140)
T ss_dssp TTTHHHHHHTCSSSSSEECHHHHHHHHHHTSC-CCCHHHHHHHHT----TSCSSEEHHHHHHHHCTTSSSSSSC-CHHHH
T ss_pred HHHHHHHHHHCCCCCCcCCHHHHHHHHHHcCC-CCCHHHHHHHHh----CCCCcCcHHHHHHHHHHHhcccCcc-cHHHH
Confidence 457789999999 9999999999999999987 478888888887 7899999999998766543211110 02568
Q ss_pred HHHHHHHcccCCCcccHHHHHHHh---C--CchH-HHHHHHHHccCCCCceeHHHHHHHHcc
Q 016471 323 ITAFDYFEQEGNRVISVEELALEL---N--LAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHG 378 (389)
Q Consensus 323 ~~aF~~~D~d~~G~I~~~el~~~l---~--~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~ 378 (389)
+.+|+.||+|++|+|+.+||+.++ | +... +..+++.+|. ++|.|+|+||+.+|.+
T Consensus 79 ~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d~-~dg~i~~~eF~~~~~~ 139 (140)
T 1ggw_A 79 VKGFQVFDKDATGMIGVGELRYVLTSLGEKLSNEEMDELLKGVPV-KDGMVNYHDFVQMILA 139 (140)
T ss_dssp HHHHHTTCSSCSSCCCHHHHHHHHHHHHSCSCHHHHHHHHHHTTC-SSCCSTTTHHHHHHHC
T ss_pred HHHHHHhCCCCCCcEeHHHHHHHHHHcCCCCCHHHHHHHHHhccC-CCCcEeHHHHHHHHhc
Confidence 999999999999999999999998 3 3333 9999999999 9999999999999864
|
| >1alv_A Calpain, S-camld; calcium binding, calmodulin like, domain of cystein protease; 1.90A {Sus scrofa} SCOP: a.39.1.8 PDB: 1alw_A* 1nx0_A 1nx1_A 1nx2_A 1nx3_A* 1kfu_S 1kfx_S 3bow_B 1u5i_B 1df0_B 3df0_B 1aj5_A 1dvi_A 1np8_A | Back alignment and structure |
|---|
Probab=99.77 E-value=1.3e-18 Score=146.40 Aligned_cols=127 Identities=18% Similarity=0.213 Sum_probs=109.3
Q ss_pred HHHHHHHHhhhcCCCCCcccHHHHHHHHHHh-cc------ccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHh
Q 016471 242 ELVYLRAQFMLLEPKDGCVSLNNFKVALMRQ-AT------DAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEA 314 (389)
Q Consensus 242 e~~~l~~~F~~~D~~~G~i~~~el~~~l~~~-~~------~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~ 314 (389)
++..++..|..+|.++|.|+.+||..++..+ |. ..++..++.+++..+|.+++|.|+|+||+..+..
T Consensus 2 ~~~~l~~~F~~~Dd~~G~i~~~el~~~l~~~~g~~~~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~eF~~~~~~------ 75 (173)
T 1alv_A 2 EVRQFRRLFAQLAGDDMEVSATELMNILNKVVTRHPDLKTDGFGIDTCRSMVAVMDSDTTGKLGFEEFKYLWNN------ 75 (173)
T ss_dssp HHHHHHHHHHHHHGGGTSBCHHHHHHHHHHHHHTCSTTCCSCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHH------
T ss_pred chhHHHHHHHHHhCCCCCcCHHHHHHHHHHhhhcccccccCCCCHHHHHHHHHHHcCCCCCccCHHHHHHHHHH------
Confidence 4667888999998779999999999999987 51 2478899999999999999999999999986542
Q ss_pred hHHHHHHHHHHHHHHcccCCCcccHHHHHHHh---CC--chH-HHHHHHHHccCCCCceeHHHHHHHHccc
Q 016471 315 LERWDQIAITAFDYFEQEGNRVISVEELALEL---NL--APA-AYSLLNDCIRNSDGKLSFLGYKRFLHGV 379 (389)
Q Consensus 315 ~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l---~~--~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~ 379 (389)
...++.+|+.+|+|++|+|+.+|++.++ |. ... +..++..+| |++|.|+|+||+.+|...
T Consensus 76 ----~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d-d~dg~i~~~eF~~~~~~~ 141 (173)
T 1alv_A 76 ----IKKWQAIYKQFDVDRSGTIGSSELPGAFEAAGFHLNEHLYSMIIRRYS-DEGGNMDFDNFISCLVRL 141 (173)
T ss_dssp ----HHHHHHHHHHHCTTCCSSBCTTTHHHHHHHHTCCCCHHHHHHHHHHHT-CSSSCBCHHHHHHHHHHH
T ss_pred ----HHHHHHHHHHHCCCCCCCCCHHHHHHHHHHcCCCCCHHHHHHHHHHhc-CCCCcCcHHHHHHHHHHH
Confidence 2358899999999999999999999988 43 333 899999999 999999999999998654
|
| >2i7a_A Calpain 13; calcium-dependent cytoplasmic cysteine proteinases, like, EF-hand, structural genomics, structural genomics CON SGC, hydrolase; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.77 E-value=1.5e-18 Score=146.17 Aligned_cols=112 Identities=15% Similarity=0.161 Sum_probs=95.4
Q ss_pred CCCcccHHHHHHHHHHhc-----cccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHHHHHc
Q 016471 256 KDGCVSLNNFKVALMRQA-----TDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFE 330 (389)
Q Consensus 256 ~~G~i~~~el~~~l~~~~-----~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D 330 (389)
++|.|+.+||+.+|+.++ ...++.+++.+++..+|.+++|.|+|+||+..+... ..++.||+.||
T Consensus 17 ~dG~I~~~EL~~~l~~l~~~~~~g~~~~~~~~~~l~~~~D~d~~G~I~f~EF~~~~~~~----------~~l~~aF~~fD 86 (174)
T 2i7a_A 17 RGSDIDATQLQGLLNQELLTGPPGDMFSLDECRSLVALMELKVNGRLDQEEFARLWKRL----------VHYQHVFQKVQ 86 (174)
T ss_dssp -CCCEEHHHHHHHHHHHHC-----CCCCHHHHHHHHHHHCSSCSSEECHHHHHHHHHHH----------HHHHHHHHHHC
T ss_pred CCCcCCHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHH----------HHHHHHHHHhc
Confidence 799999999999999882 225788999999999999999999999999854321 34889999999
Q ss_pred ccCCCcccHHHHHHHhC-------Cc--hH-HHHHHHHHccCCCCceeHHHHHHHHccc
Q 016471 331 QEGNRVISVEELALELN-------LA--PA-AYSLLNDCIRNSDGKLSFLGYKRFLHGV 379 (389)
Q Consensus 331 ~d~~G~I~~~el~~~l~-------~~--~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~ 379 (389)
|++|+|+.+||+.++. .. .+ +++++.++| |++|.|+|+||+.+|.+.
T Consensus 87 -d~~G~I~~~El~~~l~~l~~~~G~~~~~~~~~~l~~~~d-d~dG~I~~~EF~~~~~~~ 143 (174)
T 2i7a_A 87 -TSPGVLLSSDLWKAIENTDFLRGIFISRELLHLVTLRYS-DSVGRVSFPSLVCFLMRL 143 (174)
T ss_dssp -SBTTBEEGGGHHHHHHTCGGGTTCCCCHHHHHHHHHHHS-CTTSEECHHHHHHHHHHH
T ss_pred -CCCCcCCHHHHHHHHHHhHhccCCCCCHHHHHHHHHHHc-CCCCeEcHHHHHHHHHHH
Confidence 9999999999999883 21 22 889999999 999999999999998754
|
| >1dgu_A Calcium-saturated CIB; helical, EF-hands, blood clotting; NMR {Homo sapiens} SCOP: a.39.1.5 PDB: 1dgv_A 1xo5_A 1y1a_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=2.2e-18 Score=146.41 Aligned_cols=137 Identities=16% Similarity=0.238 Sum_probs=111.5
Q ss_pred hcCHHHHHHHHHHhhhcCC------C-C--CcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcc-eeHHHHHHHH
Q 016471 237 ALTEEELVYLRAQFMLLEP------K-D--GCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQK-LAYEEFCAAA 306 (389)
Q Consensus 237 ~l~~ee~~~l~~~F~~~D~------~-~--G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~-i~~~eF~~~~ 306 (389)
.++.+++..++..|..+|. + + |.|+.+||.. +..++.. ++. .+++..+|.+++|. |+|+||+..+
T Consensus 13 ~ls~~~~~~l~~~F~~~D~~~~~~~~~~~~G~i~~~el~~-l~~~g~~-~~~---~~l~~~~D~d~~G~~I~~~EF~~~~ 87 (183)
T 1dgu_A 13 FLTKQEILLAHRRFCELLPQEQRSVESSLRAQVPFEQILS-LPELKAN-PFK---ERICRVFSTSPAKDSLSFEDFLDLL 87 (183)
T ss_dssp SCCHHHHHHHHHHHHHHSCSTTCSSCCCTTTCSCHHHHHT-STTSSSC-TTH---HHHHHHHSCSSSSCCCCHHHHHHHH
T ss_pred CCCHHHHHHHHHHHHHhCccccccccccccCcCcHHHHHH-HHhhhcC-cHH---HHHHHHhCCCCCCCEecHHHHHHHH
Confidence 4678889999999999998 4 7 9999999999 8777763 443 47888899999999 9999999876
Q ss_pred hchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHh---CC-----chH---HH----HHHHHHccCCCCceeHHH
Q 016471 307 TSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALEL---NL-----APA---AY----SLLNDCIRNSDGKLSFLG 371 (389)
Q Consensus 307 ~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l---~~-----~~~---~~----~~~~~~d~~~~g~i~~~e 371 (389)
......... ++.++.+|+.||+|++|+|+.+||+.++ +. ..+ +. .++..+|.|++|.|+|+|
T Consensus 88 ~~~~~~~~~---~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~I~~~E 164 (183)
T 1dgu_A 88 SVFSDTATP---DIKSHYAFRIFDFDDDGTLNREDLSRLVNCLTGEGEDTRLSASEMKQLIDNILEESDIDRDGTINLSE 164 (183)
T ss_dssp HHHSTTCCH---HHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHSSSCCCHHHHHHHHHHHHHHHHHHCTTSSSEEEHHH
T ss_pred HHhcCCCCH---HHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhcccccCCCCHHHHHHHHHHHHHHhCCCCCCeEcHHH
Confidence 543322111 3568999999999999999999999988 22 112 44 499999999999999999
Q ss_pred HHHHHccccC
Q 016471 372 YKRFLHGVTV 381 (389)
Q Consensus 372 f~~~~~~~~~ 381 (389)
|+.+|.+.+.
T Consensus 165 F~~~~~~~~~ 174 (183)
T 1dgu_A 165 FQHVISRSPD 174 (183)
T ss_dssp HHHHHCSSCH
T ss_pred HHHHHHhChH
Confidence 9999988764
|
| >1fpw_A Yeast frequenin, calcium-binding protein NCS-1; EF-hand, metal binding protein; NMR {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2ju0_A | Back alignment and structure |
|---|
Probab=99.76 E-value=3e-18 Score=146.30 Aligned_cols=148 Identities=11% Similarity=0.144 Sum_probs=116.6
Q ss_pred HHHHHHHH--hcCHHHHHHHHHHhhhcCCCCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHH
Q 016471 229 AALKALSK--ALTEEELVYLRAQFMLLEPKDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAA 306 (389)
Q Consensus 229 ~~l~~i~~--~l~~ee~~~l~~~F~~~D~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~ 306 (389)
..+..+.. .++.+++..+...|... .++|.|+.+||..++..++....+..++.++|..+|.+++|.|+++||+.++
T Consensus 11 ~~l~~l~~~~~~~~~~i~~~~~~fd~~-~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~f~~~D~d~~G~i~~~ef~~~~ 89 (190)
T 1fpw_A 11 DDLTCLKQSTYFDRREIQQWHKGFLRD-CPSGQLAREDFVKIYKQFFPFGSPEDFANHLFTVFDKDNNGFIHFEEFITVL 89 (190)
T ss_dssp HHHHHHTTTCCSTHHHHHHHHHHHHHH-CTTCCEEHHHHHHHHHHHCTTSCCSHHHHHHHHTCCSSCSSEECHHHHHHHH
T ss_pred HHHHHHHHhcCCCHHHHHHHHHHHHHH-CCCCcCcHHHHHHHHHHHcCCCCcHHHHHHHHHHHCCCCCCcEeHHHHHHHH
Confidence 33444433 46777777777776654 3599999999999999886433456779999999999999999999999876
Q ss_pred hchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHhCC----------------c-hH-HHHHHHHHccCCCCcee
Q 016471 307 TSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALELNL----------------A-PA-AYSLLNDCIRNSDGKLS 368 (389)
Q Consensus 307 ~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~----------------~-~~-~~~~~~~~d~~~~g~i~ 368 (389)
........ ++.++.+|+.+|.|++|+|+.+|+..++.. . .. +.++++.+|.|++|.|+
T Consensus 90 ~~~~~~~~----~~~~~~~f~~~D~d~~G~i~~~ef~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~I~ 165 (190)
T 1fpw_A 90 STTSRGTL----EEKLSWAFELYDLNHDGYITFDEMLTIVASVYKMMGSMVTLNEDEATPEMRVKKIFKLMDKNEDGYIT 165 (190)
T ss_dssp HHHSCCCS----THHHHHHHHHHCSSCSSEEEHHHHHHHHHHHHTTSCSTTSSSCCCCCHHHHHHHHHHHHTTTCSSEEE
T ss_pred HHHccCCc----HHHHHHHHHHhcCCCCCcCcHHHHHHHHHHHHHHhccccCcccccchHHHHHHHHHHHhCCCCCCcCc
Confidence 54322111 346899999999999999999999998721 1 12 88999999999999999
Q ss_pred HHHHHHHHccccC
Q 016471 369 FLGYKRFLHGVTV 381 (389)
Q Consensus 369 ~~ef~~~~~~~~~ 381 (389)
|+||+.++...+.
T Consensus 166 ~~Ef~~~~~~~~~ 178 (190)
T 1fpw_A 166 LDEFREGSKVDPS 178 (190)
T ss_dssp HHHHHHHHHSSTT
T ss_pred HHHHHHHHHhChH
Confidence 9999999988664
|
| >2l2e_A Calcium-binding protein NCS-1; NCS1P, myristoylated, metal binding protein; HET: MYR; NMR {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.76 E-value=2.5e-18 Score=146.85 Aligned_cols=131 Identities=16% Similarity=0.189 Sum_probs=108.3
Q ss_pred HHHHhhhcCC--CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHH
Q 016471 246 LRAQFMLLEP--KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAI 323 (389)
Q Consensus 246 l~~~F~~~D~--~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~ 323 (389)
+...|..+|. ++|.|+.+||..++..++....+..++.++|..+|.+++|.|+++||+.++........ ++.++
T Consensus 27 l~~~f~~~D~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~f~~~D~d~~G~i~~~ef~~~~~~~~~~~~----~~~~~ 102 (190)
T 2l2e_A 27 LQQWYKGFFKDCPSGHLNKSEFQKIYKQFFPFGDPSAFAEYVFNVFDADKNGYIDFKEFICALSVTSRGEL----NDKLI 102 (190)
T ss_dssp HHHHHHHHHHHSCCCEECHHHHHHHHHHHCCCSCHHHHHHHHHHHHCSSSTTCEEHHHHHHHHTTSSCSCS----HHHHH
T ss_pred HHHHHHHHHHhCCCCcCCHHHHHHHHHHhCCCCCccHHHHHHHHHhcCCCCCeEeHHHHHHHHHHHcCCCH----HHHHH
Confidence 4445666666 49999999999999988654456678999999999999999999999987765433222 45689
Q ss_pred HHHHHHcccCCCcccHHHHHHHhCC-----------------chH-HHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 324 TAFDYFEQEGNRVISVEELALELNL-----------------APA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 324 ~aF~~~D~d~~G~I~~~el~~~l~~-----------------~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
.+|+.+|.|++|+|+.+|+..++.. ... +.++++.+|.|++|.|+|+||+.++...+
T Consensus 103 ~~f~~~D~d~~G~i~~~e~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~~ 177 (190)
T 2l2e_A 103 WAFQLYDLDNNGLISYDEMLRIVDAIYKMVGSMVKLPEDEDTPEKRVNKIFNMMDKNKDGQLTLEEFCEGSKRDP 177 (190)
T ss_dssp HHHHHHCTTSCSCBCHHHHHHHHHHHHHHHHHHSCCCSSCCCTHHHHHHHHHHHTCCSSCCBCHHHHHHHHHTCT
T ss_pred HHHhHccCCCCCcCcHHHHHHHHHHHHHHhccccCcccccccHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHhCc
Confidence 9999999999999999999998732 122 88999999999999999999999998765
|
| >1jba_A GCAP-2, protein (guanylate cyclase activating protein 2); EF-hand, calcium-binding protein, guanylyl cyclase regulation, lyase; NMR {Bos taurus} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=99.76 E-value=1.9e-18 Score=149.47 Aligned_cols=135 Identities=16% Similarity=0.192 Sum_probs=112.7
Q ss_pred HHHHHHHHHhhhcCC--CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHH
Q 016471 241 EELVYLRAQFMLLEP--KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERW 318 (389)
Q Consensus 241 ee~~~l~~~F~~~D~--~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~ 318 (389)
-....++..|..+|. ++|.|+.+||..++..++. ..+..++.++|..+|.+++|.|+|+||+.++........
T Consensus 19 ~~~~el~~~f~~~D~~~~~G~i~~~e~~~~l~~~~~-~~~~~~~~~~f~~~D~d~~G~i~~~Ef~~~~~~~~~~~~---- 93 (204)
T 1jba_A 19 ADAAQLQEWYKKFLEECPSGTLFMHEFKRFFKVPDN-EEATQYVEAMFRAFDTNGDNTIDFLEYVAALNLVLRGTL---- 93 (204)
T ss_dssp HHHHHHHHHHHHHHSSSTTCCEEHHHHHHHHHCCSS-STTHHHHHHHHHHHCCSSSSEECHHHHHHHHHHHSSCCC----
T ss_pred CCHHHHHHHHHHHHhhCCCCCcCHHHHHHHHHHhcC-CCcHHHHHHHHHHHcCCCCCeEeHHHHHHHHHHHccCCH----
Confidence 344556777888887 5999999999999998887 478889999999999999999999999987654322212
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHhCC---------------------ch-H-HHHHHHHHccCCCCceeHHHHHHH
Q 016471 319 DQIAITAFDYFEQEGNRVISVEELALELNL---------------------AP-A-AYSLLNDCIRNSDGKLSFLGYKRF 375 (389)
Q Consensus 319 ~~~l~~aF~~~D~d~~G~I~~~el~~~l~~---------------------~~-~-~~~~~~~~d~~~~g~i~~~ef~~~ 375 (389)
++.++.+|+.||.|++|+|+.+||..++.. .. . +..+++.+|.|+||.|+|+||+.+
T Consensus 94 ~~~~~~~F~~~D~d~~G~I~~~E~~~~l~~~~~~~g~~~~~~~~~~~g~~~~~~~~~~~~f~~~D~d~dG~Is~~Ef~~~ 173 (204)
T 1jba_A 94 EHKLKWTFKIYDKDRNGCIDRQELLDIVESIYKLKKACSVEVEAEQQGKLLTPEEVVDRIFLLVDENGDGQLSLNEFVEG 173 (204)
T ss_dssp THHHHHHHHHHCSSCSSCBCHHHHHHHHHHHHHHHHHSSCCTTSSTTTCCCCHHHHHHHHHHHHCCSCCSCBCHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHHHHhCCCCccccccccCchhhHHHHHHHHHHHhCCCCCCeEcHHHHHHH
Confidence 356899999999999999999999998721 11 2 889999999999999999999999
Q ss_pred Hcccc
Q 016471 376 LHGVT 380 (389)
Q Consensus 376 ~~~~~ 380 (389)
|.+.+
T Consensus 174 ~~~~~ 178 (204)
T 1jba_A 174 ARRDK 178 (204)
T ss_dssp HTTTT
T ss_pred HHcCh
Confidence 98654
|
| >2qac_A Myosin A tail domain interacting protein MTIP; malaria invasion, structural genomics, PSI, protein structur initiative, structural genomics of pathogenic protozoa CONS SGPP; 1.70A {Plasmodium falciparum} PDB: 2auc_A | Back alignment and structure |
|---|
Probab=99.76 E-value=1.7e-18 Score=141.35 Aligned_cols=128 Identities=16% Similarity=0.148 Sum_probs=107.7
Q ss_pred HHHHHHHHHhhhcCC-C-CCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHH
Q 016471 241 EELVYLRAQFMLLEP-K-DGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERW 318 (389)
Q Consensus 241 ee~~~l~~~F~~~D~-~-~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~ 318 (389)
++...++..|..+|. + +|.|+.+|+..+|..+|. .++..++..++..+|.+ |+|+||+..+.........
T Consensus 11 ~~~~~l~~~F~~~D~d~~~G~i~~~el~~~l~~~g~-~~~~~~~~~l~~~~d~~----i~~~eF~~~~~~~~~~~~~--- 82 (146)
T 2qac_A 11 EEKVDESDVRIYFNEKSSGGKISIDNASYNARKLGL-APSSIDEKKIKELYGDN----LTYEQYLEYLSICVHDKDN--- 82 (146)
T ss_dssp HHHSCHHHHHHHHHHHCBTTBEEHHHHHHHHHHTTC-CCCHHHHHHHHHHHCSE----ECHHHHHHHHHHTCCTTCC---
T ss_pred HHHHHHHHHHHHhCccCCCCcccHHHHHHHHHHhCC-CCCHHHHHHHHHHhCCC----CCHHHHHHHHHHHhcCcch---
Confidence 455668999999999 9 999999999999999987 47889999999999877 9999999876533211111
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHh---C--CchH-HHHHHHHHccCCCCceeHHHHHHHHcc
Q 016471 319 DQIAITAFDYFEQEGNRVISVEELALEL---N--LAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHG 378 (389)
Q Consensus 319 ~~~l~~aF~~~D~d~~G~I~~~el~~~l---~--~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~ 378 (389)
...++.+|+.||+|++|+|+.+||+.++ | ++.. +..++..+ |++|.|+|+||+.+|.+
T Consensus 83 ~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~--d~dg~i~~~eF~~~l~~ 146 (146)
T 2qac_A 83 VEELIKMFAHFDNNCTGYLTKSQMKNILTTWGDALTDQEAIDALNAF--SSEDNIDYKLFCEDILQ 146 (146)
T ss_dssp HHHHHHHHHTTCTTCSSEEEHHHHHHHHHHSSSCCCHHHHHHHHHHH--CSSSEEEHHHHHHHHTC
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhCCCCCHHHHHHHHHHc--CCCCcCcHHHHHHHHhC
Confidence 3568999999999999999999999998 3 3333 89999999 99999999999999863
|
| >1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A | Back alignment and structure |
|---|
Probab=99.76 E-value=1.4e-19 Score=167.63 Aligned_cols=196 Identities=15% Similarity=0.209 Sum_probs=142.4
Q ss_pred CCCHHHHHHHHhhh---ccCcCCCCCHHHHhCC------CCCCCCCCCC-------------------Ccc--H----HH
Q 016471 168 SVSPEAKDFVRRLL---NKDHRKRMTAAQALTH------PWLHDENRPV-------------------PLD--I----LI 213 (389)
Q Consensus 168 ~~~~~~~~li~~~l---~~~p~~R~s~~e~l~h------~~~~~~~~~~-------------------~~~--~----~~ 213 (389)
+++.++.+|.+++. ..+|..|.+.++.+.| +|+....... ... . .+
T Consensus 16 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~a~g~~~~e~q~~~~v 95 (323)
T 1ij5_A 16 KVHENLEELQKKLDHTSFAHKEDRDRLEAQIAQKEQEQKAKLAEYDQKVQNEFDARERAEREREAARGDAAAEKQRLASL 95 (323)
T ss_dssp HHHHHHHHHHHHHTTCCCC-----CCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTSCHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcChhhhhHHHHHHHHhhcCCCCCcchhhHHH
Confidence 45678899999998 8899999999988877 6764331000 000 0 01
Q ss_pred HHHHH-HHhhcChhHHHHHHHHHHhcCHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCC
Q 016471 214 YKLVK-SYLRATPLKRAALKALSKALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEP 291 (389)
Q Consensus 214 ~~~~~-~~~~~~~l~~~~l~~i~~~l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~ 291 (389)
+..++ .+...+++++ +...++.+++..+...|..+|. ++|.|+.+||..+|..+|. .++..++..++..+|.
T Consensus 96 l~~l~~~f~~~~~lkk-----~~~~Ls~~e~~~l~~~F~~~D~d~dG~Is~~El~~~L~~lg~-~~~~~~i~~l~~~~D~ 169 (323)
T 1ij5_A 96 LKDLEDDASGYNRLRP-----SKPMLSEEDTNILRQLFLSSAVSGSGKFSFQDLKQVLAKYAD-TIPEGPLKKLFVMVEN 169 (323)
T ss_dssp HHHC------------------CCCCCHHHHHHHHHHHTSSSSTTSSCCCHHHHHHHHHHHHT-TSCSSHHHHHHHHHHH
T ss_pred HHHHHHHHHHhhhHHH-----HHHhCCHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHcCC-CCCHHHHHHHHHHhcC
Confidence 11111 1112222222 2346788999999999999999 9999999999999999986 4788889999999999
Q ss_pred CCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHh-CCc--hH-HHH-HHHHHccCCCCc
Q 016471 292 LSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALEL-NLA--PA-AYS-LLNDCIRNSDGK 366 (389)
Q Consensus 292 ~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l-~~~--~~-~~~-~~~~~d~~~~g~ 366 (389)
+++|.|+|.+|+... .. ...++.+|..||.|++|+|+.+||..++ |.. .. +.. ++..+|.|++|.
T Consensus 170 d~~G~I~f~ef~~l~------~~----~~~l~~~F~~~D~d~dG~Is~~El~~~l~g~~~~~~ei~~~l~~~~D~d~dG~ 239 (323)
T 1ij5_A 170 DTKGRMSYITLVAVA------ND----LAALVADFRKIDTNSNGTLSRKEFREHFVRLGFDKKSVQDALFRYADEDESDD 239 (323)
T ss_dssp CCSSTHHHHHHTTSH------HH----HHTSCCCHHHHCTTCCSEECHHHHHHHHHHTTCCCHHHHHHHHHHHCTTCSSC
T ss_pred CCCCcCcHHHHHhhh------hH----HHHHHHHHHHHCCCCCCcCcHHHHHHHHcCCCCCHHHHHHHHHHHhcCCCCCE
Confidence 999999999998632 11 3458889999999999999999999997 322 22 889 999999999999
Q ss_pred eeHHHHHHHHccc
Q 016471 367 LSFLGYKRFLHGV 379 (389)
Q Consensus 367 i~~~ef~~~~~~~ 379 (389)
|+|+||+.+|...
T Consensus 240 Is~~EF~~~l~~~ 252 (323)
T 1ij5_A 240 VGFSEYVHLGLCL 252 (323)
T ss_dssp EEHHHHHHHHHHH
T ss_pred EeHHHHHHHHHHH
Confidence 9999999998653
|
| >1bjf_A Neurocalcin delta; calcium-binding, myristoylation, neuronal specific guanylate cyclase activator; 2.40A {Bos taurus} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=99.75 E-value=8.7e-18 Score=143.82 Aligned_cols=147 Identities=19% Similarity=0.216 Sum_probs=113.1
Q ss_pred HHHHHHHHH--hcCHHHHHHHHHHhhhcCCCCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHH
Q 016471 228 RAALKALSK--ALTEEELVYLRAQFMLLEPKDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAA 305 (389)
Q Consensus 228 ~~~l~~i~~--~l~~ee~~~l~~~F~~~D~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~ 305 (389)
+..+..+.. .++.+++..+...|..- .++|.|+.+||..++..++........+.++|..+|.+++|.|+|+||+.+
T Consensus 10 ~~~l~~l~~~~~~~~~~i~~~f~~fd~~-~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~f~~~D~d~~g~i~~~Ef~~~ 88 (193)
T 1bjf_A 10 PEVMQDLLESTDFTEHEIQEWYKGFLRD-CPSGHLSMEEFKKIYGNFFPYGDASKFAEHVFRTFDANGDGTIDFREFIIA 88 (193)
T ss_dssp HHHHHHHHHHSSCCHHHHHHHHHHHHHH-STTSEEEHHHHHHHHTTTSSSSCCHHHHHHHHHHHCSSCSSEEEHHHHHHH
T ss_pred HHHHHHHHHHcCCCHHHHHHHHHHHHHH-CCCCCcCHHHHHHHHHHhcCcCChHHHHHHHHHHhCCCCCCcCcHHHHHHH
Confidence 344444443 36676666555554431 169999999999999888654345677899999999999999999999987
Q ss_pred HhchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHh-------C----Cch------H-HHHHHHHHccCCCCce
Q 016471 306 ATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALEL-------N----LAP------A-AYSLLNDCIRNSDGKL 367 (389)
Q Consensus 306 ~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l-------~----~~~------~-~~~~~~~~d~~~~g~i 367 (389)
+........ +..++.+|+.+|.|++|+|+.+|+..++ | +.. . +.++|+.+|.|++|.|
T Consensus 89 ~~~~~~~~~----~~~~~~~f~~~D~d~~G~I~~~E~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~I 164 (193)
T 1bjf_A 89 LSVTSRGKL----EQKLKWAFSMYDLDGNGYISKAEMLEIVQAIYKMVSSVMKMPEDESTPEKRTEKIFRQMDTNRDGKL 164 (193)
T ss_dssp HHHHTSSCH----HHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHTTCCCTTTSCGGGSSHHHHHHHHHHHSCTTCSSEE
T ss_pred HHHHcCCCH----HHHHHHHHhhcCCCCCCeECHHHHHHHHHHHHHHhccccCCCcccccHHHHHHHHHHHhCCCCCCeE
Confidence 654322211 4568999999999999999999999987 2 111 1 8899999999999999
Q ss_pred eHHHHHHHHccc
Q 016471 368 SFLGYKRFLHGV 379 (389)
Q Consensus 368 ~~~ef~~~~~~~ 379 (389)
+|+||+.++...
T Consensus 165 ~~~Ef~~~~~~~ 176 (193)
T 1bjf_A 165 SLEEFIRGAKSD 176 (193)
T ss_dssp CHHHHHHHHHHC
T ss_pred eHHHHHHHHhcC
Confidence 999999998654
|
| >2l4h_A Calcium and integrin-binding protein 1; metal binding protei; NMR {Homo sapiens} PDB: 2l4i_A 2lm5_A | Back alignment and structure |
|---|
Probab=99.75 E-value=2.2e-18 Score=150.44 Aligned_cols=136 Identities=18% Similarity=0.280 Sum_probs=111.5
Q ss_pred hcCHHHHHHHHHHhhhcCC------C-C--CcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcc-eeHHHHHHHH
Q 016471 237 ALTEEELVYLRAQFMLLEP------K-D--GCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQK-LAYEEFCAAA 306 (389)
Q Consensus 237 ~l~~ee~~~l~~~F~~~D~------~-~--G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~-i~~~eF~~~~ 306 (389)
.++.+++..+...|..+|. + + |.|+.+||.. +..++.. ++ ..++++.+|.+++|. |+|+||+.++
T Consensus 44 ~~s~~ei~~l~~~F~~~D~~~~~~d~~~~dG~I~~~E~~~-l~~lg~~-~~---~~~lf~~~D~d~dG~~I~f~EF~~~~ 118 (214)
T 2l4h_A 44 FLTKQEILLAHRRFCELLPQEQRSVESSLRAQVPFEQILS-LPELKAN-PF---KERICRVFSTSPAKDSLSFEDFLDLL 118 (214)
T ss_dssp SCCHHHHHHHHHHHHHHSCGGGCCHHHHTTSEECHHHHTT-CHHHHTS-TT---HHHHHHHHCCSSSCCSEEHHHHHHHH
T ss_pred CCCHHHHHHHHHHHHHhCcccccccccccCCcCCHHHHHH-hhccCCC-hH---HHHHHHHhCcCCCCCEecHHHHHHHH
Confidence 5788999999999999997 2 5 9999999999 8887763 34 457899999999999 9999999876
Q ss_pred hchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHhC----------CchH-HH----HHHHHHccCCCCceeHHH
Q 016471 307 TSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALELN----------LAPA-AY----SLLNDCIRNSDGKLSFLG 371 (389)
Q Consensus 307 ~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~----------~~~~-~~----~~~~~~d~~~~g~i~~~e 371 (389)
......... ++.++.+|+.||.|++|+|+.+||+.++. +.++ +. ++++++|.|+||.|+|+|
T Consensus 119 ~~~~~~~~~---~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~~~~~~~~~s~~e~~~~~~~~~~~~D~d~dG~Is~~E 195 (214)
T 2l4h_A 119 SVFSDTATP---DIKSHYAFRIFDFDDDGTLNREDLSRLVNCLTGEGEDTRLSASEMKQLIDNILEESDIDRDGTINLSE 195 (214)
T ss_dssp HHTSSCSCH---HHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHHHSSSCTTCSCTHHHHHHHHHHHHHCCSCCSSBCSHH
T ss_pred HHHcCCCCH---HHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhccccCCCCCHHHHHHHHHHHHHHhCCCCCCcCCHHH
Confidence 643322111 45799999999999999999999999881 2222 44 599999999999999999
Q ss_pred HHHHHcccc
Q 016471 372 YKRFLHGVT 380 (389)
Q Consensus 372 f~~~~~~~~ 380 (389)
|+.+|.+.+
T Consensus 196 F~~~~~~~p 204 (214)
T 2l4h_A 196 FQHVISRSP 204 (214)
T ss_dssp HHHHHHTCH
T ss_pred HHHHHHhCh
Confidence 999998765
|
| >1gjy_A Sorcin, CP-22, V19; calcium binding, calcium-binding, phosphorylation; 2.2A {Chinese hamster} SCOP: a.39.1.8 | Back alignment and structure |
|---|
Probab=99.75 E-value=9.5e-18 Score=140.31 Aligned_cols=120 Identities=13% Similarity=0.228 Sum_probs=103.7
Q ss_pred HHhhhcCC-CCCcccHHHHHHHHHHhccc----cCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHH
Q 016471 248 AQFMLLEP-KDGCVSLNNFKVALMRQATD----AMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIA 322 (389)
Q Consensus 248 ~~F~~~D~-~~G~i~~~el~~~l~~~~~~----~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l 322 (389)
+.|..+|. ++|.|+.+|+..++..++.. .++..++.+++..+|.+++|.|+|+||+..+... ..+
T Consensus 5 ~~F~~~D~d~~G~i~~~el~~~l~~lg~~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~eF~~~~~~~----------~~~ 74 (167)
T 1gjy_A 5 YGYFASVAGQDGQIDADELQRCLTQSGIAGGYKPFNLETCRLMVSMLDRDMSGTMGFNEFKELWAVL----------NGW 74 (167)
T ss_dssp HHHHHHHCCTTSCBCHHHHHHHHHHHTCSTTSCCCCHHHHHHHHHHHCTTCCSCBCHHHHHHHHHHH----------HHH
T ss_pred HHHHHHHcCCCCcCCHHHHHHHHHhhcccCCCCCcCHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHH----------HHH
Confidence 45888999 99999999999999998752 4688999999999999999999999999855432 348
Q ss_pred HHHHHHHcccCCCcccHHHHHHHh---CC--chH-HHHHHHHHccCCCCceeHHHHHHHHccc
Q 016471 323 ITAFDYFEQEGNRVISVEELALEL---NL--APA-AYSLLNDCIRNSDGKLSFLGYKRFLHGV 379 (389)
Q Consensus 323 ~~aF~~~D~d~~G~I~~~el~~~l---~~--~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~ 379 (389)
+.+|+.+|.|++|+|+.+|++.++ |. ... +.+++..+ |++|.|+|+||+.+|...
T Consensus 75 ~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~--d~dg~i~~~eF~~~~~~~ 135 (167)
T 1gjy_A 75 RQHFISFDSDRSGTVDPQELQKALTTMGFRLNPQTVNSIAKRY--STSGKITFDDYIACCVKL 135 (167)
T ss_dssp HHHHHHHCTTCCSEECHHHHHHHHHTTTCCCCHHHHHHHHHHT--CBTTBEEHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHh--CcCCcCcHHHHHHHHHHH
Confidence 899999999999999999999998 32 333 88999998 899999999999988654
|
| >1k94_A Grancalcin; penta-EF-hand protein, calcium binding protein, metal binding protein; 1.70A {Homo sapiens} SCOP: a.39.1.8 PDB: 1k95_A 1f4q_A 1f4o_A | Back alignment and structure |
|---|
Probab=99.75 E-value=6e-18 Score=141.20 Aligned_cols=120 Identities=13% Similarity=0.246 Sum_probs=103.9
Q ss_pred HHhhhcCC-CCCcccHHHHHHHHHHhccc----cCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHH
Q 016471 248 AQFMLLEP-KDGCVSLNNFKVALMRQATD----AMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIA 322 (389)
Q Consensus 248 ~~F~~~D~-~~G~i~~~el~~~l~~~~~~----~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l 322 (389)
..|..+|. ++|.|+.+||..++..++.. .++..++.+++..+|.+++|.|+|+||+..+... ..+
T Consensus 3 ~~F~~~D~d~~G~i~~~el~~~l~~lg~~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~eF~~~~~~~----------~~~ 72 (165)
T 1k94_A 3 YTYFSAVAGQDGEVDAEELQRCLTQSGINGTYSPFSLETCRIMIAMLDRDHTGKMGFNAFKELWAAL----------NAW 72 (165)
T ss_dssp HHHHHHHHGGGTSBCHHHHHHHHHHHTTTTTSCCCCHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHH----------HHH
T ss_pred HHHHHHhCCCCCcCCHHHHHHHHHHhccccCCCCCCHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHH----------HHH
Confidence 45888999 99999999999999998852 4688999999999999999999999999854431 347
Q ss_pred HHHHHHHcccCCCcccHHHHHHHh---CC--chH-HHHHHHHHccCCCCceeHHHHHHHHccc
Q 016471 323 ITAFDYFEQEGNRVISVEELALEL---NL--APA-AYSLLNDCIRNSDGKLSFLGYKRFLHGV 379 (389)
Q Consensus 323 ~~aF~~~D~d~~G~I~~~el~~~l---~~--~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~ 379 (389)
+.+|+.+|+|++|+|+.+|++.++ |. ... +.+++..+ |++|.|+|+||+.+|...
T Consensus 73 ~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~--d~dg~i~~~eF~~~~~~~ 133 (165)
T 1k94_A 73 KENFMTVDQDGSGTVEHHELRQAIGLMGYRLSPQTLTTIVKRY--SKNGRIFFDDYVACCVKL 133 (165)
T ss_dssp HHHHHHHCTTCCSBCCHHHHHHHHHHTTCCCCHHHHHHHHHHH--CBTTBCBHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCceECHHHHHHHHHHhCCCCCHHHHHHHHHHh--CCCCeEcHHHHHHHHHHH
Confidence 899999999999999999999998 32 333 88999999 899999999999998754
|
| >2d8n_A Recoverin; structural genomics, NPPSFA, national project on protein STR and functional analyses, riken structural genomics/proteomi initiative; 2.20A {Homo sapiens} PDB: 2i94_A 1iku_A* 1jsa_A* 1omr_A 1rec_A 1la3_A* 1omv_A 2het_A | Back alignment and structure |
|---|
Probab=99.74 E-value=1e-17 Score=145.13 Aligned_cols=138 Identities=18% Similarity=0.183 Sum_probs=111.0
Q ss_pred cCHHHHHHHHHHhhhcCCCCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHH
Q 016471 238 LTEEELVYLRAQFMLLEPKDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALER 317 (389)
Q Consensus 238 l~~ee~~~l~~~F~~~D~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~ 317 (389)
++.+++..+...|...+ ++|.|+.+||..++..++....+..++.++|..+|.+++|.|+|+||+.++........
T Consensus 30 ~~~~~i~~~f~~~d~~~-~~G~i~~~ef~~~l~~~~~~~~~~~~~~~~f~~~D~d~~G~i~~~Ef~~~~~~~~~~~~--- 105 (207)
T 2d8n_A 30 FSEEELCSWYQSFLKDC-PTGRITQQQFQSIYAKFFPDTDPKAYAQHVFRSFDSNLDGTLDFKEYVIALHMTTAGKT--- 105 (207)
T ss_dssp CCHHHHHHHHHHHHHHC-TTSEEEHHHHHHHHHHTCTTSCCHHHHHHHHHHHCTTCCSEEEHHHHHHHHHHHSCSSS---
T ss_pred CCHHHHHHHHHHHHhhC-CCCCCCHHHHHHHHHHhccCCCcHHHHHHHHHHhcCCCCCeEeHHHHHHHHHHHcCCCH---
Confidence 46666666555554332 49999999999999988754467888999999999999999999999987654322111
Q ss_pred HHHHHHHHHHHHcccCCCcccHHHHHHHhCC-----c--------------hH-HHHHHHHHccCCCCceeHHHHHHHHc
Q 016471 318 WDQIAITAFDYFEQEGNRVISVEELALELNL-----A--------------PA-AYSLLNDCIRNSDGKLSFLGYKRFLH 377 (389)
Q Consensus 318 ~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~-----~--------------~~-~~~~~~~~d~~~~g~i~~~ef~~~~~ 377 (389)
++.++.+|+.+|.|++|+|+.+|+..++.. . .. +..+++.+|.|++|.|+|+||+.+|.
T Consensus 106 -~~~~~~~f~~~D~d~~G~I~~~E~~~~l~~~~~~~g~~~~~~l~~~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~ 184 (207)
T 2d8n_A 106 -NQKLEWAFSLYDVDGNGTISKNEVLEIVMAIFKMITPEDVKLLPDDENTPEKRAEKIWKYFGKNDDDKLTEKEFIEGTL 184 (207)
T ss_dssp -STTHHHHHHHHCTTCSSEECHHHHHHHHHHHHHHSCHHHHHTSCTTTSSHHHHHHHHHHHTTCCTTCCEEHHHHHHHHH
T ss_pred -HHHHHHHHHHhcCCCCCeEcHHHHHHHHHHHHHHhccccCCCcccccccHHHHHHHHHHHcCCCCCCcCcHHHHHHHHH
Confidence 345899999999999999999999998722 1 12 88999999999999999999999998
Q ss_pred ccc
Q 016471 378 GVT 380 (389)
Q Consensus 378 ~~~ 380 (389)
..+
T Consensus 185 ~~~ 187 (207)
T 2d8n_A 185 ANK 187 (207)
T ss_dssp HCH
T ss_pred hCh
Confidence 754
|
| >1juo_A Sorcin; calcium-binding proteins, penta-EF-hand, PEF, X-RAY, metal transport; 2.20A {Homo sapiens} SCOP: a.39.1.8 PDB: 2jc2_A | Back alignment and structure |
|---|
Probab=99.74 E-value=3.3e-18 Score=147.34 Aligned_cols=127 Identities=13% Similarity=0.223 Sum_probs=108.7
Q ss_pred HHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccc----cCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHh
Q 016471 240 EEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATD----AMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEA 314 (389)
Q Consensus 240 ~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~----~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~ 314 (389)
..+...++. |..+|. ++|.|+.+||+.++..++.. .++..++.+++..+|.+++|.|+|+||+..+...
T Consensus 29 ~~~~~~l~~-F~~~D~d~~G~i~~~el~~~l~~lg~~~~~~~~~~~~~~~l~~~~D~d~~g~i~~~eF~~~~~~~----- 102 (198)
T 1juo_A 29 GQTQDPLYG-YFAAVAGQDGQIDADELQRCLTQSGIAGGYKPFNLETCRLMVSMLDRDMSGTMGFNEFKELWAVL----- 102 (198)
T ss_dssp TCCCCTTHH-HHHHHHTTTTEECHHHHHHHHHHHTTTCSSCCCCHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHH-----
T ss_pred ccccHHHHH-HHHHhCCCCCcCCHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhCCCCCCeECHHHHHHHHHHH-----
Confidence 345566777 889999 99999999999999998752 4688999999999999999999999999855432
Q ss_pred hHHHHHHHHHHHHHHcccCCCcccHHHHHHHh---CC--chH-HHHHHHHHccCCCCceeHHHHHHHHccc
Q 016471 315 LERWDQIAITAFDYFEQEGNRVISVEELALEL---NL--APA-AYSLLNDCIRNSDGKLSFLGYKRFLHGV 379 (389)
Q Consensus 315 ~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l---~~--~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~ 379 (389)
..++.+|+.+|+|++|+|+.+||+.++ |. ... +.++++.+ |++|.|+|+||+.++...
T Consensus 103 -----~~~~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~l~~~~--d~dg~i~~~eF~~~~~~~ 166 (198)
T 1juo_A 103 -----NGWRQHFISFDTDRSGTVDPQELQKALTTMGFRLSPQAVNSIAKRY--STNGKITFDDYIACCVKL 166 (198)
T ss_dssp -----HHHHHHHHTTCTTCCSEECHHHHHHHHHHTTCCCCHHHHHHHHHHT--CSSSSEEHHHHHHHHHHH
T ss_pred -----HHHHHHHHHhCCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHh--CCCCeEcHHHHHHHHHHH
Confidence 358899999999999999999999998 32 333 88999998 899999999999988654
|
| >2r2i_A Guanylyl cyclase-activating protein 1; EF hand, GCAP, guanylate cyclase activating protein, GCAP1, GCAP-1, calcium, lipoprotein, myristate; HET: MYR; 2.00A {Gallus gallus} | Back alignment and structure |
|---|
Probab=99.74 E-value=6.3e-18 Score=145.53 Aligned_cols=131 Identities=18% Similarity=0.207 Sum_probs=106.0
Q ss_pred HHHHhhhcCC--CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHH
Q 016471 246 LRAQFMLLEP--KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAI 323 (389)
Q Consensus 246 l~~~F~~~D~--~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~ 323 (389)
++..|..+|. ++|.|+.+||..++..++.......++.++|..+|.+++|.|+|+||+.++........ ++.++
T Consensus 16 l~~~f~~fd~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~f~~~D~d~~G~I~~~Ef~~~~~~~~~~~~----~~~~~ 91 (198)
T 2r2i_A 16 CHQWYKKFMTECPSGQLTLYEFKQFFGLKNLSPSANKYVEQMFETFDFNKDGYIDFMEYVAALSLVLKGKV----DQKLR 91 (198)
T ss_dssp HHHHHHHHHHHCTTSEECHHHHHHHHTCCSCCHHHHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHSSCCH----HHHHH
T ss_pred HHHHHHHHHHhCCCCcCCHHHHHHHHHHhCCCcchHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHHccCch----HHHHH
Confidence 4566666665 59999999999999887754323456999999999999999999999987654322111 45689
Q ss_pred HHHHHHcccCCCcccHHHHHHHhCC-----------ch-H-HHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 324 TAFDYFEQEGNRVISVEELALELNL-----------AP-A-AYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 324 ~aF~~~D~d~~G~I~~~el~~~l~~-----------~~-~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
.+|+.||.|++|+|+.+||..++.. .. . +..+++.+|.|++|.|+|+||+.+|.+.+
T Consensus 92 ~~F~~~D~d~~G~I~~~Ef~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~~ 161 (198)
T 2r2i_A 92 WYFKLYDVDGNGCIDRGELLNIIKAIRAINRCNEAMTAEEFTNMVFDKIDINGDGELSLEEFMEGVQKDE 161 (198)
T ss_dssp HHHHHHCTTCSSCEEHHHHHHHHHHTTGGGGSSSCCCHHHHHHHHHHHHCTTCSSEECHHHHHHHHTTCH
T ss_pred HHHHHhcCCCCCcCcHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHcCH
Confidence 9999999999999999999998821 11 2 88899999999999999999999997543
|
| >2ggz_A Guanylyl cyclase-activating protein 3; EF hand, guanylate cyclase activating protein, GCAP, GCAP3, GCAP-3, lyase activator; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.74 E-value=2.5e-18 Score=149.68 Aligned_cols=132 Identities=19% Similarity=0.228 Sum_probs=105.4
Q ss_pred HHHHHhhhcCC--CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHH
Q 016471 245 YLRAQFMLLEP--KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIA 322 (389)
Q Consensus 245 ~l~~~F~~~D~--~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l 322 (389)
.++..|..+|. ++|.|+.+||..++..++.......++.++|..+|.+++|.|+|+||+.++........ ++.+
T Consensus 20 ei~~~f~~fD~~~~~G~is~~El~~~l~~~~~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~~~~~~----~~~l 95 (211)
T 2ggz_A 20 ETHVWYRTFMMEYPSGLQTLHEFKTLLGLQGLNQKANKHIDQVYNTFDTNKDGFVDFLEFIAAVNLIMQEKM----EQKL 95 (211)
T ss_dssp ----CCCSHHHHCTTSEEEHHHHHHHTTCCSCCHHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHSCSSH----HHHH
T ss_pred HHHHHHHHHHHhCCCCcCCHHHHHHHHHHhCCCcchHHHHHHHHHHHcCCCCCeEeHHHHHHHHHHhccCch----HHHH
Confidence 35677888875 69999999999999877753333556999999999999999999999987654322111 4568
Q ss_pred HHHHHHHcccCCCcccHHHHHHHhC--------C--ch-H-HHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 323 ITAFDYFEQEGNRVISVEELALELN--------L--AP-A-AYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 323 ~~aF~~~D~d~~G~I~~~el~~~l~--------~--~~-~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
+.+|+.||.|++|+|+.+||..++. . .. + +..+++.+|.|++|.|+|+||+.+|.+.+
T Consensus 96 ~~~F~~~D~d~~G~I~~~E~~~~l~~~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~~ 165 (211)
T 2ggz_A 96 KWYFKLYDADGNGSIDKNELLDMFMAVQALNGQQTLSPEEFINLVFHKIDINNDGELTLEEFINGMAKDQ 165 (211)
T ss_dssp HHHHHHHCTTCSSSBCHHHHHHHHHHHTTSSCCCSCTHHHHHHHHHHHHCTTCSSSBCHHHHHHHHHTTT
T ss_pred HHHHHHhcCCCCCcCcHHHHHHHHHHHHhhcCCccccHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCH
Confidence 9999999999999999999999882 1 12 2 78899999999999999999999998654
|
| >2jul_A Calsenilin; EF-hand, calcium, LXXLL, DNA binding protein, dimer, alternative splicing, apoptosis, cytoplasm, endoplasmic reticulum, golgi apparatus; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=99.73 E-value=1.8e-17 Score=148.67 Aligned_cols=140 Identities=15% Similarity=0.183 Sum_probs=116.2
Q ss_pred hcCHHHHHHHHHHhhhcCCCCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhH
Q 016471 237 ALTEEELVYLRAQFMLLEPKDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALE 316 (389)
Q Consensus 237 ~l~~ee~~~l~~~F~~~D~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~ 316 (389)
.++.+++..+...|...+ ++|.|+.+||..++..++....+..++.++|..+|.+++|.|+|+||+.++........
T Consensus 87 ~~s~~ei~~l~~~fd~~~-~~G~I~~~ef~~~l~~~~~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~l~~~~~~~~-- 163 (256)
T 2jul_A 87 KFTKKELQSLYRGFKNEC-PTGLVDEDTFKLIYSQFFPQGDATTYAHFLFNAFDADGNGAIHFEDFVVGLSILLRGTV-- 163 (256)
T ss_dssp TSCHHHHHHHHHHHHHHC-TTSSEEHHHHHHHHHHHCCSSCCHHHHHHHHHHSSCSCCSEECSHHHHHHHHHHHSCCH--
T ss_pred CCCHHHHHHHHHHHHhhC-CCCcCCHHHHHHHHHHHcccCCcHHHHHHHHHHhccCCCCcCcHHHHHHHHHHHhccCh--
Confidence 467888888877776432 59999999999999988754567888999999999999999999999987655432222
Q ss_pred HHHHHHHHHHHHHcccCCCcccHHHHHHHh-------CC----------chH-HHHHHHHHccCCCCceeHHHHHHHHcc
Q 016471 317 RWDQIAITAFDYFEQEGNRVISVEELALEL-------NL----------APA-AYSLLNDCIRNSDGKLSFLGYKRFLHG 378 (389)
Q Consensus 317 ~~~~~l~~aF~~~D~d~~G~I~~~el~~~l-------~~----------~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~ 378 (389)
++.++.+|+.||.|++|+|+.+|+..++ |. ... +.++|+.+|.|+||.|+|+||+.+|.+
T Consensus 164 --~~~l~~~F~~~D~d~dG~I~~~Ef~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~Is~~Ef~~~~~~ 241 (256)
T 2jul_A 164 --HEKLKWAFNLYDINKDGCITKEEMLAIMKSIYDMMGRHTYPILREDAPLEHVERFFQKMDRNQDGVVTIDEFLETCQK 241 (256)
T ss_dssp --HHHHHHHHHHTCCSSSSCBCHHHHHHHHHHHHHHCCCCCSCCSCCCCHHHHHHHHHHHSCCSTTCSBCHHHHHHHHHH
T ss_pred --HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHHHHhCCCCCcccchhhHHHHHHHHHHHHCCCCCCcEeHHHHHHHHHh
Confidence 4578999999999999999999999987 31 112 899999999999999999999999987
Q ss_pred ccC
Q 016471 379 VTV 381 (389)
Q Consensus 379 ~~~ 381 (389)
.+.
T Consensus 242 ~~~ 244 (256)
T 2jul_A 242 DEN 244 (256)
T ss_dssp CSS
T ss_pred CHH
Confidence 654
|
| >2hps_A Coelenterazine-binding protein with bound coelent; bioluminescence, southeast collabora structural genomics, secsg, structural genomics, PSI; HET: CTZ; 1.72A {Renilla muelleri} PDB: 2hq8_A | Back alignment and structure |
|---|
Probab=99.72 E-value=3.7e-18 Score=145.27 Aligned_cols=138 Identities=12% Similarity=0.138 Sum_probs=111.1
Q ss_pred hcCHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHh------ccccCCHHHHHHH---------HhhcCCCCCcceeHH
Q 016471 237 ALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQ------ATDAMTDSRVFEI---------LNVMEPLSDQKLAYE 300 (389)
Q Consensus 237 ~l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~------~~~~~~~~~~~~~---------~~~~d~~~~g~i~~~ 300 (389)
.+++++...++..|..+|. ++|.|+.+||..++..+ |. .++..++.++ |..+|.+++|.|+|+
T Consensus 7 ~l~~~~~~~l~~~F~~~D~d~dG~i~~~El~~~l~~~~~~~~~g~-~~~~~~~~~l~~~~~~~~~f~~~D~d~dg~I~~~ 85 (186)
T 2hps_A 7 SERAYHLRKMKTRMQRVDVTGDGFISREDYELIAVRIAKIAKLSA-EKAEETRQEFLRVADQLGLAPGVRISVEEAAVNA 85 (186)
T ss_dssp HHHHHHHHHHHHHHHTTCTTCSSEEEHHHHHHHHHHHHHHHTCCH-HHHHHHHHHHHHHHHHHTCCTTCEEEHHHHHHHH
T ss_pred cccHHHHHHHHHHhhhcCCCCCCccCHHHHHHHHHHHHHHHHcCC-CCCcHHHHHHHHHHHHHHHHHhcCCCCCCcccHH
Confidence 4567788899999999999 99999999999999876 55 3577788888 499999999999999
Q ss_pred HHHHHHhchhHHHhhHHHHHHHHHHH--HHHcccCCCcccHHHHHHHh---C--CchH-HHHHHHHHccCCCCceeHHHH
Q 016471 301 EFCAAATSVYQLEALERWDQIAITAF--DYFEQEGNRVISVEELALEL---N--LAPA-AYSLLNDCIRNSDGKLSFLGY 372 (389)
Q Consensus 301 eF~~~~~~~~~~~~~~~~~~~l~~aF--~~~D~d~~G~I~~~el~~~l---~--~~~~-~~~~~~~~d~~~~g~i~~~ef 372 (389)
| ..+......... .+.+..+| ..||+|++|+|+.+||+.++ | .... +.++++.+|.|++|.|+|+||
T Consensus 86 E--~~~~~~~~~~~~---~~~~~~~f~~~~fD~d~~G~I~~~E~~~~l~~~g~~~~~~~~~~~~~~~D~d~dG~i~~~ef 160 (186)
T 2hps_A 86 T--DSLLKMKGEEKA---MAVIQSLIMYDCIDTDKDGYVSLPEFKAFLQAVGPDLTDDKAITCFNTLDFNKNGQISRDEF 160 (186)
T ss_dssp H--HHHHHCCTHHHH---HTTHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHCTTCCHHHHHHHHHHHCTTCSSEEEHHHH
T ss_pred H--HHHHHhcCChHH---HHHHHHHHHHHHccCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHHcCCCCCcCcHHHH
Confidence 9 322221111111 23466777 88999999999999999998 3 3344 999999999999999999999
Q ss_pred HHHHcccc
Q 016471 373 KRFLHGVT 380 (389)
Q Consensus 373 ~~~~~~~~ 380 (389)
+.+|....
T Consensus 161 ~~~~~~~~ 168 (186)
T 2hps_A 161 LVTVNDFL 168 (186)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHh
Confidence 99998754
|
| >2f33_A Calbindin; EF-hand, Ca2+-binding, metal binding protein; NMR {Rattus norvegicus} PDB: 2g9b_A | Back alignment and structure |
|---|
Probab=99.72 E-value=3.1e-17 Score=147.28 Aligned_cols=135 Identities=18% Similarity=0.193 Sum_probs=109.7
Q ss_pred HHHHHHHhhhcCC-CCCcccHHHHHHHHHHh----ccccCCHHHHHH----HHhhcCCCCCcceeHHHHHHHHhch----
Q 016471 243 LVYLRAQFMLLEP-KDGCVSLNNFKVALMRQ----ATDAMTDSRVFE----ILNVMEPLSDQKLAYEEFCAAATSV---- 309 (389)
Q Consensus 243 ~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~----~~~~~~~~~~~~----~~~~~d~~~~g~i~~~eF~~~~~~~---- 309 (389)
...++..|..+|. ++|.|+.+||..++..+ +. .++..++.+ ++..+|.+++|.|+|+||+..+...
T Consensus 102 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~g~-~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~~~~ 180 (263)
T 2f33_A 102 CEEFMKTWRKYDTDHSGFIETEELKNFLKDLLEKANK-TVDDTKLAEYTDLMLKLFDSNNDGKLELTEMARLLPVQENFL 180 (263)
T ss_dssp HHHHHHHHTTSSTTTCSSBCHHHHHHHHHHHHHHHTS-CCCHHHHHHHHHHHHHHTCSSSSSCBCHHHHHHHSCTTTCSH
T ss_pred HHHHHHHHHHHCCCCCCCcCHHHHHHHHHHHHhhcCC-CCCHHHHHHHHHHHHHhcCCCCCCeEcHHHHHHHHHHHHHHH
Confidence 3457889999999 99999999999999887 54 467787776 9999999999999999999865431
Q ss_pred -hHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHh---C------CchH-HHHHHHH-HccCCCCceeHHHHHHHHc
Q 016471 310 -YQLEALERWDQIAITAFDYFEQEGNRVISVEELALEL---N------LAPA-AYSLLND-CIRNSDGKLSFLGYKRFLH 377 (389)
Q Consensus 310 -~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l---~------~~~~-~~~~~~~-~d~~~~g~i~~~ef~~~~~ 377 (389)
..... ......++.+|+.||+|++|+|+.+||+.++ + +++. +..+++. +|.|+||.|+|+||+.+|.
T Consensus 181 ~~~~~~-~~~~~~~~~~F~~~D~d~~G~is~~El~~~l~~~~~~~~~~~~~~e~~~~~~~~~D~d~dG~i~~~EF~~~~~ 259 (263)
T 2f33_A 181 LKFQGI-KMCGKEFNKAFELYDQDGNGYIDENELDALLKDLCEKNKQELDINNISTYKKNIMALSDGGKLYRTDLALILS 259 (263)
T ss_dssp HHHHHT-CCCHHHHHHHHHHHCCSSSSCEEHHHHHHHHHHHHHHCTTTCCTTTHHHHHHHHHTTSBTTEECGGGTHHHHC
T ss_pred HHhcCc-chHHHHHHHHHHHhCCCCCCcccHHHHHHHHHHHHHhcCCCCCHHHHHHHHHHhhccCCCCeEcHHHHHHHHh
Confidence 11000 0013568999999999999999999999988 2 2333 8888887 7999999999999999998
Q ss_pred cc
Q 016471 378 GV 379 (389)
Q Consensus 378 ~~ 379 (389)
+.
T Consensus 260 ~~ 261 (263)
T 2f33_A 260 AG 261 (263)
T ss_dssp CS
T ss_pred cc
Confidence 64
|
| >2be4_A Hypothetical protein LOC449832; DR.36843, BC083168, calicium binding, EF-hand superfamily, S genomics, protein structure initiative, PSI; 2.10A {Danio rerio} PDB: 2q4u_A | Back alignment and structure |
|---|
Probab=99.71 E-value=4.8e-17 Score=146.81 Aligned_cols=137 Identities=12% Similarity=0.118 Sum_probs=108.5
Q ss_pred HHHHHHHhhhcCC-CCCcccHHHHHHHHHHh----ccccCCHHHHH----HHHhhcCCCCCcceeHHHHHHHHhch----
Q 016471 243 LVYLRAQFMLLEP-KDGCVSLNNFKVALMRQ----ATDAMTDSRVF----EILNVMEPLSDQKLAYEEFCAAATSV---- 309 (389)
Q Consensus 243 ~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~----~~~~~~~~~~~----~~~~~~d~~~~g~i~~~eF~~~~~~~---- 309 (389)
...+...|..+|. ++|.|+.+||..++..+ |. .++..++. +++..+|.+++|.|+|+||+..+...
T Consensus 103 ~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~g~-~~~~~~~~~~~~~~~~~~D~~~dg~i~~~ef~~~~~~~~~~~ 181 (272)
T 2be4_A 103 SVEFMKIWRKYDADSSGYISAAELKNFLKDLFLQHKK-KIPPNKLDEYTDAMMKIFDKNKDGRLDLNDLARILALQENFL 181 (272)
T ss_dssp HHHHHHHHHHHCTTCCSEEEGGGHHHHHHHHHHHTTC-CCCHHHHHHHHHHHHHHHCSSCSSEEEHHHHGGGSCCSSCSS
T ss_pred HHHHHHHHHHhCCCCCCccCHHHHHHHHHHHHHhcCC-CCCHHHHHHHHHHHHHHhccCCCCcCcHHHHHHHHhhhHHHH
Confidence 3457788999999 99999999999999887 54 46777765 49999999999999999999865431
Q ss_pred -hHH---HhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHhC---------CchH-HHH----HHHHHccCCCCceeHHH
Q 016471 310 -YQL---EALERWDQIAITAFDYFEQEGNRVISVEELALELN---------LAPA-AYS----LLNDCIRNSDGKLSFLG 371 (389)
Q Consensus 310 -~~~---~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~---------~~~~-~~~----~~~~~d~~~~g~i~~~e 371 (389)
... .......+.++.+|+.||+|++|+|+.+||+.++. +.+. +.. ++..+|.|+||.|+|+|
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~Is~~E~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~~D~d~dG~is~~E 261 (272)
T 2be4_A 182 LQFKMDASSQVERKRDFEKIFAHYDVSRTGALEGPEVDGFVKDMMELVRPSISGGDLDKFRECLLTHCDMNKDGKIQKSE 261 (272)
T ss_dssp TTSCCCHHHHHHHHHHHHHHHHHHCTTCCSEEETHHHHHHHHHHHHHHSSSCCHHHHHHHHHHHHHHHCCSTTCEEEHHH
T ss_pred hhhhhhhccccccHHHHHHHHHHhCCCCCCeecHHHHHHHHHHHHHHcCCCCCHHHHHHHHHHHHHHhCCCCCCcCcHHH
Confidence 000 00001145789999999999999999999999881 3333 554 99999999999999999
Q ss_pred HHHHHcccc
Q 016471 372 YKRFLHGVT 380 (389)
Q Consensus 372 f~~~~~~~~ 380 (389)
|+.+|...+
T Consensus 262 F~~~~~~~p 270 (272)
T 2be4_A 262 LALCLGLKH 270 (272)
T ss_dssp HHHHTTCCC
T ss_pred HHHHHccCC
Confidence 999998655
|
| >2f33_A Calbindin; EF-hand, Ca2+-binding, metal binding protein; NMR {Rattus norvegicus} PDB: 2g9b_A | Back alignment and structure |
|---|
Probab=99.71 E-value=8.5e-18 Score=151.00 Aligned_cols=140 Identities=14% Similarity=0.114 Sum_probs=113.8
Q ss_pred HHhcCHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCC------HHHHHHHHhhcCCCCCcceeHHHHHHHHh
Q 016471 235 SKALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMT------DSRVFEILNVMEPLSDQKLAYEEFCAAAT 307 (389)
Q Consensus 235 ~~~l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~------~~~~~~~~~~~d~~~~g~i~~~eF~~~~~ 307 (389)
...+++.+...++..|..+|. ++|.|+.+||..++..++.. ++ ..++.+++..+|.+++|.|+|+||+..+.
T Consensus 7 ~~~l~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~l~~~-~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~Ef~~~~~ 85 (263)
T 2f33_A 7 HLQSSLITASQFFEIWLHFDADGSGYLEGKELQNLIQELLQA-RKKAGLELSPEMKTFVDQYGQRDDGKIGIVELAHVLP 85 (263)
T ss_dssp HTTTSCCCHHHHHHHHHHHCTTCSSSBCSHHHHHHHHHHHHH-HHHHTCCCCHHHHHHHHHHTTGGGCCBCHHHHHHHTT
T ss_pred hhhcCcccHHHHHHHHHHhCCCCCCCcCHHHHHHHHHHHHhh-cCCCccchHHHHHHHHHHhCCCCCCcCcHHHHHHHHh
Confidence 345666677789999999999 99999999999999988753 23 27789999999999999999999998764
Q ss_pred chh--------HHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHh-------CCc--hH-HHH----HHHHHccCCCC
Q 016471 308 SVY--------QLEALERWDQIAITAFDYFEQEGNRVISVEELALEL-------NLA--PA-AYS----LLNDCIRNSDG 365 (389)
Q Consensus 308 ~~~--------~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l-------~~~--~~-~~~----~~~~~d~~~~g 365 (389)
... ..... .+.++.+|+.||.|++|+|+.+||+.++ |.. .. +.. ++..+|.+++|
T Consensus 86 ~~~~~~~~~~~~~~~~---~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~d~~~dg 162 (263)
T 2f33_A 86 TEENFLLLFRCQQLKS---CEEFMKTWRKYDTDHSGFIETEELKNFLKDLLEKANKTVDDTKLAEYTDLMLKLFDSNNDG 162 (263)
T ss_dssp SCTTHHHHHGGGTSSC---HHHHHHHHTTSSTTTCSSBCHHHHHHHHHHHHHHHTSCCCHHHHHHHHHHHHHHTCSSSSS
T ss_pred hhhhHHHHHHHhhccH---HHHHHHHHHHHCCCCCCCcCHHHHHHHHHHHHhhcCCCCCHHHHHHHHHHHHHhcCCCCCC
Confidence 321 11111 4568999999999999999999999987 332 22 444 99999999999
Q ss_pred ceeHHHHHHHHcc
Q 016471 366 KLSFLGYKRFLHG 378 (389)
Q Consensus 366 ~i~~~ef~~~~~~ 378 (389)
.|+|+||+.+|..
T Consensus 163 ~i~~~ef~~~~~~ 175 (263)
T 2f33_A 163 KLELTEMARLLPV 175 (263)
T ss_dssp CBCHHHHHHHSCT
T ss_pred eEcHHHHHHHHHH
Confidence 9999999999875
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=3.9e-18 Score=155.15 Aligned_cols=90 Identities=22% Similarity=0.256 Sum_probs=75.3
Q ss_pred CccccceeecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeecCCCCC
Q 016471 3 HQKLQHLFYSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAP 82 (389)
Q Consensus 3 Hpni~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~~~~~~ 82 (389)
|+++..++..+..|+|||||+||+|.+ +. ...+..++.||+.||.|||++||+||||||+|||++ ++.
T Consensus 163 ~~~v~~~~~~~~~~lvmE~~~g~~L~~-l~-------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~----~~~ 230 (282)
T 1zar_A 163 GLAVPKVYAWEGNAVLMELIDAKELYR-VR-------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS----EEG 230 (282)
T ss_dssp TSSSCCEEEEETTEEEEECCCCEEGGG-CC-------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE----TTE
T ss_pred CCCcCeEEeccceEEEEEecCCCcHHH-cc-------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE----CCc
Confidence 467777777777899999999999987 41 133557999999999999999999999999999994 688
Q ss_pred EEEeecCCccccCCCCCcccccccCCcccccccc
Q 016471 83 LKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH 116 (389)
Q Consensus 83 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~ 116 (389)
+||+|||+|.. +..+.|||.+.
T Consensus 231 vkl~DFG~a~~------------~~~~~a~e~l~ 252 (282)
T 1zar_A 231 IWIIDFPQSVE------------VGEEGWREILE 252 (282)
T ss_dssp EEECCCTTCEE------------TTSTTHHHHHH
T ss_pred EEEEECCCCeE------------CCCCCHHHHHH
Confidence 99999999864 34578999874
|
| >1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A | Back alignment and structure |
|---|
Probab=99.70 E-value=5e-17 Score=150.45 Aligned_cols=126 Identities=12% Similarity=0.194 Sum_probs=109.3
Q ss_pred HHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHH-HHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHH
Q 016471 241 EELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFE-ILNVMEPLSDQKLAYEEFCAAATSVYQLEALERW 318 (389)
Q Consensus 241 ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~-~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~ 318 (389)
.....+...|..+|. ++|.|+.+||..+| +|. .++..++.. ++..+|.+++|.|+|+||+..+....
T Consensus 185 ~~~~~l~~~F~~~D~d~dG~Is~~El~~~l--~g~-~~~~~ei~~~l~~~~D~d~dG~Is~~EF~~~l~~~~-------- 253 (323)
T 1ij5_A 185 NDLAALVADFRKIDTNSNGTLSRKEFREHF--VRL-GFDKKSVQDALFRYADEDESDDVGFSEYVHLGLCLL-------- 253 (323)
T ss_dssp HHHHTSCCCHHHHCTTCCSEECHHHHHHHH--HHT-TCCCHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHH--------
T ss_pred hHHHHHHHHHHHHCCCCCCcCcHHHHHHHH--cCC-CCCHHHHHHHHHHHhcCCCCCEEeHHHHHHHHHHHH--------
Confidence 455667888999999 99999999999998 655 467888999 99999999999999999998655432
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHh----CCc--hH-HHHHHHHHccCCCCceeHHHHHHHHccc
Q 016471 319 DQIAITAFDYFEQEGNRVISVEELALEL----NLA--PA-AYSLLNDCIRNSDGKLSFLGYKRFLHGV 379 (389)
Q Consensus 319 ~~~l~~aF~~~D~d~~G~I~~~el~~~l----~~~--~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~ 379 (389)
.+..+|+.||.|++|+||.+||+.++ |.. +. +..++..+|.|+||.|+|+||+.+|.+.
T Consensus 254 --~l~~~F~~~D~d~dG~Is~~El~~~l~~~~g~~ls~~e~~~l~~~~D~d~dG~Is~~EF~~~~~~~ 319 (323)
T 1ij5_A 254 --VLRILYAFADFDKSGQLSKEEVQKVLEDAHIPESARKKFEHQFSVVDVDDSKSLSYQEFVMLVLLM 319 (323)
T ss_dssp --HHHHHHHHTCSSSCSSEEHHHHHHHHHHTTCCGGGCSTHHHHHHHHTTTTCSEECHHHHHHHHHHH
T ss_pred --HHHHHHHHhCCCCCCCccHHHHHHHHHHHcCCCCCHHHHHHHHHHHCCCCCCcEeHHHHHHHHHHh
Confidence 47889999999999999999999988 432 22 9999999999999999999999999754
|
| >3fs7_A Parvalbumin, thymic; calcium-binding protein, EF-hand, acetylation, calcium, metal binding protein; 1.95A {Gallus gallus} SCOP: a.39.1.4 PDB: 2kqy_A | Back alignment and structure |
|---|
Probab=99.66 E-value=2.6e-16 Score=121.74 Aligned_cols=97 Identities=16% Similarity=0.259 Sum_probs=82.0
Q ss_pred hccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHhCCc--
Q 016471 272 QATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALELNLA-- 349 (389)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~-- 349 (389)
++. .++++++.++++.+| ++|.|+|+||+..+..... . .+.++.+|+.||+|++|+|+.+||+.++...
T Consensus 3 l~~-~~~~~ei~~~~~~~D--~~g~i~~~eF~~~~~~~~~--~----~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~ 73 (109)
T 3fs7_A 3 ITD-ILSAKDIESALSSCQ--AADSFNYKSFFSTVGLSSK--T----PDQIKKVFGILDQDKSGFIEEEELQLFLKNFSS 73 (109)
T ss_dssp GGG-TSCHHHHHHHHHHTC--STTCCCHHHHHHHHTCTTC--C----HHHHHHHHHHHSTTCSSSBCHHHHHTTGGGTCT
T ss_pred ccC-cCCHHHHHHHHHhcC--CCCcCcHHHHHHHHhcCCC--c----HHHHHHHHHHHCCCCCCeEeHHHHHHHHHHHhc
Confidence 444 478999999999998 7999999999987654211 1 4569999999999999999999999988321
Q ss_pred ------hH-HHHHHHHHccCCCCceeHHHHHHHHc
Q 016471 350 ------PA-AYSLLNDCIRNSDGKLSFLGYKRFLH 377 (389)
Q Consensus 350 ------~~-~~~~~~~~d~~~~g~i~~~ef~~~~~ 377 (389)
.. +.++++.+|.|++|.|+|+||+.+|+
T Consensus 74 ~~~~~~~~~~~~~~~~~D~~~dg~i~~~EF~~~~~ 108 (109)
T 3fs7_A 74 SARVLTSAETKAFLAAGDTDGDGKIGVEEFQSLVK 108 (109)
T ss_dssp TSCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHT
T ss_pred ccccCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHh
Confidence 22 99999999999999999999999986
|
| >5pal_A Parvalbumin; calcium-binding protein; 1.54A {Triakis semifasciata} SCOP: a.39.1.4 | Back alignment and structure |
|---|
Probab=99.65 E-value=4.5e-16 Score=120.37 Aligned_cols=96 Identities=15% Similarity=0.227 Sum_probs=81.5
Q ss_pred cCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHh------CCc
Q 016471 276 AMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALEL------NLA 349 (389)
Q Consensus 276 ~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l------~~~ 349 (389)
.++++++.++++.+|. +|.|+|+||+..+..... . .+.++.+|+.||+|++|+|+.+||+.++ |..
T Consensus 5 ~~s~~ei~~~~~~~d~--~g~i~~~eF~~~~~~~~~--~----~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~g~~ 76 (109)
T 5pal_A 5 VLKADDINKAISAFKD--PGTFDYKRFFHLVGLKGK--T----DAQVKEVFEILDKDQSGFIEEEELKGVLKGFSAHGRD 76 (109)
T ss_dssp TSCHHHHHHHHHHTCS--TTCCCHHHHHHHHTCTTC--C----HHHHHHHHHHHCTTCSSEECHHHHHTHHHHHCTTCCC
T ss_pred cCCHHHHHHHHHHhCC--CCcCcHHHHHHHHhhccC--c----HHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHHHcCCC
Confidence 4789999999999997 899999999997654211 1 4568999999999999999999999987 222
Q ss_pred --hH-HHHHHHHHccCCCCceeHHHHHHHHccc
Q 016471 350 --PA-AYSLLNDCIRNSDGKLSFLGYKRFLHGV 379 (389)
Q Consensus 350 --~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~ 379 (389)
.. +..+++.+|.|++|.|+|+||+.+|+++
T Consensus 77 ~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~~~ 109 (109)
T 5pal_A 77 LNDTETKALLAAGDSDHDGKIGADEFAKMVAQA 109 (109)
T ss_dssp CCHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHC
T ss_pred CCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHhC
Confidence 22 9999999999999999999999999753
|
| >2be4_A Hypothetical protein LOC449832; DR.36843, BC083168, calicium binding, EF-hand superfamily, S genomics, protein structure initiative, PSI; 2.10A {Danio rerio} PDB: 2q4u_A | Back alignment and structure |
|---|
Probab=99.64 E-value=9.8e-17 Score=144.76 Aligned_cols=139 Identities=17% Similarity=0.224 Sum_probs=108.9
Q ss_pred CHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHH----Hhccc-cCCHHHHHHH----HhhcCCCCCcceeHHHHHHHHhc
Q 016471 239 TEEELVYLRAQFMLLEP-KDGCVSLNNFKVALM----RQATD-AMTDSRVFEI----LNVMEPLSDQKLAYEEFCAAATS 308 (389)
Q Consensus 239 ~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~----~~~~~-~~~~~~~~~~----~~~~d~~~~g~i~~~eF~~~~~~ 308 (389)
+..+...++.+|..+|. ++|.|+.+||..+|. .+|.. .++..++.++ |..+|.+++|.|+|+||+..+..
T Consensus 6 ~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~~~~~lg~~~~~~~~~~~~~~~~~f~~~D~d~~g~i~~~Ef~~~~~~ 85 (272)
T 2be4_A 6 ANLDAAGFLQIWQHFDADDNGYIEGKELDDFFRHMLKKLQPKDKITDERVQQIKKSFMSAYDATFDGRLQIEELANMILP 85 (272)
T ss_dssp CCCCHHHHHHHHHHHCTTCCSEEEGGGHHHHHHHHHHHHSTTSCCCHHHHHHHHHHHSCHHHHTCCSEEEHHHHHHHHSC
T ss_pred HhcCHHHHHHHHHHhcCCCCCCcCHHHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhcCCCCCcEeHHHHHHHHhh
Confidence 34456678899999999 999999999999998 77752 3677777764 47889999999999999987443
Q ss_pred h--------hHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHh-------CCc--hH-H----HHHHHHHccCCCCc
Q 016471 309 V--------YQLEALERWDQIAITAFDYFEQEGNRVISVEELALEL-------NLA--PA-A----YSLLNDCIRNSDGK 366 (389)
Q Consensus 309 ~--------~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l-------~~~--~~-~----~~~~~~~d~~~~g~ 366 (389)
. ....... ....++.+|+.||+|++|+|+.+|+..++ |.. .. + ..++..+|.|++|.
T Consensus 86 ~~~~~~~~~~~~~~~~-~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~D~~~dg~ 164 (272)
T 2be4_A 86 QEENFLLIFRREAPLD-NSVEFMKIWRKYDADSSGYISAAELKNFLKDLFLQHKKKIPPNKLDEYTDAMMKIFDKNKDGR 164 (272)
T ss_dssp HHHHHHHHHHHHSCCC-CHHHHHHHHHHHCTTCCSEEEGGGHHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHCSSCSSE
T ss_pred hhHHHHHHHhhccCcc-cHHHHHHHHHHhCCCCCCccCHHHHHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHhccCCCCc
Confidence 1 1110000 13568999999999999999999999987 222 22 3 45999999999999
Q ss_pred eeHHHHHHHHcc
Q 016471 367 LSFLGYKRFLHG 378 (389)
Q Consensus 367 i~~~ef~~~~~~ 378 (389)
|+|+||+.+|..
T Consensus 165 i~~~ef~~~~~~ 176 (272)
T 2be4_A 165 LDLNDLARILAL 176 (272)
T ss_dssp EEHHHHGGGSCC
T ss_pred CcHHHHHHHHhh
Confidence 999999998865
|
| >3bow_A Calpain-2 catalytic subunit; cysteine protease, inhibitor, cell membrane, hydrolase, MEMB protease, thiol protease, phosphoprotein; 2.40A {Rattus norvegicus} PDB: 3df0_A 1df0_A 1u5i_A 1kfu_L 1kfx_L | Back alignment and structure |
|---|
Probab=99.64 E-value=5.5e-16 Score=157.98 Aligned_cols=130 Identities=16% Similarity=0.184 Sum_probs=113.3
Q ss_pred cCHHH-HHHHHHHhhhcCCCCCcccHHHHHHHHHHh--------ccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhc
Q 016471 238 LTEEE-LVYLRAQFMLLEPKDGCVSLNNFKVALMRQ--------ATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATS 308 (389)
Q Consensus 238 l~~ee-~~~l~~~F~~~D~~~G~i~~~el~~~l~~~--------~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~ 308 (389)
+++++ ...++..|..+|.++|.|+.+||+.+|..+ +. .++.+++.+++..+|.|++|.|+|+||+..+..
T Consensus 525 ls~~e~~~~l~~~F~~~Dd~dG~Is~~El~~~L~~l~~~~~~~~g~-~~s~~~~~~l~~~~D~d~~G~I~f~EF~~l~~~ 603 (714)
T 3bow_A 525 ANEEDIGDGFRRLFAQLAGEDAEISAFELQTILRRVLAKREDIKSD-GFSIETCKIMVDMLDEDGSGKLGLKEFYILWTK 603 (714)
T ss_dssp CSGGGCCHHHHHHHHHHHGGGTSBCHHHHHHHHHHHHTTCTTSCCS-CCCHHHHHHHHHHHCCSSCSSBCHHHHHHHHHH
T ss_pred CChhhHHHHHHHHHHHHcCCCCcCCHHHHHHHHHHHhhhcccccCC-CCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHH
Confidence 56666 788999999999889999999999999987 43 578999999999999999999999999986543
Q ss_pred hhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHh---C--CchH-HHHHHHHHccCCCCceeHHHHHHHHccc
Q 016471 309 VYQLEALERWDQIAITAFDYFEQEGNRVISVEELALEL---N--LAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHGV 379 (389)
Q Consensus 309 ~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l---~--~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~ 379 (389)
. +.++.+|+.||+|++|+|+.+||+.+| | +... ++.++..+| |+||.|+|+||+.+|.+.
T Consensus 604 ~----------~~l~~~F~~~D~d~dG~Is~~El~~~L~~~G~~ls~~~~~~l~~~~D-d~dG~Isf~EF~~~l~~~ 669 (714)
T 3bow_A 604 I----------QKYQKIYREIDVDRSGTMNSYEMRKALEEAGFKLPCQLHQVIVARFA-DDELIIDFDNFVRCLVRL 669 (714)
T ss_dssp H----------HHHHHHHHHHCTTCCSSEEHHHHHHHHHHTTEECCHHHHHHHHHHHS-CTTCEECHHHHHHHHHHH
T ss_pred H----------HHHHHHHHHhCCCCCCeECHHHHHHHHHHcCCCCCHHHHHHHHHHhC-CCCCeEcHHHHHHHHHHH
Confidence 2 348899999999999999999999998 3 2333 999999999 999999999999998754
|
| >1bu3_A Calcium-binding protein; 1.65A {Merluccius bilinearis} SCOP: a.39.1.4 | Back alignment and structure |
|---|
Probab=99.64 E-value=9.6e-16 Score=118.51 Aligned_cols=98 Identities=19% Similarity=0.257 Sum_probs=81.8
Q ss_pred HhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHhC---
Q 016471 271 RQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALELN--- 347 (389)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~--- 347 (389)
++|. .++++++.+++..+| ++|.|+|+||+..+... . .. .+.++.+|+.||+|++|+|+.+||+.++.
T Consensus 2 slg~-~~~~~e~~~~~~~~d--~~g~i~~~eF~~~~~~~-~-~~----~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~ 72 (109)
T 1bu3_A 2 AFSG-ILADADVAAALKACE--AADSFNYKAFFAKVGLT-A-KS----ADDIKKAFFVIDQDKSGFIEEDELKLFLQVFS 72 (109)
T ss_dssp CCSC-SSCHHHHHHHHHHTC--STTCCCHHHHHHHHTGG-G-SC----HHHHHHHHHHHCTTCSSSEEHHHHHTHHHHHS
T ss_pred cccc-cCCHHHHHHHHHHhC--CCCcCcHHHHHHHHHcC-h-hh----HHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHc
Confidence 3455 478999999999999 88999999999865422 1 11 45689999999999999999999999882
Q ss_pred ---C--chH-HHHHHHHHccCCCCceeHHHHHHHHc
Q 016471 348 ---L--APA-AYSLLNDCIRNSDGKLSFLGYKRFLH 377 (389)
Q Consensus 348 ---~--~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~ 377 (389)
. ... +.++++.+|.|++|.|+|+||+.+|+
T Consensus 73 ~~g~~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~ 108 (109)
T 1bu3_A 73 AGARALTDAETKAFLKAGDSDGDGAIGVDEWAALVK 108 (109)
T ss_dssp TTCCCCCHHHHHHHHHHHCTTCSSEECHHHHHHHHT
T ss_pred ccCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHh
Confidence 1 222 99999999999999999999999986
|
| >2pvb_A Protein (parvalbumin); calcium binding protein, metal binding protein; 0.91A {Esox lucius} SCOP: a.39.1.4 PDB: 1pvb_A 2pal_A 1pal_A 3pal_A 4pal_A 4cpv_A 1cdp_A 5cpv_A 1b8r_A 1b9a_A 1b8l_A 1b8c_A 1a75_B 1a75_A | Back alignment and structure |
|---|
Probab=99.64 E-value=6.7e-16 Score=119.17 Aligned_cols=93 Identities=20% Similarity=0.248 Sum_probs=79.3
Q ss_pred CCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHhCC--------
Q 016471 277 MTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALELNL-------- 348 (389)
Q Consensus 277 ~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~-------- 348 (389)
++++++.++++.+| ++|.|+|+||+..+... . .. .+.++.+|+.||+|++|+|+.+||+.++..
T Consensus 6 ~~~~e~~~l~~~~d--~~g~i~~~eF~~~~~~~-~--~~---~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~ 77 (108)
T 2pvb_A 6 LKDADVAAALAACS--AADSFKHKEFFAKVGLA-S--KS---LDDVKKAFYVIDQDKSGFIEEDELKLFLQNFSPSARAL 77 (108)
T ss_dssp SCHHHHHHHHHHTC--STTCCCHHHHHHHHTGG-G--SC---HHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTSCCC
T ss_pred CCHHHHHHHHHHhC--CCCcCcHHHHHHHHhCC-h--hH---HHHHHHHHHHHCCCCCCcCCHHHHHHHHHHHhccCCCC
Confidence 78899999999998 78999999999865322 1 11 456899999999999999999999999832
Q ss_pred chH-HHHHHHHHccCCCCceeHHHHHHHHc
Q 016471 349 APA-AYSLLNDCIRNSDGKLSFLGYKRFLH 377 (389)
Q Consensus 349 ~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~ 377 (389)
... +..+++.+|.|++|.|+|+||+.+|+
T Consensus 78 ~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~ 107 (108)
T 2pvb_A 78 TDAETKAFLADGDKDGDGMIGVDEFAAMIK 107 (108)
T ss_dssp CHHHHHHHHHHHCTTCSSSBCHHHHHHHHH
T ss_pred CHHHHHHHHHHhCCCCCCcEeHHHHHHHHh
Confidence 222 99999999999999999999999986
|
| >1rwy_A Parvalbumin alpha; EF-hand, calcium-binding, calcium-binding protein; HET: PG4; 1.05A {Rattus norvegicus} SCOP: a.39.1.4 PDB: 1rtp_1* 2jww_A 3f45_A 1s3p_A 1xvj_A 1rjv_A 1rk9_A 1g33_A | Back alignment and structure |
|---|
Probab=99.63 E-value=1e-15 Score=118.34 Aligned_cols=95 Identities=11% Similarity=0.210 Sum_probs=80.5
Q ss_pred cCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHhC------C-
Q 016471 276 AMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALELN------L- 348 (389)
Q Consensus 276 ~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~------~- 348 (389)
.++++++.++++.+| ++|.|+|+||+..+... . .. .+.++.+|+.||+|++|+|+.+||+.++. .
T Consensus 5 ~~t~~e~~~~~~~~d--~~g~i~~~eF~~~~~~~-~--~~---~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~ 76 (109)
T 1rwy_A 5 LLSAEDIKKAIGAFT--AADSFDHKKFFQMVGLK-K--KS---ADDVKKVFHILDKDKSGFIEEDELGSILKGFSSDARD 76 (109)
T ss_dssp HSCHHHHHHHHHTTC--STTCCCHHHHHHHHTGG-G--SC---HHHHHHHHHHHSTTCSSEECHHHHHTHHHHHCTTCCC
T ss_pred cCCHHHHHHHHHHcC--CCCcEeHHHHHHHHhcC-c--ch---HHHHHHHHHHHCCCCCCeEcHHHHHHHHHHHhccCCC
Confidence 478999999999999 89999999999865321 1 11 45789999999999999999999999882 2
Q ss_pred -chH-HHHHHHHHccCCCCceeHHHHHHHHcc
Q 016471 349 -APA-AYSLLNDCIRNSDGKLSFLGYKRFLHG 378 (389)
Q Consensus 349 -~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~ 378 (389)
... +..+++.+|.|++|.|+|+||+.+|++
T Consensus 77 ~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~~ 108 (109)
T 1rwy_A 77 LSAKETKTLMAAGDKDGDGKIGVEEFSTLVAE 108 (109)
T ss_dssp CCHHHHHHHHHHHCTTCSSSEEHHHHHHHHHT
T ss_pred CCHHHHHHHHHHHCCCCCCcCCHHHHHHHHHc
Confidence 222 999999999999999999999999875
|
| >3h4s_E KCBP interacting Ca2+-binding protein; kinesin, motor protein, regulation, complex, calcium, EF- hand, calmodulin, ATP-binding, microtubule; HET: ADP; 2.40A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=99.63 E-value=3.3e-16 Score=126.18 Aligned_cols=96 Identities=13% Similarity=0.188 Sum_probs=59.7
Q ss_pred HHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHh---CC-c--hH-HHH
Q 016471 282 VFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALEL---NL-A--PA-AYS 354 (389)
Q Consensus 282 ~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l---~~-~--~~-~~~ 354 (389)
+.++|..+|.+++|.|+|+||+..+......... .+.++.+|+.||+|++|+|+.+||+.++ |. . .. +.+
T Consensus 5 ~~~l~~~~D~d~~G~I~~~EF~~~~~~~~~~~~~---~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~e~~~ 81 (135)
T 3h4s_E 5 EKSMLLETTSTTKMETKYEDMLPVMAEKMDVEEF---VSELCKGFSLLADPERHLITAESLRRNSGILGIEGMSKEDAQG 81 (135)
T ss_dssp --------------CCCC-----------CHHHH---HHHHHHHHHHHSBTTTTBBCHHHHHHHGGGGTCCCCCHHHHHH
T ss_pred HHHHHHHHcCCCCCcEeHHHHHHHHHHHccccch---HHHHHHHHHHHCCCCCCcCCHHHHHHHHHHhCCCCCCHHHHHH
Confidence 5689999999999999999999866543222211 4579999999999999999999999998 42 2 22 999
Q ss_pred HHHHHccCCCCceeHHHHHHHHcccc
Q 016471 355 LLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 355 ~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
+++.+|.|++|.|+|+||+.+|.+..
T Consensus 82 ~~~~~D~d~dG~I~~~EF~~~~~~~~ 107 (135)
T 3h4s_E 82 MVREGDLDGDGALNQTEFCVLMVRLS 107 (135)
T ss_dssp HHHHHCSSCSSSBCHHHHHHHHHHHH
T ss_pred HHHHhCCCCCCCCcHHHHHHHHHHhC
Confidence 99999999999999999999997653
|
| >1pva_A Parvalbumin; calcium binding; 1.65A {Esox lucius} SCOP: a.39.1.4 PDB: 2pas_A 3pat_A | Back alignment and structure |
|---|
Probab=99.63 E-value=9.7e-16 Score=118.65 Aligned_cols=98 Identities=15% Similarity=0.269 Sum_probs=82.1
Q ss_pred hccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHhCC---
Q 016471 272 QATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALELNL--- 348 (389)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~--- 348 (389)
+|. .++++++.+++..+| ++|.|+|+||+..+... . .. .+.++.+|+.||+|++|+|+.+||+.++..
T Consensus 3 lG~-~~t~~e~~~~~~~~d--~~g~i~~~ef~~~~~~~-~-~~----~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~ 73 (110)
T 1pva_A 3 AKD-LLKADDIKKALDAVK--AEGSFNHKKFFALVGLK-A-MS----ANDVKKVFKAIDADASGFIEEEELKFVLKSFAA 73 (110)
T ss_dssp HHH-HSCHHHHHHHHHHTC--STTCCCHHHHHHHHTCT-T-SC----HHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCT
T ss_pred ccc-cCCHHHHHHHHHhcC--CCCcCcHHHHHHHHccC-c-ch----HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhh
Confidence 454 478999999999998 78999999999876321 1 11 456899999999999999999999999832
Q ss_pred -----chH-HHHHHHHHccCCCCceeHHHHHHHHcc
Q 016471 349 -----APA-AYSLLNDCIRNSDGKLSFLGYKRFLHG 378 (389)
Q Consensus 349 -----~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~ 378 (389)
... +..+++.+|.|++|.|+|+||+.+|++
T Consensus 74 ~g~~~~~~~~~~~~~~~d~~~dg~i~~~eF~~~~~~ 109 (110)
T 1pva_A 74 DGRDLTDAETKAFLKAADKDGDGKIGIDEFETLVHE 109 (110)
T ss_dssp TCCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHC
T ss_pred cCCCCCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHh
Confidence 222 999999999999999999999999875
|
| >1sjj_A Actinin; 3-helix bundle, calponin homology domain, calmodulin-like domain, actin binding protein, contractIle protein; 20.00A {Gallus gallus} SCOP: i.15.1.1 | Back alignment and structure |
|---|
Probab=99.62 E-value=4.6e-16 Score=162.91 Aligned_cols=137 Identities=18% Similarity=0.345 Sum_probs=117.9
Q ss_pred hcCHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhh
Q 016471 237 ALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEAL 315 (389)
Q Consensus 237 ~l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~ 315 (389)
.++.++...+...|..+|. ++|.|+.+||..+|..+|.. ++..++..+|..+|.|++|.|+|+||+..+.........
T Consensus 718 ~l~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~g~~-~~~~~~~~~~~~~D~d~dG~I~~~EF~~~~~~~~~~~~~ 796 (863)
T 1sjj_A 718 GISQEQMNEFRASFNHFDRKKTGMMDCEDFRACLISMGYN-MGEAEFARIMSIVDPNRMGVVTFQAFIDFMSRETADTDT 796 (863)
T ss_dssp CSSHHHHHHHHHHHTTTCSSSSSEEESTTHHHHHHHHTCC-CCTHHHHHHHHHHCTTSCSEEETTHHHHTHHHHSTTCSS
T ss_pred CCCHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHHcCCC-CCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhcCCCC
Confidence 4567788899999999999 99999999999999999874 788999999999999999999999999866543211111
Q ss_pred HHHHHHHHHHHHHHcccCCCcccHHHHHHHhCCchH-HHHHHHHHccC-----CCCceeHHHHHHHHcccc
Q 016471 316 ERWDQIAITAFDYFEQEGNRVISVEELALELNLAPA-AYSLLNDCIRN-----SDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 316 ~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~~~-~~~~~~~~d~~-----~~g~i~~~ef~~~~~~~~ 380 (389)
.+.++.+|+.| .|++|+|+.+||+.+|. +. ++.++..+|.+ +||.|+|+||+.+|.+.+
T Consensus 797 ---~~~l~~aF~~~-~d~~G~Is~~El~~~l~--~~~~~~l~~~~d~~~~~~~~dg~I~~~eF~~~~~~~~ 861 (863)
T 1sjj_A 797 ---ADQVMASFKIL-AGDKNYITVDELRRELP--PDQAEYCIARMAPYNGRDAVPGALDYMSFSTALYGES 861 (863)
T ss_dssp ---SHHHHHHHHGG-GTSSSEEEHHHHHHHSC--HHHHHHHHHHSEECCSSCCCTTEEESHHHHHHHSCCS
T ss_pred ---HHHHHHHHHHH-hCCCCcCcHHHHHHHCC--HHHHHHHHHHcchhcCCCCCCCceeHHHHHHHHhcCC
Confidence 34689999999 89999999999999985 44 89999999987 699999999999998754
|
| >1rro_A RAT oncomodulin; calcium-binding protein; 1.30A {Rattus rattus} SCOP: a.39.1.4 PDB: 1omd_A 2nln_A 1ttx_A | Back alignment and structure |
|---|
Probab=99.62 E-value=1.8e-15 Score=116.77 Aligned_cols=94 Identities=13% Similarity=0.251 Sum_probs=79.8
Q ss_pred cCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHhCC-------
Q 016471 276 AMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALELNL------- 348 (389)
Q Consensus 276 ~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~------- 348 (389)
.++++++.+++..+| ++|.|+|+||+..+.. .. .. .+.++.+|+.||+|++|+|+.+||+.++..
T Consensus 5 ~~t~~e~~~~~~~~d--~~g~i~~~eF~~~~~~-~~-~~----~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~ 76 (108)
T 1rro_A 5 ILSAEDIAAALQECQ--DPDTFEPQKFFQTSGL-SK-MS----ASQVKDIFRFIDNDQSGYLDGDELKYFLQKFQSDARE 76 (108)
T ss_dssp TSCHHHHHHHHHHTC--STTCCCHHHHHHHHSG-GG-SC----HHHHHHHHHHHCTTCSSEECTHHHHTGGGGTCTTSCC
T ss_pred cCCHHHHHHHHHHcc--CCCCcCHHHHHHHHhc-Cc-cc----HHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhhccCC
Confidence 478999999999998 8899999999986532 11 11 456899999999999999999999999832
Q ss_pred -chH-HHHHHHHHccCCCCceeHHHHHHHHc
Q 016471 349 -APA-AYSLLNDCIRNSDGKLSFLGYKRFLH 377 (389)
Q Consensus 349 -~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~ 377 (389)
... +.++++.+|.|++|.|+|+||+.+|+
T Consensus 77 ~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~ 107 (108)
T 1rro_A 77 LTESETKSLMDAADNDGDGKIGADEFQEMVH 107 (108)
T ss_dssp CCHHHHHHHHHHHCCSSSSSEEHHHHHHHHT
T ss_pred CCHHHHHHHHHHhCCCCCCcCcHHHHHHHHc
Confidence 222 99999999999999999999999986
|
| >1djx_A PLC-D1, phosphoinositide-specific phospholipase C, isozyme delta1; phosphoric diester hydrolase, hydrolase, lipid degradation, transducer; HET: I3P; 2.30A {Rattus norvegicus} SCOP: a.39.1.7 b.7.1.1 c.1.18.1 PDB: 1djg_A 1dji_A 1djh_A* 1djw_A* 1djy_A* 1djz_A* 2isd_A 1qas_A 1qat_A | Back alignment and structure |
|---|
Probab=99.60 E-value=2.9e-16 Score=156.68 Aligned_cols=127 Identities=18% Similarity=0.191 Sum_probs=58.0
Q ss_pred HHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHH
Q 016471 244 VYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIA 322 (389)
Q Consensus 244 ~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l 322 (389)
..+++.|..+|. ++|.|+.+||+.+|+.+|.. ++++++.++|+.+|.+++|.|+|+||+..+.... . ++++
T Consensus 11 ~~l~~~F~~fD~d~dG~Is~~El~~~l~~lg~~-~s~~el~~lf~~~D~d~~G~I~f~EF~~~~~~l~---~----~~el 82 (624)
T 1djx_A 11 HWIHSCLRKADKNKDNKMNFKELKDFLKELNIQ-VDDGYARKIFRECDHSQTDSLEDEEIETFYKMLT---Q----RAEI 82 (624)
T ss_dssp ----------------------------------------------------------CTTHHHHHHT---C----CHHH
T ss_pred HHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCC-CCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHHhc---c----HHHH
Confidence 357899999999 99999999999999998874 7888999999999999999999999998665432 1 2358
Q ss_pred HHHHHHHcccCCCcccHHHHHHHhC-------CchH-HHHHHHHHccC----CCCceeHHHHHHHHccc
Q 016471 323 ITAFDYFEQEGNRVISVEELALELN-------LAPA-AYSLLNDCIRN----SDGKLSFLGYKRFLHGV 379 (389)
Q Consensus 323 ~~aF~~~D~d~~G~I~~~el~~~l~-------~~~~-~~~~~~~~d~~----~~g~i~~~ef~~~~~~~ 379 (389)
+.+|+.||++ +|+|+.+||+++|. ...+ +++|++++|.| ++|.|+|+||+.+|...
T Consensus 83 ~~aF~~fD~~-~G~Is~~EL~~fL~~~qge~~ls~ee~~~ii~~~d~d~~~~~dG~Is~deF~~~L~s~ 150 (624)
T 1djx_A 83 DRAFEEAAGS-AETLSVERLVTFLQHQQREEEAGPALALSLIERYEPSETAKAQRQMTKDGFLMYLLSA 150 (624)
T ss_dssp HHHHHHHHTT-SSSEEHHHHHHHHHHTSCCSSCSHHHHHHHHHHHCCCHHHHHTTEECHHHHHHHHHST
T ss_pred HHHHHHhcCC-CCeecHHHHHHHHHHHhCCCCCCHHHHHHHHHHhCCChhhccCCCCCHHHHHHHhcCc
Confidence 9999999986 89999999999982 2333 99999999998 79999999999999764
|
| >1y1x_A Leishmania major homolog of programmed cell death protein; SGPP, structural genomics, PSI; 1.95A {Leishmania major} SCOP: a.39.1.8 | Back alignment and structure |
|---|
Probab=99.53 E-value=7e-14 Score=119.43 Aligned_cols=122 Identities=12% Similarity=0.080 Sum_probs=101.2
Q ss_pred HHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHH
Q 016471 246 LRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAIT 324 (389)
Q Consensus 246 l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~ 324 (389)
+...|..+|. ++|.|+.+||..++... .++.++|+.+|.+++|.|+.+||..++........ ++.+..
T Consensus 65 ~~~l~~~~D~d~dG~I~~~EF~~~~~~~-------~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~g~~~~----~~~~~~ 133 (191)
T 1y1x_A 65 TEKLLHMYDKNHSGEITFDEFKDLHHFI-------LSMREGFRKRDSSGDGRLDSNEVRAALLSSGYQVS----EQTFQA 133 (191)
T ss_dssp HHHHHHHHCTTCSSSBCHHHHHHHHHHH-------HHHHHHHHHHCTTSSSCBCHHHHHHHHHTTSCCCC----HHHHHH
T ss_pred HHHHHHHhCCCCCCeEcHHHHHHHHHHH-------HHHHHHHHHhCCCCCCeEcHHHHHHHHHHhCCCCC----HHHHHH
Confidence 4456777899 99999999999877543 45889999999999999999999987655422222 346889
Q ss_pred HHHHHcccCCCcccHHHHHHHhCCchHHHHHHHHHccCCCCc--eeHHHHHHHHcc
Q 016471 325 AFDYFEQEGNRVISVEELALELNLAPAAYSLLNDCIRNSDGK--LSFLGYKRFLHG 378 (389)
Q Consensus 325 aF~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~d~~~~g~--i~~~ef~~~~~~ 378 (389)
.|+.+|.|++|.|+.+|+..++.....+.++++.+|.|++|. ++|+||+.+|..
T Consensus 134 ~~~~~D~d~dg~i~~~eF~~~~~~~~~~~~~F~~~D~d~dG~i~~~~~eF~~~~~~ 189 (191)
T 1y1x_A 134 LMRKFDRQRRGSLGFDDYVELSIFVCRVRNVFAFYDRERTGQVTFTFDTFIGGSVS 189 (191)
T ss_dssp HHHHHCTTCSSSBCHHHHHHHHHHHHHHHHHHHHHCTTCCSEEEEEHHHHHHHHHH
T ss_pred HHHHhCCCCCCeEeHHHHHHHHHHHHHHHHHHHHhCcCCCceEEeeHHHHHHHHHh
Confidence 999999999999999999999855555889999999999999 789999998864
|
| >2d8n_A Recoverin; structural genomics, NPPSFA, national project on protein STR and functional analyses, riken structural genomics/proteomi initiative; 2.20A {Homo sapiens} PDB: 2i94_A 1iku_A* 1jsa_A* 1omr_A 1rec_A 1la3_A* 1omv_A 2het_A | Back alignment and structure |
|---|
Probab=99.51 E-value=4.8e-14 Score=121.88 Aligned_cols=121 Identities=9% Similarity=0.120 Sum_probs=101.4
Q ss_pred cCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCC-CCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHHHHHc
Q 016471 253 LEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPL-SDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFE 330 (389)
Q Consensus 253 ~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~-~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D 330 (389)
++. ++|.|+.+|+..++..++ ++..++.++|..+|.+ ++|.|+++||..++......... ...+..+|+.+|
T Consensus 8 mg~~~~g~l~~~el~~~~~~~~---~~~~~i~~~f~~~d~~~~~G~i~~~ef~~~l~~~~~~~~~---~~~~~~~f~~~D 81 (207)
T 2d8n_A 8 MGNSKSGALSKEILEELQLNTK---FSEEELCSWYQSFLKDCPTGRITQQQFQSIYAKFFPDTDP---KAYAQHVFRSFD 81 (207)
T ss_dssp CTTCCTTCCCHHHHHHHHHHSS---CCHHHHHHHHHHHHHHCTTSEEEHHHHHHHHHHTCTTSCC---HHHHHHHHHHHC
T ss_pred hccccCCCCCHHHHHHHHHHcC---CCHHHHHHHHHHHHhhCCCCCCCHHHHHHHHHHhccCCCc---HHHHHHHHHHhc
Confidence 567 899999999999888775 5889999999999998 79999999999876543221111 346899999999
Q ss_pred ccCCCcccHHHHHHHh---C--CchH-HHHHHHHHccCCCCceeHHHHHHHHccc
Q 016471 331 QEGNRVISVEELALEL---N--LAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHGV 379 (389)
Q Consensus 331 ~d~~G~I~~~el~~~l---~--~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~ 379 (389)
.|++|.|+.+|+..++ + .... +..+|+.+|.|++|.|+++||..+++..
T Consensus 82 ~d~~G~i~~~Ef~~~~~~~~~~~~~~~~~~~f~~~D~d~~G~I~~~E~~~~l~~~ 136 (207)
T 2d8n_A 82 SNLDGTLDFKEYVIALHMTTAGKTNQKLEWAFSLYDVDGNGTISKNEVLEIVMAI 136 (207)
T ss_dssp TTCCSEEEHHHHHHHHHHHSCSSSSTTHHHHHHHHCTTCSSEECHHHHHHHHHHH
T ss_pred CCCCCeEeHHHHHHHHHHHcCCCHHHHHHHHHHHhcCCCCCeEcHHHHHHHHHHH
Confidence 9999999999999988 2 2222 9999999999999999999999999874
|
| >1qxp_A MU-like calpain; M-calpain, MU-calpain, catalytic triad, Ca(2+) requirement, hydrolase chimera; 2.80A {Rattus norvegicus} SCOP: a.39.1.8 a.39.1.8 b.14.1.1 d.3.1.3 | Back alignment and structure |
|---|
Probab=99.49 E-value=6.4e-15 Score=154.47 Aligned_cols=128 Identities=17% Similarity=0.226 Sum_probs=99.4
Q ss_pred HHHHHHHHHhhhcCCCCCcccHHHHHHHHHHhcc-------ccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHH
Q 016471 241 EELVYLRAQFMLLEPKDGCVSLNNFKVALMRQAT-------DAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLE 313 (389)
Q Consensus 241 ee~~~l~~~F~~~D~~~G~i~~~el~~~l~~~~~-------~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~ 313 (389)
++...++..|..+|.++|.|+.+||+.+|..++. ..++.+++.+++..+|.+++|.|+|+||+..+...
T Consensus 531 e~~~~l~~~F~~~D~~dG~Is~~El~~~L~~~~~~~~~~~~~~~s~~~~~~l~~~~D~d~~G~I~~~EF~~~~~~~---- 606 (900)
T 1qxp_A 531 EIDDNFKTLFSKLAGDDMEISVKELQTILNRIISKHKDLRTNGFSLESCRSMVNLMDRDGNGKLGLVEFNILWNRI---- 606 (900)
T ss_dssp ----------CCCCCSSSSCCCSCTTTTTCC---------CCCCCHHHHHHHHHHHCC--CCCCCSSSHHHHHHHH----
T ss_pred hHHHHHHHHHHHHcCCCCcCCHHHHHHHHHHhhcccccccCCCCCHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHH----
Confidence 3477899999999988999999999999987764 15789999999999999999999999999865432
Q ss_pred hhHHHHHHHHHHHHHHcccCCCcccHHHHHHHh---C--CchH-HHHHHHHHccCCCCceeHHHHHHHHccc
Q 016471 314 ALERWDQIAITAFDYFEQEGNRVISVEELALEL---N--LAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHGV 379 (389)
Q Consensus 314 ~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l---~--~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~ 379 (389)
+.++.+|+.||+|++|+|+.+||+.+| | +... ++.++..+| |++|.|+|+||+.+|...
T Consensus 607 ------~~l~~~F~~~D~d~~G~Is~~El~~~l~~~g~~l~~~~~~~l~~~~d-d~dg~I~~~eF~~~~~~~ 671 (900)
T 1qxp_A 607 ------RNYLTIFRKFDLDKSGSMSAYEMRMAIEAAGFKLPCQLHQVIVARFA-DDELIIDFDNFVRCLVRL 671 (900)
T ss_dssp ------HHHHHHHGGGCTTCCSCCBHHHHHHHHHHTTEECCHHHHHHHHHHTS-CSSSBCCHHHHHHHHHHH
T ss_pred ------HHHHHHHHhhCCCCCCeECHHHHHHHHHHhCCCCCHHHHHHHHHHhC-CCCCeEcHHHHHHHHHHH
Confidence 358999999999999999999999998 3 2333 999999999 999999999999998653
|
| >2kyc_A Parvalbumin-3, parvalbumin, thymic CPV3; EF-hand protein, calcium binding protein; NMR {Gallus gallus} PDB: 2kyf_A | Back alignment and structure |
|---|
Probab=99.49 E-value=2.2e-15 Score=116.24 Aligned_cols=95 Identities=13% Similarity=0.236 Sum_probs=79.4
Q ss_pred cCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHhC------C-
Q 016471 276 AMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALELN------L- 348 (389)
Q Consensus 276 ~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~------~- 348 (389)
.++++++.+++..+| ++|.|+|+||+..+... . .. .+.++.+|+.||+|++|+|+.+||+.++. .
T Consensus 5 ~~~~~e~~~l~~~~d--~~g~i~~~eF~~~~~~~-~-~~----~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~ 76 (108)
T 2kyc_A 5 ILSPSDIAAALRDCQ--APDSFSPKKFFQISGMS-K-KS----SSQLKEIFRILDNDQSGFIEEDELKYFLQRFESGARV 76 (108)
T ss_dssp SSCHHHHHHHHTTSC--STTTCCHHHHHHHHTCT-T-CC----SSSHHHHCSSSCSCCSSCCCGGGTTTSHHHHSSSCCC
T ss_pred cCCHHHHHHHHHHcC--CCCcCCHHHHHHHHhhC-c-cc----HHHHHHHHHHhCCCCCCeEcHHHHHHHHHHHhhccCC
Confidence 478999999999998 89999999999876422 1 11 34589999999999999999999999872 2
Q ss_pred -chH-HHHHHHHHccCCCCceeHHHHHHHHcc
Q 016471 349 -APA-AYSLLNDCIRNSDGKLSFLGYKRFLHG 378 (389)
Q Consensus 349 -~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~ 378 (389)
... +..+++.+|.|++|.|+|+||+.+|++
T Consensus 77 ~~~~~~~~~~~~~D~d~dg~i~~~eF~~~~~~ 108 (108)
T 2kyc_A 77 LTASETKTFLAAADHDGDGKIGAEEFQEMVQS 108 (108)
T ss_dssp CCTTTTHHHHTTTCCSSSSCCCSSHHHHHHHC
T ss_pred CCHHHHHHHHHHhCCCCCCcCCHHHHHHHHhC
Confidence 222 899999999999999999999999863
|
| >2znd_A Programmed cell death protein 6; penta-EF-hand protein, calcium binding protein, apoptosis, calcium, endoplasmic reticulum, membrane, nucleus; 1.70A {Homo sapiens} PDB: 2zn9_A 2zn8_A 1hqv_A 3aak_A 2zne_A 2zrs_A 2zrt_A 3aaj_A | Back alignment and structure |
|---|
Probab=99.48 E-value=2.2e-13 Score=114.04 Aligned_cols=120 Identities=10% Similarity=0.147 Sum_probs=88.8
Q ss_pred HHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHH
Q 016471 248 AQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAF 326 (389)
Q Consensus 248 ~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF 326 (389)
..|..+|. ++|.|+.+||..++... .++.++|..+|.+++|.|+.+||..++........ ++.+..+|
T Consensus 48 ~l~~~~D~~~~g~i~~~ef~~~~~~~-------~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~----~~~~~~~~ 116 (172)
T 2znd_A 48 SIISMFDRENKAGVNFSEFTGVWKYI-------TDWQNVFRTYDRDNSGMIDKNELKQALSGFGYRLS----DQFHDILI 116 (172)
T ss_dssp HHHHHHCSSSSSEECHHHHHHHHHHH-------HHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCC----HHHHHHHH
T ss_pred HHHHHhCCCCCCcCCHHHHHHHHHHH-------HHHHHHHHHHCCCCCCccCHHHHHHHHHHcCCCCC----HHHHHHHH
Confidence 44566688 88888888888766432 45778888888888888888888876544321111 34577888
Q ss_pred HHHcccCCCcccHHHHHHHhCCchHHHHHHHHHccCCCCcee--HHHHHHHHcc
Q 016471 327 DYFEQEGNRVISVEELALELNLAPAAYSLLNDCIRNSDGKLS--FLGYKRFLHG 378 (389)
Q Consensus 327 ~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~d~~~~g~i~--~~ef~~~~~~ 378 (389)
+.+|.|++|.|+.+|+..++.....+..+++.+|.|++|.|+ |+||+.++..
T Consensus 117 ~~~d~~~dg~i~~~eF~~~~~~~~~~~~~F~~~D~d~dG~i~~~~~ef~~~~~~ 170 (172)
T 2znd_A 117 RKFDRQGRGQIAFDDFIQGCIVLQRLTDIFRRYDTDQDGWIQVSYEQYLSMVFS 170 (172)
T ss_dssp HHHCTTCSSSEEHHHHHHHHHHHHHHHHHHHHHCTTSSSCCCCCHHHHHHHHHT
T ss_pred HHhCCCCCCcCcHHHHHHHHHHHHHHHHHHHHhCCCCCCeEeeeHHHHHHHHHh
Confidence 888888888888888888774433477888888888888885 7888887754
|
| >1bjf_A Neurocalcin delta; calcium-binding, myristoylation, neuronal specific guanylate cyclase activator; 2.40A {Bos taurus} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=99.47 E-value=5.4e-14 Score=119.99 Aligned_cols=121 Identities=16% Similarity=0.287 Sum_probs=91.1
Q ss_pred HHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhH-------HHhhH
Q 016471 245 YLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQ-------LEALE 316 (389)
Q Consensus 245 ~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~-------~~~~~ 316 (389)
.+...|..+|. ++|.|+.+||..++...+. ..+..++..+|..+|.+++|.|+++||...+..... ....+
T Consensus 64 ~~~~~f~~~D~d~~g~i~~~Ef~~~~~~~~~-~~~~~~~~~~f~~~D~d~~G~I~~~E~~~~~~~~~~~~g~~~~~~~~~ 142 (193)
T 1bjf_A 64 FAEHVFRTFDANGDGTIDFREFIIALSVTSR-GKLEQKLKWAFSMYDLDGNGYISKAEMLEIVQAIYKMVSSVMKMPEDE 142 (193)
T ss_dssp HHHHHHHHHCSSCSSEEEHHHHHHHHHHHTS-SCHHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHTTCCCTTTSCGGG
T ss_pred HHHHHHHHhCCCCCCcCcHHHHHHHHHHHcC-CCHHHHHHHHHhhcCCCCCCeECHHHHHHHHHHHHHHhccccCCCccc
Confidence 45678889999 9999999999999987765 356788999999999999999999999986643210 11000
Q ss_pred -HHHHHHHHHHHHHcccCCCcccHHHHHHHhCCchHHHHHHHHHccCCCCce
Q 016471 317 -RWDQIAITAFDYFEQEGNRVISVEELALELNLAPAAYSLLNDCIRNSDGKL 367 (389)
Q Consensus 317 -~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~d~~~~g~i 367 (389)
..+..+..+|+.+|.|++|+|+.+|+..++...+.+.+++ ++|.|++|.|
T Consensus 143 ~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~~~~~~~~-~~D~~~dG~i 193 (193)
T 1bjf_A 143 STPEKRTEKIFRQMDTNRDGKLSLEEFIRGAKSDPSIVRLL-QCDPSSAGQF 193 (193)
T ss_dssp SSHHHHHHHHHHHSCTTCSSEECHHHHHHHHHHCTHHHHTT-CC--------
T ss_pred ccHHHHHHHHHHHhCCCCCCeEeHHHHHHHHhcCHHHHHHh-ccCCCCCCCC
Confidence 1135689999999999999999999999986555588999 9999999986
|
| >1eg3_A Dystrophin; EF-hand like domain, WW domain, structural protein; 2.00A {Homo sapiens} SCOP: a.39.1.7 a.39.1.7 b.72.1.1 PDB: 1eg4_A | Back alignment and structure |
|---|
Probab=99.46 E-value=4.6e-13 Score=117.82 Aligned_cols=132 Identities=11% Similarity=-0.001 Sum_probs=99.3
Q ss_pred HHHHHHHhhhcCC--CCCcccHHHHHHHHHHhccc----cC--------CHHHHHHHHhhcCCCCCcceeHHHHHHHHhc
Q 016471 243 LVYLRAQFMLLEP--KDGCVSLNNFKVALMRQATD----AM--------TDSRVFEILNVMEPLSDQKLAYEEFCAAATS 308 (389)
Q Consensus 243 ~~~l~~~F~~~D~--~~G~i~~~el~~~l~~~~~~----~~--------~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~ 308 (389)
+..+.++|....- ++..++..++..+|..+... .+ ...-+.-+|+.+|.+++|.|+|.||+.++..
T Consensus 81 l~~~~~~f~~~~l~~~~~~l~~~~l~~~L~~lY~~l~~~~p~~v~~~~~~~~~a~~lf~~FD~~~~G~I~f~ef~~aLs~ 160 (261)
T 1eg3_A 81 LSAACDALDQHNLKQNDQPMDILQIINCLTTIYDRLEQEHNNLVNVPLCVDMCLNWLLNVYDTGRTGRIRVLSFKTGIIS 160 (261)
T ss_dssp HHHHHHHHHHTTCCCTTSEEEHHHHHHHHHHHHHHHHHHSTTTCCHHHHHHHHHHHHHHHHCTTCCSEEEHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHHHHHHHhhCcCcCCchhhHHHHHHHHHHHccCCCCceEeHHHHHHHHHH
Confidence 4455556655433 56678888888877666321 01 1333556899999999999999999988776
Q ss_pred hhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHh----------CC-------chH--HHHHHHHHccCCCCceeH
Q 016471 309 VYQLEALERWDQIAITAFDYFEQEGNRVISVEELALEL----------NL-------APA--AYSLLNDCIRNSDGKLSF 369 (389)
Q Consensus 309 ~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l----------~~-------~~~--~~~~~~~~d~~~~g~i~~ 369 (389)
...... +++++.+|++|| |+||+|+.+||..++ |. .++ ++++|+.+| +||.|+.
T Consensus 161 l~rG~l----eeKL~w~F~lyD-D~~G~I~~~El~~il~~i~~i~~~vge~~~~~~~~~e~~v~~~F~~~d--~dg~It~ 233 (261)
T 1eg3_A 161 LCKAHL----EDKYRYLFKQVA-SSTGFCDQRRLGLLLHDSIQIPRQLGEVASFGGSNIEPSVRSCFQFAN--NKPEIEA 233 (261)
T ss_dssp TSSSCH----HHHHHHHHHHHS-CTTSCBCHHHHHHHHHHHHHHHHHTTCGGGGTCSCCHHHHHHHHHHTT--TCSCBCH
T ss_pred HcCCCH----HHHHHHHHheee-CCCCCCcHHHHHHHHHHHHHHHHhcCCcccCCCCCHHHHHHHHHHhCC--CCCcCCH
Confidence 544332 578999999999 999999999999977 21 112 888999985 8999999
Q ss_pred HHHHHHHccccC
Q 016471 370 LGYKRFLHGVTV 381 (389)
Q Consensus 370 ~ef~~~~~~~~~ 381 (389)
+||++.++..+.
T Consensus 234 ~EFl~~~~~dp~ 245 (261)
T 1eg3_A 234 ALFLDWMRLEPQ 245 (261)
T ss_dssp HHHHHHHHTCCT
T ss_pred HHHHHHHHhCcH
Confidence 999999988764
|
| >3a4u_B Multiple coagulation factor deficiency protein 2; lectin, ergic, ER, golgi, transport, disulfide bond, endopla reticulum, ER-golgi transport; 1.84A {Homo sapiens} PDB: 2vrg_A 3lcp_C | Back alignment and structure |
|---|
Probab=99.46 E-value=4.6e-14 Score=114.64 Aligned_cols=95 Identities=16% Similarity=0.204 Sum_probs=47.3
Q ss_pred HHHHhhcCCCCCcceeHHHHHHHHhchhHHHh-hHHHHHHHHHHHHHHcccCCCcccHHHHHHHhCC-------------
Q 016471 283 FEILNVMEPLSDQKLAYEEFCAAATSVYQLEA-LERWDQIAITAFDYFEQEGNRVISVEELALELNL------------- 348 (389)
Q Consensus 283 ~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~-~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~------------- 348 (389)
..+|..+|.|++|.|+|+||+..+........ ....++.++.+|+.||+|++|+|+.+||+.++..
T Consensus 30 ~~~f~~~D~d~dG~I~~~Ef~~~l~~~~~~~~~~~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~g~~~ 109 (143)
T 3a4u_B 30 FSQPGSMGLDKNTVHDQEHIMEHLEGVINKPEAEMSPQELQLHYFKMHDYDGNNLLDGLELSTAITHVHKEEGSEQAPLM 109 (143)
T ss_dssp ---------------------------------CCCHHHHHHHHHHHTCTTCSSCEEHHHHHHTCC-------------C
T ss_pred HHHHHHhCCCCCCcCcHHHHHHHHHHHhcccccccCHHHHHHHHHHHhCCCCCCccCHHHHHHHHHHHHhhhccccCCCC
Confidence 46888999999999999999876654322100 0001456899999999999999999999998832
Q ss_pred chH-H----HHHHHHHccCCCCceeHHHHHHHHc
Q 016471 349 APA-A----YSLLNDCIRNSDGKLSFLGYKRFLH 377 (389)
Q Consensus 349 ~~~-~----~~~~~~~d~~~~g~i~~~ef~~~~~ 377 (389)
... + ..+|+++|.|+||.|+|+||+.+|+
T Consensus 110 s~~e~~~~~~~~f~~~D~d~dG~Is~~EF~~~~~ 143 (143)
T 3a4u_B 110 SEDELINIIDGVLRDDDKNNDGYIDYAEFAKSLQ 143 (143)
T ss_dssp CHHHHHHHHHHHHHHHCTTCSSEECHHHHHC---
T ss_pred CHHHHHHHHHHHHHHcCCCCCCcEeHHHHHHHHC
Confidence 222 4 4555999999999999999998763
|
| >2ggz_A Guanylyl cyclase-activating protein 3; EF hand, guanylate cyclase activating protein, GCAP, GCAP3, GCAP-3, lyase activator; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.45 E-value=2.9e-13 Score=117.43 Aligned_cols=128 Identities=11% Similarity=0.141 Sum_probs=103.8
Q ss_pred HHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchh-----HHHhh
Q 016471 242 ELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVY-----QLEAL 315 (389)
Q Consensus 242 e~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~-----~~~~~ 315 (389)
....+...|..+|. ++|.|+.+||..++..++. ....+++..+|+.+|.+++|.|+++||..++.... .....
T Consensus 55 ~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~~~-~~~~~~l~~~F~~~D~d~~G~I~~~E~~~~l~~~~~~~~~~~~~~ 133 (211)
T 2ggz_A 55 ANKHIDQVYNTFDTNKDGFVDFLEFIAAVNLIMQ-EKMEQKLKWYFKLYDADGNGSIDKNELLDMFMAVQALNGQQTLSP 133 (211)
T ss_dssp HHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHSC-SSHHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHTTSSCCCSCTH
T ss_pred hHHHHHHHHHHHcCCCCCeEeHHHHHHHHHHhcc-CchHHHHHHHHHHhcCCCCCcCcHHHHHHHHHHHHhhcCCccccH
Confidence 34457788999999 9999999999999987765 35677899999999999999999999998765432 11111
Q ss_pred HHHHHHHHHHHHHHcccCCCcccHHHHHHHhCCchHHHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 316 ERWDQIAITAFDYFEQEGNRVISVEELALELNLAPAAYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 316 ~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
++.+..+|+.+|.|+||.|+.+|+..++...+.+.+++.. .++|++|+.+|.+..
T Consensus 134 ---~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~~~~~~~~~~-------~~d~~~f~~~~~~~~ 188 (211)
T 2ggz_A 134 ---EEFINLVFHKIDINNDGELTLEEFINGMAKDQDLLEIVYK-------SFDFSNVLRVICNGK 188 (211)
T ss_dssp ---HHHHHHHHHHHCTTCSSSBCHHHHHHHHHTTTTTHHHHHH-------HSCTTHHHHHHHHHC
T ss_pred ---HHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCHHHHHHHhc-------cCCHHHHHHHHhcCC
Confidence 3458899999999999999999999999766667777774 356999999998764
|
| >2zkm_X 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta-2; phospholipase C, phosphoinositide phospholipase, PLC-beta-2, calcium, coiled coil; 1.62A {Homo sapiens} SCOP: a.39.1.7 b.7.1.1 b.55.1.1 c.1.18.1 PDB: 2fju_B | Back alignment and structure |
|---|
Probab=99.45 E-value=6.5e-14 Score=143.08 Aligned_cols=125 Identities=16% Similarity=0.214 Sum_probs=91.5
Q ss_pred HHHHHHHHhh--hcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCC-------CCCcceeHHHHHHHHhchhH
Q 016471 242 ELVYLRAQFM--LLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEP-------LSDQKLAYEEFCAAATSVYQ 311 (389)
Q Consensus 242 e~~~l~~~F~--~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~-------~~~g~i~~~eF~~~~~~~~~ 311 (389)
....+++.|. .+|. ++|.|+.+|+..+|.. .++++.++++.+|. +++|.|+|+||+..+....
T Consensus 144 ~~~~Lk~~F~~~~fD~d~dG~Is~~EL~~~l~~------~~~ev~~li~~~d~~~~~~D~d~~g~idf~EF~~~~~~l~- 216 (799)
T 2zkm_X 144 RSTFLDKILVKLKMQLNSEGKIPVKNFFQMFPA------DRKRVEAALSACHLPKGKNDAINPEDFPEPVYKSFLMSLC- 216 (799)
T ss_dssp HHHHHHHHHHHHHHSCCTTSCEEHHHHHHHSCS------CHHHHHHHHHHTTCCCCTTCEECGGGCCHHHHHHHHHHHS-
T ss_pred HHHHHHHHhHHhccCCCCCCeECHHHHHHHHhh------hHHHHHHHHHHhCcCccccccCCCCcCCHHHHHHHHHHcc-
Confidence 3456788898 7899 9999999999987643 46889999999984 7889999999998654432
Q ss_pred HHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHh----CC-----------chH-HHHHHHHHccC----CCCceeHHH
Q 016471 312 LEALERWDQIAITAFDYFEQEGNRVISVEELALEL----NL-----------APA-AYSLLNDCIRN----SDGKLSFLG 371 (389)
Q Consensus 312 ~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l----~~-----------~~~-~~~~~~~~d~~----~~g~i~~~e 371 (389)
. +++++.||+.||+|++|+||.+||+++| |. ..+ +++|++++|.| ++|.|+|+|
T Consensus 217 --~----r~el~~aF~~fD~d~~g~Is~~eL~~fL~~~Qge~~~~~~~~~~~t~ee~~~iI~~~d~d~~~~~dg~is~ee 290 (799)
T 2zkm_X 217 --P----RPEIDEIFTSYHAKAKPYMTKEHLTKFINQKQRDSRLNSLLFPPARPDQVQGLIDKYEPSGINAQRGQLSPEG 290 (799)
T ss_dssp --C----CHHHHTTCC--------CCCHHHHHHHHHHTCC---------------CHHHHHHHHCCC--------CCHHH
T ss_pred --C----HHHHHHHHHHhccCCCCeEcHHHHHHHHHHhcCCcccccccccCCCHHHHHHHHHHhhcccccccCCccchhh
Confidence 1 2458999999999999999999999999 22 122 99999999998 899999999
Q ss_pred HHHHHccc
Q 016471 372 YKRFLHGV 379 (389)
Q Consensus 372 f~~~~~~~ 379 (389)
|+.+|...
T Consensus 291 F~~~L~S~ 298 (799)
T 2zkm_X 291 MVWFLCGP 298 (799)
T ss_dssp HHHHHHST
T ss_pred hhhcccCc
Confidence 99999764
|
| >3sjs_A URE3-BP sequence specific DNA binding protein; EF-hand, structural genomics, seattle S genomics center for infectious disease, ssgcid; 1.90A {Entamoeba histolytica} PDB: 3sia_A 3sib_A | Back alignment and structure |
|---|
Probab=99.44 E-value=3.1e-13 Score=118.14 Aligned_cols=122 Identities=10% Similarity=0.100 Sum_probs=97.2
Q ss_pred HHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHH
Q 016471 246 LRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAIT 324 (389)
Q Consensus 246 l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~ 324 (389)
+...|..+|. ++|.|+.+||..++... ..+..+|+.+|.+++|.|+.+||..++.......+ .+.+..
T Consensus 89 ~~~l~~~~D~d~dg~I~~~EF~~~~~~~-------~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~----~~~~~~ 157 (220)
T 3sjs_A 89 ALRMMRIFDTDFNGHISFYEFMAMYKFM-------ELAYNLFVMNARARSGTLEPHEILPALQQLGFYIN----QRTSLL 157 (220)
T ss_dssp HHHHHHHHCTTCSSCBCHHHHHHHHHHH-------HHHHHHHHHHCCSSTTEECHHHHHHHHHHHTCCCC----HHHHHH
T ss_pred HHHHHHHhCCCCCCcCCHHHHHHHHHHH-------HHHHHHHHHHCCCCCCCCcHHHHHHHHHHhCCCCC----HHHHHH
Confidence 4455667788 89999999998877653 45889999999999999999999886654322222 345888
Q ss_pred HHHHHcccCCCcccHHHHHHHhCCchHHHHHHHHH-ccCCCC------ceeHHHHHHHHccc
Q 016471 325 AFDYFEQEGNRVISVEELALELNLAPAAYSLLNDC-IRNSDG------KLSFLGYKRFLHGV 379 (389)
Q Consensus 325 aF~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~-d~~~~g------~i~~~ef~~~~~~~ 379 (389)
.|+.+| |+||.|+.+|+.+++.....+.++++.+ |.+++| .|+|+||+.++...
T Consensus 158 l~~~~d-d~dg~I~~~eF~~~~~~l~~~~~~F~~~~D~~~~G~i~~~~~i~~~ef~~~~~~~ 218 (220)
T 3sjs_A 158 LHRLFA-RGMAFCDLNCWIAICAFAAQTRSAYQMIFMNPYYGPMKPFNPMEFGKFLDVVTSL 218 (220)
T ss_dssp HHHHHC---CCSEEHHHHHHHHHHHHHHHHHHHHHHTSGGGCSCCCCCHHHHHHHHHHHHHT
T ss_pred HHHHhc-CCCCcCcHHHHHHHHHHHHHHHHHHHHhcccCCCCCcccccceeHHHHHHHHHHh
Confidence 999999 9999999999999885555578899998 999999 88999999988654
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.43 E-value=1.9e-14 Score=129.12 Aligned_cols=76 Identities=18% Similarity=0.233 Sum_probs=60.9
Q ss_pred eecCeEEEEEEccCC-C----ChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCCEecCCCCCcEEEeecCCCCCE
Q 016471 10 FYSNSFLFFTRFCEG-G----ELLDRILSRGGRYLEEDAKTIVEKILNIVAFCH-LQGVVHRDLKPENFLFTTREEDAPL 83 (389)
Q Consensus 10 ~~~~~~~lv~E~~~g-g----~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH-~~~i~Hrdlkp~Nill~~~~~~~~~ 83 (389)
+.....++|||||.+ | +|.+... ..++..+..++.|++.||.||| ++||+||||||+|||++ . .+
T Consensus 138 ~~~~~~~lVmE~~g~~g~~~~~L~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl~---~--~~ 208 (258)
T 1zth_A 138 YTYMKNVLLMEFIGEDELPAPTLVELGR----ELKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYI---D--KV 208 (258)
T ss_dssp EEEETTEEEEECCEETTEECCBHHHHGG----GGGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEES---S--SE
T ss_pred EEcCCCEEEEEecCCCCCccccHHHHhh----ccChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEc---C--cE
Confidence 334567899999942 4 5655432 2345678899999999999999 99999999999999994 3 89
Q ss_pred EEeecCCcccc
Q 016471 84 KVIDFGLSDFV 94 (389)
Q Consensus 84 kl~Dfg~a~~~ 94 (389)
+|+|||+|...
T Consensus 209 ~liDFG~a~~~ 219 (258)
T 1zth_A 209 YFIDMGQAVTL 219 (258)
T ss_dssp EECCCTTCEET
T ss_pred EEEECcccccC
Confidence 99999998754
|
| >2l2e_A Calcium-binding protein NCS-1; NCS1P, myristoylated, metal binding protein; HET: MYR; NMR {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.43 E-value=3.7e-13 Score=114.56 Aligned_cols=117 Identities=12% Similarity=0.134 Sum_probs=97.0
Q ss_pred CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCC-CCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHHHHHcccCC
Q 016471 256 KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPL-SDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGN 334 (389)
Q Consensus 256 ~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~-~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~ 334 (389)
.+|.++.+++..+....+ ++..++.++|..+|.+ ++|.|+++||..++......... ...++.+|+.+|.|++
T Consensus 4 ~~~~l~~~el~~~~~~~~---~~~~el~~~f~~~D~~~~~G~i~~~e~~~~l~~~~~~~~~---~~~~~~~f~~~D~d~~ 77 (190)
T 2l2e_A 4 SQSKLSQDQLQDLVRSTR---FDKKELQQWYKGFFKDCPSGHLNKSEFQKIYKQFFPFGDP---SAFAEYVFNVFDADKN 77 (190)
T ss_dssp SSCCSCHHHHHHHHHHHC---SCSHHHHHHHHHHHHHSCCCEECHHHHHHHHHHHCCCSCH---HHHHHHHHHHHCSSST
T ss_pred ccccCCHHHHHHHHHhcC---CCHHHHHHHHHHHHHhCCCCcCCHHHHHHHHHHhCCCCCc---cHHHHHHHHHhcCCCC
Confidence 578999999999877653 5788999999999999 89999999999865543111111 3468999999999999
Q ss_pred CcccHHHHHHHhCC-----chH-HHHHHHHHccCCCCceeHHHHHHHHcc
Q 016471 335 RVISVEELALELNL-----APA-AYSLLNDCIRNSDGKLSFLGYKRFLHG 378 (389)
Q Consensus 335 G~I~~~el~~~l~~-----~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~ 378 (389)
|.|+.+|+..++.. ... +..+++.+|.|++|.|+++||..+++.
T Consensus 78 G~i~~~ef~~~~~~~~~~~~~~~~~~~f~~~D~d~~G~i~~~e~~~~~~~ 127 (190)
T 2l2e_A 78 GYIDFKEFICALSVTSRGELNDKLIWAFQLYDLDNNGLISYDEMLRIVDA 127 (190)
T ss_dssp TCEEHHHHHHHHTTSSCSCSHHHHHHHHHHHCTTSCSCBCHHHHHHHHHH
T ss_pred CeEeHHHHHHHHHHHcCCCHHHHHHHHHhHccCCCCCcCcHHHHHHHHHH
Confidence 99999999999832 122 889999999999999999999999976
|
| >2i7a_A Calpain 13; calcium-dependent cytoplasmic cysteine proteinases, like, EF-hand, structural genomics, structural genomics CON SGC, hydrolase; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.41 E-value=8.1e-13 Score=110.95 Aligned_cols=119 Identities=13% Similarity=0.112 Sum_probs=95.3
Q ss_pred HHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhch----hHHHhhHHHHH
Q 016471 246 LRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSV----YQLEALERWDQ 320 (389)
Q Consensus 246 l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~----~~~~~~~~~~~ 320 (389)
++..|..+|. ++|.|+.+||..++... .++.++|+.+| +++|.|+.+||..++... ....+ ++
T Consensus 48 ~~~l~~~~D~d~~G~I~f~EF~~~~~~~-------~~l~~aF~~fD-d~~G~I~~~El~~~l~~l~~~~G~~~~----~~ 115 (174)
T 2i7a_A 48 CRSLVALMELKVNGRLDQEEFARLWKRL-------VHYQHVFQKVQ-TSPGVLLSSDLWKAIENTDFLRGIFIS----RE 115 (174)
T ss_dssp HHHHHHHHCSSCSSEECHHHHHHHHHHH-------HHHHHHHHHHC-SBTTBEEGGGHHHHHHTCGGGTTCCCC----HH
T ss_pred HHHHHHHHCCCCCCcCCHHHHHHHHHHH-------HHHHHHHHHhc-CCCCcCCHHHHHHHHHHhHhccCCCCC----HH
Confidence 4456777898 89999999998876432 45889999999 999999999999876654 21112 34
Q ss_pred HHHHHHHHHcccCCCcccHHHHHHHhCCchHHHHHHHHHccCCCC-ceeHHHHHHHHc
Q 016471 321 IAITAFDYFEQEGNRVISVEELALELNLAPAAYSLLNDCIRNSDG-KLSFLGYKRFLH 377 (389)
Q Consensus 321 ~l~~aF~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~d~~~~g-~i~~~ef~~~~~ 377 (389)
.+...++.+| |++|.|+.+|+..++.....+.++|+.+|.+++| .++++||+.++.
T Consensus 116 ~~~~l~~~~d-d~dG~I~~~EF~~~~~~~~~~~~~F~~~D~d~~GI~~~~~Ef~~~~~ 172 (174)
T 2i7a_A 116 LLHLVTLRYS-DSVGRVSFPSLVCFLMRLEAMAKTFRNLSKDGKGLYLTEMEWMSLVM 172 (174)
T ss_dssp HHHHHHHHHS-CTTSEECHHHHHHHHHHHHHHHHHHHHHCSSSSCCCCCHHHHHHHHH
T ss_pred HHHHHHHHHc-CCCCeEcHHHHHHHHHHHHHHHHHHHHhCCCCCCceecHHHHHHHHH
Confidence 5788999999 9999999999999884444488899999999999 459999998753
|
| >2kld_A Polycystin-2; PC2, PKD2, calcium binding domain, EF hand, cytosolic, calcium, coiled coil, disease mutation, glycoprotein, ION transport; NMR {Homo sapiens} PDB: 2kle_A 2kq6_A 2y4q_A | Back alignment and structure |
|---|
Probab=99.41 E-value=2.2e-14 Score=113.28 Aligned_cols=100 Identities=11% Similarity=0.024 Sum_probs=49.9
Q ss_pred HHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHH-----HHhchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHH
Q 016471 269 LMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCA-----AATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELA 343 (389)
Q Consensus 269 l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~-----~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~ 343 (389)
|+.+|. .++.+++.+++... +|.|+|+||+. .+........ ..+.++.||+.|| |+|+.+||+
T Consensus 2 lr~lG~-~~t~~ei~~~~~~~----~g~i~f~EF~~~~~~~~~~~~~~~~~---~~~~l~~aF~~fD----G~I~~~El~ 69 (123)
T 2kld_A 2 STAIGI-NDTYSEVKSDLAQQ----KAEMELSDLIRKGYHKALVKLKLKKN---TVDDISESLRQGG----GKLNFDELR 69 (123)
T ss_dssp ---------------------------------------------------------CCSCSSTTTT----TCEEHHHHH
T ss_pred hhhcCC-CCCHHHHHHHHHHc----CCCccHHHHHhHhHHHHHHHhhcChh---HHHHHHHHHHHhC----CCCCHHHHH
Confidence 556676 47888899998876 78999999998 4433211111 1356889999998 999999999
Q ss_pred HHh---CCchH-HHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 344 LEL---NLAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 344 ~~l---~~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
.+| |.+.. +.++++++|.|++|.|+|+||+.+|....
T Consensus 70 ~~l~~lG~t~~ei~~~~~~~D~d~dG~I~~~EF~~~~~~~~ 110 (123)
T 2kld_A 70 QDLKGKGHTDAEIEAIFTKYDQDGDQELTEHEHQQMRDDLE 110 (123)
T ss_dssp HHTTTCCSSHHHHHHHHHHHSSSSCCEECSHHHHHCSCTTT
T ss_pred HHHHHhCCCHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHH
Confidence 998 44333 99999999999999999999999997665
|
| >1qxp_A MU-like calpain; M-calpain, MU-calpain, catalytic triad, Ca(2+) requirement, hydrolase chimera; 2.80A {Rattus norvegicus} SCOP: a.39.1.8 a.39.1.8 b.14.1.1 d.3.1.3 | Back alignment and structure |
|---|
Probab=99.41 E-value=9.1e-13 Score=138.17 Aligned_cols=125 Identities=17% Similarity=0.234 Sum_probs=101.8
Q ss_pred HHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHH
Q 016471 243 LVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQI 321 (389)
Q Consensus 243 ~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~ 321 (389)
...++.+|..+|. ++|.|+.+||+.+|..++. .++.+++..++..+| +++|.|+|+||+..+... ..
T Consensus 606 ~~~l~~~F~~~D~d~~G~Is~~El~~~l~~~g~-~l~~~~~~~l~~~~d-d~dg~I~~~eF~~~~~~~----------~~ 673 (900)
T 1qxp_A 606 IRNYLTIFRKFDLDKSGSMSAYEMRMAIEAAGF-KLPCQLHQVIVARFA-DDELIIDFDNFVRCLVRL----------EI 673 (900)
T ss_dssp HHHHHHHHGGGCTTCCSCCBHHHHHHHHHHTTE-ECCHHHHHHHHHHTS-CSSSBCCHHHHHHHHHHH----------HH
T ss_pred HHHHHHHHHhhCCCCCCeECHHHHHHHHHHhCC-CCCHHHHHHHHHHhC-CCCCeEcHHHHHHHHHHH----------HH
Confidence 3678999999999 9999999999999999986 478999999999999 999999999999865532 12
Q ss_pred HHHHHHHHcccCC----------------------------------------------------------CcccHHHHH
Q 016471 322 AITAFDYFEQEGN----------------------------------------------------------RVISVEELA 343 (389)
Q Consensus 322 l~~aF~~~D~d~~----------------------------------------------------------G~I~~~el~ 343 (389)
+..+|+.+|+|++ |.|+.+||+
T Consensus 674 l~~~F~~~D~d~~G~It~~~~efl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~F~~~D~~~G~Is~~El~ 753 (900)
T 1qxp_A 674 LFKIFKQLDPENTGTIQLDLISWLSFSVLGKLAAAIEHHHHHHMHYSNIEANESEEERQFRKLFVQLAGDDMEVSATELM 753 (900)
T ss_dssp HHHHHHHSCSSCCSCEEEEHHHHHHHTCC--------------CCCCCC--------------CCCCTTCSSCBCHHHHT
T ss_pred HHHHHHhhCCCCCceEEecHHHHHHHhhhccccccccccccccccccCCCCCChHHHHHHHHHHHHhcCCCCccCHHHHH
Confidence 4445555555555 455889999
Q ss_pred HHhCCc-------------hH-HHHHHHHHccCCCCceeHHHHHHHHccc
Q 016471 344 LELNLA-------------PA-AYSLLNDCIRNSDGKLSFLGYKRFLHGV 379 (389)
Q Consensus 344 ~~l~~~-------------~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~ 379 (389)
+++... .. ++.+++.+|.|+||.|+|+||+.++...
T Consensus 754 ~~L~~~~~~~~~~~~~~~s~~~~~~l~~~~D~d~dG~Is~~EF~~l~~~~ 803 (900)
T 1qxp_A 754 NILNKVVTRHPDLKTDGFGIDTCRSMVAVMDSDTTGKLGFEEFKYLWNNI 803 (900)
T ss_dssp TTSCC----CCSCC--CCCHHHHHHHHHHHCCSSSSSBCSHHHHHHHHHH
T ss_pred HHHHHhcccccccccCCCCHHHHHHHHHHHCCCCCCeECHHHHHHHHHHH
Confidence 888331 12 8899999999999999999999998654
|
| >2lv7_A Calcium-binding protein 7; metal binding protein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.40 E-value=3.3e-13 Score=102.17 Aligned_cols=59 Identities=24% Similarity=0.395 Sum_probs=53.0
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHh---CCchH---HHHHHHHHccCCCCceeHHHHHHHHc
Q 016471 319 DQIAITAFDYFEQEGNRVISVEELALEL---NLAPA---AYSLLNDCIRNSDGKLSFLGYKRFLH 377 (389)
Q Consensus 319 ~~~l~~aF~~~D~d~~G~I~~~el~~~l---~~~~~---~~~~~~~~d~~~~g~i~~~ef~~~~~ 377 (389)
...++++|+.||+|++|+|+.+||+.+| |...+ ++++++++|.|+||.|+|+||+.+|.
T Consensus 35 ~~el~~~F~~~D~d~~G~I~~~El~~~l~~lg~~~~~~ei~~l~~~~D~d~dG~I~~~EF~~~m~ 99 (100)
T 2lv7_A 35 LEEIREAFKVFDRDGNGFISKQELGTAMRSLGYMPNEVELEVIIQRLDMDGDGQVDFEEFVTLLG 99 (100)
T ss_dssp HHHHHHHHHHTCSSCSSCBCHHHHHHHHHHHTCCCCTTTHHHHHHHHCSSCSSSBCHHHHHHHTC
T ss_pred HHHHHHHHHHHcCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHHCCCCCCeEeHHHHHHHhC
Confidence 3569999999999999999999999998 44332 99999999999999999999999985
|
| >1alv_A Calpain, S-camld; calcium binding, calmodulin like, domain of cystein protease; 1.90A {Sus scrofa} SCOP: a.39.1.8 PDB: 1alw_A* 1nx0_A 1nx1_A 1nx2_A 1nx3_A* 1kfu_S 1kfx_S 3bow_B 1u5i_B 1df0_B 3df0_B 1aj5_A 1dvi_A 1np8_A | Back alignment and structure |
|---|
Probab=99.35 E-value=2.3e-12 Score=107.94 Aligned_cols=111 Identities=8% Similarity=0.109 Sum_probs=61.2
Q ss_pred HHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHH
Q 016471 248 AQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAF 326 (389)
Q Consensus 248 ~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF 326 (389)
..|..+|. ++|.|+.+||..++... .++..+|..+|.+++|.|+.+||..++........ .+.+..+|
T Consensus 51 ~l~~~~D~~~~g~i~~~eF~~~~~~~-------~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~----~~~~~~~~ 119 (173)
T 1alv_A 51 SMVAVMDSDTTGKLGFEEFKYLWNNI-------KKWQAIYKQFDVDRSGTIGSSELPGAFEAAGFHLN----EHLYSMII 119 (173)
T ss_dssp HHHHHHCTTCSSSBCHHHHHHHHHHH-------HHHHHHHHHHCTTCCSSBCTTTHHHHHHHHTCCCC----HHHHHHHH
T ss_pred HHHHHHcCCCCCccCHHHHHHHHHHH-------HHHHHHHHHHCCCCCCCCCHHHHHHHHHHcCCCCC----HHHHHHHH
Confidence 34445566 66666666665554322 33556666666666666666666554432211111 23455566
Q ss_pred HHHcccCCCcccHHHHHHHhCCchHHHHHHHHHccCCCCceeHH
Q 016471 327 DYFEQEGNRVISVEELALELNLAPAAYSLLNDCIRNSDGKLSFL 370 (389)
Q Consensus 327 ~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~d~~~~g~i~~~ 370 (389)
+.+| |++|.|+.+|+..++.....+.++++.+|.|++|.|+.+
T Consensus 120 ~~~d-d~dg~i~~~eF~~~~~~~~~~~~~F~~~D~d~~G~i~~~ 162 (173)
T 1alv_A 120 RRYS-DEGGNMDFDNFISCLVRLDAMFRAFKSLDKDGTGQIQVN 162 (173)
T ss_dssp HHHT-CSSSCBCHHHHHHHHHHHHHHHHHHHHHSSSCCSEEEEE
T ss_pred HHhc-CCCCcCcHHHHHHHHHHHHHHHHHHHHhCCCCCCeecHh
Confidence 6666 666666666666655333335566666666666666544
|
| >1s6c_A KV4 potassium channel-interacting protein kchip1B; EF-hand, transport protein; 2.00A {Rattus norvegicus} SCOP: a.39.1.5 PDB: 2nz0_A 2i2r_E | Back alignment and structure |
|---|
Probab=99.34 E-value=2.3e-12 Score=108.90 Aligned_cols=114 Identities=11% Similarity=0.084 Sum_probs=88.3
Q ss_pred ccHHHHHHHHHHhccccCCHHHHHHHHhhcCC-CCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHHHHHcccCCCccc
Q 016471 260 VSLNNFKVALMRQATDAMTDSRVFEILNVMEP-LSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVIS 338 (389)
Q Consensus 260 i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~-~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~ 338 (389)
++.+++..+++..+ ++.+++.++++.+|. +++|.|+++||..++......... ...++.+|+.+|.|++|.|+
T Consensus 1 l~~~el~~l~~~~~---~s~~~i~~l~~~fd~~d~~G~i~~~e~~~~l~~~~~~~~~---~~~~~~~f~~~D~d~~g~i~ 74 (183)
T 1s6c_A 1 HRPEGLEQLEAQTN---FTKRELQVLYRGFKNEXPSGVVNEETFKQIYAQFFPHGDA---STYAHYLFNAFDTTQTGSVK 74 (183)
T ss_dssp -----CHHHHHHSS---CCHHHHHHHHHHHHHHCTTSEECHHHHHHHHHHHSTTSCC---HHHHHHHHHHHCTTCSSCEE
T ss_pred CChHHHHHHHHhcC---CCHHHHHHHHHHHHHhCCCCcCCHHHHHHHHHHHcCCCCh---HHHHHHHHHHhCCCCCCcEe
Confidence 35677777666543 588889999999988 899999999999865543221111 35688999999999999999
Q ss_pred HHHHHHHhC-----CchH-HHHHHHHHccCCCCceeHHHHHHHHccc
Q 016471 339 VEELALELN-----LAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHGV 379 (389)
Q Consensus 339 ~~el~~~l~-----~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~ 379 (389)
.+|+..++. .... +..+|+.+|.|++|.|+++||..+++..
T Consensus 75 ~~Ef~~~~~~~~~~~~~~~~~~~f~~~D~d~~G~i~~~e~~~~~~~~ 121 (183)
T 1s6c_A 75 FEDFVTALSILLRGTVHEKLRWTFNLYDINKDGYINKEEMMDIVKAI 121 (183)
T ss_dssp HHHHHHHHHHHHHCCHHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHH
T ss_pred HHHHHHHHHHHcCCCHHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHH
Confidence 999999883 2222 8899999999999999999999999764
|
| >1s1e_A KV channel interacting protein 1; kchip, calcium-binding protein, EF-finger, transport protein; 2.30A {Homo sapiens} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=99.31 E-value=3.9e-12 Score=111.45 Aligned_cols=118 Identities=11% Similarity=0.090 Sum_probs=90.4
Q ss_pred CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCC-CCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHHHHHcccCC
Q 016471 256 KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPL-SDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGN 334 (389)
Q Consensus 256 ~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~-~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~ 334 (389)
..+.++.+++..+++..+ ++.+++.++++.+|.+ ++|.|+++||..++......... ...++.+|+.+|.|++
T Consensus 30 ~~~~l~~~~l~~l~~~~~---~s~~ei~~l~~~Fd~~d~~G~I~~~E~~~~l~~l~~~~~~---~~~~~~~f~~~D~d~~ 103 (224)
T 1s1e_A 30 TMVCHRPEGLEQLEAQTN---FTKRELQVLYRGFKNECPSGVVNEETFKQIYAQFFPHGDA---STYAHYLFNAFDTTQT 103 (224)
T ss_dssp --------CHHHHHHHSS---CCHHHHHHHHHHHHHHCTTSCBCHHHHHHHHHTTCTTSCC---HHHHHHHHHHHCTTCS
T ss_pred CccCCCHHHHHHHHHHcC---CCHHHHHHHHHHHHhhCCCCCCCHHHHHHHHHHhcCCCCc---HHHHHHHHHHhcCCCC
Confidence 568899999998876654 6889999999999884 89999999999876543221111 3468899999999999
Q ss_pred CcccHHHHHHHhC-----CchH-HHHHHHHHccCCCCceeHHHHHHHHccc
Q 016471 335 RVISVEELALELN-----LAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHGV 379 (389)
Q Consensus 335 G~I~~~el~~~l~-----~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~ 379 (389)
|.|+.+|+..++. .... +..+|+.+|.|++|.|+++||..+++..
T Consensus 104 G~I~~~Ef~~~l~~~~~~~~~~~l~~~F~~~D~d~dG~Is~~E~~~~l~~~ 154 (224)
T 1s1e_A 104 GSVKFEDFVTALSILLRGTVHEKLRWTFNLYDINKDGYINKEEMMDIVKAI 154 (224)
T ss_dssp SCBCHHHHHHHHHHHHHCCHHHHHHHHHHHHCTTCCSEECHHHHHHHHHHH
T ss_pred CcEeHHHHHHHHHHHccCCHHHHHHHHHHHHcCCCCCeECHHHHHHHHHHH
Confidence 9999999999882 2222 8899999999999999999999999764
|
| >1gjy_A Sorcin, CP-22, V19; calcium binding, calcium-binding, phosphorylation; 2.2A {Chinese hamster} SCOP: a.39.1.8 | Back alignment and structure |
|---|
Probab=99.30 E-value=9.9e-12 Score=103.41 Aligned_cols=111 Identities=13% Similarity=0.059 Sum_probs=71.2
Q ss_pred HHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHH
Q 016471 247 RAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITA 325 (389)
Q Consensus 247 ~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~a 325 (389)
...|..+|. ++|.|+.+||..++... ..+.++|..+|.+++|.|+.+||..++........ .+.+..+
T Consensus 45 ~~l~~~~D~~~~g~i~~~eF~~~~~~~-------~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~----~~~~~~~ 113 (167)
T 1gjy_A 45 RLMVSMLDRDMSGTMGFNEFKELWAVL-------NGWRQHFISFDSDRSGTVDPQELQKALTTMGFRLN----PQTVNSI 113 (167)
T ss_dssp HHHHHHHCTTCCSCBCHHHHHHHHHHH-------HHHHHHHHHHCTTCCSEECHHHHHHHHHTTTCCCC----HHHHHHH
T ss_pred HHHHHHHCCCCCCcCCHHHHHHHHHHH-------HHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCCCCC----HHHHHHH
Confidence 445556677 77777777777665432 34667777777777777777777765543321111 2346666
Q ss_pred HHHHcccCCCcccHHHHHHHhCCchHHHHHHHHHccCCCCceeHH
Q 016471 326 FDYFEQEGNRVISVEELALELNLAPAAYSLLNDCIRNSDGKLSFL 370 (389)
Q Consensus 326 F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~d~~~~g~i~~~ 370 (389)
|..+ |++|.|+.+|+..++.....+.++++.+|.|++|.|+.+
T Consensus 114 ~~~~--d~dg~i~~~eF~~~~~~~~~~~~~F~~~D~d~~G~i~~~ 156 (167)
T 1gjy_A 114 AKRY--STSGKITFDDYIACCVKLRALTDSFRRRDSAQQGMVNFS 156 (167)
T ss_dssp HHHT--CBTTBEEHHHHHHHHHHHHHHHHHHHHHCTTCCSEEEEE
T ss_pred HHHh--CcCCcCcHHHHHHHHHHHHHHHHHHHHhCCCCCeeEEee
Confidence 6666 677777777777766433346677777777777777753
|
| >4drw_A Protein S100-A10/annexin A2 chimeric protein; atypical EF-hand, heteropentameric complex, membrane repair; 3.50A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.29 E-value=5.6e-12 Score=98.18 Aligned_cols=106 Identities=12% Similarity=0.171 Sum_probs=72.3
Q ss_pred HHHHHHHHHHhhhcCCCCCcccHHHHHHHHHH-----hccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHh
Q 016471 240 EEELVYLRAQFMLLEPKDGCVSLNNFKVALMR-----QATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEA 314 (389)
Q Consensus 240 ~ee~~~l~~~F~~~D~~~G~i~~~el~~~l~~-----~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~ 314 (389)
+..+..+..+|..+|..+|.||.+||+.+|.. ++. ..+.+++.++++.+|.|+||.|+|+||+..+......
T Consensus 11 E~~ie~l~~~F~~yd~ddG~Is~~EL~~~l~~~~~~~l~~-~~~~~~v~~~i~~~D~d~DG~IdF~EF~~lm~~l~~~-- 87 (121)
T 4drw_A 11 EHAMETMMFTFHKFAGDKGYLTKEDLRVLMEKEFPGFLEN-QKDPLAVDKIMKDLDQCRDGKVGFQSFFSLIAGLTIA-- 87 (121)
T ss_dssp HHHHHHHHHTTGGGSCTTCSCCHHHHHHHTTTSCHHHHTT-SSCTTHHHHHHHHHCTTCSSCCCHHHHHHHHHHHHHH--
T ss_pred HHHHHHHHHHHHHHcCCCCEEcHHHHHHHHHHHhhhhccc-CCCHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHHHH--
Confidence 34467889999999998899999999999876 443 4678899999999999999999999999865543221
Q ss_pred hHHHHHHHHHHHHHHcccCCCcccHHHHHHHhCCchHHHHHHHHHccCCC
Q 016471 315 LERWDQIAITAFDYFEQEGNRVISVEELALELNLAPAAYSLLNDCIRNSD 364 (389)
Q Consensus 315 ~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~d~~~~ 364 (389)
..+.|....+..+++... ..+++++|+++|.|||
T Consensus 88 -------~he~f~~~~k~~~~~~~~---------d~~~~e~~~~~d~~gd 121 (121)
T 4drw_A 88 -------CNDYFVVHMKQENLYFQG---------DSTVHEILSKLSLEGD 121 (121)
T ss_dssp -------HHHHHTTSCC------------------CCHHHHHHHCCC---
T ss_pred -------HHHHHHHHHHHhccCCCC---------chHHHHHHHHhcccCC
Confidence 233455444444433322 1127777888877764
|
| >1fpw_A Yeast frequenin, calcium-binding protein NCS-1; EF-hand, metal binding protein; NMR {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2ju0_A | Back alignment and structure |
|---|
Probab=99.29 E-value=1.6e-11 Score=104.30 Aligned_cols=115 Identities=13% Similarity=0.263 Sum_probs=92.3
Q ss_pred HHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHh--------h
Q 016471 245 YLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEA--------L 315 (389)
Q Consensus 245 ~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~--------~ 315 (389)
.+...|..+|. ++|.|+.+||..++...+.. .+.+++..+|..+|.+++|.|+++||...+........ .
T Consensus 64 ~~~~~f~~~D~d~~G~i~~~ef~~~~~~~~~~-~~~~~~~~~f~~~D~d~~G~i~~~ef~~~~~~~~~~~g~~~~~~~~~ 142 (190)
T 1fpw_A 64 FANHLFTVFDKDNNGFIHFEEFITVLSTTSRG-TLEEKLSWAFELYDLNHDGYITFDEMLTIVASVYKMMGSMVTLNEDE 142 (190)
T ss_dssp HHHHHHHTCCSSCSSEECHHHHHHHHHHHSCC-CSTHHHHHHHHHHCSSCSSEEEHHHHHHHHHHHHTTSCSTTSSSCCC
T ss_pred HHHHHHHHHCCCCCCcEeHHHHHHHHHHHccC-CcHHHHHHHHHHhcCCCCCcCcHHHHHHHHHHHHHHhccccCccccc
Confidence 36788999999 99999999999999888753 67788999999999999999999999987654211000 0
Q ss_pred HHHHHHHHHHHHHHcccCCCcccHHHHHHHhCCchHHHHHHHHHc
Q 016471 316 ERWDQIAITAFDYFEQEGNRVISVEELALELNLAPAAYSLLNDCI 360 (389)
Q Consensus 316 ~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~d 360 (389)
...++.+..+|+.+|.|++|+|+.+|+.+++...+.+.+++...|
T Consensus 143 ~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~~~~~~~~~~~d 187 (190)
T 1fpw_A 143 ATPEMRVKKIFKLMDKNEDGYITLDEFREGSKVDPSIIGALNLYD 187 (190)
T ss_dssp CCHHHHHHHHHHHHTTTCSSEEEHHHHHHHHHSSTTHHHHHHHHH
T ss_pred chHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHhChHHHHHHhhcc
Confidence 001456899999999999999999999999976666666676665
|
| >3nso_A Protein S100-A3; EF-hand, Ca2+, Zn2+ binding, metal binding protein; 1.45A {Homo sapiens} SCOP: a.39.1.2 PDB: 3nsi_A 1kso_A 3nsk_A 3nsl_A | Back alignment and structure |
|---|
Probab=99.29 E-value=2.8e-12 Score=96.80 Aligned_cols=63 Identities=17% Similarity=0.226 Sum_probs=54.1
Q ss_pred HHHHHHHHHHHc-ccCC-CcccHHHHHHHhCC--------c--hH-HHHHHHHHccCCCCceeHHHHHHHHccccC
Q 016471 319 DQIAITAFDYFE-QEGN-RVISVEELALELNL--------A--PA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVTV 381 (389)
Q Consensus 319 ~~~l~~aF~~~D-~d~~-G~I~~~el~~~l~~--------~--~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~ 381 (389)
...+++||+.|| +|++ |+|+++||+.+|.. . .. ++++++++|.|+||.|+|+||+.+|.+...
T Consensus 9 i~~l~~aF~~fd~~dg~~G~Is~~EL~~~l~~~l~~~lg~~~~~~ev~~~i~~~D~dgDG~Idf~EF~~~~~~~~~ 84 (101)
T 3nso_A 9 VAAIVCTFQEYAGRCGDKYKLCQAELKELLQKELATWTPTEFRECDYNKFMSVLDTNKDCEVDFVEYVRSLACLCL 84 (101)
T ss_dssp HHHHHHHHHHHHTTSSCTTEECHHHHHHHHHHHTTTCCCCTTCHHHHHHHHHHHHHCCCSCEEHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhhcCCCCCEECHHHHHHHHHHHhhhhcCCCCCHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHHH
Confidence 356899999998 8997 99999999998831 1 22 999999999999999999999999987653
|
| >1k94_A Grancalcin; penta-EF-hand protein, calcium binding protein, metal binding protein; 1.70A {Homo sapiens} SCOP: a.39.1.8 PDB: 1k95_A 1f4q_A 1f4o_A | Back alignment and structure |
|---|
Probab=99.29 E-value=9.9e-12 Score=103.14 Aligned_cols=117 Identities=16% Similarity=0.143 Sum_probs=74.0
Q ss_pred HHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHH
Q 016471 247 RAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITA 325 (389)
Q Consensus 247 ~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~a 325 (389)
...|..+|. ++|.|+.+||..++... .++.++|+.+|.+++|.|+.+||..++........ ++.+..+
T Consensus 43 ~~l~~~~D~~~~g~i~~~eF~~~~~~~-------~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~----~~~~~~~ 111 (165)
T 1k94_A 43 RIMIAMLDRDHTGKMGFNAFKELWAAL-------NAWKENFMTVDQDGSGTVEHHELRQAIGLMGYRLS----PQTLTTI 111 (165)
T ss_dssp HHHHHHHCTTCSSCBCHHHHHHHHHHH-------HHHHHHHHHHCTTCCSBCCHHHHHHHHHHTTCCCC----HHHHHHH
T ss_pred HHHHHHhCCCCCCcCCHHHHHHHHHHH-------HHHHHHHHHhCCCCCceECHHHHHHHHHHhCCCCC----HHHHHHH
Confidence 445556677 77777777776655432 34667777777777777777777765543221111 2345666
Q ss_pred HHHHcccCCCcccHHHHHHHhCCchHHHHHHHHHccCCCCceeHHHHHHHHc
Q 016471 326 FDYFEQEGNRVISVEELALELNLAPAAYSLLNDCIRNSDGKLSFLGYKRFLH 377 (389)
Q Consensus 326 F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~ 377 (389)
|..+ |++|.|+.+|+..++.....+.++++.+|.|++|.|+.+ |.++|+
T Consensus 112 ~~~~--d~dg~i~~~eF~~~~~~~~~~~~~F~~~D~d~~G~i~~~-~~~~l~ 160 (165)
T 1k94_A 112 VKRY--SKNGRIFFDDYVACCVKLRALTDFFRKRDHLQQGSANFI-YDDFLQ 160 (165)
T ss_dssp HHHH--CBTTBCBHHHHHHHHHHHHHHHHHHHTTCTTCCSEEEEE-HHHHHH
T ss_pred HHHh--CCCCeEcHHHHHHHHHHHHHHHHHHHHhCCCCCCeEeee-HHHHHH
Confidence 6666 677777777777776433346677777777777777655 554443
|
| >1jfj_A Ehcabp, calcium-binding protein; EF-hand, helix-loop-helix, metal binding protein; NMR {Entamoeba histolytica} SCOP: a.39.1.5 PDB: 1jfk_A 2nxq_A 3px1_A 3qjk_A 2jnx_A 2i18_A | Back alignment and structure |
|---|
Probab=99.29 E-value=1.1e-11 Score=98.53 Aligned_cols=95 Identities=19% Similarity=0.200 Sum_probs=79.3
Q ss_pred HHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHhC----Cc--hH---H
Q 016471 282 VFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALELN----LA--PA---A 352 (389)
Q Consensus 282 ~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~----~~--~~---~ 352 (389)
+.++|..+|.+++|.|+++||..++........ ...+..+|+.+|.|++|.|+.+|+..++. .. .+ +
T Consensus 2 l~~~F~~~D~~~~g~i~~~e~~~~l~~~~~~~~----~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~ 77 (134)
T 1jfj_A 2 AEALFKEIDVNGDGAVSYEEVKAFVSKKRAIKN----EQLLQLIFKSIDADGNGEIDQNEFAKFYGSIQGQDLSDDKIGL 77 (134)
T ss_dssp HHHHHHHHCTTCSSEEEHHHHHHHHHTTCCSSH----HHHHHHHHHHHCSSCCSEEEHHHHHHHTTCSSCCSSHHHHHHH
T ss_pred HHHHHHHHCCCCCCcCCHHHHHHHHHHcCCCCC----HHHHHHHHHHHcCCCCCeEcHHHHHHHHHHhcccccCCCHHHH
Confidence 678999999999999999999987655432222 45689999999999999999999999983 21 11 8
Q ss_pred HHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 353 YSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 353 ~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
..+++.+|.|++|.|+++||..++....
T Consensus 78 ~~~f~~~D~d~~G~i~~~e~~~~l~~~~ 105 (134)
T 1jfj_A 78 KVLYKLMDVDGDGKLTKEEVTSFFKKHG 105 (134)
T ss_dssp HHHHHHHCCSSSSEEEHHHHHHHHTTTT
T ss_pred HHHHHHHCCCCCCccCHHHHHHHHHHhC
Confidence 8999999999999999999999998643
|
| >2r2i_A Guanylyl cyclase-activating protein 1; EF hand, GCAP, guanylate cyclase activating protein, GCAP1, GCAP-1, calcium, lipoprotein, myristate; HET: MYR; 2.00A {Gallus gallus} | Back alignment and structure |
|---|
Probab=99.29 E-value=2.6e-11 Score=103.85 Aligned_cols=115 Identities=14% Similarity=0.207 Sum_probs=91.5
Q ss_pred HHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHH---hhHH
Q 016471 242 ELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLE---ALER 317 (389)
Q Consensus 242 e~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~---~~~~ 317 (389)
....+...|..+|. ++|.|+.+||..++..++.. .+.+++..+|..+|.+++|.|+++||...+....... ....
T Consensus 50 ~~~~~~~~f~~~D~d~~G~I~~~Ef~~~~~~~~~~-~~~~~~~~~F~~~D~d~~G~I~~~Ef~~~~~~~~~~~~~~~~~~ 128 (198)
T 2r2i_A 50 ANKYVEQMFETFDFNKDGYIDFMEYVAALSLVLKG-KVDQKLRWYFKLYDVDGNGCIDRGELLNIIKAIRAINRCNEAMT 128 (198)
T ss_dssp HHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHSSC-CHHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHTTGGGGSSSCCC
T ss_pred hHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHHccC-chHHHHHHHHHHhcCCCCCcCcHHHHHHHHHHHHhhcCCCchhh
Confidence 34457788999999 99999999999999888753 5678899999999999999999999998765442110 0000
Q ss_pred HHHHHHHHHHHHcccCCCcccHHHHHHHhCCchHHHHHHH
Q 016471 318 WDQIAITAFDYFEQEGNRVISVEELALELNLAPAAYSLLN 357 (389)
Q Consensus 318 ~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~ 357 (389)
.++.+..+|+.+|.|++|.|+.+|+..++...+.+.+++.
T Consensus 129 ~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~~~~~~~~~ 168 (198)
T 2r2i_A 129 AEEFTNMVFDKIDINGDGELSLEEFMEGVQKDEVLLDILT 168 (198)
T ss_dssp HHHHHHHHHHHHCTTCSSEECHHHHHHHHTTCHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCcCcHHHHHHHHHcCHHHHHHHh
Confidence 1345889999999999999999999999976666666665
|
| >1g8i_A Frequenin, neuronal calcium sensor 1; calcium binding-protein, EF-hand, calcium ION, metal binding protein; HET: 1PE P6G; 1.90A {Homo sapiens} SCOP: a.39.1.5 PDB: 2lcp_A | Back alignment and structure |
|---|
Probab=99.28 E-value=1.2e-11 Score=105.11 Aligned_cols=117 Identities=10% Similarity=0.086 Sum_probs=93.8
Q ss_pred CCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCC-CCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHHHHHcccCCC
Q 016471 257 DGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPL-SDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNR 335 (389)
Q Consensus 257 ~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~-~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G 335 (389)
.+.++.+++....... .++.+++.++|+.+|.+ ++|.|+++||..++......... ...+..+|+.+|.|++|
T Consensus 5 ~~~l~~~~l~~l~~~~---~~~~~~i~~~f~~fd~~~~~G~i~~~e~~~~l~~~~~~~~~---~~~~~~~f~~~D~d~~g 78 (190)
T 1g8i_A 5 NSKLKPEVVEELTRKT---YFTEKEVQQWYKGFIKDCPSGQLDAAGFQKIYKQFFPFGDP---TKFATFVFNVFDENKDG 78 (190)
T ss_dssp CCSCCHHHHHHHHHTS---SSCHHHHHHHHHHHHHHCTTSEEEHHHHHHHHHHHCTTSCT---HHHHHHHHHHHCTTCSS
T ss_pred cccCCHHHHHHHHHcc---CCCHHHHHHHHHHHHHhCCCCcCCHHHHHHHHHHhCCCCCh---HHHHHHHHHHHhcCCCC
Confidence 4578899988865543 36889999999999988 89999999999865543110111 23589999999999999
Q ss_pred cccHHHHHHHhC-----CchH-HHHHHHHHccCCCCceeHHHHHHHHccc
Q 016471 336 VISVEELALELN-----LAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHGV 379 (389)
Q Consensus 336 ~I~~~el~~~l~-----~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~ 379 (389)
.|+.+|+..++. .... +..+|+.+|.|++|.|+++||..++...
T Consensus 79 ~i~~~ef~~~~~~~~~~~~~~~~~~~f~~~D~d~~G~i~~~e~~~~l~~~ 128 (190)
T 1g8i_A 79 RIEFSEFIQALSVTSRGTLDEKLRWAFKLYDLDNDGYITRNEMLDIVDAI 128 (190)
T ss_dssp EEEHHHHHHHHHHHHHCCHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHH
T ss_pred eEeHHHHHHHHHHhcCCCHHHHHHHHHHhhcCCCCCeECHHHHHHHHHHH
Confidence 999999999882 2222 8899999999999999999999999773
|
| >1juo_A Sorcin; calcium-binding proteins, penta-EF-hand, PEF, X-RAY, metal transport; 2.20A {Homo sapiens} SCOP: a.39.1.8 PDB: 2jc2_A | Back alignment and structure |
|---|
Probab=99.28 E-value=1.8e-11 Score=104.93 Aligned_cols=118 Identities=13% Similarity=0.072 Sum_probs=76.7
Q ss_pred HHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHH
Q 016471 246 LRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAIT 324 (389)
Q Consensus 246 l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~ 324 (389)
+...|..+|. ++|.|+.+||..++... .++.++|..+|.+++|.|+.+||..++........ ++.+..
T Consensus 75 ~~~l~~~~D~d~~g~i~~~eF~~~~~~~-------~~~~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~----~~~~~~ 143 (198)
T 1juo_A 75 CRLMVSMLDRDMSGTMGFNEFKELWAVL-------NGWRQHFISFDTDRSGTVDPQELQKALTTMGFRLS----PQAVNS 143 (198)
T ss_dssp HHHHHHHHCTTCSSCEEHHHHHHHHHHH-------HHHHHHHHTTCTTCCSEECHHHHHHHHHHTTCCCC----HHHHHH
T ss_pred HHHHHHHhCCCCCCeECHHHHHHHHHHH-------HHHHHHHHHhCCCCCCcCCHHHHHHHHHHhCCCCC----HHHHHH
Confidence 3445566677 77788888877765432 44677777778878888888887765543221111 234666
Q ss_pred HHHHHcccCCCcccHHHHHHHhCCchHHHHHHHHHccCCCCceeH--HHHHHHH
Q 016471 325 AFDYFEQEGNRVISVEELALELNLAPAAYSLLNDCIRNSDGKLSF--LGYKRFL 376 (389)
Q Consensus 325 aF~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~d~~~~g~i~~--~ef~~~~ 376 (389)
.|+.+ |++|.|+.+|+..++.....+.++++.+|.|++|.|+. .+|+.++
T Consensus 144 l~~~~--d~dg~i~~~eF~~~~~~~~~~~~~F~~~D~d~~G~is~~~~~~l~~~ 195 (198)
T 1juo_A 144 IAKRY--STNGKITFDDYIACCVKLRALTDSFRRRDTAQQGVVNFPYDDFIQCV 195 (198)
T ss_dssp HHHHT--CSSSSEEHHHHHHHHHHHHHHHHHHHHTCTTCCSEEEEEHHHHHHHH
T ss_pred HHHHh--CCCCeEcHHHHHHHHHHHHHHHHHHHHhCCCCCCeEeecHHHHHHHH
Confidence 77777 67777888887777644344667777778887887766 5555443
|
| >4eto_A Protein S100-A4; calcium-binding protein, EF-hand, structural genomics, PSI-B protein structure initiative, NEW YORK structural genomics consortium; 1.54A {Homo sapiens} PDB: 1m31_A 2q91_A 3cga_A 3ko0_A* 3m0w_A* | Back alignment and structure |
|---|
Probab=99.25 E-value=8e-12 Score=93.12 Aligned_cols=62 Identities=24% Similarity=0.382 Sum_probs=53.1
Q ss_pred HHHHHHHHHHHc-ccCC-CcccHHHHHHHhC--C--------chH-HHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 319 DQIAITAFDYFE-QEGN-RVISVEELALELN--L--------APA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 319 ~~~l~~aF~~~D-~d~~-G~I~~~el~~~l~--~--------~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
...+++||+.|| +||+ |+|+++||+.+|. + ... ++++++++|.|+||.|+|+||+.+|.+..
T Consensus 9 ~~~l~~~F~~fd~~dg~~G~Is~~EL~~~l~~~lg~~l~~~~~~~ev~~~i~~~D~d~DG~Idf~EF~~~~~~~~ 83 (93)
T 4eto_A 9 LDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSNRDNEVDFQEYCVFLSCIA 83 (93)
T ss_dssp HHHHHHHHHHHHTSSSSTTSBCHHHHHHHHHHHCGGGC---CCHHHHHHHHHHHCTTSSSSBCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHcccCCCCCeECHHHHHHHHHHHhhhhccCCCCHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHHH
Confidence 456999999998 6885 8999999999883 1 122 99999999999999999999999998754
|
| >2lv7_A Calcium-binding protein 7; metal binding protein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.25 E-value=6.5e-12 Score=95.00 Aligned_cols=69 Identities=19% Similarity=0.330 Sum_probs=63.1
Q ss_pred hcCHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHH
Q 016471 237 ALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAA 306 (389)
Q Consensus 237 ~l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~ 306 (389)
.+++++...++++|..+|. ++|.|+.+||+.+|+.+|. .++.+++.++++.+|.|++|.|+|+||+..+
T Consensus 29 ~l~~~~~~el~~~F~~~D~d~~G~I~~~El~~~l~~lg~-~~~~~ei~~l~~~~D~d~dG~I~~~EF~~~m 98 (100)
T 2lv7_A 29 DIPEDELEEIREAFKVFDRDGNGFISKQELGTAMRSLGY-MPNEVELEVIIQRLDMDGDGQVDFEEFVTLL 98 (100)
T ss_dssp CCCGGGHHHHHHHHHHTCSSCSSCBCHHHHHHHHHHHTC-CCCTTTHHHHHHHHCSSCSSSBCHHHHHHHT
T ss_pred cCCHHHHHHHHHHHHHHcCCCCCcCCHHHHHHHHHHhCC-CCCHHHHHHHHHHHCCCCCCeEeHHHHHHHh
Confidence 3567788889999999999 9999999999999999987 4789999999999999999999999999853
|
| >1fi6_A EH domain protein REPS1; EPS15 homology domain, EF hand, calcium, RAS signal transduction, endocytosis/exocytosis complex; NMR {Mus musculus} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=99.25 E-value=1.1e-11 Score=92.30 Aligned_cols=62 Identities=16% Similarity=0.108 Sum_probs=55.3
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHh---CCchH-HHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 319 DQIAITAFDYFEQEGNRVISVEELALEL---NLAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 319 ~~~l~~aF~~~D~d~~G~I~~~el~~~l---~~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
...++++|+.||+|++|+|+.+|++.+| |...+ +.++++.+|.|+||.|+|+||+.+|....
T Consensus 8 ~~~~~~~F~~~D~d~dG~I~~~el~~~l~~~g~~~~~~~~i~~~~D~d~dG~i~~~EF~~~~~~~~ 73 (92)
T 1fi6_A 8 RQYYVNQFKTIQPDLNGFIPGSAAKEFFTKSKLPILELSHIWELSDFDKDGALTLDEFCAAFHLVV 73 (92)
T ss_dssp HHHHHHHHTTTCCSTTCEEEHHHHHHHHHHHSSCHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHH
Confidence 4568999999999999999999999988 55555 99999999999999999999999997543
|
| >3zwh_A Protein S100-A4; Ca-binding protein-motor protein complex, S100 proteins, EF-; 1.94A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.25 E-value=8.9e-12 Score=94.69 Aligned_cols=62 Identities=23% Similarity=0.361 Sum_probs=53.2
Q ss_pred HHHHHHHHHHHc-ccCC-CcccHHHHHHHhCC----------chH-HHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 319 DQIAITAFDYFE-QEGN-RVISVEELALELNL----------APA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 319 ~~~l~~aF~~~D-~d~~-G~I~~~el~~~l~~----------~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
...++.||+.|| +|+| |+|+++||+.+|.. ... ++++++++|.|+||.|+|+||+.+|.+..
T Consensus 12 ~~~l~~aF~~fD~~dgd~G~Is~~EL~~~l~~~lg~~l~~~~~~~ev~~~i~~~D~dgDG~Idf~EF~~~m~~~~ 86 (104)
T 3zwh_A 12 LDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSWLGKRTDEAAFQKLMSNLDSNRDNEVDFQEYCVFLSSIA 86 (104)
T ss_dssp HHHHHHHHHHHHTSSSSTTSBCHHHHHHHHHHHCGGGSCSSCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhccCCCCCeECHHHHHHHHHHHcchhccCCCCHHHHHHHHHHHcCCCCCCCcHHHHHHHHHHHH
Confidence 456999999998 7885 89999999998831 122 99999999999999999999999998754
|
| >1iq3_A Ralbp1-interacting protein (partner of ralbp1); EF-hand domain, POB1 EH domain, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=99.24 E-value=1.2e-11 Score=95.16 Aligned_cols=62 Identities=13% Similarity=0.130 Sum_probs=54.8
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHh---CCchH-HHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 319 DQIAITAFDYFEQEGNRVISVEELALEL---NLAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 319 ~~~l~~aF~~~D~d~~G~I~~~el~~~l---~~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
.+.++++|+.||+|++|+|+.+||+.+| |+..+ +.++++++|.|++|.|+|+||+.+|....
T Consensus 21 ~~~~~~~F~~~D~d~dG~Is~~el~~~l~~~gl~~~el~~i~~~~D~d~dG~I~~~EF~~~m~~~~ 86 (110)
T 1iq3_A 21 REYYVNQFRSLQPDPSSFISGSVAKNFFTKSKLSIPELSYIWELSDADCDGALTLPEFCAAFHLIV 86 (110)
T ss_dssp HHHHHHHHHHHCCSSSSEEEHHHHHHHCCSSSCSSCCHHHHHHHHCSSSCSEEEHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHCCCCCCeEcHHHHHHHHHHcCCCHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHH
Confidence 3568999999999999999999999999 43333 99999999999999999999999997654
|
| >2ehb_A Calcineurin B-like protein 4; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} PDB: 1v1g_A 1v1f_A | Back alignment and structure |
|---|
Probab=99.24 E-value=1.7e-11 Score=105.79 Aligned_cols=117 Identities=15% Similarity=0.084 Sum_probs=84.3
Q ss_pred CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCC--CCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHHHHHcccC
Q 016471 256 KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPL--SDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEG 333 (389)
Q Consensus 256 ~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~--~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~ 333 (389)
++|.++.+++.......+.......++.++|..+|.+ ++|.|+++||..++.... ... +..+..+|..+|.|+
T Consensus 13 ~~g~l~~~el~~l~~~~~~s~~~~~~l~~~F~~~D~d~~~~G~i~~~e~~~~l~~~~-~~~----~~~~~~~f~~~D~d~ 87 (207)
T 2ehb_A 13 AMRPPGYEDPELLASVTPFTVEEVEALYELFKKLSSSIIDDGLIHKEEFQLALFRNR-NRR----NLFADRIFDVFDVKR 87 (207)
T ss_dssp --------CHHHHHHHSSCCHHHHHHHHHHHHHHTTSSSCSSCEEHHHHHHHHHSCT-TCC----CHHHHHHHHHHCTTC
T ss_pred cccccCHHHHHHHHHhCCCCHHHHHHHHHHHHHhccccCCCCccCHHHHHHHHhccc-ccc----HHHHHHHHHHhcCCC
Confidence 4789999999987665543222233456888899999 999999999998765411 111 234678999999999
Q ss_pred CCcccHHHHHHHhCC-----c-hH-HHHHHHHHccCCCCceeHHHHHHHHc
Q 016471 334 NRVISVEELALELNL-----A-PA-AYSLLNDCIRNSDGKLSFLGYKRFLH 377 (389)
Q Consensus 334 ~G~I~~~el~~~l~~-----~-~~-~~~~~~~~d~~~~g~i~~~ef~~~~~ 377 (389)
+|.|+.+|+..++.. . .. +..+|+.+|.|++|.|+.+||..+++
T Consensus 88 ~g~i~~~Ef~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~I~~~E~~~~l~ 138 (207)
T 2ehb_A 88 NGVIEFGEFVRSLGVFHPSAPVHEKVKFAFKLYDLRQTGFIEREELKEMVV 138 (207)
T ss_dssp SSEECHHHHHHHHGGGSTTSCHHHHHHHHHHHHCTTCCSSEEHHHHHHHHH
T ss_pred CCeEeHHHHHHHHHHHccCCCHHHHHHHHHHHhCCCCCCcCcHHHHHHHHH
Confidence 999999999998832 1 12 88999999999999999999999985
|
| >1c07_A Protein (epidermal growth factor receptor pathway substrate 15); calcium binding, signaling domain, NPF binding, FW binding, EF-hand, EH domain; NMR {Homo sapiens} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=99.23 E-value=1.3e-11 Score=92.63 Aligned_cols=62 Identities=16% Similarity=0.099 Sum_probs=55.4
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHh---CCchH-HHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 319 DQIAITAFDYFEQEGNRVISVEELALEL---NLAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 319 ~~~l~~aF~~~D~d~~G~I~~~el~~~l---~~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
.+.++.+|+.||+|+||+|+.+|++.+| |...+ +.++++.+|.|+||.|+|+||+.+|....
T Consensus 9 ~~~~~~~F~~~D~d~dG~I~~~el~~~l~~~g~~~~~~~~i~~~~D~d~dG~i~~~EF~~~~~~~~ 74 (95)
T 1c07_A 9 KAKYDEIFLKTDKDMDGFVSGLEVREIFLKTGLPSTLLAHIWSLCDTKDCGKLSKDQFALAFHLIS 74 (95)
T ss_dssp HHHHHHHHHHHCTTCSSEECHHHHHHHHHTTTCCHHHHHHHHHHHCTTCSSSEETTTHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCcEeHHHHHHHHHHcCCCHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHHH
Confidence 4568999999999999999999999998 55544 99999999999999999999999997654
|
| >2jjz_A Ionized calcium-binding adapter molecule 2; EF-hand, actin crosslinking, ionized calciu binding adapter molecule 2, metal-binding protein; 2.15A {Homo sapiens} PDB: 2jjz_B 2vtg_A | Back alignment and structure |
|---|
Probab=99.23 E-value=1.2e-11 Score=101.19 Aligned_cols=88 Identities=14% Similarity=0.252 Sum_probs=69.6
Q ss_pred HHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHH
Q 016471 240 EEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERW 318 (389)
Q Consensus 240 ~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~ 318 (389)
.++...++..|..+|. ++|.|+.+||+.+|..+|. .++..++.+++..+|.+++|.|+|+||+..+....
T Consensus 46 ~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~-~~~~~e~~~l~~~~D~d~dg~I~~~eF~~~~~~~~-------- 116 (150)
T 2jjz_A 46 PEKLTAFKEKYMEFDLNNEGEIDLMSLKRMMEKLGV-PKTHLEMKKMISEVTGGVSDTISYRDFVNMMLGKR-------- 116 (150)
T ss_dssp HHHHHHHHHHHTTSCCCTTSSBCHHHHHHHHHHTTC-CCCHHHHHHHHHHHHTTSCSSBCHHHHHHHHHSSS--------
T ss_pred HHHHHHHHHHHHHhCCCCcCcCCHHHHHHHHHHcCC-CCCHHHHHHHHHHHCCCCCCcEeHHHHHHHHHHhH--------
Confidence 4567789999999999 9999999999999999886 47899999999999999999999999998766541
Q ss_pred HHHHHHHHHHHcccCCCcc
Q 016471 319 DQIAITAFDYFEQEGNRVI 337 (389)
Q Consensus 319 ~~~l~~aF~~~D~d~~G~I 337 (389)
..++.+|+.||.|++|+-
T Consensus 117 -~~i~~aF~~~D~d~~G~~ 134 (150)
T 2jjz_A 117 -SAVLKLVMMFEGKANESS 134 (150)
T ss_dssp -CCHHHHHHC---------
T ss_pred -HHHHHHHHHHcCCCCCCC
Confidence 248899999999999974
|
| >1jba_A GCAP-2, protein (guanylate cyclase activating protein 2); EF-hand, calcium-binding protein, guanylyl cyclase regulation, lyase; NMR {Bos taurus} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=99.23 E-value=9.3e-11 Score=100.83 Aligned_cols=113 Identities=14% Similarity=0.224 Sum_probs=90.4
Q ss_pred HHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHh--------
Q 016471 244 VYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEA-------- 314 (389)
Q Consensus 244 ~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~-------- 314 (389)
..+...|..+|. ++|.|+.+||..++...+.. .+.+++..+|..+|.+++|.|+++||..++........
T Consensus 59 ~~~~~~f~~~D~d~~G~i~~~Ef~~~~~~~~~~-~~~~~~~~~F~~~D~d~~G~I~~~E~~~~l~~~~~~~g~~~~~~~~ 137 (204)
T 1jba_A 59 QYVEAMFRAFDTNGDNTIDFLEYVAALNLVLRG-TLEHKLKWTFKIYDKDRNGCIDRQELLDIVESIYKLKKACSVEVEA 137 (204)
T ss_dssp HHHHHHHHHHCCSSSSEECHHHHHHHHHHHSSC-CCTHHHHHHHHHHCSSCSSCBCHHHHHHHHHHHHHHHHHSSCCTTS
T ss_pred HHHHHHHHHHcCCCCCeEeHHHHHHHHHHHccC-CHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHHHHhCCCCccccc
Confidence 345667888999 99999999999999887653 57788999999999999999999999987655422110
Q ss_pred -----hHHHHHHHHHHHHHHcccCCCcccHHHHHHHhCCchHHHHHHH
Q 016471 315 -----LERWDQIAITAFDYFEQEGNRVISVEELALELNLAPAAYSLLN 357 (389)
Q Consensus 315 -----~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~ 357 (389)
....++.+..+|+.+|.|+||.|+.+|+..++...+.+.+++.
T Consensus 138 ~~~g~~~~~~~~~~~~f~~~D~d~dG~Is~~Ef~~~~~~~~~~~~~~~ 185 (204)
T 1jba_A 138 EQQGKLLTPEEVVDRIFLLVDENGDGQLSLNEFVEGARRDKWVMKMLQ 185 (204)
T ss_dssp STTTCCCCHHHHHHHHHHHHCCSCCSCBCHHHHHHHHTTTTTHHHHHH
T ss_pred cccCchhhHHHHHHHHHHHhCCCCCCeEcHHHHHHHHHcChHHHHHHH
Confidence 0011456899999999999999999999999977666666666
|
| >1s6j_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=99.22 E-value=1.4e-12 Score=96.11 Aligned_cols=79 Identities=13% Similarity=0.140 Sum_probs=61.6
Q ss_pred CCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHh---CC--chH-HHHHHHHHccCCCC
Q 016471 292 LSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALEL---NL--APA-AYSLLNDCIRNSDG 365 (389)
Q Consensus 292 ~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l---~~--~~~-~~~~~~~~d~~~~g 365 (389)
|++|.|+|+|++.+ ..... .. ...++.+|+.||+|++|+|+.+||+.++ |. ... +.++++.+|.+++|
T Consensus 1 ~~~G~i~~~e~~~~-~~l~~-~~----~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~l~~~~d~~~~g 74 (87)
T 1s6j_A 1 HSSGHIDDDDKHMA-ERLSE-EE----IGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADIDKSG 74 (87)
T ss_dssp CCSSSSSSHHHHSS-SSSCS-SS----TTTTTTHHHHHCTTCSSCEEHHHHHHHHHTTTSSCCHHHHHHHHHHHCTTCSS
T ss_pred CCCCccCccHHHHH-HHCCH-HH----HHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCC
Confidence 56899999995432 11111 11 2358899999999999999999999998 32 233 99999999999999
Q ss_pred ceeHHHHHHHH
Q 016471 366 KLSFLGYKRFL 376 (389)
Q Consensus 366 ~i~~~ef~~~~ 376 (389)
.|+|+||+.++
T Consensus 75 ~i~~~eF~~~~ 85 (87)
T 1s6j_A 75 TIDYGEFIAAT 85 (87)
T ss_dssp EECHHHHTTCC
T ss_pred cCcHHHHHHHH
Confidence 99999998765
|
| >1qjt_A EH1, epidermal growth factor receptor substrate substrate 15, EPS15; EH domain, EF-hand, solution structure, S100 protein; NMR {Mus musculus} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=99.22 E-value=1e-11 Score=93.82 Aligned_cols=61 Identities=15% Similarity=0.032 Sum_probs=54.6
Q ss_pred HHHHHHHHHHcccCCCcccHHHHHHHh---CCchH-HHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 320 QIAITAFDYFEQEGNRVISVEELALEL---NLAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 320 ~~l~~aF~~~D~d~~G~I~~~el~~~l---~~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
+.++.+|+.||+|++|+|+.+|++.+| |+..+ +.++++.+|.|+||.|+|+||+.+|+...
T Consensus 11 ~~~~~~F~~~D~d~dG~Is~~el~~~l~~~~l~~~~l~~i~~~~D~d~dG~i~~~EF~~~~~~~~ 75 (99)
T 1qjt_A 11 PVYEKYYRQVEAGNTGRVLALDAAAFLKKSGLPDLILGKIWDLADTDGKGVLSKQEFFVALRLVA 75 (99)
T ss_dssp THHHHHHHHHCCTTSSCCCSHHHHHHHHTSSSCHHHHHHHHHHHCCSSSSSCCSHHHHHHHHHHH
T ss_pred HHHHHHHHHHCCCCCCcCCHHHHHHHHHHcCCCHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHHH
Confidence 468999999999999999999999998 55444 99999999999999999999999997543
|
| >3khe_A Calmodulin-like domain protein kinase isoform 3; calcium dependent kinase, structural genomics, structural GE consortium, SGC, ATP-binding; 1.95A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.21 E-value=1.6e-10 Score=98.06 Aligned_cols=96 Identities=10% Similarity=0.100 Sum_probs=80.7
Q ss_pred CHHHHHHHHhhcCCCCCcceeHHHHHHHHhch-----------hHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHh
Q 016471 278 TDSRVFEILNVMEPLSDQKLAYEEFCAAATSV-----------YQLEALERWDQIAITAFDYFEQEGNRVISVEELALEL 346 (389)
Q Consensus 278 ~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~-----------~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l 346 (389)
...++.++|..+|.+++|.|+++||..++... ..... ...+..+|+.+|.|++|.|+.+|+..++
T Consensus 38 ~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~D~d~~g~i~~~ef~~~~ 113 (191)
T 3khe_A 38 ETKELTQIFRQLDNNGDGQLDRKELIEGYRKLMQWKGDTVSDLDSSQI----EAEVDHILQSVDFDRNGYIEYSEFVTVC 113 (191)
T ss_dssp TTHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHC-----CCHHHHHHH----HHHHHHHHHHTCTTCSSSEEHHHHHHHH
T ss_pred HHHHHHHHHHHHcCCCCCCCcHHHHHHHHHHHHhhcccccccccchhh----HHHHHHHHHHhCCCCCCcCCHHHHHHHH
Confidence 45678999999999999999999999866543 11111 4568999999999999999999999988
Q ss_pred CCc-----hH-HHHHHHHHccCCCCceeHHHHHHHHc
Q 016471 347 NLA-----PA-AYSLLNDCIRNSDGKLSFLGYKRFLH 377 (389)
Q Consensus 347 ~~~-----~~-~~~~~~~~d~~~~g~i~~~ef~~~~~ 377 (389)
... .. +..+|+.+|.|++|.|+.+||..++.
T Consensus 114 ~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~E~~~~l~ 150 (191)
T 3khe_A 114 MDKQLLLSRERLLAAFQQFDSDGSGKITNEELGRLFG 150 (191)
T ss_dssp SCHHHHCCHHHHHHHHHHHCTTCSSEECHHHHHHHTT
T ss_pred HHhcccchHHHHHHHHHHHCCCCcCcCCHHHHHHHHc
Confidence 332 22 88999999999999999999999988
|
| >1wy9_A Allograft inflammatory factor 1; EF-hand, calucium binding, metal binding protein; 2.10A {Mus musculus} PDB: 2g2b_A | Back alignment and structure |
|---|
Probab=99.20 E-value=2.1e-11 Score=99.33 Aligned_cols=88 Identities=11% Similarity=0.224 Sum_probs=74.0
Q ss_pred HHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHH
Q 016471 240 EEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERW 318 (389)
Q Consensus 240 ~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~ 318 (389)
.++...++..|..+|. ++|.|+.+||..++..+|. .++..++.+++..+|.+++|.|+|+||+..+....
T Consensus 44 ~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~g~-~~~~~~~~~l~~~~D~d~dg~I~~~eF~~~~~~~~-------- 114 (147)
T 1wy9_A 44 PSKLEAFKVKYMEFDLNGNGDIDIMSLKRMLEKLGV-PKTHLELKRLIREVSSGSEETFSYSDFLRMMLGKR-------- 114 (147)
T ss_dssp HHHHHHHHHHHTTSCCCTTSSEEHHHHHHHHHHTTC-CCCHHHHHHHHHHHCSSCTTEECHHHHHHHHCSSG--------
T ss_pred HHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCC-CCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHhH--------
Confidence 5778889999999999 9999999999999999886 47899999999999999999999999998766541
Q ss_pred HHHHHHHHHHHcccCCCcc
Q 016471 319 DQIAITAFDYFEQEGNRVI 337 (389)
Q Consensus 319 ~~~l~~aF~~~D~d~~G~I 337 (389)
..+..+|+.||.|++|..
T Consensus 115 -~~~~~aF~~~D~d~~g~~ 132 (147)
T 1wy9_A 115 -SAILRMILMYEEKNKEHK 132 (147)
T ss_dssp -GGGGGGGGGCCCC-----
T ss_pred -HHHHHHHHHHccCCCCCC
Confidence 237889999999999984
|
| >4drw_A Protein S100-A10/annexin A2 chimeric protein; atypical EF-hand, heteropentameric complex, membrane repair; 3.50A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.20 E-value=1.1e-11 Score=96.49 Aligned_cols=61 Identities=20% Similarity=0.393 Sum_probs=53.3
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHhCC----------chH-HHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 319 DQIAITAFDYFEQEGNRVISVEELALELNL----------APA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 319 ~~~l~~aF~~~D~d~~G~I~~~el~~~l~~----------~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
-+.++.+|..||.| +|+||++||+.+|.. .+. +.++++++|.|+||.|+|+||+.+|.++.
T Consensus 14 ie~l~~~F~~yd~d-dG~Is~~EL~~~l~~~~~~~l~~~~~~~~v~~~i~~~D~d~DG~IdF~EF~~lm~~l~ 85 (121)
T 4drw_A 14 METMMFTFHKFAGD-KGYLTKEDLRVLMEKEFPGFLENQKDPLAVDKIMKDLDQCRDGKVGFQSFFSLIAGLT 85 (121)
T ss_dssp HHHHHHTTGGGSCT-TCSCCHHHHHHHTTTSCHHHHTTSSCTTHHHHHHHHHCTTCSSCCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHcCC-CCEEcHHHHHHHHHHHhhhhcccCCCHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHH
Confidence 35699999999988 899999999999832 122 99999999999999999999999998765
|
| >2lnk_A Protein S100-A4; EF-hand, calcium binding, all alpha, metal binding protein, binding protein; NMR {Homo sapiens} PDB: 3c1v_A | Back alignment and structure |
|---|
Probab=99.20 E-value=2.1e-11 Score=93.88 Aligned_cols=62 Identities=24% Similarity=0.413 Sum_probs=53.7
Q ss_pred HHHHHHHHHHHc-ccCCC-cccHHHHHHHhC------C----chH-HHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 319 DQIAITAFDYFE-QEGNR-VISVEELALELN------L----APA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 319 ~~~l~~aF~~~D-~d~~G-~I~~~el~~~l~------~----~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
.+.++.||+.|| +|++| +|+.+||+.+|. + ... ++++++++|.|+||.|+|+||+.+|.+..
T Consensus 21 ~~~l~~aF~~fD~~dgdGG~Is~~EL~~~l~~~l~~~lg~~~t~~ev~~li~~~D~dgdG~Idf~EF~~~m~~~~ 95 (113)
T 2lnk_A 21 LDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSNRDNEVDFQEYCVFLSCIA 95 (113)
T ss_dssp HHHHHHHHHHTTTTTSCTTCBCHHHHHHHHHHHCGGGGTTCCCTTHHHHHHHHHCSSSSSCBCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHcccCCCCCEECHHHHHHHHHHHcchhcCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHHH
Confidence 456999999999 89997 999999999883 1 122 99999999999999999999999997654
|
| >3dd4_A KV channel-interacting protein 4; EF-hands protein, ION transport, ionic channel, membrane, PO potassium channel, potassium transport, transport; 3.00A {Mus musculus} PDB: 2e6w_A | Back alignment and structure |
|---|
Probab=99.19 E-value=8.6e-11 Score=103.16 Aligned_cols=116 Identities=15% Similarity=0.193 Sum_probs=92.1
Q ss_pred HHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHH--------hh
Q 016471 245 YLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLE--------AL 315 (389)
Q Consensus 245 ~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~--------~~ 315 (389)
.+...|..+|. ++|.|+.+||..++..... ....+.+..+|+.+|.|++|.|+++||...+....... ..
T Consensus 103 ~~~~lf~~~D~d~~G~I~~~Ef~~~l~~~~~-~~~~~~l~~~F~~~D~d~dG~Is~~E~~~~l~~~~~~~~~~~~~~~~~ 181 (229)
T 3dd4_A 103 YAHFLFNAFDTDHNGAVSFEDFIKGLSILLR-GTVQEKLNWAFNLYDINKDGYITKEEMLDIMKAIYDMMGKCTYPVLKE 181 (229)
T ss_dssp HHHHHHHTTCSSCCSSCCHHHHHHHHHHHHH-SCHHHHHHHHHHHHCTTCSSCCBHHHHHHHHHHHHHHCC---------
T ss_pred HHHHHHHHcCCCCCCeEeHHHHHHHHHHHcC-CChHHHHHHHHHHhCCCCCCeECHHHHHHHHHHHHHHhccccCCCcch
Confidence 35678889999 9999999999999887754 34567899999999999999999999998765432100 00
Q ss_pred HHHHHHHHHHHHHHcccCCCcccHHHHHHHhCCchHHHHHHHHHcc
Q 016471 316 ERWDQIAITAFDYFEQEGNRVISVEELALELNLAPAAYSLLNDCIR 361 (389)
Q Consensus 316 ~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~d~ 361 (389)
...++.+..+|+.+|.|+||.|+.+|+.+++...+.+.++++.+|.
T Consensus 182 ~~~~~~~~~~f~~~D~d~dG~Is~~EF~~~~~~~~~~~~~~~~~D~ 227 (229)
T 3dd4_A 182 DAPRQHVETFFQKMDKNKDGVVTIDEFIESCQKDENIMRSMQLFEN 227 (229)
T ss_dssp --CCTHHHHHHHHHCSSCSSBCCHHHHHHHHHTCHHHHHHHHHHTT
T ss_pred hhHHHHHHHHHHHhcCCCCCcEeHHHHHHHHHhCHHHHHHHHhccc
Confidence 0013468999999999999999999999999877777777877763
|
| >3ohm_B 1-phosphatidylinositol-4,5-bisphosphate phosphodi beta-3; PH domain, EF hand, TIM barrel, C2 domain, GTPase, lipase, C binding, GTP binding; HET: GDP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.19 E-value=5.4e-11 Score=121.71 Aligned_cols=124 Identities=19% Similarity=0.245 Sum_probs=101.9
Q ss_pred HHHHHHHhhh--cCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCC-------CCcceeHHHHHHHHhchhHH
Q 016471 243 LVYLRAQFML--LEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPL-------SDQKLAYEEFCAAATSVYQL 312 (389)
Q Consensus 243 ~~~l~~~F~~--~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~-------~~g~i~~~eF~~~~~~~~~~ 312 (389)
...+++.|.. +|. ++|.|+.+|+.+.|.. ...++.++|+.+|.+ ++|.|+|+||+..+....
T Consensus 149 ~~~L~kaf~~~~~D~n~dGkIs~kel~~~l~~------~~~~v~~l~~~~d~~~~~~d~~~~g~i~feEF~~f~~~l~-- 220 (885)
T 3ohm_B 149 NTFLRKAYTKLKLQVNQDGRIPVKNILKMFSA------DKKRVETALESCGLKFNRSESIRPDEFSLEIFERFLNKLC-- 220 (885)
T ss_dssp HHHHHHHHHHHHHSCCTTSCEEHHHHHHTTGG------GHHHHHHHHHTTTCCCSTTCEECGGGCCHHHHHHHHHHHS--
T ss_pred HHHHHHHHHHhcCccCCCCccCHHHHHHHHhc------CHHHHHHHHHHhCCCccccccCCCCcCCHHHHHHHHHhcC--
Confidence 4567788887 798 9999999999887643 356799999999987 788999999998654322
Q ss_pred HhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHh---CCc------------hH-HHHHHHHHccC----CCCceeHHHH
Q 016471 313 EALERWDQIAITAFDYFEQEGNRVISVEELALEL---NLA------------PA-AYSLLNDCIRN----SDGKLSFLGY 372 (389)
Q Consensus 313 ~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l---~~~------------~~-~~~~~~~~d~~----~~g~i~~~ef 372 (389)
. ..+++.+|+.||.+++|+||.+||+++| +.. .+ +.+||++++.+ ++|.|++++|
T Consensus 221 -~----R~EI~eiF~~ydsd~~g~mT~~EL~~FL~~~Q~e~~~~e~~~~~~t~e~~~~iI~k~e~~~~~~~~g~LsldgF 295 (885)
T 3ohm_B 221 -L----RPDIDKILLEIGAKGKPYLTLEQLMDFINQKQRDPRLNEVLYPPLRPSQARLLIEKYEPNQQFLERDQMSMEGF 295 (885)
T ss_dssp -C----CHHHHHHHHHTTCCSTTCEEHHHHHHHHHHHSSCTTSCTTTSCCCCHHHHHHHHHHHCCCHHHHHTTEECHHHH
T ss_pred -C----HHHHHHHHHHHhcCCCCccCHHHHHHHHHHhcCcccccccccccCCHHHHHHHHHHhcCChhhhccCccchhhh
Confidence 2 2359999999999999999999999999 211 13 89999999998 7899999999
Q ss_pred HHHHccc
Q 016471 373 KRFLHGV 379 (389)
Q Consensus 373 ~~~~~~~ 379 (389)
..+|...
T Consensus 296 ~~yL~S~ 302 (885)
T 3ohm_B 296 SRYLGGE 302 (885)
T ss_dssp HHHHTST
T ss_pred hhhccCc
Confidence 9999854
|
| >2jjz_A Ionized calcium-binding adapter molecule 2; EF-hand, actin crosslinking, ionized calciu binding adapter molecule 2, metal-binding protein; 2.15A {Homo sapiens} PDB: 2jjz_B 2vtg_A | Back alignment and structure |
|---|
Probab=99.19 E-value=6.1e-12 Score=102.93 Aligned_cols=89 Identities=10% Similarity=0.104 Sum_probs=71.3
Q ss_pred CCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHh---CC--chH
Q 016471 277 MTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALEL---NL--APA 351 (389)
Q Consensus 277 ~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l---~~--~~~ 351 (389)
++..++.+++..+|.+++ |.+|... .. ..+.++.+|+.||+|++|+|+.+||+.+| |. ...
T Consensus 21 ~~~~~~~~i~~~~d~~~~----~~~~~~l-------~~---~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~ 86 (150)
T 2jjz_A 21 RQERRLAEINREFLCDQK----YSDEENL-------PE---KLTAFKEKYMEFDLNNEGEIDLMSLKRMMEKLGVPKTHL 86 (150)
T ss_dssp HHHHHHHHHHHHHHTCGG----GSSCTTH-------HH---HHHHHHHHHTTSCCCTTSSBCHHHHHHHHHHTTCCCCHH
T ss_pred CcHHHHHHHHHHhccCCC----chhhHhH-------HH---HHHHHHHHHHHhCCCCcCcCCHHHHHHHHHHcCCCCCHH
Confidence 467789999999987654 4444331 01 14568999999999999999999999998 43 233
Q ss_pred -HHHHHHHHccCCCCceeHHHHHHHHccc
Q 016471 352 -AYSLLNDCIRNSDGKLSFLGYKRFLHGV 379 (389)
Q Consensus 352 -~~~~~~~~d~~~~g~i~~~ef~~~~~~~ 379 (389)
+.+++..+|.|++|.|+|+||+.+|...
T Consensus 87 e~~~l~~~~D~d~dg~I~~~eF~~~~~~~ 115 (150)
T 2jjz_A 87 EMKKMISEVTGGVSDTISYRDFVNMMLGK 115 (150)
T ss_dssp HHHHHHHHHHTTSCSSBCHHHHHHHHHSS
T ss_pred HHHHHHHHHCCCCCCcEeHHHHHHHHHHh
Confidence 9999999999999999999999999764
|
| >2opo_A Polcalcin CHE A 3; calcium-binding protein, dimer, domain-swapping, EF-hand; 1.75A {Chenopodium album} SCOP: a.39.1.10 PDB: 1h4b_A | Back alignment and structure |
|---|
Probab=99.18 E-value=5e-11 Score=87.40 Aligned_cols=73 Identities=18% Similarity=0.242 Sum_probs=63.7
Q ss_pred HHhcCHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhch
Q 016471 235 SKALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSV 309 (389)
Q Consensus 235 ~~~l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~ 309 (389)
+..+++++...++..|..+|. ++|.|+.+|++.++..+| .++..++..++..+|.+++|.|+|+||+..+...
T Consensus 2 ~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g--~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~~~ 75 (86)
T 2opo_A 2 AAEDTPQDIADRERIFKRFDTNGDGKISSSELGDALKTLG--SVTPDEVRRMMAEIDTDGDGFISFDEFTDFARAN 75 (86)
T ss_dssp ----CHHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHTTT--TCCHHHHHHHHHHHCTTCSSEECHHHHHHHHHHC
T ss_pred CccCCHhhHHHHHHHHHHHCCCCCCCcCHHHHHHHHHHcC--CCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHC
Confidence 345678889999999999999 999999999999999988 4789999999999999999999999999876544
|
| >3nxa_A Protein S100-A16; S100 family, calcium binding protein, APO, EF-hand calcium binding proteins, S100 proteins, protein dynamics, binding protein; 2.10A {Homo sapiens} SCOP: a.39.1.0 PDB: 2l0u_A 2l0v_A 2l50_A 2l51_A | Back alignment and structure |
|---|
Probab=99.17 E-value=4.1e-11 Score=90.44 Aligned_cols=63 Identities=24% Similarity=0.301 Sum_probs=53.8
Q ss_pred HHHHHHHHHHHcccC---CCcccHHHHHHHhC------Cc----hH-HHHHHHHHccCCCCceeHHHHHHHHccccC
Q 016471 319 DQIAITAFDYFEQEG---NRVISVEELALELN------LA----PA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVTV 381 (389)
Q Consensus 319 ~~~l~~aF~~~D~d~---~G~I~~~el~~~l~------~~----~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~ 381 (389)
...++.||+.||+|+ +|+|+++||+.+|. +. .. ++++++++|.|+||.|+|+||+.+|.+...
T Consensus 10 i~~l~~~F~~fD~~~g~~~G~Is~~EL~~~l~~~~~~~l~~~~~~~ev~~~i~~~D~d~DG~Idf~EF~~~m~~~~~ 86 (100)
T 3nxa_A 10 VIVLVENFYKYVSKYSLVKNKISKSSFREMLQKELNHMLSDTGNRKAADKLIQNLDANHDGRISFDEYWTLIGGITG 86 (100)
T ss_dssp HHHHHHHHHHTSCTTCSCTTCBCHHHHHHHHHHHSTTTTCSSHHHHHHHHHHHHSCCCSSCCBCHHHHHHHHHHHHG
T ss_pred HHHHHHHHHHHcCcCCCCCCeEcHHHHHHHHHHHccccccccccHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHHH
Confidence 456999999999974 79999999999882 11 12 999999999999999999999999987654
|
| >2jul_A Calsenilin; EF-hand, calcium, LXXLL, DNA binding protein, dimer, alternative splicing, apoptosis, cytoplasm, endoplasmic reticulum, golgi apparatus; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=99.17 E-value=8.4e-11 Score=105.05 Aligned_cols=116 Identities=14% Similarity=0.186 Sum_probs=90.4
Q ss_pred HHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHh--------
Q 016471 244 VYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEA-------- 314 (389)
Q Consensus 244 ~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~-------- 314 (389)
..+...|..+|. ++|.|+.+||..++..++. ....+++..+|+.+|.+++|.|+++||...+........
T Consensus 129 ~~~~~~f~~~D~d~dG~I~~~Ef~~~l~~~~~-~~~~~~l~~~F~~~D~d~dG~I~~~Ef~~~l~~~~~~~g~~~~~~~~ 207 (256)
T 2jul_A 129 TYAHFLFNAFDADGNGAIHFEDFVVGLSILLR-GTVHEKLKWAFNLYDINKDGCITKEEMLAIMKSIYDMMGRHTYPILR 207 (256)
T ss_dssp HHHHHHHHHSSCSCCSEECSHHHHHHHHHHHS-CCHHHHHHHHHHHTCCSSSSCBCHHHHHHHHHHHHHHCCCCCSCCSC
T ss_pred HHHHHHHHHhccCCCCcCcHHHHHHHHHHHhc-cChHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHHHHhCCCCCcccc
Confidence 346778999999 9999999999999988764 356788999999999999999999999987654321100
Q ss_pred hHHHHHHHHHHHHHHcccCCCcccHHHHHHHhCCchHHHHHHHHHc
Q 016471 315 LERWDQIAITAFDYFEQEGNRVISVEELALELNLAPAAYSLLNDCI 360 (389)
Q Consensus 315 ~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~d 360 (389)
....++.+..+|+.+|.|+||.|+.+|+..++...+.+.+.+..+|
T Consensus 208 ~~~~~~~~~~~f~~~D~d~dG~Is~~Ef~~~~~~~~~l~~~l~~~d 253 (256)
T 2jul_A 208 EDAPLEHVERFFQKMDRNQDGVVTIDEFLETCQKDENIMNSMQLFE 253 (256)
T ss_dssp CCCHHHHHHHHHHHSCCSTTCSBCHHHHHHHHHHCSSHHHHHHHHH
T ss_pred hhhHHHHHHHHHHHHCCCCCCcEeHHHHHHHHHhCHHHHHHHHhhc
Confidence 0001456899999999999999999999999865555545555444
|
| >2joj_A Centrin protein; N-terminal domain, centrin solution structure, EF-hand calcium binding protein, cell cycle; NMR {Euplotes octocarinatus} | Back alignment and structure |
|---|
Probab=99.17 E-value=7.5e-11 Score=84.44 Aligned_cols=62 Identities=21% Similarity=0.354 Sum_probs=54.6
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHh---CCchH---HHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 319 DQIAITAFDYFEQEGNRVISVEELALEL---NLAPA---AYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 319 ~~~l~~aF~~~D~d~~G~I~~~el~~~l---~~~~~---~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
...++.+|+.||+|++|+|+.+||+.++ |...+ +..++..+|.+++|.|+|+||+.+|....
T Consensus 6 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~ 73 (77)
T 2joj_A 6 KQEIKEAFDLFDTNKTGSIDYHELKVAMRALGFDVKKPEILELMNEYDREGNGYIGFDDFLDIMTEKI 73 (77)
T ss_dssp HHHHHHHHHHHCCSSSSEEEHHHHHHHHHHHTCCCHHHHHHHHHHHHCCSSSSEEEHHHHHHHHTHHH
T ss_pred HHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhCCCCCHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHh
Confidence 4568999999999999999999999998 44322 99999999999999999999999997643
|
| >2h2k_A Protein S100-A13; calcium binding protein, metal binding protein; 2.00A {Homo sapiens} PDB: 1yur_A 1yus_A 1yut_A 1yuu_A 2egd_A 2k8m_B 2ki4_B* 2ki6_C* 2kot_A* 2l5x_B 2cxj_A | Back alignment and structure |
|---|
Probab=99.16 E-value=6.9e-11 Score=90.12 Aligned_cols=62 Identities=26% Similarity=0.314 Sum_probs=53.2
Q ss_pred HHHHHHHHHHHc-ccCC-CcccHHHHHHHh----C-Cch--H-HHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 319 DQIAITAFDYFE-QEGN-RVISVEELALEL----N-LAP--A-AYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 319 ~~~l~~aF~~~D-~d~~-G~I~~~el~~~l----~-~~~--~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
.+.++.||+.|| +|++ |+|+.+||+.+| | ..+ . +.++++++|.|+||.|+|+||+.+|....
T Consensus 21 ~~~l~~aF~~fD~~dg~~G~Is~~EL~~~l~~~lg~~~~~~~ev~~li~~~D~d~dG~Idf~EF~~~~~~~~ 92 (106)
T 2h2k_A 21 IETVVTTFFTFARQEGRKDSLSVNEFKELVTQQLPHLLKDVGSLDEKMKSLDVNQDSELKFNEYWRLIGELA 92 (106)
T ss_dssp HHHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHCTTTTTTCCCHHHHHHHHCTTCSSSEEHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHcccCCCCCEECHHHHHHHHHHHcCcCCCCHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHHH
Confidence 457999999999 7996 799999999998 2 122 2 99999999999999999999999987643
|
| >2kgr_A Intersectin-1; structure, alternative splicing, calcium, cell junction, cell projection, coiled coil, endocytosis, membrane, phosphoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.15 E-value=7e-11 Score=91.16 Aligned_cols=62 Identities=18% Similarity=0.114 Sum_probs=54.4
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHh---CCchH-HHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 319 DQIAITAFDYFEQEGNRVISVEELALEL---NLAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 319 ~~~l~~aF~~~D~d~~G~I~~~el~~~l---~~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
.+.++.+|+.||+|+||+|+.+||+.+| +.... +.++++.+|.|+||.|+|+||+.+|....
T Consensus 13 ~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~~i~~~~D~d~dG~I~~~EF~~~~~~~~ 78 (111)
T 2kgr_A 13 RLKYRQLFNSHDKTMSGHLTGPQARTILMQSSLPQAQLASIWNLSDIDQDGKLTAEEFILAMHLID 78 (111)
T ss_dssp HHHHHHHHHTTSCSSCCEEEHHHHHHHHHTTCCCHHHHHHHHHHHCSSCCSEEEHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHCCCCCCcCcHHHHHHHHHhCCCCHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHHH
Confidence 4568999999999999999999999999 33333 99999999999999999999999986543
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.15 E-value=5.2e-12 Score=118.35 Aligned_cols=71 Identities=11% Similarity=0.172 Sum_probs=55.7
Q ss_pred EEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeecCCC-------CCEEEeec
Q 016471 16 LFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREED-------APLKVIDF 88 (389)
Q Consensus 16 ~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~~~~-------~~~kl~Df 88 (389)
+|||||+.|++|.+. ...+.+..++.||+.+|.|||++|||||||||.|||++..++. ..+.|+||
T Consensus 187 ~LVME~i~G~~L~~l-------~~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~ 259 (397)
T 4gyi_A 187 TIVMSLVDALPMRQV-------SSVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXF 259 (397)
T ss_dssp EEEEECCSCEEGGGC-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCC
T ss_pred eEEEEecCCccHhhh-------cccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccccccccceEEEEe
Confidence 699999999988652 1223456788999999999999999999999999999743210 13789999
Q ss_pred CCccc
Q 016471 89 GLSDF 93 (389)
Q Consensus 89 g~a~~ 93 (389)
+-+..
T Consensus 260 ~Q~V~ 264 (397)
T 4gyi_A 260 PQMVS 264 (397)
T ss_dssp TTCEE
T ss_pred CCccc
Confidence 86654
|
| >2y5i_A S100Z, S100 calcium binding protein Z; metal-binding protein, EF-hand, calcium regulation, oligomer neuronal development, spine2; 2.03A {Danio rerio} | Back alignment and structure |
|---|
Probab=99.15 E-value=5.8e-11 Score=89.57 Aligned_cols=62 Identities=27% Similarity=0.408 Sum_probs=53.3
Q ss_pred HHHHHHHHHHHc-ccCCC-cccHHHHHHHhCC----------chH-HHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 319 DQIAITAFDYFE-QEGNR-VISVEELALELNL----------APA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 319 ~~~l~~aF~~~D-~d~~G-~I~~~el~~~l~~----------~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
.+.++.||+.|| +|++| +|+.+||+.+|.. ... +.++++++|.|+||.|+|+||+.+|....
T Consensus 9 ~~~l~~~F~~fDd~dg~gG~I~~~El~~~l~~~~~~~lg~~~~~~~v~~l~~~~D~d~dG~I~f~EF~~~~~~~~ 83 (99)
T 2y5i_A 9 MDALITVFHNYSGSEGDKYKLSKGELKELLNAELTDFLMSQKDPMLVEKIMNDLDSNKDNEVDFNEFVVLVAALT 83 (99)
T ss_dssp HHHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHSGGGGTTSCCHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhccCCCcCcCCHHHHHHHHHHHhhhhccccccHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHH
Confidence 456999999998 89998 9999999999731 222 99999999999999999999999997643
|
| >2bl0_C Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} | Back alignment and structure |
|---|
Probab=99.15 E-value=1.8e-10 Score=92.67 Aligned_cols=97 Identities=10% Similarity=0.038 Sum_probs=80.2
Q ss_pred HHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHhCC------chH-H
Q 016471 280 SRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALELNL------APA-A 352 (389)
Q Consensus 280 ~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~------~~~-~ 352 (389)
.++.++|..+|.+++|.|+++||..++........ ...+..+|+.+|.|++|.|+.+|+..++.. ... +
T Consensus 6 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~----~~~~~~l~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~ 81 (142)
T 2bl0_C 6 SEFKEAFELFDSERTGFITKEGLQTVLKQFGVRVE----PAAFNEMFNEADATGNGKIQFPEFLSMMGRRMKQTTSEDIL 81 (142)
T ss_dssp HHHHHHHHHHCTTCSSEEEHHHHHHHHHHHTCCCC----HHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHTTCCCHHHH
T ss_pred HHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCC----HHHHHHHHHHhCcCCCCeeeHHHHHHHHHHHhcCCChHHHH
Confidence 45789999999999999999999986554322222 345889999999999999999999998832 122 8
Q ss_pred HHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 353 YSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 353 ~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
..+|+.+|.|++|.|+.+||..+++...
T Consensus 82 ~~~F~~~D~d~~G~i~~~el~~~l~~~g 109 (142)
T 2bl0_C 82 RQAFRTFDPEGTGYIPKAALQDALLNLG 109 (142)
T ss_dssp HHHHHHTCCSSCSCEEHHHHHHHHHHSS
T ss_pred HHHHHHHCCCCCCcCcHHHHHHHHHHcC
Confidence 8999999999999999999999998654
|
| >1tiz_A Calmodulin-related protein, putative; helix-turn-helix, structural genomics, protein structure initiative; NMR {Arabidopsis thaliana} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=99.15 E-value=5.8e-11 Score=82.43 Aligned_cols=57 Identities=12% Similarity=0.244 Sum_probs=51.1
Q ss_pred HHHHHHHHcccCCCcccHHHHHHHh---CC--chH-HHHHHHHHccCCCCceeHHHHHHHHcc
Q 016471 322 AITAFDYFEQEGNRVISVEELALEL---NL--APA-AYSLLNDCIRNSDGKLSFLGYKRFLHG 378 (389)
Q Consensus 322 l~~aF~~~D~d~~G~I~~~el~~~l---~~--~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~ 378 (389)
++.+|+.+|+|++|+|+.+|++.++ |. ... +..++..+|.|++|.|+|+||+.++++
T Consensus 3 l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dg~i~~~ef~~~~~~ 65 (67)
T 1tiz_A 3 AKRVFEKFDKNKDGKLSLDEFREVALAFSPYFTQEDIVKFFEEIDVDGNGELNADEFTSCIEK 65 (67)
T ss_dssp HHHHHHHHCTTSSSCEEHHHHHHHHHHTCTTSCHHHHHHHHHHHCCSSSSEECHHHHHHHHHT
T ss_pred HHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHHCCCCCCcCcHHHHHHHHHH
Confidence 7889999999999999999999988 32 233 899999999999999999999999875
|
| >2kz2_A Calmodulin, CAM; TR2C, metal binding protein; NMR {Gallus gallus} | Back alignment and structure |
|---|
Probab=99.14 E-value=8e-11 Score=88.03 Aligned_cols=60 Identities=17% Similarity=0.318 Sum_probs=53.2
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHh---CC--chH-HHHHHHHHccCCCCceeHHHHHHHHcc
Q 016471 319 DQIAITAFDYFEQEGNRVISVEELALEL---NL--APA-AYSLLNDCIRNSDGKLSFLGYKRFLHG 378 (389)
Q Consensus 319 ~~~l~~aF~~~D~d~~G~I~~~el~~~l---~~--~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~ 378 (389)
++.++.+|+.||+|++|+|+.+||+.++ |. ... ++++++.+|.|++|.|+|+||+.+|..
T Consensus 28 ~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~e~~~l~~~~D~d~dG~I~~~EF~~~~~~ 93 (94)
T 2kz2_A 28 EEEIREAFRVEDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMTA 93 (94)
T ss_dssp HHHHHHHHHHHCTTCCSCBCHHHHHHHHHHHTCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHC
T ss_pred HHHHHHHHHHHCCCCcCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHhc
Confidence 4568999999999999999999999988 43 333 999999999999999999999999864
|
| >2kax_A Protein S100-A5; EF-hand, calcium binding protien, calcium, polymorphism, structural genomics, spine2, structural proteomics in europe, spine; NMR {Homo sapiens} PDB: 2kay_A | Back alignment and structure |
|---|
Probab=99.14 E-value=8.2e-11 Score=87.58 Aligned_cols=64 Identities=23% Similarity=0.393 Sum_probs=54.9
Q ss_pred HHHHHHHHHHHc-ccCCC-cccHHHHHHHhC-------CchH-HHHHHHHHccCCCCceeHHHHHHHHccccCC
Q 016471 319 DQIAITAFDYFE-QEGNR-VISVEELALELN-------LAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVTVR 382 (389)
Q Consensus 319 ~~~l~~aF~~~D-~d~~G-~I~~~el~~~l~-------~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~ 382 (389)
...++.+|+.|| +|++| +|+.+||+.+|. .... +.++++++|.|++|.|+|+||+.+|......
T Consensus 9 ~~~l~~~F~~~D~~d~dG~~I~~~El~~~l~~~~~~~~~~~~~i~~~~~~~D~d~dG~I~f~EF~~~~~~~~~~ 82 (92)
T 2kax_A 9 LTTMVTTFHKYSGREGSKLTLSRKELKELIKKELCLGEMKESSIDDLMKSLDKNSDQEIDFKEYSVFLTMLCMA 82 (92)
T ss_dssp HHHHHHHHHHHHTTSSCSSEEEHHHHHHHHHHHSCCTTTCCTTHHHHHHHHTTTCSSEEEHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhhCCCCCeeCHHHHHHHHHHHcCCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHHHH
Confidence 356899999999 99999 999999999872 1122 9999999999999999999999999876533
|
| >2sas_A Sarcoplasmic calcium-binding protein; 2.40A {Branchiostoma lanceolatum} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=99.14 E-value=8.3e-11 Score=99.06 Aligned_cols=100 Identities=10% Similarity=0.019 Sum_probs=76.9
Q ss_pred HHHHHHHHhhc-CCCCCcceeHHHHHHHHhchh----HHHhhHHHHHHHH--------HHHHHHcccCCCcccHHHHHHH
Q 016471 279 DSRVFEILNVM-EPLSDQKLAYEEFCAAATSVY----QLEALERWDQIAI--------TAFDYFEQEGNRVISVEELALE 345 (389)
Q Consensus 279 ~~~~~~~~~~~-d~~~~g~i~~~eF~~~~~~~~----~~~~~~~~~~~l~--------~aF~~~D~d~~G~I~~~el~~~ 345 (389)
..++.++|..+ |.|++|.|+++||..++.... .....+ ....+. .+|+.+|.|++|.|+.+|+..+
T Consensus 7 ~~~l~~~F~~~~D~d~dG~i~~~E~~~~l~~~~~~~~~~~~~~-~~~~l~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~ 85 (185)
T 2sas_A 7 KQKIKFTFDFFLDMNHDGSIQDNDFEDMMTRYKEVNKGSLSDA-DYKSMQASLEDEWRDLKGRADINKDDVVSWEEYLAM 85 (185)
T ss_dssp HHHHHHHHHHHTCTTCSSEECHHHHHHHHHHHHHHHGGGSCHH-HHHHHHHHHHHHHHHHHHHHCTTCSSCEEHHHHHHH
T ss_pred HHHHHHHHHHheeCCCCCeEcHHHHHHHHHHHHHhhcCCCCHH-HHHHHHHHHHHHHHHHHHhcCCCCCCeEcHHHHHHH
Confidence 45688999999 999999999999987655443 111111 112222 4599999999999999999988
Q ss_pred hCCc-------------h-H-HHHHHHHHccCCCCceeHHHHHHHHccc
Q 016471 346 LNLA-------------P-A-AYSLLNDCIRNSDGKLSFLGYKRFLHGV 379 (389)
Q Consensus 346 l~~~-------------~-~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~ 379 (389)
+... . . +..+|+.+|.|++|.|+++||..+++..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~dG~Is~~E~~~~l~~~ 134 (185)
T 2sas_A 86 WEKTIATCKSVADLPAWCQNRIPFLFKGMDVSGDGIVDLEEFQNYCKNF 134 (185)
T ss_dssp HHHHHHTCCSGGGSCTTHHHHHHHHHHHHCTTSSSCCCHHHHHHHTTSS
T ss_pred HHHHhccccchhhhhHHHHHHHHHHHHHHcCCCCCeEcHHHHHHHHHHh
Confidence 7210 1 2 8899999999999999999999999765
|
| >1eh2_A EPS15; calcium binding, signaling domain, NPF binding, EF-hand, EH domain; NMR {Homo sapiens} SCOP: a.39.1.6 PDB: 2jxc_A 1f8h_A 1ff1_A | Back alignment and structure |
|---|
Probab=99.14 E-value=6.7e-11 Score=90.20 Aligned_cols=61 Identities=16% Similarity=0.048 Sum_probs=54.2
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHh---CCchH-HHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 319 DQIAITAFDYFEQEGNRVISVEELALEL---NLAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 319 ~~~l~~aF~~~D~d~~G~I~~~el~~~l---~~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
...++++|+.||+ +||+|+.+|++.+| |++.+ +.++++.+|.|+||.|+|+||+.+|....
T Consensus 14 ~~~~~~~F~~~D~-~dG~Is~~el~~~l~~~gl~~~el~~i~~~~D~d~dG~id~~EF~~~m~~~~ 78 (106)
T 1eh2_A 14 KAKYDAIFDSLSP-VNGFLSGDKVKPVLLNSKLPVDILGRVWELSDIDHDGMLDRDEFAVAMFLVY 78 (106)
T ss_dssp HHHHHHHHTTSCC-SSSCCBHHHHHHHHHTTTCCHHHHHHHHHHHCSSCSSBCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhCC-CCCeEcHHHHHHHHHHcCCCHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHH
Confidence 4568999999999 99999999999999 55554 99999999999999999999999986543
|
| >2wcb_A Protein S100-A12; calcium signalling, HOST-parasite response, metal binding PR; 1.73A {Homo sapiens} PDB: 1odb_A* 2wc8_A 2wcf_A 2wce_A 1e8a_A 1gqm_A | Back alignment and structure |
|---|
Probab=99.14 E-value=3.8e-11 Score=89.97 Aligned_cols=61 Identities=16% Similarity=0.202 Sum_probs=53.1
Q ss_pred HHHHHHHHHHHc-ccCCC-cccHHHHHHHhCC----------chH-HHHHHHHHccCCCCceeHHHHHHHHccc
Q 016471 319 DQIAITAFDYFE-QEGNR-VISVEELALELNL----------APA-AYSLLNDCIRNSDGKLSFLGYKRFLHGV 379 (389)
Q Consensus 319 ~~~l~~aF~~~D-~d~~G-~I~~~el~~~l~~----------~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~ 379 (389)
.+.++.+|+.|| +|++| +|+.+||+.+|.. ... ++++++++|.|+||.|+|+||+.+|.+.
T Consensus 11 ~~~l~~~F~~fD~~dg~gg~I~~~El~~~l~~~~~~~lg~~~~~~~v~~~~~~~D~d~dG~I~f~EF~~~~~~~ 84 (95)
T 2wcb_A 11 LEGIVNIFHQYSVRKGHFDTLSKGELKQLLTKELANTIKNIKDKAVIDEIFQGLDANQDEQVDFQEFISLVAIA 84 (95)
T ss_dssp HHHHHHHHHHHHTSSSSTTEEEHHHHHHHHHHHTHHHHHHCCCHHHHHHHHTTSSSSTTSEEEHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhccCCCCCccCHHHHHHHHHHHhhhhccccccHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHH
Confidence 456999999999 89998 9999999999831 222 8999999999999999999999999764
|
| >2jq6_A EH domain-containing protein 1; metal binding protein; NMR {Homo sapiens} PDB: 2kff_A 2kfg_A 2kfh_A 2ksp_A | Back alignment and structure |
|---|
Probab=99.14 E-value=7.4e-11 Score=93.95 Aligned_cols=61 Identities=15% Similarity=0.022 Sum_probs=54.6
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHh---CCchH-HHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 319 DQIAITAFDYFEQEGNRVISVEELALEL---NLAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 319 ~~~l~~aF~~~D~d~~G~I~~~el~~~l---~~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
...++.+|+.|| |+||+|+.+|++.+| ++..+ +.+|++.+|.|+||.|+|+||+.+|....
T Consensus 50 ~~~l~~~F~~fD-d~dG~Is~~El~~~l~~~gl~~~el~~I~~~~D~d~dG~Ld~~EF~~am~li~ 114 (139)
T 2jq6_A 50 KPTYDEIFYTLS-PVNGKITGANAKKEMVKSKLPNTVLGKIWKLADVDKDGLLDDEEFALANHLIK 114 (139)
T ss_dssp HHHHHHHHHHSC-CSSSEEEHHHHHHHHHHTTCCHHHHHHHHHHHCSSCCSEEEHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhC-CCCCeECHHHHHHHHHHhCcCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHH
Confidence 456899999999 999999999999998 55555 99999999999999999999999996543
|
| >1wlz_A DJBP, CAP-binding protein complex interacting protein 1 isoform A; EF-hand like, unknown function; 1.60A {Homo sapiens} SCOP: a.39.1.7 | Back alignment and structure |
|---|
Probab=99.14 E-value=8.4e-11 Score=89.77 Aligned_cols=80 Identities=18% Similarity=0.150 Sum_probs=62.3
Q ss_pred ceeHHHHHHHHhchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHh---CC--chH-HHHHHHHHccCCCCceeH
Q 016471 296 KLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALEL---NL--APA-AYSLLNDCIRNSDGKLSF 369 (389)
Q Consensus 296 ~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l---~~--~~~-~~~~~~~~d~~~~g~i~~ 369 (389)
.++++++...+...... . ...++.+|+.||+|++|+|+.+||+.+| |. ... +.+++..+|.|++|.|+|
T Consensus 5 ~~~~~~~~~~l~~~~~~-~----~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~e~~~l~~~~d~~~~g~i~~ 79 (105)
T 1wlz_A 5 ATADRDILARLHKAVTS-H----YHAITQEFENFDTMKTNTISREEFRAICNRRVQILTDEQFDRLWNEMPVNAKGRLKY 79 (105)
T ss_dssp TTCCHHHHHHHHHHHHH-T----HHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHTCCCCHHHHHHHHTTSCBCTTSCBCH
T ss_pred chhHHHHHHHHHHHHHc-h----HHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHcCCCCCCCCcH
Confidence 45677777654443221 1 4568999999999999999999999998 43 333 999999999999999999
Q ss_pred HHHHHHHcccc
Q 016471 370 LGYKRFLHGVT 380 (389)
Q Consensus 370 ~ef~~~~~~~~ 380 (389)
+||+.+|....
T Consensus 80 ~eF~~~~~~~~ 90 (105)
T 1wlz_A 80 PDFLSRFSSET 90 (105)
T ss_dssp HHHHHHHC---
T ss_pred HHHHHHHhccC
Confidence 99999998654
|
| >2pmy_A RAS and EF-hand domain-containing protein; rasef, calcium-binding domain, structural genomics, structural genomics consortium, SGC; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.14 E-value=1.1e-10 Score=86.79 Aligned_cols=61 Identities=18% Similarity=0.230 Sum_probs=54.7
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHh---CCchH-HHHHHHHHccCCCCceeHHHHHHHHccc
Q 016471 319 DQIAITAFDYFEQEGNRVISVEELALEL---NLAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHGV 379 (389)
Q Consensus 319 ~~~l~~aF~~~D~d~~G~I~~~el~~~l---~~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~ 379 (389)
.+.++.+|+.||+|++|+|+.+||+.++ |.... +..++..+|.|++|.|+|+||+.++.+.
T Consensus 26 ~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~~~~D~d~dg~I~~~EF~~~~~~~ 90 (91)
T 2pmy_A 26 LARLRSVFAACDANRSGRLEREEFRALCTELRVRPADAEAVFQRLDADRDGAITFQEFARGFLGS 90 (91)
T ss_dssp HHHHHHHHHHHCTTCSSSEEHHHHHHHHHHTTCCHHHHHHHHHHHCTTCSSEECHHHHTHHHHHT
T ss_pred HHHHHHHHHHHCCCCCCCCcHHHHHHHHHHcCcCHHHHHHHHHHhCCCCCCCEeHHHHHHHHHHH
Confidence 4678999999999999999999999988 65555 9999999999999999999999998753
|
| >3li6_A Calcium-binding protein; calcium signaling protein, assemble free energy, dynamic behaviour, cytoskeleton, metal binding; 2.50A {Entamoeba histolytica} | Back alignment and structure |
|---|
Probab=99.13 E-value=3.5e-11 Score=83.41 Aligned_cols=58 Identities=14% Similarity=0.251 Sum_probs=49.8
Q ss_pred HHHHHHHHcccCCCcccHHHHHHHhCC---c--hH-HHHHHHHHccCCCCceeHHHHHHHHccc
Q 016471 322 AITAFDYFEQEGNRVISVEELALELNL---A--PA-AYSLLNDCIRNSDGKLSFLGYKRFLHGV 379 (389)
Q Consensus 322 l~~aF~~~D~d~~G~I~~~el~~~l~~---~--~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~ 379 (389)
++.+|+.+|.|++|+|+.+|++.++.. . .. +..+++.+|.|++|.|+|+||+.+|++.
T Consensus 2 l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~ 65 (66)
T 3li6_A 2 AEALFKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQLIFKSIDADGNGEIDQNEFAKFYGSI 65 (66)
T ss_dssp CCHHHHHHCTTCSSSCCHHHHHHHHHHHHHHHHHHHHHHHHHHHCTTCSSSCCHHHHHHHHTCC
T ss_pred HHHHHHHHCCCCCCcccHHHHHHHHHHccCCCcHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc
Confidence 457899999999999999999998832 2 22 8899999999999999999999999764
|
| >1j55_A S-100P protein; metal binding protein; 2.00A {Homo sapiens} SCOP: a.39.1.2 PDB: 1ozo_A | Back alignment and structure |
|---|
Probab=99.13 E-value=6.5e-11 Score=88.65 Aligned_cols=62 Identities=23% Similarity=0.387 Sum_probs=52.2
Q ss_pred HHHHHHHHHHHc-ccC-CCcccHHHHHHHhCC--------chH---HHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 319 DQIAITAFDYFE-QEG-NRVISVEELALELNL--------APA---AYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 319 ~~~l~~aF~~~D-~d~-~G~I~~~el~~~l~~--------~~~---~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
.+.++.+|+.|| +|+ +|+|+.+||+.+|.. ..+ ++++++++|.|+||.|+|+||+.+|.+..
T Consensus 8 ~~~l~~~F~~fD~~dgd~G~I~~~El~~~l~~~~~~~lg~~~~~~~v~~l~~~~D~d~dG~I~f~EF~~~~~~~~ 82 (95)
T 1j55_A 8 MGMIIDVFSRYSGSEGSTQTLTKGELKVLMEKELPGFLQSGKDKDAVDKLLKDLDANGDAQVDFSEFIVFVAAIT 82 (95)
T ss_dssp HHHHHHHHHHHTTSSSCTTEECHHHHHHHHHHHSTTCC------CHHHHHHHHHCSSSSSSEEHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhccCCCCCcCCHHHHHHHHHHHhHhhcccccCHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHH
Confidence 456899999999 798 589999999999831 122 99999999999999999999999997643
|
| >2opo_A Polcalcin CHE A 3; calcium-binding protein, dimer, domain-swapping, EF-hand; 1.75A {Chenopodium album} SCOP: a.39.1.10 PDB: 1h4b_A | Back alignment and structure |
|---|
Probab=99.12 E-value=1.3e-10 Score=85.24 Aligned_cols=64 Identities=22% Similarity=0.296 Sum_probs=56.0
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHh---C-CchH-HHHHHHHHccCCCCceeHHHHHHHHccccCC
Q 016471 319 DQIAITAFDYFEQEGNRVISVEELALEL---N-LAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVTVR 382 (389)
Q Consensus 319 ~~~l~~aF~~~D~d~~G~I~~~el~~~l---~-~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~ 382 (389)
...++.+|+.||+|++|+|+.+||+.++ | .... +..++..+|.|++|.|+|+||+.++...+..
T Consensus 10 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~~~~~~ 78 (86)
T 2opo_A 10 IADRERIFKRFDTNGDGKISSSELGDALKTLGSVTPDEVRRMMAEIDTDGDGFISFDEFTDFARANRGL 78 (86)
T ss_dssp HHHHHHHHHHHCTTCSSEEEHHHHHHHHHTTTTCCHHHHHHHHHHHCTTCSSEECHHHHHHHHHHCTTT
T ss_pred HHHHHHHHHHHCCCCCCCcCHHHHHHHHHHcCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHCccH
Confidence 4579999999999999999999999998 4 2222 9999999999999999999999999877643
|
| >3e3r_A Calcyphosin, calcyphosine; human calcyphosine, EF-hand, phosphoprotein, calcium binding; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.11 E-value=1.3e-10 Score=99.82 Aligned_cols=96 Identities=14% Similarity=0.177 Sum_probs=78.6
Q ss_pred HHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHhCCc--h---H-HH
Q 016471 280 SRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALELNLA--P---A-AY 353 (389)
Q Consensus 280 ~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~--~---~-~~ 353 (389)
.++.++|..+|.+++|.|+++||..++........ ...+..+|+.+|.|++|.|+.+|+..++... . . +.
T Consensus 37 ~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~----~~~~~~~~~~~D~d~dg~i~~~ef~~~~~~~~~~~~~~~~~ 112 (204)
T 3e3r_A 37 QGLARFFRQLDRDGSRSLDADEFRQGLAKLGLVLD----QAEAEGVCRKWDRNGSGTLDLEEFLRALRPPMSQAREAVIA 112 (204)
T ss_dssp ---CHHHHHHCTTCCSSBCHHHHHHHHHTTTCCCC----HHHHHHHHHHHCTTCSSSBCHHHHHHHTSCCCCHHHHHHHH
T ss_pred HHHHHHHHHHccCCCCCcCHHHHHHHHHHcCCCCC----HHHHHHHHHHhccCCCCcCcHHHHHHHHHhhcCchHHHHHH
Confidence 45778999999999999999999987665432222 3468999999999999999999999999431 1 1 88
Q ss_pred HHHHHHccCCCCceeHHHHHHHHccc
Q 016471 354 SLLNDCIRNSDGKLSFLGYKRFLHGV 379 (389)
Q Consensus 354 ~~~~~~d~~~~g~i~~~ef~~~~~~~ 379 (389)
.+|+.+|.|++|.|+.+||..+++..
T Consensus 113 ~~F~~~D~d~~G~I~~~El~~~l~~~ 138 (204)
T 3e3r_A 113 AAFAKLDRSGDGVVTVDDLRGVYSGR 138 (204)
T ss_dssp HHHHHHCTTCSSEECHHHHHHHCCCT
T ss_pred HHHHHhCcCCCCeEeHHHHHHHHccc
Confidence 99999999999999999999999853
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.11 E-value=2.6e-10 Score=112.12 Aligned_cols=168 Identities=11% Similarity=0.045 Sum_probs=107.4
Q ss_pred cHHHHHHHHHHhhcChhHHHHHHHHHHh---------cCHHHHHHHHHHhhhcCC--CCCcccHHHHHHHHHHhccccCC
Q 016471 210 DILIYKLVKSYLRATPLKRAALKALSKA---------LTEEELVYLRAQFMLLEP--KDGCVSLNNFKVALMRQATDAMT 278 (389)
Q Consensus 210 ~~~~~~~~~~~~~~~~l~~~~l~~i~~~---------l~~ee~~~l~~~F~~~D~--~~G~i~~~el~~~l~~~~~~~~~ 278 (389)
+.....+++.++..+|.+|+....+... ........+......+.. ....+....+......+.. ...
T Consensus 275 s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~~a~l~~i~~~~~~-~~~ 353 (504)
T 3q5i_A 275 SDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNMRKFEGSQKLAQAAILFIGSKLTT-LEE 353 (504)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCCCCGGGHHHHHHHHHHHHHCCCCSHHHHHHHHHHHHHTSC-HHH
T ss_pred CHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhcccccchhhHHHHHHHHHHHHHHHHHHHHHHHHhhccCCc-HHH
Confidence 4456677888888888877766554320 010111111111111111 2233333333222222211 123
Q ss_pred HHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHh----hHHHHHHHHHHHHHHcccCCCcccHHHHHHHhCCc-----
Q 016471 279 DSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEA----LERWDQIAITAFDYFEQEGNRVISVEELALELNLA----- 349 (389)
Q Consensus 279 ~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~----~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~----- 349 (389)
..++.++|..+|.|++|.|+++||..++........ ....+..+..+|+.+|.|+||.|+.+|+..++...
T Consensus 354 ~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~I~~~EF~~~~~~~~~~~~ 433 (504)
T 3q5i_A 354 RKELTDIFKKLDKNGDGQLDKKELIEGYNVLRNFKNELGELKNVEEEVDNILKEVDFDKNGYIEYSEFISVCMDKQILFS 433 (504)
T ss_dssp HHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHHHC--CCSCCCHHHHHHHHHHHHCTTCSSSEEHHHHHHHHSCHHHHTC
T ss_pred HHHHHHHHHeeCCCCCCeEcHHHHHHHHHHhhhcccccccccccHHHHHHHHHHhCCCCCCcEeHHHHHHHHHhhhcccC
Confidence 456789999999999999999999886554422100 00114568999999999999999999999988432
Q ss_pred hH-HHHHHHHHccCCCCceeHHHHHHHHcc
Q 016471 350 PA-AYSLLNDCIRNSDGKLSFLGYKRFLHG 378 (389)
Q Consensus 350 ~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~ 378 (389)
.+ +.++|+.+|.|++|.|+.+||..++..
T Consensus 434 ~~~~~~~F~~~D~d~dG~Is~~El~~~l~~ 463 (504)
T 3q5i_A 434 EERLRRAFNLFDTDKSGKITKEELANLFGL 463 (504)
T ss_dssp HHHHHHHHHHHCTTCCSEECHHHHHHHTTC
T ss_pred HHHHHHHHHHhcCCCCCcCcHHHHHHHHhh
Confidence 22 889999999999999999999999875
|
| >2b1u_A Calmodulin-like protein 5; CLSP, calmodulin-like SKIN protein, solution structure, backbone dynamic, structural genomics; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.11 E-value=6.5e-11 Score=83.26 Aligned_cols=60 Identities=22% Similarity=0.395 Sum_probs=52.9
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHh---CC--chH-HHHHHHHHccCCCCceeHHHHHHHHcc
Q 016471 319 DQIAITAFDYFEQEGNRVISVEELALEL---NL--APA-AYSLLNDCIRNSDGKLSFLGYKRFLHG 378 (389)
Q Consensus 319 ~~~l~~aF~~~D~d~~G~I~~~el~~~l---~~--~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~ 378 (389)
++.++.+|+.+|+|++|+|+.+||+.++ |. ... +..++..+|.+++|.|+|+||+.+|.+
T Consensus 5 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~ 70 (71)
T 2b1u_A 5 LEDLQVAFRAFDQDGDGHITVDELRRAMAGLGQPLPQEELDAMIREADVDQDGRVNYEEFARMLAQ 70 (71)
T ss_dssp HHHHHHHHTTSCCSSSSEEEHHHHHHHGGGTTCSSCHHHHHHHHHHCCSSSSSEEETTHHHHHHTC
T ss_pred HHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHhh
Confidence 3568999999999999999999999998 32 233 999999999999999999999999865
|
| >3a4u_B Multiple coagulation factor deficiency protein 2; lectin, ergic, ER, golgi, transport, disulfide bond, endopla reticulum, ER-golgi transport; 1.84A {Homo sapiens} PDB: 2vrg_A 3lcp_C | Back alignment and structure |
|---|
Probab=99.11 E-value=5.4e-11 Score=96.40 Aligned_cols=101 Identities=14% Similarity=0.033 Sum_probs=50.9
Q ss_pred HHHHhhhcCC-CCCcccHHHHHHHHHHhcc----ccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhH--------H
Q 016471 246 LRAQFMLLEP-KDGCVSLNNFKVALMRQAT----DAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQ--------L 312 (389)
Q Consensus 246 l~~~F~~~D~-~~G~i~~~el~~~l~~~~~----~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~--------~ 312 (389)
....|..+|. ++|.|+.+||..++..... .....+++..+|+.+|.|++|.|+++||..++..... .
T Consensus 29 ~~~~f~~~D~d~dG~I~~~Ef~~~l~~~~~~~~~~~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~g~~ 108 (143)
T 3a4u_B 29 SFSQPGSMGLDKNTVHDQEHIMEHLEGVINKPEAEMSPQELQLHYFKMHDYDGNNLLDGLELSTAITHVHKEEGSEQAPL 108 (143)
T ss_dssp ----------------------------------CCCHHHHHHHHHHHTCTTCSSCEEHHHHHHTCC-------------
T ss_pred CHHHHHHhCCCCCCcCcHHHHHHHHHHHhcccccccCHHHHHHHHHHHhCCCCCCccCHHHHHHHHHHHHhhhccccCCC
Confidence 3567889999 9999999999988865522 1123567889999999999999999999986654321 1
Q ss_pred HhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHh
Q 016471 313 EALERWDQIAITAFDYFEQEGNRVISVEELALEL 346 (389)
Q Consensus 313 ~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l 346 (389)
...+.....+..+|+.+|.|+||.|+.+|+..++
T Consensus 109 ~s~~e~~~~~~~~f~~~D~d~dG~Is~~EF~~~~ 142 (143)
T 3a4u_B 109 MSEDELINIIDGVLRDDDKNNDGYIDYAEFAKSL 142 (143)
T ss_dssp CCHHHHHHHHHHHHHHHCTTCSSEECHHHHHC--
T ss_pred CCHHHHHHHHHHHHHHcCCCCCCcEeHHHHHHHH
Confidence 1222223445788999999999999999998764
|
| >1avs_A Troponin C; muscle contraction, calcium-activated, E-F hand calcium-binding protein; 1.75A {Gallus gallus} SCOP: a.39.1.5 PDB: 1blq_A 1skt_A 1tnp_A 1tnq_A 1zac_A 1smg_A 1npq_A 1trf_A | Back alignment and structure |
|---|
Probab=99.11 E-value=1.6e-10 Score=85.53 Aligned_cols=62 Identities=18% Similarity=0.278 Sum_probs=54.4
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHh---CCc--hH-HHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 319 DQIAITAFDYFEQEGNRVISVEELALEL---NLA--PA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 319 ~~~l~~aF~~~D~d~~G~I~~~el~~~l---~~~--~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
...++.+|+.||+|++|+|+.+||+.++ |.. .. +..++..+|.|++|.|+|+||+.++....
T Consensus 19 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~D~~~dg~i~~~eF~~~~~~~~ 86 (90)
T 1avs_A 19 IAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGSGTIDFEEFLVMMVRQM 86 (90)
T ss_dssp HHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTCCSSEEHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHHHh
Confidence 4568999999999999999999999998 433 33 99999999999999999999999987643
|
| >3mse_B Calcium-dependent protein kinase, putative; CDPKS, malaria, structural genomics consortium, SGC, transfe; 2.10A {Plasmodium falciparum} | Back alignment and structure |
|---|
Probab=99.11 E-value=3.3e-10 Score=95.42 Aligned_cols=94 Identities=13% Similarity=0.070 Sum_probs=79.1
Q ss_pred HHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHhCCc---h-H-HH
Q 016471 279 DSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALELNLA---P-A-AY 353 (389)
Q Consensus 279 ~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~---~-~-~~ 353 (389)
..++.++|..+|.+++|.|+++||..++..... . ...+..+|..+|.|++|.|+.+|+..++... . . +.
T Consensus 38 ~~~l~~~F~~~D~d~~G~i~~~El~~~l~~~g~--~----~~~~~~~~~~~D~d~~g~i~~~Ef~~~~~~~~~~~~~~~~ 111 (180)
T 3mse_B 38 IKYINELFYKLDTNHNGSLSHREIYTVLASVGI--K----KWDINRILQALDINDRGNITYTEFMAGCYRWKNIESTFLK 111 (180)
T ss_dssp HHHHHHHHHHHCTTCSSSEEHHHHHHHHHHTTC--C----HHHHHHHHHHHCTTCCSEECHHHHHHHHSCCTTC--CHHH
T ss_pred HHHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCC--C----HHHHHHHHHHhCCCCCCcCcHHHHHHHHHhcccCCHHHHH
Confidence 456889999999999999999999987654322 1 2358899999999999999999999988321 1 2 88
Q ss_pred HHHHHHccCCCCceeHHHHHHHHcc
Q 016471 354 SLLNDCIRNSDGKLSFLGYKRFLHG 378 (389)
Q Consensus 354 ~~~~~~d~~~~g~i~~~ef~~~~~~ 378 (389)
.+|+.+|.|++|.|+.+||..+++.
T Consensus 112 ~~F~~~D~d~~G~I~~~El~~~l~~ 136 (180)
T 3mse_B 112 AAFNKIDKDEDGYISKSDIVSLVHD 136 (180)
T ss_dssp HHHHHHCTTCSSCBCHHHHHHHTTT
T ss_pred HHHHHHCCCCCCCCCHHHHHHHHcC
Confidence 9999999999999999999999984
|
| >2obh_A Centrin-2; DNA repair complex EF hand superfamily protein-peptide compl cycle; 1.80A {Homo sapiens} SCOP: a.39.1.5 PDB: 3kf9_A 1m39_A 2a4j_A 2k2i_A 1oqp_A | Back alignment and structure |
|---|
Probab=99.10 E-value=1.5e-10 Score=93.56 Aligned_cols=97 Identities=11% Similarity=0.150 Sum_probs=79.5
Q ss_pred HHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHhCCc-----h-H-H
Q 016471 280 SRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALELNLA-----P-A-A 352 (389)
Q Consensus 280 ~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~-----~-~-~ 352 (389)
.++.++|..+|.+++|.|+.+||..++........ +..+...|..+|.|++|.|+.+|+..++... + . +
T Consensus 6 ~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~----~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~l 81 (143)
T 2obh_A 6 QEIREAFDLFDADGTGTIDVKELKVAMRALGFEPK----KEEIKKMISEIDKEGTGKMNFGDFLTVMTQKMSEKDTKEEI 81 (143)
T ss_dssp HHHHHHHHTTCTTCCSEEEGGGHHHHHHHTTCCCC----HHHHHHHHHHHTTTCCSEEEHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCC----HHHHHHHHHHhCCCCCCeeeHHHHHHHHHHHhccccHHHHH
Confidence 45789999999999999999999886654322122 3458889999999999999999999887321 1 1 8
Q ss_pred HHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 353 YSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 353 ~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
.++|+.+|.|++|.|+.+||..+++...
T Consensus 82 ~~~F~~~D~d~~G~I~~~el~~~l~~~g 109 (143)
T 2obh_A 82 LKAFKLFDDDETGKISFKNLKRVAKELG 109 (143)
T ss_dssp HHHHHHHCTTCSSSBCHHHHHHHHHHTT
T ss_pred HHHHHHhCCCCCCcCcHHHHHHHHHHhC
Confidence 8899999999999999999999997654
|
| >3qrx_A Centrin; calcium-binding, EF-hand, cell division, calcium binding, ME binding protein-toxin complex; 2.20A {Chlamydomonas reinhardtii} PDB: 2ggm_A 2ami_A 1zmz_A | Back alignment and structure |
|---|
Probab=99.10 E-value=2e-10 Score=95.39 Aligned_cols=97 Identities=9% Similarity=0.137 Sum_probs=79.7
Q ss_pred HHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHhCCc------hH-H
Q 016471 280 SRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALELNLA------PA-A 352 (389)
Q Consensus 280 ~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~------~~-~ 352 (389)
.++.++|..+|.+++|.|+.+||..++........ ...+..+|..+|.|++|.|+.+|+..++... .. +
T Consensus 28 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~----~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~ 103 (169)
T 3qrx_A 28 QEIREAFDLFDTDGSGTIDAKELKVAMRALGFEPK----KEEIKKMISEIDKDGSGTIDFEEFLTMMTAKMGERDSREEI 103 (169)
T ss_dssp HHHHHHHHHHCTTCCSEECHHHHHHHHHHTSCCCC----HHHHHHHHHHHCSSSSSSEEHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCC----HHHHHHHHHHhcCCCCCcCCHHHHHHHHHHHhcccCcHHHH
Confidence 45778899999999999999999886644322112 3468899999999999999999999988321 11 8
Q ss_pred HHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 353 YSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 353 ~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
..+|+.+|.|++|.|+.+||..+++...
T Consensus 104 ~~~F~~~D~d~~G~i~~~el~~~l~~~g 131 (169)
T 3qrx_A 104 LKAFRLFDDDNSGTITIKDLRRVAKELG 131 (169)
T ss_dssp HHHHHHHCTTCSSSBCHHHHHHHHHHTT
T ss_pred HHHHHHhCCCCCCcCCHHHHHHHHHHcC
Confidence 8899999999999999999999998664
|
| >1qx2_A Vitamin D-dependent calcium-binding protein, INTE; EF-hand (helix-loop-helix) calcium binding protein, four-HEL domain, protein engineering; HET: FME; 1.44A {Bos taurus} SCOP: a.39.1.1 PDB: 1kcy_A 1kqv_A 1ksm_A 1n65_A 1ht9_A 4icb_A 1cdn_A 1clb_A 2bca_A 1ig5_A 1igv_A 3icb_A 1d1o_A 1b1g_A 2bcb_A 1boc_A 1bod_A | Back alignment and structure |
|---|
Probab=99.10 E-value=1.4e-10 Score=82.79 Aligned_cols=60 Identities=27% Similarity=0.444 Sum_probs=53.4
Q ss_pred HHHHHHHHHH-cccCC-CcccHHHHHHHh---CCch--H---HHHHHHHHccCCCCceeHHHHHHHHccc
Q 016471 320 QIAITAFDYF-EQEGN-RVISVEELALEL---NLAP--A---AYSLLNDCIRNSDGKLSFLGYKRFLHGV 379 (389)
Q Consensus 320 ~~l~~aF~~~-D~d~~-G~I~~~el~~~l---~~~~--~---~~~~~~~~d~~~~g~i~~~ef~~~~~~~ 379 (389)
+.++.+|+.| |+|++ |+|+.+||+.++ |... + +.+++..+|.|++|.|+|+||+.++.+.
T Consensus 5 ~~l~~~F~~~~D~d~~~G~i~~~el~~~l~~~g~~~~~~~~~~~~l~~~~D~~~~g~i~~~eF~~~~~~~ 74 (76)
T 1qx2_A 5 EEIKGAFEVFAAKEGDPNQISKEELKLVMQTLGPSLLKGMSTLDEMIEEVDKNGDGEVSFEEFLVMMKKI 74 (76)
T ss_dssp HHHHHHHHHHHTSSSCTTSEEHHHHHHHHHHHGGGSCTTSCSHHHHHHHHCTTCSSEECHHHHHHHHHHH
T ss_pred HHHHHHHHHHcccCCCcCeECHHHHHHHHHHhCCCcCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHh
Confidence 4689999999 99999 999999999988 4333 3 9999999999999999999999998764
|
| >1nya_A Calerythrin; EF-hand, metal binding protein; NMR {Saccharopolyspora erythraea} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=99.10 E-value=3.8e-10 Score=94.17 Aligned_cols=96 Identities=19% Similarity=0.191 Sum_probs=79.3
Q ss_pred HHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCC-------HHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhH
Q 016471 245 YLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMT-------DSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALE 316 (389)
Q Consensus 245 ~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~-------~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~ 316 (389)
.+...|..+|. ++|.|+.+||..++......... ...+..+|..+|.+++|.|+++||...+.... ..
T Consensus 59 ~~~~lf~~~D~d~dg~i~~~Ef~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~e~~~~l~~~g--~~-- 134 (176)
T 1nya_A 59 LFDYLAKEAGVGSDGSLTEEQFIRVTENLIFEQGEASFNRVLGPVVKGIVGMCDKNADGQINADEFAAWLTALG--MS-- 134 (176)
T ss_dssp HHHHHHHHHTSCTTCCBCHHHHHHHHHHHHSSSCHHHHHHHHHHHHHHHHHHTCSSCCSEEEHHHHHHHHHHTT--CC--
T ss_pred HHHHHHHHhCCCCCCeEcHHHHHHHHHHHhcCCchhhHHHHHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhC--CC--
Confidence 34578889999 99999999999988776543221 35689999999999999999999998765543 22
Q ss_pred HHHHHHHHHHHHHcccCCCcccHHHHHHHh
Q 016471 317 RWDQIAITAFDYFEQEGNRVISVEELALEL 346 (389)
Q Consensus 317 ~~~~~l~~aF~~~D~d~~G~I~~~el~~~l 346 (389)
++.+..+|+.+|.|++|.|+.+|+..++
T Consensus 135 --~~~~~~~~~~~D~d~dg~i~~~ef~~~~ 162 (176)
T 1nya_A 135 --KAEAAEAFNQVDTNGNGELSLDELLTAV 162 (176)
T ss_dssp --HHHHHHHHHHHCTTCSSEEEHHHHHHHH
T ss_pred --HHHHHHHHHHhCCCCCCCCcHHHHHHHH
Confidence 3568999999999999999999999988
|
| >2kn2_A Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco MKP1, metal binding Pro; NMR {Glycine max} | Back alignment and structure |
|---|
Probab=99.10 E-value=2.4e-10 Score=84.86 Aligned_cols=87 Identities=16% Similarity=0.243 Sum_probs=69.6
Q ss_pred CHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHH
Q 016471 239 TEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALER 317 (389)
Q Consensus 239 ~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~ 317 (389)
+.++...++..|..+|. ++|.|+.+||+.++..++. .++..++.+++..+|.+++|.|+|+||+..+...........
T Consensus 4 ~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~-~~~~~~~~~l~~~~d~~~dg~i~~~eF~~~~~~~~~~~~~~~ 82 (92)
T 2kn2_A 4 DTDAEEELKEAFKVFDKDQNGYISASELRHVMINLGE-KLTDEEVEQMIKEADLDGDGQVNYEEFVKMMMTVRGGGGGNG 82 (92)
T ss_dssp CCHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTC-CCCHHHHHHHHHHHCSSCCSSEEHHHHHHHHHHHTTTCCCHH
T ss_pred CccHHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHhCC-CCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHhccCCCCCch
Confidence 34567788999999999 9999999999999999986 478999999999999999999999999987654433211111
Q ss_pred HHHHHHHHHH
Q 016471 318 WDQIAITAFD 327 (389)
Q Consensus 318 ~~~~l~~aF~ 327 (389)
.+.++.||+
T Consensus 83 -~~~l~~aF~ 91 (92)
T 2kn2_A 83 -WSRLRRKFS 91 (92)
T ss_dssp -HHHHHHHHT
T ss_pred -HHHHHHHhc
Confidence 345777774
|
| >2kn2_A Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco MKP1, metal binding Pro; NMR {Glycine max} | Back alignment and structure |
|---|
Probab=99.09 E-value=2.2e-10 Score=85.14 Aligned_cols=64 Identities=17% Similarity=0.311 Sum_probs=56.1
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHh---CC--chH-HHHHHHHHccCCCCceeHHHHHHHHccccCC
Q 016471 319 DQIAITAFDYFEQEGNRVISVEELALEL---NL--APA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVTVR 382 (389)
Q Consensus 319 ~~~l~~aF~~~D~d~~G~I~~~el~~~l---~~--~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~ 382 (389)
.+.++.+|+.||.|++|+|+.+||+.++ |. ... +.+++..+|.|++|.|+|+||+.+|......
T Consensus 8 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~d~~~dg~i~~~eF~~~~~~~~~~ 77 (92)
T 2kn2_A 8 EEELKEAFKVFDKDQNGYISASELRHVMINLGEKLTDEEVEQMIKEADLDGDGQVNYEEFVKMMMTVRGG 77 (92)
T ss_dssp HHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCSSCCSSEEHHHHHHHHHHHTTT
T ss_pred HHHHHHHHHHHCCCCCCeEcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHhccCC
Confidence 4568999999999999999999999998 43 333 9999999999999999999999999876654
|
| >2aao_A CDPK, calcium-dependent protein kinase, isoform AK1; calmodulin-like domain, EF calcium binding protein, transferase; 2.00A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=99.09 E-value=8.6e-10 Score=91.19 Aligned_cols=96 Identities=9% Similarity=0.110 Sum_probs=78.6
Q ss_pred HHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHhCCc-----hH-HH
Q 016471 280 SRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALELNLA-----PA-AY 353 (389)
Q Consensus 280 ~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~-----~~-~~ 353 (389)
..+.++|..+|.+++|.|+++||..++........ ...+..+|+.+|.|++|.|+.+|+..++... .. +.
T Consensus 27 ~~l~~~F~~~D~~~~G~i~~~e~~~~l~~~~~~~~----~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~~~~~~~ 102 (166)
T 2aao_A 27 AGLKEMFNMIDADKSGQITFEELKAGLKRVGANLK----ESEILDLMQAADVDNSGTIDYKEFIAATLHLNKIEREDHLF 102 (166)
T ss_dssp HHHHHHHHHHCTTCCSSBCHHHHHHHGGGGTCCCC----HHHHHHHHHHHCTTCCSSBCHHHHHHHHTTCHHHHTTHHHH
T ss_pred HHHHHHHHHhCCCCCCeEeHHHHHHHHHHhCCCCC----HHHHHHHHHHhCCCCCCeEcHHHHHHHHHHHhhcccHHHHH
Confidence 34668899999999999999999987655422222 3458899999999999999999999988432 12 88
Q ss_pred HHHHHHccCCCCceeHHHHHHHHccc
Q 016471 354 SLLNDCIRNSDGKLSFLGYKRFLHGV 379 (389)
Q Consensus 354 ~~~~~~d~~~~g~i~~~ef~~~~~~~ 379 (389)
.+++.+|.+++|.|+.+||..+++..
T Consensus 103 ~~F~~~D~d~~G~i~~~e~~~~l~~~ 128 (166)
T 2aao_A 103 AAFTYFDKDGSGYITPDELQQACEEF 128 (166)
T ss_dssp HHHHHHCTTCSSSBCHHHHHHHTCC-
T ss_pred HHHHHhCCCCCCcCcHHHHHHHHHHc
Confidence 99999999999999999999998865
|
| >3bow_A Calpain-2 catalytic subunit; cysteine protease, inhibitor, cell membrane, hydrolase, MEMB protease, thiol protease, phosphoprotein; 2.40A {Rattus norvegicus} PDB: 3df0_A 1df0_A 1u5i_A 1kfu_L 1kfx_L | Back alignment and structure |
|---|
Probab=99.09 E-value=1.5e-10 Score=118.01 Aligned_cols=124 Identities=10% Similarity=0.092 Sum_probs=100.5
Q ss_pred HHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHH
Q 016471 245 YLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAI 323 (389)
Q Consensus 245 ~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~ 323 (389)
.+...|..+|. ++|.|+.+||..++... .++.++|+.+|.|++|.|+.+||..++........ ++.+.
T Consensus 576 ~~~~l~~~~D~d~~G~I~f~EF~~l~~~~-------~~l~~~F~~~D~d~dG~Is~~El~~~L~~~G~~ls----~~~~~ 644 (714)
T 3bow_A 576 TCKIMVDMLDEDGSGKLGLKEFYILWTKI-------QKYQKIYREIDVDRSGTMNSYEMRKALEEAGFKLP----CQLHQ 644 (714)
T ss_dssp HHHHHHHHHCCSSCSSBCHHHHHHHHHHH-------HHHHHHHHHHCTTCCSSEEHHHHHHHHHHTTEECC----HHHHH
T ss_pred HHHHHHHHhCCCCCCcCcHHHHHHHHHHH-------HHHHHHHHHhCCCCCCeECHHHHHHHHHHcCCCCC----HHHHH
Confidence 34566777899 99999999999877654 56889999999999999999999987654322222 34688
Q ss_pred HHHHHHcccCCCcccHHHHHHHhCCchHHHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 324 TAFDYFEQEGNRVISVEELALELNLAPAAYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 324 ~aF~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
.+|+.+| |+||.|+.+|+..++.....+.++|+.+|.|++|.|+++|+..++....
T Consensus 645 ~l~~~~D-d~dG~Isf~EF~~~l~~~~~l~~~F~~~D~d~dG~Is~~el~~l~~~~~ 700 (714)
T 3bow_A 645 VIVARFA-DDELIIDFDNFVRCLVRLEILFKIFKQLDPENTGTIQLDLISWLSFSVL 700 (714)
T ss_dssp HHHHHHS-CTTCEECHHHHHHHHHHHHHHHHHHSSSCSSCCSEEEEEHHHHHHHHHH
T ss_pred HHHHHhC-CCCCeEcHHHHHHHHHHHHHHHHHHHHhCCCCCCcEEHHHHHHHHHHHH
Confidence 8999999 9999999999999985444488899999999999999998877764444
|
| >4ds7_A Calmodulin, CAM; protein binding, metal binding, structura; 2.15A {Kluyveromyces lactis} PDB: 1lkj_A 2lhh_A 1f54_A 1f55_A | Back alignment and structure |
|---|
Probab=99.09 E-value=3.3e-10 Score=91.48 Aligned_cols=97 Identities=13% Similarity=0.176 Sum_probs=79.3
Q ss_pred HHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHhCC-----ch-H-H
Q 016471 280 SRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALELNL-----AP-A-A 352 (389)
Q Consensus 280 ~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~-----~~-~-~ 352 (389)
..+.++|..+|.+++|.|+.+||..++........ ...+...|..+|.|++|.|+.+|+..++.. .. . +
T Consensus 11 ~~l~~~F~~~D~~~~G~i~~~e~~~~l~~~~~~~~----~~~~~~l~~~~d~~~~g~i~~~ef~~~~~~~~~~~~~~~~~ 86 (147)
T 4ds7_A 11 AEFKEAFALFDKDNSGSISASELATVMRSLGLSPS----EAEVADLMNEIDVDGNHAIEFSEFLALMSRQLKCNDSEQEL 86 (147)
T ss_dssp HHHHHHHHHHCTTCSSEEEHHHHHHHHHHTTCCCC----HHHHHHHHHHHCTTSSSEEEHHHHHHHHHHHHHTHHHHHHH
T ss_pred HHHHHHHHHHCCCCCCCcCHHHHHHHHHHhCCCCC----HHHHHHHHHHhccCCCCcCcHHHHHHHHHHhccCCCcHHHH
Confidence 45678899999999999999999886554322222 346889999999999999999999998832 11 2 8
Q ss_pred HHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 353 YSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 353 ~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
..+++.+|.+++|.|+.+||..+++...
T Consensus 87 ~~~F~~~D~d~~G~i~~~e~~~~l~~~~ 114 (147)
T 4ds7_A 87 LEAFKVFDKNGDGLISAAELKHVLTSIG 114 (147)
T ss_dssp HHHHHHHCTTCSSEECHHHHHHHHHHTT
T ss_pred HHHHHHhCCCCCCeECHHHHHHHHHHcC
Confidence 8899999999999999999999998654
|
| >1k9u_A Polcalcin PHL P 7; pollen allergen, calcium-binding, EF-hand, cross-reactivity; 1.75A {Phleum pratense} SCOP: a.39.1.10 | Back alignment and structure |
|---|
Probab=99.09 E-value=9e-11 Score=84.30 Aligned_cols=61 Identities=20% Similarity=0.317 Sum_probs=53.6
Q ss_pred HHHHHHHHHHcccCCCcccHHHHHHHh---C-CchH-HHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 320 QIAITAFDYFEQEGNRVISVEELALEL---N-LAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 320 ~~l~~aF~~~D~d~~G~I~~~el~~~l---~-~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
+.++.+|+.||.|++|+|+.+|++.++ | .... +..++..+|.|++|.|+|+||+.++...+
T Consensus 3 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~D~~~dg~i~~~ef~~~~~~~~ 68 (78)
T 1k9u_A 3 DDMERIFKRFDTNGDGKISLSELTDALRTLGSTSADEVQRMMAEIDTDGDGFIDFNEFISFCNANP 68 (78)
T ss_dssp CHHHHHHHHHCTTCSSEECHHHHHHHHHHHHTCCHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHCH
T ss_pred HHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHCc
Confidence 358999999999999999999999988 4 2233 99999999999999999999999998764
|
| >3ll8_B Calcineurin subunit B type 1; protein-peptide docking, protein targeting, AKA beta-augmentation, calmodulin-binding, membrane, hydrolase; 2.00A {Homo sapiens} PDB: 1mf8_B* 2p6b_B 1aui_B 1m63_B* 1tco_B* | Back alignment and structure |
|---|
Probab=99.08 E-value=5.3e-10 Score=91.23 Aligned_cols=101 Identities=12% Similarity=0.141 Sum_probs=77.1
Q ss_pred HHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhch-hHHHhhHHHHHHHH
Q 016471 246 LRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSV-YQLEALERWDQIAI 323 (389)
Q Consensus 246 l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~-~~~~~~~~~~~~l~ 323 (389)
+...|..+|. ++|.|+.+||..++............+..+|..+|.+++|.|+.+||...+... ......+.....+.
T Consensus 40 ~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~ 119 (155)
T 3ll8_B 40 VQRVIDIFDTDGNGEVDFKEFIEGVSQFSVKGDKEQKLRFAFRIYDMDKDGYISNGELFQVLKMMVGNNLKDTQLQQIVD 119 (155)
T ss_dssp HHHHHHHHCTTCSSSBCHHHHHHHHGGGCSSCCHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHHGGGSCHHHHHHHHH
T ss_pred HHHHHHHHCCCCCCcCcHHHHHHHHHHHcccCCHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhccCCCHHHHHHHHH
Confidence 3456777899 999999999999887665433456789999999999999999999998876552 22222222233445
Q ss_pred HHHHHHcccCCCcccHHHHHHHh
Q 016471 324 TAFDYFEQEGNRVISVEELALEL 346 (389)
Q Consensus 324 ~aF~~~D~d~~G~I~~~el~~~l 346 (389)
.+|..+|.|++|.|+.+|+..++
T Consensus 120 ~~~~~~D~~~dg~i~~~eF~~~~ 142 (155)
T 3ll8_B 120 KTIINADKDGDGRISFEEFCAVV 142 (155)
T ss_dssp HHHHHHCTTSSSSBCHHHHHHHH
T ss_pred HHHHHhCCCCCCcCcHHHHHHHH
Confidence 55555999999999999999988
|
| >1c7v_A CAVP, calcium vector protein; EF-hand family, calcium binding protein, metal binding protein; NMR {Branchiostoma lanceolatum} SCOP: a.39.1.5 PDB: 1c7w_A | Back alignment and structure |
|---|
Probab=99.08 E-value=1.1e-10 Score=84.49 Aligned_cols=62 Identities=16% Similarity=0.349 Sum_probs=53.2
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHh---C-Cc--hH-HHHHHHHHccCCCCceeHHHHHHHHccccC
Q 016471 319 DQIAITAFDYFEQEGNRVISVEELALEL---N-LA--PA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVTV 381 (389)
Q Consensus 319 ~~~l~~aF~~~D~d~~G~I~~~el~~~l---~-~~--~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~ 381 (389)
++.++ +|+.||.|++|+|+.+||+.++ | .. .. +..++..+|.|++|.|+|+||+.+|.....
T Consensus 8 ~~~l~-~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~~~~~ 76 (81)
T 1c7v_A 8 EEILR-AFKVFDANGDGVIDFDEFKFIMQKVGEEPLTDAEVEEAMKEADEDGNGVIDIPEFMDLIKKSKN 76 (81)
T ss_dssp HHHHH-HHHHHSCSGGGEECHHHHHHHSSTTTTCCCCHHHHHHHHHHHCSSGGGSEEHHHHHHHHHCC--
T ss_pred HHHHH-HHHHHCCCCCCcCCHHHHHHHHHHhCCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHhhhh
Confidence 45689 9999999999999999999998 4 22 22 999999999999999999999999987643
|
| >3pm8_A PFCDPK2, calcium-dependent protein kinase 2; malaria, structural genomics, structural genomics CONS SGC; 2.00A {Plasmodium falciparum K1} | Back alignment and structure |
|---|
Probab=99.08 E-value=2.4e-10 Score=97.82 Aligned_cols=96 Identities=9% Similarity=0.030 Sum_probs=70.7
Q ss_pred HHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHhCC-----chH-HH
Q 016471 280 SRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALELNL-----APA-AY 353 (389)
Q Consensus 280 ~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~-----~~~-~~ 353 (389)
.++.++|..+|.+++|.|+++||..++........ ...+..+|+.+|.|++|.|+.+|+..++.. ..+ +.
T Consensus 57 ~~l~~~F~~~D~d~~G~Is~~El~~~l~~~g~~~~----~~~~~~l~~~~D~d~~g~I~~~EF~~~~~~~~~~~~~~~l~ 132 (197)
T 3pm8_A 57 NNLRNIFIALDVDNSGTLSSQEILDGLKKIGYQKI----PPDIHQVLRDIDSNASGQIHYTDFLAATIDKQTYLKKEVCL 132 (197)
T ss_dssp HHHHHHHHHHCTTCSSEECHHHHHHHHHHHC--------CHHHHHHHHC-------CEEHHHHHHTTCCHHHHCSHHHHH
T ss_pred HHHHHHHHHHCCCCCCcCCHHHHHHHHHHhCCCCC----HHHHHHHHHHhCCCCCCeEcHHHHHHHHHHHHhhhhHHHHH
Confidence 45678899999999999999999987654422222 346899999999999999999999998732 222 88
Q ss_pred HHHHHHccCCCCceeHHHHHHHHccc
Q 016471 354 SLLNDCIRNSDGKLSFLGYKRFLHGV 379 (389)
Q Consensus 354 ~~~~~~d~~~~g~i~~~ef~~~~~~~ 379 (389)
.+|+.+|.|++|.|+.+||..++...
T Consensus 133 ~~F~~~D~d~~G~Is~~El~~~l~~~ 158 (197)
T 3pm8_A 133 IPFKFFDIDGNGKISVEELKRIFGRD 158 (197)
T ss_dssp HHHHHHCTTCSSEECHHHHHHHHC--
T ss_pred HHHHHHCCCCCCCCCHHHHHHHHHhc
Confidence 99999999999999999999999875
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.08 E-value=1.6e-10 Score=113.30 Aligned_cols=100 Identities=13% Similarity=0.098 Sum_probs=78.9
Q ss_pred HHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHH----hhHHHHHHHHHHHHHHcccCCCcccHHHHHHHhCC-----c
Q 016471 279 DSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLE----ALERWDQIAITAFDYFEQEGNRVISVEELALELNL-----A 349 (389)
Q Consensus 279 ~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~----~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~-----~ 349 (389)
..++.++|..+|.|++|.|+++||..++....... .....+..+..+|+.+|.|++|.|+.+|+..++.. .
T Consensus 345 ~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~~G~I~~~EF~~~~~~~~~~~~ 424 (494)
T 3lij_A 345 TKELTDIFRHIDKNGDGQLDRQELIDGYSKLSGEEVAVFDLPQIESEVDAILGAADFDRNGYIDYSEFVTVAMDRKSLLS 424 (494)
T ss_dssp HHHHHHHHHHHCTTCSSEECHHHHHHTTHHHHSSCCCCC--CHHHHHHHHHHHHHCTTCSSSEEHHHHHHHHSCHHHHTC
T ss_pred HHHHHHHHHHhCcCCCCeEcHHHHHHHHHHhcccccccccccccHHHHHHHHHHhCCCCCCcCcHHHHHHHHHhhhcccc
Confidence 45688999999999999999999987654432100 00011456899999999999999999999998843 2
Q ss_pred hH-HHHHHHHHccCCCCceeHHHHHHHHcc
Q 016471 350 PA-AYSLLNDCIRNSDGKLSFLGYKRFLHG 378 (389)
Q Consensus 350 ~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~ 378 (389)
.+ +..+|+.+|.|++|.|+.+||..++..
T Consensus 425 ~~~~~~~F~~~D~d~~G~Is~~El~~~l~~ 454 (494)
T 3lij_A 425 KDKLESAFQKFDQDGNGKISVDELASVFGL 454 (494)
T ss_dssp HHHHHHHHHHHCTTCSSEECHHHHHHHC-C
T ss_pred HHHHHHHHHHHCCCCCCcCCHHHHHHHHHh
Confidence 22 889999999999999999999999875
|
| >3fwb_A Cell division control protein 31; gene gating, complex, cell cycle, cell division, mitosis, MR transport, nuclear pore complex, nucleus, phosphoprotein; 2.50A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2gv5_A 2doq_A 3fwc_A | Back alignment and structure |
|---|
Probab=99.07 E-value=4.7e-10 Score=92.16 Aligned_cols=97 Identities=13% Similarity=0.227 Sum_probs=79.5
Q ss_pred HHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHhCC-----c-hH-H
Q 016471 280 SRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALELNL-----A-PA-A 352 (389)
Q Consensus 280 ~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~-----~-~~-~ 352 (389)
.++.++|..+|.+++|.|+++||..++........ ...+..+|+.+|.|++|.|+.+|+..++.. . .. +
T Consensus 23 ~~l~~~F~~~D~~~~G~i~~~e~~~~l~~~~~~~~----~~~~~~l~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~ 98 (161)
T 3fwb_A 23 QEIYEAFSLFDMNNDGFLDYHELKVAMKALGFELP----KREILDLIDEYDSEGRHLMKYDDFYIVMGEKILKRDPLDEI 98 (161)
T ss_dssp HHHHHHHHHHCTTSSSEECHHHHHHHHHHTTCCCC----HHHHHHHHHHHCTTSSSCEEHHHHHHHHHHHHHTCCHHHHH
T ss_pred HHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCCCCC----HHHHHHHHHHhCcCCCCeEeHHHHHHHHHHHHhcCCcHHHH
Confidence 34678899999999999999999886654322222 346899999999999999999999998832 1 22 8
Q ss_pred HHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 353 YSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 353 ~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
..+|+.+|.+++|.|+.+||..+++...
T Consensus 99 ~~~F~~~D~d~~G~i~~~el~~~l~~~~ 126 (161)
T 3fwb_A 99 KRAFQLFDDDHTGKISIKNLRRVAKELG 126 (161)
T ss_dssp HHHHHHHCTTCSSEECHHHHHHHHHHTT
T ss_pred HHHHHHHcCCCCCeEeHHHHHHHHHHhC
Confidence 8999999999999999999999998654
|
| >3rm1_A Protein S100-B; alpha-helical, EF hand, metal binding protein-protein bindin; 1.24A {Bos taurus} PDB: 3rlz_A 1cfp_A 3cr2_A 3cr4_X* 3cr5_X* 3gk1_A* 3gk2_A* 3gk4_X* 3iqo_A 3iqq_A 3lle_A* 1psb_A 3czt_X 2h61_A 3d0y_A* 3d10_A* 3hcm_A* 3lk1_A* 3lk0_A* 1b4c_A ... | Back alignment and structure |
|---|
Probab=99.07 E-value=1.1e-10 Score=86.88 Aligned_cols=61 Identities=18% Similarity=0.233 Sum_probs=52.2
Q ss_pred HHHHHHHHHHHcccCCC---cccHHHHHHHhCC----------chH-HHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 319 DQIAITAFDYFEQEGNR---VISVEELALELNL----------APA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 319 ~~~l~~aF~~~D~d~~G---~I~~~el~~~l~~----------~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
...++.+|+.|| ++|| +|+.+||+.+|.. ... +.++++++|.|+||.|+|+||+.+|.+..
T Consensus 8 ~~~l~~~F~~~D-~~dG~~g~Is~~EL~~~l~~~~~~~lg~~~~~~~v~~~~~~~D~d~dG~I~f~EF~~~~~~l~ 82 (92)
T 3rm1_A 8 VVALIDVFHQYS-GREGDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLDSNGDGECDFQEFMAFVAMIT 82 (92)
T ss_dssp HHHHHHHHHHHH-TSSSSTTSBCHHHHHHHHHHHCTTTSCCCCSHHHHHHHHHHHCTTSSSSBCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHc-cCCCCcCeECHHHHHHHHHHHhhhhccCcccHHHHHHHHHHHcCCCCCCCcHHHHHHHHHHHH
Confidence 356899999999 7777 9999999998732 122 99999999999999999999999998765
|
| >3fs7_A Parvalbumin, thymic; calcium-binding protein, EF-hand, acetylation, calcium, metal binding protein; 1.95A {Gallus gallus} SCOP: a.39.1.4 PDB: 2kqy_A | Back alignment and structure |
|---|
Probab=99.07 E-value=3.5e-10 Score=86.85 Aligned_cols=98 Identities=10% Similarity=0.133 Sum_probs=76.1
Q ss_pred cCHHHHHHHHHHhhhcCCCCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhch---hHHHh
Q 016471 238 LTEEELVYLRAQFMLLEPKDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSV---YQLEA 314 (389)
Q Consensus 238 l~~ee~~~l~~~F~~~D~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~---~~~~~ 314 (389)
++.+++. ..|..+| ++|.|+.+||..++... ....+++.++|..+|.+++|.|+.+||..++... .....
T Consensus 7 ~~~~ei~---~~~~~~D-~~g~i~~~eF~~~~~~~---~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~ 79 (109)
T 3fs7_A 7 LSAKDIE---SALSSCQ-AADSFNYKSFFSTVGLS---SKTPDQIKKVFGILDQDKSGFIEEEELQLFLKNFSSSARVLT 79 (109)
T ss_dssp SCHHHHH---HHHHHTC-STTCCCHHHHHHHHTCT---TCCHHHHHHHHHHHSTTCSSSBCHHHHHTTGGGTCTTSCCCC
T ss_pred CCHHHHH---HHHHhcC-CCCcCcHHHHHHHHhcC---CCcHHHHHHHHHHHCCCCCCeEeHHHHHHHHHHHhcccccCC
Confidence 4455554 4455557 79999999998876432 3467889999999999999999999998865544 11112
Q ss_pred hHHHHHHHHHHHHHHcccCCCcccHHHHHHHh
Q 016471 315 LERWDQIAITAFDYFEQEGNRVISVEELALEL 346 (389)
Q Consensus 315 ~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l 346 (389)
++.+..+|+.+|.|++|.|+.+|+..++
T Consensus 80 ----~~~~~~~~~~~D~~~dg~i~~~EF~~~~ 107 (109)
T 3fs7_A 80 ----SAETKAFLAAGDTDGDGKIGVEEFQSLV 107 (109)
T ss_dssp ----HHHHHHHHHHHCTTCSSSBCHHHHHHHH
T ss_pred ----HHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 3468999999999999999999999876
|
| >2jnf_A Troponin C; stretch activated muscle contraction, EF-hand, metal binding protein; NMR {Lethocerus indicus} PDB: 2k2a_A | Back alignment and structure |
|---|
Probab=99.06 E-value=5.1e-10 Score=91.74 Aligned_cols=97 Identities=10% Similarity=0.074 Sum_probs=79.3
Q ss_pred HHHHHHHhhcC-CCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHhC----------C
Q 016471 280 SRVFEILNVME-PLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALELN----------L 348 (389)
Q Consensus 280 ~~~~~~~~~~d-~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~----------~ 348 (389)
.++.++|..+| .+++|.|+.+||..++........ ...+...|..+|.|++|.|+.+|+..++. .
T Consensus 13 ~~l~~~F~~~D~~~~~G~i~~~e~~~~l~~~~~~~~----~~~~~~l~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~ 88 (158)
T 2jnf_A 13 KLLETAFRDFETPEGSGRVSTDQIGIILEVLGIQQT----KSTIRQLIDEFDPFGNGDIDFDSFKIIGARFLGEEVNPEQ 88 (158)
T ss_dssp HHHHHHHHHSBCSSSCSSEEHHHHHHHHHHTTCSCS----HHHHHHHHHHHCTTCCSEECHHHHHHHHHHHCCCCCCTTT
T ss_pred HHHHHHHHHhCCCCCCCcCcHHHHHHHHHHhCCCCC----HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhccccchhh
Confidence 34678999999 999999999999986554322122 34688999999999999999999999882 1
Q ss_pred chH-HHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 349 APA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 349 ~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
... +..+|+.+|.|++|.|+.+||..+++...
T Consensus 89 ~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~g 121 (158)
T 2jnf_A 89 MQQELREAFRLYDKEGNGYISTDVMREILAELD 121 (158)
T ss_dssp TSSTHHHHHHHHCSSSSSSEEHHHHHHHHHHHC
T ss_pred HHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHhC
Confidence 112 99999999999999999999999997654
|
| >1exr_A Calmodulin; high resolution, disorder, metal transport; 1.00A {Paramecium tetraurelia} SCOP: a.39.1.5 PDB: 1n0y_A 1osa_A 1clm_A 1mxe_A 2bbm_A 2bbn_A 4cln_A 4djc_A 2wel_D* 2x51_B 2vas_B* 2bkh_B 3gn4_B 3l9i_C 2ygg_B* 2w73_A 1lvc_D* 1wrz_A 2bki_B 2r28_A ... | Back alignment and structure |
|---|
Probab=99.06 E-value=4.3e-10 Score=91.32 Aligned_cols=97 Identities=12% Similarity=0.149 Sum_probs=78.4
Q ss_pred HHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHhCCc------hH-H
Q 016471 280 SRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALELNLA------PA-A 352 (389)
Q Consensus 280 ~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~------~~-~ 352 (389)
.++.++|..+|.+++|.|+++||..++........ ...+...|..+|.|++|.|+.+|+..++... .. +
T Consensus 10 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~----~~~~~~l~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~l 85 (148)
T 1exr_A 10 AEFKEAFALFDKDGDGTITTKELGTVMRSLGQNPT----EAELQDMINEVDADGNGTIDFPEFLSLMARKMKEQDSEEEL 85 (148)
T ss_dssp HHHHHHHHHHCTTCSSEECHHHHHHHHHHHTCCCC----HHHHHHHHHHHCTTCSSSEEHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCCCCC----HHHHHHHHHHHCCCCCCcCcHHHHHHHHHhcccCCCcHHHH
Confidence 34678899999999999999999886544322112 3458889999999999999999999887321 11 7
Q ss_pred HHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 353 YSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 353 ~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
.++|+.+|.|++|.|+.+||..+++...
T Consensus 86 ~~~F~~~D~d~~G~I~~~el~~~l~~~g 113 (148)
T 1exr_A 86 IEAFKVFDRDGNGLISAAELRHVMTNLG 113 (148)
T ss_dssp HHHHHHHSTTCSSCBCHHHHHHHHHHTT
T ss_pred HHHHHHhCCCCCCcCCHHHHHHHHHHhC
Confidence 7899999999999999999999997654
|
| >2ccm_A Calexcitin; EF hand, calcium, signaling protein; 1.8A {Loligo pealeii} | Back alignment and structure |
|---|
Probab=99.06 E-value=6.6e-10 Score=94.26 Aligned_cols=95 Identities=13% Similarity=0.078 Sum_probs=77.1
Q ss_pred HHHHhhhcCC-CCCcccHHHHHHHHHHhcc--------ccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhH
Q 016471 246 LRAQFMLLEP-KDGCVSLNNFKVALMRQAT--------DAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALE 316 (389)
Q Consensus 246 l~~~F~~~D~-~~G~i~~~el~~~l~~~~~--------~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~ 316 (389)
....|..+|. ++|.|+.+||..++..... .......+..+|+.+|.+++|.|+++||..++.... ..
T Consensus 66 ~~~~~~~~D~d~dG~i~~~Ef~~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~dG~I~~~E~~~~l~~~g--~~-- 141 (191)
T 2ccm_A 66 WDGLRKYADENEDEQVTKEEWLKMWAECVKSVEKGESLPEWLTKYMNFMFDVNDTSGDNIIDKHEYSTVYMSYG--IP-- 141 (191)
T ss_dssp HHHHHHHHCTTCSSCEEHHHHHHHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHCTTCSSBCCHHHHHHHHHTTT--CC--
T ss_pred HHHHHHhcCCCCCCeECHHHHHHHHHHHhccccchhhchHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhC--CC--
Confidence 3455688899 9999999999998876532 122356789999999999999999999998775543 22
Q ss_pred HHHHHHHHHHHHHcccCCCcccHHHHHHHh
Q 016471 317 RWDQIAITAFDYFEQEGNRVISVEELALEL 346 (389)
Q Consensus 317 ~~~~~l~~aF~~~D~d~~G~I~~~el~~~l 346 (389)
.+.+..+|+.+|.|+||.|+.+|+..++
T Consensus 142 --~~~~~~~~~~~D~d~dG~i~~~Ef~~~~ 169 (191)
T 2ccm_A 142 --KSDCDAAFDTLSDGGKTMVTREIFARLW 169 (191)
T ss_dssp --HHHHHHHHHHHTTTTTSCCBHHHHHHHH
T ss_pred --HHHHHHHHHHhCCCCCCCcCHHHHHHHH
Confidence 3458899999999999999999999985
|
| >1avs_A Troponin C; muscle contraction, calcium-activated, E-F hand calcium-binding protein; 1.75A {Gallus gallus} SCOP: a.39.1.5 PDB: 1blq_A 1skt_A 1tnp_A 1tnq_A 1zac_A 1smg_A 1npq_A 1trf_A | Back alignment and structure |
|---|
Probab=99.06 E-value=7.2e-10 Score=81.95 Aligned_cols=74 Identities=16% Similarity=0.252 Sum_probs=66.8
Q ss_pred HHHhcCHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhc
Q 016471 234 LSKALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATS 308 (389)
Q Consensus 234 i~~~l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~ 308 (389)
+...++.++...++..|..+|. ++|.|+.+||..++..+|. .++..++..++..+|.+++|.|+|+||+..+..
T Consensus 10 ~~~~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~-~~~~~~~~~l~~~~D~~~dg~i~~~eF~~~~~~ 84 (90)
T 1avs_A 10 ARAFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQ-NPTKEELDAIIEEVDEDGSGTIDFEEFLVMMVR 84 (90)
T ss_dssp HHHHBCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTC-CCCHHHHHHHHHHHCTTCCSSEEHHHHHHHHHH
T ss_pred HHHhCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCC-CCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHH
Confidence 4556888899999999999999 9999999999999999986 478999999999999999999999999986543
|
| >2zfd_A Calcineurin B-like protein 2; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} SCOP: a.39.1.5 PDB: 1uhn_A | Back alignment and structure |
|---|
Probab=99.06 E-value=5.5e-10 Score=97.71 Aligned_cols=128 Identities=13% Similarity=0.098 Sum_probs=87.5
Q ss_pred HHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhH----HHhhHHHHH
Q 016471 246 LRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQ----LEALERWDQ 320 (389)
Q Consensus 246 l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~----~~~~~~~~~ 320 (389)
+...|..+|. ++|.|+.+||..++..........+++..+|..+|.|++|.|+++||..++..... ....+..+.
T Consensus 87 ~~~~f~~~D~d~dG~I~~~Ef~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~Is~~E~~~~l~~~~~~~g~~~~~~~~~~ 166 (226)
T 2zfd_A 87 ADRVFDLFDTKHNGILGFEEFARALSVFHPNAPIDDKIHFSFQLYDLKQQGFIERQEVKQMVVATLAESGMNLKDTVIED 166 (226)
T ss_dssp HHHHHHHHCSSCSSSBCHHHHHHHHHHTSTTSCHHHHHHHHHHHHCTTSSSSEEHHHHHHHHHHHHHHTTCCCCHHHHHH
T ss_pred HHHHHHHHcCCCCCcCcHHHHHHHHHHHccCCCHHHHHHHHHHHhCCCCCCcccHHHHHHHHHHHHHHcCCCCCHHHHHH
Confidence 4567888899 99999999999988877543345677999999999999999999999986642111 111122244
Q ss_pred HHHHHHHHHcccCCCcccHHHHHHHhCCchHHHHHHHHHccCCCCceeHHHHHH
Q 016471 321 IAITAFDYFEQEGNRVISVEELALELNLAPAAYSLLNDCIRNSDGKLSFLGYKR 374 (389)
Q Consensus 321 ~l~~aF~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~d~~~~g~i~~~ef~~ 374 (389)
.+..+|+.+|.|+||.|+.+|+..++...+.+.+.+.. ..-++...+|.+|+.
T Consensus 167 ~~~~~f~~~D~d~dG~I~~~EF~~~~~~~~~~~~~~~~-~~~~~~~~~f~~~~~ 219 (226)
T 2zfd_A 167 IIDKTFEEADTKHDGKIDKEEWRSLVLRHPSLLKNMTL-QYLKDITTTFPSFVF 219 (226)
T ss_dssp HHHHHHHHHCSSCSSEECHHHHHHHHHHSGGGGGGGCC-GGGGGHHHHC-----
T ss_pred HHHHHHHHhCCCCCCcCcHHHHHHHHHhChHHHHHhch-HHhhchhhcchhHHh
Confidence 56889999999999999999999998544441111111 112344556666643
|
| >3h4s_E KCBP interacting Ca2+-binding protein; kinesin, motor protein, regulation, complex, calcium, EF- hand, calmodulin, ATP-binding, microtubule; HET: ADP; 2.40A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=99.05 E-value=1.2e-10 Score=93.27 Aligned_cols=96 Identities=5% Similarity=0.000 Sum_probs=59.3
Q ss_pred HHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhH-HHhhHHHHHHHHH
Q 016471 247 RAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQ-LEALERWDQIAIT 324 (389)
Q Consensus 247 ~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~-~~~~~~~~~~l~~ 324 (389)
+..|..+|. ++|.|+.+||..++...........++.++|+.+|.+++|.|+.+||..++..... ... ++.+..
T Consensus 6 ~~l~~~~D~d~~G~I~~~EF~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~----~~e~~~ 81 (135)
T 3h4s_E 6 KSMLLETTSTTKMETKYEDMLPVMAEKMDVEEFVSELCKGFSLLADPERHLITAESLRRNSGILGIEGMS----KEDAQG 81 (135)
T ss_dssp -------------CCCC-----------CHHHHHHHHHHHHHHHSBTTTTBBCHHHHHHHGGGGTCCCCC----HHHHHH
T ss_pred HHHHHHHcCCCCCcEeHHHHHHHHHHHccccchHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHhCCCCCC----HHHHHH
Confidence 567888899 99999999998877653222234577899999999999999999999987665431 222 346889
Q ss_pred HHHHHcccCCCcccHHHHHHHh
Q 016471 325 AFDYFEQEGNRVISVEELALEL 346 (389)
Q Consensus 325 aF~~~D~d~~G~I~~~el~~~l 346 (389)
+|+.+|.|+||.|+.+|+..++
T Consensus 82 ~~~~~D~d~dG~I~~~EF~~~~ 103 (135)
T 3h4s_E 82 MVREGDLDGDGALNQTEFCVLM 103 (135)
T ss_dssp HHHHHCSSCSSSBCHHHHHHHH
T ss_pred HHHHhCCCCCCCCcHHHHHHHH
Confidence 9999999999999999999988
|
| >1psr_A Psoriasin, S100A7; EF-hand protein, MAD phasing, psoriasis, S100 protein family; 1.05A {Homo sapiens} SCOP: a.39.1.2 PDB: 2psr_A 2wor_A* 2wos_A* 3psr_A 2wnd_A | Back alignment and structure |
|---|
Probab=99.05 E-value=1.3e-10 Score=87.91 Aligned_cols=60 Identities=15% Similarity=0.192 Sum_probs=51.6
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHhCC----------chH---HHHHHHHHccCCCCceeHHHHHHHHccc
Q 016471 319 DQIAITAFDYFEQEGNRVISVEELALELNL----------APA---AYSLLNDCIRNSDGKLSFLGYKRFLHGV 379 (389)
Q Consensus 319 ~~~l~~aF~~~D~d~~G~I~~~el~~~l~~----------~~~---~~~~~~~~d~~~~g~i~~~ef~~~~~~~ 379 (389)
.+.++.||+.||.+ +|+|+.+||+.+|.. ..+ ++++++++|.|+||.|+|+||+.+|...
T Consensus 9 ~~~l~~~F~~fD~~-~g~Is~~El~~~l~~~~~~~lg~~~~~~~~ev~~l~~~~D~d~dG~I~f~EF~~~~~~~ 81 (100)
T 1psr_A 9 IIGMIDMFHKYTRR-DDKIDKPSLLTMMKENFPNFLSACDKKGTNYLADVFEKKDKNEDKKIDFSEFLSLLGDI 81 (100)
T ss_dssp HHHHHHHHHHTCCT-TSCBCHHHHHHHHHHHCHHHHHHHHHTTCCGGGTHHHHHCTTCSSCBCHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhCC-CCeECHHHHHHHHHHHhHhhhccccccCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHH
Confidence 45699999999976 799999999999832 112 8899999999999999999999999764
|
| >1s6i_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=99.04 E-value=3.5e-10 Score=96.03 Aligned_cols=97 Identities=8% Similarity=0.070 Sum_probs=80.2
Q ss_pred HHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHhCCc----h-H-HH
Q 016471 280 SRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALELNLA----P-A-AY 353 (389)
Q Consensus 280 ~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~----~-~-~~ 353 (389)
.++.++|..+|.+++|.|+++||..++........ ...+..+|+.+|.|++|.|+.+|+..++... . . +.
T Consensus 10 ~~l~~~F~~~D~d~dG~I~~~E~~~~l~~~g~~~~----~~~~~~l~~~~D~d~dG~I~~~EF~~~~~~~~~~~~~~~l~ 85 (188)
T 1s6i_A 10 GGLKELFKMIDTDNSGTITFDELKDGLKRVGSELM----ESEIKDLMDAADIDKSGTIDYGEFIAATVHLNKLEREENLV 85 (188)
T ss_dssp CSHHHHHHTTSSSSSSCEEHHHHHHHHTTTTCCCC----HHHHHHHHHHTCTTCSSEECHHHHHHHHTTSSSSCCCCSTH
T ss_pred HHHHHHHHHHCCCCCCcCCHHHHHHHHHHcCCCCC----HHHHHHHHHHcCCCCCCeEeHHHHHHHHHHHhccCHHHHHH
Confidence 45789999999999999999999987665432222 3458899999999999999999999987321 1 2 88
Q ss_pred HHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 354 SLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 354 ~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
.+|+.+|.|++|.|+.+||..+++...
T Consensus 86 ~~F~~~D~d~dG~Is~~El~~~l~~~g 112 (188)
T 1s6i_A 86 SAFSYFDKDGSGYITLDEIQQACKDFG 112 (188)
T ss_dssp HHHHHTTTTCSSEEEHHHHHHTTTTTT
T ss_pred HHHHHHCCCCCCcCcHHHHHHHHHHcC
Confidence 999999999999999999999987643
|
| >1fi6_A EH domain protein REPS1; EPS15 homology domain, EF hand, calcium, RAS signal transduction, endocytosis/exocytosis complex; NMR {Mus musculus} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=99.04 E-value=8.5e-10 Score=82.00 Aligned_cols=67 Identities=24% Similarity=0.358 Sum_probs=60.7
Q ss_pred cCHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHh
Q 016471 238 LTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAAT 307 (389)
Q Consensus 238 l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~ 307 (389)
++.++...++++|..+|. ++|.|+.+|++.+++.++ ++.+++.+++..+|.+++|.|+|+||+.++.
T Consensus 3 ls~~~~~~~~~~F~~~D~d~dG~I~~~el~~~l~~~g---~~~~~~~~i~~~~D~d~dG~i~~~EF~~~~~ 70 (92)
T 1fi6_A 3 ITDEQRQYYVNQFKTIQPDLNGFIPGSAAKEFFTKSK---LPILELSHIWELSDFDKDGALTLDEFCAAFH 70 (92)
T ss_dssp CCHHHHHHHHHHHTTTCCSTTCEEEHHHHHHHHHHHS---SCHHHHHHHHHHHCTTCSSEEEHHHHHHHHH
T ss_pred CCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcC---CCHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 467788899999999999 999999999999998875 5788999999999999999999999998654
|
| >5pal_A Parvalbumin; calcium-binding protein; 1.54A {Triakis semifasciata} SCOP: a.39.1.4 | Back alignment and structure |
|---|
Probab=99.04 E-value=5.5e-10 Score=85.72 Aligned_cols=98 Identities=13% Similarity=0.154 Sum_probs=75.7
Q ss_pred cCHHHHHHHHHHhhhcCCCCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhch---hHHHh
Q 016471 238 LTEEELVYLRAQFMLLEPKDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSV---YQLEA 314 (389)
Q Consensus 238 l~~ee~~~l~~~F~~~D~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~---~~~~~ 314 (389)
++.+++ ...|..+|. +|.|+.+||..++... ....+++.++|..+|.+++|.|+.+||..++... .....
T Consensus 6 ~s~~ei---~~~~~~~d~-~g~i~~~eF~~~~~~~---~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~g~~~~ 78 (109)
T 5pal_A 6 LKADDI---NKAISAFKD-PGTFDYKRFFHLVGLK---GKTDAQVKEVFEILDKDQSGFIEEEELKGVLKGFSAHGRDLN 78 (109)
T ss_dssp SCHHHH---HHHHHHTCS-TTCCCHHHHHHHHTCT---TCCHHHHHHHHHHHCTTCSSEECHHHHHTHHHHHCTTCCCCC
T ss_pred CCHHHH---HHHHHHhCC-CCcCcHHHHHHHHhhc---cCcHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHHHcCCCCC
Confidence 455554 455555676 9999999998876432 3467889999999999999999999998765543 11112
Q ss_pred hHHHHHHHHHHHHHHcccCCCcccHHHHHHHh
Q 016471 315 LERWDQIAITAFDYFEQEGNRVISVEELALEL 346 (389)
Q Consensus 315 ~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l 346 (389)
++.+..+|+.+|.|++|.|+.+|+..++
T Consensus 79 ----~~~~~~~~~~~D~~~dg~i~~~eF~~~~ 106 (109)
T 5pal_A 79 ----DTETKALLAAGDSDHDGKIGADEFAKMV 106 (109)
T ss_dssp ----HHHHHHHHHHHCTTCSSSEEHHHHHHHH
T ss_pred ----HHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 3468999999999999999999998875
|
| >1xk4_C Calgranulin B; S100 family, heterotetramer, metal binding protein; HET: FLC; 1.80A {Homo sapiens} SCOP: a.39.1.2 PDB: 1irj_A* | Back alignment and structure |
|---|
Probab=99.04 E-value=3.7e-10 Score=87.44 Aligned_cols=62 Identities=18% Similarity=0.256 Sum_probs=53.2
Q ss_pred HHHHHHHHHHHc-ccCCC-cccHHHHHHHhC----C-------chH-HHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 319 DQIAITAFDYFE-QEGNR-VISVEELALELN----L-------APA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 319 ~~~l~~aF~~~D-~d~~G-~I~~~el~~~l~----~-------~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
...++.+|+.|| +|++| +|+.+||+.+|. . ... +.++++++|.|+||.|+|+||+.+|....
T Consensus 11 ~~~l~~~F~~fD~~dgdG~~Is~~El~~~l~~~lg~~~~~~~~~~~~v~~l~~~~D~d~dG~I~f~EF~~~~~~~~ 86 (113)
T 1xk4_C 11 IETIINTFHQYSVKLGHPDTLNQGEFKELVRKDLQNFLKKENKNEKVIEHIMEDLDTNADKQLSFEEFIMLMARLT 86 (113)
T ss_dssp HHHHHHHHHHHHTTSSSTTSBCHHHHHHHHHHHTTTTTTTGGGCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhhcCCCCCEECHHHHHHHHHHHhhhhhcccccCHHHHHHHHHHhCCCCCCCEeHHHHHHHHHHHH
Confidence 356899999999 49999 999999999873 1 122 99999999999999999999999987643
|
| >2d58_A Allograft inflammatory factor 1; EF-hand, metal binding protein; 1.90A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.03 E-value=3.5e-10 Score=86.68 Aligned_cols=62 Identities=18% Similarity=0.225 Sum_probs=55.0
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHh---CC--chH-HHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 319 DQIAITAFDYFEQEGNRVISVEELALEL---NL--APA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 319 ~~~l~~aF~~~D~d~~G~I~~~el~~~l---~~--~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
...++.+|+.||+|++|+|+.+||+.++ |. +.. +.+++..+|.|++|.|+|+||+.++....
T Consensus 31 ~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~l~~~~D~d~dg~i~~~eF~~~~~~~~ 98 (107)
T 2d58_A 31 LEGFKEKYMEFDLNGNGDIDIMSLKRMLEKLGVPKTHLELKKLIGEVSSGSGETFSYPDFLRMMLGKR 98 (107)
T ss_dssp HHHHHHHHTTSCCCTTSCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHCSSSSSEECHHHHHHHHSSSS
T ss_pred HHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHcc
Confidence 4568999999999999999999999988 43 233 99999999999999999999999998765
|
| >1eh2_A EPS15; calcium binding, signaling domain, NPF binding, EF-hand, EH domain; NMR {Homo sapiens} SCOP: a.39.1.6 PDB: 2jxc_A 1f8h_A 1ff1_A | Back alignment and structure |
|---|
Probab=99.03 E-value=8.6e-10 Score=84.01 Aligned_cols=68 Identities=21% Similarity=0.223 Sum_probs=61.3
Q ss_pred cCHHHHHHHHHHhhhcCCCCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhc
Q 016471 238 LTEEELVYLRAQFMLLEPKDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATS 308 (389)
Q Consensus 238 l~~ee~~~l~~~F~~~D~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~ 308 (389)
++.++...++.+|..+|.++|.|+.+|++.+|+.++ ++.+++.+|+...|.|++|.|+|+||+.++..
T Consensus 9 ls~~e~~~~~~~F~~~D~~dG~Is~~el~~~l~~~g---l~~~el~~i~~~~D~d~dG~id~~EF~~~m~~ 76 (106)
T 1eh2_A 9 VKPEDKAKYDAIFDSLSPVNGFLSGDKVKPVLLNSK---LPVDILGRVWELSDIDHDGMLDRDEFAVAMFL 76 (106)
T ss_dssp SCHHHHHHHHHHHTTSCCSSSCCBHHHHHHHHHTTT---CCHHHHHHHHHHHCSSCSSBCCHHHHHHHHHH
T ss_pred CCHHHHHHHHHHHHHhCCCCCeEcHHHHHHHHHHcC---CCHHHHHHHHHHHcCCCCCcCcHHHHHHHHHH
Confidence 467788899999999999999999999999998875 57889999999999999999999999986543
|
| >1xk4_A Calgranulin A; S100 family, heterotetramer, metal binding protein; HET: FLC; 1.80A {Homo sapiens} SCOP: a.39.1.2 PDB: 1mr8_A | Back alignment and structure |
|---|
Probab=99.03 E-value=3.6e-10 Score=84.24 Aligned_cols=62 Identities=16% Similarity=0.203 Sum_probs=53.6
Q ss_pred HHHHHHHHHHHcc-cCCC-cccHHHHHHHh-C-Cc--hH---HHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 319 DQIAITAFDYFEQ-EGNR-VISVEELALEL-N-LA--PA---AYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 319 ~~~l~~aF~~~D~-d~~G-~I~~~el~~~l-~-~~--~~---~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
...++.+|+.||+ |++| +|+.+||+.++ . +. .+ +.++++.+|.|++|.|+|+||+.+|....
T Consensus 9 ~~~l~~~F~~~D~~d~dG~~I~~~El~~~l~~~~g~~~~~~~~~~l~~~~D~d~dG~I~~~EF~~~~~~~~ 79 (93)
T 1xk4_A 9 LNSIIDVYHKYSLIKGNFHAVYRDDLKKLLETESPQYIRKKGADVWFKELDINTDGAVNFQEFLILVIKMG 79 (93)
T ss_dssp HHHHHHHHHHHHTSSSCTTCBCHHHHHHHHHHHSCHHHHTTCHHHHHHHHCTTCSSSBCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhhcCCCcCeECHHHHHHHHHHHCcccCCHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHH
Confidence 4568999999999 9999 99999999988 2 21 12 89999999999999999999999987653
|
| >2joj_A Centrin protein; N-terminal domain, centrin solution structure, EF-hand calcium binding protein, cell cycle; NMR {Euplotes octocarinatus} | Back alignment and structure |
|---|
Probab=99.03 E-value=6.7e-10 Score=79.36 Aligned_cols=69 Identities=19% Similarity=0.404 Sum_probs=62.3
Q ss_pred CHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhc
Q 016471 239 TEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATS 308 (389)
Q Consensus 239 ~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~ 308 (389)
++++...++..|..+|. ++|.|+.+||..++..++. .++..++..++..+|.+++|.|+|+||+..+..
T Consensus 2 s~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~-~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~ 71 (77)
T 2joj_A 2 SEEQKQEIKEAFDLFDTNKTGSIDYHELKVAMRALGF-DVKKPEILELMNEYDREGNGYIGFDDFLDIMTE 71 (77)
T ss_dssp CHHHHHHHHHHHHHHCCSSSSEEEHHHHHHHHHHHTC-CCHHHHHHHHHHHHCCSSSSEEEHHHHHHHHTH
T ss_pred CHHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhCC-CCCHHHHHHHHHHHCCCCCCcCcHHHHHHHHHH
Confidence 56778889999999999 9999999999999999986 478889999999999999999999999986543
|
| >3qr0_A Phospholipase C-beta (PLC-beta); PH domain, EF hand, C2 domain, TIM barrel domain, hydrolase, calcium binding, phospholipid binding; 2.00A {Sepia officinalis} PDB: 3qr1_A | Back alignment and structure |
|---|
Probab=99.02 E-value=2.1e-10 Score=116.73 Aligned_cols=116 Identities=15% Similarity=0.204 Sum_probs=92.7
Q ss_pred cCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhc-------CCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHH
Q 016471 253 LEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVM-------EPLSDQKLAYEEFCAAATSVYQLEALERWDQIAIT 324 (389)
Q Consensus 253 ~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~-------d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~ 324 (389)
+|. ++|.|+.+|+.+.+...+. .+.++.++++.. |.+++|.|+|+||+..+.... . ..+++.
T Consensus 164 fd~n~dG~Is~kEl~~~l~~~~~---~~~el~~~~~~~~~~~~k~D~~~~g~L~FeEF~~f~~~L~---~----R~EI~e 233 (816)
T 3qr0_A 164 TVEMEKNKIPVKAIQKCLSKDKD---DRARISKALEKIGWPSGKNDAIDLKAFDFDTFFKFYLALL---E----RSEIEG 233 (816)
T ss_dssp HTSCCSSEEEHHHHHHHHCSCHH---HHHHHHHHHHHHTSCCSTTCEEETTTCCHHHHHHHHHHHC---C----CTHHHH
T ss_pred ccCCCCCCCCHHHHHHHHHhcCC---hHHHHHHHHHHhcccccccccCCCCcCCHHHHHHHHHhcC---C----HHHHHH
Confidence 577 8999999999998765432 145688888887 567889999999998654332 2 235899
Q ss_pred HHHHHcccCCCcccHHHHHHHh---CCc------------hH-HHHHHHHHcc--C----CCCceeHHHHHHHHccc
Q 016471 325 AFDYFEQEGNRVISVEELALEL---NLA------------PA-AYSLLNDCIR--N----SDGKLSFLGYKRFLHGV 379 (389)
Q Consensus 325 aF~~~D~d~~G~I~~~el~~~l---~~~------------~~-~~~~~~~~d~--~----~~g~i~~~ef~~~~~~~ 379 (389)
+|+.||.|++|+||. ||+++| +.. .+ +.+|+++++. + ++|.|++++|..+|...
T Consensus 234 iF~~y~~dg~~~mT~-eL~~FL~~~Q~E~~~~~~~~~~~t~e~~~~iI~kye~~~~~~~~~~g~LsldgF~~yL~S~ 309 (816)
T 3qr0_A 234 IFKELSKNKGNITTV-MFRDFLNDMQRHPSLHKTLFPLYTDAQCEALINDYESAVNKKGKKKGQLTKEGLLYFLMCE 309 (816)
T ss_dssp HHHHHTTTSSSEEHH-HHHHHHHHTSSCTTSCTTTSCCCCHHHHHHHHHHHHHHHHGGGCBTTEECHHHHHHHHHSG
T ss_pred HHHHHccCCCCcccH-HHHHHHHHhCCccccccccccccCHHHHHHHHHHhccccchhhhccCCccHHHHHHHhhcc
Confidence 999999999999999 999999 312 23 8899998877 5 78999999999999754
|
| >3akb_A Putative calcium binding protein; EF-hand, metal binding protein; 1.50A {Streptomyces coelicolor} PDB: 3aka_A | Back alignment and structure |
|---|
Probab=99.01 E-value=1e-09 Score=90.58 Aligned_cols=96 Identities=13% Similarity=0.163 Sum_probs=77.2
Q ss_pred HHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCC------HHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHH
Q 016471 245 YLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMT------DSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALER 317 (389)
Q Consensus 245 ~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~------~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~ 317 (389)
.+...|..+|. ++|.|+.+||..++......... ...+.++|+.+|.+++|.|+++||..++.... ..
T Consensus 56 ~~~~~f~~~D~d~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~i~~~E~~~~l~~~~--~~--- 130 (166)
T 3akb_A 56 LWQGLAGIADRDGDQRITREEFVTGAVKRLRDKPDRFAEMARPFLHAALGVADTDGDGAVTVADTARALTAFG--VP--- 130 (166)
T ss_dssp HHHHHHHHHCTTSSSCEEHHHHHHTHHHHHHHSHHHHHHHHHHHHHHHHHHHCSSSSSCCBHHHHHHHHHHTT--CC---
T ss_pred HHHHHHHHhCCCCCCcCcHHHHHHHHHHHhccCccchHHHHHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHhC--CC---
Confidence 34577889999 99999999999887766432100 23488999999999999999999998765543 22
Q ss_pred HHHHHHHHHHHHcccCCCcccHHHHHHHh
Q 016471 318 WDQIAITAFDYFEQEGNRVISVEELALEL 346 (389)
Q Consensus 318 ~~~~l~~aF~~~D~d~~G~I~~~el~~~l 346 (389)
++.+..+|+.+|.|++|.|+.+|+..++
T Consensus 131 -~~~~~~~~~~~D~d~dg~i~~~ef~~~~ 158 (166)
T 3akb_A 131 -EDLARQAAAALDTDGDGKVGETEIVPAF 158 (166)
T ss_dssp -HHHHHHHHHHHCTTCSSBCCHHHHHHHH
T ss_pred -HHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 3468999999999999999999999886
|
| >1xk4_C Calgranulin B; S100 family, heterotetramer, metal binding protein; HET: FLC; 1.80A {Homo sapiens} SCOP: a.39.1.2 PDB: 1irj_A* | Back alignment and structure |
|---|
Probab=99.01 E-value=7.4e-10 Score=85.71 Aligned_cols=86 Identities=13% Similarity=0.155 Sum_probs=60.5
Q ss_pred HHHHHHHHHhhhcC-C-CCC-cccHHHHHHHHH-Hhccc---c-CCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHH
Q 016471 241 EELVYLRAQFMLLE-P-KDG-CVSLNNFKVALM-RQATD---A-MTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQL 312 (389)
Q Consensus 241 ee~~~l~~~F~~~D-~-~~G-~i~~~el~~~l~-~~~~~---~-~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~ 312 (389)
+++..++.+|..+| . ++| .|+.+||+.+|. .++.. . .+..++.++|..+|.|++|.|+|+||+..+....
T Consensus 9 ~~~~~l~~~F~~fD~~dgdG~~Is~~El~~~l~~~lg~~~~~~~~~~~~v~~l~~~~D~d~dG~I~f~EF~~~~~~~~-- 86 (113)
T 1xk4_C 9 RNIETIINTFHQYSVKLGHPDTLNQGEFKELVRKDLQNFLKKENKNEKVIEHIMEDLDTNADKQLSFEEFIMLMARLT-- 86 (113)
T ss_dssp HHHHHHHHHHHHHHTTSSSTTSBCHHHHHHHHHHHTTTTTTTGGGCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHH--
T ss_pred HHHHHHHHHHHHHhhcCCCCCEECHHHHHHHHHHHhhhhhcccccCHHHHHHHHHHhCCCCCCCEeHHHHHHHHHHHH--
Confidence 34677899999999 5 889 999999999998 56531 1 5788999999999999999999999998655332
Q ss_pred HhhHHHHHHHHHHHHHHcccCCCc
Q 016471 313 EALERWDQIAITAFDYFEQEGNRV 336 (389)
Q Consensus 313 ~~~~~~~~~l~~aF~~~D~d~~G~ 336 (389)
.....+|...| +++|.
T Consensus 87 -------~~~~~~f~~~~-~~~g~ 102 (113)
T 1xk4_C 87 -------WASHEKMHEGD-EGPGH 102 (113)
T ss_dssp -------HHHHC------------
T ss_pred -------HHHHHHHhhCC-CCCcc
Confidence 12566888888 88885
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.01 E-value=4.6e-10 Score=109.81 Aligned_cols=101 Identities=12% Similarity=0.160 Sum_probs=74.0
Q ss_pred HHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhh----------HHHHHHHHHHHHHHcccCCCcccHHHHHHHhCC
Q 016471 279 DSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEAL----------ERWDQIAITAFDYFEQEGNRVISVEELALELNL 348 (389)
Q Consensus 279 ~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~----------~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~ 348 (389)
..++.++|..+|.|+||.|+++||..++......... ...++.+..+|+.+|.|+||.|+.+|+..++..
T Consensus 330 ~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~I~~~Ef~~~~~~ 409 (486)
T 3mwu_A 330 TKQLTEIFRKLDTNNDGMLDRDELVRGYHEFMRLKGVDSNSLIQNEGSTIEDQIDSLMPLLDMDGSGSIEYSEFIASAID 409 (486)
T ss_dssp HHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHHHHHTCCGGGHHHHTSSCHHHHHHHHHHHHCTTCCSSBCHHHHHHHHSC
T ss_pred HHHHHHHHHHhCCCCCceeeHHHHHHHHHHhhhhhcccchhcccccchhhHHHHHHHHHHhcCCCCCcCcHHHHHHHHHh
Confidence 4568899999999999999999997655433221100 001456899999999999999999999988721
Q ss_pred -----chH-HHHHHHHHccCCCCceeHHHHHHHHccc
Q 016471 349 -----APA-AYSLLNDCIRNSDGKLSFLGYKRFLHGV 379 (389)
Q Consensus 349 -----~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~ 379 (389)
... +.++|+.+|.|+||.|+.+||..++...
T Consensus 410 ~~~~~~~~~~~~~F~~~D~d~dG~Is~~El~~~l~~~ 446 (486)
T 3mwu_A 410 RTILLSRERMERAFKMFDKDGSGKISTKELFKLFSQA 446 (486)
T ss_dssp TTTTCCHHHHHHHHHHHCSSCSSSBCSSCC-------
T ss_pred hhccchHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHc
Confidence 222 8899999999999999999999998765
|
| >1dtl_A Cardiac troponin C; helix-turn-helix, structural protein; HET: BEP; 2.15A {Gallus gallus} SCOP: a.39.1.5 PDB: 1j1d_A 1j1e_A 2jt3_A 2jt0_A 1la0_A 2jtz_A* 2jt8_A* 2kfx_T* 1wrk_A* 1wrl_A* 1ap4_A 1lxf_C* 1mxl_C 1spy_A 2krd_C* 2l1r_A* 3rv5_A* 2ctn_A 2kgb_C 2jxl_A ... | Back alignment and structure |
|---|
Probab=99.01 E-value=7.3e-10 Score=91.04 Aligned_cols=97 Identities=11% Similarity=0.183 Sum_probs=77.2
Q ss_pred HHHHhhhcCC-CCCcccHHHHHHHHHHhcc---ccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHH
Q 016471 246 LRAQFMLLEP-KDGCVSLNNFKVALMRQAT---DAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQI 321 (389)
Q Consensus 246 l~~~F~~~D~-~~G~i~~~el~~~l~~~~~---~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~ 321 (389)
+...|..+|. ++|.|+.+||..++..... .......+..+|..+|.+++|.|+.+||..++........ .+.
T Consensus 57 ~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~i~~~El~~~l~~~g~~~~----~~~ 132 (161)
T 1dtl_A 57 LQEMIDEVDEDGSGTVDFDEFLVMMVRSMKDDSKGKSEEELSDLFRMFDKNADGYIDLEELKIMLQATGETIT----EDD 132 (161)
T ss_dssp HHHHHHHHCTTSSSSBCHHHHHHHHHHHHC-----CHHHHHHHHHHHHCTTCSSEEEHHHHGGGGTTC--CCC----HHH
T ss_pred HHHHHHHhCCCCCCeEcHHHHHHHHHHHhcccccchHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCC----HHH
Confidence 4556777899 9999999999998876542 2335677999999999999999999999886654432222 346
Q ss_pred HHHHHHHHcccCCCcccHHHHHHHh
Q 016471 322 AITAFDYFEQEGNRVISVEELALEL 346 (389)
Q Consensus 322 l~~aF~~~D~d~~G~I~~~el~~~l 346 (389)
+..+|+.+|.|++|.|+.+|+..++
T Consensus 133 ~~~~~~~~D~d~dg~i~~~eF~~~~ 157 (161)
T 1dtl_A 133 IEELMKDGDKNNDGRIDYDEFLEFM 157 (161)
T ss_dssp HHHHHHHHCTTSSSEEEHHHHHHHH
T ss_pred HHHHHHHhCCCCCCcEeHHHHHHHH
Confidence 8899999999999999999999876
|
| >2pvb_A Protein (parvalbumin); calcium binding protein, metal binding protein; 0.91A {Esox lucius} SCOP: a.39.1.4 PDB: 1pvb_A 2pal_A 1pal_A 3pal_A 4pal_A 4cpv_A 1cdp_A 5cpv_A 1b8r_A 1b9a_A 1b8l_A 1b8c_A 1a75_B 1a75_A | Back alignment and structure |
|---|
Probab=99.00 E-value=1.3e-09 Score=83.47 Aligned_cols=93 Identities=12% Similarity=0.091 Sum_probs=73.1
Q ss_pred HHHHhhhcCCCCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhch---hHHHhhHHHHHHH
Q 016471 246 LRAQFMLLEPKDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSV---YQLEALERWDQIA 322 (389)
Q Consensus 246 l~~~F~~~D~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~---~~~~~~~~~~~~l 322 (389)
+...|..+| ++|.|+.+||..++... .....++.++|..+|.+++|.|+.+||..++... ..... ++.+
T Consensus 11 ~~~l~~~~d-~~g~i~~~eF~~~~~~~---~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~----~~~~ 82 (108)
T 2pvb_A 11 VAAALAACS-AADSFKHKEFFAKVGLA---SKSLDDVKKAFYVIDQDKSGFIEEDELKLFLQNFSPSARALT----DAET 82 (108)
T ss_dssp HHHHHHHTC-STTCCCHHHHHHHHTGG---GSCHHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTSCCCC----HHHH
T ss_pred HHHHHHHhC-CCCcCcHHHHHHHHhCC---hhHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHHhccCCCCC----HHHH
Confidence 344555567 79999999998876432 3467789999999999999999999999866544 11112 3468
Q ss_pred HHHHHHHcccCCCcccHHHHHHHh
Q 016471 323 ITAFDYFEQEGNRVISVEELALEL 346 (389)
Q Consensus 323 ~~aF~~~D~d~~G~I~~~el~~~l 346 (389)
..+|+.+|.|++|.|+.+|+..++
T Consensus 83 ~~~~~~~D~~~dg~i~~~eF~~~~ 106 (108)
T 2pvb_A 83 KAFLADGDKDGDGMIGVDEFAAMI 106 (108)
T ss_dssp HHHHHHHCTTCSSSBCHHHHHHHH
T ss_pred HHHHHHhCCCCCCcEeHHHHHHHH
Confidence 899999999999999999998875
|
| >1bu3_A Calcium-binding protein; 1.65A {Merluccius bilinearis} SCOP: a.39.1.4 | Back alignment and structure |
|---|
Probab=99.00 E-value=1.4e-09 Score=83.49 Aligned_cols=93 Identities=13% Similarity=0.089 Sum_probs=72.6
Q ss_pred HHHHhhhcCCCCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhch---hHHHhhHHHHHHH
Q 016471 246 LRAQFMLLEPKDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSV---YQLEALERWDQIA 322 (389)
Q Consensus 246 l~~~F~~~D~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~---~~~~~~~~~~~~l 322 (389)
+...|..+| ++|.|+.+||..++... .....++.++|..+|.+++|.|+.+||..++... ..... ++.+
T Consensus 12 ~~~~~~~~d-~~g~i~~~eF~~~~~~~---~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~----~~~~ 83 (109)
T 1bu3_A 12 VAAALKACE-AADSFNYKAFFAKVGLT---AKSADDIKKAFFVIDQDKSGFIEEDELKLFLQVFSAGARALT----DAET 83 (109)
T ss_dssp HHHHHHHTC-STTCCCHHHHHHHHTGG---GSCHHHHHHHHHHHCTTCSSSEEHHHHHTHHHHHSTTCCCCC----HHHH
T ss_pred HHHHHHHhC-CCCcCcHHHHHHHHHcC---hhhHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHcccCCCCC----HHHH
Confidence 334455567 79999999998876432 2467789999999999999999999998766543 11112 3468
Q ss_pred HHHHHHHcccCCCcccHHHHHHHh
Q 016471 323 ITAFDYFEQEGNRVISVEELALEL 346 (389)
Q Consensus 323 ~~aF~~~D~d~~G~I~~~el~~~l 346 (389)
..+|+.+|.|++|.|+.+|+..++
T Consensus 84 ~~~~~~~D~~~dg~i~~~eF~~~~ 107 (109)
T 1bu3_A 84 KAFLKAGDSDGDGAIGVDEWAALV 107 (109)
T ss_dssp HHHHHHHCTTCSSEECHHHHHHHH
T ss_pred HHHHHHhCCCCCCcEeHHHHHHHH
Confidence 899999999999999999998876
|
| >1a4p_A S100A10; S100 family, EF-hand protein, ligand of annexin II, calcium/phospholipid binding protein, calcium-phospholipid protein complex; 2.25A {Homo sapiens} SCOP: a.39.1.2 PDB: 1bt6_A | Back alignment and structure |
|---|
Probab=99.00 E-value=4.5e-10 Score=84.19 Aligned_cols=61 Identities=20% Similarity=0.379 Sum_probs=51.3
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHhCC----------chH-HHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 319 DQIAITAFDYFEQEGNRVISVEELALELNL----------APA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 319 ~~~l~~aF~~~D~d~~G~I~~~el~~~l~~----------~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
.+.++.+|+.||. +||+|+.+||+.+|.. ... +.++++++|.|+||.|+|+||+.+|....
T Consensus 8 ~~~l~~~F~~fD~-~dg~Is~~El~~~l~~~~~~~lg~~~~~~ev~~l~~~~D~d~dG~I~f~EF~~~~~~~~ 79 (96)
T 1a4p_A 8 METMMFTFHKFAG-DKGYLTKEDLRVLMEKEFPGFLENQKDPLAVDKIMKDLDQCRDGKVGFQSFFSLIAGLT 79 (96)
T ss_dssp HHHHHHHHHHHHG-GGCSBCHHHHHHHHHHHCHHHHHHSCCTTHHHHHHHHHCTTSSSCBCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHcC-CCCeECHHHHHHHHHHHcccccccccCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHH
Confidence 4569999999994 5679999999999831 222 99999999999999999999999997643
|
| >3ox6_A Calcium-binding protein 1; EF-hand, calcium-sensor; 2.40A {Homo sapiens} PDB: 3ox5_A 2lan_A 2lap_A 2k7b_A 2k7c_A 2k7d_A | Back alignment and structure |
|---|
Probab=99.00 E-value=6.8e-10 Score=90.22 Aligned_cols=95 Identities=7% Similarity=0.081 Sum_probs=77.8
Q ss_pred HHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHhC-----Cc-----
Q 016471 280 SRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALELN-----LA----- 349 (389)
Q Consensus 280 ~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~-----~~----- 349 (389)
.++.++|..+|.+++|.|+.+||..++........ ...+...|..+|.|++|.|+.+|+..++. ..
T Consensus 11 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~----~~~~~~l~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~ 86 (153)
T 3ox6_A 11 EELREAFREFDKDKDGYINCRDLGNCMRTMGYMPT----EMELIELSQQINMNLGGHVDFDDFVELMGPKLLAETADMIG 86 (153)
T ss_dssp HHHHHHHHHHHHHCSSSCCHHHHHHHHHHTTCCCC----HHHHHHHHHHHHTTSTTCCCHHHHHHHHHHHHTTCCHHHHC
T ss_pred HHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCC----HHHHHHHHHHhCCCCCccCcHHHHHHHHHHHhhcccccccc
Confidence 34678899999999999999999886554322222 34588899999999999999999999882 11
Q ss_pred hH-HHHHHHHHccCCCCceeHHHHHHHHcc
Q 016471 350 PA-AYSLLNDCIRNSDGKLSFLGYKRFLHG 378 (389)
Q Consensus 350 ~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~ 378 (389)
.. +..+|+.+|.+++|.|+.+||..+++.
T Consensus 87 ~~~~~~~F~~~D~d~~G~i~~~el~~~l~~ 116 (153)
T 3ox6_A 87 VKELRDAFREFDTNGDGEISTSELREAMRA 116 (153)
T ss_dssp HHHHHHHHHHHCTTCSSSBCHHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHHHHHH
Confidence 12 888999999999999999999999976
|
| >1k8u_A S100A6, calcyclin, CACY; calcium regulatory protein, calcium free, signaling protein; HET: MSE; 1.15A {Homo sapiens} SCOP: a.39.1.2 PDB: 1k96_A 1k9k_A 1k9p_A 1a03_A 1cnp_A 1jwd_A 2cnp_A 2jtt_A | Back alignment and structure |
|---|
Probab=99.00 E-value=2.9e-10 Score=83.94 Aligned_cols=62 Identities=26% Similarity=0.456 Sum_probs=53.5
Q ss_pred HHHHHHHHHHHc-ccCCC-cccHHHHHHHhC----Cc----hH-HHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 319 DQIAITAFDYFE-QEGNR-VISVEELALELN----LA----PA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 319 ~~~l~~aF~~~D-~d~~G-~I~~~el~~~l~----~~----~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
...++.+|+.|| +|++| +|+.+||+.++. .. .. +.++++.+|.|++|.|+|+||+.++....
T Consensus 9 ~~~l~~~F~~~D~~d~~G~~i~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~~~~ 81 (90)
T 1k8u_A 9 IGLLVAIFHKYSGREGDKHTLSKKELKELIQKELTIGSKLQDAEIARLMEDLDRNKDQEVNFQEYVTFLGALA 81 (90)
T ss_dssp HHHHHHHHHHHHTSSSCTTEEEHHHHHHHHHHHSCCGGGTTSHHHHHHHHHHHHTTTCEEEHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhccCCCCCcCCHHHHHHHHHHhcccCCCCCHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHH
Confidence 356899999999 69999 999999999874 22 11 99999999999999999999999997654
|
| >1k9u_A Polcalcin PHL P 7; pollen allergen, calcium-binding, EF-hand, cross-reactivity; 1.75A {Phleum pratense} SCOP: a.39.1.10 | Back alignment and structure |
|---|
Probab=99.00 E-value=8.7e-10 Score=79.03 Aligned_cols=63 Identities=17% Similarity=0.281 Sum_probs=57.1
Q ss_pred HHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhch
Q 016471 245 YLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSV 309 (389)
Q Consensus 245 ~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~ 309 (389)
.++..|..+|. ++|.|+.+|+..++..++ .++..++..++..+|.+++|.|+|+||+..+...
T Consensus 4 ~l~~~F~~~D~~~~G~i~~~el~~~l~~~g--~~~~~~~~~~~~~~D~~~dg~i~~~ef~~~~~~~ 67 (78)
T 1k9u_A 4 DMERIFKRFDTNGDGKISLSELTDALRTLG--STSADEVQRMMAEIDTDGDGFIDFNEFISFCNAN 67 (78)
T ss_dssp HHHHHHHHHCTTCSSEECHHHHHHHHHHHH--TCCHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHC
T ss_pred HHHHHHHHHCCCCCCcCcHHHHHHHHHHhC--CCCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHC
Confidence 46788999999 999999999999999988 4789999999999999999999999999866554
|
| >3k21_A PFCDPK3, calcium-dependent protein kinase 3; calcium kinase structural genomics malaria, structural genom consortium, SGC, ATP-binding; 1.15A {Plasmodium falciparum} PDB: 3o4y_A | Back alignment and structure |
|---|
Probab=98.99 E-value=1e-09 Score=93.36 Aligned_cols=95 Identities=11% Similarity=0.034 Sum_probs=78.1
Q ss_pred HHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHhCCc----hH-HH
Q 016471 279 DSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALELNLA----PA-AY 353 (389)
Q Consensus 279 ~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~----~~-~~ 353 (389)
..++.++|..+|.+++|.|+.+||..++........ ..+...|+.+|.|++|.|+.+|+..++... .. +.
T Consensus 51 ~~~l~~~F~~~D~d~~G~i~~~El~~~l~~~g~~~~-----~~~~~l~~~~D~d~~g~i~~~EF~~~~~~~~~~~~~~l~ 125 (191)
T 3k21_A 51 VEKLKSTFLVLDEDGKGYITKEQLKKGLEKDGLKLP-----YNFDLLLDQIDSDGSGKIDYTEFIAAALDRKQLSKKLIY 125 (191)
T ss_dssp HHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCC-----TTHHHHHHHHCTTCSSSEEHHHHHHHHSCGGGCCHHHHH
T ss_pred HHHHHHHHHHHCCCCCCCCcHHHHHHHHHHcCCCcH-----HHHHHHHHHhCCCCCCeEeHHHHHHHHHhhhhccHHHHH
Confidence 345778999999999999999999987654322111 236889999999999999999999987322 22 88
Q ss_pred HHHHHHccCCCCceeHHHHHHHHcc
Q 016471 354 SLLNDCIRNSDGKLSFLGYKRFLHG 378 (389)
Q Consensus 354 ~~~~~~d~~~~g~i~~~ef~~~~~~ 378 (389)
.+|+.+|.|++|.|+.+||..+++.
T Consensus 126 ~~F~~~D~d~~G~Is~~El~~~l~~ 150 (191)
T 3k21_A 126 CAFRVFDVDNDGEITTAELAHILYN 150 (191)
T ss_dssp HHHHHHSTTCSSCBCHHHHHHHHHH
T ss_pred HHHHHhCCCCCCcCCHHHHHHHHHh
Confidence 9999999999999999999999976
|
| >3nso_A Protein S100-A3; EF-hand, Ca2+, Zn2+ binding, metal binding protein; 1.45A {Homo sapiens} SCOP: a.39.1.2 PDB: 3nsi_A 1kso_A 3nsk_A 3nsl_A | Back alignment and structure |
|---|
Probab=98.99 E-value=5.8e-10 Score=84.01 Aligned_cols=68 Identities=12% Similarity=0.198 Sum_probs=56.9
Q ss_pred HHHHHHHHHhhhcC-C-CC-CcccHHHHHHHHHH-hc---cccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhc
Q 016471 241 EELVYLRAQFMLLE-P-KD-GCVSLNNFKVALMR-QA---TDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATS 308 (389)
Q Consensus 241 ee~~~l~~~F~~~D-~-~~-G~i~~~el~~~l~~-~~---~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~ 308 (389)
..+..+..+|..+| . ++ |.|+.+||+.+|.. ++ ...++.++++++++.+|.|+||.|+|+||+..+..
T Consensus 7 ~~i~~l~~aF~~fd~~dg~~G~Is~~EL~~~l~~~l~~~lg~~~~~~ev~~~i~~~D~dgDG~Idf~EF~~~~~~ 81 (101)
T 3nso_A 7 QAVAAIVCTFQEYAGRCGDKYKLCQAELKELLQKELATWTPTEFRECDYNKFMSVLDTNKDCEVDFVEYVRSLAC 81 (101)
T ss_dssp HHHHHHHHHHHHHHTTSSCTTEECHHHHHHHHHHHTTTCCCCTTCHHHHHHHHHHHHHCCCSCEEHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhhcCCCCCEECHHHHHHHHHHHhhhhcCCCCCHHHHHHHHHHhCCCCCCCCcHHHHHHHHHH
Confidence 34677889999997 5 55 99999999999986 32 12478999999999999999999999999986543
|
| >3nxa_A Protein S100-A16; S100 family, calcium binding protein, APO, EF-hand calcium binding proteins, S100 proteins, protein dynamics, binding protein; 2.10A {Homo sapiens} SCOP: a.39.1.0 PDB: 2l0u_A 2l0v_A 2l50_A 2l51_A | Back alignment and structure |
|---|
Probab=98.99 E-value=1.8e-09 Score=81.41 Aligned_cols=69 Identities=10% Similarity=0.287 Sum_probs=57.0
Q ss_pred HHHHHHHHHhhhcCC-C---CCcccHHHHHHHHHHhccccCC----HHHHHHHHhhcCCCCCcceeHHHHHHHHhch
Q 016471 241 EELVYLRAQFMLLEP-K---DGCVSLNNFKVALMRQATDAMT----DSRVFEILNVMEPLSDQKLAYEEFCAAATSV 309 (389)
Q Consensus 241 ee~~~l~~~F~~~D~-~---~G~i~~~el~~~l~~~~~~~~~----~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~ 309 (389)
..+..++.+|..+|. + +|.|+.+||+.+|...+...++ ..+++++++.+|.|+||.|+|+||+..+...
T Consensus 8 ~~i~~l~~~F~~fD~~~g~~~G~Is~~EL~~~l~~~~~~~l~~~~~~~ev~~~i~~~D~d~DG~Idf~EF~~~m~~~ 84 (100)
T 3nxa_A 8 KAVIVLVENFYKYVSKYSLVKNKISKSSFREMLQKELNHMLSDTGNRKAADKLIQNLDANHDGRISFDEYWTLIGGI 84 (100)
T ss_dssp HHHHHHHHHHHHTSCTTCSCTTCBCHHHHHHHHHHHSTTTTCSSHHHHHHHHHHHHSCCCSSCCBCHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHcCcCCCCCCeEcHHHHHHHHHHHccccccccccHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHH
Confidence 456678999999998 4 5999999999999876432233 6789999999999999999999999866543
|
| >1yx7_A Calsensin, LAN3-6 antigen; calcium-binding protein EF-hand, helix-loop- helix, nervous system, metal binding protein; NMR {Haemopis marmorata} PDB: 1yx8_A | Back alignment and structure |
|---|
Probab=98.99 E-value=3.2e-10 Score=82.39 Aligned_cols=61 Identities=21% Similarity=0.218 Sum_probs=52.2
Q ss_pred HHHHHHHHHHcccCCCcccHHHHHHHh---C--CchH---HHH----HHHHHccCCCCceeHHHHHHHHcccc
Q 016471 320 QIAITAFDYFEQEGNRVISVEELALEL---N--LAPA---AYS----LLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 320 ~~l~~aF~~~D~d~~G~I~~~el~~~l---~--~~~~---~~~----~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
+.++.+|+.||.|++|+|+.+||+.++ | ...+ +.+ ++..+|.|++|.|+|+||+..+....
T Consensus 7 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~~~~~~D~~~dg~I~~~eF~~~~~~~~ 79 (83)
T 1yx7_A 7 AELEAAFKKLDANGDGYVTALELQTFMVTLDAYKALSKDKVKEASAKLIKMADKNSDGKISKEEFLNANAELL 79 (83)
T ss_dssp THHHHHHHHHSSSCSSSCSHHHHHHHHHHHTTCTTTTTTTTHHHHHHHHTTTCSSSCSCCSHHHHHHHHHHHH
T ss_pred HHHHHHHHHHCCCCCCcCcHHHHHHHHHHHccccCCCHHHHHHHHHHHHHHhCCCCCCCCcHHHHHHhhHHHH
Confidence 458999999999999999999999988 5 3222 777 99999999999999999998876543
|
| >3u0k_A Rcamp; fluorescent protein, calcium binding, EF-hand, genetically E calcium indicator; HET: NFA CRK; 2.10A {Entacmaea quadricolor} | Back alignment and structure |
|---|
Probab=98.99 E-value=9.5e-10 Score=102.55 Aligned_cols=96 Identities=10% Similarity=0.154 Sum_probs=78.7
Q ss_pred HHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHhCC--c----hH-HH
Q 016471 281 RVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALELNL--A----PA-AY 353 (389)
Q Consensus 281 ~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~--~----~~-~~ 353 (389)
++.++|+.+|.|++|.|+.+||..++.......+ ++.+..+|+.+|.|++|.|+.+|+..++.. . .+ +.
T Consensus 303 ELREaF~~fDkDgdG~IS~eELk~aLrsLG~~~T----eeEI~~Lf~~~D~DgDG~IdFeEFl~lms~~lk~~d~eeeLr 378 (440)
T 3u0k_A 303 EFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPT----EAELQDMINEVDADGDGTIDFPEFLIMMARKMKDTDSEEEIR 378 (440)
T ss_dssp HHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCC----HHHHHHHHHHHCSSCSSSEEHHHHHHHHHTC------CHHHH
T ss_pred HHHHHHHHHcCCCCCEECHHHHHHHHHHcCCCCC----HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhcCCChHHHHH
Confidence 3668899999999999999999886654332222 356899999999999999999999988721 1 11 88
Q ss_pred HHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 354 SLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 354 ~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
++|+.+|.|++|.|+.+||..+++...
T Consensus 379 eAFk~fDkDgdG~IS~eELr~vL~~lG 405 (440)
T 3u0k_A 379 EAFRVFDKDGNGYISAAELRHVMTNLG 405 (440)
T ss_dssp HHHHHHCTTCSSEECHHHHHHHHHHHT
T ss_pred HHHHHHCCCCcCcCCHHHHHHHHHHhC
Confidence 899999999999999999999997654
|
| >1rwy_A Parvalbumin alpha; EF-hand, calcium-binding, calcium-binding protein; HET: PG4; 1.05A {Rattus norvegicus} SCOP: a.39.1.4 PDB: 1rtp_1* 2jww_A 3f45_A 1s3p_A 1xvj_A 1rjv_A 1rk9_A 1g33_A | Back alignment and structure |
|---|
Probab=98.98 E-value=1.9e-09 Score=82.55 Aligned_cols=98 Identities=11% Similarity=0.130 Sum_probs=75.7
Q ss_pred cCHHHHHHHHHHhhhcCCCCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhch---hHHHh
Q 016471 238 LTEEELVYLRAQFMLLEPKDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSV---YQLEA 314 (389)
Q Consensus 238 l~~ee~~~l~~~F~~~D~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~---~~~~~ 314 (389)
++.+++. ..|..+| ++|.|+.+||..++... .....++.++|+.+|.+++|.|+.+||..++... .....
T Consensus 6 ~t~~e~~---~~~~~~d-~~g~i~~~eF~~~~~~~---~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~ 78 (109)
T 1rwy_A 6 LSAEDIK---KAIGAFT-AADSFDHKKFFQMVGLK---KKSADDVKKVFHILDKDKSGFIEEDELGSILKGFSSDARDLS 78 (109)
T ss_dssp SCHHHHH---HHHHTTC-STTCCCHHHHHHHHTGG---GSCHHHHHHHHHHHSTTCSSEECHHHHHTHHHHHCTTCCCCC
T ss_pred CCHHHHH---HHHHHcC-CCCcEeHHHHHHHHhcC---cchHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHHhccCCCCC
Confidence 4555544 4555567 89999999998876322 3467889999999999999999999998765543 11112
Q ss_pred hHHHHHHHHHHHHHHcccCCCcccHHHHHHHh
Q 016471 315 LERWDQIAITAFDYFEQEGNRVISVEELALEL 346 (389)
Q Consensus 315 ~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l 346 (389)
++.+..+|+.+|.|++|.|+.+|+..++
T Consensus 79 ----~~~~~~~~~~~D~~~dg~i~~~eF~~~~ 106 (109)
T 1rwy_A 79 ----AKETKTLMAAGDKDGDGKIGVEEFSTLV 106 (109)
T ss_dssp ----HHHHHHHHHHHCTTCSSSEEHHHHHHHH
T ss_pred ----HHHHHHHHHHHCCCCCCcCCHHHHHHHH
Confidence 3458899999999999999999998876
|
| >2pmy_A RAS and EF-hand domain-containing protein; rasef, calcium-binding domain, structural genomics, structural genomics consortium, SGC; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.98 E-value=7.6e-10 Score=82.06 Aligned_cols=71 Identities=15% Similarity=0.261 Sum_probs=62.2
Q ss_pred HHHhcCHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHh
Q 016471 234 LSKALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAAT 307 (389)
Q Consensus 234 i~~~l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~ 307 (389)
+...++.++...++..|..+|. ++|.|+.+||..++..+| ++..++..+|..+|.+++|.|+|+||+..+.
T Consensus 17 ~~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g---~~~~~~~~~~~~~D~d~dg~I~~~EF~~~~~ 88 (91)
T 2pmy_A 17 QGADGDGEELARLRSVFAACDANRSGRLEREEFRALCTELR---VRPADAEAVFQRLDADRDGAITFQEFARGFL 88 (91)
T ss_dssp --CHHHHHHHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHTT---CCHHHHHHHHHHHCTTCSSEECHHHHTHHHH
T ss_pred HhccCCHHHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHcC---cCHHHHHHHHHHhCCCCCCCEeHHHHHHHHH
Confidence 3445667888999999999999 999999999999999886 5788999999999999999999999998543
|
| >2f2o_A Calmodulin fused with calmodulin-binding domain of calcineurin; EF-hands, calcium, metal binding protein; 2.17A {Bos taurus} PDB: 2f2p_A | Back alignment and structure |
|---|
Probab=98.98 E-value=1.3e-09 Score=91.24 Aligned_cols=97 Identities=13% Similarity=0.218 Sum_probs=78.0
Q ss_pred HHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHH
Q 016471 246 LRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAIT 324 (389)
Q Consensus 246 l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~ 324 (389)
+...|..+|. ++|.|+.+||..++............+.++|..+|.+++|.|+.+||...+........ ++.+..
T Consensus 49 ~~~l~~~~D~~~~g~i~~~EF~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~E~~~~l~~~g~~~~----~~~~~~ 124 (179)
T 2f2o_A 49 LQDMINEVDADGNGTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLT----DEEVDE 124 (179)
T ss_dssp HHHHHHHHCTTCSSSBCHHHHHHHHHHHHHHHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHC--CCC----HHHHHH
T ss_pred HHHHHHHhccCCCCCCcHHHHHHHHHHHccCcccHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCC----HHHHHH
Confidence 4567778899 99999999999887655322234567899999999999999999999987654432222 346889
Q ss_pred HHHHHcccCCCcccHHHHHHHh
Q 016471 325 AFDYFEQEGNRVISVEELALEL 346 (389)
Q Consensus 325 aF~~~D~d~~G~I~~~el~~~l 346 (389)
+|+.+|.|++|.|+.+|+..++
T Consensus 125 ~~~~~D~~~dg~i~~~eF~~~~ 146 (179)
T 2f2o_A 125 MIREADIDGDGQVNYEEFVQMM 146 (179)
T ss_dssp HHHHHCTTCSSSEEHHHHHHHS
T ss_pred HHHHcCCCCCCcCcHHHHHHHH
Confidence 9999999999999999999999
|
| >2lmt_A Calmodulin-related protein 97A; spermatogenesis, metal binding protein; NMR {Drosophila melanogaster} PDB: 2lmu_A 2lmv_A | Back alignment and structure |
|---|
Probab=98.97 E-value=1.2e-09 Score=88.86 Aligned_cols=96 Identities=14% Similarity=0.172 Sum_probs=70.4
Q ss_pred HHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHH
Q 016471 247 RAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITA 325 (389)
Q Consensus 247 ~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~a 325 (389)
...+..+|. ++|.|+..|+...+..........+++.++|+.+|.+++|.|+.+||..++.......+ ...+...
T Consensus 49 ~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~El~~~l~~~g~~~~----~~e~~~l 124 (148)
T 2lmt_A 49 QDLIAEAENNNNGQLNFTEFCGIMAKQMRETDTEEEMREAFKIFDRDGDGFISPAELRFVMINLGEKVT----DEEIDEM 124 (148)
T ss_dssp HHHHHHHHTTSTTEEEHHHHHHHHHHTTTTTTTHHHHHHHHHHHHSSCSSEECHHHHHHHHHHHTCCCC----HHHHHHH
T ss_pred HHHHHhcccCCCCcccHHHHHHHHHHHhcccCcHHHHHHHHHHHCCCCcCcCcHHHHHHHHHHcCcccc----HHHHHHH
Confidence 344555677 88888888888776655444456677888888888888889998888776544322222 3457788
Q ss_pred HHHHcccCCCcccHHHHHHHh
Q 016471 326 FDYFEQEGNRVISVEELALEL 346 (389)
Q Consensus 326 F~~~D~d~~G~I~~~el~~~l 346 (389)
|+.+|.|+||.|+.+|+.++|
T Consensus 125 ~~~~D~d~dG~I~~~EF~~~m 145 (148)
T 2lmt_A 125 IREADFDGDGMINYEEFVWMI 145 (148)
T ss_dssp HHHHCCSCCSSEEHHHHHHHH
T ss_pred HHHhCCCCCCeEeHHHHHHHH
Confidence 888888888999988888876
|
| >2lhi_A Calmodulin, serine/threonine-protein phosphatase catalytic subunit A1; yeast calmodulin, CNA1, metal binding protein; NMR {Saccharomyces cerevisiae} | Back alignment and structure |
|---|
Probab=98.97 E-value=1.3e-09 Score=91.43 Aligned_cols=98 Identities=13% Similarity=0.163 Sum_probs=80.0
Q ss_pred HHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHhCC----c-h-H-H
Q 016471 280 SRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALELNL----A-P-A-A 352 (389)
Q Consensus 280 ~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~----~-~-~-~ 352 (389)
+++.++|..+|.+++|.|+++||..++.......+ +..+...|..+|.|++|.|+..|+..++.. . . . +
T Consensus 11 ~elk~~F~~~D~d~dG~I~~~El~~~l~~lg~~~~----~~~~~~~~~~~d~d~~~~i~~~ef~~~~~~~~~~~~~~~~l 86 (176)
T 2lhi_A 11 AEFKEAFALFDKDNNGSISSSELATVMRSLGLSPS----EAEVNDLMNEIDVDGNHQIEFSEFLALMSRQLKSNDSEQEL 86 (176)
T ss_dssp GHHHHHHHTTCSSCSSCBCHHHHHHHHHHHTCCCC----HHHHHHHHTTTCSSCSSSBCTTHHHHHHTSSCCSSHHHHHH
T ss_pred HHHHHHHHHHCCCCCCCCCHHHHHHHHHHcCCChh----HHHHHHHHHHhCcCCCccchHHHHHHHHHHhcccCCcHHHH
Confidence 35778899999999999999999886554322222 456889999999999999999999998832 1 1 1 8
Q ss_pred HHHHHHHccCCCCceeHHHHHHHHccccC
Q 016471 353 YSLLNDCIRNSDGKLSFLGYKRFLHGVTV 381 (389)
Q Consensus 353 ~~~~~~~d~~~~g~i~~~ef~~~~~~~~~ 381 (389)
.++|+.+|.|++|+|+.+||..+|+....
T Consensus 87 ~~aF~~fD~d~~G~I~~~el~~~l~~~g~ 115 (176)
T 2lhi_A 87 LEAFKVFDKNGDGLISAAELKHVLTSIGE 115 (176)
T ss_dssp HHHHHHHCSSCSSSBCHHHHHHHHHTTTC
T ss_pred HHHHHHhCCCCCCcCcHHHHHHHHHHcCc
Confidence 88999999999999999999999987543
|
| >1cb1_A Calbindin D9K; calcium-binding protein; NMR {Sus scrofa} SCOP: a.39.1.1 | Back alignment and structure |
|---|
Probab=98.97 E-value=5e-10 Score=80.23 Aligned_cols=61 Identities=25% Similarity=0.435 Sum_probs=52.9
Q ss_pred HHHHHHHHHHHcc-cCCC-cccHHHHHHHhC------C-chH-HHHHHHHHccCCCCceeHHHHHHHHccc
Q 016471 319 DQIAITAFDYFEQ-EGNR-VISVEELALELN------L-APA-AYSLLNDCIRNSDGKLSFLGYKRFLHGV 379 (389)
Q Consensus 319 ~~~l~~aF~~~D~-d~~G-~I~~~el~~~l~------~-~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~ 379 (389)
...++.+|..||. |++| +|+.+||+.++. . ... +.+++..+|.|++|.|+|+||+.+|...
T Consensus 6 ~~~l~~~F~~~D~~d~~G~~i~~~el~~~l~~~~g~~~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~~~ 76 (78)
T 1cb1_A 6 PAELKSIFEKYAAKEGDPNQLSKEELKQLIQAEFPSLLKGPRTLDDLFQELDKNGDGEVSFEEFQVLVKKI 76 (78)
T ss_dssp HHHHHHHHHHHHTTSSSTTEECHHHHHHHHHHHCSSCCSSCCCSSHHHHHTCCCSSSSEEHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhccCCCcCEeCHHHHHHHHHHHhhhhcccHHHHHHHHHHhcCCCCCCCcHHHHHHHHHHh
Confidence 3568999999999 9999 999999999872 2 222 8999999999999999999999998754
|
| >1rro_A RAT oncomodulin; calcium-binding protein; 1.30A {Rattus rattus} SCOP: a.39.1.4 PDB: 1omd_A 2nln_A 1ttx_A | Back alignment and structure |
|---|
Probab=98.97 E-value=1.8e-09 Score=82.57 Aligned_cols=98 Identities=14% Similarity=0.147 Sum_probs=75.2
Q ss_pred cCHHHHHHHHHHhhhcCCCCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchh---HHHh
Q 016471 238 LTEEELVYLRAQFMLLEPKDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVY---QLEA 314 (389)
Q Consensus 238 l~~ee~~~l~~~F~~~D~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~---~~~~ 314 (389)
.+.+++. ..|..+| ++|.|+.+||..++.. ......++.++|..+|.+++|.|+.+||..++.... ....
T Consensus 6 ~t~~e~~---~~~~~~d-~~g~i~~~eF~~~~~~---~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~ 78 (108)
T 1rro_A 6 LSAEDIA---AALQECQ-DPDTFEPQKFFQTSGL---SKMSASQVKDIFRFIDNDQSGYLDGDELKYFLQKFQSDARELT 78 (108)
T ss_dssp SCHHHHH---HHHHHTC-STTCCCHHHHHHHHSG---GGSCHHHHHHHHHHHCTTCSSEECTHHHHTGGGGTCTTSCCCC
T ss_pred CCHHHHH---HHHHHcc-CCCCcCHHHHHHHHhc---CcccHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhhccCCCC
Confidence 3444444 4455557 7999999999887632 234677899999999999999999999998665441 1112
Q ss_pred hHHHHHHHHHHHHHHcccCCCcccHHHHHHHh
Q 016471 315 LERWDQIAITAFDYFEQEGNRVISVEELALEL 346 (389)
Q Consensus 315 ~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l 346 (389)
++.+..+|+.+|.|++|.|+.+|+..++
T Consensus 79 ----~~~~~~~~~~~D~~~dg~i~~~eF~~~~ 106 (108)
T 1rro_A 79 ----ESETKSLMDAADNDGDGKIGADEFQEMV 106 (108)
T ss_dssp ----HHHHHHHHHHHCCSSSSSEEHHHHHHHH
T ss_pred ----HHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 3468899999999999999999999876
|
| >2l4h_A Calcium and integrin-binding protein 1; metal binding protei; NMR {Homo sapiens} PDB: 2l4i_A 2lm5_A | Back alignment and structure |
|---|
Probab=98.96 E-value=1.9e-09 Score=93.46 Aligned_cols=104 Identities=12% Similarity=0.121 Sum_probs=79.7
Q ss_pred HHhhhcCC-CCCc-ccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhH-----HHhhHHHHH
Q 016471 248 AQFMLLEP-KDGC-VSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQ-----LEALERWDQ 320 (389)
Q Consensus 248 ~~F~~~D~-~~G~-i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~-----~~~~~~~~~ 320 (389)
.+|..+|. ++|. |+.+||..++..........+.+..+|+.+|.+++|.|+.+||..++..... ....+..+.
T Consensus 95 ~lf~~~D~d~dG~~I~f~EF~~~~~~~~~~~~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~~~~~~~~~s~~e~~~ 174 (214)
T 2l4h_A 95 RICRVFSTSPAKDSLSFEDFLDLLSVFSDTATPDIKSHYAFRIFDFDDDGTLNREDLSRLVNCLTGEGEDTRLSASEMKQ 174 (214)
T ss_dssp HHHHHHCCSSSCCSEEHHHHHHHHHHTSSCSCHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHHHSSSCTTCSCTHHHH
T ss_pred HHHHHhCcCCCCCEecHHHHHHHHHHHcCCCCHHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhccccCCCCCHHHHHH
Confidence 35777899 9999 9999999988766432233567999999999999999999999987654432 122221223
Q ss_pred HHHHHHHHHcccCCCcccHHHHHHHhCCchH
Q 016471 321 IAITAFDYFEQEGNRVISVEELALELNLAPA 351 (389)
Q Consensus 321 ~l~~aF~~~D~d~~G~I~~~el~~~l~~~~~ 351 (389)
.+..+|+.+|.|+||.|+.+|+..++...+.
T Consensus 175 ~~~~~~~~~D~d~dG~Is~~EF~~~~~~~p~ 205 (214)
T 2l4h_A 175 LIDNILEESDIDRDGTINLSEFQHVISRSPD 205 (214)
T ss_dssp HHHHHHHHHCCSCCSSBCSHHHHHHHHTCHH
T ss_pred HHHHHHHHhCCCCCCcCCHHHHHHHHHhChH
Confidence 3556999999999999999999999865555
|
| >4eto_A Protein S100-A4; calcium-binding protein, EF-hand, structural genomics, PSI-B protein structure initiative, NEW YORK structural genomics consortium; 1.54A {Homo sapiens} PDB: 1m31_A 2q91_A 3cga_A 3ko0_A* 3m0w_A* | Back alignment and structure |
|---|
Probab=98.96 E-value=1.7e-09 Score=80.37 Aligned_cols=69 Identities=12% Similarity=0.268 Sum_probs=56.0
Q ss_pred HHHHHHHHHhhhcC-C-C-CCcccHHHHHHHHHH-hcc---ccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhch
Q 016471 241 EELVYLRAQFMLLE-P-K-DGCVSLNNFKVALMR-QAT---DAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSV 309 (389)
Q Consensus 241 ee~~~l~~~F~~~D-~-~-~G~i~~~el~~~l~~-~~~---~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~ 309 (389)
..+..+..+|..+| . + +|+|+.+||+.++.. ++. ...++.+++++++.+|.|+||.|+|+||+..+...
T Consensus 7 ~~~~~l~~~F~~fd~~dg~~G~Is~~EL~~~l~~~lg~~l~~~~~~~ev~~~i~~~D~d~DG~Idf~EF~~~~~~~ 82 (93)
T 4eto_A 7 KALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSNRDNEVDFQEYCVFLSCI 82 (93)
T ss_dssp HHHHHHHHHHHHHHTSSSSTTSBCHHHHHHHHHHHCGGGC---CCHHHHHHHHHHHCTTSSSSBCHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHcccCCCCCeECHHHHHHHHHHHhhhhccCCCCHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHH
Confidence 45677889999997 4 4 489999999999985 542 23578899999999999999999999999865543
|
| >1k2h_A S100A1, S-100 protein, alpha chain; non-covalent homodimer, X-type four-helix bundle, metal binding protein; NMR {Rattus norvegicus} SCOP: a.39.1.2 PDB: 1zfs_A 2k2f_A 2kbm_A 2l0p_A 2jpt_A | Back alignment and structure |
|---|
Probab=98.96 E-value=4.9e-10 Score=83.36 Aligned_cols=62 Identities=21% Similarity=0.346 Sum_probs=53.8
Q ss_pred HHHHHHHHHHHc-ccCCC-cccHHHHHHHhCC----------chH-HHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 319 DQIAITAFDYFE-QEGNR-VISVEELALELNL----------APA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 319 ~~~l~~aF~~~D-~d~~G-~I~~~el~~~l~~----------~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
.+.++.+|+.|| +|++| +|+.+||+.++.. ... +.+++..+|.|++|.|+|+||+.+|....
T Consensus 8 ~~~l~~~F~~~D~~d~~G~~I~~~el~~~l~~~~~~~~g~~~~~~~~~~~~~~~D~d~dg~i~~~eF~~~~~~~~ 82 (93)
T 1k2h_A 8 METLINVFHAHSGKEGDKYKLSKKELKDLLQTELSSFLDVQKDADAVDKIMKELDENGDGEVDFQEFVVLVAALT 82 (93)
T ss_dssp HHHHHHHHHHHHTTSSCCSSCCHHHHHHHHHHHTHHHHHCCCCHHHHHHHHHHHHHCTTSCCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHcccCCCcCccCHHHHHHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHH
Confidence 456899999999 79999 9999999998732 222 89999999999999999999999997754
|
| >2lnk_A Protein S100-A4; EF-hand, calcium binding, all alpha, metal binding protein, binding protein; NMR {Homo sapiens} PDB: 3c1v_A | Back alignment and structure |
|---|
Probab=98.96 E-value=1.9e-09 Score=82.90 Aligned_cols=68 Identities=15% Similarity=0.306 Sum_probs=57.5
Q ss_pred HHHHHHHHHHhhhcC-C-CCC-cccHHHHHHHHHH-----hccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhc
Q 016471 240 EEELVYLRAQFMLLE-P-KDG-CVSLNNFKVALMR-----QATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATS 308 (389)
Q Consensus 240 ~ee~~~l~~~F~~~D-~-~~G-~i~~~el~~~l~~-----~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~ 308 (389)
..+...++.+|..+| . ++| .|+.+||+.+|.. ++. .++++++.++++.+|.|+||.|+|+||+..+..
T Consensus 18 ~~~~~~l~~aF~~fD~~dgdGG~Is~~EL~~~l~~~l~~~lg~-~~t~~ev~~li~~~D~dgdG~Idf~EF~~~m~~ 93 (113)
T 2lnk_A 18 EKALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGK-RTDEAAFQKLMSNLDSNRDNEVDFQEYCVFLSC 93 (113)
T ss_dssp HHHHHHHHHHHHHTTTTTSCTTCBCHHHHHHHHHHHCGGGGTT-CCCTTHHHHHHHHHCSSSSSCBCHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHcccCCCCCEECHHHHHHHHHHHcchhcCC-CCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHH
Confidence 345677899999999 7 776 9999999999976 443 367889999999999999999999999986543
|
| >1pva_A Parvalbumin; calcium binding; 1.65A {Esox lucius} SCOP: a.39.1.4 PDB: 2pas_A 3pat_A | Back alignment and structure |
|---|
Probab=98.96 E-value=2.7e-09 Score=81.88 Aligned_cols=98 Identities=13% Similarity=0.180 Sum_probs=75.3
Q ss_pred cCHHHHHHHHHHhhhcCCCCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhch---hHHHh
Q 016471 238 LTEEELVYLRAQFMLLEPKDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSV---YQLEA 314 (389)
Q Consensus 238 l~~ee~~~l~~~F~~~D~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~---~~~~~ 314 (389)
++.+++.. .|..+| ++|.|+.+||..++.. ......++.++|..+|.+++|.|+.+||..++... .....
T Consensus 7 ~t~~e~~~---~~~~~d-~~g~i~~~ef~~~~~~---~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~ 79 (110)
T 1pva_A 7 LKADDIKK---ALDAVK-AEGSFNHKKFFALVGL---KAMSANDVKKVFKAIDADASGFIEEEELKFVLKSFAADGRDLT 79 (110)
T ss_dssp SCHHHHHH---HHHHTC-STTCCCHHHHHHHHTC---TTSCHHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTCCCCC
T ss_pred CCHHHHHH---HHHhcC-CCCcCcHHHHHHHHcc---CcchHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhhcCCCCC
Confidence 45555544 445556 7999999999887632 23467789999999999999999999999866544 11112
Q ss_pred hHHHHHHHHHHHHHHcccCCCcccHHHHHHHh
Q 016471 315 LERWDQIAITAFDYFEQEGNRVISVEELALEL 346 (389)
Q Consensus 315 ~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l 346 (389)
++.+..+|+.+|.|++|.|+.+|+..++
T Consensus 80 ----~~~~~~~~~~~d~~~dg~i~~~eF~~~~ 107 (110)
T 1pva_A 80 ----DAETKAFLKAADKDGDGKIGIDEFETLV 107 (110)
T ss_dssp ----HHHHHHHHHHHCTTCSSSBCHHHHHHHH
T ss_pred ----HHHHHHHHHHhCCCCCCeEcHHHHHHHH
Confidence 3458899999999999999999998876
|
| >1c07_A Protein (epidermal growth factor receptor pathway substrate 15); calcium binding, signaling domain, NPF binding, FW binding, EF-hand, EH domain; NMR {Homo sapiens} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=98.95 E-value=9.4e-10 Score=82.27 Aligned_cols=67 Identities=16% Similarity=0.232 Sum_probs=60.0
Q ss_pred cCHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHh
Q 016471 238 LTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAAT 307 (389)
Q Consensus 238 l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~ 307 (389)
++.++...++.+|..+|. ++|.|+.+|++.+++.++ ++.+++.+++..+|.+++|.|+|+||+.++.
T Consensus 4 ls~~~~~~~~~~F~~~D~d~dG~I~~~el~~~l~~~g---~~~~~~~~i~~~~D~d~dG~i~~~EF~~~~~ 71 (95)
T 1c07_A 4 VSPAEKAKYDEIFLKTDKDMDGFVSGLEVREIFLKTG---LPSTLLAHIWSLCDTKDCGKLSKDQFALAFH 71 (95)
T ss_dssp SCSHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHTTT---CCHHHHHHHHHHHCTTCSSSEETTTHHHHHH
T ss_pred CCHHHHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHcC---CCHHHHHHHHHHHCCCCCCcCCHHHHHHHHH
Confidence 456678889999999999 999999999999998875 5788999999999999999999999998654
|
| >3zwh_A Protein S100-A4; Ca-binding protein-motor protein complex, S100 proteins, EF-; 1.94A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.95 E-value=2e-09 Score=81.67 Aligned_cols=70 Identities=14% Similarity=0.291 Sum_probs=57.0
Q ss_pred HHHHHHHHHHhhhcC-C-C-CCcccHHHHHHHHHH-hcc---ccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhch
Q 016471 240 EEELVYLRAQFMLLE-P-K-DGCVSLNNFKVALMR-QAT---DAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSV 309 (389)
Q Consensus 240 ~ee~~~l~~~F~~~D-~-~-~G~i~~~el~~~l~~-~~~---~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~ 309 (389)
+..+..+..+|..+| . + +|.|+.+||+.+|.. ++. ...+..+++++++.+|.|+||.|+|+||+.++...
T Consensus 9 e~~~~~l~~aF~~fD~~dgd~G~Is~~EL~~~l~~~lg~~l~~~~~~~ev~~~i~~~D~dgDG~Idf~EF~~~m~~~ 85 (104)
T 3zwh_A 9 EKALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSWLGKRTDEAAFQKLMSNLDSNRDNEVDFQEYCVFLSSI 85 (104)
T ss_dssp HHHHHHHHHHHHHHHTSSSSTTSBCHHHHHHHHHHHCGGGSCSSCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhccCCCCCeECHHHHHHHHHHHcchhccCCCCHHHHHHHHHHHcCCCCCCCcHHHHHHHHHHH
Confidence 345677889999997 4 4 389999999999986 542 23578999999999999999999999999865543
|
| >1top_A Troponin C; contractIle system protein; 1.78A {Gallus gallus} SCOP: a.39.1.5 PDB: 1ncy_A 1ncz_A 1ncx_A 1ytz_C* 1yv0_C 1tnw_A 1tnx_A 5tnc_A 2w49_0 2w4u_0 4tnc_A 1a2x_A 1tcf_A 1tn4_A 2tn4_A 1aj4_A 1jc2_A 1fi5_A 1sbj_A 1scv_A ... | Back alignment and structure |
|---|
Probab=98.95 E-value=1.9e-09 Score=88.53 Aligned_cols=97 Identities=12% Similarity=0.206 Sum_probs=77.0
Q ss_pred HHHHhhhcCC-CCCcccHHHHHHHHHHhccccC---CHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHH
Q 016471 246 LRAQFMLLEP-KDGCVSLNNFKVALMRQATDAM---TDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQI 321 (389)
Q Consensus 246 l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~---~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~ 321 (389)
+...|..+|. ++|.|+.+||..++........ ....+..+|+.+|.+++|.|+.+||..++........ ++.
T Consensus 58 ~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~e~~~~l~~~g~~~~----~~~ 133 (162)
T 1top_A 58 LDAIIEEVDEDGSGTIDFEEFLVMMVRQMKEDAKGKSEEELANCFRIFDKNADGFIDIEELGEILRATGEHVT----EED 133 (162)
T ss_dssp HHHHHHHHCTTSCCEEEHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHTTTCCCC----HHH
T ss_pred HHHHHHHHcCCCCCcEeHHHHHHHHHHHhccccccccHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCC----HHH
Confidence 3456777898 8999999999988765432111 4567899999999999999999999987655432222 345
Q ss_pred HHHHHHHHcccCCCcccHHHHHHHh
Q 016471 322 AITAFDYFEQEGNRVISVEELALEL 346 (389)
Q Consensus 322 l~~aF~~~D~d~~G~I~~~el~~~l 346 (389)
+..+|..+|.|++|.|+.+|+..++
T Consensus 134 ~~~~~~~~d~~~dg~i~~~eF~~~~ 158 (162)
T 1top_A 134 IEDLMKDSDKNNDGRIDFDEFLKMM 158 (162)
T ss_dssp HHHHHHHHCTTCSSSBCHHHHHHHH
T ss_pred HHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 8899999999999999999999886
|
| >1dgu_A Calcium-saturated CIB; helical, EF-hands, blood clotting; NMR {Homo sapiens} SCOP: a.39.1.5 PDB: 1dgv_A 1xo5_A 1y1a_A* | Back alignment and structure |
|---|
Probab=98.95 E-value=4.6e-09 Score=88.40 Aligned_cols=103 Identities=12% Similarity=0.124 Sum_probs=77.4
Q ss_pred HhhhcCC-CCCc-ccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhH-----HHhhHHHHHH
Q 016471 249 QFMLLEP-KDGC-VSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQ-----LEALERWDQI 321 (389)
Q Consensus 249 ~F~~~D~-~~G~-i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~-----~~~~~~~~~~ 321 (389)
+|..+|. ++|. |+.+||..++............+..+|..+|.+++|.|+.+||..++..... ....+..+..
T Consensus 65 l~~~~D~d~~G~~I~~~EF~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~ 144 (183)
T 1dgu_A 65 ICRVFSTSPAKDSLSFEDFLDLLSVFSDTATPDIKSHYAFRIFDFDDDGTLNREDLSRLVNCLTGEGEDTRLSASEMKQL 144 (183)
T ss_dssp HHHHHSCSSSSCCCCHHHHHHHHHHHSTTCCHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHSSSCCCHHHHHHHHHH
T ss_pred HHHHhCCCCCCCEecHHHHHHHHHHhcCCCCHHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhcccccCCCCHHHHHHH
Confidence 4555688 8999 9999999988766433233567999999999999999999999887654422 1221111222
Q ss_pred HHHHHHHHcccCCCcccHHHHHHHhCCchH
Q 016471 322 AITAFDYFEQEGNRVISVEELALELNLAPA 351 (389)
Q Consensus 322 l~~aF~~~D~d~~G~I~~~el~~~l~~~~~ 351 (389)
+..+|..+|.|++|.|+.+|+..++...+.
T Consensus 145 ~~~~~~~~D~d~dG~I~~~EF~~~~~~~~~ 174 (183)
T 1dgu_A 145 IDNILEESDIDRDGTINLSEFQHVISRSPD 174 (183)
T ss_dssp HHHHHHHHCTTSSSEEEHHHHHHHHCSSCH
T ss_pred HHHHHHHhCCCCCCeEcHHHHHHHHHhChH
Confidence 345999999999999999999999865544
|
| >2h2k_A Protein S100-A13; calcium binding protein, metal binding protein; 2.00A {Homo sapiens} PDB: 1yur_A 1yus_A 1yut_A 1yuu_A 2egd_A 2k8m_B 2ki4_B* 2ki6_C* 2kot_A* 2l5x_B 2cxj_A | Back alignment and structure |
|---|
Probab=98.95 E-value=9.1e-10 Score=83.87 Aligned_cols=70 Identities=14% Similarity=0.203 Sum_probs=56.4
Q ss_pred HHHHHHHHHhhhcC-C-CC-CcccHHHHHHHHHH-hccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchh
Q 016471 241 EELVYLRAQFMLLE-P-KD-GCVSLNNFKVALMR-QATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVY 310 (389)
Q Consensus 241 ee~~~l~~~F~~~D-~-~~-G~i~~~el~~~l~~-~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~ 310 (389)
+++..++.+|..+| . ++ |.|+.+||+.+|.. ++....+..++.+++..+|.|+||.|+|+||+..+....
T Consensus 19 ~~~~~l~~aF~~fD~~dg~~G~Is~~EL~~~l~~~lg~~~~~~~ev~~li~~~D~d~dG~Idf~EF~~~~~~~~ 92 (106)
T 2h2k_A 19 ESIETVVTTFFTFARQEGRKDSLSVNEFKELVTQQLPHLLKDVGSLDEKMKSLDVNQDSELKFNEYWRLIGELA 92 (106)
T ss_dssp HHHHHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHCTTTTTTCCCHHHHHHHHCTTCSSSEEHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHcccCCCCCEECHHHHHHHHHHHcCcCCCCHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHHH
Confidence 34667899999999 6 54 79999999999976 453222346799999999999999999999998766543
|
| >2bec_A Calcineurin B homologous protein 2; calcineurin-homologous protein, calcium-binding protein, NHE1 regulating protein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.94 E-value=2e-09 Score=92.26 Aligned_cols=101 Identities=14% Similarity=0.104 Sum_probs=76.3
Q ss_pred HHHHhhhcCC-CCCcccHHHHHHHHHHhcc----------------ccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhc
Q 016471 246 LRAQFMLLEP-KDGCVSLNNFKVALMRQAT----------------DAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATS 308 (389)
Q Consensus 246 l~~~F~~~D~-~~G~i~~~el~~~l~~~~~----------------~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~ 308 (389)
+...|..+|. ++|.|+.+||..++..... .......+..+|..+|.+++|.|+.+||..++..
T Consensus 63 ~~~l~~~~D~d~dg~i~~~EF~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~ 142 (202)
T 2bec_A 63 GDRIIESFFPDGSQRVDFPGFVRVLAHFRPVEDEDTETQDPKKPEPLNSRRNKLHYAFQLYDLDRDGKISRHEMLQVLRL 142 (202)
T ss_dssp HHHHHHTTSCSSCCCCCHHHHHHHHGGGSCCCHHHHC-----CCCCTTSHHHHHHHHHHHHCTTCSSEECHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCCcCcHHHHHHHHHHhcccchhcccccccccccccccHHHHHHHHHHHhCCCCCCeEcHHHHHHHHHH
Confidence 5567888999 9999999999998865542 2234667899999999999999999999987654
Q ss_pred h-hHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHh
Q 016471 309 V-YQLEALERWDQIAITAFDYFEQEGNRVISVEELALEL 346 (389)
Q Consensus 309 ~-~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l 346 (389)
. ......+..+..+..+|+.+|.|+||.|+.+|+..++
T Consensus 143 ~~g~~~~~~~~~~~~~~~~~~~D~d~dG~Is~~EF~~~~ 181 (202)
T 2bec_A 143 MVGVQVTEEQLENIADRTVQEADEDGDGAVSFVEFTKSL 181 (202)
T ss_dssp SCCSCCCHHHHHHHHHHHHHHHCSSCSSSEEHHHHHHTT
T ss_pred hcCCCCCHHHHHHHHHHHHHHcCCCCCCcCcHHHHHHHH
Confidence 3 2111211112334455555999999999999999988
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=98.94 E-value=1.8e-09 Score=105.41 Aligned_cols=100 Identities=12% Similarity=0.091 Sum_probs=78.1
Q ss_pred HHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHH----h---hHHHHHHHHHHHHHHcccCCCcccHHHHHHHhCCc--
Q 016471 279 DSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLE----A---LERWDQIAITAFDYFEQEGNRVISVEELALELNLA-- 349 (389)
Q Consensus 279 ~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~----~---~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~-- 349 (389)
.+++.++|..+|.|++|.|+++||..++....... . ....+..+..+|+.+|.|++|.|+.+|+..++...
T Consensus 334 ~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~D~d~~g~i~~~Ef~~~~~~~~~ 413 (484)
T 3nyv_A 334 TKELTAIFHKMDKNGDGQLDRAELIEGYKELMRMKGQDASMLDASAVEHEVDQVLDAVDFDKNGYIEYSEFVTVAMDRKT 413 (484)
T ss_dssp HHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHC----CGGGCSHHHHHHHHHHHHHHHTCCTTSEEEHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhCcCCCceEeHHHHHHHHHHHhhhcccccccccccccHHHHHHHHHHhCCCCCCeEeHHHHHHHHHhccc
Confidence 45688999999999999999999965443221110 0 00114568999999999999999999999987321
Q ss_pred ---hH-HHHHHHHHccCCCCceeHHHHHHHHcc
Q 016471 350 ---PA-AYSLLNDCIRNSDGKLSFLGYKRFLHG 378 (389)
Q Consensus 350 ---~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~ 378 (389)
.+ +.++|+.+|.|+||.|+.+||..++..
T Consensus 414 ~~~~~~~~~~F~~~D~d~dG~I~~~El~~~l~~ 446 (484)
T 3nyv_A 414 LLSRERLERAFRMFDSDNSGKISSTELATIFGV 446 (484)
T ss_dssp HHHHHHHHHHHHHHCTTCCSEEEHHHHHHHHHH
T ss_pred cCcHHHHHHHHHHHCCCCCCcCCHHHHHHHHHh
Confidence 12 889999999999999999999999975
|
| >1m45_A MLC1P, myosin light chain; protein-peptide complex, myosin light chain, cell cycle protein; 1.65A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 1m46_A 1n2d_A 2fcd_A 2fce_A | Back alignment and structure |
|---|
Probab=98.94 E-value=2.1e-09 Score=86.99 Aligned_cols=97 Identities=10% Similarity=0.073 Sum_probs=76.7
Q ss_pred HHHHhhhc-CC-CCCcccHHHHHHHHHHh--c---cccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHH
Q 016471 246 LRAQFMLL-EP-KDGCVSLNNFKVALMRQ--A---TDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERW 318 (389)
Q Consensus 246 l~~~F~~~-D~-~~G~i~~~el~~~l~~~--~---~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~ 318 (389)
+...|..+ |. ++|.|+.+||..++... . ........+..+|..+|.+++|.|+.+||..++.......+
T Consensus 42 ~~~l~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~---- 117 (148)
T 1m45_A 42 VQDIINADSSLRDASSLTLDQITGLIEVNEKELDATTKAKTEDFVKAFQVFDKESTGKVSVGDLRYMLTGLGEKLT---- 117 (148)
T ss_dssp HHHHHHC--CC--CCEEEHHHHHHHHHHTHHHHHGGGCCCTHHHHHHHHTTCSSSSSEEEHHHHHHHHHHSTTCCC----
T ss_pred HHHHHHHhhCCCCCCeEcHHHHHHHHHHHHhhccccccccHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCCCCC----
Confidence 45567788 99 99999999999988766 1 22345678999999999999999999999987654422222
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHh
Q 016471 319 DQIAITAFDYFEQEGNRVISVEELALEL 346 (389)
Q Consensus 319 ~~~l~~aF~~~D~d~~G~I~~~el~~~l 346 (389)
++.+..+|+.+|.|++|.|+.+|+..++
T Consensus 118 ~~~~~~~~~~~d~d~dg~i~~~eF~~~~ 145 (148)
T 1m45_A 118 DAEVDELLKGVEVDSNGEIDYKKFIEDV 145 (148)
T ss_dssp HHHHHHHHTTCCCCTTSEEEHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCeEeHHHHHHHH
Confidence 3468899999999999999999999876
|
| >3rm1_A Protein S100-B; alpha-helical, EF hand, metal binding protein-protein bindin; 1.24A {Bos taurus} PDB: 3rlz_A 1cfp_A 3cr2_A 3cr4_X* 3cr5_X* 3gk1_A* 3gk2_A* 3gk4_X* 3iqo_A 3iqq_A 3lle_A* 1psb_A 3czt_X 2h61_A 3d0y_A* 3d10_A* 3hcm_A* 3lk1_A* 3lk0_A* 1b4c_A ... | Back alignment and structure |
|---|
Probab=98.94 E-value=2.3e-09 Score=79.64 Aligned_cols=68 Identities=15% Similarity=0.237 Sum_probs=57.8
Q ss_pred HHHHHHHHHhhhcCCCCC---cccHHHHHHHHHH-----hccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhch
Q 016471 241 EELVYLRAQFMLLEPKDG---CVSLNNFKVALMR-----QATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSV 309 (389)
Q Consensus 241 ee~~~l~~~F~~~D~~~G---~i~~~el~~~l~~-----~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~ 309 (389)
..+..++.+|..+|.++| .|+.+||+.+|.. ++. .++..++.++++.+|.|+||.|+|+||+..+...
T Consensus 6 ~~~~~l~~~F~~~D~~dG~~g~Is~~EL~~~l~~~~~~~lg~-~~~~~~v~~~~~~~D~d~dG~I~f~EF~~~~~~l 81 (92)
T 3rm1_A 6 KAVVALIDVFHQYSGREGDKHKLKKSELKELINNELSHFLEE-IKEQEVVDKVMETLDSNGDGECDFQEFMAFVAMI 81 (92)
T ss_dssp HHHHHHHHHHHHHHTSSSSTTSBCHHHHHHHHHHHCTTTSCC-CCSHHHHHHHHHHHCTTSSSSBCHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHccCCCCcCeECHHHHHHHHHHHhhhhccC-cccHHHHHHHHHHHcCCCCCCCcHHHHHHHHHHH
Confidence 456678899999986445 9999999999998 665 4789999999999999999999999999865543
|
| >2bl0_B Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} | Back alignment and structure |
|---|
Probab=98.93 E-value=2.4e-09 Score=86.20 Aligned_cols=97 Identities=10% Similarity=0.118 Sum_probs=77.4
Q ss_pred CCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHhCCc----h--
Q 016471 277 MTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALELNLA----P-- 350 (389)
Q Consensus 277 ~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~----~-- 350 (389)
++++++.++|..+|.+++|.|+.+||..++........ ...+...|.. |++|.|+.+|+..++... .
T Consensus 2 ls~~el~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~----~~~~~~~~~~---~~~g~i~~~eF~~~~~~~~~~~~~~ 74 (145)
T 2bl0_B 2 ASADQIQECFQIFDKDNDGKVSIEELGSALRSLGKNPT----NAELNTIKGQ---LNAKEFDLATFKTVYRKPIKTPTEQ 74 (145)
T ss_dssp CCHHHHHHHHHHHCTTCSSCEEGGGHHHHHHHTTCCCC----HHHHHHHHHH---HTSSEECHHHHHHHHTSCCCCGGGG
T ss_pred CCHHHHHHHHHHhCCCCcCccCHHHHHHHHHHhCCCCC----HHHHHHHHHh---cCCCeEcHHHHHHHHHHHhhcCccc
Confidence 45667999999999999999999999886554322122 2346666666 899999999999988432 1
Q ss_pred -H-HHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 351 -A-AYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 351 -~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
. +..+|+.+|.|++|.|+.+||..+++...
T Consensus 75 ~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~g 106 (145)
T 2bl0_B 75 SKEMLDAFRALDKEGNGTIQEAELRQLLLNLG 106 (145)
T ss_dssp HHHHHHHHHHHCSSSSSEEEHHHHHHHHHHSS
T ss_pred HHHHHHHHHHhCCCCCCeEcHHHHHHHHHHcC
Confidence 1 88999999999999999999999997654
|
| >1j7q_A CAVP, calcium vector protein; EF-hand family, calcium binding protein, metal binding protein; NMR {Branchiostoma lanceolatum} SCOP: a.39.1.5 PDB: 1j7r_A | Back alignment and structure |
|---|
Probab=98.92 E-value=1.1e-09 Score=80.13 Aligned_cols=61 Identities=8% Similarity=0.054 Sum_probs=52.6
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHh---CCc---hH---HHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 319 DQIAITAFDYFEQEGNRVISVEELALEL---NLA---PA---AYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 319 ~~~l~~aF~~~D~d~~G~I~~~el~~~l---~~~---~~---~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
...++.+|..||+|++|+|+.+||+.++ |.. .. +.+++..+|.+++|.|+| ||+.++.+..
T Consensus 13 ~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~~~~d~~~~g~i~~-eF~~~~~~~~ 82 (86)
T 1j7q_A 13 KDECMKIFDIFDRNAENIAPVSDTMDMLTKLGQTYTKRETEAIMKEARGPKGDKKNIGPE-EWLTLCSKWV 82 (86)
T ss_dssp HHHHHHHHHHHSTTTTSCBCHHHHHHHHHHTSCCCSHHHHHHHHHHHHCSSCSSCCBCTT-HHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHcCCCCHHHHHHHHHHHHHhCCCCCCcCCH-HHHHHHHHHH
Confidence 3568999999999999999999999988 432 23 778999999999999999 9999987643
|
| >1qls_A S100C protein, calgizzarin; metal-binding protein/inhibitor, S100 family, EF-hand protein, complex (ligand/annexin), ligand of annexin II; 2.3A {Sus scrofa} SCOP: a.39.1.2 PDB: 1nsh_A | Back alignment and structure |
|---|
Probab=98.92 E-value=3.2e-09 Score=79.90 Aligned_cols=62 Identities=24% Similarity=0.403 Sum_probs=53.8
Q ss_pred HHHHHHHHHHHc-ccCCC-cccHHHHHHHhCC-c---------hH-HHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 319 DQIAITAFDYFE-QEGNR-VISVEELALELNL-A---------PA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 319 ~~~l~~aF~~~D-~d~~G-~I~~~el~~~l~~-~---------~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
...++.+|..|| +|++| +|+.+||+.++.. . .. +.++++.+|.|++|.|+|+||+.++....
T Consensus 12 ~~~l~~~F~~~Dd~d~~G~~I~~~el~~~l~~~~~~~~~~~~~~~~~~~l~~~~D~~~dg~I~~~EF~~~~~~~~ 86 (99)
T 1qls_A 12 IESLIAIFQKHAGRDGNNTKISKTEFLIFMNTELAAFTQNQKDPGVLDRMMKKLDLDSDGQLDFQEFLNLIGGLA 86 (99)
T ss_dssp HHHHHHHHHHHHTTSSCTTCBCHHHHHHHHTTTSHHHHHHCCCTHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCcCeeCHHHHHHHHHHHcchhccccCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHH
Confidence 456899999998 99999 9999999999952 1 12 89999999999999999999999987643
|
| >2kgr_A Intersectin-1; structure, alternative splicing, calcium, cell junction, cell projection, coiled coil, endocytosis, membrane, phosphoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.91 E-value=4.3e-09 Score=81.06 Aligned_cols=67 Identities=21% Similarity=0.266 Sum_probs=59.5
Q ss_pred cCHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHh
Q 016471 238 LTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAAT 307 (389)
Q Consensus 238 l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~ 307 (389)
++.++...++.+|..+|. ++|.|+.+|++.+|. +. .++.+++.+++..+|.+++|.|+|+||+.++.
T Consensus 8 ls~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~--~~-~~~~~~~~~i~~~~D~d~dG~I~~~EF~~~~~ 75 (111)
T 2kgr_A 8 VPQSSRLKYRQLFNSHDKTMSGHLTGPQARTILM--QS-SLPQAQLASIWNLSDIDQDGKLTAEEFILAMH 75 (111)
T ss_dssp SCHHHHHHHHHHHHTTSCSSCCEEEHHHHHHHHH--TT-CCCHHHHHHHHHHHCSSCCSEEEHHHHHHHHH
T ss_pred CCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHH--hC-CCCHHHHHHHHHHHCCCCCCCCcHHHHHHHHH
Confidence 466778889999999999 999999999999997 33 47889999999999999999999999998644
|
| >1j55_A S-100P protein; metal binding protein; 2.00A {Homo sapiens} SCOP: a.39.1.2 PDB: 1ozo_A | Back alignment and structure |
|---|
Probab=98.91 E-value=2.6e-09 Score=79.79 Aligned_cols=67 Identities=12% Similarity=0.209 Sum_probs=53.3
Q ss_pred HHHHHHHHHhhhcC-C-C-CCcccHHHHHHHHHH-----hccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhc
Q 016471 241 EELVYLRAQFMLLE-P-K-DGCVSLNNFKVALMR-----QATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATS 308 (389)
Q Consensus 241 ee~~~l~~~F~~~D-~-~-~G~i~~~el~~~l~~-----~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~ 308 (389)
+++..++.+|..+| . + +|.|+.+||+.+|+. ++. .++..++.+++..+|.|++|.|+|+||+..+..
T Consensus 6 ~~~~~l~~~F~~fD~~dgd~G~I~~~El~~~l~~~~~~~lg~-~~~~~~v~~l~~~~D~d~dG~I~f~EF~~~~~~ 80 (95)
T 1j55_A 6 TAMGMIIDVFSRYSGSEGSTQTLTKGELKVLMEKELPGFLQS-GKDKDAVDKLLKDLDANGDAQVDFSEFIVFVAA 80 (95)
T ss_dssp HHHHHHHHHHHHHTTSSSCTTEECHHHHHHHHHHHSTTCC-------CHHHHHHHHHCSSSSSSEEHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhccCCCCCcCCHHHHHHHHHHHhHhhccc-ccCHHHHHHHHHHhCCCCCCcCCHHHHHHHHHH
Confidence 45677899999999 6 5 589999999999986 333 357788999999999999999999999986543
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 389 | ||||
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-56 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-56 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-56 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-53 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-53 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-51 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-51 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-51 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-47 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-47 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-46 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-46 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-45 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-44 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-43 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-42 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-42 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-41 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-41 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 6e-41 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-40 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-39 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-39 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-38 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-38 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-38 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-38 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 9e-38 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-37 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-36 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-36 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 8e-36 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-35 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-34 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-33 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-33 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 7e-33 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 8e-33 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-32 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-32 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-32 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 8e-32 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 9e-32 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 9e-31 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-30 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 8e-30 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-29 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-29 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-29 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-28 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-27 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-27 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-26 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-26 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-26 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 8e-25 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-24 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-24 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-23 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-23 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-22 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-09 | |
| d1lkja_ | 146 | a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharom | 2e-08 | |
| d1topa_ | 162 | a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) | 3e-08 | |
| d1dtla_ | 156 | a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) | 2e-07 | |
| d1s6ja_ | 87 | a.39.1.5 (A:) Calcium-dependent protein kinase sk5 | 6e-06 | |
| d1g8ia_ | 187 | a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1 | 8e-06 | |
| d1exra_ | 146 | a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetr | 3e-05 | |
| d2jxca1 | 95 | a.39.1.6 (A:121-215) Eps15 {Human (Homo sapiens) [ | 6e-05 | |
| d1wrka1 | 82 | a.39.1.5 (A:4-85) Troponin C {Human (Homo sapiens) | 2e-04 | |
| d1f54a_ | 77 | a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharom | 7e-04 | |
| d1c7va_ | 68 | a.39.1.5 (A:) Calcium vector protein {Amphioxus (B | 8e-04 | |
| d1avsa_ | 81 | a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) | 0.001 | |
| d2pq3a1 | 73 | a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [T | 0.003 | |
| d1s6ia_ | 182 | a.39.1.5 (A:) Calcium-dependent protein kinase sk5 | 0.003 |
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 186 bits (473), Expect = 2e-56
Identities = 77/230 (33%), Positives = 111/230 (48%), Gaps = 3/230 (1%)
Query: 5 KLQHLFYSNSFLFF-TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVV 63
L F ++ + F GGEL +++ + E++A + ++ + H V
Sbjct: 87 NLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYV 146
Query: 64 HRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVE 122
H DLKPEN +FTT + LK+IDFGL+ + P Q + G+A + APEV +
Sbjct: 147 HLDLKPENIMFTT-KRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYY 205
Query: 123 GDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLN 182
DMWS+GV++YILL G PF + R+V D N DS + +S + KDF+R+LL
Sbjct: 206 TDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLL 265
Query: 183 KDHRKRMTAAQALTHPWLHDENRPVPLDILIYKLVKSYLRATPLKRAALK 232
D RMT QAL HPWL N P + + K A
Sbjct: 266 ADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAWP 315
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 4e-56
Identities = 71/235 (30%), Positives = 116/235 (49%), Gaps = 5/235 (2%)
Query: 5 KLQHLFYSNSFLFFTR-FCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVV 63
L F S L F G ++ +RI + E + + V ++ + F H +
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124
Query: 64 HRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL-HRSYNVE 122
H D++PEN ++ TR + +K+I+FG + ++P + + Y APEV H +
Sbjct: 125 HFDIRPENIIYQTRR-SSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTA 183
Query: 123 GDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLN 182
DMWS+G + Y+LL G PF A T I +++ A+ F + + +S EA DFV RLL
Sbjct: 184 TDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLV 243
Query: 183 KDHRKRMTAAQALTHPWLHDENRPVPLDILIYKLVKSYLRATPLKRAALKALSKA 237
K+ + RMTA++AL HPWL + V ++ + +K L + L + A
Sbjct: 244 KERKSRMTASEALQHPWLKQKIERVSTKVI--RTLKHRRYYHTLIKKDLNMVVSA 296
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 185 bits (470), Expect = 6e-56
Identities = 72/209 (34%), Positives = 110/209 (52%), Gaps = 3/209 (1%)
Query: 5 KLQHLFYSNSFLFF-TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVV 63
L F + F GGEL DRI + + E + + + + H +V
Sbjct: 90 NLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIV 149
Query: 64 HRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRS-YNVE 122
H D+KPEN + T++ + +K+IDFGL+ + PD+ + +A + APE++ R
Sbjct: 150 HLDIKPENIMCETKK-ASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFY 208
Query: 123 GDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLN 182
DMW+IGV+ Y+LL G PF + ++V R D F + + SVSPEAKDF++ LL
Sbjct: 209 TDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQ 268
Query: 183 KDHRKRMTAAQALTHPWLHDENRPVPLDI 211
K+ RKR+T AL HPWL ++ + I
Sbjct: 269 KEPRKRLTVHDALEHPWLKGDHSNLTSRI 297
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 177 bits (449), Expect = 3e-53
Identities = 89/228 (39%), Positives = 129/228 (56%), Gaps = 4/228 (1%)
Query: 5 KLQHLFYSNSFLFF-TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVV 63
L ++ S L+ + GGEL DRI+ +G Y E DA ++ ++L+ V + H G+V
Sbjct: 71 ALDDIYESGGHLYLIMQLVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLHDLGIV 129
Query: 64 HRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL-HRSYNVE 122
HRDLKPEN L+ + +ED+ + + DFGLS P L+ G+ YVAPEVL + Y+
Sbjct: 130 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKA 189
Query: 123 GDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLN 182
D WSIGVI YILLCG PF+ ++ +F +L+A+ F W +S AKDF+R L+
Sbjct: 190 VDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLME 249
Query: 183 KDHRKRMTAAQALTHPWLH-DENRPVPLDILIYKLVKSYLRATPLKRA 229
KD KR T QAL HPW+ D + + + +K + K+A
Sbjct: 250 KDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKKNFAKSKWKQA 297
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 175 bits (445), Expect = 4e-53
Identities = 71/204 (34%), Positives = 107/204 (52%), Gaps = 12/204 (5%)
Query: 5 KLQHLFYSNSFLFF-TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVV 63
+L+ + +N+F F + GEL D + + E++ + I+ +L ++ H +V
Sbjct: 74 QLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIMRALLEVICALHKLNIV 132
Query: 64 HRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL-------H 116
HRDLKPEN L +D +K+ DFG S + P ++L ++ G+ Y+APE++ H
Sbjct: 133 HRDLKPENILLD---DDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNH 189
Query: 117 RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDF 176
Y E DMWS GVI Y LL GS PFW R + + R ++ + F W S KD
Sbjct: 190 PGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDL 249
Query: 177 VRRLLNKDHRKRMTAAQALTHPWL 200
V R L +KR TA +AL HP+
Sbjct: 250 VSRFLVVQPQKRYTAEEALAHPFF 273
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (433), Expect = 4e-51
Identities = 61/213 (28%), Positives = 103/213 (48%), Gaps = 13/213 (6%)
Query: 5 KLQHLFYSNSFLFF-TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVV 63
KL FY + L+ FC GG + +L E + + ++ L+ + + H ++
Sbjct: 73 KLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKII 132
Query: 64 HRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVLH------ 116
HRDLK N LFT D +K+ DFG+S R QR + +G+ Y++APEV+
Sbjct: 133 HRDLKAGNILFT---LDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 189
Query: 117 RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDF 176
R Y+ + D+WS+G+ + P + + +++P P S KDF
Sbjct: 190 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP-SRWSSNFKDF 248
Query: 177 VRRLLNKDHRKRMTAAQALTHPWL-HDENRPVP 208
+++ L K+ R T +Q L HP++ D N+P+
Sbjct: 249 LKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIR 281
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 6e-51
Identities = 76/244 (31%), Positives = 116/244 (47%), Gaps = 7/244 (2%)
Query: 13 NSFLFFTRFCEGGELLDRILSRGGRYL-EEDAKTIVEKILNIVAFCHLQGVVHRDLKPEN 71
L +GGEL RI RG + E +A I++ I + + H + HRD+KPEN
Sbjct: 82 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPEN 141
Query: 72 FLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL-HRSYNVEGDMWSIGV 130
L+T++ +A LK+ DFG + L + YYVAPEVL Y+ DMWS+GV
Sbjct: 142 LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGV 201
Query: 131 ITYILLCGSRPFWARTE----SGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHR 186
I YILLCG PF++ G+ + F + W VS E K +R LL +
Sbjct: 202 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 261
Query: 187 KRMTAAQALTHPWLHDENRPVPLDILIYKLVK-SYLRATPLKRAALKALSKALTEEELVY 245
+RMT + + HPW+ + + +++K R +K AL+ + E +
Sbjct: 262 QRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIK 321
Query: 246 LRAQ 249
++
Sbjct: 322 IKKI 325
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 6e-51
Identities = 56/197 (28%), Positives = 98/197 (49%), Gaps = 9/197 (4%)
Query: 5 KLQHLFYSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVH 64
+L F+ + ++ + R L + ++ E+ T + ++ N +++CH + V+H
Sbjct: 70 RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 129
Query: 65 RDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL-HRSYNVEG 123
RD+KPEN L LK+ DFG S P R + G+ Y+ PE++ R ++ +
Sbjct: 130 RDIKPENLLLG---SAGELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRMHDEKV 185
Query: 124 DMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNK 183
D+WS+GV+ Y L G PF A T ++ + R + F V+ A+D + RLL
Sbjct: 186 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF----PDFVTEGARDLISRLLKH 241
Query: 184 DHRKRMTAAQALTHPWL 200
+ +R + L HPW+
Sbjct: 242 NPSQRPMLREVLEHPWI 258
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 2e-47
Identities = 76/208 (36%), Positives = 113/208 (54%), Gaps = 4/208 (1%)
Query: 5 KLQHLFYSNSFLFF-TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVV 63
L ++ + + + GGEL D + + EE+A +++ILN V + H +
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYYLHSLQIA 135
Query: 64 HRDLKPENFLFTTREEDAP-LKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL-HRSYNV 121
H DLKPEN + R P +K+IDFGL+ + +I G+ +VAPE++ + +
Sbjct: 136 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGL 195
Query: 122 EGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLL 181
E DMWSIGVITYILL G+ PF T+ +V + F D + + S AKDF+RRLL
Sbjct: 196 EADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLL 255
Query: 182 NKDHRKRMTAAQALTHPWLHDENRPVPL 209
KD +KRMT +L HPW+ ++ L
Sbjct: 256 VKDPKKRMTIQDSLQHPWIKPKDTQQAL 283
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 5e-47
Identities = 66/209 (31%), Positives = 107/209 (51%), Gaps = 19/209 (9%)
Query: 5 KLQHLFYSNSFLFF-TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVV 63
KL F + L+F + + GELL I + G + E + +I++ + + H +G++
Sbjct: 72 KLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEYLHGKGII 130
Query: 64 HRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ---RLNDIVGSAYYVAPEVL-HRSY 119
HRDLKPEN L ED +++ DFG + + P+ R N VG+A YV+PE+L +S
Sbjct: 131 HRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 187
Query: 120 NVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRR 179
D+W++G I Y L+ G PF A E IF+ +++ + +F P+A+D V +
Sbjct: 188 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF----PEKFFPKARDLVEK 243
Query: 180 LLNKDHRKRMTAAQA------LTHPWLHD 202
LL D KR+ + HP+
Sbjct: 244 LLVLDATKRLGCEEMEGYGPLKAHPFFES 272
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 2e-46
Identities = 61/208 (29%), Positives = 95/208 (45%), Gaps = 13/208 (6%)
Query: 6 LQHLFYSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHR 65
H N F +C GGEL DRI E DA+ +++ V + H G+ HR
Sbjct: 69 YGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHR 127
Query: 66 DLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLHRS--YN 120
D+KPEN L E LK+ DFGL+ R + R LN + G+ YVAPE+L R +
Sbjct: 128 DIKPENLLLD---ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 184
Query: 121 VEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRL 180
D+WS G++ +L G P+ ++S S + + + PW + + ++
Sbjct: 185 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN-PWKKIDSAPLALLHKI 243
Query: 181 LNKDHRKRMTAAQALTHPWLHDENRPVP 208
L ++ R+T W N+P+
Sbjct: 244 LVENPSARITIPDIKKDRWY---NKPLK 268
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 2e-46
Identities = 39/191 (20%), Positives = 76/191 (39%), Gaps = 9/191 (4%)
Query: 13 NSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQG--VVHRDLKPE 70
+ T G L L R + ++ +IL + F H + ++HRDLK +
Sbjct: 85 KCIVLVTELMTSG-TLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCD 143
Query: 71 NFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGV 130
N T +K+ D GL+ R ++G+ ++APE+ Y+ D+++ G+
Sbjct: 144 NIFIT--GPTGSVKIGDLGLATLKRASF-AKAVIGTPEFMAPEMYEEKYDESVDVYAFGM 200
Query: 131 ITYILLCGSRPFW-ARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRM 189
+ P+ + + I+R V S PE K+ + + ++ +R
Sbjct: 201 CMLEMATSEYPYSECQNAAQIYRRVT--SGVKPASFDKVAIPEVKEIIEGCIRQNKDERY 258
Query: 190 TAAQALTHPWL 200
+ L H +
Sbjct: 259 SIKDLLNHAFF 269
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 156 bits (396), Expect = 2e-45
Identities = 53/242 (21%), Positives = 96/242 (39%), Gaps = 17/242 (7%)
Query: 5 KLQHLFYSNSFLFF-TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVV 63
+ + + + +C G D + E + + L +A+ H ++
Sbjct: 79 QYRGCYLREHTAWLVMEYCLGS-ASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMI 137
Query: 64 HRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL----HRSY 119
HRD+K N L + E +K+ DFG + + P N VG+ Y++APEV+ Y
Sbjct: 138 HRDVKAGNILLS---EPGLVKLGDFGSASIMAPA---NSFVGTPYWMAPEVILAMDEGQY 191
Query: 120 NVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRR 179
+ + D+WS+G+ L P + + + + S ++FV
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES--PALQSGHWSEYFRNFVDS 249
Query: 180 LLNKDHRKRMTAAQALTHPWLHDENRPVPLDILIYKLVKSYLRATPLKRAALKALSKALT 239
L K + R T+ L H ++ E P + LI + K +R L + + K L
Sbjct: 250 CLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLI-QRTKDAVRE--LDNLQYRKMKKILF 306
Query: 240 EE 241
+E
Sbjct: 307 QE 308
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 3e-44
Identities = 52/212 (24%), Positives = 92/212 (43%), Gaps = 9/212 (4%)
Query: 5 KLQHLFYSNSFLFF-TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVV 63
+ L+ + GG L D + E + + L + F H V+
Sbjct: 81 NYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHSNQVI 138
Query: 64 HRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVL-HRSYNV 121
HRD+K +N L D +K+ DFG + P+Q + + +VG+ Y++APEV+ ++Y
Sbjct: 139 HRDIKSDNILLG---MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 122 EGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLL 181
+ D+WS+G++ ++ G P+ + + +S +DF+ R L
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPELQNPEKLSAIFRDFLNRCL 254
Query: 182 NKDHRKRMTAAQALTHPWLHDENRPVPLDILI 213
+ D KR +A + L H +L L LI
Sbjct: 255 DMDVEKRGSAKELLQHQFLKIAKPLSSLTPLI 286
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 3e-43
Identities = 51/199 (25%), Positives = 86/199 (43%), Gaps = 16/199 (8%)
Query: 12 SNSFLFFTRFCEGGELLDRI---LSRGGRYLEEDAKTIVEKILNIVAFCHLQG-----VV 63
+ + +CEGG+L I EE ++ ++ + CH + V+
Sbjct: 77 NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVL 136
Query: 64 HRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLHR-SYNV 121
HRDLKP N +K+ DFGL+ + D VG+ YY++PE ++R SYN
Sbjct: 137 HRDLKPANVFLD---GKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNE 193
Query: 122 EGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLL 181
+ D+WS+G + Y L PF A ++ + + S E + + R+L
Sbjct: 194 KSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR---IPYRYSDELNEIITRML 250
Query: 182 NKDHRKRMTAAQALTHPWL 200
N R + + L +P +
Sbjct: 251 NLKDYHRPSVEEILENPLI 269
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 2e-42
Identities = 59/203 (29%), Positives = 87/203 (42%), Gaps = 15/203 (7%)
Query: 6 LQHLFYSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHR 65
L +SF+ E + L ++ G EE A++ ++L V CH GV+HR
Sbjct: 75 LDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHR 134
Query: 66 DLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL--HRSYNVEG 123
D+K EN L LK+IDFG + D D G+ Y PE + HR +
Sbjct: 135 DIKDENILID--LNRGELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYHRYHGRSA 191
Query: 124 DMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNK 183
+WS+G++ Y ++CG PF E ++R F VS E + +R L
Sbjct: 192 AVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFF----RQRVSSECQHLIRWCLAL 241
Query: 184 DHRKRMTAAQALTHPWLHDENRP 206
R T + HPW+ D P
Sbjct: 242 RPSDRPTFEEIQNHPWMQDVLLP 264
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 6e-42
Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 12/204 (5%)
Query: 5 KLQHLFYSNSFLFF-TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVV 63
+ F + LFF + GG+L+ I ++ A +I+ + F H +G+V
Sbjct: 67 HMFCTFQTKENLFFVMEYLNGGDLMYHI-QSCHKFDLSRATFYAAEIILGLQFLHSKGIV 125
Query: 64 HRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVL-HRSYNV 121
+RDLK +N L +D +K+ DFG+ + + D + N G+ Y+APE+L + YN
Sbjct: 126 YRDLKLDNILLD---KDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNH 182
Query: 122 EGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLL 181
D WS GV+ Y +L G PF + E +F S+ +P + + EAKD + +L
Sbjct: 183 SVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY----PRWLEKEAKDLLVKLF 238
Query: 182 NKDHRKRMTAAQA-LTHPWLHDEN 204
++ KR+ HP + N
Sbjct: 239 VREPEKRLGVRGDIRQHPLFREIN 262
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 2e-41
Identities = 54/243 (22%), Positives = 93/243 (38%), Gaps = 48/243 (19%)
Query: 5 KLQHLFYSNSFLFF-TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCH-LQGV 62
FYS+ + +GG L D++L + GR E+ + ++ + + +
Sbjct: 68 GFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKI 126
Query: 63 VHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNV 121
+HRD+KP N L +R E +K+ DFG+S + D N VG+ Y++PE L Y+V
Sbjct: 127 MHRDVKPSNILVNSRGE---IKLCDFGVSGQL-IDSMANSFVGTRSYMSPERLQGTHYSV 182
Query: 122 EGDMWSIGVITYILLCGSRPFWARTES---GIFRSVLRADPNFHDS-------------- 164
+ D+WS+G+ + G P +F + D
Sbjct: 183 QSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGM 242
Query: 165 -----------------------PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLH 201
P S E +DFV + L K+ +R Q + H ++
Sbjct: 243 DSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK 302
Query: 202 DEN 204
+
Sbjct: 303 RSD 305
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (363), Expect = 5e-41
Identities = 40/202 (19%), Positives = 74/202 (36%), Gaps = 12/202 (5%)
Query: 5 KLQHLFYSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVH 64
+ T++CEG L + ++ I + + + H + ++H
Sbjct: 68 LFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIH 127
Query: 65 RDLKPENFLFTTREEDAPLKVIDFGLSDFVRPD---QRLNDIVGSAYYVAPEVL----HR 117
RDLK N ED +K+ DFGL+ + + GS ++APEV+
Sbjct: 128 RDLKSNNIFLH---EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 118 SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSP--WPSVSPEAKD 175
Y+ + D+++ G++ Y L+ G P+ ++ D + K
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKR 244
Query: 176 FVRRLLNKDHRKRMTAAQALTH 197
+ L K +R Q L
Sbjct: 245 LMAECLKKKRDERPLFPQILAS 266
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 6e-41
Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 14/207 (6%)
Query: 5 KLQHLFYSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVH 64
L++ F ++ L F G L LSR + EE A+ +I++ + + H + VV+
Sbjct: 69 ALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVY 128
Query: 65 RDLKPENFLFTTREEDAPLKVIDFGLSDFVR-PDQRLNDIVGSAYYVAPEVLHRS-YNVE 122
RD+K EN + +D +K+ DFGL + G+ Y+APEVL + Y
Sbjct: 129 RDIKLENLMLD---KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRA 185
Query: 123 GDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLN 182
D W +GV+ Y ++CG PF+ + +F +L + F ++SPEAK + LL
Sbjct: 186 VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF----PRTLSPEAKSLLAGLLK 241
Query: 183 KDHRKRM-----TAAQALTHPWLHDEN 204
KD ++R+ A + + H + N
Sbjct: 242 KDPKQRLGGGPSDAKEVMEHRFFLSIN 268
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 144 bits (364), Expect = 2e-40
Identities = 54/208 (25%), Positives = 92/208 (44%), Gaps = 14/208 (6%)
Query: 5 KLQHLFYSNSFLFF-TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVV 63
+ + F++ L F GG+L LS+ G + E D + +I+ + H + VV
Sbjct: 71 CMSYAFHTPDKLSFILDLMNGGDL-HYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVV 129
Query: 64 HRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR--SYNV 121
+RDLKP N L E +++ D GL+ ++ + VG+ Y+APEVL + +Y+
Sbjct: 130 YRDLKPANILLD---EHGHVRISDLGLACDF-SKKKPHASVGTHGYMAPEVLQKGVAYDS 185
Query: 122 EGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLL 181
D +S+G + + LL G PF + R S SPE + + LL
Sbjct: 186 SADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTMAVELPDSFSPELRSLLEGLL 244
Query: 182 NKDHRKRMT-----AAQALTHPWLHDEN 204
+D +R+ A + P+ +
Sbjct: 245 QRDVNRRLGCLGRGAQEVKESPFFRSLD 272
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 139 bits (351), Expect = 3e-39
Identities = 40/196 (20%), Positives = 77/196 (39%), Gaps = 3/196 (1%)
Query: 11 YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPE 70
+ +G L D I+ G + A ++ + F H G++HRD+KP
Sbjct: 82 AGPLPYIVMEYVDGVTLRD-IVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPA 140
Query: 71 NFLFTTREEDAPLKVIDFG-LSDFVRPDQRLNDIVGSAYYVAPEVL-HRSYNVEGDMWSI 128
N + + + ++D + ++G+A Y++PE S + D++S+
Sbjct: 141 NIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 200
Query: 129 GVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKR 188
G + Y +L G PF + + +R DP + +S + V + L K+ R
Sbjct: 201 GCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENR 260
Query: 189 MTAAQALTHPWLHDEN 204
A + + N
Sbjct: 261 YQTAAEMRADLVRVHN 276
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (352), Expect = 3e-39
Identities = 51/214 (23%), Positives = 81/214 (37%), Gaps = 27/214 (12%)
Query: 13 NSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENF 72
+ E K ++ ++L + F H VVHRDLKP+N
Sbjct: 88 TKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNI 147
Query: 73 LFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRS-YNVEGDMWSIGVI 131
L T+ + K+ DFGL+ L +V + +Y APEVL +S Y D+WS+G I
Sbjct: 148 LVTSSGQI---KLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCI 204
Query: 132 TYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWP-----------------------S 168
+ F ++ +L + WP
Sbjct: 205 FAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTD 264
Query: 169 VSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 202
+ KD + + L + KR++A AL+HP+ D
Sbjct: 265 IDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 138 bits (349), Expect = 1e-38
Identities = 52/206 (25%), Positives = 92/206 (44%), Gaps = 15/206 (7%)
Query: 5 KLQHLFYSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVH 64
++ F +F G L +L + R+ AK ++ + + H + +++
Sbjct: 68 RMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIY 127
Query: 65 RDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL-HRSYNVEG 123
RDLKPEN L ++ +K+ DFG + +V + G+ Y+APEV+ + YN
Sbjct: 128 RDLKPENILLD---KNGHIKITDFGFAKYV--PDVTYTLCGTPDYIAPEVVSTKPYNKSI 182
Query: 124 DMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNK 183
D WS G++ Y +L G PF+ + +L A+ F P + + KD + RL+ +
Sbjct: 183 DWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF----PPFFNEDVKDLLSRLITR 238
Query: 184 DHRKRM-----TAAQALTHPWLHDEN 204
D +R+ HPW +
Sbjct: 239 DLSQRLGNLQNGTEDVKNHPWFKEVV 264
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 2e-38
Identities = 53/231 (22%), Positives = 82/231 (35%), Gaps = 30/231 (12%)
Query: 5 KLQHLFYSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVH 64
L F S + +L I K + L + + H ++H
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILH 123
Query: 65 RDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVL--HRSYNV 121
RDLKP N L E+ LK+ DFGL+ F P++ V + +Y APE+L R Y V
Sbjct: 124 RDLKPNNLLLD---ENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGV 180
Query: 122 EGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWP-------------- 167
DMW++G I LL ++ + + WP
Sbjct: 181 GVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSF 240
Query: 168 ----------SVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVP 208
+ + D ++ L + R+TA QAL + + P P
Sbjct: 241 PGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTP 291
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 3e-38
Identities = 54/246 (21%), Positives = 92/246 (37%), Gaps = 41/246 (16%)
Query: 1 MYHQKLQHLFYSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQ 60
+ + S FCE L + + ++ + K +++ +LN + + H
Sbjct: 78 CRTKASPYNRCKGSIYLVFDFCEHD-LAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN 136
Query: 61 GVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ-----RLNDIVGSAYYVAPEVL 115
++HRD+K N L T D LK+ DFGL+ + R + V + +Y PE+L
Sbjct: 137 KILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELL 193
Query: 116 --HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSV---- 169
R Y D+W G I + S TE + + + WP+V
Sbjct: 194 LGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYE 253
Query: 170 ------------------------SPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENR 205
P A D + +LL D +R+ + AL H + +
Sbjct: 254 LYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD-- 311
Query: 206 PVPLDI 211
P+P D+
Sbjct: 312 PMPSDL 317
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 136 bits (343), Expect = 4e-38
Identities = 56/226 (24%), Positives = 97/226 (42%), Gaps = 31/226 (13%)
Query: 5 KLQHLFYSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVH 64
KL + ++ L +L + G AK+ + ++LN +A+CH + V+H
Sbjct: 64 KLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLH 123
Query: 65 RDLKPENFLFTTREEDAPLKVIDFGLSDFVR-PDQRLNDIVGSAYYVAPEVLHRS--YNV 121
RDLKP+N L + LK+ DFGL+ P ++ + + +Y AP+VL S Y+
Sbjct: 124 RDLKPQNLLIN---REGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYST 180
Query: 122 EGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWP-------------- 167
D+WS+G I ++ G+ F +E+ + R + WP
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240
Query: 168 -----------SVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 202
+ D + ++L D +R+TA QAL H + +
Sbjct: 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 9e-38
Identities = 47/215 (21%), Positives = 76/215 (35%), Gaps = 31/215 (14%)
Query: 21 FCEGG--ELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE 78
+ + K + ++ +A+ H G+ HRD+KP+N L
Sbjct: 100 YVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--P 157
Query: 79 EDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRS--YNVEGDMWSIGVITYILL 136
+ A LK+ DFG + + + + S YY APE++ + Y D+WS G + LL
Sbjct: 158 DTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 217
Query: 137 CGSRPFWARTESGIFRSVLRAD--------------------PNFHDSPW-----PSVSP 171
G F + +++ P PW P P
Sbjct: 218 LGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPP 277
Query: 172 EAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRP 206
EA RLL R+T +A H + + P
Sbjct: 278 EAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP 312
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 2e-37
Identities = 55/235 (23%), Positives = 88/235 (37%), Gaps = 38/235 (16%)
Query: 10 FYSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKP 69
++ G +L + + + + +IL + + H V+HRDLKP
Sbjct: 80 IEQMKDVYLVTHLMGADLYKLL--KTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKP 137
Query: 70 ENFLFTTREEDAPLKVIDFGLSDFVRPDQ----RLNDIVGSAYYVAPEVLHRS--YNVEG 123
N L LK+ DFGL+ PD L + V + +Y APE++ S Y
Sbjct: 138 SNLLLN---TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSI 194
Query: 124 DMWSIGVITYILLCGSRPFWARTESGIFRSVLRA-----------------------DPN 160
D+WS+G I +L F + +L P+
Sbjct: 195 DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPH 254
Query: 161 FHDSPW----PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDI 211
+ PW P+ +A D + ++L + KR+ QAL HP+L P I
Sbjct: 255 KNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPI 309
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 133 bits (336), Expect = 1e-36
Identities = 59/227 (25%), Positives = 97/227 (42%), Gaps = 42/227 (18%)
Query: 12 SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPEN 71
S + + + D + + +IL + +CH G++HRD+KP N
Sbjct: 104 SRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHN 159
Query: 72 FLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL--HRSYNVEGDMWSIG 129
+ E L++ID+GL++F P Q N V S Y+ PE+L ++ Y+ DMWS+G
Sbjct: 160 VMID--HEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLG 217
Query: 130 VITYILLCGSRPFWA------------------RTESGIFRSVLRADPNFHDS------- 164
+ ++ PF+ I + + DP F+D
Sbjct: 218 CMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRK 277
Query: 165 ---------PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 202
VSPEA DF+ +LL DH+ R+TA +A+ HP+ +
Sbjct: 278 RWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 324
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 3e-36
Identities = 57/210 (27%), Positives = 93/210 (44%), Gaps = 13/210 (6%)
Query: 5 KLQHLFYSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVH 64
L + F + + L G L LS+ R+ E + + V +I+ + H G+++
Sbjct: 93 TLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIY 152
Query: 65 RDLKPENFLFTTREEDAPLKVIDFGLSDFVRP--DQRLNDIVGSAYYVAPEVL---HRSY 119
RD+K EN L + + + DFGLS +R D G+ Y+AP+++ +
Sbjct: 153 RDIKLENILLD---SNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGH 209
Query: 120 NVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRR 179
+ D WS+GV+ Y LL G+ PF E + R +S AKD ++R
Sbjct: 210 DKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQR 269
Query: 180 LLNKDHRKRM-----TAAQALTHPWLHDEN 204
LL KD +KR+ A + H + N
Sbjct: 270 LLMKDPKKRLGCGPRDADEIKEHLFFQKIN 299
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 8e-36
Identities = 55/233 (23%), Positives = 98/233 (42%), Gaps = 32/233 (13%)
Query: 5 KLQHLFYSNSFLFFTRFCEGGELLDRILSRGGRYLE-EDAKTIVEKILNIVAFCHLQGVV 63
KL + ++ + L+ +L + + + K+ + ++L +AFCH V+
Sbjct: 65 KLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 124
Query: 64 HRDLKPENFLFTTREEDAPLKVIDFGLSDFV-RPDQRLNDIVGSAYYVAPEVLHRS--YN 120
HRDLKP+N L + +K+ DFGL+ P + V + +Y APE+L Y+
Sbjct: 125 HRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 121 VEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPS------------ 168
D+WS+G I ++ F +E + R + WP
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241
Query: 169 -------------VSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVP 208
+ + + + ++L+ D KR++A AL HP+ D +PVP
Sbjct: 242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP 294
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 131 bits (330), Expect = 1e-35
Identities = 57/209 (27%), Positives = 89/209 (42%), Gaps = 15/209 (7%)
Query: 2 YHQKLQHLFYSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQG 61
+ KL+ F NS L+ G + L R GR+ E A+ +I+ + H
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD 161
Query: 62 VVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL-HRSYN 120
+++RDLKPEN L ++V DFG + R R + G+ +APE++ + YN
Sbjct: 162 LIYRDLKPENLLIDQ---QGYIQVTDFGFAK--RVKGRTWTLCGTPEALAPEIILSKGYN 216
Query: 121 VEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRL 180
D W++GV+ Y + G PF+A I+ ++ F S + KD +R L
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF----PSHFSSDLKDLLRNL 272
Query: 181 LNKDHRKRM-----TAAQALTHPWLHDEN 204
L D KR H W +
Sbjct: 273 LQVDLTKRFGNLKNGVNDIKNHKWFATTD 301
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 3e-34
Identities = 43/203 (21%), Positives = 75/203 (36%), Gaps = 13/203 (6%)
Query: 5 KLQHLFYSNSFLFFTRFCEGGELLDRILSRGGRYL-EEDAKTIVEKILNIVAFCHLQGVV 63
+L + T + G LLD + G+YL + +I + +A+ V
Sbjct: 76 QLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYV 135
Query: 64 HRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ--RLNDIVGSAYYVAPEVL-HRSYN 120
HRDL+ N L E+ KV DFGL+ + ++ + APE + +
Sbjct: 136 HRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 192
Query: 121 VEGDMWSIGVITYILLCGSRPFW-ARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRR 179
++ D+WS G++ L R + + V R + P D + +
Sbjct: 193 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER---GYRMPCPPECPESLHDLMCQ 249
Query: 180 LLNKDHRKRMTAAQALTHPWLHD 202
K+ +R T +L D
Sbjct: 250 CWRKEPEERPTFEYL--QAFLED 270
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 2e-33
Identities = 38/204 (18%), Positives = 76/204 (37%), Gaps = 16/204 (7%)
Query: 5 KLQHLFYSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVH 64
++ + + S++ E G L ++ L + +++ +V ++ + + VH
Sbjct: 72 RMIGICEAESWMLVMEMAELGPL-NKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 130
Query: 65 RDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLND----IVGSAYYVAPEVL-HRSY 119
RDL N L K+ DFGLS +R D+ + APE + + +
Sbjct: 131 RDLAARNVLLV---TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 187
Query: 120 NVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVR 178
+ + D+WS GV+ + G +P+ S + + + + E D +
Sbjct: 188 SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER---MGCPAGCPREMYDLMN 244
Query: 179 RLLNKDHRKRMTAAQ---ALTHPW 199
D R A L + +
Sbjct: 245 LCWTYDVENRPGFAAVELRLRNYY 268
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 2e-33
Identities = 35/204 (17%), Positives = 67/204 (32%), Gaps = 15/204 (7%)
Query: 5 KLQHLFYSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVH 64
+L + + + + GG L ++ + + ++ ++ + + + VH
Sbjct: 73 RLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVH 132
Query: 65 RDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLND----IVGSAYYVAPEVL-HRSY 119
RDL N L K+ DFGLS + D + APE + R +
Sbjct: 133 RDLAARNVLLV---NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 189
Query: 120 NVEGDMWSIGVITY-ILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVR 178
+ D+WS GV + L G +P+ + + + P PE +
Sbjct: 190 SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ---GKRMECPPECPPELYALMS 246
Query: 179 RLLNKDHRKRMTAA---QALTHPW 199
R Q + +
Sbjct: 247 DCWIYKWEDRPDFLTVEQRMRACY 270
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 7e-33
Identities = 51/226 (22%), Positives = 89/226 (39%), Gaps = 37/226 (16%)
Query: 13 NSFLFFTRFCEGGELLDRI---LSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKP 69
+ FT F + L + + E+ + +V ++L + + H G++HRDLKP
Sbjct: 90 ETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKP 149
Query: 70 ENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL--HRSYNVEGDMWS 127
N ED LK++DFGL+ D + V + +Y APEV+ Y D+WS
Sbjct: 150 GNLAVN---EDCELKILDFGLARQ--ADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWS 204
Query: 128 IGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPW--------------------- 166
+G I ++ G F + +++
Sbjct: 205 VGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKK 264
Query: 167 ------PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRP 206
+ SP A + + ++L D +R+TA +AL HP+ +
Sbjct: 265 DFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 310
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 8e-33
Identities = 58/226 (25%), Positives = 93/226 (41%), Gaps = 32/226 (14%)
Query: 10 FYSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKP 69
+S+ L +L S G E K+ + ++L + FCH + V+HRDLKP
Sbjct: 70 LHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKP 129
Query: 70 ENFLFTTREEDAPLKVIDFGLS-DFVRPDQRLNDIVGSAYYVAPEVLHRS--YNVEGDMW 126
+N L E K+ +FGL+ F P + + V + +Y P+VL + Y+ DMW
Sbjct: 130 QNLLINRNGEL---KLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMW 186
Query: 127 SIGVITYILLCGSRP-FWARTESGIFRSVLRADPNFHDSPWPS----------------- 168
S G I L RP F + + R + WPS
Sbjct: 187 SAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATT 246
Query: 169 --------VSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRP 206
++ +D ++ LL + +R++A +AL HP+ D P
Sbjct: 247 SLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 2e-32
Identities = 37/197 (18%), Positives = 66/197 (33%), Gaps = 11/197 (5%)
Query: 5 KLQHLFYSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVH 64
+L + + T G LLDR+ G +L ++ + + + +H
Sbjct: 75 RLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 134
Query: 65 RDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ----RLNDIVGSAYYVAPEVL-HRSY 119
RDL N L TR+ +K+ DFGL + + + APE L R++
Sbjct: 135 RDLAARNLLLATRDL---VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF 191
Query: 120 NVEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVR 178
+ D W GV + + G P+ S I + + + + +
Sbjct: 192 SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL--PRPEDCPQDIYNVMV 249
Query: 179 RLLNKDHRKRMTAAQAL 195
+ R T
Sbjct: 250 QCWAHKPEDRPTFVALR 266
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (303), Expect = 2e-32
Identities = 40/188 (21%), Positives = 68/188 (36%), Gaps = 11/188 (5%)
Query: 13 NSFLFFTRFCEGGELLDRILSRGGRYLEED-AKTIVEKILNIVAFCHLQGVVHRDLKPEN 71
T + G L+D + SRG L D + + + VHRDL N
Sbjct: 74 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARN 133
Query: 72 FLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL-HRSYNVEGDMWSIGV 130
L + ED KV DFGL+ Q + + APE L + ++ + D+WS G+
Sbjct: 134 VLVS---EDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGI 188
Query: 131 ITYILL-CGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRM 189
+ + + G P+ + V + + P + ++ + D R
Sbjct: 189 LLWEIYSFGRVPYPRIPLKDVVPRVEK---GYKMDAPDGCPPAVYEVMKNCWHLDAAMRP 245
Query: 190 TAAQALTH 197
+ Q
Sbjct: 246 SFLQLREQ 253
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 6e-32
Identities = 38/198 (19%), Positives = 75/198 (37%), Gaps = 11/198 (5%)
Query: 5 KLQHLFYSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVH 64
+L + +++ T+ G LLD + + +I + + + +VH
Sbjct: 75 RLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 134
Query: 65 RDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVL-HRSYN 120
RDL N L +K+ DFGL+ + +++ ++A E + HR Y
Sbjct: 135 RDLAARNVLVK---TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 191
Query: 121 VEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRR 179
+ D+WS GV + L+ GS+P+ S I + + P + + + +
Sbjct: 192 HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK---GERLPQPPICTIDVYMIMVK 248
Query: 180 LLNKDHRKRMTAAQALTH 197
D R + +
Sbjct: 249 CWMIDADSRPKFRELIIE 266
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 8e-32
Identities = 37/190 (19%), Positives = 72/190 (37%), Gaps = 10/190 (5%)
Query: 12 SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPEN 71
T + G LL+ + R+ + + + + + + + +HRDL N
Sbjct: 71 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARN 130
Query: 72 FLFTTREEDAPLKVIDFGLSDFVRPDQ--RLNDIVGSAYYVAPEVL-HRSYNVEGDMWSI 128
L + +KV DFGLS +V D+ + PEVL + ++ + D+W+
Sbjct: 131 CLVN---DQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAF 187
Query: 129 GVITY-ILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRK 187
GV+ + I G P+ T S + + S + + ++ +
Sbjct: 188 GVLMWEIYSLGKMPYERFTNSETAEHIAQ---GLRLYRPHLASEKVYTIMYSCWHEKADE 244
Query: 188 RMTAAQALTH 197
R T L++
Sbjct: 245 RPTFKILLSN 254
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 9e-32
Identities = 41/198 (20%), Positives = 76/198 (38%), Gaps = 11/198 (5%)
Query: 5 KLQHLFYSNSFLFF-TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVV 63
+L + + + F E G L D + ++ G + E + + +A+ V+
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI 123
Query: 64 HRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLND--IVGSAYYVAPEVL-HRSYN 120
HRDL N L E+ +KV DFG++ FV DQ + + +PEV Y+
Sbjct: 124 HRDLAARNCLVG---ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 180
Query: 121 VEGDMWSIGVITYILLCGSRPFW-ARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRR 179
+ D+WS GV+ + + + + R+ S + + F S +
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST---GFRLYKPRLASTHVYQIMNH 237
Query: 180 LLNKDHRKRMTAAQALTH 197
+ R ++ L
Sbjct: 238 CWKERPEDRPAFSRLLRQ 255
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 118 bits (297), Expect = 2e-31
Identities = 31/213 (14%), Positives = 74/213 (34%), Gaps = 16/213 (7%)
Query: 3 HQKLQHLFYSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGV 62
++ + G L D ++ + + +++++ + + H +
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNF 124
Query: 63 VHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ--------RLNDIVGSAYYVAPEV 114
+HRD+KP+NFL ++ + +IDFGL+ R + ++ G+A Y +
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184
Query: 115 L-HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSP----WPSV 169
+ D+ S+G + GS P+ + + R +P
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGY 244
Query: 170 SPEAKDFVRRLLNKDHRKRMTAA---QALTHPW 199
E ++ + + + Q + +
Sbjct: 245 PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 9e-31
Identities = 54/231 (23%), Positives = 92/231 (39%), Gaps = 36/231 (15%)
Query: 10 FYSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKP 69
+ ++ G +L + + + + ++ + ++ +IL + + H ++HRDLKP
Sbjct: 92 LEEFNDVYLVTHLMGADLNN--IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKP 149
Query: 70 ENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRS--YNVEGDMWS 127
N ED LK++DFGL+ D + V + +Y APE++ YN D+WS
Sbjct: 150 SNLAVN---EDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWS 204
Query: 128 IGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPW--------------------- 166
+G I LL G F + +LR
Sbjct: 205 VGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKM 264
Query: 167 ------PSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDI 211
+P A D + ++L D KR+TAAQAL H + + P +
Sbjct: 265 NFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPV 315
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 116 bits (291), Expect = 2e-30
Identities = 42/202 (20%), Positives = 75/202 (37%), Gaps = 15/202 (7%)
Query: 5 KLQHLFYSNSFLFF-TRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVV 63
L+ + ++ + T F E G L + G++ ++ I + + V
Sbjct: 91 HLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYV 150
Query: 64 HRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLND------IVGSAYYVAPEVL-H 116
HRDL N L + KV DFGLS F+ D + APE + +
Sbjct: 151 HRDLAARNILVN---SNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY 207
Query: 117 RSYNVEGDMWSIGVITY-ILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKD 175
R + D+WS G++ + ++ G RP+W T + ++ + ++ P
Sbjct: 208 RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ---DYRLPPPMDCPSALHQ 264
Query: 176 FVRRLLNKDHRKRMTAAQALTH 197
+ KD R Q +
Sbjct: 265 LMLDCWQKDRNHRPKFGQIVNT 286
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 8e-30
Identities = 41/226 (18%), Positives = 76/226 (33%), Gaps = 25/226 (11%)
Query: 6 LQHLFYSNSFLFFTRFCEGGELLDRIL---------------SRGGRYLEEDAKTIVEKI 50
L + + G LLD + S + +
Sbjct: 77 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 136
Query: 51 LNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYV 110
+ + + +HRDL N L E+ K+ DFGLS + ++
Sbjct: 137 ARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWM 193
Query: 111 APEVLHRS-YNVEGDMWSIGVITYILL-CGSRPFWARTESGIFRSVLRADPNFHDSPWPS 168
A E L+ S Y D+WS GV+ + ++ G P+ T + ++ + + + +
Sbjct: 194 AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ---GYRLEKPLN 250
Query: 169 VSPEAKDFVRRLLNKDHRKRMTAAQALTH--PWLHDENRPVPLDIL 212
E D +R+ + +R + AQ L L + V +
Sbjct: 251 CDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLY 296
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 1e-29
Identities = 38/197 (19%), Positives = 72/197 (36%), Gaps = 10/197 (5%)
Query: 5 KLQHLFYSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVH 64
KL + N C GEL + R ++ +A+ + VH
Sbjct: 72 KLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVH 131
Query: 65 RDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ--RLNDIVGSAYYVAPEVL-HRSYNV 121
RD+ N L ++ + +K+ DFGLS ++ + + ++APE + R +
Sbjct: 132 RDIAARNVLVSSNDC---VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 188
Query: 122 EGDMWSIGVITY-ILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRL 180
D+W GV + IL+ G +PF + + + + P+ P + +
Sbjct: 189 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER---LPMPPNCPPTLYSLMTKC 245
Query: 181 LNKDHRKRMTAAQALTH 197
D +R +
Sbjct: 246 WAYDPSRRPRFTELKAQ 262
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (287), Expect = 1e-29
Identities = 48/250 (19%), Positives = 85/250 (34%), Gaps = 46/250 (18%)
Query: 2 YHQKLQHLFYSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQG 61
+ L + E ++ ++L + H G
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAG 139
Query: 62 VVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPE-VLHRSYN 120
++HRDLKP N + D LK++DFGL+ + V + YY APE +L Y
Sbjct: 140 IIHRDLKPSNIVVK---SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 196
Query: 121 VEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRA----------------------D 158
D+WS+G I ++ F R + V+
Sbjct: 197 ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 256
Query: 159 PNFHDSPWPS----------------VSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 202
P + +P + +A+D + ++L D KR++ AL HP+++
Sbjct: 257 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 316
Query: 203 ENRPVPLDIL 212
P ++
Sbjct: 317 WYDPAEVEAP 326
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (282), Expect = 5e-29
Identities = 42/221 (19%), Positives = 79/221 (35%), Gaps = 33/221 (14%)
Query: 5 KLQHLFYSNSFLFF-TRFCEGGELLDRILSRGGRYLE----------------------E 41
L + ++ +C G+LL+ + S+ ++ E E
Sbjct: 105 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 164
Query: 42 DAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRL- 100
D ++ + F + VHRDL N L T +K+ DFGL+ + D
Sbjct: 165 DLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT---HGKVVKICDFGLARDIMSDSNYV 221
Query: 101 --NDIVGSAYYVAPEVLHRS-YNVEGDMWSIGVITY-ILLCGSRPFWARTESGIFRSVLR 156
+ ++APE L Y ++ D+WS G++ + I G P+ F +++
Sbjct: 222 VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQ 281
Query: 157 ADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 197
+ + E ++ D RKR + +
Sbjct: 282 NGFKMDQPFY--ATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 1e-28
Identities = 39/203 (19%), Positives = 79/203 (38%), Gaps = 13/203 (6%)
Query: 5 KLQHLFYSNSFLFFTRFCEGGELLDRILSRGGRYLEE-DAKTIVEKILNIVAFCHLQGVV 63
+L + T + E G L+D + + G L + +I +AF + +
Sbjct: 72 RLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI 131
Query: 64 HRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ--RLNDIVGSAYYVAPEVL-HRSYN 120
HRDL+ N L + K+ DFGL+ + ++ + APE + + ++
Sbjct: 132 HRDLRAANILVSDTLSC---KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 188
Query: 121 VEGDMWSIGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRR 179
++ D+WS G++ ++ G P+ T + +++ R + + E +R
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER---GYRMVRPDNCPEELYQLMRL 245
Query: 180 LLNKDHRKRMTAAQALTHPWLHD 202
+ R T + L D
Sbjct: 246 CWKERPEDRPTFDYLRS--VLED 266
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 108 bits (270), Expect = 1e-27
Identities = 36/196 (18%), Positives = 72/196 (36%), Gaps = 10/196 (5%)
Query: 5 KLQHLFYSNSFLFF-TRFCEGGELLDRILSRGGRYLEED-AKTIVEKILNIVAFCHLQGV 62
+L + + T F G LLD + + + + +I + + + +
Sbjct: 77 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 136
Query: 63 VHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ--RLNDIVGSAYYVAPEVL-HRSY 119
+HRDL N L E+ +KV DFGLS + D + APE L + +
Sbjct: 137 IHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 193
Query: 120 NVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRR 179
+++ D+W+ GV+ + + + + +L D + + +R
Sbjct: 194 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM--ERPEGCPEKVYELMRA 251
Query: 180 LLNKDHRKRMTAAQAL 195
+ R + A+
Sbjct: 252 CWQWNPSDRPSFAEIH 267
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 107 bits (268), Expect = 3e-27
Identities = 34/201 (16%), Positives = 68/201 (33%), Gaps = 15/201 (7%)
Query: 3 HQKLQHLFYSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGV 62
+ + G L D + G ++ + +++L V H + +
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSL 122
Query: 63 VHRDLKPENFLFT--TREEDAPLKVIDFGLSDFVRPD--------QRLNDIVGSAYYVAP 112
V+RD+KP+NFL + + V+DFG+ F R + ++ G+A Y++
Sbjct: 123 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182
Query: 113 EVL-HRSYNVEGDMWSIGVITYILLCGSRPFWARTESG----IFRSVLRADPNFHDSPWP 167
R + D+ ++G + L GS P+ + R +
Sbjct: 183 NTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCA 242
Query: 168 SVSPEAKDFVRRLLNKDHRKR 188
E ++ N
Sbjct: 243 GFPEEFYKYMHYARNLAFDAT 263
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 105 bits (263), Expect = 2e-26
Identities = 34/223 (15%), Positives = 70/223 (31%), Gaps = 34/223 (15%)
Query: 1 MYHQKLQHLFYSNSFLFFTRFCEGGELLDRILSRGGRYL--------------------- 39
+ L + G+L + + S +
Sbjct: 77 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 136
Query: 40 --EEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPD 97
+ I ++ +A+ + VHRDL N L E+ +K+ DFGLS +
Sbjct: 137 LSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG---ENMVVKIADFGLSRNIYSA 193
Query: 98 QRL---NDIVGSAYYVAPEVL-HRSYNVEGDMWSIGVITYILLCGSR-PFWARTESGIFR 152
+ ++ PE + + Y E D+W+ GV+ + + P++ +
Sbjct: 194 DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIY 253
Query: 153 SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQAL 195
V + + + E + +R +K R +
Sbjct: 254 YVRDGNI---LACPENCPLELYNLMRLCWSKLPADRPSFCSIH 293
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (260), Expect = 5e-26
Identities = 32/191 (16%), Positives = 68/191 (35%), Gaps = 11/191 (5%)
Query: 13 NSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENF 72
S L + + G+L + I + +D ++ + F + VHRDL N
Sbjct: 102 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNC 161
Query: 73 LFTTREEDAPLKVIDFGLSDFVRPDQ-----RLNDIVGSAYYVAPEVLH-RSYNVEGDMW 126
+ E +KV DFGL+ + + ++A E L + + + D+W
Sbjct: 162 MLD---EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVW 218
Query: 127 SIGVITYILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHR 186
S GV+ + L+ P + + L + + + + +
Sbjct: 219 SFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY--CPDPLYEVMLKCWHPKAE 276
Query: 187 KRMTAAQALTH 197
R + ++ ++
Sbjct: 277 MRPSFSELVSR 287
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 6e-26
Identities = 36/189 (19%), Positives = 71/189 (37%), Gaps = 12/189 (6%)
Query: 13 NSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENF 72
+ T + E G L + + G + ++ I + + VHRDL N
Sbjct: 82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNI 141
Query: 73 LFTTREEDAPLKVIDFGLSDFVRPDQR----LNDIVGSAYYVAPEVL-HRSYNVEGDMWS 127
L + KV DFGLS + D + + APE + +R + D+WS
Sbjct: 142 LVN---SNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWS 198
Query: 128 IGVITYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHR 186
G++ + ++ G RP+W + + +++ + F + + ++
Sbjct: 199 FGIVMWEVMTYGERPYWELSNHEVMKAI---NDGFRLPTPMDCPSAIYQLMMQCWQQERA 255
Query: 187 KRMTAAQAL 195
+R A +
Sbjct: 256 RRPKFADIV 264
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 8e-25
Identities = 32/201 (15%), Positives = 64/201 (31%), Gaps = 20/201 (9%)
Query: 12 SNSFLFFTRFCEGGELLDRILSRGGRYL---------------EEDAKTIVEKILNIVAF 56
+ G L + + +R L +D + ++ + +
Sbjct: 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEY 150
Query: 57 CHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL- 115
+ +HRDL N L T + ++ + ++APE L
Sbjct: 151 LASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF 210
Query: 116 HRSYNVEGDMWSIGVITY-ILLCGSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAK 174
R Y + D+WS GV+ + I G P+ +F+ + + + E
Sbjct: 211 DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE---GHRMDKPSNCTNELY 267
Query: 175 DFVRRLLNKDHRKRMTAAQAL 195
+R + +R T Q +
Sbjct: 268 MMMRDCWHAVPSQRPTFKQLV 288
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.5 bits (247), Expect = 3e-24
Identities = 40/214 (18%), Positives = 72/214 (33%), Gaps = 28/214 (13%)
Query: 5 KLQHLFYSNSFLFF-TRFCEGGELLDRILSRGGRYL-----------------EEDAKTI 46
L T +C G+LL+ + + ++ ED +
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 47 VEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRL---NDI 103
++ +AF + +HRDL N L K+ DFGL+ ++ D +
Sbjct: 151 SYQVAKGMAFLASKNCIHRDLAARNIL---LTHGRITKICDFGLARDIKNDSNYVVKGNA 207
Query: 104 VGSAYYVAPEVLHRSY-NVEGDMWSIGVITYILLCGSRP-FWARTESGIFRSVLRADPNF 161
++APE + E D+WS G+ + L + F +++ F
Sbjct: 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK--EGF 265
Query: 162 HDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQAL 195
E D ++ + D KR T Q +
Sbjct: 266 RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 100 bits (249), Expect = 3e-24
Identities = 48/246 (19%), Positives = 79/246 (32%), Gaps = 47/246 (19%)
Query: 21 FCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQ-GVVHRDLKPENFLFTTREE 79
L K I +++L + + H + G++H D+KPEN L +
Sbjct: 105 VLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS 164
Query: 80 DAPL-KVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVL-HRSYNVEGDMWSIGVITYILLC 137
L ++ L + D+ + + + Y +PEVL + D+WS + + L+
Sbjct: 165 PENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELIT 224
Query: 138 GSRPFWARTESGIF---------------------------------RSVLRADPNFHDS 164
G F R +LR
Sbjct: 225 GDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFW 284
Query: 165 PWPSV-----------SPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVPLDILI 213
P V + E DF+ +L D RKR A + HPWL D + +
Sbjct: 285 PLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPD 344
Query: 214 YKLVKS 219
+L S
Sbjct: 345 RELYGS 350
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.6 bits (242), Expect = 1e-23
Identities = 40/206 (19%), Positives = 76/206 (36%), Gaps = 25/206 (12%)
Query: 12 SNSFLFFTRFCEGGELLDRILSRGGRYL---------------EEDAKTIVEKILNIVAF 56
+ FC+ G L + S+ ++ E ++ + F
Sbjct: 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEF 149
Query: 57 CHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ---RLNDIVGSAYYVAPE 113
+ +HRDL N L + E +K+ DFGL+ + D R D ++APE
Sbjct: 150 LASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 206
Query: 114 VL-HRSYNVEGDMWSIGVITYILLCGSR-PFWARTESGIFRSVLRADPNFHDSPWPSVSP 171
+ R Y ++ D+WS GV+ + + P+ F L+ + +P
Sbjct: 207 TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDY--TTP 264
Query: 172 EAKDFVRRLLNKDHRKRMTAAQALTH 197
E + + + +R T ++ + H
Sbjct: 265 EMYQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.1 bits (238), Expect = 4e-23
Identities = 32/214 (14%), Positives = 71/214 (33%), Gaps = 26/214 (12%)
Query: 11 YSNSFLFFTRFCEGGELLDRILSRGGRYL---------EEDAKTIVEKILNIVAFCHLQG 61
L G+L + S + +I + +A+ +
Sbjct: 94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK 153
Query: 62 VVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRL---NDIVGSAYYVAPEVL-HR 117
VHRDL N + ED +K+ DFG++ + + +++PE L
Sbjct: 154 FVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG 210
Query: 118 SYNVEGDMWSIGVITYILLCGSR-PFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDF 176
+ D+WS GV+ + + + P+ + + R V+ + +
Sbjct: 211 VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL---LDKPDNCPDMLFEL 267
Query: 177 VRRLLNKDHRKRMTAAQALT------HPWLHDEN 204
+R + + R + + ++ P + +
Sbjct: 268 MRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 301
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.8 bits (232), Expect = 3e-22
Identities = 35/219 (15%), Positives = 71/219 (32%), Gaps = 43/219 (19%)
Query: 15 FLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQ--------GVVHRD 66
+ + E G L D + E + + +A H++ + HRD
Sbjct: 76 LWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRD 133
Query: 67 LKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ-----RLNDIVGSAYYVAPEVL------ 115
LK +N L ++ + D GL+ N VG+ Y+APEVL
Sbjct: 134 LKSKNILVK---KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM 190
Query: 116 -HRSYNVEGDMWSIGVITYILLCGSRPFWARTESGI-FRSVLRADPNFHD---------- 163
H D++++G++ + + + + + ++ +DP+ +
Sbjct: 191 KHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKL 250
Query: 164 -------SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQAL 195
+R + R+TA +
Sbjct: 251 RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 54.8 bits (131), Expect = 2e-09
Identities = 23/91 (25%), Positives = 39/91 (42%), Gaps = 7/91 (7%)
Query: 40 EEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLS-DFVRPDQ 98
E+ +++ IL VA + +G+VH DL N L + + + +IDF S +
Sbjct: 102 VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS----EEGIWIIDFPQSVEVGEEGW 157
Query: 99 RLNDIVGSAYYVAPEVLHRSYNVEGDMWSIG 129
R +I+ R+Y E D+ S
Sbjct: 158 R--EILERDVRNIITYFSRTYRTEKDINSAI 186
|
| >d1lkja_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 146 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 50.6 bits (120), Expect = 2e-08
Identities = 27/148 (18%), Positives = 62/148 (41%), Gaps = 10/148 (6%)
Query: 235 SKALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLS 293
S LTEE++ + F L + +G +S + + +++ V +++N ++
Sbjct: 1 SSNLTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGLS-PSEAEVNDLMNEIDVDG 59
Query: 294 DQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEEL-----ALELNL 348
+ ++ + EF A + + E+ A FD + G+ +IS EL ++ L
Sbjct: 60 NHQIEFSEFLALMSRQLKSNDSEQELLEAFKVFD---KNGDGLISAAELKHVLTSIGEKL 116
Query: 349 APAAYSLLNDCIRNSDGKLSFLGYKRFL 376
A + + + G+++ + L
Sbjct: 117 TDAEVDDMLREVSDGSGEINIQQFAALL 144
|
| >d1topa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} Length = 162 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 50.3 bits (119), Expect = 3e-08
Identities = 27/149 (18%), Positives = 60/149 (40%), Gaps = 8/149 (5%)
Query: 238 LTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQK 296
L+EE + +A F + + G +S + + + + I+ ++
Sbjct: 14 LSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKE-ELDAIIEEVDEDGSGT 72
Query: 297 LAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALELNLAPAAYS-- 354
+ +EEF + +A + ++ F F++ + I +EEL L +
Sbjct: 73 IDFEEFLVMMVRQMKEDAKGKSEEELANCFRIFDKNADGFIDIEELGEILRATGEHVTEE 132
Query: 355 ----LLNDCIRNSDGKLSFLGYKRFLHGV 379
L+ D +N+DG++ F + + + GV
Sbjct: 133 DIEDLMKDSDKNNDGRIDFDEFLKMMEGV 161
|
| >d1dtla_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} Length = 156 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 48.4 bits (114), Expect = 2e-07
Identities = 32/156 (20%), Positives = 67/156 (42%), Gaps = 9/156 (5%)
Query: 232 KALSKALTEEELVYLRAQFMLL--EPKDGCVSLNNFKVALMRQATDAMTDSRVFEILNVM 289
KA + LTEE+ +A F + +DG +S MR T + E+++ +
Sbjct: 2 KAAVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKV-MRMLGQNPTPEELQEMIDEV 60
Query: 290 EPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALELNLA 349
+ + ++EF + ++ + ++ F F++ + I +EEL + L
Sbjct: 61 DEDGSGTVDFDEFLVMMVRSMKDDSKGKSEEELSDLFRMFDKNADGYIDLEELKIMLQAT 120
Query: 350 PAAYS------LLNDCIRNSDGKLSFLGYKRFLHGV 379
+ L+ D +N+DG++ + + F+ GV
Sbjct: 121 GETITEDDIEELMKDGDKNNDGRIDYDEFLEFMKGV 156
|
| >d1s6ja_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} Length = 87 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Score = 42.2 bits (99), Expect = 6e-06
Identities = 17/77 (22%), Positives = 40/77 (51%), Gaps = 2/77 (2%)
Query: 232 KALSKALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVME 290
K +++ L+EEE+ L+ F +++ G ++ + K L R ++ + +S + ++++ +
Sbjct: 11 KHMAERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSE-LMESEIKDLMDAAD 69
Query: 291 PLSDQKLAYEEFCAAAT 307
+ Y EF AA
Sbjct: 70 IDKSGTIDYGEFIAATV 86
|
| >d1g8ia_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Human (Homo sapiens) [TaxId: 9606]} Length = 187 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Frequenin (neuronal calcium sensor 1) species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.1 bits (103), Expect = 8e-06
Identities = 26/171 (15%), Positives = 58/171 (33%), Gaps = 25/171 (14%)
Query: 226 LKRAALKALSKA--LTEEELVYLRAQFMLLEPKDGCVSLNNFKVALMRQATDAMTDSRVF 283
LK ++ L++ TE+E+ F+ P G + F+ +
Sbjct: 5 LKPEVVEELTRKTYFTEKEVQQWYKGFIKDCP-SGQLDAAGFQKIYKQFFPFGDPTKFAT 63
Query: 284 EILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELA 343
+ NV + D ++ + EF A + + E+ AF ++ + + I+ E+
Sbjct: 64 FVFNVFDENKDGRIEFSEFIQALSVTSRGTLDEKLRW----AFKLYDLDNDGYITRNEML 119
Query: 344 LELNLAPA------------------AYSLLNDCIRNSDGKLSFLGYKRFL 376
++ + +N+DGKL+ ++
Sbjct: 120 DIVDAIYQMVGNTVELPEEENTPEKRVDRIFAMMDKNADGKLTLQEFQEGS 170
|
| >d1exra_ a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetraurelia) [TaxId: 5888]} Length = 146 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Ciliate (Paramecium tetraurelia) [TaxId: 5888]
Score = 41.8 bits (97), Expect = 3e-05
Identities = 25/146 (17%), Positives = 61/146 (41%), Gaps = 11/146 (7%)
Query: 238 LTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQK 296
LTEE++ + F L + DG ++ + + T++ + +++N ++ +
Sbjct: 3 LTEEQIAEFKEAFALFDKDGDGTITTKELGTVMRSLGQN-PTEAELQDMINEVDADGNGT 61
Query: 297 LAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALELNLAPAAYS-- 354
+ + EF + + + E A FD ++GN +IS EL + +
Sbjct: 62 IDFPEFLSLMARKMKEQDSEEELIEAFKVFD---RDGNGLISAAELRHVMTNLGEKLTDD 118
Query: 355 ----LLNDCIRNSDGKLSFLGYKRFL 376
++ + + DG +++ + R +
Sbjct: 119 EVDEMIREADIDGDGHINYEEFVRMM 144
|
| >d2jxca1 a.39.1.6 (A:121-215) Eps15 {Human (Homo sapiens) [TaxId: 9606]} Length = 95 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (91), Expect = 6e-05
Identities = 15/69 (21%), Positives = 27/69 (39%), Gaps = 3/69 (4%)
Query: 237 ALTEEELVYLRAQFMLLEPKDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQK 296
A+ E+ A F L P +G +S + K L+ + + + + + D
Sbjct: 3 AVKPEDKAKYDAIFDSLSPVNGFLSGDKVKPVLLNS---KLPVDILGRVWELSDIDHDGM 59
Query: 297 LAYEEFCAA 305
L +EF A
Sbjct: 60 LDRDEFAVA 68
|
| >d1wrka1 a.39.1.5 (A:4-85) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} Length = 82 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]
Score = 37.3 bits (86), Expect = 2e-04
Identities = 17/75 (22%), Positives = 32/75 (42%), Gaps = 3/75 (4%)
Query: 232 KALSKALTEEELVYLRAQFMLL--EPKDGCVSLNNFKVALMRQATDAMTDSRVFEILNVM 289
KA + LTEE+ +A F + +DG +S MR T + E+++ +
Sbjct: 3 KAAVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKV-MRMLGQNPTPEELQEMIDEV 61
Query: 290 EPLSDQKLAYEEFCA 304
+ + ++EF
Sbjct: 62 DEDGSGTVDFDEFLV 76
|
| >d1f54a_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 77 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 35.7 bits (82), Expect = 7e-04
Identities = 16/71 (22%), Positives = 36/71 (50%), Gaps = 2/71 (2%)
Query: 235 SKALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLS 293
S LTEE++ + F L + +G +S + MR + +++ V +++N ++
Sbjct: 1 SSNLTEEQIAEFKEAFALFDKDNNGSISSSELATV-MRSLGLSPSEAEVNDLMNEIDVDG 59
Query: 294 DQKLAYEEFCA 304
+ ++ + EF A
Sbjct: 60 NHQIEFSEFLA 70
|
| >d1c7va_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} Length = 68 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium vector protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Score = 35.6 bits (82), Expect = 8e-04
Identities = 14/66 (21%), Positives = 27/66 (40%), Gaps = 4/66 (6%)
Query: 240 EEELVYLRAQFMLL-EPKDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLA 298
EEE+ F + DG + + FK + + + +TD+ V E + + + +
Sbjct: 1 EEEI---LRAFKVFDANGDGVIDFDEFKFIMQKVGEEPLTDAEVEEAMKEADEDGNGVID 57
Query: 299 YEEFCA 304
EF
Sbjct: 58 IPEFMD 63
|
| >d1avsa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} Length = 81 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 35.3 bits (81), Expect = 0.001
Identities = 14/68 (20%), Positives = 26/68 (38%), Gaps = 2/68 (2%)
Query: 238 LTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQK 296
L+EE + +A F + + G +S MR T + I+ ++
Sbjct: 8 LSEEMIAEFKAAFDMFDADGGGDISTKELGTV-MRMLGQNPTKEELDAIIEEVDEDGSGT 66
Query: 297 LAYEEFCA 304
+ +EEF
Sbjct: 67 IDFEEFLV 74
|
| >d2pq3a1 a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [TaxId: 10116]} Length = 73 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Rattus norvegicus [TaxId: 10116]
Score = 34.2 bits (78), Expect = 0.003
Identities = 14/68 (20%), Positives = 31/68 (45%), Gaps = 2/68 (2%)
Query: 238 LTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQK 296
LTEE++ + F L + DG ++ MR T++ + +++N ++ +
Sbjct: 2 LTEEQIAEFKEAFSLFDKDGDGTITTKELGTV-MRSLGQNPTEAELQDMINEVDADGNGT 60
Query: 297 LAYEEFCA 304
+ + EF
Sbjct: 61 IDFPEFLT 68
|
| >d1s6ia_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} Length = 182 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Score = 36.2 bits (82), Expect = 0.003
Identities = 30/157 (19%), Positives = 72/157 (45%), Gaps = 10/157 (6%)
Query: 238 LTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQK 296
L+EEE+ L+ F +++ G ++ + K L R ++ + +S + ++++ +
Sbjct: 4 LSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSE-LMESEIKDLMDAADIDKSGT 62
Query: 297 LAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELAL---ELNLAPA-A 352
+ Y EF AA + +LE E AF YF+++G+ I+++E+ + L
Sbjct: 63 IDYGEFIAATVHLNKLEREENLVS----AFSYFDKDGSGYITLDEIQQACKDFGLDDIHI 118
Query: 353 YSLLNDCIRNSDGKLSFLGYKRFLHGVTVRSSNTRHG 389
++ + +++DG++ + + + R
Sbjct: 119 DDMIKEIDQDNDGQIDYGEFAAMMRKRKGNGGIGRRT 155
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 389 | |||
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1exra_ | 146 | Calmodulin {Ciliate (Paramecium tetraurelia) [TaxI | 99.88 | |
| d1topa_ | 162 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 99.88 | |
| d1lkja_ | 146 | Calmodulin {Baker's yeast (Saccharomyces cerevisia | 99.87 | |
| d1wdcb_ | 142 | Myosin Essential Chain {Bay scallop (Aequipecten i | 99.87 | |
| d1dtla_ | 156 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 99.86 | |
| d2obha1 | 141 | Calmodulin {Human (Homo sapiens) [TaxId: 9606]} | 99.85 | |
| d1jfja_ | 134 | EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: | 99.85 | |
| d1wdcc_ | 152 | Myosin Regulatory Chain {Bay scallop (Aequipecten | 99.84 | |
| d1g8ia_ | 187 | Frequenin (neuronal calcium sensor 1) {Human (Homo | 99.83 | |
| d1auib_ | 165 | Calcineurin regulatory subunit (B-chain) {Human (H | 99.83 | |
| d2mysb_ | 145 | Myosin Essential Chain {Chicken (Gallus gallus) [T | 99.83 | |
| d1s6ia_ | 182 | Calcium-dependent protein kinase sk5 CLD {Soybean | 99.83 | |
| d2mysc_ | 145 | Myosin Regulatory Chain {Chicken (Gallus gallus) [ | 99.82 | |
| d1bjfa_ | 181 | Neurocalcin {Cow (Bos taurus) [TaxId: 9913]} | 99.82 | |
| d2zfda1 | 183 | Calcineurin B-like protein 2 {Thale cress (Arabido | 99.81 | |
| d1jbaa_ | 189 | Guanylate cyclase activating protein 2, GCAP-2 {Co | 99.81 | |
| d1fpwa_ | 190 | Frequenin (neuronal calcium sensor 1) {Baker's yea | 99.81 | |
| d1omra_ | 201 | Recoverin {Cow (Bos taurus) [TaxId: 9913]} | 99.81 | |
| d1ggwa_ | 140 | Cdc4p {Fission yeast (Schizosaccharomyces pombe) [ | 99.8 | |
| d1s6ca_ | 178 | Kchip1, Kv4 potassium channel-interacting protein | 99.79 | |
| d1m45a_ | 146 | Myosin Light Chain Mlc1p {Baker's yeast (Saccharom | 99.78 | |
| d1y1xa_ | 182 | Programmed cell death 6 protein-like protein {Leis | 99.78 | |
| d1hqva_ | 181 | Apoptosis-linked protein alg-2 {Mouse (Mus musculu | 99.77 | |
| d1w7jb1 | 139 | Myosin Essential Chain {Human (Homo sapiens) [TaxI | 99.76 | |
| d1df0a1 | 186 | Calpain large subunit, C-terminal domain (domain I | 99.75 | |
| d1xo5a_ | 180 | Calcium- and integrin-binding protein, CIB {Human | 99.75 | |
| d1alva_ | 173 | Calpain small (regulatory) subunit (domain VI) {Pi | 99.75 | |
| d1k94a_ | 165 | Grancalcin {Human (Homo sapiens) [TaxId: 9606]} | 99.75 | |
| d5pala_ | 109 | Parvalbumin {Leopard shark (Triakis semifasciata) | 99.74 | |
| d1qxpa2 | 188 | Calpain large subunit, C-terminal domain (domain I | 99.73 | |
| d1pvaa_ | 109 | Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | 99.73 | |
| d1juoa_ | 172 | Sorcin {Human (Homo sapiens) [TaxId: 9606]} | 99.71 | |
| d2sasa_ | 185 | Sarcoplasmic calcium-binding protein {Amphioxus (B | 99.7 | |
| d1ij5a_ | 321 | Cbp40 (plasmodial specific CaII-binding protein LA | 99.69 | |
| d2scpa_ | 174 | Sarcoplasmic calcium-binding protein {Sandworm (Ne | 99.68 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.68 | |
| d2pvba_ | 107 | Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | 99.67 | |
| d1rwya_ | 109 | Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} | 99.66 | |
| d1nyaa_ | 176 | Calerythrin {Saccharopolyspora erythraea [TaxId: 1 | 99.64 | |
| d1qv0a_ | 189 | Calcium-regulated photoprotein {Hydrozoa (Obelia l | 99.61 | |
| d1rroa_ | 108 | Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116 | 99.6 | |
| d1uhka1 | 187 | Calcium-regulated photoprotein {Jellyfish (Aequore | 99.58 | |
| d1jc2a_ | 75 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 99.5 | |
| d1c7va_ | 68 | Calcium vector protein {Amphioxus (Branchiostoma l | 99.47 | |
| d1fi5a_ | 81 | Troponin C {Chicken (Gallus gallus), cardiac isofo | 99.46 | |
| d1fw4a_ | 65 | Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | 99.46 | |
| d1oqpa_ | 77 | Caltractin (centrin 2) {Green algae (Chlamydomonas | 99.43 | |
| d1avsa_ | 81 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 99.41 | |
| d1f54a_ | 77 | Calmodulin {Baker's yeast (Saccharomyces cerevisia | 99.39 | |
| d1wrka1 | 82 | Troponin C {Human (Homo sapiens), cardiac isoform | 99.38 | |
| d1tiza_ | 67 | Calmodulin-related protein T21P5.17 {Thale cress ( | 99.38 | |
| d2opoa1 | 81 | Polcalcin Che a 3 {Pigweed (Chenopodium album) [Ta | 99.37 | |
| d2zkmx1 | 170 | Phospholipase C-beta-2 {Human (Homo sapiens) [TaxI | 99.37 | |
| d2pq3a1 | 73 | Calmodulin {Rattus norvegicus [TaxId: 10116]} | 99.37 | |
| d1wrka1 | 82 | Troponin C {Human (Homo sapiens), cardiac isoform | 99.36 | |
| d2fcea1 | 61 | Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | 99.36 | |
| d2opoa1 | 81 | Polcalcin Che a 3 {Pigweed (Chenopodium album) [Ta | 99.35 | |
| d1qx2a_ | 76 | Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]} | 99.35 | |
| d1f54a_ | 77 | Calmodulin {Baker's yeast (Saccharomyces cerevisia | 99.34 | |
| d1avsa_ | 81 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 99.33 | |
| d1hqva_ | 181 | Apoptosis-linked protein alg-2 {Mouse (Mus musculu | 99.32 | |
| d1s6ja_ | 87 | Calcium-dependent protein kinase sk5 CLD {Soybean | 99.31 | |
| d2pq3a1 | 73 | Calmodulin {Rattus norvegicus [TaxId: 10116]} | 99.31 | |
| d1alva_ | 173 | Calpain small (regulatory) subunit (domain VI) {Pi | 99.29 | |
| d1k94a_ | 165 | Grancalcin {Human (Homo sapiens) [TaxId: 9606]} | 99.29 | |
| d1df0a1 | 186 | Calpain large subunit, C-terminal domain (domain I | 99.28 | |
| d1jfja_ | 134 | EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: | 99.24 | |
| d1juoa_ | 172 | Sorcin {Human (Homo sapiens) [TaxId: 9606]} | 99.22 | |
| d1s6ja_ | 87 | Calcium-dependent protein kinase sk5 CLD {Soybean | 99.21 | |
| d1c7va_ | 68 | Calcium vector protein {Amphioxus (Branchiostoma l | 99.21 | |
| d1fw4a_ | 65 | Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | 99.21 | |
| d1y1xa_ | 182 | Programmed cell death 6 protein-like protein {Leis | 99.21 | |
| d1qxpa2 | 188 | Calpain large subunit, C-terminal domain (domain I | 99.19 | |
| d2fcea1 | 61 | Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | 99.18 | |
| d1jc2a_ | 75 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 99.17 | |
| d1fpwa_ | 190 | Frequenin (neuronal calcium sensor 1) {Baker's yea | 99.17 | |
| d1tiza_ | 67 | Calmodulin-related protein T21P5.17 {Thale cress ( | 99.16 | |
| d1a4pa_ | 92 | Calcyclin (S100) {Human (Homo sapiens), P11 s100a1 | 99.16 | |
| d1cb1a_ | 78 | Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]} | 99.15 | |
| d1omra_ | 201 | Recoverin {Cow (Bos taurus) [TaxId: 9913]} | 99.15 | |
| d1zfsa1 | 93 | Calcyclin (S100) {Rat (Rattus norvegicus), s100a1 | 99.15 | |
| d1c07a_ | 95 | Eps15 {Human (Homo sapiens) [TaxId: 9606]} | 99.13 | |
| d1yuta1 | 98 | Calcyclin (S100) {Human (Homo sapiens), s100a13 [T | 99.12 | |
| d1k8ua_ | 89 | Calcyclin (S100) {Human (Homo sapiens), s100a6 [Ta | 99.12 | |
| d1fi5a_ | 81 | Troponin C {Chicken (Gallus gallus), cardiac isofo | 99.11 | |
| d3c1va1 | 93 | Calcyclin (S100) {Human (Homo sapiens), s100a4 [Ta | 99.11 | |
| d1oqpa_ | 77 | Caltractin (centrin 2) {Green algae (Chlamydomonas | 99.11 | |
| d1ksoa_ | 93 | Calcyclin (S100) {Human (Homo sapiens), s100a3 [Ta | 99.1 | |
| d1wlza1 | 83 | DJ-1-binding protein, DJBP {Human (Homo sapiens) [ | 99.09 | |
| d1snla_ | 99 | Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [Tax | 99.08 | |
| d1fi6a_ | 92 | Reps1 {Mouse (Mus musculus) [TaxId: 10090]} | 99.08 | |
| d1jbaa_ | 189 | Guanylate cyclase activating protein 2, GCAP-2 {Co | 99.08 | |
| d1xk4a1 | 87 | Calcyclin (S100) {Human (Homo sapiens), calgranuli | 99.05 | |
| d1wlza1 | 83 | DJ-1-binding protein, DJBP {Human (Homo sapiens) [ | 99.04 | |
| d1pvaa_ | 109 | Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | 99.03 | |
| d1g8ia_ | 187 | Frequenin (neuronal calcium sensor 1) {Human (Homo | 99.0 | |
| d1exra_ | 146 | Calmodulin {Ciliate (Paramecium tetraurelia) [TaxI | 99.0 | |
| d1fi6a_ | 92 | Reps1 {Mouse (Mus musculus) [TaxId: 10090]} | 99.0 | |
| d1xo5a_ | 180 | Calcium- and integrin-binding protein, CIB {Human | 98.99 | |
| d1s6ca_ | 178 | Kchip1, Kv4 potassium channel-interacting protein | 98.99 | |
| d2jxca1 | 95 | Eps15 {Human (Homo sapiens) [TaxId: 9606]} | 98.99 | |
| d5pala_ | 109 | Parvalbumin {Leopard shark (Triakis semifasciata) | 98.98 | |
| d1iq3a_ | 110 | Pob1 {Human (Homo sapiens) [TaxId: 9606]} | 98.96 | |
| d1rwya_ | 109 | Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} | 98.96 | |
| d1qx2a_ | 76 | Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]} | 98.95 | |
| d1rroa_ | 108 | Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116 | 98.95 | |
| d1c07a_ | 95 | Eps15 {Human (Homo sapiens) [TaxId: 9606]} | 98.95 | |
| d2zfda1 | 183 | Calcineurin B-like protein 2 {Thale cress (Arabido | 98.94 | |
| d1e8aa_ | 87 | Calcyclin (S100) {Human (Homo sapiens), calgranuli | 98.92 | |
| d2mysc_ | 145 | Myosin Regulatory Chain {Chicken (Gallus gallus) [ | 98.91 | |
| d1bjfa_ | 181 | Neurocalcin {Cow (Bos taurus) [TaxId: 9913]} | 98.91 | |
| d1psra_ | 100 | Calcyclin (S100) {Human (Homo sapiens), psoriasin | 98.9 | |
| d2obha1 | 141 | Calmodulin {Human (Homo sapiens) [TaxId: 9606]} | 98.9 | |
| d1qjta_ | 99 | Eps15 {Mouse (Mus musculus) [TaxId: 10090]} | 98.9 | |
| d2pvba_ | 107 | Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | 98.89 | |
| d2hf5a1 | 33 | Troponin C {Human (Homo sapiens), cardiac isoform | 98.88 | |
| d1a4pa_ | 92 | Calcyclin (S100) {Human (Homo sapiens), P11 s100a1 | 98.86 | |
| d1auib_ | 165 | Calcineurin regulatory subunit (B-chain) {Human (H | 98.85 | |
| d2jxca1 | 95 | Eps15 {Human (Homo sapiens) [TaxId: 9606]} | 98.84 | |
| d1yuta1 | 98 | Calcyclin (S100) {Human (Homo sapiens), s100a13 [T | 98.79 | |
| d1lkja_ | 146 | Calmodulin {Baker's yeast (Saccharomyces cerevisia | 98.78 | |
| d1zfsa1 | 93 | Calcyclin (S100) {Rat (Rattus norvegicus), s100a1 | 98.78 | |
| d1topa_ | 162 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 98.77 | |
| d3c1va1 | 93 | Calcyclin (S100) {Human (Homo sapiens), s100a4 [Ta | 98.76 | |
| d1psra_ | 100 | Calcyclin (S100) {Human (Homo sapiens), psoriasin | 98.75 | |
| d1m45a_ | 146 | Myosin Light Chain Mlc1p {Baker's yeast (Saccharom | 98.73 | |
| d1s6ia_ | 182 | Calcium-dependent protein kinase sk5 CLD {Soybean | 98.72 | |
| d2mysb_ | 145 | Myosin Essential Chain {Chicken (Gallus gallus) [T | 98.71 | |
| d1cb1a_ | 78 | Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]} | 98.71 | |
| d1xk4a1 | 87 | Calcyclin (S100) {Human (Homo sapiens), calgranuli | 98.69 | |
| d1ksoa_ | 93 | Calcyclin (S100) {Human (Homo sapiens), s100a3 [Ta | 98.69 | |
| d2sasa_ | 185 | Sarcoplasmic calcium-binding protein {Amphioxus (B | 98.68 | |
| d1ggwa_ | 140 | Cdc4p {Fission yeast (Schizosaccharomyces pombe) [ | 98.65 | |
| d1k8ua_ | 89 | Calcyclin (S100) {Human (Homo sapiens), s100a6 [Ta | 98.64 | |
| d1wdcb_ | 142 | Myosin Essential Chain {Bay scallop (Aequipecten i | 98.63 | |
| d1snla_ | 99 | Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [Tax | 98.6 | |
| d1iq3a_ | 110 | Pob1 {Human (Homo sapiens) [TaxId: 9606]} | 98.6 | |
| d1e8aa_ | 87 | Calcyclin (S100) {Human (Homo sapiens), calgranuli | 98.6 | |
| d1qv0a_ | 189 | Calcium-regulated photoprotein {Hydrozoa (Obelia l | 98.59 | |
| d1uhka1 | 187 | Calcium-regulated photoprotein {Jellyfish (Aequore | 98.59 | |
| d2scpa_ | 174 | Sarcoplasmic calcium-binding protein {Sandworm (Ne | 98.58 | |
| d3cr5x1 | 90 | Calcyclin (S100) {Cow (Bos taurus), s100b [TaxId: | 98.54 | |
| d1wdcc_ | 152 | Myosin Regulatory Chain {Bay scallop (Aequipecten | 98.53 | |
| d1dtla_ | 156 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 98.53 | |
| d1qlsa_ | 95 | Calcyclin (S100) {Pig (Sus scrofa), calgizzarin s1 | 98.5 | |
| d1qjta_ | 99 | Eps15 {Mouse (Mus musculus) [TaxId: 10090]} | 98.49 | |
| d1nyaa_ | 176 | Calerythrin {Saccharopolyspora erythraea [TaxId: 1 | 98.49 | |
| d1w7jb1 | 139 | Myosin Essential Chain {Human (Homo sapiens) [TaxI | 98.48 | |
| d1ctda_ | 34 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 98.43 | |
| d1xk4c1 | 83 | Calcyclin (S100) {Human (Homo sapiens), s100a9 (mr | 98.35 | |
| d2zkmx1 | 170 | Phospholipase C-beta-2 {Human (Homo sapiens) [TaxI | 98.32 | |
| d1j55a_ | 94 | Calcyclin (S100) {Human (Homo sapiens), s100p [Tax | 98.31 | |
| d3cr5x1 | 90 | Calcyclin (S100) {Cow (Bos taurus), s100b [TaxId: | 98.28 | |
| d1ij5a_ | 321 | Cbp40 (plasmodial specific CaII-binding protein LA | 98.19 | |
| d1xk4c1 | 83 | Calcyclin (S100) {Human (Homo sapiens), s100a9 (mr | 98.14 | |
| d1j55a_ | 94 | Calcyclin (S100) {Human (Homo sapiens), s100p [Tax | 98.14 | |
| d1qlsa_ | 95 | Calcyclin (S100) {Pig (Sus scrofa), calgizzarin s1 | 98.08 | |
| d1tuza_ | 118 | Diacylglycerol kinase alpha, N-terminal domain {Hu | 97.59 | |
| d2hf5a1 | 33 | Troponin C {Human (Homo sapiens), cardiac isoform | 97.44 | |
| d1tuza_ | 118 | Diacylglycerol kinase alpha, N-terminal domain {Hu | 97.4 | |
| d1sraa_ | 151 | C-terminal (EC) domain of BM-40/SPARC/osteonectin | 97.38 | |
| d1ctda_ | 34 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 97.12 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 96.81 | |
| d1sraa_ | 151 | C-terminal (EC) domain of BM-40/SPARC/osteonectin | 95.58 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 95.4 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 95.35 | |
| d1qasa1 | 94 | Phosphoinositide-specific phospholipase C, isozyme | 94.88 | |
| d1h8ba_ | 73 | alpha-Actinin {Human (Homo sapiens) [TaxId: 9606]} | 94.26 | |
| d1qasa1 | 94 | Phosphoinositide-specific phospholipase C, isozyme | 92.18 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 91.56 | |
| d2cclb1 | 59 | Endo-1,4-beta-xylanase Y {Clostridium thermocellum | 90.13 | |
| d1eg3a2 | 97 | Dystrophin {Human (Homo sapiens) [TaxId: 9606]} | 90.06 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 87.48 | |
| d1h8ba_ | 73 | alpha-Actinin {Human (Homo sapiens) [TaxId: 9606]} | 86.7 | |
| d1dava_ | 71 | Cellulosome endoglucanase SS {Clostridium thermoce | 85.48 | |
| d1pula1 | 103 | Hypothetical protein c32e8.3 {Caenorhabditis elega | 84.18 | |
| d2cclb1 | 59 | Endo-1,4-beta-xylanase Y {Clostridium thermocellum | 81.79 |
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.2e-52 Score=383.92 Aligned_cols=223 Identities=38% Similarity=0.726 Sum_probs=179.8
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|+||||++++ +++.+|+|||||+||+|.+++.++ +.+++.+++.++.||+.||+|||++||+||||||+||++..
T Consensus 64 l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~ 142 (307)
T d1a06a_ 64 IKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK-GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYS 142 (307)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTC-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESS
T ss_pred CCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhcc-cCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecc
Confidence 6899999999 467899999999999999988765 78999999999999999999999999999999999999976
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVL 155 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 155 (389)
.+.++.+||+|||+|..........+.+||+.|+|||++.+ .|+.++||||+||++|+|++|++||.+....+....+.
T Consensus 143 ~~~~~~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~ 222 (307)
T d1a06a_ 143 LDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQIL 222 (307)
T ss_dssp SSTTCCEEECCC------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred cCCCceEEEeccceeEEccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHh
Confidence 56678999999999988766666677889999999999864 69999999999999999999999999999999999999
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCCC-CCCccHHHHHHHHHHhhcC
Q 016471 156 RADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENR-PVPLDILIYKLVKSYLRAT 224 (389)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 224 (389)
+....++.+.++.+|+++++||.+||.+||.+|||++|+++||||++... .......+...++.....+
T Consensus 223 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (307)
T d1a06a_ 223 KAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKKNFAKS 292 (307)
T ss_dssp TTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSSCCCCCCCHHHHHHHHHHHSCCC
T ss_pred ccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCCccccccchhHHHHHHHHHHHh
Confidence 98887777777889999999999999999999999999999999986532 3333444444444443333
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-51 Score=364.78 Aligned_cols=193 Identities=27% Similarity=0.571 Sum_probs=174.0
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|+||||++++ +.+.+|+|||||+||+|.+++.+. +.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 63 l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~~-~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill-- 139 (263)
T d2j4za1 63 LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL-- 139 (263)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE--
T ss_pred cCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeecccccee--
Confidence 6899999999 467899999999999999988766 679999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVL 155 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 155 (389)
+.++.+||+|||+|...... .....+||+.|+|||++.+ .|+.++||||+||++|+|++|++||.+.+..+.+..+.
T Consensus 140 -~~~~~~kl~DFG~a~~~~~~-~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~ 217 (263)
T d2j4za1 140 -GSAGELKIADFGWSVHAPSS-RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS 217 (263)
T ss_dssp -CTTSCEEECCCCSCSCCCCC-CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred -cCCCCEeecccceeeecCCC-cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 56789999999999876433 3456789999999999865 68999999999999999999999999999999999888
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCC
Q 016471 156 RADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 202 (389)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~ 202 (389)
+....++ +.+|+++++||.+||++||.+|||++|+++||||+.
T Consensus 218 ~~~~~~p----~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 218 RVEFTFP----DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp TTCCCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred cCCCCCC----ccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 8765544 358999999999999999999999999999999964
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.2e-50 Score=378.55 Aligned_cols=204 Identities=37% Similarity=0.646 Sum_probs=185.6
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|+||||++++ ..+++|+|||||+||+|.+++.+..+++++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 80 l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~ 159 (350)
T d1koaa2 80 LRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT 159 (350)
T ss_dssp TCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS
T ss_pred CCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeecc
Confidence 6899999999 468899999999999999988766678999999999999999999999999999999999999963
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVL 155 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 155 (389)
+.++.+||+|||+|..........+..||+.|+|||++.+ .|+.++||||+||++|+|++|+.||.+.+..+.+..+.
T Consensus 160 -~~~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~ 238 (350)
T d1koaa2 160 -KRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK 238 (350)
T ss_dssp -TTSCCEEECCCTTCEECCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred -CCCCeEEEeecchheecccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 2457899999999998876666667899999999999864 68999999999999999999999999999999999999
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCCC
Q 016471 156 RADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENR 205 (389)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~~ 205 (389)
.....++...++.+|+++++||.+||..||.+|||++|+|+||||+....
T Consensus 239 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~ 288 (350)
T d1koaa2 239 SCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 288 (350)
T ss_dssp HTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTC
T ss_pred hCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 88877777666789999999999999999999999999999999987643
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-50 Score=365.11 Aligned_cols=197 Identities=24% Similarity=0.465 Sum_probs=171.5
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|+||||++++ +.+++|+|||||+||+|.+++.+ +.+++.+++.++.||+.||+|||++||+||||||+|||+
T Consensus 74 l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl-- 149 (293)
T d1yhwa1 74 NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL-- 149 (293)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--
T ss_pred CCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEE--
Confidence 6899999999 46889999999999999987654 469999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCC-CCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPD-QRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
+.++.+||+|||+|...... ......+||+.|+|||++.+ .|+.++||||+||++|+|++|++||.+.+.......+
T Consensus 150 -~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~ 228 (293)
T d1yhwa1 150 -GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI 228 (293)
T ss_dssp -CTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred -CCCCcEeeccchhheeeccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHH
Confidence 56789999999999876543 34456789999999999864 6899999999999999999999999998887777766
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~ 203 (389)
...... ....++.+|+.+++||.+||..||.+|||++|+|+||||+..
T Consensus 229 ~~~~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~ 276 (293)
T d1yhwa1 229 ATNGTP-ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (293)
T ss_dssp HHHCSC-CCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HhCCCC-CCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 654322 122235689999999999999999999999999999999754
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-51 Score=366.36 Aligned_cols=198 Identities=29% Similarity=0.556 Sum_probs=167.4
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|+||||++++ ..+.+|+|||||+||+|.+++.++ +.+++.+++.++.||+.||+|||++||+||||||+|||+
T Consensus 60 l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl-- 136 (271)
T d1nvra_ 60 LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL-- 136 (271)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE--
T ss_pred CCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEE--
Confidence 6899999999 468899999999999999987544 689999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC---CcccccccCCccccccccc-cC-CCchhHHHHHHHHHHHHhCCCCCCCCChhHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ---RLNDIVGSAYYVAPEVLHR-SY-NVEGDMWSIGVITYILLCGSRPFWARTESGIF 151 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 151 (389)
+.++.+||+|||+|+...... .....+||+.|+|||++.+ .+ +.++||||+||++|+|++|++||.+.......
T Consensus 137 -~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~ 215 (271)
T d1nvra_ 137 -DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 215 (271)
T ss_dssp -CTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH
T ss_pred -CCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH
Confidence 567889999999998764332 2456789999999999854 44 67899999999999999999999876654443
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCC
Q 016471 152 RSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 152 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~ 203 (389)
......... ...+++.+|+++++||.+||..||.+|||++|+++||||+..
T Consensus 216 ~~~~~~~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 266 (271)
T d1nvra_ 216 YSDWKEKKT-YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 266 (271)
T ss_dssp HHHHHTTCT-TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHHHhcCCC-CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCcC
Confidence 333333322 233456789999999999999999999999999999999764
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3e-50 Score=376.12 Aligned_cols=203 Identities=36% Similarity=0.654 Sum_probs=185.9
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|+||||++++ +.+.+|+|||||+||+|.+++.++..++++.+++.++.||+.||+|||++||+||||||+|||++.
T Consensus 83 l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~ 162 (352)
T d1koba_ 83 LHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET 162 (352)
T ss_dssp CCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS
T ss_pred CCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccc
Confidence 6899999999 468899999999999999988777668999999999999999999999999999999999999953
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVL 155 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 155 (389)
..++.+||+|||+|.............||+.|+|||++.+ .|+.++||||+||++|+|++|.+||.+.+..+.+..+.
T Consensus 163 -~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~ 241 (352)
T d1koba_ 163 -KKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVK 241 (352)
T ss_dssp -TTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH
T ss_pred -cCCCeEEEeecccceecCCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 2467899999999998877766677889999999999864 69999999999999999999999999999999999999
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 156 RADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
+....++...++.+|+++++||.+||.+||.+|||++|+|+||||+...
T Consensus 242 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 242 RCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp HCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred hCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence 9888877777788999999999999999999999999999999998753
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-50 Score=366.95 Aligned_cols=199 Identities=27% Similarity=0.513 Sum_probs=174.3
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|+||||++++ ..+.+|+|||||+||+|.+++.+..+.+++.+++.++.||+.||.|||++||+||||||+|||+
T Consensus 66 l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll-- 143 (288)
T d2jfla1 66 CDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILF-- 143 (288)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--
T ss_pred CCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeE--
Confidence 6899999998 4688999999999999999887776789999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCC-CCcccccccCCcccccccc------ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhH
Q 016471 77 REEDAPLKVIDFGLSDFVRPD-QRLNDIVGSAYYVAPEVLH------RSYNVEGDMWSIGVITYILLCGSRPFWARTESG 149 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 149 (389)
+.++.+||+|||+|...... ....+.+||+.|+|||++. ..|+.++||||+||++|+|++|++||.+.+..+
T Consensus 144 -~~~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~ 222 (288)
T d2jfla1 144 -TLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR 222 (288)
T ss_dssp -CTTSCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG
T ss_pred -CCCCCEEEEechhhhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH
Confidence 56789999999999765322 2334578999999999872 348899999999999999999999999999988
Q ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCC
Q 016471 150 IFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 150 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~ 203 (389)
.+..+.+..+.... ..+.+|+++++||.+||+.||.+|||++|+++||||+..
T Consensus 223 ~~~~i~~~~~~~~~-~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 223 VLLKIAKSEPPTLA-QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp HHHHHHHSCCCCCS-SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred HHHHHHcCCCCCCC-ccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 88888876543222 225689999999999999999999999999999999753
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-50 Score=360.15 Aligned_cols=195 Identities=19% Similarity=0.368 Sum_probs=166.7
Q ss_pred CCCccccceee--------cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCCC
Q 016471 1 MYHQKLQHLFY--------SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQG--VVHRDLKPE 70 (389)
Q Consensus 1 l~Hpni~~~~~--------~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--i~Hrdlkp~ 70 (389)
|+||||+++|. ...+|+|||||+||+|.+++.+. +.+++..++.++.||+.||+|||++| |+||||||+
T Consensus 65 l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~ 143 (270)
T d1t4ha_ 65 LQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCD 143 (270)
T ss_dssp CCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGG
T ss_pred CCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChh
Confidence 68999999983 24589999999999999988766 68999999999999999999999999 999999999
Q ss_pred cEEEeecCCCCCEEEeecCCccccCCCCCcccccccCCccccccccccCCCchhHHHHHHHHHHHHhCCCCCCCCCh-hH
Q 016471 71 NFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHRSYNVEGDMWSIGVITYILLCGSRPFWARTE-SG 149 (389)
Q Consensus 71 Nill~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~ 149 (389)
|||++ +.++.+||+|||+|+.... ....+.+||+.|+|||++.+.|+.++||||+||++|+|++|+.||.+... ..
T Consensus 144 NILl~--~~~~~~Kl~DFGla~~~~~-~~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~ 220 (270)
T d1t4ha_ 144 NIFIT--GPTGSVKIGDLGLATLKRA-SFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ 220 (270)
T ss_dssp GEEES--STTSCEEECCTTGGGGCCT-TSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH
T ss_pred hceee--CCCCCEEEeecCcceeccC-CccCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH
Confidence 99995 3568899999999976443 33456789999999999988899999999999999999999999977554 44
Q ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCC
Q 016471 150 IFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLH 201 (389)
Q Consensus 150 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~ 201 (389)
+...+..... +.......++++++||.+||.+||++|||++|+++||||+
T Consensus 221 ~~~~i~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 221 IYRRVTSGVK--PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHTTTCC--CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHHHcCCC--CcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 4555554322 2222245789999999999999999999999999999995
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=360.98 Aligned_cols=196 Identities=33% Similarity=0.619 Sum_probs=172.2
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|+||||++++ +.+.+|+|||||+||+|.+++... +.+++..++.++.|++.||+|||++||+||||||+|||+
T Consensus 65 l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll-- 141 (288)
T d1uu3a_ 65 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL-- 141 (288)
T ss_dssp CCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--
T ss_pred cCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhcc-CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCcccccc--
Confidence 6899999998 467899999999999999987766 789999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC---CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ---RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFR 152 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 152 (389)
+.++.+||+|||+|+...... ...+.+||+.|+|||++. ..|+.++||||+||++|+|++|+.||.+.+..++..
T Consensus 142 -~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~ 220 (288)
T d1uu3a_ 142 -NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ 220 (288)
T ss_dssp -CTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred -CCCceEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHH
Confidence 577899999999998765322 344568999999999986 469999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHH------HhCCCCCCCCC
Q 016471 153 SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQ------ALTHPWLHDEN 204 (389)
Q Consensus 153 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e------~l~h~~~~~~~ 204 (389)
++.+....++ ..+|+++++||.+||++||.+|||++| +++||||++.+
T Consensus 221 ~i~~~~~~~p----~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~ 274 (288)
T d1uu3a_ 221 KIIKLEYDFP----EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 274 (288)
T ss_dssp HHHTTCCCCC----TTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred HHHcCCCCCC----ccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCC
Confidence 9988766554 358999999999999999999999987 58899998764
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-49 Score=362.75 Aligned_cols=203 Identities=37% Similarity=0.665 Sum_probs=181.1
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|+||||++++ +.+++|+|||||+||+|.+++..+ +.+++..++.++.||+.||+|||++||+||||||+||+++.
T Consensus 70 l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~ 148 (293)
T d1jksa_ 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLD 148 (293)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESC
T ss_pred CCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEec
Confidence 6899999999 468899999999999999988766 68999999999999999999999999999999999999964
Q ss_pred cC-CCCCEEEeecCCccccCCCCCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 RE-EDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
.+ ....+|++|||+|..........+..||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+.+..+.+..+
T Consensus 149 ~~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i 228 (293)
T d1jksa_ 149 RNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV 228 (293)
T ss_dssp SSSSSCCEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CCCcccceEecchhhhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 32 123699999999998876666677889999999999864 6999999999999999999999999999999999999
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
.+....++...++.+|+.+++||++||..||.+|||++++++||||+..+
T Consensus 229 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 278 (293)
T d1jksa_ 229 SAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 278 (293)
T ss_dssp HTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC--
T ss_pred HhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 88877666555578999999999999999999999999999999998654
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-49 Score=363.58 Aligned_cols=195 Identities=30% Similarity=0.568 Sum_probs=176.4
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|+||||++++ ..+.+|+|||||+||+|.+++.+. +.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 62 l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~~-~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl-- 138 (337)
T d1o6la_ 62 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML-- 138 (337)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE--
T ss_pred CCCCCEEEEEeeeccccccccceeccCCCchhhhhhcc-cCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEe--
Confidence 6899999999 467899999999999999988766 689999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCC-CCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRP-DQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
+.++.+||+|||+|+.... .......+||+.|+|||++. ..|+.++||||+||++|+|++|++||.+.+..++...+
T Consensus 139 -~~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i 217 (337)
T d1o6la_ 139 -DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217 (337)
T ss_dssp -CTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred -cCCCCEEEeecccccccccCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHH
Confidence 5778999999999987543 44556789999999999986 46999999999999999999999999999999999999
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCC-----HHHHhCCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMT-----AAQALTHPWLHDE 203 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s-----~~e~l~h~~~~~~ 203 (389)
......++ +.+|+++++||++||++||.+|++ ++++++||||++.
T Consensus 218 ~~~~~~~p----~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 218 LMEEIRFP----RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp HHCCCCCC----TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred hcCCCCCC----ccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccC
Confidence 88776554 458999999999999999999994 8999999999764
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=7.9e-49 Score=354.88 Aligned_cols=197 Identities=35% Similarity=0.673 Sum_probs=180.7
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
.||||++++ +++++|||||||+||+|.+++..+ +.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 68 ~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill--- 143 (277)
T d1phka_ 68 GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL--- 143 (277)
T ss_dssp TCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---
T ss_pred CCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEE---
Confidence 399999999 468899999999999999998766 689999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCCccccCCCCCcccccccCCcccccccc-------ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHH
Q 016471 78 EEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-------RSYNVEGDMWSIGVITYILLCGSRPFWARTESGI 150 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 150 (389)
+.++.+||+|||+|............+||+.|+|||++. ..++.++||||+||++|+|++|+.||.+.+....
T Consensus 144 ~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~ 223 (277)
T d1phka_ 144 DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM 223 (277)
T ss_dssp CTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred cCCCCeEEccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHH
Confidence 578899999999999887666666788999999999873 2378899999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCC
Q 016471 151 FRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 202 (389)
Q Consensus 151 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~ 202 (389)
...+......++.+.++.+|+++++||.+||+.+|.+|||++|+++||||+.
T Consensus 224 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 224 LRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp HHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred HHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 9999988877777777789999999999999999999999999999999975
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-48 Score=358.47 Aligned_cols=196 Identities=22% Similarity=0.355 Sum_probs=170.6
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|+||||++++ +.+.+|+|||||.||+|..++.. ++.+++.+++.++.||+.||.|||++||+||||||+|||++
T Consensus 72 l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~- 149 (309)
T d1u5ra_ 72 LRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS- 149 (309)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE-
T ss_pred CCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEC-
Confidence 6899999999 46789999999999998665544 47899999999999999999999999999999999999994
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc----ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH----RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFR 152 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 152 (389)
.++.+||+|||+|..... ....+||+.|+|||++. +.|+.++||||+||++|+|++|..||.+.+..+.+.
T Consensus 150 --~~~~~Kl~DFG~a~~~~~---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~ 224 (309)
T d1u5ra_ 150 --EPGLVKLGDFGSASIMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY 224 (309)
T ss_dssp --TTTEEEECCCTTCBSSSS---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred --CCCCEEEeecccccccCC---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 678999999999987543 34568999999999874 358999999999999999999999999988888888
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCCC
Q 016471 153 SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENR 205 (389)
Q Consensus 153 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~~ 205 (389)
.+........ ....+|+.+++||.+||..||.+|||++++++||||.....
T Consensus 225 ~i~~~~~~~~--~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~~ 275 (309)
T d1u5ra_ 225 HIAQNESPAL--QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 275 (309)
T ss_dssp HHHHSCCCCC--SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCC
T ss_pred HHHhCCCCCC--CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCCCC
Confidence 7776653322 23468999999999999999999999999999999976543
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=366.85 Aligned_cols=202 Identities=31% Similarity=0.614 Sum_probs=183.7
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
++||||++++ +.+++|+|||||+||+|.+++..++..+++.+++.++.||+.||+|||++||+||||||+|||++.
T Consensus 58 l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~ 137 (321)
T d1tkia_ 58 ARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT 137 (321)
T ss_dssp SCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS
T ss_pred CCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecC
Confidence 6899999999 468899999999999999988776568999999999999999999999999999999999999953
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVL 155 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 155 (389)
++...+||+|||++.............||+.|+|||.+. ..|+.++||||+||++|+|++|.+||.+.+..+.+..+.
T Consensus 138 -~~~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~ 216 (321)
T d1tkia_ 138 -RRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIM 216 (321)
T ss_dssp -SSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred -CCceEEEEcccchhhccccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 245689999999998877666666778999999999885 468999999999999999999999999999999999999
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCC
Q 016471 156 RADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~ 203 (389)
+....++...++.+|+++++||.+||.+||.+|||++|+++||||+..
T Consensus 217 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 217 NAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred hCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 988877776677899999999999999999999999999999999654
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-49 Score=353.99 Aligned_cols=194 Identities=26% Similarity=0.473 Sum_probs=159.4
Q ss_pred CCCccccceee------cCeEEEEEEccCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CEecC
Q 016471 1 MYHQKLQHLFY------SNSFLFFTRFCEGGELLDRILS---RGGRYLEEDAKTIVEKILNIVAFCHLQG-----VVHRD 66 (389)
Q Consensus 1 l~Hpni~~~~~------~~~~~lv~E~~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~~~-----i~Hrd 66 (389)
|+||||++++. ++.+|+|||||+||+|.+++.+ .++.+++..++.++.||+.||+|||++| |+|||
T Consensus 60 l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrD 139 (269)
T d2java1 60 LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRD 139 (269)
T ss_dssp CCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------
T ss_pred CCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCc
Confidence 68999999982 3568999999999999998864 3467999999999999999999999976 99999
Q ss_pred CCCCcEEEeecCCCCCEEEeecCCccccCCCC-CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCC
Q 016471 67 LKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWA 144 (389)
Q Consensus 67 lkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~ 144 (389)
|||+|||+ +.++.+||+|||+|....... .....+||+.|+|||++. ..|+.++||||+||++|+|++|++||.+
T Consensus 140 iKp~NIll---~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~ 216 (269)
T d2java1 140 LKPANVFL---DGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA 216 (269)
T ss_dssp CCGGGEEE---CTTSCEEECCHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CchhhcCc---CCCCcEEEeeccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCC
Confidence 99999999 567899999999998765433 345678999999999986 4699999999999999999999999999
Q ss_pred CChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCC
Q 016471 145 RTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 145 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~ 200 (389)
.+..++...+........ ...+|+++++||.+||..||.+|||++|+++|||+
T Consensus 217 ~~~~~~~~~i~~~~~~~~---~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 217 FSQKELAGKIREGKFRRI---PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp SSHHHHHHHHHHTCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred CCHHHHHHHHHcCCCCCC---CcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 998888888877654322 24689999999999999999999999999999996
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=368.98 Aligned_cols=204 Identities=34% Similarity=0.646 Sum_probs=171.6
Q ss_pred CCCccccceee--------cCeEEEEEEccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCc
Q 016471 1 MYHQKLQHLFY--------SNSFLFFTRFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPEN 71 (389)
Q Consensus 1 l~Hpni~~~~~--------~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~N 71 (389)
++||||++++. ..++|+|||||+||+|.+++.+++ ..+++.+++.++.||+.||+|||++||+||||||+|
T Consensus 62 ~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~N 141 (335)
T d2ozaa1 62 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPEN 141 (335)
T ss_dssp TTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred cCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccc
Confidence 37999999872 366899999999999999997653 469999999999999999999999999999999999
Q ss_pred EEEeecCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHH
Q 016471 72 FLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGI 150 (389)
Q Consensus 72 ill~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 150 (389)
||++..++.+.+||+|||+|+...........+||+.|+|||++.+ .|+.++||||+||++|+|++|++||.+.+....
T Consensus 142 Ill~~~~~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~ 221 (335)
T d2ozaa1 142 LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI 221 (335)
T ss_dssp EEESCSSTTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--
T ss_pred cccccccccccccccccceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH
Confidence 9997655677899999999998776666677899999999999865 699999999999999999999999988766554
Q ss_pred HHHHH----hcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 151 FRSVL----RADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 151 ~~~i~----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
...+. .....++...++.+|+++++||++||+.||.+|||+.|+++||||....
T Consensus 222 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 279 (335)
T d2ozaa1 222 SPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 279 (335)
T ss_dssp ------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred HHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCC
Confidence 44333 2333344444456899999999999999999999999999999997553
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1e-47 Score=354.06 Aligned_cols=194 Identities=27% Similarity=0.594 Sum_probs=174.5
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
++||||++++ ..+.+|+|||||+||+|..++... +.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 61 l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl-- 137 (316)
T d1fota_ 61 VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL-- 137 (316)
T ss_dssp CCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE--
T ss_pred ccCcChhheeeeEeeCCeeeeEeeecCCcccccccccc-ccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeE--
Confidence 6899999999 468899999999999998877655 789999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVL 155 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 155 (389)
+.++.+||+|||+|+.... ...+.+||+.|+|||++.+ .|+.++||||+||++|+|++|+.||.+.+..+....+.
T Consensus 138 -~~~g~vkL~DFG~a~~~~~--~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~ 214 (316)
T d1fota_ 138 -DKNGHIKITDFGFAKYVPD--VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL 214 (316)
T ss_dssp -CTTSCEEECCCSSCEECSS--CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred -cCCCCEEEecCccceEecc--ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHH
Confidence 5788999999999987643 3346789999999999865 69999999999999999999999999999999999998
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCC-----CHHHHhCCCCCCCCC
Q 016471 156 RADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRM-----TAAQALTHPWLHDEN 204 (389)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----s~~e~l~h~~~~~~~ 204 (389)
+....++ +.+|++++++|.+||.+||.+|+ |++++++||||++..
T Consensus 215 ~~~~~~p----~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~ 264 (316)
T d1fota_ 215 NAELRFP----PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV 264 (316)
T ss_dssp HCCCCCC----TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred cCCCCCC----CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCC
Confidence 8765544 45899999999999999999996 899999999998753
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=354.03 Aligned_cols=195 Identities=30% Similarity=0.548 Sum_probs=175.0
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
++||||++++ +.+.+|+|||||+||+|.+++... +.+++.+++.++.||+.||+|||++||+||||||+|||+
T Consensus 60 ~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~~-~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~-- 136 (320)
T d1xjda_ 60 WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL-- 136 (320)
T ss_dssp TTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE--
T ss_pred CCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceee--
Confidence 5899999999 468899999999999999988766 689999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCC-CCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPD-QRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
+.++.+||+|||+|+..... ......+||+.|+|||++.+ .|+.++||||+||++|+|++|+.||.+.+..+++..+
T Consensus 137 -~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i 215 (320)
T d1xjda_ 137 -DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI 215 (320)
T ss_dssp -CTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred -cCCCceeccccchhhhcccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 57889999999999866543 34455789999999999864 7999999999999999999999999999999999999
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHH-HHhCCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAA-QALTHPWLHDE 203 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~-e~l~h~~~~~~ 203 (389)
....+.++ +.+|+.+++||++||.+||.+|||+. ++++||||++.
T Consensus 216 ~~~~~~~p----~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~ 261 (320)
T d1xjda_ 216 RMDNPFYP----RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 261 (320)
T ss_dssp HHCCCCCC----TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred HcCCCCCC----ccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccC
Confidence 88765544 35899999999999999999999995 89999999764
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-48 Score=357.64 Aligned_cols=196 Identities=22% Similarity=0.376 Sum_probs=160.8
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCEecCCCCCcEEEe
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHL-QGVVHRDLKPENFLFT 75 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~-~~i~Hrdlkp~Nill~ 75 (389)
|+||||++++ +.+++|+|||||+||+|.+++.+. +.+++..++.++.||+.||.|||+ +||+||||||+|||+
T Consensus 61 l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl- 138 (322)
T d1s9ja_ 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV- 138 (322)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE-
T ss_pred CCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeE-
Confidence 6899999999 467899999999999999988766 689999999999999999999997 599999999999999
Q ss_pred ecCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHH--
Q 016471 76 TREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFR-- 152 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~-- 152 (389)
+.++.+||+|||+|...... ...+.+||+.|+|||++.+ .|+.++||||+||++|||++|+.||.+.+......
T Consensus 139 --~~~~~vkl~DFGla~~~~~~-~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~ 215 (322)
T d1s9ja_ 139 --NSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF 215 (322)
T ss_dssp --CTTCCEEECCCCCCHHHHHH-TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC
T ss_pred --CCCCCEEEeeCCCccccCCC-ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 56789999999999865432 2346789999999999864 79999999999999999999999998765432211
Q ss_pred ----------------------------------------HHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHH
Q 016471 153 ----------------------------------------SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAA 192 (389)
Q Consensus 153 ----------------------------------------~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~ 192 (389)
.+... ..+..+...+|+++++||.+||..||.+|||++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ 293 (322)
T d1s9ja_ 216 GCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNE--PPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 293 (322)
T ss_dssp ------------------------------CCCCHHHHHHHHHTS--CCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhcc--CCccCccccCCHHHHHHHHHHcCCChhHCcCHH
Confidence 00100 011111124689999999999999999999999
Q ss_pred HHhCCCCCCCC
Q 016471 193 QALTHPWLHDE 203 (389)
Q Consensus 193 e~l~h~~~~~~ 203 (389)
|+|+||||+..
T Consensus 294 e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 294 QLMVHAFIKRS 304 (322)
T ss_dssp HHHTSHHHHHH
T ss_pred HHhhCHhhCcC
Confidence 99999999653
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.4e-47 Score=358.22 Aligned_cols=197 Identities=25% Similarity=0.395 Sum_probs=167.4
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
+.||||++++ ..+.+|+|||||+||+|.+++.++ +.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 64 ~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl-- 140 (364)
T d1omwa3 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL-- 140 (364)
T ss_dssp SCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--
T ss_pred CCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEE--
Confidence 4699999998 457899999999999999988766 689999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc-c-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-R-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
+.++.+||+|||+|+..... .....+||+.|+|||++. + .|+.++||||+||++|+|++|+.||.+.+........
T Consensus 141 -~~~g~iKl~DFGla~~~~~~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~ 218 (364)
T d1omwa3 141 -DEHGHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 218 (364)
T ss_dssp -CSSSCEEECCCTTCEECSSS-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH
T ss_pred -cCCCcEEEeeeceeeecCCC-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 57789999999999876543 345678999999999985 3 5899999999999999999999999876554433222
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCC-----HHHHhCCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMT-----AAQALTHPWLHDE 203 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s-----~~e~l~h~~~~~~ 203 (389)
+.....+...++.+|+++++||.+||.+||.+||| ++++++||||++.
T Consensus 219 -~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i 271 (364)
T d1omwa3 219 -RMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 271 (364)
T ss_dssp -HHSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred -HhcccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence 22222222333578999999999999999999999 7999999999875
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.2e-47 Score=354.70 Aligned_cols=194 Identities=27% Similarity=0.529 Sum_probs=174.8
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|+||||++++ ....+|+|||||.||+|..++.+. +.+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 98 l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl-- 174 (350)
T d1rdqe_ 98 VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI-- 174 (350)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--
T ss_pred cCCCcEeecccccccccccccccccccccchhhhHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHccc--
Confidence 5899999998 457899999999999999988776 689999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSVL 155 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 155 (389)
+.++.+||+|||+|+.... ...+.+||+.|+|||++.+ .|+.++||||+||++|+|++|++||.+.+....+..+.
T Consensus 175 -~~~g~ikL~DFG~a~~~~~--~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~ 251 (350)
T d1rdqe_ 175 -DQQGYIQVTDFGFAKRVKG--RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 251 (350)
T ss_dssp -CTTSCEEECCCTTCEECSS--CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred -CCCCCEEeeeceeeeeccc--ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHh
Confidence 5678999999999987653 3346789999999999864 69999999999999999999999999999999999998
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCC-----CHHHHhCCCCCCCCC
Q 016471 156 RADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRM-----TAAQALTHPWLHDEN 204 (389)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----s~~e~l~h~~~~~~~ 204 (389)
.....++ +.+|+++.+||++||.+||.+|+ |++++++||||++.+
T Consensus 252 ~~~~~~p----~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~ 301 (350)
T d1rdqe_ 252 SGKVRFP----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD 301 (350)
T ss_dssp HCCCCCC----TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred cCCCCCC----ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCC
Confidence 8765543 46899999999999999999995 999999999997753
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=351.36 Aligned_cols=203 Identities=24% Similarity=0.354 Sum_probs=171.6
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|+||||++++ .++++|+|||||.||++.. +...++.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 57 l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~-~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli-- 133 (299)
T d1ua2a_ 57 LSHPNIIGLLDAFGHKSNISLVFDFMETDLEVI-IKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL-- 133 (299)
T ss_dssp CCCTTBCCEEEEECCTTCCEEEEECCSEEHHHH-HTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE--
T ss_pred CCCCCEeEEEeeeccCCceeehhhhhcchHHhh-hhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEe--
Confidence 5899999999 4688999999999987654 44555789999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC-CcccccccCCcccccccc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRS 153 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 153 (389)
+.++.+||+|||+|....... .....+||+.|+|||++. ..|+.++||||+||++|+|++|.+||.+.+..+.+..
T Consensus 134 -~~~~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~ 212 (299)
T d1ua2a_ 134 -DENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTR 212 (299)
T ss_dssp -CTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred -cCCCccccccCccccccCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHH
Confidence 578899999999998765433 345568999999999874 3589999999999999999999999999998888877
Q ss_pred HHhcCCCCCCCC------------------------CCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCCCCC
Q 016471 154 VLRADPNFHDSP------------------------WPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPV 207 (389)
Q Consensus 154 i~~~~~~~~~~~------------------------~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~~~~ 207 (389)
+.+......... ++.+++++++||.+||+.||++|||++|+|+||||++...+.
T Consensus 213 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~ 290 (299)
T d1ua2a_ 213 IFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPT 290 (299)
T ss_dssp HHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCC
T ss_pred HHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCC
Confidence 765322211111 135689999999999999999999999999999998765443
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-46 Score=343.46 Aligned_cols=201 Identities=26% Similarity=0.365 Sum_probs=171.8
Q ss_pred CCccccceee---------cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcE
Q 016471 2 YHQKLQHLFY---------SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENF 72 (389)
Q Consensus 2 ~Hpni~~~~~---------~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Ni 72 (389)
+||||+++++ ...+|++||||.||.+........+.+++..++.++.||+.||+|||++||+||||||+||
T Consensus 68 ~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NI 147 (305)
T d1blxa_ 68 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNI 147 (305)
T ss_dssp CCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred CCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEE
Confidence 7999999982 2468999999999877655555667899999999999999999999999999999999999
Q ss_pred EEeecCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHH
Q 016471 73 LFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIF 151 (389)
Q Consensus 73 ll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 151 (389)
|+ +..+.+||+|||++............+||+.|+|||++. ..|+.++||||+||++|+|++|++||.+.+..+.+
T Consensus 148 Li---~~~~~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~ 224 (305)
T d1blxa_ 148 LV---TSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL 224 (305)
T ss_dssp EE---CTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred EE---cCCCCeeecchhhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHH
Confidence 99 577899999999998766556667789999999999885 57999999999999999999999999999888887
Q ss_pred HHHHhcCCCCCC-----------------------CCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCCC
Q 016471 152 RSVLRADPNFHD-----------------------SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENR 205 (389)
Q Consensus 152 ~~i~~~~~~~~~-----------------------~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~~ 205 (389)
..+.+....... ...+.+++.+++||.+||.+||.+|||++|+|+||||++...
T Consensus 225 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~ 301 (305)
T d1blxa_ 225 GKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 301 (305)
T ss_dssp HHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred HHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence 777643211111 112457899999999999999999999999999999987654
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=340.09 Aligned_cols=194 Identities=21% Similarity=0.373 Sum_probs=159.9
Q ss_pred CCCcccccee---ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 1 MYHQKLQHLF---YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 1 l~Hpni~~~~---~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
|+||||++++ .+..+|+|||||+||+|.+++...++.+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 61 l~HpnIv~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl--- 137 (276)
T d1uwha_ 61 TRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL--- 137 (276)
T ss_dssp CCCTTBCCEEEEECSSSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---
T ss_pred CCCCCEeeeeEEEeccEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEE---
Confidence 6899999999 3567899999999999999998777789999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCCccccCCC---CCcccccccCCcccccccc----ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHH
Q 016471 78 EEDAPLKVIDFGLSDFVRPD---QRLNDIVGSAYYVAPEVLH----RSYNVEGDMWSIGVITYILLCGSRPFWARTESGI 150 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 150 (389)
+.++.+||+|||+|...... .......||+.|+|||++. +.|+.++||||+||++|||++|+.||.+.+....
T Consensus 138 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~ 217 (276)
T d1uwha_ 138 HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 217 (276)
T ss_dssp ETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH
T ss_pred cCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH
Confidence 46789999999999766432 2344568999999999984 2488999999999999999999999988776655
Q ss_pred HHHHHhcCCCCC--CCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCC
Q 016471 151 FRSVLRADPNFH--DSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 197 (389)
Q Consensus 151 ~~~i~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h 197 (389)
...+.......+ ....+.+++.+.+|+.+||..||.+|||+++++++
T Consensus 218 ~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 218 IIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp HHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 444443322222 12235689999999999999999999999999864
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-46 Score=340.81 Aligned_cols=205 Identities=26% Similarity=0.424 Sum_probs=170.8
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|+||||++++ +.+++|+|||||.|+.+........+.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 58 l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~-- 135 (298)
T d1gz8a_ 58 LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI-- 135 (298)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--
T ss_pred CCCCcEEEeccccccccceeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheee--
Confidence 6899999999 5688999999998754443334445679999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCC-CCcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPD-QRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRS 153 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 153 (389)
+.++.+||+|||+|...... .......||+.|+|||++.. .++.++||||+||++|+|++|+.||.+.+....+..
T Consensus 136 -~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~ 214 (298)
T d1gz8a_ 136 -NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 214 (298)
T ss_dssp -CTTSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred -cccCcceeccCCcceeccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHH
Confidence 57789999999999876543 34556689999999998743 468899999999999999999999999888777776
Q ss_pred HHhcCCCCCCCC-------------------------CCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCCCCCC
Q 016471 154 VLRADPNFHDSP-------------------------WPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDENRPVP 208 (389)
Q Consensus 154 i~~~~~~~~~~~-------------------------~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~~~~~ 208 (389)
+.+......... .+.+|+++++||++||++||.+|||++|+++||||++...|.|
T Consensus 215 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p~p 294 (298)
T d1gz8a_ 215 IFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP 294 (298)
T ss_dssp HHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCCCC
T ss_pred HHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCCCC
Confidence 654322211111 1356899999999999999999999999999999998877665
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-45 Score=329.22 Aligned_cols=189 Identities=30% Similarity=0.524 Sum_probs=159.7
Q ss_pred CCcccccee----ecCeEEEEEEccCC-CChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEG-GELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~g-g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
.||||++++ ..+.+|+|||||.+ +++.+++.++ +.+++.+++.++.||+.||+|||++||+||||||+|||++
T Consensus 67 ~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~-~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~- 144 (273)
T d1xwsa_ 67 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID- 144 (273)
T ss_dssp SSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE-
T ss_pred CCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEe-
Confidence 399999999 45789999999987 5777766655 6899999999999999999999999999999999999995
Q ss_pred cCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc-c-CCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR-S-YNVEGDMWSIGVITYILLCGSRPFWARTESGIFRSV 154 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 154 (389)
.+++.+||+|||+|..... ....+.+||+.|+|||++.+ . ++.++||||+||++|+|++|+.||.+. ..+
T Consensus 145 -~~~~~vkl~DFG~a~~~~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~i 216 (273)
T d1xwsa_ 145 -LNRGELKLIDFGSGALLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEI 216 (273)
T ss_dssp -TTTTEEEECCCTTCEECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHH
T ss_pred -cCCCeEEECccccceeccc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc------hHH
Confidence 3457899999999986543 34456789999999999853 3 467799999999999999999999653 234
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 155 LRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
.+....++ +.+|+++++||.+||..||.+|||++|+++||||++..
T Consensus 217 ~~~~~~~~----~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 217 IRGQVFFR----QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262 (273)
T ss_dssp HHCCCCCS----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred hhcccCCC----CCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence 44443333 46899999999999999999999999999999997653
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-45 Score=333.14 Aligned_cols=194 Identities=18% Similarity=0.288 Sum_probs=166.5
Q ss_pred CCCcccccee---ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 1 MYHQKLQHLF---YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 1 l~Hpni~~~~---~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
|+||||++++ ..+.+|+|||||+||+|.+++...++.+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 66 l~HpnIv~l~g~~~~~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~-- 143 (285)
T d1u59a_ 66 LDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV-- 143 (285)
T ss_dssp CCCTTBCCEEEEEESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--
T ss_pred CCCCCEeeEeeeeccCeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeec--
Confidence 6899999999 35789999999999999998877667899999999999999999999999999999999999995
Q ss_pred CCCCCEEEeecCCccccCCCCC----cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 016471 78 EEDAPLKVIDFGLSDFVRPDQR----LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIF 151 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~ 151 (389)
.++.+||+|||+|+....... .....||+.|+|||++. +.++.++||||+||++|||++ |+.||.+.+..++.
T Consensus 144 -~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~ 222 (285)
T d1u59a_ 144 -NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM 222 (285)
T ss_dssp -ETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH
T ss_pred -cCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHH
Confidence 578899999999987654322 23456899999999985 579999999999999999998 99999998888888
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHh---CCCCC
Q 016471 152 RSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQAL---THPWL 200 (389)
Q Consensus 152 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l---~h~~~ 200 (389)
..+.++... + ..+.+|+++.+||.+||..+|.+|||+.+++ +|+|+
T Consensus 223 ~~i~~~~~~-~--~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 223 AFIEQGKRM-E--CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp HHHHTTCCC-C--CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHcCCCC-C--CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 877765432 1 1256899999999999999999999998874 45554
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-45 Score=339.86 Aligned_cols=191 Identities=21% Similarity=0.365 Sum_probs=163.3
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcC----------------------CCCCHHHHHHHHHHHHHHHH
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG----------------------GRYLEEDAKTIVEKILNIVA 55 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~----------------------~~l~~~~~~~i~~qi~~~L~ 55 (389)
+||||++++ ..+.+|+|||||+||+|.+++..+. +.+++..++.++.||+.||+
T Consensus 99 ~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ 178 (325)
T d1rjba_ 99 SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGME 178 (325)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHH
T ss_pred CCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHH
Confidence 799999999 3678999999999999999987653 24889999999999999999
Q ss_pred HHHHCCCEecCCCCCcEEEeecCCCCCEEEeecCCccccCCCCC---cccccccCCcccccccc-ccCCCchhHHHHHHH
Q 016471 56 FCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVI 131 (389)
Q Consensus 56 ~lH~~~i~Hrdlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~i 131 (389)
|||++||+||||||+|||+ +.++.+||+|||+|+....... ..+..||+.|+|||++. +.|+.++||||+||+
T Consensus 179 yLH~~~IiHRDlKp~Nill---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvi 255 (325)
T d1rjba_ 179 FLEFKSCVHRDLAARNVLV---THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGIL 255 (325)
T ss_dssp HHHHTTEEETTCSGGGEEE---ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred HHHhCCeeeccCchhcccc---ccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHH
Confidence 9999999999999999999 4678999999999987644332 23457899999999885 579999999999999
Q ss_pred HHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCC
Q 016471 132 TYILLC-GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 197 (389)
Q Consensus 132 l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h 197 (389)
+|||++ |.+||.+.+..+.+..+......++.+ +.+|+++++||.+||+.||.+|||++|+++|
T Consensus 256 l~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p--~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 256 LWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQP--FYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp HHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCC--CcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 999997 899999877776666666655443332 4689999999999999999999999999874
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-45 Score=331.08 Aligned_cols=188 Identities=19% Similarity=0.296 Sum_probs=160.8
Q ss_pred CCCcccccee---ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 1 MYHQKLQHLF---YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 1 l~Hpni~~~~---~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
|+||||++++ ..+..|+|||||+||+|.+++.+. +.+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 65 l~HpnIv~~~g~~~~~~~~lvmE~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~-- 141 (277)
T d1xbba_ 65 LDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV-- 141 (277)
T ss_dssp CCCTTBCCEEEEEESSSEEEEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--
T ss_pred CCCCCCceEEEEeccCCEEEEEEcCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhccc--
Confidence 6899999999 356789999999999999987655 6799999999999999999999999999999999999995
Q ss_pred CCCCCEEEeecCCccccCCCCC----cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 016471 78 EEDAPLKVIDFGLSDFVRPDQR----LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIF 151 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~ 151 (389)
.++.+||+|||+|+....... .....||+.|+|||++. +.++.++|||||||++|||++ |++||.+.+..++.
T Consensus 142 -~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~ 220 (277)
T d1xbba_ 142 -TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 220 (277)
T ss_dssp -ETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH
T ss_pred -ccCcccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHH
Confidence 578899999999987654322 23357899999999885 568999999999999999998 89999998888888
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHh
Q 016471 152 RSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQAL 195 (389)
Q Consensus 152 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l 195 (389)
..+.++... + ..+.+|+++.+||.+||..||.+|||+++++
T Consensus 221 ~~i~~~~~~-~--~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~ 261 (277)
T d1xbba_ 221 AMLEKGERM-G--CPAGCPREMYDLMNLCWTYDVENRPGFAAVE 261 (277)
T ss_dssp HHHHTTCCC-C--CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred HHHHcCCCC-C--CCcccCHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence 777764322 1 1246899999999999999999999999884
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.5e-45 Score=331.88 Aligned_cols=190 Identities=24% Similarity=0.391 Sum_probs=156.0
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|+||||++++ ..+.+|+|||||+||+|.+++....+.+++.++..++.||+.||+|||++||+||||||+|||+
T Consensus 84 l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl-- 161 (299)
T d1jpaa_ 84 FDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILV-- 161 (299)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--
T ss_pred CCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEE--
Confidence 6899999999 3578999999999999999888777789999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCC------cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChh
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQR------LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTES 148 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~------~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~ 148 (389)
+.++.+||+|||+|+....... .....||+.|+|||++. +.++.++|||||||++|||+| |++||.+.+..
T Consensus 162 -~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~ 240 (299)
T d1jpaa_ 162 -NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 240 (299)
T ss_dssp -CTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred -CCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH
Confidence 5788999999999987654322 12245789999999985 579999999999999999998 89999999888
Q ss_pred HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 149 GIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 149 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
++...+.+.... + ....+++.+.+|+.+||..||.+|||+.++++
T Consensus 241 ~~~~~i~~~~~~-~--~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~ 285 (299)
T d1jpaa_ 241 DVINAIEQDYRL-P--PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVN 285 (299)
T ss_dssp HHHHHHHTTCCC-C--CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHcCCCC-C--CCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 888887765322 2 22568999999999999999999999999875
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-44 Score=323.82 Aligned_cols=191 Identities=24% Similarity=0.380 Sum_probs=155.7
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|+||||++++ ..+.+|+|||||++|+|.+++......+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 57 l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill-- 134 (263)
T d1sm2a_ 57 LSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV-- 134 (263)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEE--
T ss_pred cCCCCcccccceeccCCceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheee--
Confidence 6899999999 3578999999999999999988777789999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC--CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ--RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFR 152 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 152 (389)
+.++.+||+|||+|+...... ......||+.|+|||++. +.|+.++||||+||++|||++ |.+||...+..+...
T Consensus 135 -~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~ 213 (263)
T d1sm2a_ 135 -GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE 213 (263)
T ss_dssp -CGGGCEEECSCC------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHH
T ss_pred -cCCCCeEecccchheeccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHH
Confidence 567899999999998765432 223467899999999986 469999999999999999999 677777777777888
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCC
Q 016471 153 SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 197 (389)
Q Consensus 153 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h 197 (389)
.+..+..... ....++++.+++.+||..||.+|||++++++|
T Consensus 214 ~i~~~~~~~~---p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 214 DISTGFRLYK---PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HHHHTCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcCCCCC---ccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 7776543222 13578999999999999999999999999864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.5e-44 Score=327.57 Aligned_cols=196 Identities=22% Similarity=0.435 Sum_probs=161.4
Q ss_pred CCCccccceee----c----CeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcE
Q 016471 1 MYHQKLQHLFY----S----NSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENF 72 (389)
Q Consensus 1 l~Hpni~~~~~----~----~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Ni 72 (389)
++||||++++. . ..+|+|||||+||+|.+++... +.+++.+++.++.||+.||+|||++||+||||||+||
T Consensus 64 ~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NI 142 (277)
T d1o6ya_ 64 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANI 142 (277)
T ss_dssp CCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred cCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhccc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCccc
Confidence 58999999982 1 2489999999999999988766 6899999999999999999999999999999999999
Q ss_pred EEeecCCCCCEEEeecCCccccCCC----CCcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 016471 73 LFTTREEDAPLKVIDFGLSDFVRPD----QRLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTE 147 (389)
Q Consensus 73 ll~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 147 (389)
|++ .++.++++|||.+...... ......+||+.|+|||++.+ .++.++||||+||++|+|++|++||.+.+.
T Consensus 143 ll~---~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~ 219 (277)
T d1o6ya_ 143 MIS---ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 219 (277)
T ss_dssp EEE---TTSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccC---ccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH
Confidence 994 6788999999988755332 23445689999999999864 699999999999999999999999999998
Q ss_pred hHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCC
Q 016471 148 SGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWL 200 (389)
Q Consensus 148 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~ 200 (389)
.+....+.+..+..+...++.+|+.++++|.+||.+||.+||+..+.+.|+|.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~ 272 (277)
T d1o6ya_ 220 VSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272 (277)
T ss_dssp HHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred HHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence 88888888877776666667899999999999999999999954444445543
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4e-44 Score=326.34 Aligned_cols=198 Identities=25% Similarity=0.435 Sum_probs=162.9
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|+||||++++ +.+.+|++||||.++.+.. +....+.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 57 l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~-~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll-- 133 (286)
T d1ob3a_ 57 LKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKL-LDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI-- 133 (286)
T ss_dssp CCCTTBCCEEEEEECSSCEEEEEECCSEEHHHH-HHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--
T ss_pred CCCCcEEeeeeecccCCceeEEEEeehhhhHHH-HHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeE--
Confidence 6899999999 4688999999999876654 55556889999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC-CcccccccCCcccccccc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRS 153 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 153 (389)
+.++.+|++|||.|....... ......|++.|+|||.+. ..++.++||||+||++|+|++|+.||.+.+..+...+
T Consensus 134 -~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~ 212 (286)
T d1ob3a_ 134 -NREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMR 212 (286)
T ss_dssp -CTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred -cCCCCEEecccccceecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHH
Confidence 578899999999998765432 344567999999999885 3579999999999999999999999999888777776
Q ss_pred HHhcCCCCCCC-------------------------CCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCC
Q 016471 154 VLRADPNFHDS-------------------------PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 202 (389)
Q Consensus 154 i~~~~~~~~~~-------------------------~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~ 202 (389)
+.+........ ..+.+++.+++||++||++||++|||++|+++||||++
T Consensus 213 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 213 IFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp HHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred HHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 65422211111 12357899999999999999999999999999999964
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-44 Score=324.32 Aligned_cols=194 Identities=19% Similarity=0.348 Sum_probs=163.3
Q ss_pred CCCcccccee---ecCeEEEEEEccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF---YSNSFLFFTRFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~---~~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|+||||++++ .++.+|+|||||++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 65 l~HpnIv~~~g~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll-- 142 (272)
T d1qpca_ 65 LQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV-- 142 (272)
T ss_dssp CCCTTBCCEEEEECSSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--
T ss_pred CCCCCEeEEEeeeccCCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheee--
Confidence 6899999999 3577899999999999998775332 369999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC--CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhC-CCCCCCCChhHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ--RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCG-SRPFWARTESGIFR 152 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~ 152 (389)
++++.+||+|||+|+...... ......||+.|+|||++. +.++.++||||+||++|||+|| .+||...+..+...
T Consensus 143 -~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~ 221 (272)
T d1qpca_ 143 -SDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ 221 (272)
T ss_dssp -CTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH
T ss_pred -ecccceeeccccceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 578899999999998775433 234567899999999885 5699999999999999999995 56666677777777
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC--CCCC
Q 016471 153 SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT--HPWL 200 (389)
Q Consensus 153 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~--h~~~ 200 (389)
.+..+..... .+.+++++.+|+.+||..||.+|||++++++ |+||
T Consensus 222 ~i~~~~~~~~---p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 222 NLERGYRMVR---PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp HHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhcCCCCC---cccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 7765432221 2468999999999999999999999999987 5665
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=332.02 Aligned_cols=201 Identities=23% Similarity=0.345 Sum_probs=164.9
Q ss_pred CCCccccceee----------cCeEEEEEEccCCCChHHHH--HhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCC
Q 016471 1 MYHQKLQHLFY----------SNSFLFFTRFCEGGELLDRI--LSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLK 68 (389)
Q Consensus 1 l~Hpni~~~~~----------~~~~~lv~E~~~gg~L~~~l--~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlk 68 (389)
|+||||++++. ..++|+|||||++|.+.... ......+++.+++.++.||+.||+|||++||+|||||
T Consensus 70 l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiK 149 (350)
T d1q5ka_ 70 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIK 149 (350)
T ss_dssp CCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCC
T ss_pred cCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCC
Confidence 68999999872 23589999999876433322 2344679999999999999999999999999999999
Q ss_pred CCcEEEeecCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 016471 69 PENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILLCGSRPFWART 146 (389)
Q Consensus 69 p~Nill~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 146 (389)
|+|||+. .++..+||+|||++..........+.+||+.|+|||.+. ..|+.++||||+||++|+|++|++||.+.+
T Consensus 150 p~NILl~--~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~ 227 (350)
T d1q5ka_ 150 PQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS 227 (350)
T ss_dssp GGGEEEC--TTTCCEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSS
T ss_pred cceEEEe--cCCCceeEecccchhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCC
Confidence 9999994 234589999999998887666667789999999999864 368999999999999999999999999888
Q ss_pred hhHHHHHHHhcCCC-----------------CC--------CCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCC
Q 016471 147 ESGIFRSVLRADPN-----------------FH--------DSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLH 201 (389)
Q Consensus 147 ~~~~~~~i~~~~~~-----------------~~--------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~ 201 (389)
..+.+..+.+.... ++ ....+.+++++.+||.+||.+||.+|||+.|+|+||||+
T Consensus 228 ~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~ 307 (350)
T d1q5ka_ 228 GVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 307 (350)
T ss_dssp HHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGG
T ss_pred HHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhc
Confidence 87776666532110 00 011245789999999999999999999999999999997
Q ss_pred CC
Q 016471 202 DE 203 (389)
Q Consensus 202 ~~ 203 (389)
+.
T Consensus 308 ~~ 309 (350)
T d1q5ka_ 308 EL 309 (350)
T ss_dssp GG
T ss_pred cc
Confidence 54
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-44 Score=324.08 Aligned_cols=190 Identities=19% Similarity=0.328 Sum_probs=156.6
Q ss_pred CCCcccccee---ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 1 MYHQKLQHLF---YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 1 l~Hpni~~~~---~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
|+||||++++ .++.+|+|||||++|+|.+++....+.+++..++.++.||+.||+|||++||+||||||+||+++
T Consensus 65 l~HpnIv~l~~~~~~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~-- 142 (273)
T d1mp8a_ 65 FDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS-- 142 (273)
T ss_dssp CCCTTBCCEEEEECSSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE--
T ss_pred CCCCCEeeEEEEEecCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeec--
Confidence 6899999999 35789999999999999998887778899999999999999999999999999999999999995
Q ss_pred CCCCCEEEeecCCccccCCCC--CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHHH
Q 016471 78 EEDAPLKVIDFGLSDFVRPDQ--RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFRS 153 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~ 153 (389)
.++.+||+|||+|+...... ......||+.|+|||++. +.|+.++||||+||++|||++ |.+||.+.+..++...
T Consensus 143 -~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~ 221 (273)
T d1mp8a_ 143 -SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR 221 (273)
T ss_dssp -ETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH
T ss_pred -CCCcEEEccchhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 56789999999998765432 233456899999999985 579999999999999999998 8999999999888888
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 154 VLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 154 i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
+..+... +.++.+|+.+.+||.+||..||.+|||+.++++
T Consensus 222 i~~~~~~---~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~ 261 (273)
T d1mp8a_ 222 IENGERL---PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 261 (273)
T ss_dssp HHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHcCCCC---CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 8765432 233678999999999999999999999999986
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.8e-44 Score=323.22 Aligned_cols=190 Identities=20% Similarity=0.296 Sum_probs=157.8
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEe
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 75 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~ 75 (389)
|+||||++++ ..+.+|+|||||++|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 70 l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl- 148 (287)
T d1opja_ 70 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV- 148 (287)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE-
T ss_pred CCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEE-
Confidence 6899999999 357899999999999999988753 4578999999999999999999999999999999999999
Q ss_pred ecCCCCCEEEeecCCccccCCCCC--cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCC-CCChhHHH
Q 016471 76 TREEDAPLKVIDFGLSDFVRPDQR--LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFW-ARTESGIF 151 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~-~~~~~~~~ 151 (389)
+.++.+||+|||+|+....... .....||+.|+|||++. +.|+.++||||+||++|||++|..||. +.+...+.
T Consensus 149 --~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~ 226 (287)
T d1opja_ 149 --GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 226 (287)
T ss_dssp --CGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred --CCCCcEEEccccceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHH
Confidence 5678999999999987654332 23346899999999875 579999999999999999999766654 44555555
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 152 RSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 152 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
..+... ...+ ..+.+++.+++||.+||..||.+|||++++++
T Consensus 227 ~~i~~~-~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 227 ELLEKD-YRME--RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp HHHHTT-CCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhcC-CCCC--CCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 444433 2222 22568999999999999999999999999975
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-43 Score=315.71 Aligned_cols=191 Identities=21% Similarity=0.352 Sum_probs=167.5
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
++||||++++ .++.+|+|||||++|+|.+++......+++..+..++.||+.||+|||++||+||||||+||++
T Consensus 56 l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill-- 133 (258)
T d1k2pa_ 56 LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV-- 133 (258)
T ss_dssp CCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEE--
T ss_pred cCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEE--
Confidence 5899999999 3578999999999999999988777789999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCCC--cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQR--LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFR 152 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 152 (389)
+.++.+||+|||+|+....... .....||+.|+|||++. ..++.++||||+||++|||+| |+.||.+.+..++..
T Consensus 134 -~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~ 212 (258)
T d1k2pa_ 134 -NDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE 212 (258)
T ss_dssp -CTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHH
T ss_pred -cCCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHH
Confidence 5788999999999986654332 23457899999999985 579999999999999999998 899999999988888
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCC
Q 016471 153 SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 197 (389)
Q Consensus 153 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h 197 (389)
.+.++..... ....++.+.+||.+||+.||.+|||++++++|
T Consensus 213 ~i~~~~~~~~---p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 213 HIAQGLRLYR---PHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp HHHTTCCCCC---CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHhCCCCCC---cccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 8876543222 24678999999999999999999999999975
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-43 Score=325.19 Aligned_cols=203 Identities=25% Similarity=0.415 Sum_probs=166.3
Q ss_pred CCCccccceee------------cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCC
Q 016471 1 MYHQKLQHLFY------------SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLK 68 (389)
Q Consensus 1 l~Hpni~~~~~------------~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlk 68 (389)
|+||||++++. ..++|+|||||.+|.+. .+......+++..++.++.||+.||.|||++||+|||||
T Consensus 66 l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~-~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlK 144 (318)
T d3blha1 66 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG-LLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMK 144 (318)
T ss_dssp CCCTTBCCEEEEEEC----------CEEEEEECCCEEHHH-HHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred hcCCCccceEeeeecccccccccCceEEEEEeccCCCccc-hhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcC
Confidence 68999999882 35689999999987654 444555789999999999999999999999999999999
Q ss_pred CCcEEEeecCCCCCEEEeecCCccccCCC-----CCcccccccCCcccccccc--ccCCCchhHHHHHHHHHHHHhCCCC
Q 016471 69 PENFLFTTREEDAPLKVIDFGLSDFVRPD-----QRLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILLCGSRP 141 (389)
Q Consensus 69 p~Nill~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~p 141 (389)
|+|||+ +.++.+||+|||++...... ....+.+||+.|+|||++. ..|+.++||||+||++|+|++|++|
T Consensus 145 p~NILl---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~p 221 (318)
T d3blha1 145 AANVLI---TRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI 221 (318)
T ss_dssp GGGEEE---CTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred chheee---cCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCC
Confidence 999999 57889999999999765432 2234467999999999874 3689999999999999999999999
Q ss_pred CCCCChhHHHHHHHhcCCCCCCCCCCC----------------------------CCHHHHHHHHhhhccCcCCCCCHHH
Q 016471 142 FWARTESGIFRSVLRADPNFHDSPWPS----------------------------VSPEAKDFVRRLLNKDHRKRMTAAQ 193 (389)
Q Consensus 142 f~~~~~~~~~~~i~~~~~~~~~~~~~~----------------------------~~~~~~~li~~~l~~~p~~R~s~~e 193 (389)
|.+.+.......+.+....++...+.. .++++++||.+||+.||++|||++|
T Consensus 222 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~e 301 (318)
T d3blha1 222 MQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD 301 (318)
T ss_dssp CCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred CCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHH
Confidence 999888877776665443333222211 2678899999999999999999999
Q ss_pred HhCCCCCCCCCCCC
Q 016471 194 ALTHPWLHDENRPV 207 (389)
Q Consensus 194 ~l~h~~~~~~~~~~ 207 (389)
+|+||||+....|.
T Consensus 302 lL~Hpff~~~p~p~ 315 (318)
T d3blha1 302 ALNHDFFWSDPMPS 315 (318)
T ss_dssp HHHSGGGSSSSCCC
T ss_pred HHcChhhccCCCCC
Confidence 99999998754433
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-43 Score=323.43 Aligned_cols=197 Identities=29% Similarity=0.467 Sum_probs=163.9
Q ss_pred Ccccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeecC
Q 016471 3 HQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE 78 (389)
Q Consensus 3 Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~~ 78 (389)
||||++++ +...+|+|||||.||+|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||+ +
T Consensus 88 ~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~-~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill---~ 163 (322)
T d1vzoa_ 88 SPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL---D 163 (322)
T ss_dssp CTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---C
T ss_pred CCeEEEeeeeeccCCceeeeeecccccHHHHHHHhc-ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceee---c
Confidence 48999988 468899999999999999988766 678999999999999999999999999999999999999 5
Q ss_pred CCCCEEEeecCCccccCCC--CCcccccccCCccccccccc---cCCCchhHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 016471 79 EDAPLKVIDFGLSDFVRPD--QRLNDIVGSAYYVAPEVLHR---SYNVEGDMWSIGVITYILLCGSRPFWARTESGIFRS 153 (389)
Q Consensus 79 ~~~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 153 (389)
.++.+||+|||+|...... ....+..|++.|+|||.+.+ .++.++||||+||++|+|++|+.||.+.+.......
T Consensus 164 ~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~ 243 (322)
T d1vzoa_ 164 SNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE 243 (322)
T ss_dssp TTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH
T ss_pred CCCCEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 6789999999999766432 23455789999999998743 478899999999999999999999988766554444
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCC-----CHHHHhCCCCCCCC
Q 016471 154 VLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRM-----TAAQALTHPWLHDE 203 (389)
Q Consensus 154 i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----s~~e~l~h~~~~~~ 203 (389)
+.+..........+.+|+.+++||.+||.+||.+|| |++|+++||||+..
T Consensus 244 i~~~~~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i 298 (322)
T d1vzoa_ 244 ISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 298 (322)
T ss_dssp HHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred HHHhcccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCC
Confidence 443322222222246899999999999999999999 48999999999764
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-43 Score=320.66 Aligned_cols=191 Identities=22% Similarity=0.348 Sum_probs=152.6
Q ss_pred CCccccceee-----cCeEEEEEEccCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Q 016471 2 YHQKLQHLFY-----SNSFLFFTRFCEGGELLDRILSRG---------------GRYLEEDAKTIVEKILNIVAFCHLQG 61 (389)
Q Consensus 2 ~Hpni~~~~~-----~~~~~lv~E~~~gg~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~~lH~~~ 61 (389)
+||||+.++. +..+++|||||+||+|.+++..+. ..+++.+++.++.||+.||+|||++|
T Consensus 75 ~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ 154 (299)
T d1ywna1 75 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK 154 (299)
T ss_dssp CCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 6999999882 356999999999999999986532 35899999999999999999999999
Q ss_pred CEecCCCCCcEEEeecCCCCCEEEeecCCccccCCCC---CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh
Q 016471 62 VVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ---RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC 137 (389)
Q Consensus 62 i~Hrdlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~ 137 (389)
|+||||||+|||+ +.++.+||+|||+|+...... ......||+.|+|||++. +.++.++||||+||++|||++
T Consensus 155 ivHrDlKp~NILl---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt 231 (299)
T d1ywna1 155 CIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 231 (299)
T ss_dssp CCCSCCCGGGEEE---CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred CcCCcCCccceeE---CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHh
Confidence 9999999999999 567899999999998654332 234567999999999885 569999999999999999998
Q ss_pred C-CCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCC
Q 016471 138 G-SRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 197 (389)
Q Consensus 138 g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h 197 (389)
| .+||.+....+.+..+......++. ...+++++++++.+||..||.+|||++++++|
T Consensus 232 ~~~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 232 LGASPYPGVKIDEEFCRRLKEGTRMRA--PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp TSCCSSTTCCCSHHHHHHHHHTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHhcCCCCCC--CccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 6 5688776655555444443333322 24589999999999999999999999999875
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-43 Score=315.98 Aligned_cols=191 Identities=19% Similarity=0.327 Sum_probs=164.7
Q ss_pred CCCccccceee---cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 1 MYHQKLQHLFY---SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 1 l~Hpni~~~~~---~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
|+||||+++|. +..+++|||||++|++.+++..+.+.+++..++.++.||+.||.|||++||+||||||+||+++
T Consensus 68 l~H~nIv~~~g~~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~-- 145 (273)
T d1u46a_ 68 LDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA-- 145 (273)
T ss_dssp CCCTTBCCEEEEECSSSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE--
T ss_pred CCCCCEEEEEEEEeecchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccc--
Confidence 68999999993 5678999999999999999887777899999999999999999999999999999999999995
Q ss_pred CCCCCEEEeecCCccccCCCCC----cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 016471 78 EEDAPLKVIDFGLSDFVRPDQR----LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIF 151 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~ 151 (389)
.++.+||+|||++........ .....||+.|+|||++. ..++.++|||||||++|||++ |..||.+.+..+..
T Consensus 146 -~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~ 224 (273)
T d1u46a_ 146 -TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL 224 (273)
T ss_dssp -ETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH
T ss_pred -cccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHH
Confidence 467899999999987654332 22346788999999985 468999999999999999998 89999999999998
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 152 RSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 152 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
..+.+....++. .+.+|+.+++||.+||..||.+|||++++++
T Consensus 225 ~~i~~~~~~~~~--~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 225 HKIDKEGERLPR--PEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp HHHHTSCCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhCCCCCCC--cccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 888876544432 3578999999999999999999999999863
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.3e-42 Score=322.51 Aligned_cols=197 Identities=28% Similarity=0.516 Sum_probs=160.7
Q ss_pred CCccccceee------cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEe
Q 016471 2 YHQKLQHLFY------SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 75 (389)
Q Consensus 2 ~Hpni~~~~~------~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~ 75 (389)
.||||+++++ ...+|+|||||.+|+|.... +++++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 88 ~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~ 163 (328)
T d3bqca1 88 GGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID 163 (328)
T ss_dssp TSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE
T ss_pred CCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEc
Confidence 4999999882 35699999999999997642 5799999999999999999999999999999999999996
Q ss_pred ecCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChh-HHHH
Q 016471 76 TREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTES-GIFR 152 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~ 152 (389)
.++..+||+|||+|............+||+.|+|||.+.+ .++.++||||+||++|+|++|+.||...... ....
T Consensus 164 --~~~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~ 241 (328)
T d3bqca1 164 --HEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 241 (328)
T ss_dssp --TTTTEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHH
T ss_pred --CCCCeeeecccccceeccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHH
Confidence 3455799999999998877666777889999999998753 5899999999999999999999999765432 2222
Q ss_pred HHHhc-------------CCC--------------------CCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCC
Q 016471 153 SVLRA-------------DPN--------------------FHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPW 199 (389)
Q Consensus 153 ~i~~~-------------~~~--------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~ 199 (389)
.+... ... ........+++++++||++||++||.+|||++|+|+|||
T Consensus 242 ~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~ 321 (328)
T d3bqca1 242 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 321 (328)
T ss_dssp HHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred HHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 22110 000 011112347899999999999999999999999999999
Q ss_pred CCCCC
Q 016471 200 LHDEN 204 (389)
Q Consensus 200 ~~~~~ 204 (389)
|++..
T Consensus 322 F~~v~ 326 (328)
T d3bqca1 322 FYTVV 326 (328)
T ss_dssp GTTSC
T ss_pred cCCCC
Confidence 98753
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-42 Score=313.22 Aligned_cols=190 Identities=19% Similarity=0.346 Sum_probs=154.6
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
|+||||++++ ..+.+++|||||.+|++.+.+....+.+++.++..++.||+.||+|||++||+||||||+|||+
T Consensus 66 l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl-- 143 (283)
T d1mqba_ 66 FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV-- 143 (283)
T ss_dssp CCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--
T ss_pred cCCCCEeeeeEEEecCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEE--
Confidence 6899999999 3578999999999999999888777889999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC----CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhC-CCCCCCCChhHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ----RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCG-SRPFWARTESGI 150 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~ 150 (389)
+.++.+||+|||+|+...... ......||+.|+|||++. +.++.++|||||||++|||++| .+|+.+.+..++
T Consensus 144 -~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~ 222 (283)
T d1mqba_ 144 -NSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV 222 (283)
T ss_dssp -CTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred -CCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHH
Confidence 578899999999998764432 223356899999999885 5799999999999999999995 555556666667
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 151 FRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 151 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
...+..+.. .+ ....+++.+.+||.+||..+|.+|||+.++++
T Consensus 223 ~~~i~~~~~-~~--~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 223 MKAINDGFR-LP--TPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp HHHHHTTCC-CC--CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHhccCC-CC--CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 666655432 22 22468899999999999999999999999875
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-42 Score=314.30 Aligned_cols=198 Identities=21% Similarity=0.331 Sum_probs=160.8
Q ss_pred CCCcccccee---ecCeEEEEEEccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF---YSNSFLFFTRFCEGGELLDRILSR-GGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~---~~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
++||||+++| .++.+|+|||||++|+|..++... .+.+++.+++.++.||+.||+|||++||+||||||+|||+
T Consensus 69 l~h~nIv~~~g~~~~~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll-- 146 (285)
T d1fmka3 69 LRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV-- 146 (285)
T ss_dssp CCCTTBCCEEEEECSSSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--
T ss_pred cccCCEeEEEEEEecCCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEE--
Confidence 6899999999 356789999999999999887543 3579999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC--CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhC-CCCCCCCChhHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ--RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCG-SRPFWARTESGIFR 152 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~ 152 (389)
+.++.+||+|||+|+...... ......||+.|+|||++. +.++.++||||+||++|||++| .+|+.+....+.+.
T Consensus 147 -~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~ 225 (285)
T d1fmka3 147 -GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD 225 (285)
T ss_dssp -CGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH
T ss_pred -CCCCcEEEcccchhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 567899999999998664332 233467899999999885 5799999999999999999995 55566677777777
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC--CCCCCCCC
Q 016471 153 SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT--HPWLHDEN 204 (389)
Q Consensus 153 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~--h~~~~~~~ 204 (389)
.+.+.... + ..+.+++.++++|.+||+.||++|||+++++. ++||....
T Consensus 226 ~i~~~~~~-~--~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 226 QVERGYRM-P--CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp HHHTTCCC-C--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred HHHhcCCC-C--CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence 77654321 2 23578999999999999999999999999987 88987653
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-42 Score=322.93 Aligned_cols=195 Identities=27% Similarity=0.508 Sum_probs=161.9
Q ss_pred CCCccccceee----------cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCC
Q 016471 1 MYHQKLQHLFY----------SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPE 70 (389)
Q Consensus 1 l~Hpni~~~~~----------~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~ 70 (389)
|+||||+++++ ..++|+||||| |++|...+ ++ +++++..++.++.||+.||+|||++||+||||||+
T Consensus 74 l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~-~~-~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~ 150 (346)
T d1cm8a_ 74 MRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLM-KH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPG 150 (346)
T ss_dssp CCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHH-HH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred cCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHH-Hh-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcc
Confidence 68999999882 13579999999 55666644 44 57999999999999999999999999999999999
Q ss_pred cEEEeecCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChh
Q 016471 71 NFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTES 148 (389)
Q Consensus 71 Nill~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 148 (389)
|||+ +.++.+|++|||+|..... .....+||+.|+|||++.+ .++.++||||+||++|+|++|++||.+.+..
T Consensus 151 NIL~---~~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~ 225 (346)
T d1cm8a_ 151 NLAV---NEDCELKILDFGLARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL 225 (346)
T ss_dssp GEEE---CTTCCEEECCCTTCEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred hhhc---ccccccccccccceeccCC--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChH
Confidence 9999 5789999999999987643 3456789999999998743 5789999999999999999999999988776
Q ss_pred HHHHHHHhcCCC-----------------------CCCC----CCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCC
Q 016471 149 GIFRSVLRADPN-----------------------FHDS----PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLH 201 (389)
Q Consensus 149 ~~~~~i~~~~~~-----------------------~~~~----~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~ 201 (389)
..+..+...... .... ..+.+++.+++||.+||..||.+|||++|+|+||||+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~ 305 (346)
T d1cm8a_ 226 DQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 305 (346)
T ss_dssp HHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGT
T ss_pred HHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhC
Confidence 665544432111 1111 1246789999999999999999999999999999998
Q ss_pred CC
Q 016471 202 DE 203 (389)
Q Consensus 202 ~~ 203 (389)
..
T Consensus 306 ~~ 307 (346)
T d1cm8a_ 306 SL 307 (346)
T ss_dssp TT
T ss_pred cC
Confidence 64
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-42 Score=319.31 Aligned_cols=191 Identities=19% Similarity=0.273 Sum_probs=163.8
Q ss_pred CCCcccccee---ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeec
Q 016471 1 MYHQKLQHLF---YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTR 77 (389)
Q Consensus 1 l~Hpni~~~~---~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~ 77 (389)
|+||||++++ .++..++|||||.+|+|.+.+..+...+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 68 l~HpnIv~l~g~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~-- 145 (317)
T d1xkka_ 68 VDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK-- 145 (317)
T ss_dssp CCCTTBCCEEEEEESSSEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE--
T ss_pred CCCCCEeeEEEEEecCCeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeC--
Confidence 6899999998 46778999999999999999988878899999999999999999999999999999999999995
Q ss_pred CCCCCEEEeecCCccccCCCCC---cccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHH
Q 016471 78 EEDAPLKVIDFGLSDFVRPDQR---LNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFR 152 (389)
Q Consensus 78 ~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 152 (389)
.++.+||+|||+|+....... .....||+.|+|||++. +.|+.++|||||||++|||+| |.+||.+.+..++..
T Consensus 146 -~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~ 224 (317)
T d1xkka_ 146 -TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS 224 (317)
T ss_dssp -ETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHH
T ss_pred -CCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHH
Confidence 578899999999987654332 23346899999999875 579999999999999999998 899999888888777
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCC
Q 016471 153 SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 197 (389)
Q Consensus 153 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h 197 (389)
.+.++... +. .+.+++.+.+|+.+||..||.+|||+.+++.|
T Consensus 225 ~i~~~~~~-~~--p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 225 ILEKGERL-PQ--PPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp HHHHTCCC-CC--CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCC-CC--CcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 77664322 21 24689999999999999999999999999875
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-42 Score=322.46 Aligned_cols=199 Identities=26% Similarity=0.456 Sum_probs=160.2
Q ss_pred CCCccccceeec--------CeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcE
Q 016471 1 MYHQKLQHLFYS--------NSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENF 72 (389)
Q Consensus 1 l~Hpni~~~~~~--------~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Ni 72 (389)
|+||||++++.. ...+++++||.||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+||
T Consensus 63 l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NI 140 (345)
T d1pmea_ 63 FRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNL 140 (345)
T ss_dssp CCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred cCCCCCCcEEEEEeeccccccceEEEEEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceE
Confidence 689999998821 123445566779999998865 3799999999999999999999999999999999999
Q ss_pred EEeecCCCCCEEEeecCCccccCCCC----CcccccccCCcccccccc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 016471 73 LFTTREEDAPLKVIDFGLSDFVRPDQ----RLNDIVGSAYYVAPEVLH--RSYNVEGDMWSIGVITYILLCGSRPFWART 146 (389)
Q Consensus 73 ll~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 146 (389)
|+ ++++.+||+|||+|....... .....+||+.|+|||++. ..++.++||||+||++|+|++|+.||.+.+
T Consensus 141 Ll---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~ 217 (345)
T d1pmea_ 141 LL---NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 217 (345)
T ss_dssp EE---CTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred EE---CCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCC
Confidence 99 577899999999997654322 245567999999999884 357899999999999999999999998877
Q ss_pred hhHHHHHHHhcC-----------------------CCCCCC----CCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCC
Q 016471 147 ESGIFRSVLRAD-----------------------PNFHDS----PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPW 199 (389)
Q Consensus 147 ~~~~~~~i~~~~-----------------------~~~~~~----~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~ 199 (389)
............ +..... .++.+|+++++||.+||++||.+|||++++|+|||
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf 297 (345)
T d1pmea_ 218 YLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 297 (345)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred HHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence 655544433211 011111 13568899999999999999999999999999999
Q ss_pred CCCCC
Q 016471 200 LHDEN 204 (389)
Q Consensus 200 ~~~~~ 204 (389)
|+...
T Consensus 298 ~~~~~ 302 (345)
T d1pmea_ 298 LEQYY 302 (345)
T ss_dssp GTTTC
T ss_pred hccCC
Confidence 98653
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-41 Score=307.89 Aligned_cols=200 Identities=27% Similarity=0.451 Sum_probs=163.4
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEee
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTT 76 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~ 76 (389)
++||||++++ +..++++|||++.|++|..++ ...+.+++..++.++.|++.||+|||++||+||||||+|||+
T Consensus 58 l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~-~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli-- 134 (292)
T d1unla_ 58 LKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFD-SCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI-- 134 (292)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHH-HTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--
T ss_pred cCcCCEEeeccccccccceeEEeeecccccccccc-ccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCccccc--
Confidence 5899999998 468899999999999887755 455789999999999999999999999999999999999999
Q ss_pred cCCCCCEEEeecCCccccCCCC-CcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCC-CCChhHHHH
Q 016471 77 REEDAPLKVIDFGLSDFVRPDQ-RLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFW-ARTESGIFR 152 (389)
Q Consensus 77 ~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~-~~~~~~~~~ 152 (389)
+.++.+||+|||.|....... ......+++.|+|||++.. .++.++||||+||++|+|++|+.||. +.+..+...
T Consensus 135 -~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~ 213 (292)
T d1unla_ 135 -NRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK 213 (292)
T ss_dssp -CTTCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHH
T ss_pred -ccCCceeeeecchhhcccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHH
Confidence 567889999999998775443 3344567889999998753 47899999999999999999998864 455555555
Q ss_pred HHHhcCCCCCC-------------------------CCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCCCC
Q 016471 153 SVLRADPNFHD-------------------------SPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHDEN 204 (389)
Q Consensus 153 ~i~~~~~~~~~-------------------------~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~~~ 204 (389)
.+......... ...+.+++.+++||++||+.||.+|||++|+|+||||++..
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~ 290 (292)
T d1unla_ 214 RIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp HHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred HHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence 54432111110 11245789999999999999999999999999999998653
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-41 Score=313.35 Aligned_cols=190 Identities=19% Similarity=0.281 Sum_probs=162.1
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSR---------------GGRYLEEDAKTIVEKILNIVAFCHLQGV 62 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~---------------~~~l~~~~~~~i~~qi~~~L~~lH~~~i 62 (389)
+||||++++ ..+.+|+|||||+||+|.+++..+ ...+++..+..++.||+.||.|||++||
T Consensus 69 ~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~i 148 (309)
T d1fvra_ 69 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQF 148 (309)
T ss_dssp CCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred CCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCc
Confidence 699999999 467899999999999999988643 3679999999999999999999999999
Q ss_pred EecCCCCCcEEEeecCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCC-C
Q 016471 63 VHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGS-R 140 (389)
Q Consensus 63 ~Hrdlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~-~ 140 (389)
+||||||+|||+ +.++.+||+|||+|.............||+.|+|||.+. +.|+.++|||||||++|||++|. +
T Consensus 149 iHrDlkp~NIL~---~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~ 225 (309)
T d1fvra_ 149 IHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT 225 (309)
T ss_dssp ECSCCSGGGEEE---CGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred cccccccceEEE---cCCCceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCC
Confidence 999999999999 567899999999998765544445667999999999985 57999999999999999999964 6
Q ss_pred CCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCC
Q 016471 141 PFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 197 (389)
Q Consensus 141 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h 197 (389)
||.+.+..++...+.++.. + ..+..+++++++||.+||..||++|||+.+++++
T Consensus 226 p~~~~~~~~~~~~i~~~~~-~--~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 226 PYCGMTCAELYEKLPQGYR-L--EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp TTTTCCHHHHHHHGGGTCC-C--CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCHHHHHHHHHhcCC-C--CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 7888888888887766432 1 2235689999999999999999999999999975
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-41 Score=309.10 Aligned_cols=189 Identities=20% Similarity=0.351 Sum_probs=163.1
Q ss_pred CCcccccee----ecCeEEEEEEccCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 016471 2 YHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG---------------GRYLEEDAKTIVEKILNIVAFCHLQGV 62 (389)
Q Consensus 2 ~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~~lH~~~i 62 (389)
+||||++++ .+..+|+|||||++|+|.+++..+. .++++..+..++.||+.||+|||++||
T Consensus 77 ~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~i 156 (299)
T d1fgka_ 77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKC 156 (299)
T ss_dssp CCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred CCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCE
Confidence 799999999 3577999999999999999987542 458999999999999999999999999
Q ss_pred EecCCCCCcEEEeecCCCCCEEEeecCCccccCCCC---CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-
Q 016471 63 VHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ---RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC- 137 (389)
Q Consensus 63 ~Hrdlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~- 137 (389)
+||||||+|||+ +.++.+||+|||++....... ......||+.|+|||++. +.|+.++|||||||++|+|++
T Consensus 157 vHrDiKp~NiLl---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~ 233 (299)
T d1fgka_ 157 IHRDLAARNVLV---TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL 233 (299)
T ss_dssp CCSCCSGGGEEE---CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred Eeeeecccceee---cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccC
Confidence 999999999999 578899999999998664332 234467899999999885 579999999999999999998
Q ss_pred CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 138 GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 138 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
|.+||.+.+..+++..+..+. .++. .+.+++.+++||.+||+.||.+|||+.|+++
T Consensus 234 g~~p~~~~~~~~~~~~i~~~~-~~~~--p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 234 GGSPYPGVPVEELFKLLKEGH-RMDK--PSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp SCCSSTTCCHHHHHHHHHTTC-CCCC--CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHcCC-CCCC--CccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 799998888888777776543 2222 2468999999999999999999999999985
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-41 Score=304.12 Aligned_cols=188 Identities=21% Similarity=0.322 Sum_probs=154.2
Q ss_pred CCCccccceee-----cCeEEEEEEccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEE
Q 016471 1 MYHQKLQHLFY-----SNSFLFFTRFCEGGELLDRILSRG-GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLF 74 (389)
Q Consensus 1 l~Hpni~~~~~-----~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill 74 (389)
|+||||++++. .+.+|+|||||++|+|.+++.++. ..+++..++.++.||+.||.|||+++|+||||||+||++
T Consensus 57 l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~ 136 (262)
T d1byga_ 57 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV 136 (262)
T ss_dssp CCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhhee
Confidence 68999999992 245899999999999999986542 358999999999999999999999999999999999999
Q ss_pred eecCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCChhHHHH
Q 016471 75 TTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLC-GSRPFWARTESGIFR 152 (389)
Q Consensus 75 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 152 (389)
+.++.+|++|||+++..... .....+|+.|+|||++. +.++.++|||||||++|||++ |++||.+.+..++..
T Consensus 137 ---~~~~~~kl~dfg~s~~~~~~--~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~ 211 (262)
T d1byga_ 137 ---SEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP 211 (262)
T ss_dssp ---CTTSCEEECCCCC--------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHH
T ss_pred ---cCCCCEeecccccceecCCC--CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHH
Confidence 57889999999999865432 33457899999999885 579999999999999999998 799998888888888
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 153 SVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 153 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
.+.+.... + ..+.+++.+++||.+||..||.+|||+.++++
T Consensus 212 ~i~~~~~~-~--~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 252 (262)
T d1byga_ 212 RVEKGYKM-D--APDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 252 (262)
T ss_dssp HHTTTCCC-C--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHcCCCC-C--CCccCCHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 87654221 1 22468999999999999999999999999875
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-41 Score=317.10 Aligned_cols=197 Identities=28% Similarity=0.479 Sum_probs=160.6
Q ss_pred CCCccccceee---------cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCc
Q 016471 1 MYHQKLQHLFY---------SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPEN 71 (389)
Q Consensus 1 l~Hpni~~~~~---------~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~N 71 (389)
|+||||++++. +...++||+||.||+|.+++.. +++++..++.++.||+.||+|||++||+||||||+|
T Consensus 74 l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~N 151 (348)
T d2gfsa1 74 MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSN 151 (348)
T ss_dssp CCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred cCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcc
Confidence 68999999882 2345667788889999987733 579999999999999999999999999999999999
Q ss_pred EEEeecCCCCCEEEeecCCccccCCCCCcccccccCCccccccccc--cCCCchhHHHHHHHHHHHHhCCCCCCCCChhH
Q 016471 72 FLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLHR--SYNVEGDMWSIGVITYILLCGSRPFWARTESG 149 (389)
Q Consensus 72 ill~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 149 (389)
||+ +.++.+|++|||+|.... ....+..||+.|+|||++.+ .++.++||||+||++|+|++|++||.+.+...
T Consensus 152 ILi---~~~~~~kl~dfg~a~~~~--~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~ 226 (348)
T d2gfsa1 152 LAV---NEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID 226 (348)
T ss_dssp EEE---CTTCCEEECCC----CCT--GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccc---cccccccccccchhcccC--cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHH
Confidence 999 578899999999987653 33456789999999998643 47899999999999999999999999988877
Q ss_pred HHHHHHhcCCCCCC-----------------------C----CCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCCCCCCC
Q 016471 150 IFRSVLRADPNFHD-----------------------S----PWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTHPWLHD 202 (389)
Q Consensus 150 ~~~~i~~~~~~~~~-----------------------~----~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h~~~~~ 202 (389)
....+.+....... . .++.+++++++||.+||..||.+|||++|+|+||||+.
T Consensus 227 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~ 306 (348)
T d2gfsa1 227 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306 (348)
T ss_dssp HHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred HHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCC
Confidence 77666543222111 0 12457899999999999999999999999999999986
Q ss_pred CC
Q 016471 203 EN 204 (389)
Q Consensus 203 ~~ 204 (389)
..
T Consensus 307 ~~ 308 (348)
T d2gfsa1 307 YH 308 (348)
T ss_dssp TC
T ss_pred CC
Confidence 53
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-41 Score=316.78 Aligned_cols=195 Identities=24% Similarity=0.411 Sum_probs=150.4
Q ss_pred CCCccccceee----------cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCC
Q 016471 1 MYHQKLQHLFY----------SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPE 70 (389)
Q Consensus 1 l~Hpni~~~~~----------~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~ 70 (389)
++||||++++. ..++|+|||||.||.+ +.+ .+.+++..++.++.||+.||.|||++||+||||||+
T Consensus 73 l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~-~~~---~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~ 148 (355)
T d2b1pa1 73 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC-QVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPS 148 (355)
T ss_dssp CCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHH-HHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred cCCCCeeEEEEEEecccccccCceeEEEEeccchHHH-Hhh---hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcc
Confidence 58999999882 2689999999987544 444 257999999999999999999999999999999999
Q ss_pred cEEEeecCCCCCEEEeecCCccccCCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChhH
Q 016471 71 NFLFTTREEDAPLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTESG 149 (389)
Q Consensus 71 Nill~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 149 (389)
|||+ +.++.+|++|||++............+||+.|+|||++. ..+++++||||+||++|+|++|++||.+.+...
T Consensus 149 Nil~---~~~~~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~ 225 (355)
T d2b1pa1 149 NIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 225 (355)
T ss_dssp GEEE---CTTCCEEECCCCC---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred cccc---ccccceeeechhhhhccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHH
Confidence 9999 567889999999988777666667778999999999985 468999999999999999999999999887766
Q ss_pred HHHHHHhcCC----------------------CCCCCCC----------------CCCCHHHHHHHHhhhccCcCCCCCH
Q 016471 150 IFRSVLRADP----------------------NFHDSPW----------------PSVSPEAKDFVRRLLNKDHRKRMTA 191 (389)
Q Consensus 150 ~~~~i~~~~~----------------------~~~~~~~----------------~~~~~~~~~li~~~l~~~p~~R~s~ 191 (389)
....+..... ......+ ...|+++++||++||..||++|||+
T Consensus 226 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta 305 (355)
T d2b1pa1 226 QWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305 (355)
T ss_dssp HHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCH
T ss_pred HHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCH
Confidence 6555432111 1110000 0136789999999999999999999
Q ss_pred HHHhCCCCCCC
Q 016471 192 AQALTHPWLHD 202 (389)
Q Consensus 192 ~e~l~h~~~~~ 202 (389)
+|+|+||||+.
T Consensus 306 ~elL~Hpw~~~ 316 (355)
T d2b1pa1 306 DDALQHPYINV 316 (355)
T ss_dssp HHHHTSTTTGG
T ss_pred HHHhcCcccCC
Confidence 99999999975
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-40 Score=304.78 Aligned_cols=190 Identities=18% Similarity=0.270 Sum_probs=160.7
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHH
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG-----------------------GRYLEEDAKTIVEKILNI 53 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~-----------------------~~l~~~~~~~i~~qi~~~ 53 (389)
|+||||++++ ..+..++|||||++|+|.+++.... ..+++..+..++.||+.|
T Consensus 73 l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~g 152 (301)
T d1lufa_ 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAG 152 (301)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHH
T ss_pred cCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHH
Confidence 6899999999 3578999999999999999886532 248899999999999999
Q ss_pred HHHHHHCCCEecCCCCCcEEEeecCCCCCEEEeecCCccccCCCC---CcccccccCCcccccccc-ccCCCchhHHHHH
Q 016471 54 VAFCHLQGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ---RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIG 129 (389)
Q Consensus 54 L~~lH~~~i~Hrdlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG 129 (389)
|+|||++||+||||||+|||+ +.++.+||+|||+|+...... ...+..||+.|+|||++. ..|+.++||||||
T Consensus 153 l~ylH~~~ivHrDlKp~NILl---d~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~G 229 (301)
T d1lufa_ 153 MAYLSERKFVHRDLATRNCLV---GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYG 229 (301)
T ss_dssp HHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred hhhcccCCeEeeEEcccceEE---CCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccch
Confidence 999999999999999999999 567899999999997654322 233567899999999885 4799999999999
Q ss_pred HHHHHHHhCC-CCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 130 VITYILLCGS-RPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 130 ~il~~ll~g~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
|++|||++|. +||.+.+..+....+..+... .....+++++.+||.+||..+|.+|||+.++++
T Consensus 230 vvl~ell~~~~~p~~~~~~~e~~~~v~~~~~~---~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 230 VVLWEIFSYGLQPYYGMAHEEVIYYVRDGNIL---ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhHHHHHccCCCCCCCCCHHHHHHHHHcCCCC---CCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 9999999985 789989888888887765432 112468999999999999999999999999864
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-40 Score=304.27 Aligned_cols=191 Identities=18% Similarity=0.245 Sum_probs=157.6
Q ss_pred CCCccccceee-----cCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEe
Q 016471 1 MYHQKLQHLFY-----SNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 75 (389)
Q Consensus 1 l~Hpni~~~~~-----~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~ 75 (389)
|+||||++++. +..+++|||||++|+|.+++......+++..+..++.|++.||.|||+.||+||||||+|||+
T Consensus 85 l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl- 163 (311)
T d1r0pa_ 85 FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML- 163 (311)
T ss_dssp CCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE-
T ss_pred CCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeE-
Confidence 68999999982 357999999999999999887776778899999999999999999999999999999999999
Q ss_pred ecCCCCCEEEeecCCccccCCCC-----CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCC-Chh
Q 016471 76 TREEDAPLKVIDFGLSDFVRPDQ-----RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWAR-TES 148 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~ 148 (389)
++++.+||+|||+++...... ......||+.|+|||.+. +.++.++|||||||++|||++|..||... +..
T Consensus 164 --~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~ 241 (311)
T d1r0pa_ 164 --DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 241 (311)
T ss_dssp --CTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-----
T ss_pred --CCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH
Confidence 578899999999998664332 223356899999999875 57999999999999999999977777553 344
Q ss_pred HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhCC
Q 016471 149 GIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALTH 197 (389)
Q Consensus 149 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~h 197 (389)
+....+.++... .. .+.+++.+.+||.+||..||.+|||+.|+++|
T Consensus 242 ~~~~~i~~g~~~-~~--p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 242 DITVYLLQGRRL-LQ--PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp -CHHHHHTTCCC-CC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCCC-CC--cccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 455555554322 21 14578999999999999999999999999975
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-40 Score=303.39 Aligned_cols=190 Identities=24% Similarity=0.367 Sum_probs=159.7
Q ss_pred CCccccceee----cCeEEEEEEccCCCChHHHHHhcC-----------------CCCCHHHHHHHHHHHHHHHHHHHHC
Q 016471 2 YHQKLQHLFY----SNSFLFFTRFCEGGELLDRILSRG-----------------GRYLEEDAKTIVEKILNIVAFCHLQ 60 (389)
Q Consensus 2 ~Hpni~~~~~----~~~~~lv~E~~~gg~L~~~l~~~~-----------------~~l~~~~~~~i~~qi~~~L~~lH~~ 60 (389)
+||||++++. ...+|+|||||+||+|.+++.... ..+++..+..++.||+.||+|||++
T Consensus 85 ~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~ 164 (311)
T d1t46a_ 85 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK 164 (311)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 6999999993 467999999999999999987542 2589999999999999999999999
Q ss_pred CCEecCCCCCcEEEeecCCCCCEEEeecCCccccCCCC---CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHH
Q 016471 61 GVVHRDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ---RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILL 136 (389)
Q Consensus 61 ~i~Hrdlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll 136 (389)
|++||||||+||++ +.++.+|++|||.++...... .....+||+.|+|||++. +.++.++|||||||++|||+
T Consensus 165 ~ivHrDLKp~NIl~---~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ell 241 (311)
T d1t46a_ 165 NCIHRDLAARNILL---THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 241 (311)
T ss_dssp TCCCSCCSGGGEEE---ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred Ceeecccccccccc---cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHH
Confidence 99999999999999 467899999999998765432 223467899999999885 57899999999999999999
Q ss_pred h-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 137 C-GSRPFWARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 137 ~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
+ |.+||.+.+....+..+.........+ ..+++.+.+||.+||..||.+|||++++++
T Consensus 242 t~g~p~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 242 SLGSSPYPGMPVDSKFYKMIKEGFRMLSP--EHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp TTTCCSSTTCCSSHHHHHHHHHTCCCCCC--TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hCCCCCCCCCCHHHHHHHHHhcCCCCCCc--ccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 8 677777777666666665544333222 457999999999999999999999999885
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-39 Score=298.28 Aligned_cols=190 Identities=17% Similarity=0.261 Sum_probs=162.6
Q ss_pred CCCcccccee----ecCeEEEEEEccCCCChHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCC
Q 016471 1 MYHQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRG---------GRYLEEDAKTIVEKILNIVAFCHLQGVVHRDL 67 (389)
Q Consensus 1 l~Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~---------~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdl 67 (389)
++||||+.++ ....+++|||||++|+|.+++.... ..+++..+..++.|++.||.|||+++|+||||
T Consensus 80 l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDl 159 (308)
T d1p4oa_ 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDL 159 (308)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCC
T ss_pred cCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceE
Confidence 5899999999 3578999999999999999886431 34688999999999999999999999999999
Q ss_pred CCCcEEEeecCCCCCEEEeecCCccccCCCC---CcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhC-CCCC
Q 016471 68 KPENFLFTTREEDAPLKVIDFGLSDFVRPDQ---RLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCG-SRPF 142 (389)
Q Consensus 68 kp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g-~~pf 142 (389)
||+|||+ +.++.+||+|||+|+...... ......||+.|+|||.+. +.++.++||||+||++|||++| .+||
T Consensus 160 k~~NiLl---d~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~ 236 (308)
T d1p4oa_ 160 AARNCMV---AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY 236 (308)
T ss_dssp SGGGEEE---CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTT
T ss_pred cCCceee---cCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCC
Confidence 9999999 678899999999998664332 233447899999999985 5688999999999999999997 5889
Q ss_pred CCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHhC
Q 016471 143 WARTESGIFRSVLRADPNFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQALT 196 (389)
Q Consensus 143 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l~ 196 (389)
.+.+..+.+..+.++... + ..+.+++.+.++|.+||+.+|.+|||++++++
T Consensus 237 ~~~~~~~~~~~i~~~~~~-~--~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 237 QGLSNEQVLRFVMEGGLL-D--KPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp TTSCHHHHHHHHHTTCCC-C--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCHHHHHHHHHhCCCC-C--CcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 888888888888765432 1 12468999999999999999999999999987
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.7e-39 Score=294.52 Aligned_cols=200 Identities=15% Similarity=0.186 Sum_probs=153.4
Q ss_pred CCCcccccee-----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEe
Q 016471 1 MYHQKLQHLF-----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFT 75 (389)
Q Consensus 1 l~Hpni~~~~-----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~ 75 (389)
+.|+|++..+ ..+.+++|||||. |+|.+.+....+.+++..+..++.|++.||+|||++||+||||||+|||++
T Consensus 59 l~~~~~i~~~~~~~~~~~~~~ivme~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~ 137 (299)
T d1ckia_ 59 MQGGVGIPTIRWCGAEGDYNVMVMELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMG 137 (299)
T ss_dssp STTSTTCCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred ccCCCcccEEEEEEecCCEEEEEEEEcC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhcccc
Confidence 4566655443 4578999999995 577777777778899999999999999999999999999999999999997
Q ss_pred ecCCCCCEEEeecCCccccCCCC--------CcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 016471 76 TREEDAPLKVIDFGLSDFVRPDQ--------RLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWART 146 (389)
Q Consensus 76 ~~~~~~~~kl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~ 146 (389)
..+.+..+||+|||+|+...... .....+||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+..
T Consensus 138 ~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~ 217 (299)
T d1ckia_ 138 LGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 217 (299)
T ss_dssp CGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred ccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccc
Confidence 65667789999999998764322 2245679999999998865 69999999999999999999999998765
Q ss_pred hhHHHHHHHh---cCC-CCCCCCCCCCCHHHHHHHHhhhccCcCCCCCHHH---HhCCCCCC
Q 016471 147 ESGIFRSVLR---ADP-NFHDSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQ---ALTHPWLH 201 (389)
Q Consensus 147 ~~~~~~~i~~---~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e---~l~h~~~~ 201 (389)
.......+.+ ... .......+.+|+++.+++.+||..+|.+||++++ +|+|+|.+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 218 AATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp -------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 5433322211 110 1111123468999999999999999999999874 45666543
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-39 Score=294.06 Aligned_cols=191 Identities=19% Similarity=0.257 Sum_probs=146.1
Q ss_pred CCCccccceee----c----CeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH--------CCCEe
Q 016471 1 MYHQKLQHLFY----S----NSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHL--------QGVVH 64 (389)
Q Consensus 1 l~Hpni~~~~~----~----~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~--------~~i~H 64 (389)
++||||++++. . ..+|+|||||++|+|.+++.+. .+++..+..++.|++.||.|||+ +||+|
T Consensus 54 ~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvH 131 (303)
T d1vjya_ 54 LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAH 131 (303)
T ss_dssp CCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEEC
T ss_pred CCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeec
Confidence 58999999992 1 2589999999999999988654 69999999999999999999996 59999
Q ss_pred cCCCCCcEEEeecCCCCCEEEeecCCccccCCCC-----CcccccccCCcccccccccc-------CCCchhHHHHHHHH
Q 016471 65 RDLKPENFLFTTREEDAPLKVIDFGLSDFVRPDQ-----RLNDIVGSAYYVAPEVLHRS-------YNVEGDMWSIGVIT 132 (389)
Q Consensus 65 rdlkp~Nill~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~-------~~~~~DiwslG~il 132 (389)
|||||+|||+ +.++.+||+|||++....... .....+||+.|+|||++.+. ++.++|||||||++
T Consensus 132 rDlKp~NILl---~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl 208 (303)
T d1vjya_ 132 RDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVF 208 (303)
T ss_dssp SCCCGGGEEE---CTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHH
T ss_pred cccCccceEE---cCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHH
Confidence 9999999999 578899999999998764432 23456899999999998532 56789999999999
Q ss_pred HHHHhCCCCCCCCC---------------hhHHHHHHHhcCCCCCCC-CC--CCCCHHHHHHHHhhhccCcCCCCCHHHH
Q 016471 133 YILLCGSRPFWART---------------ESGIFRSVLRADPNFHDS-PW--PSVSPEAKDFVRRLLNKDHRKRMTAAQA 194 (389)
Q Consensus 133 ~~ll~g~~pf~~~~---------------~~~~~~~i~~~~~~~~~~-~~--~~~~~~~~~li~~~l~~~p~~R~s~~e~ 194 (389)
|||++|..||.... .......+......++.+ .+ ......+.+|+.+||..||.+|||+.|+
T Consensus 209 ~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei 288 (303)
T d1vjya_ 209 WEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 288 (303)
T ss_dssp HHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHH
T ss_pred HHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHH
Confidence 99999988773321 122222222222111110 00 1123458999999999999999999998
Q ss_pred hC
Q 016471 195 LT 196 (389)
Q Consensus 195 l~ 196 (389)
++
T Consensus 289 ~~ 290 (303)
T d1vjya_ 289 KK 290 (303)
T ss_dssp HH
T ss_pred HH
Confidence 75
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.4e-37 Score=280.24 Aligned_cols=192 Identities=17% Similarity=0.237 Sum_probs=152.3
Q ss_pred Ccccccee----ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeecC
Q 016471 3 HQKLQHLF----YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTRE 78 (389)
Q Consensus 3 Hpni~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~~ 78 (389)
|||++.++ .....|+||||| ||+|.+.+...++.+++..+..++.|++.||+|||++||+||||||+|||++...
T Consensus 60 ~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~ 138 (293)
T d1csna_ 60 CTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPN 138 (293)
T ss_dssp CTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSS
T ss_pred CCCCCEEEEEeecCCccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcc
Confidence 47777776 468899999999 6799998877767899999999999999999999999999999999999996422
Q ss_pred --CCCCEEEeecCCccccCCCC--------CcccccccCCccccccccc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 016471 79 --EDAPLKVIDFGLSDFVRPDQ--------RLNDIVGSAYYVAPEVLHR-SYNVEGDMWSIGVITYILLCGSRPFWARTE 147 (389)
Q Consensus 79 --~~~~~kl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 147 (389)
..+.+||+|||+|+...... .....+||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+...
T Consensus 139 ~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~ 218 (293)
T d1csna_ 139 SKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 218 (293)
T ss_dssp STTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCS
T ss_pred cccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccc
Confidence 35689999999998754321 2345689999999998864 699999999999999999999999976543
Q ss_pred h---HHHHHHHhcCCCCC-CCCCCCCCHHHHHHHHhhhccCcCCCCCHHHHh
Q 016471 148 S---GIFRSVLRADPNFH-DSPWPSVSPEAKDFVRRLLNKDHRKRMTAAQAL 195 (389)
Q Consensus 148 ~---~~~~~i~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e~l 195 (389)
. .....+.......+ ....+.+|+++.+++..|+..+|.+||+++.+.
T Consensus 219 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~ 270 (293)
T d1csna_ 219 ATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ 270 (293)
T ss_dssp CCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred hhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHH
Confidence 2 33333322211111 111246889999999999999999999876654
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1e-34 Score=272.69 Aligned_cols=200 Identities=24% Similarity=0.360 Sum_probs=146.8
Q ss_pred CCccccceee------cCeEEEEEEccCCCChHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCEecCCCCCcE
Q 016471 2 YHQKLQHLFY------SNSFLFFTRFCEGGELLDRIL--SRGGRYLEEDAKTIVEKILNIVAFCHL-QGVVHRDLKPENF 72 (389)
Q Consensus 2 ~Hpni~~~~~------~~~~~lv~E~~~gg~L~~~l~--~~~~~l~~~~~~~i~~qi~~~L~~lH~-~~i~Hrdlkp~Ni 72 (389)
.||||+.++. ....+++|+++.++....... .....+++..++.++.||+.||.|||+ .||+||||||+||
T Consensus 78 ~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NI 157 (362)
T d1q8ya_ 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENV 157 (362)
T ss_dssp HHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGE
T ss_pred CcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHe
Confidence 4789998872 245677777776665444333 344679999999999999999999998 8999999999999
Q ss_pred EEeecCCC---CCEEEeecCCccccCCCCCcccccccCCcccccccc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCChh
Q 016471 73 LFTTREED---APLKVIDFGLSDFVRPDQRLNDIVGSAYYVAPEVLH-RSYNVEGDMWSIGVITYILLCGSRPFWARTES 148 (389)
Q Consensus 73 ll~~~~~~---~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 148 (389)
|+...+.. ..++++|||.|..... .....+||+.|+|||++. ..++.++|+||+||++++|++|+.||.+....
T Consensus 158 ll~~~~~~~~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~ 235 (362)
T d1q8ya_ 158 LMEIVDSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGH 235 (362)
T ss_dssp EEEEEETTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC------
T ss_pred eeeccCcccccceeeEeeccccccccc--ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccc
Confidence 99643222 2489999999876543 335678999999999875 56999999999999999999999999754321
Q ss_pred ------HHHHHHHhcCC------------------------CCCC--------------CCCCCCCHHHHHHHHhhhccC
Q 016471 149 ------GIFRSVLRADP------------------------NFHD--------------SPWPSVSPEAKDFVRRLLNKD 184 (389)
Q Consensus 149 ------~~~~~i~~~~~------------------------~~~~--------------~~~~~~~~~~~~li~~~l~~~ 184 (389)
........... .... ...+..++.+++||.+||.+|
T Consensus 236 ~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~d 315 (362)
T d1q8ya_ 236 SYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLD 315 (362)
T ss_dssp ---CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSS
T ss_pred cccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCC
Confidence 11111111000 0000 001124678999999999999
Q ss_pred cCCCCCHHHHhCCCCCCCC
Q 016471 185 HRKRMTAAQALTHPWLHDE 203 (389)
Q Consensus 185 p~~R~s~~e~l~h~~~~~~ 203 (389)
|.+|||++|+|+||||++.
T Consensus 316 P~~Rpta~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 316 PRKRADAGGLVNHPWLKDT 334 (362)
T ss_dssp TTTCBCHHHHHTCGGGTTC
T ss_pred hhHCcCHHHHhcCcccCCC
Confidence 9999999999999999854
|
| >d1exra_ a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetraurelia) [TaxId: 5888]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Ciliate (Paramecium tetraurelia) [TaxId: 5888]
Probab=99.88 E-value=4.5e-22 Score=161.10 Aligned_cols=138 Identities=18% Similarity=0.378 Sum_probs=120.7
Q ss_pred hcCHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhh
Q 016471 237 ALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEAL 315 (389)
Q Consensus 237 ~l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~ 315 (389)
.++++++..+++.|..+|. ++|.|+.+||..++...+. .++...+..++..+|.+++|.|+|+||+..+.........
T Consensus 2 ~lt~~e~~~l~~~F~~~D~~~~G~Is~~e~~~~l~~~~~-~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~~~ 80 (146)
T d1exra_ 2 QLTEEQIAEFKEAFALFDKDGDGTITTKELGTVMRSLGQ-NPTEAELQDMINEVDADGNGTIDFPEFLSLMARKMKEQDS 80 (146)
T ss_dssp CCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTC-CCCHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHHHHHcCCCCCeECHHHHHHHHHhcCC-CCCHHHHHHHHHhcCCCCCCcccHHHHHHHHHHHhhccCh
Confidence 4788899999999999999 9999999999999998886 4789999999999999999999999999876544332222
Q ss_pred HHHHHHHHHHHHHHcccCCCcccHHHHHHHh---CC--chH-HHHHHHHHccCCCCceeHHHHHHHHcc
Q 016471 316 ERWDQIAITAFDYFEQEGNRVISVEELALEL---NL--APA-AYSLLNDCIRNSDGKLSFLGYKRFLHG 378 (389)
Q Consensus 316 ~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l---~~--~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~ 378 (389)
.+.++.+|+.+|.|++|+|+.+||+.++ |. ... +.++++.+|.|+||+|+|+||+++|.+
T Consensus 81 ---~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~i~~~~D~d~dG~i~~~eF~~~l~s 146 (146)
T d1exra_ 81 ---EEELIEAFKVFDRDGNGLISAAELRHVMTNLGEKLTDDEVDEMIREADIDGDGHINYEEFVRMMVS 146 (146)
T ss_dssp ---HHHHHHHHHHHSTTCSSCBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCSSSSSSBCHHHHHHHHHC
T ss_pred ---HHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhhcCCHHHHHHHHHHhCCCCCCeEeHHHHHHHhcC
Confidence 4578999999999999999999999999 32 333 999999999999999999999999863
|
| >d1topa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=99.88 E-value=8.6e-22 Score=162.38 Aligned_cols=145 Identities=19% Similarity=0.333 Sum_probs=125.2
Q ss_pred HHhcCHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHH
Q 016471 235 SKALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLE 313 (389)
Q Consensus 235 ~~~l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~ 313 (389)
...++.+++..++++|..+|. ++|.|+.+||+.++...+. .+++..+.+++..+|.+++|.++|.||+..........
T Consensus 11 ~~~ls~~~i~el~~~F~~~D~d~~G~Is~~el~~~l~~~~~-~~~~~~~~~~~~~~d~~~~~~~~~~e~~~~~~~~~~~~ 89 (162)
T d1topa_ 11 RAFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQ-NPTKEELDAIIEEVDEDGSGTIDFEEFLVMMVRQMKED 89 (162)
T ss_dssp HHHSCHHHHHHHHHHHHTTTCSCSSEEEGGGHHHHHHHTTC-CCCHHHHHHHHHHHCTTSCCEEEHHHHHHHHHHHHHHH
T ss_pred HccCCHHHHHHHHHHHHHHcCCCCCeEcHHHHHHHHhccCC-chhHHHHHhhhheeccCCCCCeeeehhhhhhhhhhhhh
Confidence 456889999999999999999 9999999999999988876 47899999999999999999999999988766544333
Q ss_pred hhHHHHHHHHHHHHHHcccCCCcccHHHHHHHhC---C--chH-HHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 314 ALERWDQIAITAFDYFEQEGNRVISVEELALELN---L--APA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 314 ~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~---~--~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
....+.+.++.||+.||.|++|+|+.+|++++|. . ... +..+|+.+|.|+||.|+|+||+++|+.++
T Consensus 90 ~~~~~~~~~~~aF~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~l~~~~D~d~dG~Is~~EF~~~l~~~~ 162 (162)
T d1topa_ 90 AKGKSEEELANCFRIFDKNADGFIDIEELGEILRATGEHVTEEDIEDLMKDSDKNNDGRIDFDEFLKMMEGVQ 162 (162)
T ss_dssp HHHHHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHTTTCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHSCC
T ss_pred cccCcHHHHHHHHHHHCCCCCCCCcHHHHHHHHHhhCCCCCHHHHHHHHHHhCCCCCCcEEHHHHHHHHHcCC
Confidence 3333466789999999999999999999999982 2 222 89999999999999999999999998763
|
| >d1lkja_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.87 E-value=4.4e-22 Score=161.21 Aligned_cols=137 Identities=20% Similarity=0.391 Sum_probs=119.9
Q ss_pred hcCHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhh
Q 016471 237 ALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEAL 315 (389)
Q Consensus 237 ~l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~ 315 (389)
.++++++..++++|..+|. ++|.|+.+||+.++...+. .++..++..++...+.++++.++|++|+..+.........
T Consensus 3 ~ls~~~i~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~g~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (146)
T d1lkja_ 3 NLTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGL-SPSEAEVNDLMNEIDVDGNHQIEFSEFLALMSRQLKSNDS 81 (146)
T ss_dssp CCCHHHHHHHHHHHHHHCCSSSSEEEHHHHHHHHHHHTC-CCCHHHHHHHHHHHCSSSCCEEEHHHHHHHHHHHTCCCCH
T ss_pred CCCHHHHHHHHHHHHHHCCCCCCcEeHHHHHHHHHhcCC-CCCHHHHHHHHHHhccCCcccccHHHHHHHHHHhhccccH
Confidence 5789999999999999999 9999999999999999886 5789999999999999999999999999865543332222
Q ss_pred HHHHHHHHHHHHHHcccCCCcccHHHHHHHh---CC--chH-HHHHHHHHccCCCCceeHHHHHHHHcc
Q 016471 316 ERWDQIAITAFDYFEQEGNRVISVEELALEL---NL--APA-AYSLLNDCIRNSDGKLSFLGYKRFLHG 378 (389)
Q Consensus 316 ~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l---~~--~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~ 378 (389)
++.++.||+.||+|++|+|+.+||+++| |. .+. ++++++++| |++|+|+|+||+++|++
T Consensus 82 ---~~~~~~aF~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d-d~dG~I~~~eF~~~m~k 146 (146)
T d1lkja_ 82 ---EQELLEAFKVFDKNGDGLISAAELKHVLTSIGEKLTDAEVDDMLREVS-DGSGEINIQQFAALLSK 146 (146)
T ss_dssp ---HHHHHHHHHHHCSSSSCEEEHHHHHHHHHHHTCSCCHHHHHHHHHHHC-CSSSEEEHHHHHHHHCC
T ss_pred ---HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCcccHHHHHHHHHhcc-CCCCeEeHHHHHHHhCC
Confidence 4568999999999999999999999988 33 333 999999999 99999999999999975
|
| >d1wdcb_ a.39.1.5 (B:) Myosin Essential Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Bay scallop (Aequipecten irradians) [TaxId: 31199]
Probab=99.87 E-value=5.3e-22 Score=159.90 Aligned_cols=133 Identities=14% Similarity=0.293 Sum_probs=113.2
Q ss_pred cCHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhH
Q 016471 238 LTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALE 316 (389)
Q Consensus 238 l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~ 316 (389)
++++++..++++|..+|. ++|.|+.+||..+|+.+|.. ++..++.+++. +++|.|+|+||+..+.........
T Consensus 1 L~~~qi~e~~~~F~~~D~d~~G~I~~~el~~~l~~lg~~-~~~~el~~~~~----~~~~~i~~~eF~~~~~~~~~~~~~- 74 (142)
T d1wdcb_ 1 LPQKQIQEMKEAFSMIDVDRDGFVSKEDIKAISEQLGRA-PDDKELTAMLK----EAPGPLNFTMFLSIFSDKLSGTDS- 74 (142)
T ss_dssp CCHHHHHHHHHHHHHHCTTCSSSCCHHHHHHHHHHHSSC-CCHHHHHHHHT----TSSSCCCHHHHHHHHHHHTCSCCC-
T ss_pred CCHHHHHHHHHHHHHHcCCCCCcCChHHHHHHHHHhhcC-CCHHHHHHHHH----hccCccccccccccccccccccch-
Confidence 468899999999999999 99999999999999999974 78888888885 567899999999876543322222
Q ss_pred HHHHHHHHHHHHHcccCCCcccHHHHHHHh---C--CchH-HHHHHHHHccCCCCceeHHHHHHHHccc
Q 016471 317 RWDQIAITAFDYFEQEGNRVISVEELALEL---N--LAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHGV 379 (389)
Q Consensus 317 ~~~~~l~~aF~~~D~d~~G~I~~~el~~~l---~--~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~ 379 (389)
++.++.||+.||+|++|+|+.+||+++| | ++.+ +.++++.+|.| +|+|+|+||+++|++.
T Consensus 75 --~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~g~~lt~~e~~~l~~~~d~~-~G~I~y~eF~~~l~~~ 140 (142)
T d1wdcb_ 75 --EETIRNAFAMFDEQETKKLNIEYIKDLLENMGDNFNKDEMRMTFKEAPVE-GGKFDYVKFTAMIKGS 140 (142)
T ss_dssp --HHHHHHHHHTTCTTCCSCEEHHHHHHHHHHSSSCCCHHHHHHHHHHCCEE-TTEECHHHHHHHHHTS
T ss_pred --hhhHHHhhhhhcccCCCcccHHHHHHHHHHccccCCHHHHHHHHHHhCCC-CCEEcHHHHHHHHhcC
Confidence 4579999999999999999999999998 4 3344 99999999998 5999999999999764
|
| >d1dtla_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=99.86 E-value=3e-21 Score=158.05 Aligned_cols=144 Identities=19% Similarity=0.338 Sum_probs=120.2
Q ss_pred HHhcCHHHHHHHHHHhhhcCC-C-CCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHH
Q 016471 235 SKALTEEELVYLRAQFMLLEP-K-DGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQL 312 (389)
Q Consensus 235 ~~~l~~ee~~~l~~~F~~~D~-~-~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~ 312 (389)
...+++++...++.+|..+|. + +|.|+.+||..+|+.+|. .++..++.+++..++.+++|.+++.+|..........
T Consensus 5 ~~~Lt~~~~~~l~~~F~~~D~d~~dG~I~~~e~~~~l~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 83 (156)
T d1dtla_ 5 VEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQ-NPTPEELQEMIDEVDEDGSGTVDFDEFLVMMVRSMKD 83 (156)
T ss_dssp GGGSCHHHHHHHHHHHHHHTTTCGGGSBCHHHHHHHHHHTTC-CCCHHHHHHHHHHHCTTSSSSBCHHHHHHHHHHHHC-
T ss_pred HHHCCHHHHHHHHHHHHHHcCCCCCCeECHHHHHHHHHHcCC-CCCHHHHHHHHHHhhccCCCccchhhhhhhhhhcccc
Confidence 346889999999999999998 5 799999999999999987 4789999999999999999999999998654432221
Q ss_pred HhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHhCC-----chH-HHHHHHHHccCCCCceeHHHHHHHHccc
Q 016471 313 EALERWDQIAITAFDYFEQEGNRVISVEELALELNL-----APA-AYSLLNDCIRNSDGKLSFLGYKRFLHGV 379 (389)
Q Consensus 313 ~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~-----~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~ 379 (389)
......++.++.||+.||.|++|+|+.+|+++++.. +.. +.++++.+|.|+||+|+|+||+++|+.+
T Consensus 84 ~~~~~~~~~l~~~F~~~D~d~~G~I~~~e~~~~~~~~~~~ls~~e~~~i~~~~D~d~dG~I~~~eF~~~l~g~ 156 (156)
T d1dtla_ 84 DSKGKSEEELSDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKDGDKNNDGRIDYDEFLEFMKGV 156 (156)
T ss_dssp ----CHHHHHHHHHHHHCTTCSSEEEHHHHGGGGTTC--CCCHHHHHHHHHHHCTTSSSEEEHHHHHHHHHC-
T ss_pred cccccHHHHHHHHHHHhCcCCCCcCcHHHHHHHHhhcCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHcCC
Confidence 111112567999999999999999999999999932 233 9999999999999999999999999763
|
| >d2obha1 a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.85 E-value=6.8e-21 Score=153.05 Aligned_cols=134 Identities=18% Similarity=0.316 Sum_probs=117.2
Q ss_pred CHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHH
Q 016471 239 TEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALER 317 (389)
Q Consensus 239 ~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~ 317 (389)
++++...++++|..+|. ++|.|+.+||..++...+. .++...+.+++..+|.+++|.|++.||+..+.........
T Consensus 1 t~~~~~elk~~F~~~D~~~~G~Is~~e~~~~l~~~~~-~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~~~-- 77 (141)
T d2obha1 1 TEEQKQEIREAFDLFDADGTGTIDVKELKVAMRALGF-EPKKEEIKKMISEIDKEGTGKMNFGDFLTVMTQKMSEKDT-- 77 (141)
T ss_dssp CHHHHHHHHHHHHTTCTTCCSEEEGGGHHHHHHHTTC-CCCHHHHHHHHHHHTTTCCSEEEHHHHHHHHHHHHHHHHH--
T ss_pred CHHHHHHHHHHHHHHcCCCCCeEeHHHHHHHHHhcCC-chhHHHHHHHHHhhccCCCCeechHHHHHHHHHHHhhhcc--
Confidence 46788899999999999 9999999999999998886 4789999999999999999999999999866544333222
Q ss_pred HHHHHHHHHHHHcccCCCcccHHHHHHHh---CC--chH-HHHHHHHHccCCCCceeHHHHHHHH
Q 016471 318 WDQIAITAFDYFEQEGNRVISVEELALEL---NL--APA-AYSLLNDCIRNSDGKLSFLGYKRFL 376 (389)
Q Consensus 318 ~~~~l~~aF~~~D~d~~G~I~~~el~~~l---~~--~~~-~~~~~~~~d~~~~g~i~~~ef~~~~ 376 (389)
.+.++.+|..+|.+++|+|+..+|..++ |. +.. +..+++.+|.|+||+|+|+||+++|
T Consensus 78 -~~~l~~~f~~~d~~~~G~i~~~el~~~l~~~g~~l~~~e~~~l~~~~D~d~dG~i~~~EF~~~m 141 (141)
T d2obha1 78 -KEEILKAFKLFDDDETGKISFKNLKRVAKELGENLTDEELQEMIDEADRDGDGEVSEQEFLRIM 141 (141)
T ss_dssp -HHHHHHHHHHHCTTCSSSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTSSSSBCHHHHHHHH
T ss_pred -HHHHHHHHHHhcccCCCCccHHHHHHHHHHhCCCCCHHHHHHHHHHHCCCCCCCEeHHHHHHhC
Confidence 4679999999999999999999999988 32 333 9999999999999999999999987
|
| >d1jfja_ a.39.1.5 (A:) EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: 5759]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: EHCABP species: Entamoeba (Entamoeba histolytica) [TaxId: 5759]
Probab=99.85 E-value=1.9e-21 Score=154.80 Aligned_cols=128 Identities=14% Similarity=0.176 Sum_probs=109.3
Q ss_pred HHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHH
Q 016471 247 RAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITA 325 (389)
Q Consensus 247 ~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~a 325 (389)
..+|..+|. ++|.||.+||..++..++.. .+.+++..++..+|.+++|.|+|+||+..+........ ...+..++.+
T Consensus 3 e~~F~~~D~d~dG~is~~E~~~~l~~~~~~-~~~~~~~~~~~~~D~~~~g~i~~~Ef~~~~~~~~~~~~-~~~~~~~~~~ 80 (134)
T d1jfja_ 3 EALFKEIDVNGDGAVSYEEVKAFVSKKRAI-KNEQLLQLIFKSIDADGNGEIDQNEFAKFYGSIQGQDL-SDDKIGLKVL 80 (134)
T ss_dssp HHHHHHHCTTCSSEEEHHHHHHHHHTTCCS-SHHHHHHHHHHHHCSSCCSEEEHHHHHHHTTCSSCCSS-HHHHHHHHHH
T ss_pred HHHHHHHcCCCcCCCcHHHHHHHHHHcCCC-CCHHHHHHHHHHhhhccccccccccccccccccccccc-cccccccccc
Confidence 578999999 99999999999999988864 68889999999999999999999999987654322211 1124568999
Q ss_pred HHHHcccCCCcccHHHHHHHhCC-chH-HHHHHHHHccCCCCceeHHHHHHHH
Q 016471 326 FDYFEQEGNRVISVEELALELNL-APA-AYSLLNDCIRNSDGKLSFLGYKRFL 376 (389)
Q Consensus 326 F~~~D~d~~G~I~~~el~~~l~~-~~~-~~~~~~~~d~~~~g~i~~~ef~~~~ 376 (389)
|+.+|.|++|+|+.+|++.++.. ... +.+++.++|.|+||+|+|+||+++|
T Consensus 81 F~~~D~~~~g~i~~~el~~~~~~~~~~~~~~~~~~~D~d~dG~is~~EF~~~~ 133 (134)
T d1jfja_ 81 YKLMDVDGDGKLTKEEVTSFFKKHGIEKVAEQVMKADANGDGYITLEEFLEFS 133 (134)
T ss_dssp HHHHCCSSSSEEEHHHHHHHHTTTTCHHHHHHHHHHHCSSSSEEEHHHHHHHH
T ss_pred ccccccccCCcccHHHHHHHHHhcCcHHHHHHHHHHCCCCCCCCCHHHHHHHh
Confidence 99999999999999999999943 333 8889999999999999999999987
|
| >d1wdcc_ a.39.1.5 (C:) Myosin Regulatory Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Regulatory Chain species: Bay scallop (Aequipecten irradians) [TaxId: 31199]
Probab=99.84 E-value=2.8e-21 Score=157.48 Aligned_cols=139 Identities=20% Similarity=0.275 Sum_probs=113.5
Q ss_pred cCHHHHHHHHHHhhhcC--C-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHh
Q 016471 238 LTEEELVYLRAQFMLLE--P-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEA 314 (389)
Q Consensus 238 l~~ee~~~l~~~F~~~D--~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~ 314 (389)
++++++..++++|..+| . ++|.|+.+||+.+|+.+|.. ++++++..+. ..+.+++|.|+|+||+..+........
T Consensus 1 Ls~eqi~~l~~~F~~fD~~~~~dG~I~~~el~~~l~~lG~~-~t~~e~~~~~-~~~~~~~~~i~~~eFl~~~~~~~~~~~ 78 (152)
T d1wdcc_ 1 LSQDEIDDLKDVFELFDFWDGRDGAVDAFKLGDVCRCLGIN-PRNEDVFAVG-GTHKMGEKSLPFEEFLPAYEGLMDCEQ 78 (152)
T ss_dssp CCHHHHHHHHHHHHHHHHHTCSSSCEEGGGHHHHHHHTTCC-CCHHHHHHTT-CCSSTTSCEECHHHHHHHHHHHTTSCC
T ss_pred CCHHHHHHHHHHHHHHCcCCCCCCeECHHHHHHHHHHhccC-ccHhhhhhhh-hhhccccccccccccccccccccccch
Confidence 46788999999999998 3 78999999999999999974 7888887764 567888999999999986654332211
Q ss_pred hHHHHHHHHHHHHHHcccCCCcccHHHHHHHh---C--CchH-HHHHHHHHccC--CCCceeHHHHHHHHcccc
Q 016471 315 LERWDQIAITAFDYFEQEGNRVISVEELALEL---N--LAPA-AYSLLNDCIRN--SDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 315 ~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l---~--~~~~-~~~~~~~~d~~--~~g~i~~~ef~~~~~~~~ 380 (389)
.. .+.++.||+.||+|++|+|+.+||+++| | ++++ ++++++.+|.+ ++|.|+|+||++.|...|
T Consensus 79 ~~--~~~l~~aF~~~D~~~~G~I~~~el~~~l~~~g~~ls~~e~~~l~~~~d~~~d~~G~I~y~eF~~~~~~~p 150 (152)
T d1wdcc_ 79 GT--FADYMEAFKTFDREGQGFISGAELRHVLTALGERLSDEDVDEIIKLTDLQEDLEGNVKYEDFVKKVMAGP 150 (152)
T ss_dssp CC--HHHHHHHHHTTCSSSSSEEEHHHHHHHHHHSSSCCCHHHHHHHHHHHTCCCCTTSEEEHHHHHHHHHHCS
T ss_pred hH--HHhhhhhhhccccccCccchHHHHHHHHHHcCCCCCHHHHHHHHHHhccCCCCCCEEEHHHHHHHHhcCC
Confidence 11 3568999999999999999999999998 3 3344 99999999965 468999999999997655
|
| >d1g8ia_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Frequenin (neuronal calcium sensor 1) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.83 E-value=5.3e-20 Score=155.16 Aligned_cols=151 Identities=17% Similarity=0.204 Sum_probs=120.9
Q ss_pred hHHHHHHHHHH--hcCHHHHHHHHHHhhhcCCCCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHH
Q 016471 226 LKRAALKALSK--ALTEEELVYLRAQFMLLEPKDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFC 303 (389)
Q Consensus 226 l~~~~l~~i~~--~l~~ee~~~l~~~F~~~D~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~ 303 (389)
+....+..+.+ .++..++..+...|...+ .+|.++.+++..++...+........+.++|+.+|.+++|.|+|+||+
T Consensus 5 l~~e~i~~l~~~t~fs~~Ei~~l~~~F~~~~-~~g~i~~~ef~~~~~~~~~~~~~~~~~~~if~~~d~~~dg~I~~~EF~ 83 (187)
T d1g8ia_ 5 LKPEVVEELTRKTYFTEKEVQQWYKGFIKDC-PSGQLDAAGFQKIYKQFFPFGDPTKFATFVFNVFDENKDGRIEFSEFI 83 (187)
T ss_dssp CCHHHHHHHHHTSSSCHHHHHHHHHHHHHHC-TTSEEEHHHHHHHHHHHCTTSCTHHHHHHHHHHHCTTCSSEEEHHHHH
T ss_pred CCHHHHHHHHHhcCCCHHHHHHHHHHHHHHC-CCCCcCHHHHHHHHHHhcCCCCHHHHHHHHHHHhCcCCCCCCcHHHHH
Confidence 33444444544 378899999999997665 589999999999998887543344556889999999999999999999
Q ss_pred HHHhchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHhC-----------Cc------hH-HHHHHHHHccCCCC
Q 016471 304 AAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALELN-----------LA------PA-AYSLLNDCIRNSDG 365 (389)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~-----------~~------~~-~~~~~~~~d~~~~g 365 (389)
.++........ +++++.+|+.||.|++|+|+.+|+..++. .. .. ++.+++++|.|+||
T Consensus 84 ~~l~~~~~~~~----~e~l~~~F~~~D~d~dG~i~~~El~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~if~~~D~d~dG 159 (187)
T d1g8ia_ 84 QALSVTSRGTL----DEKLRWAFKLYDLDNDGYITRNEMLDIVDAIYQMVGNTVELPEEENTPEKRVDRIFAMMDKNADG 159 (187)
T ss_dssp HHHHHHHHCCH----HHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHHHC-----CCGGGSSHHHHHHHHHHHHCSSCSS
T ss_pred HHHHHhccCch----hhhHHHHHHHHhcCCCCeEcHHHHHHHHHHHhhhhcccccCchhhccHHHHHHHHHHHhCCCCCC
Confidence 87766543322 56799999999999999999999999872 11 11 78899999999999
Q ss_pred ceeHHHHHHHHccccC
Q 016471 366 KLSFLGYKRFLHGVTV 381 (389)
Q Consensus 366 ~i~~~ef~~~~~~~~~ 381 (389)
.|+|+||++++.+.+.
T Consensus 160 ~Is~~EF~~~~~~~p~ 175 (187)
T d1g8ia_ 160 KLTLQEFQEGSKADPS 175 (187)
T ss_dssp EEEHHHHHHHHHHCHH
T ss_pred cEeHHHHHHHHHHCHH
Confidence 9999999999988763
|
| >d1auib_ a.39.1.5 (B:) Calcineurin regulatory subunit (B-chain) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcineurin regulatory subunit (B-chain) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.83 E-value=2.8e-20 Score=153.67 Aligned_cols=138 Identities=17% Similarity=0.274 Sum_probs=114.6
Q ss_pred HHhcCHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHH
Q 016471 235 SKALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLE 313 (389)
Q Consensus 235 ~~~l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~ 313 (389)
...++++++..++..|..+|. ++|.|+.+||+.++..... ..+++++..+|.+++|.|+|+||+..+.......
T Consensus 7 ~t~ft~eei~~l~~~F~~~D~d~~G~I~~~E~~~~~~~~~~-----~~~~~l~~~~d~~~~g~i~~~EFl~~~~~~~~~~ 81 (165)
T d1auib_ 7 CSHFDADEIKRLGKRFKKLDLDNSGSLSVEEFMSLPELQQN-----PLVQRVIDIFDTDGNGEVDFKEFIEGVSQFSVKG 81 (165)
T ss_dssp CCSCCHHHHHHHHHHHHHHCTTCCSEECHHHHTTSHHHHTC-----TTHHHHHHHHCTTCSSSEEHHHHHHHHGGGCTTC
T ss_pred cCCCCHHHHHHHHHHHHHHCCCCCCCCcHHHHHHhhhccCC-----HHHHHHHHHHccccchhhhhhhhhhhccccccch
Confidence 346889999999999999999 9999999999876543322 2367899999999999999999998776654332
Q ss_pred hhHHHHHHHHHHHHHHcccCCCcccHHHHHHHh----CC--chH-----HHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 314 ALERWDQIAITAFDYFEQEGNRVISVEELALEL----NL--APA-----AYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 314 ~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l----~~--~~~-----~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
.. ...++.+|+.+|.|++|+|+.+||++++ +. ... +..++.++|.|+||+|+|+||+++|++..
T Consensus 82 ~~---~~~~~~~f~~~d~d~~g~Is~~el~~~l~~~~~~~~~~~~~~~~~~~~~~~~D~~~dG~Is~~EF~~i~~~~~ 156 (165)
T d1auib_ 82 DK---EQKLRFAFRIYDMDKDGYISNGELFQVLKMMVGNNLKDTQLQQIVDKTIINADKDGDGRISFEEFCAVVGGLD 156 (165)
T ss_dssp CH---HHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHTTSSCHHHHHHHHHHHHHHHCTTSSSSEEHHHHHHHHGGGC
T ss_pred hh---HHHHHHHHHHhcccccccccHHHHHHHHHHhccccCchHHHHHHHHHHHHHcCCCCCCcEeHHHHHHHHhcCC
Confidence 21 4568999999999999999999999988 21 212 77899999999999999999999998765
|
| >d2mysb_ a.39.1.5 (B:) Myosin Essential Chain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=99.83 E-value=2.4e-20 Score=150.58 Aligned_cols=136 Identities=12% Similarity=0.203 Sum_probs=112.2
Q ss_pred cCHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhH
Q 016471 238 LTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALE 316 (389)
Q Consensus 238 l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~ 316 (389)
++++++..+++.|..+|. ++|.|+.+||..+|..+|....+.+ ++..++.+++|.|+|.||+..+.........
T Consensus 1 f~~~qi~el~e~F~~~D~~~~G~I~~~e~~~~l~~lg~~~~~~~----~~~~~~~~~~g~i~~~eF~~~~~~~~~~~~~- 75 (145)
T d2mysb_ 1 FDETEIEDFKEAFTVIDQNADGIIDKDDLRETFAAMGRLNVKNE----ELDAMIKEASGPINFTVFLTMFGEKLKGADP- 75 (145)
T ss_pred CCHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhCCCcchHH----HHHHHHHhccCceeechhhhhhhhcccccch-
Confidence 467889999999999999 9999999999999999986433333 3445556778999999999876654333222
Q ss_pred HHHHHHHHHHHHHcccCCCcccHHHHHHHh---CC--chH-HHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 317 RWDQIAITAFDYFEQEGNRVISVEELALEL---NL--APA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 317 ~~~~~l~~aF~~~D~d~~G~I~~~el~~~l---~~--~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
++.++.||+.||++++|+|+.+||+++| |. +.+ +.++++.+|.|++|+|+|.+|+++|+...
T Consensus 76 --~~~l~~aF~~fD~~~~g~I~~~el~~~l~~~g~~ls~~e~~~~~~~~d~d~dg~I~y~eF~~~l~~~~ 143 (145)
T d2mysb_ 76 --EDVIMGAFKVLDPDGKGSIKKSFLEELLTTGGGRFTPEEIKNMWAAFPPDVAGNVDYKNICYVITHGE 143 (145)
T ss_pred --HHHHHHHHHhhhhcccchhhHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHhccCC
Confidence 4569999999999999999999999998 42 333 99999999999999999999999998753
|
| >d1s6ia_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Probab=99.83 E-value=1e-21 Score=165.01 Aligned_cols=140 Identities=20% Similarity=0.445 Sum_probs=123.2
Q ss_pred hcCHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhh
Q 016471 237 ALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEAL 315 (389)
Q Consensus 237 ~l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~ 315 (389)
.++++++..++++|..+|. ++|.|+.+||..+|..++. .++..++..++..+|.+++|.|+|.+|+...........
T Consensus 3 ~Lt~~ei~~l~~~F~~~D~d~dG~Is~~e~~~~l~~l~~-~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~~- 80 (182)
T d1s6ia_ 3 RLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGS-ELMESEIKDLMDAADIDKSGTIDYGEFIAATVHLNKLER- 80 (182)
T ss_dssp SSSCTTTCSHHHHHHTTSSSSSSCEEHHHHHHHHTTTTC-CCCHHHHHHHHHHTCTTCSSEECHHHHHHHHTTSSSSCC-
T ss_pred CCCHHHHHHHHHHHHHHcCCCcCCCCHHHHHHHHHHcCC-ccccccchhhhhhhhccccccchHHHHHHHHHhhccccc-
Confidence 4677778889999999999 9999999999999999876 478999999999999999999999999987665544332
Q ss_pred HHHHHHHHHHHHHHcccCCCcccHHHHHHHh---CCchH-HHHHHHHHccCCCCceeHHHHHHHHccccC
Q 016471 316 ERWDQIAITAFDYFEQEGNRVISVEELALEL---NLAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVTV 381 (389)
Q Consensus 316 ~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l---~~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~ 381 (389)
++.++.+|+.+|.+++|+|+.++|++++ |++.. +..+++.+|.|+||.|+|+||+++|++..+
T Consensus 81 ---~e~l~~aF~~~D~d~~G~i~~~el~~~l~~~gl~~~ev~~~f~~~D~d~DG~Is~~EF~~~m~~~~~ 147 (182)
T d1s6ia_ 81 ---EENLVSAFSYFDKDGSGYITLDEIQQACKDFGLDDIHIDDMIKEIDQDNDGQIDYGEFAAMMRKRKG 147 (182)
T ss_dssp ---CCSTHHHHHHTTTTCSSEEEHHHHHHTTTTTTCCTTHHHHHHHHHCSSSSSEEETTHHHHTTSCCCS
T ss_pred ---HHHHHHHHHHHhhcCCCccchhhhhhhhhhcCccHHHHHHHHHHhhcCCCCeEeHHHHHHHHHhCcC
Confidence 3458899999999999999999999998 44444 999999999999999999999999997764
|
| >d2mysc_ a.39.1.5 (C:) Myosin Regulatory Chain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Regulatory Chain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=99.82 E-value=2.4e-20 Score=150.63 Aligned_cols=133 Identities=14% Similarity=0.217 Sum_probs=107.9
Q ss_pred HHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCC--CCcceeHHHHHHHHhchhHHHhhHHHH
Q 016471 243 LVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPL--SDQKLAYEEFCAAATSVYQLEALERWD 319 (389)
Q Consensus 243 ~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~--~~g~i~~~eF~~~~~~~~~~~~~~~~~ 319 (389)
...++++|..+|. ++|.|+.+||..+|+.+|.. ++..++..++...+.+ ++|.|+|+||+..+.........+. .
T Consensus 3 ~eelke~F~~~D~d~~G~I~~~el~~~l~~lg~~-~~~~e~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~-~ 80 (145)
T d2mysc_ 3 ADDFKEAFLLFDRTGDAKITASQVGDIARALGQN-PTNAEINKILGNPSKEEMNAAAITFEEFLPMLQAAANNKDQGT-F 80 (145)
T ss_pred HHHHHHHHHHHcCCCCCeECHHHHHHHHHHhhhc-chhhhhHHHHHHHhhcccccCccchhHHHHHHhhhhhccccch-H
Confidence 3457889999999 99999999999999999874 7888999999987654 6889999999986654322211111 3
Q ss_pred HHHHHHHHHHcccCCCcccHHHHHHHh---CC--chH-HHHHHHHHccCCCCceeHHHHHHHHcc
Q 016471 320 QIAITAFDYFEQEGNRVISVEELALEL---NL--APA-AYSLLNDCIRNSDGKLSFLGYKRFLHG 378 (389)
Q Consensus 320 ~~l~~aF~~~D~d~~G~I~~~el~~~l---~~--~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~ 378 (389)
+.++.||+.||+|++|+|+.+||+++| |. ... +.++++. |.|++|+|+|+||+++|..
T Consensus 81 ~~l~~aF~~~D~d~~G~I~~~el~~~l~~~g~~~~~~e~~~l~~~-~~d~dG~I~y~eF~~~ll~ 144 (145)
T d2mysc_ 81 EDFVEGLRVFDKEGNGTVMGAELRHVLATLGEKMTEEEVEELMKG-QEDSNGCINYEAFVKHIMS 144 (145)
T ss_pred HHHHHHHHHhhcCCCCEEcHHHHHHHHHHhCCCCCHHHHHHHHhh-cCCCCCeEEHHHHHHHHhc
Confidence 568999999999999999999999998 32 233 8888874 8899999999999998854
|
| >d1bjfa_ a.39.1.5 (A:) Neurocalcin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Neurocalcin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.82 E-value=7e-20 Score=153.61 Aligned_cols=150 Identities=19% Similarity=0.216 Sum_probs=121.5
Q ss_pred HHHHHHHHHH--hcCHHHHHHHHHHhhhcCCCCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHH
Q 016471 227 KRAALKALSK--ALTEEELVYLRAQFMLLEPKDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCA 304 (389)
Q Consensus 227 ~~~~l~~i~~--~l~~ee~~~l~~~F~~~D~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~ 304 (389)
+...+..+.. .++.+++..+...|...| ++|.|+.+||..++...+........++++|..+|.+++|.|+|+||+.
T Consensus 5 ~~~~~~~L~~~t~fs~~ei~~l~~~F~~~~-~~g~i~~~ef~~~l~~~~~~~~~~~~~~~lf~~~d~~~~g~i~~~eFl~ 83 (181)
T d1bjfa_ 5 RPEVMQDLLESTDFTEHEIQEWYKGFLRDC-PSGHLSMEEFKKIYGNFFPYGDASKFAEHVFRTFDANGDGTIDFREFII 83 (181)
T ss_dssp CHHHHHHHHHHSSCCHHHHHHHHHHHHHHS-TTSEEEHHHHHHHHTTTSSSSCCHHHHHHHHHHHCSSCSSEEEHHHHHH
T ss_pred CHHHHHHHHHhcCCCHHHHHHHHHHHHhhC-CCCCcCHHHHHHHHHHhCCCCCHHHHHHHHHHhcCCCCCCcEeHHHHHH
Confidence 3444444444 488999999999987654 5899999999999988765444456688999999999999999999998
Q ss_pred HHhchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHhC-----------Cc------hH-HHHHHHHHccCCCCc
Q 016471 305 AATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALELN-----------LA------PA-AYSLLNDCIRNSDGK 366 (389)
Q Consensus 305 ~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~-----------~~------~~-~~~~~~~~d~~~~g~ 366 (389)
++........ ++.++.+|+.||.|++|+|+.+|+..++. .. .. ++++|+++|.|+||.
T Consensus 84 ~~~~~~~~~~----~~~~~~~f~~~D~d~dg~i~~~E~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~if~~~D~d~dG~ 159 (181)
T d1bjfa_ 84 ALSVTSRGKL----EQKLKWAFSMYDLDGNGYISKAEMLEIVQAIYKMVSSVMKMPEDESTPEKRTEKIFRQMDTNRDGK 159 (181)
T ss_dssp HHHHHTSSCH----HHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHTTCCCTTTSCGGGSSHHHHHHHHHHHSCTTCSSE
T ss_pred HHHHHhhhch----HHHHHHHHHHhccCCCCeecHHHHHHHHHHHhhhccccccCCcccccHHHHHHHHHHHhCCCCCCc
Confidence 7765544322 56799999999999999999999999882 11 11 888999999999999
Q ss_pred eeHHHHHHHHccccC
Q 016471 367 LSFLGYKRFLHGVTV 381 (389)
Q Consensus 367 i~~~ef~~~~~~~~~ 381 (389)
|||+||++++.+.+.
T Consensus 160 Is~~EF~~~~~~~p~ 174 (181)
T d1bjfa_ 160 LSLEEFIRGAKSDPS 174 (181)
T ss_dssp ECHHHHHHHHHHCTH
T ss_pred EeHHHHHHHHHhCHH
Confidence 999999999988764
|
| >d2zfda1 a.39.1.5 (A:32-214) Calcineurin B-like protein 2 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcineurin B-like protein 2 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=99.81 E-value=9.4e-20 Score=153.07 Aligned_cols=144 Identities=14% Similarity=0.244 Sum_probs=117.8
Q ss_pred HHhcCHHHHHHHHHHhhhcCC---CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhH
Q 016471 235 SKALTEEELVYLRAQFMLLEP---KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQ 311 (389)
Q Consensus 235 ~~~l~~ee~~~l~~~F~~~D~---~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~ 311 (389)
...++.+++..+++.|..+|. ++|.|+.+||+.++...+.. ....+.++|..+|.+++|.|+|+||+.++.....
T Consensus 8 ~t~Fs~~ei~~L~~~F~~~d~~~~~~G~i~~~ef~~~l~~~~~~--~~~~~~~lf~~~d~~~dg~I~f~EFl~~l~~~~~ 85 (183)
T d2zfda1 8 DTVFSVSEIEALYELFKKISSAVIDDGLINKEEFQLALFKTNKK--ESLFADRVFDLFDTKHNGILGFEEFARALSVFHP 85 (183)
T ss_dssp HSSCCHHHHHHHHHHHHHHHTSSSCSSSBCHHHHHHHHHSCSSC--CCHHHHHHHHHHCSSCSSSBCHHHHHHHHHHTST
T ss_pred hCCCCHHHHHHHHHHHHHHCcCCCCCCcCcHHHHHHHHHhcCCC--CCHHHHHHHHHHccCCCCcCcHHHHHHHHHhhhc
Confidence 457899999999999999885 58999999999988766542 3345789999999999999999999987644322
Q ss_pred HHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHh-------CC--chH-----HHHHHHHHccCCCCceeHHHHHHHHc
Q 016471 312 LEALERWDQIAITAFDYFEQEGNRVISVEELALEL-------NL--APA-----AYSLLNDCIRNSDGKLSFLGYKRFLH 377 (389)
Q Consensus 312 ~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l-------~~--~~~-----~~~~~~~~d~~~~g~i~~~ef~~~~~ 377 (389)
.... +++++.+|+.||.|++|+|+.+|++.++ +. ... +.++++++|.|+||+|+|+||++++.
T Consensus 86 ~~~~---~~~~~~~F~~~D~d~~G~Is~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~if~~~D~d~dG~Is~~EF~~~~~ 162 (183)
T d2zfda1 86 NAPI---DDKIHFSFQLYDLKQQGFIERQEVKQMVVATLAESGMNLKDTVIEDIIDKTFEEADTKHDGKIDKEEWRSLVL 162 (183)
T ss_dssp TSCH---HHHHHHHHHHHCTTSSSSEEHHHHHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHCSSCSSEECHHHHHHHHH
T ss_pred cCcH---HHHHHHhhcccccCCCCCccHHHHHHHHHHHHhhhhcccchHHHHHHHHHHHHHhCCCCCCeEcHHHHHHHHH
Confidence 1111 4578999999999999999999999987 21 222 67789999999999999999999998
Q ss_pred cccCCC
Q 016471 378 GVTVRS 383 (389)
Q Consensus 378 ~~~~~~ 383 (389)
+.+...
T Consensus 163 ~~p~~~ 168 (183)
T d2zfda1 163 RHPSLL 168 (183)
T ss_dssp HSGGGG
T ss_pred HCHHHH
Confidence 877543
|
| >d1jbaa_ a.39.1.5 (A:) Guanylate cyclase activating protein 2, GCAP-2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Guanylate cyclase activating protein 2, GCAP-2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.81 E-value=7.8e-20 Score=154.41 Aligned_cols=134 Identities=16% Similarity=0.182 Sum_probs=108.5
Q ss_pred HHHHHHHHhhhcCCCCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHH
Q 016471 242 ELVYLRAQFMLLEPKDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQI 321 (389)
Q Consensus 242 e~~~l~~~F~~~D~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~ 321 (389)
++..+...|...+ .+|.|+.+||+++|...+. ..+...++++|..+|.+++|.|+|.||+.++........ ++.
T Consensus 22 ei~~~~~~F~~~~-~~G~i~~~Ef~~~l~~~~~-~~~~~~~~~lf~~~D~d~dG~I~f~Ef~~~l~~~~~~~~----~~~ 95 (189)
T d1jbaa_ 22 QLQEWYKKFLEEC-PSGTLFMHEFKRFFKVPDN-EEATQYVEAMFRAFDTNGDNTIDFLEYVAALNLVLRGTL----EHK 95 (189)
T ss_dssp HHHHHHHHHHSSS-TTCCEEHHHHHHHHHCCSS-STTHHHHHHHHHHHCCSSSSEECHHHHHHHHHHHSSCCC----THH
T ss_pred HHHHHHHHhcccC-CCCeeeHHHHHHHHHHcCC-CccHHHHHHHHHHhccCCCCeEeehhHHHHHHhhcccch----HHH
Confidence 4445555554322 5899999999999987766 367888999999999999999999999987765443222 456
Q ss_pred HHHHHHHHcccCCCcccHHHHHHHhCC---------------------ch-H-HHHHHHHHccCCCCceeHHHHHHHHcc
Q 016471 322 AITAFDYFEQEGNRVISVEELALELNL---------------------AP-A-AYSLLNDCIRNSDGKLSFLGYKRFLHG 378 (389)
Q Consensus 322 l~~aF~~~D~d~~G~I~~~el~~~l~~---------------------~~-~-~~~~~~~~d~~~~g~i~~~ef~~~~~~ 378 (389)
++.+|+.||.|++|.|+.+|+..++.. .. . +..++..+|.|+||.|+|+||+.+|++
T Consensus 96 ~~~~F~~~D~d~~g~i~~~E~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~if~~~D~d~dG~Is~~EF~~~~~~ 175 (189)
T d1jbaa_ 96 LKWTFKIYDKDRNGCIDRQELLDIVESIYKLKKACSVEVEAEQQGKLLTPEEVVDRIFLLVDENGDGQLSLNEFVEGARR 175 (189)
T ss_dssp HHHHHHHHCSSCSSCBCHHHHHHHHHHHHHHHHHSSCCTTSSTTTCCCCHHHHHHHHHHHHCCSCCSCBCHHHHHHHHTT
T ss_pred HHHHHhhhccCCCCcccHhHHHHHHHHHHHhhccccccchhhhhccccchHHHHHHHHHHhCCCCCCcEeHHHHHHHHHh
Confidence 899999999999999999999987610 11 1 678999999999999999999999998
Q ss_pred ccC
Q 016471 379 VTV 381 (389)
Q Consensus 379 ~~~ 381 (389)
.+.
T Consensus 176 ~p~ 178 (189)
T d1jbaa_ 176 DKW 178 (189)
T ss_dssp TTT
T ss_pred CHH
Confidence 774
|
| >d1fpwa_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Frequenin (neuronal calcium sensor 1) species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.81 E-value=8.7e-20 Score=154.19 Aligned_cols=141 Identities=11% Similarity=0.132 Sum_probs=116.0
Q ss_pred hcCHHHHHHHHHHhhhcCCCCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhH
Q 016471 237 ALTEEELVYLRAQFMLLEPKDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALE 316 (389)
Q Consensus 237 ~l~~ee~~~l~~~F~~~D~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~ 316 (389)
.++..++..+...|...+ .+|.++..||..++..++........++++|..+|.+++|.|+|+||+.++........
T Consensus 21 ~fs~~Ei~~l~~~F~~~~-~~G~i~~~ef~~~~~~~~~~~~~~~~~~~if~~~D~~~~G~I~~~Ef~~~~~~~~~~~~-- 97 (190)
T d1fpwa_ 21 YFDRREIQQWHKGFLRDC-PSGQLAREDFVKIYKQFFPFGSPEDFANHLFTVFDKDNNGFIHFEEFITVLSTTSRGTL-- 97 (190)
T ss_dssp CSTHHHHHHHHHHHHHHC-TTCCEEHHHHHHHHHHHCTTSCCSHHHHHHHHTCCSSCSSEECHHHHHHHHHHHSCCCS--
T ss_pred CCCHHHHHHHHHHHHHHC-CCCCccHHHHHHHHHHHCCCCChHHHHHHHHHHhCcCCCCcccHHHHHHHHHHHccCch--
Confidence 378889999999996555 48999999999999888643334455789999999999999999999987664433222
Q ss_pred HHHHHHHHHHHHHcccCCCcccHHHHHHHhC---------Cc--------hH-HHHHHHHHccCCCCceeHHHHHHHHcc
Q 016471 317 RWDQIAITAFDYFEQEGNRVISVEELALELN---------LA--------PA-AYSLLNDCIRNSDGKLSFLGYKRFLHG 378 (389)
Q Consensus 317 ~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~---------~~--------~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~ 378 (389)
++.++.+|+.||.|++|+|+.+|+..++. .. .. +.++++++|.|+||.|+|+||++++++
T Consensus 98 --~e~~~~~F~~~D~d~dG~is~~E~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~if~~~D~d~dG~Is~~EF~~~~~~ 175 (190)
T d1fpwa_ 98 --EEKLSWAFELYDLNHDGYITFDEMLTIVASVYKMMGSMVTLNEDEATPEMRVKKIFKLMDKNEDGYITLDEFREGSKV 175 (190)
T ss_dssp --THHHHHHHHHHCSSCSSEEEHHHHHHHHHHHHTTSCSTTSSSCCCCCHHHHHHHHHHHHTTTCSSEEEHHHHHHHHHS
T ss_pred --HHHHHHHHHHhccCCCCcCcHHHHHHHHHHHHHhcccccCCCchhhhHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHH
Confidence 46799999999999999999999999881 00 11 888999999999999999999999998
Q ss_pred ccCC
Q 016471 379 VTVR 382 (389)
Q Consensus 379 ~~~~ 382 (389)
.+..
T Consensus 176 ~p~i 179 (190)
T d1fpwa_ 176 DPSI 179 (190)
T ss_dssp STTH
T ss_pred CHHH
Confidence 7754
|
| >d1omra_ a.39.1.5 (A:) Recoverin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Recoverin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.81 E-value=1.5e-19 Score=154.21 Aligned_cols=139 Identities=19% Similarity=0.219 Sum_probs=114.4
Q ss_pred hcCHHHHHHHHHHhhhcCCCCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhH
Q 016471 237 ALTEEELVYLRAQFMLLEPKDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALE 316 (389)
Q Consensus 237 ~l~~ee~~~l~~~F~~~D~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~ 316 (389)
.++..++..+...|...+ .+|.|+.+||+.+|...+....+...++++|..+|.+++|.|+|.||+.++........
T Consensus 21 ~f~~~ei~~l~~~F~~~~-~~G~is~~EF~~~l~~~~~~~~~~~~~~~if~~~D~~~~G~I~f~EF~~~~~~~~~~~~-- 97 (201)
T d1omra_ 21 KFTEEELSSWYQSFLKEC-PSGRITRQEFQTIYSKFFPEADPKAYAQHVFRSFDANSDGTLDFKEYVIALHMTSAGKT-- 97 (201)
T ss_dssp SSCHHHHHHHHHHHHHHC-TTSEEEHHHHHHHHHHHCTTSCCHHHHHHHHHTTTSCSSSEEEHHHHHHHHHHHHSSCG--
T ss_pred CCCHHHHHHHHHHHHHHC-cCCCccHHHHHHHHHHhcCCCCHHHHHHHHHHHhccCCCCeEeehhHHHHHHhhcccch--
Confidence 468889999999997655 48999999999999988764455666789999999999999999999987665433222
Q ss_pred HHHHHHHHHHHHHcccCCCcccHHHHHHHhC----C-c-------------hH--HHHHHHHHccCCCCceeHHHHHHHH
Q 016471 317 RWDQIAITAFDYFEQEGNRVISVEELALELN----L-A-------------PA--AYSLLNDCIRNSDGKLSFLGYKRFL 376 (389)
Q Consensus 317 ~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~----~-~-------------~~--~~~~~~~~d~~~~g~i~~~ef~~~~ 376 (389)
++.++.+|+.||.|++|+|+.+|+..++. . . .. ++.+|..+|.|+||.|+|+||+..+
T Consensus 98 --~~~l~~~F~~~D~d~~G~is~~E~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~if~~~D~d~dG~Is~~EF~~~~ 175 (201)
T d1omra_ 98 --NQKLEWAFSLYDVDGNGTISKNEVLEIVTAIFKMISPEDTKHLPEDENTPEKRAEKIWGFFGKKDDDKLTEKEFIEGT 175 (201)
T ss_dssp --GGSHHHHHHHHCTTCSSSBCHHHHHHHHHHHHTTSCHHHHTTSCGGGSSHHHHHHHHHHHTTCCTTCCBCHHHHHHHH
T ss_pred --HHHHHHHHHHHccCCCCccCHHHHHHHHHHHHhhcChhhhhhhhhhhccHHHHHHHHHHHhCCCCCCCCcHHHHHHHH
Confidence 45689999999999999999999998771 1 0 01 6789999999999999999999988
Q ss_pred cccc
Q 016471 377 HGVT 380 (389)
Q Consensus 377 ~~~~ 380 (389)
.+.+
T Consensus 176 ~~~~ 179 (201)
T d1omra_ 176 LANK 179 (201)
T ss_dssp HHCH
T ss_pred HHCH
Confidence 6654
|
| >d1ggwa_ a.39.1.5 (A:) Cdc4p {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Cdc4p species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.80 E-value=4.7e-20 Score=147.88 Aligned_cols=128 Identities=17% Similarity=0.245 Sum_probs=104.7
Q ss_pred HHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHH
Q 016471 244 VYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIA 322 (389)
Q Consensus 244 ~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l 322 (389)
...+++|..+|. ++|.|+.+||..+|+.+|.. ++.+++.++ +.+++|.|+|+||+..+.......... ..+.+
T Consensus 5 ~~fke~F~~~D~d~dG~I~~~el~~~l~~lg~~-~t~~ei~~~----~~~~~~~i~~~eF~~~~~~~~~~~~~~-~~~~l 78 (140)
T d1ggwa_ 5 SPYKQAFSLFDRHGTGRIPKTSIGDLLRACGQN-PTLAEITEI----ESTLPAEVDMEQFLQVLNRPNGFDMPG-DPEEF 78 (140)
T ss_dssp TTTHHHHHHTCSSSSSEECHHHHHHHHHHTSCC-CCHHHHHHH----HTTSCSSEEHHHHHHHHCTTSSSSSSC-CHHHH
T ss_pred HHHHHHHHHHCCCCCCeECHHHHHHHHHHHHhh-hHHHhhhhh----hccccccccchhhhhhhhhhhhcchhh-HHHHH
Confidence 456889999999 99999999999999999974 788777655 567789999999998765432221110 13468
Q ss_pred HHHHHHHcccCCCcccHHHHHHHh---C--CchH-HHHHHHHHccCCCCceeHHHHHHHHcc
Q 016471 323 ITAFDYFEQEGNRVISVEELALEL---N--LAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHG 378 (389)
Q Consensus 323 ~~aF~~~D~d~~G~I~~~el~~~l---~--~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~ 378 (389)
+.||+.||+|++|+|+.+||+++| | ++.+ ++++++.+|.+ +|+|+|+||+++|..
T Consensus 79 ~~aF~~~D~d~~G~I~~~el~~~l~~~g~~lt~~e~~~l~~~~d~~-dG~I~y~eF~~~m~s 139 (140)
T d1ggwa_ 79 VKGFQVFDKDATGMIGVGELRYVLTSLGEKLSNEEMDELLKGVPVK-DGMVNYHDFVQMILA 139 (140)
T ss_dssp HHHHHTTCSSCSSCCCHHHHHHHHHHHHSCSCHHHHHHHHHHTTCS-SCCSTTTHHHHHHHC
T ss_pred HHHHHHHhccCCCcchHHHHHHHHHHcCCCCCHHHHHHHHHhhCCC-CCEEeHHHHHHHHhc
Confidence 999999999999999999999998 2 3444 99999999988 899999999999864
|
| >d1s6ca_ a.39.1.5 (A:) Kchip1, Kv4 potassium channel-interacting protein {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Kchip1, Kv4 potassium channel-interacting protein species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.79 E-value=7.8e-19 Score=146.69 Aligned_cols=140 Identities=15% Similarity=0.193 Sum_probs=114.6
Q ss_pred HhcCHHHHHHHHHHhhhcCCCCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhh
Q 016471 236 KALTEEELVYLRAQFMLLEPKDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEAL 315 (389)
Q Consensus 236 ~~l~~ee~~~l~~~F~~~D~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~ 315 (389)
..++..++..+.+.|...|+ +|.|+.+||+.+|...+........+.++|..+|.+++|.|+|+||+.++........
T Consensus 8 t~ft~~ei~~l~~~F~~~~~-~G~is~~ef~~~l~~~~~~~~~~~~~~~lf~~~D~~~~g~I~~~EFl~~~~~~~~~~~- 85 (178)
T d1s6ca_ 8 TNFTKRELQVLYRGFKNECP-SGVVNEETFKQIYAQFFPHGDASTYAHYLFNAFDTTQTGSVKFEDFVTALSILLRGTV- 85 (178)
T ss_dssp SSCCHHHHHHHHHHHHHHCT-TSEECHHHHHHHHHHHSTTSCCHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHCCH-
T ss_pred CCCCHHHHHHHHHHHHHHCc-CCCccHHHHHHHHHHhCCCCCHHHHHHHHHHHHCCCCCCcccHHHHHHHHHHHhccch-
Confidence 35788999999888876554 7999999999999888654335555789999999999999999999987654433222
Q ss_pred HHHHHHHHHHHHHHcccCCCcccHHHHHHHhC-------C------c----hH-HHHHHHHHccCCCCceeHHHHHHHHc
Q 016471 316 ERWDQIAITAFDYFEQEGNRVISVEELALELN-------L------A----PA-AYSLLNDCIRNSDGKLSFLGYKRFLH 377 (389)
Q Consensus 316 ~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~-------~------~----~~-~~~~~~~~d~~~~g~i~~~ef~~~~~ 377 (389)
++.++.+|+.||.|++|+|+.+|+..++. . . .. ++.+++.+|.|+||.|||+||++++.
T Consensus 86 ---~~~~~~~f~~~D~~~~g~i~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~if~~~D~d~DG~Is~~EF~~~i~ 162 (178)
T d1s6ca_ 86 ---HEKLRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVLKEDTPRQHVDVFFQKMDKNKDGIVTLDEFLESCQ 162 (178)
T ss_dssp ---HHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHHTC-----------CHHHHHHHHHHHCTTCSSEECHHHHHHHTT
T ss_pred ---HHHHHHHHHhhccCCCCeecHHHHHHHHHHHHhhcccccccCCcHHHHHHHHHHHHHHhCCCCCCcEeHHHHHHHHH
Confidence 46799999999999999999999988761 0 1 11 77899999999999999999999998
Q ss_pred ccc
Q 016471 378 GVT 380 (389)
Q Consensus 378 ~~~ 380 (389)
+.+
T Consensus 163 ~~~ 165 (178)
T d1s6ca_ 163 EDD 165 (178)
T ss_dssp SCC
T ss_pred HCH
Confidence 765
|
| >d1m45a_ a.39.1.5 (A:) Myosin Light Chain Mlc1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Light Chain Mlc1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.78 E-value=1.7e-19 Score=145.64 Aligned_cols=132 Identities=17% Similarity=0.213 Sum_probs=106.1
Q ss_pred HHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhh-cCCCCCcceeHHHHHHHHhchhHHHhh--HHHHHH
Q 016471 246 LRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNV-MEPLSDQKLAYEEFCAAATSVYQLEAL--ERWDQI 321 (389)
Q Consensus 246 l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~-~d~~~~g~i~~~eF~~~~~~~~~~~~~--~~~~~~ 321 (389)
++.+|..+|. ++|.|+.+||..+|+.+|. .++++++..++.. .+.+.+|.|+|.||+..+......... ....+.
T Consensus 4 ~k~~F~~~D~d~~G~I~~~el~~~l~~lg~-~~s~~ei~~l~~~~~~~~~~~~i~~~ef~~~~~~~~~~~~~~~~~~~~~ 82 (146)
T d1m45a_ 4 NKDIFTLFDKKGQGAIAKDSLGDYLRAIGY-NPTNQLVQDIINADSSLRDASSLTLDQITGLIEVNEKELDATTKAKTED 82 (146)
T ss_dssp CTTCHHHHCTTCCSEEEGGGHHHHHHHTTC-CCCHHHHHHHHHC--CC--CCEEEHHHHHHHHHHTHHHHHGGGCCCTHH
T ss_pred HHHHHHHHcCCCcCCCCHHHHHHHHHHcCC-chhHHHHhhhhccccccccccccccchhhhhhhhhcccccccccchHHH
Confidence 4678999999 9999999999999999987 4799999999975 456667899999999865543322111 011356
Q ss_pred HHHHHHHHcccCCCcccHHHHHHHh---C--CchH-HHHHHHHHccCCCCceeHHHHHHHHcc
Q 016471 322 AITAFDYFEQEGNRVISVEELALEL---N--LAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHG 378 (389)
Q Consensus 322 l~~aF~~~D~d~~G~I~~~el~~~l---~--~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~ 378 (389)
++.||+.||.+++|+|+.+||+.+| | +++. +.++++.+|.|++|.|+|+||++.|.+
T Consensus 83 l~~~F~~~D~~~~G~I~~~el~~~l~~~g~~l~~~ei~~l~~~~D~d~dG~I~y~eF~~~i~~ 145 (146)
T d1m45a_ 83 FVKAFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAEVDELLKGVEVDSNGEIDYKKFIEDVLR 145 (146)
T ss_dssp HHHHHHTTCSSSSSEEEHHHHHHHHHHSTTCCCHHHHHHHHTTCCCCTTSEEEHHHHHHHHHC
T ss_pred HHHHHHhhccccccccchhhhhhhhcccCCcchHHHHHHHHHHhCCCCCCcEEHHHHHHHHHc
Confidence 8999999999999999999999999 3 3344 999999999999999999999987753
|
| >d1y1xa_ a.39.1.8 (A:) Programmed cell death 6 protein-like protein {Leishmania major [TaxId: 5664]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Programmed cell death 6 protein-like protein species: Leishmania major [TaxId: 5664]
Probab=99.78 E-value=1.2e-18 Score=145.93 Aligned_cols=125 Identities=16% Similarity=0.214 Sum_probs=109.5
Q ss_pred HHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHH
Q 016471 244 VYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIA 322 (389)
Q Consensus 244 ~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l 322 (389)
..+++.|..+|. ++|.|+.+||..+|..++. .++..++.+++..+|.+++|.|+|+||+..+.. ...+
T Consensus 18 ~~l~~~F~~~D~d~dG~Is~~El~~~l~~l~~-~~s~~~~~~l~~~~d~d~~~~i~~~ef~~~~~~----------~~~~ 86 (182)
T d1y1xa_ 18 QELMEWFRAVDTDGSGAISVPELNAALSSAGV-PFSLATTEKLLHMYDKNHSGEITFDEFKDLHHF----------ILSM 86 (182)
T ss_dssp SCHHHHHHHHCTTCSSSBCHHHHHHHHCBTTB-CCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHH----------HHHH
T ss_pred HHHHHHHHHHcCCCcCCCCHHHHHHHHHHhcc-cCchhhhhhhhcccccccccccccccccccccc----------cccc
Confidence 468889999999 9999999999999988886 589999999999999999999999999874332 2347
Q ss_pred HHHHHHHcccCCCcccHHHHHHHh---CC--chH-HHHHHHHHccCCCCceeHHHHHHHHccc
Q 016471 323 ITAFDYFEQEGNRVISVEELALEL---NL--APA-AYSLLNDCIRNSDGKLSFLGYKRFLHGV 379 (389)
Q Consensus 323 ~~aF~~~D~d~~G~I~~~el~~~l---~~--~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~ 379 (389)
+.+|+.+|.+++|+|+.+||++++ |. +.. +..+++.+|.|++|.|+|+||+.+|..+
T Consensus 87 ~~~F~~~D~~~~g~I~~~el~~~l~~~g~~ls~~e~~~i~~~~d~~~dg~I~~~eF~~~~~~l 149 (182)
T d1y1xa_ 87 REGFRKRDSSGDGRLDSNEVRAALLSSGYQVSEQTFQALMRKFDRQRRGSLGFDDYVELSIFV 149 (182)
T ss_dssp HHHHHHHCTTSSSCBCHHHHHHHHHTTSCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHH
T ss_pred ccchhccccccchhhhhHHHHHHHHHhCCchhHHHHHHHHhhcccCCCCCcCHHHHHHHHHHH
Confidence 889999999999999999999988 32 333 9999999999999999999999988543
|
| >d1hqva_ a.39.1.8 (A:) Apoptosis-linked protein alg-2 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Apoptosis-linked protein alg-2 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.77 E-value=9.5e-19 Score=146.47 Aligned_cols=127 Identities=17% Similarity=0.254 Sum_probs=110.1
Q ss_pred HHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHH
Q 016471 243 LVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQI 321 (389)
Q Consensus 243 ~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~ 321 (389)
...+..+|..+|. ++|+||.+||+.+|+.++....+.+++..+++.+|.+++|.|+|+||+..+... ..
T Consensus 18 ~~~L~~iF~~~D~d~~G~Is~~E~~~~l~~~~~~~~~~~~~~~l~~~~D~d~~g~i~~~EFl~~~~~~----------~~ 87 (181)
T d1hqva_ 18 QSFLWNVFQRVDKDRSGVISDNELQQALSNGTWTPFNPVTVRSIISMFDRENKAGVNFSEFTGVWKYI----------TD 87 (181)
T ss_dssp HHHHHHHHHHHCTTCCSSBCHHHHHHHCCCSSSSCCCHHHHHHHHHHHCCSSSSSBCHHHHHHHHHHH----------HH
T ss_pred HHHHHHHHHHHcCCCCCcCcHHHHHHHHHHcCCCcccHHHHHHHhhccccccccchhhhHHHhhhhhc----------cc
Confidence 4568889999999 999999999999998887655788999999999999999999999999854321 24
Q ss_pred HHHHHHHHcccCCCcccHHHHHHHh---C--CchH-HHHHHHHHccCCCCceeHHHHHHHHccc
Q 016471 322 AITAFDYFEQEGNRVISVEELALEL---N--LAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHGV 379 (389)
Q Consensus 322 l~~aF~~~D~d~~G~I~~~el~~~l---~--~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~ 379 (389)
++.+|+.+|.+++|+|+++||++++ + +..+ +.++++.+|.+++|+|+|+||+.++...
T Consensus 88 ~~~~f~~~D~~~~G~i~~~el~~~l~~~~~~l~~e~~~~~~~~~d~~~dg~Is~~eF~~~~~~l 151 (181)
T d1hqva_ 88 WQNVFRTYDRDNSGMIDKNELKQALSGFGYRLSDQFHDILIRKFDRQGRGQIAFDDFIQGCIVL 151 (181)
T ss_dssp HHHHHHHHCTTCCSSBCHHHHHHHHHHHTBCCCHHHHHHHHHHHCSSCSSCBCHHHHHHHHHHH
T ss_pred cccccccccccccchhhhHHHHHHHHHcCCcchhHHHHHHHHHhCCCCCCcCcHHHHHHHHHHH
Confidence 6889999999999999999999998 3 2333 8999999999999999999999887543
|
| >d1w7jb1 a.39.1.5 (B:11-149) Myosin Essential Chain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.76 E-value=2e-19 Score=144.03 Aligned_cols=128 Identities=17% Similarity=0.313 Sum_probs=103.0
Q ss_pred HHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCC--CCCcceeHHHHHHHHhchhHHHhhHHHHHHH
Q 016471 246 LRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEP--LSDQKLAYEEFCAAATSVYQLEALERWDQIA 322 (389)
Q Consensus 246 l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~--~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l 322 (389)
++++|..+|. ++|.|+.+||..+|+.+|. .++..++..++..++. +++|.|+|.||+..+.........+. .+.+
T Consensus 2 ~ke~F~~~D~d~~G~I~~~el~~~l~~lg~-~~t~~e~~~~~~~~~~~~~~~~~i~~~ef~~~~~~~~~~~~~~~-~~~l 79 (139)
T d1w7jb1 2 FKEAFELFDRVGDGKILYSQCGDVMRALGQ-NPTNAEVLKVLGNPKSDELKSRRVDFETFLPMLQAVAKNRGQGT-YEDY 79 (139)
T ss_dssp HHHHHHHHCCSSSSEEESTTHHHHHHHTTC-CCCHHHHHHHTTCCCHHHHTTCEEEHHHHHHHHHHHCC---------CC
T ss_pred HHHHHHHHhCCCCCeECHHHHHHHHHHhcc-CCCHHHHHHHHHHHhcccccCCceeeeccchhhHhhhhhccccH-HHHH
Confidence 5789999999 9999999999999999987 4799999999988874 57899999999876543222211111 3458
Q ss_pred HHHHHHHcccCCCcccHHHHHHHh---C--CchH-HHHHHHHHccCCCCceeHHHHHHHH
Q 016471 323 ITAFDYFEQEGNRVISVEELALEL---N--LAPA-AYSLLNDCIRNSDGKLSFLGYKRFL 376 (389)
Q Consensus 323 ~~aF~~~D~d~~G~I~~~el~~~l---~--~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~ 376 (389)
+.||+.||+|++|+|+.+||+++| | .+.. ++.+++. |.|++|.|+|+||+++|
T Consensus 80 ~~aF~~~D~d~~G~I~~~el~~~l~~~g~~~~~~e~~~l~~~-~~d~dg~I~~~eF~~~l 138 (139)
T d1w7jb1 80 LEGFRVFDKEGNGKVMGAELRHVLTTLGEKMTEEEVETVLAG-HEDSNGCINYEAFLKHI 138 (139)
T ss_dssp HHHHHTTCTTSSSEEEHHHHHHHHHHSSSCCCHHHHHHHHTT-CCCTTSEEEHHHHHHHT
T ss_pred HHhhhhccCCCCCeEeHHHHHHHHHHhCCCCCHHHHHHHHhh-CCCCCCeEeHHHHHHHh
Confidence 999999999999999999999999 3 2333 7777765 88999999999999986
|
| >d1df0a1 a.39.1.8 (A:515-700) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), M-type [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain large subunit, C-terminal domain (domain IV) species: Rat (Rattus norvegicus), M-type [TaxId: 10116]
Probab=99.75 E-value=1.3e-18 Score=146.24 Aligned_cols=126 Identities=14% Similarity=0.146 Sum_probs=105.9
Q ss_pred HHHHHHhhhcCCCCCcccHHHHHHHHHHhccc-------cCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhH
Q 016471 244 VYLRAQFMLLEPKDGCVSLNNFKVALMRQATD-------AMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALE 316 (389)
Q Consensus 244 ~~l~~~F~~~D~~~G~i~~~el~~~l~~~~~~-------~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~ 316 (389)
..+++.|..+|.++|.|+..||+.+|..++.. .++.+++..++..+|.+++|.|+|+||+..+..
T Consensus 18 ~~~r~~F~~~d~~dG~Is~~EL~~~L~~~~~~~~~~~~~~~s~~~~~~l~~~~D~d~~G~I~~~EF~~~~~~-------- 89 (186)
T d1df0a1 18 DGFRRLFAQLAGEDAEISAFELQTILRRVLAKREDIKSDGFSIETCKIMVDMLDEDGSGKLGLKEFYILWTK-------- 89 (186)
T ss_dssp HHHHHHHHHHHGGGTCEEHHHHHHHHHHHHHC----CCCCCCHHHHHHHHHHHCCSSSSEECHHHHHHHHHH--------
T ss_pred HHHHHHHHHHcCCCCeEcHHHHHHHHHHhcccccccccccCCHHHHHHHHHHHcCCCCCcccHHHHHHHHHh--------
Confidence 34778899887789999999999999887643 245778999999999999999999999985432
Q ss_pred HHHHHHHHHHHHHcccCCCcccHHHHHHHh---CC--chHHHHHHHHHccCCCCceeHHHHHHHHccc
Q 016471 317 RWDQIAITAFDYFEQEGNRVISVEELALEL---NL--APAAYSLLNDCIRNSDGKLSFLGYKRFLHGV 379 (389)
Q Consensus 317 ~~~~~l~~aF~~~D~d~~G~I~~~el~~~l---~~--~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~ 379 (389)
...++.+|+.||+|++|+|+.+||+.+| |. ++++.+++...|.|++|.|+|+||+.+|.+.
T Consensus 90 --~~~~~~~F~~~D~d~sG~I~~~El~~~l~~~g~~~~~~~~~~~~~~d~d~dg~I~f~eFi~~~~~l 155 (186)
T d1df0a1 90 --IQKYQKIYREIDVDRSGTMNSYEMRKALEEAGFKLPCQLHQVIVARFADDELIIDFDNFVRCLVRL 155 (186)
T ss_dssp --HHHHHHHHHHHCTTCCSCEEGGGHHHHHHHTTEECCHHHHHHHHHHHCCSTTEECHHHHHHHHHHH
T ss_pred --HHHHHHHHHhhCCCCCCcccHHHHHHHHHHHHhcccHHHHHHHHHHHcCCCCeEeHHHHHHHHHHH
Confidence 2347889999999999999999999999 32 3336678888999999999999999988654
|
| >d1xo5a_ a.39.1.5 (A:) Calcium- and integrin-binding protein, CIB {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium- and integrin-binding protein, CIB species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.75 E-value=2.7e-18 Score=143.31 Aligned_cols=136 Identities=17% Similarity=0.275 Sum_probs=103.8
Q ss_pred hcCHHHHHHHHHHhhhcCC-CCCc--------ccHHHHHHHHHHhccccCCHHHHHHHHhhcCCC-CCcceeHHHHHHHH
Q 016471 237 ALTEEELVYLRAQFMLLEP-KDGC--------VSLNNFKVALMRQATDAMTDSRVFEILNVMEPL-SDQKLAYEEFCAAA 306 (389)
Q Consensus 237 ~l~~ee~~~l~~~F~~~D~-~~G~--------i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~-~~g~i~~~eF~~~~ 306 (389)
.++.+++..++..|..+|+ +.|. ++.+++.... .+.... -++++|+.+|.+ ++|.|+|+||+.++
T Consensus 10 ~ft~~EI~~l~~~F~~l~~~~~~~~~~~~~~~i~~~e~~~~~-~l~~~~----~~~rif~~fd~~~~~g~I~f~EFv~~l 84 (180)
T d1xo5a_ 10 FLTKQEILLAHRRFCELLPQEQRSVESSLRAQVPFEQILSLP-ELKANP----FKERICRVFSTSPAKDSLSFEDFLDLL 84 (180)
T ss_dssp CSCHHHHHHHHHHHHTTSCGGGCSHHHHHHCCEEHHHHHTSH-HHHTCT----THHHHHHHHCCSTTCCEECHHHHHHHH
T ss_pred CCCHHHHHHHHHHHHHHCcCccccccccccceEcHHHHhcCc-ccccCh----HHHHHHHhccCCCCCCcCcHHHHHHHH
Confidence 5778899999999999988 6654 5565554322 222111 267899999987 68999999999876
Q ss_pred hchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHhC----------CchH-----HHHHHHHHccCCCCceeHHH
Q 016471 307 TSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALELN----------LAPA-----AYSLLNDCIRNSDGKLSFLG 371 (389)
Q Consensus 307 ~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~----------~~~~-----~~~~~~~~d~~~~g~i~~~e 371 (389)
......... +++++.||+.||.|++|+|+.+||..++. ...+ +..+++++|.|+||+|||+|
T Consensus 85 ~~~~~~~~~---~~kl~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~v~~~~~~~D~d~dG~Is~~E 161 (180)
T d1xo5a_ 85 SVFSDTATP---DIKSHYAFRIFDFDDDGTLNREDLSRLVNCLTGEGEDTRLSASEMKQLIDNILEESDIDRDGTINLSE 161 (180)
T ss_dssp HHHSTTSCH---HHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHC------CCCCTTHHHHHHHHHHHHCTTCSSSBCHHH
T ss_pred HHHhhcCCH---HHHHHHhhccccCCCCCeeeHHHHHHHHHHHHhccccccccHHHHHHHHHHHHHHhCCCCCCcCcHHH
Confidence 543222121 56799999999999999999999999771 1111 66789999999999999999
Q ss_pred HHHHHcccc
Q 016471 372 YKRFLHGVT 380 (389)
Q Consensus 372 f~~~~~~~~ 380 (389)
|+++|.+.|
T Consensus 162 F~~~~~~~P 170 (180)
T d1xo5a_ 162 FQHVISRSP 170 (180)
T ss_dssp HHHHHHHCH
T ss_pred HHHHHHhCH
Confidence 999998876
|
| >d1alva_ a.39.1.8 (A:) Calpain small (regulatory) subunit (domain VI) {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain small (regulatory) subunit (domain VI) species: Pig (Sus scrofa) [TaxId: 9823]
Probab=99.75 E-value=2.1e-18 Score=143.33 Aligned_cols=129 Identities=21% Similarity=0.244 Sum_probs=107.6
Q ss_pred HHHHHHHHHhhhcCCCCCcccHHHHHHHHHHhccc-------cCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHH
Q 016471 241 EELVYLRAQFMLLEPKDGCVSLNNFKVALMRQATD-------AMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLE 313 (389)
Q Consensus 241 ee~~~l~~~F~~~D~~~G~i~~~el~~~l~~~~~~-------~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~ 313 (389)
+++..++++|..+|.++|.|+..||+.+|...+.. .++.+.+..++..+|.+++|.|+|+||+..+..
T Consensus 1 ee~~~~r~~F~~~d~~dg~I~~~EL~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~~d~d~~g~i~~~ef~~~~~~----- 75 (173)
T d1alva_ 1 EEVRQFRRLFAQLAGDDMEVSATELMNILNKVVTRHPDLKTDGFGIDTCRSMVAVMDSDTTGKLGFEEFKYLWNN----- 75 (173)
T ss_dssp CHHHHHHHHHHHHHGGGTSBCHHHHHHHHHHHHHTCSTTCCSCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHH-----
T ss_pred ChHHHHHHHHHHHcCCCCcCCHHHHHHHHHHhCCCcchhhhccCCHHHHHHHHHHhccCCCCcccchhhhhhhhh-----
Confidence 36778999999999878999999999999887642 245688999999999999999999999985432
Q ss_pred hhHHHHHHHHHHHHHHcccCCCcccHHHHHHHh---C--CchHHHHHHHHHccCCCCceeHHHHHHHHccc
Q 016471 314 ALERWDQIAITAFDYFEQEGNRVISVEELALEL---N--LAPAAYSLLNDCIRNSDGKLSFLGYKRFLHGV 379 (389)
Q Consensus 314 ~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l---~--~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~ 379 (389)
...++.+|+.||+|++|.|+.+||+.+| | ++..+.+.+..+|.|++|.|+|+||+.+|.+.
T Consensus 76 -----~~~~~~~f~~~D~d~~G~I~~~el~~~L~~~g~~~~~~~~~~~~~~d~d~~G~i~~~EF~~~~~~~ 141 (173)
T d1alva_ 76 -----IKKWQAIYKQFDVDRSGTIGSSELPGAFEAAGFHLNEHLYSMIIRRYSDEGGNMDFDNFISCLVRL 141 (173)
T ss_dssp -----HHHHHHHHHHHCTTCCSSBCTTTHHHHHHHHTCCCCHHHHHHHHHHHTCSSSCBCHHHHHHHHHHH
T ss_pred -----hhHHHHHHHHhccCCCCeecHHHHHHHHHHHHHhhHHHHHHHhhccccCCCCeEeHHHHHHHHHHH
Confidence 2347889999999999999999999999 3 23335556667888999999999999998654
|
| >d1k94a_ a.39.1.8 (A:) Grancalcin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Grancalcin species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.75 E-value=4.3e-18 Score=139.66 Aligned_cols=123 Identities=13% Similarity=0.235 Sum_probs=101.3
Q ss_pred HHHHhhhcCCCCCcccHHHHHHHHHHhcccc----CCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHH
Q 016471 246 LRAQFMLLEPKDGCVSLNNFKVALMRQATDA----MTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQI 321 (389)
Q Consensus 246 l~~~F~~~D~~~G~i~~~el~~~l~~~~~~~----~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~ 321 (389)
+...|..+..++|.|+.+||+++|...+... ++.+.+..++..+|.+++|.|+|+||+..+.. ...
T Consensus 2 ~~~~F~~~a~~dG~I~~~EL~~~L~~~g~~~~~~~~s~~~~~~li~~~D~~~~G~i~~~EF~~l~~~----------~~~ 71 (165)
T d1k94a_ 2 VYTYFSAVAGQDGEVDAEELQRCLTQSGINGTYSPFSLETCRIMIAMLDRDHTGKMGFNAFKELWAA----------LNA 71 (165)
T ss_dssp HHHHHHHHHGGGTSBCHHHHHHHHHHHTTTTTSCCCCHHHHHHHHHHHCTTCSSCBCHHHHHHHHHH----------HHH
T ss_pred hHHHHHHhcCCCCCCCHHHHHHHHHHcCCCCCcccCCHHHHHHHHHHhCCCCCCcCcHHHHHHHhhc----------cch
Confidence 3566777744899999999999999987532 35678999999999999999999999985332 235
Q ss_pred HHHHHHHHcccCCCcccHHHHHHHh---CC--chH-HHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 322 AITAFDYFEQEGNRVISVEELALEL---NL--APA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 322 l~~aF~~~D~d~~G~I~~~el~~~l---~~--~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
++.+|+.||+|++|+|+.+||+.+| |. +++ ++.++..+|. +|.|+|+||+..|.+..
T Consensus 72 ~~~~F~~fD~d~sG~I~~~El~~~l~~~G~~l~~~~~~~l~~~~d~--~g~i~~~eFi~~~~~l~ 134 (165)
T d1k94a_ 72 WKENFMTVDQDGSGTVEHHELRQAIGLMGYRLSPQTLTTIVKRYSK--NGRIFFDDYVACCVKLR 134 (165)
T ss_dssp HHHHHHHHCTTCCSBCCHHHHHHHHHHTTCCCCHHHHHHHHHHHCB--TTBCBHHHHHHHHHHHH
T ss_pred hHHHHHHhCCCCCCeEcHHHHHHHHHHhhhcCCHHHHHHHHHHcCC--CCcCcHHHHHHHHHHHH
Confidence 7899999999999999999999999 43 334 9999999865 68999999999886653
|
| >d5pala_ a.39.1.4 (A:) Parvalbumin {Leopard shark (Triakis semifasciata) [TaxId: 30493]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Leopard shark (Triakis semifasciata) [TaxId: 30493]
Probab=99.74 E-value=4e-18 Score=129.34 Aligned_cols=95 Identities=16% Similarity=0.251 Sum_probs=78.3
Q ss_pred cCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHh------C--
Q 016471 276 AMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALEL------N-- 347 (389)
Q Consensus 276 ~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l------~-- 347 (389)
.++.++|.+++..++. +|.|+|+||+..+..... . ++.++.||+.||+|++|+|+.+||+++| |
T Consensus 5 ~l~~~di~~~~~~~~~--~G~idf~eF~~~~~~~~~--~----~~~l~~~F~~~D~d~~G~I~~~El~~~l~~l~~~g~~ 76 (109)
T d5pala_ 5 VLKADDINKAISAFKD--PGTFDYKRFFHLVGLKGK--T----DAQVKEVFEILDKDQSGFIEEEELKGVLKGFSAHGRD 76 (109)
T ss_dssp TSCHHHHHHHHHHTCS--TTCCCHHHHHHHHTCTTC--C----HHHHHHHHHHHCTTCSSEECHHHHHTHHHHHCTTCCC
T ss_pred HccHHHHHHHHHhcCC--CCcCcHHHHHHHHHhcCC--C----HHHHHHHHhhhcCCCCCeEcHHHHHHHHHHhhhccCc
Confidence 3577889999998864 578999999985532211 1 4569999999999999999999999887 2
Q ss_pred CchH-HHHHHHHHccCCCCceeHHHHHHHHcc
Q 016471 348 LAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHG 378 (389)
Q Consensus 348 ~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~ 378 (389)
+... ++++++++|.|+||+|+|+||+++|++
T Consensus 77 ~~~~e~~~~~~~~D~d~dG~I~~~EF~~~m~~ 108 (109)
T d5pala_ 77 LNDTETKALLAAGDSDHDGKIGADEFAKMVAQ 108 (109)
T ss_dssp CCHHHHHHHHHHHCTTCSSSEEHHHHHHHHHH
T ss_pred CCHHHHHHHHHHhCCCCCCCEeHHHHHHHHHh
Confidence 2233 999999999999999999999999975
|
| >d1qxpa2 a.39.1.8 (A:515-702) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), mu-type [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain large subunit, C-terminal domain (domain IV) species: Rat (Rattus norvegicus), mu-type [TaxId: 10116]
Probab=99.73 E-value=3.9e-19 Score=149.14 Aligned_cols=133 Identities=18% Similarity=0.246 Sum_probs=94.9
Q ss_pred cCHHHHH-HHHHHhhhcCCCCCcccHHHHHHHHHHhcc-------ccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhch
Q 016471 238 LTEEELV-YLRAQFMLLEPKDGCVSLNNFKVALMRQAT-------DAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSV 309 (389)
Q Consensus 238 l~~ee~~-~l~~~F~~~D~~~G~i~~~el~~~l~~~~~-------~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~ 309 (389)
++++++. .+++.|..+|.++|.|+..||+.+|...+. ..++.+.+..++..+|.+++|.|+|+||...+..
T Consensus 13 ls~~~~~~~~r~~F~~~d~~dG~Is~~EL~~~L~~~~~~~~~~~~~~~s~e~~~~li~~~D~d~~G~i~~~EF~~l~~~- 91 (188)
T d1qxpa2 13 LSEEEIDDNFKTLFSKLAGDDMEISVKELQTILNRIISKHKDLRTNGFSLESCRSMVNLMDRDGNGKLGLVEFNILWNR- 91 (188)
T ss_dssp --------------CCCCCSSSSCCCSCTTTTTCC---------CCCCCHHHHHHHHHHHCC--CCCCCSSSHHHHHHH-
T ss_pred CCHHHHHHHHHHHHHHHcCCCCEECHHHHHHHHHHhCccccccccccCCHHHHHHHHHHhcCCCCCcccHHHHHHHHhh-
Confidence 3445543 588999999998899999999988755432 2246678999999999999999999999985432
Q ss_pred hHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHh---CC--chHHHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 310 YQLEALERWDQIAITAFDYFEQEGNRVISVEELALEL---NL--APAAYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 310 ~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l---~~--~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
...++.+|+.||+|++|+|+..||+.+| |. +.++.+++-+.+.+++|.|+|+||+.+|.++.
T Consensus 92 ---------~~~~~~~F~~~D~d~sG~i~~~El~~~l~~~g~~~~~~~~~~l~~~~~~~dg~i~f~eFi~~~~~l~ 158 (188)
T d1qxpa2 92 ---------IRNYLTIFRKFDLDKSGSMSAYEMRMAIEAAGFKLPCQLHQVIVARFADDELIIDFDNFVRCLVRLE 158 (188)
T ss_dssp ---------HHHHHHHHGGGCTTCCSCCBHHHHHHHHHHTTEECCHHHHHHHHHHTSCSSSBCCHHHHHHHHHHHH
T ss_pred ---------hHHHHHHHHHhCCCCCCEECHHHHHHHHHHhhhcCCHHHHHHHHHHhcCCCCcCCHHHHHHHHHHHH
Confidence 2347889999999999999999999998 43 33355555566889999999999999986654
|
| >d1pvaa_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Probab=99.73 E-value=8.9e-18 Score=127.38 Aligned_cols=94 Identities=16% Similarity=0.272 Sum_probs=78.0
Q ss_pred CCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHhC------C--
Q 016471 277 MTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALELN------L-- 348 (389)
Q Consensus 277 ~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~------~-- 348 (389)
++.++|.+++..+| ++|.|+|+||+..+...... ++.++.+|+.||+|++|+|+.+||+.++. .
T Consensus 6 l~~eeI~~~~~~~d--~dG~idf~EF~~~~~~~~~~------~~~~~~~F~~~D~d~~G~I~~~El~~~l~~l~~~g~~l 77 (109)
T d1pvaa_ 6 LKADDIKKALDAVK--AEGSFNHKKFFALVGLKAMS------ANDVKKVFKAIDADASGFIEEEELKFVLKSFAADGRDL 77 (109)
T ss_dssp SCHHHHHHHHHHTC--STTCCCHHHHHHHHTCTTSC------HHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTCCCC
T ss_pred CCHHHHHHHHHhcC--CCCCCcHHHHHHHHHHccCC------HHHHHHHhhCccCCCcCeEcHHHHHHHHHHhhhcCCCC
Confidence 67788999999875 46789999999865433221 34689999999999999999999999872 1
Q ss_pred chH-HHHHHHHHccCCCCceeHHHHHHHHcc
Q 016471 349 APA-AYSLLNDCIRNSDGKLSFLGYKRFLHG 378 (389)
Q Consensus 349 ~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~ 378 (389)
+.. ++++++.+|.|+||+|+|+||+.+|++
T Consensus 78 s~~ev~~~~~~~D~d~dG~I~~~EF~~~m~~ 108 (109)
T d1pvaa_ 78 TDAETKAFLKAADKDGDGKIGIDEFETLVHE 108 (109)
T ss_dssp CHHHHHHHHHHHCTTCSSSBCHHHHHHHHHC
T ss_pred CHHHHHHHHHHHCCCCcCcEeHHHHHHHHHh
Confidence 222 999999999999999999999999976
|
| >d1juoa_ a.39.1.8 (A:) Sorcin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Sorcin species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.71 E-value=9.3e-18 Score=139.16 Aligned_cols=126 Identities=15% Similarity=0.208 Sum_probs=100.9
Q ss_pred HHHHHHHHhhhcCCCCCcccHHHHHHHHHHhccc----cCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHH
Q 016471 242 ELVYLRAQFMLLEPKDGCVSLNNFKVALMRQATD----AMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALER 317 (389)
Q Consensus 242 e~~~l~~~F~~~D~~~G~i~~~el~~~l~~~~~~----~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~ 317 (389)
+...++..|..++.++|.||..||+.+|..+|.. .++.+++..++..+|.|++|.|+|+||+..+..
T Consensus 5 ~~~~~~~~F~~~~~~dG~Is~~EL~~~L~~~g~~~~~~~~~~~~v~~l~~~~D~d~~G~I~f~EF~~~~~~--------- 75 (172)
T d1juoa_ 5 TQDPLYGYFAAVAGQDGQIDADELQRCLTQSGIAGGYKPFNLETCRLMVSMLDRDMSGTMGFNEFKELWAV--------- 75 (172)
T ss_dssp CCCTTHHHHHHHHTTTTEECHHHHHHHHHHHTTTCSSCCCCHHHHHHHHHHHCTTCSSCEEHHHHHHHHHH---------
T ss_pred hHHHHHHHHHHhCCCCCCCCHHHHHHHHHHcCCCCCcccCCHHHHHHHHHHHCCCCCCceehHHHHHHHHh---------
Confidence 3445778888887789999999999999998753 245788999999999999999999999975432
Q ss_pred HHHHHHHHHHHHcccCCCcccHHHHHHHh---C--CchH-HHHHHHHHccCCCCceeHHHHHHHHccc
Q 016471 318 WDQIAITAFDYFEQEGNRVISVEELALEL---N--LAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHGV 379 (389)
Q Consensus 318 ~~~~l~~aF~~~D~d~~G~I~~~el~~~l---~--~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~ 379 (389)
......+|+.||+|++|+|+.+|++.+| | ++++ +..+++++| .+|.|+|+||+.+|.+.
T Consensus 76 -~~~~~~~f~~~D~d~sG~i~~~El~~~l~~~g~~ls~~~~~~l~~~~d--~~g~i~~~eF~~~~~~~ 140 (172)
T d1juoa_ 76 -LNGWRQHFISFDTDRSGTVDPQELQKALTTMGFRLSPQAVNSIAKRYS--TNGKITFDDYIACCVKL 140 (172)
T ss_dssp -HHHHHHHHHTTCTTCCSEECHHHHHHHHHHTTCCCCHHHHHHHHHHTC--SSSSEEHHHHHHHHHHH
T ss_pred -hhhhhHHHHHhCcCCCCcCCHHHHHHHHHHHHHhhhHHHHHHHHHHHH--hcCCcCHHHHHHHHHHH
Confidence 1236789999999999999999999998 3 3334 777888774 45778888888777543
|
| >d2sasa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Sarcoplasmic calcium-binding protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Probab=99.70 E-value=5.4e-17 Score=135.96 Aligned_cols=142 Identities=15% Similarity=0.191 Sum_probs=109.5
Q ss_pred cCHHHHHHHHHHhhh-cCC-CCCcccHHHHHHHHHHhcc---ccCC-----------HHHHHHHHhhcCCCCCcceeHHH
Q 016471 238 LTEEELVYLRAQFML-LEP-KDGCVSLNNFKVALMRQAT---DAMT-----------DSRVFEILNVMEPLSDQKLAYEE 301 (389)
Q Consensus 238 l~~ee~~~l~~~F~~-~D~-~~G~i~~~el~~~l~~~~~---~~~~-----------~~~~~~~~~~~d~~~~g~i~~~e 301 (389)
+++.+...++..|.. +|. ++|.|+.+||..++..++. .... ......++...|.+++|.|++++
T Consensus 2 lt~~q~~~i~~~F~~~~D~d~dG~Is~~Ef~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~i~~~~ 81 (185)
T d2sasa_ 2 LNDFQKQKIKFTFDFFLDMNHDGSIQDNDFEDMMTRYKEVNKGSLSDADYKSMQASLEDEWRDLKGRADINKDDVVSWEE 81 (185)
T ss_dssp CCHHHHHHHHHHHHHHTCTTCSSEECHHHHHHHHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHHHCTTCSSCEEHHH
T ss_pred cCHHHHHHHHHHHHHhhcCCCCCcCCHHHHHHHHHHhccccCCCcccHHHHHHHHHHHHHHHHHHHHhCcCCCCcEeeeH
Confidence 567788889999987 599 9999999999998876531 1111 11234566778999999999999
Q ss_pred HHHHHhchhHHHh-----hHHHHHHHHHHHHHHcccCCCcccHHHHHHHh---CCchH-HHHHHHHHccCCCCceeHHHH
Q 016471 302 FCAAATSVYQLEA-----LERWDQIAITAFDYFEQEGNRVISVEELALEL---NLAPA-AYSLLNDCIRNSDGKLSFLGY 372 (389)
Q Consensus 302 F~~~~~~~~~~~~-----~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l---~~~~~-~~~~~~~~d~~~~g~i~~~ef 372 (389)
|+.++........ .......+..+|+.+|.|++|+|+.+||+.++ |++.+ +..+++.+|.|++|.|+|+||
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~Is~~E~~~~l~~~~l~~~~~~~~f~~~D~d~dG~i~~~EF 161 (185)
T d2sasa_ 82 YLAMWEKTIATCKSVADLPAWCQNRIPFLFKGMDVSGDGIVDLEEFQNYCKNFQLQCADVPAVYNVITDGGKVTFDLNRY 161 (185)
T ss_dssp HHHHHHHHHHTCCSGGGSCTTHHHHHHHHHHHHCTTSSSCCCHHHHHHHTTSSCCCCSSHHHHHHHHHTTTTSCCSHHHH
T ss_pred hhHHHHHHhhhhhhhhhhhHHHHHHHHHHHHHHccCCCccCCHHHHHHHHHHcCCCHHHHHHHHHHcCCCCCCCCcHHHH
Confidence 9987653322110 00113458899999999999999999999998 55544 999999999999999999999
Q ss_pred HHHHccc
Q 016471 373 KRFLHGV 379 (389)
Q Consensus 373 ~~~~~~~ 379 (389)
..++++.
T Consensus 162 ~~~~~~f 168 (185)
T d2sasa_ 162 KELYYRL 168 (185)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9888653
|
| >d1ij5a_ a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-binding protein LAV1-2) {Physarum polycephalum [TaxId: 5791]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) domain: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) species: Physarum polycephalum [TaxId: 5791]
Probab=99.69 E-value=5.5e-17 Score=148.00 Aligned_cols=141 Identities=17% Similarity=0.221 Sum_probs=113.6
Q ss_pred HhcCHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHH--
Q 016471 236 KALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQL-- 312 (389)
Q Consensus 236 ~~l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~-- 312 (389)
..++.++...++..|..+|. ++|.|+.+||+.+|..++.. ++..++..++..+|.+++|.|+|.||+..+......
T Consensus 114 ~~l~~~~~~~~~~~F~~~D~~~~g~i~~~e~~~~l~~~~~~-~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~~ 192 (321)
T d1ij5a_ 114 PMLSEEDTNILRQLFLSSAVSGSGKFSFQDLKQVLAKYADT-IPEGPLKKLFVMVENDTKGRMSYITLVAVANDLAALVA 192 (321)
T ss_dssp CCCCHHHHHHHHHHHTSSSSTTSSCCCHHHHHHHHHHHHTT-SCSSHHHHHHHHHHHCCSSTHHHHHHTTSHHHHHTSCC
T ss_pred ccCCHHHHHHHHHHHHHHcCCCCCeEcHHHHHHHHHHcCCc-ccHHHHHHHHHHHhhcCCccccchhhhhhhhhhhhhhH
Confidence 34678888899999999999 99999999999999998874 788899999999999999999999997432110000
Q ss_pred -------------------------------H----------------------hhHHHHHHHHHHHHHHcccCCCcccH
Q 016471 313 -------------------------------E----------------------ALERWDQIAITAFDYFEQEGNRVISV 339 (389)
Q Consensus 313 -------------------------------~----------------------~~~~~~~~l~~aF~~~D~d~~G~I~~ 339 (389)
. ........+..+|..+|.|++|+|+.
T Consensus 193 ~F~~~d~d~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ef~~~~~~~~~~~~~F~~~D~d~~G~Is~ 272 (321)
T d1ij5a_ 193 DFRKIDTNSNGTLSRKEFREHFVRLGFDKKSVQDALFRYADEDESDDVGFSEYVHLGLCLLVLRILYAFADFDKSGQLSK 272 (321)
T ss_dssp CHHHHCTTCCSEECHHHHHHHHHHTTCCCHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHHHHHHHHTCSSSCSSEEH
T ss_pred HHHHHhhcccccchhHHHhhhhhcccccchHHHHHHHHhhhcccccccccccccchhhhhhHHHHHHHHHhcCCCCCCcH
Confidence 0 00000123456899999999999999
Q ss_pred HHHHHHh---CCc-hH---HHHHHHHHccCCCCceeHHHHHHHHc
Q 016471 340 EELALEL---NLA-PA---AYSLLNDCIRNSDGKLSFLGYKRFLH 377 (389)
Q Consensus 340 ~el~~~l---~~~-~~---~~~~~~~~d~~~~g~i~~~ef~~~~~ 377 (389)
.||++++ |.. .+ +..++..+|.|+||.|+|+||+.+|-
T Consensus 273 ~E~~~~l~~~~~~~~~~~~~~~l~~~~D~d~dG~Is~~EF~~~ml 317 (321)
T d1ij5a_ 273 EEVQKVLEDAHIPESARKKFEHQFSVVDVDDSKSLSYQEFVMLVL 317 (321)
T ss_dssp HHHHHHHHHTTCCGGGCSTHHHHHHHHTTTTCSEECHHHHHHHHH
T ss_pred HHHHHHHHHcCCCcCcHHHHHHHHHHhCCCCCCcCcHHHHHHHHH
Confidence 9999998 442 22 89999999999999999999999983
|
| >d2scpa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Sandworm (Nereis diversicolor) [TaxId: 126592]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Sarcoplasmic calcium-binding protein species: Sandworm (Nereis diversicolor) [TaxId: 126592]
Probab=99.68 E-value=1.8e-16 Score=131.45 Aligned_cols=139 Identities=14% Similarity=0.135 Sum_probs=103.5
Q ss_pred HHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccc-cCCHHHH-------HHHHhh--cCCCCCcceeHHHHHHHHhc
Q 016471 240 EEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATD-AMTDSRV-------FEILNV--MEPLSDQKLAYEEFCAAATS 308 (389)
Q Consensus 240 ~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~-~~~~~~~-------~~~~~~--~d~~~~g~i~~~eF~~~~~~ 308 (389)
+.....++..|..+|. ++|.|+.+||..++.+.+.. ....... ...+.. .+.++++.|+++||+..+..
T Consensus 2 ~~~~~~l~~~F~~~D~d~dG~Is~~Ef~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ef~~~~~~ 81 (174)
T d2scpa_ 2 DLWVQKMKTYFNRIDFDKDGAITRMDFESMAERFAKESEMKAEHAKVLMDSLTGVWDNFLTAVAGGKGIDETTFINSMKE 81 (174)
T ss_dssp HHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHHHSCCCTTHHHHHHHHHHHHHHHTGGGTTTTSCEEHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHccCCCCcEeHHHHHHHHHHHhccccchhHHHHHhHHhhhhhccccccccCCCCcCcHHHHHHHHHh
Confidence 4456788999999999 99999999999988765411 1111112 222222 36678899999999986553
Q ss_pred hhHHHh-hHHHHHHHHHHHHHHcccCCCcccHHHHHHHh---CCchH-HHHHHHHHccCCCCceeHHHHHHHHcc
Q 016471 309 VYQLEA-LERWDQIAITAFDYFEQEGNRVISVEELALEL---NLAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHG 378 (389)
Q Consensus 309 ~~~~~~-~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l---~~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~ 378 (389)
...... .......+..+|+.+|+|++|+|+.+|+..++ +...+ +..+++.+|.|+||.|+|+||+.++..
T Consensus 82 ~~~~~~~~~~~~~~~~~~F~~~D~d~dG~Is~~E~~~~l~~~~~~~~~~~~~f~~~D~d~dG~Is~~Ef~~~~~~ 156 (174)
T d2scpa_ 82 MVKNPEAKSVVEGPLPLFFRAVDTNEDNNISRDEYGIFFGMLGLDKTMAPASFDAIDTNNDGLLSLEEFVIAGSD 156 (174)
T ss_dssp HTSCGGGTHHHHTHHHHHHHHHCTTCSSSEEHHHHHHHHHHTTCCGGGHHHHHHHHCTTCSSEECHHHHHHHHHH
T ss_pred hhcchhhHHHHHHHHHHHHHHHCCCccccCCHHHHHHHHHHHhhhhHHHHHHHhhcCCCCCCcEeHHHHHHHHHH
Confidence 221111 11124568899999999999999999999987 55555 999999999999999999999998754
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.68 E-value=2.4e-18 Score=145.32 Aligned_cols=111 Identities=23% Similarity=0.258 Sum_probs=83.1
Q ss_pred CCCccccceeecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCCCcEEEeecCCC
Q 016471 1 MYHQKLQHLFYSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQGVVHRDLKPENFLFTTREED 80 (389)
Q Consensus 1 l~Hpni~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i~Hrdlkp~Nill~~~~~~ 80 (389)
++|+++...++....++||||++++.+. .+++..+..++.|++.||.|||++||+||||||+|||++ +
T Consensus 71 l~~~~v~~~~~~~~~~lvme~~~~~~~~--------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~----~ 138 (191)
T d1zara2 71 LQGLAVPKVYAWEGNAVLMELIDAKELY--------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS----E 138 (191)
T ss_dssp TTTSSSCCEEEEETTEEEEECCCCEEGG--------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE----T
T ss_pred ccCCCcceEEEecCCEEEEEeecccccc--------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeee----C
Confidence 4678888877555558999999987653 255666788999999999999999999999999999995 2
Q ss_pred CCEEEeecCCccccCCCCCcccccccCCccc------cccccccCCCchhHHHHHH
Q 016471 81 APLKVIDFGLSDFVRPDQRLNDIVGSAYYVA------PEVLHRSYNVEGDMWSIGV 130 (389)
Q Consensus 81 ~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~DiwslG~ 130 (389)
..++|+|||.|........ ..|.. .+.+.+.|+.++|+||+.-
T Consensus 139 ~~~~liDFG~a~~~~~~~~-------~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~ 187 (191)
T d1zara2 139 EGIWIIDFPQSVEVGEEGW-------REILERDVRNIITYFSRTYRTEKDINSAID 187 (191)
T ss_dssp TEEEECCCTTCEETTSTTH-------HHHHHHHHHHHHHHHHHHHCCCCCHHHHHH
T ss_pred CCEEEEECCCcccCCCCCc-------HHHHHHHHHHHHHHHcCCCCCcccHHHHHH
Confidence 4489999999876542211 11211 1233467899999999643
|
| >d2pvba_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Probab=99.67 E-value=2e-16 Score=119.41 Aligned_cols=94 Identities=21% Similarity=0.272 Sum_probs=77.5
Q ss_pred cCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHh---C-----
Q 016471 276 AMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALEL---N----- 347 (389)
Q Consensus 276 ~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l---~----- 347 (389)
.++.+++..++...+.+ |.|+|.||+..+... .. . .+.++.+|+.||+|++|+|+.+||+.++ +
T Consensus 4 gls~~di~~~~~~~~~~--gsi~~~eF~~~~~l~-~~-~----~~~l~~~F~~~D~d~~G~I~~~el~~~l~~l~~~~~~ 75 (107)
T d2pvba_ 4 GLKDADVAAALAACSAA--DSFKHKEFFAKVGLA-SK-S----LDDVKKAFYVIDQDKSGFIEEDELKLFLQNFSPSARA 75 (107)
T ss_dssp TSCHHHHHHHHHHTCST--TCCCHHHHHHHHTGG-GS-C----HHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTSCC
T ss_pred CCCHHHHHHHHHhccCC--CCcCHHHHHHHHhcc-cC-C----HHHHHHHHHhhccCCCCcCcHHHHHHHHHHhhccccc
Confidence 36788899999998764 569999999854422 11 1 4569999999999999999999999987 2
Q ss_pred CchH-HHHHHHHHccCCCCceeHHHHHHHHc
Q 016471 348 LAPA-AYSLLNDCIRNSDGKLSFLGYKRFLH 377 (389)
Q Consensus 348 ~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~ 377 (389)
++.. +.++++++|.|+||+|+|+||+.+|+
T Consensus 76 ~~~~~~~~l~~~~D~d~dG~I~~~EF~~~m~ 106 (107)
T d2pvba_ 76 LTDAETKAFLADGDKDGDGMIGVDEFAAMIK 106 (107)
T ss_dssp CCHHHHHHHHHHHCTTCSSSBCHHHHHHHHH
T ss_pred CCHHHHHHHHHHhCCCCCCcEeHHHHHHHHc
Confidence 1222 99999999999999999999999996
|
| >d1rwya_ a.39.1.4 (A:) Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Rat (Rattus rattus) [TaxId: 10117]
Probab=99.66 E-value=2.3e-16 Score=119.78 Aligned_cols=95 Identities=12% Similarity=0.235 Sum_probs=78.6
Q ss_pred cCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHh---C-----
Q 016471 276 AMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALEL---N----- 347 (389)
Q Consensus 276 ~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l---~----- 347 (389)
.++.+++.+++..++. +|.|+|+||+..+..... . ++.++.+|+.||+|++|+|+.+||+.+| +
T Consensus 5 ~~~~~~i~~~~~~~~~--~~~i~f~eF~~~~~~~~~--~----~~~~~~~F~~~D~d~~G~I~~~El~~~l~~l~~~~~~ 76 (109)
T d1rwya_ 5 LLSAEDIKKAIGAFTA--ADSFDHKKFFQMVGLKKK--S----ADDVKKVFHILDKDKSGFIEEDELGSILKGFSSDARD 76 (109)
T ss_dssp HSCHHHHHHHHHTTCS--TTCCCHHHHHHHHTGGGS--C----HHHHHHHHHHHSTTCSSEECHHHHHTHHHHHCTTCCC
T ss_pred hcCHHHHHHHHHhccc--CCCcCHHHHHHHHccccC--C----HHHHHHHhhcccCCCCCcCcHHHHHHHHHHhcccccc
Confidence 3678889999998854 578999999986543221 1 4568999999999999999999999988 2
Q ss_pred CchH-HHHHHHHHccCCCCceeHHHHHHHHcc
Q 016471 348 LAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHG 378 (389)
Q Consensus 348 ~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~ 378 (389)
+... ++.+++++|.|+||+|+|+||+.+|++
T Consensus 77 ~~~~e~~~~~~~~D~d~dG~i~~~EF~~~m~~ 108 (109)
T d1rwya_ 77 LSAKETKTLMAAGDKDGDGKIGVEEFSTLVAE 108 (109)
T ss_dssp CCHHHHHHHHHHHCTTCSSSEEHHHHHHHHHT
T ss_pred CCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHh
Confidence 2233 999999999999999999999999975
|
| >d1nyaa_ a.39.1.5 (A:) Calerythrin {Saccharopolyspora erythraea [TaxId: 1836]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calerythrin species: Saccharopolyspora erythraea [TaxId: 1836]
Probab=99.64 E-value=1.3e-15 Score=126.09 Aligned_cols=138 Identities=15% Similarity=0.124 Sum_probs=106.3
Q ss_pred HHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccc---cCCHHH-----------HHHHHhhcCCCCCcceeHHHHHHHH
Q 016471 242 ELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATD---AMTDSR-----------VFEILNVMEPLSDQKLAYEEFCAAA 306 (389)
Q Consensus 242 e~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~---~~~~~~-----------~~~~~~~~d~~~~g~i~~~eF~~~~ 306 (389)
...+++..|..+|. ++|.|+.+||+.++..+... .....+ ...++...|.+++|.|++.+++...
T Consensus 5 ~~~~l~~~F~~~D~d~dG~Is~~Ef~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 84 (176)
T d1nyaa_ 5 ASDRLKKRFDRWDFDGNGALERADFEKEAQHIAEAFGKDAGAAEVQTLKNAFGGLFDYLAKEAGVGSDGSLTEEQFIRVT 84 (176)
T ss_dssp HHHHHHHHHHHCCSSCCSSBCSHHHHHHHHHHHHHTSSCSSSHHHHHHHHHHHHHHHHHHHHHTSCTTCCBCHHHHHHHH
T ss_pred HHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHHHHcCCcccHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccHHHHHHHH
Confidence 34568889999999 99999999999998766321 112111 2455667788999999999998754
Q ss_pred hchhHH----HhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHh---CCchH-HHHHHHHHccCCCCceeHHHHHHHHcc
Q 016471 307 TSVYQL----EALERWDQIAITAFDYFEQEGNRVISVEELALEL---NLAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHG 378 (389)
Q Consensus 307 ~~~~~~----~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l---~~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~ 378 (389)
...... .........++.+|..||.|++|+|+.+|++.++ |+++. +.++++.+|.|+||.|+|+||+..|+.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~dG~Is~~E~~~~~~~~~~~~~~~~~~f~~~D~d~dG~i~~~Ef~~~~~~ 164 (176)
T d1nyaa_ 85 ENLIFEQGEASFNRVLGPVVKGIVGMCDKNADGQINADEFAAWLTALGMSKAEAAEAFNQVDTNGNGELSLDELLTAVRD 164 (176)
T ss_dssp HHHHSSSCHHHHHHHHHHHHHHHHHHTCSSCCSEEEHHHHHHHHHHTTCCHHHHHHHHHHHCTTCSSEEEHHHHHHHHSC
T ss_pred hhhhhhhhhhhhHHHHHHHHHHHHHHHccCCChhhhHHHHHHHHHhcCCcHHHHHHHHHHHCCCCCCcEeHHHHHHHHHH
Confidence 432111 1111124568999999999999999999999987 66666 999999999999999999999999876
Q ss_pred c
Q 016471 379 V 379 (389)
Q Consensus 379 ~ 379 (389)
.
T Consensus 165 ~ 165 (176)
T d1nyaa_ 165 F 165 (176)
T ss_dssp C
T ss_pred H
Confidence 4
|
| >d1qv0a_ a.39.1.5 (A:) Calcium-regulated photoprotein {Hydrozoa (Obelia longissima), obelin [TaxId: 32570]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-regulated photoprotein species: Hydrozoa (Obelia longissima), obelin [TaxId: 32570]
Probab=99.61 E-value=3.7e-15 Score=125.10 Aligned_cols=139 Identities=13% Similarity=0.174 Sum_probs=100.1
Q ss_pred CHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHH-----HhccccCCHHHHH-----HHHhhcCCCCCcceeHHHHHHHHh
Q 016471 239 TEEELVYLRAQFMLLEP-KDGCVSLNNFKVALM-----RQATDAMTDSRVF-----EILNVMEPLSDQKLAYEEFCAAAT 307 (389)
Q Consensus 239 ~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~-----~~~~~~~~~~~~~-----~~~~~~d~~~~g~i~~~eF~~~~~ 307 (389)
.++.+..++.+|..+|. ++|.|+.+||..++. .++.. ++..+.. ..+...+...++.|+++||+..+.
T Consensus 9 ~~~~i~r~k~~F~~~D~d~dG~I~~~E~~~~~~~~~~~~l~~~-~~~~~~~~~~~~~~~~~~~~~~~~~i~~~e~~~~~~ 87 (189)
T d1qv0a_ 9 NPRWIKRHKHMFDFLDINGNGKITLDEIVSKASDDICAKLEAT-PEQTKRHQVCVEAFFRGCGMEYGKEIAFPQFLDGWK 87 (189)
T ss_dssp CHHHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHTHHHHTTCC-HHHHHHHHHHHHHHHHHTTCCTTCCBCHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHHHHHcCCC-chhHHHHHHHHHHHhhhccccCCCceehHHHHHHHH
Confidence 35677889999999999 999999999987553 33321 2333332 223456677889999999988765
Q ss_pred chhHHHh-------hHHHHHHHHHHHHHHcccCCCcccHHHHHHHh---C--CchH-HHHHHHHHccCCCCceeHHHHHH
Q 016471 308 SVYQLEA-------LERWDQIAITAFDYFEQEGNRVISVEELALEL---N--LAPA-AYSLLNDCIRNSDGKLSFLGYKR 374 (389)
Q Consensus 308 ~~~~~~~-------~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l---~--~~~~-~~~~~~~~d~~~~g~i~~~ef~~ 374 (389)
....... .......+..+|+.||+|++|+|+.+|++.++ | +... +..+++.+|.|+||.|+|+||++
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~is~~E~~~~l~~~g~~~~~~~~~~lf~~~D~d~dG~Is~~EF~~ 167 (189)
T d1qv0a_ 88 QLATSELKKWARNEPTLIREWGDAVFDIFDKDGSGTITLDEWKAYGKISGISPSQEDCEATFRHCDLDNAGDLDVDEMTR 167 (189)
T ss_dssp HHHHHHHHHHHTTCCCHHHHHHHHHHHHTC----CEECHHHHHHHHHHHSSCCCHHHHHHHHHHSCCCTTSCEEHHHHHH
T ss_pred HHHHHhhhccccccHHHHHHHHHHHHHHHccCCCCcccchhhHHHHHhcCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHH
Confidence 4322211 01123457789999999999999999999998 3 3333 99999999999999999999999
Q ss_pred HHcc
Q 016471 375 FLHG 378 (389)
Q Consensus 375 ~~~~ 378 (389)
+|..
T Consensus 168 ~~~~ 171 (189)
T d1qv0a_ 168 QHLG 171 (189)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9865
|
| >d1rroa_ a.39.1.4 (A:) Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Oncomodulin species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.60 E-value=2.1e-15 Score=114.06 Aligned_cols=95 Identities=14% Similarity=0.261 Sum_probs=77.5
Q ss_pred cCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHhC--------
Q 016471 276 AMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALELN-------- 347 (389)
Q Consensus 276 ~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~-------- 347 (389)
.++.++|..+++.++. +|.++|++|+..+..... . .+.++++|+.||+|++|+|+.+||+.++.
T Consensus 5 ~ls~~dI~~~l~~~~~--~~s~~~~~F~~~~~~~~~--~----~~~l~~~F~~~D~d~~G~I~~~El~~~l~~l~~~~~~ 76 (108)
T d1rroa_ 5 ILSAEDIAAALQECQD--PDTFEPQKFFQTSGLSKM--S----ASQVKDIFRFIDNDQSGYLDGDELKYFLQKFQSDARE 76 (108)
T ss_dssp TSCHHHHHHHHHHTCS--TTCCCHHHHHHHHSGGGS--C----HHHHHHHHHHHCTTCSSEECTHHHHTGGGGTCTTSCC
T ss_pred hCCHHHHHHHHHhccc--CCCccHHHHHHHHccCcC--C----HHHHHHHHhhhcCCCCCeEcHHHHHHHHHHHHhccCC
Confidence 4678889999988754 567999999875432211 1 35689999999999999999999999982
Q ss_pred CchH-HHHHHHHHccCCCCceeHHHHHHHHcc
Q 016471 348 LAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHG 378 (389)
Q Consensus 348 ~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~ 378 (389)
++.. ++++++.+|.|+||.|+|+||+.+|+.
T Consensus 77 l~~~~~~~~~~~~D~d~dG~I~~~EF~~~m~s 108 (108)
T d1rroa_ 77 LTESETKSLMDAADNDGDGKIGADEFQEMVHS 108 (108)
T ss_dssp CCHHHHHHHHHHHCCSSSSSEEHHHHHHHHTC
T ss_pred CCHHHHHHHHHHhCCCCCCeEeHHHHHHHHcC
Confidence 1223 999999999999999999999999973
|
| >d1uhka1 a.39.1.5 (A:3-189) Calcium-regulated photoprotein {Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-regulated photoprotein species: Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]
Probab=99.58 E-value=2.3e-14 Score=119.93 Aligned_cols=139 Identities=12% Similarity=0.119 Sum_probs=101.8
Q ss_pred HHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccc----cCCHHHHHH-----HHhhcCCCCCcceeHHHHHHHHhch
Q 016471 240 EEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATD----AMTDSRVFE-----ILNVMEPLSDQKLAYEEFCAAATSV 309 (389)
Q Consensus 240 ~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~----~~~~~~~~~-----~~~~~d~~~~g~i~~~eF~~~~~~~ 309 (389)
+..+.+++.+|..+|. ++|.|+.+||..++...... .++..++.+ .........++.+++.+|+..+...
T Consensus 8 p~~~~~~k~~F~~~D~d~dG~Is~~Ef~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 87 (187)
T d1uhka1 8 PRWIGRHKHMFNFLDVNHNGKISLDEMVYKASDIVINNLGATPEQAKRHKDAVEAFFGGAGMKYGVETDWPAYIEGWKKL 87 (187)
T ss_dssp HHHHHHHHHHHHHHCTTCCSEEEHHHHHHHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHTTCCTTCEEEHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHHHHHhccCccHHHHHHHHHHhhhhcccccccccccHHHHHHHHHHH
Confidence 4557788999999999 99999999998876543211 122332222 2234455667789999998765543
Q ss_pred hHHHhhH-------HHHHHHHHHHHHHcccCCCcccHHHHHHHh---CC--chH-HHHHHHHHccCCCCceeHHHHHHHH
Q 016471 310 YQLEALE-------RWDQIAITAFDYFEQEGNRVISVEELALEL---NL--APA-AYSLLNDCIRNSDGKLSFLGYKRFL 376 (389)
Q Consensus 310 ~~~~~~~-------~~~~~l~~aF~~~D~d~~G~I~~~el~~~l---~~--~~~-~~~~~~~~d~~~~g~i~~~ef~~~~ 376 (389)
....... .....++.+|+.+|+|++|+|+.+||+++| |. +.+ +..+++.+|.|+||.|+|+||++++
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~Is~~El~~~l~~~g~~~~~~~~~~lf~~~D~d~dG~Is~~EF~~~~ 167 (187)
T d1uhka1 88 ATDELEKYAKNEPTLIRIWGDALFDIVDKDQNGAITLDEWKAYTKAAGIIQSSEDCEETFRVCDIDESGQLDVDEMTRQH 167 (187)
T ss_dssp HHHHHHHHHTTCCCHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTSCCSHHHHHHHHHHSCCCTTSCEEHHHHHHHH
T ss_pred HHHHHHhhhhhhHHHHHHHHHHHHHHHccCCCcccchHHHHHHHHHhCCCccHHHHHHHHHHhCCCCCCCEeHHHHHHHH
Confidence 3322110 113458899999999999999999999988 33 344 9999999999999999999999987
Q ss_pred cc
Q 016471 377 HG 378 (389)
Q Consensus 377 ~~ 378 (389)
..
T Consensus 168 ~~ 169 (187)
T d1uhka1 168 LG 169 (187)
T ss_dssp HH
T ss_pred HH
Confidence 54
|
| >d1jc2a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=99.50 E-value=2e-14 Score=100.90 Aligned_cols=61 Identities=25% Similarity=0.473 Sum_probs=55.0
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHh---CCch--H-HHHHHHHHccCCCCceeHHHHHHHHccc
Q 016471 319 DQIAITAFDYFEQEGNRVISVEELALEL---NLAP--A-AYSLLNDCIRNSDGKLSFLGYKRFLHGV 379 (389)
Q Consensus 319 ~~~l~~aF~~~D~d~~G~I~~~el~~~l---~~~~--~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~ 379 (389)
++.++.||+.||+|++|+|+.+||+.+| |... . +.+++.++|.+++|+|+|+||+++|+.+
T Consensus 8 eeel~~~F~~fD~~~~G~I~~~el~~~l~~lg~~~~~~e~~~~~~~~D~d~dg~I~~~EF~~~m~~~ 74 (75)
T d1jc2a_ 8 EEELANCFRIFDKNADGFIDIEELGEILRATGEHVIEEDIEDLMKDSDKNNDGRIDFDEFLKMMEGV 74 (75)
T ss_dssp HHHHHHHHHHHCCSTTSSEEHHHHHHHHHHSSSCCCHHHHHHHHHHHCSSSCSEECHHHHHHHHHTC
T ss_pred HHHHHHHHHHHcCCCcCeEcHHHHHHHHHhcCCCccHHHHHHHHHHhCCCCCCcEeHHHHHHHHHhC
Confidence 4579999999999999999999999998 4433 3 9999999999999999999999999865
|
| >d1c7va_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium vector protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Probab=99.47 E-value=2.3e-14 Score=98.52 Aligned_cols=59 Identities=15% Similarity=0.363 Sum_probs=53.0
Q ss_pred HHHHHHHHHHcccCCCcccHHHHHHHh---CC---chH-HHHHHHHHccCCCCceeHHHHHHHHcc
Q 016471 320 QIAITAFDYFEQEGNRVISVEELALEL---NL---APA-AYSLLNDCIRNSDGKLSFLGYKRFLHG 378 (389)
Q Consensus 320 ~~l~~aF~~~D~d~~G~I~~~el~~~l---~~---~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~ 378 (389)
+.++.+|+.||+|++|+|+.+||+.+| |. ++. ++.++..+|.|+||.|+|+||+.+|++
T Consensus 2 eel~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~s~~e~~~~~~~~D~d~dG~i~~~EF~~~m~r 67 (68)
T d1c7va_ 2 EEILRAFKVFDANGDGVIDFDEFKFIMQKVGEEPLTDAEVEEAMKEADEDGNGVIDIPEFMDLIKK 67 (68)
T ss_dssp HHHHHHHHHHSCSGGGEECHHHHHHHSSTTTTCCCCHHHHHHHHHHHCSSGGGSEEHHHHHHHHHC
T ss_pred HHHHHHHHHHcCCCcCeEcHHHHHHHHHHhCCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHh
Confidence 358999999999999999999999998 32 222 999999999999999999999999986
|
| >d1fi5a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]
Probab=99.46 E-value=5.3e-14 Score=100.34 Aligned_cols=61 Identities=25% Similarity=0.482 Sum_probs=54.7
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHh---CCc--hH-HHHHHHHHccCCCCceeHHHHHHHHccc
Q 016471 319 DQIAITAFDYFEQEGNRVISVEELALEL---NLA--PA-AYSLLNDCIRNSDGKLSFLGYKRFLHGV 379 (389)
Q Consensus 319 ~~~l~~aF~~~D~d~~G~I~~~el~~~l---~~~--~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~ 379 (389)
++.|+.||+.||+|++|+|+.+||+.+| |.. .. +++++.++|.|+||+|+|+||+.+|+..
T Consensus 14 ee~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~ev~~~~~~~D~d~dg~I~~~EF~~~m~~~ 80 (81)
T d1fi5a_ 14 EEELSDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKDGDKNNDGRIDYDEFLEFMKGV 80 (81)
T ss_dssp HHHHHHHHHHHCSSCSSEECHHHHHHHHHTSSSCCCHHHHHHHHHHHCSSSSSSEEHHHHHHHHSCC
T ss_pred HHHHHHHHHHHcCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHHCCCCCCcEeHHHHHHHHHhc
Confidence 4569999999999999999999999999 433 23 9999999999999999999999999875
|
| >d1fw4a_ a.39.1.5 (A:) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.46 E-value=2.6e-14 Score=97.44 Aligned_cols=57 Identities=19% Similarity=0.376 Sum_probs=51.5
Q ss_pred HHHHHHHHHHcccCCCcccHHHHHHHh---CCc--hH-HHHHHHHHccCCCCceeHHHHHHHH
Q 016471 320 QIAITAFDYFEQEGNRVISVEELALEL---NLA--PA-AYSLLNDCIRNSDGKLSFLGYKRFL 376 (389)
Q Consensus 320 ~~l~~aF~~~D~d~~G~I~~~el~~~l---~~~--~~-~~~~~~~~d~~~~g~i~~~ef~~~~ 376 (389)
+.++.||+.||+|++|+|+.+||+.++ |.. +. +.++++.+|.|++|.|+|+||+++|
T Consensus 3 eel~~aF~~fD~d~~G~I~~~el~~~l~~lg~~~~~~e~~~l~~~~D~d~~g~I~~~eF~~~m 65 (65)
T d1fw4a_ 3 EEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMM 65 (65)
T ss_dssp HHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHTTCTTCSSSEEHHHHHHHC
T ss_pred HHHHHHHHHHcCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHcCCCCCCcEeHHHHHHHC
Confidence 468999999999999999999999988 433 33 9999999999999999999999986
|
| >d1oqpa_ a.39.1.5 (A:) Caltractin (centrin 2) {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Caltractin (centrin 2) species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.43 E-value=9.9e-14 Score=98.04 Aligned_cols=62 Identities=15% Similarity=0.299 Sum_probs=55.3
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHh---CCc--hH-HHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 319 DQIAITAFDYFEQEGNRVISVEELALEL---NLA--PA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 319 ~~~l~~aF~~~D~d~~G~I~~~el~~~l---~~~--~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
++.+++||+.||+|++|+|+.+||+++| |.. .. +.++++++|.|++|.|+|+||+++|++..
T Consensus 8 ~e~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~e~~~~~~~~D~d~~G~I~~~EF~~~m~k~~ 75 (77)
T d1oqpa_ 8 REEILKAFRLFDDDNSGTITIKDLRRVAKELGENLTEEELQEMIAEADRNDDNEIDEDEFIRIMKKTS 75 (77)
T ss_dssp HHHHHHHHHHHCTTCSSSEEHHHHHHHHHHHTCCCCHHHHHHHHHHHCCSSSSEECHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHcCCCCCEechHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHccC
Confidence 4579999999999999999999999999 333 33 99999999999999999999999998754
|
| >d1avsa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=99.41 E-value=2.3e-13 Score=96.98 Aligned_cols=59 Identities=19% Similarity=0.325 Sum_probs=53.3
Q ss_pred HHHHHHHHHHcccCCCcccHHHHHHHh---CCc--hH-HHHHHHHHccCCCCceeHHHHHHHHcc
Q 016471 320 QIAITAFDYFEQEGNRVISVEELALEL---NLA--PA-AYSLLNDCIRNSDGKLSFLGYKRFLHG 378 (389)
Q Consensus 320 ~~l~~aF~~~D~d~~G~I~~~el~~~l---~~~--~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~ 378 (389)
..++.+|+.||+|++|+|+.+||+.+| |.. +. +.+++.++|.|++|.|+|+||+.+|++
T Consensus 14 ~el~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~s~~e~~~~~~~~D~d~~g~I~~~eF~~~m~~ 78 (81)
T d1avsa_ 14 AEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGSGTIDFEEFLVMMVR 78 (81)
T ss_dssp HHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTCCSSEEHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCCCeEchhHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHH
Confidence 468999999999999999999999998 443 33 999999999999999999999999975
|
| >d1f54a_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.39 E-value=2.7e-13 Score=95.71 Aligned_cols=61 Identities=23% Similarity=0.358 Sum_probs=54.6
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHh---CCchH---HHHHHHHHccCCCCceeHHHHHHHHccc
Q 016471 319 DQIAITAFDYFEQEGNRVISVEELALEL---NLAPA---AYSLLNDCIRNSDGKLSFLGYKRFLHGV 379 (389)
Q Consensus 319 ~~~l~~aF~~~D~d~~G~I~~~el~~~l---~~~~~---~~~~~~~~d~~~~g~i~~~ef~~~~~~~ 379 (389)
...++.+|+.||.|++|+|+.+||+.+| |...+ +.+++.++|.+++|.|+|+||+.+|.+.
T Consensus 9 i~el~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~t~~e~~~~~~~~D~~~~g~I~~~eF~~~m~~~ 75 (77)
T d1f54a_ 9 IAEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEIDVDGNHQIEFSEFLALMSRQ 75 (77)
T ss_dssp HHHHHHHHHHTCTTCSSEEEHHHHHHHHHHHTCCCCHHHHHHHHHTTCCSSCCEEEHHHHHHHHTTS
T ss_pred HHHHHHHHHHHcCCCCCeEChHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHHh
Confidence 3468999999999999999999999999 54433 9999999999999999999999999764
|
| >d1wrka1 a.39.1.5 (A:4-85) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]
Probab=99.38 E-value=3.2e-13 Score=96.24 Aligned_cols=61 Identities=18% Similarity=0.289 Sum_probs=54.3
Q ss_pred HHHHHHHHHHHcccC-CCcccHHHHHHHh---CCchH---HHHHHHHHccCCCCceeHHHHHHHHccc
Q 016471 319 DQIAITAFDYFEQEG-NRVISVEELALEL---NLAPA---AYSLLNDCIRNSDGKLSFLGYKRFLHGV 379 (389)
Q Consensus 319 ~~~l~~aF~~~D~d~-~G~I~~~el~~~l---~~~~~---~~~~~~~~d~~~~g~i~~~ef~~~~~~~ 379 (389)
...++.+|+.||+|+ +|+|+..||+.+| |..++ +++++.++|.|++|.|+|+||+.+|.+.
T Consensus 14 ~~~~~~~F~~fD~d~~~G~I~~~el~~~l~~lg~~~t~~el~~~i~~~D~d~~G~I~f~eFl~im~~k 81 (82)
T d1wrka1 14 KNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQEMIDEVDEDGSGTVDFDEFLVMMVRS 81 (82)
T ss_dssp HHHHHHHHHHHTTTCTTSSBCHHHHHHHHHHTTCCCCHHHHHHHHHTTCTTCCSSBCHHHHHHHHHHC
T ss_pred HHHHHHHHHHHcCcCCCCeEeHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHhh
Confidence 456899999999996 7999999999999 55443 9999999999999999999999999863
|
| >d1tiza_ a.39.1.5 (A:) Calmodulin-related protein T21P5.17 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin-related protein T21P5.17 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=99.38 E-value=3e-13 Score=92.67 Aligned_cols=58 Identities=12% Similarity=0.233 Sum_probs=52.4
Q ss_pred HHHHHHHHcccCCCcccHHHHHHHh---CCc--hH-HHHHHHHHccCCCCceeHHHHHHHHccc
Q 016471 322 AITAFDYFEQEGNRVISVEELALEL---NLA--PA-AYSLLNDCIRNSDGKLSFLGYKRFLHGV 379 (389)
Q Consensus 322 l~~aF~~~D~d~~G~I~~~el~~~l---~~~--~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~ 379 (389)
++++|+.||+|++|+|+.+||+.++ |.. ++ +.++++.+|.|++|+|+|+||+.+|++.
T Consensus 3 ~r~~F~~~D~d~~G~I~~~El~~~l~~lg~~~~~~~i~~~~~~~D~d~dg~I~~~EF~~~m~~~ 66 (67)
T d1tiza_ 3 AKRVFEKFDKNKDGKLSLDEFREVALAFSPYFTQEDIVKFFEEIDVDGNGELNADEFTSCIEKM 66 (67)
T ss_dssp HHHHHHHHCTTSSSCEEHHHHHHHHHHTCTTSCHHHHHHHHHHHCCSSSSEECHHHHHHHHHTC
T ss_pred HHHHHHHHCCCCcCcCcHHHHHHHHHHhccccchHHHHHHHHHhCCCCCCeEeHHHHHHHHHHh
Confidence 6889999999999999999999998 433 33 9999999999999999999999999864
|
| >d2opoa1 a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Chenopodium album) [TaxId: 3559]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Polcalcin domain: Polcalcin Che a 3 species: Pigweed (Chenopodium album) [TaxId: 3559]
Probab=99.37 E-value=7e-13 Score=94.39 Aligned_cols=63 Identities=22% Similarity=0.292 Sum_probs=55.1
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHh---CC-chH-HHHHHHHHccCCCCceeHHHHHHHHccccC
Q 016471 319 DQIAITAFDYFEQEGNRVISVEELALEL---NL-APA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVTV 381 (389)
Q Consensus 319 ~~~l~~aF~~~D~d~~G~I~~~el~~~l---~~-~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~ 381 (389)
...++++|+.||+|++|+|+.+||+.+| |. ++. +.++++++|.|++|.|+|+||+.+|+....
T Consensus 5 ~~e~~~~F~~~D~d~~G~I~~~El~~~l~~lg~~~~~ei~~~~~~~D~d~~G~I~~~EF~~~~~~~~~ 72 (81)
T d2opoa1 5 IADRERIFKRFDTNGDGKISSSELGDALKTLGSVTPDEVRRMMAEIDTDGDGFISFDEFTDFARANRG 72 (81)
T ss_dssp HHHHHHHHHHHCTTCSSEEEHHHHHHHHHTTTTCCHHHHHHHHHHHCTTCSSEECHHHHHHHHHHCTT
T ss_pred HHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhhcCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHHCcc
Confidence 4568999999999999999999999988 32 222 999999999999999999999999976543
|
| >d2zkmx1 a.39.1.7 (X:142-311) Phospholipase C-beta-2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Phospholipase C-beta-2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.37 E-value=2.3e-14 Score=117.83 Aligned_cols=120 Identities=15% Similarity=0.177 Sum_probs=81.5
Q ss_pred cCC-CCCcccHHHHHHHHHHhccc-cCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHHHHHc
Q 016471 253 LEP-KDGCVSLNNFKVALMRQATD-AMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFE 330 (389)
Q Consensus 253 ~D~-~~G~i~~~el~~~l~~~~~~-~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D 330 (389)
+|. ++|.|+.+|+.++|...+.. ....+.+..++...|.+++|.|+|+||...+.... . ..++..+|..||
T Consensus 16 ~d~n~dG~Is~~el~k~l~~~~~~~~~~~~~~~~~~~~~D~~~~~~i~F~eF~~~~~~l~---~----r~ei~~~F~~~d 88 (170)
T d2zkmx1 16 MQLNSEGKIPVKNFFQMFPADRKRVEAALSACHLPKGKNDAINPEDFPEPVYKSFLMSLC---P----RPEIDEIFTSYH 88 (170)
T ss_dssp HSCCTTSCEEHHHHHHHSCSCHHHHHHHHHHTTCCCCTTCEECGGGCCHHHHHHHHHHHS---C----CHHHHTTCC---
T ss_pred cccCCCCCCcHHHHHHHHHHhhhhHHHHHHHHhhhhccccccCCCccCHHHHHHHHhccC---C----HHHHHHHHHHHc
Confidence 688 99999999999988654321 11234556677788999999999999998654332 2 235889999999
Q ss_pred ccCCCcccHHHHHHHhC---C------------chH-HHHHHHHHccCC----CCceeHHHHHHHHccc
Q 016471 331 QEGNRVISVEELALELN---L------------APA-AYSLLNDCIRNS----DGKLSFLGYKRFLHGV 379 (389)
Q Consensus 331 ~d~~G~I~~~el~~~l~---~------------~~~-~~~~~~~~d~~~----~g~i~~~ef~~~~~~~ 379 (389)
.|++|+||.+||..+|. . ... +.+++..++.+. +|.|++++|+.+|.+.
T Consensus 89 ~d~~~~it~~el~~fL~~~Q~~~~~~e~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ls~d~F~~fL~S~ 157 (170)
T d2zkmx1 89 AKAKPYMTKEHLTKFINQKQRDSRLNSLLFPPARPDQVQGLIDKYEPSGINAQRGQLSPEGMVWFLCGP 157 (170)
T ss_dssp -----CCCHHHHHHHHHHTCC---------------CHHHHHHHHCCC--------CCHHHHHHHHHST
T ss_pred CCCCCcccHHHHHHHHHHHhcchhhhhhccccCCHHHHHHHHHHHccccccccCCeECHHHHHHHHcCc
Confidence 99999999999999992 1 112 888999988765 4889999999987543
|
| >d2pq3a1 a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Rattus norvegicus [TaxId: 10116]
Probab=99.37 E-value=2.9e-13 Score=94.44 Aligned_cols=60 Identities=18% Similarity=0.360 Sum_probs=53.8
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHh---CCc--hH-HHHHHHHHccCCCCceeHHHHHHHHcc
Q 016471 319 DQIAITAFDYFEQEGNRVISVEELALEL---NLA--PA-AYSLLNDCIRNSDGKLSFLGYKRFLHG 378 (389)
Q Consensus 319 ~~~l~~aF~~~D~d~~G~I~~~el~~~l---~~~--~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~ 378 (389)
...++.||+.||.|++|+|+.+||+.+| |.. .. +.++++.+|.+++|.|+|+||+.+|++
T Consensus 7 i~el~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~s~~~~~~~~~~~D~d~~g~I~f~eF~~~m~~ 72 (73)
T d2pq3a1 7 IAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLTMMAR 72 (73)
T ss_dssp HHHHHHHHHHTCTTSSSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHCTTCSSEEEHHHHHHHHHH
T ss_pred HHHHHHHHHHHcCCCCceEeHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHhc
Confidence 3568999999999999999999999998 443 33 999999999999999999999999975
|
| >d1wrka1 a.39.1.5 (A:4-85) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]
Probab=99.36 E-value=1.9e-12 Score=92.13 Aligned_cols=75 Identities=20% Similarity=0.295 Sum_probs=67.8
Q ss_pred HHHHHhcCHHHHHHHHHHhhhcCC-C-CCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHh
Q 016471 232 KALSKALTEEELVYLRAQFMLLEP-K-DGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAAT 307 (389)
Q Consensus 232 ~~i~~~l~~ee~~~l~~~F~~~D~-~-~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~ 307 (389)
+.....+++++...++++|..+|. + +|+|+..||+.+|+.+|.. +++.++.++++.+|.+++|.|+|+||+..+.
T Consensus 3 k~~~~~ls~eq~~~~~~~F~~fD~d~~~G~I~~~el~~~l~~lg~~-~t~~el~~~i~~~D~d~~G~I~f~eFl~im~ 79 (82)
T d1wrka1 3 KAAVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQN-PTPEELQEMIDEVDEDGSGTVDFDEFLVMMV 79 (82)
T ss_dssp HHHHHHCCHHHHHHHHHHHHHHTTTCTTSSBCHHHHHHHHHHTTCC-CCHHHHHHHHHTTCTTCCSSBCHHHHHHHHH
T ss_pred HHHHhhCCHHHHHHHHHHHHHHcCcCCCCeEeHHHHHHHHHHcCCC-CCHHHHHHHHHHhCCCCCCeEeHHHHHHHHH
Confidence 344567999999999999999998 4 6999999999999999974 8999999999999999999999999998654
|
| >d2fcea1 a.39.1.5 (A:84-144) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.36 E-value=3.2e-13 Score=90.58 Aligned_cols=54 Identities=24% Similarity=0.371 Sum_probs=48.8
Q ss_pred HHHHHHHHHcccCCCcccHHHHHHHh---CC--chH-HHHHHHHHccCCCCceeHHHHHH
Q 016471 321 IAITAFDYFEQEGNRVISVEELALEL---NL--APA-AYSLLNDCIRNSDGKLSFLGYKR 374 (389)
Q Consensus 321 ~l~~aF~~~D~d~~G~I~~~el~~~l---~~--~~~-~~~~~~~~d~~~~g~i~~~ef~~ 374 (389)
.+++||+.||+|++|+|+.+||+.+| |. +.. +..+++.+|.|++|.|+|+||++
T Consensus 2 el~~aF~~fD~~~~G~I~~~el~~~l~~~g~~~~~~ei~~l~~~~D~d~dg~I~~~eFl~ 61 (61)
T d2fcea1 2 DFVKAFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAEVDELLKGVEVDSNGEIDYKKFIE 61 (61)
T ss_dssp HHHHHHHHHCTTCCSCEEHHHHHHHHHHTTCCCCHHHHHHHHTTCCCCTTSEECHHHHHH
T ss_pred hHHHHHHHHCCCCCCeEeHHHHHHHHHHcCCCCCHHHHHHHHHHcCCCCCCcEeHHHhcC
Confidence 58999999999999999999999999 43 333 99999999999999999999974
|
| >d2opoa1 a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Chenopodium album) [TaxId: 3559]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Polcalcin domain: Polcalcin Che a 3 species: Pigweed (Chenopodium album) [TaxId: 3559]
Probab=99.35 E-value=8.4e-13 Score=93.98 Aligned_cols=68 Identities=19% Similarity=0.289 Sum_probs=62.3
Q ss_pred CHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhc
Q 016471 239 TEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATS 308 (389)
Q Consensus 239 ~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~ 308 (389)
+++++..++++|..+|. ++|.|+..||+.+|+.+|. ++..++.+++..+|.|++|.|+|+||+.++..
T Consensus 1 T~ee~~e~~~~F~~~D~d~~G~I~~~El~~~l~~lg~--~~~~ei~~~~~~~D~d~~G~I~~~EF~~~~~~ 69 (81)
T d2opoa1 1 TPQDIADRERIFKRFDTNGDGKISSSELGDALKTLGS--VTPDEVRRMMAEIDTDGDGFISFDEFTDFARA 69 (81)
T ss_dssp CHHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHTTTT--CCHHHHHHHHHHHCTTCSSEECHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhhc--CCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHH
Confidence 46788999999999999 9999999999999999983 68999999999999999999999999986543
|
| >d1qx2a_ a.39.1.1 (A:) Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calbindin D9K domain: Calbindin D9K species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.35 E-value=5.6e-13 Score=93.73 Aligned_cols=62 Identities=23% Similarity=0.357 Sum_probs=52.4
Q ss_pred HHHHHHHHHHHccc--CCCcccHHHHHHHh---CC--chH---HHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 319 DQIAITAFDYFEQE--GNRVISVEELALEL---NL--APA---AYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 319 ~~~l~~aF~~~D~d--~~G~I~~~el~~~l---~~--~~~---~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
.+.++.+|+.||.+ ++|+|+.+||+.+| |. ..+ +.++++++|.|+||.|+|+||+.+|++.+
T Consensus 4 ~eel~~~F~~fd~~~~~~G~I~~~El~~~l~~lg~~~~~~~~ei~~~~~~~D~d~dG~I~f~EF~~~m~~~~ 75 (76)
T d1qx2a_ 4 PEEIKGAFEVFAAKEGDPNQISKEELKLVMQTLGPSLLKGMSTLDEMIEEVDKNGDGEVSFEEFLVMMKKIS 75 (76)
T ss_dssp HHHHHHHHHHHHTSSSCTTSEEHHHHHHHHHHHGGGSCTTSCSHHHHHHHHCTTCSSEECHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHcccCCCCCEECHHHHHHHHHHhCCcCCCCHHHHHHHHHHhhcCCCCcCcHHHHHHHHHHHc
Confidence 35699999999765 46999999999998 32 222 89999999999999999999999998754
|
| >d1f54a_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.34 E-value=9.2e-13 Score=92.92 Aligned_cols=72 Identities=18% Similarity=0.408 Sum_probs=66.3
Q ss_pred HhcCHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhc
Q 016471 236 KALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATS 308 (389)
Q Consensus 236 ~~l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~ 308 (389)
..++++++..++.+|..+|. ++|.|+.+||+.+|+.+|. .++..++.+++..+|.+++|.|+|+||+..+..
T Consensus 2 ~~lt~eqi~el~~~F~~~D~d~~G~I~~~el~~~l~~~g~-~~t~~e~~~~~~~~D~~~~g~I~~~eF~~~m~~ 74 (77)
T d1f54a_ 2 SNLTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGL-SPSEAEVNDLMNEIDVDGNHQIEFSEFLALMSR 74 (77)
T ss_dssp CCCCHHHHHHHHHHHHHTCTTCSSEEEHHHHHHHHHHHTC-CCCHHHHHHHHHTTCCSSCCEEEHHHHHHHHTT
T ss_pred CCCCHHHHHHHHHHHHHHcCCCCCeEChHHHHHHHHHhCC-CCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHH
Confidence 35788999999999999999 9999999999999999987 489999999999999999999999999986543
|
| >d1avsa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=99.33 E-value=2.4e-12 Score=91.54 Aligned_cols=70 Identities=17% Similarity=0.275 Sum_probs=65.6
Q ss_pred hcCHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHh
Q 016471 237 ALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAAT 307 (389)
Q Consensus 237 ~l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~ 307 (389)
.++++++..++.+|..+|. ++|.|+..||+.+|+.+|. .+++.++.+++..+|.+++|.|+|+||+..+.
T Consensus 7 ~Lt~~~i~el~~~F~~~D~d~~G~I~~~el~~~l~~~g~-~~s~~e~~~~~~~~D~d~~g~I~~~eF~~~m~ 77 (81)
T d1avsa_ 7 FLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQ-NPTKEELDAIIEEVDEDGSGTIDFEEFLVMMV 77 (81)
T ss_dssp HBCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTC-CCCHHHHHHHHHHHCTTCCSSEEHHHHHHHHH
T ss_pred cCCHHHHHHHHHHHHHHcCCCCCeEchhHHHHHHHHcCC-CCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHH
Confidence 4789999999999999999 9999999999999999987 48999999999999999999999999998654
|
| >d1hqva_ a.39.1.8 (A:) Apoptosis-linked protein alg-2 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Apoptosis-linked protein alg-2 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.32 E-value=6e-12 Score=104.32 Aligned_cols=117 Identities=11% Similarity=0.152 Sum_probs=68.6
Q ss_pred HhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHHH
Q 016471 249 QFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFD 327 (389)
Q Consensus 249 ~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~ 327 (389)
.+..+|. ++|.|+.+||...+... .....+++.+|.+++|.|+.+||..++........ ++.+..+++
T Consensus 61 l~~~~D~d~~g~i~~~EFl~~~~~~-------~~~~~~f~~~D~~~~G~i~~~el~~~l~~~~~~l~----~e~~~~~~~ 129 (181)
T d1hqva_ 61 IISMFDRENKAGVNFSEFTGVWKYI-------TDWQNVFRTYDRDNSGMIDKNELKQALSGFGYRLS----DQFHDILIR 129 (181)
T ss_dssp HHHHHCCSSSSSBCHHHHHHHHHHH-------HHHHHHHHHHCTTCCSSBCHHHHHHHHHHHTBCCC----HHHHHHHHH
T ss_pred HhhccccccccchhhhHHHhhhhhc-------cccccccccccccccchhhhHHHHHHHHHcCCcch----hHHHHHHHH
Confidence 3444566 66777777766554322 22456666667777777777776655443222112 234566666
Q ss_pred HHcccCCCcccHHHHHHHhCCchHHHHHHHHHccCCCCce--eHHHHHHHH
Q 016471 328 YFEQEGNRVISVEELALELNLAPAAYSLLNDCIRNSDGKL--SFLGYKRFL 376 (389)
Q Consensus 328 ~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~d~~~~g~i--~~~ef~~~~ 376 (389)
.+|.+++|.|+.+|+..++.....+.++++.+|.+++|.| +++||+.+|
T Consensus 130 ~~d~~~dg~Is~~eF~~~~~~l~~l~~~F~~~D~~~dG~i~~~~~ef~~~~ 180 (181)
T d1hqva_ 130 KFDRQGRGQIAFDDFIQGCIVLQRLTDIFRRYDTDQDGWIQVSYEQYLSMV 180 (181)
T ss_dssp HHCSSCSSCBCHHHHHHHHHHHHHHHHHHHHHCTTCSSCCCCCHHHHHHHH
T ss_pred HhCCCCCCcCcHHHHHHHHHHHHHHHHHHHHhCCCCCCCEEecHHHHHHHh
Confidence 6777777777777766655322225566666777777744 567777665
|
| >d1s6ja_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Probab=99.31 E-value=7.7e-14 Score=100.86 Aligned_cols=79 Identities=13% Similarity=0.123 Sum_probs=61.6
Q ss_pred CCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHh---CCch--H-HHHHHHHHccCCCC
Q 016471 292 LSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALEL---NLAP--A-AYSLLNDCIRNSDG 365 (389)
Q Consensus 292 ~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l---~~~~--~-~~~~~~~~d~~~~g 365 (389)
+++|.|+.++...+ -.....+ ...++.+|+.||+|++|+|+.+||+.+| |..+ . ++++++++|.|++|
T Consensus 1 ~~~g~id~~~~~ma-~~l~~~~-----i~~l~~~F~~~D~d~~G~I~~~el~~~l~~lg~~~s~~e~~~l~~~~D~d~~g 74 (87)
T d1s6ja_ 1 HSSGHIDDDDKHMA-ERLSEEE-----IGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADIDKSG 74 (87)
T ss_dssp CCSSSSSSHHHHSS-SSSCSSS-----TTTTTTHHHHHCTTCSSCEEHHHHHHHHHTTTSSCCHHHHHHHHHHHCTTCSS
T ss_pred CCCCccCchHHHHH-hhCCHHH-----HHHHHHHHHHHcCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHcCCCCCC
Confidence 35788888886642 1111111 2348999999999999999999999999 4433 3 99999999999999
Q ss_pred ceeHHHHHHHH
Q 016471 366 KLSFLGYKRFL 376 (389)
Q Consensus 366 ~i~~~ef~~~~ 376 (389)
+|+|+||+.+|
T Consensus 75 ~I~~~EFl~am 85 (87)
T d1s6ja_ 75 TIDYGEFIAAT 85 (87)
T ss_dssp EECHHHHTTCC
T ss_pred eEeHHHHHHHH
Confidence 99999998765
|
| >d2pq3a1 a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Rattus norvegicus [TaxId: 10116]
Probab=99.31 E-value=1.7e-12 Score=90.40 Aligned_cols=70 Identities=17% Similarity=0.385 Sum_probs=65.0
Q ss_pred hcCHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHh
Q 016471 237 ALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAAT 307 (389)
Q Consensus 237 ~l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~ 307 (389)
.++++++..++.+|..+|. ++|.|+..|++.++..+|. .++++++.++++.+|.+++|.|+|+||+..+.
T Consensus 1 qLs~eei~el~~~F~~~D~d~~G~I~~~el~~~l~~~g~-~~s~~~~~~~~~~~D~d~~g~I~f~eF~~~m~ 71 (73)
T d2pq3a1 1 QLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQ-NPTEAELQDMINEVDADGNGTIDFPEFLTMMA 71 (73)
T ss_dssp CCCHHHHHHHHHHHHHTCTTSSSEEEGGGHHHHHHHTTC-CCCHHHHHHHHHHHCTTCSSEEEHHHHHHHHH
T ss_pred CcCHHHHHHHHHHHHHHcCCCCceEeHHHHHHHHHHhCC-CCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHh
Confidence 3678999999999999999 9999999999999999997 48999999999999999999999999998543
|
| >d1alva_ a.39.1.8 (A:) Calpain small (regulatory) subunit (domain VI) {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain small (regulatory) subunit (domain VI) species: Pig (Sus scrofa) [TaxId: 9823]
Probab=99.29 E-value=6.4e-12 Score=103.37 Aligned_cols=119 Identities=8% Similarity=0.080 Sum_probs=84.2
Q ss_pred HHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHH
Q 016471 246 LRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAIT 324 (389)
Q Consensus 246 l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~ 324 (389)
....+..+|. ++|.|+.+||..+.... .....+|+.+|.+++|.|+..||..++........ +....
T Consensus 49 ~~~l~~~~d~d~~g~i~~~ef~~~~~~~-------~~~~~~f~~~D~d~~G~I~~~el~~~L~~~g~~~~-----~~~~~ 116 (173)
T d1alva_ 49 CRSMVAVMDSDTTGKLGFEEFKYLWNNI-------KKWQAIYKQFDVDRSGTIGSSELPGAFEAAGFHLN-----EHLYS 116 (173)
T ss_dssp HHHHHHHHCTTCSSSBCHHHHHHHHHHH-------HHHHHHHHHHCTTCCSSBCTTTHHHHHHHHTCCCC-----HHHHH
T ss_pred HHHHHHHhccCCCCcccchhhhhhhhhh-------hHHHHHHHHhccCCCCeecHHHHHHHHHHHHHhhH-----HHHHH
Confidence 3445666788 88889998887765433 23567888888888899998888776543322111 12455
Q ss_pred HHHHHcccCCCcccHHHHHHHhCCchHHHHHHHHHccCCCCce--eHHHHHHHH
Q 016471 325 AFDYFEQEGNRVISVEELALELNLAPAAYSLLNDCIRNSDGKL--SFLGYKRFL 376 (389)
Q Consensus 325 aF~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~d~~~~g~i--~~~ef~~~~ 376 (389)
+|..+|.|++|.|+.+|+.+++-....+.++++.+|.|++|.| +|+||+.+.
T Consensus 117 ~~~~~d~d~~G~i~~~EF~~~~~~~~~~~~~f~~~D~d~~G~it~~~~efl~~~ 170 (173)
T d1alva_ 117 MIIRRYSDEGGNMDFDNFISCLVRLDAMFRAFKSLDKDGTGQIQVNIQEWLQLT 170 (173)
T ss_dssp HHHHHHTCSSSCBCHHHHHHHHHHHHHHHHHHHHHSSSCCSEEEEEHHHHHHHH
T ss_pred HhhccccCCCCeEeHHHHHHHHHHHHHHHHHHHHhCCCCCCcEEecHHHHHHHH
Confidence 6667777888999998888877333336678888899999976 688888765
|
| >d1k94a_ a.39.1.8 (A:) Grancalcin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Grancalcin species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.29 E-value=1.3e-11 Score=100.34 Aligned_cols=59 Identities=12% Similarity=0.293 Sum_probs=29.9
Q ss_pred HHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHH
Q 016471 244 VYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAA 305 (389)
Q Consensus 244 ~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~ 305 (389)
..++.+|..+|. ++|+|+.+||+.+|..+|. .++.++++.++..+|. +|.|+|+||+..
T Consensus 70 ~~~~~~F~~fD~d~sG~I~~~El~~~l~~~G~-~l~~~~~~~l~~~~d~--~g~i~~~eFi~~ 129 (165)
T d1k94a_ 70 NAWKENFMTVDQDGSGTVEHHELRQAIGLMGY-RLSPQTLTTIVKRYSK--NGRIFFDDYVAC 129 (165)
T ss_dssp HHHHHHHHHHCTTCCSBCCHHHHHHHHHHTTC-CCCHHHHHHHHHHHCB--TTBCBHHHHHHH
T ss_pred chhHHHHHHhCCCCCCeEcHHHHHHHHHHhhh-cCCHHHHHHHHHHcCC--CCcCcHHHHHHH
Confidence 344555555555 5555555555555555554 2445555555555543 344555555543
|
| >d1df0a1 a.39.1.8 (A:515-700) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), M-type [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain large subunit, C-terminal domain (domain IV) species: Rat (Rattus norvegicus), M-type [TaxId: 10116]
Probab=99.28 E-value=8e-12 Score=104.05 Aligned_cols=118 Identities=9% Similarity=0.094 Sum_probs=70.6
Q ss_pred HHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHH
Q 016471 247 RAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITA 325 (389)
Q Consensus 247 ~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~a 325 (389)
...+..+|. ++|.|+.+||....... ..+..+|..+|.+++|.|+.+|+..++........ ..+..+
T Consensus 64 ~~l~~~~D~d~~G~I~~~EF~~~~~~~-------~~~~~~F~~~D~d~sG~I~~~El~~~l~~~g~~~~-----~~~~~~ 131 (186)
T d1df0a1 64 KIMVDMLDEDGSGKLGLKEFYILWTKI-------QKYQKIYREIDVDRSGTMNSYEMRKALEEAGFKLP-----CQLHQV 131 (186)
T ss_dssp HHHHHHHCCSSSSEECHHHHHHHHHHH-------HHHHHHHHHHCTTCCSCEEGGGHHHHHHHTTEECC-----HHHHHH
T ss_pred HHHHHHHcCCCCCcccHHHHHHHHHhH-------HHHHHHHHhhCCCCCCcccHHHHHHHHHHHHhccc-----HHHHHH
Confidence 344555566 67777777776544322 23556777777777777777777665543222221 123455
Q ss_pred HHHHcccCCCcccHHHHHHHhCCchHHHHHHHHHccCCCCce--eHHHHHHHH
Q 016471 326 FDYFEQEGNRVISVEELALELNLAPAAYSLLNDCIRNSDGKL--SFLGYKRFL 376 (389)
Q Consensus 326 F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~d~~~~g~i--~~~ef~~~~ 376 (389)
|..+|.|++|.|+.+|+.+++-....+.++++.+|.+++|+| +|+||+.+.
T Consensus 132 ~~~~d~d~dg~I~f~eFi~~~~~l~~~~~~F~~~D~~~~G~i~l~~~ef~~~~ 184 (186)
T d1df0a1 132 IVARFADDELIIDFDNFVRCLVRLEILFKIFKQLDPENTGTIQLDLISWLSFS 184 (186)
T ss_dssp HHHHHCCSTTEECHHHHHHHHHHHHHHHHHHHHHCTTCCSEEEEEHHHHHHHH
T ss_pred HHHHHcCCCCeEeHHHHHHHHHHHHHHHHHHHHhCCCCCCcEEecHHHHHHHh
Confidence 666677777777777776665222225566777777777765 677777653
|
| >d1jfja_ a.39.1.5 (A:) EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: 5759]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: EHCABP species: Entamoeba (Entamoeba histolytica) [TaxId: 5759]
Probab=99.24 E-value=1.5e-11 Score=96.46 Aligned_cols=95 Identities=19% Similarity=0.199 Sum_probs=79.2
Q ss_pred HHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHhCC-----ch-H---H
Q 016471 282 VFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALELNL-----AP-A---A 352 (389)
Q Consensus 282 ~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~-----~~-~---~ 352 (389)
++++|..+|.|++|.|+++||..++........ ++.+..+|..+|.+++|.|+.+|+..++.. .. . +
T Consensus 2 ae~~F~~~D~d~dG~is~~E~~~~l~~~~~~~~----~~~~~~~~~~~D~~~~g~i~~~Ef~~~~~~~~~~~~~~~~~~~ 77 (134)
T d1jfja_ 2 AEALFKEIDVNGDGAVSYEEVKAFVSKKRAIKN----EQLLQLIFKSIDADGNGEIDQNEFAKFYGSIQGQDLSDDKIGL 77 (134)
T ss_dssp HHHHHHHHCTTCSSEEEHHHHHHHHHTTCCSSH----HHHHHHHHHHHCSSCCSEEEHHHHHHHTTCSSCCSSHHHHHHH
T ss_pred HHHHHHHHcCCCcCCCcHHHHHHHHHHcCCCCC----HHHHHHHHHHhhhcccccccccccccccccccccccccccccc
Confidence 478999999999999999999887665433322 456889999999999999999999998831 11 1 7
Q ss_pred HHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 353 YSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 353 ~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
..+++.+|.+++|.|+.+||..+++...
T Consensus 78 ~~~F~~~D~~~~g~i~~~el~~~~~~~~ 105 (134)
T d1jfja_ 78 KVLYKLMDVDGDGKLTKEEVTSFFKKHG 105 (134)
T ss_dssp HHHHHHHCCSSSSEEEHHHHHHHHTTTT
T ss_pred cccccccccccCCcccHHHHHHHHHhcC
Confidence 8899999999999999999999987654
|
| >d1juoa_ a.39.1.8 (A:) Sorcin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Sorcin species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.22 E-value=4e-11 Score=98.39 Aligned_cols=120 Identities=12% Similarity=0.061 Sum_probs=83.7
Q ss_pred HHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHH
Q 016471 246 LRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAIT 324 (389)
Q Consensus 246 l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~ 324 (389)
++..+..+|. ++|.|+.+||...+... ......|+.+|.+++|.|+.+|+..++........ .+.++.
T Consensus 49 v~~l~~~~D~d~~G~I~f~EF~~~~~~~-------~~~~~~f~~~D~d~sG~i~~~El~~~l~~~g~~ls----~~~~~~ 117 (172)
T d1juoa_ 49 CRLMVSMLDRDMSGTMGFNEFKELWAVL-------NGWRQHFISFDTDRSGTVDPQELQKALTTMGFRLS----PQAVNS 117 (172)
T ss_dssp HHHHHHHHCTTCSSCEEHHHHHHHHHHH-------HHHHHHHHTTCTTCCSEECHHHHHHHHHHTTCCCC----HHHHHH
T ss_pred HHHHHHHHCCCCCCceehHHHHHHHHhh-------hhhhHHHHHhCcCCCCcCCHHHHHHHHHHHHHhhh----HHHHHH
Confidence 3445666788 88888888887655432 23557788888888888888888776544322222 345777
Q ss_pred HHHHHcccCCCcccHHHHHHHhCCchHHHHHHHHHccCCCCce--eHHHHHHHHcc
Q 016471 325 AFDYFEQEGNRVISVEELALELNLAPAAYSLLNDCIRNSDGKL--SFLGYKRFLHG 378 (389)
Q Consensus 325 aF~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~d~~~~g~i--~~~ef~~~~~~ 378 (389)
+|+.+| ++|.|+.+++..++.....+.++++.+|.|++|.| +|+||+.++..
T Consensus 118 l~~~~d--~~g~i~~~eF~~~~~~~~~~~~~f~~~D~d~~G~Itl~~~eFl~~~l~ 171 (172)
T d1juoa_ 118 IAKRYS--TNGKITFDDYIACCVKLRALTDSFRRRDTAQQGVVNFPYDDFIQCVMS 171 (172)
T ss_dssp HHHHTC--SSSSEEHHHHHHHHHHHHHHHHHHHHTCTTCCSEEEEEHHHHHHHHTT
T ss_pred HHHHHH--hcCCcCHHHHHHHHHHHHHHHHHHHHhCCCCCCcEEecHHHHHHHHHc
Confidence 888886 45678888888876333336678888888888876 78888887653
|
| >d1s6ja_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Probab=99.21 E-value=3.9e-13 Score=97.03 Aligned_cols=74 Identities=22% Similarity=0.450 Sum_probs=66.4
Q ss_pred HHHHhcCHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHh
Q 016471 233 ALSKALTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAAT 307 (389)
Q Consensus 233 ~i~~~l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~ 307 (389)
.++..++.+++..++.+|..+|. ++|.|+.+||+.+|+.+|. .+++.++.++++.+|.+++|.|+|+||+++++
T Consensus 12 ~ma~~l~~~~i~~l~~~F~~~D~d~~G~I~~~el~~~l~~lg~-~~s~~e~~~l~~~~D~d~~g~I~~~EFl~am~ 86 (87)
T d1s6ja_ 12 HMAERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGS-ELMESEIKDLMDAADIDKSGTIDYGEFIAATV 86 (87)
T ss_dssp HSSSSSCSSSTTTTTTHHHHHCTTCSSCEEHHHHHHHHHTTTS-SCCHHHHHHHHHHHCTTCSSEECHHHHTTCCC
T ss_pred HHHhhCCHHHHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHcCC-CCCHHHHHHHHHHcCCCCCCeEeHHHHHHHHc
Confidence 34556777788889999999999 9999999999999999987 48999999999999999999999999997653
|
| >d1c7va_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium vector protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Probab=99.21 E-value=3.9e-12 Score=87.08 Aligned_cols=63 Identities=17% Similarity=0.351 Sum_probs=57.9
Q ss_pred HHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHh
Q 016471 245 YLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAAT 307 (389)
Q Consensus 245 ~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~ 307 (389)
.++.+|..+|. ++|+|+.+||+.+|+.+|...++.+++..+++.+|.|++|.|+|+||+..+.
T Consensus 3 el~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~s~~e~~~~~~~~D~d~dG~i~~~EF~~~m~ 66 (68)
T d1c7va_ 3 EILRAFKVFDANGDGVIDFDEFKFIMQKVGEEPLTDAEVEEAMKEADEDGNGVIDIPEFMDLIK 66 (68)
T ss_dssp HHHHHHHHHSCSGGGEECHHHHHHHSSTTTTCCCCHHHHHHHHHHHCSSGGGSEEHHHHHHHHH
T ss_pred HHHHHHHHHcCCCcCeEcHHHHHHHHHHhCCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHH
Confidence 47789999999 9999999999999999987667999999999999999999999999998653
|
| >d1fw4a_ a.39.1.5 (A:) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.21 E-value=1.6e-11 Score=83.15 Aligned_cols=61 Identities=21% Similarity=0.388 Sum_probs=56.5
Q ss_pred HHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHH
Q 016471 244 VYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAA 305 (389)
Q Consensus 244 ~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~ 305 (389)
..++.+|..+|. ++|+|+.+||+.+++.+|.+ ++..++.+++..+|.+++|.|+|+||+..
T Consensus 3 eel~~aF~~fD~d~~G~I~~~el~~~l~~lg~~-~~~~e~~~l~~~~D~d~~g~I~~~eF~~~ 64 (65)
T d1fw4a_ 3 EEIREAFRVFDKDGNGYISAAELRHVMTNLGEK-LTDEEVDEMIREADIDGDGQVNYEEFVQM 64 (65)
T ss_dssp HHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCC-CCHHHHHHHHHTTCTTCSSSEEHHHHHHH
T ss_pred HHHHHHHHHHcCCCCCcCCHHHHHHHHHHhCCC-CCHHHHHHHHHHcCCCCCCcEeHHHHHHH
Confidence 347889999999 99999999999999999974 89999999999999999999999999974
|
| >d1y1xa_ a.39.1.8 (A:) Programmed cell death 6 protein-like protein {Leishmania major [TaxId: 5664]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Programmed cell death 6 protein-like protein species: Leishmania major [TaxId: 5664]
Probab=99.21 E-value=5.2e-11 Score=98.64 Aligned_cols=89 Identities=12% Similarity=0.322 Sum_probs=52.3
Q ss_pred HHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHH
Q 016471 244 VYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIA 322 (389)
Q Consensus 244 ~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l 322 (389)
..+...|..+|. ++|.|+.+||+.+|..+|. .++.+++..+++.+|.|++|.|+|+||+..+... ..+
T Consensus 84 ~~~~~~F~~~D~~~~g~I~~~el~~~l~~~g~-~ls~~e~~~i~~~~d~~~dg~I~~~eF~~~~~~l----------~~~ 152 (182)
T d1y1xa_ 84 LSMREGFRKRDSSGDGRLDSNEVRAALLSSGY-QVSEQTFQALMRKFDRQRRGSLGFDDYVELSIFV----------CRV 152 (182)
T ss_dssp HHHHHHHHHHCTTSSSCBCHHHHHHHHHTTSC-CCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHH----------HHH
T ss_pred cccccchhccccccchhhhhHHHHHHHHHhCC-chhHHHHHHHHhhcccCCCCCcCHHHHHHHHHHH----------HHH
Confidence 345566666666 6666666666666666554 3566666666666666666666666666643221 124
Q ss_pred HHHHHHHcccCCCccc--HHHHH
Q 016471 323 ITAFDYFEQEGNRVIS--VEELA 343 (389)
Q Consensus 323 ~~aF~~~D~d~~G~I~--~~el~ 343 (389)
+++|+.+|.+++|+|| .+|+.
T Consensus 153 ~~~F~~~D~~~~G~is~~~~~f~ 175 (182)
T d1y1xa_ 153 RNVFAFYDRERTGQVTFTFDTFI 175 (182)
T ss_dssp HHHHHHHCTTCCSEEEEEHHHHH
T ss_pred HHHHHHhCCCCCCcEEeeHHHHH
Confidence 5566666666666643 44443
|
| >d1qxpa2 a.39.1.8 (A:515-702) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), mu-type [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain large subunit, C-terminal domain (domain IV) species: Rat (Rattus norvegicus), mu-type [TaxId: 10116]
Probab=99.19 E-value=6.6e-11 Score=98.23 Aligned_cols=89 Identities=12% Similarity=0.177 Sum_probs=67.8
Q ss_pred HHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHH
Q 016471 243 LVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQI 321 (389)
Q Consensus 243 ~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~ 321 (389)
...++..|..+|. ++|.|+..||+.+|..+|.. ++.+.+..++.. +.+++|.|+|+||+.++... ..
T Consensus 92 ~~~~~~~F~~~D~d~sG~i~~~El~~~l~~~g~~-~~~~~~~~l~~~-~~~~dg~i~f~eFi~~~~~l----------~~ 159 (188)
T d1qxpa2 92 IRNYLTIFRKFDLDKSGSMSAYEMRMAIEAAGFK-LPCQLHQVIVAR-FADDELIIDFDNFVRCLVRL----------EI 159 (188)
T ss_dssp HHHHHHHHGGGCTTCCSCCBHHHHHHHHHHTTEE-CCHHHHHHHHHH-TSCSSSBCCHHHHHHHHHHH----------HH
T ss_pred hHHHHHHHHHhCCCCCCEECHHHHHHHHHHhhhc-CCHHHHHHHHHH-hcCCCCcCCHHHHHHHHHHH----------HH
Confidence 3457788999999 99999999999999888864 666655555555 56889999999998866543 23
Q ss_pred HHHHHHHHcccCCCcc--cHHHHH
Q 016471 322 AITAFDYFEQEGNRVI--SVEELA 343 (389)
Q Consensus 322 l~~aF~~~D~d~~G~I--~~~el~ 343 (389)
+..+|+.+|++++|+| +.+|+.
T Consensus 160 ~~~~F~~~D~~~~G~i~l~~~efl 183 (188)
T d1qxpa2 160 LFKIFKQLDPENTGTIQLDLISWL 183 (188)
T ss_dssp HHHHHHHSCSSCCSCEEEEHHHHH
T ss_pred HHHHHHHhCCCCCCeEEeeHHHHH
Confidence 6678999999999987 455543
|
| >d2fcea1 a.39.1.5 (A:84-144) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.18 E-value=2.5e-11 Score=81.10 Aligned_cols=59 Identities=24% Similarity=0.385 Sum_probs=55.2
Q ss_pred HHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHH
Q 016471 245 YLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCA 304 (389)
Q Consensus 245 ~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~ 304 (389)
.++++|..+|+ ++|+|+.+||+.+|+.+|.+ ++..++.++++.+|.+++|.|+|+||+.
T Consensus 2 el~~aF~~fD~~~~G~I~~~el~~~l~~~g~~-~~~~ei~~l~~~~D~d~dg~I~~~eFl~ 61 (61)
T d2fcea1 2 DFVKAFQVFDKESTGKVSVGDLRYMLTGLGEK-LTDAEVDELLKGVEVDSNGEIDYKKFIE 61 (61)
T ss_dssp HHHHHHHHHCTTCCSCEEHHHHHHHHHHTTCC-CCHHHHHHHHTTCCCCTTSEECHHHHHH
T ss_pred hHHHHHHHHCCCCCCeEeHHHHHHHHHHcCCC-CCHHHHHHHHHHcCCCCCCcEeHHHhcC
Confidence 46789999999 99999999999999999974 8999999999999999999999999983
|
| >d1jc2a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=99.17 E-value=2.7e-11 Score=84.54 Aligned_cols=63 Identities=13% Similarity=0.306 Sum_probs=58.0
Q ss_pred HHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHh
Q 016471 244 VYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAAT 307 (389)
Q Consensus 244 ~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~ 307 (389)
..++.+|..+|. ++|.|+..||+.+|+.+|. .++.+++.+++..+|.+++|.|+|+||+..+.
T Consensus 9 eel~~~F~~fD~~~~G~I~~~el~~~l~~lg~-~~~~~e~~~~~~~~D~d~dg~I~~~EF~~~m~ 72 (75)
T d1jc2a_ 9 EELANCFRIFDKNADGFIDIEELGEILRATGE-HVIEEDIEDLMKDSDKNNDGRIDFDEFLKMME 72 (75)
T ss_dssp HHHHHHHHHHCCSTTSSEEHHHHHHHHHHSSS-CCCHHHHHHHHHHHCSSSCSEECHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCcCeEcHHHHHHHHHhcCC-CccHHHHHHHHHHhCCCCCCcEeHHHHHHHHH
Confidence 357889999999 9999999999999999997 58999999999999999999999999998654
|
| >d1fpwa_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Frequenin (neuronal calcium sensor 1) species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.17 E-value=4.1e-11 Score=100.02 Aligned_cols=114 Identities=13% Similarity=0.249 Sum_probs=89.4
Q ss_pred HHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHH--------hhH
Q 016471 246 LRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLE--------ALE 316 (389)
Q Consensus 246 l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~--------~~~ 316 (389)
...+|..+|. ++|.|+..||..++..+.. ...++.+..+|+.+|.|++|.|+++||...+....... ...
T Consensus 65 ~~~if~~~D~~~~G~I~~~Ef~~~~~~~~~-~~~~e~~~~~F~~~D~d~dG~is~~E~~~~~~~~~~~~~~~~~~~~~~~ 143 (190)
T d1fpwa_ 65 ANHLFTVFDKDNNGFIHFEEFITVLSTTSR-GTLEEKLSWAFELYDLNHDGYITFDEMLTIVASVYKMMGSMVTLNEDEA 143 (190)
T ss_dssp HHHHHHTCCSSCSSEECHHHHHHHHHHHSC-CCSTHHHHHHHHHHCSSCSSEEEHHHHHHHHHHHHTTSCSTTSSSCCCC
T ss_pred HHHHHHHhCcCCCCcccHHHHHHHHHHHcc-CchHHHHHHHHHHhccCCCCcCcHHHHHHHHHHHHHhcccccCCCchhh
Confidence 3567899999 9999999999999987765 35678899999999999999999999987654332110 001
Q ss_pred HHHHHHHHHHHHHcccCCCcccHHHHHHHhCCchHHHHHHHHHc
Q 016471 317 RWDQIAITAFDYFEQEGNRVISVEELALELNLAPAAYSLLNDCI 360 (389)
Q Consensus 317 ~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~d 360 (389)
..+..+..+|+.+|.|+||+|+.+|+++.+...|.+.+.+.-+|
T Consensus 144 ~~~~~v~~if~~~D~d~dG~Is~~EF~~~~~~~p~i~~~l~~~d 187 (190)
T d1fpwa_ 144 TPEMRVKKIFKLMDKNEDGYITLDEFREGSKVDPSIIGALNLYD 187 (190)
T ss_dssp CHHHHHHHHHHHHTTTCSSEEEHHHHHHHHHSSTTHHHHHHHHH
T ss_pred hHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHCHHHHHHhhhhc
Confidence 11456888999999999999999999999877777555555543
|
| >d1tiza_ a.39.1.5 (A:) Calmodulin-related protein T21P5.17 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin-related protein T21P5.17 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=99.16 E-value=3.1e-11 Score=82.31 Aligned_cols=61 Identities=18% Similarity=0.346 Sum_probs=56.4
Q ss_pred HHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHh
Q 016471 246 LRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAAT 307 (389)
Q Consensus 246 l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~ 307 (389)
.+.+|..+|. ++|+|+..||+.+++.+|. .++.+++.++|..+|.+++|.|+|+||+..+.
T Consensus 3 ~r~~F~~~D~d~~G~I~~~El~~~l~~lg~-~~~~~~i~~~~~~~D~d~dg~I~~~EF~~~m~ 64 (67)
T d1tiza_ 3 AKRVFEKFDKNKDGKLSLDEFREVALAFSP-YFTQEDIVKFFEEIDVDGNGELNADEFTSCIE 64 (67)
T ss_dssp HHHHHHHHCTTSSSCEEHHHHHHHHHHTCT-TSCHHHHHHHHHHHCCSSSSEECHHHHHHHHH
T ss_pred HHHHHHHHCCCCcCcCcHHHHHHHHHHhcc-ccchHHHHHHHHHhCCCCCCeEeHHHHHHHHH
Confidence 5788999999 9999999999999999987 48999999999999999999999999998654
|
| >d1a4pa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]
Probab=99.16 E-value=1.9e-11 Score=88.65 Aligned_cols=61 Identities=20% Similarity=0.393 Sum_probs=52.5
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHhCC----------chH-HHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 319 DQIAITAFDYFEQEGNRVISVEELALELNL----------APA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 319 ~~~l~~aF~~~D~d~~G~I~~~el~~~l~~----------~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
.+.+..+|..||.| +|+|+++||+++|.. .+. ++++++++|.|+||+|+|+||+.+|.+..
T Consensus 8 ie~l~~~F~~yd~d-dG~is~~El~~~l~~~~~~~~~~~~~~~~v~~~~~~~D~n~DG~I~F~EF~~li~~l~ 79 (92)
T d1a4pa_ 8 METMMFTFHKFAGD-KGYLTKEDLRVLMEKEFPGFLENQKDPLAVDKIMKDLDQCRDGKVGFQSFFSLIAGLT 79 (92)
T ss_dssp HHHHHHHHHHHHGG-GCSBCHHHHHHHHHHHCHHHHHHSCCTTHHHHHHHHHCTTSSSCBCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHcCC-CCEEcHHHHHHHHHHhccccccccCCHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHH
Confidence 35689999999988 899999999999821 122 99999999999999999999999997654
|
| >d1cb1a_ a.39.1.1 (A:) Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calbindin D9K domain: Calbindin D9K species: Pig (Sus scrofa) [TaxId: 9823]
Probab=99.15 E-value=1.3e-11 Score=86.86 Aligned_cols=61 Identities=23% Similarity=0.393 Sum_probs=51.3
Q ss_pred HHHHHHHHHHcc-c-CCCcccHHHHHHHh-----CCc--hH-HHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 320 QIAITAFDYFEQ-E-GNRVISVEELALEL-----NLA--PA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 320 ~~l~~aF~~~D~-d-~~G~I~~~el~~~l-----~~~--~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
+.++.+|..||. + ++|+|+++||+.++ +.. +. ++++++++|.|+||.|+|+||+.+|.++.
T Consensus 7 ~~l~~~F~~y~~~d~~~g~is~~Elk~ll~~~~~~~~~~~~~v~~~~~~~D~d~dG~Idf~EF~~l~~~la 77 (78)
T d1cb1a_ 7 AELKSIFEKYAAKEGDPNQLSKEELKQLIQAEFPSLLKGPRTLDDLFQELDKNGDGEVSFEEFQVLVKKIS 77 (78)
T ss_dssp HHHHHHHHHHHTTSSSTTEECHHHHHHHHHHHCSSCCSSCCCSSHHHHHTCCCSSSSEEHHHHHHHHHHHC
T ss_pred HHHHHHHHHHccCCCCCCEECHHHHHHHHHHHcCCCCCCHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHh
Confidence 568999999975 3 45899999999999 222 22 99999999999999999999999998753
|
| >d1omra_ a.39.1.5 (A:) Recoverin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Recoverin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.15 E-value=3.4e-11 Score=101.42 Aligned_cols=119 Identities=11% Similarity=0.146 Sum_probs=93.5
Q ss_pred CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhc-CCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHHHHHcccCC
Q 016471 256 KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVM-EPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGN 334 (389)
Q Consensus 256 ~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~-d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~ 334 (389)
++|.|+.++++...... .+++.++..+++.+ +.+.+|.|+++||...+......... ...+..+|+.+|.|++
T Consensus 4 ~~~~l~~e~l~~l~~~t---~f~~~ei~~l~~~F~~~~~~G~is~~EF~~~l~~~~~~~~~---~~~~~~if~~~D~~~~ 77 (201)
T d1omra_ 4 KSGALSKEILEELQLNT---KFTEEELSSWYQSFLKECPSGRITRQEFQTIYSKFFPEADP---KAYAQHVFRSFDANSD 77 (201)
T ss_dssp SSCTHHHHHHHHHGGGC---SSCHHHHHHHHHHHHHHCTTSEEEHHHHHHHHHHHCTTSCC---HHHHHHHHHTTTSCSS
T ss_pred ccCCCCHHHHHHHHHhC---CCCHHHHHHHHHHHHHHCcCCCccHHHHHHHHHHhcCCCCH---HHHHHHHHHHhccCCC
Confidence 67899999998754432 47889999988886 66679999999998865543222221 2346789999999999
Q ss_pred CcccHHHHHHHh----CC-chH-HHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 335 RVISVEELALEL----NL-APA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 335 G~I~~~el~~~l----~~-~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
|.|+.+|+...+ .. ... +..+++.+|.|++|.|+++||..+++...
T Consensus 78 G~I~f~EF~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~is~~E~~~~~~~~~ 129 (201)
T d1omra_ 78 GTLDFKEYVIALHMTSAGKTNQKLEWAFSLYDVDGNGTISKNEVLEIVTAIF 129 (201)
T ss_dssp SEEEHHHHHHHHHHHHSSCGGGSHHHHHHHHCTTCSSSBCHHHHHHHHHHHH
T ss_pred CeEeehhHHHHHHhhcccchHHHHHHHHHHHccCCCCccCHHHHHHHHHHHH
Confidence 999999999877 22 222 89999999999999999999999987654
|
| >d1zfsa1 a.39.1.2 (A:1-93) Calcyclin (S100) {Rat (Rattus norvegicus), s100a1 [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Rat (Rattus norvegicus), s100a1 [TaxId: 10116]
Probab=99.15 E-value=2.4e-11 Score=88.65 Aligned_cols=61 Identities=21% Similarity=0.334 Sum_probs=52.4
Q ss_pred HHHHHHHHHH-cccCC-CcccHHHHHHHhC----------CchH-HHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 320 QIAITAFDYF-EQEGN-RVISVEELALELN----------LAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 320 ~~l~~aF~~~-D~d~~-G~I~~~el~~~l~----------~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
+.+..+|..| |+||+ |+|+++||+++|. ..++ +.++++++|.|+||.|+|+||+.+|.+..
T Consensus 9 ~~l~~~F~~y~d~dg~~G~is~~El~~~L~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~Idf~EF~~lm~~l~ 82 (93)
T d1zfsa1 9 ETLINVFHAHSGKEGDKYKLSKKELKDLLQTELSSFLDVQKDADAVDKIMKELDENGDGEVDFQEFVVLVAALT 82 (93)
T ss_dssp HHHHHHHHHHGGGSSCCSSEEHHHHHHHHHHHSTTTSCCSSCHHHHHHHHHHHTTTCCSEECSHHHHHHHHHHH
T ss_pred HHHHHHHHHHcccCCCCCEecHHHHHHHHHHhcccccccCCCHHHHHHHHHHHcCCCCCCCcHHHHHHHHHHHH
Confidence 5689999998 88875 9999999999981 1223 99999999999999999999999997654
|
| >d1c07a_ a.39.1.6 (A:) Eps15 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.13 E-value=3.4e-11 Score=88.18 Aligned_cols=59 Identities=17% Similarity=0.103 Sum_probs=53.0
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHh---CCchH-HHHHHHHHccCCCCceeHHHHHHHHc
Q 016471 319 DQIAITAFDYFEQEGNRVISVEELALEL---NLAPA-AYSLLNDCIRNSDGKLSFLGYKRFLH 377 (389)
Q Consensus 319 ~~~l~~aF~~~D~d~~G~I~~~el~~~l---~~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~ 377 (389)
...++.+|+.+|+|++|+|+.+|++.+| ++..+ +.++++.+|.|+||+|+|+||+.+|+
T Consensus 9 ~~~~~~~F~~~D~d~~G~is~~e~~~~l~~~~l~~~~l~~i~~~~D~d~dG~l~~~EF~~am~ 71 (95)
T d1c07a_ 9 KAKYDEIFLKTDKDMDGFVSGLEVREIFLKTGLPSTLLAHIWSLCDTKDCGKLSKDQFALAFH 71 (95)
T ss_dssp HHHHHHHHHHHCTTCSSEECHHHHHHHHHTTTCCHHHHHHHHHHHCTTCSSSEETTTHHHHHH
T ss_pred HHHHHHHHHHHCCCCCCCCcHHHHHHHHHhcCCCHHHHHHHHHHhCCCCCCeEcHHHHHHHHH
Confidence 3568899999999999999999999999 55555 99999999999999999999987764
|
| >d1yuta1 a.39.1.2 (A:1-98) Calcyclin (S100) {Human (Homo sapiens), s100a13 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a13 [TaxId: 9606]
Probab=99.12 E-value=4e-11 Score=88.02 Aligned_cols=60 Identities=27% Similarity=0.350 Sum_probs=51.3
Q ss_pred HHHHHHHHHH-cccCC-CcccHHHHHHHhC-----C--chH-HHHHHHHHccCCCCceeHHHHHHHHccc
Q 016471 320 QIAITAFDYF-EQEGN-RVISVEELALELN-----L--APA-AYSLLNDCIRNSDGKLSFLGYKRFLHGV 379 (389)
Q Consensus 320 ~~l~~aF~~~-D~d~~-G~I~~~el~~~l~-----~--~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~ 379 (389)
+.+..+|..| |+||+ |+|+++||+++|. . ++. ++++++++|.|+||.|+|+||+.+|.+.
T Consensus 14 ~~l~~vF~~y~d~dg~~g~is~~El~~~l~~~~~~~~~~~~~v~~l~~~~D~d~DG~IdF~EF~~l~~~l 83 (98)
T d1yuta1 14 ETVVTTFFTFARQEGRKDSLSVNEFKELVTQQLPHLLKDVGSLDEKMKSLDVNQDSELKFNEYWRLIGEL 83 (98)
T ss_dssp HHHHHHHHHHHTTSSSSSCBCHHHHHHHHHHHCTTTTCCSSCHHHHHHHHCTTCCSCBCHHHHHHHHHHH
T ss_pred HHHHHHHHHHcccCCCCCEEcHHHHHHHHHHhccccCCCHHHHHHHHHHhcCCCCCcCCHHHHHHHHHHH
Confidence 4688899988 78875 9999999999992 1 122 9999999999999999999999999764
|
| >d1k8ua_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a6 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a6 [TaxId: 9606]
Probab=99.12 E-value=2.6e-11 Score=87.12 Aligned_cols=70 Identities=24% Similarity=0.414 Sum_probs=57.1
Q ss_pred HHHHHHHHHH-cccCCC-cccHHHHHHHhC------C--chH-HHHHHHHHccCCCCceeHHHHHHHHccccCCCccccC
Q 016471 320 QIAITAFDYF-EQEGNR-VISVEELALELN------L--APA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVTVRSSNTRH 388 (389)
Q Consensus 320 ~~l~~aF~~~-D~d~~G-~I~~~el~~~l~------~--~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~~~~~~ 388 (389)
..+..+|..| |+||+| .|++.||+.++. . .+. +.++++++|.|+||+|+|+||+.+|.++....-.+-|
T Consensus 9 ~~ii~vF~kya~~dg~~~~ls~~Elk~Ll~~e~~~~~~~~~~~~~~~~~~lD~d~Dg~IdF~EF~~l~~~la~~c~~~~~ 88 (89)
T d1k8ua_ 9 GLLVAIFHKYSGREGDKHTLSKKELKELIQKELTIGSKLQDAEIARLMEDLDRNKDQEVNFQEYVTFLGALALIYNEALK 88 (89)
T ss_dssp HHHHHHHHHHHTSSSCTTEEEHHHHHHHHHHHSCCGGGTTSHHHHHHHHHHHHTTTCEEEHHHHHHHHHHHHHHHCGGGC
T ss_pred HHHHHHHHHHcccCCCCCeecHHHHHHHHHHHHHhhccCCHHHHHHHHHHhcCCCCCCCcHHHHHHHHHHHHHHHHHHhc
Confidence 4588899988 999999 599999999982 1 222 9999999999999999999999999887655444444
Q ss_pred C
Q 016471 389 G 389 (389)
Q Consensus 389 ~ 389 (389)
|
T Consensus 89 ~ 89 (89)
T d1k8ua_ 89 G 89 (89)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >d1fi5a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]
Probab=99.11 E-value=6.5e-11 Score=83.93 Aligned_cols=63 Identities=21% Similarity=0.406 Sum_probs=57.5
Q ss_pred HHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHh
Q 016471 244 VYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAAT 307 (389)
Q Consensus 244 ~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~ 307 (389)
..++.+|..+|. ++|.|+.+||+.++..+|. .++..++.+++..+|.+++|.|+|+||+..+.
T Consensus 15 e~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~-~~~~~ev~~~~~~~D~d~dg~I~~~EF~~~m~ 78 (81)
T d1fi5a_ 15 EELSDLFRMFDKNADGYIDLEELKIMLQATGE-TITEDDIEELMKDGDKNNDGRIDYDEFLEFMK 78 (81)
T ss_dssp HHHHHHHHHHCSSCSSEECHHHHHHHHHTSSS-CCCHHHHHHHHHHHCSSSSSSEEHHHHHHHHS
T ss_pred HHHHHHHHHHcCCCCCcccHHHHHHHHHhcCC-CCCHHHHHHHHHHHCCCCCCcEeHHHHHHHHH
Confidence 357889999999 9999999999999999987 48999999999999999999999999998543
|
| >d3c1va1 a.39.1.2 (A:2-94) Calcyclin (S100) {Human (Homo sapiens), s100a4 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a4 [TaxId: 9606]
Probab=99.11 E-value=3.6e-11 Score=87.39 Aligned_cols=62 Identities=23% Similarity=0.410 Sum_probs=52.0
Q ss_pred HHHHHHHHHH-cccCCC-cccHHHHHHHhC----------CchH-HHHHHHHHccCCCCceeHHHHHHHHccccC
Q 016471 320 QIAITAFDYF-EQEGNR-VISVEELALELN----------LAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVTV 381 (389)
Q Consensus 320 ~~l~~aF~~~-D~d~~G-~I~~~el~~~l~----------~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~ 381 (389)
+.+..+|..| |+||+| +|+.+||+++|. ..+. +.++++++|.|+||.|+|+||+.+|.++..
T Consensus 9 ~~l~~~F~~ya~~dg~~~~L~~~Elk~~l~~~~~~~~~~~~~~~~~~~i~~~~D~n~DG~I~F~EF~~lm~~l~~ 83 (93)
T d3c1va1 9 DVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSNRDNEVDFQEYCVFLSCIAM 83 (93)
T ss_dssp HHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHCHHHHTTCCSHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCCCCCCeeCHHHHHHHHHHhchhccccCCCHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Confidence 5689999999 666655 699999999982 1223 999999999999999999999999987654
|
| >d1oqpa_ a.39.1.5 (A:) Caltractin (centrin 2) {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Caltractin (centrin 2) species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.11 E-value=7.2e-11 Score=82.93 Aligned_cols=65 Identities=12% Similarity=0.288 Sum_probs=59.0
Q ss_pred HHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHh
Q 016471 242 ELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAAT 307 (389)
Q Consensus 242 e~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~ 307 (389)
....++.+|..+|. ++|.|+.+||+.+|..++.+ ++..++.++++.+|.+++|.|+|+||+..+.
T Consensus 7 ~~e~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~-~~~~e~~~~~~~~D~d~~G~I~~~EF~~~m~ 72 (77)
T d1oqpa_ 7 SREEILKAFRLFDDDNSGTITIKDLRRVAKELGEN-LTEEELQEMIAEADRNDDNEIDEDEFIRIMK 72 (77)
T ss_dssp HHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHHTCC-CCHHHHHHHHHHHCCSSSSEECHHHHHHHHH
T ss_pred HHHHHHHHHHHHcCCCCCEechHHHHHHHHHhCCC-CCHHHHHHHHHHhCCCCCCcEeHHHHHHHHH
Confidence 34568899999999 99999999999999999874 7899999999999999999999999998653
|
| >d1ksoa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a3 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a3 [TaxId: 9606]
Probab=99.10 E-value=5.6e-11 Score=86.11 Aligned_cols=62 Identities=18% Similarity=0.284 Sum_probs=53.1
Q ss_pred HHHHHHHHHH-cccCCC-cccHHHHHHHhC----------CchH-HHHHHHHHccCCCCceeHHHHHHHHccccC
Q 016471 320 QIAITAFDYF-EQEGNR-VISVEELALELN----------LAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVTV 381 (389)
Q Consensus 320 ~~l~~aF~~~-D~d~~G-~I~~~el~~~l~----------~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~ 381 (389)
..+..+|..| |+||+| +|+++||+++|. .++. +.++++++|.|+||.|+|+||+.+|..+..
T Consensus 9 ~~i~~vF~kya~~dGd~~~ls~~Elk~ll~~~~~~~~~~~~~~~~~~~~~~~lD~n~Dg~IdF~EF~~l~~~l~~ 83 (93)
T d1ksoa_ 9 AAIVCTFQEYAGRCGDKYKLCQAELKELLQKELATWTPTEFRECDYNKFMSVLDTNKDCEVDFVEYVRSLACLCL 83 (93)
T ss_dssp HHHHHHHHHHHTSSSCTTCEEHHHHHHHHHHHTTTCCCCTTCHHHHHHHHHHHHHTTTCEECHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCcCCCCCeECHHHHHHHHHHhhhcccccCCCHHHHHHHHHHHcCCCCCCCcHHHHHHHHHHHHH
Confidence 4688899988 999999 599999999981 1222 999999999999999999999999987653
|
| >d1wlza1 a.39.1.7 (A:229-311) DJ-1-binding protein, DJBP {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: DJ-1-binding protein, DJBP species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.09 E-value=1.5e-10 Score=82.56 Aligned_cols=57 Identities=19% Similarity=0.239 Sum_probs=51.3
Q ss_pred HHHHHHHHHHcccCCCcccHHHHHHHh---CC--chH-HHHHHHHHccCCCCceeHHHHHHHH
Q 016471 320 QIAITAFDYFEQEGNRVISVEELALEL---NL--APA-AYSLLNDCIRNSDGKLSFLGYKRFL 376 (389)
Q Consensus 320 ~~l~~aF~~~D~d~~G~I~~~el~~~l---~~--~~~-~~~~~~~~d~~~~g~i~~~ef~~~~ 376 (389)
..++++|+.||.+++|+|+.+||+++| +. ++. +..++..+|.+++|.|+|.||+..+
T Consensus 20 ~~l~~~F~~~D~~~~G~i~~~ef~~~l~~~~~~l~~~e~~~l~~~~d~~~~g~I~y~eFl~~f 82 (83)
T d1wlza1 20 HAITQEFENFDTMKTNTISREEFRAICNRRVQILTDEQFDRLWNEMPVNAKGRLKYPDFLSRF 82 (83)
T ss_dssp HHHHHHHHHHCTTCSSCBCHHHHHHHHHHHTCCCCHHHHHHHHTTSCBCTTSCBCHHHHHHHH
T ss_pred HHHHHHHHHHCCCCCceEChhHHHHHHHHhCCCCChhHHHHHhhccccCCCCcEeHHHHHHHh
Confidence 568999999999999999999999998 33 344 9999999999999999999999875
|
| >d1snla_ a.39.1.7 (A:) Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Nucleobindin 1 (CALNUC) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.08 E-value=8.6e-11 Score=86.81 Aligned_cols=58 Identities=12% Similarity=0.106 Sum_probs=47.1
Q ss_pred HHHHHHHHcccCCCcccHHHHHHHhCC------------c------h---H-HHHHHHHHccCCCCceeHHHHHHHHccc
Q 016471 322 AITAFDYFEQEGNRVISVEELALELNL------------A------P---A-AYSLLNDCIRNSDGKLSFLGYKRFLHGV 379 (389)
Q Consensus 322 l~~aF~~~D~d~~G~I~~~el~~~l~~------------~------~---~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~ 379 (389)
++.+|+.||.|+||+|+.+||+.++.. . . . +..+++++|.|+||.|||+||+.++++.
T Consensus 18 ~r~~F~~~D~DgdG~i~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~~~D~d~DG~Is~~EF~~~~~~~ 97 (99)
T d1snla_ 18 PKTFFILHDINSDGVLDEQELEALFTKELEKVYDPKNEEDDMREMEEERLRMREHVMKNVDTNQDRLVTLEEFLASTQRK 97 (99)
T ss_dssp HHHHHHHHCSSCCSEEEHHHHHHHHHHHHHTTSCCSSCSSHHHHTTHHHHHHHHHHHHHTCSSCSSEEEHHHHHHHHHCC
T ss_pred HHHHHHHHCCCCCCcCCHHHHHHHHHHHHHhcchhhhhhhhhhhhHHHHHHHHHHHHHHcCCCCCCcCcHHHHHHHHhcC
Confidence 577888888888888888888887710 0 0 0 7789999999999999999999998763
|
| >d1fi6a_ a.39.1.6 (A:) Reps1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Reps1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.08 E-value=9.9e-11 Score=85.13 Aligned_cols=59 Identities=15% Similarity=0.119 Sum_probs=52.8
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHh---CCchH-HHHHHHHHccCCCCceeHHHHHHHHc
Q 016471 319 DQIAITAFDYFEQEGNRVISVEELALEL---NLAPA-AYSLLNDCIRNSDGKLSFLGYKRFLH 377 (389)
Q Consensus 319 ~~~l~~aF~~~D~d~~G~I~~~el~~~l---~~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~ 377 (389)
...++.+|+.+|+|++|+|+.+|++.+| +++.+ +.++++.+|.|++|+|+|+||+.+|+
T Consensus 8 ~~~y~~~F~~~D~d~~G~i~~~e~~~~l~~~~l~~~~l~~i~~~~D~d~dG~l~~~EF~~a~~ 70 (92)
T d1fi6a_ 8 RQYYVNQFKTIQPDLNGFIPGSAAKEFFTKSKLPILELSHIWELSDFDKDGALTLDEFCAAFH 70 (92)
T ss_dssp HHHHHHHHTTTCCSTTCEEEHHHHHHHHHHHSSCHHHHHHHHHHHCTTCSSEEEHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCcccchhHHHHHHHHHHccCCHHHHHHHHHHhCCCCCCeecHHHHHHHHH
Confidence 3568999999999999999999999999 66655 99999999999999999999986554
|
| >d1jbaa_ a.39.1.5 (A:) Guanylate cyclase activating protein 2, GCAP-2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Guanylate cyclase activating protein 2, GCAP-2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.08 E-value=5.5e-10 Score=92.86 Aligned_cols=111 Identities=13% Similarity=0.195 Sum_probs=86.4
Q ss_pred HHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhh---------
Q 016471 246 LRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEAL--------- 315 (389)
Q Consensus 246 l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~--------- 315 (389)
+..+|..+|. ++|.|+..||..++..... ...+..+..+|+.+|.|++|.|+++||...+.........
T Consensus 60 ~~~lf~~~D~d~dG~I~f~Ef~~~l~~~~~-~~~~~~~~~~F~~~D~d~~g~i~~~E~~~~~~~~~~~~~~~~~~~~~~~ 138 (189)
T d1jbaa_ 60 VEAMFRAFDTNGDNTIDFLEYVAALNLVLR-GTLEHKLKWTFKIYDKDRNGCIDRQELLDIVESIYKLKKACSVEVEAEQ 138 (189)
T ss_dssp HHHHHHHHCCSSSSEECHHHHHHHHHHHSS-CCCTHHHHHHHHHHCSSCSSCBCHHHHHHHHHHHHHHHHHSSCCTTSST
T ss_pred HHHHHHHhccCCCCeEeehhHHHHHHhhcc-cchHHHHHHHHhhhccCCCCcccHhHHHHHHHHHHHhhccccccchhhh
Confidence 4577889999 9999999999999887754 3466778999999999999999999998755433221100
Q ss_pred ----HHHHHHHHHHHHHHcccCCCcccHHHHHHHhCCchHHHHHHH
Q 016471 316 ----ERWDQIAITAFDYFEQEGNRVISVEELALELNLAPAAYSLLN 357 (389)
Q Consensus 316 ----~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~ 357 (389)
...++.+..+|+.+|+|+||+||.+|+.+++..+|.+.+++.
T Consensus 139 ~~~~~~~e~~~~~if~~~D~d~dG~Is~~EF~~~~~~~p~i~~~l~ 184 (189)
T d1jbaa_ 139 QGKLLTPEEVVDRIFLLVDENGDGQLSLNEFVEGARRDKWVMKMLQ 184 (189)
T ss_dssp TTCCCCHHHHHHHHHHHHCCSCCSCBCHHHHHHHHTTTTTHHHHHH
T ss_pred hccccchHHHHHHHHHHhCCCCCCcEeHHHHHHHHHhCHHHHHHhc
Confidence 001345788999999999999999999999987777545443
|
| >d1xk4a1 a.39.1.2 (A:1-87) Calcyclin (S100) {Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]
Probab=99.05 E-value=1.4e-10 Score=82.90 Aligned_cols=61 Identities=16% Similarity=0.194 Sum_probs=51.7
Q ss_pred HHHHHHHHHH-cccCCCcc-cHHHHHHHhC--Cch----H-HHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 320 QIAITAFDYF-EQEGNRVI-SVEELALELN--LAP----A-AYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 320 ~~l~~aF~~~-D~d~~G~I-~~~el~~~l~--~~~----~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
+.+..+|..| |+||+|.+ +++||++++. ... . ++++++++|.|+||+|+|+||+.+|.+..
T Consensus 10 ~~ii~~F~kya~~dG~~~~l~~~Elk~ll~~e~~~~~~~~~v~~i~~~~D~n~DG~IdF~EF~~l~~~la 79 (87)
T d1xk4a1 10 NSIIDVYHKYSLIKGNFHAVYRDDLKKLLETESPQYIRKKGADVWFKELDINTDGAVNFQEFLILVIKMG 79 (87)
T ss_dssp HHHHHHHHHHHTSSSCTTCBCHHHHHHHHHHHSCHHHHTTCHHHHHHHHCTTCSSSBCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcccCCCCCccCHHHHHHHHHHhcCCccchHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHH
Confidence 4588899888 99999975 8999999982 221 1 99999999999999999999999998754
|
| >d1wlza1 a.39.1.7 (A:229-311) DJ-1-binding protein, DJBP {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: DJ-1-binding protein, DJBP species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.04 E-value=3.6e-10 Score=80.50 Aligned_cols=64 Identities=19% Similarity=0.284 Sum_probs=59.0
Q ss_pred HHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHH
Q 016471 242 ELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAA 306 (389)
Q Consensus 242 e~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~ 306 (389)
....+.+.|..+|. ++|.|+.+||+.+|..++.+ ++++++..++..+|.+++|.|+|.||+..+
T Consensus 18 ~~~~l~~~F~~~D~~~~G~i~~~ef~~~l~~~~~~-l~~~e~~~l~~~~d~~~~g~I~y~eFl~~f 82 (83)
T d1wlza1 18 HYHAITQEFENFDTMKTNTISREEFRAICNRRVQI-LTDEQFDRLWNEMPVNAKGRLKYPDFLSRF 82 (83)
T ss_dssp THHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHTCC-CCHHHHHHHHTTSCBCTTSCBCHHHHHHHH
T ss_pred HHHHHHHHHHHHCCCCCceEChhHHHHHHHHhCCC-CChhHHHHHhhccccCCCCcEeHHHHHHHh
Confidence 45678899999999 99999999999999999874 899999999999999999999999999854
|
| >d1pvaa_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Probab=99.03 E-value=7e-10 Score=83.09 Aligned_cols=99 Identities=13% Similarity=0.181 Sum_probs=74.3
Q ss_pred hcCHHHHHHHHHHhhhcCCCCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHH---H
Q 016471 237 ALTEEELVYLRAQFMLLEPKDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQL---E 313 (389)
Q Consensus 237 ~l~~ee~~~l~~~F~~~D~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~---~ 313 (389)
.++.+++......+ | .+|.|+..||...+ +....+..++.++|+.+|.+++|.|+.+|+..++...... .
T Consensus 5 ~l~~eeI~~~~~~~---d-~dG~idf~EF~~~~---~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~l~~~g~~l 77 (109)
T d1pvaa_ 5 LLKADDIKKALDAV---K-AEGSFNHKKFFALV---GLKAMSANDVKKVFKAIDADASGFIEEEELKFVLKSFAADGRDL 77 (109)
T ss_dssp HSCHHHHHHHHHHT---C-STTCCCHHHHHHHH---TCTTSCHHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTCCCC
T ss_pred cCCHHHHHHHHHhc---C-CCCCCcHHHHHHHH---HHccCCHHHHHHHhhCccCCCcCeEcHHHHHHHHHHhhhcCCCC
Confidence 35566666554443 3 57899999997654 2234567889999999999999999999998755433211 1
Q ss_pred hhHHHHHHHHHHHHHHcccCCCcccHHHHHHHh
Q 016471 314 ALERWDQIAITAFDYFEQEGNRVISVEELALEL 346 (389)
Q Consensus 314 ~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l 346 (389)
+ ++.+...|+.+|.|+||.|+.+|+.+++
T Consensus 78 s----~~ev~~~~~~~D~d~dG~I~~~EF~~~m 106 (109)
T d1pvaa_ 78 T----DAETKAFLKAADKDGDGKIGIDEFETLV 106 (109)
T ss_dssp C----HHHHHHHHHHHCTTCSSSBCHHHHHHHH
T ss_pred C----HHHHHHHHHHHCCCCcCcEeHHHHHHHH
Confidence 1 3458889999999999999999999876
|
| >d1g8ia_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Frequenin (neuronal calcium sensor 1) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.00 E-value=3.7e-10 Score=93.78 Aligned_cols=111 Identities=14% Similarity=0.224 Sum_probs=84.7
Q ss_pred HHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHH--------hhHH
Q 016471 247 RAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLE--------ALER 317 (389)
Q Consensus 247 ~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~--------~~~~ 317 (389)
..+|..+|. ++|.|+..||..++..... ...++.+..+|+.+|.|++|.|+.+||..++....... ..+.
T Consensus 63 ~~if~~~d~~~dg~I~~~EF~~~l~~~~~-~~~~e~l~~~F~~~D~d~dG~i~~~El~~~~~~~~~~~~~~~~~~~~~~~ 141 (187)
T d1g8ia_ 63 TFVFNVFDENKDGRIEFSEFIQALSVTSR-GTLDEKLRWAFKLYDLDNDGYITRNEMLDIVDAIYQMVGNTVELPEEENT 141 (187)
T ss_dssp HHHHHHHCTTCSSEEEHHHHHHHHHHHHH-CCHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHHHC-----CCGGGSS
T ss_pred HHHHHHhCcCCCCCCcHHHHHHHHHHhcc-CchhhhHHHHHHHHhcCCCCeEcHHHHHHHHHHHhhhhcccccCchhhcc
Confidence 457888899 9999999999998876653 34466789999999999999999999987654322110 0111
Q ss_pred HHHHHHHHHHHHcccCCCcccHHHHHHHhCCchHHHHHHHH
Q 016471 318 WDQIAITAFDYFEQEGNRVISVEELALELNLAPAAYSLLND 358 (389)
Q Consensus 318 ~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~ 358 (389)
.++.+..+|+.+|.|+||+||.+|+.+.+...|.+.+++.-
T Consensus 142 ~~~~v~~if~~~D~d~dG~Is~~EF~~~~~~~p~~~~~l~~ 182 (187)
T d1g8ia_ 142 PEKRVDRIFAMMDKNADGKLTLQEFQEGSKADPSIVQALSL 182 (187)
T ss_dssp HHHHHHHHHHHHCSSCSSEEEHHHHHHHHHHCHHHHHHHCC
T ss_pred HHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHCHHHHHHHHH
Confidence 13567889999999999999999999998777765555443
|
| >d1exra_ a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetraurelia) [TaxId: 5888]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Ciliate (Paramecium tetraurelia) [TaxId: 5888]
Probab=99.00 E-value=4.9e-10 Score=88.99 Aligned_cols=98 Identities=12% Similarity=0.146 Sum_probs=79.4
Q ss_pred HHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHhCCc------hH-HH
Q 016471 281 RVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALELNLA------PA-AY 353 (389)
Q Consensus 281 ~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~------~~-~~ 353 (389)
++.++|..+|.+++|.|+++||..++........ +..+..+|+.+|.+++|.|+.+|+...+... .. +.
T Consensus 10 ~l~~~F~~~D~~~~G~Is~~e~~~~l~~~~~~~~----~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~ 85 (146)
T d1exra_ 10 EFKEAFALFDKDGDGTITTKELGTVMRSLGQNPT----EAELQDMINEVDADGNGTIDFPEFLSLMARKMKEQDSEEELI 85 (146)
T ss_dssp HHHHHHHHHCTTCSSEECHHHHHHHHHHHTCCCC----HHHHHHHHHHHCTTCSSSEEHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCCCeECHHHHHHHHHhcCCCCC----HHHHHHHHHhcCCCCCCcccHHHHHHHHHHHhhccChHHHHH
Confidence 3567799999999999999999886654322222 3568899999999999999999999988321 11 78
Q ss_pred HHHHHHccCCCCceeHHHHHHHHccccCC
Q 016471 354 SLLNDCIRNSDGKLSFLGYKRFLHGVTVR 382 (389)
Q Consensus 354 ~~~~~~d~~~~g~i~~~ef~~~~~~~~~~ 382 (389)
.+++.+|.|++|.|+.+||..++......
T Consensus 86 ~~F~~~D~d~~G~i~~~e~~~~l~~~~~~ 114 (146)
T d1exra_ 86 EAFKVFDRDGNGLISAAELRHVMTNLGEK 114 (146)
T ss_dssp HHHHHHSTTCSSCBCHHHHHHHHHHTTCC
T ss_pred HHHHHhCCCCCCcCCHHHHHHHHHHHhhc
Confidence 89999999999999999999999866543
|
| >d1fi6a_ a.39.1.6 (A:) Reps1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Reps1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.00 E-value=6.1e-10 Score=80.81 Aligned_cols=66 Identities=24% Similarity=0.365 Sum_probs=60.5
Q ss_pred cCHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHH
Q 016471 238 LTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAA 306 (389)
Q Consensus 238 l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~ 306 (389)
++.++...++..|..+|. ++|.|+.+|+..+|++.+ ++..++.+|++.+|.|++|.|+|+||+.++
T Consensus 3 ls~ee~~~y~~~F~~~D~d~~G~i~~~e~~~~l~~~~---l~~~~l~~i~~~~D~d~dG~l~~~EF~~a~ 69 (92)
T d1fi6a_ 3 ITDEQRQYYVNQFKTIQPDLNGFIPGSAAKEFFTKSK---LPILELSHIWELSDFDKDGALTLDEFCAAF 69 (92)
T ss_dssp CCHHHHHHHHHHHTTTCCSTTCEEEHHHHHHHHHHHS---SCHHHHHHHHHHHCTTCSSEEEHHHHHHHH
T ss_pred CCHHHHHHHHHHHHHhCCCcccchhHHHHHHHHHHcc---CCHHHHHHHHHHhCCCCCCeecHHHHHHHH
Confidence 678889999999999999 999999999999998875 577889999999999999999999998754
|
| >d1xo5a_ a.39.1.5 (A:) Calcium- and integrin-binding protein, CIB {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium- and integrin-binding protein, CIB species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.99 E-value=7.2e-10 Score=91.31 Aligned_cols=108 Identities=12% Similarity=0.131 Sum_probs=80.7
Q ss_pred HHHhhhcCC--CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchh-----HHHhhHHHH
Q 016471 247 RAQFMLLEP--KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVY-----QLEALERWD 319 (389)
Q Consensus 247 ~~~F~~~D~--~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~-----~~~~~~~~~ 319 (389)
.++|..+|. ++|.|+.+||-.++.........++.+..+|+.+|.|++|.|+.+|+...+.... .....+..+
T Consensus 60 ~rif~~fd~~~~~g~I~f~EFv~~l~~~~~~~~~~~kl~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~ 139 (180)
T d1xo5a_ 60 ERICRVFSTSPAKDSLSFEDFLDLLSVFSDTATPDIKSHYAFRIFDFDDDGTLNREDLSRLVNCLTGEGEDTRLSASEMK 139 (180)
T ss_dssp HHHHHHHCCSTTCCEECHHHHHHHHHHHSTTSCHHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHC------CCCCTTHH
T ss_pred HHHHHhccCCCCCCcCcHHHHHHHHHHHhhcCCHHHHHHHhhccccCCCCCeeeHHHHHHHHHHHHhccccccccHHHHH
Confidence 456777786 5899999999998876543233456788999999999999999999987544321 111112224
Q ss_pred HHHHHHHHHHcccCCCcccHHHHHHHhCCchHHHH
Q 016471 320 QIAITAFDYFEQEGNRVISVEELALELNLAPAAYS 354 (389)
Q Consensus 320 ~~l~~aF~~~D~d~~G~I~~~el~~~l~~~~~~~~ 354 (389)
+.+..+|+.+|.|+||.||.+|+.+++...|++-+
T Consensus 140 ~~v~~~~~~~D~d~dG~Is~~EF~~~~~~~P~~~~ 174 (180)
T d1xo5a_ 140 QLIDNILEESDIDRDGTINLSEFQHVISRSPDFAS 174 (180)
T ss_dssp HHHHHHHHHHCTTCSSSBCHHHHHHHHHHCHHHHH
T ss_pred HHHHHHHHHhCCCCCCcCcHHHHHHHHHhCHHHHh
Confidence 55778999999999999999999999877776333
|
| >d1s6ca_ a.39.1.5 (A:) Kchip1, Kv4 potassium channel-interacting protein {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Kchip1, Kv4 potassium channel-interacting protein species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.99 E-value=1.5e-09 Score=89.15 Aligned_cols=111 Identities=14% Similarity=0.187 Sum_probs=83.3
Q ss_pred HHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHH--------hhH
Q 016471 246 LRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLE--------ALE 316 (389)
Q Consensus 246 l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~--------~~~ 316 (389)
....|..+|. ++|.|+.+||..++..... ....+.+..+|+.+|.+++|.|+.+||...+....... ...
T Consensus 53 ~~~lf~~~D~~~~g~I~~~EFl~~~~~~~~-~~~~~~~~~~f~~~D~~~~g~i~~~e~~~~~~~~~~~~~~~~~~~~~~~ 131 (178)
T d1s6ca_ 53 AHYLFNAFDTTQTGSVKFEDFVTALSILLR-GTVHEKLRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVLKED 131 (178)
T ss_dssp HHHHHHHHCTTCSSCEEHHHHHHHHHHHHH-CCHHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHHTC----------
T ss_pred HHHHHHHHCCCCCCcccHHHHHHHHHHHhc-cchHHHHHHHHHhhccCCCCeecHHHHHHHHHHHHhhcccccccCCcHH
Confidence 3457888899 9999999999888865543 34567789999999999999999999976544322211 001
Q ss_pred HHHHHHHHHHHHHcccCCCcccHHHHHHHhCCchHHHHHHH
Q 016471 317 RWDQIAITAFDYFEQEGNRVISVEELALELNLAPAAYSLLN 357 (389)
Q Consensus 317 ~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~ 357 (389)
..+..+..+|+.+|.|+||.||.+|+.+.+...|++.++++
T Consensus 132 ~~~~~~~~if~~~D~d~DG~Is~~EF~~~i~~~~~~~~~l~ 172 (178)
T d1s6ca_ 132 TPRQHVDVFFQKMDKNKDGIVTLDEFLESCQEDDNIMRSLQ 172 (178)
T ss_dssp -CHHHHHHHHHHHCTTCSSEECHHHHHHHTTSCCHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHCHHHHHHhh
Confidence 11344678999999999999999999999977777444443
|
| >d2jxca1 a.39.1.6 (A:121-215) Eps15 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.99 E-value=5.1e-10 Score=81.64 Aligned_cols=58 Identities=16% Similarity=0.065 Sum_probs=51.5
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHh---CCchH-HHHHHHHHccCCCCceeHHHHHHHHc
Q 016471 319 DQIAITAFDYFEQEGNRVISVEELALEL---NLAPA-AYSLLNDCIRNSDGKLSFLGYKRFLH 377 (389)
Q Consensus 319 ~~~l~~aF~~~D~d~~G~I~~~el~~~l---~~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~ 377 (389)
...++++|+.+| |++|+|+.+|++.+| |++.+ +.+|++.+|.|++|.|+++||+..|+
T Consensus 9 ~~~y~~~F~~~D-~~~G~i~~~el~~~l~~~gl~~~~L~~Iw~~~D~~~dG~l~~~EF~~a~~ 70 (95)
T d2jxca1 9 KAKYDAIFDSLS-PVNGFLSGDKVKPVLLNSKLPVDILGRVWELSDIDHDGMLDRDEFAVAMF 70 (95)
T ss_dssp HHHHHHHHHHTC-CBTTEEEHHHHHHHHTTSSCCHHHHHHHHHHHCTTCSSEEEHHHHHHHHH
T ss_pred HHHHHHHHHHhC-CCCCceeHHHHHHHHHHcCCCHHHHHHHHHHhcCCCCCeEcHHHHHHHHH
Confidence 456899999999 899999999999999 66666 99999999999999999999976554
|
| >d5pala_ a.39.1.4 (A:) Parvalbumin {Leopard shark (Triakis semifasciata) [TaxId: 30493]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Leopard shark (Triakis semifasciata) [TaxId: 30493]
Probab=98.98 E-value=7e-10 Score=83.10 Aligned_cols=99 Identities=14% Similarity=0.178 Sum_probs=69.8
Q ss_pred hcCHHHHHHHHHHhhhcCCCCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHH---H
Q 016471 237 ALTEEELVYLRAQFMLLEPKDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQL---E 313 (389)
Q Consensus 237 ~l~~ee~~~l~~~F~~~D~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~---~ 313 (389)
.++.+++.+.-..| | .+|.|+..||...+ +....+++++.++|+.+|.+++|.|+.+|+..++...... .
T Consensus 5 ~l~~~di~~~~~~~---~-~~G~idf~eF~~~~---~~~~~~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~l~~~g~~~ 77 (109)
T d5pala_ 5 VLKADDINKAISAF---K-DPGTFDYKRFFHLV---GLKGKTDAQVKEVFEILDKDQSGFIEEEELKGVLKGFSAHGRDL 77 (109)
T ss_dssp TSCHHHHHHHHHHT---C-STTCCCHHHHHHHH---TCTTCCHHHHHHHHHHHCTTCSSEECHHHHHTHHHHHCTTCCCC
T ss_pred HccHHHHHHHHHhc---C-CCCcCcHHHHHHHH---HhcCCCHHHHHHHHhhhcCCCCCeEcHHHHHHHHHHhhhccCcC
Confidence 45566665544444 3 46889999986543 2223467789999999999999999999987654332111 1
Q ss_pred hhHHHHHHHHHHHHHHcccCCCcccHHHHHHHh
Q 016471 314 ALERWDQIAITAFDYFEQEGNRVISVEELALEL 346 (389)
Q Consensus 314 ~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l 346 (389)
+ ++.+...|+.+|.|+||.|+.+|+..+|
T Consensus 78 ~----~~e~~~~~~~~D~d~dG~I~~~EF~~~m 106 (109)
T d5pala_ 78 N----DTETKALLAAGDSDHDGKIGADEFAKMV 106 (109)
T ss_dssp C----HHHHHHHHHHHCTTCSSSEEHHHHHHHH
T ss_pred C----HHHHHHHHHHhCCCCCCCEeHHHHHHHH
Confidence 1 3458888999999999999999998875
|
| >d1iq3a_ a.39.1.6 (A:) Pob1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Pob1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.96 E-value=4.9e-10 Score=84.00 Aligned_cols=59 Identities=14% Similarity=0.144 Sum_probs=52.4
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHh---CCchH-HHHHHHHHccCCCCceeHHHHHHHHc
Q 016471 319 DQIAITAFDYFEQEGNRVISVEELALEL---NLAPA-AYSLLNDCIRNSDGKLSFLGYKRFLH 377 (389)
Q Consensus 319 ~~~l~~aF~~~D~d~~G~I~~~el~~~l---~~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~ 377 (389)
.+.++.+|+.+|+|++|+|+.+|++.+| |++.+ +.+|++.+|.|++|+|+++||+.+|+
T Consensus 21 ~~~y~~lF~~~D~d~~G~Is~~e~~~~l~~s~L~~~~L~~Iw~l~D~d~dG~l~~~EF~~am~ 83 (110)
T d1iq3a_ 21 REYYVNQFRSLQPDPSSFISGSVAKNFFTKSKLSIPELSYIWELSDADCDGALTLPEFCAAFH 83 (110)
T ss_dssp HHHHHHHHHHHCCSSSSEEEHHHHHHHCCSSSCSSCCHHHHHHHHCSSSCSEEEHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCcccchhHHHHHHHHHhhccchHHHHHHHHHhccCCCCeECHHHHHHHHH
Confidence 3468899999999999999999999999 45544 99999999999999999999996664
|
| >d1rwya_ a.39.1.4 (A:) Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Rat (Rattus rattus) [TaxId: 10117]
Probab=98.96 E-value=1.3e-09 Score=81.80 Aligned_cols=104 Identities=12% Similarity=0.106 Sum_probs=74.7
Q ss_pred HHhcCHHHHHHHHHHhhhcCCCCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHh
Q 016471 235 SKALTEEELVYLRAQFMLLEPKDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEA 314 (389)
Q Consensus 235 ~~~l~~ee~~~l~~~F~~~D~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~ 314 (389)
...++.+++......|. .+|.|+..||...+. ....+..++.++|+.+|.+++|.|+.+||..++........
T Consensus 3 ~~~~~~~~i~~~~~~~~----~~~~i~f~eF~~~~~---~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~l~~~~~ 75 (109)
T d1rwya_ 3 TDLLSAEDIKKAIGAFT----AADSFDHKKFFQMVG---LKKKSADDVKKVFHILDKDKSGFIEEDELGSILKGFSSDAR 75 (109)
T ss_dssp HHHSCHHHHHHHHHTTC----STTCCCHHHHHHHHT---GGGSCHHHHHHHHHHHSTTCSSEECHHHHHTHHHHHCTTCC
T ss_pred hhhcCHHHHHHHHHhcc----cCCCcCHHHHHHHHc---cccCCHHHHHHHhhcccCCCCCcCcHHHHHHHHHHhccccc
Confidence 34566667766655542 467899999976543 22346778999999999999999999999876543221100
Q ss_pred hHHHHHHHHHHHHHHcccCCCcccHHHHHHHh
Q 016471 315 LERWDQIAITAFDYFEQEGNRVISVEELALEL 346 (389)
Q Consensus 315 ~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l 346 (389)
. ..+..+...|+.+|.|+||.|+.+|+.++|
T Consensus 76 ~-~~~~e~~~~~~~~D~d~dG~i~~~EF~~~m 106 (109)
T d1rwya_ 76 D-LSAKETKTLMAAGDKDGDGKIGVEEFSTLV 106 (109)
T ss_dssp C-CCHHHHHHHHHHHCTTCSSSEEHHHHHHHH
T ss_pred c-CCHHHHHHHHHHhCCCCCCeEeHHHHHHHH
Confidence 0 003457889999999999999999999876
|
| >d1qx2a_ a.39.1.1 (A:) Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calbindin D9K domain: Calbindin D9K species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.95 E-value=5.5e-10 Score=77.98 Aligned_cols=63 Identities=14% Similarity=0.262 Sum_probs=50.7
Q ss_pred HHHHHhhhcCC---CCCcccHHHHHHHHHHhcccc-CCHHHHHHHHhhcCCCCCcceeHHHHHHHHh
Q 016471 245 YLRAQFMLLEP---KDGCVSLNNFKVALMRQATDA-MTDSRVFEILNVMEPLSDQKLAYEEFCAAAT 307 (389)
Q Consensus 245 ~l~~~F~~~D~---~~G~i~~~el~~~l~~~~~~~-~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~ 307 (389)
.++.+|..+|. ++|+|+.+||+.+|..+|... .+..++.+++..+|.|++|.|+|+||+..+.
T Consensus 6 el~~~F~~fd~~~~~~G~I~~~El~~~l~~lg~~~~~~~~ei~~~~~~~D~d~dG~I~f~EF~~~m~ 72 (76)
T d1qx2a_ 6 EIKGAFEVFAAKEGDPNQISKEELKLVMQTLGPSLLKGMSTLDEMIEEVDKNGDGEVSFEEFLVMMK 72 (76)
T ss_dssp HHHHHHHHHHTSSSCTTSEEHHHHHHHHHHHGGGSCTTSCSHHHHHHHHCTTCSSEECHHHHHHHHH
T ss_pred HHHHHHHHHcccCCCCCEECHHHHHHHHHHhCCcCCCCHHHHHHHHHHhhcCCCCcCcHHHHHHHHH
Confidence 35566776643 469999999999999988642 2345799999999999999999999998644
|
| >d1rroa_ a.39.1.4 (A:) Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Oncomodulin species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.95 E-value=8.7e-10 Score=82.50 Aligned_cols=102 Identities=13% Similarity=0.111 Sum_probs=70.2
Q ss_pred hcCHHHHHHHHHHhhhcCCCCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhH
Q 016471 237 ALTEEELVYLRAQFMLLEPKDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALE 316 (389)
Q Consensus 237 ~l~~ee~~~l~~~F~~~D~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~ 316 (389)
.++.+++....... ..+|.++..+|... .+....+..++.++|+.+|.+++|.|+++||..++.........-
T Consensus 5 ~ls~~dI~~~l~~~----~~~~s~~~~~F~~~---~~~~~~~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~l~~~~~~l 77 (108)
T d1rroa_ 5 ILSAEDIAAALQEC----QDPDTFEPQKFFQT---SGLSKMSASQVKDIFRFIDNDQSGYLDGDELKYFLQKFQSDAREL 77 (108)
T ss_dssp TSCHHHHHHHHHHT----CSTTCCCHHHHHHH---HSGGGSCHHHHHHHHHHHCTTCSSEECTHHHHTGGGGTCTTSCCC
T ss_pred hCCHHHHHHHHHhc----ccCCCccHHHHHHH---HccCcCCHHHHHHHHhhhcCCCCCeEcHHHHHHHHHHHHhccCCC
Confidence 45556665543332 25677888888543 333345778889999999999999999999987654432111000
Q ss_pred HHHHHHHHHHHHHcccCCCcccHHHHHHHh
Q 016471 317 RWDQIAITAFDYFEQEGNRVISVEELALEL 346 (389)
Q Consensus 317 ~~~~~l~~aF~~~D~d~~G~I~~~el~~~l 346 (389)
.++.++..|+.+|.|+||.|+.+|+..+|
T Consensus 78 -~~~~~~~~~~~~D~d~dG~I~~~EF~~~m 106 (108)
T d1rroa_ 78 -TESETKSLMDAADNDGDGKIGADEFQEMV 106 (108)
T ss_dssp -CHHHHHHHHHHHCCSSSSSEEHHHHHHHH
T ss_pred -CHHHHHHHHHHhCCCCCCeEeHHHHHHHH
Confidence 03458889999999999999999998876
|
| >d1c07a_ a.39.1.6 (A:) Eps15 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.95 E-value=4.4e-10 Score=82.09 Aligned_cols=66 Identities=17% Similarity=0.237 Sum_probs=59.9
Q ss_pred cCHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHH
Q 016471 238 LTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAA 306 (389)
Q Consensus 238 l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~ 306 (389)
++.++...+.++|..+|. ++|.|+.+|+..+|++.+ ++.+++.++++.+|.|++|.|+|+||+.++
T Consensus 4 lt~~e~~~~~~~F~~~D~d~~G~is~~e~~~~l~~~~---l~~~~l~~i~~~~D~d~dG~l~~~EF~~am 70 (95)
T d1c07a_ 4 VSPAEKAKYDEIFLKTDKDMDGFVSGLEVREIFLKTG---LPSTLLAHIWSLCDTKDCGKLSKDQFALAF 70 (95)
T ss_dssp SCSHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHTTT---CCHHHHHHHHHHHCTTCSSSEETTTHHHHH
T ss_pred CCHHHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHhcC---CCHHHHHHHHHHhCCCCCCeEcHHHHHHHH
Confidence 567788889999999999 999999999999998765 577889999999999999999999999864
|
| >d2zfda1 a.39.1.5 (A:32-214) Calcineurin B-like protein 2 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcineurin B-like protein 2 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=98.94 E-value=2e-09 Score=88.88 Aligned_cols=106 Identities=14% Similarity=0.136 Sum_probs=80.5
Q ss_pred HHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHH----HhhHHHHH
Q 016471 246 LRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQL----EALERWDQ 320 (389)
Q Consensus 246 l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~----~~~~~~~~ 320 (389)
...+|..+|. ++|.|+..||..++.........+..+..+|+.+|.|++|.|+.+||...+...... ...+..++
T Consensus 56 ~~~lf~~~d~~~dg~I~f~EFl~~l~~~~~~~~~~~~~~~~F~~~D~d~~G~Is~~e~~~~~~~~~~~~~~~~~~~~~~~ 135 (183)
T d2zfda1 56 ADRVFDLFDTKHNGILGFEEFARALSVFHPNAPIDDKIHFSFQLYDLKQQGFIERQEVKQMVVATLAESGMNLKDTVIED 135 (183)
T ss_dssp HHHHHHHHCSSCSSSBCHHHHHHHHHHTSTTSCHHHHHHHHHHHHCTTSSSSEEHHHHHHHHHHHHHHTTCCCCHHHHHH
T ss_pred HHHHHHHHccCCCCcCcHHHHHHHHHhhhccCcHHHHHHHhhcccccCCCCCccHHHHHHHHHHHHhhhhcccchHHHHH
Confidence 3567888999 999999999988876553322345668899999999999999999998754432111 11122345
Q ss_pred HHHHHHHHHcccCCCcccHHHHHHHhCCchH
Q 016471 321 IAITAFDYFEQEGNRVISVEELALELNLAPA 351 (389)
Q Consensus 321 ~l~~aF~~~D~d~~G~I~~~el~~~l~~~~~ 351 (389)
.+..+|+.+|.|+||.|+.+|+.+++...|.
T Consensus 136 ~~~~if~~~D~d~dG~Is~~EF~~~~~~~p~ 166 (183)
T d2zfda1 136 IIDKTFEEADTKHDGKIDKEEWRSLVLRHPS 166 (183)
T ss_dssp HHHHHHHHHCSSCSSEECHHHHHHHHHHSGG
T ss_pred HHHHHHHHhCCCCCCeEcHHHHHHHHHHCHH
Confidence 6788999999999999999999999854444
|
| >d1e8aa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]
Probab=98.92 E-value=1.2e-09 Score=77.58 Aligned_cols=61 Identities=16% Similarity=0.206 Sum_probs=50.3
Q ss_pred HHHHHHHHHH-cccCCC-cccHHHHHHHhC----------CchH-HHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 320 QIAITAFDYF-EQEGNR-VISVEELALELN----------LAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 320 ~~l~~aF~~~-D~d~~G-~I~~~el~~~l~----------~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
..+..+|..| +++|++ +|+++||+++|. .++. ++++++++|.|+||.|+|+||+.+|.++.
T Consensus 8 ~~li~vF~kya~~~g~~~~Lsk~Elk~ll~~e~~~~~~~~~~~~~v~~~~~~lD~n~Dg~idF~EF~~li~~l~ 81 (87)
T d1e8aa_ 8 EGIVNIFHQYSVRKGHFDTLSKGELKQLLTKELANTIKNIKDKAVIDEIFQGLDANQDEQVDFQEFISLVAIAL 81 (87)
T ss_dssp HHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHSTTTSTTTTSHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcccCCCCCeEcHHHHHHHHHHHccccccCCCCHHHHHHHHHHHcCCCCCcCCHHHHHHHHHHHH
Confidence 4588899988 556655 699999999981 1223 99999999999999999999999997654
|
| >d2mysc_ a.39.1.5 (C:) Myosin Regulatory Chain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Regulatory Chain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=98.91 E-value=2.3e-09 Score=84.92 Aligned_cols=99 Identities=13% Similarity=0.070 Sum_probs=77.7
Q ss_pred CHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHHHHHccc--CCCcccHHHHHHHhCC-------
Q 016471 278 TDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQE--GNRVISVEELALELNL------- 348 (389)
Q Consensus 278 ~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D~d--~~G~I~~~el~~~l~~------- 348 (389)
+.+++.++|..+|.+++|.|+++||..++.......+ ...+...+..+|.+ ++|.|+.+|+..++..
T Consensus 2 ~~eelke~F~~~D~d~~G~I~~~el~~~l~~lg~~~~----~~e~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~ 77 (145)
T d2mysc_ 2 AADDFKEAFLLFDRTGDAKITASQVGDIARALGQNPT----NAEINKILGNPSKEEMNAAAITFEEFLPMLQAAANNKDQ 77 (145)
T ss_pred CHHHHHHHHHHHcCCCCCeECHHHHHHHHHHhhhcch----hhhhHHHHHHHhhcccccCccchhHHHHHHhhhhhcccc
Confidence 3467899999999999999999999886654322222 34567777777655 6889999999988721
Q ss_pred -chH-HHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 349 -APA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 349 -~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
... +.++|+.+|.+++|.|+.+||..+|+...
T Consensus 78 ~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~g 111 (145)
T d2mysc_ 78 GTFEDFVEGLRVFDKEGNGTVMGAELRHVLATLG 111 (145)
T ss_pred chHHHHHHHHHHhhcCCCCEEcHHHHHHHHHHhC
Confidence 111 88899999999999999999999998754
|
| >d1bjfa_ a.39.1.5 (A:) Neurocalcin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Neurocalcin species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.91 E-value=3e-09 Score=87.57 Aligned_cols=117 Identities=14% Similarity=0.148 Sum_probs=90.9
Q ss_pred CcccHHHHHHHHHHhccccCCHHHHHHHHhhcC-CCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHHHHHcccCCCc
Q 016471 258 GCVSLNNFKVALMRQATDAMTDSRVFEILNVME-PLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRV 336 (389)
Q Consensus 258 G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d-~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~ 336 (389)
..++.+++.+..+.. .+++.++.+++..+. .+++|.|+++||...+......... ...+.+.|..+|++++|.
T Consensus 2 s~l~~~~~~~L~~~t---~fs~~ei~~l~~~F~~~~~~g~i~~~ef~~~l~~~~~~~~~---~~~~~~lf~~~d~~~~g~ 75 (181)
T d1bjfa_ 2 SKLRPEVMQDLLEST---DFTEHEIQEWYKGFLRDCPSGHLSMEEFKKIYGNFFPYGDA---SKFAEHVFRTFDANGDGT 75 (181)
T ss_dssp CCCCHHHHHHHHHHS---SCCHHHHHHHHHHHHHHSTTSEEEHHHHHHHHTTTSSSSCC---HHHHHHHHHHHCSSCSSE
T ss_pred CCCCHHHHHHHHHhc---CCCHHHHHHHHHHHHhhCCCCCcCHHHHHHHHHHhCCCCCH---HHHHHHHHHhcCCCCCCc
Confidence 367888888755544 368889999998854 4689999999999876654322221 234678999999999999
Q ss_pred ccHHHHHHHhC----Cc-hH-HHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 337 ISVEELALELN----LA-PA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 337 I~~~el~~~l~----~~-~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
|+.+|+...+. .. .. +..+++.+|.|++|.|+.+||..++....
T Consensus 76 i~~~eFl~~~~~~~~~~~~~~~~~~f~~~D~d~dg~i~~~E~~~~~~~~~ 125 (181)
T d1bjfa_ 76 IDFREFIIALSVTSRGKLEQKLKWAFSMYDLDGNGYISKAEMLEIVQAIY 125 (181)
T ss_dssp EEHHHHHHHHHHHTSSCHHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHH
T ss_pred EeHHHHHHHHHHHhhhchHHHHHHHHHHhccCCCCeecHHHHHHHHHHHh
Confidence 99999998872 22 22 88899999999999999999999997643
|
| >d1psra_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]
Probab=98.90 E-value=5.1e-10 Score=82.44 Aligned_cols=59 Identities=15% Similarity=0.222 Sum_probs=47.4
Q ss_pred HHHHHHHHHcccCCCcccHHHHHHHhCC------------chH-HHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 321 IAITAFDYFEQEGNRVISVEELALELNL------------APA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 321 ~l~~aF~~~D~d~~G~I~~~el~~~l~~------------~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
.+...|..|| +++|.|+++||+++|.. ++. +.++++.+|.|+||+|+|+||+.+|.+..
T Consensus 11 ~l~~~F~~y~-~~dG~i~~~El~~ll~~~~~~~~~~~~~~~~~~v~~~~~~~D~n~DG~I~F~EF~~li~~l~ 82 (100)
T d1psra_ 11 GMIDMFHKYT-RRDDKIDKPSLLTMMKENFPNFLSACDKKGTNYLADVFEKKDKNEDKKIDFSEFLSLLGDIA 82 (100)
T ss_dssp HHHHHHHHTC-CTTSCBCHHHHHHHHHHHCHHHHHHHHHTTCCGGGTHHHHHCTTCSSCBCHHHHHHHHHHHH
T ss_pred HHHHHHHHHc-CCCCcccHHHHHHHHHHHccccccccccCCHHHHHHHHHHhcCCCCCcCcHHHHHHHHHHHH
Confidence 3455555554 78999999999999921 111 89999999999999999999999997653
|
| >d2obha1 a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.90 E-value=1.4e-09 Score=85.59 Aligned_cols=99 Identities=11% Similarity=0.134 Sum_probs=81.2
Q ss_pred HHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHhCCch------H-
Q 016471 279 DSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALELNLAP------A- 351 (389)
Q Consensus 279 ~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~~------~- 351 (389)
.+++.++|..+|.+++|.|+++||..++........ +..+...|..+|.+++|.|+.+|+...+.... .
T Consensus 5 ~~elk~~F~~~D~~~~G~Is~~e~~~~l~~~~~~~~----~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~~~~~~ 80 (141)
T d2obha1 5 KQEIREAFDLFDADGTGTIDVKELKVAMRALGFEPK----KEEIKKMISEIDKEGTGKMNFGDFLTVMTQKMSEKDTKEE 80 (141)
T ss_dssp HHHHHHHHHTTCTTCCSEEEGGGHHHHHHHTTCCCC----HHHHHHHHHHHTTTCCSEEEHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHcCCCCCeEeHHHHHHHHHhcCCchh----HHHHHHHHHhhccCCCCeechHHHHHHHHHHHhhhccHHH
Confidence 357889999999999999999999886554332222 34578899999999999999999999883211 1
Q ss_pred HHHHHHHHccCCCCceeHHHHHHHHccccC
Q 016471 352 AYSLLNDCIRNSDGKLSFLGYKRFLHGVTV 381 (389)
Q Consensus 352 ~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~ 381 (389)
+..++..+|.+++|.|+.++|..+++....
T Consensus 81 l~~~f~~~d~~~~G~i~~~el~~~l~~~g~ 110 (141)
T d2obha1 81 ILKAFKLFDDDETGKISFKNLKRVAKELGE 110 (141)
T ss_dssp HHHHHHHHCTTCSSSBCHHHHHHHHHHTTC
T ss_pred HHHHHHHhcccCCCCccHHHHHHHHHHhCC
Confidence 888999999999999999999999987653
|
| >d1qjta_ a.39.1.6 (A:) Eps15 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=98.90 E-value=8.3e-10 Score=81.13 Aligned_cols=57 Identities=14% Similarity=0.038 Sum_probs=51.9
Q ss_pred HHHHHHHHHcccCCCcccHHHHHHHh---CCchH-HHHHHHHHccCCCCceeHHHHHHHHc
Q 016471 321 IAITAFDYFEQEGNRVISVEELALEL---NLAPA-AYSLLNDCIRNSDGKLSFLGYKRFLH 377 (389)
Q Consensus 321 ~l~~aF~~~D~d~~G~I~~~el~~~l---~~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~ 377 (389)
.++.+|+.+|+|++|+|+.+|++.+| |++.+ +.++++.+|.|++|.|+++||+..|+
T Consensus 12 ~y~~~F~~~D~d~~G~i~~~e~~~~l~~s~L~~~~L~~i~~~~D~d~dG~L~~~EF~~am~ 72 (99)
T d1qjta_ 12 VYEKYYRQVEAGNTGRVLALDAAAFLKKSGLPDLILGKIWDLADTDGKGVLSKQEFFVALR 72 (99)
T ss_dssp HHHHHHHHHCCTTSSCCCSHHHHHHHHTSSSCHHHHHHHHHHHCCSSSSSCCSHHHHHHHH
T ss_pred HHHHHHHHHCCCCCCcccHHHHHHHHHHcCCcHHHHHHHHHHHcCCCCCccCHHHHHHHHH
Confidence 46789999999999999999999999 66665 99999999999999999999997775
|
| >d2pvba_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Probab=98.89 E-value=1.2e-09 Score=81.48 Aligned_cols=83 Identities=12% Similarity=0.087 Sum_probs=45.2
Q ss_pred CCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHH---HhhHHHHHHHHHHHHHHcccC
Q 016471 257 DGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQL---EALERWDQIAITAFDYFEQEG 333 (389)
Q Consensus 257 ~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~---~~~~~~~~~l~~aF~~~D~d~ 333 (389)
+|.|+..||..++. + ...+.+++.++|+.+|.+++|.|+.+||...+...... .+ ++.++..|+.+|.|+
T Consensus 20 ~gsi~~~eF~~~~~-l--~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~l~~~~~~~~----~~~~~~l~~~~D~d~ 92 (107)
T d2pvba_ 20 ADSFKHKEFFAKVG-L--ASKSLDDVKKAFYVIDQDKSGFIEEDELKLFLQNFSPSARALT----DAETKAFLADGDKDG 92 (107)
T ss_dssp TTCCCHHHHHHHHT-G--GGSCHHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTSCCCC----HHHHHHHHHHHCTTC
T ss_pred CCCcCHHHHHHHHh-c--ccCCHHHHHHHHHhhccCCCCcCcHHHHHHHHHHhhcccccCC----HHHHHHHHHHhCCCC
Confidence 44566666654332 1 12345556666666666666666666666544332111 11 234566666666666
Q ss_pred CCcccHHHHHHHh
Q 016471 334 NRVISVEELALEL 346 (389)
Q Consensus 334 ~G~I~~~el~~~l 346 (389)
||.|+.+|+..+|
T Consensus 93 dG~I~~~EF~~~m 105 (107)
T d2pvba_ 93 DGMIGVDEFAAMI 105 (107)
T ss_dssp SSSBCHHHHHHHH
T ss_pred CCcEeHHHHHHHH
Confidence 6666666666554
|
| >d2hf5a1 a.39.1.5 (A:81-113) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]
Probab=98.88 E-value=7.5e-10 Score=62.21 Aligned_cols=29 Identities=31% Similarity=0.477 Sum_probs=26.7
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHhC
Q 016471 319 DQIAITAFDYFEQEGNRVISVEELALELN 347 (389)
Q Consensus 319 ~~~l~~aF~~~D~d~~G~I~~~el~~~l~ 347 (389)
++++++||+.||+|+||+|++.||+.+|.
T Consensus 2 eeel~eAF~~FDkDg~G~Is~~EL~~vm~ 30 (33)
T d2hf5a1 2 EEEIREAFRVFDKDGNGYISAAELRHVMT 30 (33)
T ss_dssp HHHHHHHHHHHSSSCCSCBCHHHHHHHTT
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHHHHH
Confidence 35699999999999999999999999984
|
| >d1a4pa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]
Probab=98.86 E-value=1.1e-09 Score=79.15 Aligned_cols=69 Identities=12% Similarity=0.260 Sum_probs=56.8
Q ss_pred HHHHHHHHHhhhcCCCCCcccHHHHHHHHHHhcc----ccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhch
Q 016471 241 EELVYLRAQFMLLEPKDGCVSLNNFKVALMRQAT----DAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSV 309 (389)
Q Consensus 241 ee~~~l~~~F~~~D~~~G~i~~~el~~~l~~~~~----~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~ 309 (389)
..+..+...|..+|..+|.||.+||+++|..... ...+...++++++.+|.|+||+|+|+||+..+...
T Consensus 6 ~~ie~l~~~F~~yd~ddG~is~~El~~~l~~~~~~~~~~~~~~~~v~~~~~~~D~n~DG~I~F~EF~~li~~l 78 (92)
T d1a4pa_ 6 HAMETMMFTFHKFAGDKGYLTKEDLRVLMEKEFPGFLENQKDPLAVDKIMKDLDQCRDGKVGFQSFFSLIAGL 78 (92)
T ss_dssp HHHHHHHHHHHHHHGGGCSBCHHHHHHHHHHHCHHHHHHSCCTTHHHHHHHHHCTTSSSCBCHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHcCCCCEEcHHHHHHHHHHhccccccccCCHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHH
Confidence 3467788999999887799999999999976421 12467789999999999999999999999865543
|
| >d1auib_ a.39.1.5 (B:) Calcineurin regulatory subunit (B-chain) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcineurin regulatory subunit (B-chain) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.85 E-value=4.1e-09 Score=85.37 Aligned_cols=99 Identities=12% Similarity=0.136 Sum_probs=77.4
Q ss_pred HHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHH-HhhHHHHHHHHHH
Q 016471 248 AQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQL-EALERWDQIAITA 325 (389)
Q Consensus 248 ~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~-~~~~~~~~~l~~a 325 (389)
..|..+|. ++|.|+.+||..++............+..+|+.+|.+++|.|+.+|+...+...... ...+..+..+..+
T Consensus 52 ~l~~~~d~~~~g~i~~~EFl~~~~~~~~~~~~~~~~~~~f~~~d~d~~g~Is~~el~~~l~~~~~~~~~~~~~~~~~~~~ 131 (165)
T d1auib_ 52 RVIDIFDTDGNGEVDFKEFIEGVSQFSVKGDKEQKLRFAFRIYDMDKDGYISNGELFQVLKMMVGNNLKDTQLQQIVDKT 131 (165)
T ss_dssp HHHHHHCTTCSSSEEHHHHHHHHGGGCTTCCHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHTTSSCHHHHHHHHHHH
T ss_pred HHHHHHccccchhhhhhhhhhhccccccchhhHHHHHHHHHHhcccccccccHHHHHHHHHHhccccCchHHHHHHHHHH
Confidence 46777899 999999999998887665433446678999999999999999999998765332111 0111224568899
Q ss_pred HHHHcccCCCcccHHHHHHHh
Q 016471 326 FDYFEQEGNRVISVEELALEL 346 (389)
Q Consensus 326 F~~~D~d~~G~I~~~el~~~l 346 (389)
|..+|.|+||.|+.+|+.++|
T Consensus 132 ~~~~D~~~dG~Is~~EF~~i~ 152 (165)
T d1auib_ 132 IINADKDGDGRISFEEFCAVV 152 (165)
T ss_dssp HHHHCTTSSSSEEHHHHHHHH
T ss_pred HHHcCCCCCCcEeHHHHHHHH
Confidence 999999999999999999988
|
| >d2jxca1 a.39.1.6 (A:121-215) Eps15 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.84 E-value=3.1e-09 Score=77.37 Aligned_cols=66 Identities=21% Similarity=0.251 Sum_probs=59.6
Q ss_pred cCHHHHHHHHHHhhhcCCCCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHH
Q 016471 238 LTEEELVYLRAQFMLLEPKDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAA 306 (389)
Q Consensus 238 l~~ee~~~l~~~F~~~D~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~ 306 (389)
++.++...+.+.|..+|.++|.|+.+|++.+|.+.| ++.+++.+|+...|.+++|.|+++||+.++
T Consensus 4 ls~ee~~~y~~~F~~~D~~~G~i~~~el~~~l~~~g---l~~~~L~~Iw~~~D~~~dG~l~~~EF~~a~ 69 (95)
T d2jxca1 4 VKPEDKAKYDAIFDSLSPVNGFLSGDKVKPVLLNSK---LPVDILGRVWELSDIDHDGMLDRDEFAVAM 69 (95)
T ss_dssp SCHHHHHHHHHHHHHTCCBTTEEEHHHHHHHHTTSS---CCHHHHHHHHHHHCTTCSSEEEHHHHHHHH
T ss_pred CCHHHHHHHHHHHHHhCCCCCceeHHHHHHHHHHcC---CCHHHHHHHHHHhcCCCCCeEcHHHHHHHH
Confidence 678889999999999999889999999999998765 467889999999999999999999998743
|
| >d1yuta1 a.39.1.2 (A:1-98) Calcyclin (S100) {Human (Homo sapiens), s100a13 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a13 [TaxId: 9606]
Probab=98.79 E-value=5.6e-09 Score=76.26 Aligned_cols=69 Identities=16% Similarity=0.259 Sum_probs=55.4
Q ss_pred HHHHHHHHHhhhc-CC-C-CCcccHHHHHHHHHHhccc-cCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhch
Q 016471 241 EELVYLRAQFMLL-EP-K-DGCVSLNNFKVALMRQATD-AMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSV 309 (389)
Q Consensus 241 ee~~~l~~~F~~~-D~-~-~G~i~~~el~~~l~~~~~~-~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~ 309 (389)
..+..+..+|..+ |. + +|.||..||+.++...+.. ..+..++++++..+|.|+||.|||+||+..+...
T Consensus 11 ~~i~~l~~vF~~y~d~dg~~g~is~~El~~~l~~~~~~~~~~~~~v~~l~~~~D~d~DG~IdF~EF~~l~~~l 83 (98)
T d1yuta1 11 ESIETVVTTFFTFARQEGRKDSLSVNEFKELVTQQLPHLLKDVGSLDEKMKSLDVNQDSELKFNEYWRLIGEL 83 (98)
T ss_dssp HHHHHHHHHHHHHHTTSSSSSCBCHHHHHHHHHHHCTTTTCCSSCHHHHHHHHCTTCCSCBCHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHcccCCCCCEEcHHHHHHHHHHhccccCCCHHHHHHHHHHhcCCCCCcCCHHHHHHHHHHH
Confidence 3466788888887 55 4 5999999999999876532 2456679999999999999999999999866543
|
| >d1lkja_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=98.78 E-value=1.6e-08 Score=79.95 Aligned_cols=96 Identities=14% Similarity=0.159 Sum_probs=77.0
Q ss_pred HHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHh-----CCchH--HHH
Q 016471 282 VFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALEL-----NLAPA--AYS 354 (389)
Q Consensus 282 ~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l-----~~~~~--~~~ 354 (389)
+.++|..+|.+++|.|+++||..++........ +..+...+..++.+++|.++.+++...+ ..... +.+
T Consensus 12 l~~~F~~~D~d~~G~i~~~e~~~~l~~~g~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 87 (146)
T d1lkja_ 12 FKEAFALFDKDNNGSISSSELATVMRSLGLSPS----EAEVNDLMNEIDVDGNHQIEFSEFLALMSRQLKSNDSEQELLE 87 (146)
T ss_dssp HHHHHHHHCCSSSSEEEHHHHHHHHHHHTCCCC----HHHHHHHHHHHCSSSCCEEEHHHHHHHHHHHTCCCCHHHHHHH
T ss_pred HHHHHHHHCCCCCCcEeHHHHHHHHHhcCCCCC----HHHHHHHHHHhccCCcccccHHHHHHHHHHhhccccHHHHHHH
Confidence 456799999999999999999886554322222 3457888999999999999999998877 11222 888
Q ss_pred HHHHHccCCCCceeHHHHHHHHccccC
Q 016471 355 LLNDCIRNSDGKLSFLGYKRFLHGVTV 381 (389)
Q Consensus 355 ~~~~~d~~~~g~i~~~ef~~~~~~~~~ 381 (389)
+++.+|.+++|.|+.+||..++.....
T Consensus 88 aF~~~D~d~~G~I~~~el~~~l~~~g~ 114 (146)
T d1lkja_ 88 AFKVFDKNGDGLISAAELKHVLTSIGE 114 (146)
T ss_dssp HHHHHCSSSSCEEEHHHHHHHHHHHTC
T ss_pred HHHHhCCCCCCcCcHHHHHHHHHHcCC
Confidence 999999999999999999999876653
|
| >d1zfsa1 a.39.1.2 (A:1-93) Calcyclin (S100) {Rat (Rattus norvegicus), s100a1 [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Rat (Rattus norvegicus), s100a1 [TaxId: 10116]
Probab=98.78 E-value=5.7e-09 Score=75.67 Aligned_cols=68 Identities=15% Similarity=0.157 Sum_probs=55.6
Q ss_pred HHHHHHHHhhhc-CC-C-CCcccHHHHHHHHHHhcc----ccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhch
Q 016471 242 ELVYLRAQFMLL-EP-K-DGCVSLNNFKVALMRQAT----DAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSV 309 (389)
Q Consensus 242 e~~~l~~~F~~~-D~-~-~G~i~~~el~~~l~~~~~----~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~ 309 (389)
.+..+..+|..+ |. + +|.|+.+||+++|...+. ...++.++.++|+.+|.|+||.|+|+||+..+...
T Consensus 7 ~i~~l~~~F~~y~d~dg~~G~is~~El~~~L~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~Idf~EF~~lm~~l 81 (93)
T d1zfsa1 7 AMETLINVFHAHSGKEGDKYKLSKKELKDLLQTELSSFLDVQKDADAVDKIMKELDENGDGEVDFQEFVVLVAAL 81 (93)
T ss_dssp HHHHHHHHHHHHGGGSSCCSSEEHHHHHHHHHHHSTTTSCCSSCHHHHHHHHHHHTTTCCSEECSHHHHHHHHHH
T ss_pred HHHHHHHHHHHHcccCCCCCEecHHHHHHHHHHhcccccccCCCHHHHHHHHHHHcCCCCCCCcHHHHHHHHHHH
Confidence 356778888877 55 4 489999999999988752 23578899999999999999999999999866543
|
| >d1topa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=98.77 E-value=7e-09 Score=83.61 Aligned_cols=96 Identities=10% Similarity=0.131 Sum_probs=76.6
Q ss_pred HHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHhC-C--------chH
Q 016471 281 RVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALELN-L--------APA 351 (389)
Q Consensus 281 ~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~-~--------~~~ 351 (389)
++.++|..+|.+++|.|+++||...+........ +..+...|..+|.+++|.++..|+...+- . ...
T Consensus 21 el~~~F~~~D~d~~G~Is~~el~~~l~~~~~~~~----~~~~~~~~~~~d~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~ 96 (162)
T d1topa_ 21 EFKAAFDMFDADGGGDISTKELGTVMRMLGQNPT----KEELDAIIEEVDEDGSGTIDFEEFLVMMVRQMKEDAKGKSEE 96 (162)
T ss_dssp HHHHHHHTTTCSCSSEEEGGGHHHHHHHTTCCCC----HHHHHHHHHHHCTTSCCEEEHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCCCeEcHHHHHHHHhccCCchh----HHHHHhhhheeccCCCCCeeeehhhhhhhhhhhhhcccCcHH
Confidence 4668899999999999999999875554333222 45688899999999999999999877551 1 111
Q ss_pred -HHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 352 -AYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 352 -~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
+.++++.+|.|++|.|+.+||..+|....
T Consensus 97 ~~~~aF~~~D~d~~G~Is~~e~~~~l~~~~ 126 (162)
T d1topa_ 97 ELANCFRIFDKNADGFIDIEELGEILRATG 126 (162)
T ss_dssp HHHHHHHHHCTTCSSCBCHHHHHHHHHTTT
T ss_pred HHHHHHHHHCCCCCCCCcHHHHHHHHHhhC
Confidence 67789999999999999999999998654
|
| >d3c1va1 a.39.1.2 (A:2-94) Calcyclin (S100) {Human (Homo sapiens), s100a4 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a4 [TaxId: 9606]
Probab=98.76 E-value=1.4e-08 Score=73.31 Aligned_cols=67 Identities=12% Similarity=0.245 Sum_probs=54.0
Q ss_pred HHHHHHHHhhhc-CC-C-CCcccHHHHHHHHHHhc----cccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhc
Q 016471 242 ELVYLRAQFMLL-EP-K-DGCVSLNNFKVALMRQA----TDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATS 308 (389)
Q Consensus 242 e~~~l~~~F~~~-D~-~-~G~i~~~el~~~l~~~~----~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~ 308 (389)
.+..+..+|..+ |. + +|.|+.+||+++|.... ....+++++.++|..+|.|+||.|+|+||+..+..
T Consensus 7 ~i~~l~~~F~~ya~~dg~~~~L~~~Elk~~l~~~~~~~~~~~~~~~~~~~i~~~~D~n~DG~I~F~EF~~lm~~ 80 (93)
T d3c1va1 7 ALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSNRDNEVDFQEYCVFLSC 80 (93)
T ss_dssp HHHHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHCHHHHTTCCSHHHHHHHHHHHCTTCSSSEEHHHHHHHHHH
T ss_pred HHHHHHHHHHHHccCCCCCCeeCHHHHHHHHHHhchhccccCCCHHHHHHHHHHHcCCCCCCCCHHHHHHHHHH
Confidence 456788888887 44 3 45799999999998752 23467889999999999999999999999986544
|
| >d1psra_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]
Probab=98.75 E-value=4.2e-09 Score=77.39 Aligned_cols=69 Identities=10% Similarity=0.198 Sum_probs=56.8
Q ss_pred HHHHHHHHHHhhhcCCCCCcccHHHHHHHHHHhccc------cCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhc
Q 016471 240 EEELVYLRAQFMLLEPKDGCVSLNNFKVALMRQATD------AMTDSRVFEILNVMEPLSDQKLAYEEFCAAATS 308 (389)
Q Consensus 240 ~ee~~~l~~~F~~~D~~~G~i~~~el~~~l~~~~~~------~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~ 308 (389)
+..+..+...|..++.++|.|+..||+++|+..+.. ..+..+++++|..+|.|+||.|+|+||+..+..
T Consensus 6 E~~i~~l~~~F~~y~~~dG~i~~~El~~ll~~~~~~~~~~~~~~~~~~v~~~~~~~D~n~DG~I~F~EF~~li~~ 80 (100)
T d1psra_ 6 ERSIIGMIDMFHKYTRRDDKIDKPSLLTMMKENFPNFLSACDKKGTNYLADVFEKKDKNEDKKIDFSEFLSLLGD 80 (100)
T ss_dssp HHHHHHHHHHHHHTCCTTSCBCHHHHHHHHHHHCHHHHHHHHHTTCCGGGTHHHHHCTTCSSCBCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHcCCCCcccHHHHHHHHHHHccccccccccCCHHHHHHHHHHhcCCCCCcCcHHHHHHHHHH
Confidence 445677888999998889999999999999876421 234567899999999999999999999986554
|
| >d1m45a_ a.39.1.5 (A:) Myosin Light Chain Mlc1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Light Chain Mlc1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=98.73 E-value=9.9e-09 Score=81.23 Aligned_cols=64 Identities=22% Similarity=0.332 Sum_probs=58.3
Q ss_pred HHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhc
Q 016471 244 VYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATS 308 (389)
Q Consensus 244 ~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~ 308 (389)
..+..+|..+|. ++|.|+.+||..+|..+|. .++++++.+++..+|.+++|.|+|+||+.+++.
T Consensus 81 ~~l~~~F~~~D~~~~G~I~~~el~~~l~~~g~-~l~~~ei~~l~~~~D~d~dG~I~y~eF~~~i~~ 145 (146)
T d1m45a_ 81 EDFVKAFQVFDKESTGKVSVGDLRYMLTGLGE-KLTDAEVDELLKGVEVDSNGEIDYKKFIEDVLR 145 (146)
T ss_dssp HHHHHHHHTTCSSSSSEEEHHHHHHHHHHSTT-CCCHHHHHHHHTTCCCCTTSEEEHHHHHHHHHC
T ss_pred HHHHHHHHhhccccccccchhhhhhhhcccCC-cchHHHHHHHHHHhCCCCCCcEEHHHHHHHHHc
Confidence 457788999999 9999999999999999987 489999999999999999999999999986653
|
| >d1s6ia_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Probab=98.72 E-value=9.6e-09 Score=84.57 Aligned_cols=96 Identities=8% Similarity=0.071 Sum_probs=79.6
Q ss_pred HHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHhCCc-----hH-HHH
Q 016471 281 RVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALELNLA-----PA-AYS 354 (389)
Q Consensus 281 ~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~-----~~-~~~ 354 (389)
++.++|..+|.+++|.|+++||..++........ ...+..+|..+|.+++|.|+.+++....... .. +..
T Consensus 11 ~l~~~F~~~D~d~dG~Is~~e~~~~l~~l~~~~~----~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~~~e~l~~ 86 (182)
T d1s6ia_ 11 GLKELFKMIDTDNSGTITFDELKDGLKRVGSELM----ESEIKDLMDAADIDKSGTIDYGEFIAATVHLNKLEREENLVS 86 (182)
T ss_dssp SHHHHHHTTSSSSSSCEEHHHHHHHHTTTTCCCC----HHHHHHHHHHTCTTCSSEECHHHHHHHHTTSSSSCCCCSTHH
T ss_pred HHHHHHHHHcCCCcCCCCHHHHHHHHHHcCCccc----cccchhhhhhhhccccccchHHHHHHHHHhhcccccHHHHHH
Confidence 4788999999999999999999987765433222 3468899999999999999999998876221 11 888
Q ss_pred HHHHHccCCCCceeHHHHHHHHcccc
Q 016471 355 LLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 355 ~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
++..+|.+++|.|+.+++.++++...
T Consensus 87 aF~~~D~d~~G~i~~~el~~~l~~~g 112 (182)
T d1s6ia_ 87 AFSYFDKDGSGYITLDEIQQACKDFG 112 (182)
T ss_dssp HHHHTTTTCSSEEEHHHHHHTTTTTT
T ss_pred HHHHHhhcCCCccchhhhhhhhhhcC
Confidence 99999999999999999999987654
|
| >d2mysb_ a.39.1.5 (B:) Myosin Essential Chain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=98.71 E-value=2.1e-08 Score=79.15 Aligned_cols=64 Identities=16% Similarity=0.304 Sum_probs=52.9
Q ss_pred HHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhc
Q 016471 244 VYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATS 308 (389)
Q Consensus 244 ~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~ 308 (389)
..+..+|+.+|. ++|.|+.+||+.+|+.+|. .++.+++.+++..+|.+++|.|+|.||+..++.
T Consensus 77 ~~l~~aF~~fD~~~~g~I~~~el~~~l~~~g~-~ls~~e~~~~~~~~d~d~dg~I~y~eF~~~l~~ 141 (145)
T d2mysb_ 77 DVIMGAFKVLDPDGKGSIKKSFLEELLTTGGG-RFTPEEIKNMWAAFPPDVAGNVDYKNICYVITH 141 (145)
T ss_pred HHHHHHHHhhhhcccchhhHHHHHHHHHHcCC-CCCHHHHHHHHHHhCCCCCCeEeHHHHHHHhcc
Confidence 456778888888 8888999998888888876 478888888888888888888999998886654
|
| >d1cb1a_ a.39.1.1 (A:) Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calbindin D9K domain: Calbindin D9K species: Pig (Sus scrofa) [TaxId: 9823]
Probab=98.71 E-value=6.1e-09 Score=72.75 Aligned_cols=66 Identities=12% Similarity=0.153 Sum_probs=52.9
Q ss_pred HHHHHHHhhhcCC---CCCcccHHHHHHHHHHhcc-ccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhc
Q 016471 243 LVYLRAQFMLLEP---KDGCVSLNNFKVALMRQAT-DAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATS 308 (389)
Q Consensus 243 ~~~l~~~F~~~D~---~~G~i~~~el~~~l~~~~~-~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~ 308 (389)
...+..+|..+|. ++|+|+.+||+.++..+.. ...+.+++++++..+|.|+||.|+|+||+..+..
T Consensus 6 ~~~l~~~F~~y~~~d~~~g~is~~Elk~ll~~~~~~~~~~~~~v~~~~~~~D~d~dG~Idf~EF~~l~~~ 75 (78)
T d1cb1a_ 6 PAELKSIFEKYAAKEGDPNQLSKEELKQLIQAEFPSLLKGPRTLDDLFQELDKNGDGEVSFEEFQVLVKK 75 (78)
T ss_dssp HHHHHHHHHHHHTTSSSTTEECHHHHHHHHHHHCSSCCSSCCCSSHHHHHTCCCSSSSEEHHHHHHHHHH
T ss_pred HHHHHHHHHHHccCCCCCCEECHHHHHHHHHHHcCCCCCCHHHHHHHHHHHcCCCCCcCcHHHHHHHHHH
Confidence 4567778888754 4589999999999988742 1345667999999999999999999999986543
|
| >d1xk4a1 a.39.1.2 (A:1-87) Calcyclin (S100) {Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]
Probab=98.69 E-value=9.4e-09 Score=73.19 Aligned_cols=69 Identities=10% Similarity=0.080 Sum_probs=54.6
Q ss_pred HHHHHHHHHhhhc-CC-CCCc-ccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhch
Q 016471 241 EELVYLRAQFMLL-EP-KDGC-VSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSV 309 (389)
Q Consensus 241 ee~~~l~~~F~~~-D~-~~G~-i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~ 309 (389)
..+..+..+|..+ |. ++|. ++.+||+.++........+..+++++++.+|.|+||+|+|+||+..+...
T Consensus 7 ~ai~~ii~~F~kya~~dG~~~~l~~~Elk~ll~~e~~~~~~~~~v~~i~~~~D~n~DG~IdF~EF~~l~~~l 78 (87)
T d1xk4a1 7 KALNSIIDVYHKYSLIKGNFHAVYRDDLKKLLETESPQYIRKKGADVWFKELDINTDGAVNFQEFLILVIKM 78 (87)
T ss_dssp HHHHHHHHHHHHHHTSSSCTTCBCHHHHHHHHHHHSCHHHHTTCHHHHHHHHCTTCSSSBCHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHcccCCCCCccCHHHHHHHHHHhcCCccchHHHHHHHHHhCCCCCCcCcHHHHHHHHHHH
Confidence 3456778888777 66 6664 69999999987653334567789999999999999999999999866543
|
| >d1ksoa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a3 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a3 [TaxId: 9606]
Probab=98.69 E-value=1.5e-08 Score=73.04 Aligned_cols=69 Identities=10% Similarity=0.215 Sum_probs=55.0
Q ss_pred HHHHHHHHHhhhc-CC-CCC-cccHHHHHHHHHHhccc----cCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhch
Q 016471 241 EELVYLRAQFMLL-EP-KDG-CVSLNNFKVALMRQATD----AMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSV 309 (389)
Q Consensus 241 ee~~~l~~~F~~~-D~-~~G-~i~~~el~~~l~~~~~~----~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~ 309 (389)
+.+..+..+|..+ |. ++| .|+.+||+..|+..... ..+..++.+++..+|.|+||.|||+||+..+...
T Consensus 6 ~~i~~i~~vF~kya~~dGd~~~ls~~Elk~ll~~~~~~~~~~~~~~~~~~~~~~~lD~n~Dg~IdF~EF~~l~~~l 81 (93)
T d1ksoa_ 6 QAVAAIVCTFQEYAGRCGDKYKLCQAELKELLQKELATWTPTEFRECDYNKFMSVLDTNKDCEVDFVEYVRSLACL 81 (93)
T ss_dssp HHHHHHHHHHHHHHTSSSCTTCEEHHHHHHHHHHHTTTCCCCTTCHHHHHHHHHHHHHTTTCEECHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHcCcCCCCCeECHHHHHHHHHHhhhcccccCCCHHHHHHHHHHHcCCCCCCCcHHHHHHHHHHH
Confidence 3456677888876 66 677 69999999999876422 2468889999999999999999999999865543
|
| >d2sasa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Sarcoplasmic calcium-binding protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Probab=98.68 E-value=9.2e-08 Score=78.40 Aligned_cols=102 Identities=10% Similarity=0.085 Sum_probs=75.6
Q ss_pred HHHHHHHHhh-cCCCCCcceeHHHHHHHHhchhHHHh-----------hHHHHHHHHHHHHHHcccCCCcccHHHHHHHh
Q 016471 279 DSRVFEILNV-MEPLSDQKLAYEEFCAAATSVYQLEA-----------LERWDQIAITAFDYFEQEGNRVISVEELALEL 346 (389)
Q Consensus 279 ~~~~~~~~~~-~d~~~~g~i~~~eF~~~~~~~~~~~~-----------~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l 346 (389)
+..+.++|.. +|.|++|.|+++||..++........ ...........+...|.+++|.|+.+++...+
T Consensus 7 ~~~i~~~F~~~~D~d~dG~Is~~Ef~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~i~~~~~~~~~ 86 (185)
T d2sasa_ 7 KQKIKFTFDFFLDMNHDGSIQDNDFEDMMTRYKEVNKGSLSDADYKSMQASLEDEWRDLKGRADINKDDVVSWEEYLAMW 86 (185)
T ss_dssp HHHHHHHHHHHTCTTCSSEECHHHHHHHHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHHHCTTCSSCEEHHHHHHHH
T ss_pred HHHHHHHHHHhhcCCCCCcCCHHHHHHHHHHhccccCCCcccHHHHHHHHHHHHHHHHHHHHhCcCCCCcEeeeHhhHHH
Confidence 4568899987 59999999999999876543321110 01112234556888899999999999998877
Q ss_pred C-------Cch-------H-HHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 347 N-------LAP-------A-AYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 347 ~-------~~~-------~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
. ... . +..+++.+|.|++|.|+.+||..+++...
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~Is~~E~~~~l~~~~ 135 (185)
T d2sasa_ 87 EKTIATCKSVADLPAWCQNRIPFLFKGMDVSGDGIVDLEEFQNYCKNFQ 135 (185)
T ss_dssp HHHHHTCCSGGGSCTTHHHHHHHHHHHHCTTSSSCCCHHHHHHHTTSSC
T ss_pred HHHhhhhhhhhhhhHHHHHHHHHHHHHHccCCCccCCHHHHHHHHHHcC
Confidence 1 111 1 77899999999999999999999998643
|
| >d1ggwa_ a.39.1.5 (A:) Cdc4p {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Cdc4p species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.65 E-value=1.8e-08 Score=79.10 Aligned_cols=62 Identities=13% Similarity=0.281 Sum_probs=54.2
Q ss_pred HHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHh
Q 016471 244 VYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAAT 307 (389)
Q Consensus 244 ~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~ 307 (389)
..+..+|+.+|. ++|.|+.+||+.+|..+|.+ ++.++++++++.+|.+ +|.|+|+||+..++
T Consensus 76 ~~l~~aF~~~D~d~~G~I~~~el~~~l~~~g~~-lt~~e~~~l~~~~d~~-dG~I~y~eF~~~m~ 138 (140)
T d1ggwa_ 76 EEFVKGFQVFDKDATGMIGVGELRYVLTSLGEK-LSNEEMDELLKGVPVK-DGMVNYHDFVQMIL 138 (140)
T ss_dssp HHHHHHHHTTCSSCSSCCCHHHHHHHHHHHHSC-SCHHHHHHHHHHTTCS-SCCSTTTHHHHHHH
T ss_pred HHHHHHHHHHhccCCCcchHHHHHHHHHHcCCC-CCHHHHHHHHHhhCCC-CCEEeHHHHHHHHh
Confidence 346788999999 99999999999999998874 8999999999999988 89999999998654
|
| >d1k8ua_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a6 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a6 [TaxId: 9606]
Probab=98.64 E-value=2.1e-08 Score=71.52 Aligned_cols=66 Identities=15% Similarity=0.292 Sum_probs=54.0
Q ss_pred HHHHHHHHhhhc-CC-CCC-cccHHHHHHHHHHh---ccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhc
Q 016471 242 ELVYLRAQFMLL-EP-KDG-CVSLNNFKVALMRQ---ATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATS 308 (389)
Q Consensus 242 e~~~l~~~F~~~-D~-~~G-~i~~~el~~~l~~~---~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~ 308 (389)
.+..+..+|..+ |+ ++| .+++.||+..+... +. ..++.++.++++.+|.|+||+|||+||+..+..
T Consensus 7 ai~~ii~vF~kya~~dg~~~~ls~~Elk~Ll~~e~~~~~-~~~~~~~~~~~~~lD~d~Dg~IdF~EF~~l~~~ 78 (89)
T d1k8ua_ 7 AIGLLVAIFHKYSGREGDKHTLSKKELKELIQKELTIGS-KLQDAEIARLMEDLDRNKDQEVNFQEYVTFLGA 78 (89)
T ss_dssp HHHHHHHHHHHHHTSSSCTTEEEHHHHHHHHHHHSCCGG-GTTSHHHHHHHHHHHHTTTCEEEHHHHHHHHHH
T ss_pred HHHHHHHHHHHHcccCCCCCeecHHHHHHHHHHHHHhhc-cCCHHHHHHHHHHhcCCCCCCCcHHHHHHHHHH
Confidence 466677888877 77 666 69999999988863 33 457788999999999999999999999986543
|
| >d1wdcb_ a.39.1.5 (B:) Myosin Essential Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Bay scallop (Aequipecten irradians) [TaxId: 31199]
Probab=98.63 E-value=9.1e-08 Score=75.11 Aligned_cols=86 Identities=8% Similarity=0.055 Sum_probs=60.9
Q ss_pred CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHHHHHcccCCC
Q 016471 256 KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNR 335 (389)
Q Consensus 256 ~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G 335 (389)
.+|.|+.+||..++........+.+++.++|+.+|.+++|.|+.+||..++.......+ ++.+...|+.+|.| +|
T Consensus 52 ~~~~i~~~eF~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~g~~lt----~~e~~~l~~~~d~~-~G 126 (142)
T d1wdcb_ 52 APGPLNFTMFLSIFSDKLSGTDSEETIRNAFAMFDEQETKKLNIEYIKDLLENMGDNFN----KDEMRMTFKEAPVE-GG 126 (142)
T ss_dssp SSSCCCHHHHHHHHHHHTCSCCCHHHHHHHHHTTCTTCCSCEEHHHHHHHHHHSSSCCC----HHHHHHHHHHCCEE-TT
T ss_pred ccCccccccccccccccccccchhhhHHHhhhhhcccCCCcccHHHHHHHHHHccccCC----HHHHHHHHHHhCCC-CC
Confidence 57788888887776554333345677888888888888888888888776554322222 34577788888887 48
Q ss_pred cccHHHHHHHh
Q 016471 336 VISVEELALEL 346 (389)
Q Consensus 336 ~I~~~el~~~l 346 (389)
.|+.+|+.++|
T Consensus 127 ~I~y~eF~~~l 137 (142)
T d1wdcb_ 127 KFDYVKFTAMI 137 (142)
T ss_dssp EECHHHHHHHH
T ss_pred EEcHHHHHHHH
Confidence 88888888776
|
| >d1snla_ a.39.1.7 (A:) Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Nucleobindin 1 (CALNUC) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.60 E-value=2.6e-08 Score=73.10 Aligned_cols=60 Identities=15% Similarity=0.252 Sum_probs=41.4
Q ss_pred HHHHhhhcCC-CCCcccHHHHHHHHHHhcccc---------------CCHHHHHHHHhhcCCCCCcceeHHHHHHH
Q 016471 246 LRAQFMLLEP-KDGCVSLNNFKVALMRQATDA---------------MTDSRVFEILNVMEPLSDQKLAYEEFCAA 305 (389)
Q Consensus 246 l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~---------------~~~~~~~~~~~~~d~~~~g~i~~~eF~~~ 305 (389)
++..|..+|. ++|+|+.+||..++...+... .....+..+|..+|.|+||.|+|+||+.+
T Consensus 18 ~r~~F~~~D~DgdG~i~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~~~D~d~DG~Is~~EF~~~ 93 (99)
T d1snla_ 18 PKTFFILHDINSDGVLDEQELEALFTKELEKVYDPKNEEDDMREMEEERLRMREHVMKNVDTNQDRLVTLEEFLAS 93 (99)
T ss_dssp HHHHHHHHCSSCCSEEEHHHHHHHHHHHHHTTSCCSSCSSHHHHTTHHHHHHHHHHHHHTCSSCSSEEEHHHHHHH
T ss_pred HHHHHHHHCCCCCCcCCHHHHHHHHHHHHHhcchhhhhhhhhhhhHHHHHHHHHHHHHHcCCCCCCcCcHHHHHHH
Confidence 4678999999 999999999999887654210 01223556666667777777777777664
|
| >d1iq3a_ a.39.1.6 (A:) Pob1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Pob1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.60 E-value=5.4e-09 Score=78.17 Aligned_cols=67 Identities=27% Similarity=0.336 Sum_probs=58.3
Q ss_pred cCHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHh
Q 016471 238 LTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAAT 307 (389)
Q Consensus 238 l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~ 307 (389)
++.++...+..+|..+|+ ++|.|+.+|++.+|.+.+ ++..++.+|++..|.|++|.|+++||+.++.
T Consensus 16 lt~ee~~~y~~lF~~~D~d~~G~Is~~e~~~~l~~s~---L~~~~L~~Iw~l~D~d~dG~l~~~EF~~am~ 83 (110)
T d1iq3a_ 16 ITEEQREYYVNQFRSLQPDPSSFISGSVAKNFFTKSK---LSIPELSYIWELSDADCDGALTLPEFCAAFH 83 (110)
T ss_dssp CSSSSHHHHHHHHHHHCCSSSSEEEHHHHHHHCCSSS---CSSCCHHHHHHHHCSSSCSEEEHHHHHHHHH
T ss_pred cCHHHHHHHHHHHHHhCCCcccchhHHHHHHHHHhhc---cchHHHHHHHHHhccCCCCeECHHHHHHHHH
Confidence 566778888999999999 999999999999987765 4556799999999999999999999987543
|
| >d1e8aa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]
Probab=98.60 E-value=5.8e-08 Score=68.73 Aligned_cols=67 Identities=16% Similarity=0.224 Sum_probs=52.6
Q ss_pred HHHHHHHHHhhhcCC--C-CCcccHHHHHHHHHHhcc----ccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHh
Q 016471 241 EELVYLRAQFMLLEP--K-DGCVSLNNFKVALMRQAT----DAMTDSRVFEILNVMEPLSDQKLAYEEFCAAAT 307 (389)
Q Consensus 241 ee~~~l~~~F~~~D~--~-~G~i~~~el~~~l~~~~~----~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~ 307 (389)
..+..+..+|..++. + .+.|+++||++.+..... ...+...+++++..+|.|+||.|||+||+..+.
T Consensus 5 ~ai~~li~vF~kya~~~g~~~~Lsk~Elk~ll~~e~~~~~~~~~~~~~v~~~~~~lD~n~Dg~idF~EF~~li~ 78 (87)
T d1e8aa_ 5 EHLEGIVNIFHQYSVRKGHFDTLSKGELKQLLTKELANTIKNIKDKAVIDEIFQGLDANQDEQVDFQEFISLVA 78 (87)
T ss_dssp HHHHHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHSTTTSTTTTSHHHHHHHHHHHCTTCSSCEEHHHHHHHHH
T ss_pred HHHHHHHHHHHHHcccCCCCCeEcHHHHHHHHHHHccccccCCCCHHHHHHHHHHHcCCCCCcCCHHHHHHHHH
Confidence 346677888888755 2 346999999999987432 134578899999999999999999999997544
|
| >d1qv0a_ a.39.1.5 (A:) Calcium-regulated photoprotein {Hydrozoa (Obelia longissima), obelin [TaxId: 32570]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-regulated photoprotein species: Hydrozoa (Obelia longissima), obelin [TaxId: 32570]
Probab=98.59 E-value=8.8e-08 Score=78.97 Aligned_cols=65 Identities=11% Similarity=0.093 Sum_probs=54.8
Q ss_pred HHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHh
Q 016471 242 ELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAAT 307 (389)
Q Consensus 242 e~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~ 307 (389)
....+..+|..+|. ++|+|+.+||..++..++. .++.+++..+|..+|.|+||.|+|+||+.++.
T Consensus 105 ~~~~~~~~F~~~D~d~~G~is~~E~~~~l~~~g~-~~~~~~~~~lf~~~D~d~dG~Is~~EF~~~~~ 170 (189)
T d1qv0a_ 105 IREWGDAVFDIFDKDGSGTITLDEWKAYGKISGI-SPSQEDCEATFRHCDLDNAGDLDVDEMTRQHL 170 (189)
T ss_dssp HHHHHHHHHHHTC----CEECHHHHHHHHHHHSS-CCCHHHHHHHHHHSCCCTTSCEEHHHHHHHHH
T ss_pred HHHHHHHHHHHHccCCCCcccchhhHHHHHhcCC-CCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHH
Confidence 34456778999999 9999999999999999887 48999999999999999999999999997544
|
| >d1uhka1 a.39.1.5 (A:3-189) Calcium-regulated photoprotein {Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-regulated photoprotein species: Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]
Probab=98.59 E-value=9.6e-08 Score=78.53 Aligned_cols=67 Identities=13% Similarity=0.192 Sum_probs=59.2
Q ss_pred HHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHh
Q 016471 240 EEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAAT 307 (389)
Q Consensus 240 ~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~ 307 (389)
......+..+|..+|. ++|.|+.+||+.+|..++. .++.+++.++|..+|.|++|.|+|+||+.++.
T Consensus 101 ~~~~~~~~~~F~~~D~d~~G~Is~~El~~~l~~~g~-~~~~~~~~~lf~~~D~d~dG~Is~~EF~~~~~ 168 (187)
T d1uhka1 101 TLIRIWGDALFDIVDKDQNGAITLDEWKAYTKAAGI-IQSSEDCEETFRVCDIDESGQLDVDEMTRQHL 168 (187)
T ss_dssp CHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTS-CCSHHHHHHHHHHSCCCTTSCEEHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHccCCCcccchHHHHHHHHHhCC-CccHHHHHHHHHHhCCCCCCCEeHHHHHHHHH
Confidence 3344567889999999 9999999999999999886 47899999999999999999999999997544
|
| >d2scpa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Sandworm (Nereis diversicolor) [TaxId: 126592]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Sarcoplasmic calcium-binding protein species: Sandworm (Nereis diversicolor) [TaxId: 126592]
Probab=98.58 E-value=2.4e-07 Score=75.09 Aligned_cols=102 Identities=14% Similarity=0.101 Sum_probs=73.0
Q ss_pred HHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHH-----hhHHHHHHHHHHHHHH--cccCCCcccHHHHHHHhC----
Q 016471 279 DSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLE-----ALERWDQIAITAFDYF--EQEGNRVISVEELALELN---- 347 (389)
Q Consensus 279 ~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~-----~~~~~~~~l~~aF~~~--D~d~~G~I~~~el~~~l~---- 347 (389)
.+++..+|+.+|.|++|.|+++||..++....... ............|..+ |.+++|.|+.+++...+.
T Consensus 5 ~~~l~~~F~~~D~d~dG~Is~~Ef~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ef~~~~~~~~~ 84 (174)
T d2scpa_ 5 VQKMKTYFNRIDFDKDGAITRMDFESMAERFAKESEMKAEHAKVLMDSLTGVWDNFLTAVAGGKGIDETTFINSMKEMVK 84 (174)
T ss_dssp HHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHHHSCCCTTHHHHHHHHHHHHHHHTGGGTTTTSCEEHHHHHHHHHHHTS
T ss_pred HHHHHHHHHHHccCCCCcEeHHHHHHHHHHHhccccchhHHHHHhHHhhhhhccccccccCCCCcCcHHHHHHHHHhhhc
Confidence 45688999999999999999999987654322111 0111122233444543 778899999999988771
Q ss_pred C--chH-----HHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 348 L--APA-----AYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 348 ~--~~~-----~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
. ... +..+++.+|.|++|.|+.+||..+++...
T Consensus 85 ~~~~~~~~~~~~~~~F~~~D~d~dG~Is~~E~~~~l~~~~ 124 (174)
T d2scpa_ 85 NPEAKSVVEGPLPLFFRAVDTNEDNNISRDEYGIFFGMLG 124 (174)
T ss_dssp CGGGTHHHHTHHHHHHHHHCTTCSSSEEHHHHHHHHHHTT
T ss_pred chhhHHHHHHHHHHHHHHHCCCccccCCHHHHHHHHHHHh
Confidence 1 111 77899999999999999999999987543
|
| >d3cr5x1 a.39.1.2 (X:0-89) Calcyclin (S100) {Cow (Bos taurus), s100b [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Cow (Bos taurus), s100b [TaxId: 9913]
Probab=98.54 E-value=8.7e-08 Score=68.03 Aligned_cols=61 Identities=20% Similarity=0.329 Sum_probs=49.6
Q ss_pred HHHHHHHHHH-cccCC-CcccHHHHHHHhC----------CchH-HHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 320 QIAITAFDYF-EQEGN-RVISVEELALELN----------LAPA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 320 ~~l~~aF~~~-D~d~~-G~I~~~el~~~l~----------~~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
..+..+|..| .++|+ +.++++||++++. .++. ++++++++|.|+||.|+|+||+.++.++.
T Consensus 9 ~~ii~vFhkYa~~~G~~~tLsk~Elk~Ll~~El~~~l~~~~d~~~~d~~m~~LD~n~Dg~vdF~EF~~li~~la 82 (90)
T d3cr5x1 9 VALIDVFHQYSGREGDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLDSDGDGECDFQEFMAFVAMIT 82 (90)
T ss_dssp HHHHHHHHHHHTSSSSTTSBCHHHHHHHHHHHCTTTSCCCCSHHHHHHHHHHHCTTSSSSBCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhccCCCcCcCCHHHHHHHHHHHHHHHhcCCCCHHHHHHHHHHhcCCCCCcCCHHHHHHHHHHHH
Confidence 4578899999 45554 4699999999992 1223 99999999999999999999999987653
|
| >d1wdcc_ a.39.1.5 (C:) Myosin Regulatory Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Regulatory Chain species: Bay scallop (Aequipecten irradians) [TaxId: 31199]
Probab=98.53 E-value=7.2e-08 Score=76.65 Aligned_cols=63 Identities=17% Similarity=0.293 Sum_probs=54.4
Q ss_pred HHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCC--CCcceeHHHHHHHHh
Q 016471 244 VYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPL--SDQKLAYEEFCAAAT 307 (389)
Q Consensus 244 ~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~--~~g~i~~~eF~~~~~ 307 (389)
..+..+|+.+|. ++|.|+.+||+.+|..+|. .+++++++++++.+|.+ ++|.|+|+||+..++
T Consensus 82 ~~l~~aF~~~D~~~~G~I~~~el~~~l~~~g~-~ls~~e~~~l~~~~d~~~d~~G~I~y~eF~~~~~ 147 (152)
T d1wdcc_ 82 ADYMEAFKTFDREGQGFISGAELRHVLTALGE-RLSDEDVDEIIKLTDLQEDLEGNVKYEDFVKKVM 147 (152)
T ss_dssp HHHHHHHHTTCSSSSSEEEHHHHHHHHHHSSS-CCCHHHHHHHHHHHTCCCCTTSEEEHHHHHHHHH
T ss_pred HhhhhhhhccccccCccchHHHHHHHHHHcCC-CCCHHHHHHHHHHhccCCCCCCEEEHHHHHHHHh
Confidence 456788999999 9999999999999999987 48999999999988854 568999999997654
|
| >d1dtla_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=98.53 E-value=1.3e-07 Score=75.45 Aligned_cols=97 Identities=12% Similarity=0.163 Sum_probs=74.4
Q ss_pred HHHHHHhhcCCCC-CcceeHHHHHHHHhchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHh----C-----Cch
Q 016471 281 RVFEILNVMEPLS-DQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALEL----N-----LAP 350 (389)
Q Consensus 281 ~~~~~~~~~d~~~-~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l----~-----~~~ 350 (389)
++.++|..+|.++ +|.|+.+||..++-....... ...+...+..++.+++|.|+.+++.... . ...
T Consensus 15 ~l~~~F~~~D~d~~dG~I~~~e~~~~l~~lg~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 90 (156)
T d1dtla_ 15 EFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPT----PEELQEMIDEVDEDGSGTVDFDEFLVMMVRSMKDDSKGKSE 90 (156)
T ss_dssp HHHHHHHHHTTTCGGGSBCHHHHHHHHHHTTCCCC----HHHHHHHHHHHCTTSSSSBCHHHHHHHHHHHHC-----CHH
T ss_pred HHHHHHHHHcCCCCCCeECHHHHHHHHHHcCCCCC----HHHHHHHHHHhhccCCCccchhhhhhhhhhcccccccccHH
Confidence 4566799999985 899999999876544322222 3457889999999999999998888754 1 112
Q ss_pred H-HHHHHHHHccCCCCceeHHHHHHHHccccC
Q 016471 351 A-AYSLLNDCIRNSDGKLSFLGYKRFLHGVTV 381 (389)
Q Consensus 351 ~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~ 381 (389)
+ +..+|+.+|.+++|.|+.+||..++.....
T Consensus 91 ~~l~~~F~~~D~d~~G~I~~~e~~~~~~~~~~ 122 (156)
T d1dtla_ 91 EELSDLFRMFDKNADGYIDLEELKIMLQATGE 122 (156)
T ss_dssp HHHHHHHHHHCTTCSSEEEHHHHGGGGTTC--
T ss_pred HHHHHHHHHhCcCCCCcCcHHHHHHHHhhcCC
Confidence 2 788999999999999999999998876654
|
| >d1qlsa_ a.39.1.2 (A:) Calcyclin (S100) {Pig (Sus scrofa), calgizzarin s100c (s100a11) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Pig (Sus scrofa), calgizzarin s100c (s100a11) [TaxId: 9823]
Probab=98.50 E-value=1.4e-07 Score=67.56 Aligned_cols=61 Identities=25% Similarity=0.428 Sum_probs=49.6
Q ss_pred HHHHHHHHHH-cccCC-CcccHHHHHHHhCC----------chH-HHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 320 QIAITAFDYF-EQEGN-RVISVEELALELNL----------APA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 320 ~~l~~aF~~~-D~d~~-G~I~~~el~~~l~~----------~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
..+..+|..| .++|+ +.++++||+.+|.. ++. ++++++.+|.|+||.|+|+||+.+|.++.
T Consensus 9 ~~ii~vFhkYa~~~G~~~tLsk~Elk~Ll~~El~~~l~~~~d~~~vd~im~~LD~n~Dg~vdF~EF~~li~~la 82 (95)
T d1qlsa_ 9 ESLIAIFQKHAGRDGNNTKISKTEFLIFMNTELAAFTQNQKDPGVLDRMMKKLDLDSDGQLDFQEFLNLIGGLA 82 (95)
T ss_dssp HHHHHHHHHHHTTSSCTTCBCHHHHHHHHTTTSHHHHHHCCCTHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhCcCCCcCcCCHHHHHHHHHHHHHHHhcCCCCHHHHHHHHHHhcCCCCCcCcHHHHHHHHHHHH
Confidence 4578899888 44554 56999999999932 222 99999999999999999999999987654
|
| >d1qjta_ a.39.1.6 (A:) Eps15 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=98.49 E-value=7e-08 Score=70.52 Aligned_cols=59 Identities=17% Similarity=0.175 Sum_probs=51.7
Q ss_pred HHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHH
Q 016471 245 YLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAA 306 (389)
Q Consensus 245 ~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~ 306 (389)
.+...|..+|. ++|+|+.+|+..+|+..+ ++..++.+|++..|.+++|.|+++||+.++
T Consensus 12 ~y~~~F~~~D~d~~G~i~~~e~~~~l~~s~---L~~~~L~~i~~~~D~d~dG~L~~~EF~~am 71 (99)
T d1qjta_ 12 VYEKYYRQVEAGNTGRVLALDAAAFLKKSG---LPDLILGKIWDLADTDGKGVLSKQEFFVAL 71 (99)
T ss_dssp HHHHHHHHHCCTTSSCCCSHHHHHHHHTSS---SCHHHHHHHHHHHCCSSSSSCCSHHHHHHH
T ss_pred HHHHHHHHHCCCCCCcccHHHHHHHHHHcC---CcHHHHHHHHHHHcCCCCCccCHHHHHHHH
Confidence 45678999999 999999999999988765 577889999999999999999999998754
|
| >d1nyaa_ a.39.1.5 (A:) Calerythrin {Saccharopolyspora erythraea [TaxId: 1836]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calerythrin species: Saccharopolyspora erythraea [TaxId: 1836]
Probab=98.49 E-value=3.7e-07 Score=73.84 Aligned_cols=103 Identities=10% Similarity=0.121 Sum_probs=76.4
Q ss_pred CCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHHH-----------hhHHHHHHHHHHHHHHcccCCCcccHHHHHHH
Q 016471 277 MTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQLE-----------ALERWDQIAITAFDYFEQEGNRVISVEELALE 345 (389)
Q Consensus 277 ~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~-----------~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~ 345 (389)
.+.+.+.++|+.+|.|++|.|+++||..++....... ............+...|.+++|.|+..+....
T Consensus 4 ~~~~~l~~~F~~~D~d~dG~Is~~Ef~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~ 83 (176)
T d1nyaa_ 4 IASDRLKKRFDRWDFDGNGALERADFEKEAQHIAEAFGKDAGAAEVQTLKNAFGGLFDYLAKEAGVGSDGSLTEEQFIRV 83 (176)
T ss_dssp HHHHHHHHHHHHCCSSCCSSBCSHHHHHHHHHHHHHTSSCSSSHHHHHHHHHHHHHHHHHHHHHTSCTTCCBCHHHHHHH
T ss_pred HHHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHHHHcCCcccHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccHHHHHHH
Confidence 3567799999999999999999999987654322110 00111233456778889999999999988876
Q ss_pred h-----CCch----H-----HHHHHHHHccCCCCceeHHHHHHHHccc
Q 016471 346 L-----NLAP----A-----AYSLLNDCIRNSDGKLSFLGYKRFLHGV 379 (389)
Q Consensus 346 l-----~~~~----~-----~~~~~~~~d~~~~g~i~~~ef~~~~~~~ 379 (389)
+ .... . +..++..+|.|++|.|+.+||..+++..
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~dG~Is~~E~~~~~~~~ 131 (176)
T d1nyaa_ 84 TENLIFEQGEASFNRVLGPVVKGIVGMCDKNADGQINADEFAAWLTAL 131 (176)
T ss_dssp HHHHHSSSCHHHHHHHHHHHHHHHHHHTCSSCCSEEEHHHHHHHHHHT
T ss_pred HhhhhhhhhhhhhHHHHHHHHHHHHHHHccCCChhhhHHHHHHHHHhc
Confidence 6 1111 1 7778999999999999999999998754
|
| >d1w7jb1 a.39.1.5 (B:11-149) Myosin Essential Chain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.48 E-value=5.7e-08 Score=75.90 Aligned_cols=62 Identities=19% Similarity=0.205 Sum_probs=53.9
Q ss_pred HHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHH
Q 016471 243 LVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAA 306 (389)
Q Consensus 243 ~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~ 306 (389)
...+..+|+.+|. ++|+|+.+||+.+|..+|. .++..+++.++.. |.+++|.|+|+||+..+
T Consensus 76 ~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~g~-~~~~~e~~~l~~~-~~d~dg~I~~~eF~~~l 138 (139)
T d1w7jb1 76 YEDYLEGFRVFDKEGNGKVMGAELRHVLTTLGE-KMTEEEVETVLAG-HEDSNGCINYEAFLKHI 138 (139)
T ss_dssp --CCHHHHHTTCTTSSSEEEHHHHHHHHHHSSS-CCCHHHHHHHHTT-CCCTTSEEEHHHHHHHT
T ss_pred HHHHHHhhhhccCCCCCeEeHHHHHHHHHHhCC-CCCHHHHHHHHhh-CCCCCCeEeHHHHHHHh
Confidence 3446788999999 9999999999999999987 4789999999975 88999999999999854
|
| >d1ctda_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=98.43 E-value=8.2e-08 Score=51.26 Aligned_cols=28 Identities=29% Similarity=0.466 Sum_probs=25.8
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHh
Q 016471 319 DQIAITAFDYFEQEGNRVISVEELALEL 346 (389)
Q Consensus 319 ~~~l~~aF~~~D~d~~G~I~~~el~~~l 346 (389)
++++.++|++||+|.||+|+.+||..++
T Consensus 3 EeELae~FRifDkNaDGyiD~eEl~~il 30 (34)
T d1ctda_ 3 EEELANAFRIFDKNADGYIDIEELGEIL 30 (34)
T ss_dssp HHHHHHHHHTTCCSSSSCBCHHHHHHHH
T ss_pred HHHHHHHHHHHccCCcccccHHHHHHHH
Confidence 4678999999999999999999999886
|
| >d1xk4c1 a.39.1.2 (C:4-86) Calcyclin (S100) {Human (Homo sapiens), s100a9 (mrp14) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a9 (mrp14) [TaxId: 9606]
Probab=98.35 E-value=4.8e-07 Score=62.95 Aligned_cols=59 Identities=19% Similarity=0.297 Sum_probs=47.5
Q ss_pred HHHHHHHHHHc-ccC-CCcccHHHHHHHhC------C-----chH-HHHHHHHHccCCCCceeHHHHHHHHcc
Q 016471 320 QIAITAFDYFE-QEG-NRVISVEELALELN------L-----APA-AYSLLNDCIRNSDGKLSFLGYKRFLHG 378 (389)
Q Consensus 320 ~~l~~aF~~~D-~d~-~G~I~~~el~~~l~------~-----~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~ 378 (389)
..+..+|..|. ++| .+.++++||++++. + .+. ++++++.+|.|+||.|+|+||+.++.+
T Consensus 10 ~~ii~vFhkYa~~~G~~~tLsk~Elk~Ll~~El~~~l~~~~~d~~~vd~~m~~LD~n~Dg~vdF~EF~~li~~ 82 (83)
T d1xk4c1 10 ETIINTFHQYSVKLGHPDTLNQGEFKELVRKDLQNFLKKENKNEKVIEHIMEDLDTNADKQLSFEEFIMLMAR 82 (83)
T ss_dssp HHHHHHHHHHHTTSSSTTSBCHHHHHHHHHHHTTTTTTTGGGCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHH
T ss_pred HHHHHHHHHHhCcCCCcccCCHHHHHHHHHHHhHHHhcCCCCCHHHHHHHHHHhcCCCCCcCcHHHHHHHHhh
Confidence 45788999994 333 35799999999981 1 222 899999999999999999999998854
|
| >d2zkmx1 a.39.1.7 (X:142-311) Phospholipase C-beta-2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Phospholipase C-beta-2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.32 E-value=8.5e-08 Score=77.74 Aligned_cols=98 Identities=9% Similarity=-0.036 Sum_probs=68.1
Q ss_pred HHHHHhh--cCCCCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHHHHHcccCCCcccHHHHHHHhC---CchHHHHHH
Q 016471 282 VFEILNV--MEPLSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYFEQEGNRVISVEELALELN---LAPAAYSLL 356 (389)
Q Consensus 282 ~~~~~~~--~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~---~~~~~~~~~ 356 (389)
+++++.. +|.|++|+|+.+|+..++......... -...+...|...|.+++|.|+-+|+...+. ..+++..+|
T Consensus 7 l~k~~~k~~~d~n~dG~Is~~el~k~l~~~~~~~~~--~~~~~~~~~~~~D~~~~~~i~F~eF~~~~~~l~~r~ei~~~F 84 (170)
T d2zkmx1 7 LDKILVKLKMQLNSEGKIPVKNFFQMFPADRKRVEA--ALSACHLPKGKNDAINPEDFPEPVYKSFLMSLCPRPEIDEIF 84 (170)
T ss_dssp HHHHHHHHHHSCCTTSCEEHHHHHHHSCSCHHHHHH--HHHHTTCCCCTTCEECGGGCCHHHHHHHHHHHSCCHHHHTTC
T ss_pred HHHHHHHHhcccCCCCCCcHHHHHHHHHHhhhhHHH--HHHHHhhhhccccccCCCccCHHHHHHHHhccCCHHHHHHHH
Confidence 3444443 699999999999999866443222111 134567789999999999999999999873 334488999
Q ss_pred HHHccCCCCceeHHHHHHHHccccC
Q 016471 357 NDCIRNSDGKLSFLGYKRFLHGVTV 381 (389)
Q Consensus 357 ~~~d~~~~g~i~~~ef~~~~~~~~~ 381 (389)
..+|.|++|.||.+||..+|...+.
T Consensus 85 ~~~d~d~~~~it~~el~~fL~~~Q~ 109 (170)
T d2zkmx1 85 TSYHAKAKPYMTKEHLTKFINQKQR 109 (170)
T ss_dssp C--------CCCHHHHHHHHHHTCC
T ss_pred HHHcCCCCCcccHHHHHHHHHHHhc
Confidence 9999999999999999999987654
|
| >d1j55a_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100p [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100p [TaxId: 9606]
Probab=98.31 E-value=6.7e-07 Score=63.85 Aligned_cols=61 Identities=23% Similarity=0.430 Sum_probs=48.6
Q ss_pred HHHHHHHHHHc-ccCC-CcccHHHHHHHhC-----C-----chH-HHHHHHHHccCCCCceeHHHHHHHHcccc
Q 016471 320 QIAITAFDYFE-QEGN-RVISVEELALELN-----L-----APA-AYSLLNDCIRNSDGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 320 ~~l~~aF~~~D-~d~~-G~I~~~el~~~l~-----~-----~~~-~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 380 (389)
..+..+|..|. ++|+ +.++++||++++. . ++. ++++++.+|.|+||.|+|+||+.++.++.
T Consensus 9 ~~ii~vFhkYa~~~g~~~tLsk~Elk~Ll~~El~~~l~~~~d~~~vd~~m~~LD~n~Dg~vdF~EF~~li~~la 82 (94)
T d1j55a_ 9 GMIIDVFSRYSGSEGSTQTLTKGELKVLMEKELPGFLQSGKDKDAVDKLLKDLDANGDAQVDFSEFIVFVAAIT 82 (94)
T ss_dssp HHHHHHHHHHTTSSSCTTEECHHHHHHHHHHHSTTCC------CHHHHHHHHHCSSSSSSEEHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcccCCCcccCCHHHHHHHHHHHHHHHhcCCCCHHHHHHHHHHhcCCCCCcCCHHHHHHHHHHHH
Confidence 45788999984 4443 4799999999982 1 122 99999999999999999999999986643
|
| >d3cr5x1 a.39.1.2 (X:0-89) Calcyclin (S100) {Cow (Bos taurus), s100b [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Cow (Bos taurus), s100b [TaxId: 9913]
Probab=98.28 E-value=1.1e-06 Score=62.11 Aligned_cols=67 Identities=13% Similarity=0.176 Sum_probs=50.5
Q ss_pred HHHHHHHHhhhcCC---CCCcccHHHHHHHHHHhc----cccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhc
Q 016471 242 ELVYLRAQFMLLEP---KDGCVSLNNFKVALMRQA----TDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATS 308 (389)
Q Consensus 242 e~~~l~~~F~~~D~---~~G~i~~~el~~~l~~~~----~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~ 308 (389)
.+..+-.+|..+.. ..+.+++.||+..+..-. .....+..++++++.+|.|+||.|||+||+..+..
T Consensus 7 ai~~ii~vFhkYa~~~G~~~tLsk~Elk~Ll~~El~~~l~~~~d~~~~d~~m~~LD~n~Dg~vdF~EF~~li~~ 80 (90)
T d3cr5x1 7 AVVALIDVFHQYSGREGDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLDSDGDGECDFQEFMAFVAM 80 (90)
T ss_dssp HHHHHHHHHHHHHTSSSSTTSBCHHHHHHHHHHHCTTTSCCCCSHHHHHHHHHHHCTTSSSSBCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhccCCCcCcCCHHHHHHHHHHHHHHHhcCCCCHHHHHHHHHHhcCCCCCcCCHHHHHHHHHH
Confidence 34556677777644 335799999999887632 22234677999999999999999999999875443
|
| >d1ij5a_ a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-binding protein LAV1-2) {Physarum polycephalum [TaxId: 5791]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) domain: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) species: Physarum polycephalum [TaxId: 5791]
Probab=98.19 E-value=7.5e-07 Score=79.46 Aligned_cols=88 Identities=11% Similarity=0.081 Sum_probs=55.6
Q ss_pred HHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhchhHH-HhhHHHHHHHHHH
Q 016471 248 AQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSVYQL-EALERWDQIAITA 325 (389)
Q Consensus 248 ~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~-~~~~~~~~~l~~a 325 (389)
..+...+. .+|.++..++....... ..+..+|..+|.+++|.|+..||..++...... .. ...+...
T Consensus 227 ~~~~~~~~~~~~~i~~~ef~~~~~~~-------~~~~~~F~~~D~d~~G~Is~~E~~~~l~~~~~~~~~----~~~~~~l 295 (321)
T d1ij5a_ 227 ALFRYADEDESDDVGFSEYVHLGLCL-------LVLRILYAFADFDKSGQLSKEEVQKVLEDAHIPESA----RKKFEHQ 295 (321)
T ss_dssp HHHHHHCTTCSSCEEHHHHHHHHHHH-------HHHHHHHHHTCSSSCSSEEHHHHHHHHHHTTCCGGG----CSTHHHH
T ss_pred HHHHhhhcccccccccccccchhhhh-------hHHHHHHHHHhcCCCCCCcHHHHHHHHHHcCCCcCc----HHHHHHH
Confidence 34455566 77777777775543222 224567777777777888877777655433211 11 2246777
Q ss_pred HHHHcccCCCcccHHHHHHHh
Q 016471 326 FDYFEQEGNRVISVEELALEL 346 (389)
Q Consensus 326 F~~~D~d~~G~I~~~el~~~l 346 (389)
|..+|.|+||+|+.+|+..+|
T Consensus 296 ~~~~D~d~dG~Is~~EF~~~m 316 (321)
T d1ij5a_ 296 FSVVDVDDSKSLSYQEFVMLV 316 (321)
T ss_dssp HHHHTTTTCSEECHHHHHHHH
T ss_pred HHHhCCCCCCcCcHHHHHHHH
Confidence 777888888888888777765
|
| >d1xk4c1 a.39.1.2 (C:4-86) Calcyclin (S100) {Human (Homo sapiens), s100a9 (mrp14) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a9 (mrp14) [TaxId: 9606]
Probab=98.14 E-value=4.2e-06 Score=58.02 Aligned_cols=64 Identities=14% Similarity=0.272 Sum_probs=47.5
Q ss_pred HHHHHHHhhhcCC---CCCcccHHHHHHHHHHhcc-----ccCCHHHHHHHHhhcCCCCCcceeHHHHHHHH
Q 016471 243 LVYLRAQFMLLEP---KDGCVSLNNFKVALMRQAT-----DAMTDSRVFEILNVMEPLSDQKLAYEEFCAAA 306 (389)
Q Consensus 243 ~~~l~~~F~~~D~---~~G~i~~~el~~~l~~~~~-----~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~ 306 (389)
+..+-.+|..+.. ..+.+++.||+..+..-.. .......+++++..+|.|+||.|||+||+..+
T Consensus 9 i~~ii~vFhkYa~~~G~~~tLsk~Elk~Ll~~El~~~l~~~~~d~~~vd~~m~~LD~n~Dg~vdF~EF~~li 80 (83)
T d1xk4c1 9 IETIINTFHQYSVKLGHPDTLNQGEFKELVRKDLQNFLKKENKNEKVIEHIMEDLDTNADKQLSFEEFIMLM 80 (83)
T ss_dssp HHHHHHHHHHHHTTSSSTTSBCHHHHHHHHHHHTTTTTTTGGGCHHHHHHHHHHHCTTCSSSBCHHHHHHHH
T ss_pred HHHHHHHHHHHhCcCCCcccCCHHHHHHHHHHHhHHHhcCCCCCHHHHHHHHHHhcCCCCCcCcHHHHHHHH
Confidence 4455566766654 3458999999998876321 11234568999999999999999999999754
|
| >d1j55a_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100p [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100p [TaxId: 9606]
Probab=98.14 E-value=2.8e-06 Score=60.54 Aligned_cols=67 Identities=12% Similarity=0.213 Sum_probs=48.7
Q ss_pred HHHHHHHHhhhcCCC---CCcccHHHHHHHHHHhcc----ccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhc
Q 016471 242 ELVYLRAQFMLLEPK---DGCVSLNNFKVALMRQAT----DAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATS 308 (389)
Q Consensus 242 e~~~l~~~F~~~D~~---~G~i~~~el~~~l~~~~~----~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~ 308 (389)
.+..+-.+|..+..+ .+.+++.||+..+..-.. ....+..+++++..+|.|+||.|+|+||+..+..
T Consensus 7 ai~~ii~vFhkYa~~~g~~~tLsk~Elk~Ll~~El~~~l~~~~d~~~vd~~m~~LD~n~Dg~vdF~EF~~li~~ 80 (94)
T d1j55a_ 7 AMGMIIDVFSRYSGSEGSTQTLTKGELKVLMEKELPGFLQSGKDKDAVDKLLKDLDANGDAQVDFSEFIVFVAA 80 (94)
T ss_dssp HHHHHHHHHHHHTTSSSCTTEECHHHHHHHHHHHSTTCC------CHHHHHHHHHCSSSSSSEEHHHHHHHHHH
T ss_pred HHHHHHHHHHHHcccCCCcccCCHHHHHHHHHHHHHHHhcCCCCHHHHHHHHHHhcCCCCCcCCHHHHHHHHHH
Confidence 345566778777552 358999999998876321 1223567999999999999999999999986544
|
| >d1qlsa_ a.39.1.2 (A:) Calcyclin (S100) {Pig (Sus scrofa), calgizzarin s100c (s100a11) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Pig (Sus scrofa), calgizzarin s100c (s100a11) [TaxId: 9823]
Probab=98.08 E-value=3.5e-06 Score=60.09 Aligned_cols=66 Identities=15% Similarity=0.178 Sum_probs=49.5
Q ss_pred HHHHHHHhhhcCC---CCCcccHHHHHHHHHH-----hccccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhch
Q 016471 243 LVYLRAQFMLLEP---KDGCVSLNNFKVALMR-----QATDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSV 309 (389)
Q Consensus 243 ~~~l~~~F~~~D~---~~G~i~~~el~~~l~~-----~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~ 309 (389)
+..+-..|..+.. +.+.++..||+..+.. +.. ......++++++.+|.|+||.|||+||+..+...
T Consensus 8 i~~ii~vFhkYa~~~G~~~tLsk~Elk~Ll~~El~~~l~~-~~d~~~vd~im~~LD~n~Dg~vdF~EF~~li~~l 81 (95)
T d1qlsa_ 8 IESLIAIFQKHAGRDGNNTKISKTEFLIFMNTELAAFTQN-QKDPGVLDRMMKKLDLDSDGQLDFQEFLNLIGGL 81 (95)
T ss_dssp HHHHHHHHHHHHTTSSCTTCBCHHHHHHHHTTTSHHHHHH-CCCTHHHHHHHHHHCTTCSSSBCHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhCcCCCcCcCCHHHHHHHHHHHHHHHhcC-CCCHHHHHHHHHHhcCCCCCcCcHHHHHHHHHHH
Confidence 4455566766544 3467999999998865 222 2456779999999999999999999998755443
|
| >d1tuza_ a.39.1.7 (A:) Diacylglycerol kinase alpha, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Diacylglycerol kinase alpha, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.59 E-value=5.4e-05 Score=56.40 Aligned_cols=74 Identities=7% Similarity=0.020 Sum_probs=56.3
Q ss_pred hcCHHHHHHHHHHhhhcC---C-CCCcccHHHHHHHHHHhcccc-CCHHHHHHHHhhcCCCCC--------cceeHHHHH
Q 016471 237 ALTEEELVYLRAQFMLLE---P-KDGCVSLNNFKVALMRQATDA-MTDSRVFEILNVMEPLSD--------QKLAYEEFC 303 (389)
Q Consensus 237 ~l~~ee~~~l~~~F~~~D---~-~~G~i~~~el~~~l~~~~~~~-~~~~~~~~~~~~~d~~~~--------g~i~~~eF~ 303 (389)
.++..++..+.+.|.... . .+|.|+.++|+..+....... ....-++++|+.+|.+++ |.|+|.||+
T Consensus 21 ~fs~~ei~~l~~~Fk~~~~~~~~p~g~i~~~~F~~~~~~~f~~~~~~~~l~~rlF~~FD~~~d~~~~~~~~g~I~f~efv 100 (118)
T d1tuza_ 21 EYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVS 100 (118)
T ss_dssp HHCCCCHHHHHHHHHTSGGGGGEETTEECHHHHHHHHHHHTTCSSCCHHHHHHHHHHSCCCCCTTCCCCCSCCEEHHHHH
T ss_pred CCCHHHHHHHHHHHhccccccCCcccccCHHHHHHHHHHhCCCCCchHHHHHHHHHHHccccccccccCCCceeeHHHHH
Confidence 467778888888886442 1 588999999999887765432 346678899999999876 889999999
Q ss_pred HHHhchh
Q 016471 304 AAATSVY 310 (389)
Q Consensus 304 ~~~~~~~ 310 (389)
.+++...
T Consensus 101 ~~LS~l~ 107 (118)
T d1tuza_ 101 CYFSLLE 107 (118)
T ss_dssp HHHHHHH
T ss_pred HHHHHHc
Confidence 8766543
|
| >d2hf5a1 a.39.1.5 (A:81-113) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]
Probab=97.44 E-value=2.9e-05 Score=43.07 Aligned_cols=30 Identities=13% Similarity=0.335 Sum_probs=25.1
Q ss_pred HHHHHHhhhcCC-CCCcccHHHHHHHHHHhc
Q 016471 244 VYLRAQFMLLEP-KDGCVSLNNFKVALMRQA 273 (389)
Q Consensus 244 ~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~ 273 (389)
..++++|+.+|. ++|.|+..||+.+|..+|
T Consensus 3 eel~eAF~~FDkDg~G~Is~~EL~~vm~~lG 33 (33)
T d2hf5a1 3 EEIREAFRVFDKDGNGYISAAELRHVMTNLG 33 (33)
T ss_dssp HHHHHHHHHHSSSCCSCBCHHHHHHHTTSCC
T ss_pred HHHHHHHHHhCCCCCCcCcHHHHHHHHHHcC
Confidence 367889999999 999999999998886654
|
| >d1tuza_ a.39.1.7 (A:) Diacylglycerol kinase alpha, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Diacylglycerol kinase alpha, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.40 E-value=6.6e-05 Score=55.90 Aligned_cols=75 Identities=16% Similarity=0.317 Sum_probs=49.8
Q ss_pred CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCC------CCCcceeHHHHHHHHhchhHHHhhHHHHHHHHHHHHHH
Q 016471 256 KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEP------LSDQKLAYEEFCAAATSVYQLEALERWDQIAITAFDYF 329 (389)
Q Consensus 256 ~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~------~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~l~~aF~~~ 329 (389)
..+.++.+++.+.-+... +++.+|.++.+.+-. ..+|.|++++|...+...-.....+ +....++|+.|
T Consensus 4 ~~s~l~p~~l~~L~~~T~---fs~~ei~~l~~~Fk~~~~~~~~p~g~i~~~~F~~~~~~~f~~~~~~--~~l~~rlF~~F 78 (118)
T d1tuza_ 4 ERGLISPSDFAQLQKYME---YSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVP--RHLSLALFQSF 78 (118)
T ss_dssp CCSCSCHHHHHHHHHHHH---HCCCCHHHHHHHHHTSGGGGGEETTEECHHHHHHHHHHHTTCSSCC--HHHHHHHHHHS
T ss_pred ccCCCCHHHHHHHHHHcC---CCHHHHHHHHHHHhccccccCCcccccCHHHHHHHHHHhCCCCCch--HHHHHHHHHHH
Confidence 567899999998554443 466678888777721 2468999999987544222211111 23578899999
Q ss_pred cccCCC
Q 016471 330 EQEGNR 335 (389)
Q Consensus 330 D~d~~G 335 (389)
|+|++|
T Consensus 79 D~~~d~ 84 (118)
T d1tuza_ 79 ETGHCL 84 (118)
T ss_dssp CCCCCT
T ss_pred cccccc
Confidence 999873
|
| >d1sraa_ a.39.1.3 (A:) C-terminal (EC) domain of BM-40/SPARC/osteonectin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Osteonectin domain: C-terminal (EC) domain of BM-40/SPARC/osteonectin species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.38 E-value=5.2e-05 Score=58.27 Aligned_cols=56 Identities=16% Similarity=0.151 Sum_probs=46.5
Q ss_pred HHHHHHHHHccc-CCCcccHHHHHHHhC-Cc-hH--HHHHHHHHccCCCCceeHHHHHHHH
Q 016471 321 IAITAFDYFEQE-GNRVISVEELALELN-LA-PA--AYSLLNDCIRNSDGKLSFLGYKRFL 376 (389)
Q Consensus 321 ~l~~aF~~~D~d-~~G~I~~~el~~~l~-~~-~~--~~~~~~~~d~~~~g~i~~~ef~~~~ 376 (389)
-+..-|..+|.| +||+|+..||+.+.. +. ++ +...++.+|.|+||.||+.||..=+
T Consensus 78 ~v~W~F~~LD~n~~D~~L~~~EL~~l~~~L~~~e~C~~~F~~~CD~n~D~~Is~~EW~~Cf 138 (151)
T d1sraa_ 78 PVHWQFGQLDQHPIDGYLSHTELAPLRAPLIPMEHCTTRFFETCDLDNDKYIALDEWAGCF 138 (151)
T ss_dssp HHHHHHHHHCCTTCSSEECTTTTGGGGSTTSTTGGGHHHHHHHHCTTCSSSEEHHHHHHHT
T ss_pred cceeehhhcCCCCCCCccCHHHHHHHHHhhcCCchHHHHHHHHhcCCCCCcCCHHHHHHHc
Confidence 467789999999 599999999999764 22 23 8889999999999999999997643
|
| >d1ctda_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.12 E-value=0.00022 Score=37.81 Aligned_cols=28 Identities=11% Similarity=0.256 Sum_probs=23.8
Q ss_pred CHHHHHHHHhhcCCCCCcceeHHHHHHH
Q 016471 278 TDSRVFEILNVMEPLSDQKLAYEEFCAA 305 (389)
Q Consensus 278 ~~~~~~~~~~~~d~~~~g~i~~~eF~~~ 305 (389)
+++|+.+.|+.+|.|.||.||-+||...
T Consensus 2 sEeELae~FRifDkNaDGyiD~eEl~~i 29 (34)
T d1ctda_ 2 SEEELANAFRIFDKNADGYIDIEELGEI 29 (34)
T ss_dssp HHHHHHHHHHTTCCSSSSCBCHHHHHHH
T ss_pred CHHHHHHHHHHHccCCcccccHHHHHHH
Confidence 4577889999999999999999999763
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=96.81 E-value=0.00063 Score=57.87 Aligned_cols=81 Identities=19% Similarity=0.177 Sum_probs=53.1
Q ss_pred cccccee-ecCeEEEEEEccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC----------------------
Q 016471 4 QKLQHLF-YSNSFLFFTRFCEGGELLDRILSRGGRYLEEDAKTIVEKILNIVAFCHLQ---------------------- 60 (389)
Q Consensus 4 pni~~~~-~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---------------------- 60 (389)
|.++.+. ..+..|+||++.+|..+.+.... ......++.++...+..||+.
T Consensus 73 P~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~ 146 (263)
T d1j7la_ 73 PKVLHFERHDGWSNLLMSEADGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLL 146 (263)
T ss_dssp CCEEEEEEETTEEEEEEECCSSEEHHHHTTT------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHH
T ss_pred CcEEEEEecCCceEEEEEecccccccccccc------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHH
Confidence 5666555 45678999999999887654321 111223444555555555531
Q ss_pred -------------------------------------CCEecCCCCCcEEEeecCCCCCEEEeecCCccc
Q 016471 61 -------------------------------------GVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 93 (389)
Q Consensus 61 -------------------------------------~i~Hrdlkp~Nill~~~~~~~~~kl~Dfg~a~~ 93 (389)
.++|+|+.|.||++. +++.+-|+||+.+..
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~---~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 147 NNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK---DGKVSGFIDLGRSGR 213 (263)
T ss_dssp HTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEE---TTEEEEECCCTTCEE
T ss_pred HHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeec---CCceEEEeechhccc
Confidence 178999999999994 444556999987654
|
| >d1sraa_ a.39.1.3 (A:) C-terminal (EC) domain of BM-40/SPARC/osteonectin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Osteonectin domain: C-terminal (EC) domain of BM-40/SPARC/osteonectin species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.58 E-value=0.024 Score=43.00 Aligned_cols=106 Identities=12% Similarity=0.136 Sum_probs=68.3
Q ss_pred cCHHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCCC-CCcceeHHHHHHHHhchhHHHhh
Q 016471 238 LTEEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEPL-SDQKLAYEEFCAAATSVYQLEAL 315 (389)
Q Consensus 238 l~~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~-~~g~i~~~eF~~~~~~~~~~~~~ 315 (389)
+++.+.......+..... ..|.-+..-+......... .-..-+.=.|..+|.| +||.++-.|........ ...
T Consensus 36 l~~k~~~~~~k~~~~~~r~~~~~~~~~~~~~d~~~~~~--~~~~~v~W~F~~LD~n~~D~~L~~~EL~~l~~~L---~~~ 110 (151)
T d1sraa_ 36 LTEKQKLRVKKIHENEKRLEAGDHPVELLARDFEKNYN--MYIFPVHWQFGQLDQHPIDGYLSHTELAPLRAPL---IPM 110 (151)
T ss_dssp SCHHHHHHHHHHHHCTTCCCSSCCCHHHHHHHHHHTGG--GGHHHHHHHHHHHCCTTCSSEECTTTTGGGGSTT---STT
T ss_pred chhhhhccchhhccchhhcccCcchhHHHHHHhhhccc--cccccceeehhhcCCCCCCCccCHHHHHHHHHhh---cCC
Confidence 345555666666666555 5565555544444433321 1222366779999999 59999999876521101 111
Q ss_pred HHHHHHHHHHHHHHcccCCCcccHHHHHHHhCCchH
Q 016471 316 ERWDQIAITAFDYFEQEGNRVISVEELALELNLAPA 351 (389)
Q Consensus 316 ~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~~~ 351 (389)
+.=++..|+..|.|+||.||..|....||+..+
T Consensus 111 ---e~C~~~F~~~CD~n~D~~Is~~EW~~Cf~v~~~ 143 (151)
T d1sraa_ 111 ---EHCTTRFFETCDLDNDKYIALDEWAGCFGIKQK 143 (151)
T ss_dssp ---GGGHHHHHHHHCTTCSSSEEHHHHHHHTTCCGG
T ss_pred ---chHHHHHHHHhcCCCCCcCCHHHHHHHcCCChh
Confidence 223567889999999999999999999987654
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=95.40 E-value=0.0094 Score=49.88 Aligned_cols=29 Identities=24% Similarity=0.206 Sum_probs=23.4
Q ss_pred CEecCCCCCcEEEeecCCCCCEEEeecCCccc
Q 016471 62 VVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 93 (389)
Q Consensus 62 i~Hrdlkp~Nill~~~~~~~~~kl~Dfg~a~~ 93 (389)
++|+|+.|.||++. ++..+-|+||+.+..
T Consensus 177 liHgD~~~~Nvl~~---~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 177 VTHGDACLPNIMVE---NGRFSGFIDCGRLGV 205 (255)
T ss_dssp EECSSCCGGGEEEE---TTEEEEECCCTTCEE
T ss_pred EEeCCCCCcceEEe---CCceEEEEEchhccc
Confidence 79999999999995 344567999987654
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=95.35 E-value=0.0086 Score=54.02 Aligned_cols=29 Identities=24% Similarity=0.403 Sum_probs=24.0
Q ss_pred CCEecCCCCCcEEEeecCCCCCEEEeecCCccc
Q 016471 61 GVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 93 (389)
Q Consensus 61 ~i~Hrdlkp~Nill~~~~~~~~~kl~Dfg~a~~ 93 (389)
.++|+|++|.|||++ .+.++++||.+|..
T Consensus 224 ~LiHGDl~~gNIlv~----~~~~~vID~E~a~~ 252 (392)
T d2pula1 224 TLIHGDLHTGSIFAS----EHETKVIDPEFAFY 252 (392)
T ss_dssp EEECSCCCGGGEEEC----SSCEEECCCTTCEE
T ss_pred ceeccCCcCCceeEc----CCceEEechhhccc
Confidence 489999999999994 34589999987754
|
| >d1qasa1 a.39.1.7 (A:205-298) Phosphoinositide-specific phospholipase C, isozyme D1 (PLC-D!) {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Phosphoinositide-specific phospholipase C, isozyme D1 (PLC-D!) species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=94.88 E-value=0.028 Score=39.20 Aligned_cols=60 Identities=23% Similarity=0.253 Sum_probs=46.2
Q ss_pred HHHHHHHHHHcccCCCcccHHHHHHHh----CC---chH-HHHHHHHHccCC----CCceeHHHHHHHHcccc
Q 016471 320 QIAITAFDYFEQEGNRVISVEELALEL----NL---APA-AYSLLNDCIRNS----DGKLSFLGYKRFLHGVT 380 (389)
Q Consensus 320 ~~l~~aF~~~D~d~~G~I~~~el~~~l----~~---~~~-~~~~~~~~d~~~----~g~i~~~ef~~~~~~~~ 380 (389)
.++..+|..+-. +.+.||.++|.+.| +. +.+ +.+++..+.++. .|.+++++|..+|.+..
T Consensus 8 ~ei~~if~~ys~-~~~~mt~~~f~~FL~~eQ~~~~~~~~~~~~ii~~~e~~~~~~~~~~ls~~gF~~fL~S~~ 79 (94)
T d1qasa1 8 AEIDRAFEEAAG-SAETLSVERLVTFLQHQQREEEAGPALALSLIERYEPSETAKAQRQMTKDGFLMYLLSAD 79 (94)
T ss_dssp HHHHHHHHHHHT-TSSSCBHHHHHHHHHHTSCCTTCSHHHHHHHHHHHCCCHHHHHTTBCCHHHHHHHHHSST
T ss_pred HHHHHHHHHHhC-CCCccCHHHHHHHHHHHcCCccCCHHHHHHHHHHHcccHhhhhcCCcCHHHHHHHHcCcc
Confidence 358889999954 44689999999999 21 222 888999987653 47899999999996553
|
| >d1h8ba_ a.39.1.7 (A:) alpha-Actinin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: alpha-Actinin species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.26 E-value=0.12 Score=33.59 Aligned_cols=57 Identities=25% Similarity=0.339 Sum_probs=42.2
Q ss_pred HHHHHHHHHHcccCCCcccHHHHHHHhCCchH-HHHHHHHHcc----C-CCCceeHHHHHHHHccc
Q 016471 320 QIAITAFDYFEQEGNRVISVEELALELNLAPA-AYSLLNDCIR----N-SDGKLSFLGYKRFLHGV 379 (389)
Q Consensus 320 ~~l~~aF~~~D~d~~G~I~~~el~~~l~~~~~-~~~~~~~~d~----~-~~g~i~~~ef~~~~~~~ 379 (389)
+.+..+|+.+. ++..+||.+||++.| .++ ++-+++.+-. + ..|-.+|..|.+-+-.-
T Consensus 8 Eqv~~aFr~lA-~~KpyVT~~dL~~~L--~peqaeyc~~~M~~y~~~~~~~~ayDY~sF~~~l~ge 70 (73)
T d1h8ba_ 8 EQVIASFRILA-SDKPYILAEELRREL--PPDQAQYCIKRMPAYSGPGSVPGALDYAAFSSALYGE 70 (73)
T ss_dssp HHHHHHHHHHT-TSCSSBCHHHHHHHS--CHHHHHHHHHHSCSCCCSSCCTTCBCHHHHHHHHTCC
T ss_pred HHHHHHHHHHh-CCCCeeCHHHHHhhc--CHHHHHHHHHHCcccCCCCCCCCcccHHHHHHHHhcc
Confidence 45889999994 667899999999996 444 5556666532 1 36779999998876543
|
| >d1qasa1 a.39.1.7 (A:205-298) Phosphoinositide-specific phospholipase C, isozyme D1 (PLC-D!) {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Phosphoinositide-specific phospholipase C, isozyme D1 (PLC-D!) species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=92.18 E-value=0.13 Score=35.61 Aligned_cols=63 Identities=13% Similarity=0.173 Sum_probs=46.2
Q ss_pred HHHhhhcCCCCCcccHHHHHHHHHHhc-cccCCHHHHHHHHhhcCCCC----CcceeHHHHHHHHhch
Q 016471 247 RAQFMLLEPKDGCVSLNNFKVALMRQA-TDAMTDSRVFEILNVMEPLS----DQKLAYEEFCAAATSV 309 (389)
Q Consensus 247 ~~~F~~~D~~~G~i~~~el~~~l~~~~-~~~~~~~~~~~~~~~~d~~~----~g~i~~~eF~~~~~~~ 309 (389)
..+|..+..+.+.++.++|..+|..-. ....+.+.+.+++..+.++. .+.+++++|+..+...
T Consensus 11 ~~if~~ys~~~~~mt~~~f~~FL~~eQ~~~~~~~~~~~~ii~~~e~~~~~~~~~~ls~~gF~~fL~S~ 78 (94)
T d1qasa1 11 DRAFEEAAGSAETLSVERLVTFLQHQQREEEAGPALALSLIERYEPSETAKAQRQMTKDGFLMYLLSA 78 (94)
T ss_dssp HHHHHHHHTTSSSCBHHHHHHHHHHTSCCTTCSHHHHHHHHHHHCCCHHHHHTTBCCHHHHHHHHHSS
T ss_pred HHHHHHHhCCCCccCHHHHHHHHHHHcCCccCCHHHHHHHHHHHcccHhhhhcCCcCHHHHHHHHcCc
Confidence 444555544557899999999998765 33467788899999987653 3679999998876654
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=91.56 E-value=0.021 Score=49.51 Aligned_cols=31 Identities=35% Similarity=0.501 Sum_probs=25.3
Q ss_pred CCCEecCCCCCcEEEeecCCCCCEEEeecCCccc
Q 016471 60 QGVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 93 (389)
Q Consensus 60 ~~i~Hrdlkp~Nill~~~~~~~~~kl~Dfg~a~~ 93 (389)
.|+||+|+.++|+++. ++...-++||+.+..
T Consensus 183 ~giIHgDl~~dNvl~~---~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFL---GDELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEE---TTEEEEECCCTTCEE
T ss_pred cccccCCcchhhhhcc---cccceeEeccccccc
Confidence 3799999999999994 455568999997753
|
| >d2cclb1 a.139.1.1 (B:1-59) Endo-1,4-beta-xylanase Y {Clostridium thermocellum [TaxId: 1515]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: Type I dockerin domain superfamily: Type I dockerin domain family: Type I dockerin domain domain: Endo-1,4-beta-xylanase Y species: Clostridium thermocellum [TaxId: 1515]
Probab=90.13 E-value=0.2 Score=31.23 Aligned_cols=19 Identities=16% Similarity=0.163 Sum_probs=9.4
Q ss_pred HHHHcccCCCcccHHHHHH
Q 016471 326 FDYFEQEGNRVISVEELAL 344 (389)
Q Consensus 326 F~~~D~d~~G~I~~~el~~ 344 (389)
|..-|.|+||.|+.-|+..
T Consensus 32 ~~aaDvn~Dg~i~i~D~~~ 50 (59)
T d2cclb1 32 KARADVDKNGSINAADVLL 50 (59)
T ss_dssp HHHHCTTCSSCCSHHHHHH
T ss_pred hhccccCCCCCCCHHHHHH
Confidence 3444555555555554443
|
| >d1eg3a2 a.39.1.7 (A:210-306) Dystrophin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Dystrophin species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.06 E-value=0.8 Score=31.35 Aligned_cols=59 Identities=10% Similarity=0.049 Sum_probs=43.9
Q ss_pred HHHHHHHHHHHcccCCCcccHHHHHHHh----------CCch---------HHHHHHHHHccCCCCceeHHHHHHHHccc
Q 016471 319 DQIAITAFDYFEQEGNRVISVEELALEL----------NLAP---------AAYSLLNDCIRNSDGKLSFLGYKRFLHGV 379 (389)
Q Consensus 319 ~~~l~~aF~~~D~d~~G~I~~~el~~~l----------~~~~---------~~~~~~~~~d~~~~g~i~~~ef~~~~~~~ 379 (389)
+++++..|+.+ .|.+|.++..-|...| |-.+ ++...|... .+...|+-++|+..|...
T Consensus 3 ~dKyRYlF~qi-sd~~g~~~~~kl~~lL~d~lqlP~~vgE~~sFG~s~ie~sv~sCF~~~--~~~~~i~~~~FL~wl~~e 79 (97)
T d1eg3a2 3 EDKYRYLFKQV-ASSTGFCDQRRLGLLLHDSIQIPRQLGEVASFGGSNIEPSVRSCFQFA--NNKPEIEAALFLDWMRLE 79 (97)
T ss_dssp HHHHHHHHHHH-SCTTSCBCHHHHHHHHHHHHHHHHHTTCGGGGTCSCCHHHHHHHHHHT--TTCSCBCHHHHHHHHHTC
T ss_pred HHHHHHHHHHH-hCCCCCCcHHHHHHHHHHHHHHHHHhCcccccCCCcchHHHHHHHhcc--CCCCcccHHHHHHHHHhC
Confidence 46799999999 7889999999988877 2111 155555443 345579999999999876
Q ss_pred c
Q 016471 380 T 380 (389)
Q Consensus 380 ~ 380 (389)
+
T Consensus 80 P 80 (97)
T d1eg3a2 80 P 80 (97)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=87.48 E-value=0.16 Score=43.90 Aligned_cols=28 Identities=18% Similarity=0.229 Sum_probs=22.4
Q ss_pred CCEecCCCCCcEEEeecCCCCCEEEeecCCccc
Q 016471 61 GVVHRDLKPENFLFTTREEDAPLKVIDFGLSDF 93 (389)
Q Consensus 61 ~i~Hrdlkp~Nill~~~~~~~~~kl~Dfg~a~~ 93 (389)
+++|+|+.|.|||+. + + ..++||+-+..
T Consensus 193 ~liHgDlh~~NvL~~---~-~-~~~IDFdd~~~ 220 (325)
T d1zyla1 193 LRLHGDCHAGNILWR---D-G-PMFVDLDDARN 220 (325)
T ss_dssp EECCSSCSGGGEEES---S-S-EEECCCTTCCE
T ss_pred eeecCCCCcccEEEe---C-C-ceEEechhccc
Confidence 689999999999993 2 3 45899997764
|
| >d1h8ba_ a.39.1.7 (A:) alpha-Actinin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: alpha-Actinin species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.70 E-value=1.7 Score=27.88 Aligned_cols=56 Identities=14% Similarity=0.176 Sum_probs=42.2
Q ss_pred HHHHHHhhhcCCCCCcccHHHHHHHHHHhccccCCHHHHHHHHhhcCC----C-CCcceeHHHHHHHHh
Q 016471 244 VYLRAQFMLLEPKDGCVSLNNFKVALMRQATDAMTDSRVFEILNVMEP----L-SDQKLAYEEFCAAAT 307 (389)
Q Consensus 244 ~~l~~~F~~~D~~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~----~-~~g~i~~~eF~~~~~ 307 (389)
..+...|+.+-.+..+|+.+||++. ++.++++-++..|-+ + ..|..||..|...+.
T Consensus 8 Eqv~~aFr~lA~~KpyVT~~dL~~~--------L~peqaeyc~~~M~~y~~~~~~~~ayDY~sF~~~l~ 68 (73)
T d1h8ba_ 8 EQVIASFRILASDKPYILAEELRRE--------LPPDQAQYCIKRMPAYSGPGSVPGALDYAAFSSALY 68 (73)
T ss_dssp HHHHHHHHHHTTSCSSBCHHHHHHH--------SCHHHHHHHHHHSCSCCCSSCCTTCBCHHHHHHHHT
T ss_pred HHHHHHHHHHhCCCCeeCHHHHHhh--------cCHHHHHHHHHHCcccCCCCCCCCcccHHHHHHHHh
Confidence 4566788888558889999999874 456678888887743 2 357899999998654
|
| >d1dava_ a.139.1.1 (A:) Cellulosome endoglucanase SS {Clostridium thermocellum [TaxId: 1515]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: Type I dockerin domain superfamily: Type I dockerin domain family: Type I dockerin domain domain: Cellulosome endoglucanase SS species: Clostridium thermocellum [TaxId: 1515]
Probab=85.48 E-value=0.11 Score=33.98 Aligned_cols=20 Identities=15% Similarity=0.072 Sum_probs=11.0
Q ss_pred HccCCCCceeHHHHHHHHcc
Q 016471 359 CIRNSDGKLSFLGYKRFLHG 378 (389)
Q Consensus 359 ~d~~~~g~i~~~ef~~~~~~ 378 (389)
+|.|+||+|+..++..+.+.
T Consensus 39 aDvn~DG~Id~~D~~~l~~~ 58 (71)
T d1dava_ 39 ADLNEDGRVNSTDLGILKRY 58 (71)
T ss_dssp TCSSSSSSCSSHHHHHHHHH
T ss_pred eecCCCCCcCHHHHHHHHHH
Confidence 45555666665555555443
|
| >d1pula1 a.39.1.11 (A:18-120) Hypothetical protein c32e8.3 {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: p25-alpha domain: Hypothetical protein c32e8.3 species: Caenorhabditis elegans [TaxId: 6239]
Probab=84.18 E-value=4.8 Score=27.68 Aligned_cols=69 Identities=13% Similarity=0.086 Sum_probs=51.5
Q ss_pred HHHHHHHHHHhhhcCC-CCCcccHHHHHHHHHHhc---cccCCHHHHHHHHhhcCCCCCcceeHHHHHHHHhch
Q 016471 240 EEELVYLRAQFMLLEP-KDGCVSLNNFKVALMRQA---TDAMTDSRVFEILNVMEPLSDQKLAYEEFCAAATSV 309 (389)
Q Consensus 240 ~ee~~~l~~~F~~~D~-~~G~i~~~el~~~l~~~~---~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~ 309 (389)
..++......|..+-. .+-.++...|...++..+ ...++..+++-+|...-..+ ..|+|++|+.++-..
T Consensus 4 ~~~l~~~F~aF~~FG~~~~~em~~~~f~Kl~kdc~lid~K~~T~tdvDIiF~K~k~k~-~ri~f~~F~~aL~~l 76 (103)
T d1pula1 4 DADVKKRWDAFTKFGAATATEMTGKNFDKWLKDAGVLDNKAITGTMTGIAFSKVTGPK-KKATFDETKKVLAFV 76 (103)
T ss_dssp HHHHHHHHHHHHHHTCSSSSCCCHHHHHHHHHHHTSCCSSSSCHHHHHHHHHHHTCSS-SCCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhcCCCCcCCCHHHHHHHHHHcCCCcCCCCCccchhhhhHhhcCCC-CCcCHHHHHHHHHHH
Confidence 4566677777777765 434699999999888764 23588899999999986554 469999998865543
|
| >d2cclb1 a.139.1.1 (B:1-59) Endo-1,4-beta-xylanase Y {Clostridium thermocellum [TaxId: 1515]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: Type I dockerin domain superfamily: Type I dockerin domain family: Type I dockerin domain domain: Endo-1,4-beta-xylanase Y species: Clostridium thermocellum [TaxId: 1515]
Probab=81.79 E-value=0.78 Score=28.33 Aligned_cols=48 Identities=8% Similarity=0.084 Sum_probs=34.8
Q ss_pred cccCCCcccHHHHHHHh----CCchHHHHHHHHHccCCCCceeHHHHHHHHc
Q 016471 330 EQEGNRVISVEELALEL----NLAPAAYSLLNDCIRNSDGKLSFLGYKRFLH 377 (389)
Q Consensus 330 D~d~~G~I~~~el~~~l----~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~ 377 (389)
|.|+||.|+.-++..+. +....-..-+..+|.|+||.|+-.+...+++
T Consensus 2 DvN~Dg~vni~D~~~l~~~il~~~~~~~~~~~aaDvn~Dg~i~i~D~~~l~~ 53 (59)
T d2cclb1 2 DVNGDGTINSTDLTMLKRSVLRAITLTDDAKARADVDKNGSINAADVLLLSR 53 (59)
T ss_dssp CTTCSSSCCHHHHHHHHHHHTTSSCCCHHHHHHHCTTCSSCCSHHHHHHHHH
T ss_pred CCCCCCCCcHHHHHHHHHHHhCCCCCChhhhhccccCCCCCCCHHHHHHHHH
Confidence 67889999988888765 3221112336778999999999988887765
|